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The work which is described in these papers is presented in chronological order, in each of five 
connected areas. The overall theme is the discovery of new drug molecules and an understanding 
of how they work.
In section (1), the primary focus is on the development of new methods for the synthesis of 
isoquinolines, developing towards the synthesis of natural product analogues which have 
anticancer activity. This led directly to much of the work in section (3).
In section (2), the chemical synthesis of isoquinolines is developed in the specialist area of 
neuromuscular blocking agents. These culminate in the synthesis of atracurium, which is widely 
used as a surgical muscle relaxant.
In section (3) a variety of ideas are explored in the general context of drug discovery, many 
associated with isoquinolines. This section includes antimalarials and antileukaemics (for 
example benzo[c]phenanthridines) with biological activity mediated via DNA, as well as the 
development of new assay methods for DNA binding. The most recent work is focused on the 
discovery of new DNA-binding compounds, analogues of natural products, with potential 
anticancer and antiparasitic activity
Section (4) is concerned with the isolation and structure elucidation of a variety of natural 
products. This section cross-relates to sections (1), (2) and (3) in the isolation and identification 
of the benzo[c]phenanthridine alkaloid nitidine, which is a potent antimalarial.
The fmal section is concerned with the mechanisms of action and solution behaviour of drug 
molecules. A major theme in this group is the use of NMR, which reflects the methodology used 
in most of the other work.
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A N ew  S yn th esis  of 4 - O x o -1,2,3.4- tetrahy droisoqu inolin es
B y  D .  N . H a r c o u r t *  and R . D . W a i g h  
(School o f  Pharm acy, B ath  U niversity o f  Technology, A sh ley  Down, Bristol, 7)
D u r i n g  som e synthetic work on 3-arylisoquino- 
lines, w e prepared certain 4-oxo-l,2 ,3 ,4-tetra- 
hydroisoquinolines. N one of the reported routes1 >a 
possessed the flexib ility  th a t w e sought, w ith  the  
exception of th e unsuccessful attem pt8 to cyclise  
a-am ino-nitriles of the ty p e  (I), which are formed in 
good yield  b y  a  modified Strecker synthesis*  and 
potentia lly  afford ready variation in substitution at 
th e C-3 position of th e isoquinoline. In view  of 
the recorded2 instab ility  of simple 4-oxo-isoquino- 
lines, w e considered th is route warranted investiga­
tion, and found the mild conditions for the 
cyclisation of a  number of nitriles ( I ; R l =  OMe). 
The nitrile (2 g.) was dissolved in  concentrated  
sulphuric acid (10 ml.) and heated a t  50° for 4 hr., 
or left overnight a t  room temperature. D ilution  
followed b y  basification w ith  6 n  sodium hydroxide  
gave th e  product (II) in good yield and a high state  
of purity.
<l-Oxo-l,2,Z,i-tetrahydroisoqumolines (I I ; R l =  OMe)
Structural assignm ent of the isoquinolines is 
based upon elem ental analysis and diagnostic i.r. 
and n.m.r. spectra.
Some difficulty was encountered in th e isolation 
of the free base ( I I ; R 1 =  OMe, R2 =  Ph, R8 =  H) 
and best yields were obtained by isolation as the 
hydrochloride. W e are further preparing the 
3-raono- and 3-un-substituted 4-oxo-1,2.3,4-tetra- 
hydroisoquinolines in view  of the low yields 
recently reported® for the cyclisation o f .V-benzyl- 





R 8 R 8 % yield m .p .f  (°C)
P h H 53 138
P h Me 83 160
Me Me 60 135
C H 2 [C H ,]3•CHj 80 147
A ttem pted cyclisation of am ino-nitriles (I; 
R1 =  H) has so far resulted in failure; w ith the 
conditions described here, conversion to  the corre­
sponding am ide occurs.
W e thank th e Pharm aceutical Society  of Great 
Britain for a research scholarship (to R .D .W .).
f  D e te rm ined  fo r a n a ly tica l sam ple on  a  K ofler h o t-  (Received, A p r il 29th, 19 6 8 ; Com. 516.)
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1 N eth . P a t. 6,504,208/1965; T. K am e tan i an d  K . F ukum oto , / .  Chem. Soc., 1963, 4289; N . I to h  a n d  S. Sugasaw a, 
Tetrahedron, 1959, 6, 16.
2 I. G. H in to n  an d  F . G. M ann, J . Chem. Soc., 1969, 599.
8 B . B . D ey an d  T . R . G ovindachari, Arch. Pharm., 1937, 275, 383.
4 R. B. W agner and  H . D . Zook, “ S y n th e tic  O rganic C hem istry ,” W iley, N ew  Y ork , 1953, p. 606 and  references cited. 
6 G. G rethe, H . L. Lee, M. U skokovic, an d  A. Brossi, J . Org. Chem., 1968, 33, 491.
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Synthesis of Ssoquinoiines from BenzylaminoacetonitrsSes. Part I. Com­
pounds prepared from Veratryiamane 1
By D. IM. H a rc o u r t  and R. D. W aigh ,"t School of Pharmacy, Bath University of Technology, Claverton Down, 
Bath BA2 7AY, Somerset
3,4-Dimethoxybenzylaminoacetonitriles cyclise in concentrated sulphuric acid to give, after hydrolysis, 1.2-di- 
hydroisoquinolin-4(3W)-ones. in excellent yield. 3.3-Disubstituted 1,2-dihydroisoquinolin-4(3W)-ones are 
stable as the free base, in contrast to the 3 unsubstituted and 3-monosubstituted analogues. 1,2-Dihydro-
6.7-dim ethoxy-3-phenylisoquinolin-4(3«)-one as the free base underwent aerial oxidation to give 6.7-dimethoxy-
3-phcnylisoquino!in-4-ol, and could also be converted by a series of reactions into 6.7-dimethoxy-3-phenyliso- 
quinoline in good yield.
A m u c h -q u o t e d  review of tw enty years ago 2 placed 
emphasis on the difficulty of synthesis of isoquinolines 
b y routes analogous to  the Pom eranz-Fritsch reaction. 
Many failures were reported,3 and an attem pt was made 
to  rationalise the situation in general terms.4
Since then, the work of several groups 5-8 has altered 
the picture fundam entally. I t  is now apparent th at the 
benzylam ine route has no inherent theoretical barriers, 
but that the primary product is  often difficult to  isolate. 
The 1,2-dihydro-, 4-hydroxytetrahydro-, and 4-oxotetra- 
hydro-isoquinolines, usual products of this kind of 
reaction, are all now known 7>9-10 to be relatively un­
stable. Thus the reduction o f a reactive isoquinoline 
intermediate, without isolation, dramatically increased  
the yield  of the corresponding tetrahydroisoquinoline.®
In view  of the natural advantages of this approach 
to  isoquinolines, particularly regarding the availability of 
starting materials, we were attracted to a reappraisal of 
one of th e past unsuccessful routes. I t  was reported3 
that internal Hoesch reaction of the benzylaminonitrile 
(la) with zinc chloride and dry hydrogen chloride in dry 
ether failed to  give the required isoquinolinone (2a); 
other failures with similar system s under similar condi­
tions were reported b y  other workers.11 However, 
since a-aminonitriles are readily available,18 this route 
potentially possesses great flexib ility  with respect to the 
3-position of the isoquinoline (Scheme 1).
W ith a view  to later extension to alkaloid syntheses, 
and in connection with other synthetic work,13 w e first 
studied the aminonitrile (lb ), which would give a 3- 
phenylisoquinoline. U nfortunately, this compound and 
the corresponding tertiary base (lc ) gave only the amide, 
formed by normal hydrolysis.
W ith the ‘ activated ’ analogue (Id) we were a t first 
unsuccessful w ith a variety of acid treatments. We
t  Present address: D epartm ent of Pharm aceutical Chemistry, 
U niversity of Strathclyde, Glasgow C .l.
1 Prelim inary communication, D. N. H arcourt and R. D. 
Waigh, Chem. Comm., 1968, 692.
2 W. J. Gensler, Org. Reactions, 1951, 6, 191.
3 For example B. B. Dey and T. R. Govindachari, Arch. 
Pharm., 1937, 275, 383.
4 J . Malan and R. Robinson, J . Chem. Soc., 1927, 2653.
6 R. Quelet and N. Vinot, Compt. rend., 1957, 244, 909; 
N. Vinot, A nn. Chim. (France), 1958, 3, 461; N. Vinot and 
R. Quelet, Bull. Soc. chim. France, 1959, 1164.
0 J . M. Bobbitt, K. L. K hanna, and  J . M. ICiely, Chem. and 
Ind., 1964, 1950; J . M. Bobbitt, J . M. Kiely, K. L. K hanna, and 
R. Ebermann, ./. Org. Client., 1965, 30, 2247.
eventually succeeded in effecting cyclisation to compound 
(2d) by use of concentrated sulphuric acid, at first over­



































[C H Jt 
Ph Me 
DMP H
DMP =  3,4-(MeO),C0H a
at 50 °C for 3-5— 4 h. I.r., n.m.r., and analytical data  
for the product were unambiguous.
While the salts of the isoquinolinone produced were 
apparently stable indefinitely, in agreem ent with a 
previous report,10 the free base underwent aerial oxid­
ation on exposure to the air for several days, giving the 
aromatic isoquinolin-4-ol (4), possibly v ia  the enolic 
form (3) (Scheme 2).
_  OH 
M e O ^ ^ r r - '^ P h
M e o k / k ^ - N H
(3) (4)
To test both the enolisation hypothesis and the 
flexibility of our route, we attem pted cyclisation of the
7 J. M. B obbitt and J . C. Sih, J . Org. Chem., 1988, 33, 856.
» U.S.P. 357,318/1964; D utch 'P . 6,504,208/1965; G. Grethe, 
H. L. Lee, M. Uskokovic, and A. Brossi, J. Org. Chem., 1968, 
33, 491.
“ H. Schmid and P . Karrer, Helv. Chim. Acta, 1949, 32, 960.
10 1. G. H inton and F. G. Mann, J. Chem. Soc., 1959, 599.
"  S. H. Oakeshott and S. G. P. P lant, / .  Chem. Soc., 1927, 484; 
R. D. Haworth, W. H. Perkin, and J. Rankin, ibid., 1925, 1444.
44 For a review, see P. van Daele, Mededel. vlaant. chem. F n  ., 
1961, 23, 163.
13 J. R. Brooks and D. N. H arcourt, J . Chem. Soc. (C), 1969, 
625; D. N. H arcourt and R. D. Waigh, in preparation.
908 J. Chem. Soc. (C), 1971
aminonitrile (le). The expected product is incapable 
of enolisation, and was in fact found to be stable under all 
the conditions employed, being obtained crystalline from 
hot, strong sodium hydroxide solution.
In the case of the cyclohexanone derivative (If ) th e  
initial product of the reaction, obtained b y  dilution of the  
concentrated sulphuric acid solution b y  direct addition  
to  cold 5N-sodium hydroxide solution, was n ot the pure 
isoquinolinone (2f). T he major com ponent of the  
m ixture gave an elem ental analysis closer to  that calcu­
lated for th e imine (5); however it was not obtained
analytically pure. The i.r. and n.m.r. data of the mixture 
were ambiguous, but accurate mass measurement of 
the parent ion in the mass spectrum (?«/e 274) indicated  
the molecular formula to  be C16H 22N 20 2, consistent w ith  
the im ine structure. Treatm ent of the im ine w ith  
aqueous acid generated th e expected ketone quickly and 
quantitatively. Similar experiences w ith  imines from  
nitrile cyclisations have been recorded.14 Another 3,3- 
disubstituted isoquinolinone (2g) was obtained in excel­
lent yield, w ithout difficulty.
W ith th e 3-unsubstituted isoquinoiine (2a), using 
direct basification of th e sulphuric acid cyclisation  
medium w ithout a preliminary dilution stage, we at first 
could obtain no product whatever. Presumably the 
interm ediate imine is subject to attack b y  hydroxide, 
giving highly acid-, base-, and water-soluble product(s). 
H owever, when the concentrated acid was added care­
fully to  ice-water, and set aside before basifying, the 
isoquinolinone could be isolated as the hydrochloride, 
after extraction with chloroform. The 30— 50% yield  
represents a substantial im provem ent over th at obtained  
by Grethe and his co-workers,8 from cyclisation of the  
analogous glycine ester.
In order to investigate further the applicability of the 
route to  alkaloid synthesis, we studied the cyclisation of 
the am inonitrile (lh). The expected product is potenti­
ally an intermediate for both  benzo[c]phenanthridine and  
protoberberine types of ring system . A lthough the  
cyclisation succeeded, th e  low solubility of th e product 
and by-product hydrochlorides in m ost solvents reduced 
the yield  of pure material to  24% . N o doubt this could 
be increased by improvements in the work-up technique.
The recent publication 15 of a sim ple synthesis of nor- 
coralydine from 3-(3,4-dim ethoxyphenyl)-6,7-dim eth- 
oxyisoquinoline has anticipated our own scheme. In  
order to  realise the synthesis from our interm ediate, it  
would be necesary to convert the dihydroisoquinolin-
4-one (2h) into the corresponding arom atic isoquinoline
u  C. K. B radsher and D. J . Beavers, I. Ore. Chem.. 1956, 21, 
1067.
16 N. L. D utta , M. S. W adia, and A. A. B indra, Indian J . 
Chem., 1969, 7, 527.
(6b). As a model, we had chosen to  convert th e iso­
quinolinone (2d) (Scheme 3) into the aromatic isoquino-
OH
(2d) _____ ^  M eOf*r ' Y A Y R
(2h) M e O k ^ A ^ N H
\  CH
M e O f ^ R  MeOr**;:>Y ' ' y R
M e o A A ^ - N  M e o A A ^ N
(6 )  
a; R = Ph
b ;R  =  3 ,4--[M eO )2C6H3-
SCHEME 3
line (6a). Each of the stages is w ell established in  
principle,18,17 and in fact the conversion was achieved  
in 44%  overall yield.
W e hope shortly to publish the results of cyclisations 
of other aminonitriles, including several with IV-alkyl 
substituents, which have given different results.
E X P E R IM E N T A L
M .p.s of bases w ere ta k e n  w ith  a  K ofler h o t-s ta g e  a p p a r­
a tu s , a n d  a re  co rrec ted . M .p.s of sa lts  (n o t co rrec ted) w ere 
ta k e n  fo r sam ples in  cap illa ry  tu b e s  w ith  a  G allenkam p  
ap p a ra tu s ;  th e  tu b e  w as in se rted  15-—20° below  th e  m .p . 
an d  h ea ted  a t  5— 7° p e r  m in . I.r . sp e c tra  w ere o b ta in ed  
w ith  a  U n icam  SP 200 in s tru m e n t fo r p o ta ss iu m  brom ide 
discs o r liqu id  films. N .m .r. sp e c tra  w ere reco rded  w ith  a 
V arian  AGO in s tru m e n t ( te tram e th y ls ilan e  as in te rn a l 
reference). O rganic so lu tions w ere d ried  o v er anh y d ro u s  
m agnesium  su lp h a te . H ydroch lo rides w ere p rep ared  b y  
ad d itio n  o f h yd rogen  chloride in  e th e r  to  a n  o rgan ic so lu tion  
of th e  base.
Preparation o f A m inon itriles  .— G eneral method. A  so lu ­
tio n  of 3 ,4 -d im ethoxybenzy lam ine  (0-1 m ol) in  w a te r (200 
ml) w as m ad e  ju s t  ac id  w ith  d ilu te  hyd ro ch lo ric  ac id . T he 
a ldehyde o r  k e to n e  (0*1 m ol), d isso lved  in  e th an o l (100 ml) 
if necessary , w as ad d e d  w ith  stirr in g . P o ta ss iu m  cyan ide 
(10 g) in  w a te r  (50 ml) w as added  d u rin g  10 m in  w ith  
v igorous s tir r in g ; th e  so lu tion  w as th e n  s tirre d  fo r 1 h 
an d  s e t as ide  overn igh t. T h e  p ro d u c t w as filte red  off o r 
e x tra c te d  w ith  e th e r  o r  ch lo roform  a s  a p p ro p ria te , th e  
so lid  o r so lu tion  being  w ashed  th o ro u g h ly  w ith  w ate r. 
C rysta llisa tion , if necessary , o r  ev a p o ra tio n  followed by  
c ry sta llisa tion , gave th e  am inonitrile  (see T ab les  1 a n d  2). 
W here  th e  m .p . an d  i.r. sp ec tru m  in d ica ted  a  sa tisfac to ry  
degree o f p u r ity , th e  c ru d e  am in o n itr ile  w as used  for 
cyclisation .
1,2-D ihydro-d ,l-d im ethoxyisoquinolin-i{[iH )-ones .—  
General method. T he  am in o n itr ile  (2 g) w as d isso lved  w ith  
ca re  in  co n c en tra ted  su lphu ric  ac id  (10 m l), so as to  avoid  
excessive h e a tin g  a n d  conseq u en t ch a rrin g . T h e  so lu tion
18 G. G rethe, H. L. Lee, M. Uskokovic, and A. Brossi, J . Org. 
Chem.. 1968, 33, 494.
17 W. G. D. Lugton, personal com m unication; M. Sainsbury 
D. W. Brown, S. F. Dyke, and G. H ardy, Tetrahedron, 1969, 25, 
1881.
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was heated at 50° for 4 h; slight variations in time had 
little effect. No systematic effort was made to discover the 
best reaction conditions. Cyclisation overnight at room 
temperature gave slightly lower yields. The chilled solution 
was added cautiously to ice-water; more ice was added as 
necessary to maintain the temperature below 5°. The final
T a b l e  1
Spectroscopic data for benzylaminoacetonitriles (1)




a  3350 2230
b 3350 2230 7 (10H, m). 4-3 (1H), 3-6 (2H), l-8br (1H) *f
rl 3340 2220 7 16 (5H, m). 6-7 (3H, m), 4-5 (1H), 3-7 (2H),
3-65 (OH). l-9br (1H) t  
e 3330 2230 6-9 (3H. m), 3-85 (8H, d). 1-5 (7H) t
f 3325 2226 6-9 (3H, m), 3-86 (8H, d). l-65br (U H ) t
g 3300 2230 7-5 (5H, in), 6-85 (3H, m), 3-76 (8H). 2-7br,
(1H) f 1-75 (3H)
h  3350 2220
* In CC1„. f  1H exchangeable.
T a b l e  2 
Benzylaminoacetonitriles (1)
Yield M.p. F ound (%) Required (%)
(%) 7/°C C H N C H N
a 66 181— 185 *« 54-2 6-3 111 54-4 6-2 11-6
(decomp.)
d 93 86 » 72-3 6-4 9-8 72-3 6-4 9-9
e 100 53 • 06-5 7-8 11-95 66-1 7-9 12-2
f 80 88 c 70-4 7-7 10-3 70-0 8-1 10-2
g 53 72—74 « 73-1 6-7 9-4 72-9 6-8 9-45
h 98 60— 61« 07-1 6-6 7-8 66-65 6-5 8-2
* Hydrochloride (lit.,3 188"). The free base had m.p.
ao—oz pic.,- atccr crystallisation irom etner-petroieum
(b.p. 40—00°) and m.p. 98— 100“ after crystallisation from 
benzene-petroleum (b.p. 60—80“).
° From  ethanol. 1 From ether-pctro leum  (b.p. 80— 100°). 
• From  petroleum  (b.p. 80— 100°).
volum e w as a b o u t 200 ml. T h is  so lu tion  w as s e t  aside fo r 
30 m in, an d  then  basified ca re fu lly  w ith  5N -sodium  h y d ro x ­
id e  o r co n c en tra ted  am m on ium  hyd rox ide , th e  ad d itio n  
o f ice being  co n tin u ed  as before. T he isoquinolinone  w as
T a b l e  3
S pectroscop ic d a ta  for l,2 -d ih y d ro -6 ,7 -d im eth o x y - 
isoqu ino lin -4 (3 //)-ones (2)
iW i./cm 1 i h  N .m.r. (8 values in p.p.rn.; solvent
(NH) (C=0) CDCI,)
a  3350 1660 7-5 (1H). 6-65 (1H). 4-05 (2H), 3-9 (6H.d),
3-5 (2H), 3-0br (1H) * 
d  3350 1665 7-3 (IH), 7-1 (5H), 6-4 (1H), 4-4 (1H), 3-95
(2H), 3-8 (6H). 2-lb r (IH) * 
e 3340 1655 7-5 (IH ). 6-6 (IH ). 4-1 (2H). 3-9 (6H), 2-3
(6H), 2-3br (IH),'" 1-3 (6H) 
f  3300 1650 7-5 (IH ), 6-65 (IH ). 4 0 (2H), 3-9 (8H), 1-65
(10H, m) f
g 3300 1650 7-7 (IH). 7-4 (5H. m). 3-95 (6H), 3-85 (3H),
2-7br (1H),* 1-6 (3H)
h  2750 t  1680 {
* IH  exchangeable, f In teg ral trace indicated IH  between 
2-2 and 3-2 p.p.rn. before shaking w ith deuterium  oxide, but 
no t afterwards. J Hydrochloride.
f ilte red  off o r ex tra c te d  w ith  chloroform , an d  w ashed  w ith  
w a te r, before evapo ra ting , if necessary , an d  d ry in g . A t 
th is  s tag e  th e  isoquinolinones (2a) an d  2(h) w ere co n v e rted
T a b l e  4
i,2 -D ihyd io -6 ,7 -d im ethoxy isoqu ino lin -4 (3H )-ones  (2) 
Yield M.p. Found (%) Required (%)
(%) r / “C C H  N C H  N
a  30—50 235—236° * “
d 60 138— 139 ‘ 71-8 6-2 4-8 7 2 0  6-05 4-9
e 53 135" 66-4 7-3 6-1 66-4 7-3 5-95
f  80 147 ■< 70-0 7-8 5-3 69-8 7-7 5-1
g 83 ISO* 72-8 6-3 4-7 72-8 6-46 4-7
h  24 265— 256 f  59-7 5-8 3-3 60-0 5-8 3-7
* Hydrochloride (lit.,0 236—237°). t  Hydrochloride.
“ From methanol. 6 From ether. c From benzene-petrol­
eum  (b.p. 80— 100°). d From  petroleum  (b.p. 80— 100°). 
* F rom  w ater.
in to  th e  hyd roch lo rides , s ince th e  free bases a re  u n s tab le . 
T h e  need  fo r su ch  a  p rocedu re  w as in d ica ted  w ith  th e  
isoqu ino line (2d), b u t  i t  w as m ore co n v en ien t to  avo id  
basification  of th e  d ilu ted  ac id  so lu tion , since on  pro longed  
re frig e ra tio n  th e  so lu tio n  deposited  m icrocry sta lline  1,2- 
dihydro-6J-dim ethoxy-3-phenyliscquinolin-4:(3H )-one  (2d) 
hydrogen sulphate, w h ich  w as s tab le  a n d  could  be  rec ry s ta ll­
ised  from  m e th a n o l-e th e r  to  g ive g rey-green  rods, m .p . 
132— 135° (decom p.), vinllt 1680 cm -1 (F o u n d : C, 54-0; 
H , 5-2; N, 3-55. C17H „ N O TS req u ires  C, 53-5; H , 5-0; 
N , 3-7% ); yield 67% , a f te r  f iltra tio n  from  th e  m o th e r  
liquo r, w ash ing  w ith  w ate r, an d  d ry ing .
\  ,2,'i,4i-Tetrahydro-4:-iniino-§,l -dim ethoxyisoquinoline-'S- 
spirocyclohexane (5).— T h e  p rocedu re  a d o p te d  w as as  fo r th e  
p re p a ra tio n  o f th e  isoquinolin-4-ones, ex c ep t th a t  th e  con ­
c e n tra te d  su lp h u ric  ac id  so lu tion  a f te r  cyc lisa tion  w as 
added , w ith  cau tio n , d irec tly  to  ice -co ld  10%  sod ium  
h yd rox ide . T h e  w h ite  p rec ip ita te  w as filte red  off, w ashed, 
an d  d ried  th o ro u g h ly  (1*1 g ; m .p. 123°). [This solid  could 
b e  co n v e rted  q u a n tita tiv e ly  in to  l,2 -d ih y d ro -6 ,7 -d im eth o x y - 
isoquinolin-4(3H )-one-3-sp irocyclohexane, m .p . 148°, iden­
tic a l w ith  th a t  o b ta in ed  p rev iously , b y  d isso lu tion  in  d ilu te  
hy d roch lo ric  ac id  an d  rebasification  w ith  sod ium  hydrox ide .] 
A fte r rep ea ted  c ry s ta llisa tio n  from  p e tro leu m  (b.p. 80— 100°) 
th e  solid  h a d  m .p . 125— 126°, an d  p ro b ab ly  co n ta in ed  a b o u t 
20%  of th e  isoquinolin-4-one (i.r. sp ec tru m  a n d  e lem en ta l 
a n a ly s is ) . T h e  m a jo r com ponen t w as iden tified  b y  ac cu ra te  
m ass  m e asu rem en t o f th e  p a re n t ion  in  th e  m ass sp ec tru m  
(F o u n d : M +, 274-1682. CI0H 2!!N 2O,! requ ires  M , 274-1681).
ti,l-D im ethoxy-3-phenylisoquinolin-4-o l (4).— 1,2 -D ihydro-
6 .7 -d im ethoxy-3-pheny lisoqu ino lin -4 (3H )-one (2d) (1-6 g) 
d isso lved  in  50%  eth er-ch lo ro fo rm  (300 ml) w as se t aside  
fo r 3 days . E v a p o ra tio n  gave a  p a le  b row n  gum , w hich  
on  tr i tu ra t io n  w ith  e th e r  con ta in ing  a  l i t t le  e th a n o l gave  th e  
isoquinolin-4r-ol (0-55 g, 37% ) as a  pale yellow  pow der, m .p . 
220°. A  sam ple  c rysta llised  tw ice from  aqueous e th an o l as 
p a le  yellow  p la te s  h a d  m .p . ca. 240°; fina l c ry s ta llisa tio n  
from  c h lo ro fo rm -p e tro leu m  (b.p. 40— 60°) gave  w h ite  m icro ­
c ry sta ls , m .p. 249°, \>msix 3250 an d  1625 cm "1,  8 (CF3-COaH ) 
8-7 (IH ), 7-5 (7H ), an d  4-1 (6H, d) p .p .rn . (F o u n d : C, 
72-6; H , 5-5; N , 5-1. Cl7H 16N 0 3 req u ires  C, 72-6; H , 5-4; 
N , 5-0% ).
6,7-D im elhoxy-3-phenylisoquinoline  (6a).— 1,2-D ihydro-
6 .7 -d im ethoxy-3-pheny lisoqu ino lin -4 (3 f/)-one  (2d) h y d ro 1- 
gen su lp h a te  (30 g) d isso lved  in  e th an o l (300 ml) w as basified 
ca re fu lly  w ith  sod ium  hyd rox ide , an d  sod ium  bo ro h y d rid e  
(10 g) w as ad d ed . N e x t d a y  th e  excess o f b o ro h y d rid e  w as 
d estro y ed  w ith  d ilu te  acetic  ac id , an d  th e  so lu tio n  w as rebasi- 
fied w ith  sod ium  h y d ro x id e  an d  e x tra c te d  w ith  ch lo ro ­
fo rm . D ry in g  an d  ev a p o ra tio n  of th e  e x t ra c t  y ie lded  a
5970
b ro w n  glass, w hich  on  tr i tu r a t io n  w ith  e th a n o l-e th e r  gave  
a  yellow  solid  (19 g), m .p . 134—-144°, clearly  a  m ix tu re  of 
bases, p resu m a b ly  th e  d ia stereo isom ers  of th e  te tra h y d ro -  
isoquinolin-4-ol an d  th e ir  d e h y d ra tio n  p ro d u c t.
T h e  m ixed  bases (16-5 g) w ere d isso lved  in  ch lo roform  
(200 ml) a n d  AT-brom osuccinim ide (10-7 g) w as ad d ed  w ith  
sw irling. A fter 2 h  th e  so lu tio n  w as d ilu te d  w ith  e th e r  
(800 m l.), a n d  th e  green am o rp h o u s  p re c ip ita te  (23 g.) w as 
filte red  off an d  w ashed w ith  e th er. T h e  g reen  solid w as 
su spended  in co n c en tra ted  hyd ro ch lo ric  ac id  (100 ml) an d  
h e a te d  on  a  boiling w a te r  b a th  fo r 30 m in . T h e  cooled  
so lu tion  w as d ilu ted  w ith  w a te r  (400 ml) a n d  th e  solid  w as 
filte red  off, su spended  in  w a te r, a n d  tre a te d  w ith  sod ium  
h y d ro x id e  an d  ethano l, to  g ive SJ-d im ethoxy-'i-phenyliso -  
quino line  (6a) as a  b row n c ry s ta llin e  solid , m .p . 127° (8 g, 
44%  b ased  on  isoqu ino linone h y d ro g en  su lp h a te ), vraaJC 1620 
cm "1, 8 (CDC13) 9 (IH ), 8-1 (2H , m), 7-8 (IH ), 7-4 (3H , m), 
7 ( IH ), 6-9 (IH ), an d  3-9 (6H ) p .p .rn ., w hich  w as c ry sta llised  
from  pe tro leu m  (b.p. 80— 100°) to  g ive e lo n g a ted  prism s, 
m .p. 131— 132° (F o u n d : C, 76-8; H , 5-8; N , 5-4. C17H ,5-
N O j requ ires C, 77-0; H , 5-7; N , 5-3% ).
T h e  methiodide hem ihydrate, o b ta in e d  b y  use o f d im e th y l 
s u lp h a te  followed by  ion  ex c h an g e  in  p o ta ss iu m  iodide so lu ­
tion , h a d  m .p . 219— 226° (decom p.) (from  e th an o l) , vnmx 
1635 an d  1615 c m 1, 8 [(CD 3)2SO] 9-9 (IH ), 8-3 (IH ), 7-8 
(7H , m ), 4-2 (3H), a n d  4-05 (6H, d) p .p .rn . (F o u n d : 
C, 62-1; FI, 4-45; N, 3-0. C18H l8IN O 3,0-5H sO requ ires 
C, 51-9; H , 4-6; N, 3-4% ).
2-Benzylam ino-2-phenylacetaniide. — B enzy lidenebenzy l- 
am in e  (49 g) w as tre a te d  w ith  an  excess o f co n c e n tra te d  
sod ium  d isu lp h ite  so lu tion , g iv in g  a  s lu rry  w hich  w as w ashed 
w ith  e th er. E xcess o f co n c e n tra te d  p o ta ss iu m  cy a n id e  
so lu tion  w as added, g iv in g  a  Clear so lu tion  w ith  a n  oil,
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w hich  w as e x tra c te d  w ith  e ther. D ry in g  an d  ev ap o ra tio n  
gave 2 -b enzy lam ino -2 -pheny laceton itrile  (lb ) (51 g, 91% ). 
A  so lu tion  o f th e  am in o n itr ile  (2-2 g) in  co n c en tra ted  su l­
ph u ric  ac id  (20 m l) w as h ea ted  on a  bo iling  w ate r b a th  for 
3 h , cooled, a n d  a d d e d  ca re fu lly  to  w a te r  (200 m l); th e  
re su lting  so lu tio n  w as w ashed  w ith  e th e r, basified w ith  
sod ium  hyd ro g en  ca rb o n a te , a n d  e x tra c te d  w ith  e th er. 
D ry in g  an d  e v a p o ra tio n  o f th e  e x t r a c t  gave th e  am ino- 
acetamide a s  a  w h ite  p ow der (1-34 g, 56% ), w hich c ry s ta l­
lised from  aqu eo u s e th a n o l as leaflets, m .p . 106— 107°, an d  
w as rec ry sta llised  from  e th y l a c e ta te -p e tro le u m  (b.p. 80— 
100°) to  g ive w h ite  ro se ttes , m .p . 116— 117°, vniaJC 1690 an d  
3300 c m '1, 8(CDC13) 7-0 (10H , d), 6-35br (2H, d, exchange­
able), 4-0 (IH ), 3-6 (2H), an d  2-0 (IH , exchangeable) 
p .p .rn . (F o u n d : C, 74-9; H , 6-7; N , 11-4. C16FI10N 2O 
requ ires  C, 75-0; H , 6-7; N , 11-7% ).
2-(N -B enzylm ethylam ino)-2-phenylacetam ide .— 2-(N -
b enzy lm eth y lam in o )-2 -p h en y lace to n itrile  (le ) was p rep ared  
b y  th e  genera l m e th o d , from  A A m ethylbenzylam ine in  p lace 
of 3 ,4 -d im ethoxybenzy lam ine , in  88%  y ie ld ; i t  c ry s ta llised  
slow ly, m .p . 4 5 —47°, vmaK 2230 c m '1. T he am ino -n itrile  
(5 g) w as t r e a te d  as if fo r cy c lisa tion  w ith  co n c en tra ted  
su lphu ric  a c id ; w orlc-up in  th e  u su a l w a y  gave th e  am ino-  
acetamide a s  a  w h ite  solid, m .p . 124° (2-95 g, 55% ), w hich  
w as rec ry sta llised  from  aqueous e th a n o l;  m .p . 135°, vraux 
1670, 3450, a n d  3200 c m '1, 8 (CDC13) 7-1 (10H , d). 6-5br 
(2H, d , exchangeab le), 3-9 (IH ), 3-35 (2H , d), an d  2-0 (3H) 
p .p .rn . (F o u n d : C, 75-5; H , 6-9; N , 11-2. C10FIwN 2O 
requ ires C, 75-6; H , 7 1 ;  N, 11-0% ).
W e th a n k  th e  P h a rm a ceu tica l S o c ie ty  of G rea t B rita in  
fo r a  research  sch o la rsh ip  (to  R . D . W .).
[0/1553 Received, September 9Ih, 1970]
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Rearrangement in the Synthesis of Isoquinolines from Benzylam inoacetonitriles
B y D . N . H a r c o u r t *  an d  N. T a y l o r  
(School o f  Pharm acy, U niversity o f  B ath , Claverlon D own, B a th  BA 2 7AY) 
a n d  R . D . W a i g h
(D epartm ent o f Pharm aceutical Chem istry, U niversity o f  Strathclyde, Glasgoiv G1 1XW )
S u m m a ry  T h e  tr e a tm e n t  o f m e th o x y b en zy lam in o ace to - W e  h av e  re p o r te d 1 th e  fo rm a tio n  o f l,2 -d ih y d ro -6 ,7 -d i-
n itr ile s  w ith  c o n c e n tra te d  su lp h u ric  ac id  a t  50° g av e  m ethoxy isoqu ino lin -4 (3 f/)-ones b y  tre a tm e n t  o f 3 ,4 -d i­
p ro d u c ts  arising  fro m  H a y a s h i- ty p e  rea rran g em en t. m e tho x y b en zy lam in o ace to n itr ile s  w ith  co n c e n tra te d  su l-
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phuric. ac id  a t  50°. W ork  d escrib ed  here suggests  th a t  
c o n tra ry  to  genera lly  accep ted  m echan ism s fo r th e  Popae- 
ra n z  -F ritsch  sy n th es is2 an d  its  m odifica tions, cyc lisa tio n  in  
th is  case occurs p re feren tia lly  b u t  n o t exc lusively  via  a
R i R » R » R »
(1) H  OMe Me C H ,Ph
(2) H H  - [ C H J .-
(3) OMe OMe - [C H J6-
sp iro -in te rm ed ia te  ob ta ined  from  electroph ilic  a t ta c k  para  
to  th e  C-4 m e th o x y -su b s titu e n t (Schem e 1).
(5 )
S c h e m e  1.
In  the  a t te m p te d  p rep ara tio n  of a  3 -benzyiisoquinolinone 
from  th e  am in o n itr ile  (1), th e  so le  p ro d u c t iso la ted  w as th e  
isoqu ino line  (6), m .p . 138° (20%  y ie ld ). W e p o s tu la te  a  
m echan ism  (Schem es 1 an d  2) invo lv ing  th e  sp iro -in ter- 
m e d ia te  (4), rem in iscen t of t h a t  suggested  in  th e  H ay ash i 
rea rra n g e m e n t o f or/Ao-benzoylbenzoic ac id s ,3 an d  su b ­









S c h e m e  2 .
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T he fa te  of th is  in te rm e d ia te  is d e p e n d e n t upon th e  
n a tu re  of th e  s u b s t itu e n ts  R* a n d  K l a n d  th e  re a c tiv i ty  of 
th e  m e th o x y -su b s titu te d  ring . T h e  d e a c tiv a tin g  influence 
of th e  im ino-group  on  th e  m e th o x y -rin g  fav o u rs  P ic te t  
Speng ler cyc lisa tion  to  th e  benzy l s u b s t itu e n t (5; R 4 ~  
C H 2Ph) th u s  fo rm ing  th e  3 ,3 -d isu b s titu ted -te trah y d ro iso - 
qu ino line  (Schem e 2).
T he 4 -m e th o x y b en zy lam in o ace to n itrile  (2) w as c o n ­
v e rted  in to  th e  spirocycloh .exyl-3-im idazoline (7), m .p . 92° 
(80% ) (Schem e 3). H ere  th e  low o rd e r of re a c tiv i ty  of th e  
a ro m a tic  nucleus in  th e  ortho po sitions  a n d  th e  absence  of an  
a l te rn a t iv e  nucleoph ile  allow  o n ly  ad d itio n  of th e  im ine to  






S c h e m e  3 .
T h e  hypo thesis  is s u p p o rte d  b y  cyc lisa tion  of (3) (Schem e 
4). C yclisation  via  (5) to  th e  sp irocyc lohexy lisoqu ino lin -4  
(3 / / ) -one (8), m .p . 149° o ccu rred  in  20— 30%  y ie ld . T he 
c o n c o m itan t O -d em eth y la tio n  h ere  observ ed  is n o t in 
acco rd  w ith  th e  w ork  o f G re th e  an d  h is  co -w orkers ,4 b u t  
m a y  occur in th e  tra n s i t io n  s ta te  (4), g iv in g  e lectron ic 
s ta b i lity  an d  re liev ing  s te ric  s tra in . S u ch  a  c e n tra l m e th y l 
g roup  is co m p ara tiv e ly  easily  lo s t u n d e r  ac id ic  co n d itio n s .5 
A sm all q u a n t i ty  (9% ) of th e  " n o rm a l"  sp irocyc lohexy l- 
isoqu ino lin -4 (3f/)-one  (9), m .p . 128°, w as also  iso la ted . 
T h u s  "n o rm a l"  cy c lisa tio n  is n o t  excluded .
S c h e m e  4 .
P reference  fo r fo rm a tio n  of th e  sp iro -in te rm ed ia te  o ver 
e lec troph ilic  a t ta c k  para  to  a  C-3 m e th o x y -s u b s t itu e n t is 
a lso  e v id en t in  th e  cy c lisa tio n  of 2 -(2 ,3 -d im ethoxybenzy l- 
am in o )-2 -sp irocyclohexy laceton itrile , w here th e  o n ly  p ro ­
d u c t  iso la ted  w as l,2 -d ih yd ro -6 ,6 -d im ethoxy -3 -sp irocyc lo - 
hexy lisoqu ino lin -4 (3 /7 )-one, m .p . 110°, in  9%  yield.
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W here th e  s ta r tin g  m a te r ia l possesses 8 ,4 -d im ethoxy- 
su b s t i tu t io n  and  lacks  a lte rn a t iv e  nucleophiles, as  in  th e  
firs t exam ples we re p o r te d ,1 th e  p ro d u c t is th e  sam e w h e th e r 
p ro d u ced  b y  ''n o rm a l"  cyc lisa tion  o r  by  rea rra n g em e n t 
w ith  cyclisation .
1 D. N. H arcourt and It. D. Waigh, J . Chem. Soc. (C), 1971, 967.
2 W. J. Gensler, Org. Reactions. 1951, 6, 191.
3 R. B. Sandin, R. Melby, R. Crawford, and D. McGreer, / .  Amer. Chem. Soc., 1956, 78, 3817; M. S. Newman and I t .  G. Ihrm an,
ibid., 1958, 80, 3652; S. J. Cristol and ML L. Caspar, J . Org. Chem., 1868, 33, 2020.
4 G. Grethe, V. Toome, H . L . Lee, M. Uskokovic, and A. Brossi, J . Org. Chem., 1968, 33, 504.
6 E.g., A. Brossi, T. Van Burik, and S. Teitel, Helv. Chim. Acta, 1968, 51, 1965.
Structural assignments are based upon satisfactory 
elemental analysis, diagnostic i.r., n.m.r., and mass spectra 
We thank Dr. A. M. Comrie for helpful discussions.
(Received, 28<A March 1972; Com. 531.)
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CyclSsation of /V-(Prop-2-yny3)foenzylamiines. Part HI.1 Synthesis o f 1,2- 
Dihydro-3-phenylisoquinoiines and an Isopavine Derivative
By J. R obin Brooks. David W. Harcourt. and R oger D. W aigh ,” t School of Pharmacy, Bath University, 
Claverton Down, Bath BA2 7AY
A/-(1-Phenylprop-2-ynyl)- and /V-methyl-A/-(1 -phenylprop-2-ynyl)-benzylamine cyclised in polyphosphoric acid 
to give good yields of 1.2-dihydro-4-methyl-3-phenylisoquinolines (2). The initial products of cyclisation were 
unstable and underwent atmospheric oxidation. The tertiary base (2: R = Me) gave an isoquinolin-1 (2W)-one 
(7) and the secondary base (2; R = H) an unusual 1,4-dihydroisoquinolin-4-ol (8), which was readily dehydrated 
to the isoquinoline. Polyphosphoric acid treatment of N -(prop-2-ynyl) -1.2-diphenylethylamine (3) caused double 
cyclisation to give 10.11 • dihydro-10 .5 -(iminomethano)-B-methyl-bW-dibenzofa.c/Jcycloheptene (4) (an isopavine 
derivative).
W e have reported the cyclisation of simple JV-(prop-
2-ynyl)benzylam ines with polyphosphoric acid,1 in which 
difficulties were encountered owing to the tendency of 
the primary reaction products to oxidise and dis­
proportionate. W e envisaged two w ays in which the 
reaction could be investigated while avoiding these 
difficulties. In the first instance, we could take ad­
vantage of the ease of synthesis of 1-substituted  
propyn ols2 to produce substitu ted  bromo- and hence 
amino-propynes. Commencing w ith an aromatic alde­
hyde the resultant aminopropynes would cyclise to
3-aryl-l,2-dihydroisoquinolines (Scheme 1) which are 
reputedly s ta b le3 and are potentially adaptable inter­
m ediates in alkaloid synthesis.4 Here the substituent 
chosen was phenyl, both for sim plicity and because 
l-phenylprop-2-yn-l-ol was commercially available.
In the second, a benzyl substituent attached to the
(I ; R  =  Me) w ith  polyphosphoric acid gave the expected  




f i p T h
( 2 )
PhHX
first-formed isoquinoline m ight trap the reactive inter­
mediate in any of three w ays 5 7 (Scheme 2).
Reaction of l-phenylprop-2-yn-l-ol w ith phosphorus 
tribromide gave a good yield  of the required 1-bromo-l- 
phenylprop-2-yne.8 The bromo-compound was highly 
lachrym atory, like the nitrile analogue.9 It was possible 
to  distil it, despite a rep o rt10 that the compound 
polymerised explosively on attem pted isolation.
Alkylation of benzylamine and IV-methylbenzylamine 
gave moderate yields of the required aminopropynes (1; 
R =  H  and R =  Me). Cyclisation of the aminopropyne
t  Present address: D epartm ent of Pharm aceutical Chemistry, 
University of Strathclyde. Glasgow GI 1XW.
1 J. R. Brooks and D. N. H arcourt, J .  Chem. Soc. (C), 1969, 
025, is regarded as P art I.
2 E.g., E. R. H. Jones and J . T. McCombic, J . Client. Soc., 
1942. 733.
3 S. F. Dyke and M. Sainsbury, Tetrahedron, 1905, 21. 1907.
4 D. N. H arcourt and R. D. W aigh, J . Chem. Soc. (C), 1971, 
907.
6 A. R. B attcrsby  and D. A. Yeowell, J . Chem. Soc., 1958, 
1988.
< 4 ^ * e c r  
*  ( 1 2 ) 7  ( 6 )
as an oil, identified by its n.m.r. spectrum. On exposure 
to the air for several days the oil solidified, and chrom ato­
graphy of the solid on alumina gave the isoquinolin- 
1 (2//)-one (7). Similar reactions of 1,2-dihydroiso- 
quinolines have been recorded,11 and presumably a 
normal autoxidation occurs,12 followed by dehydration  
of the peroxide (Scheme 3).
Cyclisation of the aminopropyne (1; R  =  H) also 
gave an oil, but in this case the n.m.r. spectrum  could 
not be interpreted, the oil obviously consisting of a 
m ixture of compounds. On trituration w ith an ether— 
petroleum m ixture the oil solidified, and chromato­
graphy on alum ina gave tw o crystalline materials. The 
first product showed i.r. absorption indicative of the 
presence of -O H  and -C = N -  groups. E lem ental analysis 
and the presence in the n.m.r. spectrum of a  two-proton 
AB quartet w ith geminal coupling (J  20 Hz) at 8 4-4 
(ArCHo N  ), together w ith other consistent absorption, 
suggested the 1,4-dihydroisoquinolin-4-ol structure (8).
6 A. R. B attersby  and R. Binks, J .  Chem. Soc., 1955, 2888.
7 S. F. Dyke, Adv. Heterocyclic Chem., 1972, 14, 319.
“ T. Y. Lai, Bull. Soc. chim. France. 1933, 63, 1633.
0 J . P. Robinson, in ' Chemical and Biological W arfare,’ ed. 
S. Rose, G. G. H arrap  & Co. Ltd., London, 1968.
10 M. Gaudemar, A nn. Chim. (France), 1956, 1, 161.
u  M. Sainsbury, S. F . Dyke, and A. R. Marshall, Tetrahedron, 
1966, 22, 2447; cf. E. Hoeft, A. R iechcand H. Schultzr, Annalen, 
1966, 697, 181.




At first the form ation of such a product was difficult 
to rationalise, but by analogy with recent work with  
other cyclic enamines,13 it would appear that oxidation  
to the peroxide (9) m ay occur, which then ‘ proportion­
ates ' w ith a molecule of th e 1,2-dihydroisoquinoline (2; 
R H) or its tautom er, to  give tw o molecules of the 
dihydroisoquinolinol [(8), Scheme 4]. It seems that the 
imino-form of th e dihydroisoquinoline (2; R =  H) is
4-ol (8) through a similar alumina column, when quanti­
tative conversion into isoquinoline (10) occurred (Scheme
The isoquinoline (10) could be quaternised with m ethyl 
iodide, and the quaternary salt thus obtained oxidised 
with potassium ferricyanide in alkaline solution,14 to  
give an isoquinolin-1 (2//)-one. (7), identical with that 
obtained from cyclisation of aminopropyne (1; R =  Me).
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subject to  rapid oxidation, which would explain the 
difference in oxidation products of the secondary and 
tertiary bases, since in the absence of acid the latter is
2:R =H )
Ph (2SR--H)
8) tw o m o le c u le s
OH'kFeCNg
No tendency to disproportionate1 w as found w ith any  
of the 3-phenylisoquinolines.
Cyclisation of Al-(prop-2-ynyl)-l ,2-diphenylethylam ine
(3) gave a crude yield (68%) of a viscous oil. The major 
component of the crude product was the ' isopavine 1 
derivative (4), for which the n.m.r. spectrum was 
diagnostic, although complicated by overlapping. Both  
AB and A B X  spin coupling system s could be discerned 
owing to the non-equivalence of the protons of each 
-C H 2~ group, with large geminal coupling constants. 
Significantly, the m ethyl group signal was a sharp 
singlet, eliminating possible alternative structures (5) 
and (6). A mass spectrum and accurate mass measure­
m ent of the parent ion confirmed th e structure of the  
major product.
Some impurities were indicated in the n.m.r. spectrum  
of the crude material, notably a sharp singlet at S 2-1 
of unknown origin, and a doublet at 8 1-46 which 
in theory could have originated from a variety of 
products, including (5) and (6). Further work by  
another grou p 15 interested in the pharmacological 
activ ity  of the isopavine derivative (4) has indicated that 
the latter impurity was probably the pavine derivative
(5).
S c h e m e  4
unable to tautomerise. The existence of both tautomeric 
forms of the isoquinoline (2; R  =  II) may explain the 
com plexity of the n.m.r. spectrum of the crude cyclisation 
product, compared with that of the tertiary base (2; 
R =  Me).
The second crystalline fraction from chromatography 
of the oxidised cyclisation product [from (1; R — H)] 
was identified as 3-m ethyl-3-phenylisoquinoline (10) 
(i.r., n.m.r., elem ental analysis). The suspicion that 
this was an artefact from chromatography was confirmed 
on repassing a pure sample of the 1,4-dihydroisoquinolin-
13 G. Berti. A. Da Settimo, G. Di Colo, and E. Nannipieri, 
J . Chem. Soc. (C), 1969. 2703.
EtO OEt 





It thus appears that the am inopropyne (3) cyclises in 
a very similar manner to the acetal (11) used by
1434
R. D. H aw orth and W. II. Perkin, J .  Chem. Soc,, 1925, 
D. C. Bishop, personal communication.
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Battersby 5 to obtain ' isopavine,' and that the dihydro- 
isoquinoline [(12), Scheme 2] is not formed to  any great 
extent.
E X P E R IM E N T A L
U nless s ta te d , m .p .s  w ere ta k e n  w ith  a  K ofler h o t-s tage  
a p p a ra tu s , an d  a re  co rrec ted . I.r . sp ec tra  w ere o b ta in ed  
w ith  a  U n icam  S P  200 in s tru m e n t for p o ta ss iu m  brom ide 
d iscs  o r liqu id  film s. N .m .r. sp ec tra  w ere recorded  w ith  a  
V arian  A60 in s tru m e n t ( te tra in e th y ls ilan e  as  in te rn a l 
reference).
1 -B rom o-1 -phenylprop-2-ync. l-P hen y lp ro p -2 -y n o l (100 
g) an d  d ry  p y rid in e  (5 g) w ere d isso lved  in  d ry  e th e r  
(100 m l). P h o sp h o ru s  tr ib ro m id e  (80 g) w as ad d e d  d rop- 
wise w ith  s tir r in g , and  th e  m ix tu re  le ft overn ig h t. T he 
so lu tion  w as refluxed fo r 2 h, cooled, poured  in to  w ate r 
(400 m l), an d  th e  e th e r la y e r decan ted . T h e  w a te r  layer 
w as d ec an ted  from  th e  h ea v y  oil w hich had  sep a ra ted , an d  
tlve oil ad d ed  to  th e  e th e r  layer. T he w a te r  lay er was 
ex tra c te d  w ith  e th e r, and  th e  e th e r  layers w ere com bined , 
w ashed w ith  sod ium  hydrogen  c a rb o n a te  so lu tion , dried, 
an d  ev a p o ra ted . T he res id u a l oil w as d is tilled  u n d e r h igh 
vacuum , th e  d is tilla tio n  being  s to p p ed  w hen  th e  ra te  
slow ed ap p rec iab ly  (in one ex p e rim e n t th e  te m p e ra tu re  w as 
allow ed to  rise  a n d  th e  b o iler residue  decom posed vigorously, 
resu ltin g  in  loss of th e  p ro d u c t;  see te x t) . T he bromide 
(90-5 g, 61% ) w as a  m obile, pa le  yellow  liqu id  w ith  s tro n g  
la c h ry m a to ry  p roperties , sufficien tly  p u re  for fu r th e r  re­
ac tions . T h e  an a ly tica l s am p le  w as tw ice  frac tiona lly  
d is tilled , b .p . 76— 80° a t  2-5 m m H g, 2120 an d  3300 
cm "1 (F o u n d : C, 55-3; H , 3-6; B r, 40-7. C„H7B r requ ires 
C, 55-4; H . 3-6; B r, 4 1 0 % ).
N -(l-P henylprop-2-yny l)benzylam ine  (1; R  =  H ).—  
B enzy lam ine (53-5 g, 0-5 m ol), w as disso lved  in sodium - 
d ried  benzene (300 m l). l-B ro m o -l-p h en y lp ro p -2 -y n e  
(32-5 g, 0-167 m ole), in sod ium -d ried  benzene (150 m l), was 
ad d ed  dropw ise, w ith  stirrin g . S tirring  w as con tinued  2 h, 
th e  so lu tion  reftuxed  2 h , a n d  allow ed to  s ta n d  48 h . The 
benzene so lu tion  w as shaken  w ith  5N-sodium hydrox ide  
so lu tion  (100 m l), an d  se p a ra te d . T h e  aqueous la y e r  was 
e x tra c te d  w ith  benzene. A fte r d ry ing , e v a p o ra tio n  of the  
com bined  benzene so lu tions gave  a n  oil. F rac tio n a tio n  (at 
1 m m H g) gave  b enzy lam ine  (32 g) a n d  then  th e  benzylamine 
(1; R =  H) (16 g, 43% ). T h e  a n a ly tica l sam p le  w as 
red istilled , b .p . 136— 137° a t  0-7 m m H g, vnmx 3300 c m 1, 
8 (CC1J 7-85 (10H , m), 4-45 ( IH , m), 3-75 (2H . m), and  
0-45 (IH , exchangeable) (F o u n d ; C, 86-6: H , 6-8; N, 6-55. 
C I6H I5N requ ires  C, 86-9; H . 6-8; N, 6-3% ).
\4-M ethyl-\A -(\-phenylprop-2-ynyl)benzylam ine  (1; R — 
Me).-—T h e  p rocedu re  w as in itia lly  as  above, b u t th e  
d is ti lla tio n  w as s topped  a f te r  rem o v a l o f A -m ethy lbenzy l- 
am ine , an d  th e  residue  w as cooled an d  e x tra c te d  w ith  e th er. 
T he e th e r  so lu tion  was e x tra c te d  w ith  d ilu te  hydroch lo ric  
ac id , th is  so lu tion  basified, an d  re -ex trac ted  w ith  ether. 
D ry ing  an d  rem o v a l of so lv en t gave th e  benzylam ine  (1; 
R  : - Me) (14-9 g. 38% ), as a  p a le  brow n oil w hich  c ry s ta l­
lised on  cooling a t  0° fo r 7 d ay s  (m .p. 34— 41°). R e- 
c ry s ta llisa tio n  from  aqueous e th an o l gave p rism s, m .p. 
43— 45°, 3300 cm -1, 8 (CCl4) 7-1 (10H , m), 4-5 ( IH , m),
3-45 (2H ), 2-35 ( IH , m), a n d  2-05 (3H) (F o u n d : C, 86-9; 
H , 7-15; N, 6-0. Cn H „ N  requ ires  C, 86-8; H , 7-3; N, 
5-95% ).
l,4-Dihydro-4-m ethyl-3-phenylisoquinolin-4k-ol (8) and  4- 
M elhyl-'H-phenylisoquinoline (10).— T he am in o p ro p y n e  (1; 
R  =  IT) (2-18 g) w as h e a te d  w ith  p o lyphospho ric  acid
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(20 g) fo r 6 h a t  140° w ith  s tirring . T h e  m ix tu re  w as 
cooled, d ilu ted  w ith  ice-w ater, m ade alkaline  w ith  s tro n g  
am m onium  h y d ro x id e  so lu tion  w ith  a d d itio n  of ice, an d  
ex tra c te d  w ith  e th e r. D rying  an d  ev ap o ra tio n  gave a  
viscous, p a le  b row n oil (1-78 g, 82% ), w hich  showed no 
-O H  abso rp tio n  in  th e  i.r. spectrum . T ritu ra tio n  w ith  
e th e r-p e tro leu m  (b .p . 40— 60°) caused  solidification to  a  
brow n g ran u la r m a te ria l, m .p. ca. 130°, w ith  s trong  -O H  
abso rp tion , vltmic 3180 cm -1. C h ro m a to g rap h y  w ith benzene 
on an  a lu m in a  co lum n  (B .D .H . a lum ina , u n tre a ted ), gave 
th e  dihydroisoquinolinol (8), a  pale yellow , cry sta lline  solid 
(0-92 g), w hich w as recry sta llised  from  benzene-petro leum  
(b.p. 40— 60°) as  needles, m .p. 139-— 141°, vra|ut 3180 and  
1625 cm "1, 8 7-1 (9H , m ), 3-95—4-85 (2H , A Bq, /  20 H z),
3-35 (IH , exchangeable), an d  1-35 (3H) (F ound : C, 80-85; 
H , 6-4; N, 5-9. C l8H 16NO requ ires C, 81-0; H , 6-3; N,
5-9% ).
C ontinued e lu tion  w ith  benzene gave  4-m ethylS-phenyl- 
isoquinoline (10) a s  a  cry sta llin e  solid (0-305 g), w hich was 
recrysta llised  from  petro leum  (b.p. 40— 60°), as prism s, 
m .p. 103— 104°, vniM 1620 cm"1, 8 9-2 (IH ), 7-7 (9H, m), 
a n d  2-6 (2H) (Found ': C, 87-7; H , 6-0; N, 6-25. CInH lsN  
requ ires C, 87-7; H , 5-9; N, 6-4% ).
W hen th e  ch ro m a to g rap h y  w as ca rried  o u t using 
p etro leum  (b .p . 40— 60°) in itia lly , w ith  increasing p ro ­
p o rtions  of benzene, th e  m a te ria l rem ained  in  co n tac t w ith  
th e  a lum ina  fo r a  longer tim e, an d  on ly  4 -m ethyl-3-phenyl- 
isoquinoline w as iso la ted  (65%  yield based  on am ino­
propyne). S im ilarly , p u re  isoquinolinol (8) gave a  q u a n ti­
ta tiv e  yield o f th e  a ro m a tic  isoquinoline (10) on passing  
th ro u g h  an  a lu m in a  colum n e lu ted  firs t w ith  petro leum  
(b.p. 40— 60°), th e n  10, 20, 50% , an d  fina lly  pure  benzene.
2.4-D im et hyl-2-phenylisoquinolin ium  Iod ide .— T he salt 
form ed very  slow ly  as long yellow  needles w hen excess of 
m e th y l iodide w as added  to  a  d ry  e th e rea l so lu tion  of th e  
isoquinoline (10), m .p. 263-— 265° (decom p., cap illary  tube) 
(F ound : C, 56-1; H , 4-65; N, 3-9. C „ H l0IN  requires 
C, 56-5; H , 4-5: N, 3-9% ).
2 .4-D im ethyl-3-phenylisoquinolin-l(2H )-one  (7).— (a) From
2,4-d.im ethyl-Z-phenylisoquinolinium  iodide. T he isoquino- 
lin ium  m eth iod ide  (see above, 0-47 g) w as dissolved in  
aqueous e th an o l (10 m l). A so lu tion  of po ta ss iu m  h ydrox ide  
(0-5 g) a n d  po ta ss ium  hex acy an o ferra te (m ) (1-4 g) in  w a te r 
(10 ml) w as added , giving a  w hite  p re c ip ita te  w hich d is­
solved on w arm ing. T he so lu tion  w as cooled and  ex trac te d  
w ith  e ther, w hich  on  evap o ra tio n  gave  a  p a le  yellow  solid 
(0-285 g, 88% ), m .p . an d  m ixed m .p . w ith  th e  isoquinolin- 
1 (2/7)-one o b ta in ed  below, 104— 105° a n d  hav ing  an  
id en tica l i.r. spectrum .
(b) From  ti-m ethyl-N -(l-phenylprop-2-ynyl)bcnzylam ine  
(1; R  =  Me). T he am inop ropyne (1; R  =  Me) (2-32 g), 
tre a te d  as  described  for cyclisation  of am inop ropyne (1; 
R  =  H) above, gave  an  oil (2-05 g, 88% ). B y  evap o ra tin g  
so lven ts un d er n itrogen  an d  w orking qu ick ly , th e  p rim ary  
p ro d u c t, l,2-dihydrO -2,4-d im ethyI-3-phenylisoquinoline, 
could be o b ta in ed  in  a  high s ta te  of p u rity , a s  de term ined  by  
th e  n.m .r. sp ec tru m ; 8 7-1 (9H, m ), 4-2 (2H), 2-35 (3H), 
an d  1-85 (3H ). A fte r severa l d ay s ' exposu re  to  a ir  th e  oil 
solidified, an d  ch ro m a to g rap h y  w ith  p e tro leu m  (b.p. 40—  
60°) on an  a lu m in a  colum n gave th e  isoquinolinone (7) (61%  
based on am inopropyne), as  w h ite  needles, m .p . 107— 108° 
[from  petro leum  (b.p. 80— 100°)], vmnx. 1640 cm -1, 8 8-2 (IH , 
m ), 7-15 (8H . m ), 3-1 (3H), and  1-9 (3H) (F o u n d : C, 81-7; 




K -( Prop-2-ynyl)-1,2-diphenyle/hylam ine  (3) H ydro­
chloride. 3 -B ron iopropyne (3-0 g) in d ry  e th e r  (50 ml) w as 
ad d ed  dropw ise to  a  so lu tion  of 1,2 -d ipheny le thy lam ine  
(15 g) in e th e r  (20 m l). A fter 48 h th e  c ry s ta ls  w ere 
fd te red  off a n d  th e  so lu tion  e x tra c te d  w ith  d ilu te  h y d ro ­
ch lo ric  ac id . A solid (4-3 g) cry sta llised  from  th e  ac id  so lu ­
tio n  a n d  w as filtered  off. R ec ry sta llisa tio n  from  e th a n o l-  
ace to n e  gav e  th e  hydrochloride a s  needles, m .p. 198— 200° 
(3-8 g, 60% ), 8 (free base, CC1J 6-9 (10H , m ), 3-95 (IH , t, 
J  7 Hx), 2-95 (2H, d, /  3 H z), 2-7 (2H. d, J  7 H z), 1-9 (IH , 
t ,  J  3 H z), an d  1 35 (IH , exchanged  w ith  b 20 )  (F o u n d : C, 
74-8; H . 6-55; N, 4-8. C ^H jpC lN  requ ires C, 75-1; II,
6-6; N, 5-2% ).
10,11 -D ihydro-5-tnelhyl-10,5- (im inom ethano) -5H -dibenzo- 
\a.,e\\cycloheptene (4).- .V -(P rop-2-ynyI)-I,2 -d ipheny lethy l- 
am ino  hyd roch lo ride  (2-2 g) w as d issolved in polyphosphoric
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acid  (20 g) an d  h ea ted  a t  145° for 6 h . T h e  so lu tion  w as 
d ilu ted  w ith  w a te r (100 ml) and  m ade a lk a lin e  a f te r  being 
left for 30 m in. T h e  n .m .r. spec trum  of th e  oil w as o b ta ined  
by  th e  Physico-C hem ical M easurem ents U n it, H arw ell, a t  
100 M H z in CDC13 so lu tion , 8 7-1 (8H , m ), 4-2 (IH , t .  J  
a p p a re n t 3-5 H z), 3-2 (4H, AB or A B X , / a x  a p p a re n t =  
,/n x  a p p a re n t =  3-5, J ab 17 an d  AB, J  12 H z), 2-0 (IH , 
exchangeable), an d  1-8 (3H ). T h e  base, reg en e ra ted  from  
th e  hydroch lo ride , show ed a  single peak  on  g.l.C. using 2£%  
SE  301 silicone gum  ru b b e r  on C hrom osorb  G. T he hydro­
chloride w as used  to  o b ta in  th e  m ass sp ec tru m  (F o u n d : 
M +, 235-1300. C „ H n N  requ ires M ,  235-1361).
W e th a n k  th e  P h a rm a ceu tica l S ocie ty  o f G rea t B rita in  
for research  scho la rsh ips (to  J . R . B . an d  R . D . W  ).
[3 /1 1 9 0  Received, 8th June. 1973)
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Synthesis of 3-Arylisoquinolines by Therm olysis of 3-A ryl-1,2- 
dihydroisoquinolin-4(3if) -one Salts
B y  D a v i d  A. L i v i n g s t o n e  
(Department o f Pharmaceutical Chemistry, University o f Strathclyde, Glasgow G1 1X W ) 
a n d  R o g e r  D .  W a i g h *
(Department o f Pharmacy, University o f Manchester, Manchester M13 9PL)
Summary  3-A ry l-l,2 -d ihydro isoqum olin -4 (3£f)-one sa lts  
give m ix tu re s  of 3-ary lisoqu ino lines an d  3 -ary l-4 -hyd r- 
oxyisoqu ino lines a f te r  h e a tin g  in  d im eth y lfo rm am id e  and  
ex trac tio n .
M a s s  sp e c tra  of s a lts  (hydroch lo rides o r h y d rogen  su lphates) 
of 3 -a ry l-1,2 -d ihydroisoquinolin-4( Mi) -ones (1) show  tw o 
m a in  peaks, M  — 2H  a n d  M  — H 20 .  T h e  fo rm er corres­
p o n d s  to  loss o f 2H  from  th e  1 ,2-bond w ith  eno lisa tion  to  
give th e  a ro m atic  4 -hydroxy isoqu ino line  (2) a n d  th e  la t te r  
suggests  loss o f oxygen  a t ta c h e d  to  th e  4 -position  an d  tw o
hydrogens to  give th e  4 -u n su b stitu ted  a ro m a tic  isoquinoline
(3). T he firs t p rocess is expec ted , b u t  th e  loss o f d o ub ly - 
bonded  oxygen is difficult to  exp la in  b y  th e  u su a l frag ­
m en ta tio n  p a th w a y s,, since i t  invo lves a  d u a l r e d u c t io n -  
ox ida tion  occurring  s im u ltaneously  a t  d iffe ren t p a r ts  of th e  
heterocycle. W e the refo re  env isaged  a  th e rm a l process, 
and  rep ea ted  i t  b y  h e a tin g  th e  sa lts  in  e v a cu a te d  tubes. 
T h is w as successful w ith  v ery  sm all sam ples, b u t  w ith  
sy n th e tica lly  usefu l q u a n titie s  gum s w ere p ro d u ced  from  
w hich  on ly  sm all a m o u n ts  of p ro d u c t could  be iso la ted . 
W e reso rted  to  th e  use of a  h igh-bo iling  in e r t so lv en t
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[d im eth y lfo rm am id e  (D M F )], an d  o b ta in ed  a  sa tis fa c to ry  
sy n th e tic  p rocedu re , w h ich  rep laces th e  th re e  s tep s  p re ­
v iously  necessary  to  effect th e  convers ion .1 Y ields of (2) a n d  
(3), a f te r  w ork -u p  an d  iso la tio n  by  p re p a ra tiv e  th in - lay e r  
o r  co lum n  ch ro m a to g ra p h y  in fou r cases, a re  given  in  th e  
T ab le.
OH
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Since th e  4 -hyd roxy isoqu ino line  (2) is an  expec ted  
p ro d u c t of a ir  ox id a tio n  w e rep ea ted  tw o  of th e  reac tions  
u n d e r  n itrogen  and , a s  expected , th e  yield o f (3) w as 
increased  (see T ab le).
W hile  th is  th e rm o ly sis  is rem in iscen t o f th e  sy n th esis  of 
n a p h th a len e s  from  3 ,4 -d ih y d ro n a p h th a le n -1 (2/7)-ones2*3an d  
of p heno ls  from  cy c lo h ex an e -1,4-diones,4 th e  reac tio n  
cond itio n s  are  different. N ap h th a len e  p ro d u c tio n  is s tro n g ly  
h in d e red  b y  a  s u b s t i tu e n t a d ja c e n t to  th e  ca rb o n y l,3 w hich 
also suggests  a  d iffe ren t m echan ism . S ince th e  4 -h y d ro x y ­
isoqu ino line (2) is p ro d u ced  u n d e r n itrogen  a n d  in h igh  
vacu u m , we suggest a n  in te rm o lecu la r m echan ism  (Schem e), 
w here th e  h y d ro x y te trah y d ro iso q u in o lin e  (4) is re-genera ted . 
D eh y d ra tio n  o f (4) w ould  give th e  pow erfu lly  red u c in g 6
1,2-d ihydro isoqu ino line (5). T h u s  every  t im e  th e  cha in  
w as in itia ted , a  m olecule o f (2) w ould  be p roduced , b u t  
th e re a f te r  consum ption  o f (1) w ould  p ro d u ce  o n ly  (3).
A lte rn a tiv e  in tram o lecu la r an d  b im o lecu lar (head-to -ta il) 
m echan ism s fail to  a c c o u n t fo r th e  p ro d u c tio n  of (2). 
H ow ever, i t  m u s t be recogn ised  th a t  o x id a tio n  to  th e  4- 
hy d roxy isoqu ino line  is v e ry  easy . I n  th e  case w here 
R  =  2 -pyridy l, we h a v e  been  u n ab le  to  iso la te  th e  iso- 
qu ino linone from  th e  p rev io u s  sy n th e tic  s tep , th e  p ro d u c t 
oxid ising  ra p id ly  to  (2; R  =  2 -pyridyl).
M ass sp e c tra  o f th e  free  bases  of th e se  3 -ary lisoqu ino lin - 
ones also  ex h ib it p ea k s  co rrespond ing  to  M  — 2H  a n d  
M  Hj.O, b u t  these no  longer rep resen t th e  m a jo r  frag -
S c h e m e
m ents. T he m a in  peaks co rrespond  in s tead  to  a  retro- 
D ie ls-A lder hom olysis  in  w hich  th e  n itrogen  a to m  is lo s t 
to g e th e r w ith  C-3 a n d  th e  3 -su b s titu e n t as a  benzy lidene  
im ine. W here  th e  3 -su b stitu e n t is la ck in g  as in  (1; R  =  H ), 
th is  m ode o f decom position  leads to  loss o f m e th y len e  im ine 
even  w hen th e  h y d roch lo ride  is  used , a n d  th e re  is n o  sign of 
a ro m a tisa tio n  to  isoquinoline (3). T he h y d roch lo ride  
(1; R  =  H ) also  gave  a n  in tra c ta b le  p ro d u c t w h en  h ea te d  
in DM F, as d id  th e  free base  w hen fu sed  w ith  N a O H -K O H .2 
T he m a jo r fu n c tio n  of th e  3 -ary l su b s t i tu e n t in th e  th e rm o ly ­
sis is p ro b ab ly  to  ass is t eno lisa tion  (Schem e).
W e th a n k  th e  U n iv ers ity  of S tra th c ly d e  fo r a  scho la rsh ip  
(to  D . A. L.).
(Received, 3rd J u ly  1978; Com. 695.)
1 D. N. H arcourt and R. D. W aigh, J . Chem. Soc. (C), 1971, 967.
a A. J . B irch and D. A. W hite, / .  Chem. Soc., 1964, 4086.
3 J . M. Springer, C. W. H inm an, E . J . E isenbraun, P. W. K. Flanagan, and M. C. H anning, J . Org. Chem.., 1970, 35, 1260.
4 C. G. Rao, S. Rengaraju, and  M. V. B hatt, J.C .S . Chem. Comm., 1974, 584.
s H . Schmid and P. K arrer, Helv. Chim. Acta, 1949, 32, 960.
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Cyclisatiors of Benzylaminoacetomtriies. Part 2 .1 Evidence for Two 
SVlechamisms of Cyciisation
By D a v id  W. H a r c o u r t  and N o rm a n  T aylor,"  S ch ool of Pharmacy and Pharm acology, University o f Bath, 
Claverton D ow n, Bath BA2 7AY 
R o g e r  D. W a ig h , Department o f Pharmacy, University of M anchester, M anchester M 13 9PL
Treatment of 3 ,4-dim ethoxybenzylam inoacetonitriles w ith concentrated sulphuric acid gives 2 ,3-d ihydroiso-  
quin olin -4(1W )-on es. Cyciisation of 1 -(3,4,5-trim ethoxybenzylam ino)cyclohexanecarbonitrile (2 ) at room tem ­
perature gave 3 .4-d ihydro-5.6.7-trim ethoxyisoquinoline-3-sp irocyclohexan-4(1 H)~one (8) (22% ) and 1 -(3 .4 .5 -  
trim ethoxybenzylam ino)cyclohexanecarboxam ide (9) (7%). At 50  °C. cyciisation  gave 3,4-d ihydro-7-hydroxy-
6 ,8 -d im eth oxy isoq uin o lin e-3 -sp irocyc loh exan -4(1H )-on e (10 ) as the major product. A dual m echanism  for 
cyciisation is postulated, on e m ode involving electrophilic attack para to  the C -3 m ethoxy-substituent. th e secon d  
attack para to the C -4 m ethoxy-substituent, giving a spiro-intermediate w hich  undergoes rearrangement to an 
iminium ion, the fate of w hich  is dependent on  the proximity of differing nucleophiles. The latter m echanism  is 
con sisten t with the formation of 1 ,2 ,3 .4-tetrah yd ro-6 ,7-d im eth oxy-2-(4-m eth oxyp henacyl)isoq uinolin e by treat­
m ent of 2-[A /-(3 .4-d im ethoxyphenethyl)-4-m ethoxybenzylam ino]aceton itrile (6 ) w ith sulphuric acid.
W e  h a v e  d escr ib ed  1 th e  sy n th es is  o f 2 ,3 -d ih yd ro-6 ,7 - 
d im e th o x y iso q u in o lin -4 (l//) -o n e s  from  vera try la m in o -  




nitrites [e.g. (1)3, which lack alternative nucleophilic 
sites for attack by the iminium ion, would yield the same 
isoquinoline by orthodox cyciisation or via the spiro- 
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R 1 R 2 R 3 R* R s R° R 7
(1) * H MeO MeO H CSH 10 H
(2) H MeO M eO MeO c 6h 10 H
(3) H MeO E tO MeO c 6h 10 H
(4) H MeO H H c 6h 10 H
(5)
(6)
H MeO H H H  H H
H H M eO H H  H D M P E
(7) MeO MeO H H H
S c h e m e  1
orthodox cyciisation via electrophilic attack para  to the 
C-3 methoxy-substituent (Scheme 1). Subsequent work, 
described here, has indicated that cyciisation may
H*
o  R N }
m ' ° y V ' n h  , - » •
0
S c h e m e  2
R NH
proceed preferentially by attack para to the C-4 
methoxy-group (Scheme 2).
The cyciisation of 3,4-dimethoxybenzylaminoaceto-
trimethoxybenzylaminonitrile (2) would be expected to 
yield a 5,6,7-trimethoxyisoquinolinone according to 
Scheme 1 (R — OMe), but the 6,7,8-trimethoxyiso- 
quinolinone by Scheme 2 (R =  OMe). Cyciisation of 
the amino-nitrile (2) with concentrated sulphuric acid at 
room temperature gave, after dilution and basification 
with 5N-sodium hydroxide, an oil which on fractional 
crystallisation from petroleum gave the amide (9) in 7% 
yield and the 5,6,7-trimethoxyisoquinolone (8) in 22% 
yield (Scheme 3). The orientation of the methoxy- 
groups in 8 was unambiguously established by the 
chemical shift of the signal due to the aromatic proton, 
which appears as a singlet at 8 6.38. We envisage the 
amide (9) being formed by either hydration of the 
nitrile or hydrolytic attack on the spiro-intermediate 
(Scheme 3).
These products were isolated in the same manner when 
cyciisation was carried out at 50 °C. The major product 
was obtained by addition of concentrated hydrochloric 
acid to the aqueous alkaline solution, which gave a
1 P a r t  1, D. N. H a rc o u rt a n d  R . D. W aigh , J .  Chem. Soc. (C), 
1971, 967.
* P rev iously  rep o rte d .1 D M P E  — 3 ,4 -d itn e th o x y p h en e th y l.
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copious white precipitate from which was regenerated a 
phenolic isoquinolinone with sodium hydrogen carbonate 
solution. Recrystallisation from petroleum gave 2,3- 
dihydro-7-hydroxy-6,8-dimethoxyisoquinoline-3-spiro- 
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carbonitrile (3), which gave the same phenolic iso- 
quinolone (10).
Whilst the ‘ central ’ methyl group is relatively easily 
removed by sulphuric acid, as for example in the 
preparation of syringic aldehyde, it is possible that 
demethylation occurs in the transition state to give a 
dienone which might then undergo rearrangement to the 
phenol (10). There is evidence from other amino- 
nitrile cyclisations 3 that the latter process may contri­
bute, but in this case we are unable to exclude the 
possibility that demethylation occurs at a penultimate 
stage after rearrangement has been completed.
Further evidence for Scheme 2 being the favoured 
mechanism is seen in the cyciisation of 2-|7V-(3,4-di- 
methoxyphenethyl)-4-methoxybenzylamino]acetonitrile 
(6), which gave l,2,3,4-tetrahydro-6,7-dimethoxy-2-(4- 
methoxyphenacyl)isoquinoline (11) (Scheme 4), in 33% 
yield. This latter reaction clearly demonstrates the 
ability of the iminium ion to cyclise by interaction with 
an alternative and more reactive nucleophile when one is 
present. The structure was unequivocally confirmed by 
spectroscopy and by an unambiguous synthesis from 
l,2,3,4-tetrahydro-6,7-dimethoxyisoquinoline and 4- 
methoxyphenacyl bromide.
MeO
S c h e m e  3
Here, orientation of the aromatic substituent groups was 
less readily established. Location of the aromatic 
proton at C-5 was unambiguous on the basis of n.m.r. 
data, the signal appearing at 8 7.34 owing to deshielding 
by the C-4 carbonyl function. Double irradiation 
experiments confirmed a C-6 methoxy-substituent, long- 
range coupling and the nuclear Overhauser effect being 
observed between the methoxy-group and the C-5 
proton.
Orientation of the remaining methoxy-group could 
not be established by these techniques. Similarly, 
attempts to remove the phenolic hydroxy-group by the 
method of Lonsky and his co-workers 2 were also un­
successful (dehydroxylation at C-8 would yield a 
product previously characterised,1 and at C-7 the product 
should show mete-coupling with the C-5 proton in the 
n.m.r. spectrum).




( 1 1 ) 'OMe
OMe
S c h e m e  4
Benzylamino-nitriles with methoxy-substituents in 
the 2- and 3- or the 3-position [(4), (5), and (7)] and with 
C-4 unsubstituted were extensively sulphonated during
2 W . L onsky , H . T ra itle r , a n d  K . K ra ty l, J .C .S . P e rk in  I .  
1975, 169.
3 R . D. W aigh , u n p u b lish e d  w ork.
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the attempted cyciisation. The 2,3-dimethoxy com­
pound (7) gave 2,3-diliydro-5,6-dimethoxyisoquinoline- 
3-spirocyclohexan-4 (I id) -one in 5% yield, the main 
product being an uncharacterised sulphonic acid. The 
orientation of the methoxy-groups in this isoquinolinone 
was assigned on n.m.r. evidence. The calculated 
chemical shifts of the two aromatic protons (S 6.90 and 
8 7.06) are in agreement with the experimental values, 
whereas the chemical shifts of the aromatic protons in 
the 7,8-dimethoxy-isomer are calculated as 8 6.84 and 
7.45. Cyciisation must therefore proceed v ia  the spiro- 
intermediate, the activating group being the C-2 
methoxy-group.
The cyciisation of benzylaminonitriles with only a 
w^a-methoxy-substituent necessarily follows Scheme 1,
3-methoxybenzylaminoacetonitrile (5) giving the known 
2,3-dihydro~7-methoxyisoquinolin-4(l//)-one in 27% 
yield. The spirocyclohexane analogue (4) however, did 
not cyclise, the only product isolated being an un­
characterised sulphonic acid. Elemental and spectro­
scopic analysis showed this to be a I-(3-methoxybenzyl- 
amino)cyclohexanecarboxamide sulphonic acid, but the 
orientation of the acid group could not be determined 
owing to the complexity of the aromatic n.m.r. signal.
EXPERIMENTAL
M .p.s were taken on  a  Kofler hot-stage apparatus and are 
corrected. I.r. spectra  were obtained w ith  a U nicam  
S P  200 instrum ent. N .m .r. spectra were determ ined for 
solu tion s in  deuteriochloroform  w ith JE O L  P5100 and 
Varian HA-100 instrum ents. Mass spectral d ata  were 
obtained w ith an A .E .I. MS 12 instrum ent in th e  School of 
Chem istry, U niversity  of B ath .
T he benzylam inoacetonitriles (1) —(7) were obtained as 
reported .1
C yciisation o f  B enzylam inoacetonitriles. General Method. 
—T he benzylam inoacetonitrile (5 g) was added carefully to  
concentrated sulphuric acid (25 ml) in an ice-bath , w ith  
stirring continuously until dissolution was com plete. The 
so lu tion  was kept a t room  tem perature overn ight (‘ cold ’ 
cyciisation) or heated to  50 °C for 4 h (‘ hot ’ cyciisation), 
diluted  b y  pouring on  to crushed ice, and set aside for 30 
m in. T he diluted m ixture w as basified w ith  aqueous 
sodium  hydroxide (20% w /v), ice being added from  tim e  
to  tim e to  prevent an excessive rise in tem perature. The 
product was either filtered off or extracted  w ith  chloroform, 
w ashed, dried, and recrystallised from petroleum  (b.p. 
60— 80 °C).
C yciisation o f  1 -(3 ,4 ,5 -trim ethoxybenzylam ino)cyclohexane- 
carbonitrile  (2). ' Cold ' cyciisation. The chloroform  ex ­
tract gave on evaporation  an o il (1.6 g) which after refluxing  
w ith  petroleum  (b.p. 40— 60 °C) gave 1~(3,4,5-trim ethoxy- 
benzylam ino)cyclohexanecarboxam ide  (9) (375 m g, 7% ), m.p. 
154", as small w hite prisms, vmnx 3 200 and 3 450 (N H 2 
am ide), 3 320 (NH  am ine), and i 660 cm"1 (CO); 8 7.17br 
(1 H , s, exch. N H  am ide), 6 .56 (2 H , s, ArH), 6.14br (I H, 
s, exch . N H  amide), 3.84— 3.88 (9 H , 2 s, 3 MeO), 3.56 
(2 H , s, ArCHjj), 1.6 (11 H, m , C5H 10 and exch. N H ); m/e 
322 (M 1, < l% ) ,  278 (90), 196 (50), and 181 (100) (Found: 
C, 63.7; H, 8.1; N , 8.5. C17H 28N 20 4 requires C, 63.4; H,
8.1; N , 8.7% ). C oncentration of the petroleum  solution  
yielded 2,3-dihydro-5,G ,T-trim ethoxyisoquinoline-3-spirocyclo-
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hexan-l{\'K )-one  (8) (1.1 g, 22% ), m .p. 128°; vniax 3 290 
(NH) and 1 650 cm '1 (CO); 8 6.38 (1 H , s, ArH), 4.00 (2 H , 
s, ArCH2), 3.90 (6 H , s, 2MeO), 3.84 (3 H, s, MeO), 1.85 
(1 H , s, exch. N H ), and 1.60 (10 H , m, C ,H ln) ; m/e 305 
(Af+, 31% ), 303 (10), 288 (5), 277 (3), 234 (3), 208 (100), 
193 (20), 181 (72), and 185 (20%) (Found: C, 66.5; H, 7.2; 
N, 4.6. C17H 23N 0 4 requires C, 66.8; H, 7.5; N , 4.6% ).
T he extracted aqueous solution  was reacidified w ith  
concentrated hydrochloric acid, basified w ith potassium  
hydrogen carbonate, and extracted  w ith  chloroform. 
D rying (M gS04) and rem oval of th e chloroform gave a 
small am ount of unidentified intractable gum.
T a b l e  1
Spectroscopic data  for benzylam inoacetonitriles
•'man./cm-1
C om pd. N H  C £N  Su
(2) 3 300 2 200 6.70 (2 H , s, A rH ). 3.85 (11 H , d , 3 Met)
a n d  A rC H a), 1.0— 2.2 (11 H *, m, C5H 10 
a n d  N H )
(3) 3 300 2 220 6.60 (2 H . s, A rH ), 4.0D (2 H , q, J  7 H z,
CHgCiTjO), 3.85 (8 H . s. 2 MeO an d  
A rC H 2), 1.7 (11 H  *, m, C6H 10 a n d  N H ), 
1.35 (3 H , t ,  /  7 H z, Q H jC H 2)
(4) 3 300 2 240 6.6— 7.4 (4 H , m, A rH ), 3.85 (2 H , s.
A rC H 2), 3.75 (3 H , s, MeO), 1.2— 2.2 
(11 H  *, m, C6H 10 an d  N H )
(5) 3 370 2 200 6.6— 7.4 (4 H , m, A rH ). 3.50 (2 H , s,
A rC H 2) , 3 .40 (2 H , s, N C H 2CN). 1.80 
(1 H  *, s, N H )
(6) 2 230 7.20 (2 H , d , J  9 H z, MeO CaH 4), 6.85 (2
H , d , J  9 H z, MeO C„H4), 6.71 [3 H , m,
(MeO)2 CaH a], 3.70 (6 H , s, 2 MeO), 3.6 
(3 H , s, M eO), 3.62 (2 H , s, A rC H 2N), 
3.43 (2 H , s, NCH..CN), 2.80 (4 II , s, N- 
(C H JgA r)
(7) 3 350 2 250 6.9 (3 H , in , A rH ), 3.82 (6 H , s, 2 MeO),
3.42 (2 H , s, A rCH 2), 2.50 (1 H  *, s, 
N H ), 1.85 (10 H , m, CcH l0)
* In te g ra l reduced  b y  1 H  a f te r  d eu te ria tio n .
' H o t 1 cyciisation. The dried chloroform extract, on 
evaporation  and fractional crystallisation  from petroleum  
(b.p. 40— 60 °C) gave the am ide (9) (320 mg, 6%), m.p. 
154", m ixed m .p. 154°, and th e  isoquinolone (8) (360 mg, 
6%), m .p. 128°, m ixed m.p. 128".
T a b l e  2 
B enzylam inoacetonitriles  
Found(%) R equ ired (% )
m pd. Y ield  (%) M.p.("C) C H N C H N
(2) 79 70 67.2 7.9 9.1 67.1 7.9 9.2
(3) 89 74 68.3 8.3 8.8 67.9 8.2 8.8
(4) 84 oil 74.0 8.3 11.4 73.8 8.2 11.5
(fi) 61 129 56.5 6.2 13.3 56.5 6.2 13.2
(decom p.) *
(6) 63 62 71.4 7.2 8.2 70.6 7.1 8.2
(7) 42 60 70.0 7.8 10.3 70.0 8.1 10.2
* B ase  HC1.
R eacidification of th e extracted  aqueous solution w ith  an 
excess o f concentrated hydrochloric acid gave a copious 
w hite precipitate (1.4 g) w hich was collected and suspended 
in w ater (100 ml). An excess o f potassium  hydrogen  
carbonate was added, the m ixture was extracted  three 
tim es w ith  chloroform (40 ml), and the com bined extracts  
were w ashed once w ith  w ater (10 ml), dried (MgSOa), and 
evaporated. R ecrystallisation  of th e  residue from 
petroleum  (b.p. 60— 80 °C) gave 2 ,3-dihydro-l - hydroxy-i) ,S-
18
1978
diniethoxyisoquinoline-'i-spirocyclohexan-4:(lH .)-one (10) (1.0 
g. 20%), m .p. 149°; vmnx 3 450 (OH), 3 350 (NH), and 
1 660 cm-1 (CO); 8 7.34 (1 H , s, ArH), 4 06 (4 H , s w ith  
shoulder, ArCHa, exch. N H  and  OH), 3.90 (3 H , s, MeO), 
3.88 (3 H , s, MeO), and 1.6 (10 H, m, CSH 10) ; m /e  291 
(M +, 40%), 290 (5), 263 (4), 248 (4), 232 (40), 220 (20), 
194(16), 167 (100), and 145.5 (10) (Found: C, 66.2; H , 7.3; 
N , 4.7. ClaH alN 0 4 requires C, 66.0; H , 7.2; N , 4.8% ).
Cyciisation o f  l-(i-ethoxy-3,5-dim ethoxybenzylam ino)cyclo- 
hexanecarbonitrile (3). ‘ H ot ’ cyciisation. A fter basific-
ation th e m ixture was washed w ith chloroform and th e  
organic layer discarded. R eacid ification w ith  concen­
trated hydrochloric acid gave a  w hite  precipitate which was 
collected and worked up as described in th e preparation of 
th e  isoquinolone (10). Crystallisation from petroleum  
(b.p. 60— 80 °C) gave w hite crystals (1.5 g, 30%), m .p. 
149°, which i.r. and n.m.r. spectra  showed to  be identical 
w ith  the isoquinolinone (10) (m ixed  m.p. 149°).
Cyciisation o f  2~(2-metkoxybenzylamino)acetonitrile (5).
' H o t ' cyciisation. The chloroform  extract gave 2,3-di- 
hydro-7-inethoxyisoquinolin-4( If/)-o n e  as a w hite solid  
(1.07 g, 27% ). The hydrochloride was prepared by  
addition of an excess of ethereal hydrogen chloride to  an  
ether-propan-2-ol solution and after crystallisation from  
ether-m ethanol (1 : 1) had m .p. 216— 218° (decomp.) 
(capillary tube, heated a t 10° m in-1 after insertion a t 200°) 
lit .,1 214— 215° and 224— 225°); 'j,n(ix (hydrochloride) 
1 675 cm '1 (CO).
Cyciisation o f  2-[N-(3,4:-dimethoxyphenetliyl)-4-methoxy- 
benzylamino]acetonitrile  (6). ' H o t  ' cyciisation. The dried 
chloroform extract, on rem oval o f the so lven t and re­
crystallisation from petroleum  (b.p. 60— 80 °C), gave  
\,2,2,A:-tetrahydro-tS,7-dimethoxy-2-(^-methoxyphenacyl)iso- 
quinoline  (11) (1.7 g, 33%), m .p. 121°, as pale yellow  needles; 
vnmx 1 675 cm  1 (CO); S 8.04 (2 H . d, J  8 Hz) and 6.88 
(2 H , d, /  8 H z, MeOC6H 4), 6 .56 (1 H, s, ArH), 6.47 (1 H , 
s, ArH), 3.88 (2 H , s, COCH2N ), 3.79— 3.82 (9 H , 3s, 
3MeO), 3.70 (2 H, s, ArCHaN ), and 2.74 (4 H, s, ArCHj- 
CHa*N); m /e  341 (Af+, 6%), 206 (100), 192 (60), 135 (26), and 
107 (12) (Found: C, 70.5; H , 6.7; N, 4.1. Ca0H 2aNO 4 
requires C, 70.4; H , 6.7; N , 4.1% ).
725
Cyciisation o f  1-(2,3-dim ethoxybenzylam ino) cyclohexane- 
carbonilnle  (7). ' H o t '  cyciisation. The dried chloroform  
extract on  rem oval of so lvent and recrystallisation from  
petroleum  (b.p. 80— 100 °C) gave 2,3-dihydro-5,Q-dimethoxy- 
<t-spirocyclohexylisoquinoline-3-spirocyclohexan-ik(lJi)-one  
(12) (0.25 g, 5% ), m.p. 106°; v ^ ' 3  250 (NH ) and 1 660 
cm '1 (CO); 8 7.05 (1 H , d, /  8 H z, ArH), 6.80 (1 H , d, 
f  8 Hz, ArH), 3.9 (2 H , s, ArCHaN), 3.80 (6 H , s, 2MeO), 
1.95 (1 H, s, exch. N H ), and 1.70 (10 H, m , CcH 10); m /e  
275 (M+, 30%), 247 (14), 232 (3), 178 (48), 151 (100), and  
150 (8) (Found: C, 70.0; H, 7.7; N , 5.2. ClaH 21N 0 3 
requires C, 69.8; FI, 7.7; N , 5.1% ).
A ttem pted cyciisation o f  l-(2>-methoxybenzylamino)cyclo- 
hexanecarbonitrile (4). ‘ H ot ’ cyciisation. The am ino-
nitrile (4) (5 g), after dissolution in concentrated sulphuric 
acid, dilution, basification, and extraction w ith chloroform  
gave only a trace of intractable gum . The extracted  
aqueous solution w as acidified to  pH  7 (pH  meter) and after 
tw o days w hite  crystals (4 g) appeared. These were 
collected, recrystallised from distilled w ater and dried ; 
m.p. 305° (m icro-hot-stage; uncorrected); vmft!C 1 090 and 
1 160 (SOa str.), 1 660 (CO amide), and 3 150’ and 3 400 
c u r 1 (N H a am ide); 8 9.10 (2 H , s, CO NH a) , 7.0— 7.80 (5 H , 
m , ArHj, N H , and S 0 3H ), 4.30 (2 H , s, ArCHa), 3.80 (3 H . 
s, MeO), and 1.4— 2.2 (10 H , m, CBH l0) (Found: C, 52.35; 
H, 6.45; N, 7.9; S, 9.1. ClsH aaN aOBS requires C, 52.6; 
H , 6.45; N , 8.2; S, 9.35% ).
Synthesis o f  l ,2 ,‘3,4:-Tetrahydro-6,7-dimethoxy-2-(4:- 
methoxyphenacyl) isoquinoline  (11).— 2-B rom o-4'-m ethoxy-
acetophenone (5.95 g, 0.026 mol) d issolved in absolute  
ethanol (50 ml) was added dropwise to  a  refluxing m ixture  
of l,2,3 ,4-tetrahydro-6,7-d im ethoxyisoqu inoline (5 g, 0.026  
mol) and anhydrous sodium  carbonate (5 g) in absolute 
ethanol (50 m l). A fter 8 h th e  m ixture w as filtered and  
cooled giving pale yellow  crystals. R ecrystallisation from  
absolute ethanol gave th e  product (4 g, 45% ) as pale yellow  
needles, m.p. 121° (m ixed m .p. 121°).
[7/1304 Received. 20th July. 1977]
1 G. Grethe, H. L. Lee, M. Uskokovic, and A. Brossi, J . Org. 
Chem., 1968, 33, 491.
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Cyciisation of Benzylamino-nitriles. Part 3.2 Synthesis of 
3-Imidazolines
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aSchool o f Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath 
BA2 7A Y
bDepartment o f Pharmacy, University o f Manchester, Manchester M 13 9PL
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Nucleophilic attack on the imino-iminium ion 
produced by treatment of (methoxybenzylamino)- 
acetonitriles with sulphuric acid has been shown to 
produce tetrahydroisoquinolinones.2 We now report 
that, with 4-methoxybenzylaminoacetonitriles (1), 
the absence of an alternative nucleophile allows only 
the addition of the imine to the iminium ion, with 
the formation of a 3-imidazoline ring (2). This is due, 
we assume, to the low reactivity of the aromatic 
nucleus in the o/Tfto-positions (relative to the imino 
group) and the high reactivity of the iminium ion. In 
accord with the work of Kirchner,3 the 
5-monosubstituted imidazoline (2k) was found to be 
unstable.
Techniques used: I.r.,1 H n.m.r., mass spec. 
References: 5
Tables 1—6: Spectroscopic data, m.p.s, and CHN 
analyses of 4-methoxybenzylaminoacetonitriles
(Tables 1 —3) and 3-imidazolines (Tables 4—6)
Scheme 2: General pattern of electron-
impact-induced fragmentation of 3-imidazolines
Scheme 3: Detailed fragmentation pattern of the 
imidazoline (2d)
Scheme 4: Postulated mode of decomposition of the 
imidazoline (2k)
Scheme 5: Fragmentation pathway of a pyrazine 
derivative derived from the imidazoline (2k)
MeO
( l i l - l l )
R R
cch 2 ] 5




c c h 2: 5 
C c h 2 ] 4
Me Me




[C H 21 5 
CCH2] 5
B z l  = b e n z y l  DMBzl = v e r a t r y l  
CIBzl = 4 - c h l o r o b e n z y l  
Scheme 1










B z l H




C IB z l 11
Paper: E/016/78
Received (as a submission to JCS Perkin I) on 27th 
September 1977; transferred by the Authors to J. 
Chem. Research on 10th February 1978
References cited in this synopsis:
2 Part 2, D. N. Harcourt, N. Taylor, and R. D. Waigh, JCS 
Perkin / ,  in the press.
JG. Kirchner, Artnalen, 1959,625, 104.
2 0
1330 J.C.S. Perkin I
Cyciisation of Banzyiamino-initrilas. Part 4 .1 Rearrangement with  
Cyciisation to a Benzyl! or Phenethyi Substituent
By David N. H arcourt and Norman Taylor, School of Pharmacy and Pharmacology, The University of Bath 
Bath BA2 7 AY
R oger D. W aigh ,” Department of Pharmacy, University of Manchester, Manchester M13 9PL
Methoxybenzylamino-acetonitriles with benzyl or phenethyi substituents attached to the nitrile a-carbon undergo 
spiro-cyclisation in concentrated sulphuric acid followed by rearrangement with cyciisation to the benzene ring of 
the substituent. The product is a tetrahydroisoquinoline or a 2-benzazepine depending on the substituent.
W e  have shown1 that methoxybenzylamino-aceto- 
nitriles produce a range of products when treated with 
concentrated sulphuric acid, all consistent with an initial 
spiro-cyclisation. One observation which led us to 
propose this mechanism was the production of a 3- 
benzoyltetrahydroisoquinoline (2a) rather than the 
expected 3-benzylisoquinolin-4(3//)-one (3a) from the 
nitrile (la) (Scheme 1). Here we describe further 
examples of this kind of rearrangement, and details of 
the original example.8
If the spiro-intermediate (4) is formed as described, 
only the ^>«ra-methoxy substituent should be required 
to produce a rearrangement product. This was con­
firmed by cyciisation of four nitriles (lb—e) which all 
gave the expected products (2b—e) in moderate to good 
yield and a high state of purity. As in the case of the 
original dimethoxybenzoyl rearrangement product (2a), 
spectral data were unambiguous. The presence of the 
methoxybenzoyl moiety is clear from the XH n.m.r. 
spectra, with typical AA'XX' coupling in the case of the
1 P a r t 2, D. N. H arcourt, N. Taylor, and R. D. Waigh. 
J.C .S. Perkin I, 1978, 722; P a r t 3. J . Chem. Research. 1978, (S) 
154; (M) X954.
monomethoxy-compounds, and fragmentation with loss 
of this moiety provides the base peak in the mass spectra.
Where the amino-nitrile is derived from veratrylamine 
[i.e. (1; R1 =  OMe)] there is a possibility of straight­
forward orf/io-cyclisation to give an isoquinolone (3). It 
is also possible to arrive at the same product after spiro- 
cyclisation, if the cyciisation to the imino- and methoxy- 
substituted ring is energetically comparable with 
cyciisation to the competing alternative. For an iso­
quinolone derived from an unlabelled CK-achiral or Ca- 
racemic veratrylamine it is not possible to distinguish 
between the two mechanisms. The amino-nitrile (If) 
produced equal amounts of the two products (2f) and 
(3f), the latter probably1 by a combination of both 
mechanisms. Alteration of reaction conditions (tem­
perature, concentration of acid) did not greatly affect 
the proportions of the two products. Separation was 
achieved by fractional crystallisation of the hydro- 
bromide salts, other approaches having failed.
When the aminonitrile a-substituent was increased in




length to phenethyi, as in structures (8a and b), the re­
arrangement process and concomitant cyciisation gave a 







a OMe H Me
b H H H
c H H Me
d H H CH2Ph
e H OMe Me
f OMo H H
data only, since it was not sufficiently volatile for mass 
spectrometry. In each case the most significant 
structural feature is the ^>-methoxy benzoyl moiety, 
which is clearly defined in both the 1H n.m.r. and mass 
spectra (where feasible). The sulphonic acid (9) shows 
a second AA'XX' aromatic system in the *H n.m.r. 
spectrum, for the sulphonated ring.
Together, these results suggest that spiro-cyclisation 
is often more favourable than the alternative ortho- 
cyclisation, even where the latter leads to a six- 
membered ring. This tends to support the assertion 4 
that ‘ reactions which involve spirocyclic intermediates 
are general. Such reactions may be expected whenever 
a compound containing a suitably substituted aromatic 
ring is subjected to reaction conditions which allow for 
aromatic participation.'
E X P E R IM E N T A L
M .p.s w ere ta k e n  on  a  K ofler h o t-s ta g e  a p p a ra tu s . I .r .  
sp ec tra  w ere recorded  w ith  a  U nicam  S P  200 o r Perlc in- 
E lm er 137 sp ec tro p h o to m e te r for p o ta ss iu m  brom ide d iscs  
o r liqu id  films. N .m .r. sp ec tra  w ere d e te rm in ed  fo r 
so lu tions in  deu terioch lo ro fo rm  using  P e rk in -E lm e r R 12  o r  
V arian  H A  100 in s tru m en ts . M ass sp e c tra  w ere o b ta in e d  
using A .E .I . M S12 o r  M S902 spectrom ete rs. M ass s p e c tra l 
ion  fo rm u lae  w ere o b ta in ed  b y  c o m p u te r  m a tch in g  o f 
a c cu ra te  m asses.
C yclisations w ere perfo rm ed  as  p rev io u sly .6 H y d ro ­
chlorides w ere p rep a re d  by  ad d itio n  of e th e rea l h y d ro g en  
ch lo ride to  a n  o rgan ic  so lu tion  of th e  base.
m Me
t c  * ■ ;« Q 3
CH2
( 6 ) a ; R= H 
b; R = 0M e
( 8 )
is interesting that a perfectly straightforward alternative 
carbocyclic reaction is possible, particularly with the 
amino-nitrile (6b), which has a second activated ring, 
to give a I-tetralone (8) (Scheme 2). Similar cyclisations 
in concentrated sulphuric acid are known,3 but in the 
present example only the 2-benzazepine was isolated, 
indicating the surprisingly low energy associated with 
the nitrogen-containing five-membered spirocyclic 
system. It is significant in this respect that where the 
secondary cyciisation was not aided by an activating 
group, as in (6a), the major product was a sulphonic acid 
(9), produced by rearrangement but without secondary 
cyciisation.
As with the other products reported here, the struc­
tures of the benzazepines (7a and b) are confirmed by 
n.m.r. and mass spectral data, elemental analysis, and 
i.r. data, while the sulphonic acid is assigned structure 
(9) from elemental analysis and i.r. and n.m.r. spectral
8 C. K. Bradsher, E. D. L ittle, and  D. J. Beavers, / .  Amer. 










S c h e m e  2
SGjH
(9)
P reparation o f  A m ino -n itr ile s .— C om pounds ( la — f) a n d  
(0a a n d  b) w ere p rep a re d  as p rev iously  described .8 A ll
8 M. S. Newman, Accounts Chem. Res., 1972, 8 , 364.




free  bases show ed w eak  ~C=N i.r. ab so rp tio n  a t  cu. 2 240 
cm "1; secondary  bases h a d  ab so rp tio n  a t  ca. 3 300
cm "1. l I I  N .m .r. d a ta  a re  given  in  T a b le  1, ana lyses in  
T a b le  2. T he p re p a ra tio n  o f th e  am in o -n itrile  (6b) w as
T a b l e  1
lH  N .m .r. d a ta  for b enzy lam ino -n itriles  (8 values, ]  in  H z)
(la) 1.45 (3 H), 1.59 (1 H), 3.00 (2 H), 3.85 (8 H), 6.84 (3 H, 
m), 7.30 (6 H)
(lb) 1.61 (1 H),* 2.94 (2 H, d, /  6 Hz), 3.53—4.05 (3 H, m),
3.67 (3 H). 0.78 (2 H , d, J  8 Hz), 7.17 (d, 2 H , /  8 Hz), 
7.22 (5 H)
(lc) 1.34 (3 H), 1.54 (1 H),* 2.89 (2 H), 3.64 (3 H). 3.78 (2 H),
6.70—6.79 (2 H, d, J  9 Hz), 7.08—7.30 (7 H, m)
(Id) 2.04 (1 H).* 2.93 (4 H). 3.86 (3 H), 3.77 (2 H), 6.76 (2 H,
d, J  8 Hz), 7.12 (2 H, d, J 8 Hz), 7.24 (10 H)
(le) 1.46 (3 H), 2.25 (1 H).« 2.90 (2 H), 3.80 (2 H), 3.84 (3 H).
3.87 (6 H), 8.75— 7.36 (7 H, m)
(If) |  3.4—3.7 (2 H . m). 3.86 (6 H), 4.05— 4.70 (3 H, m)
6.9—7.9 (8 H , m)
(6a) 1,47 (3 H). 1.50— 1.85br (1 H),* 1.70—2.15 (2 H , m),
2.62—2.95 (2 H , in), 3.72 (3 H, ) 3.80 (2 H), 0.76—7.30 
(9 H, m)
(6b) 1.42 (1 H),» 1.48 (3 H), 2.0 (2 H, m), 2.7 (2 H. m), 3.6—
3.84 (11 H, p a rtly  resolved), 6.6— 7.30 (7 H, m)
* Exchangeable, f Hydrochloride, in C6DtN.
T a b l e  2
B enzy lam ino -n itriles
Yield M.p. Found (°/(,) Required (%)
(%) (T/°C) C H N C H N
(la) 80 82 73.6 6.8 4.3 73 4 6.7 4.5
(lb) 56 160 » 07.2 6.1 9.2 67 4 8.3 9.3
(lc) 80 80 76 9 7.2 9.7 77.1 7.1 10.0
(id) 65 153*
(le) 75 c, d
(If) 33 176 " 64.8 6.2 8.7 65.0 6.3 8.4
(6a) 05 2 2 0 * 69 1 6.9 8.3 BOO 7.0 8.5
(6b) 65 c 71.4 7.5 8.1 71.2 7.3 7.9
• Hydrochloride, from cthanol-ether (m.p. with decomp.). 
* Crude hydrochloride, decomposed on warming in ethanol. 
'Sem i-solid. 13 Therm olabile; hydrochloride unstable.
ca rried  o u t  using  a  bo iling  w a te r-b a th , in s tead  o f a t  room  
te m p era tu re .
Isoqu ino lines.—-3-(3,i-D im ethoxybenzoyl)-3-m ethyl-1 ,2,3,4- 
tetrahydroisoquinoline (2a) cry sta llised  from  lig h t pe tro leum  
(b.p. 60— 80°); yield 33% , m .p . 138°, vmajL 1 660 an d  3 260 
cm "1, 8 1.55 (3 H ), 1.96 (1 H , exchangeab le), 2.65 an d  3.55 
(2 H , A B q, /  20 H z), 3.9 (8  H ), 6 .86  (1 H , d , J  8 H z), 6 .8— 
7.25 (4 H , in), 7.8 (d, J  2 H z), an d  8.25 (dd, J 8 , 2 H z), 
m /e  311 (2% , C ^H ^N O .,, M +), 165 (15, C0H 0Os), 146 (100. 
(Cl0H lsN), an d  144 (20) (F o u n d : C, 73.6; H , 6 .8 ; N, 4.3. 
C .oH ^N O s requ ires C. 73.6; H , 0.8; N, 4 .5% ).
3-(4-M ethoxybenzoyl)-l ,2 ,3 ,4-tetrahydroisoquinoli?ie (2b) 
w as o b ta in e d  as a  pa le  yellow  solid a f te r  ex trac tio n  w ith  
e th e r  a n d  rec ry s ta llisa tio n  from  lig h t pe tro leu m  (b.p. 80—  
100°); m .p . 110°, y ie ld  42% , 1 675 an d  3 300 cm "1,
8 2.23 (1 H ), 2.6— 3.1 (2 H , m), 3.83 (3 H ), 4.12 (2 H), 4.53 
(I  H , dd , J  6 , 10 Hz), 0.90 (2 H , d, /  9 H z), 6.90— 7.25 (4 H, 
m), an d  7.95 (2 H , d, J  9 H z), m /e 267 (2 .2% , C17H 17N O Pi, 
M ' ) ,  135 (21.2, C oH A j), 132(100, C„H10N), an d  130 (21.3, 
C0H „N ) (F o u n d : C, 76.4; H , 6 .5; N, 6.2. CI7H ,7NO fl 
req u ires  C, 76.4; H . 6 .4; N , 5 .2% ).
3-(4-M ethoxybenzoyl)-3-m ethyl-l,2 ,3 ,i-tetrahydroiso- 
quinoline  (2c) w as o b ta in ed  as w h ite  needles from  ligh t 
p e tro leu m  (b.p. 60— 80°) in  73%  y ie ld ; m .p. 125°,
1 660 an d  3 400 cm "1, 8 1.55 (3 H ), 1.90 (1 H , exchangeable),'
2.65 (1 H ; d , J  16 H z), 3.50 (1 H , d , J  16 H z). 3.82 (3 H ),
J.C.S. Perkin I
3.91 an d  3.94 (2 H , o u te r  lines of AB q u a r te t  n o t d iscernible),
8.85 (2 H , d , J  10 H z), 6.90—7.20 (4 H , m), and  8.33 (2 H . 
d , J  10 H z) (F o u n d : C, 78.8; H , 0 .7; N , 4.8. CmHmNO, 
requ ires  C, 76.9; H , 8 .8 ; N , 6.0% ).
3-Benzyl-3-{4i-methoxybenzoyl) 1,2 ,3,A-tefauhydroiso- 
quinoline  (2d) w as o b ta in ed  b y  e x tra c tio n  w ith  chloroform , 
followed b y  cry s ta llisa tio n  from  aqueous ethano l, in  38%  
y ie ld ; m .p . 136°, 1 886  an d  3 300 cm "1. 8 1.86 (1 H ),
2.66 (1 H , d , J  16 H z), 2.98— 3.36 (2 H , ABq, J  13 H z), 
3.38 (1 H , d, J  16 H z), 3.77 (3 H ), 3.86 (2 H ), 6.81 (2 H , d, 
J  9 H z), 6.7— 7.3 (9 H , m), an d  8.37 (2 H , d, J  9 H z), m /e  
357 (0.8% , CmH 2SN 0 8, M +). 266 (39.8, Cn H 16N 0 8), 222 
(100, CwH l0N), 136 (41.6, C8H 70 8), 131 (14.3, C„H0N), 130 
(44.4, CPH„N), 91 (21.0, C7H 7), an d  77 (13.4, C6H 6) (F ound : 
C. 79.8; H , 6 .6 ; N, 4.1. CMH MN O s requ ires C, 80.2; H , 
6.7; N. 4 .1% ).
6 ,7-D im ethoxy-3- (4-methoxybenzoyl) - 3-m ethyl-1,2,3,4-tetra- 
hydroisoquinoline (2e) w as ob ta in ed  a s  w h ite  needles in 
30%  y ie ld ; m .p . 116° [from  lig h t pe tro leu m  (b.p. 60— 80°], 
W  3 400  cm ~l . 8 1-60 (3 H ), 1.74 (1 H ), 2.55 (1 H , d, 
J  16 H z), 3.39 (1 H . d, J  16 H z), 3.74 (2 H ), 3.79 (9 H ), 
6.40 (1 H ). 6.56 (1 PI), 6.84 (2 H , d, J  8 H z), an d  8.37 (2 H , 
d , /  8 H z), m /e  341 ( < 1 % , M +). 206 (100), a n d  77 (20) 
(F o u n d : C, 70.6; H , 6 .8 ; N . 4.3. C ^H ^N O * requ ires 
C, 70.4; H , 6 .7; N, 4 .1% ).
3-(3,4-Dimethoxybenzoyl)-l,2,3,4r-tetrahydroisoquinoline 
(2f) and  3-B enzyl-^, 7-dim ethoxy-1,2-dihy droisoquinolin-
4(3H)-owe (3f) w ere o b ta in ed  as a  1 : 1 m ix tu re  (n .m .r.) 
(0.74 g, m .p . 84°) from  cyciisation  o f th e  am ino -n itrile  
hyd roch lo ride  (2g). C onversion in to  h yd rob rom ide sa lts  
w ith  gaseous h y d rogen  brom ide in  ch loroform  a n d  p re­
c ip ita tio n  w ith  e ther, followed b y  c ry s ta llisa tio n  from  
e thano l, gave cry sta ls , m .p . 240°, w hich  disso lved  in  w ate r. 
B asification  a n d  e x tra c tio n  p roduced  a  gum  w h ich  a f te r  
tr i tu ra t io n  w ith  e th e r  an d  c ry s ta llisa tio n  from  lig h t 
p e tro leum  (b.p. 80— 100°) gave th e  isoquinolinone (3f), 
m .p. 120°, vmIis. 1 670 an d  3 270 cm "1, 8 2.04 (1 H ), 2.66—
3.85 (3 H , m), 3 .94 (6  H ), 4.06 (2 H ), 6.05 (1 H ), 7.36 (5 H ), 
a n d  7.62 (1 H) (F o u n d : M \  297.138 9. ClaH leN 0 8 
requ ires  M , 297.136 5), m /e  297 (8.3% ) an d  .206 (100, 
Cu H laN O ,).
A ddition  of e th e r  to  th e  m o th er liq u o r gave, o ver severa l 
d ays, a  second c rop  of crysta ls , m .p . 228°, w hich  a f te r  
t re a tm e n t as above  a n d  rec ry s ta llisa tio n  from  ligh t 
pe tro leu m  (b.p. 60— 80°) gave th e  tetrahydroisoquinoline 
(21), m .p . 103°, Mmnr 1 675 an d  3 300 cm "1, 8 2.83 (1 H ). 
2.80— 3.10 (2 H , m), 3.93 (6 H), 4.19 (2 H ), 4.82 (1 H . dd , 
J  6 , 10 H z), 6.91 (1 H , d, J  9 H z), 7.12 (4 H , m), an d  7.54—  
7.78 (2 H , in) (F o u n d : M } , 297.135 6 . CtnH 10N O a requ ires 
M ,  297.136 5), m /e  297 (6.2% ), 165 (8.4, C8H „ 0 8). 132 
(100, C„HI0N), 131 (11.6, C8H„N), an d  130 (29.4, C0H 0N). 
A peak  a t  m /e  206 (13.3% , Cu H lsN 0 3) w as p resu m ed  to  
a rise  from  a  sm all a m o u n t of isoquinolinone (3).
3-(4rMethoxybenzoyl)-3-methyl-2,3,4k,5-tetrahydro-lH-2- 
benzazepine (7a).— T his  w as o b ta in ed  from  th e  am ino- 
n itr ile  (6a) in  6 % yie ld  as  a  sem i-solid  w hich  w ould  n o t 
crysta llise , 1 6 6 6  a n d  3 400 cm "1, 8 1.10 (3 H ), 1.20—  
1.30 (I H , m), 1.60 (1 H . exchangeab le), 2 .3— 3.3 (3 H , m),
3.48 (2 H ), 3.60 (3 H ), 6.69 (2 H , d J  9 H z), 6.70— 7.0 (4 H , 
m ). an d  8.30 (2 H , d , /  9 H z), m /e  295 ( < 1 % , M +), 160 
(100), an d  135 (20) (F o u n d : C, 77.3; H , 7 .2; N, 4.6. 
C10H 8IN O a requ ires  C, 77.3; H , 7.1; N. 4.75% ).
4t-[3-Amino-3-(i-m ethoxybenzoyl)buty[]benzenesulphonic 
A c id  (9).—-This w as o b ta in ed  from  th e  am in o -n itrile  (6a) by  
reacid ification  o f th e  cyc iisa tion  m ed ium  to  p H  6 .6  w ith
2 3
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hyd roch lo ric  ac id  a f te r  basifica tion  an d  ex trac tio n . A fte r 
severa l d a y s  w h ite  cry s ta ls  w ere  filtered  off a n d  rec ry s ta l­
lised from  w a te r  to  y ie ld  th e  su lphonic acid  (9), 30% , m .p. 
220° {decom p.), 890, 850, 1 010, 1 170, 1 665, an d
3 400 cm -1, 8 (D ,0 -C F sC O ,H ) 2.0 (3 H), 2 .30— 3.00 (4 H , 
m), 3.94 (3 H ), 7.0— 7.2 (4 H , 2d overlapp ing , J  8 .6  H z), 
7.75 (2 H , d , J  8.6  H z), an d  8.05 (2 H , d, J  8.5 H z) (F o u n d : 
C, 57.6; H , 5.85; N, 3 .5; S, 8 .8 . Cl0H alN O 5S ,0 .5H aO 
requ ires  C, 58 .05; H , 6 .0; N , 3 .8 ; S, 8 .6 % ).
7 ,&-Dimet hoxy-3-(<l-methoxy benzoyl)-‘S-m etkyl-2,3,4,5-tetra- 
hydro-lH -2-benzazepine  (7b).— T h is  was o b ta in ed  from  th e  
am in o -n itr ile  (6b) in  50%  y ie ld  as  fine w h ite  need les [from  
lig h t p e tro leu m  (b .p . 60— 80°)], m .p . 116°, vniftl 1 665 an d
1333
3 400 c m '1, 8 1.42 (3 H ), 1.50— 1.61 (1 H , m  an d  1 H , 
exchangeable), 2.60— 3.0 (3 H , m ), 3.63 (2 H ), 3.82 (3 H ).
3.86 (6 H ), 6.56 (1 H ), 6.70 (1 H ), 6.92 (2 H , d , J  9 H z), 
an d  8.28 (2 H , d , J  9 H z) [irrad ia tio n  of th e  m u ltip le t (8 
2.60— 3.0) reduced  th e  signal a t  8 1.50— 1.61 to  a  singlet], 
m /e  356 (1%  M \  CalH a5N 0 4), 312 (6 . C19H aaN 0 3), 220 
(100, C13H l0N O a), 203 (16, C „ H 16O a), a n d  135 (24) (F ound : 
C. 71.4; H , 7 .1; N, 3 .7% . CalH a5N 0 4 requ ires  C, 71.0; 
H , 7.4; N, 3 .9% ).
W e th a n k  Mr. P . L . H illis for ex p e rim en ta l assistance.
[7/2123 Received, 5th December, 1977]
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Oxidative C-defoeiizylatiort of 
bromide under mild alkaline
f-benzylpapaverinium
David Beaumont and Roger D Waigh
Department of Pharmacy, University of Manchester, Manchester MI3 9PL
Reaction of amines with 6- or 8-alkoxyisoquinolinium salts 
has been reported to give high yields of 6- or 8-alkylamino- 
isoquinolinium salts as appropriate.1 Whereas the authors 
have been able to improve these reactions using pyrrolidine 
or benzylamine with W-benzylpapaverinium bromide (I) 
to obtain amines (II), reaction with diethylamine did not 
proceed readily under the usual conditions. Prolonged heating 
was required for significant changes to be detectable by t.l.c., 
and work-up then gave the isocarbostyril (III, 35 per cent 
after recrystallisation from ethanol, mp 163-164°C, lit.2 
162-163 °C) as the only crystallisable product. Since this 
seemed most likely to result from air oxidation of the 
benzylidene isoquinoline (IV) occurring in the alkaline solu­
tion, rather than a specific effect of diethylamine, the reaction 
was repeated with potassium hydroxide as base. Under 
reflux in /-butanol in a system flushed with nitrogen no 
reaction occurred, but occasional bubbling with oxygen 
gave a 95 per cent yield of isocarbostyril (III). It was also 
possible to identify veratraldehyde as the other oxidation 
product by isolation as the dinitrophenylhydrazone and 
comparison with an authentic sample.






papaverinium salts in alkaline solution was reported3 using 
either copper(II) chloride or ultraviolet light with a free- 
radical initiator. None of the extra catalysts appears to be 
necessary.
Presumably the lack of reactivity of diethylamine in the 
alkoxy-substitution reaction is attributable to a slight increase 
in effective bulk compared with pyrrolidine, an effect further 
exemplified by the difference in reactivity between methyl- 
amine and dimethylamine. Both undergo reaction at room 
temperature over a period of several days, the former to 
give the amine (II, R =  MeNH, mp 200-202°C, 76 per cent 
yield), the latter to give dimethylamine hydrobromide as 
well as the isocarbostyril (III) and veratraldehyde, with no 
indication of any other products on t.l.c. All three products 
were identified by n.m.r. spectroscopy.
Amino-isocarbostyril has not been detected in reactions 
producing amino-isoquinolinium salts (II), which may be 
attributable to resonance stabilisation of the positive charge 
between the two nitrogens. However, under more forcing 
conditions (potassium hydroxide and oxygen), the quaternary 
salt (II, R =  MeNH) was converted cleanly into the amino- 
isocarbostyrils (V), mp 153-156°C, vmax. 1640 (C =0); 
8 2 92 (3H, d (broad), J =  4Hz, NH C//3); 3-92 (3H, OCH3)\ 
4-8 (1H, broad, NH)\ 519 (2H, NCtf2 Ph); 6-35 (1H, d, 
J =  7Hz, C4H)\ 6-43 (1H C5H); 7-28 (5H, Ar); 7-70 (1H, 
CRH). (Found: M+; 294 1366. Cl8H18N20 2 requires M; 
294-1368).
Monitoring of the reactions by t.l.c. was carried out 
using silica with butanol (70)/acetic acid (10)/water (25 parts 
by volume) as eluting solvent. Isocarbostyrils and veratralde­
hyde were separated on silica with ether as eluting solvent. 
Spots were visualised with aqueous potassium permanganate 
or iodochlorplatinate reagent. Melting points are corrected.
The SRC is thanked for an award to D.B.
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Bischler—Napieralski CycSssation of A/-[2-(2-Maphthy!)ethyl] amides 
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Electronic factors favour angular cyciisation o f 
naphthylethylamine derivatives (1), but steric inter­
actions between R1 and R3 in the product (3) have 
an opposing effect. Thus the dimethoxy analogue 
(la ) gave5 the angular dihydrobenz(ft]isoquinoline 
(3a), but the isomer (lb )  gave6 the linear 
dihydrobenz [gjisoquinoline (2b). The first reports 
of such cyclisations1 assigned, for example, the linear 
structure to the product from amide (lg )  but ac­
knowledged the inadequacy o f the data available at 
the time in distinguishing linear from angular isomers.
We have cyclised a series o f amides under typical 
Bischler—Napieralski conditions, and have obtained 
good yields o f  angular isomers (3) rather than the 
linear products (2), the distinction being made by 
means o f the aromatic coupling constants in the 
1 H n.m.r. spectra, clarified by the use o f Eu(fod)3 as 
shift reagent.
Angular cyciisation occurred despite acute steric 
interactions in the diphenylacetamide ( le ) , and with 
expulsion o f the blocking group (lh , i, j) where 
attempts were made to force linear cyciisation.
Attempts were made to isomerise the angular 
isoquinolinone (4) [from amide (If)] by analogy 
with other work,9 but without success.
a H H H OMe OMe
b H H OMe OMe H
c 11 H H H H
d CH2 Ph H H H H
e CHPh„ H U H H
f OEt H II H H
K Ph H H H H
h H Br H H H
i CH2 Ph Br H 11 H
j 11 SE t H H H
( 4 )
Techniques used: I.r., 1 H n.m.r., mass spec. 
References: 17
Paper: E /110/79
Received (as a submission to J.C.S. Perkin 1) on 21st 
May, 1979; transferred by the authors to J. Chem. 
Research on 30th July 1979
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Amine substitution in quaternary isoquinoiinium salts




Department of Pharmacy, University of Manchester, Manchester M13 9PL
Quaternary isoquinoiinium salts have been reported to 
undergo substitution in which a 6- or 8-methoxy group is 
replaced by an amino function on treatment with the appro­
priate am ine.1 2 N ow , it has been found that, whereas the 
quaternary salt (In) gives the expected product (Ha) on 
treatment with benzylamine and salt (16) gives the expected 
product (116) on treatment with methylamine (see Scheme 1), 
salt (la) undergoes an unexpected double substitution with 
methylamine to give (III), with the alternative m ono­
substitution products (IV) and (V) as intermediates (see 
Scheme 2).
2 -B en zy l-6, 7-dim ethoxy-l - isopropylisoquinolinium bro­
mide (16), mp 157— 158°C, was boiled with a 20-fold excess 
of benzylamine in ethanol for 20h to give the 6-benzylamino- 
isoquinolinium salt (Ha) in 94 per cent yield, mp 179— I80°C, 
from ethanol-ethyl acetate-ether. 2-Benzyl-6,7-dim ethoxyiso- 
quinolinium bromide (16) monohydrate, mp 115— 117°C, 
was treated with a large excess o f  methylamine in ethanol at 
room temperature for 8 days to give the 6-m ethylaminoiso- 
quinolinum salt (116), in 90 per cent crude yield, which 
recrystallised from ethanol-ethyl acetate-ether as the m ono­
hydrate, mp 114— 116°C. Heating in a pressure vessel at 
100°C for 7 days gave a similar result.
When the 1-isopropyl salt (la) was heated at 100°C with 
methylamine for 3— 11 days, or left at room temperature for 
28 days, the major product (61— 88 per cent yield) was 
I - isopropyl- 7-methoxy-2-m ethyl-6-methylam inoisoquinolin - 
iura bromide (III), together with benzylamine (identified 
by gas chromatography and by conversion into benzyl 
benzamide) and small quantities o f  benzyl alcohol and 
6,7-dim ethoxy-l-isopropylisoquinoline, presumably arising 
from hydrolysis. The structure o f  the major product was 
confirmed by reaction o f  methylamine with 6,7-dim ethoxy-i- Scheme 2
R'NH,
CH,Ph MeO CH,Ph
(1) (a), R' = i-Pi 
(b), R’ = H
(II) (a), R1 = i-Pr, R3 = CHjPh 













N H C II jP h
■■■ \'i i
(V)
P h C H jN H j
2 7
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isopropyl-2-methyiisoquinolinium iodide (V, X  =  I) which 
gave the expected 6-methylamino derivative (III), as the 
iodide. This iodide and the bromide (III, X^-Br) from the 
benzyl quaternary (la) gave the same tetrahydroisoquinoline 
(dihydrochloride mp 178— 181 °C), on reduction with sodium  
borohydride. Reaction o f  com pound (la ) with methyl 
amine at room temperature for 64h allowed the isolation 
o f  2-benzyl-l-isopropyl-7-m ethoxy-6-m ethylam inoisoquinc- 
linium bromide (IV), mp 211— 213°C, in 23 per cent yield, 
and the identification o f  6,7-dim ethoxy-l-isopropyl-2- 
methylisoquinolinium bromide (V), mixed with starting 
material, by 'H  n.m.r. spectral measurements.
The only precedents that can be found are the reactions o f  
/V-2,4-dinitrophenyl isoquinoiinium  or pyridinium salts with 
aniline, which are reported to give /V-phenyl products.3
It is proposed that the first step is attack at C (l)  by the 
amine (Scheme 2). In the present example this would give a 
highly crowded intermediate; steric strain would be reduced 
by ring opening and reclosure to give a 3-benzylam ino  
intermediate which would eliminate benzylamine to give the
Chemistry and Industry, 5 April 1980
observed product. Relief from steric strain would be much 
less o f  a factor in the absence o f  the 1-isopropyl substituent. 
Reaction o f Ar-benzylisoquinoIinium bromide with methyla­
mine produced a dark red viscous gum which was not 
readily amenable to the isolation o f  products. However, the 
presence o f benzylamine and /V-methylisoquinolinium bro­
mide could be demonstrated from 'H  n.m.r. spectra and by 
t.l.c., although the major products were not identified.
All isolated compounds had infrared, 'H  n.m.r. and 
C ,H , N  analyses consistent with structure; melting 
points are corrected.
The S.R.C. is thanked for an award to D.B.
Received 10 December 1979
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Rearrangement of Benzylam inonitriles to give Cyclohepta[c]pyrrol-6(2^1)-ones
B y R o g e r  D. W a i g h  
(D epartm ent o f P harm acy , U niversity o f M anchester, M anchester M l3 9PL.)
S u m m a ry  N -4-M ethoxybenzyl- an d  N -3 ,4 -d im ethoxy - 
benzy l-am inoace ton itriles w ith  b o th  2-aryl an d  JV-alkyl 
s u b s titu e n ts  undergo O -dem ethy la tion  and  rea rra n g em e n t 
w ith  e lim ination  of am m o n ia  in  con cen tra ted  su lphu ric  
ac id  to  give l-a ry l-lV -alky lcyclohep ta[e ]py rro l-6 (2 //)- 
ones.
P r e v i o u s  w ork1 has show n th a t  th e  benzy lam inon itriles  
( la ,b )  cyclise in co n c en tra ted  su lphu ric  ac id  to  give good 
y ields of th e  isoquinolinones (2 ), an d  th e re  is good evidence 
th a t  a  m a jo r ro u te  of cyc iisa tion  in m any  s im ilar exam p les2 
is th ro u g h  a  spiro in te rm e d ia te  (Schem e). I t  h a s  now  been 
show n th a t  th e  N -a lk y l analogues (S c.d .e an d  4) rearrange, 
p ro b ab ly  th ro u g h  a  com parab le  in te rm ed ia te , to  g ive  
in s tead  th e  cy c lohep ta [c]py rro l-0 (2H )-ones (3 c ,d ,e  an d  5) 
respective ly , in  10— 50%  yield.]:
T he difference in beh av io u r can  be te n ta tiv e ly  ex p la ined  if 
th e  sp iro  in te rm e d ia te  (Schem e) is considered  in  deta il. 
U n d er th e  v ery  s trong ly  ac id ic  co nd itions  p ro to n a tio n  w ould 
p ro b ab ly  occur on b o th  n itro g en  a tom s, w ith  th e  possib ility  
of ta u to m e rism  to  give th e  m o s t s tab le  con juga ted  im in ium  
sa lt. S uch a  sa lt could  undergo  cleavage of th e  five- 
m em bered  ring  to  give th e  in te rm e d ia te  p o s tu la ted  p re v i­
ously, o r a  tau to m er, w hen  th e  s ta r t in g  am ine is secondary  
(R 1 =  H , Schem e), b u t  w hen R ‘ =  alky l th is  p a th  is 
b locked. A longer lifetim e of th e  sp iro  in te rm e d ia te  m igh t 
rea so n ab ly  .be expected  to  le ad  to  O -dem ethy la tion , a p p a r­
e n tly  followed by  a  1,2 sh ift w ith  e lim ination  of am m o n ia  to  
g ive th e  observed  p ro d u c ts  (Schem e).
A ll an a ly tica l an d  sp ec tra l d a ta  (i.r., 1H  n .m .r., m.s., 
C ,H ,N  analysis) su p p o rt th e  cyc lo p h ep ta [c ]p y rro le  s tru c ­
tu re s . T he coupling c o n s ta n ts  for th e  ad ja c e n t p ro to n s  in 
th e  seven-m em bered  rin g  a re  12— 13 H z, in acco rdance  w ith  
pub lish ed  d a ta  on th e  p a re n t co m p o u n d ,3 a s  a re  th e  chem ical 
sh ifts  of th e se  p ro to n s  a n d  th o se  of th e  pyrro le  r in g  an d  th e  
N -m e th y l group. T he com pounds a re  b r ig h t yellow , chang ­
ing  to  deep  b lue o r green in  acid .
T o  te s t  th e  p roposed m echan ism , th e  am inon itrile  ( lc )  was 
p rep a re d  w ith  po ta ss ium  [,13C ]cyah ide  and  cyclised  as usual. 
T h e  p ro d u c t (3c) show ed en h a n cem e n t of a  p rev io u sly  low- 
in te n s ity  s ing le t a t  119-1 p .p .m . in  th e  13C n .m .r. spectrum , 
w ith  no sp lit tin g  in th e  off-resonance decoupled  spec trum , in 
accordance  w ith  ex p e c ta tio n  fo r a  ca rbon  in th e  r in g  ju n c tio n .
o
h 2 s o 4
tvl ,  f o r  O M e
r’
Me -  0
R r  H





- r ' -2 H*
CK
■’WT"..
{ 3 c - e )
R 1 R* R3 R*
a H Ph OMe OMe
b H DMP OMe OMe
c Me Ph OMe OMe
d Me DMP OMe OMe
e Me Ph H OMe
f Me Ph OMe H
DMP = 3,4-dimethoxyphenyl
S c H E M E f
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T he rem ain ing  concern w as w ith  th e  position  of th e  
m e thoxy -g roup  in the  seven-m em bered  rin g  o f com pounds 






th a t  th e  p re fe rred  isom er w ould be as  dep ic ted  since on ly  
th e n  could  th e  m e th o x y  g roup stab ilise  th e  positive charge 
develop ing  on  th e  sp iro  carbon  d u rin g  th e  1,2-shift. T his 
supposition  is borne  o u t b y  th e  la rge  (0-6  p .p .m .) chem ical 
sh ift difference show n b y  th e  p ro to n  f3 to  the  ca rbony l 
( /  13 H z) in  (3c) and  (3d) com pared  to  (5), w h ich  w ould only 
be ex p ec ted  if th is  p ro to n  could be desh ie lded  by  th e  rig id ly  
held a ro m atic  ring  in (5).
I t  has been n o ted  prev iously  t h a t  s tra ig h tfo rw ard  ortho- 
cyclisation  w ith  a  single a c tiv a tin g  m eth o x y -g ro u p  is n o t 
fav o u red ,4 an d  th is  w as borne o u t  b y  cyc iisation  o f th e  
n itrile  (If) w hich gave 10— 12%  yie lds of th e  isoquinolinone 
(6 ) a n d  w as o therw ise largely  su lp h o n a ted , w ith o u t cyciisa­
tion .
P . B ak e r an d  P . L . H illis a re  th a n k e d  fo r experim en ta l
assistance.
(Received, 1th A u g u s t 1980; Com. 873.)
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SHORT COMMUNICATION
Differentiation of Isomeric 
l 92-Dihydroisoquinolin“4(3ff)-one§ by 
Proton Magnetic Resonance of their 
4-BenzyI Derivatives
R oger D . W aigh
Department of Pharmacy, University of Manchester, Manchester M B  9PL, UK
Reaction of a 3,3-diniethyl-l,2-dihydroisoquinolin-4(3J[f)-one with a benzyl Grignard reagent gives a
4-bcnzyltetrahydroisoquinoline in which the signal of a 6-methoxy group suffers u large upheld shift in the 
‘HNM R spectrum, whereas a 7-methoxy group is relatively unaffected. This effect can be used to determine 
whether un RO-substituent is in the 6- or 7-position and, in particular, to distinguish isomeric derivatives 
with different RO-groups in the 6- and 7-positions. The method will allow the mechanism of cyclization of
3,4-dijnethoxybeuzylarainoacetonitriles to  be more fully elucidated.
It has been shown that benzylam inoacetonitriles un­
dergo cyclization in concentrated sulphuric acid to give 
l,2 -d ih yd ro isoq u in o lin -4 (3H )-on es' and that cycliza­
tion can proceed both by straightforward ortho  attack, 
and by rearrangem ent2 (Schem e 1). W here the starting 
m aterial is a 3 ,4 -d ioxygenated  benzylam ine, the two  
routes o f cyclization will give different 6 ,7 -  
dioxygenated l,2 -d ih ydroisoq u inolin -4(3fT )-ones, un­
less both oxygen substituents are the sam e. A  m ethod  
for distinguishing the isom ers where the oxygen sub­
stituents are different will be extrem ely useful, both to 
identify reaction products and to investigate the 
m echanism  of cyclization.
R-C)
S chem e 1. Alternative courses of cyclization of 
benzylaminoacetonitriles.
A s may be seen from  th e data given here, neither 
the 'H  N M R  spectra o f a representative ketone, 1, nor 
its reduction product, 2 , allow  any distinction to be 
m ade betw een 6 - and 7-m ethoxy groups, although 
there is the expected upheld shift o f H -5  caused by 
loss o f the anisotropic deshield ing effect o f the car­
bonyl group (see Fig. 1).
'H  NM R  spectra o f 1-b en zy l-1 ,2 ,3 ,4 -tetrahydroiso- 
quinolines have been studied  in considerable detail.1 
T he conclusion reached is that alkyl substituents vici­
nal to  the benzyl group in the heterocyclic ring force 
the benzyl group to adopt a conform ation in which the
aromatic ring lies under the 7 - and 8-positions o f the 
tetrahydroisoquinoline, with an anisotropic shielding  
effect which results in substantial upheld shifts o f the 
signals of H -8  and the 7-alkoxy group.
It was apparent that the introduction of a benzyl 
group into the 4-position of a 3-substituted tetrahyd­
roisoquinoline should produce a sterically analogous  
situation, with an upheld shift o f H -5  and the 6-aikoxy  
group. This was specifically accom plished in the pres 
ent instance by reaction with a benzyl Grignard reag­
ent to give the 4-hydroxytetrahydroisoquinoline 3. 
The induced shifts were even larger than those ob ­
served for 1-benzyltetrahydroisoquinolines,3 and will 
allow structure determ inations w here R' R 2 to be 
made with total confidence. In order to ensure that the 
effect is attributable to the anisotropic effect, and is 
not caused by a 4-alkyl substituent in any other way, 
the methyl Grignard adduct 4  was also prepared: the 
shift data are conclusive.
A s an exam ple o f the application o f the m ethod, the 
partially dem ethylated isoquinolinone 5, isolated from  
cyclization o f the appropriate 3,4-dim ethoxybenzy- 
lam inoacetonitrile, was considered. From NM R  data 
on the ketone itself two isom ers were possible, but 
reaction with benzylm agnesium  chloride gave adduct 
6, for which the chemical shift o f the O^—C H 3 sub­
stituent show s conclusively that it is in the 6-position .
E X P E R IM E N T A L ___________________________________
Spectra w ere obtained on  a Perkin-Elm er R 12B  spec­
trom eter, using 10% solutions in deuterochloroform  
with tetram ethylsilane as internal standard.
A cknow ledgem ents
I thank M. R. Euerby and C. Green for experimental assistance.
CCC-0030-4921/80/0013-0310$01.00
310 ORGANIC MAGNETIC RESONANCE. VOL. 13, NO. 4, 1980 © H eyden & Son Ltd, 1980
31
DIFFERENTIATION OF ISOMERIC 1.2-DIHYDROISOQUlNOLIN-4(3H)-ONES
Figure 1. Significant ’H
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A CONVrr-JILrjr S YNTM'l SIG OF 3-F'LTHYLTHIDUEN 2 AL DF MY f)E 
MgIvin Fueroy and Roger 0 . Waigh.
Depart  non t o f  Pharmacy. tin i  ve rs  i  t  y o f  M anchester .M anchester  M13 ?°i .
R e q u ir in g  t h e  t i t l e  compound as  a s t a r t i n g  m a t e r i a l ,  we were 
s u r p r i s e d  t o  f i n d  on ly  one p u b l i s h e d  s y n t h e s i s , ^  i n v o l v i n g  f i v e  
s t e p s  w i t h  an o v e r a l l  y i e l d  o f  151. This i s  in  c o n t r a s t  to  th e  2-  
and 4 - a l K y l t h i o b e n r a l d e h y d e s ,  which  nay be s y n t h e s i s e d  in  one s t e p  
by r e a c t i o n  o f  sodium a l h a n e t h i o l a t e s  w ith  the  r e a d i l y  a v a i l a b l e  
r . a i u b e n . ' n l . ' . ‘o s ' .  3 -Hal obenca ldehy  dc. •:». a l th o u g h  r e a d i l y  a va l  1 s t  is ,  
do n o t  r e a c t  under t h e s e  co n d i t io n s '" .
This  lacs*, o f  r e a c t i v i t y  was overcome by p r o t e c t i n g  t h e  a id e*  
hyde f u n c t i o n ,  as  the a c s t o l , form ing the Grignard r e a g e n t ,  and 
i n t r o d u c i n g  the  m e t h y l t h io  s u u s t i t u o n t  by r e a c t io n  w i t h  d im ethy l  
b i s u l p h i d e ,  in  an a d a p t a t io n  o f  a method r e p o r te d  by Ando and 
Emoto^ f o r  a r e l a t e d  s t r u c t u r e .  D e p r o t e c t io n  and d i s t i l l a t i o n  
gave t h e  pure a ld ehyde  in  B7'„ o v u r a l l  y i e l d .
*To whom c o r res p o n d en ce  should  be a d d r es se d .
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The Grignard r e o g c n t  was p repared  from 3-bromc:):enzaUiuhydc!
d i c t h y l a c e t a l  ( 5 ? g ) and magnesium ( 2 . 6 g )  in  dry TitK l.TU'Tml) ,  under
a a tm o sph ere ,  w hich was m a in ta in ed  w h i l e  d im eth y l  d i s u l p h i d e
( 9 .4 m l )  in  dry THE (50ml)  was added d ropwise , o v e r  39 m in u te s .
The s o l u t i o n  was r e f l u x e d  f o r  3;  h. , c o o lo d  and 20°. Ml 1.C1 s o l u t i o n
( 4 7 5 m l) added c a u t i o u s l y , Keeping the tem perature  t e l o w  2 9 ° .
E v o lu t io n  o f  m e t h a n e t h io l  was n o ted  dur in g t h i s  p r o c e s s ;  a t r a p  i s
a d v i s a b l e .  E x t r a c t i o n  w i th  e t h e r  gave  a l i g h t  brown o i l  ( 2 2 g , 9 3 t )
5 ( CDCl^) 7 .5 -1 -7 .11  ( 4H.m) , 5 . 4 4 ( 1 H , s ) . 3 . 56(4H.q J 7Hz) . 2 . 4 5 { 3 H , s ) , 1 . 2 1
( S H . t J  7Hz) ,  m/e 226 ( M*,2 3 * ) .  181 (100)  , 1 S3( 44 ) , 131 (6 ) , 125 ( 5 3 ) ,  7 7
( 2 1 ) .  Measured; (1*226-1026. C H 0Q_5 r e q u ir e s  fl 2 2 6 - 1 0 2 7 .12 10 .2
3 - M e t h y l th l o b e n z a ld e h y d e .
The abovu a c e t a l  (22g)  wjs  r e f l u x e d w i i r  2 M.,90 .  (250ml ) f o r
45 min. Work-up gave  the  a ld ehyde a s  a brown o i l  ■ I ' lg / r i ' , )  «t ic n
mss d i s t i l l e d  under a n i t r o g e n  a tm o s p h er e ,b .p ,  82 - 3 ° / ' - .  i5mm Hg
1 1 i  t 19 D ° /C . 4nm H g) , to  g iv e  1 1 . 1g (7 5 “.) o f  Pure a ld e h y d e ,  6 ( C Jf'l ^1
9 . 8 9  ( 1 H , s )  . 7 . 7 5 - 7 . 29(4rl,m) . 2 . 4 7 (  3 H . s ! , m/e 15 2 (T>r . 1 C P U , V. 1 (51)  .
1 2 3 ( 2 3 ) ,  1 0 3 ( 1 0 ) .  Measured: . 2 5 4 .  CJLllB requir e; , 152-U235.J o
We thanK the  S .R .C . fo r  an award ( t o  (•'.. R.C. )
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Rearrangements of benzylaminonitriles in sulphuric acid 
have previously been shown to provide routes to 
imidazolines1 and benzazepines20 and to various 
isoquinolines.17 20 The present work shows that alkyl- 
thio substituents on the benzene ring are effective 
activating groups for this kind of reaction, which does not 
proceed in the absence o f an electron-donating group.
To date the only activating group which had been 
utilised was alkoxy1'21720 which has the disadvantage 
when the reaction is applied to the synthesis of specifi­
cally required products, e.g. in medicinal chemistry, of 
being very difficult to remove later. We have therefore 
looked for removable activating groups, which might find 
application in many other synthetic sequences, using the 
aminonitrile rearrangement, with which we are familiar, 
as a test case. So far we have examined only the
1 ^ 1
i  V : : H*
X v
V MJ-Y y v v l
( l a - o )
< 2a -j ,m )
X Y Z R1 R2 R3
a MeS H H H Ic h 2 »5
b MeS H H H Me Me
c MeS H H Me ic ii2 :>5
d MeS H H Me Me Me
e EtS H H H lCH2 :>5
f EtS H H H Me Me
6 EtS H H Me [CH2 j>5
h EtS II II Me Me Me
i EtS H EtS H [CH2 ]>5
J EtS H E tS H Me Me
k EtS H H H Me PhCH,
1 PhCHgS H H H Me Me
m PhS H H II [CH2 ] 5
n PhS PhS II 11 [ch2 ]is
° It 11 H H (CH2 ]1 e
S cham a 2
activating potential of alkylthio and arylthio substituents 
in this context, without attempting their removal. 
However, there are many precedents for the removal of 
sulphur from aromatic rings.3
Our results show that spiro rearrangement (Scheme 2) 
to give the imidazoline (2a-h) was effectively activated 
by a single para methylthio or ethylthio substituent; 
rather longer reaction times were needed than with 
alkoxy activating groups,1 but yields were comparable, 
particularly at room temperature, with concentrated 
sulphuric acid as cyclising agent. At higher temperatures 
there was a tendency for S-dealkylation to occur, 
presumably giving the thiol which was isolated as the 
imidazoline disulphide (3a-d). Surprisingly, the doubly 
activated aminonitriles ( l i  and j) required a longer 
reaction time, perhaps because o f steric interactions in 
the transition state.
Lack o f an activating group, as with the aminonitrile
(10), again gave only the amide (5b) by hydrolysis. The 
amide (12) was also the only product identified when the 
para substituent was benzylthio, as with the aminonitrile
( 11).
Phenylthio activating groups, as in (lm  and n), gave no 
extractable product when sulphuric acid was used as 
cyclising agent. We attribute this to sulphonation, since 
the phenyl rings are themselves activated by the sulphur 
atom to which they are attached, and have sterically 
unprotected para positions. To avoid this problem, we 
investigated the use of polyphosphoric acid as cyclising 
agent. With the methylthio analogue ( lb ), we obtained 
both the imidazoline (2b) and the amide (13), in 
approximately equal proportions, and a time-profile of 
the reaction using gas chromatography indicated that
a 1 R2 R3
a H tCH2 '5
b H Me Me
c Me ( ch„;' 5
d Me Me Me
O NHR
"To receive any correspondence. 
tP art 4 is ref. 20.
R1 R2 R3
r H Me Me
s Me tCH2i>5
h Me Me Me
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(5 b ) H it tCH,21 5
( 1 2 ) PhCH2S II Me Me
(1 3 ) MeS H Me Me
(17) PhS It [CH,2*5
(19) PhS PhS [CH2*5
( i i )
longer reaction times would make little difference. With 
the phenylthio compound (lm ) a comparable picture was 
obtained, but with relatively little imidazoline (2m) 
formation compared to amide (17). This is consistent 
with a weaker activating effect from the phenylthio 
substituent compared to methylthio, and inability of the 
amide to form a suitable electrophile in polyphosphoric 
acid for electrophilic attack at the spiro  position. In 
accord with these results, the disubstituted nitrile (In) 
gave only the amide (19).
It was found previously20 that a b e n z y l  side-chain 
could attack the iminium ion after rearrangement to 
give a 3-benzoyl-l,2,3,4-tetrahydroisoquinoline as the 
ultimate product. This was also the case with an ethylthio 
activating group, in the one example studied, where the 
aminonitrile (lk ) gave the tetrahydroisoquinoline (11).
The ready hydrolysis o f the imidazolines was exemp­
lified by the conversion o f (2 f-h ) to the aminoketones 
(9f-h) in dilute hydrochloric acid.
In the full text we have given preparative methods, 
physical constants, and spectroscopic and analytical data 
for the benzaldehydes and benzylamines required as 
intermediates, as several of the aldehydes and all but two 
of the benzylamines are new.
We thank the S.E.R.C. for an award (to M.R.E.). 
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Table 1: Yields of benzylaminonitriles 
Table 2: Yields of 3-imidazolines
Table 3: Relative yields of 3-imidazolines and 3-imidazoline 
disulphides formed under differing ‘hot’ cyciisation 
conditions
Tables 4 and 3: Spectroscopic data for benzaldehydes
Table 6 : M.p.s., yields, and reaction conditions for the 
benzaldehyde oximcs
Tables 7 -9 : B.p.s., m.p.s., and CHN and spectroscopic data for 
the benzylamines
Tables 10-12: M.p.s. and CHN and spectroscopic data for the 
benzylaminonitriles
Tables 13-15: .Yields, m.p.s., and CHN and spectroscopic data 
for the 3-imidazolines
Tables 16-19: M.p.s., and CHN and spectroscopic data for the 
3-imidazoline disulphides
Tables 20-22: Yields, m.p.s., and CHN and spectroscopic data 
for the a-aminoketones
Figures 1 and 2: The proportion of reaction products from the 
cyciisation of aminonitriles ( lb )  (Figure 1) and (lm ) (Figure 2) 
in polyphosphoric acid at 75 °C versus time
Schemes 1 and 2: The postulated mode o f formation of 
3-imidazolines
Scheme 3: a-Aminoketones synthesised
Scheme 4: The postulated mode of formation of 3-benzoyl- 
1,2,3,4-tctrahydroisoquinolines
Scheme 5: Polyphosphoric acid cyciisation of the aminonitrile 
( lb )
Schemes 6 and 7: Postulated mode of formation of products 
from polyphosphoric acid cyclisations
Schemes 8 and 9: Polyphosphoric acid cyclisations of amino­
nitriles lm  (Scheme 8) and In  (Scheme 9)
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Rearrangement and Cyciisation of A/-(2-Hydroxyph@nethy8)“ 
2“aminom8thylthiophans
C h a r le s  SVlackay a n d  R o g e r  D . W a ig h  *’
D epartm en t o f  Pharm acy, U niversity  o f M anchester, M an ch ester M 1 3  9PL, U.K.
Treatm ent w ith  acids converted  /V -(2-hydroxy-2-pheneth yl)-2 -am inom ethylth iophens into thienotetrahydro- 
pyridines in g o o d  yield; w ith  trifluoroacetic acid th e  major product w a s th e rearranged 7 -p h e n y l-4 ,5 ,6 ,7 -  
tetrahydrothieno[3 ,2 -c ]  pyridine, w hereas w ith polyphosphoric acid th e product formed exclu sively  w a s the 
non-rearranged 4-p h en y!-4 ,5 ,6 ,7 -tetrah yd roth ien o[2 ,3 -c]p yrid in e.
As part o f an investigation1 into sp/ro-rearrangements of the 
system aryl-C -N -C -C , we have been investigating the claims 
made in a patent8 that thiophen derivatives o f type (1) cyclise 
under various acidic conditions (specifically mentioned are 
phosphoric, polyphosphoric, concentrated sulphuric, and 
trifluoroacetic acids) to give thienopyridines (2). In our hands, 
trifluoroacetic acid (TFA) under reflux for 8 h has given clean 
products with very high yields o f cyciised material (Table 1), 
which n.m.r. spectroscopy has shown to consist of mixtures 
of the two isomers (2) and (3), the latter predominating
(Table 1). We assume that the latter is formed by a spirocyclic 
rearrangement, as in Scheme I . Cyciisation of the 3-substituted 
thiophen (4) gave exclusively the thienopyridine (3; R=H), 
identical with that obtained by rearrangement from alcohol 
(1), in accord with the expected position of electrophilic 
attack on thiophen. The isomers were readily distinguished by 
the separate resonances of 3-H in (2) and (3), the former 
showing a relative upfield shift o f ca. 0.2 p.p.m. owing to 
shielding by the phenyl ring (Table 1).
We were surprised by a recent report by Maffrand and co-
Table 1.
Isom er
irting  materia! Cyclising agent Crude yield (% ) com position (% ) N.m.r. (3-H , 8)
(2 ) (3)
(1, R  =  H) TFA 100 2 0 11 80 * 6.55, 6.76
PPA 89 100 6.55
H F 100 100 6.55
(1; R  =  Me) TFA 100 l l a 89" 6.24, 6.41
PPA 100 100 6.24
(4) TFA 70 100 6.76
“ Approxim ate, from n.m .r. integrals.
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w o rk ers ,3 th a t cyciisation o f  th io p h en  (1) w ith  po lyphospho ric  
ac id  (P P A ) a t 60 °C  gave, a f te r  c rysta llisa tion  o f  the herai- 
oxa la te , a  57 %  yield o f  the th ien o p y rid in e  (2 ; R = H ). H ow ever, 
w e have been  ab le to  confirm  th e  iden tity  o f th e  p ro d u c t using  
th e ir  c o n d itio n s  an d  to  show  th a t  th e  c ru d e  cyciisation  p ro d u c t 
co n ta in ed  n o  rearranged  m a te ria l de tec tab le  by 'H  n .m .r. 
spectro scopy . F u rth e r, w ith  p o ly p h o sp h o ric  ac id , the m ethyl 
ana lo g u e  (1 ; R =M e), in w hich  rea rrangem en t is even m o re  
likely, gave only  the th ieno [2 ,3 -c]py rid ine  (2 ; R = M e).
i t  is possib le  th a t the  fo rm a tio n  o f  d ifferent p roducts  is 
re la ted  to  different m echan ism s o f  cyciisation , one  in  the  
strong ly  ac id ic  tr ifluo roace tic  a c id  involv ing  a  c a rb o n iu m  ion  
in te rm e d ia te  an d  the  o th e r in  th e  m uch  less strong ly  ac id ic  
p o ly p h o sp h o ric  ac id  involving a  com plexed  a lco h o l (Schem e 1).
794
Phocr
Scheme 2. Only one optical form is represented for simplicity.
H ydrogen  fluoride, w hich is also relatively  w eakly ac id ic , gave 
a  sim ilar resu lt to  po lyphospho ric  ac id  (T ab le 1).
I f  cyciisation  o f  th e  com plexed a lco h o l to  give th e  spiro- 
in term ed ia te  is un fav o u rab le  fo r s teric  reasons, as  seem s qu ite  
p ro b ab le  fro m  m olecu lar m odels, th e n  th e  lack o f  rea rra n g e ­
m ent in p o ly phospho ric  ac id  an d  h yd rogen  fluoride is ex­
p la ined . C yciisation  o f  a  com plexed  alcoho l, in  a  m an n er 
ana logous to  an  S N2  reac tion , is a lso  consisten t w ith  the 
observation  by  M affrand  an d  co -w orkers3 o f  inversion  o f  
configura tion  a t th e  c a rb o n , w hich is sub jec t to  nucleophilic  
attack , in /V -th ienylm ethylnorephedrine (Schem e 2) w hen 
using po ly p h o sp h o ric  acid . I t shou ld  be  no ted , how ever, th a t 
cyciisation o f  iV -benzoylephedrines a n d  pseudoephedrines in 
su lphu ric  ac id , to  give isoqu ino line derivatives, p ro d u ced  the 
sam e trans  p ro d u c t w hether the s ta rtin g  m ateria l w as threo  o r  
erythro .4 T h is  im plies a  m echan ism  ana logous to  an  ,SN1 
reaction , sterically  co n tro lled  by th e  ad jacen t ch iral centre.
In the  p resen t case, fo rm a tio n  o f  a  ca rbon ium  io n  w ould  
result in a  less sterically  h indered  e lectroph ile , w hich co u ld  be 
a ttacked  by the  th iophen  rin g  from  its  electronically  preferred  
2 -position  to  give the  .spiro-interm ediate (Schem e 1), w ith  
subsequen t ring-open ing  a n d  rec lo su re  to  give the  isom er (3). 
I f  these m echan istic  argum ents a re  co rrec t, th e  presence o f 
substituen ts  o n  the  phenyl ring  w hich stabilise the  ca rb o n iu m  
ion  will tend  to  favou r rearrangem en t, w hether th e  cyclising 
agent is s trong ly  o r  w eakly acidic. S om e recen t s tru c tu ra l 
assignm ents fo r p-m ethoxypheny l ana logues6 m ay  therefo re  
need to  be revised, as indeed  m ay so m e o f  the stru c tu res  de­
scribed in  th e  ea rlie r p a te n t .3
W e th a n k  the  S .E .R .C . fo r a  C .A .S .E . aw ard  (to  C . M .), 
D r. C . W . T h o rn b e r  fo r his in terest, a n d  I.C .I. P harm aceu ticals  
D ivision  fo r ad d itiona l suppo rt.
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Rearrangement of /V""f4-metho.xybeniyi!“1"plieiiyf”2 “amino- 
ethanol to give 4-aryltetrahydrossoqyinolines and a 
diarylethylanmine
Melvin R Euerby and Roger D Waigh
Department of Pharmacy, University of Manchester, Manchester Ml 3 9PL
Over the past decade considerable use has been made o f  the 
cycljsation o f  /V-benzylphenylethanolam ines (see Schem e) in 
order to produce tetrahydroisoquinolines1'6 o f  medicinal 
interest. The am ino-alcohols have been cyciised with various 
reagents, for exam ple polyphosphoric acid ,6,7 sulphuric 
a c id ,1,5,6 hydrogen brom ide,7 m ethanesulphonic acid,6 
anhydrous alum inium  chloride,3 ,1 hydrochloric acid ,8 boron  
trifluoride,6 and trifluoroacetic acid/sulphuric acid 
m ixtures.2 The general im pression is that m ost acids are 
effective and that the choice is an individual one.
Recently, it has been found that the closely analogous 
yV-(2-hydroxy-2-phenethyl)-2-am inom ethylthiophens,9 yield 
4-phenyl-4,5,6,7-tetrahydrothieno[2,3-clpyridines in poly­
phosphoric acid (P P A ) and 7-phenyI-4,5,6,7-tetrahydro- 
th ieno[3,2-clpyridines in trifluoroacetic acid (TFA ) by 
rearrangement through a spiro-interm ediate. This 
observation prom pted the authors to investigate the 
cyciisation o f  /V-(4-m ethoxybenzyl)-1 -phenyl-2-am ino- 
ethanol (I), in which the m eth oxy group activates the 
benzene ring towards form ation o f  spiro-interm ediate (II)
(see Schem e).
Cyciisation in P P A  ( lh , 75-80°C ), as indicated by ‘H  
n .m .r. and g .c .,  yielded only the unrearranged 6-methoxy-4~ 
ph en yl-1 ,2 ,3 ,4-tetrahydroisoquinoline (III, 96 per cent, mp 
HC1 237-8°C , L it.10 mp 238-9°C ). By com parison, 
cyciisation in T FA  (16h, reflux and then r.t. for 32h) was 
fou nd  to yield an o il (88 per cent) which from  g .c. on  1 per 
cent Dexsil 300 at 210°C  contained at least three products, 
o f  retention tim es and proportions 3 .0  min (67 per cent), 4 .4  
m in (21 per cent) and 5.3 m in  (12 per cent). The un­
rearranged product (III) from  P P A  cyciisation had a 
retention tim e o f  4 .4  min and an identical mass spectrum to 
that in the g .c ./m .s .  o f  the m ixture, for the peak at 4 .4  min.
If the spiro-interm ediate (II) w as formed, it w ould ring- 
open to yield the im inium  ion (IV) which could be attacked 
by either o f  the arom atic rings giving the tetrahydroiso- 
quinolines (V) and (VI) (see Schem e). C om pounds (V), mp 
HC1 201-6°C , (Lit. mp" 210-11°C ) and (VI), mp 74°C , (Lit. 
m p12 76°C) were unam biguously prepared by cyclisations o f
the corresponding am ino-alcohols in P P A . The cyciisation  
o f  the am ino-alcohol which gave the 7-m ethoxy-4-phenyl- 
1,2 ,3 ,4-tetrahydroisoquinoline (V) also yielded ortho- 
cyclised 5-m ethoxy-4-phenyl-1 ,2 ,3 ,4-tetrahydroisoquino­
line. In this synthesis, vV-(3-m ethoxybenzyl)-l-phenyl-2- 
am inoethanol w as heated in P P A  at 75-80°C for lh  to give a 
mixture o f  the tw o isom ers with a crude yield o f  94 per cent.
.hydro lysis
Scheme
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The product hydrochlorides were separated by fractional 
crystallisation from  absolute ethanol to give isomer (V) in 31 
per cent isolated yield and the 5-m ethoxy analogue, mp 
96-7°C , mp HC1 227-31°C, in 15 per cent isolated yield; the 
crude yield was 50 per cent o f  isomer (V) and 44 per cent o f  
the 5-m ethoxy analogue, based on n.m .r. spectra and g .c. o f  
the mixture.
Unfortunately both com pounds (V) and (VI) had reten­
tion times o f  5.3 min. A ttem pted separation by m ethylation  
and silylation failed to resolve the com pounds on the above  
colum n and also on  3 per cent Dexsil 410 and 2 per cent 
OV-17 colum ns. Normal phase h .p .l.c . using a Partisil 5 
colum n also failed to resolve the com pounds. The g .c ./m .s .  
o f  the peak at 5.3 min when compared to the m .s. o f  
com pounds (V) and (VI) indicated that both were present, 
but the exact proportions cou ld  not be determined.
The major product from treatment with TFA  was the 
diarylethylam ine (VII) arising from hydrolysis o f  the imine 
(IV). C om pound (VII), m p HC1 176-8°C (Lit. m p13 
182-4°C) was unam biguously prepared by the reduction o f
2-(4-m ethoxyphenyl)-2-phenylethanenitrile. The authentic  
material had the same retention time as the com pound  
giving the peak at 3 .0  min, and was identical as shown by 
infrared, n .m .r. and mass spectral measurements.
C yclisation o f  the am ino-ethanol (I) in a mixture o f  TFA , 
80 per cent w /w  sulphuric acid and dichlorom ethane, 
essentially as described by Pridgen and co-w orkers,10 gave as 
major product the non-rearranged isoquinoline (III), 
confirm ing their results. H ow ever, the presence o f  the 
rearrangement products in a total yield o f  26 per cent was 
dem onstrated by g .c ..
It seems highly probable that the reactive intermediate
(IV) would cyclise in much higher yield if  one o f  the 
aromatic rings bore a suitable activating substituent. This 
will be the subject o f  further study.
G .c. studies with 1 per cent Dexsil 300 were performed on  
a Pye-Unicam  series 204 instrum ent with a 1 .7 M x 4 m m  
Chrom osorb W .H .P . mesh 80-100 colum n. A ll com pounds 
gave mass spectra, and infrared and 'H n.m .r. spectra which 
were in accord with the structures proposed. All melting  
points are corrected. The SERC is thanked for an award (to  
M .R. Euerby).
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SWethySihao Activating Groups in the Synthesis off Isoquanolines
M elvin R. Eueriby and R oger D. W aigh*
D epartm ent o f  Pharmacy, U niversity o f  M anchester, M anchester M l3 9PL, U.K.
Methylthio activating groups have been found to improve the yields in six different isoquinoline syntheses: in four 
cases the im provem ent w as from zero, in the unactivated system , to betw een 54 and 94%.
M ost o f the widely used  syntheses of isoquinolines p roceed  by 
acid-catalysed a ttack  o f a su itab le  functionalised  /'/-substitu ted  
phene thy lam ine  o r benzy lam ine on th e  benzene ring o f the 
am ine. They a re  thus rep resen ta tiv e  o f a  w ider range of 
reac tions p roceed ing  by electroph ilic  a ttack  on  an  arom atic  
system , many o f which a re  d ependen t on  the presence of 
su itab ly  placed e lec tron -dona ting  substituen ts . In the  absence 
of activating  g roups, reac tio n s  o f the  last kind e ith e r fail 
com pletely , at te m p era tu res  below  the decom position  point of 
the  starting  m ateria l, o r  give relatively p o o r yields under 
forcing conditions.
T h e  m ost widely used  ac tivating  g roup  in the synthesis of 
isoquinolines has been  the  m ethoxy g roup , which is difficult to 
rem ove after cyclisation an d  is th e re fo re  not desirab le  w here 
the u nsubstitu ted  ring is req u ired . M ethylth io  ap p eared  to  be 
a su itab le  a lternative , w hich w ould lend  itse lf to  rem oval by 
reductive d esu lphu risa tion . T he ac tivating  po ten tia l o f 
m ethy lth io  in this kind o f  reaction  has been  estab lished  in the 
benzylam inonitrile  re a rra n g e m e n t . 1
It w as an im portan t prelim inary  to  this w ork tha t we should 
find a conven ien t synthesis of 3-m ethy lth iobenza ldehyde ,3 
from  w hich all th e  phene thy lam ines an d  benzylam ines used as 
in term edia tes are derived . All the  starting  m aterials w ere 
p rep a re d  from  this a ldehyde by variations o f the  litera tu re 
m ethods used for the m ethoxy an a lo g u es .3''1
T he types of cyclisation chosen fo r investigation w ere those 
w hich we have found to  be reliab le with the m ethoxy 
analogues: they a re  detailed  in Schem e 1 as reactions 
(A )— (F ). W here possib le reac tion  conditions w ere as des­
c ribed  in  the orig inal lite ra tu re  fo r the  m ethoxy analogues; any 
variations o r  innova tions a re  de ta iled  in foo tno tes to T able 1. 
T he use o f anhyd rous  hydrogen fluoride in place o f concen­
tra ted  su lphuric  acid for the benzylam inonitrile  [reaction (C)] 
was particu larly  beneficial and is also useful for the m ethoxy 
ana lo g u e .5
It m ay be no ted  th a t, com pared  to  th e  results in T able 1, 
reac tions (A )— (C ) an d  (E ) do  not give any cyclisation 
p roducts6—10 in the absence o f an  activating group. The
Table I. The results and conditions for reactions (A)—(F)
Isomer compositions (isolated yield)h/%
Cyclisation" Cyclising agent Crude yield/% ortho M .p .fC ) para M .p .rc )
(A) HCI 9  p . 37 (7) 138— 140 49(32) 102
B) HC1 54 7(4) oil 47 (33) 46— 47(c) H,SO* 13 7.5 (21) 5.5'
HFC 76 69(51') 182— 1851 7'
(D) PPA" 88 42 (0 ) 169— 174i 46 (241) 203—208'
TFA" 79 37 42
HF' 78 38 40
(E )R  = 1-Ph TFA 94 — 94 (75) 79—80
R = 1-H HCI 58 _ 58 (511) 230—2351
(F) R -  1 -Ph POCI, 89 89 (64k) 166—169"
R = 1-H POCI, 21 21( l5 k) 147—151"
" For the methoxy analogues of (A), see refs. 6 . 7; (B). ref. 8 : (C). refs. 9. 10; (D). ref. 13: (E), ref. 14 (Ph). 15 (H); (F). ref. 16 (Ph), 
17 (H). I-4-Hydroxytetrahydroisoquinolines (ref. 6 ). ‘ Room temp., 20 days. 11 PPA = polyphosphorie acid, 75—80°C for I h. * TFA = tri- 
fluoro acetic acid, reflux. 7 h. 1 Room temp.. 18 h. » Determined by gas chromatography or 'H  n.m.r. spectroscopy. h For identification 
purposes only: no attempt was made to optimise isolation procedures. 1 Identified by reduction and comparison with the product from 
reaction (A), i Hydrochloride. k Flemioxalate.
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Pictet-Spengler reaction [(E), R = Ph] was recently reported 
to succeed without activation,11 but in our hands only starting 
materials were obtained.
We have desulphurised several of our cyclic products by 
treatment with nickel boride in yields of between 84 and 93%. 
The method, which is basically that of Truce and co­
workers,12 also reduces ketones to alcohols. In the present 
series of compounds the crude product from reaction (D), i.e. 
the mixture of methylthio-4-phenyltetrahydroisoquinolines, 
gave clean 4-phenyl-I,2,3,4-tetrahydroisoquinoline in 84% 
yield, using a molar ratio of organosulphur compound: nickel 
chloride : sodium borohydride of 1:10:30. Provided that
128
sufficient nickel boride was formed the ratios were not critical. 
In some cases a basic product was adsorbed on the catalyst and 
was best liberated by dissolution in dilute hydrochloric acid 
followed by basification with ammonia to form the nickel 
complex before extraction with chloroform. With this modifi­
cation applied when required, no desulphtmsation has as yet 
failed. Some of the other compounds which have been 
desulphurised are as follows (product and percentage yield in 




hydroisoquinoline, 91%], 4-(4-methylthiophenyl)-3-imidazo- 
line-5-spirocydohexane1 (5-phenylimidazoline-4-spirocycIo- 
hexane, 92%), 4-(4-methylthiophenyl)-l,5,5-trimethyl-3- 
imidazoline1 (5-phenyl-3,4,4-trimethylimidazoline, 93%). 
The imidazolines underwent a double-bond shift which will be 
discussed elsewhere.
Since the activating group is removed later it does not 
matter whether cyclisation proceeds ortho or para, but it is 
interesting to note the variation in the proportions of the two 
isomers. The benzylamjnes gave proportionately more 
material from cyclisation ortho to the activating group than the 
phenethylamines: in one case the ortho product [reaction (C) 
with hydrogen fluoride] predominated.
We thank the S.E.R.C. for an award (to M. R. E.).
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A NEW SYNTHESIS OF 1 ,2-DIHYDRO'B'CARBOl.IN-4 ( 3H)-ONES 
C h a r le s  Mackay and R oger 0 . Waigh
D epartm ent o f  Pharm acy, U n iv e rs i ty  o f  M anchester, M an ch es te r  M13 9PL, U.K. 
A b s t r a c t  -  A m in o n it r i le s  d e r iv e d  from 3 -am inom ethy1in d o le s  a re  r e a r r a n g e d  by
t r e a tm e n t  w ith  p o ly p h o sp h o ric  a c id  a t  UQ C o r s u lp h u r ic  a c id  a t  0 C, to  g iv e  
1, ? -d ih y d ro -(5 - o a rb o l in -4 (  3H) - o n e s .
m -
■44 '
0 4  
> - »■
I t  h as  been w e ll  e s ta b l i s h e d  t h a t  c y c l i s a t i o n  o f  b e n z y la m in o n i tr i l e s  to  i s o q u in o lin o n e s  
and o th e r  p ro d u c ts ^  in v o lv e s  th e  rea rran g e m e n t o f  a  s p i r o  in te r m e d ia te .  R earrangem ent o f  
s p i r o  in te r m e d ia te s  d e r iv e d  from  ^ - s u b s t i t u t e d  i n d o le s  in  th e  fo rm a tio n  o f  t e t r a h y d r o c a rh a z o le s  
h as  been  th e  s u b je c t  o f  i n te n s iv e  s tu d y  by Ja ck so n ^  1  ^ and c o -w o rk e rs . S in c e  3 -am in o m eth y lin -  
d o ie s  C sk a ty lam in es)  a re  r e a d i ly  a v a i l a b le ,  rea rran g e m e n t o f  a s k a ty l a m in o a c e to n i t r i l e  (Scheme) 
o f f e r s  an a t t r a c t i v e  ro u te  to  new B -c a rb o l in e s ,  c u r r e n t ly  o f  c o n s id e r a b le  i n t e r e s t  f o r  t h e i r  
















A m in o n it r i le s  (1) w ere p rep a re d  by S t r e a k e r  r e a c t io n s  on 3 -am in o m e th y lin d o le s  o b ta in e d  v i a  th e  
V ilsm e ie r-H aack  fo rm y la t io n  o f  in d o le  and re d u c t io n  o f  th e  c o rre sp o n d in g  oxime o r  im inB. C yclo- 
hexanone and a c e to n e  w ere chosen  f o r  th e  S t re a k e r  r e a c t io n s ,  s in c e  th e s e  had g iv en  good y i e ld s  
in  th e  iso q u in o 1in a n e  s y n th e s e s 1 . No i d e n t i f i a b l e  p ro d u c t  was o b ta in e d  when fo rm aldehyde  was 
u sed  a s  th e  c a rb o n y l component o f  th e  m ix tu re .
t a b le  1 d e s c r ib e s  th e  y i e l d s ,  m e l t in g  p o in ts  and s u b s t i t u t i o n  p a t t e r n s  o f  th e  a m in o n i t r i l e s  
p re p a re d . S t r u c tu r e s  were c o n firm ed  by IR , NMR and MS, and f o r  s o l id s  by C.H.N a n a ly s i s .
T ab le  1 A m in o n it r i le s  t i l




CH, CH. 97 9 2 - 3
CH, CH. -(C H ,)
As c y c l i s in g  a g e n t  we i n i t i a l l y  t r i e d  s u lp h u r ic  a c id  un d er th e  c o n d it io n s  used  to  r e a r r a n g e  
b e n z y la m in o a c e to n i t r i le s 1 '' b u t o b se rv e d  e x te n s iv e  p o ly m e r is a tio n  a n d /o r  s u lp h o n a t io n ;  no 
i d e n t i f i a b l e  p ro d u c ts  w ere i s o l a t e d .  P o ly p h o sp h o ric  a c id  (0n°C . 1h) was more s u c c e s s f u l ,  a s  
d e s c r ib e d  in  T ab le  2 , b u t r e a c t io n  c o n d it io n s  w ere c r i t i c a l ;  y i e l d s  d e c re a s e d  r a p id ly  a t  
te m p e ra tu re s  above 80°C. S u lp h u r ic  a c id  a t  low er te m p e ra tu re s  (0°C f o r  15 m in) was a 
c o n s id e ra b le  im provem ent (T ab le  2 1 , in  th e  f i v e  in s ta n c e s  f o r  w hich we have d a ta .
T ab le  2 0 -C a rb o lin o n es  (3)
Product. Y ie ld  (%)t M o ltin g  P o in t  (°C) >c=o
* 25 ( 0 0 ) ’ 109 1610
b 20  (50) 196-8 1630
e 24 (41) 104-6 1630
d 34 (65) 104-6 1630
e 17 (53) 1 2 0 -2 1605
■ I s o l a te d  a s  im in e  ( 2 ) ,  mp 2 0 6 -8 ° , a f t e r  a llo w in g  th e  r e a c t io n  m ix tu re  to  s ta n d  
f o r  o n ly  4 h a t  room te m p e ra tu re .
+ F ig u re s  i n  b r a c k e ts  a re  y i e ld s  from  r e a c t io n s  i n  c o ld  s u lp h u r ic  a c id  ( se e  t e x t ) .
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Both w ith  p o ly p h o sp h o r ic  a c id  and s u lp h u r ic  a c id ,  th e  r e a c t io n  m ix tu re  was c o o led  i f  
n e c e s s a ry , d i l u t e d ,  and a llo w ed  to  s ta n d ,  f i l t e r e d  to  remove p o ly m eric  b y - p ro d u c ts , and 
b a s i f l e d .  The p ro d u c t  was f i l t e r e d  o f f  o r  e x t r a c te d  w ith  ch lo ro fo rm  o r  e th y l  a c e t a t e .  I t
was found th a t  h y d r o ly s i s  o f  th e  im in es  (2) to  t h e  K etones (31 was slow  compared w ith
i in in o te t ra h y d r o is o q u in o lin e s 1 ; w ork-up  b e fo re  24h a f t e r  d i l u t i o n  ten d ed  to  g iv e  (2) r a t h e r  th an  
(3 ) ,  o r  m ix tu re s .  The im in es  t h a t  w ere i s o l a t e d  w ere a ls o  c o n v e rte d  w ith  aqueous a c id  to  th e  
Ketones a s  c o n f i rm a t io n  o f  s t r u c t u r e .
A ll th e  p ro d u c ts  have  been c h a r a c te r i s e d  by IR , NMR, US and m ost by C.H.K1 a n a ly s i s .  The
o n ly  q u e s tio n  c o n c e rn in g  th e  c a rb o l in e s  was th e  p o s i t io n  o f a tta c h m e n t o f  th e  c a rb o n y l g ro u p ,
at or C^  °1 the indole i . e .  whether rearrangement had in fact  occurred. In th is respect
th e  work o f  Neukomm and H e s s e ^  was p a r t i c u l a r l y  h e lp f u l ,  a llo w in g  a  com parison  w ith  d i r e c t l y
an a lo g o u s o x o c a rb a z o le s . Of m ajo r s ig n i f ic a n c e  a r e  (a) th e  c a rb o n y l s t r e t c h i n g  fre q u e n c y ,
1
which f o r  3 -a c y l  i n d o le s  I s  1630 cm . w hereas f o r  2 -a c y l in d o le s  I t  i s  30-30 cm h ig h e r  tb )  
th e  d o w n fie ld  s h i f t  in  th e  \(. NNR sp ec tru m  o f  th e  b e n z e n e - r in g  p ro to n  n e a r  to  th e  co rb u n y 1 
g roup! in  2 -a c y l  in d o le s  th e r e  i s  no such  p ro to n  (c )  th e  UV s p e c t r a ,  w hich  show th re e  bands o f 
s im i l a r  w av e len g th  and i n t e n s i t y  to  th e  4 -o x o c a rb a z o le s .
The a u th o r s  g r a t e f u l l y  acknow ledge th e  r e c e i p t  o f  an S .E .R .C . C .A .S .E . award ( to  C.M.l in
c o l l a b o r a t io n  w ith  TCI P h a rm a c e u tic a ls  D iv is io n ,  and th e  i n t e r e s t  and a s s i s ta n c e  o f
Dr- C.W. T hornber.
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A Theoretical! Study o f  th e  S ite  S e lectiv ity  o f A ctivating M ethylth io and 
M ethoxy Groups in th e  S yn th esis  o f Ssoquinoiines
M e lv in  R . E u e rb y  a n d  R o g e r  D . W a ig h
D e p a rtm en t o f  Pharm acy, U n iversity  o f  M anchester, M a n ch ester  M l  3  9PL  
lam H. H ilS ier “ a n d  J e r e m y  P . H u k e  
D ep a rtm e n t o f  C hem istry, U n ivers ity  o f  M anchester, M a n ch ester  M 1 3 9 P L
T he site  selectiv ity  o f activating m ethylthio and m ethoxy groups in th e syn th esis  o f isoq u in o lin es  has 
b een  studied  theoretically  in terms o f the static index approach. T he d ep e n d en ce  of th e  relative am ounts  
o f o rth o -  and p a r a - isom er produced upon the nature of th e electrophilic group has b een  explained in 
term s o f th e d egree  o f charge localization  in th e  e lectrophile, togeth er  w ith  th e  ca lcu lated  electronic  
structure o f the activated  b en zen e  ring.
Most of the widely used syntheses of isoquinolines proceed via 
acid-catalysed attack of a suitable functionalized ^/-substituted 
phenethylamine or benzylamine on the benzene ring of the 
amine. To facilitate the attack of the electrophilic function of the 
side-chain upon the benzene ring, the latter is activated by 
suitable electron-donating substituents, in the absence of such 
activating groups, the reaction either fails, or gives poor yields. 
The most widely used activating group has been methoxy, but 
this is difficult to remove after cyclization and is thus to be 
avoided when the unsubstituted ring is sought. However, 
methylthio has been found to be a suitable alternative,1 which 
may be subsequently removed by reductive desulphurization. 
With the MeS group placed meta to the attacking side-chain, 
activation of the positions ortho and para to this group can yield 
two possible isomeric final products. The reactions we have 
studied are detailed in the Scheme; the first product is referred to 
as the ortho-isomer and the second as the para-isomer. The 
charged structures depicted in the Scheme are simplistic, taking 
no account of charge delocalization or solvent participation. 
However, we believe them to represent the major features of the 
reactive state. We have found that the relative amounts of the 
ortho- and para-products arc dependent upon the nature of the 
side-chain electrophile.2 A summary of these experimental 
results, mainly for methylthio activation, together with some for 
methoxy activation, is given in the Table. (Reaction conditions 
for the methoxy analogues were as described for the methylthio 
compounds.2 The product ratios for reaction C were derived 
from cyclizations in anhydrous hydrogen fluoride.2) It can be 
seen that the products range from essentially 100% ortho-isomer 
(for a carbocation electrophile), to 100% para-isomer (for an 
iminium ion electrophile). In this paper we seek a theoretical 
explanation of these findings.
Theoretical M ethods
We shall consider electronic and steric effects, both of which 
may influence the relative amounts of ortho- and para-isomer 
produced. The simplest theoretical approach which accounts 
for electronic effects is to attempt to correlate the observed 
reactivities with the ground-state elecronic structures of the 
reactants, using electronic properties (‘static indices’), which are 
taken to be indicative of important factors influencing the 
transition state.3,4 Such simple considerations are appropriate 
in the absence of accurate calculations of the transition state, 
which are certainly not feasible at the present time if ab initio 
wavefunctions are employed.
We examine the possibilities that the reactions considered 
may be dominated by ‘frontier orbital' 4 or ‘charge-control’3







Reaction ortho para ortho/para ortho para ortho[para
A 95
B 74
C 69 7 10 59 41 1.4
D 49 37 1.3 10 58 0.2
E 40 40 1.0 45 53 0.8
F 8 53 0.2
G 7 47 0.1 4 71 0.06
H 21 25
I 58 68
J 89 7.5 78.5 0.1
K 94 2 85 0.03
considerations. Attack on the benzene ring by a ‘hard’ 
electrophile, in which the positive charge is localized, would be 
expected to be ‘charge-controlled,’ and in that case the preferred 
site of attack may be expected to correlate with the charge 
distribution of the methoxy- or methylthio-substituted benzene 
ring.
In the ‘frontier orbital’ approach, attention is focused on the 
HOMO of the nucleophile (the benzene ring) and the LUMO of 
the electrophile, the stability of the transition state being taken 
to depend on the amplitudes of these two MOs on the atoms 
involved in bond formation.4,5 Such an approach is generally 
taken to be appropriate for attack by a ‘soft’ electrophile, in 
which the positive charge is delocalized.4
To examine both the charge distribution and form of the 
HOMO of the nucleophile, ab initio SCF-M O calculations were 
carried out for 3-methyl(thioanisole) and 3-methylanisole. The 
geometries of these two molecules were estimated as follows. 
Data for 3-methylanisole were taken from published electron 
diffraction results for anisole;6 a methyl group in a standard 
geometry 7 was added to the 3-position to take some account of 
the side-chain of the benzene ring. In both molecules the methyl 
groups attached to the heteroatom are assumed to be coplanar 
with the benzene ring. Bond lengths and angles for the PhS 
fragment of 3-methyl(thioanisole) were taken from those quoted 
in a microwave study of benzenethiol;8 the CH3S group 
geometry was adapted from that of dimethyl sulphide.9 As for 
anisole, a methyl group was added at the 3-position to model 
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various reactions, such differences are not expected to  alter the 
electronic struc tu re  o f the benzene ring so as to  alter 
significantly the conclusions of this study. T he SC F  M O  
calculations w ere carried ou t in an S TO -3G  basis. 10
Theoretical Results
The calculated charge d istribu tions obtained  by a M ulliken 
popula tion  analysis, and  H O M O  coefficients are given in the 
Figure. F rom  these results we conclude tha t (a) a ‘charge- 
controlled’ m echanism  favours the ortho- over the paro-isom er, 
since the co rresponding form al atom ic charges a t the ortho- and  
para-positions are  0.094 and —0.080 for 3-m ethyl(thio- 
anisole) and  —0.095 and —0.086 for 3-m ethylanisole; (h) a 
‘frontier o rb ita l’ m echanism  favours the para- over the ortho- 
isom er since the m agnitudes o f the H O M O  coefficients a re  0.385 
and 0.248 a t the para- and  or/fco-positions for 3-methyl- 
(thioanisole) and  0.493 and  0.309 for 3-m ethylanisole. Thus, 
from these quite simple theoretical considerations we would 
expect th a t cyclization involving a  ‘h a rd ’ electrophile w ould 
favour the orf/io-isomer, w hilst a ‘soft’ electrophile w ould favour 
the para-isom er.
The electrophiles in the Schem e can  be divided into three 
main classes: carbocations, in which the charge resides formally 
on a carbon  atom ; p ro tona ted  carbonyls in which the charge lies 
on an oxygen atom ; and  p ro tona ted  imines and  isonitriles in 
which the charge resides, a t least form ally, on a n itrogen atom . 
E lectronegativity considerations suggest tha t the positive 
charge on the electrophilic ca rbon  a tom  will be least for the 
third group, som ew hat g reater for the second group, and  
greatest for the carbocations. T ak ing  the degree of positive 
charge localization to  determ ine the ‘hardness’ o f the electro­
phile leads to  the prediction tha t th e  ca rbocations will give the 
greatest ortho:para  ratios, the carbonyls rather low er ratios, 
and the im ines and  isonitriles the low est ratios o f  all. This is the 
generally observed trend  from  the d a ta  in the Table.
There are  how ever exceptions to  these simple rules, evident 
from the d a ta  in the Table, which we now discuss. G roups 
attached to  the reactive ca rbon  a to m  of the electrophile m ay 
exert an  influence on the ‘hardness’. In  particu lar, a  phenyl 
group will partially  delocalize the positive charge, leading to  a 
decrease in ‘hardness,’ an d  to  a predicted low ering of the 
ortho:para  ratio . This is indeed found experim entally for the 
reactions E and  F  as com pared  w ith A and B. However, the 
reaction F leads to  considerably less ortho-isom er than  does E, 
in spite o f very sim ilar electronic effects. Large groups attached  
to  the electrophilic ca rbon  atom  m ay be expected to  favour the 
para-isom er because of steric in teractions with the X M e group. 






Figure. Electronic structure of 3-methyI(thioanisole) and 3-methyl­
anisole. (a) Formal atomic charges, (b) Coefficients of the HOMO. The 
values for 3-methylanisole are given in parentheses
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attr ib u ted  to  the increased steric repulsion on fo rm ation  of the 
seven- as opposed to  the six-m em bered ring on  cyclization. 
However, the observed differences in ortho, para  ra tio  between 
D  and G  canno t be explained by o u r simple considerations. 
F urtherm ore , C  unexpectedly appears  from the ortho: para  
ra tios to  involve a  harder e lectrophile  than  the isonitriles.
T urn ing  now  to  the d a ta  availab le for m ethoxy, as opposed to 
m ethylth io  ac tivation  (Table), we no te  tha t the trends discussed 
for the la tte r g roup  are also p resen t here. H owever, the ortho: 
para  ra tio  is in m ost cases sm aller th an  for the correspond ing  
m ethylth io-activated  reaction. T h e  calculation for 3-methyl- 
anisole reveals smaller charge differences between the ortho- and 
paro-positions than  for 3-m ethyl(thioanisole) (F igure). Hence, a 
‘charge con tro lled ’ m echanism  still favours p roduction  o f the 
orr/10-isom er, bu t no t to  such an  ex ten t as in the m ethylth io  case. 
This effect is reinforced in the ‘fron tier o rb ita l’ m echanism  since 
in the H O M O  o f 3-m ethylanisole (F igure) there is a  larger 
difference between the m agnitudes o f the coefficients a t the 
ortho- an d  pnra-positions th an  in the case o f 3-m ethyl(thio- 
anisole). Thus, the sm aller ortho: para  ra tio  observed for 
m ethoxy ac tivation  m ay be a ttr ib u ted  to  these tw o effects.
Cemdusions
W e have used the static  index ap p ro ach  to  unders tand  the site 
selectivity o f ac tivating  g roups in  the synthesis of isoquinolines.
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We find tha t considerations o f the degree o f  charge delocaliz- 
ation  in the electrophile, together w ith ca lcu la tions o f the 
electronic structu re o f the nucleophile, a re  broad ly  able to 
account for the observed trends in the isom er p ro d u c t ratios in 
these cyclization reactions. H owever, the ro le o f steric effects in 
such reactions has yet to  be m ore clearly defined.
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SYNTHESIS OF 4,5-DIHYDRO-1H-IMIDAZOLES FROM 1,5-DIHYDRO-2H-IMIDAZOLES USING 'NICKEL 
BORIDE'
Melvin R. Euerby,a Amanda C. Oldroyd ,b and Roger D. Waighb
a Department of Pharmaceutical Chemistry, School of Pharmacy, University of London, 
29-59 Brunwick Square, London, WC1N 1AX, England
b
Department of Pharmacy, University of Manchester, Manchester, M13 9PL, England
Abstract - In situ prepared 'nickel boride' generated from sodium borohydride and 
nickel (II) chloride cleanly transforms 1,5-dihydro-2H-imidazoles into 4,5-dihydro-1H- 
imidazoles in high yields by a double bond migration.
Research into the use of methylthio substituents as removable activating groups in the synthesis of 
1 2
N-heterocycles ’ prompted their application to the synthesis of 1,5-dihydro-2H-imidazoles (2^ ) by 
the cyclisation of the methylthio activated benzylaminonitriles (J_)^  (Scheme 1). In the absence of 
the methylthio activating group, cyclisation fails to occur,^ but it was anticipated that the un­
substituted 4-phenyl-1,5-dihydro-2H-imidazole (3) could be obtained by removal of the methylthio 
group from (2^. This could be effected by reductive desulphurisation using 'nickel boride' 
generated by the action of sodium borohydride on nickel (II) chloride in situ, a method which we
4




( 2 ) ( 3 )
(Scheme 1, R = MeS)
As expected, the methylthio substituted 1,5-dihydro-2H-imidazoles (^a and to_), when treated with 
'nickel boride', underwent reductive desulphurisation of the thioether bond; unexpectedly, 
migration of the dihydroimidazole double bond occurred yielding the corresponding 4,5-dihydro-1H-
imidazoles (4a and b) which are of potential pharmacological interest. As a corollary the
4 9
analogous methoxy substituted 1,5-dihydro-2H-.imidazoles (2c and d.) were treated with 'nickel boride'. 
In these reactions double bond migration occurred yielding the corresponding methoxy subs­
tituted 4!5-dihydro-1H-imidazoles (4c and d). (Scheme 2).
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The structure of the 4,5-dihydro-1H-imidazoles (£) was unambiguously confirmed by the use of 1H and
15 C n.m.r. and mass spectroscopy. The 'h n.m.r. spectra of the 4,5-dihydro-1H-imidazoles (4_)
exhibited characteristic features including resonances in the region of (5 7.22 - 6 . 9 7 and 4.82 -
H
4 . 4 9  for the amidine and methine protons at positions 2 and 4 respectively; in comparison, the 1,5-
dihydro-2H-imidazoles (2) possessed resonances in the region of <5 4.79 - 4-58 for the methylene
H
3 6 * 3
protons at position 2. ’ Off resonance C n.m.r. spectroscopy easily distinguished between the
1 .5-dihydro-2H-imidazoles (2^) and the 4,5-dihydro-1H-imidazoles (4) (Table 1): the former exhibited
singlets and triplets in the region of 6 176.5 - 175-7 and 82.1 - 73-9 for the carbons in posit-u
ions 4 and 2 respectively, whereas the latter possessed two doublets in the region of 5 7 8 - 5 -
c
73.5 and 156.7 - 152.2 for the carbons in the same positions. Carbon assignments (Table 1) were 
completed using the D.E.P.T. technique.
The plane of symmetry in the 1,5-dihydro-2H-imidazoles (£) is absent in the 4 ,5-dihydro-1H-imidazol-
1 2
es (4j and as a consequence the R and R substituents in the latter are non-equivalent. This 
difference in symmetry is observable in both the and n.m.r. spectra.
The fragmentation pattern in the mass spectra is also diagnostic in that the base peaks from the
3 61.5-dihydro-2H-imidazoles ( 2 )  correspond to the aziridinium ion (5.), whereas the base peaks for 
the 4 ,5-dihydro-1H-imidazoles (4.) correspond to the iminium ion ( 6) .
Table 1: 13C N.m.r. spectra of the dihydroimidazoles (2a - d and 4a - d) , (Solvent CDCl^).
Compound R R1 R2 R3 C-2 C-4 C-5 C-11 C-2' C-31 C-4'
2a 14.5 32.5 25.0 73.9 176.0 71.0 129.6 124.9 127-7
140.2
(q) 25.0 (3 x t) (t) (s) (a) (a) (d) (d) (a)
2b 14.7 20.5 20.5 30.7 79-4 176.1 67.0 129.1 125.0 127.4 140-9
(q) (q) (q) (q) (t) (a) (a) (a) (d) (d) (s)
2c 54.8 33-0 2 5 . 2 - 73.9 175-7 71.3 125.4 113-0 128.7 160 . 0
(q) 22.6 (3 x t) (t) (a) (a) (a) (d) (d) (a)
2d 55.0 38.1 25.5 29-6 82.1 176.5 74-0 127.0 113-5 129-2 160.5
(q) 22.7 (3 x t) (q) (t) (a) (a) (a) (d) (d) (a)
4a - 39-4 33.5 - 153.5 73.5 68.0 138.2 127.9 127.3 127-3
25.1 22.6 (d) (d) (a) (a) (d) (d) (d)
22.6 (5 x t)
4b - 26.0 19 . 8 28.2 156.7 78.3 65-3 139.0 127.0 127.3 125.1
(q) (q) (q) (d) (d) (a) (a) (d) (d) (d)
4c 55.1 39.4 33.8 - 152.2 78.3 68.3 131.5 113-5 128.5 159.0
(q) 25.5 23.0 (d) (d) (a) (a) (d) (d) (a)
22.7 (5 x t)
4d 55.1 32.6 29-3 27.8 155-7 77-6 65-7 131.6 113-2 129.7 158.8
(q) 25.1 22.9 (q) (d) (d) (a) (a) (d) (d) (a)
21.8 (5 x t)
o
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Double bond migration involving conversion of a 1,5—dihydro-2H-itnidazole to a 4,5~dihydro-1H-irnid- 
7
azole was observed when the 1,5-dihydro-1B-imidazole (J) was treated with base (Scheme 5).
Ph Ph Ph Ph
^  Base





However, in our hands the 1,5-dihydro-2H-imidazole (2&) was inert to the effects of base treatment 
and also to nickel (II) chloride alone. In contrast, exposure of the 1,5-dihydro-2H-imidazole (2c) 
to sodium borohydride yielded the corresponding 1,3,4,5-tetrahydro-2H~imidazole (8) via reduction 
of the imine, suggesting that it is 'nickel boride' which is responsible for the double bond 
migration of 1 ,5-dihydro-2H-imidazoles (2) yielding 4, 5-dihydro-1H-imidazoles (4_).
MeO
l-IN-v /NH
Research is currently being undertaken to elucidate the mechanism, applicability and scope of this 
reaction.
EXPERIMENTAL
Melting points were determined on a Reichert hot stage apparatus and are corrected. I.r. spectra
were recorded with a Pye-Unicam SP3-100 instrument for potassium bromide discs or liquid films. PI
and n.m.r. spectra, unless otherwise stated, were recorded on a Bruker WP80 spectrometer oper­
ating at 80 and 20.1 MHz respectively. M.S. data were obtained using an A.E.I. M530 spectrometer
using electron ionisation unless otherwise stated. Microanalysis was carried out on a Perkin-Elmer
240 CHN analyser. The methylthio and methoxy substituted 1,5-dihydro-2H-imidazoles (2a - d) were
5 2
prepared as described in the literature.3’^
General Reaction
The 1,5-dihydro-2H-imidazole (2^  2mmol-) and nickel (II) chloride hexahydrate (12mmol) were dissolv­
ed in methanol (20ml) and sodium borohydride (60mmol) added portionwise over a period of 30 min to 
the ice-cold mixture. Evolution of hydrogen and a black precipitate were observed on addition of 
sodium borohydride. When the addition was complete, the ice-bath was removed and stirring contin­
ued for 16 - 18 h at room temperature. To the ice-cooled reaction mixture was added hydrochloric 
acid (32% W/w, 40ml) and stirring continued for 10 min. Then ammonia solution (s.g. 0.88, 60ml) was 
added slowly to basify the mixture. The reaction mixture was filtered through a bed of 'celite', 
the filter cake washed with chloroform (3 x 25ml) and this chloroform used to extract the product 
from the aqueous filtrate. The combined chloroform extracts were washed with brine (1 x 25ml), 
dried with magnesium sulphate and evaporated to yield the 4,5-dihydro-1H-imidazoles (4a - cl). The
4,5-dihydro-1H~imidazoles could be purified by column chromatography using basic (grade 1) alumina 
eluting with varying proportions of chloroform and methanol or by crystallisation from chloroform - 
petroleum (60-80°C).









4a 92(57) 152-155 CHCl^-petroleum
60-80°C
78.2 8.4 13.0 78.5 8.5 13-1
4b 93(60) 125-1272 EtOH-di-iso- 
propyl ether
60.5 6.7 10.0 60.4 6.5 10.1
4c 96(75) 142-144 CHCl^-petroleum 
60-80°C
73.8 8.2 11.2 73.8 8.2 11.5
4d 85(67) oil3
Crude yields calculated from n.m.r. data, values in parenthesis 
are purified non-op timi-sed yields
2
Hemioxalate salt
3 Salt forms too hygroscopic for analysis
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Table 3: 1H N.m.r. and i.r. data for the 4,5-dihydro-1H-imidazoles (4a - d ) .
Compound V max/cm 
C = N
1H N.m.r. ( 5 values in p.p.m. Solvent CDCl^)
4a 1590 1 7.27(5H,s,ArH), 7 .21 (-1H, s ,N=CH-N), 4.49( 1H, s , ArCHN) , 4.28(1H,s,
NH exchangeable), 1.84-0.40(10H,m,5xCH2).
4b 1590 1 7-27(5H,s,ArH), 7.11(1H,d,J=2Hz,N=CH-N), 4.76(1H,d,J=2Hz,ArCHN),
2.78(3H,s ,CH3N), 1.37(3H,s ,CH5C), 0.62(3H,s,CH5C).
4c 1585 7■33(1H,s,N=CH-N), 7.l6(2H,d,J=8.5Hz,ArH), 6.85(2H,d,J=8-5Hz,
ArH), 4.44(1H ,s,ArCHN), 3.80(3H,s,CH30), 2.86(1H,s,NH exchange­
able) , 1.92-0.67(l0H,m,5xCH2).
4d 1590 7.13(2H,d,J=8.5Hz,ArH), 6 .97(1H,s,N=CH-N), 6.81(2H,d,J=8.5Hz,
ArH), 4.82(1H ,s,ArCHN), 3 .80(3H,s.CH^O), 2.78(3H,s,CH^N),
1.89-0.65(10H,m,5xCH2).
60 MHz Perkin-Elmer R12B
Table 4: Mass spectral fragmentation of the 4,5-dihydro-1H-imidazoles (4a - d).
Compound Principal fragments, m/z (rel. intensity %)
4a m/z • 214(M+ ,4496), 132(12), 120(18), 106(68), 98(92), 83(100), 79(11), 67(10
47(14), 30(5).
4b m/z 188(M+,20%), 173(2), 117(7), 90(8), 72(100), 56(5), 45(14), 29<3).
4c m/z 244(M+,33%), 136(60), 121(17), 109(57), 98(72), 67(56), 4Q(100).
4d m/z 258(M+ ,45%), 136(11), 121(24), 112(100), 91(16), 86(30),'81(22), 77(20)
68(25), 55(28), 44(100), 40(93).
Sodium borohydride reduction of 1,5-dlhydro-2H-imidazole (1c)
The general method was followed with the exception that nickel (II) chloride hexahydrate was 
omitted. 1,3,4,5-Tetrahydro-2H-imidazole (j3) was formed as a mobile brown oil which, after purifi­
cation by column chromatography on silica gel 60 (Merck 70-230 mesh) eluting with varying proport­
ions of methanol in ethyl acetate, gave a golden oil (7 9 % ), 6  (CDC1 ) 7.16 and 6.84(2 x  2H,
H 3 .
2 x  d, J=8.5Hz, AA'XX', ArH), 4.18 and 3-97(2H, 2 x d, J=9Hz, NCH^N), 3.82(4H, s, CH^O and CHN),
1.82(2H, s, NH x 2 exchangeable), 1.85-0.47(10H, m,'CH x 5); (5 _ (CDC1_) 158.7(0-41,s) , 133-0
“ 2 ^ j
(C-1',s), 128.6(C-3',d), 113.4(C-21,d), 70.8(C-4,d), 63.8(0-5,3), 62.2(C-2,t), 55.0(CH^O,q), 36.2, 
33.0, 25.8, 23-2, 22.5(CH x5); m/z (chemical ionisation, isobutane), 247(M+,14%). 235(28), 218
54
(60), 148(7), 136(8), 98(100), 94(17), 81(5), 37(7). The picrate had m.p. 217-220°C (decomp.)
(From EtOH-diethyl ether) (Pound: 0,46.0; H,4.3; N,15.g. C H N 0 requires 0,46.0; H.4.0;
27 28 8 15
N,15.996) •
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A CONVENIENT PROCEDURE FOR THE REDUCTIVE
DESULPHURISATION OF THIOETHERS WITH NICKEL BORIDE
Melvin R Euerby and Roger D Waigh*
Department of Pharmacy,University of Manchester,Manchester M13 9PL.
Nickel boride, conveniently prepared in situ from nickel (II) 
chloride hexahydrate and sodium borohydride, cleanly desulphurises 
thioethers in excellent yields.
Research into the use of alkylthio and arylthio moieties as
1 2removable activating groups in the synthesis of N-heterocycles ’ 
prompted the reappraisal of desulphurisation techniques for the 
reductive cleavage of thioether bonds from aromatic systems. The 
most widely used method to date involves a Raney nickel catalyst^ 
which possesses certain drawbacks including cleavage and reduction 
of many other functional groups^- ;^ the highly pyrophoric nature 
of the catalyst and its subsequent deactivation on storage make 
standardisation of reactions difficult.
During our initial studies we observed that alkylthiobenzene 
derivatives were more efficiently desulphurised with nickel boride
Q
than with Raney nickel . Nickel boride was first reported to
9 10bring about desulphurisation in the early sixties ’ , but since
then little use has been made of this reagent.
* To whom correspondence should be addressed.
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Owing to the fact that nickel boride can be easily prepared
. 9,10
in 3itu from stable nickel chloride hexahydrate and sodium 
borohydride and the catalyst appears to be completely non-pyrophoric, 
a reappraisal of its utility in reductive desulphurisations appeared 
appropriate.
Otar findings are listed in the Table and clearly demonstrate 
that various ethylthio, methylthio and phenylthio compounds could 
be cleanly desulphurised in high yields with nickel boride provided 
that sufficient active catalyst was formed (compare reactions 1a-c). 
The most cost effective molar ratio of substrate; nickel chloride
hexahydrate: sodium borohydride was 1: 6: 30. In a typical
experiment the sodium borohydride was added pcrtionwise to an ice- 
cold methanolic solution of the substrate and nickel chloride hexa­
hydrate, followed by stirring at room temperature overnight. The 
work up procedure was found to affect the yield of recovered product 
especially in the case of the desulphurisation of alkylthiobenzyl- 
amines (for example, compare reactions 6a and 6b) when the product 
was strongly adsorbed onto the catalyst. This problem was over­
come by dissolution of the catalyst and product in hydrochloric 
acid followed by basification with ammonia to form a nickel complex 
before extraction of the product.
In addition to desulphurisation concomitant reduction of 
carbonyl groups to alcohols occurred under the reaction conditions 
employed, but the use of other transition metal salts or the use 
of isolated nickel boride may allow even greater selectivity.
R£DUCTIV£ DESULPHURISATION OF THIOETHERS 781
Our findings illustrate that nickel boride is more selective than
Raney nickel in the desulphurisation of benzaldehydes and benzyl-
4
alcohols in that Raney nickel has been reported to yield toluene
whereas nickel boride gives good yields of benzylalcohol.
These preliminary investigations have shown that nickel
boride is a convenient and effective reagent for the reductive
desulphurisation of thioethers and its use in place of the more
traditional Raney nickel is recommended.
Desulphurisation with sodium borohydride and nickel (II) 
chloride hexahydrate:-General method.
The substrate (0.002mol) and nickel (II) chloride hexa­
hydrate (see Table) were dissolved in methanol (20ml) and 
sodium borohydride (see Table) added portionwise over a period 
of 30min. to the ice-cold mixture. Evolution of hydrogen gas 
and a black precipitate were observed on addition of the sodium 
borohydride. When the addition was complete, the ice-bath was 
removed and stirring continued for 16-18hr. at room temperature. 
Work up was achieved by methods A or B.
Method A
The reaction mixture was filtered through a bed of kiesel- 
guhr and the filter-cake washed with hot methanol/0.88 ammonia 
(4:1, 6 x 25ml). The filtrate was evaporated under pressure. 
Water (50ml) was added to the residue and the product extracted 
with chloroform (3 x 25ml). The combined chloroform extracts 
were washed with brine (1 x 25ml), dried with anhydrous magnesium 
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Method B
To the ice-cooled reaction mixture was added hydrochloric 
acid (32% w/w, 40ml) and stirring continued for lOmin, Then
0.88.ammonia (60ml) was added slowly to basify the mixture. The 
mixture was filtered through a bed of kieselguhr, the filter cake 
washed with chloroform (3 x 25ml) and this chloroform used to 
extract the product from the aqueous filtrate. The combined 
chloroform extracts were washed with brine (I x 25ml), dried and 
evaporated.
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It has generally been assumed that isoquinoline syntheses 
involving acid-catalysed attack of a side-chain on an 
electron-rich benzene ring will occur preferentially para 
rather than ortho  to a methoxy substituent, where both posi­
tions are free.2 5 The observation that this is certainly not 
always true with closely analogous methylthio activating 
groups6 has led us to re-examine some of the reactions pre­
viously reported and to quantify the products using crude 
rather than crystallised material. In most cases cyclisation
involving a benzylamine intermediate and those proceeding 
via a phenylcthylaminc. The methods described in the litera­
ture were followed closely, up to the stage before purifica­
tion, where the crude material was examined by !H n.m.r. 
and/or g.c., using authentic material where appropriate. The 
results are summarised in Table 1.
It is clear that, unlike cyclisations activated by a hydroxy 
group where regioselectivity is pH dependent,12 the directing 
effect of a methoxy group tends to be para for both elec-
X Y MeO X Y
MeO
R eaction A (la ) R1 =R2 =H,R3=CH(OMe)2 
Reaction B (lb ) R1 = MeO,R2= H, R3 = CH(0Me) 2 
R eaction E (la ) R1 =R2 = H,R3= C =N  
Reaction F (I f)  R1=R2j=H,R3= CH(OH)Ph 
Reaction G (1g) R1 = MeO,R2 = H,R3= CH(0H)Ph 
R eaction  H (Ih) R1 = H,R2=CH2Ph,R3 = C02Et









(1c) R 1 = H 
(Id) R1 = MeO
r




(15c) R = H 
(15d) R1 = Ph
MeO 
,1(2 )  R = R  =X = H.Y = OH
(4 ) R' = MeO,R2 = X = H,Y = OH
( 8 ) R1 = R2 =H,XY=0
(10) R1 =R2 =X = H, Y =Ph
(12) R1 =MeO, R2 = X= H,Y = Ph (13) R^MeO, R2 = X = H, Y =Ph
(H )R 1 =H,R2 = CH2Pb, XY=0
(3 )  R1 = R2 = X=H,Y = OH
(9 ) R1 = R2=H ,X Y =0  
(11) r ’=R2=K=H. Y = Ph
MeO
(5 )  R' =H
) R = MeO
) R = H
(17) R1 = Ph
(19) R 1 = H
( 2 0 ) R1 = Ph
MeO
i ) R =H
MeO R1 
(18) R ^ P h
MeO R‘ 
(21) R’=Ph
para to the methoxy group does predominate, although 
rarely to the exclusion of ortho attack: in a few reactions the 
latter is substantial.
Synthetic procedures were chosen from the literature to 
represent a wide variety of isoquinoline syntheses, all involv­
ing acid catalysis. These may be broadly grouped into those
* To receive any correspondence.
tronic8 and presumably steric reasons. It is curious, however, 
that aminonitrile and phenylethanolamine side-chains (reac­
tions E -G ) appear to be less affected by steric considera­
tions, and that a bulky phenyl substituent in Pictet-Spengler 
and Bischler-Napieralski reactions (J and L) tends to result 
in more product with adverse steric interactions, rather than 
less.
We thank the S.E.R.C. for an award (to M. R. E.) and Dr. 
R. E. Banks for assistance with the use of hydrogen fluoride.
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Table 1 Ortho : para ratios and crude yields of methoxy 
isoquinolines
Isomer composition (%)“
Reaction Cyclisation  ---------------------------------  ortho: para
agent ortho para ratio
A HCI 9 55 0.16
B HCI 70
C HCI 4 71 0.06
D HCI 70
£ H,SOrt 7 20 0.35
HF 55 38 1.45
F PPAb 45 53 0.85
TFAC 37 47 0.79
G PPAb 9 81 0.11
TFA" 10 74 0.14
H HjSO,, 34
1 HCI 58
J TFAC 2 85 0.02
K POCI3 26
L POCI-, 8 79 0.10




Techniques used: i.r,, 'H  n.m.r., mass spec., g.c.
References: 24
Tables 2-4: Spectroscopic data for the 1,2,3,4-tetrahydroisoquino- 
lines
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Tables 5 - 7: Spectroscopic data for the isoquinolines
Tables 8 10: Spectroscopic data lor the 1,2-dihydroisoquinolin- 
4(3/7)-ones
Tables 11 13: Spectroscopic data for the /V-benzyl-l-phenyl-2- 
aminoethanols
Tables 14-16: Spectroscopic data for the 3,4-dihydroisoquinolincs
Scheme 1: Postulated fate of ortho and para isomers in concentrated 
sulphuric acid
Received, / 6th May 1986; Paper E /1 74/86
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The majority of isoquinoline syntheses involve acid- 
catalysed ring closure to a benzene ring and benefit consider­
ably from the presence of an electron-donating sub­
stituent.2"3 The use of methylthio as the activating group 
allows the cyclisation to proceed in high yield at moderate 
temperatures: the methylthio group can then be removed 
cleanly to give the unsubstituted benzene ring.* In order to 
establish the scope of the reaction, a wide range o f iso- 
quinoline syntheses was chosen, using both benzylamine and 
phenylethylamine intermediates, with a variety of functional 
side-chains. In most cases, reaction conditions for the 
cyclisations which were successful for the methoxy ana-
A striking feature of the results is the relatively large 
amounts of several products formed by cyclisation ortho 
rather than para to the activating group. To-a certain extent 
this can be explained using frontier orbital theory.1' The 
methylthio activating groups have been successfully removed 
from selected tetrahydroisoquinolines by reductive de­
sulphurisation using nickel boride; an investigation into the 
potential of this reagent has been reported elsewhere.25
We thank the S.E.R.C. for an award (to M. R. E.) and Dr. 
R. E. Banks for assistance with the use of hydrogen fluoride.
MeS X Y
MeS -R'
Reaction A (1a) R =H, R = CH(0Me)>>
Reaction C (1c) R'=H, R2 = C=N  
Reaction 0  (Id) R1 = CH2Ph, R2 = C02Et 
Reaction E (1e) R1 = H, R2= CH(0H)Ph
MeS v  R
( 2 )  R’ = X=H, Y = 0H 




( 3 )  R1 = X=H,Y = 0H 
( 7 )  R '=H ,XY =0




Reaction F (Iff) R1 = H




Reaction H (1h) R1 = H
Reaction I (1i) R1 =Ph
MeS





(12) r ’ = H
(13) R1 = Ph
logues" 18 were equally effective for the methylthio com­
pounds. Yields were also comparable, the methylthio deriva­
tives even giving somewhat better yields in a few instances. 
The yields and ortho: para ratios are given in Table 1.
Techniques used: I.r„ 'H  n.m.r., mass spec., and g.c. 
References: 29
1 To receive any correspondence Received, 16th May 1986; Paper E /175/86
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A HCI 37 49 0.76
B HCI 7 47 0.15
C HjSO, 7.5 5.5 1.36
HF 69 7 9.86
D h ,s o 4 b
HF ' c
E PPAd 42 46 0.91
TFA” 37 42 0.88





'’Determined by gas chromatography and/or 'H n.m.r. 
spectroscopy.
bNo chloroform extractable material recovered. 
’■Quantitative recovery of starting material. 
•'Polyphosphoric acid.
"Trifluoroacetic acid.
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Il is possible to cyclise /V-allyl- and /V-cinnamyl- 
benzylamines using polyphosphoric acid (PPA) at high tem­
peratures to give 4-methyl-1,2,3,4-tetrahydroisoquinolines 
and 5-phenyl-2,3,4,5-tetrahydro-l //-2-benzazepines respec­
tively. In the latter case yields are poor owing to extensive 
polymerisation of the starting material, but this adverse effect 
can be overcome by the use of a methylthio group which 
facilitates cyclisation and can then be reductivcly removed.
Previous work with N-allylbenzylamines had shown that 
the A/,/V-dimethyl quaternary salts could be cyclised with 
PPA1 at high temperatures (300 °C). it was readily estab­
lished that similar conditions (1 8 0 “C) would cyclise the 
secondary and tertiary bases (1) to give the 4-methyltetra- 
hydroisoquinolines in high yield (see Scheme A). By analogy 
with the benzylaminopropynes2 it was expected that N- 
cinnamylbenzylamines (3) would give the 2-bcnzazepines (4) 
through the phenyl-stabilised carbonium ion (Scheme B). In
benzene rings to electrophilic attack in both ortho  and part: 
positions.6 This was also effective with the /V-cinnamyl- 
benzyiamines (3c) which gave a mixture of the 6- and 
8-methylthio-2-benzazepines (4d and c) in ca. 60% crude 
yield, with the 8-methylthio compound predominating. 
Desulphurisation of the crude mixture gave the 2-benz- 
azepine (4a) in an overall yield of 53%.
Cyclisation of /V-allyl-3-methylthiobenzylamines (Ic  and 
d) gave 4-methyltetrahydroisoquinolines (2 c -e ) as expected, 
at substantially lower temperatures than with the unactivated 
analogues (2a), but with the remarkable feature that cyclisa­
tion ortho  to the methylthio group was strongly preferred to 
attack at the para  position |see Scheme A, (2d) and (2e) pre­
ferred]. Production of the 5-methylthio derivative appears to 
be sterically very unfavourable but electronically advanta­
geous.10
Cyclisation o f the methoxyallylamine (He) failed to give
R
(1) O; R = R =H 
b ; R1 = H, R2 = Me 
c : R1 = MeS,R2 =H 
d : R*= Me5,R2 = Me 
e ; r '=  MeO.R2 = H
(3 ) Q; R1= R2 = H 
b ; r '=H, R2=M<? 
c ; R1 = Me5,R2=H 
d ; R1=MeO,R2=H
Schem e A
(2 )  a ; R = R = R = H (91%) 
b ; r ’ = R3 =H, R2 = Me (95%) 
c ; R1 = MeS, R2=R 3=H (3%) 
d ; R1 = R2 = H, R3 = MeS (81%)
e : R = H, R = Me, R = MeS (84% )
(4) a ; R1 =R 2 = R3 = H (5%) 
b ; R1 =R3 = H,R2 = Me (6%) 
c ; R1 =M eS,R2=R 3=H (52%) 
d; R1 =R2 = H,R3 = MeS (8%) 
e ; R1 = MeO, R2 = R3= H (39%) 
f ; R1 =R2 = H,R3=MeO(43%)
Schem e B
practice, yields were very poor (ca. 5%), presumably because 
intermolccular reactions involving the carbonium-ion inter­
mediate were favoured over the formation o f a seven- 
membered ring.
Wc have shown that methylthio substituents will activate
* To receive any correspondence.
any isolable product on treatment with PPA, although start­
ing material was consumed. The methoxy cinnamylamine 
(3d), however, gave a mixture of 6- and 8-methoxy-2-benz- 
azepines (4e and f).
We thank the S.E.R.C. for an award (to M. R. E.) and Dr. 
B. E. Mann for assistance with nuclear Overhauser experi­
ments.
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Techniques used: I.e., 'H  and UC n.m.r., mass spec., g.c., h.p.l.c. 
References: 16
Tables 1 -4: Analytical and spectroscopic data for the N-allyl- and 
/V-cinfinamyl-benzylamines (1) and (3)
Scheme 1: Polyphosphoric acid cyclisation of the /V-allylbenzyl- 
amines (1)
Scheme 2: Polyphosphoric acid cyclisation of the /V-cinnamyl- 
benzylamines (3)
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separated. The solvent is evaporated and the crude product is chroma­
tographed on a silica gel column (20 cm x 3.5 cm; 70- 230 mesh) using 
toluene (400 mL) as eluent. After evaporation of the solvent, diph- 
enylphosphinc is distilled off (100 "C/0.01 mbar) to yield a colorless oil. 
1’hosphines 11-13 crystallize on trituration with McOH (Table 3).
(7J)-( )-2-Benzoyloxy-3,3-(limethyl-1,4-bi.s(diphenylphosphino)lmtune 
(21):
A solution of phosphine 20 (12.1 g, 25.7 mmol) in toluene (60 mL) is 
cooled to 0°C and benzoyl chloride (4 mL, 34.5 mmol) is added. After 
stirring the mixture for 10 min at room temperature, the solvent is 
evaporated. Trituration of the remaining yellow oil with petroleum 
ether (bp 40-60°C) yields colorless crystals. The partly oxidized pro­
duct is dissolved in benzene (20 mL) and reduced in an autoclave with 
an excess of trichlorosilane (3 mL) to pure phosphine 21, which is again 
crystallized from petroleum ether.
We thank the Fonda der Chemischen Industrie and BASF AG, Ludwigs- 
ha fen, for support o f  this work.
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A Modified Synthesis of 4-Chronianones
Brian Cox, Roger D. Weigh*
Department of Pharmacy, University o f Manchester, Manchester, M 13 
9PL, England
Problems in the synthesis of 4-chromanones by condensation of 2- 
hydroxyacetophenones with formaldehyde can be avoided by the iso­
lation of the Mannich base hydrochlorides and cyclization by titration 
with potassium hydroxide.
A very simple and effective route to 4-chromanones involves 
the base-catalyzed condensation and cyclization o f an aldehyde 
or ketone with 2-hydroxyacetophenone.1 A limitation of this 
approach occurs with formaldehyde. The sodium salt of 2- 
hydroxyacetophenone in aqueous formaldehyde at 50"C gives
Comm unications 709
only a polymeric material.2 Interestingly, the sodium salt o f 2- 
hydroxypropiophenone under the same conditions yields 
27-50%  of 3-methyl-4-chromanone.2,3 Pyrrolidine is used 
widely as a basic catalyst in these reactions.1 Normally a 
mixture of the appropriate 2-hydroxyacetophenone 1, aldehyde 
or ketone 2, and pyrrolidine 3, in the ratio o f about 1:1:0.5 in 
toluene is allowed to stand for a time and then heated to 
boiling in an apparatus fitted with a water separator.1
Ref. s
H ;C=0/N H R; R:> 12:11
H ;C=0/NHR?R3 (3:2)
6
A mixture of 2-hydroxyacetophenone, aqueous formaldehyde, 
and pyrrolidine in the ratio of 1; 1:0.5 under these conditions 
yields no 4-chromanone, but a multi-component mixture of 
unidentifiable polar/polymeric compounds.4 Increasing equiva­
lents of aqueous formaldehyde and secondary amine result in 
the formation of 3-aminomethyl-4-chromanones 5 and 3,3- 
bis(ami nomethyl)-4-chromanones 6.5
We have been able to show that Mannich base hydrochlorides 
7 a -d , formed from 2-hydroxyacetophenone by reaction with 
formaldehyde and dimcthylamine under acidic conditions6 will 
cyclize to 4-chromanones 8 a -d  on titration with potassium 
hydroxide. If allowance is made for recovered starting material 
the yield on this final step is good. The 4-chromanones are 
obtained in pure form very readily since they are non-basic, so 
that separation from the starting material is very simple.
0 0.02M KOH 0
R' 35 “ Cca. 15 min Y Y j + Me2NH
R2 s ^ r ) B  'NHMsg
3 4 -5 0 7 ,
7 a - d 8  a - d





2-Hydroxyacctophcnones were prepared by the method of Juckcr and 
Vogel1 from the corresponding phenyl acetates. Phenyl acetates were 
prepared by O-acetylation of commercially available phenols.
Yields quoted are for purified materials. Melting points were obtained on 
a Kofler hot-stagc apparatus, and arc corrected. IR spectra were recorded 
on a Pye Unicam SP3-100 spectrophotometer. ‘H-NMR spectra were 
obtained using a Brukcr WP 80 spectrometer. Mass spectra were 
recorded on a Kratos MS 30 spectrometer equipped with a DS-50 data 
system.
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or Lit. mp (°C)
1R (KBr) 
v (cm - 1)
'H-NMR (DjO/DSS1') 
5
MS (70 eV) 
rnjz (%)
7a 45 154-160 156-157" 1650 (C = 0 ) 6.9-8.1 (m, 4 H); 3.4-3.8 (m ,4H); 193 (M ' .  1.9); 58 (100)
2.7 (s, 6H)
7b 22 195-197 188-189'' 1645 (C = 0 ) 6.85-7.9 (m, 3H); 3.5-3.6 (m, 229 (M ' ,  0.3); 227 (M 1,
4H); 2.85 (s, 6H) 1.0); 58 (100)
7c 25 179-181 C‘i iH 1sCIjN 0 2 1650 (C = 0 ) 6.9-7.8 (m, 3H); 3.45-3.55 (m. 229 (M 1, 0.6); 227 (M ',
(264.2) 4H); 2.85 (s, 611) 1.7); 58 (100)
7d 7 185 C u H l4C!3NOj 1640 (C = 0 ) 7.95 (s, 1H); 7.05 (s, 1 H); 3.5 -3.6 7.63 (M ’ , 0.4); 261 ( M \
(298.6) (m, 4H); 2.85 (s, 6H) 0.6); 58 (100)
" Satisfactory microanalyses obtained: C ±0.4, H ±0.2, N ±0.2, 
b Internal standard, sodium 2,2-dimethyl-2-silapcnlane-5-sulfonate.


















‘H-NM R (CDC13/TMS) 
6, J  (Hz)
MS (70 eV) 
m/z (%)
8a 50 32 74 36-37 38.510 1670 (C = 0 ) 6.9-7.95 (m, 4 H); 4.45-4.6 (t, 
2H, J  = 6.5); 2.7-2.9 (t, 2H, 
J  = 6.5)
148 (M +, 67.3); 120 (100)
8b 38 52 79 101-103 106“ 1670 (C=G) 6.9-7.9 (m, 3 H); 4.S-4.7 (t, 
2H, J  =  6.5); 2.7-2.9 (t, 2H, 
J  =  6.5)
184 (M M 8 .4 ); 182 ( M \  
57.2); 154 (100)
8c 35 37 56 65-67 7 2 -74 '2 1670 (C=G) 6.9-7.9 (m, 3H); 4.5-4.7 (t, 
2H, J =  6.5); 2.7-2.9 (t, 211, 
J = 6.5)
184 (M ”, 19.1); 182 (M ' .  
59.6); 181 (100)
8d 34 34 52 126-132 131-133'2 1670 (C —O) 7.95 (s, 1H); 7.15 (s, 1H); 
4.45-4.65 (t, 2H, 7 =  6.5); 
2.7-2.9 (t, 2H , J  =  6.5)
220 (M \  5.9); 218 (M ' , 
34.7); 216(M ”, 56.0); 188 
(100)
Mannich Base Hydrochlorides 7 a—d; General Procedure:
A stirred mixture of the 2-hydroxyacetophenone (0.05 mol), paraform­
aldehyde (3.0 g, 0.1 mol), Me2HN HC1 (6.08 g, 0.05 mol), 2-propanol 
(25 mL) and concentrated HC1 (0.1 mL) is heated at reflux temperature 
for 5h. After this time the mixture is cooled to 0 “C whereupon 
crystallization occurs. The mixture is triturated with acetone (20 mL) 
and the crystalline material is filtered off. In each case the product is 
recrystallized from abs. EtOH. Product 7d, although crystalline, has a 
deep-blue coloration which cannot be removed even with repeated 
recrystallization. The material is therefore dissolved in abs. EtOI-f 
(50 mL) and boiled with activated charcoal (1 g) for 10 min. The 
charcoal is filtered off and EtOH is evaporated off to yield a pale-yellow 
crystalline solid.
4-Chromanones 8n -d ; General Procedure:
The appropriate Mannich base hydrochloride 7 a—d (0.5 mmol) is 
dissolved in and made up to 25 mL with H 20 . The solution is then 
titrated with aq. KOH (0.02 M). During the titration the solution is 
maintained at 35°C between pH 3 0  and pH l l - O ,  and the pH is 
monitored with a pH-meter. The addition rate of KOH is such as to 
give a total time for titration o f approximately 15 min. The titration is 
stopped when no further increase in pH is observed. After the titration 
the mixture is cooled to r. t. Any solid that has formed is filtered off and 
dried. The mixture is shaken with EtzO (3 x 50 mL), the ethereal 
extracts are combined, dried (M gS04), and the solvent is evaporated. 
The residue is redissolved in E tzO (20 mL) and saturated ethereal HC1 is 
added until no further precipitation occurs. The solid material is filtered 
oft' and dried, and the ethereal filtrate is evaporated to dryness.
In each case the material precipitated by addition of ethereal HC1 is 
found to be the starting material (Mannich bases 7 a—(I). The material 
obtained from the evaporation o f the ethereal filtrate is found to be the
corresponding 4-chromanone 8a-d . The titration o f Mannich base 7d 
produces crystalline 6,7-dichloro-4-chromanone (8d) during the 
titration.
Tlte authors are grateful to the Science anel Engineering Research Council 
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The Cychsataoo o f Benzy!anmiinioniitril©s. P a rt? .8 R eg iosp ecific  Form ation o f  
SVlethoKy-substituted lsoq u in o iin -4 -on es using IVBethyflthoo A ctivating Groups
Jam es P. Gavin and R oger D. W aigh "
D ep a rtm en t o f  Pharm acy, U n ivers ity  o f  M anchester, M a n ch ester  M l 3  9PL
C yclisation of 3 ,4 -d ia lk oxyb en zy lam in oaceton itriles  proceed s preferentially through a spiro intermediate. 
A 2 ,3 -d ia lk oxy  a n a lo g u e  will therefore norm ally g ive  a 5 ,6 -d ia lk oxy isoq u in o lin on e  after rearrangement 
and 7 ,8 -a ’im ethoxy substitu tion  is not obta ined . It is sh o w n  that a suitably p laced  m ethylthio group, 
w h ich  can be rem oved after cyclisation , can ch a n g e  th e  m od e o f cyclisation  from rearrangem ent via  a 
spiro interm ediate to  sim ple ortho-attack, g iv in g th e desired 7 ,8 -d ia lk oxy  su b stitu tion  pattern. In 
principle, this approach to  regiocontrol cou ld  b e  o f value in m any reactions involving electrophilic  attack  
on  a ben zen e  ring.
T he cyclisation o f a  2,3-dim ethoxybenzylam inoacetonitrile such 
as the cycfohexyl derivative ( la )  has been show n to  give the  5,6- 
dim ethoxyisoquinolinone (2a) on  treatm ent w ith sulphuric 
acid.2 This can  be readily explained, as in Schem e 1, by 
rearrangem ent through  a sp iro  interm ediate . In o u r hands this 
reac tion  also produced a sm all am oun t o f 7,8-dim ethoxy- 
isoquinoiinone (3a), p resum ably  by o rthodox  cyclisation 
(Schem e 1); this canno t be regarded as a viable synthesis o f 7,8- 
dim ethoxyisoquinolinones, how ever, in view of the strong  
preference for the sp iro  route . T he am inonitrile cyclisation 
provides an  efficient rou te to  valuable interm ediates in the 
synthesis o f ben zo [c ]p h cn an th rid in es34 which m akes a tten tion  
to  con tro l o f the substitu tion  p a tte rn  w orthwhile.
M ethylth io  substituents have been show n to  activate 
benzene rings sufficiently for a variety  o f cyclisations involving 
electrophilic a ttack .5”9 As an  extension of the app roach  we 
envisaged several com binations o f m ethoxy an d  m ethylthio 
substituents w hich could give the desired 7,8-dim ethoxy 
substitu ted  isoquinolinone, tw o o f which are described here. T o 
simplify iso la tion  of the p ro d u c ts  o f cyclisation we chose 2- 
spirocyclohexane and  2,2-dim ethyl derivatives th roughou t, 
thereby avoid ing  problem s arising  through enolisation  and  
oxidation  o f the  isoquinolinone.
Results and Discussion
W ith 2-m ethylthio-4,5-dim ethoxy substitu tion  as in (4a, lb) 
trea tm en t o f the am inonitrile w ith sulphuric acid gave fairly 
good yields o f the im idazolines (5a, b), together w ith small 
am oun ts  of the tw o isoquinolines (6a, b) and (7a, b) (Schem e 2). 
The im idazolines (5a, b) are characte ristic  o f reactions in which 
fo rm ation  o f the sp iro  in term ediate  is favoured bu t cyclisation 
to  the w r/jo-position  o f the benzene ring is inhibited. In  previous 
exam ples this has been a ttr ib u tab le  to  lack o f a  suitably placed 
electron dono r, bu t this is no t th e  case here, since the 5-m ethoxy 
g roup  could fulfil this function a n d  does so to  a certain  extent, 
accounting  for the form ation o f sm all am ounts o f the desired 
7,8-dim ethoxyisoquinolinones (7a, b). T ha t this secondary 
cyclisation does n o t occur readily  is a ttribu tab le  to  adverse 
steric in teractions, as in s truc tu re  (X). As a  m inor alternative, 
a ttack  a t the ine thy lth io -substitu ted  ca rbon  followed by a  1,2 
shift o f  M eS + can  account for fo rm ation  of the isoquinolinones 
(6b, b). P ro o f of s tructu re o f all th e  isoquinolinones is described 
below.
T he 2,3-dim ethoxy-5-m ethylthio derivatives (8a, b) had  tw o 
groups activating  the 6-position (Schem e 3), w ith the result tha t 
cyclisation proceeded by d irect a ttack  and form ation  o f the
MeO















Scheme 1. a; R 'R 2 =  -(CH 2)5 -. h; R> = R2 =  Me.
spiro interm ediates was precluded. A lthough  yields were only 
m oderate there were no m ajor by-products and  a tten tion  to 




Scheme 3. a; R






















SM e n h















'R 2 = -(C H 2)S-. b; R 1 = R2 = Me.
finding a  simple rou te  to  3-substituted 7,8-dim ethoxy- 
isoquinolinones has thus  been achieved.
Several m ethods were used to  identify the cyclisation 
products. T he isom ers (2) and  (3) were readily distinguished 
by the chem ical shift differences between the tw o arom atic  
p ro tons. In the 5,6-dim ethoxy isom ers (2a, t>) the differences 
were only 0.25 and  0.24 ppm , w hereas in the 7,8-dim ethoxy 
analogues (3a, lii) the differences were 0.93 an d  0.92 ppm , ow ing 
to  deshielding of the p ro to n  in the 5-position by the carbonyi. 
R eduction of these ketones w ith sodium  borohydride gave four 
isom eric alcohols, tw o o f which (9a, b) (Scheme 4) were show n 
to  be identical w ith the p roducts o f nickel boride desulphuris- 
a tion  of (7a, b).
T he identity  of the 6,7-dirnethoxy-8-m ethylthio analogue (6a)
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Scheme4. u; R 'R 2 -  -(CH 2)S-. b; R ‘ = R1 = Me.
was partly  established by reductive desu lphurisa tion  to the 
alcohol (10). T he chemical shift (5 6.82) o f the single arom atic  
p ro ton  in (6a) was indicative o f a  position peri to  the carbonyl, 
and this was confirm ed by exam ination  o f nuclear O verhauser 
effects w ithin the molecule. I rrad ia tio n  o f the S-m ethyl pro tons 
in (6a) p roduced an  enhancem ent of the signal from the 
m ethylene p ro tons a t position  1, an d  vice versa.
T he 7,8-dim ethoxy-5-m ethylthio analogues (7) produced in 
the cyclisation o f (4) were show n to be identical w ith the 
products  obta ined  from o rth o d o x  cyclisation o f (8).
It is o f prim ary im portance, if th is  app roach  to  regiocontro l is 
to  be generally useful, th a t the app ro p ria te  syn thons are readily 
available. A valuable m ethod fo r the in troduction  o f m ethylthio 
on to  a benzene ring involves b rom ination  and  a G rignard  
reaction w ith dim ethyl d isu lph ide .10 This app roach  was 
adopted  for the synthesis o f 2 ,3-dim ethoxy-5-m ethylthio- 
benzaldehyde, s tarting  from o-vanillin. T he isom eric 2-methyl- 
thio-4,5-dim ethoxybenzaldehyde was p repared  by the m ethod 
o f Jacob  an d  co-w orkers.11
Experimental
M.p.s were taken  on  a R eichert hot-stage ap p a ra tu s  and are 
corrected. IR  spectra were o b ta in ed  on a Pye-U nicam  SP3-100 
spectropho tom eter for po tass ium  brom ide discs for solids and  
liquid films for oils. 'H  N M R  spectra  were recorded on Bruker 
W P80 and V arian  SC300 instrum ents with C D C I3 as solvent
505
and SiM e4 as in ternal standard . M ass spectral d a ta  were 
obtained  w ith an  A.E.I. M S30 instrum ent in the School of 
Chem istry, U niversity  of M anchester. Cyclisation products 
were separated  on  grade 1 basic alum ina , w ith ethyl ac e ta te- 
light petroleum  (b.p. 60-80 °C) (2:1) as eluant. R, Values were 
obtained  using U V 254 sensitive alum ina plates, w ith ethyl 
acetate-light petro leum  (b.p. 60-80  °C) (2 :1 )  as eluant.
2,3-D im ethoxy-5-m ethylthiobenzaldehyde.—T o o-vanillin
(100 g, 0.66 mol) an d  potassium  brom ide (156.6 g, 1.32 m ol) in 
80% acetic acid (1 300 ml), b rom ine (35.5 ml, 0.74 mol) in glacial 
acetic acid (65 ml) was added, dropwise. A fter stirring for 15 min 
a t 110 °C an d  24 h a t room  tem perature, w ater (2 500 ml) was 
added. The precip itate  was filtered off, w ashed with w ater, and 
rccrystallised from  aqueous ethano l (50% v/v) to yield 5-brom o-
2-hydroxy-3-m ethoxybenzaldehyde (144.3 g, 95%) as a  white 
solid, m.p. 129 °C  (lit.,12 128-129 °C); vmax 3 200 (O H ) and 
1 660 (C = 0 ) cm -1; SH 10.94 (1 H, s, O H  exchangeable), 9.86 
(1 H, s, C H O ), 7.31 1 H, d, J  1.5 Hz, A rH ), 7.17 (1 H, d, J  1.5 
Hz, A rH), and  3.92 (3 H , s, O M e); m /z  232 (M  + , 98%), 230 
(100), 186 (37), 184 (34), 161 (13), 159 (14), 108 (22), 79 (30), 51 
(69), and 29 (38).
5-B rom o-2-hydroxy-3-m ethoxybenzaldehyde (141 g, 0.62 
mol) was dissolved in d im ethylform am ide (D M F; 1 200 ml), 
containing sodium  hydroxide (24.5 g), an d  stirred a t 70 °C  for 
30 min. M ethyl iodide (115 ml, 1.84 m ol) was added, an d  the 
m ixture set aside for 12 h, then p o u red  into w ater. After 
ex traction  w ith e th er (4 x  50 ml), the so lu tion  was w ashed with 
2m  aqueous sodium  hydroxide (4 x  50 m l) and  w ater (2  x  50 
ml), dried, and  evapora ted , and  the p ro d u c t recrystallised from 
ethanol to  yield 5-brom o-2,3-dim ethoxybenzaldehyde (114.3 g, 
76%) as a w hite solid, m.p. 82-83 °C (lit.,13 85 °C); vmux 1 670 
( O O )c n v  6„ 10.34(1 H, s, C H O ), 7.53 (1 H ,d ,7 2 .5  Hz, ArH), 
7.23 (1 H, d, J 2.5 Hz, A rH ), 3.98 (3 H, s, O M e), and 3.91 (3 H, s, 
OM e); m /z 246 (M  ' ,  98%), 244 (M  \  98%), 231 (30), 229 (38), 
200 (30), 198 (22), 188 (48), 186 (27), 107 (33), 94 (92), 44 (100), 
and  29 (78).
5-Brom o-2,3-dim ethoxybenzaldehyde ( 1 14.3 g,0.47 m ol) was 
dissolved in abso lu te  e thano l (82 ml, 1.43 mol). Triethyl 
o rthoform ate (85.3 ml, 0.51 mol) was then  added, followed by 
32% hydrochloric  ac id  (0.2 ml), w hereupon  the tem perature 
rose quickly. T he reaction  m ixture was heated  under reflux on 
a steam  bath  for 30 min, then rapidly cooled , and  basified with 
aqueous sodium  hydroxide (20% w/v). T h e  com bined ethereal 
extracts were w ashed w ith w ater (50 ml), dried , and evapora ted  
to yield 5-brom o-2,3-dim ethoxybenzaldehyde diethyl acetal 
(133 g, 93%) as an  oil, v„,„x 1 050 (C O C ) cm r1; 5„ 7.31 ( I H , d, J
1 Hz, ArH), 7.00 (1 H, d, J  1 Hz, ArH), 5.72 (1 H, s, C H ), 3.85 
(3 H, s, O M e), 3.83 (3 H, s, O M e), 3.66 (4 H, q, J  7 Hz,
2 x C H zO), and  1.23 (6 H , t, J  1 Hz, 2 x  C H 2C / /3); m /z  320 
( M \  15%), 318 (M  + , 13%), 275 (100), 273 (96), 245 (37), 138 
(54), 75 (42), 44 (52), an d  29 (57).
5-B rom o-2,3-dim ethoxybenzaldehyde diethyl acetal (133 g, 
0.42 m ol) w as added  to  dry  te trahyd ro fu ran  (T H F ; 1 1) 
contain ing  m agnesium  (10.25 g, 0.42 m ol), under an  atm osphere 
of nitrogen. U pon  fo rm ation  o f the G rig n ard  complex, dim ethyl 
disulphide (37.7 ml, 0.42 mol), in dry T H F  (250 ml) w as added 
dropw ise over 30 min. T he so lu tion  w as heated  under reflux for 
3 j h and  cooled, an d  aqueous N H 4C1 (20% w/v; 2 1) added 
cautiously, keeping the tem peratu re below 20 °C, and 
em ploying a  th io l tra p .10 T he m ixture w as filtered and extracted  
w ith e ther (3 x 250 ml), and  the ex trac ts  were dried  and 
evapora ted  to  yield 2,3-dim ethoxy-5-m ethylthiobenzaldehyde 
diethyl acetal (108.6 g, 91%) as an  oil; vmax 1 050 (C O C ) c m 1; 5H 
7.09(1 H . d . J l  Hz, A rH ), 6.82 (1 H ,d ,7 1  Hz, A rH), 5.72 (1 H ,s, 
CH ), 3.85 (3 H, s, O M e), 3.83 (3 H, s, O M e), 3.60 (4 H, q, J  7 
Hz, 2 x C H zO), 2.48 (3 H, s, O M e), an d  1.23 (6 H, t, J  7 Hz, 
2 x C H 2C H 3); m /z 286 ( M \  47%), 241 (80), 212 (17), 195
69
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Table 1. Spectroscopic data for benzylaminoacetonitriles.








3 300 2 240
3 310 2.200
3 300 2 200
3 300 2 200
3 300 2 200
234 ( M \ 0.3%), 207 (15), 192 (7.5), 176 (38) 
167 (54), 165 (34), 152 (59), 151 (60), 
136(100), 121 (28), 106 (32), 77 (31)
293 (M 4 -  27,15%)„ 278 (7), 246 (56),
197 (100), 182 (23), 151 (19), 138 (16),
27(7)
253 (M  4, 74%), 238 (29), 206 (64), 197 (100), 
182 (53), 151 (40), 138 (40), 70 (15),
45 (10)
320 {M 4, 0.5%), 293 (12), 262 (36)
197 (17), 182 (48), 98 (45), 56 (88)
41 (68), 27 (100)
253 (M * -  27,47%), 238 (20), 222 (35)
213 (37), 198 (20), 197 (100), 193 (29)
161 (36), 137 (45), 77 (33), 45 (46), 30 (43)
5„
6.97-6.91 (3 H, m, ArH), 3.89 (5 H, s,
OMe and CH 2N), 3.87 (2 H, s, OMe),
1.92 (1 H, s, N H ”)  1.52 (6 H, s, CH3)
6.92 (1 H, s, ArH), 4.0 (2 H, s, ArCH2N),
3.88 (6 H, s, OMe), 2.45 (3 H, s, SMe),
1.69(1 H, s, NH°), 1.83-1.54
(10 H, br, CsH l0)
6.93 (1 H, s, ArH), 6.90 (1 H, s, ArH),
3.98 (2 H, s, ArCHjN), 3.89 (6 H, s, OMe)
2,45 (3 H, s, SMe), 1.60 (1 H, s, NH"),
1.55 (6 H, s, CH3)
6.86 (1 H, s, ArH), 6.84 (1 H, s, ArH), 3.86 
(8 H, s, 2 x OMe and CH2N), 2.48 (3 H, s, SMe), 
1.77(1 H .br.N H "), 2.12-1.48 
(10 H, br, C SH 10)
6.83 (2 H, br, 2 ArH), 3.86 (8 H, s, 2 x OMe and 
ArCH2N), 2.48 (3 H, s, SMe), 1.84 
(1 H, br, N/7"), 1.52 (6 H, s, 2 x CH,)
H exchangeable.
Table 2. Benzylaminoacetonitriles.
F ound(%) Required (%)
Compound Yield (%) M.p. , tl°C Q H N C H N
(lb) 80 98- 101 57.2 7.2 9.8 57.6 7.2 10.3
l4a) 78 81 63.6 7.6 8.8 63.7 7.6 8.7
(4b) 88 77 60.0 7.3 9.8 60.0 7.2 10.0
(8a) 92 119- 121" 57.3 7.1 7.8 57.2 7.1 7.9
(8b) 88 Oil b
" Of hydrochloride, h Found: M *, 280.12.51; C 14H 20N 2O 2S requires M, 
280.1246.
(29), 138 (56), 105 (100), 77 (51), 47 (48), and  29 (15) (Found: 
M  1, 286.1249. C l4H 220 4S requires M , 286.1248).
2 .3-D im ethoxy-5-m ethylthiobenzaldehyde diethyl acetal 
(108.5 g, 0.38 mol) w as heated  under reflux w ith 2m sulphuric 
acid (1 1) for 1 h. T he m ixture was rapidly cooled  and  extracted 
w ith ether (3 x 150 ml). T he com bined ex tracts  were washed 
w ith dilute aqueous sod ium  hydroxide (50 m l) and  w ater (50 
ml), dried, and  evapo ra ted  to  yield a  b row n oil (49.8 g, 79%). 
V acuum  distilla tion  afforded the aldehyde as a pale yellow 
oil, b.p. 117°C  a t 0.05 m m H g, w hich rapidly solidified. 
R ecrystallisation from  ethano l yielded pale yellow needles, m.p. 
60-61 °C (F ound: C , 56.3; H , 5.8%. C 10H 12O 3S requires C, 56.5; 
H , 5.7%); vm„x 1 680 (0 = 0 )  c m '1; 5„ 10.38 (1 H, s, C H O ), 7.26 (1 
H , d, J  1.5 Hz, A rH), 7.15 (I  H, d, J  1.5 Hz, ArH), 3.96 (3 H , s, 
O M e), 3.90 (3 H , s, O M e), and  2.50 (3 H , s, SM e); m /z 212 (M  ' ,  
100%), 197 (70), 169 (22), 154 (27), 141 (30), 111 (24), an d  32
(15).
2-M ethylthio-4,5-dim ethoxybenzaldehyde.— This com pound  
w as p repared  according  to  the m ethod  of Jacob an d  co­
w orkers,1 1 in 50% overall yield, m.p. 111 °C  (lit.,11 112-113 °C).
Preparation o f  Benzylam ines and Benzylam inoacetonitriles.— 
These com pounds were ob ta ined  by established m ethods.5
2.3-D im ethoxy-5-m ethylthiobenzylam ine hydrochloride was 
recrystallised from e thano l (95% yield over 2 steps), m.p. 153 °C 
(F ound: C, 48.0; H, 6.5; N, 5.3%. C I0H 16C 1 N 0 2S requires C, 
48.1; H, 6.5; N, 5.6%); vmnx 3 400 (N H ) c m '1; 8„ 7.21 (1 H, d,
J  2.5 Hz, ArH), 6.78 (1 H, d, J  2.5 Hz, A rH), 4.24 (2 H , s, 
A rC H 2N), 4.00 (3 H, s, O M e), 3.82 (3 H , s, O M e), 2.49 (3 H , s. 
M e), and 2.38 (2 H , br, N H 2, exchangeable); m /z 214 (M  ' ,
1 1%), 213 (88), 198 (15), 182 (21), 166 (14), 151 (15), 36 (93), and  
31 (100).
4,5-D im ethoxy-2-m ethylthiobenzylam ine hydrochloride was 
recrystallised from ethano l (89% yield over 2 steps), m.p. 180 °C  
(F ound: C, 48.3; H, 6.7; N , 5.4%. C 10H 16C lN O 2S requires C, 
48.1; H, 6.5; N, 5.6%); vmnx 3 380 (N H ) cm ■; 8„ 6.92 (2 H, s, 
A rH), 3.92 (2 H, s, C H 2N), 3.89 (6 H , s, 2 x O M e), 2.44 (3 H, s, 
SM e), and  1.64 (2 H , br, N H 2, exchangeable); m /z 213 ( M \  
76%), 212 (91), 198 (100), 181 (60), 164 (25), 151 (29), 138 (49), 
and  30 (36).
Cyclisation o f  Benzylaminoacetonitriles: G eneral M ethods .— 
The benzylam inoacetonitrile (2 g) in ch loroform  (8 ml) was 
added  to  94% sulphuric  acid (10 ml) a t 0  °C du ring  5 min. T he 
m ixture w as then stirred  for 15 min at room  tem perature. 
W ork-up  was then achieved using m ethod A or B.
M ethod  A. T he so lu tion  was added dropw ise to  ice-w atcr and  
stirred for 5 min after which it w as added slowly to  an  ice-cooled 
sa tu ra ted  solu tion  of sodium  hydrogen carbonate. T he free base 
was extracted  w ith ch loroform , an d  the extracts were w ashed 
w ith w ater, d ried  (M g S 0 4), and  evaporated.
M ethod  B. The so lu tion  was added  dropw ise cautiously to  
ice-d ilu te  aqueous am m onia. T he cyclised p roducts  were 
extracted w ith chloroform , and  the extracts w ere w ashed with 
w ater, dried, and  evapora ted  (w ater bath  <  30 °C).
Spectral and  analytical da ta  for the novel isoqu ino lin -4 (3 //)- 
one p roducts are presented in Tables 3 and 4.
Cyclisation o f  1 -(2,3-dim ethoxybenzylamino)cyclohexanecar- 
bonilrile ( la ) . W ork-up  using m ethod  A yielded a brow n oil 
(0.5 g). rH  N M R  and T L C  of the crude m ixture suggested the 
presence of l,2-dihydro-5,6-dim ethoxyisoquinoline-3-spiro- 
cyc lohexan-4(3 //)-onc (2a) (Rr 0.61) and the correspond ing  
7,8-dim ethoxy com pound  (3a) (R c 0.73), in a 4:1 ratio . P artia l 
purification o f the m ixture was achieved by form ation  o f the 
hydroch lo ride salt, by add ition  of ethereal hydrogen chloride. 
P repara tive  TL C  of the rebasified m ixture gave (2a) (0.26 g, 
13%), and  (3a) (0.06 g, 3%) as green translucen t plates. 
Spectroscopic p roperties of (2a) w ere identical w ith those found 
previously.2
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Table 3. Spectroscopic data for t,2-dihydroisoquinolm-4(3/t)-oncs. 
vlml ,/cm"1 
Compound NH 0= 0  m/z
507
(2b) 3 300 1 680 235 (M  \  18%), 207 (10), 176 (27), 167 (41), 
151 (36), 136 (100), 91 (46), 77 (17), 58 (10)
7.09 (1 H, d, J  8.4 Hz, ArH), 6.85 
(1 H, d, J  8.4 Hz, ArH), 4.07 (2 H. s, ArCH2N), 
3.89 (2 H, s, OMe), 3.87 (3 H, s, OMe), 2.08 
(1 H, br, N H ”), 1.35 (6 H, s, CH,)
(3a) 3 300 I 660 275 (A t',  23%), 216 (52), 204 (13), 178 (11), 
151 (17), 136 (17), 91 (16), 40 (100), 29 (63)
7.82(1 H, d, 7 8 Hz, ArH), 6.89(1 H ,d ,7  8Hz, 
ArH) 4.12 (2 H, s, NCH2N), 3.91 (3 H, s, OMe), 
3.83 (3 H, s, OMe), 1.93 (1 H, s, N H “), 2.12-1.35 
(10 H, br, C SH ,0)
(3b) 3 300 1 680 235 (At+, 16%), 219 (4), 207 (10), 178 (59), 
151 (100), 136 (49), 120 (17), 91 (37), 77 (14), 
58 (26), 40 (47), 32 (64)
7.77 (1 H, d, J  4.7 Hz, ArH), 6.85 
(1 H, d, J  4.7 Hz, ArH), 3.87 (3 H, s, OMe), 3.85 
(3 H, s, OMe), 3.68 (2 H, s, ArCH2N), 1.69 
(1 H, br, N H “), 1.41 (6 H, s, CH3)
(6a) 3 400 2 680 321 (M  1, 60%), 306 (17), 250 (48), 246 (88), 
224 (31), 197 (96), 182 (58), 84 (55), 49 (84), 
36 (100)
7.58 (1 H, s, ArH), 4.21 (2 H, s, ArCH2N), 3.96 
3.90 (3 H, s, OMe), 2.39 (3 H, s, SMe),
1.88 (1 H .s, N H ”), 1.67-1.50(10 H, br, C SH 10)
(6b) 3 320 I 660 281 (At \  49%), 224 (100), 208 (34), 197 (8), 
182(61), 58 (81), 29 (15)
7.59 (1 H, s, ArH), 4.28 (2 H, ArCH2N), 3.97 
(3 H, s, OMe), 3.94 (3 H, OMe), 2.39 
(3 H, s, SMe), 2.08 (1 H, s, NH”), 1.36 
(6 H, s, CH,)
(7a) 3 300 1 650 321 (A th, 60%), 306 (17), 250 (48), 246 (88), 
224 (31), 197 (96), 182 (58), 84 (55), 49 (84), 
36(100)
6.68 (1 H, s, ArH), 4.12 (2 H, s, ArCH2N), 3.95 
(3 H, s, OMe), 3.80 (3 H, s, OMe), 2.42 
(3 H, s, SMe) 2.05 (1 H, s, N H ”), 1.84-1.68 
(10 H, br, C 5H io)
(7b) 3 280 1 650 321 (At+, 37%), 224 (100), 209 (41), 196 (45), 
182 (50), 58 (97)
6.65 1 H, s, ArH), 4.15 (2 H, s, ArCH2N), 3.92 
(3 H, s, OMe), 3.78 (3 H, s, OMe), 2.42 
(3 H, s, SMe), 2.10 (1 H, s, N H ”), 1.42 
(6 H ,s ,C H s)
1 H exchangeable.
Table 4. l,2-Dihydroisoquinolin-4(3H)-ones.
F o u n d (%) Required (%)
Compound M.p., //“C” C H N C H N
(2a) 98 ^
(2b) 198' 57.6 6.8 5.2 57.4 6.7 5.2
(3a) 75 69.4 7.6 5.2 69.6 8.0 5.1
(3b) — d
(6a) 67-68 63.8 7.2 4.3 63.5 7.2 4.3
(6b) Oil
(7a) 102-104 63.8 7.5 4.3 63.5 7.2 4.3
(7b) 110-112 60.1 6.8 4.9 59.8 6.8 5.0
" From light petroleum (b.p. 60-80 °C). 6 Lit.,2 106 "C. '  Of hy­
drochloride (from methanol ether, 1:1). ‘'Found: A t+, 235.1179; 
C, ,H 17N O , requires At, 235.1176.
c Cyclisation o f  2-(2,3-dim ethoxybenzylamino)-2-m ethylpropio-
h nitrile (lb ). W ork -up  using m e th o d  A yielded a  brow n oil (0.66
g). l H N M R  an d  T L C  of the  p ro d u c t suggested the presence 
). o f l,2-d ihydro-5 ,6-d iinethoxy-3 ,3-d im ethylisoquinolin-4(3//)-
one (2b) (R , 0.39), and  l,2-dihydro-7,8-dim ethoxy-3,3-dim ethyl- 
>•- isoquinolin-4(3W )-one (3b) (R f 0.43), in a 4:1 ratio . F o rm ation
il o f  the  hydroch lo ride salt followed by prepara tive T L C  gave (2b)
ic as yellow -green needles (0.28 g, 14%), and (3b) as a pale yellow
>- oil (0.06 g, 3%).
ig Cyclisation o f  \-{4,5-dim ethoxy-2-m ethylthiobenzylam ino)-
a! cyclohexanecarbonitrile  (4a). W o rk -u p  using m ethod B yielded
ie a  pale oil (1.55 g). T L C  show ed the presence o f one m ajo r
e. p roduct plus three m inor ones. T hese were separa ted  by colum n
g, chrom atography . T he three m in o r com ponen ts were 1,2-
:s. d ihydro-6,7-dim ethoxy-8-m ethylthioisoquinoline-3-spirocyclo-
id h ex an -4 (3 //)-one  (6a) (0.12 g, 6%; R, 0..87), the starting
am inoaceton itrile  (4a) (0.06 g, 3%; R ( 0.75), an d  the
correspond ing  7,8-dim ethoxy com pound  (7a) (0.04 g, 2%; R, 
0.58). T he m ajo r p roduct obta ined  as a  colourless oil was 4-(4,5- 
dim ethoxy-2-m ethylthiophenyl)-4,5-dihydroim idazole-5-spiro- 
cyclohexane (5a) (1.34 g, 67%; Rf 0.39) (F ound : M  + , 320.1552; 
C 17H 24N 20 2S requires M, 320.1545); v,nox 3 260 (N H ) and 
1 590 (C=N) c m '1; m /z  320 ( M ' 1.3%), 305 (2), 276 (3), 111 
(100), 110 (23), 83 (40), an d  82 (10); 8„ 6.97 (1 H , s, A rH ), 6.66 (1
H, s, ArH), 4.89 (2 H, s, A rC H 2N), 3.92 (3 H , s, O M e), 3.86 (3 H, 
s, O M e), 2.40 (3 H , s, SM e), 1.85 (1 H , br, N H , exchangeable), 
and  1.84-1.48 (10 H , br, C sH l0).
Cyclisation o f  2-(4,5-dim ethoxy-2~m ethylthiobenzylam ino)-2- 
m ethylpropionitrile (4b). W ork-up  using m ethod  B yielded a 
pale oil (1.8 g). T L C  show ed one m ajor p ro d u c t plus tw o m inor 
ones. These were separa ted  by colum n ch rom atog raphy . The 
tw o m inor p roducts were identified as 1,2 -d ihydro-6,7- 
d im ethoxy-3 ,3-d im ethyl-8-m ethylth io isoquinolin-4(3//)-one 
(6b) (0.08 g, 4%; Rf 0.78), and  l,2-dihydro-7,8-dim ethoxy-3,3- 
d im ethyl-5-m ethylth io isoquinolin-4(37/)-one (7b) (0.06 g, 3%; 
R t 0.59). T he m ajor p roduct, ob ta ined  as a  w hite solid  w as 2,5- 
dihydro-4-(4,5-dim ethoxy-2-m ethylthiophenyl)-5,5-dim ethyl- 
imidazole (5b) (1.2 g, 60%; R, 0.45), m.p. 64-66  °C  (F ound : C, 
60.1; H , 7.5; N , 9.8%. C 14H 20N 2O 2S requires C, 60.0; H , 7.2; N, 
10.0%); vmnx 3 260 (N H ) and  1 590 ( O N )  cm  >; m /z  280 (M  ' ,  
0.8%), 265 (1.4), 84 (13), 72 (36), and 71 (100); 5„ 6.96 (1 H, s, 
A rH ), 6.74 (1 H, s, A rH ), 4.89 (2 H, s, A rC H 2N), 3.93 (3 H, s, 
O M e), 2.42 (3 H , s, SM e), 2.39 (1 H, s, N H , exchangeable), and
I.36 (6 H, s, C H 3).
Cyclisation o f  1 -(2 ,3-dim ethoxy-5-m ethylthiobenzylam ino)- 
cyclohexanecarbonitrile (8a). W ork-up  using  m ethod A yielded 
a brow n oil (1.05 g). T L C  showed one m a jo r and  one m inor 
com ponent w hich were separa ted  by co lum n  chrom atography . 
T he m ajo r p ro d u c t was the dim ethoxy co m pound  (7a) (0.68 g, 
34%; R( 0.60). T h e  m ino r com ponen t w as uncyclised s tarting  
m aterial (0.32 g, 16%; R t 0.79).
Cyclisation o f  1 -(2 ,3-dim ethoxy-5-m ethylthiobenzylam ino)-2-
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(9a) 60748'’ 3 440 227 (M  \  16%), 275 (21), 257 (21), 206 (19), 
180 (43), 165 (24), 136 (21), 98 (100), 40 (76), 
29(51)
6.95 (2 H, ABq,7 7 Hz, 2 ArH), 4.14
(1 H, s, C //O H ) 3.96 (2 H, d, J  3 Hz ArCH2N),
3.85 (3 H, s, OMe) 3.81 (3 H, s, OMe), 2.23 br
(2 H, br, NHr and O H “), 1.60 1.26
(10 H, br, C SH 10)
(9) 55741" 3 300 237 (M  *. 10%), 220 (5), 204 (3), 101 (31), 
165 (11), 58 (100), 42 (53), 39 (20), 27 (23)
6.92 (2 H, ABq,./ 8 Hz, 2 ArH), 4.19 
(1 H, s, C /fOH) 4.11 (2 H, d, ,/4.5 Hz, ArCH2N), 
3.84 (3 H, s. OMe) 3.80 (3 H, s, OMe), 1.42 
(2 H, br, N H ‘ and O H c), 1.40 (3 H, s. Me), 1.29 
(3 H, s. Me)
(10) 55“ 3 340 277 (M \  11%). 275 (10), 257 (44), 180 (73). 
166 (50), 151 (6.8), 136 (54), 98 (100), 40 (60), 
29 (42)
6.82 (1 H, s, ArH), 6.40 (1 H, s, ArH), 4.10 
(1 H, s, CHOH), 3.86 (3 H, s, OMe),’ 3.83 
(3 H, s, OMe), 3.79 (2 H, s. ArCH2N), 2.45 
(2 H, br, N H ‘ and O H c), 1.59-1.19 
(10 H, br, CSH ,0)
" From sodium borohydride reduction of l,2-dihydroisoquinoIin-4(3//)-ones." From nickel boride dcsulphurisation of 1,2-dihydroisoquinoIin- 
4(3//)-oncs.c 1 H exchangeable.
methylpropionitrile  (8b). W o rk -u p  using m ethod A yielded a 
brow n oil (0.8 g). T L C  show ed two p roducts, which were 
identified by colum n ch rom atog raphy  as the isoquinolinone 
(7b) (0.6 g, 30%; R( 0.47) and uncyclised starting  m aterial (0.2 g, 
10%; R, 0.84).
Sodium  Borohydride Reductions.— Isoquinolin-4(.3//)-ones 
(3a), (3b) an d  (6a) were reduced  under stan d a rd  conditions to 
give the corresponding l,2 ,3 ,4-tetrahydroisoquinolin-4-ols (9a), 
(9b), and  (10). Spectroscropic an d  analytical d a ta  arc  presented 
in T able 5.
Nickel Boride Desulphurisations.— Isoquino lin -4 (3 //)-ones 
(7a) and  (7b) were reductively desulphurised  in accordance w ith 
litera ture m ethods.7 8 The respective p roducts (9a) and (9b) 
were iso la ted  upon w ork-up  as uncrystallisable glasses. 
Spectroscopic and  analytical d a ta  are presented in  T able 5.
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A Very Short Route to  Fully Arom atic 2,3,8,3- and 2,3.8,9,112 -0 x y g en a ted  
B enzo[c]phenaothridiines
T iw a la d e  A. O lu g b a d e , R o g er  D. W a ig h ,' and  S im o n  P. IViackay 
D ep a rtm en t o f  Pharm acy, U n iversity  o f  M an ch ester, M an ch ester  M l 3  9FL
C yclisation of suitably substitu ted  2-b en zy lam in o-2 -p h en y laceton itr iles  proceeds by rearrangement, 
in sulphuric acid or anhydrous hydrogen fluoride, to  g ive 3-aryl 1 ,2 -d ih yd ro isoq u in o lin on es  
p o sse ss in g  all but tw o  carbons o f th e ben zo[c]p h en an th rid in e  ring system . T hese tw o  carbon atom s  
are introduced in h igh  yield by m eans o f a m odified Reformatski reaction and the resulting ester is 
cy clised  in sulphuric acid, w ith concom itan t dehydration and oxidation, to  g ive th e  fully aromatic 
four-ring system  in on ly  four step s.
N aturally  occurring  2,3,8,9-oxygenated benzo[c]phenanthri- 
d ines are o f interest for the po ten t antileukaem ic activity (in 
anim als) o f the ir /V-methyl sa lts .1 The published synthetic 
m ethods are num erous, but alm ost w ithout exception are very 
long, o r  include one o r m ore photochem ical steps which a re  not 
am enable to  large scale reactions. T he num ber o f analogues 
w hich have been prepared for s truc tu re -ac tion  studies is 
therefore qu ite  sm all. In con trast to  the literature procedures, a 
tw o-stage synthesis o f a  3-arylisoquinoline provides all but two 
carbons o f the ring system,2 with su itab le  functionalisation  for 
the rem aining ring to  be added. T he synthesis has now  been 
com pleted (Schem e 1).
A tten tion  to  detail im proved the yield o f the isoquinolinone 
(2a) from 24% to  54%, in sulphuric acid, and was further raised 
to  66% in anhyd rous  hydrogen fluoride (H F). W ith a  view to  the 
synthesis o f  analogues o f the highly potent antileukaem ic 
alkalo id  fagaronine,3 the isopropyl derivative (lib) was prepared 
and  cyclised, giving the phenolic isoquinolinone (2d) in both 
su lphuric  acid an d  H F. Since depro tection  was no t desired at 
this early stage, the ethyl analogue ( lc )  was used, giving the O 
ethyl isoquinolinone (2c). The use o f  H F  as cyclising agent 
resulted in a 68% yield, com pared to  29% in su lphuric acid.
A tw o-carbon synthon was required, w ith app rop ria te  
substitu tion  for generation  o f a nucleophile, and  w ith function­
ality  on the o the r carbon su itab le for a subsequent acid- 
catalysed  ring closure. T he first choice w as an «-halogcno acetal, 
but these are  reported  not to  form  stab le  G rignard  com plexes.4 
A R eform atski reac tion  was an alternative, although  giving a 
different ox ida tion  state. T he no rm al cond itions for the 
R eform atski reaction  involve in troduction  of the halogeno ester 
an d  ketone in to  the reaction m ix tu re together, to  m inim ise self- 
condensation  o f the  ester and  zinc com plex. T his w as no t an 
a ttrac tive  p roposition  when using an  am ino ketone which 
could  react nucleophilically w ith the halogeno ester, but a 
m odification described by C ure an d  G audem ars offered a way 
ro u n d  the problem . In their m ethod, the com plex between zinc 
an d  ethyl b rom oaceta te  is form ed in the presence of 
d im ethoxym ethane. A ddition o f the ketone can  be delayed until 
the com plex is fully formed. At first we found th a t very pure zinc 
had  to  be used bu t the use of trim cthylsilyl ch loride as an 
in itia to r6 avoids even this draw back. T he m ethod is a  significant 
im provem ent a n d  deserves to  be m ore  widely know n. U sing this 
m ethod the esters (3a) and (3c) were obta ined  in yields in excess 
o f  80%. In each case only one o f the diastereoisom eric pairs was 
formed. We presum e tha t attack  occurs from the opposite  side 
o f the ring from the phenyl substituen t, giving the isomers in 




























c; R = Et
d; R = H
Scheme 1. Reagents and conditions: i, H + ; ii, Reformatski; iii, H 2SO„; 
iv, 5-chloro-l-phenyl-1//-tetrazole, K_2C.O,; v, H 2/Pd.
involved dehydration  the stereochem istry is no t significant for 
the present.
C yclisation o f the p-hydroxy esters (3a) an d  (3c) in sulphuric 
acid gave the fully arom atic  benzo[c ]phenan th rid ines (4a) and  
(4c) in 52 and  70% yields respectively. T here  was some de- 
ethy lation  in the la tte r reaction, giving the d iphenol (4d) in up 
to  14% yield w ith longer reaction  times. T he conversion  from P- 
hydroxy ester in to  fully arom atic  four-ring system  m ust involve
73
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four steps, the preferred o rd er o f which is no t entirely clear. 
C yclisation to  give a ketone and  dehydration  o f the tertiary  
alcohol could occur in either order. Enolisation of the ketone 
would then be followed by oxidation o f the 5,6-dihydro- 
benzo[c ]phenan th rid ine by air o r by su lphuric  acid; such 
com pounds are know n to oxidise readily .1 T he oxidative 
stage is probably  final, since dehydration  and  spontaneous 
arom atisation  in cthanolic hydrogen chloride gave the ester (7a)
C O ,! '
(7) a; R = El
b;R = H
which did no t cyclise in su lphuric  acid. H ow ever, when the 
d ihydrobenzo[c]phenan th rid ine  was first hydrolysed using 
hydrochloric acid, to p roduce  the acid (7b), the cyclisation in 
su lphuric acid proceeded readily. The la tter procedure offers an 
a lternative (longer) rou te to  the desired benzophenan th rid ine 
but is probably  no t relevant to  the cyclisation o f the P-hydroxy 
esters.
In o rder to establish th is  rou te  to the m ajo r antileukaem ic 
alkaloids, it was necessary to  show that the 12-hydroxy g roup  
could be rem oved. Tw o m ethods were tried; the first used 
therm al rearrangem ent o f the d im cthylth iocarbam ate (8a) as a 








\j -N M e ?
Scheme 2. Reagents and conditions: i, diinethylthiocarbamoyl chloride, 
K.OH; ii, heat.
p roduct was obta ined  in p o o r yield, so the dehydroxylation  was 
attem pted  instead via the tetrazolyl e ther (Schem e 1). W ith 
palladium  on charcoal, hydrogenation  under pressure gave the 
de-hydroxybenzo[c]phenan th rid ines (6a) an d  (6c). The base 
(6c) is the required in term ediate  for a sim ple synthesis o f the 
m ost potent an tileukaem ic alkalo id , fagaronine.
Solu tions o f extracted p roducts  in organic solvents were dried 
over anhydrous m agnesium  sulphate before evapora tion . IR 
spectra were recorded using potassium  chloride discs o r liquid
films as appropria te . Elem ental analyses which are quo ted  as 
hydrates are the results obta ined  after thorough  dry ing  and 
repeated com bustion.
6,7-D im ethoxy- 7>-{f>A-dimethoxyphenyl)-1,2 -dihydroiso- 
quinolin-4(3H )-one (2a) Hydrochloride.— 3,4-Dimethoxy benzy 1- 
am ine (16.7 g) in w ater (200 ml) w as treated  with d ilu te  HC1 
until just acid. A solu tion  o f 3 ,4-dim ethoxybenzaldehyde (16.6 
g) in ethanol (100 ml) was added and  the m ixture hea ted  on a ]f 
steam  bath for 30 min. Potassium  cyanide (10 g) in w ater (50 ml) 
was added dropw ise with vigorous stirring  and the m ixture 1 
stirred for a further 2 days, after which 2-(3,4-dim ethoxybenzyl- t 
am ino)-2-(3,4-dim ethoxyphenyl)acetonitrile (30.1 g, 88%) was 
collected by filtration and thoroughly  washed with w ater. The 
am ino n itrile ( la )  had  m.p. 55-57 °C  (lit.,2 60-61 °C); IR, ‘H 
N M R  and M S were in accord w ith those o f au thentic 
samples.
Cyclisation in hydrogen fluoride. T h e  am ino nitrile (27.4 g) in 
anhydrous hydrogen fluoride (150 m l) was stirred in a  stoppered 
plastic bottle for 24 h. T he reaction m ix tu re was transferred to a 
plastic beaker and  the H F  allowed to  evaporate. After 2 h the 
residue was d ilu ted  by the addition  o f crushed ice, stirred  for 10 
min and basified w ith solid sodium  hydrogen ca rbona te  while 
bubbling w ith nitrogen. The p ro d u c t was ex tracted  with 
chloroform , the so lu tion  dried over anhydrous m agnesium  
sulphate, d ilu ted  w ith e ther and  the isoquinoline hydrochloride 
(20.1 g, 66%) precipitated by ad d itio n  of ethereal hydrogen 
chloride. T he hydrochloride was sufficiently pure for further use 
and  could be crystallised from w ater (m.p. 250-252 °C; lit.,2 
255-256 °C).
Cyclisation in sulphuric acid. T he  am inonitrile (27.4 g) in 
chloroform  (50 ml) was added to  conc. sulphuric acid (100 ml) 
over a period o f 10 min, the m ixture stirred  for 15 min, and the 
acid layer separa ted  and  diluted w ith crushed ice (ca. 500 g). The 
resulting greenish so lu tion  was s tirred  for 5 min and basified 
carefully w ith conc. am m onium  hydroxide while cooling 
externally w ith an  ice-bath and by ad d itio n  of m ore ice. N itro ­
gen was bubbled  through  the reaction  m ixture during 
basification. T he isoquinolinone was ex tracted  with chloroform , 
and  the so lu tion  w ashed with w ater and  dried (M g S 0 4). After 
filtration, excess ethereal hydrogen chloride was added  to the 
chloroform  so lu tion  and the crude isoquinolinone hydro­
chloride collected by filtration. P urification  was effected by 
boiling w ith 96% ethanol which, on  cooling, gave a  white 
pow der (16.4 g, 54%).
3-(4-H ydroxy-3-m etlw xyphenyl)-6,7-dim ethoxy-l,2-dihydro- 
isoquinolin-4{3H)-one (2d) Hydrochloride.— The m ethod des­
cribed above, using 4-isopropoxy-3-m ethoxybenzaldehyde in 
place of 3 ,4-dim ethoxybenzaldehyde gave 2-(4-isopropoxy-3- 
m ethoxyphenyl)-2-(3,4-dim ethoxybenzylam ino)acetonitrile 
(lb ), by chloroform  extraction as an  uncrystallisabie gum  in 97% 
yield; vmux 2 240 (C sN ) and 3 320 cm 1 (N H ); 8„(300 MHz; 
C D C Ij) 1.35(6 H, d, J 1 Hz, M e2C), 1.90(1 H, br s, exch., NH), 
3.80 (9 H, s, O M e), 3.90 (2 H, s, C H 2N), 4.45 (1 H, sept, J  7 Hz, 
C H O ), 4.65 (1 H, s, C H -N ), an d  6.7-7.1 (6 H , m, Ar); m/z 
343.1784 (A /+ -  27, 18%. C 20H 25N O 4 requires 343.1783).
The am inon itrile  (5 g) cyclised in anhydrous hydrogen 
fluoride, using the procedure described above, to give the 
isoquinolinone hydrochloride, m.p. 185-188 °C from  w ater, in 
31% yield (F ound: C, 58.7; H, 5.5; N, 3.6. C lgH 20C lN O 5 
requires C, 59.1; H , 5.5; N, 3.8%); v,nuK 1 680 (C = 0 ) an d  3 460 
cm -1 (O H ); 8„(300 M Hz; [ 2H 6]D M S O ) 3.78 (3 H, s, O M e), 3.86 
(3 H, s, O M e), 3.92 (3 H, s, O M e), 4.43 and 4.66 (2 H, AB system, 
J  15 Hz, 1-H), 5.46 (1 H, s, 3-H), 6.82-6.90 (2 H, m, Ar), 7.25 (1 
H, br s, Ar), 7.26 (1 H, s, 8-H), an d  7.47 (1 H, s, 5-H); m/z 329 
( M \  27%), 327 (11), 300 (32), 178 (100), and 150 (15). T he yield 
from sulphuric  acid was 11%.
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3-(4-E thoxy-3-niethoxyphenyl)-6,7-dim ethoxy-l,2-dihydro-  
isoquinolin-4(3H)-one (2c) Hydrochloride. T he am inonitrile 
synthesis described above, using  4-ethoxy-3-m ethoxybenz- 
aldehyde, gave the desired p ro d u c t (He) in 90% yield, m.p. 55- 
59 °C; vml„  2 220 (C sN ) and 3 320 cm  1 (N H ); 5H(300 M Hz; 
CDC13) 1.45 (3 H, t, J 1  Hz, C H 3C ), 1.90 (1 H, b r s, exch., N H ), 
3.85 (9 H , s, O M e), 3.90 (2 H, s, C H 2N), 4.05 (2 H , q, J  7 Hz, 
C H j-O ) , 4.65 (I H, s, C H -N ), an d  6.7-7.1 (6 H , m, Ar); m /z  
329.1623 {M *  -  27, 18%; C 19H 23N 0 4 requires 329.1627) and 
151 (100). T he 2-(4-cthoxy-3-m ethoxyphenyl)-2-(3,4 dim eth 
oxybenzylam ino)acetonitrile thus  obta ined  cyclised in anhy
11 d rous hydrogen fluoride, as described above, to  give the 
isoquinolinone hydrochloride, m.p. 170-172°C  from  aqueous 
ethano l, in 68% yield (F ound: C, 58.6; H, 5.9; N, 3.4. 
C 20H 24C lN O 5.H 2O  requires C , 58.3; H, 6.4; N , 3.4%); vm„x 
1 670 cm "1 (0 = 0 ) ; 5„(300 M Hz; CD C13; free base) 1.30 (3 H, t, J  
7 Hz, C H jC ), 2.50 (1 H , b r s, exch., N H ), 3.70 (3 H, s, O M e), 3.77 
(3 H , s, O M e), 3.81 (3 H, s, O M e), 3.95 (2 H, q, J  7 Hz, C H 2- 0 ) ,  
3.95 (2 H, s, 1-H), 4.40 (1 H, s, 3-H ), 6.65-7.0 (4 H, m , Ar), and 
7.40 (1 H , s, 5-H); m /z  357 (M  ' , 16%), 355 (25), 339 (100), 328
(16), 310 (60), 178 (41), and 150 (15). The yield from sulphuric 
ac id  was 29%.
4 -E thoxy  carbonylmethyl-6,7-dime thoxy-3~{3,4-dimethoxy- 
p h en y l)-\,2,3,4-tetrahydroisoquinolin-4-ol (3a).—Z inc pow der 
(98%) w as w ashed with dry e th e r  and dried under reduced 
pressure a t 80 °C  for 2 h. E thyl b rom oaceta te  w as freshly 
distilled under reduced pressure. D im ethoxym ethane was 
treated  w ith sodium  wire daily un til no  m ore reaction  occurred 
an d  then distilled. D ioxane and benzene were d ried  over sodium  
wire an d  glassw are was dried a t 150 °C overnight. The 
isoquinolinone hydrochloride w as converted  in to  the free base, 
dried  u nder reduced pressure for 3 h, and  used fresh.
Z inc pow der (19.22 g), d im ethoxym ethane (60 ml), and 
ch loro trim ethylsilane (3 ml) were placed in a flask fitted with a  
dropp ing  funnel, condenser, an d  dry ing  tubes and  stirred at 
room  tem peratu re  for 15 min. T he flask contents were heated to 
reflux an d  stirred while ethyl brom oaceta te  (30 ml) in 
d im ethoxym ethane (60 ml) was added  dropwise: ad d ition  was 
halted  after the  add ition  of 10 ml o f so lu tion  to  ensure tha t the 
reaction  s ta rted  smoothly. The rem aining  so lu tion  was added 
slowly w ith the reaction tem pera tu re  m ainta ined  a t 90 100°C, 
an d  the m ix tu re stirred  for 3 h. T h e  hea t was tu rned  off and  a 
so lu tion  o f isoquinolinone (2a) (25.0 g) in dioxane (200 ml) 
added  an d  the m ixture stirred for 20 h. S atu ra ted  aqueous 
am m onium  chloride (100 ml) and  sufficient ch loroform  to  form 
tw o layers were added and after filtration  the o rgan ic layer was 
separa ted , w ashed w ith sa tu ra ted  aqueous am m onium  chloride 
so lu tion  (2 x  30 ml) and  w ate r (2 x 20 ml), dried, and 
evapora ted . T he residue was redissolved in chloroform  (50 ml) 
and  added  dropw ise to  light petro leum  (b.p. 40-60  °C; 250 ml), 
to  give the  tetrahydroisoquinolinol (97% ) as a w hite pow der, m.p. 
185-186 °C  (from  EtOA c) (F ound : C, 63.9; H , 6.7; N , 3.6. 
C 23H 29N O , requires C, 64.0; H, 6.8; N , 3.3%); v„,„x 1 715 (C = 0 ) 
and  3 280 cm 1 (N H ); 8H(300 M H z; CD C1,) 1.16 (3 H , t,.7 7 Hz, 
C H 3C), 1.88 (2 H, br, O H  and N H ), 2.75 and  3.12 (2 H, AB 
system, J  15 Hz, 4 -C H 2), 3.90 (6 H , s, O M e), 3.92 (6 H , s, O M e),
4.05 (2 H , q, 7 7  Hz, 0 - C H 2), 4.04 an d  4.26 (2 H, AB system , J  15 
Hz, 1 H), 4.48(1 H ,s, 3-H), 6.60(1 H ,s ,8 -H ), 6.90(1 H ,d ,./9 H z , 
Ar), 7.07 (1 H, dd, J  2 and  9 Hz, Ar), 7.08 ( I H, s, 5-H), and  7.12 (1 
H, d, J  2 Hz, Ar); m /z 431 ( M 4, 0.4% ), 343 (17), 314 (19), 178 
(40), 166(100), and 150(17).
4-Ethoxycarbonylm ethyl-3-(4-ethoxy-3-m ethoxyphenyl)-6,7- 
d im eth o xy-\,2,3,4-letrahydroisoquuiolin-4-ol (3c). —U sing the 
above m ethod, the isoquinolinone (2c) gave the tetrahydro­
isoquinolinol (86%), m.p. 169-170 DC  (from E tO H ) (F ound: C, 
64.5; H, 7.0; N, 3.1. C 24H 31N 0 7 requires C, 64.7; H , 7.0; N,
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3.1%); vm„  I 715 ( 0 = 0 )  and 3 280 cm 1 (N H ); 8„(90 M Hz; 
CDC13) 1.10 (3 H, t, J  7 Hz, ester M e), 1.44 (3 H, t, J 1 Hz, e ther 
Me), 2.95 (2 H, br, O H  and N H ), 2.66 and  3.07 (2 H, AB system,
J  15 Hz, 4 -C H 2), 3.80 (3 H, s, O M e), 3.82 (3 H, s, OM e), 3.84 (3 
H, s, OM e), 3.95 (2 H, q , ./7  Hz, e ther C H 2), 4.05 (2 H, q, J  7 Hz, 
ester C H 2), 3.88 an d  4 .15 (2 H, AB system, J  15 Hz, 1-H), 4.38 (1 
H , s, 3-H) 6.48 (1 H , s, 8-H), 6.78 (1 H, d, J  9 Hz, Ar), 6.95 (1 H, 
dd, J  2 and 9 Hz, Ar), 7.00 (1 H, s, 5-H), and  7.04 (1 H, d, J  2 Hz, 
Ar); m /z 445 (M  4, 0.2%), 357 (17), 328 (21). 180 (100), 178 (54), 
and  150(24).
2,3,&,9-Tetramethoxybenzo[c] phenanthridin-12-ol (4a).—
C oncentrated  su lphuric  acid (40 ml) was added to the P- 
hydroxy ester (3a) (8.2 g), w hereupon heat was evolved initially. 
After being stirred for 4 days the reaction  m ixture was poured  
onto  ice and the yellow benzo[c\ phenanthridine sulphate (4.6 g ,  
52%) collected by filtration. T he free base crystallised from 
ch lo rofo rm -ethano l an d  could be recrystallised from pyrid ine- 
e thanol, m.p. >  320 °C, softening a t 204 °C  (Found: C, 68.8; H, 
5.3; N , 3.7. C 2,H 19N 0 5 requires C, 69.0; H , 5.2; N, 3.8%); 
XnlllI(M eO H ) 232 (e 35 700 d m 3 mol 2 c m 1), 250 (25 500), 286 
(79 600), 340 (12 200), 358 (9 200), 380 (5 100) shifted to 294 
(69 400), and 396 nm  (12 200) with N aO H ; 8H(80 M Hz; 
[ 2H 6]D M S O ) 3.97 (3 H , s, O M e), 4.00 (3 H, s, OM e), 4.03 (3 H, 
s, O M e), 4.10 (3 H, s, O M e), 7.63 (2 H, s, Ar), 7.73 (1 H, s, Ar), 
7.80(1 H ,s ,A r) , 8.60(1 H ,s , A r),9 .13 (I H ,s ,6 -H ) ,a n d  10.38(1 
H, br, O H ); m/z 365 100%), 364 (24), 350 (10), and  336
( 12).
2-Ethoxy-3,'&,(7~trim ethoxybenzo[c\ phenanthridin-12-ol (4c) 
and 3,& ,9-Trimethoxybenzo[y]phenanthridine-2,12-diol (41d).— 
C oncentrated  su lphuric  acid (60 ml) was added to the p- 
hydroxy ester (3c) (12.0 g). The m ixture w as stirred for 24 h, 
d iluted with ice, basified and extracted  to  give the crude 
benzo[c]phenan th rid ine. C hrom atography  on  neutral alum ina, 
e luting with ch lo ro fo rm -ethano l (9 :1) gave the pure 2-ethoxy- 
benzoic] phenanthridine (4c) (70%) m.p. >  320 °C  (from CH - 
C l3-E tO H ) (F ound: C , 67.9; H, 5.6; N, 3.5. C „ H 21N O s- 
0.5H 2O ) requires C, 68.0; H, 5.7; N, 3.6%); X.m„,(M eO H ) 233 (e 
25 000 d m 3 rnoT* cm -1), 251 (19 400), 287 (58 900), 342 (8 900), 
359 (7 800), 378 (4 400) shifted to  294 (52 800), and 396 nm  
(9 400) with N aO H ; 8„(90 M Hz; [ zH 6]D M S O ) 1.40(3 H, t, 7 7  
Hz, C H 3C), 3.97 (3 H , s, O M e), 4.03 (3 H, s, O M e), 4.07 (3 H , s, 
O M e), 4.20 (2 H, q, J  7 Hz, 0 - C H 2), 7.63 (2 H, s, Ar), 7.73 (1 H, 
s, Ar), 7.80 (1 H, s, Ar), 8.62 (1 H, s, Ar), 9.13 (1 H, s, 6-H), and
10.36 (1 H, br, O H ); m /z 379 ( M ' ,  100%), 378 (13), 350(38), and  
322(14).
If exposure to  su lphuric  acid was extended to 2 days, 
ch rom atography as above gave first the 2-ethoxybenzo- 
[c ]  phenan th rid ine (4c) (21%). E lu tion  w ith ch lo ro fo rm - 
e thanol (1 :4) then gave the benzo[c]phenanthridine-2,\2-diol 
(4d) (14%), m.p. 225-227 °C (from C H C l3-E tO H )  (Found: C, 
66.7; H, 4.8; N , 3.8. C 20H , 7N O s-0.5H 2O  requires C, 66.7; H, 5.1; 
N, 3.9%); ^ J M e O H )  235 (e 31 500 d m 3 m o l '1 cm •), 251 
(20 700), 289 (53 200), 343 (8 100), 356 (6 300), 380 (4 000) 
shifted to  296 (39 200), and  359 nm (9 000) w ith N aO H ; S„ 3.97 
(3 H, s, O M e), 4.03 (3 H , s, O M e), 4.07 (3 H , s, O M e), 7.60 (1 H, 
s, Ar), 7.63 (1 H , s, Ar), 7.70 (1 H, s, Ar), 7.80 (1 H, s, Ar), 7.80 (1 
H, s, Ar), 8.60 (I H , s, Ar), 9.13(1 H ,s , 6-H), and  10.36(2 H, br, 
O H ); m /z  351 (M  ' ,  100%), 350 (29), and 308 (10).
3-(3,4-Dime thoxypheny l)-4 -ethoxy carbony Im ethy 1-6,7-di- 
methoxyisoquinoline (7a).— The P-hydroxy ester (3a) (2.06 g) 
was heated under reflux in ethano lic  hydrogen chloride (55 ml) 
for 3 h. T he m ixture w as concentrated  to  one-fifth volum e and  
the crystalline isoquinoline hydrochloride (1.2 g, 56%; vmux 1 720 
c m 1) collected by filtration. The isoquinoline was obtained by 
basification and  ex traction  with chloroform , m.p. 123-125 °C
75
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[from  EtO A c light petroleum  (b.p. 60-80 °C)] (Found: C, 67.0; 
H, 6.1; N, 3.4. C ,3FI25N 0 6 requ ires C,67.1, H, 6.1; N , 3.4%); m/z 
411 (M  ' ,  100%’),' 396 (17), 382 (6), and  338 (43).
W hen the isoquinoline hydroch lo ride (0.6 g) was dissolved in 
concentrated  su lphuric acid (4 ml), stirred  and  m onitored  by 
T L C  daily, no b en z o [r]phenan th rid ine  (4a) w as detected in 22 
days.
4-Carboxym ethyl-3-(3,4-dim ethoxyphenyI)-6J-dim ethoxyiso- 
quinoline Hydrochloride (7b) and  Its  Conversion into 2,3,8,9- 
tetramethoxyben7.o[c\ phenanthridin-12-ol (4a). T he ester 
hydrochloride (7a) (0.3 g) w as boiled under reflux in 5m 
hydrochloric acid for 5 h. E vapo ra tion  to dryness gave the 4- 
carboxymethylisoquinoline hydrochloride (0.22 g, 79%). T he 
analytical sam ple was crystallised from eth an o l-e th er, m.p. 169- 
174 °C (F ound: C, 58.9; H, 5.2; N , 3.7. C 21H 21N 0 6-().5H20  
requires C, 58.8; H, 5.4; N, 3.3%); v,„„, 1 700 cm
The carboxym ethyl isoquinoline hydrochloride (0.14 g) was 
added to concentrated  su lphuric  acid (5 m l) and  stirred 
overnight. D ilu tion  w ith ice, basification w ith sodium  carbona te  
and ex trac tion  with ch lo ro fo rm  gave 2,3,8,9-tetram ethoxy- 
benzo[c]phenanthrid in-12-ol (80 mg, 66%).
12-(D im ethy lth iocarbam oyloxy)-l,3,8,9-te tram ethoxy benzo- 
[c ] phenanthridine  (8a). T h e  benzo[c]phenan th rid in -12-o l 
(4a), (1.0 g) w as dissolved in aqueous potassium  hydroxide 
(10%; 15 ml). T etrahyd ro fu ran  (3 ml) was added and  the 
solu tion  cooled to below 10 °C  w ith an  ice-bath. D im ethyl- 
thiocarbam oyl chloride (1.7 g) in te trahydrofu ran  (5 m l) was 
added dropw ise, w ith cooling. S tirring  was con tinued  for 15 min 
after which the m ixture was d ilu ted  w ith w ater (20 ml) and  the 
crude p roduct collected by filtration. C rystallisation  (CHC1-, 
M eO H ) gave the thiocarbamate  (0.41 g, 42%), m.p. 274 276 °C  
(Found. C, 61.3; H , 5.4; N , 5.8. C 24FI24N 20 5-H 2Q  requires C, 
61.3; H, 5.6; N, 6.0%); 5„ 3.65 (6 H , s, N M e2), 4.05 (3 H, s, O M e), 
4.10(3 H, s, O M e), 4.15(3 H , s, O M e), 4.20 (3 H, s, O M e), 7.18 (1 
H ,s , Ar), 7.38(1 H ,s , Ar), 7.78(1 H, s, Ar), 8.00 (1 H ,s ,A r),8 .7 5  
(1 H, s, Ar), an d  9.23 (1 H, s, 6-H ); m /z 452 (M  ' ,  61%), 365 (14), 
88 (100), and  72(81).
\2-(D im ethylcarbam oylthio)-2,3,8,9-tetram ethoxybenzolc\-  
phenanthridine. -T he O -ary lth iocarbam ate  described above 
(8a) (42 mg) in  digol (1 ml) was heated  a t 250 °C for 1.5 h, 
cooled, an d  refrigerated for 1 week. T he supernaten t was 
decanted and  the residue tr itu ra ted  w ith ether. T he solid was 
collected by filtration an d  crystallised (E tO H ) to  give the 
benzophenanthridine (10 mg, 24%), m.p. 235-240 °C, re- 
crystallising a t 222 °C. T h e re  was insufficient m aterial for 
m icroanalysis, bu t IR, ‘ FI N M R , and  M S confirm ed the 
structure: v ^ ^ K C l)  1 660 cm  1 (C = 0); 5H 3.18 (6 H, br, N M e2),
4.08 (6 H, s, O M e), 4.15 (3 H, s, O M e), 4.18 (3 H, s, O M e), 7.35 (1 
H, s, Ar), 7.73(1 H ,s,A r), 7 .83(1 H, s, Ar), 8.60 (1 H ,s ,A r),8 .7 3  
(I H, s, Ar), and 9.23 (1 H, s, 6-H); m /z  452.1416 (68%; 
C 24H 24N 20 5S requires 452.1406), 380 (16), and  72 (100).
2,3,8,9-T etram ethoxy-12-( I -phenyl-1H -te trazol-5-yloxy)- 
benzol c] phenanthridine (5a). A m ixture of dry acetone (20 ml), 
anhydrous potassium  ca rb o n a te  (3 g) and  the benzo[c]phen- 
an th rid ino l (4a) sulphate (2.48 g) was stirred  an d  w arm ed for 15 
min. 5 -C h lo ro -l-p h en y l-l//- te traz o le  (1.4 g) was added and  the 
m ixture heated  under reflux fo r 24 h. After cooling and add ition  
of aqueous sodium  hydroxide (5%; 20 m l) the solid product w as 
collected by filtration and  w ashed with w ater. The te trazolyl 
ether crystallised from M eO H —CHC13 as long w hite needles 
(2.033 g, 75%), m.p. 258 -260 °C  (dccom p.) (F ound: C, 64.9; H , 
4.3; N, 13.3. C 28H 23N ,O s-0.5FI2O requires C, 64.9; H, 4.7; N, 
13.5%); m /z  509.1703 ( M 1; C 2BH 23N 50 ,  requires 509.1699); 
8h(80 M Hz; CDC13), 3.85 (3 H, s, O M e), 4.09 (3 H, s, O M e),
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4.14 (3 H, s, O M e), 4.17 (3 H, s, O M e), 7.24 (1 H, s, Ar), 7.36(1 H, 
s, Ar), 7.59-7.75 (4 H, s, and m, Ar), 7.91 7.98 (2 H, m, Ar), 8.73 
(2 H, s, Ar), and 9.19(1 H ,s ,6 -H ).
2/i,&,9-Tetramethoxybenzo[c~]phenanthridine (6a).—T he 
above tetrazolyl ether (5a) (2.0 g) in dioxane (100 ml) was 
hydrogenated  over pallad ium -on-charcoal (5%; 1.0 g) at 60 °C 
for 24 h., a t 10 atm . The cooled m ix tu re  was filtered and the 
solid collected, placed on  a sho rt co lum n of silica gel and  eluted 
with C H C l3-E tO H  (9:1) to  give the benzophenanthridine (0.9 g, 
66%). A sam ple recrystallised from pyrid ine had m.p. 307- 
310°C  (lit.,8 m.p. varies from  299-301 °C  to 306-308 °C); 5„
4.08 (3 H, s, O M e), 4.09 (3 H, s, O M e), 4.15 (3 H, s, O M e), 4.20 (3 
H ,s, O M e), 7.29(1 H ,s ,A r), 7.37(1 H, s, A r), 7.85 (1 FI, s, .79 Hz. 
Ar), 7.90 (1 H, s, Ar), 8.29 (1 H , d, J  9 H z, Ar), 8.74 (1 H, s, Ar), 
and 9.24 ( I H, s, Ar), and  9.24 (1 H ,s, 6-H); m/z  349 (M  ' ,  100%,).
2-E thoxy-3,8,9-trim ethoxy-l2-( 1 -phenyl-1 W-S-tetrazol-S- 
yloxy)benzo[c] phenanthridine (5c).— A m ixture of the benzo- 
[c jphenan th rid ino l (4c) 0.8 g dry dim ethylform am ide (10 ml), 
and  potassium  t-butoxide (0.33 g) w as stirred  under nitrogen 
until the phenol dissolved (3 min). 5 -C h lo ro -1 -phenyl-1H- 
tetrazole (0.5 g) was added and  the  m ixture stirred under 
nitrogen for 20 min. The cloudy so lu tion  was poured on to  ice 
and  the te trazolyl ether (0.7 g, 64%) collected by filtration. The 
analytical sam ple crystallised as long needles, m.p. 260-266 °C 
(M eO H -C H C l3) (Found: C, 66.2; H, 5.0; N , 13.4. C 2<,H25N 5O s 
requires C, 66.5; H, 4.8; N, 13.4%); m /z  523 (M  \  8%), 495 (49), 
453 (32), and  379 (100); 5„(80 M Hz; C F  ,C O O D ) 1.39 (3 H, t , ./
7.8 Hz, C H 3C), 4.14 (6 H , s, O M e), 4.25 (3 H, s, O M e), 4.08 (2 
H, q, J  7.8 Hz, CF12C), 7.45 (1 H, s, Ar), 7.61 7.85 (6 H, m and s, 
Ar), 8.08 (1 H , s, Ar), 8.20 (1 H , s, Ar), 8.84 (1 H, s, Ar), and 9.42 
(1 H, s, 6-H).
2-E th o xy -i,8,9-trim ethoxybenzo[c]phenanthridine  (6c).—
T he above tetrazolyl e ther (5c) (0.56 g) was hydrogenated as 
described to give the benzolc\phenanthrid ine  (155 mg, 40%), 
m.p. 2 7 1 -2 7 4 °C, recrystallising at 233-238 °C  (from CHC13-  
M eO H); 8„ 1.60 (3 H, t, J  8 Hz, C H 3C), 4.10 (3 H, s, O M e), 4.17 
(3 H, s, O M e), 4.20 (3 H, s, O M e), 4.33 (2 H , q , ./ 8 Hz, C H 20 ) ,  
7.30 (1 H, s, Ar), 7.40 (1 H , s, Ar), 7.87 (1 FI, d, J  9 Hz, Ar), 7.93 ( I 
H, s, Ar), 8.33, (1 H, d, J 9 Hz, Ar), 8.77 (1 H , s, Ar), and  9.27 (1 H, 
s, 6-H); m/z 363.1467 (100%; C 22H 21N 0 4 requires 363.1470), 
348 (6.1), 334 (40.6), and 318 (5.7).
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Cyclisatioei of Benzylaminonitriles. Part 8.t Anfoydroys 
Hydrogen Flyoride as Cyciasing Agent
IVJelvsirs R. Euerby, J a m e s  P. G avin , Tiw alade A. O lugbade, Sanjay S. Patel an 
R oger D. W aigh*
D ep a r tm en t o f  Pharm acy, U n ivers ity  o f  M anchester, M a n c h e s te r  M 13 9PL, UK
J. Chem. Research (S), 
1991,58 59 
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1991,0545-0554
Wc report that the preferred cyclisation pathway for benzyl- 
aminonitnles in anhydrous HF is through a spiro inter­
mediate, as it is in sulphuric acid. However, unlike sulphuric 
acid, HF can be used in the cyclisation of /V-alkyl benzyl­
aminonitriles to give /V-alkylisoquinolinones and also 
succeeds with methylenedioxy-substiluted amines which 
decompose in sulphuric acid.
Scheme 1 X = OMe or SMe
The cyclisation of benzylaminonitriles has been shown to 
be a useful route to isoquinolinones, imidazolines and 
benzazepincs.1 It may proceed by direct attack of the 
protonated nitrile on the benzene ring (Scheme I), but where 
possible a preferred route is through a spiro intermediate 
(Scheme 2). Almost all the work on the reaction in the last 20 
years has involved the use of concentrated sulphuric acid as 
solvent and catalyst; many other acids have been tried but 
with minimal success. In many cases the use of sulphuric acid 
gives perfectly acceptable results, but in some instances 
problems arise through sulphonation, dealkylation or 
diversion to quite unexpected products. All these problems 
are avoided by the use of anhydrous hydrogen fluoride as 
solvent and cyclisation catalyst.
ketone. Despite the precautions which have to be taken in 
the use of HF, particularly to avoid inhalation or skin contact 
and to be aware o f the corrosive effect on building materials, 
it remains a highly effective reagent which has been 
employed regularly for cyclisations in the years since Fieser’s 
work.’
Previous work has demonstrated that HF can result in 
improved yields of isoquinolinones from cyclisation of 
benzylaminonitriles, most importantly by avoiding sulphona- 
tion4 but also through a reduced susceptibility to O-dealkyla- 
tion.5 There is an important benefit, also, in the very un­
complicated work-up required with HF, which can be 
allowed to evaporate or blown off with nitrogen.
In view of the different mechanisms which operate in 
sulphuric acid it was important to determine the mecha- 
nism(s) of cyclisation in HF. The earlier work had shown that 
direct attack by the protonated nitrile on the benzene ring 
was possible,4 as in Scheme 1, but other reported cyclisa­
tions5 could have proceeded by either route. From cyclisa­
tion of la  it is apparent that the spiro rearrangement 
(Scheme 2) is also the preferred route in HF. The product 2a 
was obtained in low yield owing to a strong tendency to 
oxidise in air, as has been observed previously with analo­
gous isoquinolinones/' The chemical shift o f the aromatic 
protons of the isoquinolinone B ring (7.31 and 7.49 ppm) 
suggested that rearrangement had occurred, since a 5-proton 
in a 7,8-dimethoxyisoquinoIin-4-one would be expected to 
resonate at ca. 7.9 ppm, and this was confirmed by observa­
tion of nuclear Overhauser effects between H-8 (7.31 ppm) 
and the protons at position 1. A preference for the spiro 
route was confirmed by cyclisation of lb  to give the imi­
dazoline 3b and by ring closure of the trimelhoxy derivative 




Scheme 2 X or Y = OMe or SMe
The use of anhydrous hydrogen fluoride (HF) for intra­
molecular acylations was pioneered by Fieser in the late 
1930’s. He obtained very high yields2 in reactions where a 
carboxylic acid attacked a benzene ring in solution in HF. 
The latter was then allowed to evaporate, leaving the cyclic
*To receive any correspondence.













With two types of aminonitrile the effects of sulphuric acid 
are peculiar, yet HF gives ‘normal’ results which significantly 
extend the scope of the reaction. These are summarised in 
Schemes 3 and 4. Use of sulphuric acid resulted in the 
production of a non-basic, strongly coloured cyclohepta- 
pyrrole" from the aminonitrile Id as shown in Scheme 3. This 
was a major product in the presence of an /V-alkyl substitu­
ent and meant that /V-alkylisoquinolinones were not directly 
available by this route. In HF the reaction proceeded 
normally, giving excellent yields of the isoquinolinones 2d 
and 2e from the aminonitriles Id and He.
7 7
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decomposition 
S chem e 4
Concentrated sulphuric acid has been used as a reagent 
for the detection of methylenedioxy groups through libera­
tion o f formaldehyde.9 It is not surprising, therefore, that 
treatment of methylenedioxy-substituted aminonitriles with
R’ R2 R3 R4 R5 R6 R7
a H H MeO MeO DMP H H
b H MeS H H Me Me Me
c MeO MeO H MeO -[CH2]5- H
d H MeO MeO H DMP H Me
e H MeO MeO H EMP H Me
f H -o-ch2-o - H -[CH2l5- H
9 H -o-ch2-o- H Me Me H
sulphuric acid does not give the desired isoquinolinones. In 
contrast (Scheme 4), the cyclisation of I f  and Ig succeeded 
in HF, giving moderate yields of the 6,7-methylenedioxyiso- 
quinolinones 2 f and 2g. NMR spectra showed the presence 
of the 7,8-methylenedioxy isomer from both I f  and !g  in ca. 
7% yield in the crude product. No attempt was made to 
isolate the minor product.
We thank the S.E.R.C. for studentship support of M. R. E. 
and .1. P. G. and the Nigerian Government foi suppoit of 
T. A. O.
Techniques used: IR ,'H  NMR 
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Schemes: 4
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R' R2 R3 R4 R5 R6 R7
a MeO MeO H H DMP H H
c MeO H MeO MeO -ici-bk- H
d H MeO MeO H DMP H Me
e H MeO MeO H EMP H Me
f H -o -ch2-o - H [CH2k- H
9 H -o -ch2-o - H Me Me H
DMP = 3,4-dimethoxyphenyl 
EMP = 4-ethoxy-3-methoxyphenyl
R1 R2 R3 R4 R5 Rb R7
b H H MeS H Me Me Me
c MeO H Met) MeO -[CH2]5- H
N -V
N—R7
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Hz), 1.41-1.60 [overlapping Cga-H and (CH2 -CH3)2, 5 H],
0.90 (s, 3 H, Cj-CH3), 0.88 [overlapping t's, 6 H, (CH2- 
CH.3)2] ; chemical shifts were determined from the *H 
COSY spectrum; 8 a 'H NMR (CDC13) 8 7.22 (t, 1 H, m-Ar H),
6.78 (m, 3 H o- and p-Ar H's), 5.76 (m, 1 H, C10-H), 5.20 
(m, 2 H, Cj pH 's), 4.73 (d, 1 H, C2 -H, J2a.8a = 1.0 Hz), 4.17 
(ddd, 1 H, C4 -H, J4.5 »  1.1, J4. 12 = 6 .6  and J4_12. = 8.7 Hz),
3.79 (s, 3 H, OCH3), 3.32 [p, 1 H, CH(Et)2, J = 5.8 Hz], -3.17  
(dd, 1 H, ArCHj2H 12', J4.12' = 8-7 and Jn .\2' = 1 4 -2  Hz)> 
2.97(ddd, 1 H, C7 a-H, J7a.8e = 9.0, J7a.8a = 12 and J7a.7e =
16 Hz), -2.85 (dd, 1 H, ArCH12H 12. l ± n  = 6 -6 and J12-12’ 
=14.2 Hz), 2.76 (br d, 1 H, C9 -H, J9. 10= 8 Hz), 2.38 (br s, 1
H, Cr H), 2.30 (dd, 1 H, C7e-H, dd, J7e.8a= 6.2 and J7a.7e =
16 Hz), 2.20 (dd, 1 H, Cge-H, J7a.ge = 9 and Jga.8e =12 Hz],
I.35-1.54 [overlapping Cga-H and (CH2-CH3)2, 5 H], 0.96 
(s, 3 H, C,-CH3), 0.89 (t, 3 H, CH2 -CH3, J = 7 Hz), 0.78 (t, 3 
H, CH2 -CH3 , J = 7 Hz) ; chemical shifts were determined 
from the ]H COSY spectrum; 8 b ]H NMR (CDC13) 8 7.20 (t,
1 H, m-Ar H), 6.70 (m, 3 H o- and p-Ar H's), 5.73 (m, 1 H, 
C 10-H), 5.19 (m, 2 H, Cu -H's), 4.73 (s, 1 H, C2 -H), 3.98 (dd, 
1 H, C4 -H, J4. 12 = 5.0 and J4_12. = 10 Hz), 3.77 (s, 3 H, 
OCH3), 3.75 [m, 1 H, CH(Et)2], -3.3 (dd, 1 H, ArCH12H]2. J4. 
12. = 10.3 and J12. 12. = 14 Hz), -3 .2  ( dd, 1 H, ArCH12H 12. , 
J4. 12 = 5, and J12. 12. = 14 Hz), 3.22 (d, 1 H, C9 -H, J9. 10 = 8 
Hz)" 2.84 (ddd, 1 H, C7a-H, J7a.8c = 9.4 , J7a.8a =11 . 9  and 
J7a.7e = 16.3 Hz), 2.37 (br s, 1 H, C5 -H), 2.26 (dd, 1 H, C7e- 
H, J7e.8a = 6 and, J7a_7e = 16 Hz), 1.50-1.93 (overlapping 
Cga-H, Cge-H and (CH2-CH3)2, 6  H], 0.95 (s, 3 H, Cr CH3), 
0.89 [t, 6 H. (CH2 -CH3)2], J = 7 Hz] ; chemical shifts were 
determined from the JH COSY spectrum.
14. Satisfactory analytical and high-resolution mass spectral 
data were consistent with the proposed structures.
(R eceived  in  US 26 O ctober, 1990)
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IMPROVED REGIOSELECTIVITY OF LITHIATION OF 
METHOXYBENZALDEHYDES
Olivier Duval and Roger D. Waigh*
Dept, of Pharmacy, University of Manchester, M anchester M13 9PL, U.K.
Abstract: Protection of the aldehyde moiety a s  a  N,N’- 
diisopropylimidazolidine allows improved preferential lithiation ortho to the 
methoxy group of 4- m ethoxybenzaldehyde cr in the 4-position of 3- 
m ethoxybenzaldehyde. Reaction with a suitable electrophile, such as  
dimethyldisulphide, g ives good yields of 3-substituted-4- 
m ethoxybenzaldehydes or moderate yields of 4-substituted-3- 
m ethoxybenzaldehydes a s  appropriate.
Lithiation of m ethoxybenzaldehydes presents a problem, in that normal 
protection strategies such a s  acetal formation tend to induce lithiation ortho 
to the protecting group , 1 in competition with lithiation o/T botothe methoxy 
substituent, where this is required. Euerby and co-workers2 have shown 
that the choice of protecting group and of lithiating reagent allows som e  
regioselectivity, f-butyllithium tending to result in a preference for reaction 
ortho to a  N,N'-dimethylimidazoline protecting group, while n-butyllithium 
tends to favour lithiation ortho to the methoxy, particularly in the presence of 
N,N,N',N'-tetramethylethylenediamine. With a requirement for efficient
*To whom correspondence should be addressed .
4 3
C o p y r ig h t©  1 99! by  M arcel D ek k e r. Inc.
DUVAL AND WAIGH
sy n th eses  of both 3-methoxy-4-methylthio and 4-methoxy-3-methylthio 
benzaldehyde we set out to improve the preference for lithiation ortho to the 
methoxy group, by increasing the bulk of the imidazoiidine N-substituents.
(a) R = Me, (b) B = Et, (c) R = iPr, (d) R = CH2CMe3
The previous work2 has shown that the presence of TMEDA in the reaction 
mixture improves selectivity towards lithiation at sterically unobstructed sites, 
presumably by forming an intermediate com plex which increases the 
effective steric bulk of the lithium. With one mole of the p- 
methoxyimidazolidine (1a) and two m oles of all the other reagents, Euerby 
and co-workers reported2 that the required intermediate (2a) w as obtained
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as 84% of the mixture of products, with 8% of each  of the unwanted  
methylthiolated derivatives (3a) and (4a). In our hands the results were 
similar, although the relative proportions of (3a) and (4a) were slightly 
different (Table) and purification resulted in substantial lo sses . W hen the N- 
substituents of the protecting group were changed to ethyl (1b), but 
otherwise using the sam e methodology a s  the previous workers2, the 
regioselectivity w as substantially improved, with the required isom er (2b) 
obtained as 95% of the product mixture. A further increase in bulk to 
isopropyl (1c) virtually eliminated the unwanted products and gave 97% of 
the reaction product a s the required 4-m ethoxy-3- 
methylthiophenylimidazolidine (2c). Both N,N'-diethyl and N,N'-diisopropyl 
1,2-diam inoethane are readily available from commercial sources. 
Deprotection of the imidazolidines proceeded in dilute acid2, to give almost 
quantitative yields of the aldehydes; from (2c) the aldehyde w as sufficiently 
pure for further reactions with no need for either distillation or crystallisation.
There is a particular problem with the 3-m ethoxy isomer, s ince  
lithiation between the two substituents offers the possibility of stabilisation  
from both sides. The previous workers had reported2 that the required 4- 
substituted aldehyde w as formed as only 68% of the product when m- 
m ethoxybenzaldehyde w as the starting material and reaction conditions 
were as described above, with two m oles of each  of TMEDA, butyllithium 
and dimethyldisulphide. From the N,N'-dimethylimidazolidine (5a) w e  
obtained very similar results (Table). With the N.N’-diethyl analogue (5b) the 
proportion of the desired isomer w as increased to 79%  and the N,N'- 
diisopropyl compound (5c) gave a further increase to 82%. A change to 4
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Table
Starting imidazoiidine Product ratios (%)a
(2) (3) (4)
(1a) 8 6 10 4
(1b) 95 2.5 2.5




(5c) 8 6 14
(5d) 70 30
aAII with a ratio of protected benzaidehyde: TMEDA: butyllithium: 
dimethyldisulphide of 1 :2:2:2 except for (5c) where the ratio w as 1 :4:2:2. 
Ratios with less  TMEDA, such as 1 :1:2:2 gave consistently poorer yields of 
the desired  products.
m oles of TMEDA made a further slight improvement, to 86%. In making 
th ese  ch an ges the amount of unwanted isom er (7) w as reduced from ca  
30% to 14%. After hydrolysis of the imidazoiidine (6c), 3-methoxy-4- 
m ethylthiobenzaldehyde could be obtained in a  pure form by flash column 
chromatography in an overall yield of 57%.
In an attempt to improve the regioselectivity further, we investigated  
the use of the N,N'-dineopentyl analogue (5d). The required diamine is not
LITHIATION OF METHOXYBENZALDEHYDES * b7
commercially available, unlike the other diam ines described above. The 
synthesis w as achieved by m eans of reauction with diborane of the N,N'- 
dipivalamide of ethylene diamine, after which the imidazoiidine (5d) w as  
produced with slightly greater difficulty than required for the analogu es with 
smaller protecting groups. Unfortunately, the regioselectivity obtained w as  
no better than with the N,N'-dimethyl compound (5a). With molecular 
modelling it is possible to show  that the important region for increased steric 
bulk is immediately around the imidazoline nitrogens and not one carbon 
further removed. The modelling show s that the effect of increased bulk in 
the region of the imidazoiidine nitrogens is to ca u se  the aromatic ring to 
rotate, preferring to adopt conformations in which the planes of the two rings 
are approximately orthogonal. This rotational preference is reflected in the 
chemical shift of the proton betw een the two nitrogens, which in the ser ies  
(1a)-(1b)-(1c) ch an ges from 53.19 - 3 .43 - 4 .15 and in the ser ies (5a)-(5b)- 
(5c)-(5d) from 53.23 - 3 .48 - 4 .19  - 3.57, approximately in parallel with the 
regioselectivity induced.
As a brief test of the generality of th ese  findings we have carried out 
reactions with methyl iodide a s  the electrophile, on the lithiation product of 
both (1) and (5). In both c a se s  the reaction conditions were a s for the 
majority of the reactions in the Table, i.e. 1 :2:2:2 a s  defined there, and very 
similar results were obtained.
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SYNTHESIS OF A NOVEL HEXA CYCLIC BENZlMIDAZO[l,2-c]INDAZOLO- 
[2,3-a]QUINAZOLINE
V. Rama Kishan Reddy, P.S.N . Reddy and C.V. Ratnam
Departm ent of Chem istry, Osmania University,
Hyderabad 500 007, INDIA
ABSTRACT : Two alternate  syn th etic  routes are described for the 
synthesis of the hitherto unknown benzim idazo[l,2-c]indazolo[2,3-a]quina- 
zoline (3). While dehydrative cyclisa tion  of 2-[2-(2-azidobenzoylam in0)- 
phenyljbenzim idazole (2) in polyphosphate ester  gave 3 in Jow yield, 
very good yields were obtained in tr iethyl phosphite reductive c y c li­
sation of 6-(2-n itrophenyl)benzim idazo[l,2-c]quinazolines (8).
Quinazolines annelated to benzim idazoles and to indazoles w ere ex ten ­
sively studied for anti-inflam m atory a c t i v i t y T h e  paucity of litera ­
ture on a system  incorporating th ese three heterocycles has encouraged  
us to  work out a fa c ile  synthesis of the novel hexacyclic  system  benzi- 
m idazo[l,2-c]indazoio[2,3-a]quinazoline, and we present here two a lter­
nate routes. One of th e m ethods involves the polyphosphate ester  
dehydrative cyclisation  of 2 -[ 2 -( 2 -azidobenzoylam ino)phenyl]benzim idazoie  
(2) and the other is by triethyl phosphite reductive cyclisation  of 6-(2- 
nitrophenyl)benzim idazo[l,2-c]quinazoline (8). R ecently , we reported
*To whom correspondence should be addressed.
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H igh-yield ing  to ta l synthesis o f fagaronine chloride
Michael A Lynch“, Olivier Duval"*, Pierre Pochet", Roger D Waigh'’
a Labomtoire de Chimie Organique, UFR de Medecine et Pharmacic,
16 Bd Daviers, 49100 Angers, Prance 
6 Department o f Pharmaceutical Sciences, University o f Strathclyde, Glasgow G1 1XQ, UK
(received 30 M arch 1994, accep ted  20 Ju n e  1994)
S u m m a ry  -  A v ersa tile  m e th o d  for th e  syn thesis  o f th e  benzo[e]phenan th rid ine nucleus was developed  an d  ap p lied  to  th e  
p rep a ra tio n  o f fagaron ine ch loride. T h is  m e th o d  provided an  overall yield o f 14%, su perio r to  o th e r ex isting  s tra teg ie s , from 
a  linear ro u te  com prising  o f  n ine  s tep s  an d  read ily  availab le reagents.
benzo[c] p h e n a n th r id in e  a lk a lo id  /  fa g a ro n in e  /  a m in o n itr i le  R e fo rm a ts k i re a c tio n  /  phen o lic  d e h y d ro x y la tio n
Introduction
Fully arom atized quaternary 2,3,8,9-tetraoxygenated  
benzo[c] phenanthridine alkaloids, which occur naturally 
in Papaveraceous and R utaceous plants, have attracted  
much attention  following th e discovery o f their potent 
antiviral [l] and anticancer activities [2] Fagaronine 
chloride 1 along w ith  several other members o f the 
benzo[c]phenanthridine fam ily of alkaloids, has been re­
ported to exhibit antileukem ic activities in L-1210 and 
P-388 system s in m ice [3]. Moreover, fagaronine has 
been shown to exhibit a cellular differentiation action  
on hum an leukemia K 562 [4] and has recently been re­
ported to  inhibit topoisom erase I and II [5]. Fagaro­
nine has been chosen as th e reference com pound for 
the assessm ent o f HIV- RT inhibition by natural prod­
uct extracts [6]. The c losely related alkaloid nitidine 2 
has been shown to  inhibit AVM reverse transcriptase




A lthough numerous synthetic and sem i-synthetic  
m ethods may be found in the literature detailing the 
m eans o f  access of these alkaloids, relatively few efficient 
strategies are known for th e synthesis o f 2-hydroxy- 
3 ,8 ,9 -  trirnethoxy-5 - m ethylbenzo [c] phenanthridinium  
chloride, (fagaronine chloride). E xisting syntheses [9] 
are long and em ploy low-yielding steps resulting
in m oderate overall returns. We have sought to 
overcome practical drawbacks in th e preparation of 
benzo[c]phenanthridines and now report the first high- 
yielding total synthesis o f fagaronine via  a  linear- se­
ries o f known chemical transformations am enable to  
scale-up procedures, employing relatively inexpensive  
reagents.
Results and discussion
In th is study, we succeeded in improving our exist­
ing m ethod [10] for the synthesis o f 2-ethoxy-3,8,9- 
trim ethoxybenzo[c]phenanthridine (scheme 1), which  
allowed us to com plete the crucial final steps in the  
synthesis o f the natural product fagaronine.
The modified Strecker synthesis o f the am inonitrile  
3  was refined giving yields in excess o f 95%. T he re­
action proceeded sm oothly and cleanly when the rate 
of addition o f the aqueous potassium  cyanide solution  
to the imine was substantially reduced. C yclization of 
the am inonitrile, conducted in anhydrous hydrogen flu­
oride, resulted in 95% yields o f the am inoketone salt. 
The fluoro salt was found to be relatively soluble in 
water, which m ay account for previous inferior yields. 
Consequently, the crude product was stirred for 2 h in 
an aqueous saturated solution o f  sodium  chloride until 
the counterion exchange was effected giving th e insolu­
ble hydrochloride salt o f 4. The solid was filtered and 
washed copiously w ith water giving the pure product as 
a white precipitate. During several concentration stud­
ies on a sim ilar derivative, using decreasing quantities 
of HF in the cyclization, we isolated the interm ediary  
primary am ide 10 , whose structure was confirmed by  
1II and 13C NM R.
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Phenolic oxidation product
T he Reform atski reaction, w hich introduces the two- 
carbon synthon required for th e ensuing cyclization, was 
previously carried out using a very expensive high pu­
rity grade o f zinc, giving a y ield  o f 86%. W e effected 
this reaction using zinc o f m od est purity w ith result­
ing yields o f 65-70%. W hereas th is reaction was con­
ducted on th e  am inoketone free base, which is very 
prone to oxidation giving 11 , we have circumvented 
th e need for th is wasteful step  (in which more than  
10% o f the product is lost) by carrying out th e  reac­
tion  directly on the dried sa lt. T h e  cyclization o f the 
analytically  pure form o f th e /3-hydroxyester 5 in sul­
furic acid w as com plete in on ly  30 min w ith a  yield 
o f 70%. T his short period o f exposure m ost probably 
decreases sulfonation, an d /or de-ethylation giving the 
w ater-soluble diphenol. T he cata ly tic  hydrogenation of 
th e phenyltetrazole derivative 7  o f the resulting phe­
nolic sulfate 6  gave th e deoxygenated 2-ethoxy-3,8,9- 
trim ethoxybenzo[c]phenanthridine 8  in a yield o f 70%. 
T he product was found to  adhere strongly to th e P d /C  
catalyst, which proved advantageous for the elim ination 
of im purities by filtration. T he pure com pound was ob­
tained thereafter from th e continual extraction o f the  
residual solid in chloroform using the Kumaguwa sys­
tem .
TV-methylation at 170°C in the presence o f methyl 
m ethanesulfonate proceeded very c lean ly  in a high 
yield. T he 77-m ethyl derivative 9 was subsequently  
treated with concentrated sulfuric acid to effect the lysis 
of the 2-ethoxy m oiety (scheme 2).
An ‘ H NM R study using 99% deuterated  sulfuric 
acid (1% D 2 O) showed that the optim um  yield was ob­
tained after 3 days. Fagaronine sulfate precipitated as a 
very fine suspension following the add ition  o f th e acidic 
reaction m ixture to cold water. T he product was ad­
sorbed onto silica by the passage o f  th e d ilute acidic 
solution through a short column and was washed thor­
oughly w ith water. T he product was liberated from the  
dried silica absorbent support by stirring in methanol. 
Following filtration, th e solvent was rem oved under re­
duced pressure giving th e crude fagaronine sulfate as a 
yellow /green solid. T he trivial counterion exchange was 
effected by stirring the phenolic iV-m ethyl sulfate in an 
aqueous solution o f sodium  chloride to  yield the tit le  
com pound 1.
Conclusions
T he overall yield for the synthesis o f fagaronine from  
readily obtainable, inexpensive starting m aterials was 
14%, a notable improvement over ex istin g  m ethods. 
This convenient strategy perm its the isolation  o f large 
quantities of the pharm acologically active  target alka­
loid and will be o f great value for the continual supply  
of fagaronine for biological tests  and future studies di­
rected towards th e preparation o f lipophilic derivatives. 














IR spectra were recorded on a Perkin-Elmer 640 spectro­
meter. IR absorption bands are quoted as weak (w), medium 
(m) or strong (s). NMR spectra were recorded in deuterated 
chloroform, unless otherwise stated, using a Jeol FT-NMR 
spectrometer operating at 270 MHz. Melting points were 
determined on a hot stage apparatus and repeated on an 
electrothermal melting point apparatus. All solutions were 
dried over anhydrous sodium sulfate before evaporation.
2- (3 ,4-D im eth.oxybenzylam ino )-2 -(4 - e thoxy-
3-m ethoxyphenyl)ace ton itr ile  3
Following a modified Strecker synthesis, 4-ethoxy-
3-methoxybenzaldehyde (30.5 g, 169 mmol) in ethanol 
(340 mL) was added to an aqueous solution of
3,4-dimethoxybenzylamine (28.3 g, 169 mmol) made slightly 
acidic (pH 6 ) by the addition of dilute aqueous HC1. The re­
sulting Schiff’s base, formed in situ, was treated by the drop- 
wise addition of an aqueous solution of potassium cyanide 
(16.7 g, 256 mmol/100 mL H2 O) over a period of several 
hours with vigorous stirring. Stirring was continued in this 
manner for 4 days during which the product precipitated 
as a light-yellow solid which was collected by filtration and 
thoroughly washed with water. The aminonitrile was dried 
under vacuum giving a yellow crystalline solid. (57.3 g, 95%), 
mp 59-60°C (lit 60-61°C), [10].
IR * w  3 320 (NH, m), 2 220 cm - 1  (CN, w).
*H NMR (CDCI3 ) 1.46 (3H, t, J  =  7 Hz, CH3 C), 3.44 (1H, d, 
J  =  13 Hz, 4 -CH2 ), 3.77 (1H, d, J  = 13 Hz, 4-CfI2) ; 3.87 
(3H, s, OCH3 ), 3.88 (3H, s, OCH3), 3.89 (3H, s, OCII3 ),
4.09 (2H, q, J  = 7 Hz, O-CII2 ), 4.81 (III, s, CH), 6.93 
(6H, m, Ar).
6,7 -D im ethoxy-3 -(4 -e thoxy-3 -m ethoxyphenyl)-  
l,2-d ihydro isoqu ino lin~ 4(3H )-one (4) hydro­
chloride 4
The aminonitrile (32 g, 89.9 mmol) was added portionwise 
to 60 mL of anhydrous hydrogen fluoride in a plastic bot­
tle cooled externally with ice in a well-ventilated fume cup­
board. The bottle was stoppered and the contents were 
stirred for 24 h. The bottle was opened and HF was al­
lowed to evaporate over 4 h under a flow of nitrogen gas. 
The resulting brown viscous liquid was stirred with a satu­
rated sodium chloride solution whereupon the hydrochloride
precipitated as white solid with a brown hue (32.5 g, 95%). 
Purification of the analytical sample was effected by boiling 
with 96% ethanol which on cooling and filtering gave a white 
powder, mp 258-260°C; (lit 255-256°C) [10].
IR  omax 1 680 cm -1 (CO, s).
‘H NMR (CDCI3  +  CF3 COH [1%]) 1.42 (3H, t, J  = 7 Hz, 
CH3 C), 3.82 (3H, s, OCH3), 3.98 (3H, s, OCH3), 4.10 
(2H, q, J  =  7 Hz, CH2C), 4.60 (2H, s, broad, CH2), 5.41 
(1H, s, broad, CH), 6.83 (3H, m, Ar), 6.97 (1H, s, Ar), 
7.64 (1H, s, Ar), 8.60 (1H, s, broad, NH), 9.20 (1H, s, 
broad, NH).
M ethyl-3- (4 -ethoxy-3 -m ethoxyphenyl) -hydroxy-
6 ,7-d im eth .oxy-l, 2 ,3 ,4-te trahydroisoquinoline-
4 -acetate 5
All apparatus was thoroughly dried and left overnight in an 
oven at 100°C. Dioxan and dimethoxymethane were both 
refluxed with sodium metal for 1 h and distilled prior to use. 
The aminoketone salt was oven dried at 100°C for 3 days 
and stored under nitrogen immediately before the reaction.
To complete the characterization of this relatively insolu­
ble compound, an analytical sample was liberated as its free 
base and was checked by spectroscopic methods.
IR i w  3 410 (NH, m), 1 685 cm "1 (CO, s). 
l H NMR (CDCI3 , free base) 1.43 (3H, t, J  =  7 Hz, CH3C), 
2.28 (1H, s, broad, NH), 3.83 (3H, s, OCH3), 3.91 (3H, 
s, OCH3 ), 3.92 (3H, s, OCH3 ), 4.05 (2H, q, J  =  7 Hz, 
CH2C), 4.10 (2H, s, CH2-N ), 4.51 (1H, s, CH-N), 6.61 
(2H, s, Ar), 6.81 (1H, s, Ar), 6.94 (1H, s, Ar), 7.54 (1H, 
s, Ar).
The Reformatski reagent was prepared by the dropwise 
addition of ethyl bromoacetate (21 mL, 189 mmol) to a 
solution containing zinc, (13.5 g, 207 mmol, “mossy” , 99% 
+) in dry dimethoxymethane, at such a rate as to maintain a 
slight reflux without external heating. Prior to the addition 
of the a-haloester, the zinc was activated by refluxing for 
15 min with dimethoxymethane (45 mL) in the presence 
of trimethylsilyl chloride (2 mL). The solution darkened as 
the zinc was consumed and the characteristic green color of 
the organometallic complex appeared after a  short period. 
Stirring was continued for 2 h after complete addition of the 
haloester.
Dioxan (30 mL) was added to the dry aminoketone salt 
(20 g, 51 mmol) to form a slurry to which the Reformatski 
reagent was added. The resulting solution developed a turbid 
brown color and gradually became homogeneous. Stirring 
was continued under nitrogen for 24 h at room temperature. 
Saturated aqueous ammonium chloride was added to the
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solution and enough dichloromethane to form two layers. 
After filtration of residual suspended solids, the organic layer 
was removed and washed twice with ammonium chloride and 
once with water. The organic layer was dried over anhydrous 
sodium sulfate and the solvent was removed under reduced 
pressure to give a dark-brown residue. The residue was 
washed by swirling with a small portion of acetone to 
liberate the crude product as a light-browu solid following 
vacuum filtration (14.79 g, 65%). The pure product was 
obtained as a  white powder following a second wash with 
a few drops of acetone, mp 182-1840,C (lit 185-186°C) [1 0 ]. 
IR i/ma* 3 400 (OH, m, broad), 3 300 (NH, m), 1 725 cm - 1  
(CO, s).
‘H NMR (CDCI3 ) 1.09 (3H, t, ,/ =  7 Hz, CH3 C, ester),
1.46 (3H, t, .1 = 7 Hz, CH3 C, ether), 2.68 and 3.08 (2H, 
AB system ,.7 =  15 Hz, 4-CH2), 3.80 (3H, s, OCH3), 3.86 
(3H, s OCHa), 3.91 (3H, s, OCH3), 2.95 (2H, q, .7 =  7 Hz, 
CII2, ether), 4.07 (2H, q, J  = 7 Hz, CH2, ester), 3.90 (1H, 
d, J  =  15 Hz, 1-H), 4.17 (1H, d, .7 =  15 Hz, 1-H), 4.86 
(111, s, 3-H), 6.54 ( 1H, s, Ar, 8 -H), 6.83 (1H, d, .7 =  9 Hz, 
Ar), 7.02 (111, s, 5-H), 7.06 (III, d, .7 9 Hz, Ar), 7.37 
( LII, s, Ar).
2-E th o xy -3 ,8 ,9-lrirnethoxybenzo [c Jphe.nanthri.dvn~ 12- ol, 
su lfa te  6
The tetrahydroisoquinolinol (4.5 g, 10.1 mmol) was added 
portionwise to concentrated sulfuric, acid (25 mL, 98%), 
cooled externally by an ice bath, and stirred for 30 min. 
The resulting deep-red solution was added to cracked ice pre­
cipitating the yellow benzo[c]phenanthridinol sulfate (3.2 g, 
6 6 %) which was collected by filtration, mp > 320°C [10].
Ml NMR (CDCla, free base) 1.62 (311, t, ,7 =  7 Hz, CH3 C), 
4.11 (3H, s, OCH3 ), 4.22 (311, s, OCH3), 4.23 (311, s, 
OCH3), 4.32 (2H, q, .7 =  7 Hz, CtI2 C), 7.41 (IH, s, Ar),
7.47 (III, s, Ar), 7.91 (1H, s, Ar), 8.25 (1H, s, Ar), 8.82 
(1H, s, Ar), 9.25 (111, s, Ar).
2 -E th o xy-3 ,8 ,9 -tr im e th o xy-1 2 -( 1 -•phenyl- lH -te trazo l- 
5-yloxj))  benzo[cJphenanthridine  7
The benzo[c]phenanthridin-12-ol sullate (3.2 g, 6.1 mmol) 
was added to dry acetone (50 mL) along with anhydrous 
sodium carbonate (3.5 g, 33.3 mmol). The solution was 
heated with stirring for 15 min until the free base had 
formed and the phenol dissolved. 5-Chloro-l-phenyl-li7- 
tetrazole (1.3 g, 7.3 mmol) was added to the mixture and 
the solution was stirred at reflux overnight. The solvent 
was removed under reduced pressure and the residual solid 
containing excess potassium carbonate was washed with 
dichloromethane to remove unreacted chlorophenyltetrazole. 
The product was obtained following the Soxhlet extraction 
of the chlorotetrazole-ffee solids from chloroform ( 8  h). The 
tetrazole derivative was recovered in pure form as a white 
solid (2.7 g, 77%), mp 259°C (lit 260-262°C) [1 0 ],
*H NMR (CDCI3 ) 1.49 (3H, t, J  =  7.6 Hz, CH3 C), 4.05 (2H, 
q, J  = 7.6 Hz, CCII2), 4.10 (3H, s, OCfI3), 4.17 (311, s, 
OCH3 ), 4.19 (3H, s, OCH3), 7.41 (1H, s, Ar), 7.62-7.80 
(6 H, m and s, Ar), 7.96 (1H, s, Ar), 7.99 (1H, s, Ar), 8.73 
(IH, s, Ar), 8.76 (HI, s, Ar), 9.25 (1H, s, Ar).
2-E th o xy -3 ,8 ,9-trim et,hoxybenzo[c]phenanthridine  8
The tetrazole derivative (1.5 g, 2.9 mmol) was partially 
dissolved in dioxan (70 mL) and further solubilized by 
ultrasound before being hydrogenated (H2/9  atm) over 
palladium-on-charcoal (10%, 0.5 g) at 60°C for 24 h. 
The cooled mixture was filtered and the solid collected 
was subjected to continuous extraction in chloroform
(7 h), by means of a Kumaguwa extractor, to give the 
benzo[e]phenanthridine (0.73 g, 70%), mp 269-272°C, (lit 
271-274°C) [10].
'H NMR (CDCla) 1.60 (3H, t, .7 =  7 Hz, CH3 C), 4.10 (3H, 
s, OCH3 ), 4.16 (311, s, OCHa), 4.18 (311, s, OCH3 ), 4.30 
(2H, q, . 7 — 7 Hz, CCH2), 7.28 (IH, s, Ar), 7.38 (IH, s, 
Ar), 7.83 (HI, d, J =  9 Hz, Ar), 7.88 (III, s, Ar), 8.26 
(IH, d, J  =  9 Hz, Ar), 8.70 (IH, s, Ar), 9.27 (IH, s, 6-H).
2-E thoxy-3 ,8 ,9-trirnethoxy-5-m ethylbenzo[c)  
p henan th iid ine , rnethanesulfonate  9
The ethoxybenzo[c]phenanthridine (0.42 g, 1.2 mmol) was 
added to methyl rnethanesulfonate (4.5 mL, 53.1 mmol) in 
the presence of diisopropylethylamine (1.5 mL, 8.6 mmol) 
and refluxed on a metal alloy bath for 30 min at 170°C. 
Shortly after heating to the desired temperature, the so­
lution became homogeneous and darkened in color. Upon 
cooling, acetone was added to the solution precipitating the 
product as a bright-yellow solid, which was filtered under 
vacuum and washed with dry ether (0.51 g, 93%), mp >  
340°C dec, softens 223°C.
Ml NMR (CDCI3  +  CF3C 0 2H (1%)) 1.63 (3H, t, J  =  7 Hz, 
CH3C), 3.01 (311, s, CII3 SO3 ), 5.01 (3H, s, NCH3), 4.12 
(611, s, 2 x OCH3), 4.27 (3H ,s, OCH3), 4.36 (2H, q, J =  7, 
CCH2), 7.43 (IH, s, Ar), 7.74 (III, s, Ar), 7.92 (IH, s, Ar),
8.00 (HI, s, Ar), 8.11 (IH, d, .7 -  9, Ar), 8.39 (111, d, 
J  = 9, Ar), 9.71 (IH, s, Ar).
MS (El, 70 eV) m /z  (%) 393 (M+ +  CH3, 1.4%), 378 (M+ , 
1.7%), 363 (M '-C H s, 100%), 334 (26%). Exact mass 
calculated for M+-CH3 C22H21NO+ : 363.147. Found : 
363.146.
Fagaronine (2 -hydroxy-3,8,9- tr im ethoxy-
5-m ethylbenzo /clphenanthrid in ium , chloride  1
The 2-ethoxy-5-methylbenzo[c]phenanthridine salt (300 mg, 
0.63 mmol) was added to concentrated sulfuric acid (30 mL) 
and stirred at room temperature for 3 days under a nitrogen 
atmosphere. The resulting viscous, red-colored solution was 
added to cold water in the presence of ice to precipitate fa­
garonine sulfate as a fine yellow solid. The phenolic product 
was recovered by filtering the aqueous solution through silica 
gel and eluting the dried stationary phase with methanol. 
Removal of the solvent under reduced pressure gave the 
crude fagaronine sulfate as a yellow-green crystalline solid 
(198 mg, 70%).
'H NMR (CDC13 +  CF3C 0 2H [1%]) 4.13 (311, s, OCH3),
4.16 (3H, s, OCH3 ), 4.30 (3H, s, OCH3), 5.01 (3H, s, 
NCHs), 7.62 (IH, s, Ar), 7.68 (IH, s, Ar), 7.98 (IH, s, 
Ar), 7.99 (IH, s, Ar), 8.12 (IH, d, J  =  9 Hz, Ar), 8.41 
(IH, d, J  =  9 Hz, Ar), 9.43 (IH, s, Ar, 6-H).
MS (El, 70 eV) m /z  (%) 350 (M+ , 13%), 349 (M+-H, 
66.5%), 335 (M+-CH3, 100%). Exact mass calculated for
C2i H19N 0 4^  349.1314. Found : 349.1317.
The counterion exchange was effected by stirring the 
sulfate in an 8% aqueous solution of sodium chloride [11]. 
The resulting bright-yellow precipitate was filtered and dried 
to give fagaronine chloride in an 88% yield, mp 198-200°C, 
(lit 202°C) [9],
Ml NMR (DMSO-d6) 4.04 (3H, s, OCH3), 4.11 (3H, s, 
OCH3), 4.24 (311, s, OCH3 ), 5.11 (3H, s, NCH3), 7.66 
(IH, s, Ar), 7.94 (IH, s, Ar), 8.13 (IH, s, Ar), 8.16 (IH, 
d, .7 =  9 Hz, Ar), 8.63 (IH, s, Ar), 8.86 (IH, d, J  =  9 Hz, 
Ar), 9.97 (HI, s, Ar).
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S u m m a ry  — T h e  chem ical b eh av io r of a -am in o  n itriles tow ards the  R eform atsky  reagen t has  been  s tu d ie d . U nder ce rta in  
cond itions, secondary  a lip h a tic  a -a m in o  n itr ile  derivatives yielded a  m ix tu re  of four p ro d u c ts  consisting  o f  a  /3-amino es te r, 
a  /3-lactam , a  bulky  te r tia ry  am in e  and  a  cinnam ic derivative. In  an  a liphatic  and  an  alicyclic, fully n itro g e n -su b s titu te d  
exam ple, a  /3-am inoester is o b ta in e d  in high yield sis th e  sole p roduct.
a-am ino nitrile /  /3-amino ester /  Reformatsky reaction
Resume — Synthese de /3-aminoesters a partir de la reaction de Reformatsky sur les a-am inonitriles. Le comportement 
chimique des a-aminonitriles soumis aux conditions de la reaction Reformatsky a ete etudie. Dans ces conditions, 
les a-aminonitriles tertiaires alicycliques ou aliphatiques conduisent aux /?-aminoesters correspondants avec de bons 
rendements. Les a-aminonitriles secondaires conduisent a un melange de /3-aminoesters, un /3-lactame, une amine t-ertiaire 
et un derive de I’acide einnamique.
a-amirionitrile /  /3-arninoester /  reaction Reformatsky
Introduction
In its classical form, the Reform atsky reaction involves 
the zinc-induced formation o f /3-hydroxyalkanoates 
from ethyl haioacetates 'and aldehydes or ketones [1]. 
tv-Amino nitriles are extrem ely versatile synthons, easi­
ly obtained from the Strecker synthesis and frequently 
used in the synthesis of am ino acids. We have re­
cen tly  exploited the virtues o f such interm ediates to 
construct substitu ted  isoquinolinol derivatives, which 
upon further reaction led to th e benzo[c]phenanthridine 
ring system  [2a,b). To the best o f  our knowledge, the 
, Reform atsky-type reaction betw een a-brom o esters and 
a-am ino nitriles has received no attention. Looking for 
organic interm ediates containing more convenient func­
tional groups for a straightforward access to  our substi­
tu ted  structures, we herein describe the results of our 
studies using a-am ino nitriles as carbanionic acceptor.
R esults and discussion
W e first considered the reaction w ith one o f our inter­
m ediates l a  under previously described reaction condi­
tions [2]. T he m etal is activated using trim ethylchlorosi- 
lane (TM CS) [3] and the reaction is conducted in the 
presence of ethyl brom oacetate in dim ethoxym ethane
(DMM) at room tem perature. T he first attem pts led to  
the isolation o f mixtures of three products (schem e 1 
and table I). Two main products were isolated: a  
/3-amino ester 2a , apparently resulting from a nucle- 
ophilic displacem ent o f the cyano group of 1 and the 
/3-lactam 3 resulting from an intram olecular nucle­
ophilic attack. T he third product, obtained in a  low 
yield, was identified as the cinnam ic ester derivative 4.
T he cyano group is known to  react w ith the Refor­
m atsky reagent to yield th e corresponding /?-keto ester  
[4], In our reaction, which gave 2a , no nucleophilic ad­
dition occurred on the cyano function. T h e  formation o f  
the /3-aminoester 2 a  is explained either by the direct nu­
cleophilic displacem ent o f the nitrile group borne on th e  
a-carbon or the indirect nucleophilic addition on a tran­
sient imine. It has been reported that nitriles, in which  
th e cyano group is weakly bonded to  a-carbons, react 
with carbanionic species, such as the Grignard reagent, 
in a coupling process [4]. An interm ediate nucleophilic  
imine addition has been proposed for th e  case of Grig­
nard addition [4]. In a  second step, an intram olecular 
nucleophilic reaction led to 3. These two steps were only  
observed when the com bination o f trim ethylchlorosilane  
(as zinc-activating reagent) and d im ethoxym ethane as 
solvent were used.
Similar results have previously been recorded us­





/. r - Y ^ o M e
R<A^k.N.R R4,kJL^N.R + o N
2a, b 3 OMe
1a r=r,=r1= h. u2=r4= och-,
Rl E t 0 2C ( ^ 'j ,
1b r=ch3. r'=rjbR2»r4c qcHj fy  V ' ^ ' O M e
E t 0 2C ^ ^ " R 2 M e O '— — ',
C 0 2Et
4a, b 5
S ch em e 1. i. Zn, BrCH2C 0 2Et, TMCS, DMM.
T a b le  I . R eaction  o f Q-ainino-nitrileK l a ,  l b  and 6  w ith  the  R eform atsky reagen t 
(Zn, B rC H 2C G 2 E t).
Substrate Solvenl/m elal Zn /T M C S/B rC thC O -iE t Yields (%)a
activation ratio
2 n , b / 7 3 4 5
la DMM/TMCS 3.3:0.33:3.3 16 33 12
la DMM/TMCS 6.6:0.66:6.6 30 53 5 6
la Dioxane/ 6.6:0.66:6.6 46 15 3
US/TMCS
la Dioxane/TMCS 6.6:0.66:6.6 17 5 3 35
lb DMM/TMCS 3.3:0.33:3.3 87
6 DMM/TMCS 3.3:0.33:3.3 89
° Y ie ld s  o f  is o la te d  p ro d u c e s  is o la te d  a f te r  c h r o m a to g ra p h ic  s e p a ra t io n
imine in the presence or not o f a catalytic amount of 
trimethylch lorosilane in benzene or d i m ethoxy methane 
as solvents (5 a,b]. In a recent work, additions of 
Reform atky reagents to iniines in th e presence of 
1- (trim ethylsilyl) benzotriazole afforded /3-amino esters 
(5c). Other authors have used amino trimethylsilyl 
derivatives as interm ediates for the preparation of the 
m onobactam  antibiotic, thienarnycin [6]. In our case, a 
possible transient silylated  interm ediate could enhance 
the reactivity o f our secondary amine leading to the  
/3-lactam structure. A ttem p ts to improve this cyclisa­
tion led us first to use increasing amounts o f organo- 
zinc and activator reagents (table I). Besides the three 
com pounds previously isolated an unexpected tertiary 
am ine 5 was identified. Su bstituting th e solvent, still in 
the presence of TM S, w ith a polar or less polar solvent 
such as tetrahydrofuran or benzene, was unfruitful. A 
striking improvement was observed when dioxane was 
used. Dioxane is known to  be a poor solvent for the 
Reformatsky reaction except when ultrasonic (US) ac­
celeration is associated [7]. Under these conditions our 
reaction failed. W hen TM CS was added, in conjunction 
w ith  ultrasonic activation, the reaction led to an in­
crease in the yield o f 2a . W ithout ultrasonic activation  
the main product, isolated turned out to be the tertiary 
amine 5. The presence o f 4  may be explained through a 
retro-Miehael reaction, w ith the loss o f 3,4-dim ethoxy- 
benzylam ine.
In order to extend th e scope o f this reaction, tertiary 
am ines were studied as substrates. Under the usual con­
ditions described above (table I), l b  yielded a sole prod­
uct 2 b . Surprisingly, after purification o f 2 b  by column  
chromatography (silica gel, cyclohexane/ ethyl acetate, 
98:2 as e luent), a  second product 4 b ,  corresponding to  
an elim ination product, was isolated in very low yield, 
while with the identical reaction performed on the ali- 
cyclic com pound 6  [8], only one product 7  was obtained  
in very high yield (scheme 2).
f> 7
Schem e 2. i. (PliIO),,, Me3SiCN8; 
ii. Zn, BrCH2C 0 2Et, TMCS, DMM.
Conclusions
In conclusion, the Reformatsky reaction w ith a sec­
ondary aliphatic a-am ino nitrile led to an unexpected  
mixture o f two different amines, a /3-lactam and a cin- 
nainate derivative. Starting from tertiary am ine ana­
logues, this route represents a very facile access to  func- 
tionalized amines when a /3-amino ester synthon is re­
quired. Further investigations toward th e application of 




T h e  'I I  an d  1JC N M R  s p e c tra  wen* recorded in  deul-e- 
rochloroform  so lu tions (excep t w hen s ta te d  o therw ise) on 
a  JE O L  G SX  270 W B sp ec tro m e te r  a t  270.5 an d  OS MHz 
respectively. C hem ical sh ifts  a re  rep o rted  in ppm  relative to 
te tram e th y ls ilan e  in deu teroch lo ro fo rm , excep t w here o th e r­
wise specified. 1R sp ec tra  were recorded  on P erk in -E lm er 
580 o r 457 sp ec tro p h o to m ete rs  using po tassium  brom ide 
d iscs for solids, o r  n ea t liquid film s for liquids. O nly signi­
ficant 1R b an d s  a re  quo ted . M elting  po in ts  were d eterm ined  
on a  E lec tro th erm a l 8100 m elting  po in t a p p a ra tu s  an d  are 
unco rrec ted . H R  m ass sp e c tra  w ere determ ined  on a  high- 
reso lu tion  V arian  M AT 311 or M .S/M S ZabSpec T O F  M icro­
m ass at. 70 eV  or using FAB.
General •procedure
To a  suspension  of zinc d u s t (15.8 g) in d im ethoxym ethane 
(60 mL) u n d e r n itrogen , trim ethy lch lo rosilane  was added  
(2.80 m L , 0.024 mol) an d  th e  resu ltin g  m ix tu re  was s tirred  
a t  room  te m p e ra tu re  for 15 m in an d  then  under reflux 
for 5 m in. T h e  suspension  was cooled, and  a  so lu tion  of 
e th y l b ro m o a ce ta te  (27 mL, 0.24 m ol) in d im ethoxym ethane 
(30 mL) is slowly added  a t  such  a ra te  th a t  th e  so lvent 
gently  refluxes, A fter being hea ted  to  reflux for 2 h, th e  d ark  
g reen  so lu tion  is cooled an d  th e  correspond ing  am ino  n itrite  
1 (0.073 m ol) added . T h e  m ix tu re  is th en  s tirre d  for 6 h a t 
room  te m p era tu re . T h e  m ix tu re  is poured  over a  so lu tion  
o f N IL  Cl (40 m L , s a tu ra te d  so lu tion ) and  the  organ ic layer 
is s ep a ra ted , e lim inated  un d er reduced  pressure, an d  30 m L 
of d ich lo ro rnethane  is added . T h e  organic layer is w ashed 
th re e  tim es w ith  w ate r (20 m L ), d ried  (N a2SC>4 ), and  the  
so lven t ev ap o ra ted  u nder reduced  p ressu re  to  give an  oily 
residue , w hich is then  purified by colum n chrom atography  
(cy c lo h ex an e /e th y l ace ta te : 70:30 to  95:5 and  M erck 60H 
silica gel, 70-230 m esh).
® E thyl 3-[(3-m ethoxybcnzyl)aniino]-
3- (3-methoxyphenyl)propanoat.e 2 a  
IR (KBr): t/(C = 0) 1 720 cm "1.
'H  N M R  (CDC13, 270 M H z): 1.20 (t, C H 2- C / / 3 , 311, 
.7 =  7.5 H z); 2.25 (b ro ad  s, N/Y); 2.62 (dd , C H -C H 2 
C O aE t, 1H, .7 =  15.5 H z , J  =  9.0 Hz); 2.68 (dd , CH- 
C l h  C O zE t, H I, J =  15.5 Hz, J  =  5.00 Hz); 3.52 (d, 
A r-C /Y 2-N , 1H, .7 =  13.5 H z); 3.68 (d , A r-C /7 2-N , 1H, 
.7 ^  13.5 Hz); 3.79, 3.81 (s, O C / /3 , 6 H); 4 .1 ( q ,C / / 2-C H 3, 
2H, J  =  7.5 Hz); 4.10 (dd , N -C /Y -A r, 1H, .7 =  5.0 llz , 
J  =  9.0 H z); 6 .75-6 .95  (m , arom atic  H, 6 H); 7 .15-7 .29  
(m , arom atic H , 2H).
,:,C NMR (CDCI3 , 68  MHz): 14.1 [OCH2CH3); 42.9 [CH- 
CH2]; 51.1 (A r-C H z-N ); 55.1, 55.2 [O CH 3]; 58.7 [N-CH- 
Arj; 60.5 (O-CHz-CHaj; 112.4, 112.5, 112.9, 113.5, 119.4, 
120.3, 129.2, 129.5 [arom atic CH]; 141.7, 144.0, 159.6,
159.8 [a ro m a tic  C |; 171.7 [C = 0 [ .
M S-IE: m / z  (% ): 343 (M 1, faible) 342 (M -H+ , 1), 256 (60), 
136 (62), 121 (100).
HR-M S: calc for (M -H + ) 342.1705, found 342.1717.
® Ethyl 3-((3,4-dimet.hoxybenzyl)methylaminoJ-
3- (3,4- dime thoxyphenyljpropanoate. 2b  
IR  (K B r): ! / (C = 0 )  1 720 c m " 1.
'H  N M R  (CDC13, 270 M Hz): 1.19 ( t ,  C H 2-C /Y 3 , 3H, 
.7 =  7.5 Hz); 2.12 (s, N -C/Y 3); 2 .72 (dd , CH -C/Y 2 - C 0 2 Et, 
IH , .7 =- 14.6 Hz, .7 7.5 Hz); 3.03 (dd , CH-CYY2- C 0 2E t,
111, .7 =  14.6 Hz, .7 =  8.0 H z); 3.24 (d , A r - C / /2 -N , 1H, 
.7 =  13.0 Hz); 3.50 (d, Ar-CY72 -N, lH , .7 =  13.0 Hz); 
3.86, 3.88, 3.89, 3.90 (s, OC/Y3 , 1211); 4.10 (q , C / / 2 -C H 3 ,
7 7 1
2H, .7 7.5 Hz); 4.16 (dd , N-C/7-Ar, 111, J  - 7.5 Hz,
.7 =  8.0 Hz); 6.78-6.86 (m, aromatic II ,  611).
I3C  NMR (CDCI3 , 6 8  MHz): 14.1 |OCH2 CH3|; 37.6 
[N-CII3 ]; 37.9 [CH-CH2 I; 55.7 [OC’Hal; 55.8 [OCHa]; 
55.9 [2C, OCH3 ]; 58.1 [Ar-CH2 -N]; 60.3 (0 -C H 2-  
CH3); 63.9 [N-CH-Arj; 110.5, 110.6, 111.7, 120.4, 120.6 
[a ro m atic  C/7]; 130.9, 132.1, 147.9, 148.2, 148.5, 148.8 
[arom atic  C); 171.9 |C—0 |.
HR-FAB (positive) MS: calc 418.223, found  418.223 
(M + H+).
® 1- (3-Methoxybenzyl)-4-(3-m e.thoxyphenyl) 
azetidin-2-one 3 
IR (KBr): i/(C = 0) 1 750 cm- 1 .
*11 NMR (CDCI3 , 270 MHz): 2.72 (dd , C O -C / / 2  CH, 1H, 
J  =  14.6 Hz, .7 =  2.2 Hz); 3.34 (dd , C O -C //2 -CH, 1H, 
.7 =  14.6 Hz, J  =  5.2 Hz); 3.76, 3.78 (s, OC/Y3 , 6 H); 3.78 
(d , Ar-C/Yz-N, IH, J  =  15 Hz); 4.39 (d d , N-C/Y-Ar, 
1H, J  -  5.2 Hz, J  =  2.2 Hz); 4.75 (d , A r-C /Y zN , IH, 
J  =  15 Hz); 6.60-6.80 (m, arom atic H , 6 H); 7.20-7.10 
(m, aromatic II ,  2H).
I3C NMR (CDCI3 , 6 8  MHz): 42.1 [CO-CII2  CH|; 46.7 
(Ar-CHz-N); 53.5 [N-CH-Ar]; 55.1, 55.2 [OCH3|; 
111.7, 113.3, 113.8, 113.9, 118.7, 120.7, 129.7, 130.0 
[aromatic CH\; 136.9, 139.5, 159.7, 159.9 [aromatic C[;
167.0 [C=Of.
MS-IE: m /z  (%): 297 (MH , 31), 134 (100), 121 (26), 91 (22). 
HR-MS: calc 297.1365, found 297.1369.
« Ethyl trann-3-(3 ,4-dim .ethoxyphenyl)prop-2-enoate  
4 / 9 ] '
IR (KBr): o(C = 0)  1 685 cm -1 .
1H N M R (CD CI3 , 270 M Hz): 1.34 ( t ,  C H 2-C/Y a, 3H , 
.7 =  7.5 Hz); 3.83 (s, OC/Y;i, 6 H); 4 .26 (q , C/Y2-C H 3 , 
2H, J  = 7.5 Hz); 6.42 (d , C H =C 77, III , J  = 16 Hz); 
6.93 (d, 77 a ro m a tic ,  IH , J  =  8.5); 7.04 (d , I I  a ro m a tic ,  
IH , .7 =  2.3 Hz); 7.12 (dd , a ro m a tic  H , IH , J  =  8.5 Hz, 
.7 =  2.3 Hz); 7.65 (d , C7Y=CH, IH , J  =  16 Hz).
13C NMR (CDCI3 , 68 MHz): 14.3 [OCH2 -C H 3 ); 55.9 
[OCH3|; 55.8 [OCHa]; 46.7 [OCH2-C H 3], 109.5, 110.9,
122.5 [arom atic  CII)-, 115.9, 144.5 [C/Y=l, 127.3, 149.1,
151.0 [a ro m a tic  C); 167.2 [C =0[.
MS-IE: m /z  (%): 236 (M *, 65), 191 (100), 163 (27), 28 (26). 
IIR-MS: calc 236.1048, found 236,1048.
® D iethyl 3-(3-m ethoxybenzyl)-4-(3-m .ethoxyphr.nyl)-
3-azahexanedioate 5
IR (KBr): i/(C = 0) 1 720 c m -1 (b road).
*H N M R (C D C la, 270 M Hz): 1.15 ( t ,  C H 2-C7Y3, 311, 
.7 =  7.3 Hz); 1.22 ( t ,  C H 2- C I I3, 3H, J  =  7.3 Hz); 2.71 
(dd , C H -C /7 2- C 0 2E t, III , J  -  14.5 Hz, J  =  8.2 H z);
3.00 (dd , CH -C /Y 2- C 0 2E t , IH , .7 =  14.5 H z, .7 =  6.8 Hz);
3.16 (d, N -C /Y z-C O zE t, IH , .7 =  17.2 H z); 3.38 (d, N - 
C/7z C O zE t, III , .7 =  17.2 Hz); 3.59 (d , A r-C /Y z-N , IH , 
J  =  14.0 Hz); 3.79 (d , Ar-C7Y2-N , IH, .7 =  14.0 Hz); 3.79, 
3.80 (s, OC/Ya, 6H); 4.05 (q, C/Y2 -CHa, 2H , J  = 7.3 Hz);
4.10 (q, C 7 /z -C H 3, 2H , J  =  7.3 H z); 4.42 (d d , N -C /Y -A r, 
III, .7 =  8.2 Hz, .7 =  6.8 H z); 6.70 6.95 (m , a ro m a tic  H , 
6H); 7.10-7.30 (m , a ro m a tic  H , 2H).
13C NMR (CDCla. 68 MIIz): 14.0 [OCH2CH3|; 14.2 
|OCH2CH3]; 37.9 [CH CH2[; 51.2 [N -C Il2- C 0 2Et]; 54.7 
[Ar-CHz-N]; 55.1, 55.2 (OCH3[; 60.3, 60.4 [0 -C H 2-  
CH3); 61.4 [N-C7H-Ar|; 112.7, 112.9, 114.0, 114.0, 120.5, 
120.9, 129.1, 129.2 [aromatic CH]\ 140.7, 144.9, 159.5, 
159.6 [aromatic C]; 171.3, 171.5 [C = 0 |.
M S-IE: m /z  (% ): 384 (faib le), 356 (44), 121 (100).
HR-FAB (positive) MS: calc 430.223, found 430.223.
9 0
772
® / - B em ylp ip e rid in e -2- caiftonitrik- 6
IR  (K B r): i>(C-=N) 2 215 c m " 1.
’H N M R  (CDCla, 270 M H z): 1.55 1.95 (in , C H 2, 6H ); 2.43 
(m , C / / a -N , 111); 2 .80 (m , C H h -N , IH ), 3.53 (d , A r- 
C H 2 N, IH , ./ =  13.2 Hz); 3.69 (d , Ar-CW a N, IH , 
.7 =  13.2 H z); 3.73 (t, C / / - C N , 2H, .7 =  3.5 Hz); 7.25- 
7.35 (in , a r o m a tic  I f ,  5H).
,:'C N M R  (CDCla, 68 M H z): 20.4, 24.9, 28.5, 60.7 |alicyclic- 
CH a]; 49.7 |A r -C H 2-N ); 52.0 (CH-CN); 116.7 [CN); 
127.5, 128.4, 128.9 C f f ] ;  136.9 \a ro m a tie  ( 7).
® Ethyl l-Benzylpiperidine-2-acetaie 7
IR  (KBr): u (C = 0 )  I 720 cm l .
1H N M R  (C D C b , 270 M Hz): 1.24 ( t, C H j-C T /a , 311, 
.7 =  7.3 Hz); 1.35 1.85 (in, C f f 2 ,  6H ); 2.18 (m , C 7 /2 
N, 2H ); 2.44 (dd , C IT  C / / 2- C 0 2E t, IH , .7 =  14.6 Hz, 
.7 =  8.0 Hz); 2.72 (d d , C I I - C / /2- C 0 2E t, II I , J  = 14.6 Hz, 
,7 =  5.0 Hz); 2.98 (m , C / / - C H 2- C 0 2E t, 111); 3.37 (cl, 
A r - C /f 2-N , III, J  =  13.5 Hz); 3.82 (d , A r - C / /2-N , III, 
,7 =  13.5 Hz); 4.13 (q , C / f 2-C H » , 2H, .7 -  7.3 Hz); 6.78 
6.86 (n i, arom atic . H ,  5H ).
,3C  N M R  (C D C la, 68 M H z): 14.1 (O CH 2C H aj; 22.2, 25.1, 
30.8, 58.4 (alicyclic-C H a]; 36.1 (C H -C H 2); 50.6 |A i— 
C H 2 -N); 57.5 |C H -C H 2); 60.3 (O -C Ifa-C H a); 126.7, 
128.0, 128.4, 128.6 [aro m a tic  C H }\ 139.4 [arom atic  C |;
172.8 |C = 0 | .
M S-IE: m / z  (%): 261 (M w eak), 174 (100), 91 (74).
H R-M S: calc 261.1729, found 261.1745.
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Table 5. Selected geom etric parameters (A, “) fo r  the title 
cations
M A H M A D M A H M A
N l —CS 1 4 8 1 6 ( 1 1 ) N l - -C S 1 .4 7 6 5  (9)
N l  —  H I N 0 .9 0 1  (11 ) N 1 —  C 6 1 .4 7 9 9  (9)
N l —  H 2 N 0 .9 0 3 ( 1 1 ) N l — H I N 0 .9 4 4 ( 9 )
N l — H 3 N 0 .9 4 3 ( 1 0 ) N l -H 2 N 0 .9 2 8  (9)
C 5 — N l 1 .4 8 1 5 (1 1 ) C S — H 5 0 .9 5 3  (9 )
C S — H 5 0 .9 3 0 ( 1 0 ) C 5 — H 6 0 .9 7 1  (9 )
C 5 — H 6 0 .9 3 9 ( 1 0 ) C S — H 7 0 .9 8 4  (9 )
C S — H 7 0 .9 8 7 ( 1 0 ) C 6 — H 8 0 .9 9 0 ( 1 0 )
C 6 — H 9 0 .9 6 6  (9 )
C 6 — H I 0 0 .9 6 0 ( 1 0 )
C S — N l — B I N 108 .7  (6 ) C S — N 1 —C 6 1 1 2 .7 5 (6 )
C S — N l —  II2 N I I  1.6 (7 ) C S— N l — H IN 1 0 8 .5 (5 )
C S — N l — H 3N 111.5 (6 ) C S — N 1 — H 2N 109.1 IS )
N 1— C S — H 5 1 0 6 .8 ( 6 ) N l — C S — 117 1 0 7 .4 ( 5 )
N l — C S — H 6 1 0 9 .3 ( 6 ) N 1 — C 6 — H 8 1 1 1 .0 (5 )
N l — C S — H ? 1 0 8 .7 ( 6 ) N l C 6 - H 9 109 .3  (5 )
N l — C 6  - H 10 1 0 9 .5 (6 )
Table 6 .  Selected geometric param eters (A, 0) fo r  the
m aleate ions
M A H M A D A H M A
C l — 01 1 .2 4 4 7  (8 ) C l — O l 1 .2 3 9 6  (7 )
C 2 — O l 1 .2 8 1 9 ( 9 ) C l  - 0 2 1 .2 9 1 5 (8 )
C l — C 2 1 .4 9 0 8 ( 1 0 ) C l — C 2 1.4911 (9)
C 2 — C 2 ' 1 .3 3 9 2 ( 1 4 ) C 2 — C 4 1 .3 3 5 9 (9 )
C 3 — 0 3 1 .2 4 0 6 (9 ) C 4— C3. 1 .4 9 2 0 (9 )
C 3 — 0 4 1 .2 8 6 8  (9) C 3 — 0 3 1.2381 (8 )
C 3 — C 4 1 .4 9 0 9 ( 1 0 ) C 3 — 0 4 1 2 8 7 4  (8)
C 4 — C 4 ‘ 1 .3 3 9 9 ( 1 4 )
O l  - C I — C 2 - C 2 ' 167 5 7  (4 ) O l — C I - - C 2 -  C 4 1 7 8 .8 7 ( 7 )
0 2 — C l —  C 2 — C 2 ' -  1 2 .0 0 ( 9 ) 0 2 - - C l  -  C 2 — C 4 - 1 . 6 5 ( 1 1 )
0 3 — C 3 — C 4 — C 4 ' 1 7 7 .3 9 ( 5 ) C l — C 2 - C 4 — C 3 - 0 . 3 9 ( 1 3 )
0 4  —C 3 — C 4 — C 4 ' 2 .3 6 ( 1 0 ) C 2 — C 4 — C 3 — 0 3 1 7 9 .5 1 (7 )
C 2 — C 4  - C 3 — 0 4 0 .2 9 ( 1 1 )
Symmetry code: (i)A',y, j  -
For both compounds, data collection: CAD -4 EXPRESS 
(Enraf-N onius, 1992); cell refinement: CAD -4 EXPRESS', data 
reduction: DREADD  (Blessing, 1987); progratn(s) used to 
solve structures: SHELXSS6  (Sheldrick, 1990); program(s) 
used to refine structures: SHELXL93  (Sheldrick, 1993); molec­
ular graphics: ORTEPU  (Johnson, 1976),
The authors wish to thank Mr Flemming Hansen for 
help with the data collections.
Supplementary data for this paper are available from the lUCr 
electronic archives (Reference: ABI534), Services for accessing these 
data are described at the back of the journal.
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Abstract
An important precursor to biologically active com­
pounds, 2,8-dimethylphenoxathiin 10-oxide (ChH i?- 
O2 S), is found to adopt a folded geometry. The dihe­
dral angles between the aromatic rings are 11.8(2) and 
15.4(2)° for the two independent molecules, with the S 
atoms lying out o f the ring planes.
Comment
The synthesis o f phenoxathiins is o f current interest 
because they show a variety o f biological activities. 
Some have antibacterial properties (Gavriliu el al., 1996; 
Maior et al., 1995), others have exhibited antitumor 
activity (Palmer et al., 1988), and yet others can be 
used as antidepressants (Cooper et al., 1992). These 
compounds may also be used as catalysts, for example, 
in chlorination reactions (Mais & Fiege, 1990) and in 
hydroformulation reactions (Kranenburg et al., 1995).
The molecular structures o f the two crystallograph- 
ically independent conformations o f the title com­
pound, (I), are shown in Fig. 1. They are approxi­
mately related by a non-cryslallographic inversion cen­
tre at (0.56,0.26,0.38). Both display a folded geometry 
with dihedral angles between the least-squares planes 
of the aromatic rings o f 11.8(2) and 15.4(2)°. Thus, 
the molecule is flatter than the related unsubstituted
(i)
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compound phenoxathiin 10-oxide (PTO), where the cor­
responding angle is 28° (Chen e t a l., 1979). This is 
not, however, a simple fold about the S • O axis of 
the heterocyclic ring, for although the O atoms are 
coplanar with the aromatic rings the S atoms lie out 
o f the plane. Examination o f the geometric parame­
ters (Table 1) reveals that the bond lengths are in good 
agreement with those in PTO, but that the internal bond 
angles o f the heterocyclic ring are slightly larger in (I). 
This is consistent with a flattened geometry [C7— SI —  
C l 96 .76(16), C21— S2— € 1 5  95 .98(16), C6— 0 2 —  
C12 120.8 (3) and C20— 0 4 — C26 120.3 (3)°, compared 
with 94 .8 (3) and 118.8(4)° in PTOJ. The sulfoxide 
group lies nearly normal to the ring systems, as is shown 
by the torsion angles O l— S I— C l— C6 and 0 3 — S2—  
C15—C16 [92.1 (3) and 86.5 (3)°, respectively; see also 
Table 1],
Monoclinic 
P2 , / c
a = 13.274(2) A 
b = 12.214(4) A 
c = 15.044(3) A 
0  = 110.606(14)°
V=  2282.9(10) A*
Z =  8






Absorption correction: none 
4676 measured reflections 
4481 independent reflections 
2980 reflections with 
I > lo ( l )
Refinement 
Refinement on F2 
R[F2 > 2<t(F3)] = 0.058 
wR(F2) = 0.170 
S =  1.036 
4481 reflections 
311 parameters 
H atoms riding 
w = l/[o-2(F,r) + (0.083 IP )2 
+ 1.7748P] 
where P  = (P,r + I F 2)/3
Cell parameters from 24 
reflections 
0 = 17.0-19.6° 
p. = 0.268 mm ‘ 1 
T =  123 K 
Cut needle
0.40 x 0.40 x 0.35 mm 
Colourless
Rin, = 0.038 
= 26.01° 
h -  0 -+ 16 
ft = 0 — 15 
/ = — 18 —♦ 17 
3 standard reflections 
every 150 reflections 
intensity decay: 4.85%
( A /a ) raax <  0.001 
A p mM = 0.337 e A -3 
A p mi„ = -0 .6 5 9  e A ' 
Extinction correction: none 
Scattering factors from 
International Tables fo r  
Crystallography (Vol. C)
Table 1. S e lec te d  g eo m etric  p a r a m e te r s  (A, °)
Fig. I. The molecular structure of (I) with 50% probahility ellipsoids 
and H atoms as small spheres of arbitrary size.
Experimental
2,8-Dimethylphenoxathiin (5.2 g, 22.8 mmol) was heated under 
reflux overnight in the presence of ethanol (125 ml) and hydro­
gen peroxide (15 nil, 27%). An additional amount of hydro­
gen peroxide (10 ml, 27% ) was added and the solution heated 
for a further 3 h. The reaction mixture was cooled to room 
temperature, then the volume of solvent was reduced by half 
in vacuo. The white solid obtained was dissolved in toluene 
tind purified by silica-gel column chromatography. The first 
fraction, assigned as 2,8-dimethylphenoxathiin 10,10-dioxide 
was obtained in 8% yield. Ethyl acetate was then used to elute
(I) in 75% yield (m.p. 403-405 K). Solutions of (I) left in air 
were found to oxidize slowly back to 2,8-dimethylphenoxathiin
10,10-dioxide.
Crystal data
C m H uO iS  
M, = 244.30
S I - O I 1 .499  (2) S 2 — C 2 I 1 .7 7 2 (3 )
S I — C 7 1 .7 6 6 (3 ) 0 2 — C 6 1 .3 7 6 (4 )
S I — C l 1 .7 7 5 ( 4 ) 0 2 — C l  2 1.381 (4 )
S 2 — 0 3 1 .5 0 3 (3 ) 0 4 — C 2 0 1 .3 7 0  (4)
S 2 — C I S 1 .7 6 8 (4 ) 0 4 — C 2 6 1 .3 8 8 (4 )
O l — S I — C 7 1 0 7 .3 8 ( 1 5 ) 0 3 — S 2 — C 2 I 1 0 7 .7 5 (1 5 )
O l  - S I — C l 1 0 7 .4 6 ( 1 5 ) C l  5 — S 2 — C 21 9 5 .9 8 ( 1 6 )
C 7 — S I — C l 9 6 .7 6 ( 1 6 ) C 6 — 0 2 — C I 2 120.8  (3 )
0 3 — S 2— C l  5 1 0 6 .7 0 ( 1 5 ) C 2 0 — 0 4 — C 2 6 1 2 0 .3 ( 3 )
O l — S I — C l — C 6 9 2 .1  (3 ) 0 3 — S 2 — C l  5 — C 2 0 - 8 4 . 9  (3 )
O l — S I — C l — C 2 - 8 1 . 3  (3 ) 0 3 — S 2 — C l  5 — C I 6 8 6 .5  (3 )
S I — C l  —C 6  0 2 7 .7 ( 5 ) S 2 — C l  5— C 2 0 — 0 4 - 1 1 . 4  (5 )
O l — S I —  C 7 — C I 2 - 9 3 . 5  (3 ) 0 3 — S 2 — C 2 1 -— C 2 6 8 6 .2 ( 3 )
O l —  S I —  C 7 - C 8 8 3 .4 ( 3 ) 0 3 — S 2 — C 2 I - C 2 2 - 8 6 . 9  (3 )
S I — C 7 — C l  2— 0 2 - 5 . 0 ( 5 ) S 2 — C 2 1 — C 2 6 — 0 4 6 .8  (5 )
Mo K a  radiation 
A = 0.71069 A
H atoms were refined as riding, including free torsion of the 
methyl groups. Um, values for H atoms on aromatic C atoms 
were set to 1.2 times the (7cq values o f the parent atoms and 
to 1.5 times the Ucq values for those in methyl groups.
Data collection: MSCIAFC Diffractometer Control Soft­
ware (M olecular Structure Corporation, 1985). Cell refine­
ment: M SCIAFC Diffractometer Control Software. Data reduc­
tion: TEXSAN  (M olecular Structure Corporation, 1993). Pro­
g ram ^) used to solve structure: SIR (Burla et al., 1989). Pro 
gram(s) used to refine structure: SHELXL91  (Sheldrick, 1997). 
M olecular graphics: ORTEPU  (Johnson, 1976). Software used 
to prepare material for publication: SH ELXL91.
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A bstract
In the title compound, imidazol-1-ylmethyl 2-naphthyl 
ketone oximc, G1 5 H 1 3N 3 O, the naphthalene and imid­
azole rings are essentially planar. The oxime group is 
twisted by 36 .2 (1)° out o f the naphthalene plane. The 
oximc configuration is Z. The structure is stabilized by 
intra- and intemiolecular hydrogen bonds.
© 1998 International Union of Crystallography 
Printed in Great Britain -  all rights reserved
Com m ent
Oximes show geometric isomerism due to the double 
bond between the N and C atoms. The reaction o f 
hydroxylamine hydrochloride with an unsymmelrical 
ketone may result in either a mixture o f  two isomeric 
oximes or only one o f the isomers, depending on 
the structure o f the ketone or the reaction conditions 
(Mixich & Thiele, 1979; Migrdichian, 1957). Because o f 
the great differences in physical, chemical and biological 
properties o f the geometric isomers, determination o f the 
configuration o f  the isomers is important (Mathison et 
al., 1989).
Oximes and oxime ethers have a broad pharmacolog­
ical activity spectrum, encompassing antifungal, anti­
bacterial, antidepressant and insecticidal activities, as 
well as activity as a nerve-gas antidote, depending on 
the pharmacophoric group o f  the molecule (Polak, 1982; 
Balsamo et al., 1990; Holan et al., 1984; Forman, 1964). 
An oximino group usually modifies the activity or some­
times is directly responsible for the activity.
In connection with our interest in the anticonvul­
sant compound nafimidone and antifungal-antibacterial 
agents with (arylalkyl)azole structures, we have pre­
pared nafimidone oxime (Walker et al., 1981). Since the 
structure o f this oxime is important with respect to the 
activity and configuration o f the O-ether derivatives o f 
this compound that have been prepared in our labora­
tory, we studied its spectral properties and molecular 
geometry by UV, IR, 'H NMR, mass spectroscopy, 
elemental analysis and X-ray crystallography. We report 
here the structure o f nafimidone oxime, (I).
NOH
0 0  T 
1 1
(i)
The naphthalene moiety is essentially planar, with 
bond lengths and angles in good agreement with those 
observed in other naphthalene derivatives (Elmah et al., 
1995; Imgartinger et al., 1993). The imidazole ring is 
also planar [E(A/cr ) 2  = 1.6]. The dihedral angle between 
these two planes is 96 .98(8)°. Som e significant differ­
ences are observed for the bond distances in the imid­
azole ring compared with the averages derived from the 
Cambridge Structural Database quoted by Allen et al. 
(1987) [given in square brackets]: N l— C13 1.360(3) 
[1 .349(18)], N l— C15 1.335(2) [1 .370(10)], N2— C I4  
1.364(3) [1 .3 7 6 (H )] , N2— C15 1 .305(3) [1 .313 (H )]  
and C I3— C14 1.344(3) A [1 .360(14) A], In two other 
imidazole oxime derivatives, all the C— N bond dis­
tances in the imidazole ring are intermediate between the 
expected single- and double-bond lengths (Grassi et al., 
1993; Bruno et al., 1994). The exocyclic angles around 
the N l atom show considerable asymmetry. However,
Acta Ctyxtallographica Section C 
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Neuromuscular blocking agents. 
The preparation and properties of c/s­
and tran s- D- and L-morcoralydane methiodides
John B. S t e n l a k e  (*), William D. W il l i a m s  (*), N irm al C. D h a r  (*), Roger D. W a ig h  (*)
a n d  I a n  G. M a r s h a l l
From the Departments o f  Pharmaceutical Chemistry (*) and Pharmacology, 
The School o f  Pharmaceutical Sciences, University o f  Strathclyde, Glasgow, Scotland
( Received October 29, 1973) .
Cis- and nam -isom ers o f  D- and L-norcoralydine m ethiodide have been separated ehrom atographicatly and their neurom uscular blocking potencies 
measured against tubocurarine on the chick biventcr cervicis muscle preparation.
Conform ations have been assigned to the four isomers on the basis o f their N M R  and circular diehroism  spectra, and N M R  spectra o f  the correspon­
ding ethiodides. The relative potencies o f  the four norcoralydine methiodides and the related laudanosinc m ethiodides have been explained in terms of 
afavourcd tetrahydroisoquinolinium  conform ation for interaction with the postulated anionic receptor.
M ost series o f  quaternary am m onium  neuromuscular 
blocking agents show falling potencies, becom ing less 
depolarising and increasingly curare-like, as quaternary 
methyl groups are successively replaced by other larger 
N-alkyl substituents (1). These changes in pharm acological 
response reflect both electronic and steric effects. The 
former spread the charge density at the quaternary centre 
across adjacent a-carbon atom s (2, 3, 4), influencing the 
strength o f  the electrostatic interaction with the anionic 
binding ccntre(s), whilst steric effects determine the closeness 
o f  fit o f the quaternary groups at the effective binding 
site (5, 6, 7).
The marked influence on potency o f  steric effects due to  
chain-branching close to the quaternary centre has been 
dem onstrated in flexible m olecules such as D -, L- DL- and 
mt'.vo-isomers o f  succinyl d i-a- and P-methylcholine 
di-iodides (8, 9, 10). Thus, equipotent molar ratios relative 
to  suxam ethonium  (1) for succinyl di-P-m ethylcholine 
di-iodides were L -(+  )-, 887, D -( —)-, 1 200 and DL-(me,vo)-, 
913.
The norcoralydine m ethiodides (I) are structurally and 
stereochem ically related to  the tetrahydropapaveriniuin  
sub-units o f  tubocurarine and related bisbenzylisoquinoli- 




unequivocal method o f  distinguishing steric from electronic 
effects in the action o f  quaternary com pounds at the neuro­
muscular junction. The present paper describes the separa­
tion, pharm acological evaluation and stereochemical 
assignm ents o f  cis- and trans- D - and L-norcoralydine 
m ethiodides. The fr««i-isom ers have rigid H an.v-decalin-like 
conform ations, but the m -isom ers are flexible and may 
adopt one o f  tw o alternative m -decalin -lik e conform ations. 
Evidence is presented in favour o f  one o f  two possible 
crs-conform ations.
C H E M ISTR Y
(I)
OM e M o y n e h a n ,  S c h o f i e ld ,  J o n e s  and K a t r i t z k y  (11, 12) 
have shown by infrared and 'H — N M R  spectroscopy that 
the ring system  in quinolizidine exists predom inantly in
9 5
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the /rans-fused conform ation, and that quinolizidine inethio- 
dide, prepared by direct m ethylation o f  quinolizidine, 
similarly has the /ran.v-fused conform ation with the N-methyl 
group orientated axially (II). Quinolizidine methiodide 
prepared by ring-closure leads on the other hand mainly to 
the d.r-com pound. In our experience, however, direct m ethy­
lation o f  quinolizidine gives a product which on the evidence 
o f  its N M R  spectrum contains some cis-isomer (III).
Similarly, treatment o f  D - and L-norcoralydines with 
methyl iodide gave m ethiodides, each o f  which showed  
evidence o f  the presence o f  two isomers by their N M R  
spectra and by thin-layer chrom atography on cellulose  
with 0.1N  hydrochloric acid (R F 0.35 and 0.86), with the 
isomer mixtures containing som e 25-30 %  o f  the minor 
com ponent (RF 0.86). C olum n chromatography o f  each 
m ethiodide in 0.1N  hydrochloric acid on cellulose afforded 
separations to give pure cis- and trans- D- and L-norcora­
lydine methiodides.
The isomers show characteristic differences in their 
ultraviolet, infrared, circular dichroism and 'II N M R  
spectra. The minor isomer has been assigned the c/.v-fused 
configuration and the tnajor isomer the trans-fused configu­
ration on the basis o f  their 100 M Hz N M R  spectra. The 
two isomers showed marked differences in their solubilities. 
The m -racem ate was much m ore soluble in CDC13 than the 
/rans-racemate. The optically active forms o f  the ircms- 
isomer, however, were significantly m ore soluble than the 
racemate, sufficient for spectroscopic exam ination.
According to M o y n e h a n ,  S c h o f i e ld ,  J o n e s  and 
R a t r i t z k y  (12), the N -m ethyl groups absorb at lower 
field in m -fu sed  N -m ethylquinolizidinium  ions (t6 .85 )  
than in the trans-fused isom ers (x 7,04). 100 M Hz N M R  
spectra o f  the norcoralydine methiodides showed in the
major product an intense N - C H 3 signal at x6.92 (axial 
with respect to rings B and C), with a corresponding signal 
at x6.41 (equatorial with respect to ring B, axial with respect 
to ring C, or vice versa) in the minor isomer, in accord with 
the tentative assignment o f  configuration as the trans- 
and ra-fused isomers respectively. The latter is in good
agreement with the signal at x6,48 (equatorial N - C H 3) 
in D -laudanosine hydrochloride. None-the-less, we have 
sought and obtained additional evidence o f  these assign­
ments elsewhere in the spectrum.
B h a c c a ,  C y m e r m a n - C r a ig ,  M a n s k f ., R o y , S h am m a and 
S l u s a r c h y k  (13) have show n that the 100 M H z spectrum  
o f  cularine (IV) shows a pair o f  doublets at x5.56 attribu­
table to the C -l proton which is spin-coupled in an ABX  
pattern (JAX =  4 and JBX =  12 Hz) to the two non-identical 
protons at C-9, in agreem ent with the conform ation (IV). 
By analogy, if the hydrogen at C -l3a  is designated as H x 
and the two hydrogens at C - l3 are designated H A and H B, 
N e w m a n  projections o f  / ran.v- n o rco ra 1 yd i n e m ethiodide (V) 
and the two possible conform ations o f  m -norcoralydine  
methiodide (VI and VII) show  that whereas H A and H B are 
equivalent (both dihedral angles ca 60° to H x) in the cis- 
isomer o f  conform ation (VI), they are non-equivalent with 
dihedral angles o f  ca 60" (A X ) and ca 180“ (BX) respectively  
in the /ran.v-isomer and the ra-isom er o f  conform ation (V II).
-  c h im ic a  t h e r a p e u t ic a , m a y -j u n e  197 4  -  9 ,  n " 3
The signal patterns for the 13a protons are complicated 
by the additional signals arising from the two C-8 protons 
which lie in a closely similar environment, and appear in the 
spectrum of the /ra/tv-isomer in CDC13 only as part of a 
complex pattern of three protons intensity in the x4,60-
5.00 region. These signals, however, are clearly separated 
in D M SO  appearing as a pair of doublets (1 proton) at 
x4.90 (JAX = 4, JBX =  12 Hz) attributable to the C-13a 
proton, and two doublets (1 proton each) at x 5 .16 and 
x5.39 showing geminal coupling (J =  14 Hz) due to the 
two protons at C-8 . The corresponding signals in the cis- 
isomer are somewhat more clearly resolved in CDC13 than 
those of the /ran.v-isomer, and also appear as a pair of 
doublets of one proton intensity (C-l 3a) at x4.70 (JAX = 4, 
JBX = 12 Hz) and a singlet (two C-8  protons) at x4.88.
The identity of the two isomers and the assignment of 
conformation (VII) to the m-isomer is confirmed by the 
C -l3 proton signals, which in the latter isomer fall within the 
shielding cone of ring A. As a result, the C -l3 proton 
signals are at much lower field in the trans-isomer and 
appear as a pair of multiplets, each of 1 proton intensity at 
x5.25 and x5.50. In contrast, comparable signals are not 
evident in the m-isomer, since, as shown by the integral, 
they form part of the complex pattern of 9 protons (7 in the 
/rans-isomer) in the region x6.2-7.2, which apart from the
N — CH3 signals is poorly resolved in both isomers.
We have similarly prepared and separated the cis- and 
trans-isomers of D-norcoralydine ethiodide. As anticipated, 
the isomers are identified by their N M R  spectra which
show characteristic N .C H 2 .CH 3 triplets at t8,9 (J =  7) 
in the major product, and at x8.43 (J = 8 ) in the minor pro­
duct. The signal at higher field in the major product is wholly 
consistent with its assignment as the /ran.v-isomer, since the
N . CH2 . CH3 group falls within the shielding cones of both 
aromatic rings. Likewise, the lower field signal in the minor 
product accords with the ds-conformation (as VII), since
the N .C H 2 .CH 3 group falls within the shielding cone of 
only one (ring A) of two aromatic rings.
The C-13a proton is seen in the /ra«.v-ethiodide as a pair of 
doublets centred at x4.30 (JAX =  5, JBX = 13 Hz), clearly 
separated from the pair of doublets due to the two C-8 
protons at x4.70 and 5.08 showing geminal coupling 
(J =  17). In contrast the C-l3a proton signal is shifted
+
marginally upfield in the m-isomer due to the N . CH2 . CH3 
group, and shows only as part of a poorly resolved complex 
of three protons intensity in the region i4 .7  to 5.1 attribu­
table to both C-l3a and C-8 protons. The /r/m-ethiodide 
also shows a pair of multiplets (each 1 proton) at x5.60 
and 5.78 attributable to the two C -l3 protons, which are not 
apparent in the d.v-isomer since, as in the ds-methiodide, 
they form part of the complex pattern in the x 6.2-7.0 region.
The ultraviolet and circular dichroism  spectra o f  cis- and 
trans-( 4- )-norcoralydine m ethiodide a lso show sm all, but 
characteristic differences which reflect the differences o f  
m olecular shape. The ultraviolet absorption o f  the d.v- 
isomer show s an intensification o f  the benzenoid local
OMe (VI)
OMe
excitation baud at 286 nm compared with the t/aws-isomc \  
and also shows a small maximum at 350 nm, which is not 
evident in the trans-isomer. These spectral differences are 
reflected in the circular dichroism spectra of cis- and trans- 
D-norcoralydine methiodides. Thus, whereas the trans- 
isomer shows only two positive maxima at 210 and 240 nm 
respectively, the ra-isomer shows an additional band which 
appears as a negative minimum at 278 nm in correspondance 




As anticipated, all the compounds show a low level of 
potency compared with that of ( + )-tubocurarine. Nonc- 
the-less, potency differences (table 1) between the four 
isomeric norcoralydine methiodides are highly significant 
(P <  0.01). In contrast to the related laudanosine methio­
dides, of which the L-compound is more potent than the
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(TC = 100) 
±  S.E.M.
D -( + ) - c/s-Norcoralydine methiodide 13.6 ±  0.75
D -( +)~trans-Norcoralydine methiodide 4.3 ±  0 .15
L-( - ) - c/s-Norcoralydine methiodide 2.1 ±  0 .06
L- ( —) -trans-Norcoralydine methiodide 3.2 ±  0.15
L-{ +)-Laudanosine methiodide 8.1 ±  0.75
D - ( —) - Laudanosine m ethiodide 2.2 ±  0.15
D -isom er (14), both cis- and na«.v-D-norcoialydine m ethio­
dides are m ore potent than the corresponding L-isomers. 
Significantly, the circular dichroism spectra o f  both cis- 
and /rans-norcoralydine methiodides (fig. 1) also show  
positive m axim a at 210 and 240 nm, corresponding to that 
o f L-laudanosine m ethiodide (15). Com parison o f  these C D  
spectra is valid, since the laudanosines and norcoralydines 
have identical methoxyl substitution patterns (16, 17). 
C orrespondance o f the C D  spectra o f  both D-norcoralydine 










Fig. 1. -  Circular dichroism curves o f
D -(+  )-tram -Norcoralydine methiodide.
D -( +  )-ctj-Norcoralydine methiodide.
L-( +  )-laudanosine m ethiodide.
m ethiodide reflects their general chiral similarity, corn- 
com prising a com bination o f both 2" (ring B) and 3r chiral 
spheres (rings C  and D ), rather than that o f the second chiral 
spheres alone (16, 17, 18).
None-the-less, it is perhaps significant that o f  the two 
norcoralydine m ethiodides, only the D -m -isom er shows 
a C D  spectrum corresponding in all three maxima at 210, 
240 and 280 nm with that o f L-laudanosine. This not only 
accords with the fact that the conform ation o f  the tetrahy- 
droisoquinolinium  moiety com prising rings A and B in the 
more potent D-d.v-isomcr is identical with that o f  the confor­
mation o f  L-laudanosine m ethiodide (VIII) (14, 19, 20, 21), 
but also strongly suggests the very close overall molecular 
shape o f  these tw o molecules in solution. Similar conside­
rations determine the relative potency o f  the four isomers.
Since D -m -  and nam -norcoralydine m ethiodides have 
different A /B  ring conform ations, but identical C /D  ring 
conform ations, and since the A /B  ring conform ation o f  the 
D-d.v-isomer is also identical w ith that o f the m ore potent 
L-laudanosine methiodide, it appears that the A /B  tetrahy- 
droisoquinolinium  conform ation plays a key role in deter­
mining the potency o f  such com pounds. Furthermore, the 
markedly angular shape o f  D-d.v-norcoralydine methiodide 
is such that rings C and D  represent a major hindrance to  
receptor interaction at the a-face o f  the m olecule. Conse­
quently, onium  ion-receptor interaction at the unhindered 
upper P-face o f  the A /B  tetrahydroisoquinolinium  moiety is 
strongly favoured.
The P-face o f  the less potent D-fr««s-norcoralydine 
m ethiodide is similarly unhindered, but this face presents 
an A /B  tetrahydroisoquinolinium  group o f opposite confor­
mation to that o f  the D -m -isom er  and identical with that 
in D -laudanosine m ethiodide (IX). On the other hand, 
the a-face o f  the D-rran.v-isomer is such that either ring B 
or ring C (but not the entire tetrahydroisoquinolinium  
m oieties) presents a similar, but not identical, conform a­
tional aspect to a potential anion ic receptor as the P-face 
o f  ring B in the D-ci.v-isomer. R ings C and D  o f  the D-trans- 
isomer, however, lie in a plane at an angle o f  about 30° to 
that o f  rings A and B. Rings C and D , therefore, project 
below the plane o f  the m olecule, so  that it would be hindered 
in any such alignm ent o f  the a-face to an anionic receptor. 





The concept o f  a sterically favoured receptor interaction  
in neuromuscular block is supported by the low  potency o f  
L-rrans-norcoralydine m ethiodide (X). This is capable o f  
presenting its P-face to an anionic receptor in the same 
favourable P-face orientated conform ation as the D -cis-
9 8
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isomer. The P-face approach, however, is subject to steric 
hindrance by rings C and D  which project upwards in a 
plane angled at about 30°. A dditionally, two axial hydrogens 
protrude prom inently from the P-face o f  the L-/ram-com- 
pound at C-5 and C - l3, both in 1,3-locations with respect to 
the onium  N -m ethyl group, com pared with only one such 
at C-8 in the more active D -ra-com pou nd .
Me h






O nium  group receptor interactions ar the p-face o f  the 
least active isom er, L -m -norcoralydine m ethiodide (XI), 
are even less favoured due to the com bination o f  the unfa­
vourable A /B  ring conform ation and strong steric hindrance 
from rings C and D , which are angled upwards at about 60° 
on the P-face.
EX PE R IM E NTA L
Melting points are uncorrected. Analytical results for C, H, N and I were 
obtained within experimental error of the theoretical value, and are not 
reported in the paper. NMR spectra were determined in deutcrochloroform 
with TMS as internal standard on a Perkin-Eliner RI4 by Dr. P. B l a d o n  
of this University, to whom we are indebted for this service. Circular 
dichroism spectra were recorded in methanol on a Cary, Model 6001, 
recording spcctropolarimetcr fitted with a circular dichroism attachment.
L-( -  )-Norcoralydine Hydrochloride
L-(-)-N orcoralydine hydrochloride was prepared from L-( +  )-tetrahy- 
dropapaverinc hydrochloride as described by C o r r o o i  and H a r d e g g e r  (22) 
as colourless needles (from methanol), m.p. 204-206° (decomp.), 




L-(—)-Norcoralydine was prepared from L-( — )-norcoratydine hydro­
chloride, as colourless needles (from methanol), m.p. 185-186°, 
M d !  5 -  298.4“ (c, 0.892, CHC13), RF 0.80 in C H C l,-E tO H  (90 : 10) 
on thin-layer silica gel G  (Merck). C o r r o d i  and H a r d e g g e r  (22) report 
m.p. 177°, [ot]D -  277“ (c, 1.0, CHC13). Anal, for C21H 250 4N : C, H, N.
cis -and frans-L-( — )- Norcoralydine Methiodides
L-( -  )-Norcoralydine (2.02 g) was refluxed with methyl iodide (15 ml) for
3.5 hr. Excess methyl iodide was removed by evaporation, the product 
washed with dry ether and dried over P2Os under vacuum. Thin-layer 
chromatography of the crude product in 0.1 N hydrochloric acid on What­
man Cellulose Chromedia CC41 showed two components Rf 0.35 and 0.86. 
The crude product (2.02 g) was chromatographed on a column (40 x  3.5 cm) 
of Whatman Cellulose Chromedia CC3I-celite (50 : 50) in 0. IN hydro­
chloric acid.
The minor component (thin-layer Rr 0.86), cis-L-( — )-norcoralydine 
methiodide was obtained from methanol-ether as a yellowish solid (0.044 g), 
m.p. 150-151°, [a]p° -  167.2“ (c, 0.204 in MeOH). Anal, for
C22H28N 0 4I,H 20  : C, H, N.
The major component (thin-layer RF 0.35) trans-L-( — )-norcoralydine 
methiodide was obtained from methanol as a pale yellow solid (0.174 g), 
m.p. 247-249°, [ot]*° 8 - 132.8“ (c, 0.308 in MeOH). Anal, for 
C 22H28N 0 4I,H20  : C, H, N.
D-( + )-Norcoralydine Hydrochloride
D-( +  (-Norcoralydine hydrochloride was prepared from D-( (-tetraby- 
dropapaverine hydrochloride (3 g) by the method of C o r r o d i  and 
H a r d e g g e r  (22). D-( + )-Norcoralydine hydrochloride was obtained as 
colourless needles (3.1 g) from methanol, m.p. 203-205“ (decomp.), 
[ot]*° + 241.6“ (c, 0.896, EtOH). Anal, for C21H 26N 0 4CI : N.
D-( + )-Norcoralydine
D-(+ )-Norcoralydine was prepared as for the L-isomer, and obtained as 
colourless crystals from methanol, m.p. 185-186°, [a]^,2 +  298.8“ (c, 1.239 
in CHClj). RF 0.80 in CHCI3-E tO H  (90 : 10) on thin-layer silica gel G 
(Merck). Anal fo rC 21H 250 4N : C, H, N
cis- and trans-D-( + )-Norcoralydine Methiodides
cis- and fran.v-D( + )-Norcoralydine methiodides were prepared (2.8 g) 
and separated as described for the L-isomers. The minor component 
(thin-layer RF 0.86), cis-D-( +  )-norcoralydine methiodide was obtained from 
methanol-ether as a yellowish solid (0.078 g), m.p. 150-152°, [a]^9 8 +  165.8“ 
(c, 0.405 in MeOH). Circular dichroism (c, 0.02052 in MeOH) 
[0 ]28 2 6,000, [0 ]265 - 13,300, [0]242 5 +  38,900, [0]23o -  25,400
[0J2or.s + 133,000. Anal, for C 22H 2BN 0 4I,H20  : C, H, N.
The major component (thin-layer RF 0.35), trans-D-( +  )-norcoralydine 
methiodide, was obtained from methanol as a pale yellow solid (0.320 g), 
m.p. 248-250°, [a]^9 8 + 134.5“ (c, 0.430 in MeOH). Circular dichroism 
(c, 0.02126 in MeOH) [0 ]24O + 28,000, [0]227O, [0 ]21O +  154,500. Anal. 
fo rC 22H 28N 0 4l,H 20  : C, H, N.
cis - and trans-D-( + )-Norcoralydine Ethiodides
cis- and trans-D-(+ (-Norcoralydine ethiodides were prepared and sepa­
rated as described for the corresponding methiodides. The minor compo­
nent (thin-layer RF 0.85), cis-D-( t- )-norcoralydine ethiodide was obtained 
from methanol, m.p. 113.5-116.5°, [a]p‘ + 143.2“ (c, 0.221 in MeOH). 
Anal, for C 23H30NO4l,H 2O : C, H, N.
The major component (thin-layer RF 0.40), trans-D-( + )-norcoralydinc 
ethiodide, was obtained from methanol, m.p. 180-182°, [“ Id0 5 +  136.7“ 
(c, 0.201 in MeOH). Anal, for C 23H 30NO4I,H2O : C, H, N.
L-(+)-Laudanosine Methiodide
Circular dichroism (c, 0.01946 in MeOH), [0]28O + 13,500,
[0 ]2S7 +  6,800, [0 ]237 5 + 41,500. [0 ]226 + 26,000, [0 ]211 +  105,500.
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Neuromuscular blocking potency
The compounds were tested on the isolated biventer cervicis muscle from 
chicks (23) as described in the accompanying paper (14),
Because of their water insolubility, the isomeric D- and L-norcoralydi- 
nium iodides were initially dissolved in dimethylsulphoxide (DMSO) and 
subsequently diluted with Krebs-Henseleit solution. Large concentrations 
of DMSO (30-50 mg/ml) themselves modify neuromuscular transmission 
in the biventer cervicis muscle preparation (24), possessing both facilitatorv 
and blocking properties. Lower concentrations of DMSO (8-20 mg/ml) 
do not themselves modify neuromuscular transmission, but slightly modify 
the blocking action of tubocurarine. In order to reduce the influence of the 
DMSO in the experiments described in this paper, the maximum final bath 
concentration of DMSO used was 8 mg/ml, and the norcoralydinium 
compounds were always compared with tubocurarine solutions containing 
an identical quantity of DMSO. All the compounds tested produced a non­
depolarizing type of neuromuscular blockade, exhibiting no propensity to 
cause contracture of muscle, and reducing the response to exogenous ace­
tylcholine (30 pg/ml).
R esume
Les isomercs cis- et trans- des formes D et L dc l'iodomethylate de la 
norcoralydine ont ete separes par chromatographie et leurs pouvoirs 
curarisants ont et£ evalues par rapport a la tubocurarine sur une prepa­
ration de muscle « biventer cervicis » de poussin.
On a determine les conformations des quatre isomercs d’apres leurs 
spectres dc RMN et de dichroisme circulaire, et les spectres RMN des 
iodoethylates correspondants.
Les pouvoirs respcctifs des quatre iodomethylates des norcoralydine et 
laudanosine associees ont etc explicitcs a la faveur d’une conformation 
tetrahydroisoquinolinium lors de l’interaction avec 1c rccepteur anioniquc.
Zus AMMENFASSU NG
Cis- und 7Van.risomere des D- and L-Norcoralydin Methiodid sind 
chromatographisch getrennt worden, wobei ihre neuromuskuljiren Bloc- 
kierkrafte dem Tubocurarin gegeniiber bci dcr Preparation des Muskels 
biventer cervicis des Kukens abgemessen worden ist. Verschiedene Gestal- 
tungen sind den vier Isomeren aufgrund der NMR und kreisformigen 
Dichroismenspcktrcn wie auch die NMR-Spektren der entsprcchenden 
Ethiodide zugeschrieben worden.
Die relativen kriiftc der vier Norcoralydin Methiodide und der ver- 
wandtcn Laudanosinen Mcthiodiden iasz sich erklarcn, mit Rucksicht auf
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die Gestaltung mil einem Tetrahydroisochinolinium der am Hkufigsten 
mit dem vorausgesetzten anionschcn Rezcptoren zusammenwirkt.
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Biodegradable neurom uscular blocking agents, 
h Quaternary es te rs
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A new approach to the preparation of metabolically-dogradable, short-acting neurom uscular blocking agents, modelled on tihe facile 
H ofm ann degradation o f the quaternary alkaloid petaline, 5, has been examined. A series o f 1-ethoxycarbonylmethyltetrahydroisoqui- 
nolinium and polymethylene-Wi-l-ethoxycarbonylmethylteti'ahydroisDquinolinium com pounds has been prepared. The compounds had 
low neurom uscular blocking potencies, and underw ent only partial H ofm ann elimination in vitro  at physiological pH. The elimination 
products underwent a retro-Hofmann reaction, and equilibria with the quaternary salt were slowly attained.
T o date biodegradation and short duration of action 
in neuromuscular blocking agenits has been achieved 
alm ost exclusively by incorporation of cstter groups, which 
are subject to enzym ic hydrolysis and hence fragmentation 
of the m olecule. Thus Suxamethonium. 1, owes its short 
action to hydrolysis by non-specific plasm a esterases 
(1 , 2, 3) into succinylm onocholine, 2, and choline both 
of which have negligible neuromuscular blocking potency 
(4 , 5). Suxamethonium is widely used clinically for muscle 
relaxation, but suffers from a number o f important disad­
vantages. Thus, iit induces neuromuscular block by depo­
larisation o f the motor end plate, and in consequence  
block is not readily reversed by anticholinesterases such 
as Neostigm ine and Edrophonium . Depolarisation also 
raises plasma potassium, a phenom enon which can lead 
to cardiac arrest in patients w ith hyperkalaemia (6). Suxa­
methonium also induces fasciculation prior to  onset of 
paralysis, which results in painful post-operative craimps 
(7), and repeated doses can give rise to asystole due to 
vagal stimulation (8). A further serious hazard which 
attends the use o f Suxamethonium is that its action may 
be unduly prolonged resulting in severe apnoea in patients 
with a deficiency of plasma esterases due to liver disease 
or to genetically determined deficiencies (9 , 10, II) .
A  number of other related ester-linked quaternary 
com pounds have been examined as potential short-acting 
neuromuscular blocking agents, including the reversed









esters (12), 3  and 'the tris-onium compounds (13), 4  
(R  =  M e or B t ; n =  1 or 2). T he former suffer from  
the same disadvantages as Suxamethonium, whilst the 
latter proved insufficiently potent to warrant developm ent 
for clinical, use. A ll other muscle relaxants in general use, 
including Tubocurarine chloride, Gallam ine triethiodide, 
Alcuronium brom ide (14, 15), Pancuronium bromidic
(16, 17, 18), Fazadinium (AH  8165 ; 19), although com p e­
titive non-depolarising neuromuscular blocking agents and 
readily reversible by anticholinesterases, are slow er in 
onset and significantly longer acting than Suxamethonium  
in man. There still remains, therefore, a need for a really 
short-acting non-depolarising neurom uscular blocking
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agent for use in intubation and surgical procedures. Such 
an agent should also desirably be both non-depolarising 
and free from the vagal-stimulating effeols shown by all 
the major com petitive blockers currently in use. The latter 
result in tachycardia, and arterial hypertension, which is 
the oause o f excessive bleeding during surgery (20).
The general structural similarity of the sim ple m ono- 
quaternary ammonium alkaloid, petaline (21), 5, to  the 
benzy 1 isoqu inoliniuin units o f tubocurarine, and the ease  
with which it undergoes H ofm ann elim ination in solution  
on Am beriite IRA  400  (O H ) ion exchange resin to yield  
petaliniemethinc, 6, suggested the possibility of exploiting  
similar elim inations effective at physiological pH (7 .4) as 
an alternative and novel moans of terminating neuromuscu­
lar blocking action in a new approach to short-acting  
muscle relaxants.
CHEMISTRY
In an attempt to delineate (he essential parameters for 
continuing rapid H ofm ann elimination at physiological 
pH with an effective level o f com petitive neuromuscular
H. COOK,
o R1 , R2 - H
h R* - OMe, R •= II




block, w e have confined our attention initially to a num­
ber o f simple isoquinolinium compounds. The (1-amino 
ester m ethiodide (22). 7b , which undergoes an almost, 
instantaneous Hofm ann elim ination to the unsaturated 
ester, 8b . in aqueous sodium hydroxide formed the basis 
of the present study.
T he ester, 7b , is readily available by Bishler-Napieralski 
cyclisation o f ethyl W -3,4-dimethoxyphenethylmalamate 
followed by reduction and methylation of the product 
(22, 23). H owever, both this route (24) and the Pictet- 
Spengler synthesis (25) seem ed insufficiently flexible for 
synthesis of the particular 1 -substituted-1,2,3,4-tetraihy- 
droisoquinolm es envisaged in this work. Accordingly, we 
turned our attention to the alternative nucleophilic addi­
tion o f  Grignard and Refonnatski reagents to  3,4-di'hydro- 
isoquiinolinium salts. Similar nucleophilic additions to  iso- 
quinoliniuni salts are known (26 , 27) but this route to 
1-substituted-1,2,3.4-tetrahydroisoquinoline has n o t found 
favour as a general method because of the instability of 
the intermediate 1 -substituted-1,2-d rhyd roisoquinohnes. 
N ucleophilic addition to 3,4-dihydroisoquinolines, howe­
ver, is free from  this disadvantage, and further, offers the 
advantage that the required I-substituted products are 
obtainable from preformed dihydroisoquinolines of known 
constitution.
The esters, 7a  and b, were prepared from the corres­
ponding 3,4-dihydroisoquinolinium  salts, 9 a  and b 
(Scheme I) by a Reformatski type condensation with zinc 
and ethyl bromoacetate (28) and m ethylation o f the pro­
duct. The only difficulty encountered in the R efonnatski 
addition arose from the poor solubility of the 3,4-dihydro- 
isoquinalinium  salt in the usual reaction solvents. T'etma- 
hydrofuran gave the cfeanest products, buit it was neces­
sary to  add die quaternary salt in .solid form. Sim ultaneous 
introduction o f the solid and brom oester to  the zinc sus­
pension proved difficult, and the most satisfactory proce­
dure was found to be portionwise addition o f the salt either 
prior to or after addition o f  the bromoester. In Che pre­
paration o f 1 0 a . substantial amounts of the by-product, 
11, were obtained. This is formed presumably by a bim o- 
lecular reduction o f the 3,4-dihydroisoquinolinium  iodide 
in a reaction analogous to the reduction of 3 ,4 -d ih ydro-l- 
mothylisoquinolin.es with aluminium amalgam (29, 30).
a R - R - H 
b R1 = OMo, R2 - 
c R1 OMo, R2 -
Scheme I
The facility with which the quaternary salts, 7a anti b, 
undergo Hofm ann elim ination must be due largely to the 
effect of d ie  ester carbonyl in increasing th e acidity o f 
the adjacent methylene hydrogen atoms. Introduction o f 
a phenyl or second alkoxy carbonyl group at this position
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should still further increase the acidity of the remaining 
hydrogen atom. The esters, 12a, 12b, 14a and 14b, were 
prepared 'by addition of sod io  ethyl phenylacetate and the 
sodio m alonate esters respectively to the appropriate 3 ,4- 
dihydroisoquinolinium  salts (9). The phenylmal'omuDe 
ester, 12a, and its destim elhoxy analogue, 12b, were 
readily methylated to stable m ethiodides, 13a and 13b.
12 a R McO
b R H
13 a R - McO 
b R - H
The corresponding dimethyl ester, 14b. and the des- 
dim ethoxydim ethyl ester, 14c. behaved similarly with  
methyl iodide. The stoichiom etry and products are 
explained by the reaction sequence (Schem e 2). L i b b e r -  
m ann  and G l a w e  (3 1 ) obtained analogous products from  
the base, 19. and methyl iodide, which gave cotam ine  
iodide, 20 , and the quaternary benzylidenem alonic ester, 
21. Tlhe base, 19, is also readily, c leaved  in cold dilute 
hydrochloric acid to cotam ine chloride and diethyknalo- 
nate.
McO CH(COOEl),
In contrast, the m ethiodide, 15, of the m alonate ester, 
14a, proved to be unstable and oould not be isolated. 
Insteaid, reaction of 14a with methyl iodide gave a mixture 
of the 3,4-dihvdroisoquinoliniiium iodide, 9b, the quater­
nary sat!, 18 , and diethyl m alonate via 16 and 17. A na­
lysis o f the PM R spectrum o f th e products formed in 
CDClj show ed the reaction to have the follow ing stoichio­
metry :
2 14a +  2 Mel ------- •>- 9b T  18 +  € H 2(CO O Bt)3
OX.
= OMo, R = E 
= OMe, R2 - R 








^ O - O C T O O l '
Scheme 2
Since the m onoquatem ary salts ware expected to 
possess only a low level of neuromuscular blocking acti­
vity, the decaimethyIene-bis-quaternary salt, 24, was pre­
pared by treatment of the deoa met h y 1 en eh is-3,4-dhh ydro- 
isoquinolinium  compound, 22, with ethyl bromoaoetate 
and zinc, and m ethylation of the reaction product, 23 . A s  
described below, Hofm ann elim ination o f the bisquater 
nary com poim d, 24 , proceeded slow ly and only to  the 
extent of som e 20  %  at pH 7.4. In order to circumvent 
the possibility that elim ination is unnecessarily retarded by 
concom itant hydrolysis of the ethoxycarbonyl to the cor­
responding, less powerfully electron-attracting carboxyl 
groups, w e have also synthesised the bisquaternary com p ­
ound, 25, by condensation o f  9b, w ith ethylenoglycol 
bispheny 1 acefate, 26 , in the presence o f sodam ide in tw o  
stages, follow ed by methylation of the resulting ditertiary 
base, 27 . Enzym ic ester hydrolysis o f this com pound, 
whilst similarly unmasking free carboxylic acid groups 
capable of retarding Hofm ann elim ination, would at ‘the 
same tim e give rise to two m onoquaternary com pounds  
with attendant low  neuromuscular b locking activity.
HOFMANN ELIMINATION STUDIES
H ofm ann elim ination o f the quaternary esters procee­
ded alm ost instantaneously on addition o f a slight excess 
of dilute N aO H  solution to aqueous solutions of the salts. 
Our finding that their neurom uscular blocking action.
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although low, as expeoted, was not of short duration 
prompted us to  examine in detail the behaviour at pH 7.4  
of the monoquaternary salt, 7b , and the hydriodide o f its 
H ofm ann elimination product, the cinnam ic ester, 8b. 
The ad d s, 2 8  and 2 9 , which are th e hydrolysis products 
of 7b  and 8b , respectively, were also exam ined to inves­
tigate the possibility that ester hydrolysis at pH 7 .4  might 
be confusing the picture.
The behaviour of com pounds, 7 b  and 8b , ait pH 7 .4  
was follow ed by com parison of changes in their U V  
speotra with time (Figs. 1 and 2) with corresponding  
spectra o f the two com pounds in water. H ofm ann elim i­
nation is characterised by th e disappearance of the 283 nm 
band and the appearance of two stronger bands at 2 9 2  nm 
and 329  nm. Figures 1 and 2 show that both the quater­
nary salt, 7b , and the cinnam ic ester, 8b , slowly reach 
equilibrium. The small changes in the spectrum o f 7b  
(Fig. 1), which contrast with the very much larger changes 
in the spectrum of the corresponding cinnam ic ester, 8b, 
are consistent with equilibrium concentrations equivalent 
to  about 80 %  quaternary salt, 7b , and 20  % cinnam ic  
ester, 8b .
alkali, failed to eliminate to any measurable extent in 
60 min at pH 7.4. The corresponding cionamaite, 3 0 , was 
also stable at pH 7.4. A  similar lack of reactivity was 
exhibited by the methyl-substituted ester, 7 c , which was 
chosen in order to inhibit recyciIi9ation. W ithout doubt Che 
presence o f the methyl group in the cinnamate, 8c , would  
prevent recyclisation, but the slow  rate of Hofm ann elim i­
nation nullified this advantage.
c O 'O c h 2 -c h 2- o
N  M o , I
n, n
In contrast, but as expected , the rate o f elim ination of 
the acid, 2 8 , was negligible, the U V  spectrum being similar 
to, but quite distinct from that of the ester, 7b . The acid, 
2 9 , ring-closed, but extrem ely slowly, the reaction being 
not quite complete after 10 days at pH 7 .4 , as judged by 
the U V  absorption spectrum.
A s anticipated, the H ofm ann elim ination reaction at 
pH 7 .4  was highly sensitive to steric factors. Thus the 
phenylacetane. 13a, w hich, like the sim pler ester, 7a , 
elim inated immediately with a slight excess of dilute
The bisquaternary derivative, 2 4 , showed similar H of­
mann elimination behaviour to the analogous m onoqua- 
temary, 7b , about 20 % elim ination being reached in
18.5 hours. The more com plex bisquaternary ester, 25 ,  
like th e simple phenylacetate, 1 3 a , eliminated even more 
slow ly at pH 7 .4 , elimination being still incom plete after 
11 days.
PHARMACOLOGICAL RESULTS AND DISCUSSION
Com pounds 7 a , 7b , 13a, 1 3 b , 2 4  and 2 5  were tested 
for neurom uscular blocking activity on the isolated rat 
diaphragm using ( +  )-Tu'bocurarine chloride as standard. 
A ctivity in each  case was very weak. A s expec­
ted, the two bisquaternary salts, 2 4  and 2 5 , were m ost 
active in th is tesit, having activities o f 1.7 and 0 .7  %  of 
that o f ( +  )-Tubocurarine chloride respectively, and these
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•n buffer pH 7.4 (Cone. 1.9 mg/100 ml) 
(o) ofler 15 min (b) 24h
275
Fig. 1
in buffer pH 7.4CH2CH2N(Me)2 HIl.d
GH =  CHCOOEf





two com pounds were tested in v ivo  on the gastrocnemius 
m uscle - sciatic nerve preparation o f anaesthetised catts. 
Potencies were then 14 and 5 .4  % of tubocurarine respec­
tively (Table 1).
The m ost active com pound, 24 , had an action only 
slightly shorter than that o f  ( +  )-Tubocurarine, which may 
be explained by the finding that the Hofm ann elimination  
reaction is reversible. Ester hydrolysis in v ivo  m ay contri­
bute to the long action since the resultant acid would not 
be expected to Hofm ann elim inate very quickly, ow ing to
ionisation at physiological pH. The duration o f action of 
the ester-linked bisquaternary, 25 , was also slightly 'shorter 
than that of ( +  )-Tubocurarine, and the block w as not 
antagonised by Edrophonium. In th is case presumably 
ester hydrolysis in  v ivo  is slow , since the monoquaternary  
salts produced by hydrolysis w ould be expected to be 
relatively inactive, and Hofm ann elim ination, although not 
reversible, is not fast enough to provide a short action. 
Both com pounds, 24  and 25, caused hypotension and 
greatly impaired cardiac slowing in response to vagal 
stimulation.
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TABLE 1
Relative neuromuscular block in); potencies (Tubocurarine =  100).
C o m p o u n d fie
P o te n c y
it
I n i t ia l  p o t e n t i a t i o n  
e s e r in e
C o t
7a 0 . 5 + ++
7 b 0 . 4 •l-H-
13 o < 0 . 4 -H + -
1 3 b 0 . 5 -1
2 4 1 . / l 14
2 5 0 . 7 + + M
EXPERIMENTAL
M elting points were obtained on a K ofler hot-bench anti are 
corrected. Analytical results (C,H ,N) were within ±  0.3 % o f theo­
retical. HR and proton N M R spectra were obtained for each com p­
ound and were in accord with the structures given.
3,4-Dihydroisoquinolinium Salts (9 and 22). 3,4-Dihydroisoquino- 
line and 3,4-dihydro-6,7-dimethoxyisoquinoline were prepared by 
oxidation o t the corresponding letrahydroisoquinolines with TV-bro- 
mosuccinimide (32) and tire resulting bases converted to 9a and b 
with methyl iodide. 3,4-Dihydro-,6 ,7-airaethoxy-l-methylisoquinoline 
was prepared by cyclisation ot TV-acctylhomoveratrylamine using 
polyphosphoric ester (33) and converted to 9c with methyl iodide
(34). A  solution of 1,10-dttododecane (40 g, 0.1 mole) and 3,4- 
dihydro-6,7-dimcthoxyisoquinoline (50 g, 0.262 mole) in dry CjH6 
(100 ml) was heated under reflux for 10 min, cooled and diluted 
with Et2D. The precipitate was recrystallised from EtO H  - Bt20  to 
give 22, as yellow prisms (66 g, 85 %), m.p. 168-170“C . Anal. 
for C hH ^N jO J, ; C,H,N.
Ethyl 1,2 J , 4- Telrahydro- 2- methylisoquinolin-1 - yl-acctatc (10a) 
and 1,1'-Bi {1,2,3,4-tetrahydro-2-methylisoquinolinyI) (11). Eithylbro- 
moacetate (3.34 g, 0.02 mole) in dry T R F  (10 ml) was added over 
10 min to a stirred, refltrxing mixture of Zn powder (1.31 g, 0.02 
mole) and 9a (5.46 g, 0.02 mole) in T H F  (20 ml). Refluxing was 
continued for 30 min, and the mixture cooled, diluted with E t20  
(200 ml) and filtered. The filtrate was washed with H 20  and 
extracted with 2N HC1. Basification and extraction with E t20  
yielded, after drying and evaporation, an am ber oil (2.30 g), con­
taining two substances (TiLC) which were separated on a column of 
silica gel using CHClj as solvent. The first to be eluted was 10a 
(1.67 g, 36 % ), as an amber oil, Hydrochloride m.p. 124-125*'C from 
Me.CO - EtjO. Anal, for C mH 20N O 2C1 ; C,H ,N. The second com po­
nent gave 11 (0.20 g), colourless needles m.p. 129-130“C  from H 20  - 
EtOH. Anal, for C2(,HMN 2 ; C ,H ,N . The base, 10a, gave the methio­
dide, 7a, as colourless prisms m.p. 112-114°C decomp, from EtO H  - 
EtjO.
Ethyl 1,2,3,4- Tetrahydro- 6,7 -dimethoxy-2 -methylisoquinolin-1-yl- 
acetate (10b) was prepared as above (19 % yield) from 9b. The base, 
10b, gave the methiodide, 7b, as colourless prisms m.p. 172”C  from  
EtOH  - E t20  (lit.io m.p. 167-168"C).
12,3,4 - Tetrahydro-6,7- dim ethoxy-2- m ethylisoquinolin -1-ylacetic 
acid m ethiodide (28). The ester methiodide, 7b (20 g) was distilled 
with 5 %  w /v  HI (20 ml) over 1.5 h, replacing distillate with H 20  
to maintain levels, until 30 ml of distillate was collected. The resi­
due was triturated with AcMe - E.t20  to give a crystalline product
which was washed with AcMe - E l2Q, then ether, and dried. Crys­
tallisation from MeOH - Et20  gave 28 as colourless prisms (1.29 g), 
m.p. 183-185°C. Anal, for C .T M N O , ; C,H,N.
Ethyl 1,2,3,4-Tetrahydro-6,7-dim ethoxy-l,2-dimetliylisoquinolin-l- 
yl-acetate (10c) was prepared as above from 9c in 15 % yield. The 
M ethiodide, 7c, formed colourless prisms, m.p. 15'8-159“C  from  
EtOH - E l20 .  Anal, for C,sH2eNO,I ; C,H ,N.
1,10-D ecam cthy lenebis-N,N'~ (1-ethoxy carbonyhnethy I-1,2,3,4-te­
rra hydro-6,7-dimet hoxy isoquinoliniuni) dim ethiodide (24). A mixture 
of Zn powder (2.60 g, 0.04 mole), ethyl bromoacetate (6.68 g, 0.04 
mole) and 22 (3.88 g, 0.005 mole) in dry TH E (10 ml) was stirred 
and heated under reflux for 1 h, cooled, treated w ith H 20 ,  and 
extracted with CHOlj. Evaporation left a pale brown oil which was 
taken up in E l20 , filtered, and evaporated to leave the bis tertiary 
base, 23, as an oil. The oil was dissolved in CHjl (10 ml) and 
rcfluxed for 30 min. On cooling and dilution with Et20  to 150 ml 
a yellow solid separated (1.9 g, 39 % ). Pure 24, m.p. 80-110°C, was 
obtained by dissolving the solid in hot EtOH, filtering, and adding 
the solution dropwise to an excess of E t20 .  Anal, for C«Hsel2N 20s ; 
C,H ,N.
E thyl Phenyl (7,2 J,4-tetrahydro-6,7-diincthoxy-2-methylisoquino-
lin-l-yl)-acetate (12a). Ethyl phenylaeetate (4.0 g, 0.0245 mole) was 
added to a solution of N a (0.56 g, 0.0245 mole) in absolute EtOH  
(15 ml). The solution was refluxed for 10 min, cooled, 9b (8.12 g, 
0.0245 mole) was added, and the m ixture heated for an  additional 
10 min. The EtOH  was distilled, H aO (50 ml) added to the cooled 
residue, and the product extracted with Bt20  (100 ml). The Et20  
solution was extracted with 2N H O  (2 X 50 ml), the solution basi- 
fied with 2N N aOH and re-extracted with Et20 . Drying and evapo­
ration left a gum (4.28 g) which was crystallised (twice) from  Et20  - 
petrol (b.p. 40-60“C) to give the 12a (1.64 g, 18 % ) as colourless 
prisms m.p. 107-108"C. Anal, for C22H 22N 0 2 ; C ,H ,N. The m ethio­
dide, 13a, form ed pale yellow prisms, m.p. 116-119°C from  E tO H - 
Et20 .  Anal, for C2)H „ lN O ,; C,H,N.
Ethyl Phenyl (7,2,3,4-tetrahydro-2-methylisoquinolin-l-yl)-acetate 
(12b). T he crude product, prepared as above front 9a (5.46 g, 0.01 
mole) and ethyl phenylaeetate, was purified by passage through a 
column of silica gel using GHC1, as solvent, to give crystalline 
m aterial (1.95 g) which was recrystallised from  petrol (b.p. 40-60“C) 
to yield 12b as colourless prisms, m.p. 105-107“C . Anal, fo r CaiHu 
N O ;; C,H ,N. The m ethiodide 13b formed colourless prisms, m.p. 
144 145“C  from EtOH  - E t,0 . Anal, for C,,H»1N02 ; C,H ,N.
D iethyl 1,2,3,4 -Tetraliydro-6,7-d im ethoxy-2  - methylisoquinolin-1- 
ylm alonate (14a). 9b (6.66 g, 0.02 mole) was added to  a solution 
of diethyl sodio-malonate [prepared from  N aN H 2 (0.78 g, 0.02 mole) 
and diethyl malonate (3.20 g, 0.02 mole)] in dry TH E (25 ml). After 
refluxing for 30 min the solution was cooled and diluted w ith E t20  
to 150 ml, filtered, and evaporated to leave an  am ber oil. This was 
redissolved in Et20  (50 ml), the solution decanted from  insoluble 
m aterial and evaporated to leave 14a (4.12 g, 56 % ).
A ttem pted  M ethylation o f 14a.
14a (3.20 g) was dissolved in methyl iodide (15 ml) and allowed 
to stand for 3 h. Evaporation left a yellow semi-solid residue which 
was dissolved in hot EtOH . On cooling, the solution slowly deposited 
9b (0.95 g) as yellow prisms, m.p. 199-202°C decomp., undepressed 
on adm ixture with authentic m aterial. D ilution of the m other liquor 
with Bt20  gave a second crystalline fraction (1.26 g) which was 
recrystallised twice from  EtOH - E t2Q to give diethyl 4,5-dimethoxy- 
2(2-dim ethylam inoethyl)-benzylidene malonate methiodide, 18 
(0.70 g) as yellow prisms, m.p. 143-146“C. Anal, for C21H J21N06 ; 
C,H ,N.
D im ethyl 1,2,3,4-Tetrahydro-6,7-dim ethoxy-2-m ethylisoquinolin-1- 
ylm alonate  (14b) was prepared as for the ethyl ester from  dimethyl 
m alonate (2.64 g, 0.02 mole) and 9b (6.66 g, 0.02 mole), using 
N aN H 2 (0.78 g, 0.02 mole). The crude product was recrystallised 
from Et20  - petrol (b.p. 40-6D"C) to give 14b (2.37 g, 35 % ) as 
colourless prisms, m.p. 68-70“C . Anal, for C pH nN O t; C,H,N.
D im ethyl 1 ,22,4 - Tetrahydro - 2 - m ethylisoquinolin -1 - ylmalonate 
(14c) was prepared as above from 9a. The product crystallised from
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petrol (b.p. 40-60“C) to give 14c (80 % ) as colourless prisms, m.p. 
57 58"C. Anal, for C,sH „N 0 4 ; C,H,N.
/ ,2-Di-(plienylacetoxy)-ethanc (26). Phenylacetic acid (136 g) and 
clhyicne gjycoi (31 g) were healed with CiH6 (200 ml) containing 
HjSO« (0.5 ml) in a Dean-Stark apparatus untd no m ore H zO was 
formed. The solution was cooled, shaken with anhydrous N a2COj 
(20 g), filtered, and evaporated. The ester, 26, was crystallised from 
M eOH as colourless prisms (80 g, 54 % ), m.p. 45-46”C. Anal, for 
C „H ,,04 ; C,H.
3,6 - D iuxa-2,7 -d io x o -1,11-diphenyloctam ethylene- l,$ -b is { l \6 ’,7‘- 
dimeUioxy-l -2-3'-4'-tetraliydroisoquinoline)\ (2 /) and J,6-Dioxa-2,7- 
aioxo-l fi-dipheriytoclamcthyiene-i ,ts-bis If (0 ,/  -ilimethoxy-1 ’2 , 3 , 4 ’- 
tetrahydroisoquinolinium)] dnnetliiodidc (25). l,2-Di-(pnenytaceio- 
xy)-etnane ( i t.92 g, o.Orn moie) in diy r f tF  (40 m l; was stirred 
and reuuxea with N aN U 2 (f.ao  g, O.oh mole) to r 30 min, cooled, 
vt) (1.1.32 g, 0.04 mole) adaed, and heated for a  further 30 mm. 
A fter cooung, the mixture was diluted with E t2U ( to o  ml) and  filte­
red using m ore ii t20  (150 mi). The E t2(J solution was washed with 
H 20  and extracted with 2M HOI (2 X 25 ml), the acid extract reba- 
sitied with 2N N aO H , re-extracted with etner, dried and evaporated 
to leave an oil (6.24 g). This oil was taken up in JL'HiF (25 ml), 
retreated with NaNFL (0.48 g, 0.0124 mole) and then with 9b 
(4.13 g, 0.0124 mole) as above. A lter extraction as above, th e  gum 
(4.5 gi was chrom atographed on a column ot silica gel with CHClj 
as soivent, giving a gum (3.3y g) which solidified on trituration with 
Et20 - p e t r o l  (b.p. 4U-60‘'C). Kecrystallisation from C H O lj-petro l 
(b.p. 8u-100“C) gave 27 (0.67 g, 2.3 %  overall) as colourless prisms, 
m.p. 134-135"C (decomp.). Anal, tor C«H«N20« ; C,'H,N. The dime­
thiodide, 25, form ed a  pale yellow powder, m.p. 145-147"C, from 
EtOH  - Et20 .  A nal, for C „H 5,12N 20 , ; C ,H ,N.
E thyl 3[2-(2- D im ethy laminoetliy I)-4,5-dim ethoxy phenyl]-aery late 
(8b) hydriodide. A solution, 7b (0.5 g, 1.15m mole) in H 20  (20 ml) 
was basified with 2'N NaOH (2 ml). The oil precipitated was extrac­
ted with EhO, and the EtjO solution washed with H 20 ,  dried, filte­
red, and saturated with dry HI. The dark brown precipitate was 
recrySta'ilised from  E tO H  - E t20  to give 8b hydriodide (0.31 g, 62 %) 
as pale yellow plates, m.p. 178-180"C. Anal, for C ^H ^IN O ,; C,H,N.
3 [4,5 - D im ethoxy -2-12- dim ethylam inoethyl) - phenyl]-acrylic acid 
hydriodide (29). The methiodide, 7b (2.0 g, 4.6pi mole) was heated 
with 5N NaO H  (5 ml) until homogeneous (15 min). After cooling 
and dilution with H 20  to 20 ml the solution was acidified with 55 % 
aqueous HI, giving a brown solid (2.12 g). Recrystallisation from 
aqueous Me*CO gave 29 (1.12 g, 60 % ) as pale yellow prisms, m.p. 
230-23 T'C (decomp.) lit.16 232-234”C.
Ethyl 2 - P henyl-3- [4,5-dim ethoxy -2-(2 -dim ethylam inoethyl) -phe- 
nyl]-acrylate (30). The methiodide, 13a (0.79 g) suspended in H 20  
(25 ml) was treated w ith 2N NaOH (5 ml), and the product extrac­
ted with ether (50 ml), shaking well for 5 min. The ether layer was 
washed, dried, evaporated, and the residue crystallised by trituration 
with petrol (b.p. 40-60°C) to give 30 (0.33 g, 56 % ) as colourless 
prisms, m.p. 80-81°C. The hydrochloride gave colourless needles, 
m.p. 168-170"C, from EtOH - EtjO. A nal, for CuHi„G1N04 ; C,H,N.
H ofm ann elimination studies. UV spectra were recorded on an 
autom atic recording spectrophotometer (Unicam SP 800), using the 
« fast scan » mode, commencing at the long wavelength end of the 
spectrum. Solutions were prepared by adding u /15  phosphate buf­
fer, pH 7.4, to the compound (0.5 — 1.0 mg, accurately weighed), 
and adjusting to 25.00 ml with buffer. Bisquaternary salts were dis­
solved in EtOH  (1 ml) before adjusting to volume with buffer solu­
tion, since in buffer alone the rate of dissolution was very slow. The 
effect of the EtOH on pH was negligible.
Neuromuscular blocking potency.
(a) Eat phrenic-nerve diaphragm. D uplicate preparations from 
male Wistar rats (130-150 g) were set up as described by BiiLBRlNG
(35) in parallel in K r e b s -ZHe n s e l e i t  (36) solution (100 ml), bubbled 
with oxygen containing 5 % C 0 2 and maintained at 35°G. The 
phrenic nerve was threaded through a thin rubber diaphragm into 
a small glass tube filled with solution and containing one electrode, 
the other electrode being in contact with the bath fluid. Maximal 
twitches were produced by stim ulation at supramaximal voltage,
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using square wave pulse of 0.2 m sec duration for the nerve and 
2 m sec for the muscle, normally at a frequency of 1 shock per 
5 sec. Contractions of the diaphragms were recorded by isotonic 
levers on a smoked drum .
(b) Cat gastrocnemius muscle - sciatic nerve. Cats of either sex, 
weighing between 2.8 and 4.2 kg were used. Anaesthesia was indu­
ced was induced with 4-8 % halothane and maintained with chlor- 
alose (60-80 m g/kg  i.v.) after cannulation of a jugular vein. The 
right sciatic nerve was exposed between the thigh muscles, crushed 
centrally and placed on  shielded bi-poiar platinum  electrodes. The 
hind limb was fixed securely to a rigid fram e by a  steel drill through 
the tibia o r femur at the knee and a clamp at the ankle. The limb 
was m aintained at 37l,C  by radiant heat. T he tendon of the right 
gastrocnemius muscle was cut and attached to a Grass F T  10 
force displacement transducer. The sciatic nerve was stim ulated at 
a frequency of 0.1 H z with rectangular pulses of supramaximal 
voltage and 0.05-0.1 m  sec duration. Recordings wore made on a 
Beckman type R Dynogriuph. The oesophagal tem perature was m oni­
tored with a termistor probe (Yellow Spring Instruments) and body 
tem perature was maintained at 36-37!>C w ith a tem perature con­
troller and rectal probe (Southern Scientific). Drugs were given i.v. 
and, during neurom uscular paralyses, the lungs were ventilated 
with air using a Starling Ideal pump (rate 20/m in, tidal volume 
40-50 ml) ; arterial blood-gas tensions were maintained within 
norm al limits. Test drugs were com pared ( + ^tubocurarine chloride.
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R e s u m e
Une nouvelle approche pour la preparation d’agents bloquants 
neurom usculaires a action courte esl examinee. Ei'le est modelec 
sur la  degradation simple solon H o f m a n n  de 1’alcaloi'de quater- 
naire petaline, 5. Une serie de composes de I’ethoxycarbonylniethyl- 
1-tetrahydroisoquinolinium et poly methylene b i.v-et hoxyca r bony 1- 
methyl-1 -tetrahydroisoquinolinium a ete preparee. Ces composes 
ont des effets bloquants neuromusculaires faibles, et subissent seu- 
lement une elimination partielle suivant H o f m a n n  in vitro a pH  
physiologiquc. Les produits d ’elimination subissent une retro-rCac- 
tion d ’HoFMANN, et un equilibre avec le sel quatem aire s’etablit 
lenlement.
ZUSAMMENFASSUNG
Ein neuer Weg zur Herstcllung von im Stoffwechsel abbaubaren, 
kurz wirkenden neurom uskular-blockierenden Verbindungen wurde 
untersucht, der auf dem leichten Hofm ann'schen Abbau des qua- 
ternaren Alkaloids Petalin 5 basiert. Eine Reihe von l-E thoxycarbo- 
nylm ethyltetrahydroisochinolinium - und Polymethylen-bis-1 -ethoxy- 
carbonylmethyltetrahydroisochinolinium- Verbindungen wurde her- 
gestellt. Die Verbindungen hatten nur geringe neuromuskular- 
blockierende A ktivitat und unterlagen in vitro bei physiologischem 
pH nur einer unvollstiindigen Hoffmann-Eliminierung. Die Elimi- 
nierungsprodukte gehen eine retro-H offm ann-Reaktion ein und das 
Gleichgewicht mit dem quaterniiren Salz wird nur langsam erreicht.
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Biodegradable neurom uscular blocking agen ts  
IL Quaternary ketones
John B. S t e n l a k e .  John U r w i n  and Roger D. W a ig h  (* )
D epartm ent of Pharmaceutical C hem istry, University o f  Strathclyde, George Street, Glasgow, G l IX IV , Scotland.
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Q uaternary l-phenacyl-l,2,3,4-tetrahydroisoquinolinium salts underw ent reversible H ofm ann elimination at pH 7.4. The extent of eli­
m ination (up to 90 % ) was dependent on the nitrogen substituents (Me, E t or decainethylene), and the rate of elimination was largely 
governed by the phenacyl ring substituents (H, OMe or Cl). A lthough H ofm ann elimination in some cases proceeded very rapidly in 
buffer at pH 7.4, the compounds were long-acting neurom uscular blocking agents and of low potency.
W e have outlined the rationale behind a new approach 
to the preparation of short-acting neuromuscular blocking  
agents, based on Hofm ann elim ination at physiological 
pH  (1). In that paper we described the preparation and 
properties of esters such as 1, w hich show moderate neuro­
muscular blocking activity, w ith a slow  but reversible 
H ofm ann elimination at pH 7 .4 . With the objective of 
improving the rate and extent o f Hofm ann elimination, 
and hence shortening the block, we have now extended  
the study to the phenyl ketones, 2, which show a resem­
blance to  laudexium, 3, .a long-acting but otherwise effect­












The methylene protons adjacent to the oarbonyl group 
are more acidic in the ketones than in the esters tested  
previously. Hence, m ore rapid H ofm ann elimination was 
anticipated. The acidity of these protons can also be 
influenced by alteration of the substituents on the phenyl 
ring, so that, additionally, the rate of Hofm ann elimina­
tion can be manipulated in this way.
CHEM ISTRY
A  series of monoquaternary salts, 7 , in which the ring 
and nitrogen substituents were varied, were first prepared 
as model com pounds. The tertiary bases, 6, were synthe­
sised by base catalysed addition of substituted aoetophc- 
nones, 4, to 3,4-dihydroisoquinOllinium methiodides, 5 (3, 
Scheme 1) and the method was later applied to decam e- 
thylene h/s-isoquinolines without difficulty. Quaternisa- 
tion o f the bases with methyl iodide proceeded normally, 
except in the case of the sim plest derivative, 7a, where the 
crude salt appeared to  have the correct structure, but on
(*) Present address 
M anchester.
D epartm ent of Pharm acy, University of
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crystallisation from n-propanol underwent spontaneous 
Hofmann elimination to give the methine base hydrio­
dide, 8 . Attempted quafemisaition of the b/j-isoquinoiines 








pound bv comparison with a spectrum of the methine base 
obtained by treating an aqueous solution of the quater­
nary salt with a slight excess of sodium hydroxide. Under 
these conditions of high pH, Hofmann elimination was 
immediate, as with the esters investigated previously ( 1) 
and was assumed to be complete, since in cases where the 
methine base was isolated and characterised, the uv spec­
trum was identical with that obtained as described.
It may be seen from Table I that Hofmann elimination 
was much more rapid with the ketones than with the 
esters tested® previously (data for the ester, 1 , are given 
for comparison). Compounds 2 a -d  were all of low potency 
when tested on the rat phrenic nerve-diaphragrn prepara­
tion, and, despite rapid and almost compHtete (90 %) 
Hofmann elimination showed no evidence of being short- 
acting. Their action, however, was not antagonised by 
physostigmine.
TABLE I
b OMe OMe Mo Me
c OMe H Me Me
d Cl H Mo Me
e OMe OMe Et Me
I  OMe OMo Et Et
Scheme I
HOFMANN ELIMINATION STUDIES 
AND PHARMACOLOGICAL RESULTS
Uv spectra were used to follow the Hofmann elimina­
tion (Scheme 2) in buffer at pH 7.4, as described pre­
viously (I). The half-time to reach equilibrium and the 
percentage elimination (Table 1) were based on visual 
estimates from the uv speotra. The extent of elimination 
was judged after equilibrium was reached for each com­
COMPOUND
HOFMANN ELIMINATION 










1 30 20 1.7
7a * 4 10 -
b 4 10 -
c 3.5 10
d 1.5 IS
c 7.5 55 -
f 1.5 25 -
To 5 90 1.3
b 7 90 0.7
c \ 1 90 0.7
d 2.5 90 0.5
(*) Rat phrenic nerve - diaphragm preparation.
(*) C rude m aterial. A ttempts to recrystallise this materia! resul­
ted in its conversion to the isomer 6.
.NMe.
Clearly, the effect of electron-donating (OMe) groups 
liais a retarding effect on the rate of Hofmann slimination, 
whereas an electron-withdrawing (Cl) substituent increases 
the rate of elimination to a poin't where, if elimination 
were complete and the other requirements for potency 
were satisfied ( 1) neuromuscular block would he very 
short. lit has thus been shown that Hofmann elimination 
is in theory a viable basis for shortening drug action, and 
that compounds which undergo rapid Hofmann elimination 
in buffer at pH 7.4 are not necessarily too unstable to be 
obtained in a pure state.
The effect of increased bulk at the quaternary centre was 
inanity to increase the equilibrium concentration of methine 
base, an effect which is understandable since steric 
strain will be relieved in the opcn-ohain form. It seems 
probable that the quatermisalbion of the decamethylene bis- 
isoquinolines with ethyl iodide, which failed, would have 
given compounds exhibiting virtually complete elimination 
at pH 7.4. Many attempts at quiaternisatiion of similar 
bases with ethyl iodide 'have also failed (4), apparently 
because the relatively slow rate of quatemisation allows 
•the base present in solution to catalyse the Hofmann 
elimination of any quaternary salt formed, giving a mixture 
of products.
In order ito be certain that these ketones, like ithe 
esters (1), undergo a reversible Hofmann reaction, we 
studied the behaviour at pH 7.4 of the methine base 
obtained by treatment of 7b  with excess NaOH. As exipecit- 
I ed, the spectuim of the methine base changed on standing 
in buffer pH 7.4 and after equilibration was identical 
with that obtained directly from the quaternary salt in ithe 
I region above 250 nm unaffected by the anion, the equrli- 
> brium position corresponding to about 10 % elimination.
EXPERIMENTAL
Melting points were obtained on a Kofler hot-bench, and are 
corrected. A nalytical results (C,H,N) were within ±  0.3 % of theo­
retical. Ir and proton NM R spectra were obtained for each com­
pound and were in accord with the structures given.
J ,4-I)ihydroisoquinolinium Salts S. 3,4-'Dihydroj6,7-dimethoxy-2- 
isoquinolinium iodide, 5 (R3 =  M e) and decamethylenebis (3,4- 
dihydro-6,7-dimethoxyisoquinolinium iodide) were prepared as des­
cribed previously (1). A solution o f 3,4-dihydro-6,7-dimethoxyisoqui- 
noline (32 g) in EtO H  (50 ml) and ethyl iodide (50 ml) was kept 
at room tem perature overnight, then diluted with B t,0  to  500 ml. 
Recry st alii.sation of the precipitate, from  EtOH-EtjO gave 5 (R-Bt) 
(51 g, 87 % ) as yellow prisms, m.p. 188-189°C. Anal, for 
I  C „H „N O d ; C .II.N .
|  2-A lkyl-1 ,2,3,4-tetrahydro-6,7 -d im eth o xy-1 -phenacyltsoquinolines
6. These compounds were prepared by condensing the appropriate 
acetophenone 4 and 3,4-dihydroisoquinolinium salt 5 in the pre- 
I  sencc of alkali, by the general method 3 (Table II). Anal, for 
|  CnHjnNOsCh, 0.5 HjO ; C.H.N.
i  2,2-Dialky 1-1,2,3,4-tetrahydro-6,7 -dimethoxy-1-plienacylisoquinoli-
t;. niuin iodides 7. A solution of the te r tia ry  base, 6 (1.0 g) in the 
I  alkyl halide (5 ml) was allowed to stand at room temperature. 
1 A fter 15 min (24 h when using e th y l iodide), other (75 ml) was 
if| added to precipitate the crude product. Recrystallisation gave the 
111 pure isoquinolinium salts (Table HI), except in the case of 7a. In
TABLE H
6 m.p. m.p. of HCI sail
R1 R2 R3 Found lit.3 Found lit,3
H H Me 80° 80 - 81° 150°
OMe OMe Me oil 120 - 122° 120°
OMe H Me 84° 91 - 92° 120°
Gl H Me 104 - 105° 106 - 107° 151 - 152°
OMe OMe El oil 124 - 126° *




Solvent Formula (Anal. C,H,N)
£ C2lH26NCy
b 146 - 150° MeOH —  EtjO C23H30NO5 ''JH2°
139 - 145° n-PrOH C22H28N04 1
d 140 - 148° EtOH —  Et?0 C21H25N03CI 1
« 180 - 182° CHCIj —  EtjO C24H32NOs'
f 123 - 125° n-PrOH S5H m n o 5 «.h2o
(*) See text.
this case, the crude product appeared to have the required cyclic 
structure. However, recrystallisation from n-PrQH  gave the isomer 
2 -(2-dlm cthylam inocthyi>- 4,5 - dim ethoxybenzylidene-acetophenone  
hydriodide, 6, as a bright yellow powder, m.p. 250-252°C. Anal. 
for C2,H«NO>I ; C,H,N.
H ojm ann reaction o f 1,2,3,4-tctrahydro-6,7-dim ethoxy-2,2-dime- 
thyl-1 -(3,4-dimethoxyphenacyl) isoquinolinium iodide 5b. A suspen­
sion of the quaternary salt (3.00 g) in w ater (25 nil) was basified 
with 2N sodium hydroxide (10 ml). After shaking thoroughly, the 
mixture was extracted with ether (150 ml total) which was washed 
with water, dried (iN«2S 0 4), and evaporated to leave an am ber oil 
(2.09 g). With ethereal hydrogen chloride this furnished 2-(2-dime- 
thyknninoethyl)-4,5 - dim ethoxy benzylidene - 3,4 dim ethoxy acctophe- 
itone hydrochloride which formed pale yellow prisms (1.23 g, 
5 0 % ), m.p. 178->181°C, from ethanol/ether. Anal, for C2,H raN O sCl, 
0.5 H 20  ; C,H/N.
D ccametliylenebisll-phenacylisoquinolinium iodides) 2.
Example : decamethylenebis(l ,2,3,4-tetrahy dro-6,7-dim cthoxy-2 ~ 
methyl-1 -(3,4-dimethoxyphenacyl) isoquinolinium iodide) “2c. 3N 
N aOH (3.85 ml) was added to a solution o f dccamethylencbis(3,4- 
dihydro-6,7-dimethoxyisoquinolinium iodide) (5.00 g) and aceto- 
veratrone (2.90 g) in methanol (50 ml). T he solution was kept al 
room tem perature overnight, then evaporated. The residue was 
digested with ethyl acetate (100 ml), which was w ashed with 
brine, dried (N a2SO<), and evaporated to leave an am ber gum
I l l
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(6.22 g). This material was purified, using a colum n of neutral alu­
mina and ethyl acetate as eluting solvent, to give the bis(tertiary 
base) (4.00 g, 71 %) as an am ber o i l  A solution of this m aterial 
(1.00 g) in chloroform  (3 ml) and methyl iodide (3 ml) was allowed 
to stand at room  temperature overnight, then diluted with ether 
(150 ml). The precipitated solid was dissolved in hot ethanol (15 
ml) and this solution was filtered and added dropwise to ether 
(150 ml). The precipitated solid was collected, washed with ether, 
and dried to give decamethylenebis( 1,2,3,4-tetrahydro-6,7-dime- 
thoxy-2-metbyl- l-t3,4-dliirnetJhoxypihienacyl) isoquin olimium iodide), 
2c (see Table IV) as a pale yellow powder. The other compounds 
in the series were prepared and purified similarly.
T A B L E  IV
2 m.£. Formula (Anal. C,H,N) Yield (%)
« 148 - 150° C50H66N2°6,2 2H2° 51
b 154 - 158° C52H70N 2°8,2 H2° 42
- 140 - 142° C54H74N2°10,2 H2° 45
d 139 - 142° C50H64N 2O6C,2l2 H2° 43
Re su m e
Les sels quaternaires de phenacyl-l-tetrahydro-1,2,3,4-isoquinoli- 
nium subissent une elimination d’H ofm ann reversible it pH  7,4. Le 
degre d’elimination (jusqu’a 90 % ) depend des substituants de 
l’azote (Me, Et ou decamethylene), et la vitesse d’elimination depend 
largement des substituants du cycle phenacyle (H, OMe ou Cl). Bien 
que I’elimination d ’Hofmann se fasse, dans certains cas, tres rapi- 
dem ent dans un tampon it pH 7,4, les composes sont des agents 
bloquants musculaires ii action longue et puissance faible.
Z usa m m en fa ssu ng
Q uaternare 1 -Phenacyl- 1,2,2,4-tetrahydroisochinolinium -Salze 
unterliegen bei pH 7,4 einer reversiblen Hofmann-Elim inierung. 
Das AusmaB der Eliminierung (bis zu 90 % ) hangt von den 
Substituenten am  Stickstoff (Me, Et oder decamethylen). Die 
Geschwindigkeit der Eliminierung wird weitgehend beeinfluB durch 
die Substituenten am Phenacylring (H, OMe oder Cl). Obwohl 
die Hofmann-Elim inierung in cinigen Fallen im Puffer bei pH 7,4 
sehr schnell erfolgte, waren die Verbindungen von langdauernder 
neurom uskuliir blockierender W irkung und geringer Aktivitat.
H o fm a n n  elim ination  'studies were carried out as 
previously described (1). 
N eurom uscu lar blocking  p o te n cy  was measured on ithe 
rat phimnic nerve-diaphragm preparation as previously 
described (I ). 
A c k n o w l e d g e m e n t s . —  W e thank the U .K . Medical 
Research Council for financial assistance.
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Biodegradable neuromuscular blocking agents.
Part 3. B is-quaternary  e s te rs
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(Received Novem ber 26, 1980)
Two series of bis-quaternary am monium salts bearing ester carbonyl moieties adjacent to the (1-carbon of the ammonium group and 
designed to undergo Hofm ann elimination in vivo have been synthesised and tested as potential neurom uscular blocking agents in cats. 
Variations in duration of action, potency and vagal block are reported and related to  structure.
In previous papers (I , 2 ), we have outlined our ideas 
for producing biodegradable neuromuscular blocking  
agents by utilising the rapid Hofm ann elimination of 
certain quaternary am m onium  salts to bring about their 
destruction in  vivo  w ithout the intervention o f enzymes. 
Our earlier efforts were unsuccessful ( 1 , 2 )  because after 
Hofmann elimination, both m oieties remained attached 
(o the sam e residue, and an unpredicted retro-reaction 
occurred to re-form the quaternary salt, producing an 
equilibrium mixture with a long duration of action.
Two ways of overcom ing the problem, w hile retaining 
the same theoretical basis o f Hofm ann elimination in bis­
quaternary ammonium salts, are represented generally 
for the esters in Schemas 1 and 2. In Schem e 1, w e utilised  
two tetrahydroisoquinoline units linked through the 
1-position, in the hope o f obtaining potent non-depola­
rising agents by analogy with som e AW-linked com pounds
(3). Unfortunately, the bis-quaternary salts 1 that we 
obtained were not short-acting, perhaps because of ester 
hydrolysis, which slows H ofm ann elimination and leaves 
the quaternary centres intact. The products also showed  
vagal blockade. We, therefore, concentrated our efforts 
on a thorough investigation of salts having the basic struc­
ture o f Schem e 2. This offers the advantage that ester 
hydrolysis also destroys the bis-quaternary structure to 
give two mono-quaternary structures which would be 
expected to have negligible paralysing activity, as in 
Suxamethonium.
(*) A uthor to whom correspondence should be addressed.
(**) P resent address: D epartm ent of Pharm acy, University of 
M anchester.
(***) P resent address : School of Pharm acy and Pharmacology, 
University o f Bath.
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Scheme 2 
CH EM ISTR Y
The salts, la - I d  and 7a-7f, were prepared by the routes 
shown in Schemes 3 and 4  respectively. These salts arc 
quaternary derivatives o f M ichael addition products 
between bis-am ines, 2 , and methyl acrylate (Schem e 3), 
or certain m ono-am ines 4  and ethylene glycol diacrylate, 3 
(Schem e 4).
The necessary 1-substituted l,2 ,3 ,4-tetrahydro-6,7-d im - 
ethoxyisoquinolines 2 were obtained by Bischler N apie- 
ralski (4 , 5) cyclisation of appropriate amides 12 to 3,4- 
dihydroisoquinolines 13, followed by sodium  borohydride 
reduction. Tetrahydropapaverine, 4  (R =  3,4-dim ethoxy- 
benzyl) Was prepared by a m odification (6) o f the method 
described by T a y l o r  (7) in which papaverine is reduced 
by zinc and hydrochloric acid. 1,2 ,3,4-T etrahydro-6,7- 
dim ethoxyisoquinoline 4  (R =  H ) was prepared by a 
Pictet Spengler (8, 9) synthesis using hom overatryl- 
amine hydrochloride and formaldehyde. In som e initial
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M O jN C lljC H , c  0  — ^   CO ClIjCH ;
■ ' H .’„
MeO
MeO
R2M eN CH 2CHjCO OCH jCH iO CO CH jCH jN M eR,. 21 
(11a, R =  Me)
(11b, R =  Et)
experiments, an excess of form aldehyde was em ployed  
in this preparation and, under these conditions, basification 
of the mixture at the end o f the reaction gave only bis- 
(l,2 ,3 ,4-tetrahydro-6,7-dim ethoxvisoquinolin-2-yl)m ethane. 
This gem -diam ine has been previously reported (10) 
from an alternative synthesis. Its formation was avoided in 
the present work by maintaining acidic conditions (11)  
throughout the preparation.
M ichael addition o f all secondary amines to appropriate 
acrylate esters proceeded sm oothly to yield the corres­
ponding tertiary amines, 5  and 6. T he M ichael bases, 5 
and 6, were quaternised by methyl iodide to the corres­
ponding salts, and the bis-am ine (6a , Scheme 4) was also  
successfully quaternised by allyl bromide to give com ­
pound (7b, Schem e 4). Successful quaternisation of M an- 
nich and M ichael amines (where a carbonyl function is 
positioned P to the amino group) by methyl iodide is w ell 
docum ented (1, 2, 12-14). Less reactive alkyl halides than 
methyl iodide and m ore reactive, but bulkier, halides, such 
as benzyl bromide (15), may quaternise such bases with  
accom panying in situ  Hofm ann elim ination, quaternised 
m olecules in the system being H ofm ann-elim inated by the 
basic, unquaternised amino functions still present
T he factors affecting the incidence o f such in s itu  elim i­






quaternised, the steric requirement (16 ) and reaotivity of 
the alkylating agent, and the acidity of the (3-protons in the 
resulting quaternary compound. The importance o f steric 
features in the alkylating agent is illustrated from our 
attemps to quaternise M ichael amines w ith benzyl bromide. 
T hese have repeatedly shown in situ  H ofm ann elim ination 
whereas allyl brom ide, with relatively unhindered amines 
at least, has shown no such tendency, despite the fact that 
the former is reported to be three times m ore powerful as 
an alkylating agent than the latter in other system s (15). 
W here the fi-proton in the resultant quaternary is parti­
cularly acidic, in  s itu  elimination even accom panies qua- 
ternisation using methyl iodide arid other powerful 
methylating agents such as dimethyl sulphate and methyl 
methanesulphonate. Thus, the bis-am ino diketone, 8 , gave 
tetramethylammonium iodide and trimethylainm onium  
iodide as the only nitrogenous products on treatment 
with methyl iodide (17). Similar results w ere obtained  
with methyl m ethanesulphonate. W e have also found that, 
to a limited extent, elim ination can accom pany the quater­
nisation of sterically-hindered 1-benzyltetrahydroiso- 
quinoline bis-am ines, such as 6d, w ith methyl iodide and
1 1 4
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methyl m ethanesulphonate, and precautions have to be 
taken to minimise this tendency by using a large excess 
of methylating agent.
It is clear that where in  situ  elimination accom panies 
quaternisation o f bis-amine M ichael addition products, 
the resultant mixture is com plex. Com plete Hofmann 
elim ination of the pure bis-quaternary salts, 7 , however, 
will give exactly two m ole equivalent o f tertiary amine and 
one m ole equivalent of acrylate. Such decom position 
has been applied in the characterisation of 7e using 
thin-layer and gas-liquid chromatography.
PH AR M A C O LO G IC A L R ESU LTS A N D  DISCUSSION
Neurom uscular blocking potency and the extent of 
vagal block were measured in anaesthetised cats. The 
results are given in Tables I and II. Potencies of the ato-bis- 
isoquinoilin-l-ylailkanes (1, Table I) were consistently of
TA BLE II
Mean neuromuscular blocking potencies and vagolytic effects o f
1,10-bis-amino-4,7-dioxa-3,8-dioxodecanc quaternary salts,
7 and  11, in cats
c ° T r " b I tic k in g  po tency*
,.D50> v n jo 4 vi»50/ | , u50
Z£ 6 (a)* 2 .2 a .  2 1 .0
5 c f e 0 .5
1 2 12) U»i 1 .9 i
<j 1 5 (2 ) X.V v .o ‘>-7
r $ 0 (2 ) 0 .  $6 2 .6 7 .2
l l a V20*(3) - -
!l 17 (2 ) O. VC* 2 .V 5 .2
Schem e 4
' Tubocurarine =  100.
2 No. of animals.
‘ Dose in  m g/kg  iv producing 50 % neurom uscular blockade.
* Dose in m g/kg iv producing 50 % vagal blockade.
* N o block recorded at doses up to 2 m g/kg.
‘ Relative to Suxamethonium Chloride ; depolarising block as con­
tracture on isolated chick biventer-eervicis preparation.
TABLE I
M ean neuromuscular blocking potencies and vagolytic effects o f o.<o-bis[l,2,3,4- 
tetrahydro-6,7-diinetlioxy-2-(2-metlioxycarbonylethyl)isoquinolin-l-yl]alkane 
dim ethiodides  1 in cats
C om pound "
R e l a t i v e  m o l a r  n e u r o m u s c u la r  
b l o c k i n g  p o t e n c y 1
PD 503 VI) 5 0 4 V D S O / ^ o
I n /| 0S( 2 ) 2 - V. 6 -
l> 6 2 0 ( 3 ) 0 . 0 6 3 . 1
c 0 2 0 ( 2 ) 0 .8 V 1 .6 1 - 9
& 10 2 2 ( 2 ) 0 . 7 7 1 .6 2 .  1
1 Tubocurarine =  100.
2 N o. of animals.
5 Dose in m g/kg iv producing 50 % neurom uscular blockade.
4 Dose in m g/kg iv producing 50 % vagal blockade.
5 N o block recorded at doses up to 4 m g/kg.
4 Calculated by extrapolation.
-  — — v ; r  r  r
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a low level. Com pound la  was inactive in cats as a neuro- 
muscular blocking agent, while compounds lb - ld  all 
had similar potencies about 20  %  of that of Tubocurarine. 
On the other hand, vagal blockade was greater in the 
longer chain com pounds, 1c and Id , than in lb .
In view o f the substantial anticholinesterase activity 
( 18) of the related com pound 9, the pharm acological 
observations in the present series may be the result of 
som e com plex pharm acodynamics. A lso, in v ivo  Hofm ann  
elim ination could occur stepwise. The resulting m ono­
quaternary com pound, 10, like Tubocurarine, would then 
possess substantial neuromuscular blocking activity. This 
factor could, therefore, contribute to the disappointingly 
long action of com pound lb  (recovery from onset of full 
block ca 70  min). Such a possibility is quite clearly much 
less likely in com pounds which fragment according to 
Schem e 2. and consequently w e have directed the bulk 
of our efforts in that direction.
Several com pounds, which formally accord with the 
bis-quaternary structure in Schem e 2 have already been 
described (14, 19, 20). The reversed succinylcholine ester, 
11 a, has been reported to be m ore potent than Suxame­
thonium (19). This has been confirmed in the present 
work, and the com pound shown to produce a depolarising 
block with contracture in the chick biventer cervicis pre­
paration (Table II). Substitution of two methyls on each 
nitrogen by ethyl produced a non-depolarising agent, l i b ,  
as expected (21 , 22), but potency was reduced (19). There 
was also som e vagal block, one of the major disadvantages 
associated with most com petitive neuromuscular blocking 
agents (23).
Introduction of a 6 ,7-d im ethoxy-l,2 ,3 ,4-tetrahydroiso- 
nucleus in the bis-quaternary com pound, 7a, 
following the work o f T a y l o r  (3), resulted in a  duration 
of action (recovery from onset o f full block ca 14-20 min) 
shorter than that o f lb  and som e reduction in vagal 
blockade. Potency was also reduoed. Attempts to shorten 
duration of action in the (V-allyl com pound, 7b, as in 
Alcuronium  (24), resulted in com plete loss of activity, and 
an increase in vagal block. We, therefore, turned our 
attention to tetrahydroisoquinolines with a bulky 1-substi­
tuent (Table II), whioh in earlier work had reduced side- 
effects while maintaining potency (25). Of the three substi­
tuents used, the 3,4-dim ethoxybenzyl group, as in 7e, gave 
by far the best results with respect to potency and a wide 
separation between neuromuscular and vagolytic effects ; 
full recovery from onset of 100 %  paralysis occurred in 
20 min. Detailed accounts of the activity of this and close­
ly-related analogues and hom ologues arc presented in 
Part 4  of this series.
E X PE R IM E N T A L
Unless stated otherwise, melting points were recorded on a 
ICofler Heizbank 184321 melting point apparatus. Infrared spectra 
were obtained on a Perkin-Elmer 157 instrum ent using either 
liquid films or in KC1 discs (for solids). Proton magnetic resonance 
spectra were recorded on a Perkin-Elm er R12 instrum ent operating 
at 60 M Hz. TM S was used as internal standard. IR and proton
5 1 1
N M R spectra were in accord with the structures given and are 
available from  the authors (RDW and G HD ) on request. Micro- 
analytical results (CHN, except where otherwise stated) were 
within ±  0,4 % of theoretical.
N-[2-(3,4-Dimethoxyphenyljeihyllcyclopent-2-enylacelam idc
Homoveratrylam ine (19 g ; 0.105 mole) and cyclopent-2-enyl- 
acetic acid (12.6 g ;  0.1 mole) were heated together in an open 
vessel at 190-200° C for 2 h. The dark oil rem aining on cooling 
was dissolved in ethyl acetate, and the solution was then boiled 
with charcoal and filtered. To the filtrate, warmed to reflux 
tem perature, was added sufficient light petroleum  (b.p. 60-80° C) 
to deposit an almost black, viscous oil. The liquid was decanted 
from the oil and refrigerated for 18 h. T he amide  (11.3 g ; 39 %) 
crystallised as long, fine needles from light petroleum  (b.p. 40- 
60°C), m.p. 74°C. Anal, for C 17H„NO., : C ,H ,N.
N -l 2-(3,4-Dimethoxyplienyl)ethyll-2-pyridylacetamide
H omoveratrylam ine (11.9 g ;  0.066 mole) and methyl 2-pyridyl- 
acetate (10 g ; 0.066 mole) were heated together in an open vessel 
fo r 4 h. The dark oil was cooled and stirred with ether (100 ml). 
The pale yellow solid (14.5 g ;  74 %), m.p. 98-99°C, was filtered, 
dried, and crystallised from n-hexane —  ethyl acetate to give the 
amide as fine needles, m.p. 99.5-100.5° C  [Lit (26) 94-95°C].
NN-Bis-[2-(3,4 - dim ethoxyphenyl)ethyl]alkane - a.o-dicarboxamides 
12
The dicarboxylic acid diethyl esters (1 mole) were heated with 
homoveratrylamine (2.05 mole) at 180-190°C for 3 h. The Crys­
talline masses obtained on cooling crystallised from ethanol or 
aqueous ethanol as colourless needles. Relevant data are presented 
in Table III.
TABLE III
C om p o u n d m .p .
(°C >
%
Y i e l d
L i t  (2 7 )  
m . p .
1 2 a 1 6 2  -  1 63 5 6 1 6 9
L2 b 1 6 0 'tO 1 6 1
1 2 c 1 5 5  -  1 5 6 ' i l  ; 1 5 6
1 2 d ’ 1 5 2  -  1 5 3 8 1 1 5 5 -  1 5 6
* Synthesised from  decane-1,10-dicarboxylic acid.
aoy-Bis~(3,4-dihydro-6,7-dimetlioxyisoquinolin-l-yl)alkanes 13
The appropriate bis-amide (12, ca 7.0 g) in dry toluene (60 ml) 
was stirred under reflux with phosphoryl chloride (30 ml) for 1 h. 
The liquid was decanted from  the solid which precipitated on 
cooling. The solid, after washing with petroleum  ether (b.p. 40- 
60°C) and drying, was suspended in ethanol (25 ml), and basificd 
with sodium hydroxide solution (5N). Tire partially crystallised 
solid obtained on addition of water (ca 200 ml) was extracted 
with chloroform (2 x  100 ml). The com bined extracts were washed 
with water, dried (Na,SO,), and evaporated to  leave a yellow oil 
which solidified on  scratching. The percentage yields, crystallising 
solvents, and m.p.’s for the compounds arc presented in Table IV.
/  ,2,3,4-Tetrahydro-6,7-dim ethoxy-l-(2-pyridylm ethyl)isoquinoline
N - [2-(3,4- Dimethoxyphenyl)ethyl] - 2 - pyridylacetam ide (14.0 g ; 
0.047 mole) in dry toluene (60 ml) was refluxed with phosphoryl 
chloride (40 ml) for 3 h. The partially cooled reaction mixture 
was poured into light petroleum (b.p. 60-80° C ; 400 ml) and the 
liquid was decanted from  the semi-so>lid which precipitated. The 
precipitate was washed well with light petroleum  (b.p. 40-60°C), 
dried, and crystallised from  ethanol-ether to give 3,4-dihydro-6,7-
2325
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% Y ie ld  
f ro m  
Am i  d o , 1 2 ,
C r y s t a l l i s i n g m .p .
(°c )
j L i t .  
m .p
R e f .
13A 08 E t h y l  a c e t a t e 1 7 1 - 1 7 2 1 7 2 - 1 7 3 2 7
1 3 b 87 IH e x a n e  e t h y l  a c e t a t e 10 2 | 9 2 ?o
92 H e x a n e  e t h y l  a c e t a t e 1 1 5  ! 1 1 6 2 7
U* 9'» H e x a n e  e t h y l  a c e t a t e 1 2 0 - 1 2 1 1 1 7 - 1 1 8 2 9
M elting point data for the corresponding dihydrochlorides arc 
recorded in Table V. No attem pt was m ade to establish the stereo­
chemical composition (raeemate an d /o r meso form) of the salts.
TA BLE V
dim cthoxy -1 - (2 -pyridylmethyI)isoquinoline dihydrochiloride, m.p. 
203°C (d) [Lit (30) 207°C  (d)].
The above salt, in ethanol (60 m l ; 95 % ), was treated with 
sodium borohydride (4.0 g ; 0.11 mole) in portions over 1 h and the 
mixture stirred tor 18 h. The excess borohydride was destroyed by 
the cautious addition of dilute hydrochloric acid and the mixture 
evaporated to dryness in vacuo. The off-white crystalline mass 
rem aining was suspended in w ater (2U0 ml), basified with sodium 
hydroxide solution (5N), and the liberated am ine extracted with 
ether (2 x  200 ml). The com bined extracts were washed with 
water, dried (NajSO,), filtered, and treated with an ethereal hydro­
gen chloride solution. The solid obtained crystallised from metha- 
nol-ether in minute, colourless needles of l,2,3,4-tetrahydro-6,7- 
dim cthoxy-l-(2-pyridylmethyl)isoquinoline dihydrochloride (8.6 g ; 
52 % ), m.p. 189-190“C (d) LLit (30) ^ O - m 'C  (d)J. The free base 
was a pale yellow, viscous oil.
I -(Cyclopent-2-enyl m ethyl) - 1,2,3,4-tetrahydro-6,7-dim ethoxyisoqui- 
noline
N  - j 2 - (3 ,4  - Dimethoxypheny 1) ethyl J cyclopent- 2 - enylacctamide 
(10.0 g ; 0.035 mole) treated as described to r the preparation of 
1,2,3,4 - letrahydro - 6,7 - dim ethoxy -1 - (2 - pyridylmethyl) isoquinoline 
(except that oxalic acid solution replaced ethereal hydrogen chlor­
ide solution) gave the required amine oxalate (7.3 g ;  5 8 % ) as 
colourless, crystalline rosettes from  ethanol, m.p. 198°C. Anal, for 
CwHzjNOs : C,H ,N. The free base, obtained by ether extraction, 
was a colourless oil which partially crystallised on standing.
1 .2.3.4-T ctrahyclro-6,7-dim ethoxyisoquinoline
M cthylal (50 g ; 0.66 mole) was added to hom overatrylam ine 
(100 g ; 0.55 mole) in w ater (200 mi) and concentrated hydro­
chloric acid (60 ml), and the m ixture warmed on a boiling water 
bath for 8 h. Removal of solvents in vacuo gave a dark crystalline 
mass which crystallised as needles of l,2,3,4-tetrahydro-6,7-dime- 
thoxyisoquinolinc hydrochloride (110 g ;  8 8 % ), m.p. 256-257°C 
LLit (31) 253°C].
The free base, obtained by basifioation of the hydrochloride with 
sodium hydroxide solution, had m.p. 86°C [Lit (32) 84-85°C],
1.2.3.4- Tetrahydro-6,7-dim ethoxy-1 -(3 ,4-dim ethoxybenzyl) isoquino­
line (tetrahydropapaverine) was prepared as previously described 
(6).
m n-Bis-(l,2,3,4-tetrahydro-6,7-dimelhoxyisoquinolin-l-yl)alkanes 2
The appropriate dihydroisoquinoline, 13 (ca 1.0 g) in ethanol 
(20 m l ; 95 % ) was treated cautiously with sodium borohydride 
(ca 0.5 g) over 0.5 h. The m ixture was stirred for 2.5 h at room 
tem perature, and the excess borohydride destroyed with dilute 
hydrochloric acid. Ethanol was rem oved in vacuo, and the aqueous 
suspension basified with sodium  hydroxide solution. The liberated 
amine was extracted with chloroform  (2 X 50 ml), and the com b­
ined extracts washed with w ater, dried (Nu;SO<), and evaporated 
to leave the corresponding bis-amine, 2. All the products were 
colourless, viscous oils, and yields were 98-100 % of theoretical.
C om pound M o l t i n g  p o i n t  ( C ) a n d  
C r y s t a l l i s i n g  S o l v e n t
L i t  ( 2 9 )  
m .p .
a . 2 5 7 - 2 5 8  ( d ) 2 6 0 - 2 6 1  ( d )
( w a t e r )
2 b 2 6 0 - 2 6 3  ( d ) 2 6 4 - 2 6 5  <d)
( m e t h a n o l )
2 c 2 5 3 - 2 5 5  (c l) 2 5 8 - 2 5 9  t« l)
( a q u e o u s  e t h a n o i )
2d 2 2 7 - 2 3 0 2 3 2 - 2 ) ' t
( e t h a n o l )
Ethylene glycol diacrylate 3
Acryloyl chloride (31.8 ml ; 0.4 mole) in dry benzene (60 ml) 
was added over 0.5 h to a mechanically stirred mixture of ethylene 
glycol (12.4 g ;  0.2 mole), triethylam ine (60 m l; 0.4 mole) and 
pyrogaliol (0.1 g) in dry benzene (100 ml) at 5°C. A further quan­
tity of benzene (100 ml) and triethylam ine (10 ml) was added, and 
the mixture stirred at 50°C  for 0.5 h. F iltration and removal of 
solvent in vacuo gave a yellow oil which was distilled. T he fraction 
(17.6 g ;  5 2 % ), b.p. 118-121°C/25 mm Hg [Lit (34, 35) b.p. 66- 
6 8 °C /l-2  mm Hg and 75*‘C /1  mm Hg respectively), was collected 
as a colourless oil, using distillation apparatus protected from 
light.
1 ,lO-Bis-dimethylamino-4,7-dioxa-3,8-dioxodecane
A solution of dim cthylamine (3.53 g ; 0.078 mole) in dry ether 
(25 ml) was added during 5 min to a cooled, stirred solution of 
ethylene glycol diacryiatc (5.0 g ; 0.029 mole) in dry ether (25 ml). 
The solution was kept at room tem perature for 20 h and then 
evaporated to leave the bis-amine (7.65 ; 100 % ) as an  almost 
colourless oil.
The dimethiodide, l l a ,  was prepared by adding methyl iodide 
(10 ml) to a solution of the bis-amine (2.0 g ;  0.0077 mole) in 
methanol (20 ml). A fter 2 h, the m ixture was diluted with ether 
(20 ml) and the precipitate crystallised from m ethanol-ether to 
yield colourless needles (3.2 g ;  7 6 % ), m.p. 170-175°C [L it (36) 
182°C |. Anal. C ,J l raLN20 4 : C,H ,N.
1,1 Q-Bis-diethylatnino-4,7-dioxa-3,8-diaxodecane
A solution of diethylamine (5 m l ; 0.05 mole) in dry ether (5 ml) 
was added during 5 min to ethylene glycol diacrylate (2.0 g ; 0.012 
mole) in dry ether (10 ml) a t 0°C . T he mixture was stirred at 
room tem perature for 18 h, and then the solvent and excess diethyl­
am ine were removed in vacuo. l,10-Bis-diethylamino-4,7-dioxa-3,8- 
dioxodecanc (3.7 g ; 100 % ) was a pale yellow oil which showed 
a single spot on tic (Polygram Alox. N for t i c ; ethanobethyl 
acetate, 1:1, iodoplatinate spray re a g e n t; 37).
The Dimethiodide, l i b ,  was obtained by adding the bis-amine 
(0.4 g ; 0.0013 mole) in acetonitrile (5 ml) dropwise to refluxing 
methyl iodide (10 ml), and continuing reflux for 2 h. A ddition of 
ether (20 ml) gave an oil which crystallised from  ethanol as colour­
less crystals (0.63 g ; 83 % ), m.p. 143-144°C. Anal, for C,»H„LN;0 „  
0.5H20  : C,H,N.
1,10 - Bis -(1,2,3,4 -letrahydro -6,7 - dim et hoxyisoquinolin - 2 -y l) -4 ,7 - 
dioxa-3,8-dioxodecane 6a and 1-substituted derivatives 6b-6d
The following general m ethod for addition was em ployed. The 
appropriate secondary amine (ca 5.0 g ; 2 mole equivalents) and 
ethylene glycol diacrylate (I mole equivalent) in dry benzene 
(20 ml) were stirred for 48 h under reflux and excluding light. The
1 1 7
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solvent was rem oved in vacuo and the residual oil dissolved in 
chloroform  (15 ml). Ether (300 ml) was then added, followed by 
a saturated solution of oxalic acid dihydrate in ether (300 ml). The 
precipitated solid was filtered off, washed well with ether, dried 
in vacuo over PjOs, and crystallised from ethanol. Yields and 
melting points for the bis-amine oxalates, 6a, 6b and 6d, are pre­
sented in Table VI. The bis-amine oxalate, 6c, could not be crys­
tallised, and the crude am ine was used in the final quaternisation 
step. Bisamine, 6d, had m.p. 47-49°C (Rcickcrt’s microscopic mel­
ting point apparatus) and gave a dihydrochloride, m.p. 181-184°C. 
Anal, for C«H62C l2N 2O,s,H20  : C,H,N.
[A BLE VI
C o m p o u n d
D io x a l a t e  S a l t
94 Y i e l d
m .p .
( ° C )
6 n 6 0 2 0 2 .5 -2 0 * 1  ( d )
6 b 6 5 7 8 -8 8
6 d 6 9 1 2 4 -1 2 8
T he purified bis-amines were liberated by dissolving the oxalate 
salts in water, basifying with dilute sodium carbonate solution and 
solvent extraction. The corresponding meihiodicle quaternary salts, 
7u, 7c and 7c (Table VII) were prepared by dissolving the amine 
Ica 1.0 g) in chloroform  (10  ml) and adding methyl iodide (10 ml). 
A lter leaving for 20 h at room  tem perature, the filtered reaction 
mixture was added drop by drop to mechanically stirred, filtered, 
dry ether (ca 500 ml). The flocculent solid produced was filtered 
off, washed copiously with ether and dried. The solid was dissolved 
in methanol (10 ml) and re-precipitated by adding to mechanically 
stirred dry ether (500 ml). The ally! com pound, 7b, was prepared 
similarly, using allyl brom ide in place of methyl iodide. Methio- 
dide, 7d, was prepared using acetonitrile in place of chloroform. 
1 he mesylate salt, 7f, was prepared using freshly distilled methyl 
m ethanesulphonate in place of methyl iodide. Date relating to 
these salts are given in Table VII.
TABLE VII
C o m p o u n d X in .p .  
< °C )
94 Y i e l d M i c r o o n b l y s i s
— I 1 1 8 - 1 2 0 81 * 3 * H* A V «
C .H .N
7 b D r 9 6 - 1 0 1 77 C 36H 5 0 B r 2 N2 ° a ' Ha ° C .H .N
7c 1 1 3 3 - 1 9 9 90
c « H6 a 1 a N2 ° f l C .H .N
-
I S o f t e n s  a t  
19 0
20 *
C«.6H6 * W 8 C .l l .N
; ~
1 1 2 0 - l ‘JO 
( S o f t e n s  
a t  9 5 )
95 C5 oH66I z Na 0 12 C .H .N
7 £ CHjSO, 1 0 0 - 1 1 0 90 C 5 2 H „ N 2 ° l 8 S3,2U2 0 C .H .N
Crystallised from acetonitrile-— methyl iodide (1:1).
H ofm ann elim ination ■— gas chromatographic characterisation of 
com pounds 7e and 7f
Reference samples of methyl acrylate, ethyl acrylate, AW-dime- 
thylbcnzylamine and ethylene glycol diacrylate were applied in 
standard am ounts to a column of 10 % Carbowax 20M on Chro- 
mosorb W AW-DMCS (80-100 mesh) in a Perkin-Blmer F 1I fitted 
with a flame-ionisation detector and tem perature programmer.
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The quaternary salts, 7e and 7f, dissolved in chloroform (10 m g/m l) 
were treated with AW -dimethylbenzylamine in chloroform to ini­
tiate Hofinann elimination, and appropriate aliquots applied to 
the column. Methyl acrylate and ethyl acrylate applied to the 
column at 50°C had retention times of 0.75 and 1.1 min respecti­
vely. Ethyleneglycol diacrylate and the AW-dimcthylbcnzylamine- 
treated com pounds, 7e and 7f at column temperatures of 50“C 
held for 3 min and raised to 115°C at 20°C  per min had identical 
retention times of 6 .6  min.
aw - Bis - (1,2,3,4-terrahydro-6,7-dimethoxy-2~(2-methoxycarbonyl- 
ethyl) isoquinolin-l-yl)alkanes  5
The following general method was adopted. The appropriate 
ouo-bis-(l,2,3,4-tetrahydro-6,7-dimethoxyisoquinoIin-l-yl)aIkane (2 ; 
co 3.0 g) was refluxed with methyl acrylate (10 ml) for 2 h. The 
cooled reaction mixture was dissolved in ether (ca 50 ml), and 
filtered to remove traces of undissolved solid material. The ethereal 
solution was washed with dilute hydrochloric acid (IN  ; 2 x  30 ml) 
and the combined aqueous layers re-extracted with ether (50 ml). 
The aqueous layer was then basified with sodium  hydroxide solu­
tion (5N), and the liberated am ine extracted quickly with ether 
(2 x  100 ml). The combined extracts were washed with water 
(2 x  30 ml), dried (Na2SO«), and evaporated to leave the corres­
ponding ato - b is -(1,2,3,4-tetrahydro-6,7-dimethoxy-2-( 2-methoxycar- 
bonylethyl)isoquinolin-l-yl)alkane  5. Yields were 84-99 % of theo­
retical. The corresponding dimethiodides  ( la -Id  ; Table I), were 
prepared by the general method described above for the prepara­
tion of 1,1 0 -b is - (1,2,3,4-letrahydro-6,7-dimcthoxyisoquinolin-2-yl)-
4,7-dioxa-3,8-dioxodecane dimethiodide and 1-substituted deriva­




M i c r o a n o l y s  i s
C om p o u n d °C 94 Y i e l d F o r m u l a
I n 1 9 0 - 1 5 0 81
C36,V . 12N2tV H2 °
C .H .N
lb 1 3 0 -1 3 9 93 C30" 5 8 12 Na V H2° C .H .N
1c 1 2 7 -1 3 5 89 S o 1,62I2N20a C .H .N
I d 9 9 -1 2 1 79 C<.2H66X2W ° - 5V C .H .N
Neuromuscular blocking potency
Neuromuscular blocking potencies were determined on ca t gas­
trocnemius muscle-sciatic nerve preparations as previously des­
cribed (1). The results are given in Tables 1 and II.
Vagal block
Vagal block was determined in anaesthetized cats by periodic 
stim ulation of the cardiac stum p of the cu t right cervical vagus 
nerve (10-20 Hz, lm  sec duration, supramaximal voltage) and 
m easurement of the ensuing bradycardia as a percentage o f the 
initial response.
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R e s u m e
Les auteurs ont prepare deux series de sels d’ammonium bisqua- 
ternaires portant, adjacentes au carbone-(l du groupe am monium , 
des fonctions ester. Ces composes sont conpus pour subir in vivo
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une elim ination cl’H ofmann. L eur activite cventuelie comine cu ra • 
risants a 6te evaluee sur le C hat. Les variations de la durec dc 
Taction et de sa puissance ainsi que 1’etfet de bloeage du nerf 
vague sont rapportes et relics a la structure.
ZUSAM M BNFASSUNG
Zwei Reihen bisquartiirer Ammoniumsalze, die am  (1-lCohlcn- 
stoff zur Am m onium gruppe eine Esterearbonyl-G ruppe tragen, 
vvurden synthetisiert. Diese V crbindungen sollten in vivo  eincr 
Hofmann-Elim inierung unterliegen und vvurden auf ihren cura- 
risierenden Effekt an der Katze getestet. D auer und Intensitat 
der blockicrcnden Wirkung auf den Vagus vverden m it der Struk- 
tur der Vcrbindungen in Zusam m enhang gebracht.
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Bis-3, 4-Dihydroisoquinolinium salts 
as potential neuromuscular blocking agents
John B. S t e n l a k e  (*)> Roger D. W a ig h  (**), John U r w i n  and George H. D e w a r  (* * * )
D epartm ent o f Pharmaceutical Chem istry, University o f Strathclyde, George Street, Glasgow, G1 1X W , Scotland.
R oy H u g h e s  and Dennis J. C h a p p l e
D epartm ent o f Pharmacology, The W ellcome Research Laboratories, Beckenham, Kent.
(Received Novem ber 26, 1980)
A  series o f AW-poIymethylene-/.>/.v-3,4-dihydroisoquinolmium salts has been prepared and examined for neurom uscular blocking 
activity. Some members of the series have been shown to be po ten t, neurom uscular blocking agents, bu t with an unacceptable level 
of vagal blockade for clinical use.
In the course of studies aimed at producing a clinically 
useful neuromuscular blocking agent (1, 2), we prepared 
as an intermediate the bis-quaternary 3,4-dihydroisoqui- 
nolinium  salt ( lb ) . This salt resem bles a series o f 1 ,2 ,3 ,4- 
tetrahydroisoquinolinium salts prepared by T a y l o r  (3), 
o f which one (Laudexium ; 2) was used clinically, 
although it suffered from the disadvantage o f having too 
long a duration of action. M ore significantly, a series of 
1,1 -linked h/.y-3,4-dihydroisoquinolinium salts (3) has 
been prepared by C o p p  et a l (4 ) and shown to possess 
adequate potency and short duration of action in cats. 
W hen the intermediate (lb )  proved to be active and shorter 
acting (ca  14 min) than tubocurarine (ca 26  min), it was 
decided to explore the series further, with the objective 
of increasing activity and reducing vagal block, since this 
latter feature had resulted in withdrawal o f one of the 
related 1 ,1 -polym ethylene-3.4-dihvdroisoquinolinium  com ­
pounds (3) from clinical trial (5).
CHEMISTRY
The bis-quaternary salts, la ,  I c - lm , and 4 . were synthe­
sized by treatment o f the corresponding 3,4-dihydroisoqui- 
noline with the appropriate «,to-dihaloalkane. The required
3.4-dihydroisoquinolines were prepared by B i s c h l e r -  
N a p i f . r a i . s k i  cyclisation (6, 7) o f the appropriate amides. 
In general, these 3,4-dihydroisoquinolines are stable (7). 
I -benzyI-3,4-dihydroisoquinolines, however, are excep­
tional in that they undergo air-oxidation to 1-b en zoyl-3 ,4- 
dihydroisoquinolines in neutral or alkaline media (7, 8). 
C onsequently, special care was required in the quater- 
nisation of 3,4-dihydropapaverine.
The com pound, 5, was obtained by quaternisation o f the
1.4-6(.v-[3,4 - d ihydro-6,7-dim ethoxyisoquinolin-l-yl)m etho-
(*) A uthor to whom correspondence should be addressed.
(** P resent address : D epartm ent of Pharm acy, University of 
M anchester.
(***) P resent address : School of Pharm acy and Pharmacology, 
U niversity of Bath.
xyjbenzenc with an excess of methyl iodide. The u n sy m m e - 
trical bis-quaternary compound, 6, w as prepared in two 
stages, firstly by reaction of 3,4-dihydropapaverine with a 
large excess o f decam thylene di-iodide to give an interme­
diate monoqualernary, followed by quaternisation o f the 




Methoxy substituents in the isoquinoline ring enhance 
neuromuscular blocking potency substantially (3). A ccor­
dingly, efforts were concentrated on com pounds possessing  
the readily available 6,7-dim ethoxy substitution pattern 
(Table I). The first compounds investigated possessed the 
10-carbon separation o f onium centres present in decame- 
thonium and Laudexium  (3), and in the related 1,1-linked
3,4-dihvdroisoquinolinium  salts (4). Potency in cats 
increased substantially in com pounds le ,  l i  and 1/ with 
alkyl substituents in place o f hydrogen at C -l ( lb )  of the 
dihydroisoquinolinium  units, and reached a peak at ethyl 
in com pound l i ,  thereafter decreasing in the propyl com ­
pound, 1/. Increase in inter-onium chain length from 10 
to 11 or 12 m ethylene units in com pounds I f  and lj ,  and 
in l g  and lk  respectively, in general reduced the activity 
with both methyl and ethyl C -l substituents, with the 
exception of I f  in cats. On the other hand, reduction in 
chain length to eight methylene units increased activity 
to a maxmum in Id  where the C -l substituent was methyl. 
The activity in 1h with ethyl at C -l was less pronounced. 
Further reduction o f the inter-onium chain to six methylene 
units, attempted only with a C -l methyl substituent, resul­
ted in a subtantial drop in activity in com pound 1c to the 
same level as l e  and If. It is evident, therefore, that in 
this series as in many others, both inter-onium  distance 
and the presence o f appropriate adjacent lipophilic groups, 
capable o f interacting with a hydrophobic bonding receptor 
subsite, are important determinants of activity (9). It is of
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interest in this context that super-position of structures 
3el (octam ethylene chain ; C -l =  Me) and Ih  (decam e- 
thylene chain ; C-1 — E t) as at a bis-anionic receptor, 
shows near super-position o f the C -l methyl groups of 
Id with the terminal m ethyls of the C -l ethyl groups of 
Ih, yet potency of Ih was less than that o f Id. However, 
all these com pounds also showed powerful and persistent 
vagal b lock ; sufficient to render them clinically valueless 
(Table II).
TA BLE I. —  Mean neuromuscular Mocking potencies o f 
bis-3,4-dihydroisoquiitolinium salts.
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TABLE II. —  Mean neuromuscular and vagal blocking closes 
Of bis-3,4-dihydroisoquinolinium salts in cats.
C om pound P D 501 VO 9 0  2
V D 50 /
PI) 50
b 2 . 7  ( U rt 2 . 1  ( 1 ) 0 . 7 8
c 0 - 3 9 ( 2 ) 0 . 1 8 ( 2 ) 0 . 4 6
d 0 . 2 3 ( 2 ) 0 . 2 0 ( 2 ) -
c 0 . 9 0 ( 2 ) O.VOS( 2 ) -
t 0 . * l ( l ) O .V V ( i) l . I
s 2 . 3  ( 3 ) 0 - 2 0 ( 3 ) O .O d
h 0 . 2 V( 2 ) 0 . 2 V( 2 ) 1 .0 0
1 0 . 2  JL ( 3 > 0 . 5 0 ( 3 ) -
j O .G 2 (V) 0 .5 8 ( V ) 0 . 9 *
k U 5  ( 3 ) X .3  ( 3 ) O .8 7
I 0 - 7 2 ( 2 ) 0 . 6 1 ( 2 ) 0 . 8 3
0 . 3 9 ( 2 ) 0 . 6 5 ( 2 ) 1 -  7
5 O4  ( 2 ) 3 . 2  m -
6 0 . 1 9 ( 2 ) 0 . 1 3 ( 2 ) 0 . 6 8
' Dose in m g/kg  iv producing 50 % neurom uscular block. 
1 Dose in m g/kg ic producing 50 %  vagal block.
5 N o block recorded at doses up to  4 m g/kg.
5 N o of animals.
5 Dose in m g/kg iv producing 100 % vagal block.
Introduction of 3,3-dim ethyl substituents into the 3,4- 
dihydroisoquinolne com pounds, 3  (4), increased activity, 
and did so  again in the present series. Thus, 4  was more 
potent than lb , but again vagal b lock  was severe. We, 
therefore, attempted to modify the basic structure to avoid 
vagal block, using a 3,4-dim ethoxybenzyl substituent at 
C -l of the isoquinoline ring in place of alkyl, such a 
substituent having a beneficial effect in Laudexium ; 2. 
Thus, we obtained Ini (n =  10 ; R  =  MeO ; R’ =  3,4- 
dim ethyoxybenzyl ; X  =  I) which unfortunately produced 
an irreversible block on the rat diaphragm.
A number o f the 3,4-dihydroisoquinolinium  compounds 
proved to be of relatively short duration of action (ca 
10-20 min) in cats compared with such compounds as 
tubocurarine (ca 26 min) and G allam ine (ca  33 min) (10). 
It seem ed possible that this might be associated with the 
electron-deficient carbon at C - l ,  which could be subject 
to nucleophilic attack by a variety of agents in  v ivo , 
with rem oval o f the charge on nitrogen (Schem e 1). W e, 
therefore, attempted to com bine one of these potentially 
degradable units with a Iaudanosm e unit in a single bis- 
quaternary com pound 6, in an endeavour to achieve both 
•short-action and freedom  from side-effects. In the event, 
the product was reasonably potent in cats, but showed 
severe vagal block.
Scheme 1
Our final attempt to incorporate the 3,4-dihydroiso- 
quinoline unit into an acceptable drug m olecule is repre­
sented in 5, which possesses a resem blance to tubocurarine 
and Laudexium . Surprisingly for a bis-quaternary, this 
com pound had no measurable neuromuscular blocking 
activity. This lack of blocking effect could be associated 
with the proximity of the ether oxygen atoms to the onium  
centres (11 ).
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E X PE R IM E N T A L
Unless stated otherwise, melting point were recorded dn a 
Kofler Hcizbank 184321 melting point apparatus. Infrared spec­
tra were recorded on a Perkin Elmer 157 instrum ent using liquid 
films or KC1 discs (for solids). Proton magnetic resonance spec­
tra were recorded on a Perkin Elmer R12 instrum ent operating at 
60 M Hz. TM S was used as internal standard, M icroanalyiical 
results (C, H, N except where otherwise stated) were within 
±  0.4 % of theoretical.
N -[2-(3,4-Dimethoxyphcnyl)ethyl] propanamide
Propanoic anhydride (30 m l ; 0.23 mole) was added cautiously 
to homoveratrylamine (20 g ;  0.11 mole) at 5°C and the mixture 
allowed to stand for 10 min. Ethanol (15 ml) was added and 
the mixture boiled for 5 min, cooled, diluted with water (200 ml) 
and extracted with chloroform (100 ml ; 50 ml). The combined 
extracts were washed with water, dried (NajSO,) and evaporated 
to leave a yellow oil which solidified on trituration with several 
quantities of ether —  light petroleum  (b.p. 40-60°). Crystalli­
sation from, ethyl acetate —  light petroleum (60-80°) gave 
/V-[2-(3,4-dimethoxyphenyl)ethyt]propanamide (14 g ; 53 %), m.p. 
5 7-59° C [Lit. (12) 57.5-59°C |.
N -f2-(3,4-D im ethoxyphenyl)ethyl]butananiide
Treatm ent of homoveratrylamine (20 g ;  0.11 mole) with buta- 
noic anhydride (30 m l; 0.19 mole) by the method described for 
the preparation of W -[2-(3,4-dimethoxyphenyl)ethyllpropanarnidc, 
gave A /-|2-(3,4-dim ethoxyphenyl)ethyl|butanamide (14.5 g ;  5 0 % ) 
as colourless needles from ethyl acetate —  light petroleum (b.p. 
40-60°C), m.p. 47-50° C [Lit. (12) 51-53“C].
(A-l 2-(3,4-D im ethoxy phenyl )ethyl 1-3,4-di met hoxyplienylacelamide
Homoveratrylam ine (1.025 mole) was heated with 3,4-dime 
thoxyphenylacetic acid (1 mole) in an open vessel at 190-210°C 
for 2 h. The solid mass obtained on cooling crystallised from 
ethanol as colourless needles (9 2 % ), m.p. 1!8-120°C [Lit. (13) 
124°C[.
N N ’ - Bis-12-(3,4-dimetItoxyphenyl)ethyIJ hydraquinone - O O ’- diacet- 
am ide
Homoveratrylam ine (10 g ; 0.055 mole) and hydroquinone-OO’- 
diacetic acid (5 g ; 0.022 mole) were heated together in an open 
vessel for 2 h at 190-210°C. The solid mass obtained on cooling 
crystallised from ethanol as fine, colourless needles which were 
filtered off, washed well w ith ethanol and dried. The bis-amidc 
(9.5 g ;  75 % had m.p. 138-139°C [Lit. (14) 143-145°C], 3300,
1650, 1510 cm -'. 8 (CDCI,) : 2.80 (411, t, 2 x A r C H j), 3.57 (4H, 
t, 2X C7/.N H C O -), 3.85 (12H, s, 4 x A rO C f/,) , 4.42 (4H, s, 
2 X A rOCf/jCO-), 6.60-6.90 (12H, in, A r - tf+ 2 x N /7 ) .
3 .4-Dihydroixoc/uinnline ,3,4-dihydro-6,7-dinietlioxyixoquinoline and
3.4-Dihydro-6,7-dimcthoxy-1-methylisoquinaline were prepared as 
described previously (1).
I-Ethyl-3,4-dihydro-6,7-dimethoxyisoquinoline
/V-[2 (3,4-dimcthoxyphenyI)ethyl]propanamide (5 g ; 0.021 mole) 
and polyphosphorie ester (25 g) were heated together at 120°C 
for 1 h. The mixture was cooled, diluted with water (100 ml), 
and basified with sodium hydroxide solution (5N ; 100 ml). The 
aqueous solution was extracted with chloroform (100 m l ; 50 ml), 
and the combined extracts were washed with w ater, dried 
(Na2S 0 4) and evaporated to give an oil (4.1 g ; 89 %) sufficiently 
pure for subsequent use. Pure l-ethyl-3,4-dihydro-6,7-dimethoxy- 
isoquinoline had b.p. 106-110°C/0.05 mm Hg [Lit. (12) 127- 
l30°C /0 .3  mm Hg].
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3.4-Dihydro-6 ,7-dim ethoxy-1 -propyl isoquinoline
N-| 2-(3,4-D im cthoxyphenyl)ethyl[butanamide (5 g ;  0.019 mole), 
treated as described in the synthesis of l-ethyl-3,4-dihydro-6,7- 
dimethoxyisoquinoline, gave the product as an oil (4.2 g ; 90 % ) 
sufficiently pure for subsequent use. Pure 3,4-dihydro-6,7-dime­
thoxy-1-propylisoquinoline had b.p. 109-1 !0°C /0.05 mm Hg 
[Lit. (12) 150-170°C/2-3 mm Hg].
3 .4 -D ihydro-6,7-dim ethoxy-1 - (3,4 - dim ethoxybcnzyl)ixoquinoline- 
(3 ,4-dihydropapaverine)
/V-|2-(3,4-Dimethoxyphenyl)elhyl]-3,4-dimethoxyphenylacetamide 
(0.024 mole) was refluxed in dry toluene (60 ml) with phosphoryl 
chloride (40 ml) for 3 h. The partially cooled reaction mixture 
was poured into light petroleum  (b.p. 60-70°C ; 40 ml), and the 
liquid decanted from the semi-solid precipitate over 15 min. The 
semi-solid was washed well with light petroleum (b.p. 40-60°C), 
dried, and crystallised from ethanol-ether to give 3,4-dihydropapa- 
vcrine hydrochloride. The free base was obtained by basification 
and rapid extraction in the usual way im mediately prior to use.
1,4-\ikf(3,4-dihydro-6,7-dim etlioxyisoquinolin - l-y l)  metlioxy] ben­
zene
WA,-Bis-[2-(3,4-dimethoxyphenyl)ethylJhydroquinone-CIO'-diacet- 
amide (5 g ; 0.0064 mole) in dry toluene (60 ml) was stirred under 
reflux with phosphorus oxychloridc (30 m l ; 0.33 mole) for 1 h. 
The liquid was decanted from the solid which precipitated on 
cooling. The solid, after washing with light petroleum (40-60°C) 
and drying, was suspended in ethanol (25 ml) and basified with 
sodium hydroxide solution (5N). The partially crystalline solid 
obtained on addition of water (200 in!) was extracted with chlo­
roform (2 x  100 ml). The combined extracts were washed with 
water, dried (N a2S 0 4), and evaporated to  leave a yellow solid. 
Crystallisation from ethanol gave the required product (3.8 g ; 
8 0 % ), m.p. 174°C [Lit. (14) 166-168°C1 as long, colourless 
needles. vm„ : 1640, 1600, 1500 cm '. 5 (CDCb) : 2.63 (4H, i, 
2 x A r CH,-), 3.78 (4H, t-, CH,N =  C-), 3.84 (6H. s. 2 xA rO C H ,). 
3.92 (6H, s, 2 X ArOCHi), 5.05 (4H, s. 2 x  ArOCH I-C =  N ), 6.71 
(2H, s, Ar-H), 6.98 (4H, s, Ar-fT), 7.25 (2H , s, Ar-W).
The D im ethiodide  (5) prepared by refluxing the bis-amine with 
excess methyl iodide for 4 h, had m.p. 228-230°C, from aqueous 
methanol. Re-crystallisation from aqueous methanol gave the ana­
lytical sample, m.p. 229-231°C. v,„a, : 2930, 2810, 1630, 1605. 
1570, 1505 cm -'. Anal, for Q T L .L N A ,, 1.5 HjO : C, H, N.
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C o m p o u n d m .p .  ( ° C ) F o r m u l a  ( A n a l .  C.H.N')
l a 186 -  188 C2 8 H 3 8 I 2 N2
i 2 'U  ( d ) C 3 0 l , i ,3 B r J V2° < , - 1 H -“
.1 n o  -  120 c32H<,6B'a-Vi
* 130 -  1*10 c .iAH5 0 I a N >°ii
f 172 C .1 H^O
« 138 -  ! M C 36H 5^lB r ',? i'j 0 ' r  1
h 2 2 2  -  22*1 C 3 ^ H 5 0 B r 2 V2 ° V  2 U2 °
169 -  171 C 36H5'»I 2 'V / l
i 190 -  198 37 f  6  2 2 h '  2
k 200  -  203 l H '*°
Jt 173 -  176
123 -  128 • C501I6 6 I 2N3 0 ^
6.7-Dim ethoxy-l-(3,4-dim ethoxybenzyl)-2-tnethylisoquinoline  (lau- 
danosine)
This compound was prepared from tetrahydropapaverine by the 
Eschweiler-Clarke method (15) and had m.p. 115-116°C.
Bis-.?,4-Diliydroisoquinolinium salts (1)
The following general m ethod was adopted : the appropriate
3,4-dihydroisoquinoline base (4 mole equ ivalen ts; ca 4 g) and 
alkane-’aiio-dihalide (1 mole equivalent) in dry benzene (25 ml) 
were refluxed for about 24 h. The mixture was cooled, ether (ca 
100 ml) added, and the solid material filtered off, washed well 
with ether, dried, and crystallised from ethanol. Relevant data for 
all compounds prepared by this method are presented in Table III.
J ,10-Bis-(3,4-Dihydro-6 J-dimethoxy-3,3-diinethyl-2-isoquinolinium ) 
decane di-iodide (4)
3,4-D ihydro-6 ,7-d im ethoxy-3 ,3-d im ethylisoquinoline (1,2 g ; 
0.0055 mole) prepared as described by C o p p  ( 1 6 )  and decamethy- 
lene di-iodide (0.7 g ;  0.0018 mole) in benzene (10 ml) were 
refluxed fo r 24 h. Addition of ether (30 ml) to the cooled reac­
tion m ixture gave a yellow solid which was filtered off, washed 
well with ether and dried. Crystallisation from u-propanol gave 4 
(0.72 g ; 4 9 % )  as yellow prisms, m.p. 170-172°C (softens at 
160“C). Anal, for C ^ H ^ N A  ; : C, H , N.
I -[1 ,2 ,3 ,4 -Tetrahydro-6,7- d im ethoxyy 1 -(3,4-dim ethoxybenzy!) - 2- 
methyl-2-isoquinolinium ] 10-(3,4-dihydro-6,7-dim ethoxy-l-m ethyl-2- 
isoquinolinium)decane di-iodide (6)
Laudanosine (0.5 g ; 0.0014 m ole) and decamethylene di-iodide 
(5.5 g ;  0.014 mole) in dry benzene (15 ml) were refluxed for 
30 h, left a t room  tem perature fo r 60 h, and then refluxed for a 
further 5 h. The semi-solid (0.75 g ;  71 %) obtained on careful 
addition of dry ether to the partially cooled reaction mixture was 
hygroscopic. A portion of the semi-solid (0.3 g ; 0.0004 mole) in 
absolute ethanol (5 ml) was refluxed with 3,4-dihydro-6,7-dime- 
thoxy-l-m ethylisoquinoline (0.5 g ; 0.0024 mole) fo r 24 h. Addi­
tion of ether to  the cooled reaction mixture gave a semi-solid 
which was dissolved in methanol (10 ml) and added dropwise, 
w ith filtration, to mechanically stirred, filtered, dry ether (500 ml). 
Repetition of the precipitation process gave 6 (0.28 g ; 47 %), 
m.p. 131-136°C w ith preliminary softening at 124°C. v,„», : 2940, 
1625, 1510 c n r 1. Anal, for GuH62l j N A  : C, H , N .
Neurom uscular blocking potency
N eurom uscular blocking potencies were determ ined on the rat 
phrenic-nerve diaphragm  and ca t gastrocnemius muscle-sciatic 
nerve preparations as previously described (1). T he results are 
given in Table I.
Vagal block
V agal block was determ ined in  anaesthetised cats by periodic 
stim ulation of the cardiac stum p of the cut right cervical vagus 
nerve (10-20 Hz, 1 m  sec duration , supramaximal voltage) and 
m easurem ent of the ensuing bradycardia as a percentage of the 
initial response. The results are given in Table II.
. , . . . . . .
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R e s u m e
Preparation d ’une seric de sels de N.N-poIymethylene-bis- 
dihydro-3,4 isoquinolinium ct etude de leur activiti curarisante ; 
certains derives sont de puissants agents de rel&chemcnt muscti- 
laire de courte durce d’action. Toutcfois, le niveau eleve de leur 
action sur le nerf vague les rend im propres ii  l’usage clinique.
Z u s  AMMEN FASSUNG
Eine Reihc von N ,N ’-PoIymethylen-3,4-dihydroisochinolinium- 
Salzen wurde hergestellt und auf ihre neuromuskuliire Hemmwir- 
kung untersucht. Einige G lieder der Reihe erwicsen sich als 
starke, kurzfristig xvirkende M uskcl-relaxantien, hatten aber eine 
fur die klinische Anwendung unannehm bar starke W irkung auf 
den Vagus.
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Biodegradable neuromuscular blocking agents.
Fart 4„ A tracurium  BesySate and re la ted  polyalkylene d i-es te rs
John B. S t f .n i .a k e  *, Roger D . W a ig h  ** and George H. D e w a r  * * *
Department o f Pharmaceutical Chem istry, University o f Strathclyde, George Street, Glasgow, G1 1XW , Scotland.
R oy H u g h e s ,  Dennis J. C h a p p l e  and Geoffrey G. C o k e r
Departm ents o f Pharmacology and Chemistry, The W ellcome Research Laboratories, Beckenham , Kent.
(Received Novem ber 26, 1980)
A series of aco-bisbenzy(isoquinolinium polyalkylene di-esters designed to undergo H ofm ann elimination at physiological pH  has been 
synthesised. Initially, neurom uscular blocking potency increases w ith interonium spacing up to 13 to 14 atoms, thereafter declining. The 
most active com pounds have been shown to possess good non-depolarising neurom uscular blocking activity with high specificity for the 
neurom uscular junction and medium duration of action. A tracurium  Besylale ( l , l ’,2,2’,3,3’,4,4’-octahydro-6 ,6’,7,7’ -tetram ethoxy-2,2’- 
d im ethyl-l,T-diveratryl-2,2’-(3-ll-dioxo-4,10-dioxatridecam ethylene)diisoquinolinium  dibcnzcnesulphonate) which is being developed for 
clinical use as a neurom uscular blocking agent appears to be inactivated by both enzymic and non-cnzymic mechanisms. There is 
evidence to suggest that the chemically-based H ofmann elimination pathway plays an im portant part In this inactivation.
Previous papers in this series have described the 
developm ent o f a novel approach to biodegradable neuro­
muscular blocking agents based on Hofmann elimination 
o f suitably substituted quaternary ammonium salts (1-3). 
In this paper, we describe a continuation o f the basic 
studies which led to the promising derivative of tetrahydro- 
papaverine, the bisquatemary l a  (Scheme 2) (3). In cats, 
this compound showed a m oderate potency as a non­
depolarising neuromuscular blocking agent, with a medium  
duration of action and with distinct separation between 
neuromuscular and vagal blockade. Compound la  is a 
reversed ester analogue of a compound, 2, prepared by 
C o i . l i e r ,  G l a d y c h ,  M a c a u l a y  and T a y l o r  (4) as a non­
depolarising analogue of succinyldicholine. This latter 
com pound, 2, possessed only one-third o f the potency of 
( +  )-tubocurarine and was slightly longer acting (4), 
whereas l a  was somewhat shorter acting (recovery from 
onset of full block ca 14-20 min) than ( T-^-tubocurarine 
(ca 20-33 min), although no more potent than 2. It would 
appear, therefore, that 2 is not a good substrate for 
esterases at the neuromuscular junction which might 
inactivate it, whereas we have shown that compounds 
related to la ,  e.g. Ik , can also be degraded in vitro  by a 
base-catalysed mechanism independent o f esterases at 
physiological pH. W e describe here our successful attempts 
to increase the potency without losing the specificity for 
the neuromuscular junction which was an attractive feature 
of la .
(») A uthor to  whom correspondence should be addressed.
(**) Present address : D epartm ent of Pharm acy, University of 
M anchester.
(***) present address : School of Pharmacy and Pharmacology, 
University of Bath.
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CH EM ISTRY
The bis-quaternary ammonium salts, la - I s ,  were pre­
pared by the route outlined in Schem es 1 and 2. These 
com pounds are quaternary derivatives of the bis-tertiary 
amino esters, 3, obtained by M ichael condensation of the 
1-benzyl-1 ,2 ,3 ,4~tetrahydroisoquinolines, 4, with diol dia­
crylate esters, 5  (5).
The 1-b en zyl-1 ,2 ,3 ,4-tetrahydroisoquinolines, 4, were 
prepared by Bischler-Napieralski cyclisation (6, 7) of 
appropriate amides, 6  (Scheme 1), using phosphorus oxy- 
chloride, to give the 3,4-dihydroisoquinolines, followed by 
reduction with sodium borohydride. Due to the tendency 
of 1-benzyl-3,4-dihydroisoquinolines to undergo air-oxi- 
dation to 1-benzoyl-3,4-dihydroisoquinoIines (7, 8) in 
neutral or alkaline m edia, no attempt was made to isolate 
the free bases. Since such oxidation does not occur in 
acidic m edia (8), this com plication was avoided by redu­
cing directly (9) the partially purified 3,4-dihydroisoquino- 
line proton salt from phosphorus oxychloride cyclisation, 
and purifying the resulting 1,2,3,4-tetrahydroisoquinoline. 
1,2,3,4 - tetrahydro - 6 ,7  - dim cthoxy-1 - [ 2 (3 ,4-dim ethoxyphe- 
nyl)ethyl]isoquinoline was prepared similarly.
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M ichael addition of the various 1-benzyltetrahydroiso- 
quinolines, 4, to appropriate diacrylates, 5, proceeded 
smoothly without side-reactions to yield bis-amines, 3 
and 7. Purification of all bis-am ines was achieved by 
crystallisation o f dioxalate proton salts. N o attempt was 
made in the present work to establish the racemate —  
m e m  ratio of these purified oxalates, arising from the 
asymmetry associated with position 1 of the tetrahydroiso- 
quinoline ring.
The bis-am ine, 9 , was prepared by an alternative route. 
y-Butyrolactone was treated with propane-1,3-diol in the 
presence of hydrogen bromide to yield propane-1,3-bis 
(4-brom obutanoate), and the latter then condensed with 
tetrahydropapaverine.
T he bis-quaternary salts, l a - l c  and Ik -lq , were pre­
pared from the corresponding bis-am ines by alkylation 
with methyl iodide. It became evident, however, in the 
course o f preliminary pharm acological studies that the 
m ethiodides o f this series were not Sufficiently soluble to 
permit the preparation of small volum e intravenous injec-
Scheme 1
The bis-acrylate esters, 5, were prepared by the reaction 
of acryloy! chloride with the appropriate diol in the 
presence o f triethylamine as acid scavenger. A ll of the 
liquid acrylates tended to polym erise at elevated tempera­
tures ( >  ca  150°C ). Consequently, distillations were 
performed with the exclusion o f light, in the presence o f a 
polym erisation inhibitor such as 4-m ethoxyphenol, and 
using the highest possible vacuum. Despite a wide patent 
literature, the physical constants of m ost o f these diacryl­
ates have only recently been reported (10).
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lion solutions for clinical use. Attention was turned, there­
fore, to other alkylating agents, notably methyl methane- 
sulphonate. Careful purification and rigorous exclusion of 
water were found to be necessary with this reagent, not 
only to prevent hydrolysis of the quaternary products 
themselves, but also to avoid hydrolysis of methyl methane- 
sulphonate to methanesulphonic acid. The presence of 
this acid in the mixture would obviously protonate, rather 
than quaternise, the tertiary amine, and the use of scrupul­
ously dry precursor bis-amine was found to be essential. 
This was best obtained by extracting the base, liberated 
from purified oxalate, with toluene, evaporating to azeo- 
trope water, and completing the process by drying in vacuo 
over P2O5 at ca 60-80°C. The water-soluble methanesul- 
phonates, la, ld-11, lr, Is, 8 and 10, were prepared by 
this method.
Concern over the stability of Ik mesylate led to the 
evaluation of other salts prior to clinical development. The 
bcnzenesulphonate (besylate), toluenesulphonate (tosylate) 
and I- and 2 -naphthalenesuP.phonatcs of lk  were prepa­
red by the same method as the mesylate. Both naphtha- 
lenesulphonates had lower solubilities than the methiodide, 
but the besylate (lk,X =  Ph . S0 20 “ ) and tosylate were 
readily soluble in water to the extent of about 60 and 
35 mg/ml at 25°C respectively.
There are four asymmetric centres in all the compounds 
described, but considerations of symmetry reduce the 
number of possible isomers to ten. We have evidence that 
the synthetic methods used give rise to batchwise consistent 
isomer ratios, and details of these stereochemical studies 
will be reported in a later paper in the series. The results 
reported in Table 1 are for unresolved isomer mixtures.
PHARMACOLOGICAL RESULTS 
AND DISCUSSION
Neuromuscular blocking potency and the extent of vagal 
block were measured in anaesthetised cats and Rhesus 
monkeys. The results are given in Tables I and if I.
Consideration of structure la  (Scheme 2 ) suggested 
three obvious points for modification to enhance potency ; 
alteration of (a) the central chain, (b) the isoquinoline 
benzene ring, or (c) the 1-benzyl substituent. Alteration of 
the /V-methyl substituent would be counter-productive (3) 
and the two-carbon separation of carbonyl and nitrogen 
had to be maintained in order to preserve the potential 
for Hofmann elimination (1-3).
Modification of the 1-benzyl substituents was readily 
effected by the use of appropriately substituted phenyl- 
acetic acids in the synthesis. Choice of substituents was 
based partly on the usual considerations of bulk, electron 
distribution and lipophilicity, and partly on availability of 
suitable phenylacetic acids. The results presented in 
Tables I and H for the produots, Ib-lh, iri each case show 
a reduction in neuromuscular blocking potency and an 
increase in effect on the vagus compared to la.
In view of the foregoing results, the 3,4-dimethoxy- 
benzyl group was retained in all but three of the remaining 
compounds, li- ls . One 3,4-dimethoxyphenethyl homolo- 
gue, 8, and two 6, 7-methylenecHoxy compounds, lo  and 
‘P. were also prepared, but none of these compounds 
showed advantage over the corresponding l-(3, 4-dimeth- 
oxybenzyl) compound, lk. These results were not encou­
raging, and left only the central chain of the three para­
meters described for further modification.
TABLE I. — Mean neuromuscular blocking potencies and duration o f action 
o f cmo-bisbetizyltetrahydroisoquinolinium polyalkylene di-esters, 1, 8 and 10, 
in cats and rhesus monkeys.
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TA BLE II. —  Mean neuromuscular and vagal blocking doses o f im-bisbenzyltetraliydro- 
isoquinoliiiium polyalkylene di-esters 1, 8 and  10 in  cats and rhesus monkeys.
PD501
C A I 
VD50* ^ pdso PD501
4 0 N K  E Y
VD502 WM/fDSO
io 0.36(2)' 2.6 7.2 13(2) 6.0 5.2
b 1 7  (2) 1.2 1.0
« 1.0 (?) 4.9 4.7
.1 l.fl (2) 2.1 1.3
C ».0(2) 1.7 l /
1 1 7 (2) 4.5 7 /
1) 1.6(2) 7 J 1.4
». B-2 (2) 3.5 0.4
i 0.26(2) 7.3 2V 0.75\2) 4.3 5.0
1 0.13(2) S. 4 47 0.27(3) 2 6 9.6
V 0.13 -0.01 (6) 3.08 - 0.76 74.4-6 .1 O 12-0.07(7) 4 70- 0.99 39.0 - 0.4
t 0.09 - 0.01 (4) 3.02 - 0.34 34.6 * 5.5 0.11- 0.0! (4) 3 65 - 0.64 32.6? 10..1
m 0.15(2) 2.6 17
» 0.18(2) 1.5 8.6
0.43(2) 3.1 7.2
i> 0.44 - 0.16 (4) 2.4 ?0.5 7 1 ! i  :i 0.47(2) 7.6
n 0.46(2) 10.B 73
0.49(2) 2 4 4.9
» 0.20(3) 2.7 9.6
o 0 24(3) 14 5.8
10 0.16 • 0.02(6) 7.78 - 0.44 IB-B - 3 9 0 41 - 0.08 (4) t  M  - 0.91 6.V9 - 7.94
lutocutntl'nc 0.13-0.01(4) 0 19 • 0.01 1 5-0 .15 0.12 -  0.02 (4) 0 64 -* 0.00 6.7 io.VIl
Dima lliyl luboc urfl'lne 0.02 * 0.003(4) 0.50 - 0.09 24.6 - 4 .46 0 OS - 0.01 (4) 1 0  -0.16 22.0 5.5
Gallominc 0.83 - 0 13(4) 0.56 - 0,07 0.7 - 0.17 CI.57 - 0.06 (4) l . /J  i 0.43 3.3 - 1 It
Puncurftmum 0.02 i  0.002(4) 0.08 - 0.01 5 .2 - 0 00 0.007 - 0.001(4) 0.08 • 0.0? 17.6 - 3.2
FntocKnlum 0.6V - 0.15(4) 0.29 - 0 09 0.5-0 .11 0.27 - 0.02(4) 0.20 - 0.01 0 9 -0.411
' Dose in m g/kg iv producing 50 %  neurom uscular blockade ±  SEM where shown. 
1 Dose in m g/kg  iv producing 50 % vagal blockade ±  SEM  where shown.
* No. of animals.
Com pound la  was less potent in monkeys than in cats 
(Tables I and II). Increase in inter-onium  chain length in 
com pounds l i - l n  increased neuromuscular blocking acti­
vity in both species, and with com pounds lk  and 11, the 
relative increase in potency was similar in m onkeys and 
cats (Fig. 1). Although potencies of lm  and In  were not 
recorded in the monkey, the similarity of l k  and II in cats 
and m onkeys suggests that maximum potency is probably 
reached at this point in both species. Thus, optimum  
activity is reached in this series with an inter-onium spa­
cing of som e 13-14 methylene or other spacially equivalent 
groups. This characteristic is in accord with simpler poly- 
methylene-6/.v-ethonium and polym ethylene-po/y-ethonium  
com pounds, which are also com petitive blockers, and 
contrasts with the optimum inter-onium spacing of 
10-11 units in the depolarising polymethylene-/j/.v-mctho- 
nium series (11).
T he tendency to cause vagal blockade at neuromuscular 
blocking doses was markedly reduced in l k  and II with 
V D 5 0 /P D 5 0  in monkeys greater than 30 (Table 2). For 
(his and other reasons, l k  was chosen for more detailed  
study and developm ent (12) as a neuromuscular blocking 
agent offering a number o f  potential advantages over 
similar agents in present clinical use (13).
R eplacem ent o f the central methylene group o f the inter- 
onium chain in l k  by an ether oxygen, as in lq , had little 
effect on vagal block, but reduced the paralysing potency 
threefold. This potency drop accords with T aylor’s 
results (14).
°  too- •
CAT
MONKEY
NUMBER OF INTER-ONIUM ATOMS
Fig. 1
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In a series of depolarising neuromuscular blocking 
agents of related structure (15 ), the introduction o f  a 
benzene ring into the middle of the chain resulted in an 
increase in potency. In the present series, the opposite  
effect was observed, lr  being less potent than lk . Thus 
structure'potency relationships in depolarising agents may 
not be directly applicable to non-depolarising compounds.
The compound lk  as the besylate salt ( lk , X  =  
P h .. S 0 20  ), designated Atracurium Besylate (British 
Approved N am e), has been confirmed as a potent, non­
depolarising (competitive) neuromuscular blocking agent in 
cats and rhesus monkeys (16). Similar effects have been 
demonstrated in anaesthetised man (17 and 17 a-c) w ith no 
cardiovascular effects at the doses required for neuro­
m uscular paralysis in the range 0 .2  to 0 .6  m g/k g.
T he structure o f atracurium ( lk ,  m — 2) em bodying, 
in duplicate, the two-carbon separation between quater­
nary nitrogen and ester carbonyl (m =  2) provides the 
basis for mutual promotion o f H ofm ann elim ination and 
ester hydrolysis (Schem e 3). In a preliminary experiment 
in cats, similar substantial falls in potency were observed 
when atracurium was incubated for 30  min at 3 7 °C  with 
pH 7 .4  buffer, cat and human plasma from two subjects, 
respectively (Table Til). It is evident, therefore, that the 
extent and rate o f breakdown o f atracurium in buffer 
contrasts sharply with that recorded for Suxamethonium  
which is only 6 %  hydrolysed in pH 7 .4  buffer in one 
hour, and no more than 12 % hydrolysed in the same 
time at pH 7 .7  (18).
TA BLE III. —• Neuromuscular blocking potency o/ atracurium  
besylate (in cats) following incubation at 37° C in pH 7.4 buf­
fer, cat and human plasma for 30 minutes.
C a t  p la s m a  
H uman p la s m a  (S u b . 
Human p la s m a  (S u li . 
H u tT c r  pi I 7 -'I  
C o n t e n  I *
PU 501
0 . 32( 1) 
0 .1(0(1) 
0 . 3 1 ( 1 )  
0 . 3011) 
0 . 0 9 ( ' l )
1 Dose in m g/kg iv producing 50 % neurom uscular paralysis.
1 No. of animals.
3 Solution not incu b a ted ; acidified to pH  3.0.
Experiments with potency measurements in mice follow  
ing incubation with appropriate buffers showed that atra­
curium undergoes non-enzymic decom position which is 
three times faster at pH 7.6  than at pH 6.9  (19) indicating 
that chemical breakdown contributes substantially to the 
termination o f neuromuscular blockade. Furthermore, simi­
lar in vitro  experiments showed that the rate o f decom posi­
tion in human plasma was twice as rapid as that in buffer at 
the same pH, indicating the involvem ent of an enzyme- 
catalysed pathway.
Evidence for the non-enzymic breakdown was further 
supported by the significant reduction (P  <  0 .01) of neuro­
muscular paralysing potency and recovery time in eight 
anaesthetised cats after the pH o f arterial blood was 
increased from 7.31 to 7.63 by hyperventilation (20).
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Preliminary studies with 14C-labellcd atracurium iodide 
(21), prepared by m ethylation of the tertiary base 3 
(m — 2, x — 1, A — 0 ) with MC-methyl iodide confirms 
that a base-activated H ofm ann elimination at physiological 
pH is a major biodegradation pathway. Thus, incubation 
of the labelled com pound in both normal human plasma 
and w hole blood at 3 7 ° C, leads to a rapid release o f som e 
5 0  % o f the radio'labd as l4C-laudanosine 11. T he sub­
sequent sharp change in the slope of the curve (Fig. 2) 
is consistent with an initial fast Hofm ann elim ination of 
the intact ester accom panied by ester hydrolysis, with a 
reduction in ibhe elim ination rate as th e quaternary acid 12 
is formed. Similar results were obtained in atypical human 
plasma deficient in pseudocholinesterase (35 %  of normal 
activity'), which suggests that in contrast to Suxam etho­
nium, the inactivation o f atracurium is not dependent on 
this enzyme.
TA BLE IV. —  Direct comparison o f neuromuscular blocking  
potency, vagal blockade and recovery time o f atracurium besy­
late, lk  {m =  2, A  =  3) and com pound  10 (m =  3, A =  7) 
in groups o f 6 cats.
FORMATION OF ’’C-IAUDANQSINE FROM 
UC-ATRACURIUM IODIDE IN HUMAN PLASM' 
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Fig. 2
Direct comparison o f  atracurium besylate, l k  (m =  2, 
A =  3) with compound 10 (m =  3, A  =  1) demonstra­
tes the role o f the interquaternary chain structure in deter­
mining potency, vagal block and m etabolism (Table IV). 
Inter-onium group spacing is identical in both compounds 
(13 m ethylene or other spacially equivalent units), and 
accordingly no difference is observed in either potency  
(P D 50) or vagal block (V D 50). Compound 10 with its 
frimethylene separation between ester carbonyl and onium  
groups, is markedly less activated for both Hofm ann elim i­
nation and ester hydrolysis than atracurium. In contrast to 
atracurium, this com pound shows a significant increase in 
the time taken for full recovery from the onset o f com plete  
neuromuscular block (P  <  0 .01).
Studies of the effects o f simulated renal failure on the 
action o f atracurium in anaesthetised cats (in comparison 
with gallam ine ; 20) underline the importance of its facile 
m etabolic breakdown. These show that in the absence
1 Dose in m g/kg i.v. (mean ±  SEM ).
2 Difference not significant.
! Time in minutes following standard dose of 0.25 m g/kg (mean 
±  SEM).
4 P < 0 .0 1 .
of renal excretion (bilateral renal ligation), the neuro­
muscular paralysing potency and the time-course o f action  
of atracurium were not significantly changed, whereas the 
potency o f gallamine was increased about twofold and 
recovery considerably delayed.
E X PE R IM E N T A L
Unless stated otherwise, melting points were recorded on a 
Kofler Heizbank 184321 melting point apparatus. Infrared spectra 
were obtained on a Perkin-Elmer 157 instrum ent using either liquid 
films or in KC1 discs (for solids). P roton magnetic resonance spec­
tra were recorded on a Perkin-Elmer R12 instrument operating at 
60 M Hz. TM S was used as internal standard. IR and N M R data 
were in accord with the structures given and are available on 
request from the authors (RDW  and G H D ). M icroanalytical results 
(C,H,N except where stated otherwise) were within ±  0.4 % of 
theoretical.
1,4-Bishyclroxymeihylbenzene
Terephthaloyl chloride (20 g ; 0.10 mole) in a mixture of dry 
tetrahydrofuran (80 ml) and dry ether (50 ml) was added dropwise 
over 0.5 h to a stirred slurry of lithium  aluminium hydride (20 g ; 
0.53 mole) in dry ether (250 ml). The mixture was refluxed for 
4 h, cooled to  5°C, and the complex and excess hydride destroyed 
by the careful addition of water (20 ml), sodium hydroxide solu­
tion (5N ; 15 ml) and w ater (70 nil) respectively (22). The granular 
mass was filtered off and the filtrate evaporated in vacuo to leave 
a colourless solid which was triturated  with ether (50 ml), filtered 
off and dried. The diol (13.5 g ; 84 % ) had m.p. 115°C [Lit (23) 
115-116°C and 117.5-118.5°C (24)1.
3-M ethyl pent an-L ,5-diol
3-M ethylglutaric anhydride (25 g ; 0.20 mole) in a mixture of 
dry tetrahydrofuran (100 ml) and dry ether (100 ml) was added 
dropwise over 0.5 h to a stirred slurry of lithium aluminium 
hydride (25 g ; 0.66 mole) in dry ether (150 ml) at 5°C. The mix­
ture was refluxed for 6 h, cooled to 0-5°C, and the complex and 
excess hydride destroyed by careful addition of w ater (25 ml), 
sodium hydroxide solution (5N ; 18.5 ml) and water (87.5 mi) 
respectively (22). The inorganic salts were filtered off, the solvents 
removed in vacuo, and the oil distilled. The diol (7.6 g ; 33 % ) 
had b.p. 110-112.5°C/0.77 mmHg [L it (25) b.p. 117°C /0.4 m m Hgl.
A lkane-wo-diol diacrylalex (5 ; Table V)
Acryloyl chloride (0.2 mole) in dry benzene (60 ml) was added 
over 0.5 h to a mechanically stirred mixture of the appropriate 
alkane-wn-diol (0.1 mole) in dry benzene (100 ml) containing tri-
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cthylam inc (0.2 mole) and pyrogallol (0.1 g). Further quantities of 
benzene (ca 100 ml) and triethylamine (10 ml) were added and 
the m ixture stirred at 50°C  for 0.5 h. The triethylam ine hydro­
chloride was filtered off, and the solvent removed in vacuo to 
leave dark yellow or pale red oils which were distilled under 
vacuum in the presence of a trace of p-methoxyphenol and exclud­
ing light. A fter distillation, the products were stored in the dark. 
D ata relating to the liquid acrylates prepared by this method are 
presented in Tabic V.
TA BLE V
Mo. (°C/mmHg) 55 r i c ld
L i t  b . p .  a m .
„ 6 .p.
( C/mmHg) l» c fe rn u :c
So 113-120/11 102/2 10
li 132-130/13 7*» 73-8 6 /0 .6 26
? 90-95/0 .1 61 110/1 10
« 150-165/5 33 130/1 t o
110- 113/ 0.03 62
c 121-122/0.02 67
K 9 6 - 9 9 / 0 .1 *10 1 18 / 0 . 8 10
'! 8 9 -9 3 /0 .'t 50
1.4-D ixylidyl diacrylate
1,4-Bishydroxymethylbenzene (12 g ; 0.09 mole) and acryloyl 
chloride (13.8 m l ; 0.018 mole) in dry tetrahydrofuran (60 ml) and 
dry ether (30 ml) were treated with triethylam ine (24.2 ml ; 0.18 
mole) in dry ether (60 ml) over 0.5 h, with mechanical stirring. A 
further quantity of dry ether (100 ml) was added followed by 
triethylamine (10 ml), and the mixture stirred for a further 0.5 h. 
The triethylam ine hydrochloride was filtered off and the solvents 
removed in vacuo. The yellow solid diacrylate crystallised from 
petroleum ether (b.p. 60-80°C) as pale yellow needles (6.3 g ; 
29 % ), m.p. 72-73°C [Lit (10) 74°C1.
3 .4-Dichlorophenylacetic acid
Prepared from 3,4-dichlorobenzyl chloride by the method of 
M ay  and M o s e t t ig  (27) had m.p. 79-80°C , from petroleum ether 
(b.p. 60-80°C ) ; [Lit (27) m.p. 82-82.5°C],
2-Bromo-4,5-dimethoxyphenylacetic acid
Bromine in chloroform  (20 g in 100 m l; 0.012 mole) was 
added dropwise to a solution of 3,4-dim ethoxyphenylacetic acid 
(20 g ; 0.012 mole) in chloroform (50 ml) over 2 h with stirring. 
The organic layer was washed with dilute sodium thiosulphate 
solution (2 x  100 ml) and then with dilute sodium bicarbonate 
solution (250 ml, 150 ml). The com bined bicarbonate washings 
were washed with ether (50 ml) and acidified with dilute hydro­
chloric acid. The colourless solid which precipitated was filtered 
off, washed with water, and dried in vacuo over P>05 at 50°C.
2-Bromo-4,5-dimethoxyphenylacetic acid (22.5 g ; 80 % ), m.p. 
118°C, crystallised as fine needles from  petroleum ether (b.p. 60- 
80°C)-cthyl acetate, m.p. 118-119°C [Lit (28, 29) 115-116°C and 
114-116°C respectively],
N-(2~Phenylethyl)phcnylacctamides (6 ; Table VI)
The amides prepared from various substituted phenylacetic 
acids were synthesised by the following general method. The phc- 
nylacetic acid (1 mole equivalent) and appropriate 2-phenylethyl- 
am inc (1.025 mole equivalent) were heated together in an open 
vessel a t 190-210°C for 2 h. The crystalline mass obtained on 
cooling the reaction mixture was purified by recrystallisation 
from  ethanol o r aqueous ethanol (except where otherwise stated 
in Table VI) as colourless needles. Relevant data for various 





L i t  m .p . a n a  , c f o r , n e t /A n a l .
<Scr n « r c r n n ,w
.m 11) 75 .0 8 JO
110 31
> 126- 12? 112 1 * 3 ,5 J*
118-120
1 0 0 .5 -1 0 1
92 12'.
AiwU. f o r  e 20H25JIO,.t
IH -1»»2 i»i2-l%'» 33
f 100-101 n 1 0 1 .3-102 3-‘i
158 80 A n a l. Co. C ^ H ^D rK O y  C .H .N .O r
- 128* 61* AnoV. f o r
1 135 -136 69 136 1 -
1 Recrystallised from  ethyl acetate.
’ Recrystallised from petroleum ether (b.p. 100-120°C). 
J Recrystalliscd from petroleum ether (b.p. 80-100°C).
N-l2-(3,4-D iinetlioxyphenyl)ethyl]-3(-3,4-dim etliaxyphenyl)propioii-
amide
3-(3,4-Dimcthoxyphenyl)propionic acid (10 g ; 0.05 mole) and 
homoveratrylamine (9 g ; 0.05 mole), treated exactly as described 
for the preparation of the /V-(2-phenylethyl)phcnylacetamides, gave 
the am ide (10.5 g ;  5 7 % , m.p. 102-104°C [Lit (36) 98-99°C].
Substituted I - benzyl-1 ,2 ,3,4-tetrahydro-6,7-dimethoxyisoquinolines
(4, Table VII)
These were prepared by a general method given in detail for the 
synthesis of l,2,3,4-tetrahydro-6,7-dimethoxy-l-(2-(3,4-dimethoxy- 
phenyl)ethyl]isoquinoline as follows ; N-[2-(3,4-dimethoxyphcnyl) 
cthyl)-3-(3,4-dimethoxyphcnyl)propionamide (9.0 g ; 0.024 mole) in 
dry toluene (60 ml) was refluxed with phosphoryl chloride (40 
ml) for 3 h. The partially cooled reaction mixture was then pou­
red into petroleum  ether (b.p. 60-80° C ; 400 ml), and the liquid 
was decanted from the semi-solid which precipitated over 15 min. 
The semi-solid was washed well with petroleum ether (b.p. 40- 
60“C), dried, and crystallised from ethanol-ethcr. This 3,4-dihy- 
droisoquinolinium salt in ethanol (95 %  ; 60 ml) was treated 
with sodium borohydride (4.0 g ; 0.105 mole) in portions over 1 h, 
and the mixture was then stirred for 18 h a t room tem perature. 
The excess of borohydride was then destroyed by the addition of 
hydrochloric acid (2N), and the mixture evaporated to dryness 
in vacuo. The off-white mass rem aining was treated with sodium 
hydroxide solution, and the liberated amine extracted with ether 
(2 X 200 ml). The combined extracts were washed with water 
(2 x  50 ml), dried (Na.SO,), filtered, and treated with an ethereal 
hydrogen bromide solution. Crystallisation of the precipitated solid 
from methanol gave 1,2,3,4-tetrahydro-6,7-dimethoxy-l-[2-(3,4- 
dim ethoxyphenyl)ethyl]isoquinoline hydrobromide as colourless 
needles (4.2 g ; 40 % ), m.p. 167°C. The hydrochloride, prepared 
from base purified via the hydrobromide salt, had m.p. 184°C 
[Lit (36) m.p. 185-186°C]. The free base was a colourless, viscous 
oil.
Data for the l-benzyl-l,2,3,4-tetrahydroisoquinoIines prepared 
by this m ethod are given in Table V II. W here appropriate, oxa- 
.lates were prepared by addition of ethereal oxalic acid solution 
at the relevant stage of the synthesis.
Propane-1,3-bis(4-broinobutanoate)
A y-butyrolactone (36 g) and propane-1,3-diol (15.2 g) mixture 
a t 0-5°C was saturated over 2 h with hydrogen bromide gas, and 
then left a t 0°C  for 24 h. The mixture was added to  w ater (300
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TA BLE Vll
P r o to n  a a 1r
Compound C r y H ta l -U s iu s
s o lv o n t
r. Y io t.i
?®G)
L i t  m .p . and  r o C c rc n v V A n a l .
(°C ) R c f e r c m f f
W MeOH-BtfcO 7*1 2A *' 215* 37
b Mo01t-Ef_.fi 65 A 7 7 -1 7 9 ‘ 182* 32
; MeGH-E t ., i» 71 S I S ' 2 1 7 -2  lV 3«
EtOli 68 2 0 7 -2 0 8 * A n a l . f o r  C.,„H 0 • C 11 N8 '
McOH 6 9 1 1* 2 - 1  VV* l» l» t-lV 6 ‘
r.» MeGU W ; 126*-1 3 0 1
«*■ MeOlt 56 - 2 2 6 ' A n a l , f o r  Co0l t„ .8 C.M.K
h £cO|l th e n ;,0 2 1 8 -219* Ana 1 . f o r 1,5*0 : C.H.N*
EtO H -Et,,G
•i : MoOH-Rt.o 2 38 ' 2 3 b1 ! 4V
H ydrochloride.
Oxalate.
Free base partially crystallised on standing.
F ree base, m.p. 120°C (petroleum ether, b.p. 80-100°C - ethyl 
acetate). [Lit (41) m.p. 1U °C, aqueous ethanol].
Yield after borohydride destruction, evaporation of solvents, 
and crystallisation of the hydrochloride from aqueous solu­
tion.
The free base, 7, obtained by ether extraction, was a colourless, 
viscous oil. Tic on polygram Sil G /U V 2S< in cthanol-ethyl acetate 
(1:1) showed a single spot, R[ ca 0.6.
The N N ’-dim ethyl ilimesylate, 8, was obtained by treating scru­
pulously dry bis-amine, 7 (0.3 g ; 0.0003 mole) in spectroscopi­
cally pure acetonitrile (1.5 ml) with freshly-distilled methyl metha- 
nesulphonate (1.0 ml) at room tem perature for 48 h, maintaining 
anhydrous conditions throughout. The filtered reaction mixture 
was added dropwise to mechanically stirred, filtered, dry ether 
(ca 500 ml). The flocculent white precipitate was washed with 
dry ether, and dried in vacuo over P2O s at 50” C. The bis-quater­
nary salt, 8 (0.27 g ; 73 %) had m.p. 98-105°C. Anal, for 
CwH^N.O.A • 3HjO : C, H, N.
Bis-l-benzyltetrahydroixoquinoline esters, 3
The bis-amine esters, 3, were synthesised from the appropriate 
l-benzyl-l,2,3,4-tetrahydroisoquinoline, 4, and diol diacrylate, 5, 
by the method outlined above for the preparation of 1,13-bis- 
{1,2,3,4-tetrahydro-6,7-dimcthoxy-l - [2-(3,4 - .dimcthoxyphcnyl)ethyl ] 
isoquinoIin-2-yl}-4,10-dioxa-3,ll-dioxotridecane, 7. The dioxalate 
salts were crystallised from  ethanol and recrystallised, where 
necessary, from the same solvent until the free base showed a sin­
gle spot by TLC using polygram Sil G /U V w , ethanol : ethyl ace­
tate (1:1), with iodoplatinate visualisation (42). The dioxalate 
salts were characterised by their melting points and IR characte­
ristics (Table V III). The free base, obtained from pure dioxalate 
salt, was isolated with ether or preferably toluene.
TA BLE V III
ml), and extracted with ethylene dibromide (2 X 100 ml). The 
combined extracts were washed with w ater, dried (Na.SOi), and 
evaporated to leave an oil. The m ajor distillablc com ponent (ctt 
50 g ; b.p. 106-140°C/0.05 mmHg) was 3-bromo-l-propy! 4-bro 
m obutanoate. The viscous pot residue was extracted with petro­
leum ether (60-80°C ; 3 x  150 ml) and the combined extracts eva­
porated to leave a colourless oil (12.5 g ; 17 % ) shown by IR  and 
NM R data  to be propane-l,3-bis-(4-brom obutanoate).
W J'-5,9-Dioxa-4,J0-dioxotridecylane-1,13-bis-tetraliydropapaverine,
Propane-l,3-bis(4-brom obutanoate)- (1.8 g) in refluxing dry 
toluene (10 ml) was treated with tetrahydropapaverine (6.8 g) in 
toluene (50 ml) dropwise over 0.5 h. The mixture was refluxed for 
18 h, cooled, and filtered from tetrahydropapaverine hydrobromidc. 
The filtrate was evaporated in vacuo, and the residual oil dissolved 
in chloroform  (10 ml). A ddition of ether (ca 500 ml), followed by 
saturated ethereal oxalic acid solution (ca 500 ml), gave a floccu­
lent white precipitate which was filtered off, washed with ether, 
and dried. Crystallisation from ethanol (twice) gave NN'-5,9- 
dioxur4.,l O-dio-xotridecylene-1,13-bis-tetraJiydropapaverine dioxa­
late (2.6 g ; 49 % ) as a w hite powder, m.p. 107-115°C.
The free base, 9, obtained by ether extraction, was a colour­
less, viscous oil. The TLC on Polygram Sil G /U V 25) in ethanol : 
ethyl acetate (1:1) gave a single spot, R r ca 0.65.
/ ,13-B is-{l ,2,3,4-tetrahydroi-6,7-dim ethoxy-1 -[2-(3,4-di.methoxy pbe- 
nyl)ethyl]-isoquinolin-2-yl}-4,10-dioxa-3,11 -dioxotridecane, 7, and 
bisquaternary salt, 8
1,2,3,4-Tetrahydro -6 ,7 -d im eth o x y -1 - [2 -(3 ,4 -dim ethoxy phenyl) 
ethyl]isoquinoline (3.4 g ;  0.01 mole) and pentane-l,5-diol dia­
crylate (1.0 g ; 0.005 mole) in dry benzene (16 ml) were stirred 
for 48 h under reflux and excluding light. The solvent was rem o­
ved in vacuo and the residual oil dissolved in chloroform (15 ml). 
Ether (300 ml) was then added followed by a saturated solution of 
oxalic acid dihydrate in ether (ca 300 ml). The precipitated solid 
was filtered off, washed with ether, and dried in vacuo over P2Os. 
The 7 dioxalate (2.8 g ; 53 % ) was obtained as a yellow powder, 
m.p. 69-75°C, from ethanol.
C om pound
N o .
B a s e D i o x a l a t e s a l t
m .p .  ( ° C ) % Y i e l d  f ro m
d i a c r y l n t e
m .p .  (°C >
3« 6 9 1 2 6 - 1 2 8 ’
b O i l (A 1 2 0 - 1 2 6
c O i l 70 1 2 6 - 1 2 6
a V i -*i 6 3 /, 1 1 3 - 1 1 7
» 66-66 3 8 1 2 9 - 1 3 7
r *i 6-* i 7 6 2 1 2 6 - 1 2 8
s 6 5 - 6 7 -18 1 2 8 - 1 3 3
t. /»5 - 6 8 2 5 1 3 0 - 1 3 8
i. '16-'18 50 1 2 6 - 1 3 2
S *»A- 6 6 <18 1 2 3 - 1 2 6
k O i l 5 t 1 1 7 - 1 2 1 *
I o n 6 ? 1 1 5 - 1 1 9
m G l a s s 7 6 1 1 2 - 1 1 6
n G l a s s 60 1 2 9 - 1 3 5
o 6 9 - 5 0 68 1*1 6 -1 5 1
p 39 1 2 0 - 1 2 7
,, 57 1 1 3 - 1 1 8
r 35 1 2 8 - 1 3 5
a 38 1 1 2 - 1 1 8
1 Anal, for Cs5H,„N20 2„, C, H, N.
: Anal, for CS2H hN 2Ow, H 20 ,  C, H, N.
The N N ’-dim ethyl quaternary salts ( la -Is  and 10, Table IX) 
were prepared and isolated in a sim ilar way to that described for 
synthesis of /V/V’-dimcthyl-l,13-bis-{ 1,2,3,4-tetrahydro-6,7-dimcth- 
oxy - 1 - l2-(3,4-dimethoxyphenyl)ethyl)isoquinolinium-2-y!}-4,10- 
dioxa-3,11-dioxotridecane dimesylate (8, above) using scrupulously 
dry bis-amine and purified methyl iodide or methyl methanesul- 
phonate, as appropriate. l4C-A tracurium  iodide was prepared simi­
larly from the base 3k and uC-methyl iodide.
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TABLE IX
Studies with UC-Atracurium  iodide in normal human plasma in 
vitro
"C-A tracurium  iodide in methanol (1 ml ; 100 jig/tnl) was 
placed in a test lube, and the methanol removed in a current 
of nitrogen at 37°C. Freshly reconstituted pooled Dried Human 
Plasma (5 ml ; pH 7.4) was added, mixed, and the solution main­
tained at 37° C with gentle shaking. Plasma samples (0.6 ml) were 
taken at timed intervals, extracted with ether (5 ml), and appro­
priate aliquots taken for counting. Controls were effected by 
repeating the experiment in duplicate using water (5 ml) in place 
of plasma, and extracting immediately with ether (5 ml). The 
results in a typical experiment are shown in Fig. 2. Similar 
results were obtained with a sample of fresh whole blood and fresh 
plasma from a norm al subject ; also with atypical hum an plasma 
with a 65 % deficiency in pseudocholinesterasc.
Neurom uscular and vagal blocking potencies
N eurom uscular and vagal blocking potencies were determined 
on gastrocnemius muscle-sciatic nerve preparations from cats and 
rhesus monkeys as previously described (43, 44). The results are 
given in Tables I and II.
Stability o f Atracurium  besylate in pH 7.4 buffer, cat and human 
plasma
A tracurium  besylate was incubated with 0.2M tris buffer 
pH 7.4, cat and human plasma (2 subjects) respectively at 37°C 
for 30 min. The solution was adjusted to pH 4.2 with glacial 
acetic acid, cooled in ice, and its neurom uscular blocking potency 
determ ined in the cat as described above (1). The results are given 
in Table III.
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R e s u m e
Une serie de di-esters d ’w.oi-bisbenzylisoquinolinium destines a 
subir une 61imination d’H ofm ann au pH physiologique a etc syn- 
thdtisde. La puissance du blocage ncurom usculairc augmente jus- 
qtt’a un cspacement de 13 ou 14 atonies, pour diminuer ensuite. 
11 a ct6 dcinontre que Ies composes les plus actifs posscdent une 
bonne activite de blocage neurom usculaire non-depolarisante avec 
une forte specificit6 envers la jonction neurom usculaire et une 
durcc d’action moyenne. Le Besylate d’A tracurium  (dibenzene- 
sulfonate di-isoquinolinium f l . l 1, 2,2', 3,3', 4,4'-octahydro-6,6\ 
7 ,7l-tctram ethoxy-2,2 '-dim 6lhyl-l,l1-diveratryI-2,2 '-(3,ll-dioxo-4,10- 
dioxatrideca-methylene)! qui est en corns d ’clude clinique comme 
agent de blocage neurom usculaire semble etre rendu inactif par 
des m tatnism es enzymatiques et non-enzymatiques. II semble que 
la voie chimique de 1’elimination d’Hofmann joue un role impor­
tant dans ccttc inactivation.
Z u s amm en  f a s s u n g
Eine Reihe a.m-Bisbenzylisochinolinium-poIyalkylen-diester. die 
bci physiologischem pH  ciner Hofmann-Elim inierung unterliegen 
sollten, wurde synthetisiert. Die neurom uskular blockicrende Wir- 
kttng steigt bis zu einer Interonium -D istanz von 13 bis 14 Atomen, 
daruber nimmt sic wieder ab. Die wirksamstcn Vcrbindungen 
zeigtcn gutc nicht depolarisierende neurom uskulare A ktivitat mit 
lioher Spezifizitiit fur die neurom uskulare Junktion und m ittlercr 
Wirkungsdauer. A tracurium  Besylat ( l , l ’.2,2’,3,3’.4.4’-Octahydro- 
6.6’.7.7’,- tetram ethoxy-2,2’-d im ethy l-l.l’-diveratryl-2,2’-(3,l 1-dioxo-
4,10-dioxatridecam ethylen)-diisochinolinium -dibenzosulfonat) wur­
de Fur klinische Zweckc entwickelt zur neurom uskularen Blockier- 
ung. Es wird offenbar sowohl durch enzvmatische als auch nicht- 
enzymatische M echanismen inaktiviert. Es gibt Anzeichen fiir die 
Vcrmutung, daB die chemisch crwartete Hofmann-Elim inierung 
eine wichtige Rolle in dieser Inaktivierung spielt.
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A Preliminary Assessment of Atracurium, a New 
Competitive Neuromuscular Blocking Agent
G . G. C o k e r ,  G. H . D e w a r .,  R. H u g h e s ,  T. M . H u n t ,  J .  P. P a y n e ,  J .  B. S t k n la k i:  a n d  R. D . W a k ;h
Wcllriiinc Rcscair.li Laboratories, Beckenham, Kcm ; Department o f Pharm aceutical Chemistry, University of Strathclyde, Glasgow; and 
Research Department of Anaesthetics, Royal College of Surgeons of England and St. Peter’s Hospitals, London, U.K.
Atracurium  besylate, 2,2'-(3,l I-dioxo-4, lO-dioxalridccylcne)-bts-|6,7-diincthoxy-I-(3,4-dimelhoxybciizyl)-2- 
m ethyl 1,2,3,1 -let rahydroisoquinolin i uni j dibenzcuesulphonate is a potent non-depolarising (competitive) 
neurom uscular blocking agent in the eat, monkey, dog and anaesthetised m an. In m an, it caused complete 
paralysis of the tetanic response of the adductor pnllicis muscles at doses or 0.2 itig/kg. Blockade was of medium 
duration  with rapid spontaneous recovery, and was readily reversed by neostigmine. The electrocardiogram, 
heart rate, arterial blood pressure and central venous pressure were virtually unchanged following doses ol 
0 .2 -0 .'I tug/kg. Intubation was readily accomplished in 1.5-2 min after adm inistration til 0.25-0.3 mg/kg.
Itecciued 4 August, accepted Jo> publication 24 Octobe, 19110
All non-depolarising (competitive) neuromuscular 
blocking agents in present clinical use have disadvan­
tages. In particular, all exhibit vagal blockade and other 
cardiovascular effects in some degree ( H u g h e s  &  
C h a i t i .k 1976a), and all show a significant increase in 
the duration of neuromuscular blockade when excretion 
is inhibited by renal insufficiency (YVin g a r d  & C o o k  
1977).
Atracurium besylate (British approved name), 2,2'- 
(3,11 -d ioxo-4,10-dioxatridecylene)-bis-[6,7-dim eihoxy  
1 -(3,4-dim ethoxybenzyl)-2-m ethyl-l ,2,3,4-tctrahydroi- 
soquinolinium] dibertzcnesulpltonate (Fig. 1), is sub­
stantially free of these disadvantages. Il is one of a series 
of non-depolarising neuromuscular blocking agents de­
signed to induce ready fragmentation to inactive m oie­
ties iti vivo by a com bination of enzymic ester hydrolysis 
and facile base-catalysed degradation of its quaternary 
amm onium groups initiated at physiological pH (S t e n ­
l a k e  et al. 1977). A preliminary account o f its 
properties has already been reported to the Anaesthetics 
Research Society ( H u g h e s  & C haimm.e 1980, HuNi etal. 
1980).
M ATERIAL AND M E T H O D S
Effects of atracurium  besylate (0 .5 -1.0 pg/m l) were studied oti isolated 
chick bivenler-eervicis preparations,equilibrated with 95 % O? and 5% 
CO? in Krebs solution at 35° and stimulated at 0.12 Hz with 
rectangular pulses of supram axim al voltage and duration. Effects on 
neurom uscular transmission following bolus intravenous injection of 
atracurium  were studied on sciatic nerve-gastroencmius muscle
preparations in anaesthetised rats  as described by H cohks & G uawrlk 
(1976a), by similar techniques in beagle dogs, and  in rhesus monkeys 
(Hirmivs & Ghaimh.k 1976b) using the anaesthetic regime dcsciibed 
for man. Arterial blood pressure, respiration and  heart rate were 
recorded. Effects on autonom ic nervous transmission were assessed by 
stimulating the cervical vagus nerve and m easuring the ensuing 
bradycardia, and by stimulating the cervical sympathetic nerve and 
recording the contractions of the nictitating m em brane. Histamine 
release was assessed In beagle dogs using Hi - and Hx-rrceptor 
antagonists.
Studies in anaesthetised m an using tlu* techniques described by 
111 m m s et al. (1976) were performed in 12 male patients who had 
given their informed consent and were about to undergo urological 
surgery. ‘Hie trial was conducted with the authority  of a Clinical Trial 
Certificate issued with the approval of the Com m ittee on Safely or 
Medicines. Approval was also obtained from the Ethics Committee of 
St Peter's Hospitals. No premedication was given. Anaesthesia was 
induced with 5% thiopentone (300-600 mg) and in 9 of the 12 patients 
continued with 2 to 4% halothanc in oxygen until deep enough for 
m tubalioii, which was carried out without the use o f a neuromuscular 
blocking agent after the larynx had been sprayed with 4% lignocainc.
H alothanc was then w ithdrawn and anaesthesia m aintained with 
60-75% nitrous oxide and oxygen combined with interm ittent positive 
pressure ventilation. Supplements of 100-200 mg thiopentone and 
25-50 mg pethidine were given as required. T etanic and single twitch 
con tract ions of the adductor pollicis muscles were recorded simul­
taneously by stim ulating each u lnar nerve supra maximally a I the wrist 
every 12 s, one with tetanic bursts (50 Hz; 1 s) and the other with single 
shocks.
Arterial pressure and  central venous pressure were measured 
directly from catheters in the radial artery and the right heart, 
respectively; heart rate was obtained from the electrocardiogram. 
Arterial blood gases were m aintained within normal limits.
Thereafter, a tracurium  was given intravenously in the dose range 
0.2-0.3 mg/lcg. Three patients, who were not given halothane but 
m aintained on nitrous oxide and oxygen alone, were intubated after 
the adm inistration of the drug.
0001-5172 /81 /010067-03  *02 .50 /0  ©1981 The Scandinavian Society of Anaesthesiologists
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R E SU LT S
Atracurium caused a non-depolarising block of the chick 
biventer-cervicis preparation without producing initial 
contracture. In anaesthetised cats, intravenous doses of 
0.25 m g/kg (four cats) or0.5 m g/kg (two cats) caused full 
neuromuscular blockade and arrested breathing in 1-2 
min; full recovery required 35 +  4.7 min. Edrophonium  
(0.2 m g/kg i. v.) and neostigmine (0.05 m g/kg i.v.) were 
effective antagonists. Vagal blockade only became ap­
preciable at doses 8 times the full neuromuscular 
paralysing dose (Fig. 2). At these doses, sympathetic 
effects were slight. Arterial blood pressure was reduced 
by a mean o f 34± 5 .4%  only with 16 times the full 
paralysing dose; changes in heart rate were minimal. In 
six other cats, neuromuscular paralysing potency and 
the course of recovery were similar whether atracurium  
was administered via the hepatic portal vein or via the 
jugular vein. The action of atracurium and its duration 
were unaltered when renal function was abolished by 
ligating the artery, vein and ureter o f each kidney.
In h ib i t io n
Mean of 6 Cats
N e u r o m u s c u la  i 
V a g a l
Sympathetic
0 0 6 2 5 0 1 2 5  0-25 0  5 1-0 2 0  4-0
Potency and the time course o f action of atracurium  
were similar in seven rhesus monkeys and four beagle 
dogs to results in cats. Appreciable vagal blockade 
occurred only at 16 times full neuromuscular paralysing 
doses in the monkey. At this dose, sympathetic effects 
were slight and changes in heart rale minimal, though 
19±7%  reduction in arterial blood pressure occurred. In 
four beagle dogs, only doses of 4 and 8 times the full 
neuromuscular paralysing dose (0.25 m g/kg i.v.) caused 
mean reductions respectively in arterial blood pressure 
of 28 ± 1 4 .I%  and 47 +  20.2%, and in heart rate of 
10 +  4.0% and 1 2 ±  1.5%. M epyram inc 10 m g/kg i.v. 
(Hi-receptor antagonist) and burimamide 15 m g/kg i. v. 
(Hz-receptor antagonist) reduced the fall in arterial 
blood pressure, caused by 2 m g/k g atracurium (8 x full 
paralysing dose) from 52 to 1'6% and 42 to 25%, 
respectively, in each o f two dogs.
In anaesthetised man, atracurium, 0.2 m g/kg i.v. 
caused complete paralysis of the tetanic response of the 
adductor pollicis muscles; 0.3 m g/kg was required to 
block the single twitch response ( H u n t  et al. 1980). 
Blockade was of medium duration (6-19  min) with 
spontaneous recovery o f the tetanic response in approx. 
30 min; paralysis was readily reversed by neostigmine. 
No important changes in the electrocardiogram, heart 
rate, arterial blood pressure or central venous pressure 
were observed following doses o f 0.2 to 0.4 m g/kg  
atracurium (Fig. 3). In each o f three patients, intubation 
was accomplished in 1.5-2 m in after administration of 
0.25-0 .3  m g/kg atracurium and when the vocal cords 
were relaxed. A paralysing dose o f 0.2 m g/kg in one 
patient maintained on 1 % halothane throughout did not
40s a f te r  ATRACURIUM 0.25m g/kg  i . v .
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Fig, 2. Dose-re-sponsc curves for a tracurium  showing blockade of 
neuromuscular and autonom ic mechanisms in anaesthetised eats. 
Vertical lines indicate s.e.mean.
2.5m in 17min
Fig. 3. Tracings from an anaesthetised patient recorded at a faster 
paper speed showed that an intravenous dose of 0.25 m g/kg atra- 
eurium, which abolished the tetanic and single twitch responses of the 
adductor pollicis muscle, did not change the electrocardiogram, heart 
rate, arterial blood pressure or central venous pressure.
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potentiate the hypotensive effects of halothanc. AH 12 
patients studied made uneventful recoveries.
D ISC U SSIO N
The results in laboratory animals show that atracurium  
is a potent, non-depolarising neuromuscular blocking 
agent. Il is readily antagonised by neostigmine and 
shows a wide separation between its neuromuscular 
paralysing actions and cardiovascular side-elTects.
In man, the potency and duration of action of 
atracurium proved to be similar to those observed in 
laboratory studies. The tetanic response was depressed 
more readily than that o f the single twitch, and tetanic 
lade was prominent. Intubation was possible within 
90-120 s o f injection. Recovery which followed a 
sigmoid pattern in both responses resembled that follow­
ing suxamethonium (S tJG A i et al. 1975) rather than non­
depolarising drugs. Neuromuscular paralysis was rapid­
ly reversed by neostigmine. Cardiovascular stability 
following administration of atracurium to man was good 
and comparable with that of dimethyl tubocurarine 
(Hogues et al. 1976). No important changes were 
observed in the electrocardiogram, heart rate, arterial 
blood pressure or central venous pressure (Fig. 3). The  
very consistent rate o f recovery observed in patients is 
seen as a distinct advantage, which animal studies 
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Biodegradable neurom uscular blocking a g en ts
P art. 5 -  a , u >-b isquatem ary pojyalkylene phenolic esters
John B. S t e n l a k e  (*), Roger D. W a ig h  (**) and George H. D e w a r  (***)
Department o f  Pharmaceutical Chemistry, University o f  Strathclyde, George Street, Glasgow, Gl I XW,  Scotland
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Department o f  Pharmacology, The Wellcome Research Laboratories, Beckenham, Kent 
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Summary. A small group of a ,u-bisquaternary polyalkylene esters of quinol, catechol and pyrogallol have been synthesised, and tested as poten­
tial biodegradable neuromuscular blocking agents. Three o f the compounds were virtually inactive and the remainder o f low potency compared 
to that of tubocurarine. Duration o f action and vagal blockade have also been recorded.
Resume. Un groupe restreint d ’esters polyalkeniques a, <>> bisquatcrnaire; de quinol, catechol et pyrogallol ont ete synthetises et essayes en tant 
q u ’agents bloquants dans le domaine neuromusculaire, biodegradables. Trois des composes sont inactifs et le dernier n ’a q u ’une faible activite 
en comparaison de cellc de la tubocurarine. La duree d ’action et le blocage vagal ont aussi ete enregistrcs.
Zusainmenfassung. — Einigc a.oi-bisquartarc Polyalkylen-ester von Hydrochinon, Brenzcatechin und Pyrogallol wurden synthetisiert und als 
potentielle abbaubarc, neuromuskulare HetnmstolTe getestet. W irkungsdauer und Vagus-Hemmung wurden bestimml.
Key-words : Neuromuscular blocking agents. — Quinol, catechol, pyrogallol (a, ta-bisquaternary polyalkylene esters) Q uaternary ammonium 
derivatives. Esters (quinol, catechol, pyrogallol). Vagal blockade.
In previous papers (1-4), wc have described a new approach 
to  shorter acting neuromuscular blocking agents based on 
Hofm ann elimination o f appropriate quaternary ammonium  
salts, rather than enzymatic biotransform ation. These studies 
led (4) to a particularly promising agent, atracurium besylate, 
o f high neuromuscular blocking potency and exceptional 
freedom from side effects, but neither atracurium nor any 
similar com pounds possessed the extreme brevity o f  action  
o f succinylcholine. This paper describes attempts to shorten 
the duration o f  drug action by studying analogous quaterni- 
sed 3-am inopropanoyl derivatives o f  quinol, catechol and 
pyrogallol. It was anticipated that such com pounds would 
undergo more rapid Hofm ann elimination at physiological 
pH than those esters reported hitherto (1-4) and also m ore 
rapid hydrolysis, both o f  which would contribute to shorter 
action and m ore rapid recovery.
CHEMISTRY
The quaternary salts (3a-g) were prepared by the route 
shown in Schem e 1. Quinol diacrylate la , catechol dia­
crylate lb  and pyrogallol triacrylate If were synthesised 
by m ethods previously described (3, 4). Attempts to prepare 
lesorcinol diacrylate and phloroglucinol triacrylate gave
(*) Author to whom correspondence should be addressed.
(#*) p reSent address : Department o f Pharmacy, University of 
Manchester.
(***) Present address : School o f Pharmacy and Pharmacology, 
University o f Bath.
only polymeric material. The quinol, catechol and pyro­
gallol acrylates proved to be remarkably reactive acceptors 
in the Michael reaction with secondary amines, as with 
diethylamine and l,2,3,4-tetrahydro-6,7-dim ethoxyquino- 
line, which react rapidly at room temperature. Tetrahydro­
papaverine, likewise, adds readily to quinol diacrylate to 
yield the required di-tertiary base 2g. However, in the reac­
tion between tetrahydropapaverine and catechol diacrylate, 
IR evidence suggested extensive am idation and pure bis- 
amine, 2, could not be obtained.
The reaction between ethanolic dim elhylam ine and quinol 
diacrylate also resulted in som e am ide formation, but 
pure 2a was obtained by crystallisation. Catechol diacrylate 
and ethanolic dim elhylamine, however, failed to yield the 
di-tertiary base, 2h, giving a mixture o f  its decom position  
products, ethyl 3-dimethylam inopropionate, 4, N ,N -dime- 
thyl-3-dimethylam inopropionamide, 5, and colourless need­
les (m.p. 64 from light petroleum) o f  a product with IR 
and N M R  spectroscopic properties consistent with the 
structure o f  the dim ethylammonium salt o f  2-(3-dimethyl- 
am inopropionoxy)phenol, 6 . N M R  evidence from this 
reaction and the following study o f the pyrogallol triacrylate 
reaction with diethylamine show that an initial rapid Michael 
addition is followed by alcoholysis and am idation as shown  
in Scheme 2.
The reaction between pyrogallol triacrylate and dimethyl- 
amine was followed by N M R  spectroscopy. The course 
o f  the reaction was effectively followed by observing the 
disappearance o f  the olefinic protons in the 85.80-6.80 
region and the emergence o f the C O C //2C //2N  proton 
resonance at ca 82.70, indicative o f  M ichael addition.
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(d) 1 1 ,2
(o) I 1,4
(I) 2 1 ,2 ,3
(9 ) 1 M
as a singlet at 82.71 indicating equivalence o f  the methylene 
protons in the resulting tris-amine, 7. The aromatic protons 
appeared as multiplet at 87.14-7.26. However, all attem pts 
to  isolate 7 resulted in extensive alcoholysis and amidation.
The driving force for the breakdown o f  2h and 7 seems 
to be relief o f  steric strain in these bulky 1,2-di- and 1,2,3- 
triesters. This is absent in the corresponding 1,4-quinol 
di-esters accounting for their stability. It is also inhibited  
in the 1,2- and 1,2,3-compounds derived from bulkier 
secondary amines, presumably due partly to shielding o f  
the ester carbonyl by the larger 3-am ino-substituents in the 
Michael addition products and partly to steric hindrance 
to attack at the ester carbonyl by the larger secondary  
bases.
The simple dim ethylamino base, 2a, was readily quater- 
nised with methyl iodide in ethanol to yield 3a. Similar 
treatment o f  the diethylamine bases, 2b and 2c, under a 
variety o f  conditions failed to yield the required quaternary 
salts. Evidence o f  elimination was observed not only in 
these unsuccessful quaternisation reactions, but also during 
the crystallisation o f  the corresponding dihydrochlorides 
from ethanol-ether. The ease o f  decom position o f  these 
phenolic amine salts is reminiscent o f the rapid decom po­
sition observed in (3-aminoketone proton salts and m ethio- 
dides which are profitably em ployed in the R obinson  
modification (5, 6) o f  the Mannich and Michael reactions, 
for the in situ  formation o f acrylates.
Amide formation was observed by the appearance o f  the 
C 0 ’N (C //3)2 singlets o f  A, A'-dimethyl-3-dimcthylamino- 
propionamide at 82.97 and 83.06, together with the asso­
ciated singlet at ca 88.10 for the phenolic hydroxyl group. 
Careful addition o f dimethylamine gas to the N M R  sample 
o f pyrogallol triacrylate (0. lg) in CDC13 at 5° C gave com ­
plete Michael addition in 2.75 min. without amide formation. 
The 18 yV-methyl protons appeared as a singlet at 82.28, 
the 12 protons arising from the C O C //2C / /2N moieties
M cj-N -CO-CH2-CH2-NMo2
O-CO-CHj CH2* NM«2 
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In contrast, the 1,2,3,4-tetrahydro-6,7-dim ethoxyisoquino­
line derivatives, 2d, 2e and 2f, were all successfully quater- 
nised at room  temperature by methyl iodide. The tetra- 
hydropapaverine analogue, 2g, however, could not be quater- 
nised with methyl iodide under a variety o f  reaction condi­
tions without accom panying side reactions. M ore reactive 
reagents such as dimethyl sulphate and methyl methane- 
sulphonate, likewise, failed to yield pure material. The 
more powerful methyl fluorosulphonate (7), however, gave 




Neuiom uscular blocking potencies and the extent o f  
vagal blockade o f  the quaternary salts, 3a and d-g, were 
measured in anaesthetised cats (Table I). Com pounds,
TABLE I. 
o f  a
— Neuromuscular blocking potencies and vagolytic effects 
o-bis-quaternary polyalkylene phenolic esters in cats.
C o m p o u n d  
N o .  n
R e la t i v e  m o la r 2
P D 5 0 V D 5 0 3 V D 5 0 / P D 5 0
R e c o v e r y '
p o t e n c y  1
II
3 a 1 9 .2
1 6 .1
0 . 5 2
0 . 6 2
1 2 .7  
4 . 1









e 4 . 2
4 . 4








f 0 5 - 7 . 8 - -
9 1 1 .7
8 . 0
1 .6 3
2 . 4 0





1 Individual results ; Tubocurarine -  100
- Dose in ing/kg i.v. producing 50 % neuromuscular blockade 
:l Dose in mg/kg i.v. producing 50%  vagal blockade 
1 Time in minutes for full recovery from onset o f complete paralysis 
5 No block recorded at doses up to 8 mg/kg.
3d and 3f, were inactive in doses up to 8 mg/kg. As expected 
from the spacial separation o f  its quaternary groups and 
their tri-A-methyl substituents, 3a was depolarising, pro­
ducing partial block and contracture o f  the chick biventer 
cervicis preparation (12) ; 3e also showed similar properties. 
Only 3g was non-depolarising as shown by the ready reversal 
o f neuromuscular blockade by edrophonium. Both 3e and 
3g showed low potencies com pared to tubocurarine and 
both caused vagal blockade at doses below those required 
for neuromuscular paralysis. All three com pounds, 3a, 
3e and 3g, were short-acting with a rapid rate o f  recovery.
EXPERIMENTAL
Unless stated otherwise, melting points were recorded on a Kofler 
Heizbank 184321 melting point apparatus. Infrared spectra were 
obtained on a Perkin-Elmcr 157 instrument and were obtained on 
liquid films or as K.CI discs (for solids). Proton magnetic resonance 
spectra were recorded on a Pcrkin-Elmer R12 instrument operating 
at 60 MHz. TMS was used as internal standard. IR and NMR data 
were obtained routinely and arc available on request from the authors 
(RDW and GHD). Microanalytieal results (C,H,N except where 
stated otherwise) were within ,-t- 0.4 % of theoretical.
Quinol Diacrylate, la. Acrylcyl chloride (18.1 g ; 0.2 mole) in dry 
benzene (60 m l)  was added over 0.5 h to quinol (11.0 g ; 0,1 mole) 
in benzene (100 m l)  and triethylamine (21.0 g) stirred at 5“ C. A 
further quantity of dry benzene (ca 100 rnL) was added followed by 
triethylamine (10 rnL) and the mixture stirred at 50” C for 0.5 h. The 
triethylamine hydrochloride was filtered off and the solvent removed 
in vacuo to leave a pale-red oil which solidified on addition o f «-hexane 
(ca 80 mL). Re-crystallisation from /t-hcxanc gave the diacrylate as 
colourless plates (10.1 g ;  46%), m.p. 86“ C (Lit (8), m.p. 86" C).
Catechol Diacrylate, lb .  Triethylamine (21.0 g) in dry ether (60 mL) 
was added over 0.5 h to catechol (11.0 g ; 0,1 mole) and acryloyl chlo­
ride (18,1 g ; 0.2 mole) in dry ether (200 mL) stirred at 5“ C. A further 
quantity of dry ether (100 mL) was added, followed by triethylamine 
(10 mL) and the mixture stirred at room temperature for a further 0.5 h. 
The triethylamine hydrochloride was filtered oft' and the solvent removed 
in vacuo. The red oil remaining was boiled with petroleum ether (b.p. 
40-60“ C ; 3 x 150 mL) and the separate decanted organic layers 
refrigerated to yield the diacrylate as pale-yellow needles (from petro­
leum ether, b.p. 40-60" C) (9.7 g ; 45 %), m.p. 35-36" C. Anal, for 
C(aHM0 4 : C.H.
Pyrogallol Triacrylate, If . Pyrogallol (6.3 g ; 0.05 mole) was treated 
with acryloyl chloride (11.8 mL; 0.15 mole) exactly as described 
for the synthesis of catechol diacrylate. The yellow solid produced 
on evaporation of the solvent was crystallised in petroleum ether 
(b.p. 60-80" C) to yield the triacrylate (5.2 g ;  36 %) as colourless 
needles, m.p. 80“ C. Anal, for Ct5H ,2Ou ; C,H.
1,2,3,4-Tetraliydro-6,7-diineth ixyisoquinnline was prepared as descri­
bed previously (3). The hydrochloride had m.p. 256-257“ C (Lit. (9), 
m.p. 253“ C) and the free base m.p. 86" C (Lit. (10), m.p. 84-85“ C).
Tetrahydropapaverine. Telrahydropapaverinc, as a colourless, vis­
cous oil, was obtained as described previously (3, 4). The hydrochloride 
had m.p. 218" C (Lit. (11), m.p. 217-219" C).
/,4-Bis-( 3-diniethylaminopropiunyloxy) benzene, 2a. Dimethylamine 
(I mL, 33 % solution in ethanol) in dry ether (10 inL) was added over 
15 min to a stirred solution of quinol diacrylate (0.5 g ; 0.0045 mole) 
in dry ether (10 mL) at 0 “ C. Stirring was continued at 0"C for 1 h 
and solvents removed in vacuo. The oil partially crystallised on standing. 
Crystallising solvents and other relevant data for this compound are 
given in Table II.
Bis-f3-aminopropionyloxy)benzene derivatives (2b-e and 2 g) and 
the tris-amine, 2f. The following general method was adopted.
To the secondary amine (ca 2.0 g ; 2 mole equivalents ; see Table 11) 
in dry ether or chloroform (ca 10 mL ; see Table II) at 0“ C was added 
the appropriate bis-acrylate (1 mole equivalent) and the mixture stirred 
at room temperature for 2-48 h (Table II ) . The proton salts of 2b  and 
2c were prepared by addition o f a saturated solution o f hydrogen 
chloride in dry ether, followed by ether, and crystallised from ethanol 
or ethanol-ether. Data relating to amines 2 b -g  are presented in Table II.
Quaternary salts (3a and d-f) were prepared by methods already 
described (3, 4 and 5). 3g was prepared by adding the theoretical 
quantity of freshly distilled methylfluorosulphonate (“ magic methyl ” - 
care !) to a solution o f pure 2g in dry CH2C12 (approx. 20 % w/v 
solution). The solid which had precipitated after 0.5 h was filtered 
off, washed with CH2C12 , then ether, and dried in vacuo. The micro- 
analytical sample was obtained by dissolving the material in spectro­
scopically pure acetonitriie and adding the filtered solution dropwise
1 4 0
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TABLE If—  Phenolic bis-amine esters (2).
C o m p o u n d R e a c tio n R e a c t io n
%  Y ie ld  o f
N o . so lv e n t tim e  (hr) p u re  a m in e
2 a e i 2 0 2 6 1 '
b e , 2 ° 6
9 9  2
C e,2o 6 9 9  2





F 6 CHCI3 2 . 5 6 9
9 C H C ,3
4 8 6 9
' Yield refers to the free base after crystallisation from petroleum 
ether (b.p. 40-60") and re-crystallisation twice from the same solvent. 
M.p. 38° C.
- NMR and tic (Polygram/Alox N for tic ; EtOH : EtOAc, 1 : 1) 
indicated purity o f the product on evaporation o f the solvent after 
the stated reaction time.
:1 After crystallisation o f the dihydrochloride from EtOH {see also 
Table 3).
1 The pure solid product, m.p. 150" C, was obtained by adding 
EtaQ (100 mL) to the reaction mixture, filtering off and drying in vacuo.
5 After crystallisation of the trihydrochloride from ethanol (see 
also Table 3).
6 Three mole equivalents o f secondary amine employed in the 
synthesis (see experimental).
to mechanically stirred. Filtered, dry ether (3, 4). Their characters arc 
shown in Table III.
Neuromuscular blocking potency
Neuromuscular blocking potencies were determined on cat gastrocne­
mius muscle-sciatic nerve preparations as previously described (1). 
H'he results are given in Table 1.
Vagal block
Vagal block was determined in anaesthetised cats as previously 
described (3). The results are given in Table 1.
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TABLE III. — Phenolic ester bis-amine hydrochlorides and quaternary salts (3).
C o m p o u n d
N o .
M o lt in g  p o in t  
H y d ro c h lo r id e s  ^
<°C )  -  
Q u a t e r n a r y  s a l Is
Y ie ld  o f  q u a t e r n a r y  
s a l t s  fro m  a m in e  (3 )
M ic r o a n a ly s is
F o r m u la
3 a - 1 2 1 - 1 2 5 8 2 3
C , 8 H 3 0 I2 N 2 ° 4
C , H , N
b 1 7 1 . 5 - I 7 2 4 - - C 2 0 H 3 4 C ,2 N 2 ° 4
C , H , N
c 2 0 3 - 2 0 4 4 - - C 2 0 H 3 4 C I 2 N 2 ° 4
C , K , N
d 1 9 9 - 2 0 2  ( d o c ) 1 3 8 - 1 3 9 7 5  5 C 3 6 H 4 6 W 8 ’ ° - 5 H 2 0
C , H , N
e - 1 7 0 - 1 9 0 9 5  5 C 3 6 H 4 6 I2 N 2 ° 8
C , H , N
f 1 6 1 - 1 6 6 1 4 6 - 1 5 0 8 8 5 C 5 1 H6 6 ‘3 N 3 ° 1 2
C , H , N
9 2 0 6  ( d e c . ) 6 S o f te n s  c a  150 4 3 C 5 4 H 6 6 F 2 N 2 ° 1 8 S 2 ' ,H 2 0
C , H , N
1 3, R H, X Cl.
2 X" as shown in Scheme 1.
:l Quaternised in EtOH - Mef ( 1 : 1 )  and crystallised from EtOH - H20 .
4 Crystallised from EtOH - Et20 .
f‘ Quaternised (2, 3) in CHCI3 and isolated by dripping the reaction mixture into Et20 .
« Anal, for Cfl2H02Cl2N 2O I2, 2H20  : C, H, N.
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Biodegradable neurom uscular blocScing ag en ts
Part 6. — Stereochem ical studies on atracurium and related poiyalkylene d i-esters
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Summary. -  Stereoisomers of atracurium (3, n - 5) and one of its homoiogues each having the configuration, / ’ R, SS  and RS  at the C( Impositions 
have been synthesised. The ratio of cis and nans components in the RR-, SS- and RS/we.ro-products, which contain three, three and four isomers 
respectively, measured by 'H and l8C NM R is approximately 3.0. The ratio o f cis-cis-, cis-trans- and trans-trans-isomers in the isomer mixtures, 
determined by HPLC, is in reasonable agreement with the cis/trans ratios found by 'H NMR. Variable temperature |:,C NMR suggests that the 
totrahydropapavcrinium ring system undergoes fast ring inversion at ambient temperature.
The relative molar neuromuscular blocking potencies of the three atracurium isomer products in anaesthetised cats were found to be RR (231), 
RS/meso (133) and SS  (89) compared to that of tubocurarine (100). The significance o f these relative potencies is discussed in relation to the poten­
cies o f  norcoralydine and tubocurarine stereoisomers.
Resume. Des stereoisomeres d'atracurium (3, n =- 5) et un de ses homoiogues, chacun ayant la configuration RR, SS  et RS  a la position C(l) 
out ete prepares par synthese. Le rapport des constituants cis et trans dans les produits RR-, SS- et RS/meso, contenant trois, trois et quatre iso- 
meres respectivement, determine par RMN ‘H et 13C est approximalivement 3,0. Le rapport des isomeres cis-cis-, cis-trans- et trans-trans dans les 
melanges d’isomeres, determines par chromatographie cn piiase liquide a haute performance, est en raisonnable accord avee les rapports donnes 
par la RMN ‘H. La RMN ,3C it temperature variable suggere que le systeme a anneau de tetrahydropapaverinium subit une inversion rapide ii 
temperature ambiante.
Les puissances relatives de blocage neuromusculaire molairc des trois produits isomeres d ’atracurium dans les chats anesthesies sont les suivantcs : 
RR (231), RS/meso (133) et SS  (89) par rapport it la tubocurarine (100). L’importancc de ces puissances relatives est discutce par rapport aux 
puissances des stereoisomeres de norcoralydine et de tubocurarine.
Zusammenfassung. — Es wurden Stereoisomere sowohl von Atracurium (3, n 5) als auch eines seiner Homologen mil RR-, SS- und W.S-Konfigu- 
ration an den C(l)-Positiopen dargestellt. Das Vethaltnis der cis- und traits- Komponenten dcr RR-/3 fsomere), SS-Q  fsomere) und RS/Mcso- 
(4 fsomere) Verbindungen wurde dutch ‘H und ,3C NMR Spektroskopie zu etwa 3.0 bcstimmt. Das in den isomeren Mischungen dutch HPLC 
bestimmte Verhiiltnis dcr cis-cis, cis-trans, und trans-trans Isomeren befindct sich in bcfricdigender Ubereinslimmung mil den durch NMR-Spektro- 
skopie bestimmten cis-trans Verhaltnissen. Ergebnisse, die durch l3C-NMR-Spektroskopie bei verschiedsnen Temperaturen erhalten wurden, 
lassen vermuten, daII das Tetrahydropapaverinsystem bei Raumtemperatur schnelle Ringinversionen erleidet.
Die relative molare neuromuskulare Blockierungskapazitat der drei Atracurium-Isomeren wurde in anasthetisierten Kaizen zu 231 (R R ), 133 
( RS/meso) und 89 (S S )  bcstimmt (Tubocurarin 100). Die rclativen Hemmkapazitaten der Stereoisomere wurden untereinandcr als auch mit 
dcnen von Norcoralydin und den Stereoisomeren von Tubocurarin verglichen und diskutiert.
Key-words : Atracurium — Poiyalkylene di-esters — Neuromuscular blocking agents Biodegradable agents Stereochemical studies.
Atracurium (3, n -• 5) and similar com pounds in the 
related series o f  poiyalkylene di-esters (3) show identical 
stereochemical features to laudexium (1). These com pounds 
have four chiral centres at C (l)  and N(2) in the two tetra- 
hydropapaverine units. Because o f  m olecular symmetry, 
the sixteen isomers which are theoretically possible reduce 
to ten. Atracurium and related quaternary salts, therefore, 
consist o f four racemates and tw o mevo-co.mpounds. Each 
isomer can be defined by its configuration at C (l)  relative 
to that o f the tetrahydropapaverine unit (R  or S )  from
(*) Author to whom correspondence should be a dressed.
(**) Present address : Department o f Pharmacy, University 
Manchester
(***) Present address : School o f Pharmacy and Pharmacology 
University of Bath.
which it is derived together with the relative configuration 
(cis 1 or trans 2) about the two C j— N 2 bonds. The cis- 
configuration (1) is defined arbitrarily as that in which 
the two bulky substituents [l-(3,4-dim ethoxybenzy!) and 
2-alkylene-ester groups] are cis.
^  rH ^  /CHyCHjR
*N.r 3
H > C  ,,CH2CH2-R ch3
CH2-Ar CH2'Ar
R - c / i - i s o m c r  ( 1 )  R-trans-i s o m e r  (2 )
Stereoisomeric quaternary salts having the configurations 
R R , S S  and R S  at the C , positions have been prepared
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corresponding to the structures 3 (n =  2), and 3 (n -•= 5). 
In each ease, the RR-, SS- and RS/m eso-products are 
mixtures o f  three, three and four isomers respectively 
(Scheme 1). These products have not been separated into  
their com ponent isomers. Their neuromuscular blocking  
potencies have been measured in anaesthetised cats, and 
correlated with estimates o f  their isomeric com position  




Product Configuration o f componc•lit isome
c , Cr-N* c , C,—N,
RR R cis R cis
R cis R trans
R trans R trans
SS S eis S cis
S cis s trans
S trans s trans
RS/meso R cis s cis
R trans s trans
R cis s trans
R trans s cis
Scheme 1.
CHEMISTRY
The R R - and SS - products 3  (n 2 and 5) were prepared 
by m ethods already described (2, 3). Either R- or 5-tetra- 
hydropapaverine was condensed with the appropriate alky lene 
diacrylates (4) to give the corresponding optically active 
AA'-dioxa-dioxoalkylene-aco-bis-tetrahydropapaverine (as 6 
but with R R - or SS-geometry). These optically active di- 
tertiary bases were quaternised with either methyl iodide 
(3, n - 2), methyl m ethanesulphonate (3, n - 2 and 5), 
or methyl benzenesulphonate (3, n — 5).
The RS/m eso  dim esylate (7, n =  5) was prepared as 
shown in Scheme 2. (S)-(— )-Tetrahydropapaverine was 
condensed with excess (5 m ole) o f  pentamethylene diacrylate 
(4, n = 5) to  yield the intermediate, S -(-|-)-!-tetrahydro- 
papaverin-2'-yl-4,10-dioxa-3, 1 l-d ioxotridec-12-ene(5). C on­
densation o f  the latter with !?-(-(-)-tetrahydropapaveripe 
gave the R S  di-tertiary base, A A '-4,10-dioxa-3,l 1-dioxo- 
tridecylene-l-13-bis-tetrahydropapaverinc (6) which was 
isolated as the oxalate salt. The base was quaternised 
with methyl methanesulphonate and methyl benzenesulpho­
nate to yield the RS/meso  dimesylate, and RS/m eso  dibesy- 
iatc, 7 (n 5) respectively. The /?.S'/m?wo-dim esylate, 7 
(n 2), was prepared similarly starting from ethylene 
diacrylate and R-( | )-tetrahydropapaverine.
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RESULTS A N D  D ISC U SSIO N
Isomer composition
The N M R  spectrum o f  S’-A-ethyltetrahydropapaverinium
•I-
methiodide shows splitting o f  the H-8 proton and N C H 2C / / 3 
signals (4) due to shielding differences in the cis and trans 
isomers. Recent ‘H studies have assigned the lower field 
H(8) proton signal at 5.79 8 to the civ-isomer and the higher 
field H(8) signal at 5.72 8 to the trans-isomer (5). Similar 
assignments have also been made for other related pairs 
o f isomers with A-benzyl and A-butyl substituents (5), 
in conformity with a higher potential barrier to rotation  
in the cis configuration, and these conclusions have been 
confirmed by single crystal X-ray analysis o f trans-N-3- 
hydroxypropyl-5'-m ethoxylaudanosinium perchlorate and 
cis- A-3-hydroxypropyl-5'-methoxylaudanosinium iodide m o­
nohydrate.
Atracurium salts (3, n =  5) and other com pounds in the 
same series (3, n - -  2) show a similar splitting o f H-8 proton  
signals into two peaks with the major component at lower 
field (5.9 8) and the minor com ponent at 5.65 S. Likewise, 
the ,3 C N M R  spectrum o f  Atracurium shows two A-M e 
resonances, at 47.4 ppm for the major component and 49.2  
ppm for the minor com ponent. Accordingly, the major 
com ponent is assigned the m -configuration in conformity  
with the conclusion o f Lindon and Ferrige (6), determined 
by a com bination o f N M R  nuclear Overhauser experiments 
and syntheses o f laudanosine m ethiodide using 13C-enriched 
methyl iodide, that direction o f  attack during quatcm isation  
o f 1-benzyl-A-m ethyl-tetrahydroisoquinolines is from the 
side o f the ring opposite to  the 1-benzyl side chain. The 
Atracurium assignments are confirmed by the similar A-M e 
resonances at higher field (46.8 ppm and lower field (49.0 ppm  
in cis- and trun.v-N-ethyltetrahydropapaverinium m ethiodide 
(5). The major atracurium com ponents associated with the 
lower field H-8 signals at 8 5.9 are, therefore, cis and the 
corresponding .minor com ponents associated with the higher 
field H-8 signals at 8 5.65 are trans. Figure 1 shows the 
400 M Hz ‘ H N M R  spectrum o f ( ± )  Atracurium Bcsylate 
in dmso-dg solution.
The relative intensities o f the tw o H-8 proton signals in 
(:l:)-atracuriu.m besylate give a cis/trans-isom er ratio o f  ca. 
3.0. The isomer ratio, however, cannot be determined  
precisely by routine 90 M H z N M R  because o f  the near 
coincidence o f the single H-8 resonance o f laudanosine 
methiodide, which is present as a trace impurity, with the 
high field signal o f atracurium. On the other hand, the 
ratio can be determined with much greater precision by 
high pressure liquid chromatography, which show's three 
separate peaks attributable to the cis-cis-, cis-trans- and 
trans-trans-isom ers  respectively (Fig. 2).
The overall ratio o f  cis- and trans- entities can be deter­
mined from the ratio o f  the area o f  the cis-cis peak j- half 
o f the area o f the cis-trans peak to  the area o f the trans- 
trans peak +  half o f  the area o f  the cis-trans peak.
Peaks are consistently observed by HPLC analysis o f  




tram -trans-iso.mers respectively within experimental error 
in the ratio o f 10.5 : 6.2 : 1. From  this, the calculated ratio 
o f cis/trans-cntitics is 3.07 in reasonable agreement with 
the approxim ate ratio o f  3.0 derived by 90 M H z N M R . 
Similar, though not precisely identical ratios, have been 
found for the mesylate salts.
H igh pressure liquid chromatography has also been used 
to determine the total isomer content and cis-cis, cis-trans 
and trans-trans isomer ratios o f  the RR-, SS- RS-/m eso- 
isomer mixtures (Table II) and these are confirmed by the 
cis/trans ratios o f  3.0, 3.0 and 3.2 obtained from the 90 M Hz 
N M R  spectra.
The areas o f the individual cis-cis, cis-trans and trans- 
trans isomers can be predicted from the overall cis-trans 
ratio. The derivation, shown in Schem e 3, assumes that 
the two basic centres o f  the di-tertiary base are quaternised 
independently and form cis or trans centres in the ratio  
represented by the overall cis/trans ratio. Each c/.v-mono- 
quaternised m olecule can then form a cis-cis atracurium  
m olecule or a cis-trans m olecule and again will do so in 
the ratio o f  the overall cis-trans ratio because this represents 
the probability o f  a cis or trans centre being formed on 
quaternisation o f  a  tertiary base moiety. A  similar argument 
applies for Pa/w-monoquaternised m olecules.
1 4 4
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Fig. 1. — The 400 MHz 'H NM R spectrum
\ cis • cir.
S mm
F i g . 2. — High-pressure liquid chromatogram of atracurium dibe- 
sylate separation. The various species are as labelled. Column : Partisil 
10, 25 cm x 0.4 cm (i.d.) ; Mobile phase MeOH, HBr, HaPG4 , 
500:1:1 ; U.v. detection at 280 nm.
H ence it can be seen that the cis-cis, cis-trans and trans- 
trans isomers o f  Atracurium should occur in the ratio o f
—4------ 1— S -----L *----- 1------ U—
of atracurium dibcsylate in dmso-d6 solution.
x2 : 2x : 1, where x is the overall cis/trans ratio. This pre­
diction is consistent with observations m ade in all o f  the 
many preparations o f  (± )-atracurium  besylate made to  
date.
Examination o f the 400 M Hz ’ H N M R  spectra o f a 
typical sample o f  ( 1  )-atracurium besylate in CDC13 shows 
four cis peaks which are observed in the ratio 1 : 1 : 3 : 3 
(Fig. 3 a). This conform s with the expectation that the two 
larger peaks arise from cis-cis m olecules and the two smaller 
ones from the m -residues in cis-trans m olecules, since 
R R- and 5 5 -  forms, being mirror images, give identical 
N M R  spectra, and the R S/m eso-mixture will have the 
same relative abundance as the sum o f  the R R- and 5 5 -  
forms. These conclusions are supported by the correspond­
ing spectra for the R R - and SS- isomer mixtures each o f  
which shows only tw o o f  the cis peaks in a I : 3 ratio cor­
responding to the cis-trans and cis-cis isomers respectively 
(Fig. 3 b). Theoretically, the R S/m eso  mixture should also  
show another pair o f  cis peaks in a 1 : 3 ratio, the first 
corresponding to  the ( R )-cis-(S)-transl(S)-cis-(R)-trans mir­
ror image pair and the second to the (R )-cis-(S)-cis-isomer. 
The isomer mixture obtained actually shows two pairs o f  
peaks (Fig. 3 c), each in a 1 : 3 ratio with a pair to pair 
abundance ratio o f  4  : 21 corresponding to  a RS/meso  
content o f  84 %  together with som e 16 % o f RR- and 5 5 -  
isomers probably arising from incom plete resolution o f  
optically active tetrahydropapaverine used in the synthesis.
The corresponding trans resonances are less well resolved. 
The trans-trans and trans-cis resonances are not resolved  
at all in the spectra o f  R R- and 5 5 -  products. In the R S/ 
mevo-mixture the trans-trans resonance merely appears as 
a shoulder causing asymmetric broadening o f  the trans-cis 
peak, though this is observed m ore explicitly in ( | )-atracu- 
rium where the trans resonances are clearly resolved.
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Scheme 3 : To illustrate how the ratio of the three isomer mixtures of Atracurium can be derived from an overall cis/trans ratio.
x is the overall cis/trans ratio.
i_________i_________i_________i i_________i_________i
60 5.9 5.7 5.6 6
F i g . 3 . —  The partial 4 0 0  MHz ,H  NM R spectra o f atracurium 
dibesylate isomers in CDCI3 solution. Only the H8 region is shown. 
The top trace (a) is from a typical production batch o f (1 )—Atra­
curium Besylate, the centre trace (b) is from the RR isomer and the 
bottom trace (c) arises from the RS/meso material.
The arrows mark impurity peaks and the asterisks denote the pre­
sence o f RR  and SS  isomers in the RS/meso material.
Conformational mobility
The question o f  conformational flexibility o f atracurium  
is o f considerable interest in relation to the relevance o f  
stereo-selectivity as a criterion o f  drug-receptor interaction. 
Low temperature 13C NM R  studies o f  laudanosine base, 
salt and quaternised analogues (as 10) over a range o f  
temperature down to — 80° C have shed som e light on the 
problem (5). In all these compounds, considerable broaden­
ing o f the signals for the four a-carbons on nitrogen, C(4), 
the benzylic carbon and C-8 was observed in contrast to 
the remaining signals which remained sharp. It was conclu­
ded that these observations were in conform ity with fast 
conformational changes at room temperature which are 
slowed by cooling with exchange broadening o f  signals 
which are substantially different in two contributing confor- 
mers.
Similar 13C N M R  studies have been conducted with 
(±)-A tracurium  Besylate in which spectra have been recor­
ded as a function o f  temperature. A cetone was chosen as 
solvent since by analogy with (C D 3) 2SO it was expected 
to show minimal effects due to interaction between the 
two ends o f  the molecule, so that increased ambiguity from  
resolving cis-cis, trans-cis and trans-trans  resonances would  
be minimised. Examples o f  the spectra are shown in Figure 4.
Integration o f  the 13C resonances at 47.4 ppm and 
49.2 ppm due to the cis and trans /V-Me groups indicates 
a ratio o f  ca 3.0. The agreement with the value obtained 
by 'H N M R  from the study o f  the H-8 peaks is reasonable 
bearing in mind the known difficulties o f  integrating 13C 
resonances.
All the 13C resonances were sharp at 50° and 24° C. 
A t — 19° C all aliphatic peaks rem ained sharp with the 
exception o f  the trans 7V-Me peak which had begun to  
broaden. A t —  33° C the trans N -M e peak was broad 
and other aliphatic resonances began to broaden uniformly. 
At — 40° C all the aliphatic signals were broad but the 
cis A -M e remained sharp as did the besylate anion reso­
nances and som e o f  the atracurium aromatic signals.
At —  33° C som e degrees o f  flexibility in the molecule  
such as the 1-dimethoxybenzyl rotation and aliphatic ester 
side chain m ovem ent, begin to slow  down for both cis-
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less energy than the corresponding Ccq —  N ctl ^  C3X —  N„x 
inversion o f  the trans isomer.
On balance, therefore the evidence favours fast ring 
inversion o f  both cis and trans forms at physiological tempe­
ratures (37° C). It must be emphasised, however, that 
observations which are fast on the N M R  time scale occur 
in the 0.1-100 sec-1 range, which is extremely slow in 
terms o f  processes such as molecular tumbling or receptor 
binding. Hence, no firm conclusion on the relevance o f  
ring flip to pharmacological effects in this series is possible. 
Equally there is no evidence to suggest that ring flip is a 
significant determinant in potency correlations between 
chemically related compounds or like three dimensional 
characteristics such as are discussed in the sequel.
Neuromuscular block
Neuromuscular blocking potencies were measured in 
anaesthetised cats by methods already described (2, 3). 
N o  significant differences were found between the potencies 
o f  iodide, methanesulphonate and benzcnesulphonate salts 
o f  individual isomers. The results given in Tables I and II 
show that, as with the analogous laudexium isomers (1 ; 
tested on isolated chick biventer cervicis muscle), the (R R )-  
products o f  both com pounds (3, n =  2 and 5) are signifi­
cantly m ore potent than the corresponding (S S )-  isomers. 
This difference is greater in the shorter chain laudexium  
m ethiodides ( R R /S S  potency ratio 2.75) and markedly 
m ore so in 3, n 2 ( R R /S S  potency ratio ca 4) than in 
the more potent atracurium derivatives, 3, n —- 5 ( R R /S S  
potency ratio 2.5). Inadequacies in stereochemical fit are 
thus clearly com pensated in the latter com pounds by the 
ability o f  both charged centres to associate with the receptor 
effectively when the inter-quaternary distance is at its 
optimum . As anticipated the R S /m eso  isomer mixture is 
intermediate in potency between that, o f  the (R R )-  and (5 5 )-  
products.
F i g . 4. — The partial 90.47 MHz 13C NMR spectra o f atracurium 
dibesylate at 254“ K (top) and at 240“ K (Bottom) showing differen­
tial broadening of the N-methyl (24), Benzyl (11) and N-CH, (18) 
resonances.
TABLE 1. Neuromuscular blocking potencies o f  compound 3 (n 
isomeric products in anasthetised cats.
and (ra/w-forms, thereby broadening all aliphatic resonances 
and obscuring any observation o f  ring inversion for the 
m -en tities. However, in contrast to the TV-Me signals, 
the cis dim ethoxybenzyl methylene peak broadens before 
the corresponding trans peak on cooling. This suggests 
that this methylene resonance is m onitoring the benzyl 
group rotation which would be expected to slow down 
first in cis residues due to the greater steric hindrance in 
this isomer compared to that in the trans compound.
The observed line broadening o f the trans N  M e signal 
is consistent with the conclusion that the trans residues 
arc undergoing a fast ring flip at ambient temperature 
between two conform ations in which the energy difference 
is not large. This is also likely to be true o f the cis form, 
where the energy difference between the two cis conformers 
is not expected to be large and indeed is likely to be less 
than o f  the trans isomer because it is probable that the 
C;,x — N cq ^  CL.(1 —  N ax inversion in the cis isomer requires
Isomeric product PD 50 i
RR 0.42 ±  0.047 (5) 2
SS 1.60 ±  0.24 3 (3)
1 Dose in mg/kg i.v. producing 50 % neuromuscular blockade ±  SEM.
Number o f animals.
:l Significantly different from that o f RR-isomcr P <  0.05
Observations that the (/?/?)-polyalkylene-bisquaternary 
salts o f the atracurium series are m ore potent than the 
corresponding (55 )- products are consistent not only with 
the analogous laudexium isomers (1 ; tested on the isolated 
chick biventer cervicis muscle) but also with the greater 
potency o f  (RR)-isom ers in the related N , /V-decamethylene- 
bispavinium methiodides (7). These results, however, appear 
to  be in conflict with those o f the simple monoquaternary 
m ethiodide salts o f  laudanosine (4, 8), carnegine (8), N- 
inethylpavine (8), corydine (8), isocorydine (8), giaucine (8)
1 4 7
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AtraeUimin stereoisomers. Isomer composition and mean neuromuscular blocking potencies in groups o f  4 anaesthetised eats
■OMe
Me
'(c h 2)^c o -o (c h 2)sO*c o (c h ?)2 O M ,
MeO
OM e OMe
Product Configuration o f  component isomers Isomer content Isomer ratios Percent cis and trans components PDml Relative molar potency1
C, Q - N . , Q c ,  —N* (HPLC assay) (HPLC
RR R cis R cis 10.7
R cis R trans 88.0 6.5
R trans R trans 1.0
RS/mcso R cis S cis 10.3
R cis S trans | 88.2 6.3R trans s cis 1
R trans s trans 1.0
SS s cis s cis 10.6
s cis s trans 93.6 6.6
s trans s trans 1.0
R -cis R—trans S -cis S—trads 
76.5 23.5 0 0.I03±0.008  
38.2 11.8 38.2 11.8 0.1791.0.0152
0 0 76.5 23.5 0.25 I 0.0332




1 Dose in mg/kg i.v. producing 50 % neuromuscular blockade : SEM. 
* Significantly different from that oi‘ RR-isomer P 0.01. 
n Tubocurarine =  100.
and boldine (8) in which the (S’)- series isomers are all more 
potent in the cat than their corresponding (/?)- isomers.
In contrast to  these monoquaternary salts, the potencies 
o f  the four stereoisomers o f the closely related norcoralydine 
methiodides are in the order (R )-m  >  (R )-trans  >  (S)- 
tcans >  (S)-cis (9). This potency order is consistent with 
ion-pair bonding to an anionic receptor site which is stereo­
selective for the quaternary centre and its environs at the 
upper, (3-face, o f  the molecule as represented in 8. This 
hypothesis has been tested, and finds support in the enhanced 
potencies observed in (/?)-c/5-norcoralydine trideuterio­
methiodide, ( /?)-d.v-[8,8-2 H]-norcoralydine methiodide, (R)- 
m -[8 ,8 -2HJ-norcoralydine trideuteriom ethiodide and (R )- 
m -[13 , 13, I3“- 2H]-norcoralydine trideuteriomethiodide (10) 
com pared to that o f  (/?)-m -norcoralydine methiodide. 
These com pounds provide a closer fit to the receptor and 
hence show higher potency than the corresponding undeute- 
rated com pound due to the lower zero point energy of 
deuterium. This reduces the am plitude o f vibration o f  the 
C— D  bonds compared to the corresponding C— H bonds, 
and shortens the van der Waals radius in deuterium com pa­
red to hydrogen.
Circular dichroism spectrometry also suggests that (S)- 
laudanosine m ethiodide favours a com bination o f ring- 
conform ation and C(l)-substituent orientation that offers 
the same (3-face receptor recognition features as ( R)-cis- 
norcoralydine m ethiodide (8), the m ost potent o f  the four 
stcreoisomeric norcoralydine m ethiodides (9). It has also 
been established (11) that isotubocurarine (12) which is 
som e 2.3 times m ore potent than tubocurarine, exhibits 
the same receptor-favourable, (3-face, stereochemical charac­
teristics about its sole quaternary centre as (i?)-c/.r-norcoraly- 
dine methiodide. This feature is in contrast to that in tubo­
curarine in which the (3-face R -C (l)— N  geometry and ring 
conform ation about the single quaternary centre relates 
to the pharmacologically less active (S)-//W7.v-norcoraIydine 
methiodide (9).
N M R  and HPLC evidence, although not completely  
unequivocal, now implies that the major com ponents o f  
(3, n =  2 and 5), and presumably, those o f laudexium are 
c/.v-entities (12) in which pseudo-equatorial and pseudo- 
axial orientations, or their converse, are favoured for the 
bulky (V-substituent and C (l)-dim ethoxybenzyl substituents 
respectively.
Examination o f  models shows that only the ( R)-cis entities 
o f com pounds 3 (n — 2 and 5) in their Cai[— N cq confor­
mations have both the same substituent configurations and 
ring conform ation, as (/?)-m -norcoralydine methiodide. 
Thus the m ost active o f the Atracurium isomer products 
consists predominantly o f  (/?)-c/.v-components which cor­
respond closely in m olecular shape to  that o f  ( R)-cis- 
norcoralydine methiodide, which in turn offers the m ost 
favourable (3-face receptor recognition features o f  the four 
norcoralydine isomers for the induction o f  neuromuscular 
blockade (9, 10 and 11). Similarly, (R )-trans, (S)-cis- and
(5)-/ra/7V-entities in 3 (n =  2 and 5) feature ring conform a­
tions and substituent orientations which relate to those o f  
the corresponding norcoralydine m ethiodide stereoisomers, 
all o f which are less potent than (R)-c/.y-norcoralydine 
m ethiodide. The relative contributions o f  the four stereo­
chemical entities to potency may, therefore, be expected to  
be in the same relative order in both series.
The higher potency o f the ( /?/^-products is, therefore, 
consistent with their high content (ca 75 %) o f ( R)-cis 
entities (12) with their capability o f  adopting the m ore 








o f (/?)-(7.v-norcoralydine m ethiodide (8). Likewise, the less 
potent (SS)-products consist mainly (ca 75 '/„) o f entities 
which can only relate to the stereochemical parameters o f  
the pharmacologically less favourable (S )-m -norcoralydine  
m ethiodide (11). The RS/m eso-products  w ith about 37.5 % 
each o f  favourable (R)-cis- and less favourable (S)-ct.v- 
entities should, therefore, be intermediate in potency as 
found (1) in the laudexium series (relative potencies o f  
R R , RS/m eso, S S ,  275/140/98 ; tubocurarine =  100). A 
similar potency order (R R , RS/m eso, S S ,  231/133/89 seems 
to be apparent in 3, n 5 (Table II) with the R S/m eso- 
product intermediate between R R  and SS.
EXPERIM ENTAL
Unless stated otherwise, melting points were recorded on a Kofier 
Hcizbank 184321 melting point apparatus. Infrared spectra were 
obtained on a Pcrkin-Elmer 157 instrument using either liquid films 
or K.C1 discs (for solids). Routine proton magnetic resonance spectra 
were recorded for synthetic work on a Perkin-Elmer R32 instrument 
operating at 90 MHz. TMS was used as internal standard. 1R and NMR
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data were in accord with the structures given. Microanalytical results 
(C, 1-1, N except were slated otherwise) were within -i 0.4 % of theore­
tical. Thin-layer chromatography was run on Polygram Sil G/UV 154.
N, N'-4,7- Dioxa-3,8-dioxodecy!ene-1, IO-diyl-bis-( II)-(—)-tetrahydro- 
papaverine was prepared from (/?)-(+)-tetrahydropapaverine (1.0 g) 
and ethylene diacrylate (0.26 g) by the method described for the cor­
responding (J )-contpound (2). The clioxalate was obtained as a colour­
less solid from ethanol (1.02 g ; 66%), m.p. 151-153° C. Anal, for 
C02H,1.lN2O20 , HjO : C, H, N. The dihydrochloride was obtained as 
an almost colourless solid from isopropanol, m.p. 125-132° C [“115
57.07° (c, 1.104 in CHC13).
The dioxalate (1.01 g) was dissolved in water, basified with saturated 
sodium hydrogen carbonate solution, and the precipitated base extracted 
with chloroform. The combined extracts were dried (Na2SO., anhydrous) 
and the solvent evaporated in vacuo to yield N ,N '-4,7-DiOxa-3,8- 
dioxodecylene-l,IO-diyl-bis-( !()-( - )-tetrahydropapaverine as a colour­
less solid (0.85 g ; 69%), m.p. 47-49” C [a]^ — 58.2° (c, 1.323 in CHCI3). 
Rp 0.55 in ethyl acetate : ethanol (I : 1).
N-N'- 4,7- Dioxa-3,8- dioxodecylene-1,10-diyl- bis- ( S)-( I j - tctrahydro- 
papaverine was prepared from (S)-(—)-tetrahydropapaverine as descri­
bed for the bis-(W)-isomerie produet. The dioxalate had m.p. 151- 
153” C. Anal, for C,,?H0.1N.,O.!11, H..O : C, H, N. The dihydrochloridc 
had m.p. 124-132° C [a]2? I 58.12° C (c, 1.253 in CHC!:i). The base 
was obtained as a colourless solid m.p. 48-50“ [a]/,1'0 I 58.9" 
(c, 1.021 in CHCI-j). RF 0.55 in ethyl acetate : ethanol (1 : 1).
N-N'- 4,10-Dioxa-3,I I - dioxotridecylene-1, 13-diyl- bis- ( R)-( —) - tetra- 
hydropapaverine. ( R)-( -I-)-Tetrahydropapaverine (3.39 g) and 1,5- 
pentamethylenediacrylate (1.0 g) were heated with glacial acetic acid 
(0.2 mL) at 70° C for 4 hr. The reaction mixture was dissolved in 
toluene, the solution stirred for 5 hr with silica gel 60 (Merck, column 
chromatography grade, 70-230 mesh), filtered and evaporated to give 
a light brown viscctis oil. The product in dry acetone (50 mL) treated 
with a solution of oxalic acid in dry acetone (6 %) yielded N ,N ’-4,/0- 
dioxa-3,1 l-dioxotridecylene-1,13-bis-{ II)- ( )- tctrahydropapavcrine dio­
xalate as a colourless crystalline solid (78%), m.p. 119-122° C lot]2,( 
-  62.8“ (c, 1.051 in CHCI3) [a]tf -  43.28° (c, 2.087 in water). Anal, for 
C55H7nNaO20 : C, H, N. The base was obtained as a colourless oil
[a]:g 's — 53.62° (c, 1.408 in CHCI3). RF 0.54 in ethyl acetate : ethanol.
N, N '-4,/0-Dioxa-3, I l-dioxotridecylene-1,13-diyl-bis-(S)-( T  )-tetra- 
hydropapaverine was prepared from (S)-(—)-tetrahydropapavcrinc 
(4.14 g) and 1,5-pentamethylenc diacrylate (1.22 g) by the method 
described for the bis-(7?)-isomeric product. The dioxalate was obtained 
as a colourless crystalline solid (76%), m.p. 116-119” C I 62.1°
(c, 1.035 in CHCI3), [a]/,2 I 44.78” (c, 1.155 in water). Anal, for 
f  'i,:,H,nNrO..,n : C, H, N. The base was obtained as a colourless oil 
[af/j I 52.65° (c, 0.961 in CHC13). RF 0.54 in ethyl acetate : ethanol 
(1 : 1).
( R )-(—)-l-Tetrahydropapaverin-2'-yl-4,7-dioxa-3,8-dioxodec-9-ene(5, 
n — 2). (R)-(T)-Tetrahydropapaverinc (0.92 g) in dry benzene (20 mL) 
was added dropwise to ethylene diacrylate (2.62 g) in dry benzene 
(10 mL), and the mixture refluxcd for 4 hr. The solvent was evaporated 
in vacuo, and the oily residue washed three times with light petroleum 
(b.p. 40-60° C ; 100 ml). The oily residue was dissolved in benzene 
(10 mL) and light petroleum added to precipitate an oil. Re-solution 
in benzene and reprecipitation with light petroleum twice more gave 
an oily mass, which solidified on drying over P20 6 1,1 vacuo at 50° C, 
to yield ((?)-(—)-\-tetrahydropapaverin-2'-yl-4,-7-dioxa-3,8-dioxodec-9- 
ene (0.61 g ; 44%), m.p. 52-55° C, [a]/,1 44.2“ (c, 0.625 in CHCI3).
(,S>( I )-!- Tetrahydropapaverin-2'-yl- 4,10-dioxa-3,II-dioxotrrdec-l2- 
ene (5, n — 5). (5)-(—)-Tetrahydropapaverine (3.01 g) and 1,5-penta­
methylenc diacrylate (9.34 g) were heated with glacial acetic acid 
(0.2 mL) at 70“ C for 4 hr. The product was dissolved in ether (400 mL) 
and shaken with dilute hydrochloric acid. The aqueous layer was 
washed twice with ether (200 mL and 100 mL), made alkaline with 
potassium hydroxide solution and extracted with ether. The ether 
solution was dried (anhydrous Na.,S04) and evaporated to yield an 
oily residue (4.34 g ; 89 %), which showed three spots of RF 0.75,
0.50 and 0.37 when chromatographed on thin layer using Polygram 
sil G/UVjM and chloroform/ethanol (95 : 5).
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The components o f the mixture were separated on a column 
(360 mm x 22 mm) o f silica gel 60 (Merck, 70-230 mesh) using chloro­
form followed by chloroform/ethanol (99 :1). Evaporation of the 
eluate gave (5)-( 4 )-l-tetrahydropapaverin-2'-yl-4,I0-dioxa-3, U-dioxo- 
tridec-12-cnc (3.47 g ; 71 %), [«1JJ.* -I- 38.50“ (c, 1.196 in CHCI.,), 
V,„.,x : 1730 cm 1 (ester C O) ; 1640 ( CH CH.J, RF 0.50 on 
Polygram sil G/UV254 in chloroform/ethanol (95 :5). Homogeneity 
was confirmed by HPLC using a Portisil 10 |xm silica column and 
solvent system acetonitrile/water/phosphoric acid (90 ; 9 :1) as described 
under High Pressure Liquid Chromatography.
( RS) /mesa - N ,N'- 4 ,7- Dioxa-3,8- dioxodecylene-l, 10-diyl- bis- tetrahy- 
dropapaverine (6, n -  2). ( !<)-(—)-l-Tetrahydropapaverine-2’-yl-4,7- 
dioxa-3,8-dioxodec-9-ene (0.33 g) and (S)-(—)-tctrahydropapaverine 
(0.215 g) were refluxed in dry benzene (15 mL) for 48 hr with constant 
stirring. The solvent was evaporated, the residue dissolved in chloroform 
(3 mL), and the solution treated with a saturated solution of oxalic 
acid in dry ether. The white floccuient precipitate was recrystallized 
from ethanol to yield ( RS)lmeso-H,H'-4,7-dioxa-3,8-dioxodecyleite-l, 
10-bis-tetrahydropupaverine dioxalate (0.40 g ; 65 %), m.p. 87-90“ C. 
Mixed m.p. with (T ) base oxalate 85-130° C, [<x]p ±  0”, RF 0.55 
in ethyl acetate : ethanol (1 :1). Anal, for C52Ho4N 2Oau , H20  : C, H, N. 
The base (6, r. ••• 2) was obtained as a gummy solid.
( RS) Intern N, N '-4,10- Dioxa-3,1 l-dioxotridecylene-1,13-diyl-bis-tetra- 
Itydropapaverine (6, n 5) prepared from (S )-( I )-1 -tetrahydropapa- 
verin-2’-yI-4,10-dioxa-3,tl-dioxotridec-12-ene (3.17 g) and (/?)-(+)- 
tetrahydropapaverine (1.98 g) by the method described for the prepa­
ration o f (RS)/meso-A, A ’-4,7-dioxa-3,8-dioxodecylene-l ,10-bis-tetra- 
hydropapaverine. The dioxalate was obtained as colourless crystals 
(3.78 g, 74%), m.p. 107-110° C, [a®  ±  0°. Anal, for Q 5HV0N2O.,0 : 
C, H, N. The base (6, n =  5) was obtained as an oil, [a]p 1 0 “ 
(c, 1.018 in CHClj), RF 0.54 in ethyl acetate : EtOH (1 :1).
Quaternary salts
The (RR)-, (SS)- and ( /?.S)/«i<?.ro-di-tcrtiary bases (6, n - 2 and 
5) were quaternised with either methyl iodide, methyl melhanesulpho-
electronically with an Autolab System TVb Chromatography Data 
Analyzer (Spectra-Physics Ltd).
The column was slurry packed at a pressure of 35 MNm ;l with 
10 (xm particle size silica gel. Two systems were used under the condi­
tions set out below. System 1 resolves atracurium from its impurities 
and was used for the determination of isomer content. System 2 resolves 
the isomers and was used to determine the isomer ratios. Isomer content 
and isomer ratios o f the atracurium besylate isomer products are given 
in Table 2.
System I. Mobile phase, acetonitrile ; water : phosphoric acid 
(90 : 9 : 1). Flow rate, 2 mL min '. Loading, 5 L of 1 1 % w/v aqueous 
solution. Detection at 280 nm. Sensitivity, 0.2 AUFS.
System 2. Mobile phase, methanol : phosphoric acid : hydrobromic 
acid (500 : 1 :1). Flow rate, 1 mL min-1. Loading, 2 L of a I % aqueous 
solution. Detection at 235 nm. Sensitivity, 0.1 AUFS.
NM  R spectroscopy
Cis/trans ratios were determined routinely using 90 MHz 'H NMR  
o f dmso-d,., solutions. The spectra were acquired with a Bruker HFX-90 
instrument coupled to an fnstem DATAMAG data system, operating 
in the pulse-Fr mode at 24“ C. Sample concentration was routinely 
50 mg . mL-1. Detailed studies o f the RR, SS  and RS/meso mixtures 
and their cis/cis, cis/trans and trans/trans components were performed 
using 'H NMR at 400 MHz in CDC!3 solution on a Bruker WM-400 
instrument at ambient temperature.
The conformational mobility of atracurium was probed by the measu­
rement of laC NM R spectra at 90.57 MHz on a Bruker WM-360 spectro­
meter using an acctone-d0 solution containing a small amount of 
CDC13 . Measurements were taken at 323”, 297", 254", 240" and 233° IC.
Neuromuscular blocking potencies
Neuromuscular blocking potencies were determined on gastrocne­
mius muscle-sciatic nerve preparations from cats as previously descri­
bed (13). The results are given in Tables 1 and 2.
TABLE 3.
c ompoiind Isomeric product Salt m.p.
“C
Specific rotation (CHC13) Anal.
3 (n -- 2) RR !- 122-125 [ * «  --  48.9“ (c,1.208) C,H,N
SS 1 122-126 MS’ -- 48.1" (c,1.105) C,H,N
RR c h 3 s o 2 o 105-113 M l) '5 -  55.9" (c,0.948) C,H,N
SS c h 3 s o , o 105-114 W d 'S 1 56.4" (c, 1.140) C,H,N
7 (n - 2) RS/mcso CH3-S02.0 - 100-112 [<*]£>' -fc 0“ (c,0.049) C,H,N
3 (n = 5) RR c h 3 s o 2 o - 110-114 M o 's - 41.7" (c,1.323) C,H,N
SS c h 3-so 2 o - 110-114 M B  ■-  40.3“ (c,1.016) C,H,N
7 (n = 5) RS/mcso c h 3 s o 2 o - 102-107 M B 1 0” (c,0.935) C,H,N
3 (n = 5) RR Ph SCVO- * M b --  44.0° (c, 1.000) C,H,N
SS Ph S 0 2 0 - * Md +  30.0° (c,1.000) C,H,N
7 (n = 5) RS/mcso Ph S 0 2 0 * [ “ I d f  0“ (c,1.000) C,H,N
These samples did not give definite melting points.
nate or methyl benzcnesulphonate by methods as previously described
(3). The characteristics of the product isomers arc described in Table 3.
Isomer content and ratios o f  atracurium besylate isomer products 
Isomer content and ratios were determined by high performance 
liquid chromatography. The apparatus used was constructed from 
a CE 210 coil pump fitted with an injection port (Cecil Instruments 
Ltd.) and a chromatographic column 250 mm Y 4 mm i.d. precision 
bore, seamless stainless-steel tubing. All connections were made with 
low dead-volume stainless steel couplings (Reeve Angel Scientific 
Ltd.). Injections were made with a 10 |a ! Type 701N syringe (Hamilton 
Micromeasure BV) through a silicone rubber septum faced with PTFE 
and the column eluate monitored using a CE 212 variable-wavelength 
ultraviolet spectrophotometer fitted with a 10 pi flow cell (Cecil Instru­
ments Ltd.). Results were displayed on a Autograph S pen recorder 
(Shandon Southern Instruments Ltd.) and peak areas were integrated
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sm m m
Roger D. W aigh
Muscle relaxants are used in surgery to make the surgeon's job easier and 
the operation safer. When m uscles are relaxed, particularly in the 
abdomen, much lower doses of anaesthetic are needed—just enough to 
produce unconsciousness. Before these drugs were available the 
anaesthetic had also to serve as a muscle relaxant, which meant that the 
required high doses produced a deep and dangerous depression of the 
central nervous system . Atracurium is a new muscle relaxant and is one of 
the very few  drugs designed and synthesised in an academic environment.
All the m u scle relaxants used  in surgery  
stem from the original observation of the  
paralysing South Am erican arrow poison, 
curare, w hich contains a mixture of 
alkaloids, th e b est know n being tu ­
bocurarine (1). Like th e  arrow poison, th e  
modern drugs paralyse the diaphragm  
and cau se  death  by suffocation  in th e  
absence of artificial respiration. There 
would therefore be a major practical 
advantage in using a m u scle relaxant 
that does not persist in th e body beyond  
the end of the operation, so  that th e  
patient can be returned to th e ward  
breathing normally. Several workers have  
searched for the ideal drug.1
In the 19 6 0 s , research  groups in th e  
department of pharmacy at th e University 
of Strathclyde and th e  chem istry depart­
ment at G lasgow  University had co m ­
bined to find the structure of an alkaloid2 
from the Egyptian plant Leontice leon- 
topetalum. itself of no great m edicinal 
importance. Isolated a s  th e  reineckate 
salt, the quaternary alkaloid hydroxide 
was prepared by p assin g  th e  com pound  
down an ion exch an ge colum n. The 
researchers w ere  concerned  to find that 
evaporation of the solution th u s obtained  
changed the properties of the material 
very considerably: there w a s  a m uch  
-stronger ultraviolet absorption and no  
quaternary nitrogen. T hese observations  
were explained2 a s  th e  b ase  catalysed  
Hofmann elim ination of th e  alkaloid, n ow  
known as  petaline(2), w ith anchim eric  
(neighbouring group) a ssista n ce  from  
the nearby 8-hydroxy group.
The Strathclyde group had been active  
for many years in th e search  for better  
muscle relaxants, so  by putting tw o and  
two together th ey cam e up w ith the idea  
that a b ase catalysed  Hofmann elim in ­
ation of a com pound w ith tw o petaline  
units might produce a m u sc le  relaxant 
with a shorter duration of action, allowing  
the patient to be returned to the w ard  
more quickly. To explain w hy this m ight 
work a little pharm acology is required; 
more details are available e lse w h ere .1
Pharm acologists have show n  that 
m uscles are controlled by nerve im pulses, 
w hich are transm itted over the nerve-  
m u scle junction by the re lea se  of m inute 
am ounts of acety lcholine (3), itself a 
quaternary am m onium  salt. Other quater­
nary sa lts— su ch  a s  th e arrow poison  
alkaloids—can interfere w ith  th is pro­
ce ss , and th e  interruption of the flow  of 
chem ica I m essa g es  c a u s e s  th e  m u scle to 
relax. It h as a lso  b een  found that 
com pounds w ith tw o quaternary nitro­
gen s  w ere  often  m ore potent inhibitors, 
provided that the n itrogens w ere  sep ­
arated from each  other—the best 
distance apart w as thought to correspond  
to 10  m eth ylene units, a s  in th e  potent 
but long acting drug laudexium  (4). 
Furthermore, it w a s  a lm ost invariably 
true that tertiary a m in es  w ere  inactive or 
m uch le ss  active than th e corresponding  
quaternary sa lts. The logic w a s  com p el­
ling: th e com bination  of tw o  'end groups’
as  in (2) into a b is-quaternary com pound  
like (4) m ight g ive a com p ou nd  w hich  
w ould d ecom p ose in alkaline solution  to 
give an inactive bis-tertiary b ase . Blood  
and m ost body t is su e s  are kept at pH 7 .4  
by sen sitive  b iochem ical m ech a n ism s—  
w ould th is pH be sufficient to prom ote  
Hofmann elim ination? The Medical 
R esearch Council (MRC) w a s  sufficiently  
intrigued to fund a research  fellow ship  
for three years, and I took up the post at 
Strathclyde in October 1 9 6 9 .
The an sw er to th e m ain q u estion —  
w a s  pH 7 .4  sufficient to prom ote elim in ­
ation in a quaternary benzylisoquino- 
line—w a s  an sw ered  ev en  before th e  
fellow ship  started. Further work at 
G lasgow  had sh o w n  that com p ou nd s  
sim ilar to (4) a lso  u nd erw ent Hofm ann  
elim ination  w h en  th e  quaternary h y­
droxide w a s  evaporated, so  th ere w a s  
nothing special about p etaline, after all. 
The 8-hydroxy group in (2) w a s  not 
required to prom ote elim ination and  
there w a s  little point in syn th es is in g  a 
bis-quaternary an alogu e, b eca u se  there  
w a s  no indication that su ch  a com pound  
w ould d ecom p ose m ore rapidly than (4). 
The project had collap sed  even  before it 
had begun.
The next few  w eek s  w ere  taken up 
w ith an in tensive library search . A
M u scle re laxan ts—a va lu ab le aid in m odern  surgery. (Photo: SPL)
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glim m er of light cam e from the reported 
rapid decom position  in alkali of the 
tetrahydroisoquinolinium salt (6),3 obtain­
ed in a few  step s  from th e  dihydroiso- 
q uin olin e (5), itself the product of th e  
Bischler-N apieralski cyclisation  of a 
m alonam ide. The decom position  of (6) 
w a s  aided at the rate determ ining step  by 
th e carbonyl group adjacent to the  
reactive centre and w a s  severa l orders of 
m agnitude faster than th e  breakdown of 
p eta line (2). It w a s  possib le  to  record the  
ultraviolet spectrum  of (6), to add on e  
drop of very dilute alkali to  th e  cuvette, 
and im m ediately to record th e spectrum  
of th e  b a se  (7). The very ex isten ce  of (6) 
w a s  crucial, b ecau se  it sh ow ed  that 
com p ou n d s w hich  u n d erw en t rapid 
Hofm ann elim ination in very dilute alkali 
cou ld  be obtained pure, provided that 
su itab le  precautions w ere  taken in th e  
sy n th esis . W e had to u se  a large ex c ess  
of concentrated  m ethyl iodide in pre­
paring (6) from its b ase  precursor, so  that 
quaternisation  w a s  rapid. S low  quater- 
nisation  resulted  in self cata lysed  elim in­
ations, giving com plex m ixtures from  
w hich  th e  quaternary sa lt could not be 
iso la ted —a major problem  throughout 
th e project. Even with only on e  centre to 
be q uatern ised  the likely im purities are 
n um erou s— in th is c a se  com pounds (8),
(9) and (10) are alm ost certain. They all 
arise from th e elim ination of com pound
(6), ca ta lysed  by the starting material and  
subsequent proton exchange, with quater­
n isation  of any free b a se  w hich  is 
present.
The sy n th es is  of an a logu es of (5) w a s  
likely to be limited by th e preferen ce for 
electron  donating sub stitu en ts such  a s  
the m ethoxy group in th e  B isch ler- 
Napieralski cyclisation step . This w a s  
overcom e quite n icely by a novel u se  of 
th e  Reformatski procedure in w hich the  
quaternary salt (77)  w a s  u sed  in p lace of 
a keton e to g ive the free b a se  of (8), but 
w ith the labile ester function  added after 
th e cyclisation . By using th is  m ethod th e  
b is-ester  (12) w a s  obtained, quaternised  
and sen t for pharm acological evaluation.'’ 
To our chagrin the b is-quaternary sa lt 
w a s  not only lacking in potency but 
p ersisten t in the body. W e could sy n ­
th es ise  an alogu es w hich elim inated more 
quickly,5 but th is  did not cure the  
problem. Our understanding of the ch em ­
istry w a s  obviously incom plete, and  
further work sh ow ed  that th e  elim ination  
was' reversible. At pH 7 .4  th e quaternary  
salt (6) and the tertiary sa lt (9) w ere in 
equilibrium.
The next step
Shortly before th is stage  w a s  reached I 
w a s  appointed to a lecturesh ip  in the  
pharm acy departm ent at Strathclyde and 
Joh n  Urwin took over th e  MRC p ost­
doctoral fellow ship . O ne of our first tasks  
w a s  to find a w ay of m aking th e  
elim ination  irreversible and th e obvious  
w ay w a s  to allow  separation  of the am ine  
and e s ter  groups w hich  w ere  held in 
c lo se  proximity in (7). The reverse  
reaction w ould then b ecom e inter- 
rather than intram olecular and so  w ould  
1210
jl 2 Cl CH3COOCH2CH2N(CH3)3 Cl
3CH,
■Several steps
:o o c 2r .
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be improbable. The objective could be a c ­
com plished m ost readily in a structure 
such as (73), w hich  after a certain  
amount of difficulty with the quater- 
nisation w a s  sh ow n  to elim inate in a 
satisfactory m anner at pH 7 .4 . The 
adoption of th is approach to a bis- 
quaternary required the syn th esis  of a 
bis-acrylate (14), w hich  w ould add the  
amine 'end group’ in a M ichael reaction  
before quaternisation. The u se  o f eth y l­
ene glycol a s  th e centre portion of (14) 
gave a chain of 10  units w hich  w a s  
supposed to be th e optimum, a s  in (4). 
Compounds w ith th is chain length  and 
with tw o ester  links had previously  
provided highly effective m u scle relax­
ants, specifically the succin ate b is-ester  
with choline a s  the quaternary moiety, 
known as succinyl choline or su xa­
methonium.
Although the b is-acrylate sh o w ed  a 
distressing tend en cy to polym erise, the  
problem w a s  not insuperable and (74) 
w as converted  to a num ber of bis- 
quaternary sa lts  w ith different end  
groups. O ne o f th e se —(75), w h ich  w a s  
coded BW 18A  by W ellcom e R esearch  
Laboratories—w a s  a very good m u sc le  
relaxant in laboratory tes ts .6 It w a s  quite 
potent and, above all, free from the  
common s id e effec ts  a ssoc ia ted  w ith  th is  
kind of drug. M any of th ese  desirable  
attributes stem m ed  from th e u s e  of 
tetrahydropapaverine a s  the en d  group, 
taking the structure m uch closer to (4) 
and to the original curare alkaloids such  
as (7), but w ith  a substantially shorter 
duration of action.
At this point th e MRC grant ran out and 
renewal w a s  refused. Fortunately, a 
student approaching finals had exp ressed  
interest in doing research  in isoquinoline  
chemistry w ith m e and w a s  p ersuaded  to 
carry the m uscle relaxant project forward. 
The student, G eorge Dewar, over the  
next three years m ade a contribution to 
the outcom e of th e project w hich  could  
scarcely h ave b een  surpassed.
He first sh o w ed  that the Hofmann  
elimination rates w hich  had b een  ob­
tained w ere  c lo se  to th e  limit. Faster 
rates could be ach ieved7 but w ere  a s ­
sociated w ith  difficulties in sy n th es is  
through self-cata lysed  elim ination. It 
was also probable that very fast elim in­
ation w ould result in m ost of th e  drug 
being destroyed before reaching th e  site  
of action, w ith  a con seq u en t lo s s  of 
potency.
Up to th is tim e, th e an ion  X- in 
structure (75) had b een  iodide b eca u se  
methyl iodide w a s  used  in quaternisation. 
As long as  th ey  w ere  reasonably pure the  
products w ere  pale yellow  so lid s w hich  
were fairly ea sy  to handle. Their solubility  
w as limited, how ever, and in anticipation  
of a requirem ent for larger d o s e s  in 
further pharm acological tests , a request 
was m ade for a more so lub le sa lt. After 
due consideration m ethyl m eth an esu lph ­
onate w as u sed  a s  q u atem isin g agent, 
giving the m ore hydrophilic Ch3S 0 3 
anion. The product w a s  certainly very 
soluble—so  m uch so  that under certain  
conditions it w a s  hygroscopic, declin ing
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rapidly from a fluffy w h ite  solid to an 
intractable gum . This problem w a s  solved  
on the laboratory sca le  by G eorge running  
to th e  desiccator with th e powder, freshly  
obtained by dripping th e  reaction mixture 
into a large volum e of dry ether. Neither 
aspect later com m ended  itself to the  
production chem ists!
A con siderab le am ount of work on  
an a logu es of BW 18A  sh ow ed  that the  
only w orthw hile m odification w a s  to th e  
centre chain  of (75), th e  com pounds w ith  
n = 5 or 6  being m uch m ore potent.8 The  
form er (BW 33A) w a s  ch osen  for e x ­
ten sive study, at w hich point the chem ical 
problem s b ecam e th o se  of scaled-up  
syn th esis  and quality control. To facilitate  
the former, the anion w a s  ch an ged  on ce  
again to ben zen esu lp h onate, avoiding  
the n ecess ity  for large quantities of dry 
ether and th e resulting unacceptab le fire 
hazard. In retrospect th e  iodide w ould  
probably have b een  perfectly acceptable, 
b eca u se  in clinical trials the product had
m ore than adequate potency. 
S tereo ch em istry
The stereochem istry of BW 33A  w a s  com ­
plex.9 There w ere  1 0  p ossib le  isom ers  
arising from four asym m etric cen tres, six  
few er  than  w ould  be exp ected  if there  
w ere  no sym m etry about the middle of 
the ch a in . If the end  groups w ere  categor­
ised  a s  cis or trans  th e physically  
distinguishable com pounds w ere  cis/cis, 
c is /tra n s  and trans/trans .  T h ese could  
b e determ in ed  by HPLC and a s  long as  
th e proportions did not vary the potency of 
th e  product w a s  reproducible. It is prob­
ab le that all th e isom ers contribute to th e  
pharm acological actions of the mixture, 
so m e being m ore potent than others.
After a great deal of preparatory work 
by W ellcom e R esearch  Laboratories, 
B W 33A  b ecam e atracurium  and a su c ­
ce ss fu l surgical m u sc le  relaxant— 
Tracrium—eventually  reached  the mar­
ket. Apart from the lack of sid e e ffec ts  the
I 2 I I
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major sign ificance of th e  drug is that its 
decom position  is controlled by pH. Even 
in p atients with a defective liver or 
kidneys the pH of blood is close ly  
controlled and the drug breaks dow n at a 
predictable rate. A lthough w e  have called  
atracurium 'biodegradable' the d ecom ­
position d o es  not dep en d  on any bio­
logical p rocess except the m ain ten an ce  
of blood pH and the com pound should  
perhaps be called  'chem odegradable'. In 
a w ay th is represents a triumph for the  
predictability of chem istry over th e  
random ness of biology.
For stud en ts of m edicinal chem istry  
the atracurium project offers som e useful 
le sso n s. M ost important, a good idea is 
w orth pursuing even  if th e  theory and 
experim ents w hich led to it are later 
found faulty. Three foundation s ton es  
w ere removed from the theory underlying 
th e search  for short acting m u scle  
relaxants a s  th e work p roceeded . O ne of 
th ese , concerning th e  rate of decom  
position  of petaline, h as  b een  explained  
in so m e detail already. The second , 
w hich  cam e from totally independent 
work at W ellcom e Research Laboratories 
soon  after the project started ,10 sh ow ed  
that th e  potent arrow p oison  constituent 
tubocurarine w a s  not a bis-quaternary  
salt, a s  had been  believed for nearly 4 0  
years. The third foundation s to n e  w a s  
th e  so  ca lled  'interonium  distance'. A s I 
h ave explained, th e optim um  separation  
of th e tw o quaternary n itrogens w a s
w idely b elieved  to correspond to 10  
atom s, a s in decam ethonium , laudexium  
and the b is-ester succinyl ch o lin e .1 W ith­
out a w illin gn ess to abandon th is pre­
conception and m ove to longer chains, 
atracurium would never have been  made. 
A full a s se ssm e n t of th e literature sh o w s  
that there are sufficient excep tion s to the 
10 unit rule to have discredited  the  
theory so m e tim e before atracurium w as  
m ade, although th o se  w h o  had been  
working in th e  field for m any years w ere  
reluctant to  abandon on e  of the few  
guiding principles.
A secon d  le sson  con cern s th e general 
philosophy behind th e syn th esis  and 
testing  of potential m edicinal agents. At 
no point up to the se lection  of BW 33A  
w as m ore than on e person involved 
actively at any on e tim e w ith bench  
chem istry, but each  candidate com pound  
w a s  exam ined  very carefully by the  
pharm acologists. The contribution to the 
project by the pharm acologists Roy 
H ughes and D ennis Chapple extended  
far beyond th e  provision of potency  
evaluation. Their test m eth od s w ere  
arrived at by consultation  and they  
provided a full pharm acological profile 
for each  and every com pound sen t for 
testing: feedback from th ese  resu lts w as  
then used to design  th e  next tw o or three 
com pounds. In the right kind of project 
the careful selection  of synthetic targets 
m ust offer a greater ch an ce  of su c c e ss  
than th e sh otgu n  approach w ith lots of
n ew  com pounds evaluated in a super­
ficial preliminary 'screen'.
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Chem odegradable neurom uscular blocking 
agen ts—I: Bts~3,4-dihydroisoquinolinium  salts
George H. Dewar*, Ian G. M arshallt, Sanjay S. Patel* and 
Roger D. W aight
*School of Pharmacy and Pharmacology, University of Bath, Avon; tDepartment of Pharmacy, University of 
Strathclyde, Scotland
A ser ies o f N ,A /'-p o ly m eth y len e-b is-3 ,4 -d ih y d ro iso q u in o Iin iu m  quaternary salts has b een  prepared  
an d  exam in ed  for neurom u scu lar b lo ck in g  activity o f  short duration. C yclod eh yd ration  o f N -[ l ,3 -  
di-(3 ,4 -d im eth oxyp h en y l)p rop -2 -y ll form am ide y ie ld e d  3 ,4 -d ih yd ro-3-(3 ,4 -d im eth oxyb en zyl)-6 ,7 -d i-  
m eth o x y iso q u in o lin e  w h ich , w h en  reacted w ith  a variety  o f  a ,« -d iio d o a lk a n e s , gave  th e required  
agen ts. T h e  sy n th esis  o f tw o an a logu es  o f la u d ex iu m  is a lso  described . T h e 3 ,4 -d ih y d ro iso q u in o li-  
n iu m  sa lts  exh ib ited  a short action in  the cat, bu t p o ten cy  w as w eak  and accom panied  b y  v ago ly tic  
g a n g lio n  b lo ck in g  actions.
K eyw ord s: NM B agents; his quaternaries; 3 ,4-d ih ydroquin olin ium  salts
Introduction
□-Tubocurarine 1 (R =  H; Figure 1) is the proto­
type anti-depolarizing neurom uscular blocking  
agen t (NM B agent) and it still see s  som e clinical 
u se , d esp ite  s ide-effects such as tachycardia and  
h istam ine release [1]. T he corresp ondin g bis- 
quaternary d im ethyl ether ('m etocurine'; 1; 
R = M e) is a m ore protent, longer acting drug  
but it is essentia lly  free o f the side-effects  associ­
ated w ith  the parent [2], and it is in this regard 
that m etocurine has a ssu m ed  a place o f im port­
ance in stru ctu re-action  stu d ies and drug d esign  
[3]. O n  the other han d , su xam eth on iu m  2 
(Figure 1) d isp lays an undesirable depolarizing  
m od e o f action but it is  still u sed  clinically  
because o f  its short duration o f action in the 
m ajority o f patients [4].
For m any years, w orkers in the field  h ave  tried 
to id en tify  a good , short-acting, neurom uscular
Address correspondence to: G. H. Dewar, School of Phar­
macy and Pharmacology, University of Bath, Claverton 
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Figure 1. Chemical structures of tubocurarine (1; R 
FI), metocurine (1; R = Me) and suxamethonium.
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b locking agen t (the curariform  equ iva len t o f 
suxam ethon ium ); a short action in NM B agents is 
considered  essen tia l to avoid  prolonged  m u scle  
paralysis after com p letion  o f th e surgical pro­
cedure [5]. O n e  approach h as b een  to incorpor­
ate the tetrahydropapaverinyl feature 3 (Figure 
2), see n  in  m etocurine, in to  a bis-quaternary 
structure (this p rov id es for NM B action o f  the 
anti-depolarizing type), and  m anipulate the inter­
nitrogen  chain chem ically  to  a llow  for m olcular  




3 O M e
or non-quaternary sp ecies  d evo id  o f  activity. A 
few  g o o d  exam ples of th is  approach are to be  
fou nd  in  agents 4 - 6  (Figure 2) [6 -1 3 ].
This paper concentrates on  the susceptib ility  o f
3,4-d ih ydroisoq u inolin ium  salts, such  as 7 
(R =  M e, Et, Pr, etc.; Figure 3), to n u cleop h ilic  
attack on  position  1, w ith  attendant lo ss  o f per­
m an en t charge [14]. From the above con sid era ­
tions, a target m olecule w o u ld  be the b is-l-vera- 
tryl agen t 8 (Figure 3), bu t such  a co m p ou n d  
(e .g . n =  10) has been  fou n d  to be o f low
(p H ,) ;  O  C (C H ,)j C O (C H ,) ' O M e






(C H*)2—CO,*— (c H*)s— O —  CO —  (c H,)?'
.Z P h S O f
C H , Figure 2. The tetrahydropapaveri­
nyl unit, 3, and some related 
potential short-acting, non-depo­
larizing neuromuscular blocking 
agents, 4 -6 .
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OMeMeO
OM e 9 OM e
N - - M e  ,  ; 
n HCI
Figure 3. Some 3,4-dihydroisoqui- 
nolinium salts, together with their 
possible breakdown and tautomer- 
iza tion.
po ten cy  and severe in its side-effects [14]. This 
observation  has b een  rationalized on  the basis  o f  
the ability o f 8 to u n d ergo  tautom erism  to 9 
(Figure 3), a ch an ge  that loses the n ecessary  
quaternary status o f the m olecule. Such sh ift o f  
an en d ocyclic  dou ble  b on d  into conjugation  b e­
tw een  tw o  arom atic rings is, h ow ever, w ell d o cu ­
m en ted  in 1 -b en zy l-3 ,4 -d ih yd ro isoq u in o lin es  of  
type 10 (Figure 3) [1 5 -1 7 ],
W e en v isa g ed  that a translocation o f the vera- 
tryl un it from C -l to C-3 o f the isoq u in o lin e  ring, 
to g iv e  c o m p o u n d s 17 (Schem e 1), sh o u ld  cir­
cu m ven t the p rob lem s o f tautom erism  and  th us  
give  co m p o u n d s w ith  the desired  short action
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"COOH +
OMe
OMeN H .OH .H CI/
NaOAc
N ickel -Aluminiut 
a llay puwderMeO-
OMe
H C O O H /M eO H / 
180 °C 5 - lOmin
-OMe
CHCIjMeO'




b : n  = 8
c :  n = 10 
d :  n = 12
NaBH./EtOH
OMe OMe
McO^ J- 1 OMe
2 PhSOjM e
.2 PhS O ,
Schem e 1.
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profile. A dditionally , the tetrahydro-lns-quater- 
nary c om p ou n d s 19 (S ch em e 1), w hich  are iso ­
m eric to laud exium  (Figure 4), w ere prepared to 
g iv e  a qualitative com parison  o f the change in 
NM B p oten cy  as a result o f transposition  or the  
veratryl fu nction  around th e  tetrahydroisoqu ino- 
Iine ring.
M aterials and m ethods
C hem istry
Synthetic  routes. T he bis-quaternary salts 17 (see  
Sch em e 1; inclu des interm ediates) w ere prepared  
by treatm ent of 3 ,4-d ih ydro-3-(3 ,4-d im ethoxy- 
benzy!)-6 ,7 -d im eth oxyisoq u i noline 16 w ith  the
appropriate a ,  a>-diiodoalkane. T he interm ediate  
diveratrylketone 12 w as prepared, in th e first 
instance, b y  th e C orey -S eeb ach  procedure  
[18 ,19] (S ch em e 2) w h ich  in vo lves an um polung  
(d ipole inversion) o f a carbonyl fu nction . T hus, 
seq uentia l lith iation  and alkylation o f 1,3-d ith iane  
gave  the 2 ,2-d isu b stitu ted  1,3-d ith iane 21 
(Schem e 2). M ercuric chloride hyd rolysis  [20] of 
the thioketal 21 afforded d iveratrylketone. R epe­
titive colum n chrom atography w a s necessary  to  
isolate 21, and th e su b seq u en t deth ioketalization  
process also p roved  to be inefficient; the reaction  
pathw ay exp ressed  in Schem e 2 w a s  clearly too  
cum b ersom e for the preparation o f the large  
quantities o f d iveratrylketone that w ere  required. 
E lsew here, P rud hom m eau x et a l. have p rev iou sly
MeO OMe







F ig u r e !. Chemical structure of laudexium.
B u L i /  T H F
3(1 “C
1 ,3 -  D ith ia
C H . — Cl






( l ) « - B u L i /  T H F
H g C I, /
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21 Schem e 2.
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reported [21] a ttem pts to sy n th esize  diveratryl­
k eton e by o th er  m eans, and even tually  achieved  
y ie ld s  o f not m ore than 30% by pyro lysis  o f the 
lead salt o f  3 ,4 -d im eth oxyp h en ylacetic  acid 
[22, 23]. In our h a n d s this m eth od  proved  m essy , 
an d  y ie ld s w ere  very low .
W e therefore pu rsu ed  an alternative o n e-step  
procedure (S ch em e 1), prev iously  reported by  
Sainsbury an d  W yatt [24], to secure diveratryl­
k eton e. A d d ition  o f 0 .25 m ole o f lithium  alum in­
ium  hydride (LAH ) to a decarbonated so lu tion  
o f 3 ,4 -d im eth oxyp h en y lacetic  acid and N ,N '~  
carb onyld iim idazole  in dry THF gave  diveratryl­
k eton e. V arious m od ification s o f the procedure  
to secure y ie ld s  greater than 52% proved fruit­
less . R eductive am in ation  o f diveratrylketone via 
the interm ediate oxim e 13 gave diveratrylm ethy- 
lam ine 14. T he procedure in vo lved  in situ  cata­
lytic reduction o f the oxim e 13 w ith  n ick e l-a lu - 
m in ium  alloy p o w d er . Form ylation of diveratryl- 
m eth ylam in e 14, w ith  an equim olar quantity o f 
form ic acid g ave  the substitu ted  /T phenylethyla- 
m id e 15, and  standard B isch ler-N ap iera lsk i cycl- 
ization  [25, 26] o f  this w ith  p h osp h oru s pentach- 
loride gave th e desired  3 ,4 -d ih ydro isoq u inolin e  
16. T reatm ent o f  16 w ith  half a m ole-q uivalent o f 
the appropriate a ,  rv-diiodoalkane gave  the bis- 
quaternary sa lts  17. Further reduction w ith  so ­
d iu m  borohyride, fo llow ed  b y  quaternization  
gave  the saturated  bis-quaternary salts 19.
Description o f  experiments. M elting poin ts w ere  
recorded on  a G allenk em p m elting p o in t appara­
tus and are uncorrected . Infrared spectra w ere  
recorded on  a P erk in -E lm er 782 (or Unicam  
SP1025) instrum en t and w ere  obtained on  liquid  
film s or as KC1 d iscs (for so lid s). ’H m agnetic  
resonan ce spectra  w ere recorded on  JEOL JNM  
270 FT and JEOL GX 400 FT instrum en ts. 13C 
m agnetic reson an ce  spectra w ere recorded on  a 
JEOL JNM 270 FT instrum en t operating at
67.8 M H z. CDCI3 w as the standard so lv en t of 
choice (u n less  ind icated  oth erw ise), w ith  TMS as 
internal standard. M ass spectra w ere recorded on  
a VG analytical M icrom ass 7070E sp ectrop h oto­
m eter (70 eV  El, Cl and FAB). W here appropri­
ate, co lu m n  chrom atograph y w as perform ed u s­
ing M erck silica g e l (K ieselgel 60: 230 -400  m esh). 
U n less  sta ted  o th erw ise , all reagents are com ­
m ercially available. IR and NM R data for the 
bis-3 ,4-d ihydroisoqu in olin ium  salts w ere recorded  
and are available on request from the authors 
(G H D  and SSP).
3,4-D m etlw xybenzylchloride (veratryl chloride). 
C oncentrated etheral hydrochloric acid solution  
(32 ml) w as added d rop w ise  at 0°C to a solution  
of 3 ,4 -d im eth oxyb en zyla lcoh ol (20 g, 119 mmol; 
secured  by standard so d iu m  borohydride reduc­
tion o f veratraldehyde) in  dry d ieth yl ether  
(30 m l). T he mixture w as left stand ing  at 1-2°C  
for 24 h , after w hich it w as concentrated in vacuo 
to an oil. Crystallization from  light petroleum  (bp 
3 0 -4 0 ) gave  colourless p late  crystals of the title 
com p ou n d  (17.9 g, 80.7%).
Mp: 49-50°C  ([27] 50 -50 .5°C ).
IRvmax(KBr) c m ' 1: 3020, 2950, 2840, 1615, 1610, 
1520.
s H: 6.90 (3H, m , Ar-H); 4‘.58 (2H, s, -C H r );
3.90 (6H , s ,  2 x  O M e).
2,2-D i-(3f4-dim ethoxybenzyl)-l,3-dithiane, 21. Pre­
pared by the C orey -S eeb a ch  procedure [18]: n- 
butyllith ium  (9.35 ml o f a 2 .6  M so lu tion  in 
hexane; 25 m m ol) w as ad d ed  d rop w ise  to a 
stirred so lu tion  of 1 ,3-d ith iane (2.6 g, 22 m m ol) 
in dry THF (100 ml) u n d er  n itrogen at -3 0 °C .  
After 2 h, veratryl chloride (4.2 g, 22.5 m m ol) in 
dry THF (60 ml) w as ad d ed  d rop w ise  over 5 m in  
at — 1°C. T he ye llow  so lu tion  w as stirred at 8°C 
for 70 h after w hich  H-butyllithium  (9.35 m l of a 
2.6 M so lu tion  in hexane, 25 m m ol) w as added  
d rop w ise  at —30°C, and stirred at —30°C for a 
further 3 h. To the resultant red /m aroon solu tion  
w as ad d ed , d ropw ise, veratryl ch loride (4.2 g, 
22.5 m m ol) in dry THF (60 m l) over 5 m in at 
— 10°C. T he so lu tion  regained its ye llow  colour  
and w a s stirred for a further 16 h at 0°C, poured  
into three tim es its vo lu m e o f w ater, acidified to 
pH 5 - 6  and extracted w ith  d ieth y l ether  
(5 x  200 m l). The com bin ed  extracts w ere w ash ed  
w ith  3% sod iu m  bisu lp h ite  (2 x  200 ml), 5% po  
tassium  hyd roxid e (2 x  100 m l), w ater and dried  
(M g S 0 4). Evaporating th e so lv en t in vacuo gave a 
dark ye llo w  oil. C olum n chrom atographic separa­
tion (d iethyl ether: light petroleum , bp 60-80; 
1:3) and su b seq u en t crystallization from ethanol 
gave co lourless plate crystals o f the thioketal 
(3.5 g , 37.9% ).
Mp: 101.5-102°C .
IRvmax(KBr) cm  ' 1: 2980, 2860, 1610, 1530.
s H: 6 .9 0 -6 .8 0  (6H, m , Ar-H); 3 .9 0 -3 .8 0  (12H, s, 
4 x  OM e); 3.15 (4H, s, 2 x  A r-CH r ); 2 .80 (4H, 
t, 2 x  -C H r S); 1.90 (2H , m, -C H r ).
MS (Cl): m /z  421 (86%, M + +  1).
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The co lu m n  chrom atographic procedure , also  
yie ld ed  the corresp on d in g  m on o-su b stitu ted  di- 
th iane, and the fo llow in g  data w ere secured  for
2-(3 ,4 -d im eth oxyb en zy l)-l,3 -d ith ian e , 20.
IRvmax(KBr) cm -1 : 2900, 2870, 1620, 1605, 1535.
s H: 6 .80 (3H , in, Ar-H); 4 .24 (1H , f, J =  7.4  H z, 
-CH-); 3.84 (6H , in, 2 x  OM e); 3 .00 (2H , d,
] = 7 A  H z, A r-CH 2); 2 .9 0 -2 .8 0  (4H , m ,
2 X -C H 2-S); 2 .2 0 -2 .0 0  (2H, m , S-C H 2-C H 2-).
MS (Cl); m /z 271 (90%, M + +  1).
1,3-D i-(3,4-diinethoxyphenyl)propan-2-one (diveratryl­
ketone), 12.
(a) By h yd ro lysis  o f 21 [20]
A m ixture o f 2 ,2 -d i-(d im eth oxyb en zyI)-l,3 - 
dith iane 21 (0.5 g, 1.2 m m ol), m ercuric chloride  
(0.68 g, 2 .5  m m ol) and cadm iu m  carbonate (0.4 g, 
2 .3  m m ol), in m eth anol (30 m l), w a s heated  at 
55°C for 24 h. After coo lin g , the m ixture w as  
filtered, and the filtrate extracted w ith  chloro­
form  (2 x  100 m l). T he com b in ed  organic extracts 
w ere w a sh ed  (w ater), dried (M g S 0 4) and the  
so lv en t rem oved in vacuo to leave a ye llo w  oil 
w hich  so lid ified  on  sta n d in g  overn igh t. Crystal­
lization from 95% eth an o l gave y e llo w  star crys­
tals of d iveratrylketone (0.23 g , 58%).
(b) Sainsbury and W yatt procedure [24]
To a stirred so lu tion  o f  N ,N '-carb on y ld iim id a- 
z o le  (16.5 g, 102 m m ol) in dry THF (200 m l) w as  
add ed  3 ,4 -d im eth oxyp h en y lacetic  acid (20 g, 
102 m m ol). Carbon d iox id e  w as ev o lv ed  and
w h en  th is had su b sid ed , dry n itrogen  w as
b u bbled  through the m ixture for 30 m in . The 
resu lting  y e llo w  so lu tio n  w as coo led  to — 10°C 
and lith ium  alum in iu m  h yd rid e (1 g, 26 m m ol) 
a d d ed  in  sm all portion s. The reaction m ixture 
w a s a llow ed  to w arm  to room  tem perature and  
stirred for 8 h . A  further quantity o f THF
(150 m l) w as ad le d , fo llo w ed  by w ater until all 
bu bblin g had com p lete ly  su b sid ed . T he m ixture  
w a s filtered and w a sh ed  through w ith  cop ious  
qu antities o f chloroform . The aq u eou s layer from  
th e filtrate w as iso la ted  and extracted w ith
chloroform  (3 x  200 m l). T he extracts w ere  com ­
b in ed  w ith  the organic layer, w a sh ed  (w ater), 
dried (M g S 0 4) and  th e  so lven t evaporated  in 
vacuo to g ive  the k e to n e  12 as an  oil, w h ich  
s low ly  crystallized  on  s ta n d in g  (8.45 g, 51%).
Mp; 98 -99°C  (m eth an ol) ([28] 98-99°C ).
I R w ( K B r )  cm "1: 3040, 2980, 2860, 1730, 1600, 
1540. sH: 6 .80 (2H , d , Jortho =  8 H z,
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(2FI, dd, lortho.meta =  8 H z and  1.9 z,
2 x  6-Ar-H); 6 .60 (2H , d , Jmeta =  1.9 H z,
2 x  2-Ar-H); 3 .82 (12H , s, 4 x  O M e); 3.64  
(4H , s, 2 x  -C H 2-).
MS (70 eV  El): m /z 330 (20%, M +).
2-Am ino-1,3-di-(3,4-dim ethoxyphenyl)propane (divera- 
trylmethylam ine), 14. D iveratrylketone (5.1 g, 15.5 
m m ol) w a s heated  u n d er  reflux in  m ethanol 
(50 m l) w ith  hyd roxylam ine hydrochloride  
(1.56 g, 22 .4  m m ol) and  sod iu m  acetate (3.27 g,
39.9 m m ol) for 6 h . A fter co o lin g , the mixture 
w a s m ade alkaline to litm us pap er w ith  5 N  
sod iu m  h yd roxid e so lu tion , an d  n ick el-a lu m i- 
nium  alloy p ow d er  (6.56 g, 76 m m ol) w as add ed  
cautiou sly  over 0.5  h . The m ixture w as then  
stirred for 4 h , filtered, and  w a sh ed  through w ith  
cop iou s qu antities o f ch loroform  (4 x  100 ml). 
From the filtrate, the aqu eou s layer  w as separ­
ated and extracted w ith  chloroform  (4 x  50 ml). 
The extracts w ere com b in ed  w ith  the organic 
layer, w a sh ed  (w ater), dried (M g S 0 4), and the 
so lv en t evaporated  in vacuo to g iv e  a ye llo w  oil. 
C rystallization from  light p etro leu m  (bp 6 0 -80 ) 
gave the title com p ou n d  as co lou rless flakes 
(4.3 g, 87%).
Mp: 83-84°C  ([28] 88-89°C ).
IRvmax(KBr) cm "1: 2950, 2840, 1600, 1530.
s H: 6.80 (6H , m, Ar-H); 3 .86 (12H , s, 4 x  OM e); 
3.20 (1H , m , CH); 2 .80 (2H, dd, J =  11.25 H z  
and 3 .38  H z -CH 2-); 2 .50 (2H , dd,
) =  11.25 H z and 7.31 H z -C H 2-); 1 .4 0 -1 .2 0  
(2H, s, NFI2: exch angeab le  w ith  D zO).
MS (Cl): m /z 332 (100%, M + +  1).
N-[l,3-di-(3,4-dim ethoxyphenyl)prop-2-yl]forinam ide,
15. Formic acid (0.5 g , 10.9 m m ol) w as add ed  to 
a so lu tion  o f  the am in e 14 (4.2 g , 12.7 m m ol) in 
m eth anol (10 m l) and left to  stan d  for 15 m in . 
Evaporation o f  the so lv en t in vacuo gave a yellow  
solid  w h ich  w a s  heated  at 180°C for 10 m in  to 
g ive  a dark brow n oil. C rystallization from  95% 
ethan ol gave  fine, co lourless crystals o f th e title 
com p ou n d  (3.9 g, 85.5% ).
Mp: 124°C ([21] 129-130°C ).
IRvmax(KBr) cm " 1: 3300, 2960, 2850, 1680, 1620, 
1600, 1530.
s H: 8 .06 (1H , s, -CH O ); 6 .8 5 -6 .6 0  (6H , m, 
Ar-H); 5 .45  (1H , d, -H N -); 4 .5 5 -4 .4 5  (1H , m , 
-CH-); 3 .85  (12H, s, 4 x  O M e); 2 .9 0 -2 .6 0  
(4H , m, 2 x  -C H ,-).
MS (70 eV El): m /z 359 (22%, M +).
Pharm aceutical Science C om m unications Vol 4 N o 1 9
1 6 2
G. H. Dewar et al.
3,4-D ihydro-3-(3,4-dim ethoxybenzyl)-6,7-dirnethoxy- 
isoquinoline, 16. P h osp h oru s p entach loride (3 g, 
14.4 m m ol) w as ad d ed  to a stirred so lu tion  o f  the  
am ide 15 (2 g, 5 .6  m m ol) in dry chloroform  
(10 ml) and stirred at room  tem perature for 24 h . 
Dry diethyl e th er (60 m l) w a s th en  add ed  to g ive  
a flocculent precip itate. This w a s filtered o ff and  
recrystallized from  propan-2-ol to  g ive a y e llo w  
crystalline proton  salt o f th e title com p ou n d  
(1.8 g, 85%). A sm all quantity o f  the proton salt 
w a s liberated to  the free b ase and converted  to 
the corresp ondin g  hyd rob rom ide salt.
M p (HBr salt): 270-271°C  ([21J 272-273°C ).
IR (HBr salt)vmax(KBr) cm -1 : 2960, 2860, 1640, 
1615, 1530.
s H (free base): 8 .25  (1H , d , 1-Ar-H); 6 .8 5 -6 .7 5  
(4H, m, 2'-, 5 '-, 6'- and 8-Ar-H); 6 .60 (1H , s, 
5-Ar-H); 3 .9 0 -3 .7 5  (13H, m , 4 x  O M e and
3-H); 3 .20 (1H , dd, 9a-H , J =  13.50 H z-w ith  
9b-H , J =  5 .63  H z-w ith  3-H); 2 .75 (1H, dd, 
9b-H, j  =  13.50 H z-w ith  9a-H , J  =  9.00 H z- 
w ith  3-H); 2 .60  (1H, dd, 4cq-H , J =  15.75 H z- 
w ith  4ax-H , an d  J =  5.63 H z-w ith  3-H); 2.45  
(1H, dd, 4ax-H , J =  15.75 H z-w ith  4eq.H and  
J =  11.25 H z-w ith  3-H ).
MS (70 eV El): m /z 341 (10%, M *).
tv, co-Bis-[3,4-dihydro-3-(3,4-dimethoxybenzyl)-6,7- 
dimethoxyisoquinolinium]alkanes, 17. The general 
m eth od  ad op ted  w as a m od ification  o f that em ­
p loyed  by Sten lake et al. [14].
Example: l,10-br's-[3,4-dihydro-3-(3,4-d im ethoxy-
b en zy l)-6 ,7 -d im eth oxyisoq u in olin iu m ] d ecan e  d i­
iod ide, 17c. A  m ixture o f  3 ,4-d ihydro-3-(3 ,4- 
d im eth oxyb en zy l)-6 ,7 -d im eth oxy isoq u in o lin e  16 
(2.07 g , 6 m m ol) an d  1 ,10-d iiod od ecan e  (790 m g, 
2 m m ol) in a ceton e  (15 m l) w a s  heated  u n d er  
reflux in a n itrogen  atm osp h ere  for 48 h. After 
cooling, th e bis-quaternary salt w as iso lated  by  
a llow in g  the so lu tio n  to drip th rou gh  a sinter  
funnel in to rapidly stirred pre-filtered dry d ieth yl 
ether. The resu ltin g  floccu lent so lid  w as filtered  
off, w a sh ed  w e ll w ith  dry d ieth yl ether, and  
dried in  a v a cu u m  d essicator for 24 h  in the  
presence o f p h o sp h o ru s p en tox id e  to g ive  
l,10-b zs-[3 ,4-d ih ydro-3-(3 ,4-d im ethoxyb en zyl)-6 ,7- 
d im eth oxy isoq u in o lin iu m ]d ecan e d iiod ide, 17c, 
as a ye llo w  p o w d er .
Yield: 96%; M p 100-102°C  D ec.
C5oH6flI2N 20 8: C ,H ,N .
Data for other m em bers o f th e  series (as above):
17a: 95%; 134°C D ec.
C46H 58l2N 20 8: C ,H ,N .
17b: 98%; 94-96°C  D ec.
C48H 62I2N 20 8: C ,H ,N .
17d: 97%; 98-100°C  D ec.
C S2H 70I2N 2O 8: C ,H ,N .
а , ta-B is-ll, 2 ,3 ,4 -tctrahydro-3-(3,4-dimethoxybenzyl)-
б,7-dimethoxyisoquinolin-2-yl]alkane methyl benzene- 
sulphonates, 19.
Example: l,10-b is-[l,2 ,3 ,4 -t:'.rah ydro-3-(3 ,4 -d im e-  
thoxybenzy l)-6 ,7 -d im ethoxyisoqu ino lin -2-y l ] 
decane d im ethyl b en zen esu lp h o n a te , 19a. To a 
solu tion  o f th e b /s-3 ,4-d ihydroisoqu in olin ium  salt 
17c (4 g, 3 .7  m m ol) in 95% eth an ol (50 m l) w as  
add ed  sod iu m  borohyd rid e (10 g , 0 .2  m m ol) in 
sm all portion s over 0 .5  h . The m ixture w as  
stirred for 24 h, qu en ch ed  w ith  d ilu te  hyd ro­
chloric acid (10%), su b seq u en tly  m ad e alkaline to 
litm us paper w ith  5 N  so d iu m  hyd roxid e so lu ­
tion, and extracted w ith  d ieth yl ether 
(3 x  100 m l). T he com bin ed  organic extracts w ere  
w ash ed  (w ater), dried (M gSO^), and evaporated  
in vacuo to g ive  the corresp on d in g  red u ced  com ­
p ou n d  as a crude yellow  o il. T his w as converted  
to the oxalate salt, and the resultant flocculent 
precipitate filtered off and recrystallized  to g ive  
the tertiary proton salt 18a. T he free b ase (liber­
ated by d isso lv in g  the d ioxalate  salt in  w ater, 
basify ing w ith  am m onia an d  extracting w ith  d i­
ethyl ether) (480 m g, 0 .6  m m ol) w a s treated w ith  
m eth yl b en zen esu lp h o n a te  (0.3 g, 1.7 m m ol) at 
room  tem perature for 24 h  to g iv e  1,10-bis- 
[l,2 ,3 ,4 -te trah yd ro-3-(3 ,4 -d im eth oxyb en zyl)-6 ,7 - 
d im eth oxyisoq u in o lin -2-y l]d ecan e d im eth y l b e n ­
zen esu lp h o n a te  19a, w hich  w as iso la ted  as a 
colourless p ow d er  by precip itation  from  dry d i­
eth y l e ther according to th e sam e p roced ure u sed  
for the b is-3 ,4-d ihydroisoqu in olin ium  salts above.
Yield: 96%; M p 98-104°C  D ec.
C64H84N2O mS2. 2H zO: C ,H ,N .
19b: 98%; 113-116°C  D ec.
C66H 88N 2O h S2. 4H 20 :  C ,H ,N .
Pharmacology
N eurom uscu lar b locking p o ten cies , vagal and  
gan glion  blocking actions, and  oth er cardio­
vascular data w ere d eterm in ed  in an a n a esth e­
tized cat according to the procedure described
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e lsew h ere  [29]. The results are presented  in  
Table 1. AH pharm acological data w ere obtained  
on  the racem ic m ixtures secured  from chem ical 
w ork-up  procedures.
Pharmacological results
By translocating the veratryl m oeity  from th e C -l 
to C-3 position  o f th e isoq u in o lin e  ring, w e  had  
anticipated  tw o advantages: firstly, the favour­
able poten cy and h yd rop h ilic -lip op h ilic  balance  
associated  w ith  laudexium  (Figure 4) is p o ten ­
tially m aintained in the n ew  com p ou n d s, and, 
secon d ly , prev ious w ork [14 ,30] on  3,4-d ihydro- 
isoq u in o lin iu m  com p ou n d s has sh o w n  that
3-alkyl substitu tion  in itself en h an ces poten cy , 
and  therefore w e  exp ected  a further increase in  
p o ten cy  o f the n ew  com p ou n d s.
Three o f the 3 ,4 -d ih ydroisoq u inolin ium  com ­
p o u n d s , 1 7 a -c , exhib ited  neurom uscular block­
in g  action o f short duration (ca 10 m in; Figure 5). 
T he m in im u m  d o se  required w a s 1.6 m g/k g  
(Table 1), thus su g g estin g  a m uch reduced  
p o ten cy  in th ese  com p ou n d s com pared to sim ilar
3 ,4 -d ih yd roisoq u in olin iu m  salts reported by  
oth er w orkers [14, 31]. Furtherm ore, at paralys­
in g  d o se s , 17b m arkedly low ered  b lood pressure, 
and atropine-like effects w ere exhibited by all 
three active com p ou n d s. 17b and 17c a lso  
s h o w ed  gan glion  b locking action; surprisingly, 
th is action is virtually absent in 17a (bis-onium
Chcmodegradable neuromuscular blocking agents
com p ou n d s w ith  a six-atom  in ter-on ium  spacing  
are usually  associated  w ith  peak ganglion  block­
ing action [31]). The d o d ecam eth y len e  analogue  
17d lacked neurom uscular b lock ing action at 
d o ses  up  to 1.6 m g /k g , but produ ced severe  
cardiovascular disturbances at th ese  doses.
C onclusion
In com parison  to oth er b is-3,4-dihydroisoquino- 
lin ium  sa lts  7 and 22 (Figure 6) [30], the 
m arkedly red u ced  p o ten cies ob served  in our  
com p ou n d s m ay be exp lain ed  as follow s: firstly, 
nucleoph ilic  attack at C -l in  co m p o u n d s 7 and 22 
m ay be h in d ered  by su b stitu en ts present at C -l 
w hereas in 17 access to n u cleop h iles rem ains 
u n hind ered , and th is m ay a llow  for a m ore rapid  
attack. C on seq u en tly , the low  neurom uscular  
blocking p o ten cy  o f com p ou n d s 17 m ay w ell be  
an exp ress ion  o f rapid in vivo  breakdow n, so that 
the proportion o f intact m o lecu les actually reach­
ing the site  o f action is low  in  relation to the  
injected d o se .
S econdly , it is qu ite likely that the conform a­
tion ad op ted  by th e veratryl m o iety  im p oses a 
steric h in drance to th e interaction o f the onium  
head w ith  th e receptor site. T his is ev ident from  
an approxim ate com parison  o f th e neurom u s­
cular b lock ing po ten cy  o f the bis-quaternary salt 
19a w ith that o f laud exium  (Figure 4), w hich
Table 1. Neuromuscular blocking potencies and cardiovascular effects of N ,N '-polymethylene-bis-3,4-dihydro- 
isoquinolinium (17) and N,N'-polymethylene-bi's-l,2,3,4-tetrahydroisoquinolinium (19) quaternary salts in the cat"





Soleus Tibialis BP HR
17a 1600 26 52 24 6 6 5
17b 1600 70 89 30 16 35 12
17c 1600 21 60 44 19 *» *»
17d 1600 * * 27 * 25 38
19a 200" 92 75 0 0 0 2
19b 400" 93 100 37 7 15 3
"Individual results (n = 1).
''Cumulative dose in /xg/kg.
"Ganglionic blockade indicated by contractility changes of nictitating membrane.
^Changes in blood pressure (BP) and heart rate (HR); bold numbers indicate an increase in % change. 
"Bolus dose in /xg/kg.
*No effect on muscles, vagus or nictitating membrane.
" N o effect on the blood pressure or heart rate.
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Figure 5. Effects in a cat of Ws-3,4-dihydroisoquinolinium salts (17) on arterial blood pressure (BP), heart rate 
(HR), contractions (upward deflections) of the nictitating membrane (NM) to preganglionic stimulation (2 -5  Hz for 
10 s every 100 s), and maximal contractions (upward deflections) of the tibialis anterior (TIB) and soleus (SOL) 
muscles evoked by stimulation of motor nerves (0.1 Hz), The right vagus nerve was stimulated every 100 s for 10 s  
at 5-10 Hz to produce decrease in heart rate (downward deflection of the HR trace). Neuromuscular blocking 
profiles shown are at doses of /xg/kg.
ind icates that the latter is app roxim ately  1.5 
tim es m ore p oten t than its 3-veratryl isom er. 
This d ifference in p o ten cy  as a result o f the 
translocation o f the veratryl m oiety  to th e  C-3 is 
high ligh ted  further in the secon d  paper o f this 
series.
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Microanalyses
2 ,2-D i-(3 ,4 -d im eth oxyb en zy l)-l,3 -d ith ian e , 2 1 .
Found: C, 63.0; H , 6.73%;
C 2 2 H 2 8 0 4 S 2 requires C, 62.8; H , 6.71%.
2- A m in o-1 ,3-d i~(3 ,4-d im ethoxyp henyt)propane  
(d iveratrylm ethylam in e), 14.
(Free base):
Found: C, 6 8 .6 ; H , 7.32; N , 3.71%;
Q 9 H 2 5 N O 4  requires C, 68.9; FI, 7.60; N , 4.23% .
N -[l,3 -d i-(3 ,4 -d im eth oxyp h en y l)p rop -2 -y l]form a- 
m ide, 15.
Found: C, 66.5; H , 6.91; N , 3.71% ,
Q 0 H 2 5 N O 5  requires C, 6 6 .8 ; H , 7.01; N , 3.90% .
ar,o>-BiS-[3,4-dihydro-3-(3,4-dim ethoxybenzyl)-6,7  
d im eth oxyisoq u in olin iu m ]a lk an e  d iiod id es , 17.
17a
Found: C, 52,4; H , 5.58; N , 2.67%;
C 4 6 H 5 8 I2 0 8. 2H zO  requires C, 52.3; H , 5.91; N , 
2.65%.
17b
Found: C, 52.8; H , 5.88; N , 2.35%;
C 4 8 H 6 2 12 0 8. 2H 20  requires C, 53.1; H , 6.13; N , 
2.58% .
17c
Found: C, 54.5; H, 5.93; N , 2.40%;
C5 oH6 6 I2 O h. H 20  requires C, 54.8; H, 6.26; N , 
2.56% .
17d
Found: C, 54.8; H , 6.26; N , 2.23%;
C 5 2 H 7 0 I2 N 2 O 8. 2H zO  requires C, 54.7; H , 6.54; N , 
2.46% .
t.
a',a>-B /s-(l,2 ,3 ,4-tetrahydro-3-(3,4-d im ethoxyben- 
zy l)-6 ,7 -d im eth oxyisoq u in olin -2  y l]a lkane m e­
thyl b en zen su lp h o n a tes, 19.
19a
Found: C, 63.4; H, 7.02; N , 1.64%; 
C 6 4 H 8 4 N 2 0 1 4 S2. 2H 20  requires C, 63.8; H, 7.36; 
N , 2.32% .
19b
Found: C, 62.4; H, 7.06; N , 2.27%; 
C 66H 8 8 N 2 0 1 4 S2. 4H 20  requires C, 62.4; H , 7.62; 
N , 2.21% .
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Salsolinol (I) and 6,7-dihydroxy-l,l-dimethyl-l,2,3,4-tetrahydroisoquinoline hydrobromide (2) were synthesized and 
their effects at adreno- and cholinoceptors investigated both in vivo and in vitro. Both 1 and 2 produced agonist 
effects at cholinoceptors and or- and d-adrenoceptors. Neuromuscular blocking actions were evident in vitro. Compound 
2 exhibited anticholinesterase properties both in vivo and in vitro. These results indicate that dopamine derivatives 
of this type exhibit not only sympathomimetic activity but also complex actions at cholinoceptors.
T he pharmacological activity of certain tetrahydro- 
isoquinolines has long been established.1 Within the series 
of 1-substituted  6,7-dihydroxytetrahydroisoquinolines 
there are several active sym pathom im etic am ines,2,3 one 
of which, trimetoquinol, is a potent bronchodilator.'1 7 To  
date, all the reported findings with compounds o f this 
series have concerned their activity at adrenoceptors. We 
have found that, in addition to actions at adrenoceptors, 
several o f these compounds exhibit activity at cholino  
ceptors. T his paper describes the effects of 1-methyl- (1)
1, R = H
2, R = CH,
and l,l-d im eth y l-6 ,7 -d ih y d ro x y -1,2,3,4-tetrahydroiso- 
quinoline (2).
C h e m is tr y . Salsolinol (1) hydrobromide was syn­
thesized by the method of Craig e t al.2 with minor 
modifications. 6,7-Dihydroxy-1,1-dim ethyl-1,2,3,4-tetra- 
hydroisoquinoline (2) hydrobrom ide was prepared from 
one of the intermediates in the synthesis of salsolinol (1).
Thus, 3,4-dihydro-6,7-dim ethoxy-l-m ethylisoquinoline 
was quaternized with benzyl bromide, the quaternary salt 
was treated with an excess of methylm agnesium  iodide, 
and the 1,1-dim ethyltetrahydroisoquinoline was hydro­
genated over 10% palladium  on charcoal to effect N- 
debenzylation. Dem ethylation with refluxing, constant- 
boiling hydrobromic acid gave the required product. The 
hydrochloride salt, prepared by a different route, was used 
by Gray e t al.8 
R e su lts
(A ) In  V ivo. In anesthetized cats, both 1 and 2 (0.2-3.0 
m g/kg) produced dose-related falls in mean blood pressure, 
but only 1 caused a fall in heart rate. These effects were 
antagonized by atropine (1 m g/kg).
In atropinized animals, both 1 and 2 caused dose-related 
elevations in mean blood pressure th at were blocked by 
phentolam ine (2 m g/kg). Compound 1 produced a re­
duction in the tension and degree of fusion of the in­
com plete tetanic contractions of the soleus muscle, an 
effect antagonized by propranolol (0.4 mg/kg). In contrast, 
2 induced fasciculations in and augmented (by up to 100% 
over control) twitches o f the skeletal muscle.
(B ) In  V itro. In the chick biventer cervicis preparation,
1 (10 200 fig/m L) produced initial twitch augmentation, 
followed by blockade accompanied by a slowly developing 
contracture. Responses to exogenous carbachol were 
unaffected while those to acetylcholine were augmented. 
T he neuromuscular blockade was unable to be reversed
Table I. R ates o f Hydrolysis o f A cetylth ioch olin e by 
Hom ogenates o f  Chick Biventer Cervicis Muscle at 37 “C 
in the Presence and A bsence o f  1 and 2“
c o n c n r a t e  o f  h y d r o ly s i s
Mg/
(fx m o l m in ” 1 g ' 1)
d ru g m l , m o la r c o n t r o l d ru g  tr e a te d
1 3 3 3 1 . 3  X 1 0 " 3 6 . 8 2  i  0 . 1 5 7 . 4 8  i  0 . 1 4
2 1 0 3 . 7  X 1 0 " s 7 . 0 1  ± 0 . 1 2 3 . 5 5  ± 0 . 0 9
“ Values quoted  are the mean ± SE o f  n = 4.
by choline, caffeine, physostigmine, or tetanus. Compound 
2 (1—10 jug/mL) produced a similar twitch augm entation  
accompanied by slight contracture. There was, however, 
no twitch blockade. Concentrations o f 2 in excess of 10 
Mg/mL induced contractions that were rapid in onset, 
readily maintained, easily reversed by washing, but poorly 
reproducible.
In the guinea pig ileum, 1 rarely produced contraction  
whereas 2 consistently did so. T he resulting log con- 
centration effect curves for 2 were parallel to  those 
produced by carbachol with sim ilar maxima (Figure 1). 
The contractions elicited by 2 and carbachol were readily 
reversed by washing. Atropine antagonized equally the 
effects of both agonists (Figure 1). Compound 2 was 
approximately 85 tim es less potent than carbachol when 
calculated at the £ mni =  50 level. Concentrations of 
hexam ethonium  that antagonized th e action of nicotine  
were w ithout effect on 2.
In chick biventer cervicis hom ogenates, 1 in concen­
trations up to 333 pg/m L  (1.3 X 10 3 M; the highest 
practical concentration) caused no inhibition of the rate 
of hydrolysis o f acetylthiocholine by esterase enzym es 
(Table I). Compound 2 produced 50% inhibition (Iso) of 
hydrolysis at 10 jtg/m L (3.7 X 10 s M) (Table I). Thus, 
in comparison with physostigmine that has a reported 1$0 
of 2 X 10-® M,9 compound 2 was approxim ately 540 times 
less potent as an anticholinesterase.
Discussion
In anesthetized cats, both 1 and 2 exhibited agonist 
activity at muscarinic cholinoceptors and at a- and 0- 
adrenoceptors. T he muscle fasciculations and augm en­
tation of soleus muscle twitches induced by 2 are typical 
characteristics of an anticholinesterase agent. In this 
capacity, 2 was approximately 200 tim es less poten t than 
neostigmine. The possibility th a t the cardiac, blood 
pressure, and soleus defusion effects were produced in­
directly, through release of the appropriate chem ical 
transmitter by 1 and 2, is unlikely but cannot be excluded. 
Reduction in the tension and degree o f fusion o f the in­
complete tetanic contractions o f the soleus m uscle is an
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F igure 1. Log concentration-effect curves lor carbachol ( • )  and 
2 (■) on the guinea pig isolated ileum preparation. Solid lines 
represent the control curves before and broken lines the effect 
after 1 x  10 ‘H M atropine. The points plotted are the means of 
at least four separate experiments. Standard errors of the means 
are illustrated on the symbols HB-, and '-®->.
effect mediated through stimulation of /32-adrenoceptors.10 
The muscle is known to be sensitive to adrenaline but not 
noradrenaline;10,11 hence, any indirect effect would ne­
cessitate the release o f adrenaline from the adrenal me- 
dullae.
In vitro, both com pounds possessed activity at choli­
noceptors. In the chick biventer cervicis nerve-muscle 
preparation, both 1 and 2 produced neuromuscular 
blockade w ith accom panying contractures. Since the 
responses to exogenous carbachol were unaffected while 
those to exogenous acetylcholine were potentiated, it may 
be concluded that the blockade was of the depolarization 
type affecting principally the focally innervated fibers. 
This could be a consequence of anticholinesterase activity, 
such as was detected in biventer hom ogenates with 2. In 
the sm ooth muscle of the guinea pig ileum, 1 caused little 
effect, whereas 2 acted as a full agonist at muscarinic 
cholinoceptors.
T he structural resem blance o f the tetrahydroiso- 
quinoline skeleton to dopamine has led to its use in studies 
of the conform ational requirem ents for agonism  at 
adrenoceptors.8 In their study, Gray et al.8 reported that 
2 induced contraction o f the guinea pig tracheal chain 
preparation at a concentration o f 100 /±g/mL. Adrenergic 
activ ity  was assessed in other preparations over the 
concentration range 0.01 2000 *ig/mL. Our studies have 
clearly dem onstrated the existence of cholinergic effects 
for salsolinol (1) and 2 at concentrations well within the 
range used by Gray et al.8 T he closely related compound 
/V-m ethyl-1,2,3,4-tetrahydroisoquinoline has also been 
shown to possess cholinergic activity.12 T he existence o f  
this activity at cholinoceptors clearly complicates the use 
of such dopam ine derivatives in the pursuit o f the 
structural elucidation o f adrenoceptors. These actions at
Notes
cholinoceptors appear to have gone undetected in previous 
studies.
Experimental Section
(A) Pharm acological M ethods. (1) A nesthetized Cat. The 
experiments were performed on ten adult cats of either sex which 
were anesthetized by the intraperitoneal injection of a mixture 
of cv-choralose (80 mg/kg) and sodium pentobarbitone (6 mg/kg). 
The trachea was intubated and the cats were artificially ventilated 
by positive pressure at a frequency at 27-30 breaths/m in and a 
stroke volume of 13 mL/kg of body weight. The general arterial 
blood pressure was measured from a cannulated carotid artery 
by means of a Statham (Model P23AC) pressure transducer. 
Heart rate was measured by means of a Grass (Model 7P4) ta­
chograph triggered by the general arterial pulse.
The tendon of insertion of a soleus muscle was cut and attached 
to a Grass (Model FT03) force displacem ent transducer. In­
complete tetanic contractions of the soleus muscle were evoked 
by stimulating the peripheral end of the sciatic nerve, which had 
been dissected out and ligated deep in the thigh, at a frequency 
of 6-10 Hz for 1 s every 10 s. The method was identical with that 
described by Bowman and Nott.10 In some experiments, maximal 
twitches of the soleus muscle were evoked by stimulating the 
sciatic nerve at a frequency of 0.1 Hz.
In all but one experiment, the cats were bilaterally vagotomized. 
All measurements were continuously recorded on a Grass six- 
channel curvilinear polygraph (Model 7). Drugs dissolved in 
acid-0.9% (w /v) saline (pH 4.5) were administered through a 
cannula inserted in either a femoral or brachial vein.
(2) Iso la ted  C hick  B iv en ter  C erv ic is  N erve M u sc le  
Prep aration . Biventer cervicis muscles from chicks aged 3-10 
days were set up in Krehs-Henseleit solution at 37 °C and aerated 
with 5% C 0 2 in oxygen. The method was identical with that 
described by Ginsborg and Warriner.13
(3) Iso lated  G uinea P ig  Ileum . The isotonic contractions 
of segments of guinea pig ileum, set up in Tyrode1'1 solution at 
32 °C and bubbled with air, in response to several cholinoceptor 
agonists were recorded on a Washington (Model 400M D /2) pen 
recorder.
(4) A n tich o lin estera se  D eterm ination . The anticholin­
esterase activity o f the two analogues was assessed by measuring 
the cholinesterase activity of homogenates of chick biventer 
cervicis muscle in the presence of each drug according to the 
colorimetric method of Ellman et al.,1® as modified by Gandiha 
et al.1G The absorbance changes were measured, using an SP 800 
spectrophotometer, at a wavelength of 412 nm and a temperature 
of 32 °C.
(B ) C hem ical M ethods. Melting points were recorded on a 
Kofler hot stage apparatus and are uncorrected. IR and 60-MHz 
NMR spectra were recorded routinely for all steps and were 
consistent with assigned structures. Elemental analyses were 
performed by the Chemistry Departments of the Universities of 
Strathclyde and Manchester, U.K.
6,7-B ihydroxy-l-m ethyl-l,2,3,4-tetrahydroisoquinoline (1) 
Hydrobrom ide (S a lso lin o l H ydrobrom ide). 3,4-Dihydro- 
6,7-dimethoxy-l-methylisoquinoline (1.0 g, 0.005 M) prepared by 
routine m ethods2 was dissolved in EtOH (20 mL), N aBH 4 (0.5 
g, 0.014 M) was added, and the solution was left overnight. The 
solution was acidified with dilute HC1, rebasified with 20% NaOH, 
and extracted with CHC13 to give a viscous oil, which was dissolved 
in concentrated HBr (25 mL), refluxed for 4 h, evaporated, and 
azeotroped with a CHC1;) EtOH mixture, and the residue was 
crystallized from ethanol-ether to give salsolinol (1) hydrobromide 
as small off-white prisms: mp 195-198 °C (lit.2 186-187 °C); MS 
m /e  179 (CI0H I3NO2, 12%), 178 (C10H l2NO2, 18%), 164 
(C9H I0NO2, 100%). Anal. (C10H MNO2Br) C, H, N.
(>,7-Dihydroxy-l,l-dim ethyl-l,2,3,4-tctrahydroisoquinoline
(2) H ydrobrom ide. 3,4-Dihydro-6,7-dimethoxy-l-methyliso- 
quinoline (7.0 g, 0.034 M) prepared as usual was treated with 
benzyl bromide (6.0 g, 0.035 M) to give as a first crop 6.0 g of 
off-white solid, which was washed thoroughly with ether containing 
a little ethanol and then dried in vacuo. This salt (2.0 g, 0.005 
M) was added to a solution of MeMgl in ether, which was prepared 
from Mel (4.0 g) and Mg (0.8 g). After 2 h of stirring, excess 
reagent was decomposed with NH4C1 solution, and the aqueous 
layer was separated and extracted thoroughly with ether. The
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combined ether layers were washed with water, dried, and 
evaporated to give a colorless gum (1.53 g). The gum (1.40 g) was 
taken up in ethanol (100 mL), and concentrated HC1 (2 mL) and 
10% Pd on C (0.2 g) were added and hydrogenated overnight at 
atmospheric pressure. Filtration and evaporation gave a pale- 
yellow oil (1.1 g). The oil (1.0 g) was dissolved in concentrated 
HBr (20 mL), and the solution was refluxed for 5 h. It was then 
evaporated, azeotroped twice with benzene methanol so as to 
remove most of the water, and crystallized from 1-butanol to give 
small pale-gray plates that were washed with 1-butanol and ether 
and dried thoroughly. The yield at this stage was 0,70 g, but the 
product contained 1-butanol on crystallization that was removed 
by recrystallization from ethanol ether to give small off-white 
prisms (mp 254-256 °C) containing no butanol (GLC): MS m /e  
193 (Cn H |r,N 0 2, 2%), 178 (C,„H,2N 0 2, 100%). Anal. (C„- 
H l6N 0 2Br) C, H, N.
A ck n ow led gm en t. We are grateful to Mr. J. Houston 
for technical assistance. A.S.H. was in receipt of a Science 
Research Council Scholarship. 
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Synthesis o f l-(Am m om ethyl)-l,,2,3,4-tetrahydroisoquinolines and T heir Actions at 
Adrenoceptors in Vivo and in Vitro
David Beaumont,* Roger D. W aigh,*’* M ethi Sunbhanich,1^  and M ichael W. N ott1
D epartm ent of Pharmacy, U niuersity of M anchester, M anchester M 13 9PL, U nited  K ingdom , and D epartm en t of
Pharmacology, Uniuersity of M elbourne, Parkuille, Victoria, Australia 3052. Received A pril 19, 1982
An improved synthesis of l-(ammomethyl)T,2,3,4-tetrahydroisoquinoiines has been developed by using aluminum 
hydride reduction of l-cyano-l,2,3,4-tetrahydroisoquinoline8. Three l-(aminomethyl)-6,7-dihydroxytetrahydro- 
isoquinolines were tested for actions at (1 adrenoceptors in order to examine a proposed similarity between this series 
and the related phenylethanolamines. The aminomethyl, (isopropylamino)methyl, and (terf-butylamino)methyl 
derivatives all showed weak partial agonist activity at 0  adrenoceptors and the first also showed weak a  adrenoceptor 
agonist activity in vivo. Their low potency implies that the catechol group of THIQ sympathomimetics, such as 
trimetoquinol, binds differently from that of the natural catecholamines. The protonation behavior of representative 
aminomethyl-THIQ’s was investigated by pK a measurement and *H and I3C NMR, and the compounds were shown 
to be substantially monoprotonated, on the exocyclic nitrogen, at physiological pH.
Extensive work on the structural requirements for sym­
pathomim etic activity in phenylethanolam ines related to 
the natural transm itters epinephrine ( la )  and nor­
epinephrine (lb ) has underlined the importance o f the 
side-chain hydroxy group for high potency.1 The discovery 
of poten t /3-adrenoreceptor stim ulant activity2 in the 
benzyltetrahydroisoquinoline derivative trimetoquinol (2) 
appeared to contradict th e  previous conclusions, since  
trim etoquinol and the phenylethanolam ines could be 
partially superimposed (A and 2, Chart I). However, this 
requires the phenylethanolam ine to adopt an unlikely  
cisoid conformation, and Brittain and co-workers made the 
suggestion3 that the basic amino function o f trimetoquinol 
might fulfill the receptor-binding role of the hydroxy group 
of the phenylethanolam ine side chain (B  and 2, Chart I). 
It has been reported4 that the diam ine (3) retains ap­
proximately one-twentieth of the potency o f epinephrine 
(lb ), which offers limited support to the concept that some 
N H /O H  functions may be interchangeable. The proposal 
by Brittain and co-workers also requires the 3,4,5-tri- 
m ethoxy group of trim etoquinol to  fulfill the role o f the  
amino group o f epinephrine, which seem s som ewhat less 
likely. If this were so, then  tetrahydroisoquinolines (4) 
should be effective sympathomimetics, and a recent patent 
claims “muscle-relaxant” activity among derivatives in this 
series.5 We set out to improve the synthesis o f some  
appropriately substituted analogues (4a-c) and to examine 
their actions at adrenoceptors.
C h em istry . T he first generally successful syntheses o f  
the title class o f compounds involved Bischler-Napieralski 
cyclization o f (V -phenethyl-2-phthalim idoacetam ides, 
followed by reduction to the 1,2,3,4-tetrahydroisoquinoline 
and hydrazinolysis to rem ove the phthalyl protecting  
group.6 A more attractive route (Schem e I) through the  
readily available l-(nitrom ethyl)tetrahydroisoquinolines  
was reported to be unsuccessful,7 resulting in elim ination  
of nitrom ethane with a variety o f reducing agents. In our 
hands, use o f lithium  alum inum  hydride [or sodium  bis- 
(2-m ethoxyethoxy)alum inum  hydride] gave yields o f up 
to  25% o f th e desired product from the dim ethoxy com ­
pound (5) (Schem e I). In seeking to improve on th is, we 
noted that l-cyano-2-methyl-1,2,3,4-tetrahydroisoquinoline 
(S, R =  CHa) was reported9 to be reduced by lithium  alu­
minum  hydride to the l-(am inom ethyl)tetrahydroiso- 
quinoline (7) in good yield (Scheme II). When we applied
1 University o f Manchester.
1 University of Melbourne.
8 Present address: Faculty of Science, Prince of Songkla
University, Haad-Yai, Thailand.
Chart I. Structural Relationships betw een  

















» e 2C O /  9  CH,NH2 
N aB H jC N / ,
_/H2/pd JHJ/Pd
CH2NHIPr ch?nh 2
this method to the secondary am ine (6, R — H), the cyano 
function was largely elim inated to  give as major product
(1) R. T. Brittain, C. M. Dean, and D. Jack, Pharmacol. Ther., 
Part B, 2, 423 (1976), provide a useful overview.
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Table I. (i-Adrenoceptor A gonist A ctivities o f THP and 4a-c  in Guinea Pig, Isolated, Spontaneously Beating, Right 
Atrial Preparations
intrinsic act.° p D, drug Emax(b0)llsa b Emax(r)0)
com pd mean SEM mean SEM mean SEM n
THP 0.94 0.01 6 .96 0.09 26 2 4
4a 0 .70 0.05 4 .49 0 .13 8 .8  X 1 0 3 3.4 X 1 0 3 3
4b 0 .42 0 .03 5.05 0 .09 2.7 X 10 3 0.4 X 1 0 3 3
4c 0 .14 0.01 5.10 0 .12 2.1 X 10 3 0.3  X 1 0 3 5
“ Isoproterenol = 1 . 6 Iso = isoproterenol.
Table II. 0 -Adrenoceptor A gonist A ctivities o f  THP and 4a-c in Reserpine-Pretreated, Guinea Pig, Isolated, Spontaneously
Beating, Right Atrial Preparations
intrinsic act.“ P d 2 drug g m lu t(5 0 ) / l s o b  f lm a x (5 0 )
com pd mean SEM mean SEM mean SEM n
THP 0.95 0.01 7 .05 0 .03 38 8 4
4a 0 .53 0 .03 4 .22 0.18 32.6  X 1 0 ’ 12 .2  X 1 0 3 3
4b 0 .59 0 .06 5.18 0.06 4.4  X 103 1 .3  X 1 0 3 3
4c 0.29 0 .05 5.23 0.02 3.6  X 1 0 3 0 .7  x 1 0 3 3
u Isoproterenol = 1 . b Iso = isoproterenol.
1,2,3,4-tetrahydroisoquinoline itself, with only traces of the 
desired diam ine. T his could be attributed to initial re­
moval o f a proton from nitrogen by the basic reagent 
(Scheme II). However, use o f the acidic reagent aluminum  
hydride was also unsuccessful, the major product (14% ) 
being th e un exp ected  l,T -b i(l,2 ,3 ,4 -te tra h y d ro iso -  
quinolinyl) (8). Similar products have been reported from 
the reduction o f isoquinolines with aluminum amalgam.24
These problems were finally overcome by reduction of 
the (V-benzyl derivative (6, R  = CH 2Ph) with alum inum  
hydride, resulting in excellent yields of the am inom ethyl 
com pound (9), which was readily hydrogenolyzed to  the  
m odel noradrenaline analogue (10). T he model isopro­
terenol analogue (11) was prepared by reductive alkylation 
w ith acetone and sodium cyanoborohydride prior to  de- 
benzylation.
This process was applicable to the dim ethoxy analogue 
(12, R  =  CH3) as part o f a route to the required 6,7-di­
hydroxy analogues (4, Schem e III), but a more convenient 
procedure was through the 6,7-bis(benzyloxy) derivatives 
13 (R = CH 2Ph) and 14, where O- and N -debenzylation  
could be effected simultaneously at the final stage, to give 
4a, or where interm ediate alkylation was carried out, to 
give 4b. T he tert-butyl derivative 4c was not available by 
th is m ethod, so a route was adopted that took advantage 
of the bulky tert-butyl group as a protecting function.
(2) E. Yomato, M. Hirakura, and S. Sugasawa, Tetrahedron, 
Suppl., 8(1), 129 (1966). Y. Iwasawa and A. Kiyomoto, Jpn. 
J. Pharmacol., 17, 143 (1967). J. Houston and I. W. Rodger, 
Clin. Exp. Pharmacol. Physiol., 1,401 (1974). The subject has 
recently been reviewed: D. Beaumont and R. D. Waigh, Prog. 
Med. Chem., 18. 45 (1981).
(3) R. T. Brittain, D. Jack, and A. C. Ritchie, Ado. Drug Res., 5, 
197 (1970).
(4) G. Lehmann and L. 0 . Randall, J. Pharmacol. Exp. Ther., 93, 
114 (1948).
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(1976). T. Kishimoto, I. Ueda, and M. Kato, British Patent 
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Table HI. p -Adrenoceptor Antagonist Activities o f  
4a-c and THP in Guinea Pig, Isolated, Spontaneously  
Beating, Right Atrial Preparations
pA, slope
compd mean SEM mean SEM n
4a 4.63 0.06 0 .79 0 .09 4
4b 4.84 0.01 0 .99 0 .02 5
4c 4 .68 0 .02 0 .7 2 ° 0 .03 6
THP N A '3 3
“ S lope differs significantly from  1 .0  (S tu d en t’s t test, 
p  > 0 .05 ). b NA -  no antagonism  o f  isoproterenol 
responses up to 2 .2  X 10 ~8 m ol/L .
Thus, dopam ine hydrochloride and (ferf-butylamino)- 
acetaldehyde diethyl acetal were condensed in a P ictet-  
Spengler reaction to give the required product directly  
(Scheme III). With less bulky N-substituents, the amino 
group o f the amino acetal would need to be protected, as 
in a recent report6 where iV-benzyloxycarbonyl functions 
were used.
P h arm acology. Preliminary tests showed that only the 
6,7-dihydroxy analogues ( 4 a c )  possessed any agonist or 
antagonist activity; the synthetic precursors and model 
compounds described in Schemes I—III were inactive. The 
detailed examination was therefore confined to compounds 
4 a -c , and the results are sum m arized in Tables I-VI. 
Isoproterenol was used as standard throughout, but the 
compounds were also compared to tetrahydropapaveroline 
(T H P ) as a representative 6,7-dihydroxytetrahydroiso- 
quinoline.
1 7 2
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Table IV. (3-Adrenoeeptor Agonist A ctivities o f  4a-c  and THP in Guinea Pig, Isolated , Carbachol-Contvacted  
Tracheal Preparations
intrinsic act." p/5, drug / ? m a x ( 5 0 ) / I s o  ^ r a a x ( 5 0 )
com pd mean SEM mean SEM mean SEM n
THP ~ 0 .62 0 .04 6 .45 0 .09 6 1 4
4a 0 .20  b 0 .02 3 .4 4 b 2 ,5  X 104C 0.6  x 1 0 5 4
4b 0 .0 6 b 0.02 3 .49  b ND 3
4c 0 .1 8 b 0.01 3 .5 1 6 2.0 X 104C 0.6  x 1 0 s 5
“ isoproterenol = L. b The niaxirnum concentration used was 100 pg/m L. This did n ot give m axim um  responses. 
Therefore, estim ates o f  intrinsic activities are low , the values merely reflecting the response to 100  /rg/mL. Likewise, p/5, 
values were n ot determ ined. Values cited here are - lo g  (m olar equivalent o f  1 00  pg/m L ). c Ratio determ ined at con cen ­
trations required to produce 15% o f  m axim um  isoproterenol response.
All four drugs (4a-c) and T H P  increased atrial rate, but 
maxim um  effects were less than those o f isoproterenol. 
T hese effects were blocked by propranolol (1 pm ol/L ). 
Because of differences in intrinsic activity between the 
agents and isoproterenol, activity ratios rather than po­
tency ratios were used in characterizing the drugs. T he  
activity ratio is the ratio o f the molar concentration of the 
drug required to produce 50% o f its m axim um effect 
1 and the molar concentration o f isoproterenol
required to produce its E „ „ inn\ in the sam e experim ent. 
Intrinsic activities, pD ? values, and activity ratios are 
shown in Table I. T able II shows sim ilar results from  
reserpine pretreated guinea pigs.
A n ta g o n ist ic  A ction . All drugs, with the exception of  
T H P , sh ifted  cum ulative concentration-effect curves o f 
isoproterenol to the right without affecting their maximum  
responses. Atrial rate was increased by the concentrations 
of the drugs required for antagonistic action; the increased 
rate was sustained over the 15-min contact period. pA2 
values and slopes o f the relationship between log (dose 
ratio m inus 1) and negative log (molar antagonist con­
centration) from all experim ents are shown in Table III.
G u in ea  P ig  T ra ch ea . A g o n is tic  A c tio n . T H P  pro­
duced the greatest relaxing activity, and th e maximum  
effect was obtained within the concentration range studied. 
The analogues 4a -c  were very weak agonists, and with the 
highest concentration used (100 pg/m L), maximum effects 
were not obtained. T hus, pD 2 values, intrinsic activities, 
and activity ratios o f the drugs could not be calculated, 
but approxim ations o f the values are shown in T able IV. 
T h e agonist effects were blocked by propranolol (1 
jamol/L).
A n tagon istic  A ction . All of the compounds under test, 
w ith th e exception o f T H P , shifted cum ulative concen­
tration-effect curves o f isoproterenol to  the right without 
affecting their maxim um effects. W ith the lowest co n ­
centration o f the drugs (4c, 31; 4b, 32; 4a, 36 jtm ol/L ), 
generally no relaxation in response to  the drugs per se 
occurred. With concentrations 3 and 10 times higher, some 
relaxation occurred. pA 2 values and the slopes of the  
relationship between log (dose ratio minus 1) and negative 
log (molar antagonistic concentration) are shown in Table  
V.
A n esth etized  Cat C ard iovascu lar  S ystem . All three 
analogues (4a -c) caused tachycardia in anesthetized and  
bilaterally vagotomized cats, but maximum responses were 
less than that produced by isoproterenol. The effect was 
blocked by prior administration of propranolol (100 Mg/kg 
iv). T he maxim um depression o f pressure caused by 4b 
and 4c was achieved at doses that just produced a m axi­
mum increase in heart rate. Again, the maxim um de­
pression was less than th at seen with isoproterenol.
In contrast to the other agents, 4a  produced a pro­
nounced pressor response; this was abolished by prior 
adm inistration o f phenoxybenzam ine (3 m g/kg). These
Table V. (3-Adrenoceptor Antagonist A ctivities o f  4a-c  




nmean SEM mean SEM
4a 4.66 0.08 0 .5 8 “ 0 .08 4
4b 5 .05 0 .05 0 .5 7 “ 0 .04 4
4c 5.76 0 .69 0 .4 4 “ 0 .08 6
THP N A b 3
“ Slope differs significantly from 1.0 (S tud en t’s t test, 
p  >  0 .05 ). b N A  = no antagonism  o f  isoproterenol 







m ot. k g  '
100
-tl -610 10 mot. kg ’
F igure 1. Log concentration-effect curves for isoproterenol (O), 
4a (®), 4b (□), 4c (a), and norepinephrine ( 0 ) in chloralose-an- 
e3thetized, bilaterally vagotomized cats: (A) positive chronotropic 
effect, (B) decrease in diastolic blood pressure, (C) increase in 
systolic blood pressure. Results in A and B are expressed in terms 
of percent maximum response (/?mux) produced by isoproterenol 
and in C in terms of increase in pressure (mmHg). Individual 
points show mean plus or minus SEM  responses from three to 
six experiments.
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Table VI. Intrinsic A ctivity R atios and Equieffective Dose R atios o f  4a-c  in Increasing (HR) and Reducing Diastolic 
Blood Pressure (DBP) in C hloralose A naesthetized, Bilaterally V agotom ized Cats
HR ~~ DBP
<*“ activity ratio* a  act. ratio
com pd mean SEM mean SEM mean SEM mean SEM n
4a (TIo o !b i lr ir T x l io 4 0 .4 2  X 104 pressor 5
4b 0 .60  0 .05  0 .17 X 104 0 .05  X 10’  0 .56  0 .07 2 .20  X LO3 0 .81  X 103 5
4c 0 .38  0 .03  0 .09  X 10 4 0 .01  X 10 4 0 .34  0 .05  1 .05  x 103 0.7 2 x 103 5
“ Isoproterenol = 1. !l For calculation o f  the activity ratio, the molar concentration o f  the com pound required to 
produce 50% o f its ow n m axim um  response was divided by the molar concentration  o f  isoproterenol required to produce 
50% o f  isoproterenol m axim um  response in the sam e experim ent.
results are illustrated in dose-response form in Figure 
1A-C. Table VI shows the intrinsic activities and activity 
ratios o f the compounds on heart rate and diastolic blood 
pressure.
D iscu ssion
T he results show that the compounds are weak partial 
agonists at /J adrenoceptors. Thus, in guinea pig isolated 
preparations, they exerted a positive chronotropic effect 
on atria, and all relaxed tracheal sm ooth muscle; these 
effects were antagonized by th e /3-adrenoceptor antagonist 
propranolol. Their antagonistic action was m anifested by 
their ability to block response to isoproterenol. The sym­
pathom im etic effects appear to  be due to a direct action 
at 0  adrenoceptors, since the positive chronotropic effect 
was unaffected by reserpine pretreatm ent.
In term s o f drug-receptor interactions, the affinity of 
a partial agonist for receptors is related to its pA2 or pD2 
values. For their antagonistic action on atria, data on the 
com pounds under test conform  with criteria for com pe­
titive interactions; the slopes o f the plot between negative 
log (dose ratio minus 1) and negative log (molar antagonist 
concentration) do not differ significantly from unity. 
However, the data from th e experim ents on tracheae are 
inconsistent with com petitive interactions at a single re­
ceptor site; the slopes o f the plots are only around 0.5. 
T hus, th e pA2 values from atrial experim ents provide a 
more appropriate measure o f affinity than those obtained 
from experiments on tracheae. For agonistic potency, only 
the pjD2 values from atria could be determ ined, since the 
activity o f the com pounds on the tracheae was very low; 
at the highest concentration used, maximum relaxation was 
not obtained.
T h e affinities o f the com pounds did not change with 
increasing size o f aminoalkyl loading at the 1-position but 
increased greatly when th e substituent at the 1-position 
was a 3,4-dihydroxybenzyl group (i.e., TH P); this is more 
closely related to, and can rotate as freely as, the catechol 
moiety of catecholamines. It is still uncertain which of the 
two dihydroxy groups, if either, combines with the catechol 
site o f the physiological receptor. Yamato et al. found2 that
l-[3,4-(ethylenedioxy)benzyl]-6,7-dihydroxy-l,2,3,4-tetra- 
hydroisoquinolines possessed agonist activity considerably 
greater than that o f l-(3,4-dihydroxybenzyl)-6,7-(ethyl- 
enedioxy)-(l,2,3,4-tetrahydroisoquinolines and suggested 
that the two hydroxy groups in the 6- and 7-position were 
essential for th e activity.
T he high agonist activity o f trim etoquinol (2) and the  
deleterious effect on potency o f modifications to the 6,7- 
dihydroxy substitution pattern10 emphasize the importance
(10) K. Ikezawa, H. Takenaga, M. Sato, H. Nakajima, and A. Ki-
yomoto, Jpn. J. Pharmacol., 27, 537 (1977). M. Sato, I. Yam- 
aguchi, and A. Kiyomoto, Jpn. J. Pharmacol., 17,153 (1967). 
K. Ikezawa, H. Takenaga, M. Sato, N. Itoh, H. Nakajima, and 
A. Kiyomoto, Yakugaku Zasshi, 74, 441 (1978); Chem. Abstr., 
89, 190806a (1978).
of the catechol groups in this position for receptor binding 
and suggest that the extra catechol m oiety of T H P is 
finding an alternative binding site, which is not the same 
as the ammonium binding site o f the phenethanolamines, 
as evidenced by the present results.
In the present experim ent, because o f dose lim itations 
the activities of the compounds could not be determined  
in the trachea. However, it seems that true values were 
higher than those shown in Table IV, since in occasional 
experiments when higher concentrations were used, they  
produced further relaxation. In contrast, the activities of 
all compounds were easily determined in the atria. W ith 
this lim ited inform ation on tracheal activities, some in­
ference can be made about selectivity for ft adrenoceptors 
in this tissue and in the atria.
In terms o f selectivity for bronchial vs. cardiac 0  adre­
noceptors, it has been shown for phenylethanolamines that 
selectivity can be achieved by different means. Thus with  
tert-butyl substitution at the amino group, N -tert-b u ty \-  
norepinephrine is found to be more selective than iso­
proterenol.1
The present results agree in som e respects with the  
above report. W ith its l-[(fert-butylam ino)m ethyl] sub­
stitution, 4c showed some degree o f selectivity, in terms 
of a higher intrinsic activity in tracheae than in atria, 
although in terms o f the ratio of the potency with that of 
isoproterenol, it is 10 tim es less selective for tracheal 0  
adrenoceptors (compare ratios in Tables I and IV). It thus 
differs from selective /3-adrenoceptor agonists, such as 
salbutamol, soterenol, terbutaline, and carbuterol, which 
show a marked selectivity for tracheal 0  adrenoceptors but 
have high intrinsic activity in atria. T he question arises 
whether a compound with a pharmacological profile com­
parable to 4c with higher intrinsic activity in tracheae than 
in atria and in spite o f low potency vis a vis isoproterenol 
in tracheae could show a functional selectivity for bronchial 
smooth-muscle relaxation over cardiac excitation. It seems, 
however, that unless a molecular modification can be made 
to enhance their potency, such compounds are unlikely to 
be useful as bronchodilators in clinical practice. Indeed, 
the /3-adrenoceptor antagonist actions of the existing  
compounds would presumably be clinically undesirable in 
asthmatics who depend on endogenous catecholamines for 
maintenance o f adequate caliber o f airways.
R esults obtained w ith 4 a -c  on blood pressure in an­
esthetized cats show th at the in vivo /3-adrenoceptor 
agonist activity of the com pounds is enhanced by an in­
crease in size of th e 1-substituent. Thus, w ith its 1- 
(aminomethyl) substituent, 4a possessed a strong pressor 
action that was prevented by the a-adrenoceptor antago­
nist phenoxybenzam ine, but the com pounds with large 
substituents were depressor agents, w ith a weak pressor 
action only m anifested in the presence of /3-adrenoceptor 
blockade. T he enhancem ent in /3-adrenoceptor agonist 
selectivity with increasing size o f an N -substituent in the  
catecholamine m olecule is well docum ented1 and implies
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Table VII. UC NMR Spectral Data for I -(A m inom ethyl)-! ,2 ,3 ,4-tetrahydroisoquinolines
10, R=H
it, R= —do
CDCI, H ,0  containing 15-20%  v/v D 20
solvent












C8a 1-34.8 137 .0  (s)° 136 .4  (s )° 137 .3  (s )° 134 .0  (s )“ 128.1 (s)
C4a 136.1 136.1 (s )“ 135 .9  (s)° 136 .5  (s)° 136 .3  (s)° 1 33 .0  (s)
C5 129 .2 129.4 (d) 130.3  (d) 130 .3  (d) 1 30 .6  (d) 130 .5  (d )°
C8 126.1 1 26 .2  (d )b 127 .8  (d )b 127 .7  (d )b 128 .4  (d )b 130 .3  (d )°
C l 125 .9 126.1 (d ) b 127 .3  (d ) b 127 .5  (d ) b 127.4 (d )b 128 .5  (d )b
C6 125 .6 125 .9  (d ) b 127.1 (d ) b 127.1 (d ) b 127.4  (d )b 127 .9  (d )b
C l 48 .2 57.6  (d) 56.9 (d) 55.0  (d) 51.7 (d) 53.7 (d )c
CIO 51.3  (d) 52.6 (d) 53 .3  (d )c
C9 46.4  (t) 4 5 .5  (t) 4 9 .0  (t) 48 .7  (t) 4 7 .9  (t)
C3 43 .8 4 0 .3  (t) 39.9 (t) 39 .5  (t) 38 .8  (t) 39 .7  (t)
C4 29.1 29.8  (t) 28 .8  (t) 29 .0  (t) 28 .5  (t) 25.1 (t)
C l l 22.1  (q) 19-7 (q) 19 .0  (q)
C l 2 2 1 .9  (q) 19.3  (q) 19.0  (q)
a~c Indicate assignments may be interchanged, 
obtained from  SFO R D  spectra. d From ref 13.
that the exocyclic am ino function of 4a e is binding in a 
similar way to the amino function of phenethanolamines. 
If th is is accepted, the low potency o f 4a- c  im plies that 
the phenethanolam ine receptor does not bind readily to 
the 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline nucleus, 
at least when presented in a way that allows the exocyclic 
am ino group to bind.
Some doubt existed concerning the protonation behavior 
o f the diamines; we therefore sought to exclude this as a 
reason for lack o f potency. Double protonation at phys­
iological pH would lead to  repulsion between the charged 
groups and the adoption of a conformation different from 
that suggested for active catecholam ines.11 M ono­
protonation could occur on either nitrogen, with one of the 
alternatives bearing markedly reduced resemblance to the 
monobasic phenylethanolam ines. Determ ination of pK a 
values for the sim ple diam ines (10 and 11) by potentio- 
m etric titration established th at both would be substan­
tially monoprotonated at physiological pH (pK„ values for
10 were 8.9 and 5.7; for 11 they were 9.2 and 5.4). Cor­
rection to 37 °C did not change this conclusion. To de­
term ine whether protonation was selective, i.e., which if 
either nitrogen was protonated predom inantly first, we 
exam ined ‘H and 13C N M R  spectra o f the bases 10 and
11 and the monohydrochloride and dihydrochloride of 11. 
Overlapping of peaks in the 'H NM R spectra reduced the  
useful inform ation to th e observation that C (l) H un­
derwent downfield shifts o f 0.18 and 1.11 ppm on mono- 
and diprotonation, respectively, indicating that protonation 
occurred preferentially on the exocyclic nitrogen. More 
extensive information was obtained from l3C NM R spectra, 
although protonation sh ifts in 13C NM R  spectra of poly­
am ines are com plex.12
(11) A. M. Anderson, Acta. Chem. Scand., Ser. B, 29, 239 and 871
(1975). M. Mathew and G. J. Palenik, J. Am. Chem. Soc., 93, 
497 (1971). N. C. Stephenson and J. P. Beale, J. Pharm. 
Pharmacol., 24, 277 (1972). J. E. Forrest, R. A. Heacock, and 
T. P. Forrest, J. Pharm. Pharmacol., 22, 512 (1970). R. R. 
Ison, P. Parkington, and C. C. K. Roberts, Mol. Pharmacol.,
9, 756 (1973). C. Petrongola, J. Tomasi, B. Macchia, and F.
Macchia, J. Med. Chem., 17, 501 (1974). J. M. George, L. B.
Kier, and J. R. Hoyland, Mol. Pharmacol., 2, 328 (1971).
m ultiplicities [singlet (s), d oub let (d), triplet (t), and quartet (q )j were
Chart II. (a) M onoprotonation and (b ) Diprotonation
S hifts0 in n C NMR Spectra o f
l-( A m inom ethyl ) - l ,  2 ,3 ,4-tetrahydroisoquinolinesb
° In parts per m illion. b Values in parentheses are 
uncertain peak assignments.
13C NM R  chemical shifts for compounds 10 and 11 are 
given in Table VII. Data for compound 10 were obtained 
in deuteriochloroform to facilitate comparison with pub­
lished assignm ents for 1,2,3,4-tetrahydroisoquinoline,13 
although, in fact, there were only slight differences between 
spectra in chloroform and water. To a certain extent the 
assignm ents are arbitrary, and w ith a few significant ex­
ceptions, the protonation shifts are uncertain. Fortunately, 
a sufficient number of the peaks can be assigned to allow 
useful conclusions to be drawn; the protonation shifts re­
sulting from the assignments in the table are expressed  
diagramm atically (Chart II).
The salient conclusions drawn from published amine 13C 
NM R data are that (a) 0 carbons invariably show upfield 
protonation shifts while y  and 5 carbons show small upfield 
shifts and (b) protonation shifts for a  carbons vary from 
2.5 ppm upfield to 8.8 ppm downfield.12 It is apparent that 
the shifts in Chart II are consistent with monoprotonation 
occurring substantially on the exocyclic nitrogen. Of 
particular significance are the shifts of the isopropyl methyl 
carbons, which show a substantial upfield shift on mono­
protonation and a much sm aller extra sh ift on di­
(12) J. E. Sarneski, H. L. Surprenant, F. K. Molen, and C. N. 
Reilley, Anal. Chem., 47, 2116 (1975).
(13) D. W. Hughes, H. L. Holland, and D. B. MacLean, Can. J. 
Chem., 54, 2252 (1976). The assignments given by another 
group may be in error: S. P. Singh, S. S. Parmar, V. I. Sten- 
berg, and S. A. Farnum, J. Heterocycl. Chem., 15, 541 (1978).
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protonation, and C(4), which only show9 a significant up­
field shift on diprotonation. In both cases, the carbons are 
/3 to the proposed protonation site and unambiguously 
assignable.
Unam biguous inform ation as to  the conformation  
adopted by non-, mono-, and diprotonated species was not 
obtained. Solution of the Karplus equation for the cou­
pling constants for C (l) H w ith the adjacent CH2 group 
gave sets o f dihedral angles from which two possible con­
formations for each species could be constructed. The  
conformations depicted in Chart II are permitted, and it 
is conceivable that the conform ation o f th e m ono­
protonated molecule could be maintained by intramolec­
ular hydrogen bonding. Such a conformation places the 
aryl and two amino functions in the same relative spatial 
arrangement as the aryl, amino, and hydroxy functions of 
arylethanolamines in what is considered to be their active 
conform ation.11 Further, such an arrangement closely  
resembles the relatively rigid and highly poten t14 tetra- 
hydronaphthalenes, such as 16. It appears that the di­
amines 4 a -c  are closer in structure to active compounds 
in other series than is trimetoquinol. Their lack of potency 
compared to trimetoquinol indicated that the latter may 
bind to the receptor in a quite different manner from other 
/3-adrenoceptor stim ulants. For a fuller discussion, see 
Beaum ont and W aigh.2 T he lack of potency o f the two 
salbutam ol analogues (15a,b) tends to support this hy­
pothesis, although no pharmacological details were given.16 





E xperim ental Section
C hem ical M ethods. M elting points were obtained on a 
Reichert hot-plate apparatus and are corrected. Infrared spectra 
were obtained on a Perkin-Elmer 237 spectrophotometer from 
liquid films between sodium chloride plates or, for solids, from 
potassium chloride disks and are quoted in wavenumbers (re­
ciprocal centimeters). Nuclear magnetic resonance spectra were 
obtained at 60-MHz on a Perkin-Elmer R 12B instrument, at 
90-MHz on a Perkin-Elmer R32 spectrometer, or at 80-MHz on 
a Bruker W P80 machine. The latter machine was also used to 
obtain l3C NM R spectra at 20 MHz. Unless stated otherwise, 
deuteriochloroform was used as solvent with tetramethylsilane 
as internal standard. Chemical shifts are quoted in parts per 
million downfield from Me4Si on the b scale. Mass spectra were 
obtained on an A El MS12 spectrometer and are quoted as mass 
per charge ratio and relative abundance (percent) for the most 
abundant ions. Microanalyses was carried out on a Perkin-Elmer 
240 CHN analyzer and were within 0.4% of theory. Compounds 
are only described as hemihydrates, where spectral data indicated 
a high degree o f purity, and repeated recrystallization, thorough 
drying and repeated analyses, gave consistent results. Aluminum 
hydride was generated and used according to Brown and Yoon,8 
and reactions were worked up by the method of Hey and Palluel.18
2 -B e n z y l-6 ,7 -d im e th o x y -l- (n itr o m e th y l) -1,2,3,4-tetra-  
h ydroisoquinoline (5). Benzyl bromide (17 mL, 142 mmol) was
(14) M. Nishikawa, M. Kanno, H. Kuriki, H. Sugihara, M. Mot- 
ohashi, K. Itoh, O. Miyashita, Y. Oka, and Y. Sanno, Life. Sci., 
16, 305 (1975). Y. Oka, M. Motohaahi, H. Sugihara, O. Miya­
shita, K. Itoh, M. Nishikawa, and S. Yurugi, Chem. Pharm. 
Bull., 25, 632 (1977).
(15) S. F. Dyke, A. W. C. White, and D. Hartley, Tetrahedron, 29, 
857 (1973).
(16) D. H. Hey and A. L. Palluel, J. Chem. Soc., 2926 (1957).
added to a solution of 6,7-dimethoxy-3,4-dihydroisoquinoline (13 
g, 68 mmol) in dry benzene (80 mL), and the mixture was stirred 
and boiled under reflux for 2 h. The mixture was cooled, and 
the precipitate was filtered off, washed with ether, dried, and 
recrystallized from methano 1-ether to give the /V-benzyldi- 
hydroisoquinolinium bromide (23 g, 93%): mp 186-188 °C (from 
/V,/V-diinethylformamide ethanol -ether) (lit.17 mp 192 -195 °C 
dec); IR 1645 cm -1; XH NMR b 3.0-3.4 (2 H, t, J„pp =  8 Hz, 
ArC//2CH2), 3.7-4.1 (2 H, m, CH2C //2N +), 3.84 and 3.94 (3 H, s, 
OCH3), 5.47 (2 H, s, N C //2Ph+), 6.91 (1 H, a, ArH), 7.2-7.65 (6
H, m, Ar//), 10.33 (1 H, s, C( H).
A solution of nitromethane (2.2 mL, 41 mmol) and potassium  
hydroxide (3 g, 54 mmol) in methanol (30 mL) was added to a 
solution of 2-benzyl-6,7-dimethoxy-3,4-dihydroisoquinolinium  
bromide (9.8 g, 27 mmol) in methanol (50 mL). After standing 
for 1 h, the mixture was evaporated to dryness, dissolved in water, 
neutralized with dilute hydrochloric acid, rebasified with sodium 
bicarbonate, and extracted with chloroform to give the l-(n i-  
trom eth y l)-!,2,3,4-tetrah yd ro isoq u in o lin e  (7.8 g, 84%): 'H 
NMR b 2.1-3.4 (4 H, m, ArC//2C //2N), 3.73 (2 H, N C //2Ph), 3.78 
and 3.81 (3 H, s, OCH3), 4.2-4.8 [3 H, m, ArC //(N )C //2N 0 2l, 6.53 
and 6.61 (1 H, s, Ar//), 7.24 (5 H, s, Ar//). A portion purified from 
acetone had mp 104-105 °C; IR 1550 and 1360 c m 1. Anal. 
(C19H22N 20„) C, H, N.
R ed uction  o f  2 -B en zy l-6 ,7 -d im eth oxy-l-(n itrom eth y l)-
I,2,3,4-tetrahydroisoquinoline. 1. W ith  L ithium  A lum inum  
Hydride: “N orm al Addition”. A solution of the l-(nitromethyl) 
derivative (1.9 g, 5.5 mmol) in dry tetrahydrofuran (50 mL) was 
added to a stirred suspension of lithium aluminum hydride (0.6 
g, 16 mmol) in dry tetrahydrofuran (30 mL), and the mixture was 
boiled under reflux for 1 h. Workup gave a mixture o f products, 
which were dissolved in dry ether and dripped into ethereal 
hydrogen chloride. The solid was collected and recrystallized from 
methanol to give l-(aminoinethyl)-2-benzyl-6,7~dimethoxy-
1,2,3,4-tetrahydroisoquinoline dihydrochloride (0.35 g, 16%), which 
was converted to the free base and gave spectral data identical 
with those of an authentic sample (see below).
(2) W ith  L ith iu m  A lu m in u m  H ydride: “R ev erse  
Addition”. Lithium aluminum hydride (1 g, 26 mmol) was placed 
in a soxhlet thimble. The l-(nitromethyl) derivative (2.8 g, 8.3 
mmol) in dry tetrahydrofuran (100 mL) was placed in the flask 
beneath, boiled under reflux for 1 h, and worked up to give 
2-benzyl-6,7-dimethoxy-l,2,3,4-tetrahydroisoquinoline (2 g, 85%): 
•H NMR b 2.70 (4 H, br s), 3.48 and 3.60 (2 H, s), 3.70 and 3.73 
(3 H, s), 6.40 and 6.53 (1 H, s), 7.1-7.5 (5 H, m). A portion 
crystallized from toluene-petroleum ether (bp 60-80 °C) had mp 
68-69 °C (lit.17 mp 88-89 °C). The spectral data and melting point 
were identical with those of an authentic sample prepared by the 
sodium borohydride reduction of 2-henzyl-6,7-dimethoxy-3,4- 
dihydroisoquinolinium bromide.
(3) W ith S odium  B is(2 -m eth oxyeth oxy)a lu m in u m  Hy  
dride. A solution of the l-(nitromethyl) derivative (2.1 g, 6  mmol) 
in dry benzene (60 mL) was dripped into a stirred, boiling solution 
of Red-Al (6 mL), containing approximately 16 mmol of sodium  
bis(2-methoxyethoxy)aluminum hydride in dry benzene (40 mL), 
and the mixture boiled under reflux for 1 h. Dilute sodium  
hydroxide (40 mL) was added, and the mixture was stirred vig­
orously for 1 h. The organic layer was separated and evaporated 
to give a mixture o f products, which were dissolved in ethanol 
and dripped into ethereal hydrogen chloride. The precipitate was 
collected and purified from 2-propanol to give l-(am ino- 
methyl)-2-benzyl-6,7-dimethoxy-l,2,3,4-tetrahydroisoquinoline 
dihydrochloride (0.6 g, 25%), which was converted to the free base 
and gave spectral data identical with those of an authentic sample.
1-C yano-l,2,3,4 -tetrah yd ro isoq u in o lin e (6, R = H ). A so­
lution of potassium cyanide (2.5 g, 38 mmol) in water (20 mL) 
was added to a solution of 3,4-dihydroisoquinoline (4 g, 30 mmol) 
in water (20 mL) previously acidified with dilute hydrochloric 
acid. Extraction with ether gave the nitrile (4.7 g, 98%): IR 3340 
and 2220 cm"1; 7H  NM R b 2.21 (1 H, s, exchangeable), 2.5-3.4 (4 
H, m), 4.94 (1 H, s), 7.13 (4 H, s). The hydrochloride salt had 
mp 158-161 °C (lit .18 mp 160-162 °C).
(17) J. H. Chapman, P. G. Holton, A. C. Ritchie, T. Walker, G. B. 
Webb, and K. D. E. Whiting, J. Chem. Soc., 2471 (1962).
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R eduction  o f  l-C yano-l,2 ,3 ,4~tetrahydroi8oquinoline. 1. 
W ith L ith iu m  A lu m in u m  H ydride. I -Cyano-l,2,3,4-tetra- 
hydroisoquinoline (4.6 g, 29 mmol) was reduced with lithium  
aluminum hydride (3 g, 89 mmol) in ether to give a mixture of 
products. The crude products were distilled to give 1,2,3,4- 
tetrahydroisoquinoline (1.6 g, 41%): bp 104-106 °C (0.8 mmHg); 
IR 3250 c m 1; ■H NMR b 1.42 (1 H, s), 2.5-3.2 (4 H, m), 3.85 (2
H, s), 6.7-7.3 (4 H, m). The hydrochloride salt had mp 195-196 
°C (from ethanol) (lit.19 mp 197-198 °C). The residue after 
distillation was dissolved in ethanol and dripped into an ethereal 
solution of oxalic acid. The precipitate was collected and purified 
from ethanol to give l-(um inom ethyl)-l,2,3,4-tetrahydroiso­
quinoline dioxalate (0.2 g, 2 %): spectral data identical with those 
of an authentic sample.
(2) W ith  A lu m in u m  H yd rid e . A solution of 1-cyano-
I,2,3,4-tetrahydroisoquinoline (4.2 g, 27 mmol) in dry ether (50 
mL) was dripped into a cooled, stirred solution of aluminum  
hydride (262 mmol) in dry ether (400 mL) and stirred overnight 
to give a mixture of products. The mixture was dissolved in 
ethanol and dripped into an ethereal solution of oxalic acid. The 
precipitate was collected and boiled in an ethanol-m ethanol 
mixture. After the mixture cooled, the precipitate was filtered 
off and recrystallized from water to give l-(am inom ethyl)-
1.2.3.4-tetrahydroisoquinoline dioxalate (0.2 g, 2%): melting point 
and spectral data identical with those of an authentic sample. 
The filtrate (ethanol-methanol) was evaporated to dryness, and 
the residue was recrystallized from methanol to give 1,1'-bi­
l l , 2,3,4-tetrahydroisoquinolyl) (8 ) dioxalate (0.8 g, 14%): mp 
190-192 °C; lH NMR (DzO; external M e4Si) <S 2.8-3.6 (8 H, m, 
2 ArC//2C //2N H 2+), 4.25 (2 H, s, 2 ArC H N H ./), 7.1-7.5 (8 H, m, 
Ar//); MS, m /e  133 (53), 132 (84), 104 (100). No molecular ion 
was observed; requires m /e  264. Anal. (C22H24N 2Og)
C, H, N. The free base gave IR 3260 cm-1.
1 -(A m in o m e th y l)-1,2,3,4 -te tra h y d r o iso q u in o lin e  (10). 
Benzyl bromide (28 mL, 235 mmol) was added to a solution of
3.4-dihydroisoquinoIine (18.7 g, 143 mmol) in dry ether (300 mL), 
and the mixture was Btirred overnight at ambient temperature. 
The precipitate, which was hygroscopic, was filtered off to give 
the d ihydroisoquinolin ium  brom ide (31.5 g, 73%), which after 
drying on a rotary evaporator was obtained as a golden oil: !H 
NMR b 3.20 (2 H, t, J„pp = 8 Hz, A rC//2), 4.05 (2 H, t, J  = 8 
Hz, CH2C //2N +), 5.60 (2 H, s, N C //2Ph+), 7.0-8.15 (9 H, m, Ar//), 
10.55 (1 H, s, CtH). A portion crystallized from aqueous etha- 
nol-ether had mp 60-72 °C; IR 3400 (H20 ) , 1655.
A solution of potassium cyanide (1 g, 15 mmol) in water (20 
mL) was added to a solution of 2-benzyl-3,4-dihydroisoquinolinium 
bromide (3.6 g, 12 mmol) in water (20 mL) and extracted with 
ether to give 2-benzyl-1-cyano-1,2,3,4-tetrahydroisoquinoline (2.8 
g, 96%): [H NM R b 2.5-3.3 (4 H, m), 3.78 (2 H, s), 4.59 (1 H, 
s), 6.8-7.5 (9 H, m). A portion recrystallized from petroleum ether 
(bp 60-80 °C) had mp 82-84 °C (lit.9 mp 82 °C); IR 2220 c m 1. 
The nitrite (5.7 g, 23 mmol) dissolved in dry ether (250 mL) wus 
added to aluminum hydride (131 mmol) in dry ether (200 mL) 
and stirred overnight to give l-(aminomethyI)-2-benzyI-l,2,3,4- 
tetrahydroisoquinoline (9; 5.1 g, 88%): IR 3360 c m 1; (H NMR  
b 1.35 (2 H, s, N H 2), 2 .5-3.3 (6 H, m, A rC //2C //2N and 
C HC//2N H 2), 3.55 [1 H, t, J  = 6 Hz, ArC//(CH2)N], 3.56 and 3.80 
(I H, d, J gom = 13.5 Hz, CH of NCH2Ph), 6.8-7.4 (9 H, m, Ar//).
The tetrahydroisoquinoline (9; 5 g, 20 mmol) in 96% ethanol 
(150 mL) was hydrogenated at atmospheric pressure over 5% 
palladium on charcoal (1 g). Hydrogen uptake was slow, and after 
24 h only 75% of theoretical uptake had occurred. The mixture 
was heated at 50 °C for a further 12 h. The mixture was filtered 
through Kieselguhr, and the filtrate was evaporated to give 1- 
(aminomethyl)-l,2,3,4-tetrahydroisoquinoline (10; 3 g, 93%): IR 
3260 cm ’; (H NM R b 1.91 (3 H, s, N H 2 and N H ), 2.55-3.20 (6 
H, m, A rC //2C //2N H  and C H C //2N H 2), 3.87 [1 H, t, J  =  6 Hz, 
ArCH (CH2)N], 7.05 (4 H, s, Ar//). The d ioxa late  sa lt  had mp 
187-189 °C (from aqueous methanol); ‘H NMR (D20; DSS) b 3.17 
(2 H, m A rC //2CH2), 3 .5-3.8 (4 H, m, CH2C //2N H 2+ and
(18) H. Boehme and R. Schweitzer, Arch. Pharm. (Weinheim, 
Ger.), 303, 225 (1970).
(19) J. Z. Ginos, G. C. Cotzias, E. Tolosa, L. C. Tang, and A. Lo- 
Monte, J. Med. Chem., 18, 1194 (1975).
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C H C //2N H3f), 50.1 (1 H, t, J  =  6 Hz, ArC//(CH2)N H 2+], 7.32 (4 
H, br s, Ar//); MS, m /e  132 (100). No molecular ion was observed; 
Cl0H 14N 2 requires m /e  162. Anal. (Ci4H i8N 20 8) C, H, N.
l-[(Isopropylam ino)m ethyl]-l,2,3,4-tetrahydroisoquinoline
(11) D ih yd roch lor id e . l-(A m inom ethyl)-2-benzyl-l,2,3,4-
tetrahydroisoquinoline (9; 3.1 g, 12 mmol) in a mixture of methanol 
(40 mL), acetone (10 mL), and concentrated hydrochloric acid 
(2.4 mL, 24 mmol) was treated with sodium cyanoborohydride 
(1.9 g, 30 mmol), as in the preparation of 4b, to give 2-benzyl-
l-[(isopropylam ino)m ethyll-l,2,3,4-tetrahydroisoquinoline (3.5 
g, 97%): IR 3290 cm’1; (H NM R b 1.00 and 1.10 [3 H, d, J  = 7 
Hz, C H (C //3)2], 2.4 (br, 1 H, exchangeable, NH), 2.3-3.4 (7 H, 
m, ArC //2C //2NH, C //2NH, and C //N H ), 3.55-4.0 (1 H, m, 
ArC/ZN), 3.70 (2 H, s, ArC//2N), 6.9-7.5 (9 H, m, Ar//). Of this, 
3.4 g was hydrogenated over 5% palladium on charcoal (350 mg) 
in a mixture of 96% ethanol (80 mL) and concentrated hydro­
chloric acid (2.5 mL) to give, after recrystallization from ethanol, 
the tetrahydroisoquinoline (11) dihydrochloride (1.75 g, 55%): 
mp 230-238 °C dec; IR 3100-2300 c m 1; ■H NMR (D20; external 
Me4Si) b 1.37 [6 H, d, J  =  7 Hz, C H (C //3)2], 2.9-3.35 (2 H, m, 
A rC //2C H 2), 3 .4 -3 .9 5  [5 H, m, CH2C //2N H 2+ and 
C H C //2N H 2C //(C H 3)2+], 5.08 [1 H, d o f d, ^  = 7.5 Hz, Jab- = 
5 Hz, ArC//(CH2)NH2+l, 7.36 (4 H, s, A r//). Anal. (C^H^CljN.,) 
C, H, N. The free base gave IR 3260 c m 1; 'H NMR b 1.05 [6 H, 
d, J  = 6 Hz, CH(C//3)2], 1.88 (2 H, s, exchangeable, NH and NH), 
2.5-3.2 (7 H, m, ArC//2C //2NH, C //2NH, and C //N H ), 3.97 (1 H, 
d of d, J AB = 8 Hz J AB- = 5 Hz, A rC //N H ), 7.04 (4 H, s, Ar//); 
■H NM R (D20; DSS) b 1.07 (6 H, d, J  = 7Hz), 2.5-3.2 (7 H, m), 
4.02 (1 H, d of d, Jab = 8 Hz, Jab' =  5-5 Hz), 7.16 (4 H, s), 
assignments as for CDC13 spectrum.
Equimolar amounts of the free base and the dihydrochloride 
salt were mixed together and recrystallized from ethanol-ether 
to give the monohydrochloride salt: mp 146-149 °C; IR 3280, 
3100-2300 c m 1; [H NMR (D20; external Me4Si) b 1.20 [6 H, d, 
J  = 7 Hz, CH(CZ/3)2], 2.4-3.5 (7 H, m, ArC//2C //2NH, C //2NH2+ 
and C //N H 2+), 4.15 (1 H, d of d, Jab =  8.5 Hz, Jab- = 5 Hz, 
ArCHNH), 7.05 (4 H, s, Ar//). The 13C NMR spectra of the free 
base, mono-, and dihydrochloride salts are given in Table VII.
1 -(A m in om eth y  l)-2 -b en zy l-6 ,7 -d im eth oxy -1,2,3,4-tetra- 
h ydro isoq uino lin e (13, R = Me) D ih yd roch lorid e  Hemi- 
hydrate. A solution of potassium cyanide (2 g, 31 mmol) in water 
(20 mL) was added to a suspension of 2-benzyl-6,7-dimethoxy-
3,4-dihydroisoquinolinium bromide (7.5 g, 21 mmol), and the 
mixture was extracted with ether to give 2-benzyl-l-cyano-6 ,7- 
dimethoxy-1,2,3,4-tetrahydroisoquinoline (6.3 g, 98%): !H NMR  
b 2.4-3.2, (4 H, m, ArC//2C //2N), 3.70 and 3.74 (3 H, s, OCH3), 
3.72 (2 H, s, ArC //2N) 4.54 [1 H, s, ArC//N (C N)], 6.51 and 6.53 
(1 H, s, Ar//), 7.1-7.5 (5 H, m, Ar//). A portion recrystallized from 
ether -petrol (bp 60-80 °C) had mp 107-108 °C; IR 2220 c m 1. 
A solution of the nitrile (12, R = Me; 4.15 g, 13.5 mmol) in a 
mixture of dry ether (100 mL) and dry tetrahydrofuran (5 mL) 
was added to a cooled, stirred solution of aluminum hydride (79 
mmol) in dry ether (150 mL), and the mixture was stirred at 
ambient temperature for 16 h to give l-(am inom ethyl)-2- 
benzyl-6,7-dimethoxy-l,2,3,4-tetrahydroisoquinoline (13, R = Me; 
3.9 g, 92%): IR 3350 cm"1; ‘H NMR b 1.7 (br, 2 H, exchangeable, 
N H J, 2.3-3.3 (6 H, m, ArC//2C //2N and C HC//2N H 2), 3.51 [1 H, 
t, J  = 6 Hz, ArC//(CH2)N), 3.73 (2 H, s, N C //2Ph), 3.78 (6 H, s, 
2 OCH3), 6.55 (2 H, s, A r//), 7.1-7.4 (5 H, m, Ar//). The di- 
hydroch loride h em ih yd rate had mp 206-208 °C (from 2- 
propanol-ether). Anal. (CI8H26Cl2N 2O2-0.5H2O) C, H, N.
l-(A m inoethyl)-2-benzyl-6,7-b is(benzyloK y)-1,2,3,4-tetra- 
h y d ro iso q u in o lin e  (13, R = C H 2P h ) D ih yd roch lor id e .  
Phosphorus pentachloride (45 g, 216 mmol) was added portionwise 
to a cooled, stirred solution of 7V-[2-[3,4-bis(benzyloxy)phenyl]- 
ethyl)formamide (31 g, 86 mmol) in dry chloroform (200 mL), and 
the mixture was stirred overnight at ambient temperature. Dry 
ether (120 mL) was added, and the precipitate was filtered off, 
immediately added to water (150 mL), and stirred for 24 h. The 
resulting fine precipitate was filtered off, resuspended in water, 
basified with sodium hydroxide, and extracted with ethyl acetate 
to give 6,7-bis(benzyloxy)-3,4-dihydroisoquinoline (19.1 g, 65%). 
Benzyl bromide (13.5 mL, 113 mmol) was added to a solution of 
the dihydroiBoquinoline (19 g, 55 mmol) in dry benzene (300 mL), 
and the mixture was stirred at ambient temperature for 64 h. The 
precipitate was filtered off and washed with ether to give the crude
1 7 7
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product (19.7 g), which was recrystallized from ethanol-ethyl 
acetate-ether to give the N-benzyldihydroisoquinolinium bromide 
(16.2 g, 57%): mp 165-166 °C; IR 1640 c m 1; 'H NMR 8 3.05 (2 
H, t, Japp = 8 Hz, ArCH2CH2), 3.80 (2 H, t. J npp = 8 Hz, 
CH2CH2N +), 5.07 and 5.18 (2 H, s, OCH2Ph), 5.39 (2 H, s, 
NCH2Ph+), 6.90 and 7.78 (1 H, s, ArH), 7.0-7.7 (15 H, m, ArH), 
10.31 (1 H, s, C\ H).
A solution of potassium cyanide (4 g, 61 mmol) in water (50 
mL) was added to a solution o f 2-benzyl-6,7-bis(benzyloxy)-3,4- 
dihydroisoquinolinium bromide (16.2 g, 31 mmol) in methanol 
(100 mL), methanol was then evaporated off, and the aqueous 
residue was extracted with ethyl acetate to give 2-benzyl-l- 
cyano-6,7-bis(benzyloxy)-l,2,3,4-tetrahydroisoquinoline (14 g, 
96%): IR 2220 cm '1; ‘H NM R 8 2.4-3.1 (4 H, m), 3.78 (2 H, s), 
4.50 (1 H, s), 4.98 and 5.04 (2 H, s), 6.64 (2 H, s), 7.0-7.5 (15 H, 
m), which was dissolved in a mixture o f dry ether (200 mL) and 
dry tetrahydrofuran (50 mL), added to aluminum hydride (153 
mmol) in dry ether (250 mL), and stirred overnight to give a 
mixture of products. The mixture was dissolved in ethanol and 
dripped into ethereal hydrogen chloride, and the precipitate was 
collected and recrystallized from acetone to give 2-benzyl-6,7- 
bi8(benzyloxy)-l,2,3,4-tetrahydroisoquinoline hydrochloride (2.65 
g, 18.5%); IR 2600-2200 c m ‘H NM R 8 2.85-3.50 (4 H, m, 
ArCH2CH2N H +), 4.02 (2 H, br s, ArCH2N H +), 4.18 (2 H, s, 
NCH2Ph+), 5.00 and 5.04 (2 H, s, OCH2Ph), 6.50 and 6.66 (1 H, 
s, Artf), 7.1-7.7 (15 H, m, ArH), 8.0-10.0 (1 H, exchangeable, 
N H +). A portion recrystallized from ethanol had mp 183-186 °C. 
Anal. (C3„H30ClNO2) C, H, N. T he free base gave 8 2.67 (4 H, 
hr b , ArCH2CH2N ), 3.46 (2 H, br s, ArCH2N), 3.58 (2 H, s ,  
NCH2Ph), 5.00 and 5.02 (2 H, s, OCH2Ph), 6.53 and 6.65 (1 H, 
s, ArH), 7.1-7.7 (15 H, m, Ar//). The filtrate from the preceding 
crystallization was evaporated, and the residue was purified from 
2-propanol-acetone to give l-(aminomethyl)-2-benzyl-6,7-bis- 
(benzyloxy)-l,2,3,4-tetrahydroisoquinoline (13, R = CH2Ph) di- 
hydrochloride (8 g, 49%): mp 177-181 °C; IR 3100-2200 c m 1. 
Anal. (C31HmC12N 20 2) C, H, N. The free base gave IR 3350 cm '1; 
•H NM R 5 1.4 (br, 2 H, exchangeable, N H 2), 2.45-3.2 (6 H, m, 
ArCH2CH2N  and CHCH2N H 2), 3.3-3.6 [1 H, m, ArC//(CH2)N], 
3.70 (2 H, s, NCH2Ph), 5.06 (4 H, s, 2 OC /f2Ph), 6.58 and 6.63 
(1 H, s, ArH), 7.0-7.7 (15 H, m, ArH).
I - (A m in o m eth y l)-6 ,7 -d ih y d ro x y -1,2,3 ,4 -tetrah yd ro iso - 
q u in o lin e  (4a) D ih yd roch lorid e  H em ihydrate. l-(Amino- 
methyl)-2-benzyl-6,7-bis(benzyloxy)-l,2,3,4-tetrahydroisoquinoline 
(2.2 g, 5 mmol) in a mixture o f methanol (150 mL) and concen­
trated hydrochloric acid (2 mL) was hydrogenated over 5% 
palladium on charcoal (0.6 g), the mixture was filtered through 
Kieselguhr, the filtrate was evaporated, and the residue was 
recrystallized from m ethanol-acetone-ether to give the tetra ­
h yd ro isoq u in o lin e (4a) d ih yd roch lorid e  h em ihydrate (0.93 
g, 71%): mp 135-143 °C; IR 3400, 3300-2300 cm-'; lH NMR (D20; 
DSS) 8 2.85-3.25 (2 H, m, ArCH2CH2), 3.45-3.90 (4 H, m, 
CH2CH2N H 2 f and CHCH2N H3+), 4.95 [I H, t, J  =  6 Hz, ArCH- 
(CH2)N H 2+1, 6.79 and 6.84 (1 H, s, ArH). Anal. (Cl0H ,6Cl2N2-
O2-0.5H2O) C, H, N.
f>,7-D ihydroK y-l-[(isopropylum ino)m ethyl]-1,2,3,4-tetra- 
h yd ro isoq u in o lin e  (4b) D ih yd roch lorid e . Sodium cyano- 
borohydride (0.85 g, 13.5 mmol) was added portionwise to a cooled, 
stirred solution o f l-(am inom ethyl)-2-benzyl-6,7-bis(benzyl- 
oxy)-l,2,3,4-tetrahydroisoquinoline (2.5 g, 5.4 mmol) in a mixture 
of methanol (30 mL), acetone (5 mL), and concentrated hydro­
chloric acid (1.1 mL, 11 mmol), and the mixture was stirred at 
ambient temperature for 16 h. T he mixture was acidified with 
dilute hydrochloric acid, organic solvents were evaporated off, 
and the residue was basified with sodium bicarbonate and ex­
tracted with ethyl acetate to give 2-benzyl-6,7-bis(benzyloxy)-
l-[(isopropyIam ino)m ethyll-l,2,3,4-tetrahydroisoquinoline (2.5 
g, 92%): IR 3275 c m 1; ■H NM R 8 0.98 and 1.03 [6 H, d, J  = 7 
Hz, CH(CH3)2], 2.3-3.3 (8 H, becoming 7 H with D20 , m, ArC- 
H2CH2N, CH2N, and CHN), 3 .4-3.8 (1 H, m, ArCHN), 3.69 (2 
H, s, ArCH2N), 5.06 (4 H, s, ArCH20 ) , 6.63 and 6.66 (1 H, s, ArH), 
7.1-7.6 (15 H, m, ArH). The dihydrochloride salt, which had mp 
113-123 °C (from 2-propanol-ether), IR 3100-2200 cm"1 (2.1 g, 
4 mmol), in methanol (150 mL) was hydrogenated over 5% 
palladium on charcoal (0.5 g), the mixture was filtered through 
Kieselguhr, the filtrate was evaporated to dryness, and the residue 
was purified from ethanol to give tetrah yd ro isoq u in o lin e (4b)
Beaumont et al.
dihydrochloride (0.7 g, 64%): mp 241-243 °C dec; IR 3410, 3270, 
3100-2200 cm"1; JH NM R (DzO, DSS) S 1.43 [6 H, d, J  = 7 Hz, 
CH(CH3)2], 2.85-3.25 (2 H, m, ArCH2CH2), 3.35-3.90 [5 H, m, 
CH2CH2N H 2+ and CHCH2N H 2CH(CH3)2+], 4.75-5.15 [1 H, m, 
ArCH(CH2)NH2+], 6.80 and 6.87 (1 H, s, ArH); MS m /e  236 (M+, 
5), 177 (37), 164 (46), 163 (59), 162 (54), 149 (41), 72 (100). A 
portion recrystallized from aqueous m ethanol-ether had mp 
252-254 °C dec (lit.6 mp 268-270 °C dec). Anal. (C13H22C12N 20 2) 
C, H, N.
l-[(  tert-B u ty lam in o)m eth y l]-6 ,7-d ih yd roxy-l,2,3,4-tetra- 
h y d ro isoq u in o lin e  (4c) B ih yd roch lor id e . A mixture o f bro- 
moacetaldehyde diethyl acetal (20.3 g, 0.103 mol), tert-butylamine 
(50 mL, 0.47 mol), and dry benzene (50 mL) was boiled under 
reflux for 48 h, cooled, and evaporated almost to dryness. The 
residue was dissolved in ether and washed with dilute sodium  
hydroxide, and the organic layer was evaporated to dryness. The 
residue was distilled (90 °C at 1.5 mmHg) to give N -(tert-bu \- 
ylamino)acetaidehyde diethyl acetal (15.6 g, 80%): decomposes 
at 160 °C at 758 mmHg; IR 3320 c m 1; JH NM R 8 1.08 (9 H, s), 
1.20 (6 H, t, J  =  7 Hz), 0.9-1.4 (1 H, exchangeable), 2.66 (2 H, 
d, J  = 6 Hz), 3.23-3.90 (4 H, m), 4.54 (1 H ,t ,J  = 6 Hz). A mixture 
of the acetal (3 g, 15.9 mmol), dopamine hydrochloride (2 g, 10.6 
mmol), 1-butanol (40 mL), concentrated hydrochloric acid (2.4 
mL), and water (5 mL) was boiled under reflux in a nitrogen 
atmosphere for 4 h. The progress of the reaction was followed 
by TLC on silica eluting with ethyl acetate-acetic acid-water 
(15:15:10, v /v ) and visualizing with 1% ferric chloride solution. 
The mixture was evaporated to dryness, the residue was dissolved 
in ethanol and filtered, and the filtrate was dripped into dry ether. 
T he precipitate was collected and recrystallized from 2- 
propanol-acetone-isopropyl ether to give the tetra h y d ro iso ­
q u in o lin e  (4c) d ih yd roch loride (1.1 g, 32%): mp 239-242 °C 
dec; IR 3330, 3075-2350 cm"1; ‘H NMR (D20; DSS) 8 1.46 (9 H, 
s, C(CH3)3J, 2.85-3.25 (2 H, m, ArCH2CH2), 3.4-3.8 (4 H, m, 
CH2CH2N H j1 and CHCH2N H 2+), 4.7-5.1 [1 H, m, ArCH(CH2)- 
N H 2+1, 6.78 and 6.85 (1 H, s, ArH); MS, m /e  250 (M+-, 13), 164 
(68), 163 (72), 162 (70), 86 (100). Anal. (C14H 24C12N 20 2) C, H, 
N.
p i£ 0 D eterm in a tio n  o f l-(A m in om eth y l) and l-[(Iso -  
propylam in o)m eth y l]-l,2 ,3 ,4 -tetrah ydro isoq uino lin es. The
pH of a solution of the test substance (1.5-2 mmol) in distilled  
water (50-100 mL) titrated with N /20  hydrochloric acid, delivered 
at a rate of 2.4 m L/m in by a Watson-Marlow flow Inducer Type 
22, was continually monitored by a Pye-Unicam 401 combined 
electrode linked through a Pye-Unicam PW9418 pH meter to a 
chart recorder. From the graph of pH vs. volume of titrant added, 
the pH at half neutralization was taken as a measure of p K n. 
Values obtained were as follows: l-(aminomethyl)-l,2,3,4-tetra- 
hydroisoquinoline (10), 5.7 and 8.9;/V-isopropyl analogue 11, 5.4 
and 9.2. The bases 10 and 11 were generated from their dioxalate 
and hydrochloride salts, respectively, immediately before use.
The experimentally determined values were obtained at 20 °C. 
It is probable that values at 37 °C would be about 0.3 p K a units 
lower.20 It is also probable that the introduction of 6,7-dihydroxy 
groups would alter the amine p K a values slightly, since 2- 
phenylethylam ine is reported21 to have pK„ of 9.88 at 25 °C, 
whereas dopamine is reported22 to have p K a of  10.63 at 20 °C. 
T hese considerations do not alter the main conclusion that the  
diamines under consideration would be substantially mono­
protonated under physiological conditions.
P h arm aco log ica l M ethods. G u in ea P ig , Iso lated  P rep a­
ra tio n s. Guinea pigs (300-400 g) of either sex were killed by 
cervical dislocation. Right atrial and tracheal preparations were 
removed and mounted in 10-rnL tissue baths containing Krebs- 
Henseleit solution of the following composition (mmol/L): NaCl, 
118; N aH C 03, 24.9; KCl, 4.7; M gS 04-7H20 , 1.2; CaCl2, 1.9; 
KH2P 0 4, 1.2; glucose, 11.1 at 37 °C. It was bubbled with 5% C 0 2 
in 0 2. The bathing solution contained ethylenediaminetetraacetic 
acid (EDTA, 67 pm ol/L) and ascorbic acid (10 /xmol/L) to reduce 
oxidation of catecholamines. In all experiments a 30- to 60-min
(20) A. Albert and E. P. Serjeant, “Ionization Constants of Acids 
and Bases. A Laboratory Manual", Methuen, London, 1962.
(21) T. Kappe and M. D. Armstrong, J. Med. Chem., 8, 368 (1965).
(22) B. R. Martin, J. Phys. Chem., 75, 2657 (1971),
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equilibration period was allowed before addition of drugs to the 
t.issue bath. In some experiments, guinea pigs were injected 
intraperitoneolly with reserpine (Serpasil, Ciba Chemical Co.) in 
a dose of 5 mg/kg. Tissues were removed for study 18-24 h later. 
These preparations were tested with tyramine at a concentration 
of 17 /umol/L before commencing further experiment.
R ight A tria . A tension o f 0.02 N  (2 g wt) was applied to the 
atrium. Contractions were recorded with a Grass force-dis- 
placement transducer (FT03), and the rate was recorded with a 
Grass tachograph (7P44B1) on a polygraph (790).
To obtain agonist activity, two cumulative concentration-re- 
sponse curves to isoproterenol and a single cumulative concen- 
tration-response curve for the test compound were established  
with 30-min intervals. The bath was washed three tim es at the 
end of each cumulative determination. In control experiments, 
three successive concentration-response curves for isoproterenol 
were established. Slight desensitization occurred: between curves 
two and three the factor was 1.2. Therefore, in experiments with 
test compounds, only the second isoprenaline dose-response re­
lationship was used for potency determination, and appropriate 
correction was made to the E value for the test compound.
For determination of antagonistic activity, a concentration- 
effect curve for isoproterenol was established before and 15 min 
after the drug under test was added to the tissue bath. After 
washing, the process was repeated with higher concentration of 
the drug under test. pA2 values were determined by the method 
of Arunlakshana and Schild .23
T rach ea . Tracheae were removed and placed in K rebs- 
Henseleit solution bubbled with C 02 in 0 2 at room temperature 
and then cleared of connective tissue. An incision was made 
longitudinally in the cartilaginous band opposite to the 
smooth-muscle band. Transverse cuts through approximately 
three-quarters of the width of the preparation at two to three ring 
intervals were then made alternately from each side of the trachea. 
A near vertical alignment of the smooth-muscle fibers along the 
axis through which tension was measured was thus obtained. A 
resting tension of 0.02 N (2 g wt) was applied to the preparation 
in the tissue bath, and tension was recorded as for atria.
Carbachol (10 nm ol/L) was used to induce a submaximal in­
crease in tone in the preparations. Two cumulative concentra- 
tion-response curves for isoproterenol and then a single curve 
for the test drug were established with 30-min intervals. The bath 
was washed three times after each determination. Only the second 
curve for isoproterenol was used in potency determinations, and, 
as with atria, a desensitization factor (1.3) was applied to the 
results for the test compound. The maximum response to all drugs 
under test was leas than that of isoproterenol, a maximum response 
to which was reestablished during the period of maximum response 
to  the drug under test. pD2 values were obtained as with atria.
Antagonistic action was established with a procedure the same 
as that used with atria, except that the preparations were con­
tinuously exposed to carbachol (1 gm ol/L ).
A n esth etized  C ats. Cats o f either sex and weighing 2.3-3.6  
kg were anesthetized by intraperitoneal injection of a mixture 
of chloralose (80 mg/kg) and sodium phenobarbitone (6 mg/kg).
(23) O. Arunlakshana and H. O. Schild, Br. J. Pharmacol., 14, 48 
(1959).
(24) P. Cerutti and H. Schmidt, Helv. Chim. Acta, 47, 203 (1964).
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The trachea was cannulated, but the cat was allowed to breathe 
spontaneously. Drugs were injected into a brachial vein. Blood 
pressure was recorded from a cannulated common carotid artery 
by using a Druck pressure transducer (PDGR75), and heart rate 
was recorded by using a Grass Tachograph triggered by the arterial 
pulse.
After constant submaximal responses to a single dose of iso­
proterenol, concurrent cumulative dose-response curves for effects 
on the heart rate and blood pressure were established. Effects 
of isoproterenol were first determined, followed by responses to 
other drugs. In each experiment, one cumulative dose-response 
relationship was determined. Dose-response curves were plotted 
in terms of percentage of the maximum responses produced by 
isoproterenol.
D rugs. Drugs used were isoproterenol hydrochloride (Sterling 
Pharm aceuticals), tetrahydropapaveroline hydrobromide 
(Wellcome Research Laboratories), propranolol hydrochloride 
(Imperial Chemical Industries), carbachol (injection BP, Abbott 
Laboratories), reserpine (Serpasil, Ciba-Geigy), tyramine hy­
drochloride (Koch-Light), a-chloralose (British Drug Houses, and 
pentobarbitone sodium (Nembutal sodium, Abbott Laboratories). 
All drugs solutions, except reserpine, carbachol, and pento­
barbitone sodium, were weighed and diluted to the appropriate 
concentrations with Krebs-Henseleit solution for in vitro prep­
arations or 0.9%, w /v , NaCl solution for anesthetized cat prep­
arations at the beginning o f each experiment. The commercial 
carbachol, reserpine, and pentobarbitone sodium preparations 
were used undiluted. All working solutions were kept on ice during 
the experimental period.
A ck n o w led g m en t. D.B. was supported by a S.R.C. 
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R eg istry  N o. 4a, 84500-62-9; 4a-2HCl, 60085-38-3; 4b, 
84500-63-0; 4b-2HCl, 60085-35-0; 4c, 84500-64-1; 4c-2HCl, 
84500-65-2; 5, 84500-66-3; 6 (R = H), 84500-67-4; 6-HC1 (R = H), 
27002-40-0; 6 (R = CH2Ph), 37039-47-7; 8 dioxolate, 84500-69-6; 
9, 40615-06-3; 10, 84500-70-9; 10 dioxolate, 84500-71-0; 11, 
84500-72-1; 11-HC1, 84500-73-2; 11-2HC1, 84500-74-3; 12 (R = Me), 
73154-44-6; 12 (R = CH2Ph), 84500-75-4; 13 (R = Me), 84500-76-5; 
13HC1 (R = Me), 84500-77-6; 13 (R =  CH2Ph), 84500-78-7; 13-HC1 
(R = CH2Ph)-2HCl, 84500-79-8; 14, 84500-80-1; 14-2HC1, 84500-
81-2; benzyl bromide, 100-39-0; 6,7-dimethoxy-3,4-dihydroiso- 
quinoline, 3382-18-1; N-benzyl-6,7-dimethoxy-3,4-dihydroiso- 
quinolinium bromide, 5096-82-2; potassium cyanide, 151-50-8;
3,4-dihydroisoquinoline, 3230-65-7; lithium aluminum hydride, 
16853-85-3; sodium bis(2-methoxyethoxy)aluminum hydride, 
22722-98-1; aluminum hydride, 7784-21-6; 2-benzyi-3,4-dihydro- 
isoquinolinium bromide, 84500-82-3; acetone, 67-64-1; 2-benzyl-
l-[(i8opropylam ino)m ethyl]-l,2 ,3 ,4-tetrahydroisoquinoline, 
84500-83-4; N-[2-[3,4-bis(benzyloxy)phenyl]ethyl]formamide, 
84500-84-5; 6,7-bis(benzyloxy)-3,4dihydroisoquinoline, 84500-85-6; 
N-benzyl-6,7-bis(benzyloxy)-3,4-dihydroisoquinolinium bromide, 
84500-86-7; 2-benzyl-6,7-bis(benzyloxy)- 1,2,3,4-tetrahydroiso­
quinoline hydrochloride, 84500-87-8; 2-benzyl-6,7-bis(benzyl- 
oxy )-l,2,3,4-tetrahydroisoquinoline, 84500-88-9; bromoacet- 
aldehyde diethyl acetal, 2032-35-1; tert-butylamine, 75-64-9; 
(V-(tert-butylamino)acetaldehyde diethyl acetal, 84500-89-0; do­
pamine hydrochloride, 62-31-7.
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Synthesis and A nalgesic Properties of Two Leucine-enkephalin Analogues 
Containing a Conform ationally Restrained N-Terrainal Tyrosine Residue
Trevor Deeks, Peter A. Crooks,* and Roger D. Waigh
D epartm ent o f Pharmacy, U niuersity of M anchester, M anchester, M13 9PL, U nited  K ingdom . Received N ovem ber 16, 1981
Two analogues of Leu-enkephalin, in which the terminal tyrosine- 1 residue has been replaced by a conformationally 
restrained tyrosine analogue, have been synthesized by classical solution methods, and their opiate agonist potencies 
on electrically stim ulated guinea pig ileum and mouse vas deferens preparations were determined in comparison 
with Leu-enkephalin. The restriction in the degree o f freedom of the tyrosine moiety in [(2-amino-6-hydroxy-2- 
tetralinyl)carbonyl]glycylglycylphenylalanyileucine methyl ester (3e) leads to a 7 to 8 times higher agonist activity 
at the m-receptor subtype in guinea pig ileum when compared to Leu-enkephalin, and an almost 30-fold decrease 
in potency, vs. Leu-enkephalin, on mouse vas deferens preparation. l(2-Amino-5-hydroxy-2-indanyl)carbonyl]- 
glycylglycylphenylalanylleucine methyl ester (2e) was inactive in the above tests. These results demonstrate the 
differential effect of restricting conformational flexibility on receptor recognition. Neither analogue had any analgesic 
properties when evaluated by the hot-plate test in mice after sc and icv administration.
The role o f enkephalins as natural endogenous ligands 
for the opiate receptor in the central nervous system is now 
well established.12 A large number of structural analogues 
of both leucine- and m ethionine-enkephalins ( lg  and If , 
respectively) have been synthesized over the past 5 years,
3
a, R' COOH; R' H; R 3 = OH
b, R ‘ ■= COOH; R' H; R 3 - OCH2C„H.
c , R ’ -  COOH; R1 COOCH2C6H s; R 3 O C H ,C ,H s
d, R 1 = CO-Gly-Oly-L-Phe-L-Leu-OCH,;
R ' = COOCHJC6H 5 ; R 3 = OCH2C«Hs
e, R 1 = CO-Gly-Gly-L-Phe-L-Leu-OCH,; R 2 = H;
R 3 = OH
f, R ‘ = CO-Glv-Gly-i. Phe-L-Leu-OH; R 2 = H;
R 3 = OH
g, R ’ = CO-GIy-Gly-L-Phe-L-Met-OH; R 2 = H;
R 3 = OH
h, R' = CO-D-Ala-Gly-L-Phe-L-Leu-OCH, ; R 2 = H;
R 3 = OH
which have been aimed a t affording active compounds 
having greater stability toward m etabolizing enzym es 
and/or to facilitate entry into the central nervous system  
after oral or peripheral adm inistration.3 Such structural 
m odifications include shortening or lengthening of the 
pentapeptide chain, substitution of individual amino acids 
by other amino acids, and chemical m odification of indi­
vidual am ino acids, particularly term inal am ino acids. 
Numerous conformational studies4 have been carried out 
that propose particular “active” conform ations for enke­
phalins at the analgesic receptor, and the structural 
analogy between enkephalins and m orphine5 has been  
discussed. This analogy em phasizes th e close corre­
spondence between the tyram ine m oiety in the morphine 
m olecule and the phenolic ring and am ino group o f the  
terminal tyrosine residue in the enkephalins. Since mor­
phine is a rigid m olecule, this infers th at the flexible 
tyrosine m oiety in the enkephalins interacts at the anal­
gesic receptor in a specific conformation that is presumably
* Address correspondence to College of Pharmacy, University 
of Kentucky, Lexington, Kentucky 40536-0053.
0022-2623/83/1826-0762$01.50 /0
stereochemically compatible with the tyramine unit in the 
rigid morphine molecule.
Leucine-enkephalin (Leu-enkephalin, I f)  has been 
crystallized and its structure determ ined.5 X-ray crys- 
tallographic data suggest that the orientation o f th e  tyr­
osine side chain is not unique, th e tyrosine aromatic ring 
experiencing disorder of either a static or dynamic nature. 
A solid-state N M R  investigation o f the Leu-enkephalin 
structure7 has recently shown th at in the polycrystalline  
state, the aromatic tyrosine ring is undergoing 180° flipping 
about the Cff- C y axis at a rate o f approxim ately 5 X 104 
s-1 at room temperature.
In order to  explore the effect o f a restriction in the 
degree of conformational freedom o f the tyrosine moiety  
on the biological properties of Leu-enkephalin analogues, 
we have synthesized two analogues, 2e and 3e, o f Leu- 
enkephalin in which the term inal tyrosine unit has been
(1) J. A. H. Lord, A. A. Waterfield, J. Hughes, and H. W. Kos- 
terlitz, “Opiates and Endogeneoua Opioid Peptides’’, H. W. 
Kosterlitz, Ed., North-Holland Publishing Co., Amsterdam, 
1976.
(2) S. H. Synder, Sci. Am., 236, 44 (1977).
(3) For a recent review, see J. Morley, Annu. Rev. Pharmacol. 
Toxicol., 20, 81 (1980), and references cited therein.
(4) S. Combrisson, B. P. Roques, and R. Oberlin, Tetrahedron  
Lett., 3455 (1976); H. E. Bleich, J. D. Cutnell, A. R. Day, R. 
J. Freer, J. A. Glasel, and J. F. McKelvy, Proc. Natl. Acad. Sci. 
U.S.A., 73, 2589 (1976); B. P. Roques, C. Garby-Jaurequiberry, 
and R. Oberlin, Nature {London), 262, 778, (1976); C. R. Jones, 
W. A. Gibbons and V. Garskey, ibid., 262, 779; (1976); E. R. 
Stimson, Y. C. Meinwald, and H. A. Scheraga, Biochemistry, 
18, 1661 (1979) and references cited therein; J. DiMaio, P. W. 
Schiller, and B. Belleau, “Peptides, Structure and Biological 
Function”, Proceedings of the American Peptide Symposium, 
6th, Georgetown University, Washington, DC, June 17-22, 
1978 E. Gross and J. Meienhofer, Eds., Pierce Chemical Co., 
Rockford, 1L, 1979; M. C. Summers and R. J. Hayes, FEBS 
Lett., 113, 99-101 (1980); D. Hudson, R. Sharpe, and M. 
Szelke, Int. J. Protein Res., 15, 122 (1980); J. S. Shaw and M. 
J. Turnbull, Eur. J. Pharmacol., 49, 313, (1978).
(5) A. S. Horn and J. R. Rodgers, N ature {London), 260, 795
(1976); B. E. Maryanoff and M. J. Zelesko, J. Pharm. Sci., 67, 
590 (1978); R. H. B. Galt, J. Pharm. Pharmacol., 29, 711
(1977); B. P. Roques, G. Gacel, M.-C. Fournie-Zaluski, B. Se- 
nault and J.-M. Lecomte, Eur. J. Pharmacol., 60, 109 (1979). 
J. DiMaio, and P. W. Schiller, Proc. Natl. Acad. Sci. U.S.A., 
77, 7162 (1980).
(6) G. D. Smith and J. F. Griffin, Science, 199, 1214 (1978); T. L. 
Blundell, L. Hearn, I. J. Tickle, R. A. Palmer, B. A. Morgan,
G. D. Smith, and J. F. Griffin, ibid., 205, 220 (1979).
(7) D. M. Rice, R. J. Wittebort, R. G. Griffin, E. Meirovitch, E. R. 
Stimson, Y. C. Meinwald, J. H. Freed and H. A. Scheraga, J. 
Am. Chem. Soc., 103, 7707 (1981).
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Table I. Opioid Activities o f  Leucine-enkephalin Analogues
com pd
guinea pig ileum® mouse vas deferens®
rel p otency  
(m orphine -  1 ) IDS„, nM (95% CL)
rel potency  
(m orphine = 1 ) ID S0, nM (95% CL)
2e 0.03 0 .0 2 b
3e 1.38 65.3  (3 2 .1 -1 1 0 .2 ) 2 .9 1 c 333 .4  (2 6 1 .7 -4 6 0 .1 )
l 6d 1.06 90.1 (3 1 .3 -1 9 0 .5 ) 55 .32 17 .3  (6 .8 -5 2 .4 )
l f e 0.11 5 04 .2  (2 9 7 .2 -8 8 1 .2 ) 89 .38 12.1 (5 .6 -2 0 .9 )
le^ no inhibn 8.31 201 .2  (1 4 2 .1 -2 4 3 .1 )
a Data are from  four determ inations for each com pound. b 37% naloxone reversible at 27 ng/m L. e 100% naloxone  
reversible at 27 pg/mL. d M ethionine-enkephalin. e Leucine-enkephalin. f Leucine-enkephalin m ethyl ester.
m odified by incorporating it in to different ring system s 
and in which the terminal leucine-5 residue has been es- 
terified to aid passage into the CNS. These analogues have 
been evaluated for analgesic activity on isolated guinea pig 
ileum m yenteric plexus m uscle and mouse vas deferens 
tissue and by the hot-plate te s t in mice after icv adm in­
istration.
C hem istry . 2-Amino-5-hydroxy-2-indancarboxylic acid 
(2a) and 2-am ino-6-hydroxy-tetralincarboxylic acid (3a) 
were prepared by literature m ethods8,9 and obtained as 
racemates. T he tetrapeptide H-Gly-Gly-Phe-Leu-OCH3
(4) was synthesized by classical solution m eth ods.12 
Preparation of the pentapeptides 2e and 3e were carried 
out as follows. The racemic tyrosine analogues 2a and 3a 
were N protected with carbobenzoxy chloride in base, 0  
protected with benzyl bromide, and then coupled with 
tetrapeptide 4 by using N ,N -dicyclohexylcarbodiimide and
1-hydroxybenzotriazole. Hydrogenolysis of the fully pro­
tected pentapeptides 2d and 3d and purification o f the 
resulting deprotected products by gradient buffer elution 
from carboxymethylceliulose at pH 5.1 afforded the pen- 
tapeptide m ethyl esters 2e and 3e. Both pentapeptides 
were obtained as a mixture o f their respective diastereo- 
isomers.
P h a rm a co lo g y . T he opiate agonist potential o f the 
pentapeptide methyl esters 2e and 3e were carried out on 
electrically stimulated guinea pig ileum and in mouse vas 
deferens preparations and are summarized in Table I. In 
the guinea pig ileum, the analgesic actions of enkephalins 
and opiates are m ediated by their interaction w ith the p 
receptor, whereas in mouse vas deferens, a different type 
of receptor, the 5 receptor, predom inates.10 T his latter 
receptor type interacts more strongly with opioid peptides 
than with the classical opiates.
Interestingly, a significant difference in potency was 
observed between 2e and 3e on both guinea pig ileum and 
mouse vas deferens preparations. T he restriction in the 
degrees o f freedom o f the tyrosine m oiety in 3e leads to 
a 7 to 8 times increase in agonist activity at the p-receptor 
subtype as compared to Leu-enkephalin, coupled with an 
alm ost 30-fold decreased potency, vs. Leu-enkephalin, on
(8) R. M. Render, B. H. Butcher, D. A. Buxton, and D. J. Howells, 
J. Med. Chem., 14, 892 (1971).
(9) S. N. Rastogi, J. S. Bindra, and N. Anand, Indian J. Chem., 
9, 1175 (1971).
(10) J. A. H. Lord, A. A. Waterfield, J. Hughes, and H. W. Kos- 
teriitz, Nature (London), 267, K.-J. Chang and P. Cuatrecasas, 
J. Biol. Chem., 254, 2610 (1979); B. K. Handa, A. C. Land, J. 
A. Lord, B. A. Morgan, M. J. Ranee, and C. F. Smith, Eur. J. 
Pharmacol., 70, 531 (1981); Y. Kiso, T. Miyazaki, T. Akita, and
H. Nakamura, ibid., 71, 347 (1981); G. Gacel, M.-C. Fournie- 
Zaluski, and B. P. Roques, FEBS Lett., 118, 245 (1980).
(11) E. G. Clark, “Isolation and Identification of Drugs in Phar­
maceutical Body Fluids and Post Mortem Material”, Phar­
maceutical Press, London, 1969, p 803.
(12) E. Vilkas, M. Vilkas, and J. Sainton, Int. J. Pept. Protein Res., 
15, 29 (1980).
the mouse vas deferens preparation. N either o f the two 
Leu-enkephalin analogues were active as analgesics when 
exam ined by the hot-plate test in m ice after sc and icv 
injection.
The results from the isolated tissue experim ents dem ­
onstrate the differential effect of restricted conformation 
on receptor recognition and indicate that opiate activity  
in Leu-enkephalin derivatives can be retained by re­
placement of the terminal tyrosine unit with a less flexible 
structural analogue. T he difference in potency o f alm ost 
two orders of magnitude between the indan derivative 2e 
and the tetralin derivative 3e is worthy of note. T he  
drastic decrease in potency of the indan derivative 2e 
compared to 3e suggests a preferred conformation for the 
tyrosine moiety in Leu-enkephalin at the p receptor. This 
finding warrants greater scrutiny. T he greater potency of 
the Leu-enkephalin analogue 3e at the p  receptor as com­
pared to the 5 receptor is in accord with other studies, 
which indicate that greater structural flexibility is required 
in analgesic molecules for 5-receptor recognition than for 
p-receptor binding. Shaw and Turnbull4 have reported 
that the pentapeptide 3h is about 7 tim es more potent as 
an agonist on the guinea pig ileum than on m ouse vas 
deferens preparations. Thus, 3e appears to resemble 
morphine, rather than Leu-enkephalin, in its receptor 
characteristics.
While the lack of in vivo activity o f 3e is unlikely to be 
due to inadequate CNS penetration, metabolic factors may 
play a significant role in this respect, since it is possible  
that 3e could be a substrate for am ino peptidase and /or  
enkephalinase enzymes.
Experim ental Section
Melting points were determined on a Reichert hot-stage mi­
croscope and are uncorrected. Microanalyses were performed by 
the Micro-analytical Laboratory, Department of Chemistry, 
University of Manchester. Analytical results obtained for all 
compounds were within ±0.4%  of the theoretical value unless 
otherwise stated. 'H NM R sepctra were recorded on a Varian 
HR 220 or a Varian SC 300 spectrometer and are quoted on the 
5 scale. IR spectra were recorded as KC1 disks, Nujol m ulls, or 
liquid films on a Perkin-Elmer 237 spectrophotometer. Mass 
spectra were determined on an A.E.I. MS9 spectrometer operating 
at a probe temperature o f 250 °C. Thin-layer chromatographic 
separations were carried out on 0.25-mm Polygram silica gel U V ^ . 
2-Amino-5-hydroxy-2-indancarboxylic acid8 and 2-amino-6 -hy- 
droxy-2-tetralincarboxylic acid9 were prepared by literature 
procedures. Amino acids and peptides with free amino functions 
were visualized by spraying with 1% ninhydrin in ethanol. N- 
Protected amino acids and peptides were visualized with 5% 
potassium dichromate in concentrated H aS 0 4, and amino acids 
and peptides possessing a phenolic hydroxy function were visu­
alized with Pauli’s reagent.11 Other compounds were visualized 
in iodine vapor. Hydrogenations were carried out on a Gallen- 
kampf hydrogenator operating at atmospheric pressure and room 
temperature.
Ion-exchange chromatographic separations of N-deprotected  
pentapeptides were carried out on Whatman CMC 52 carboxy- 
methylcellulose, prewashed with 0.5 N aqueous sulfuric acid,
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followed by 0.2 N aqueous ammonium acetate buffer adjusted 
to pH 5.1 with 0.880 specific gravity ammonia solution or glacial 
acetic acid und measured with a Pye-Unicam PW 9418 pH meter 
fitted with a Pye-Unicam 401 combined electrode. Ion-exchange 
columns were rim under slight pressure with a peristaltic pump 
set for an effluent output o f 100 m L/h. Column effluents were 
monitored by UV spectrophotometry at 280 nm with a Cecil CE 
202 spectrophotometer fitted with a 10-mm path-length flow­
through cell. Columns were eluted with 0.005-0.5 N gradient 
ammonium acetate buffer solutions at pH 5.1, and fractions were 
collected on an automatic fraction collector.
Amino acid analyses of peptides were performed on a Beck­
mann SPINCO Model 123 amino acid analyzer using ninhydrin 
as visualizer. The peptides were hydrolyzed in 6 N HC1 at 110 
°C for 24 h in a sealed, evacuated tube.
2-A m in o-5-(benzyloxy)-2-in d ancarb oxylic  A cid  (2b) and  
2-A m in o-6-(b en zy loxy)-2 -tetra lin carb oxy lic  A cid  (3b). As 
a general method, the appropriately substituted 2-amino-2- 
carboxylic acid (0.039 mol) in 2 N  NaOH solution (48 mL) was 
treated with copper sulfate (C uS04-5H20 ,  5.92 g, 0.024 mol) in 
water (24 mL). The mixture was mechanically stirred at 20-25  
°C for 30 min, and methanol (140 mL) and then benzyl bromide 
(5.90 mL, 0.041 mol) were added. Vigorous stirring was main­
tained at 22-25 °C for 15 h. The resulting blue copper complex 
was collected and washed with water (3 X  25 mL), methanol (2 
X  25 mL), and diethyl ether (2 X  25 mL), and the air-dried product 
(11.4 g) was stirred for 30 min at 50-60 °C with concentrated HC1 
(10 mL) and water (100 mL). While the solution was cooling, a 
brown colloidal gel formed, which was difficult to filter. This gel 
was triturated with 2 N hydrochloric acid (100 mL) and centri­
fuged at 48000 rpm for 10 min. The green supernatant was 
decanted, and the gel was again stirred at 50-60 °C for 30 min 
with concentrated hydrochloric acid (10 mL) and water (100 mL). 
The resulting supernatant was decanted, and the residue was 
air-dried and crystallized from glacial acetic acid to afford the 
appropriately substituted 2-amino-2-carboxylic acid.
2 -A m in o-5 -(b en zy loxy )-2 -in d an carb oxy lic  acid  hydro­
ch lorid e (2b) was prepared as described above from 2a as white 
crystals (5.0 g, 40%): mp 220-225 °C; IR (Nujol) 3350, 3145, 3090, 
3000, 1728, 1612, 1588 c m 1; NM R (Me2SO-d8, 60 MHz) 3.35 (m, 
4 H, C -l and C-3 protons), 5.03 (s, 2 H, benzyl CH2), 6.68-7 56 
(m, 8 H, aromatic protons), 8.95 (br s, 4 H, replaceable with DaO, 
NH 3 and COOH). Anal. (CI7H l7NOs-HCl) C, H, N.
2 -A m in o-6-(benzy loxy)-2 -tetra lin carb oxy lic  acid  hydro­
ch lorid e (3b) was prepared as described above from 3a as white 
crystals (5.6 g, 43%): mp 212-215 °C; IR (KC1) 3370, 3030, 2890, 
2650, 2550,1720,1605,1573 c m 1; NMR (TFA, 60 MHz) 2.55 (m, 
2 H, C-3 protons), 3.07 (m, 2 H, C-4 protons), 3.42 (m, 2 H, C-l 
protons), 5.19 (s, 2 H, benzylic CH2), 6.70-7.65 (m, 8 H, aromatic 
protons). Anal. (C18H 19N 0 3-HC1) C, H, N.
P rep ara tion  o f  IV -B en zy loxycarb on yl-P rotected  Am ino  
A cids. As a general method, the appropriate amino acid (0.011 
mmol) suspended in 2 N  NaOH solution (1000 mL) was heated 
on a steam  bath to dissolve the amino acid and then cooled in 
an ice bath to 0-5 °C, which caused the sodium salt of the amino 
acid to precipitate out. Carbobenzyloxy chloride (2.11 g, 0.012 
mol) was added dropwise to the cooled, stirred mixture, over 40 
min. The ice bath was then removed, and the mixture was stirred 
at room temperature for 30 h. T he reaction mixture was cooled 
to  0 -5  °C, and a further 2.11 g (0.012 mol) of carbobenzyloxy 
chloride was added dropwise. After a total reaction time of 60 
h, the mixture was carefully adjusted to pH 1 with 5 N HC1 and 
extracted with diethyl ether (2 X 100 mL). The combined organic 
extracts were dried, filtered, and evaporated to dryness, and the 
residue was crystallized from diethyl ether/petroleum  ether (bp 
30-40 °C) to afford the appropriate /V-benzyloxycarbonyl-prot 
ected amino acid.
5 - (B e n z y lo x y ) -2 - [ (b e n z y lo x y )c a r b a m id o ] - 2 - in d a n -  
carb oxy lic  acid (2c) was prepared as described above from 2b 
in 41% yield: mp 115.5-121 °C; IR (KC1) 3320, 2995, 2970, 2870, 
1738, 1705, 1650, 1604, 1580,1534 c m 1; NM R (CDC13, 60 MHz)
3.37 (m, 4 H, C- l and C-3 protons), 4.96 (s, 2 H, benzyl CH2), 5.03 
(s, 2 H, benzloxy CH2), 6.60-7.95 (m, 14 H, reducing to 13 H on 
addition of D 20 , NH and aromatic protons), 9.78 (br s, 1 H, 
replaceable with D20 , COOH); mass spectrum, m /e  417 (M+). 
Anal. (C25H23NOr>) C, H, N.
N otes
6 -(B en zy loxy)-2 -[(b en zyIoxy)carbam ido]-2 -tetra lin car-  
b oxylic  acid  (3c) was prepared as described above from 3b in 
52% yield; mp 150-156 °C; IR (KC1) 3380, 3255, 3050, 3020, 2945, 
2915, 2840,1718,1710,1685,1605,1545,1500 cm'1; NMR (CDC1;„ 
60 MHz) 2.28 (m, 2 H, C-3 protons), 2.82 (m, 2 H, C-4 protons), 
3.12 (m, 2 H, C -l protons), 4.98 (s, 2 H, benzyl CH2), 5.05 (s, 2 
H, benzyloxy CH2), 6.55-7.50 (m, 14 H, reducing to 13 H on 
addition of D 20 , N H  and aromatic protons), 9.00 (br s, 1 H, 
replaceable with D 20 , COOH). Anal. (C26H26N 0 5) C, H, N.
P rep aration  o f  N -P rotected  P en tap ep tid es. As a general 
method, a solution o f the appropriate racemic N-benzyloxy- 
carbonyl-protected amino acid (1.9 mmol), glycylglycyl-L- 
phenylalanyl-L-leucine methyl ester (4;12 1.9 mmol), and tri- 
ethylamine (2.2 mmol) in CH2C12 (50 mL) was cooled in an ice 
bath, and 1-hydroxybenzotriazole (3.9 mol) in CH2C12 (10 mL) 
was added dropwise. The mixture was stirred for 5 min before 
adding N ,N '-dicyclohexylcarbodiimide (2.1 mol) in CH2C12 (20 
mL) in one portion. The ice bath was removed, the reaction was 
stirred at room temperature for 56 h, the precipitated dicyclo- 
hexylurea was removed by filtration, and the filtrate was evap­
orated to a volume of 10 mL and then refiltered. The resulting 
filtrate was evaporated to dryness, dissolved in ethyl acetate (50 
mL), and washed with 1 N HC1 (50 mL), saturated N aH C 03 
solution (50 mL), and finally water (50 mL). The organic layer 
was then dried and filtered, and the filtrate was evaporated to 
dryness. The resulting gummy residue was triturated with diethyl 
ether to afford the appropriate N-protected pentapeptide as a 
buff-colored, amorphous solid, consisting of a mixture o f dia- 
stereoisomers.
[[5 -(B en zyIoxy )-2 -[(b en zy loxy )carb am id o]-2 -in d an y l]-  
carbonyl]glycylglycyl-L-phenylalanyl-i,-leucine m ethyl ester 
(2d) was prepared as above from 2c in 74% yield: mp 75-78 °C; 
TLC (silica) R, (ethyl acetate/m ethanol, 40:60) 0.64; IR (KC1) 
3175, 3050, 3020, 2945, 2920, 2860, 1718, 1682,1670, 1645, 1635, 
1535, 1525, 1518 c m 1; NM R (CHC13, 300 MHz) 0.86 (d, 6 H, 
leucine <5-(CH3)2], 1.57 (m, 2 H, leucine 0-CH2), 1.98 (m, 1 H, 
leucine y-CH2), 3.06 (d of d, 4 H, indan 1- and 3-protons), 3.29 
(m, 2 H, phenylalanine 0-CH2), 3.56 and 3.61 (2 s, 3 H, leucine 
OCH3), 3.72 (m, 2 H, one of glycine a -C H /s), 3.85 (m, 2 H, one 
of glycine a-CH2’s), 4.54 (m, 1 H, leucine u-CH), 4.68 (m, 1 H, 
phenylalanine a-CH), 5.01 (d, 4 H, 2 benzyloxy CH2’s), 6.72- 7.45 
(m, 18 H, aromatic protons), 6.82 (d, 1 H, replaceable with D20 , 
NH), 7.20 (m, 2 H, replaceable with D 20 , 2 NH), 7.72 (m, 1 H, 
replaceable with D20 , NH), 8.30 (m, 1 H, replaceable with DsO, 
NH). Anal. (C45H6IN 60 9) C, N; H: calcd, 6.4; found, 6.9.
[[6-(B enzyloxy)-2-[(benzyIoxy)carbam ido]-2-tetralinyl]-  
carbonyl]glycylglycyl-L-phenylalanyl-L-leucine m ethyl ester 
(3d) was prepared as above from 3c in 89% yield: mp 78-81 °C; 
TLC (silica) Rt (chloroform/methanol/acetic acid, 120:90:5) 0.68; 
IR (KC1) 3265, 3060, 3020, 2950, 2920, 2855,1758, 1688,1675, 1655, 
1545, 1525 c m 1; NMR (CDC13, 300 MHz) b 0.88 [d, 6 H, leucine
6-(CH3)2), 1.29 (m, 2 H, leucine /3-CH2), 1.56 (m, 1 H, leucine 
y-CH2), 1.94 (m, 2 H, tetralin 3-protons), 3.12 (m, 4 H, tetralin
1- and 4-protons), 3.34 (m, 2 H, phenylalanine (3-CH2), (s, 3 H, 
leucine OCH3), 3.87 (m, 2 H, one o f glycine a-C H /s), 3.93 (m, 2 
H, one of glycine a -C H /s), 4.51 (m, 1 H, leucine a-CH), 4.72 (m, 
1 H, phenylalanine a-CH), 5.02 (m, 4 H, benzyloxy CH2’s), 6.32 
(m, 1 H, replaceable with D20 , NH), 6.74-7.60 (m, 18 H, aromatic 
protons), 7.12 (m, 2 H, replaceable with D20 , 2 NH), 7.80 (m, 1 
H, replaceable with D20 , NH), 8.31 (m, 1 H, replaceable with D20 ,  
NH). Anal. (C46H53N 50 9) C, H, N.
S y n th es is  o f  U np rotected  P en tap ep tid es . As a general 
method, the appropriate N-protected pentapeptide (16 nmol) was 
dissolved in absolute ethanol (100 mL), 5% palladium on charcoal 
catalyst (0.5 g) was added, and the mixture was hydrogenated, 
with stirring, at room temperature and atmospheric pressure for 
20 h. The catalyst was then removed by filtration, the filtrate 
was evaporated to dryness, and the residue was dissolved in ethyl 
acetate (50 mL). The organic solution was extracted with 1 N 
hydrochloric acid (2 X  50 mL), followed by water (1 X  30 mL). 
The combined aqueous extracts were basified to pH 9 with solid 
sodium bicarbonate and back extracted with ethyl acetate (2 X  
50 mL). The combined ethyl acetate extracts were dried and 
filtered, the filtrate was evaporated to dryness, and the residue 
was purified on a carboxymethylcellulose column, eluting with 
ammonium acetate buffer, as previously described, to afford the
1 8 2
appropriate N-deprotected pentapeptide in buffer solution. The 
water and buffer salts were removed by freeze-drying, redissolving 
the residue in water (200 mL), and redrying on an Edwards EF03 
freeze-drying apparatus as 10 '1 to  10'2 torr.
[(2-A m ino-5-hydroxy-2-indanyl)carbonyl]glycylglycyl-L - 
p h en y la lan yb i.-leu c in e  m eth y l e s ter  (2e) was prepared as 
above from 2d in 13% yield: mp 173-176 °C; TLC (silica) Rf 
(chloroform/methanol/acetic acid, 120:90:5) 0.68; IR (KC1) 3395, 
3358, 3315, 3280, 3080, 3035, 2960, 2925, 2860, 1750, 1690, 1652, 
1635,1585,1558, 1540,1525,1508 c m 1; NM R (CDC13, 220 MHz)
0.82 [m, 6 H, leucine fi-(CH3)2], 1.50 (m, 2 H, leucine )i-CH2), 1.95. 
(m, 1 H, leucine y-CH), 2.62 (m, 2 H, phenylalanine 0-CH2), 2.96 
(m, 4 H, indan 1- and 3-protons), 3.62 (s, 3 H, leucine OCH3), 3.65 
(br a, replaceable with D20 ,  N H 2 and OH), 3.69 (m, 2 H, one of 
glycine a -C H /s), 3.75 (m, 2 H, one of glycine a-CH2’s), 4.24 (m,
1 H, leucine a-CH), 4.60 (m, I H, phenylalanine a-CH), 6.50-7.16 
(m, 8 H, aromatic protons), 8.03 (m, 2 H, replaceable with D20 ,
2 NH), 8.34 (m, 1 H, replaceable with D20 ,  NH) 8.42 (m, 1 H, 
replaceable with D20 , NH). Anal. (C30H3i)N5O7) C, H, N; amino 
acid (after acidic hydrolysis): 2a, 0.94; Gly, 2.03; Phe, 1.01; Leu, 
LOO.
[(2 -A m in o -6 -h y d r o x y -2 - te tr a l in y l)c a r b o n y l]g ly c y l -  
glycyl-L .-phenylalanyl-L -leucine m eth y l e s ter  (3e) was pre­
pared as above from 3d in 34% yield: mp 100-104 °C; TLC (silica) 
R/ (chloroform /m ethanol/acetic acid, 120:90:5) 0.70; IR (KC1)) 
3270, 3055, 3020, 2950, 2930, 2860, 1740, 1690,1675, 1645, 1565, 
1546, 1500 cm-'; NM R (CDC13, 300 MHz) 0.80 and 0.85 [2 d, 6 
H, leucine M C H 3)2], 133  (m, 2 H, leucine /?-CH2), 1.51 (m, 1 H, 
leucine y-CH), 1.56 (m, 2 H, tetralin 3-protons), 3.06 (m, 2 H, 
phenylalanine )3-CH2), 3.07 (m, 4 H, tetralin 1- and 4-protons), 
3.65 (s, 3 H, leucine OCH3), 3.82 (m, 2H, one of glycine a-C H /s), 
3.93 (m, 2 H, one of glycine a -C H /s), 4.30 (br s, 3 H, replaceable 
with D 20 ,  N H 2 and OH), 4.47 (m, 1 H, leucine a-CH), 4.70 (m,
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1 H, phenylalanine a-CH), 6.56-7.40 (m, 8 H, aromatic protons),
7.00 (m, 2 H, replaceable with D20 , 2 N H ), 7.42 (m, 1 H, re­
placeable with D20 , NH), 8.43 (m, 1 H, replaceable with D20 , NH). 
Anal. (C31H4IN r,0 7) C, H, N; amino acid (after acidic hydrolysis): 
3a no color reaction with ninhydrin; Gly, 2.08; Phe, 1.00; Leu, 1.00.
P h arm acology. Compounds were evaluated for analgesic 
properties in albino mice (Tuck, TFW strain) by the following 
procedures: in vitro testing was carried out by measuring the 
inhibition of electrically stimulated contractions of the guinea 
pig ileum myenteric plexus muscle using the method of Kosterlitz 
and Watt13 and by measuring the inhibition of mouse vas deferens 
tissue after stimulation wth twin rectilinear pulses 10-ms apart.u 
In vivo evaluation was carried out by using the mouse hot-plate 
test.16
A ck n o w led g m en t. We gratefully acknowledge the  
support of the Wellcome Research Laboratories in carrying 
out and releasing results o f the biological testing and the  
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R egistry  No. 2a, 33709-81-8; 2bH C l, 84802-81-3; 2c, 84802-
82-4; 2d, 84802-83-5; 2e, 73309-72-5; 3a, 84809-70-1; 3b H C l, 
84802-84-6; 3c, 84802-85-7; 3d, 84802-86-8; 3e, 73301-07-2; 4, 
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501-53-1.
(13) H. W. Kosterlitz and A. J. Watt, Br. J. Pharmacol. Chemo- 
ther., 33, 266 (1968).
(14) J. Hughes, H. W. Kosterlitz, and F. M. Leslie, Br. J. Phar 
macol., 53, 371 (1975).
(15) N. B. Eddy and D. Leimbach, J. Pharmacol. Exp. Ther., 107,
385 (1953).
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Synthesis  and S tereochem ical Analysis o f  2-Am ino-1.2,3,4-tetrahydro-  
1,4-m efhanonaphthalene-2-carboxylic  Acid, A Conformationally Rigid 
Phenylalanine Derivative
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A rigid phen ylalan in e analogu e, 2 -a m in o -1 ,2 ,3 ,4 -te tra h y d ro -1 ,4 -m eth a n o n a p h th a len e-2 -ca rb o x y lic  
acid (3 ) of un k n ow n  stereochem istry w a s  obtained  as th e  so le  am ino acid product from a Strecker 
reaction w ith 1 ,2 ,3 ,4 -te tra h y d ro -1 ,4 -m e th a n o n a p h th a len -2 -o n e  (4 ) . C om pound (4 ) w a s initially 
treated w ith benzylam ine and p otassiu m  cyan id e  to  g ive 2 -b en zy la m in o -2 -cy a n o -1 ,2 ,3 ,4 -te tra h y d ro -  
1 ,4 -m eth an on ap h th a len e  (5 ), w h ich  w a s  then converted  into 2 -b en zy la m in o -2 -ca rb o x a m id o -1 ,2 ,3 ,4 -  
te trah yd ro-1 ,4 -m eth an on ap h th alen e  (6 ) by treatm ent w ith  70% sulphuric acid. A /-D ebenzylation o f (6 )  
by hyd rogenolysis  w ith  5% p allad iu m -on -ch arcoal catalyst afforded 2 -a m in o -2 -ca r b o x a m id o -1 ,2 ,3 ,4 -  
te trah yd ro-1 ,4 -m eth an on ap h th alen e  (7 )  w h ich  g a v e  th e  acid (3 ) on  heating in 10% sulphuric acid. A 
stereochem ica l an a lysis  of (3 ) by 1H n.m.r., 13C n.m.r., and auto-correlated  tw o-d im en sion a l n.m.r. 
sp ectroscop y , determ ined the structure to  be 2 -e /7d o -a m in o -1 ,2 ,3 ,4 -te tra h y d ro -1 ,4 -m eth a n o n a p h -  
th a len e-2 -e x o -ca rb o x y lic  acid ( l a ) .  Treatm ent o f 1 ,2 ,3 ,4 -te tra h y d ro -1 ,4 -m eth a n o n a p h th a len e-2 -sp iro -  
5 '-h ydanto in  (9 ) [ob ta in ed  from a Bucherer reaction w ith  (4 )]  w ith aq u eou s barium hydroxide a lso  
afforded (1 a ) as th e  on ly  am ino acid product.
Structure-activity studies recently carried out in this laboratory 
have focused on the biological properties o f  rigid phenylethyl- 
amine systems in order to examine the importance o f  molecular 
conform ation on the biological activity. We have shown that 2- 
am ino substituted 1,2,3,4-tetrahydro-1,4-methanonaphthalenes 
represent rigid, pharmacologically interesting analogues o f  
more conformationally flexible phenylethylamine com pounds 
such as amphetamine,1 dopam ine,2 and noradrenaline,3 which 
may provide useful information about the nature o f  agonist- 
rcceptor interactions in these phenylethylamine systems. 
Recently, our interest has been directed towards the synthesis o f  
enkephalin derivatives containing a conform ationally restrained 
/V-terminal tyrosine residue, and we have shown 4 that replacing 
the l-tyrosyl moiety in Leu-enkephalin methyl ester with a (2- 
am ino-6 -hydroxy-1,2,3,4-tetrahydronaphthalenyl)-2-carbonyl 
grouping, leads to a 7 to 8 times higher agonist activity at the 
analgesic p receptor subtype in guinea pig ileum, when 
compared to Leu-enkephalin, and an almost 30-fold decrease 
in potency, versus Leu-enkephalin, on mouse vas deferens 
preparation, a tissue in which the 5-receptor predominates. The 
completely rigid aromatic amino acids ( l a )  and (2a), and ( l b )  
and (2b), thus represent conform ationally defined analogues o f  
phenylalanine and tyrosine, respectively, which should be o f  
potential value in determining the effect o f  completely 
restricting the conformational flexibility o f  the tyrosyl moiety in 
the enkephalins on receptor recognition.
This present report describes the synthesis and stereochemical 
analysis o f  2-am ino-1,2,3,4-tt,trahydro-l,4-methanonaphth- 
alene-2-carboxylic acid (3); this was obtained from a Strecker 
synthesis, starting from the previously reported ketone (4), and 
afforded only one o f  the two expected stereoisomers o f  (3) from 
this reaction sequence.
Results and Discussion
Treatment o f  l,2,3,4-tetrahydro-l,4-methanonaphtha!en-2- 
one (4) with benzylamine and K.CN in aqueous ethanolic HCI 




H 02C n h 2
a; R = H
b ; R = OH
product could be detected in the reaction mixture. This product 
could be hydrolysed to the carboxamido derivative (6) in 70% 
H 2S 0 4 solution. Hydrogenolytic TV-debenzylation o f com ­
pound (6 ) was carried out in ethanolic glacial acetic acid, using 
palladium ch arcoa l (5%) as catalyst, and afforded the product 
(7) in 45% yield. Hydrolysis o f  com pound (7) in 10% H 2S 0 4 
solution, heated at reflux for 5 h, afforded 2-am ino-1,2,3,4- 
tetrahydro-1,4-methanonaphthalene-2-carboxylic acid (3) in 
79% yield (Scheme).
In a rigid molecule such as (3) the Karplus relationship 5 can 
be applied to interpret the n.m.r. spectra and elucidate the 
stereochemistry at C-2. It is clear from D reiding models o f  the 
tw o possible isomers o f  the acid (3) that the largest 37CH vicinal 
coupling o f  the carbonyl carbon should be to the 3-H which is 
cis to it. I f the carboxy group has the exo  geometry as in 
com pound ( la )  this coupling would be to the exo  3-H, while if  it 
is endo as in (2a), then coupling would be to the endo 3-H; 1-H is 
not at a favourable angle for coupling to the carbonyl carbon in 
either configuration o f  the carboxy group. Selective decoupling 
o f  the doublet o f  doublets centred at 3.04 p.p.m. in the ‘H n.m.r. 
spectrum o f  com pound (3) causes the carbonyl doublet in the 
proton coupled l3C n.m.r. spectrum to collapse to a singlet (see 
Figure I ). Hence, the problem o f  assigning the configuration o f  
the carboxy and am ino groups in the acid (3) is narrowed down  
to  being able to unequivocally assign the exo  and endo 3-H.
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(4 ) (5 )  ( 6 )
CQJy- -  03= — 03='
(9 )  ( 3 )  (7 )
Scheme. Reagents: PhCH2NH2, KCN; ii. H2S 04; iii, Pd-C 5%, EtOH; iv, NH4C 0 3, K.CN; v. Ba(OH)2; vi, 10% H 2S 0 4
I 1 p.p.m . 1
Figure 1 .13C N.m.r. spectrum of compound (3) in (CD3)2SO-DCl with 
the scale expanded in the region of 173 p.p.m., (a) showing the 3J(CH) 
vicinal coupling of the carbonyl carbon, and (b) showing collapse of 
the \7(CH) coupling after selective decoupling o f the doublet of 
doublets centred at 3.04 p.p.m. in the lH n.m.r. spectrum of (3)
The aliphatic region o f the 'H n.m.r. spectrum o f (3) in 
deuteriotrifluoroacetic acid ([2H2]-TFA) shows resonances in 
six regions, each of these signals integrating for one proton. 
These regions consist o f a doublet of doublets (J  2.78, 13.9 Hz) 
with a central chemical shift of 3.04 p.p.m., a broad doublet 
centred at 2.67 p.p.m. (J  10.31 Hz), a doublet with unresolved 
fine structure centred at 2.18 p.p.m. (J  10.31 Hz), and a doublet 
of doublets centred at 1.79 p.p.m. (J  3.96 Hz, 13.9 Hz), and two 
broad singlets at 3.95 and 3.70 p.p.m. The methylenes at C-3 and 
C-9 should each have large geminal coupling and give rise to AB 
patterns. Only vicinal couplings are possible at the bridgeheads, 
and of these the coupling from 4-H to the exo 3-H should be the 
largest because of the small dihedral angle between these 
hydrogens.
An auto-correlated two-dimensional (2-D) n.m.r. experi­
ment6 was run and a contour plot o f the results is shown in 
Figure 2. Two AB patterns are readily identifiable from the off- 
diagonal peaks. One consists o f the resonances at 3.04 and 1.79 
p.p.m.; the other shows the resonances at’2.67 and 2.18 p.p.m.
There is a coupling of 3.79 Hz from the bridgehead signal at 3.70 
p.p.m. to the doublet at 3.04 p.p.m. This is the largest coupling of 
the bridgehead hydrogens and the doublet at 3.04 p.p.m. is 
therefore assigned to the exo 3-H. The resonance at 1.79 p.p.m. 
is assigned to the endo 3-H leaving the remaining pair of 
resonances attributable to the 9-H’s. These can be distinguished 
by further analysis o f the 2-D experiment which shows a 
coupling between the endo 3-H at 1.79 p.p.m. and the resonance 
at 2.18 p.p.m. of 3.96 Hz. This would be the expected long range 
W-coupling from the endo 3-H to the syn 9-H, leaving the 
remaining resonance at 2.67 p.p.m. to be assigned to the anti 9-
H. Because the syn 9-H is juxtaposed over the aromatic ring, 
whereas the anti 9-H is not, the ring anisotropy would tend to 
push the chemical shift of the syn 9-H more upfield than the anti 
9-H.
Since the carbonyl carbon resonance collapses to a singlet on 
irradiation of the 3.04 p.p.m. resonance in the ‘H n.m.r. 
spectrum, and is unaffected upon irradiation o f the 1.79 p.p.m. 
resonance, the carboxy group must be in the exo-configuration, 
and the stereochemistry of compound (3) is as indicated in 
structure (la). The large downfield shift o f the exo 3-H is 
probably due to a preference for the conformation in which it 
lies in the plane of the carbonyl group. The shift assignments 
and couplings described above and additional confirmation 
from 2-D J  spectra 6 are summarized in the Table.
The assignment o f exo-stereochemistry to the 2-carboxy 
group in (3) indicates that in the initial reaction o f (4) with 
benzylamine, attack o f cyanide ion on the resulting imino 
intermediate (8) occurs at the exo-face of the molecule to give 
the kinetically more favourable 2-en</o-benzylamino-2-exo- 
cyano stereoisomer o f (5). From similar reactions with other 
cyclic ketones,7 10 including norbornanone9 and the related 
ketone, l,4-dihydro-l,4-ethanonaphthalen-2(3/7)-one11 (10), 
mixtures o f both exo- and endo-amino acids are obtained. The 
present results obtained with compound (4) are interesting in 
that, to our knowledge, they represent the first example of 
stereochemical specificity in a Strecker reaction involving a 
cyclic ketone.
We have also observed that the acid (la) is the only isomeric 
product obtained from the Bucherer reaction of compound (4) 
with ammonium carbonate and KCN followed by barium 
hydroxide hydrolysis o f the intermediate spirohydantoin (9). 
Again, these results are somewhat surprising in view o f a report 
on the formation o f nearly equal mixtures o f isomeric 
hydantoins from the reaction o f (10)11 with ammonium 
carbonate and KCN under similar conditions. So far, we have 
been unable to detect the presence o f the isomeric amino acid 
(2a) in the reaction products from either of the above synthetic 
routes.
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Figure 2.200 MHz Auto-correlated two-dimensional1H n.m.r. spectrum of compound (3) in TFA
( 8 )
Experimental
M.p.s were measured on
COT0
( 1 0 )
a Reichert hot-stage microscope.
Recrystallization solvents arc shown in parentheses. Yields of
solids refer to products obtained prior to recrystallization. I.r. 
spectra were recorded on a Perkin-Elmer model 237 grating 
spectrophotometer.
‘H N.m.r. spectra were recorded on Perkin-Elmer R24 (60 
MHz) or Varian XL-200 (200 MHz) spectrometers; 13C n.m.r. 
spectra (50.3 MHz) and two dimensional n.m.r. spectra were 
recorded on a Varian XL-200 spectrometer. As expected, the 
n.m.r. parameters are solvent and pH dependent. Microanalyses 




T a b le .  N.m.r. parameters for the acid (3)
8„  J<„l H z  5c /p .p .m .
([2H,]l-TFA) (C2H,]-TFA) [(CD3)2SO-DCl]
1-H 3.15 2*^ 2-cxo,3-endo 13.9(3) C-l 52.4
3-exo-H 3.04 1 JJ 9-ant 1,9-syn 10.30 C-2 63.8
3-endo-H 1.79 y 3.„„,4 3.78 C-3 49.4
4-H 3.15 J$-cnAo.9-syn 3.96 C-4 43.5
9-anti-H 2.67 J73.m4o.4 (0.48) C-4a 141.0
9-syn-H 2.18 3Ji.9-,yn 1.26 C-5° 127.0
•11.9-anti 1.76 C-6b 122.3





a-b Signals may be interchanged.
2-Benzylamino-2-cyano-1,2,3,4-tetrahydro-1,4-methanonaph­
thalene (5).— 1,2,3,4-Tetrahydro-1,4-methanonaphthalen-2-
one (4 )12 (1 g, 6.0 mmol) in ethanol (20 ml) was added to a 
solution of benzylamine (0.75 g, 7.0 mmol) in water (20 ml), 
made just acid with dilute HC1. The solution was cooled to 0 °C 
in an ice sodium chloride bath, and KCN (0.49 g, 8.0 mmol) in 
water (20 ml) was added dropwise, during 5 min, with vigorous 
stirring. The cooling bath was removed and the solution stirred 
at room temperature for 24 h, during which time the oily 
precipitate, formed after addition o f the KCN, had crystallized. 
The crystals were collected by filtration affording
2-benzylamino-2-cyano-\,2,3,4-tetrahydro-\,4-methanonaphtha- 
lene (5) (1.49 g, 86%), m.p. 93— 100 °C, vmo, (KC1) 2 210 cm 1 
(C=N); 5(CDC13) 1.12(1 H, s, exchangeable with D 2O.NH), 1.21 
(1 H, d of d, J  3 and 12 Hz, exo 3-H), 2.09 (2 H, m, 9-H), 2.63 (1 
H, d o f d ,./ 4 and 12 Hz, endo 3-H), 3.36(1 H,m, 1-H), 3.77(1 H, 
m, 4-H), 3.83 (2 H, s, benzyl CH2), and 6.96— 7.50 (9 H, m, 
aromatic H) (Found: C.83.2; H.6.5; N, 10.2. C „ H 18N 2 requires 
C, 83.2; H, 6.6; N, 10.2%).
2-Benzylamino-2-carboxamido-1,2,2,4-tetrahydro-1,4-meth- 
anonaphthalene (6).—Compound (5) (1.3 g) was stirred with 70% 
H2S 0 4 (20 ml) at room temperature for 1 h and the mixture 
poured onto crushed ice (100 g). When all the ice had melted the 
resulting mixture was filtered and the filtrate adjusted to pH 3 
with 5M-NaOH solution. A white precipitate was formed, which 
was collected by filtration at the pump and crystallized from 
diethyl ether to afford 2-henzylamino-2-carboxamido-1,2,3,4- 
tetrahydro-1,4-methanonaphthalene (6) (950 mg, 69%), m.p. 
145— 148 °C, vmax (KC1) 1 655 and 5 858 c m 1, 5(CDC13) 1.20 
(1 H, d of d, endo 3-H), 2.22 (2 H, m, 9-H), 2.70 (1 H, d of d, exo 3- 
H), 3.31 (1 H, m, 1-H), 3.57 (2 H, d o f d, benzyl CH2), 3.69 (1 H, 
m, 4-H), 6.08 (3 H, br s, NH), 6.84— 7.55 (4 H, m, ArH), and 7.14 
(5 H, s, aromatic H o f benzyl group) (Found: C, 77.6; H, 6.9; N, 
9.2. C 19H20N 2O-l/8H2O requires C, 77.5; H, 6.9; N,9.5%). (This 
trace of water was not removable on prolonged drying.)
2-Amino-2-carboxamido-\,2,3,4-tetrahydro-\,4-methano- 
naphthalene (7).—Compound (6) (8.9 g) was dissolved in 
absolute ethanol (100 ml), and palladium-charcoal catalyst 
(5%, 2 g) was added. Glacial acetic acid (20 ml) was added to the 
reaction mixture, and the mixture was hydrogenated with 
stirring at room temperature and atmospheric pressure 
overnight, until no further uptake o f hydrogen was observed. 
The catalyst was removed by filtration and washed with hot 
96% ethanol. The combined filtrate and washings were 
evaporated to dryness and the residue partitioned between 5m- 
HC1 (200 ml) and ethyl acetate (100 ml). The acidic aqueous
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layer was separated, basified with 4M-NaOH solution to pH 9 
and extracted with ethyl acetate (2 x 100 ml). There remained 
some insoluble material in the aqueous layer which was 
collected by filtration. The combined ethyl acetate extracts were 
dried, filtered, evaporated to dryness, and the residue 
crystallized from diethyl ether. Both the insoluble material 
and the crystallized material from the extract were identified 
as 2-amino-2-carboxamido-1,2,3,4-tetrahydro-1,4-methanonaph­
thalene (7) (2.79 g, 45%), m.p. 174— 177 °C. vmox (KC1) 3 350 
(NH2), 1 665, 1 653, 1 575, 1 560, and 1 540 cm4 ; 8(CDC13)
0.93(1 H, d of d, endo 3-H), 2.20 (2 H, m, 9-H), 2.96(1 H ,d ofd , 
exo 3-H), 3.37 (1 H,m, 1-H), 4.63 (1 H, m, 4-H), 5.75 (4 H, br s, 
NH), and 6.55— 7.90 (4 H, m, aromatic H) (Found: C, 67.8; H, 
6.8; N, 12.9. C l2H l4N 20  requires C, 68.2; H, 7.1; N, 13.2%).
1,2,3,4- Tetrahydro-1,4-methanonaphthalene-2-spiro-5’-hy- 
dantoin (9).—A solution of ammonium carbonate (28.6 g, 0.18 
mol) in 50% aqueous ethanol (200 ml) was added to a solution 
of (4) (11.1 g, 0.07 mol) in 50% aqueous ethanol (40 ml), in a two­
necked flask fitted with a reflux condenser and a dropping 
funnel. The flask was warmed to 50 °C in an oil-bath and a 
solution o f KCN (4.6 g, 0.072 mol) in water (40 ml) was added in 
small portions during 1 h. The reaction mixture was stirred 
magnetically and the temperature held at 58—60 °C for 5 h. The 
ethanol was then removed by evaporation and the aqueous 
mixture was allowed to cool and extracted with ethyl acetate (3 
x 200 ml). The combined organic extracts were dried, filtered, 
and evaporated to dryness and the residue was triturated with 
diethyl ether to afford white crystals o f 1,2,3,4-tetrahydro-1,4- 
methanonaphthalene-2-spiro-5'-hydantoin (9), m.p. 22S—229 °C 
(methanol-diethyl ether); vmox (KC1) 1 785, 1 775, and 1 725 
c m 1; 5[(CD 3)2SO] 1.28 (1 H, d o f d, J  5 and 14 Hz, endo 3-H),
1.63 (1 H, m, syn 9-H), 2.22— 2.80 (2 H, m, anti 9-H and exo 3- 
H), 3.38— 3.57 (2 H, m, 1-H and 4-H), 6.77 (1 H, br s, 
exchangeable with D 20 , 1 '-NH), 7.18 (4 H, m, aromatic H), and 
10.60 (1 H, br s, exchangeable with D 20 , 3'-NH) (Found: C, 
68.3; H, 5.4; N, 11.8. C l3H 12N20 2 requires C, 68.4; H, 5.2; N, 
12.3%). The aqueous layer was carefully acidified to pH 2 with 
concentrated H2S 0 4 to afford a further crop of the above 
product (total yield 12.07 g, 76%).
2-endo -Amino-1,2,3,4-tetrahydro-\,4-methanonaphthalene-2- 
exo-carboxylic Acid ( la ).— Method a. A solution o f (7) (2.5 g) in 
10% H2S 0 4 (100 ml) was heated at reflux, for 5 h. The reaction 
mixture was then filtered while still hot and the filtrate was 
cooled in an ice-bath, basified to pH 6 with 4M-NaOH solution, 
evaporated under reduced pressure to a low volume (ca. 20 ml), 
and allowed to cool to afford white crystals of 2-cndo-amino-
1,2,3,4-tetrahydro-l,4-methanonaphthalene-2-exo-carboxylic 
acid (la ) (1.98 g, 79%) m.p. 227.5—229.5 °C, vm„(K C l) 1 660, 
1 645, 1 625, and 1 540 cm 5(D20 ; 60 MHz) 1.48 (1 H, d of d, 
J 4 and 14 Hz, endo 3-H), 2.25 (2 H, m, 9-H), 2.95 (1 H, d of d, J  4 
and 14 Hz, exo 3-H), 3.58 (1 H, m, 1-H), 3.76 (1 H, m, 4-H), and
7.37 (4 H, m, aromatic H). The hydrochloride salt was prepared 
from a portion o f the product and had m.p. 228—231 °C (de­
comp.) (Found: C, 67.8; H, 6.8; N, 12.9. C 12H 13N 0 2-HC1- 
1/2H20  requires C, 68.2; H, 7.1; N, 13.2%).
M ethod b. Compound (9) (6.63 g, 0.029 mol), barium 
hydroxide [Ba(OH)2-8H2Oj (17.6 g, 0.056 mol), and water (100 
ml) were placed in a two-necked flask fitted with a nitrogen inlet 
and a reflux condenser, and the mixture was heated under reflux 
under nitrogen for 70 h. The mixture was then filtered while hot, 
and the collected solid washed with an equal volume o f water. 
The combined filtrate and washings were saturated with carbon 
dioxide, heated to the boiling point, and refiltered. The filtrate 
on cooling afforded white crystals of (9) (140 mg, 2% returned). 
The mother-liquors were evaporated to ca. 50 ml to afford white 
crystals (4.69 g, 80%), which had identical spectral properties
187
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(i.r., l H n.m.r., and I3C n.m.r. spectra) with ( la )  prepared via 
method a above.
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Abstract □ Three analogues of leucine enkephalin, in which the terminal 
tyrosine-1 residue has been replaced by conformationally restrained aromatic 
amino acids, have been synthesized by classical solution methods. Their opiate 
agonist potencies on electrically stimulated guinea pig ileum and mouse vas 
deferens preparations were determined and compared with morphine. Met 
enkephalin, and Leu enkephalin. None of these analogues had analgesic 
properties when evaluated on the above tissue preparations or when evaluated 
by the hot-plate test in mice after subcutaneous and intracercbrovcntricular 
administration.
Keyphrases □ Leucine enkephalin—conformationally restrained analogues, 
synthesis, analgesic activity □ Analgesics—evaluation of conformationally 
restrained leucine enkephalin derivatives, synthesis
A milestone in neurocheinical research during the last 
decade has been the elucidation o f the role of enkephalins as 
natural endogenous ligands for the opiate receptor (1 ,2 ). Since 
this discovery, the synthesis o f a mullitiude o f structural an­
alogues o f leucine and methionine enkephalins (Ig and Ih, 
respectively) have been reported (recent review, 3), some o f 
which are more potent analgesics and/or possess greater in 
vivo  stability than the natural opiate ligands. These synthetic 
analogues have resulted from modifications o f the parent 
m olecules, such as shortening or lengthening o f the penta­
peptide chain (4, 5), substitution o f individual amino acids by 
other amino acids (5 -1 1 ), and chemical modification of indi­
vidual amino acids (12 -14 ).
Preferred conformations o f enkephalin m olecules at anal­
gesic receptors have been suggested, based on data from con­
formational studies involving both spectroscopic measurements 
and structure-activity considerations (1 5 -3 3 ). These studies 
have attempted to relate the structure o f the terminal tyrosine 
residue in the enkephalin molecule to the tyramine moiety 
present in the morphine molecule. Since morphine is a con­
formationally rigid molecule, this implies that the conforma­
tionally “loose” tyrosine residue in the enkephalin may interact 
at opiate receptors in a specific conformation which is related, 
stereochem ically, to the rigid tyramine moiety present in the 
morphine molecule.
As part o f a study designed to evaluate the importance o f 
the tyrosine conformation in the enkephalins on analgesic 
activity and receptor recognition, we have initiated a prelim­
inary investigation into the synthesis of Leu enkephalin^de- 
rivatives in which the terminal tyrosine unit has been replaced 
by a variety o f conformationally restrained aromatic amino 
acids and in which the terminal leucine-5 residue has been 
esterified to aid passage into the central nervous system. The 
investigations described in this report are restricted to the 
preparation o f Leu enkephalin analogues containing a 
nonhydroxylated aromatic amino acid in place of the tyrosine-1 
residue in order to initially determine the feasibility of pre­
paring pentapeptides such as I le -V e , with a bulky terminal
amino acid unit, via  classical solution methods, before em ­
barking on the preparation of the synthetically more difficult 
aromatic hydroxy derivatives llf -V f, which were regarded as 
the ultimate target compounds.
W e now report the synthesis of the Leu enkephalin ana­
logues l ie  IVe and their evaluation as analgesic agents on 
isolated guinea pig ileum myenteric plexus muscle, mouse vas 
deferens tissue, and by the hot-plate test in mice after subcu­




a R' = COOH, R2 = R 3 = H. 
b R ‘,R 2 = CO— NHCO— , R 3 = H. 
c R 1 = COOH, R 2 = CO— O— CH,Ph, R 3 = H. 
d R 1 = CONHGlyGIyL— PheL— Leu OCH3,
R2 = CO— OCH,Ph, R 3 = H. 
c R ‘ = CONHGlyGIyL— PheL— LeuOCLt,, R 2 = R 3 = H. 
f R* = CONHGlyGIyL—PheL— LeuOCHa, R 2 = H, R 3 = OH. 
g R ‘ = CONHGlyGIyL— PheL— LeuOH, R 2 = H, R 3 = OH. 
h R 1 = CONHGlyGIyL— PheL—M etOH, R 2 = H, R 3 = OH.
Hj N GlyG ly L— PheL— Leu OCH 3 
VI
EXPERIMENTAL
Melting points were determined on a hol-stagc microscope1 and arc un- 
corrcetcd. Microanalyscs were performed by the Micro-analytical Laboratory, 
Department of Chemistry, University of Manchester, analytical results ob­
tained for all compounds were within ±0.4% of the theoretical value unless 
otherwise staled. 'H-NMR spectra were recorded on a spectrometer2 and arc 
quoted in ppm on the b  scale. nC-NMR spectra were recorded on a spec­
trometer3. IR spectra were recorded as KCI disks, nujol mulls, or liquid films
1 R e ic h e r t .
2 M o d e l H R  2 2 0  o r  S C  3 0 0 ; V a r ia n  I n s tr u m e n t s .
1 M o d e l W P  8 0 ; B ru k c r .
,NHR2 NHR2
R2HN.
0022-3549/ 84/ 0400-0457$01.00/0 
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on a spectrophotometer4. Mass spectra were determined on a spectrometer* 
operating at a probe temperature of 250°C. TLC separations were carried 
out on 0.25-mm silica gel6. 2-Aminoindan-2-carboxylic acid (34) and (±)-
2-aminotclralin-2-carboxylic acid (35) were prepared by literature procedures. 
Amino acids and peptides with free amino functions were visualized by 
spraying with 1% ninhydrin in ethanol. /V-Protcctcd amino acids and peptides 
were visualized with 5% potassium dichromatc in concentrated H2SO4; other 
compounds were visualized in iodine vapor. Hydrogenations were carried out 
on a hydrogcnator7 operating at atmospheric pressure and room tempera­
ture.
Ion-exchange chromatographic separations of /V-dcprotccted penlapeptides 
were carried out on carboxymethylcellulose8, prewashed with 0.5 M sulfuric 
acid followed by 0.2 M ammonium acetate buffer adjusted to pi I 5.1 with 0.88 
M ammonium hydroxide or glacial acetic acid and measured using a pH 
meter9 fitted with a combined electrode10. Ion-exchange columns were run 
under slight pressure using a peristaltic pump set for an effluent output of 100 
mL/h. Column effluents were monitored by UV spectrophotometry at 280 
nm using a spectrophotometer11 fitted with a 10-mm path length flow-through 
cell. Columns were eluted with 0.005-0.5 M gradient ammonium acetate 
buffer solutions at pH 5.1, and fractions were collected on an automatic 
fraction collector.
Amino acid analyses of peptides were performed on an amino acid ana­
lyzer12 using ninhydrin as visualizcr. The peptides were hydrolyzed in 6 M
l-ICI at I I0°C for 24 h in a sealed, evacuated tube.
Synthesis o f endo-2-Aminobeiizonorborneii-2-carboxylic Acid (IVa) 
Spiro[benzonorbornen-2,5'-hydantoin)(IVb)—A solution of ammonium 
carbonate (28.6 g, 0.18 mol) in 50% aqueous ethanol (200 mL) was added to 
bcnzonorborncn-2-onc (36) (11.1 g, 0.07 mol) in 50%aqueous ethanol (40 
mL). The mixture was warmed to 50°C and a solution of potassium cyanide 
(4.6 g, 0.072 mol) in water (40 mL) was added in small portions over a l-h 
period. The mixture was stirred at 58-60°C for 5 h. The ethanol was removed 
under reduced pressure, and the aqueous residue was extracted with ethyl 
acetate (3 X 200 mL). The combined organic extracts were dried, filtered, 
and evaporated to dryness, and the residue was triturated with ether to afford 
white crystals of IVb mp 225 229°C. The aqueous layer was acidified to pH 
2 with concentrated sulfuric acid to afford an additional product for a total 
of 12.07 g76%). This compound had identical spectrometric properties (IR, 
NMR) to an authentic sample recently prepared via a Slrecker synthesis 
(48).
cnAa-2-Aminobenzonorbornen-2-carboxylic Acid (/La)—A mixture of 
spiro(bcnzonorborncn-2,5'-hydantoin] (IVb) (6.63 g, 0.029 mol), barium 
hydroxide [Ba(OH)2-8H20 , 17.6 g, 0.056 mol], and water (100 ml.) was 
heated under reflux, in an atmosphere of nitrogen, for 70 h and then filtered 
while hot. The collected solid was washed with an equal volume of water, and 
the combined filtrate and washings were saturated with carbon dioxide, heated 
to boiling point, and refiltered. The filtrate (on cooling) afforded white crystals 
of IVb ( 140 mg, 2% recovery). The mother liquors were evaporated to ~50  
mL to afford white crystals of IVa (4.69 g, 79%), mp 227.0-229.5°C [lit. (48) 
mp 227.5-229.5°C]. The hydrochloride salt was prepared from a portion of 
the product and had mp 228-231°C (dec.). n C-NMR (CH3OH): 173.8 (s, 
C 02H), 149.5 and 141.8(2 X s, C-4a and C-8a), 129.5, 128.0, 125.2, and 
123.1 (4 X d, ArC), 65.1 (s, C-2), 53.9 (d, C-4), 51.1 (d, C-1), 44.9 (t, C-9), 
and 39.8 (t, C-3): m/z 203 (M+).
Preparation of /V-Benzyloxycarbonyl Amino Acids— As a general method, 
the appropriate amino acid (0.011 mol) suspended in 2 M NaOH solution (100 
mL) was heated on a steam bath to dissolve the amino acid and then cooled 
in an ice bath to 0-5°C, which caused the sodium salt of the amino acid to 
precipitate. Carbobenzyloxy chloride (2.11 g, 0.012 mol) was added in a 
dropwise manner to the cooled, stirred mixture over 40 min. The ice bath was 
then removed, and the mixture was stirred at room temperature for 30 h. The 
mixture was cooled to0-5°C , and a further 2.11 g (0.012 mol) of carboben­
zyloxy chloride added in a dropwise manner. After 60 h the mixture was 
carefully adjusted to pH I with 5 M HC1 and extracted with ether (2 X 100 
mL). The combined organic extracts were dried, filtered, and evaporated to 
dryness, and the residue was crystallized from ether-petroleum ether (bp 
30-40°C) to afford the appropriate /V-bcnzyloxycarbonyl amino acid.
2-Benzyloxycarbamidoindan-2-carboxylic acid ( l ie ) -  This compound 
was prepared as described above from I la in 32% yield, mp 46.5- 53.0°C. IR
4 M o d e l 2 3 7 ; P c r k in - E lm c r .
5 A .E .I .  m o d e l M 5 9
6 P o ly g ra m  s il ic a  ge l U V 254.
7 G a l le n k a m p f .
» W h a tm a n  C M C  52.
'> M o d e l P W  9 4 1 8 ; P y c  U n ic a m .
10 P y e  U n ic a m  4 0 1 .
11 C e c i l  C E  2 02 .
12 M o d e l 123 ; B e c k m a n n  S P I N C O .
(Nujol): 1748, 1663, 1545, and 1532 c m 1; 'H-NMR (DMSO-d6): 5 3.48 
(m, 4, C I and C-3 H), 5.04 (s, 2, bcnzyloxy CHj), 7.05-7.45 (m, 9, ArH), 
7.88 (s, I, exchangeable with D20 , NH), and 9.10 ppm (brs, I, exchangeable 
with D20 , COOH); m/z 311 (M+).
Anal. -C alc, lor C,gHnNO«: C, 69.5; H, 5.5; N, 4.5. Found: C, 69.9; H, 
5.8; N, 4.2.
2-Benzyloxycarbamidotetralin-2-carboxylic Acid ( ll lc )—Compound 
Illc was prepared as described above from Ilia in 19% yield, mp 131.0- 
137.5°C. IR (KCI): 1772, 1728, 1688, 1680, 1580,and 1526cm '; 'H-NMR 
(CDCI3): 5 2.24 (m, 2, C-3 H), 2.80 (m, 2, C-4 H), 3.18 (m, 2, C-1 H), 5.05 
(s, 2, bcnzyloxy CH2), 5.30 (brs. I, exchangeable with D20 , NH), 6.90-7.50 
(m, 9, ArH), and 10.32 (br s, 1, exchangeable with D20 , COOH); m/z 325 
(M+).
Anal.—Calc, for C,9H |9N0 4: C. 70.2; H, 5.8; N, 4.3. Found; C.70.1, H.
5.9, N, 4.0.
cndo-2-Benzyloxycarbamidobenzonorbornene-2-carboxylic Acid (IVc) 
—This compound was prepared as described above from IVa in 27% yield, 
mp90-93°C. IR (KCI): 1742, 1686, 1641, 1600,and 1582cm 'H-NMR 
(CDCI3): b 1.28 (d of d. I, J = 3.and 12 Hz, C-3 endo-H), 1.91 and 2.26 (2 
X d, AB, J = 9 Hz, C-9 H), 2.95 (d ofd, I, J =  4 and 12 Hz, C-3 exo-H), 3.37 
(m, 1.C-4H), 3.84 (m, l.C -l H), 4.80 (brs, I, exchangeable with D2O.NH),
5.00 (d,2, J = 4 Hz, bcnzyloxy CH2), 6.95-7.50 (m,9, ArH), and 11.05 ppm 
(s, I, exchangeable with D20 , COOH).
Anal.— Calc, for C20H25NO5: C, 71.2; H, 5.6; N, 4.2. Found: C, 71.6; H, 
5.8; N, 4.0.
Preparation of /V-Prolected Penlapeptides—As a general method, a solution 
of the appropriate /V-bcnzyloxycarbonyl amino acid (1.9 mmol), glycylgly- 
cyl-l.-phcnyialanyl-L-lcucinc methyl ester (VI) (37) ( 1.9 mmol), and trielh- 
ylantinc (2.2 mmol) in CH2C12 (50 mL) was cooled in an ice bath, and I- 
hydroxybcnzotriazolc (3.9 mol) in CH2CI2 (10 mL) was added in a dropwise 
manner. The mixture was stirred for 5 min before adding /V,/V'-dicyclohex- 
ylcarbodiimidc (2.1 mol) in CH2CI2 (20 mL) in one portion. The ice bath was 
removed, the reaction was stirred at room temperature for 56 h, the precipi­
tated dicyclohexylurca was removed by filtration, and the filtrate was evap­
orated to a volume of 10 mL and then refiltered. The resulting filtrate was 
evaporated to dryness, dissolved in ethyl acetate (50 mL) and washed with 
1 M HCI (50 mL), saturated NaHC02 solution (50 mL.), and finally water 
(50 mL). The organic layer was then dried, filtered, and evaporated to dryness. 
The resulting gummy residue was triturated with ether to afford the appro­
priate /V-protected pentapeptidc as a buff-colored, amorphous solid.
|[(2 - Benzytoxycarbamido) -2- indanyl]carbonyl\glycylglycyl-L-phe- 
nylalanyl-L-leucine Methyl Ester ( lid )—Compound lid was prepared as 
above from lie in 61% yield, mp I34-I38°C. TLC (silica, ethyl acetate - 
melhanol, 40:60): tf/0.60; IR (KCI): 1726, 1675, 1665, 1650, 1595, 1532, 
and 1520cm-'; 'H-NMR (CDCI3): 60.81 [d, 6 , leucine «-(CH3)2], 1.51 (m, 
2, leucine /3-CH2), 1.78 (m, 1, leucine y-CH), 3.07 (d of d, 4, indanc I - and
3-H), 3.09 (m, 2, phenylalanine /3-CH2), 3.55 and 3.57 (2 X s, 3, conforma­
tional forms of leucine OCH3), 3.72 (m, 2, one of glycine a-CH2’s), 3.92 (m, 
2, one of glycine a-CH2’s), 4.49 (m, 1, leucine a-CH), 4.71 (m, 1, phenylal­
anine a-CH), 4.99 (d, 2, C6HsOC//2-—O), 6.28 (d, I, exchangeable with D20 , 
NH), 7.03 (t, 2, exchangeable with D20 , 2 X NH), 7.08-7.35 (m, 14, ArH), 
and 7.66 ppm (m, 2, exchangeable with D20 ,  2 X NH).
Anal.— Calc, for CigH^NsOg: C, 65.2; H, 6.2; N, 10.0. Found: C, 65.3; 
H, 6.2; N, 10.0.
\[(2-Benzyloxycarbamido)-2-tetralyl]carbonyl\ glycylglycyl-L-phenyl- 
alanyl-L-lencine Methyl Ester (H id )—This compound was prepared as above 
from Illc in 91% yield, mp 86-90°C. TLC (silica, chloroform-melhanol- 
acetic acid, 120:90:5): Rj 0.62; IR (KCI): 1740, 1725,1704, 1690, 1675, 1660, 
1564, and 1530 cm"'; 'H-NMR (CDCIj): 5 0.87 [d, 6, leucine «-CH3)2], 1.55 
(in, 2, leucine/3-CH2), 2.22 (m, 1, leucine y-CH), 2.41 (m, 2, tetralin 3-H), 
2.60-3.80 (m, 4, tetralin 1- and 4-H), 3.32 (m, 2, phenylalanine /3-CH2), 3.52 
and 3.54 (2 X s, 3, leucine OCHj’s), 3.80 (m, 2, one or glycine a-CH2’s), 3.91 
(m, 2, one of glycine a-CH2’s), 4.54 (m, I, leucine a-CH), 4.73 (m, I, phe­
nylalanine a-CH), 5.02 (d, 2, bcnzyloxy CH2), 6.78-7.70 (m, 14, ArH), 6.83 
(d. I, exchangeable with D20 , NH), 7.16 (t, 2, exchangeable with D20 , 2 X 
NH), 7.78 (m, 1, exchangeable with D20 , NH), and 7.89 ppm (m, 1, ex­
changeable with D20 ,  NH).
Anal.—Calc, for CjsH^NsOg: C, 65.6; H, 6 .6; N, 9.8. Found: C, 65.2; H, 
6.7; N, 10.1.
\[(cnda-2-Benzyloxycarbamido) -2- benzonorbornenyl]carbonyl\gly- 
cylglycyl-L-phenylalanyt-L-leucine Methyl Ester (IV d )—Compound IVd 
was prepared as above from IVc in 43% yield, mp 118-I21°C. TLC (silica, 
chloroform-methanol-acetic acid, 120:90:5): R/0.72; IR (KCI): 1740, 1705, 
1690, 1660, 1632, 1565, 1545, and 1520 cm-'; 'H-NMR (CDCI3): 80.84 [d, 
6, leucine fi-(CH3)2], 1.30 (m, 1, benzonorborncnyl C-3 exo-H), 1.53 (m, 2, 
leucine (3-CH2), 1.94 (m, 1, leucine y-CH), 1.98 (m, 2, benzonorbornenyl C-9 
H), 2.64 (m. I, benzonorborncnyl C-3 endo-H), 3.09 (m, 2, phenylalanine
458 / Journal of Pharmaceutical Sciences
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j3-CHa). 3.62 (s, 3, leucine OCH3), 3.63 (m, 2, benzonorborncnyl C-l and 
C-4 H), 3,72 (m, 2, one of glycine a-CH^s), 3.94 (m, 2, one of glycine 
a-CH2's), 4.52 (m, I, leucine a-CH), 4.69 (m, I, phenylalanine a-CH), 5.17 
(d, 2, bcnzyloxy CH2), 6.38 (m, 1, exchangeable with D20 , NH), 6.70-7.55 
(m, 16, ArH and 2 exchangeable X NH), 7.60 (m, 1, exchangeable with D20 , 
NH), and 7.70 ppm (in, I, exchangeable with D20 , NH).
Anal. -Calc, for C40H47NsO,,: C, 66.2; H, 6.5, N. 9.2. Found: C, 65.8; H, 
6 .6 ; N, 8.9.
Synthesis of Unprotected Pentapeptides—As a general method, the ap­
propriate TV-protected pentapeptide (16 nmol) was dissolved in absolute 
ethanol (100 mL), 5% palladium-on-charcoal catalyst (0.5 g) was added, and 
the mixture was hydrogenated with stirring at room temperature and atmo­
spheric pressure for 20 h. The catalyst was then removed by filtration, the 
filtrate evaporated to dryness, and the residue dissolved in ethyl acetate (50 
mL). The organic solution was extracted with I M HCI (2 X 50 mL), followed 
by water ( I X 30 mL). The combined aqueous extracts were basificd to pH 
9 with solid sodium bicarbonate and back-extracted with ethyl acetate (2 X 
50 mL). The combined ethyl acetate extracts were dried, filtered, and evap­
orated to dryness, and the residue was purified on a carboxymcthylcellulose 
column, eluting with ammonium acetate buffer, as previously described, to 
afford the appropriate /V-deprotectcd pentapeptide in buffer solution. The 
water and buffer salts were removed by freeze-drying, redissolving the residue 
in water (200 mL), and redrying on a freeze-drying apparatus11 at 10—l- 10—2 
torr.
\(2-Aminoimlanyl)carbonyl]glycylglycyl - L -  phenylalanyl -L -  leucine 
Methyl Ester (lie ) This compound was prepared as above from lid in 17% 
yield, mp 93-95°C. TLC (silica, chloroform-methanol-acetic acid, 120:90:5): 
Rf  0.69; IR (KCI): 1740, 1686, 1672, 1650,1580, 1562, 1545,and 1525 cm-'; 
'H-NMR (CDCIj): 5 0.85 and 0.93 [t and d, 6 , leucine fi-(CHjhl, 1 60 (m. 
2, leucine /3-CH2), 2.12 (m. I, leucine -y-CH), 2.82 (d of d, 4, indanc 1- and
3-H), 3.08, (m, 2, phenylalanine /3-CH2), 3.65 and 3.70 (2 X s, 3, leucine 
OCHj), 3.81 (s, 2, exchangeable with D20 , NH2), 3.95 (d of d, 2, one or 
glycine a-CH2’s), 4.06 (d of d, 2, one of glycine a-CH2’s), 4.48 (m. I, leucine 
a-CH), 4.92 (t, I, phenylalanine a-CH), 7.00-7.31 (m, 9, ArH), 7.26 (d, 1, 
exchangeable with D2Ot NH), 7.49 (d, I, exchangeable with D2O, NH), 7.63 
(m, 1, exchangeable with D20 , NH),and 8.45 ppm (m, 1, exchangeable with 
D20 , NH); amino acid analysis (after acidic hydrolysis): 2d 0.95, Gly 1.97, 
Phc LOO, and Leu 1.01.
Anal. -C alc . Ibr C3oH39N50 6-H20 : C, 61.7; H, 7.1; N, 12.0. Found: C. 
61.7; H, 6 .8; N, 11.6.
|( 2-Aminotetralyl)carbonyl] glycylglycyl -/.- phenylalanyl leucine 
Methyl Ester ( Il ie )—Compound llle  was prepared as above from IIId in 
11 % yield, mp 165-170°C. TLC (silica, chloroform- methanol-acetic acid, 
120:90:5): fl/0.61; IR (KCI): 1740, 1690, 1678, 1655, 1550,and 1522 cm-'; 
'H-NMR (CDCI.1): 5 0.92 [m, 6, leucine 5-(CH3)2), 1.39 (m, 2, leucine 
/3-CH2), 1.58 (m, 2, tetralin 3-H), 1.82 (br s, 2, exchangeable with D20 , NH2), 
1.92 (m, 1, leucine y-CH), 3.01 (m, 4, tetralin 1- and 4-H), 3.38 (m, 2, phe­
nylalanine /9-CH2), 3.70 and 3.72 (2 X s, 3, leucine OCH3), 3.98 (m, 2, one 
of glycine a-C H fs), 4.05 (m, 2, one or glycine a-CH2’s), 4.46 (m, 1, leucine 
a-CH), 4.82 (m, I, phenylalanine a-CH), 6.88 (m, I, exchangeable with D20 , 
NH), 6.90-7.45 (m, 9, ArH), 7.54 (m, 1, exchangeable with D20 , NH), 7.64 
(m, I, exchangeable with 0 2O, NH), and 8.64 ppm (m, 1, exchangeable with 
D20 , NH); amino acid analysis (after acidic hydrolysis): 3d 0.92, Gly 2.02, 
Phc LOO, and Leu 1.12.
Anal. —Calc, for C3|H 4!N50 6-H20: C, 62.3; H, 7.2; N, 11.7. Found: C, 
62.8; H, 6.7; N, 11.2.
[(endo - 2 -Aminobenzonorborneny I) carbonyl] glycylglycyl -/.- phenyl­
alanyl-L-leucine Methyl Ester (IVe)- This compound was prepared as above 
from IVd in 31% yield, mp 113-116°C. TLC (silica, chloroform-methanol- 
acetic acid, 120:90:5): Ry 0.78; IR (KCI): 1742, 1703, 1688, 1657,1560,1545, 
and 1520 cm” '; 'H-NMR (CDC!3): h 0.85 [m, 6 , leucine 5-(CH3)2], 1.32 (m, 
2, leucine /8-CH2), 1.52 (d of d, I, benzonorbornene C-3 endo-H), 1.60 (m,
1, leucine 7 -CH), 1.70 (m, 2, benzonorbornene C-9 H), 1.92. (m, 2, benzo- 
norborncne C-3 exo-H), 2.47 (m, 2, benzonorbornene I - and 4-H), 3.08 (m,
2, phenylalanine/J-CH2), 3.34 (brs, 2, exchangeable with D2Ot N H2), 3.65 
(m, 3, leucine OCH3), 3.90 (m, 2, one of glycine a-CHj’s), 4.04 (m, 2, one 
of glycine a-CH2’s), 4.52 (m, 1, leucine a-CH), 4.76 (m, 1, phenylalanine 
a-CH), 6.80-7.56 (m, 9, ArH), 7.02 (m, I, exchangeable with D20 , NH),
7.63 (m, 1, exchangeable with D20 , NH), 7.77 (m, 1, exchangeable with D20 , 
NH), and 8.70 ppm (m, 1, exchangeable with D20 , NH); amino acid analysis 
(after acidic hydrolysis): 4d 0.91, Gly 2.4, Phc 1.00, and Leu 1.01.
Anal.—Calc, for C32H4 |N 50 6-H20: C.63.1; H ,7 .I;N , 11.5. Found: C, 
62.9; H, 7.4; N. 11.5.
Pharmacology—Compounds were evaluated for analgesic properties in 
albino mice (Tuck, TFW strain) by the following procedures. In vitro testing
Model EF03: Edwards.







was carried out by measuring the inhibition of electronically stimulated 
contractions of the guinea pig ileum myenteric plexus muscle using the method 
of Kostcrlitz and Watt (38) and by measuring the inhibition of mouse vas 
deferens tissue after stimulation with twin rectilinear pulses 10 msapart (39). 
In vivo evaluation was carried out using the mouse hot-plate test (40).
RESULTS
Chemistry —The amino acids Ila and Ilia were prepared by literature 
methods (34,35). Synthetic routes to IVa and Va were designed based on the 
stereochemistry of the products that have been obtained from Streckcr and 
Buchercr reactions on norbornanc-2-onc and related compounds (41-47). 
Reaction of benzonorbornen-2-one with ammonium carbonate and KCN 
afforded exclusively the expected spirohydantoin, IVb, which could be hy­
drolyzed with barium hydroxide to the endo-amino acid, IVa (Scheme 1). The 
unequivocal structural assignment of IVa was determined from data obtained 
from 1H- and UC-NMR spin-spin coupling data and from two-dimensional 
1 H-NMR studies, both of which arc reported by us elsewhere (48). Attempted 
synthesis of Va from benzonorborncn-2-one via a modified Slrccker synthesis 
resulted in formation of only the endo-amino acid IVa (48).
The amino acids Ila, IIla, and IVa were each TV-protected with carbo- 
benzoxy chloride in base and coupled with tetrapeptidc VI (37) using the 
TV./V'-dicyclohexylcarbodiimide-1 -hydroxybenztriazole method. Hydroge- 
nolysis of the protected pentapeptides Ud, Hid, and IVd and purification of 
the resulting deprotected products by gradient buffer elution from carboxy- 
incthylccllulosc at pH 5 .1 afforded the pentapeptide methyl esters lie, Illc, 
and IVc.
Pharmacology—Compound lie exhibited only weak analgesic properties 
when evaluated on electrically stimulated guinea pig ileum, showing an ID50 
of 3.8 pm (ID 50 values for morphine. Met enkephalin, and Leu enkephalin 
on the same preparation are 90.5, 86.8, and 450 nM, respectively), whereas 
compounds llle  and IVe were inactive. None of the pentapeptides were active 
analgesics in the mouse vas deferens preparation or in the hot-plate test iri mice 
after subcutaneous and intracerebrovcntricular injection.
CONCLUSIONS
This study has developed synthetic routes, based on classical solution 
techniques, which can be used to prepare Leu enkephalin derivatives in which 
the terminal tyrosine- 1 residue has been replaced by a variety of conforma- 
tionally restrained amino acid moieties, as represented in structures lie, llle, 
and IVe. None of these pentapeptides possess any significant analgesic activity, 
both in vitro and in vivo, which is consistent with the observation that en­
kephalins lacking an aromatic para-hydroxy group in the tyrosine-1 moiety 
are inactive as analgesics (4, 7). The synthetic procedures developed in this 
Study should be of value in the preparation of Leu enkephalin derivatives in­
corporating aromatic hydroxylated derivatives of lla. Ilia, and IVa in place 
of the tyrosine- 1 moiety.
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Abstract
2,3,11,12-Tetramethoxyberbinium chloride at very low doses causes a marked reduction o f parasitaemia 
produced by Plasmodium chabaudi infection in mice. The 2,3,10,11 and 13-amino-2,3,10,l 1-tetramethoxy 
analogues are inactive in this test system at the same dose levels, despite all three compounds having marked in 
vitro activity against P. falciparum. This is the first time that in vivo antiinalarial activity of a protoberberine 
alkaloid analogue has been demonstrated. The parent alkaloid berberine also has activity in vivo against P. 
chabaudi, in contrast to its reported lack of activity against P. berghei in mice.
Despite persistent reports of the use of plant extracts containing protoberberine alkaloids in the folk treatment 
of malaria1’2, and the demonstration of the potent antimalarial activity in vitro of a number of isolated 
compounds of this type3, nobody has been able to demonstrate in vivo activity until now. The clearest and 
most systematic demonstration of the difference between in vitro and in vivo activity in this class of 
compounds was that conducted by Vennerstrom and Klayman at the Walter Reed Army Institute4, who found 
in vitro potency against Plasmodium falciparum  comparable to that of quinine, but a complete lack of effect in 
mice infected with P. berghei.
We have been developing a novel protoberberine synthesis, based on cyclisation of 1-cyano-2-benzy 1-1,2,3,4- 
tetrahydroisoquinolines in anhydrous hydrogen fluoride. This method follows earlier work5'7 on the synthesis 
of simpler isoquinolines and has proved to be effective, efficient and versatile, with yields on most steps in 
excess of 80%. A noted feature of this route is the intermediacy of a spiro-cyclised cation8-9 following ipso 
attack of the protonated nitrile (1) on the benzyl substituent. The rearrangement which follows can thus give 
rise .to 10,11-dimethoxy substitution (2b), from a 3.4-dimethoxybenzyl intermediate, or an 11.12-dimethoxy 
protoberberine (2a) from a 2.3-dimethoxybenzyl intermediate (Scheme 1). Previous studies, as for example
1663
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those of Vennerstrom and Klayman, have concentrated on compounds with the naturally occurring 9,10- 
oxygenation pattern.
The synthesis which we have developed gives rise to a 13-imino derivative (2) as the first-formed product after 
rearrangement. This intermediate is unstable and will either eliminate NH3 (or hydrolyse1 0  and eliminate HiO) 
on attempted crystallisation (Scheme 2), giving directly and very conveniently the desired end-products (3a) or 
(3b). If allowed to stand in alkaline solution (2b) will oxidise to give the 13-amino salt (4). All three 
compounds ((3a), (3b) and (4)) have been tested against P. falciparum K1 multi-drug resistant strain in vitro 
and have similar ICso values of 0 . 6  - 0 . 8  (lg/ml, compared to the value for berberine3  of 0.36 pg/ml.
In preliminary in vivo experiments neither (3b) nor (4) was active at the chosen dose level o f 0.25 mg/kg. 
against P. chabaudi (AS strain) in BALB/c mice. The compound in buffered saline was given as a single 
intravenous dose one day after intraperitoneal infection with 106  parasitised red blood cells. However using a 
similar treatment regime compound (3a) not only markedly delayed the onset of a patent parasitaemia but 
significantly reduced (p< 0.025, unpaired Student's t test) the peak parasitaemia compared with untreated 




















< 2 0 -
1 0  -
1 0  -
6 8 1 02 401 50 5 10
DAYS PO ST IN FECT IO N  DAYS P O ST IN FE C T IO N
Fig 1. In vivo antimalarial activity of compound (3a) Fig 2. In vivo antimalarial activity of berberine
against P. chabaudi in BALB-c mice after a single against P. chabaudi in BALB-c mice after a single
i/v  dose of 0.25 mg/kg: 5 mice in each group. i/v  dose of 0.25 mg/kg: 5 mice in each group.
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\  standing 
(vi) X  NaCI
(a) R' = R2 = OMe, R3 = H
Yields (%), m.p.°C (i) 92,oil (ii) 98,oil (iii) 83,122-5 (iv) 100a (v) 48b, >330
(b) R1 = H, R2 = R3 = OMe
Yields (%), m.p.°C (i) 100,85 (ii) 91,85 (iii) 67,132-3 (iv) 100a (v) 34b, 221c 
"Base unstable, HCI salt gives (3) on recrystallisation. 
bAfter several recrystalllsatlons for biological tests. 
c Lit.11 212-3°C from chloroform. Lit.12207-8°C from methanol.
Scheme 1
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This experiment has now been carried out five tunes, with reproducible results. In a simitar experiment, 
berberine (0,25mg/kg) also produced a significant reduction in parasitaemia (Fig. 2).
These results show that substitution pattern is important, but may also indicate that P. berghei infections in 
mice are not an appropriate model for other Plasmodium  infections in humans. The present results with 
berberine are in direct contrast to the results reported for P.berghei in mice4. It is not yet possible to predict 
whether differences between in vitro data against P. falciparum  and in vivo data against P. chabaudi will 
reflect the differences for the same compounds against P. falciparum in vitro and in vivo.
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Abstract
Analogues of the antitumour alkaloids fagaroninc and nitidine have been synthesized to investigate their 
structurc-activity relationships against P388 leukaemia in mice. Bulky substituents at the 12-position arc well 
tolerated, whereas substituents larger than methoxy in the 2-position result in total loss of activity.
The effects of hydroxy groups in the 2- and 12-positions, which are respectively potency-enhancing and 
potency destroying, are rationalized in terms of their potential influence on bioavailability. Suitable choice of 
substituents may allow the production of more potent analogues with improved ability to penetrate lipid 
membranes.
The alkaloids fagaroninc and nitidine (Fig. 1) have been 
known for several years (Messmer et al 1972) to possess potent 
antileukaemic activity in mice. More recently, they have been 
shown to inhibit human topoisomerases (Larsen et al 1993; 
Fang et al 1993), which may be the mechanism of their 
antileukaemic effects. We have previously described a very 
efficient synthesis of 2,3,8,9-oxygenatcd benzo[c]phenan- 
thridincs (Olugbade et al 1990) which generates a hydroxy 
group in the 12-position. To complete the synthesis of fagar- 
onine requires removal of the hydroxy group, a step which can 
be neatly avoided by use of a vinyl synthon (Seraphin et al 
1995) in place of the original ester which was a key inter­
mediate. However, the 12-hydroxy group formed in the earlier 
synthesis (Olugbade et al 1990) is potentially a point of
Fagaronine
Nitidine
Flo. I. Structures of fagaroninc and nitidine.
Correspondence: R. D. Waigh, Department of Pharmaceutical 
Sciences, University of Strathclyde, Glasgow Gl 1XW.
attachment of groups which might assist receptor binding, the 
receptor generally being assumed to be DNA in the first 
instance (Pezzutq et al 1983). We now describe the synthesis 
of quaternary benzo[c]phenanthridinium salts with 12-hydroxy 
and alkoxy groups (Fig. 2) and the influence o f the 2- and 12- 
substituents on their antileukaemic activity in mice.
Methods
The syntheses of the parent benzo[c]phenanthridincs 1, 2 and 3 
were carried out as described previously (Olugbade et al 1990).
12-O-Mcthylation o f  benzo[c]phenanthridines
2,3,8,9, / 2-Pentamethoxybenzofclphenanthridine (4). The ben- 
zo[c|phcnanthridinc sulphate (l.H2S04) (1 g, 2-16 mmol) was 
stirred in 8-4% potassium hydroxide (20 mL). Dimethyl sulphate 
(I mL, 10-5 mmol) was added to the mixture and stirring con­
tinued for 20 min on a steam bath. The reaction mixture was 
diluted with water (20 mL) and the precipitate collected by fil­
tration and washed thoroughly with water. The crude product 
(0-87 g) was purified by column chromatography on basic alu­
mina eluting with chloroform: petroleum (b.p. 40-60°C) to give 
the ether 4 as a white solid (0-5 g, 61%); combustion analysis 
and properties are given in Tables I, 2, 4, and 5.
2-Ethoxy-3,8,9,12-tetramethoxybenzo[cjphenanthricline (5). 
Dimethyl sulphate was added (1 mL, 10-5 mmol) to a mixture 
of the phenol 2 (2-1 g, 5-54 mmol), and anhydrous potassium 
carbonate (2-2 g), in dimethylformamide (10 mL). The mix­
ture was stirred for 24 h and an additional quantity of dimethyl 
sulphate (1 mL) was added. After stirring for 24 h the reaction 
mixture was diluted with water and extracted with chloroform. 
The extract was washed with water and concentrated. The 
residue was diluted with diethyl ether and the product 5 col­
lected by filtration as a brown solid ( I -5 g, 69%); combustion 
analysis and properties are given in Tables I, 2, 4 and 5.
De-ethylation at 2-position
2-Hydroxy- 3,8,9,12-tetramethoxybenzo fcjphenanthridine (6). 
The ethoxybenzo[c]phenanthridine 5 (1-4 g, 3-56 mmol) in
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1 R| = Me, R2 = H
2 Ri = Et. R2 = H
3 R. = r 2 = h
4 Ri = R2 = Me
5 R! = Et, R2 = Me
6 R. = H, R2 = Me







15 R = Et
1 6 R, = R2 = Me, X = MeSOj 
1 7 R, = Me, Rj = Bn, X = McSOj
18 R, = Et, R2 = Bn, X = MeS03
19 R, = R2 = Bn, X = S 03
20 R, = Me, R2 = H, X = Cl
21 R| = R2 = H, X = Cl
22 R , =Bn, R2 = Me
23 R, = H R 2 = Me
OBn
8 R, = Me, R2 = H
9 R, =Me, R2 = Bn
10 R, = Et, R2 = H 
1 I R, = Et. R2 = Bn
12 R, = Bn, R2 = H
13 R, = R, = Bn
concentrated sulphuric acid (98%, 12 mL) was heated at 55°C 
for 1 h. The cooled mixture was diluted with ice, basified with 
solid sodium bicarbonate and treated with a 3 : 1 mixture of 
chloroform and ethanol. The inorganic matter was removed by 
filtration. The organic filtrate was washed with water and 
evaporated to dryness to give 6  as a greyish-white powder 
(1-03 g, 77%). Combustion analysis and properties are given in 
Tables 1, 2, 4 and 5.
Benzylation o f  phenolic benzo[c]phenanthridines 
Method I. The bcnzo[c]phenanthridine sulphate I.H2 SO4  
(0-49 g, 1 mmol) was dissolved in 5% sodium hydroxide 
(12 mL) with warming. Benzyl bromide (0-5 mL, 4 mmol) 
was added and the mixture heated at 110°C for 1 h. The cooled 
mixture was extracted with chloroform and concentrated. The 
residue was treated with diethyl ether and the precipitate col­
lected by filtration. The crude product was recrystallized from 
a mixture of chloroform and petroleum (b.p. 60-80°C) to give 
the geminal dibenzylbenzo[c]phenanthridine 14 (0-35 g, 60%). 
Combustion analysis and the properties of the ketone are 
summarized in Tables 1, 2, 4 and 5.
Method 2 (General). A mixture of phenolic benzo[c]phe- 
nanthridine (3 mmol), anhydrous potassium carbonate 
(7 mmol), dimethylformamide (15 mL) and benzylbromide 
(0-5 mL, 4 mmol) was stirred for 1 h. An additional amount of 
benzyl bromide (0-5 mL, 4 mmol) was added and stirring 
continued for 90 min. For the diphenol 3, twice these molar 
proportions of potassium carbonate and benzyl bromide were 
used. Finally the reaction mixture was diluted with 5% sodium 
hydroxide (20 mL). The product was extracted with chloro­
form or collected by filtration. Crystallization from chloro- 
fomi-petroleum (b.p. 60-80°C) gave the major component. 
The mother liquor was evaporated and the residue chromato­
graphed on a column of alumina eluting with petroleum 
(b.p. 60—80"C) chloroform mixtures to give the minor
components. The combustion analysis, yields, properties 
and 'id NMR spectral data are provided in Tables 1, 2, 4 
and 5.
Quaternization o f  benzo[c]phenanthridines 
Method I. General procedure. A mixture of the dry ben- 
zo[c]phenanthridine base ( 2  mmol) and fresh methyl mctlia- 
nesulphonate (4 mL) was refluxed at 170~180°C under 
anhydrous conditions for 20 min. The reaction mixture was 
allowed to cool and then diluted with dry diethyl ether. The 
resulting precipitate was collected by filtration, redissolved in 
chloroform or chloroform-ethanol mixture and precipitated 
with diethyl ether. The final precipitate was collected by 
filtration and washed thoroughly with diethyl ether. The 
combustion analysis, yields and properties of the quaternary 
products thus obtained are provided in Tables 2, 3, 4 
and 5.
8  + 9 + 1 4  
10 + 11 + 15
Is-- 1 2 + 1 3
Structures o f  synthesized compounds.
Method 2. General procedure. A mixture of the dry ben- 
zo[c]phenanthridine base ( 2  mmol), methyl methanesulpho- 
nate (4 ml.) and diisopropylethylamine (1 mL) was refluxed at 
170—180”C under anhydrous conditions for 30 min. The 
reaction mixture was allowed to cool and then diluted with dry 
diethyl ether. The clear supernatant was carefully pipetted out. 
The lower resinous material was treated with a few drops of 
ethanol and rubbed with a spatula until a solid precipitate was
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Table 1. Combustion analysis
Compound Found Required Formula
5 C, 68-3; H, 5-8; N, 3-5 C, 68 0; H, 5-7; N, 3-6 C22H21NO5 1 5 H2O
6 C, 67.1; H, 5.2; N, 3.4 C, 67.4; H, 5.4; N, 3.4 C71Hl9NO5.0.5H2O
7 C, 72.3; H, 5.4; N, 2.5 C, 72.4; H, 5.6; N, 3.0 C28H25NO5.O.5H2O
8 C, 72.5; H, 5.5; N, 2.85 C. 72.4; H, 5.6; N, 3.0 CjbHzsNOvO.SHjO
9 C, 76,3; H, 5.7; N, 2.3 C, 75.8; H, 5.8; N, 2.5 C35H3 |NO5.0.5H2O
10 C, 7.17; H, 5.7; N, 2.5 C, 71.4; H, 6.0; N, 2.9 CjsHjvNOs.HjO
11 C, 76.3; H, 5.8; N, 2.5 C, 76.0; H, 6.0; N, 2.5 C36H33NO5.0.5H2O
12 C, 75.7; H, 5.4; N, 2.6 C, 75.5; H, 5.6; N, 2.6 C34H-,9NOs.0.5H3O
13 C, 79.1; H, 5.9; N, 2.0 C, 79.2; H, 5.7; N, 2.3 c,uh35n o ,
14 C, 75.9; H, 5.8; N, 2.3 C, 75.8; H, 5.8; N 2.5 Cj5H31NO3.0.5H2O
15 M + ,  559.2356 559.2359
16 C, 57.6; H, 5.5; N, 2.6 C, 57.8; H, 5.7; N, 2.8 C24H27NOgS.0.5H2O
17 C, 62,5; H, 6.1; N, 2.2 C, 62.7; H, 5.6; N, 2.4 C30H31NO8S.0.5H2Oa
18 C, 61.9; H, 5.7; N, 2.1 C, 62.3; H, 5.9; N, 2.3 'c31h 33n o 8s.h 2o
19 C, 65.8; H, 5.4; N, 2.0 C, 65.5; H, 5.7; N, 2.1 C36H35NObS.H20
20 C, 60.8; H, 5.5; N, 3.0 C, 60.9; H, 5.6; N, 3.2 C22H22NO5CI.H2O
21 C, 62.3; H, 5.1; N, 3.3 C, 62.8; H, 5.0; N, 3.5 C21H20NO5Cl“
22 C, 62.6; H, 5.5; N, 2.3 C, 62.7; H, 5.6; N, 2.4 C22H22NOSCI.H20
“Hygroscopic (gained weight on balance).
Table 2. Yields and melting points for benzo[c]phenanthridine bases.
Compound Yield (%) m.p. (°C)












Table 3. Properties of quaternary benzo[c]phenanthridines.
“From diethylene glycol. bFrom CHC1* ethanol “From CHClj- 
pctroleum (b.p. 60-80"C). dFrom CHClj-methanol. “By-product from 
Method 2. 14 obtained in 60% yield by Method 1.
formed. The material was then diluted with diethyl ether, 
collected by filtration, and finally recrystallizcd twice from 
chloroform or chloroform-diethyl ether. The combustion ana­
lysis, yields and properties o f the salts so obtained are provided 
in Tables 2, 3 4 and 5.
Dealkylation o f  quaternary benzo[c]phenanthridines 
General method. A mixture o f  benzo[c]phcnanthridine salt, 
glacial acetic acid (10 mL), and concentrated hydrochloric 
acid (5 mL) was refluxed at 70-80°C  for 2 h during which a 
yellow precipitate was formed. The reaction mixture was fil­
tered while still warm and the collected precipitate washed 
thoroughly with diethyl ether.
The combustion analysis and properties o f 2 0  and 21  
obtained by dealkylation as chloride salts arc described in 
Tables 2, 3, 4 and 5.
Antileukaemic tests
The test system employed in the screen coded 3PS31, con­
sisted o f  the ascitic fluid o f  lymphocytic leukaemia P388 
implanted in mouse strains coded BDF, or CDF|. Tests were 
conducted by the National Cancer Institute, Bethesda, Mary­
land, USA. The inoculum site was intrapcritoneal and the


















320 sh  (34,200)





















322 sh (27,500) 












333 sh  (29,800) 
412 (17,300)
“From final step. '’Quaternization by method 1. “Quaternization by 
method 2.
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m /z  (%)
379 (M 1, 100), 364 (3.8), 3.36 (10)
393 (M+, 100), 378 (12), 3643 (27)
365 (M+, 100), 364 (17.6), 350 (11.4), 336 (3.2),
322 (12.6), 307 (13.1),306 ( l . l )
455 (M +, 43.4), 364 (100), 336 (10.5), 91 (20.3)
455 (M+, 38.7), 364 (100), 336 (29.8), 91 (17.1)
545 (M+, 7.8), 454 (100), 426 (7.0), 364 (17.0),
336 (4.8), 91 (25.8)
469 (M+, 44), 378 (100), 350 (17.6), 91 (18.7)
559 (M+, 6.4), 468 (100), 440 (9.9), 378 (15.3),
350 (4.0), 91 (26.7)
531 (M+, 19.4), 440 (27.1), 350 (8.0), 91 (100)
621 (M+, 6.2), 530 (53.8), 440 (40.0), 91 (100)
545 (M+, 12.0), 454 (100), 426 (9.4), 364 (2.6),
336 (2.0), 91 (27.0)
559 (M+, 23.3), 468 (100), 440 (9.8), 378 (23.4),
350 (5.2), 91 (49.6)
379 (100), 364 (12.6), 348 (5.6), 336 (20.6)
455 (50.6), 364 (100.0), 336 (40.1), 91 (29.6)
469 (33.0), 378 (100), 350 (50.3)
531 (25.9), 440 (32.0), 351 (43.3), 350 (23.0), 91 (100)
380 (14.6), 379 (55,2), 365 (100.0), 364 (42.3), 
350(17.1), 336(25.9)
380 (4.4), 379 (14.6), 366 (20.3), 365 (88.2), 364 (26.2), 
351 (100.0), 350 (52.0), 336 (15.4), 322 (22.5)
parameter for evaluation was the median survival lime, (MST) 
defined as the median day o f death for a test or control group 
and it was calculated according to the following formula 
(Geran et al 1972):
MST =  L +  (C x j / f M) (1)
where L is the lower boundary of class containing median 
animal, and is equal to DM 0-5, DM is that day when total 
deaths are equal to or greater than A, A is (initial count +  l)/2 , 
C is the class interval (equal to the 1 day), j is the number of 
deaths needed to reach medium animal from the lower class 
boundary and is equal to A minus total deaths prior to day DM, 
fM is the frequency of class (total deaths on day Dm- T/C 
(percent) was defined as the ratio o f the median survival time of 
the test group to the median survival time of the control group 
expressed as a percentage. In general, a minimal increase in 
survival of iTeated animals over controls resulting in a T/C 
value greater than or equal to 125% was considered necessary 
to demonstrate activity. A reproduced T/C value greater than or 
equal to 125% was considered worthy o f further study.
The antileukaemic test data are presented in Table 6.
Toxicity
A test material was considered toxic (Geran el al 1972) if any 
one of the following conditions was met in an otherwise 
inactive test: 34% deaths by the toxicity day (day 5); T/C 
greater than or equal to 85%; a negative average animal weight 
change difference (test minus control) greater than or equal to 
4 g by the toxicity day.
Table 5. ' i t  NMR spectra o f benzo[c]phenanthridines. Unless stated otherwise, spectra were obtained in CDGI3
Compound OCHj OCHjCHj Ring CH C;-(CH2Ph)2 O-CHjI’h ArCHjPh OH
OCH2CH,
4 4.09 x  2,4.18,4.20,4.21 7.38,7.48,7.70,7.78,8.73,9.15
5 1,60,1,7Hz 4.08,4.14,4.15,4.19 4.33,q,7Hz 7.33,7.38,7.68,7.68,8.70.9.11
6 4.10,4.20 x 3 7.37,7.43,7.73,7.80,8.70,9.13
7 4 10,4.20 x 3 7,3-7.7,8H,m;7.80,1 H,S;
8.73,1H,S;9.13
8 4.08 x 2,4.13,4.20 7.3-7.7,8H,m;7.77,8.72,9.11 5.47 1.60
9 3.30,3.92,4.07,4.23 7.20-7.50,1 IH.tn; 5.00 4.94 1.65
7.51,7.89,8.87,9.20
10 1.59,t,7Hz 4.09,4.14,4.20 4.31 ,q,7Hz 7.3-7.7,8H,m;7.80,8.72,9.13 5.48





13 3.20,3.96,4.18 7.13-7.44,17H,m; 4.79;5.16 4.67
7.72,8.82,9.09
14 3.96x2,4.10,4.21 6.52br,4H,d,7Hz; 3.96,4.08,4H,
6.7-6.85,6H,m; ABq,l3Hz
7,27,7.46,7.97,8,13,8.92





18 1.58,1,711/ 3.78,3.96,4.41 4.25,q,7Hz 7.38-7.86,10H,m;10.04 5.82
19f 3.86,4.00,4.40 7.38-7.60,H,m; 5.37,2H;
7.68,7.94,7.99,8.02,9.94 5.56.2H
20b 4.58 x 3,4.70 8.05,8.40,8.48br,9.52,
8.40,8,.48,9.52
21“ 4.04,4.08,4.19 7.77,7.81,7.86,7.88,8.11,9.64 10.52, 
11.40
22 3.71,4.08,4.50,4.52 7.46-7.62,6H,m; 5.34
7.70,7.85,7.92,8.10,10.08
aDMSO-d6, utrifluoroacetic acid, “CDjOD-CDCtj
SYNTHETIC BENZO (C] PHENANTHRIOINES WITH ANTILEUKAEMIC ACTIVITY 
Table 6. Leukaemia screen (3PS31) test results (T/C %).
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Compound Dose (mg kg ') Status
3.12 6.25 12.5 25 50 100 200
1“ 98 106 96 ND Toxic Toxic Toxic Inactive
16 ND ND 118 125 132 127 ND Active
17 ND 124 128 139 Toxic Toxic Toxic Active
18 118 112 91 ND Toxic Toxic Toxic Inactive
19 too 100 98 ND Toxic Toxic Toxic Inactive
20 ND ND ND ND 99 97 99 Inactive




Although 12-O-methyIation proceeded straightforwardly to 
give 4 — 7, the analogous bcnzylation was very sensitive to the 
reaction conditions in its regioselectivity. In aqueous alkali the 
major product was the 11,11-dibenzyl ketone 14, formed by 
preferential C-alkylation. In contrast, use of dimethyl for- 
mamide gave mainly the desired 12-O-benzyl adduct with 
small quantities of the 11,12 (9 and 11) and 11,11-dibenzyl 
derivatives (14 and 15). The structures could readily be dis­
tinguished by IR and NMR analysis, since the 12-O-benzyl 
compounds (8, 10 and 12) retained the aromatic Hi t in the 'H 
NMR spectrum and the 11,11-dibenzyl compounds (14 and 15) 
showed a C = 0  stretch in the IR spectrum. In support of this 
assignment, the benzyl methylene groups of 14 appeared as a 
four-proton AB quartet, centred at 4 02 ppm, while the benzyl 
methylene groups of 9 appeared as singlets at 4-94 and 
5 00 ppm.
Benzylation of ellagic acid provides a precedent for these 
observations (Jurd et al 1959), giving mixtures o f C,C and O.C 
dibenzylated products when treated with benzyl chloride in a 
pyridine/sodium hydroxide mixture. At first sight, our obser­
vations appear to indicate a change of mechanism, perhaps 
from Sn2 to SN1, depending on the solvent, with O-alkylation 
preferred under SN2 conditions. That this explanation is over­
simplified is indicated from results with alkenyl halides of 
varying chain length (Sharpies 1994).
Quaternization was expected to be relatively difficult, 
requiring high temperatures and concentrated reagents; the 
problem was overcome by the use of pure methyl methane- 
sulphonate, which has a high boiling point. The production of 
methanesulphonate salts also had the useful property of 
increasing the water solubility for biological testing. A feature 
was the tendency for the quatcmizing agent to hydrolyse on 
storage, resulting in protonation rather than quaternization of 
the base. The proton salts were very difficult to separate from 
the desired quaternary salts, a problem which was overcome by 
use of the non-nucleophilic base di-isopropylethylamine in the 
reaction mixture, giving clean products which were easy to 
purify.
An unexpected aspect of the chemistry of this series was the 
very ready demethylation at position 12 in the quaternary salt 
22 but not in the tertiary bases, observed when an attempt was 
made to prepare the 2-hydroxy-3,8,9,12-tctramethoxy analo­
gue 23, which for the reasons given below was expected to 
have greater antileukaemic activity than the compounds tested.
The proposed route started with 2 and proceeded satisfactorily 
via 12-O-mcthylation, 2-O-de-ethylation in concentrated sul­
phuric acid and 2-O-benzylation to give 22. Treatment of 22 
with acid, however, gave the diphenol 21 rather than the 
desired 12-O-methyl derivative 23. There was insufficient time 
in this study to attempt alternative methods for debertzylation 
of 22.
Antileukaemic effects
As expected (Zee-Cheng & Cheng 1975) the tertiary base 1 
was inactive. The 12-O-methyl quaternary salt 16 and the 12- 
O-benzyl A-methyl analogue 17 salts both exceeded the 
threshold criterion to be deemed worthy of further investiga­
tion (Geran et al 1972). The 12-O-benzyl derivative is parti­
cularly significant since it indicates that the binding site can 
accept bulky groups in this region, pointing the way for the 
synthesis of further analogues. In contrast, the lack of activity 
of the 2-ethoxy 18 and 2-benzyloxy 19 derivatives indicates a 
very low steric tolerance in the binding site at this point. Such 
an observation is in accord with the relative potencies of the 
alkaloid fagaroninc and the synthetic derivative O-methylfa- 
garonine (Zee-Cheng & Cheng 1975), the methyl group at
Scheme I
2 0 1
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marked activity of the 2,12-dihydroxy analogue 21. The latter 
shows that this series is well worth further investigation and 
may indicate that penetration of cell membranes is an impor­
tant determinant of potency. Most of the quaternary salts 
described in this study would be expected (Mitscher et al 1978; 
Laola & Stermitz 1979) to exist at physiological pH in a tau­
tomeric mixture with the pseudobase form (e.g. 16 and 24 
(Scheme 1)). The uncharged pseudobase would be expected to 
penetrate cell membranes more readily. It is possible that the 
12-hydroxy group of 20 may hinder nucleophilic attack at 
position 6 (Scheme 2). This effect may be compensated in 21 
by loss of the 2-hydroxy proton followed by quinone-like 
resonance to give 25 (Scheme 3).
Given the DNA-binding properties and established inhibi­
tory effects on human topoisomerase o f fagaronine, it is very 
likely that the antileukaemic effects of the analogues 16-21 are 
mediated first through DNA binding and then through form­
ation of an enzyme complex. Computer modelling of the drug- 
DNA complex may help to clarify the steric tolerance at 
position 12 in this scries and provide some guidance for the 





position 2 resulting in a substantial loss of antileukaemic 
activity.
The lack of activity of the 12-hydroxy analogue 20 cannot 
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Abstract
Berberine chloride and ten synthetic analogues were tested for antimalarial activity and for interaction 
with DNA. Antimalarial activity was assessed by measurement of inhibition of growth of Plasmodium 
falciparum in-vitro, using chloroquine-sensitive and -resistant strains. DNA interactions were assessed 
by UV spectrophotometric studies, thermal denaturation measurements and gel electrophoresis.
Four of the compounds including berberine chloride were found to show some interaction with DNA  
which showed some correlation with antimalarial activity.
Berberine is known to inhibit several enzymes, as well as DNA and these results suggest that DNA  
is not the only site o f antimalarial action of these analogues.
Malaria is one o f the most important diseases in the world, 
with an estimated mortality o f 1—2-5 million per year, mainly 
among children (Cox 1991). Prospects for the control of 
malaria have been seriously hampered by the emergence of 
resistance to all available antimalarial drugs (Bruce-Chwatt 
1993).
Recent work has cast doubts on the potential for vac­
cination in the control o f falciparum malaria (d’Alessandro 
et al 1995), so that effective treatment remains the major 
control method at present, and will always be necessary for 
infected cases.
Protoberberine alkaloids have been suggested as can­
didates in the search for new antimaiarials. The parent 
compound, berberine (I, Fig. 1), was reported to exhibit a 
potency in-vitro comparable with that of quinine (Cox 
1991). It has been extensively used in folk medicine against 
many different diseases (Kondo 1976; Creasey 1979), and 
is active against the protozoan Leishmania donovani (Ghosh 
et al 1985; Vennerstrom et al 1990). The alkaloid was 
reported to be inactive against Plasmodium berghei in mice 
(Vennerstrom & (dayman 1988), but recent results have
I 2-12
Fio. I . Chemical structures o f  berberine (1) and synthetic analogues 
(2 12). See Table 2 for explanation o f  the R groups.
Correspondence: R. D. Waigh, D epartm ent o f  Pharmaceutical 
Sciences, University o f  Strathclyde, G lasgow G l IXW, UK.
shown in-vivo activity against Plasmodium chabaudi in mice 
(McCall et al 1994).
The mode of action of berberine is unknown, although 
the drug has been shown to interact with a number of 
dehydrogenase enzymes and with DNA (Kapp & Whiteley 
1991). To test whether the DNA interaction was a de­
terminant of antimalarial activity it was first necessary to 
synthesize a range o f analogues. A flexible synthesis in­
volving the hydrogen fluoride cyclization o f benzylamino 
nitriles was developed (McCall et al 1994) supplying the 
protoberberine analogues (2-12). We now describe the 
effects of these analogues (Fig. I) against Plasmodium fa l­
ciparum in-vitro, using both chloroquine-sensitive and - 
resistant isolates and some physicochemical studies of the 
interactions of these compounds with DNA.
M ateria ls and M ethods
Materials
Berberine chloride and calf thymus DNA were obtained 
from Sigma Chemical Co. The other protoberberine 
alkaloids were prepared as described previously (McCall et 
al 1994). All were obtained as the chloride salt except 
for compound 5 which was obtained by demethylation of 
compound 2 using HBr, giving the bromide.
In-vitro antimalarial activity tests
The test was based on previously reported methods 
(Desjardins et al 1979; O’Neill et al 1985). Laboratory 
cultures of P. falciparum  were maintained by standard 
methods. For the test, 25-pL aliquots o f culture medium 
were added to all the wells o f a 96-well flat-bottomed 
microculture plate (Sterilin, UK). Samples (25 pL) of test 
solutions were added, in duplicate, to the first wells and a 
Titertek motorized hand diluter (Flow Labs, UK) used to 
make serial 2-fold dilutions o f each sample over a 64- 
fold concentration range. Samples (200 pL) of a T5% (v/v)
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suspension o f parasitized red blood cells in culture medium 
(0-4% parasitaemia, growth rate >3 per 48 h) were added 
to all test wells. Parasitized and non-parasitized red blood 
cells and solvent controls were incorporated in all tests. 
Plates were incubated at 37°C in a gas mixture of 3% C 0 2, 
5% O;, 92% Nj. After 48 h each well was pulsed with 25 pL 
culture medium containing 0 5  pCi [5H]hypoxanthine and 
incubated for a further 18 h. The contents of each well were 
then harvested onto glass fibre filters, washed thoroughly 
with distilled water, dried, and radioactivity measured by 
liquid scintillation. The regression function log (counts 
min‘ ') =  a +  bx (log drug concentration) was calculated 
using duplicate points above and below the counts min"1 
midpoint between the parasitized and non-parasitized 
controls. The concentration causing 50% inhibition of 
radioisotope incorporation (1D50) was determined by 
interpolation (Sixsmith et al 1984). This method gives a 
value equal to 100-4+10-6% (mean + s.d.) of the value 
estimated by nonlinear regression analysis (Watkins et al 
1984). Statistical differences between means of small 
populations were examined using Student’s /-test.
The K39 strain of P. falciparum  was isolated from Western 
Kenya and is sensitive to chloroquine and sulfadoxine in- 
vitro but resistant to pyrimethamine. The V l/S strain was 
isolated in Vietnam and is resistant to chloroquine, 
pyrimethamine and sulfadoxine.
UV-vis spectrophotometry
UV-vis spectra and measurements were recorded using a 
Pye Unicam PU 8800 spectrophotometer, connected to an 
SPX 876 series 2 Temperature Programmer.
For optical measurements, DN A-alkaloid complexes were 
prepared by mixing fixed amounts of protoberberine ligand 
(0-25 mL 1 him ) with varying volumes of DNA (0, 0-1, 0-2,
0-5, 1-0, l-5mL of 1 ingmL ' solution) and made up to 
10 mL with Tris buffer (0 03 m , pH 7-0). This gave a DNA: 
ligand ratio of 0:1, 1:1, 2:1, 5:1, 10:1 and 15:1, respectively. 
The solutions were allowed to stand for 3 min at room 
temperature. For each solution the absorption spectrum 
was recorded (superimposed) over a wavelength range of 
500-300 nm. ‘DNA concentration’ refers to the molar 
concentration of base pairs.
Thermal denaturation measurements 
DNA (200 pL, I tn g m L 1) was mixed with ligand (50 pL 
or 1 mM) in Tris buffer, pH 7-0. The mixture was made up 
to 10 mL with Tris buffer and allowed to stand at room 
temperature for 30 min to permit equilibration. A sample 
(3 mL.) was then pipetted into a quartz cell and absorption 
measurements at 260 nm were taken as the temperature of 
the solution was raised from 50-98pC at a rate o f 0-5°C 
min '. Tm was estimated as the temperature at which the 
midpoint of the increase in absorption occurred. The 
procedure was repeated with no ligand present. All 
measurements were duplicated.
Gel electrophoresis studies
Vacuum-desiccated plasmid DNA, pGEX-2T (obtained and 
amplified by A. Awan), was made up to a stock solution of 
approximately 400 ng pL 1 with sodium phosphate buffer 
(0-1 M, pH 7-5). The protoberberine ligand was dissolved in
Tris bufTer (0 03 m , pH 7 0) to a concentration of 0-359 mM. 
Compound 3, because of solubility problems, was dissolved 
in 9 parts of Tris buffer and 1 part of dimethylsulphoxide.
DNA stock solution (1 pL) was whirlimixed with 
appropriate volumes o f the ligand stock solution (i.e. 0,0-5,
1-0, 1-5 and 2-0 pL). The mixtures were allowed to stand 
for 1 h to equilibrate. Bromophenol blue solution (I pL, 
0-25% bromophenol blue, 40% (w/v) sucrose in HjO) was 
added to each sample and the samples left to stand for a 
further 5 min, then subjected to electrophoresis for 1-5 h in 
horizontal submarine agarose gels (1-0% w/v, 20 x 8 x  
0-6 cm) at a constant 50 V, using as gel and reservoir buffer 
TAE buffer (0-04 m Tris-acetate, 0 001 M EDTA, pH 8-0). 
On completion of electrophoresis the gels were immersed 
in a solution of ethidium bromide (0-5 pgmL-1). After 
20 min, the DNA bands were visualized by the fluorescence 
of the DNA-bound ethidium bromide using a mid-range 
UV transilluminator. Photographs o f the gels were taken 
under UV light with Polaroid type 665 black and white 
positive/negative film.
Molecular modelling
This was carried out on a Silicon Graphics IRIS 4D/240 
GTX hardware system using the Polygen QUANTA and 
CHARM software.
R esults and D iscussion
The first test of DNA binding to be carried out on these 
compounds was the UV spectrophotometric binding assay. 
This is the easiest and quickest way to decide which 
compounds show no intercalation. It is well known that 
the long wavelength absorption band of ligands which 
intercalate between the base pairs o f DNA undergoes a 
shift to longer wavelengths (the bathochromic shift) with a 
corresponding decrease in absorbance on intercalation into 
DNA. The shift is believed to be a consequence of an 
overlap between the a-electrons of the nucleic acid base 
pairs and the bound ligand chromophore. Isosbestic points 
are generally observed when the UV spectra of the 
intercalator in the presence of increasing concentrations of 
DNA are overlaid. These are points at which all the spectra 
converge and the existence of such points implies that only 
a single spectroscopically distinct bound form of the drug 
molecule exists.
Solutions with DNA base pairs:ligand ratios varying 
between 0:1 and 15:1 were prepared for each of the 12 
compounds, and their UV-vis spectra overlaid. Compounds 
1, 2 and 3 all gave small bathochromic shifts with isosbestic 
points. Compound 4, in which C l3 is substituted with an 
amino group, gave inconclusive results. There was some 
convergence of the lines but no clear isosbestic points and no 
bathochromic shift. The results o f the UV-vis spectrometry 
titrations are summarized in Table I.
The remaining compounds (5-12), in which there is 
substitution with bulky groups, gave rise to unchanged UV 
spectra on addition o f DNA. These results show that this 
substitution inhibits binding to DNA.
On heating, DNA undergoes strand separation, the T„, 
(midpoint o f the thermal transition profile) being detectable 
by monitoring the increase in absorbance at 260 nm as the
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Table 1. Bathochromic shifts and isosbestic points of protoberberine alkaloids on addition 
of 1S equivalents of DNA and effect of selected protobcrberines on the melting temperature 
of calf thymus DNA (11-67 pM).
Compound y max Ay (nm) Isosbestic points (nm) AT„, (°C)
1 343 2 354,443 2-5
2 307 2 344, 362,388, 410 3-0
3 317 2 352, 404 50
4 Inconclusive Inconclusive Not applicable 1-5
5-12 No binding No binding Not applicable Not applicable
Table 2. Antimalarial activity of protobcrberines against chloroquine-sensitive and -resistant strains of Plasmodium 
falciparum in-vitro.











3 H H OCH, OCH, H CH, 0-59 5-19 880
4 H OCH, OCH, H NH, CH, 0-16 0-84 5-25
5 H OH OH H H H 0-40 0-64 1 -60
6 H OCH, OCH, H NHCOPh CH, 7-00 82-3 11-76
7 H OCH, OCH, H NHCOCH,CH,CH, CH, 4-29 84-0 19-6
8 OCH, OCH, H SCH, H CH, 0-35 1-59 4-54
9 H OCH, OCH, H NHCOCH, CH, 0-73 3-14 4-30
10 H OCH, OCH, H NHCOCH,CH,Cl CH, 2-06 87-9 42-7
11 H OCH, OCH, H NHCONHBz CH, 0-60 8-22 13-7
12 H OCH, OCH, H NHCO(CH,)6CH, CH, I 28 10-8 8-44
Chloroquine 0-0125 0-178 14-2
temperature is raised from 50°C (at which all the DNA is 
double stranded) to 98°C (at which temperature it is all 
single stranded).
T,„ varies according to the environment of the DNA  
and is about 70°C for calf thymus DNA in Tris buffer. 
Intercalators raise the value of Tm by hindering the internal 
motion of base pairs and sugars at the site o f intercalation, 
resulting in stabilization of the DNA duplex. Intercalators 
with high affinity for DNA stabilize the duplex more 
effectively than those with lower affinity.
Compounds 1-4 were tested for their ability to raise the 
Tm for calf thymus DNA. The results are summarized in 
Table 1. From these data it appears that 2 binds with about 
the same affinity as berberine (1), whereas 3 has greater and 
4 less affinity for calf thymus DNA. None o f the increases 
in Tm is very large, suggesting fairly weak binding.
The effect o f berberine chloride and compounds 2, 3 and 
4 on plasmid DNA electrophoretic mobility was studied in 
agarose gels. Compound 7 was used as a control. 
Compounds 1 4  all exhibited the characteristic U-shape 
when treated in this way. At low values of R (the ratio of 
ligand concentration to DNA base pairs), increasing 
amounts of ligand results in a decrease in the electrophoretic 
mobility of the DNA. At a critical R value (Rt) the maximum 
decrease is observed, and at values o f R above Rc 
electrophoretic mobility increases again. At R values below 
Rc intercalation into DNA produces an unwinding of the 
supercoil of plasmid DNA, reducing the number of negative 
superhelical turns present. Such unwinding reduces the 
electrophoretic mobility of the plasmid as it becomes less 
rigid and rod-like. Above Rt, the DNA becomes positively 
supercoiled. The molecule becomes more compact and 
electrophoretic mobility increases.
Compounds 1 4  all showed a maximum decrease in 
electrophoretic mobility of about 1-2 mm when the plasmid 
was allowed to run about 40 mm through the gel. With 
these small effects it is difficult to distinguish accurately 
between the different drugs 1-4, but the general trend 3> 1, 
2> 4 was observed and this is consistent with the T,„ data 
which suggest that 3 is a better intercalator than 1 and 2 
and that 4 is rather less good.
Molecular modelling is difficult to use as a predictive tool 
in studies of DNA intercalation because energy 
minimization tends to result in unrealistic distortion of the 
DNA structure. Both 2 and 3 can be shown to fit readily 
between DNA base pairs in a double helix, but with 3 there 
is less steric crowding which could explain its slightly greater 
affinity for DNA. None of these compounds is completely 
planar, owing to the -CH2-CH2- bridge, which may explain 
their low affinity as a group.
Some clear points emerge from the antimalarial potency 
data in Table 2. None of the synthetic compounds is more 
potent than berberine itself, although compounds 2 and 4 
come close. Both 2 and 4 lack bulky substituents which 
could inhibit DNA binding, which might indicate that DNA 
binding is a factor in their antimalarial activity. Compound 
3, however, which binds more strongly to DNA than 1, 2 
and 4, is much less potent as an antimalarial compound. 
Affinity for DNA is thus not the sole determinant o f high 
potency in this series.
Compound 5 is unique in the series in having four strongly 
hydrogen-bonding OH groups, rendering the molecule very 
hydrophilic. Since the intercalative binding site is largely 
hydrophobic, simple thermodynamic considerations would 
dictate a lack of affinity for DNA, at least in the centre 
of the double helix. Antimalarial potency in the range
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0-4-0-64 |am fo r  c o m p o u n d  5 c o n f ir m s  th a t th er e  m u st b e  
s i te s  o f  a c t io n  o th e r  th a n  DNA.
This observation is reinforced by a consideration of the 
antimalarial potencies of compounds 6-12, which have 1C50 
values in the range 0-35-87-9 pM. None of these analogues 
shows any affinity for DNA. consistent with an inability to 
tolerate bulky groups at the intercalation site. However, 
there must be a site of action which is more tolerant 
of bulk at position 13, given the IC50 value 0-60 pM for 
compound 1! which has a fragmental mass at C l3 of 149.
Wc conclude that berberine is an antimalarial alkaloid 
with a range o f biological activities. Until now none of 
these activities has been correlated with its antimalarial 
action. These results show, for a range of berberine 
analogues, a weak correlation between antimalarial activity 
and intercalation into DNA. None o f the analogues shows 
a strong affinity for calf thymus DNA and several with no 
demonstrable affinity at all show antimalarial effects at sub­
microgram concentrations. However, three o f the analogues 
with some DNA affinity also show the highest antimalarial 
activity. It is possible that there is a dual mode of action in 
which DNA binding contributes to one mechanism only.
A feature of the antimalarial data is the correlation 
between the IC50 ratio for the protoberberines, comparing 
chloroquinc-resistant and -sensitive strains of P. falciparum, 
with the data for chloroquine itself. There appears to be 
some level o f cross-resistance, even though the protozoa 
have not been previously exposed to the protoberberines.
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Short communication
Separation o f p d (G C )p  from  pd(A T ) l2 by free solution capillary 
electrophoresis
Imad I. Hamdan, Graham G. Skellern, Roger D. Waigh1'
Department o f  Pharmaceutical Sciences. University o f Strathclyde, Glasgow G l IXW. UK
Abstract
The two synthetic self complementary oligonucleotides pd(A T),, and pd(G C ),, were separated fay free solution capillary 
electrophoresis (CZE) using simple borate buffers. The effects of pH (7 .5 -9 ) and the concentration of the buffer (0 .03-0.35 
M ) were investigated. Higher pH values and buffer concentrations led to better resolution and longer migration times, the pH 
having a more pronounced effect on the separation than the concentration of the buffer. It is proposed that the conformation 
and effective length o f the oligonucleotides may have a role in their separation in free solution capillary electrophoresis. 
© 1998 Elsevier Science B.V.
Keywords: Oligonucleotides
1. Introduction
Synthetic oligonucleotides are used extensively in 
biochemistry and molecular biology as probes for 
gene isolation, primers for DNA sequencing and for 
template amplification. The emergence o f  the anti­
sense nucleotides as potential therapeutic agents [ I ] 
has stimulated further research into the synthesis and 
modification o f oligonucleotides [2,3]. Thus fast and 
reliable methods for the quality control o f oligo­
nucleotides and modified analogues are necessary. 
HPLC (for short oligonucleotides) [4,5] and capillary 
gel electrophoresis (6-91 have been used.
With the use o f  a sieving medium, e.g., cross- 
linked polyacrylamide [7,10.1, single base resolution 
(separation o f oligonucleotides differing by one 
nucleotide in length) is readily achievable for oligo­
mers in the range 3 0 -6 0  nucleotides. If capillary
Corresponding author.
zone electrophoresis (CZE) is used without a sieving 
medium (free solution) the primary separation mech­
anism is primarily a function o f the charge to mass 
ratio o f the analytes. Since oligonucleotides above 
ca. 15 bases have almost the same charge to mass 
ratio, they are expected to have similar electro­
phoretic mobilities in free solution (CZE) almost 
irrespective o f length [7,11,12] and the presence of a 
sieving medium would be expected to be necessary 
to achieve separation. Even more challenging is the 
separation o f oligonucleotides with identical lengths 
but with different base composition (base specific 
recognition). With capillary affinity gel electropho­
resis (cAGE), in which an affinity ligand is incorpo­
rated into the gel matrix, e.g., poiy(9-vinyladenine) 
[13,14], oligomers o f different base composition 
have been separated by their differential interactions.
In this Short Communication we describe the 
separation o f two 24-mer oligonucleotides [pd(AT)l2 
and pd(GC)n ] in free solution CZE with an un-
0 0 2 1 -9 6 7 3 /9 8  /  $ 19.00 ©  1998 E lsevier Science B.V. All rights reserved. 
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was washed after each run tor 1 min with distilled 
water followed by I M  NaOH for 1 min. Oligo­
nucleotides were detected and identified using high 
speed scanning in the UV region (2 0 0 -350  nm) and 
the elcctropherograms were recorded at 260 nm.
3. Results and discussion
The 24-mer oligodeoxynucieotidcs pd(A T),, and 
pd(GC)l2 were chosen as model intermediate-length 
self-complementary oligonucleotides that are long 
enough to complete one hairpin turn to form the 
B-form DNA helix. Starting with a total borate 
concentration (TBC) of 0.22 M  at pH 7.5, little 
separation was obtained. The order o f migration of  
the oligonucleotides was determined from the UV 
spectra of the peaks in the region 2 0 0 -3 5 0  nm. As 
the two oligonucleotides have distinctive UV spectra 
it was confirmed that pd(AT),, passes the detector 
before pd (G C ),,. When the TBC was increased from 
0.22 to 0.35 M  with the pH constant at 7.5 a 
significant improvement in resolution was obtained 
with only a small increase in migration time (Table 
1). However complete separation of the two oligo­
nucleotides was not achieved even at a TBC o f 0.35 
M.
As sodium tetraborate solutions (0.02 M )  were 
adjusted to pH 7.5, 8.0, 8.5 and 9.0 with 0.5 M  boric 
acid the resulting TBC changed to 0.22, 0.15, 0.09 
and 0.03 M , respectively (Table I ). From the results 
at pH 7.5, it would be expected that these buffer 
solutions would show an improvement o f resolution 
at higher ionic strengths if the pH had no effect on 
the separation. However, the separation improved 
greatly with increasing pH, in spite o f decreasing 
ionic strengths (Table 1), showing that pH changes 
had a more significant effect on resolution than the 
ionic strength o f the buffer. The selective effect o f 
pH on the separation o f oligonucleotides has previ­
ously been reported [15] with crosslinked-poiy- 
acrylamide-gel filled capillaries, an optimum sepa­
ration o f three different oligonucleotide decanters 
being achieved at pH 6 [15].
In order to test if the combined effect o f  higher 
ionic strengths and higher pH values could lead to 
better resolution, 0.08 M  sodium tetraborate solu­
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Fig. I. Sam ple d ec irophcrogfam s o f  an equim olar m ixture of 
p tl(C iC ),. and p d (A T ),,  obtained w ith 0.08 M sodium  tetraborate 
solution adjusted to different pH values (Table 1). (A ) pH 7.5 , (B ) 
pH 8.0, (C ) pH 8.5, (D ) pH  9.0. Peaks: l= p d (A T ) ,, ;  2 =  
p d (G C ),,.  Conditions: Free solution C Z E . applied voltage—25 kV, 
untreated silica capillary o f  total length  40 cm  and effec tive length 
n  cm .
0.5 M  boric acid giving solutions o f 0.35, 0.29, 0.22 
and 0 1 4  (Af) TBC. The results (Fig. 1) show that the 
effects o f ionic strength and pH can be combined to 
produce yet better resolution with baseline separation 
being obtained at pH 8.0, 8.5 and 9.0. Migration 
times were found to change considerably with 
changes in pH (Fig. 1). It should be noted that at pH 
9 the current was higher than the maximum limit 
(100 p-A) for the applied voltage (25 kV) which 
resulted in an automatic adjustment of the applied 
voltage to 20 kV thereby causing a doubling o f the 
migration times and significant band spreading. The 
differential peak broadening observed in Fig. ID 
together with the pH dependence o f the UV ab­
sorbance o f the nucleotide bases [16] are responsible 
for the observed changes in relative peak height.
In all cases increasing the ionic strength o f the 
buffer and/or the pH produced an increase in the 
average current during the run. Deleterious Joule 
healing effects on the separation are unlikely except 
at pH 9 and 0.14 M  TBC since the capillary 
temperature was controlled at 20°C and the recorded 
currents were less than 100 p.A.
Baseline separation was obtained without any 
sieving medium at 0.22 M  TBC and pH 8.5 in less 
than 10 min (Fig. 1C). Using several capillaries from 
different batches, the results were reproducible with 
only slight differences in resolution from one capil­
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lary to another, irrespective o f the order o f injection 
(i.e. high to low pH or vice versa). Good migration 
time reproducibility was obtained at 0.22 M borate 
and pH 8.5 with a relative standard deviation o f less 
than 2.5% for the same capillary.
These results were not expected according to the 
charge-to-mass ratio concept which is the current 
basis for explaining separation by CZE, because the 
two 24-mers would be expected to have the same 
charge-lo-mass ratio in the pH range studied [17], 
Moreover, the separation was improved by increas­
ing the ionic strength of the buffer at constant pH 
(Table 1) which is consistent with the expectation 
that the separation is not induced by differential 
ionisation o f the oligonucleotides.
It would seem likely that the conformation o f the 
oligonucleotides may have a role in their separation. 
In a detailed study (18J it has been established that: 
(a) the minor groove is wide in G:C and mixed 
sequence B-DNA but narrow in hetero- or homo­
polymer A:T sequences and (b) propeller twist is low  
for G:C base pairs and may (but need not) be high 
for A:T base pairs. More specifically it has been 
reported that poly d(GC)-poly d(GC) can undergo 
salt induced conformational changes 119| which have 
been shown to be a transition from the A or B right 
handed conformation to the left handed Z conforma­
tion f20J. It has also been found that this transition 
occurs with poly d(G C )poly d(GC) but not widi 
poly d(AT) poly d(AT) (21,22), Thus differences in 
the helix conformation and hence overall shape 
might be responsible for the separation,
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ABSTRACT
Free solution capillary electrophoresis (FSCE) has been 
used to separate two non-self-complementary 12mer 
oligonucleotide duplexes: d(AAATTATATTAT)d(ATAA- 
TATAATTT) and d(GGGCCGCGCCGC)d(GCGGCGCG- 
GCCC). Titration of mixtures of the two oligonucleotides 
with model intercalators (ethidium bromide and 
actinomycin D) and minor groove binders (netropsin, 
Hoechst 33258 and distamycin) has shown the suitability 
of FSCE as a method to study the sequence selectivity 
of DNA binding agents. Binding data have shown 
cooperativity of binding for netropsin and Hoechst 
33258 and have provided ligandrDNA binding ratios for 
all five compounds. Cooperativity of netropsin binding to 
a 12mer with two potential sites has been demonstrated 
for the first time. Ligands binding in the minor groove 
caused changes in migration time and peak shape 
which were significantly different from those caused  
by intercalators.
INTRODUCTION
There is a wide range of established techniques for the study o f 
ligand-DNA binding, from the simple measurement o f UV  
absorption and melting temperature to demanding but highly 
informative methods using NMR and X-ray crystallography 
( I -4 ). In general, separation techniques are not used, with the 
exception o f footprinting, in which gel electrophoresis is used to 
separate DNA fragments o f  different lengths and to compare the 
patterns obtained after DNA cleavage in the presence and absence 
o f a suspected binding species (5-6).
DNA footprinting has recently been improved to allow 
quantitative comparison o f the affinity o f a ligand for different 
base pair sequences. Quantification has demonstrated remarkable 
selectivity o f binding, for example showing a preference for 
binding of netropsin, distamycin and Hoechst 33258 to AATT 
and AAAA rather than T IA A  and TATA, in contrast to previous 
general findings o f a preference for AT over GC sequences (7). 
Selectivity o f binding is o f the utmost importance in designing 
new ligands for the treatment o f  disease, Footprinting has been 
the best method for this puipose for a number of years, but suffers 
from some experimental disadvantages where large numbers o f  
compounds have to be tested. For simple intercalators the 
sequence preference is more difficult to detect by standard
footprinting methods, since they dissociate rapidly from the 
binding sites (8-10).
In the present paper we describe a capillary electrophoresis 
method which is fast, economical and highly informative. The 
development o f such a method for the comparative study o f DNA  
binding affinity, using a competition experiment, required that 
oligonucleotides o f different base pair sequence be separable. 
While there have been reports o f electrophoretic separations 
based on length, down to 1 bp resolution, using gel-filled capillaries 
(11), there were no reports of sequence-based separation other than 
those using affinity labelling (12), which was not suitable for our 
puipose. In preliminary studies we were surprised and gratified 
to find that the oligonucleotides d(AT)i2  and d(GC)i2  were 
separable on a simple silica capillary (13), using borate buffer at 
pH 8.0-8.5.
When we attempted to use d(AT)i2  and d(GC)i2  in a model 
experiment to test whether capillary electrophoresis could be used 
to detect selective ligand binding, the results were encouraging. 
Unfortunately, the electropherograms showed multiple peaks for 
the oligonucleotides in the presence o f  DNA binding ligands 
which we attributed to the propensity o f these self-complementary 
oligomers to associate in different ways, i.e. hairpin loops as well 
as interstrand base pairing. On this basis we designed two directly 
analogous non-self-complementary AT and GC dodecamers, 
with a random element in the sequence. The two double-stranded 
oligomers d(AAATTATATTAT)d(ATAArArAArTT) and d(GGG- 
CCGCGCCGC) d(GCGGCGCGGCCC) were used for tire ligand 
binding studies, initially in competition experiments and then 
singly when it became apparent that a large amount o f useful 
information was obtainable.
MATERIALS AND METHODS 
Materials
Boric acid (reagent grade), sodium tetraborate decahydrate 
(electrophoretic grade), actinomycin D (AcD), ethidium bromide 
(EtB), distamycin (distamycin A, Dst) and Hoechst 33258 (Ht) 
were purchased from Sigma Chemical Co. (St Louis, MO). 
Netropsin (Nt) was a gift from Dr A.R.Pitt (University o f  
Strathclyde). The non-self-complementary oligonucleotides 
d(A AATTATATTAT) d(ATAATATAATTT) (AT 12mer) and 
d(GGGCCGCGCCGC) d(GCGGCGCGGCCC) (GC 12mer) 
were obtained as single strands from Cruachem Ltd (Glasgow, 
UK). Concentrations o f the oligonucleotides were measured by
*To whom correspondence should be addressed. Tel: +44 141 548 4355; Fax: +44 141 552 6443; Email: pharmacy@strath.ac.uk
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LTV spectrophotometry at 260 nm using the molar absorptivities 
provided by the supplier. Samples o f the oligomers were diluted 
in distilled water (0.5-1 ml) and stored at -2 0  C until use. The 
single-stranded oligonucleotides were mixed in equimolar 
amounts directly before sample preparation for all experiments.
Capillary electrophoresis (CE) separations
Separations were carried out using a TSP-CE1000 capillary 
electrophoretic separation system (Thermo Separation Products, 
USA). Data were acquired and processed using OS/2 Warp v.3 
software. Untreated fused silica capillaries (375 pm O.D. and 50 pm
I.D.; Composite Metal Ltd, UK) were used with an effective 
length o f 32 cm and a total length o f 40 cm. The applied voltage 
was 25 kV and the capillary temperature was maintained at 20 ±  
0.1 C. Oligonucleotides were detected and identified using high 
speed scanning in the UV region (200-350 nm) and the 
electropherograms were recorded at 260 nm. Buffer solutions 
were prepared by adjusting the pH o f 0.02 M and 0.08 M sodium 
tetraborate solutions to 7.5 and 8.0 using 0.5 M boric acid, giving 
total borate concentrations (TBC) o f 0.22 and 0.3 M. Sample and 
buffer solutions were prepared by milli-Q water purification 
(Millipore, Bedford, MA) and filtered through 0.2 pm pore size 
filters (Whatman International Ltd, UK). Free solution capillary 
electrophoresis (FSCE) showed our sample o f AcD to be 87% 
pure, a figure which was used in subsequent calculations o f 
binding ratios.
Competition experiments
Equimolar mixtures (10 pmol/pl) o f each of the AT 12mer and 
GC I2mer single strands were incubated (1 h) with increasing 
concentrations o f ligand, producing ligand to oligonucleotide 
(12mer duplex) ratios (r) in the ranges 1:0.0-1:7 for AcD, 
1:1-1:15 for EtB and 1:1-1:5 for all minor groove binders (Dst, 
Nt and Ht). Electropherograms were obtained for all samples with 
a control sample (zero drug) injected before each ran. All 
injections were made hydrodynamically for 5 s. For EtB, NaCl 
was added to give a final concentration o f 0.02 M in the 
incubation mixture prior to elecU ophoresis.
Individual titration experiments
The individual oligonucleotide single strands were incubated for 
1 h at room temperature with increasing concentrations o f the 
drag and electropherograms obtained in the same way as for the 
competition experiments. All experiments were carried out in 
tr iplicate (at least) and average values were used to obtain the 
var ious plots. Peak height was used rather than peak area because 
there was not enough resolution to permit peak area quantification; 
calibration curves were constructed for samples containing 
increasing concentrations o f  equimolar mixtures o f AT 12mer and 
GC I2mer to ensure the presence o f a quantitative relationship 
between peak height and the amount o f the oligonucleotide and 
were found to be linear in the range 2.5 -20  pmol/fxl. The relative 
standard deviations (RSD) for the peak height method (n = 10) o f  
an equimolar mixture o f AT 12mer and GC 12mer (at 
2.5 pmol/|i.l) were found to be <5.2% for the AT 12mer and 
<6.6% for the GC 12mer.
RESULTS AND DISCUSSION
CE is a relatively new analytical technique which is based on the 
separation of analytes in microcapillaries (10-100 pm I.D.) under 
the influence o f a high electric field. The advantages of CE 
include speed, quantification, use of an aqueous environment and 
low sample consumption. Several reports have described the use 
of CE as a method to study ligand-macromolecule interactions, 
including drug-DNA (14), drag-protein (15) and antigen-antibody 
interactions (16). There have been no published studies on the 
interaction o f small molecules with DNA by FSCE.
In order to evaluate the suitability o f the FSCE method, 
well-studied compounds representing the two main types of 
reversible interaction with DNA (intercalation and minor groove 
binding) were chosen. AcD, with definite specificity to sequences 
containing GC base pairs (17,18), and EtB were chosen as typical 
intercalators. Dst, Ht and Nt, which possess high specificity for 
AT-containing sequences (7,19), were chosen as minor groove 
binders.
Two non-self-complementary oligonucleotide duplexes were 
designed to examine the potential o f the technique: d(AAATTA- 
TATTAT)-d(ATAATATAATTT) (AT 12mer) and d(GGGCCGC- 
GCCGC) d(GCGGCGCGGCCC) (GC 12mer). The AT 12mer 
and GC 12mer were chosen so that: (i) one complete turn o f  DNA  
duplex was available for binding; (ii) the non-self-complementary 
nature of the oligonucleotide duplexes precluded the possibility 
o f hairpin formation, which was found to complicate the analysis 
(unpublished data); and (iii) the oligonucleotides provided 
general GC and AT base pair combinations which served as 
templates for the sequence preference o f DNA binding agents. A 
previously developed method (13) was found to be satisfactory 
for the separation of the AT 12mer and GC 12mer using borate 
buffer at pH 7.5 and 0.22 M TBC.
For four o f the ligands studied (AcD, Nt, Dst and Ht) it was 
sufficient to prepare mixtures of the oligomer(s) and ligand in 
distilled water prior to electrophoresis: in general, peak shape is 
improved if the sample is o f low ionic strength (20). Under these 
conditions the AT 12mer annealed only when bound to ligand (Nt, 
Dst or Ht). In the absence o f a stabilizing ligand the single AT 
strands annealed on the column: variation in pH allowed the 
separation o f excess single-strand from duplex, demonstrating 
duplex formation. UV spectra of eluted AT duplexes coinplexed 
with ligands (Fig. 5) were characteristic (21).
AcD did not complex with the AT 12mer, resulting in 
electropherograms in which the AT was unaffected by increasing 
concentrations o f AcD. Addition o f NaCl to the pre-column 
incubate to bring about AT annealing did not affect this result, the 
only difference being slight broadening o f the oligomer peaks 
even in the absence o f AcD. With EtB it was necessary to add 
NaCl to the pre-column incubate, otherwise there appeared to be 
no binding to the AT 12mer, which in distilled water would not 
anneal even in the presence of EtB.
Intercalators
Actinomycin D. Mixtures and individual samples o f the AT 12mer 
and GC 12mer were titrated with A cD  and electropherograms 
obtained at various drug to oligonucleotide ratios (r); selected 
electropherograms are shown in Figure 1. As expected (17,18), 
the electropherograms show selective binding to the GC 12mer 
with no sign o f  binding to the AT 12mer. This is inferred from the
2 1 1
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Figure 1. Electropherograms showing the competition experiment of AT 12mcr 
and GC 12mer with actinomycin D. Ratios of AcD per 12mer duplex (r) are 
indicated. Peaks: I, free AT I2mer; 2, free GC 12men 3, AcD-GC 12mer 
complex form(s); 4, AeD-related substances; 5, excess AcD. Buffer, 0.22 M 
TBC, pH 7.5.
gradual disappearance of the GC peak and the emergence o f a 
broad diffuse peak with a shorter migration time than that o f the 
free GC peak. This broad peak was confirmed to be a complex of 
GC with AcD by UV spectral scanning. The broadness o f  the 
peak may be attributable to some dissociation o f the complex 
during passage through the column and/or to different modes o f  
binding.
In order to obtain quantitative binding data titration experiments 
were carried out for the GC 12mer with AcD. A plot o f the 
percentage peak height of the GC 12mer compared with that o f  
the GC 12mer in a control sample (no drug added) against r 
provides an estimate o f the binding curve (Fig. 2), where r is the 
molar ratio of the added drug per GC 12mer duplex.
Given that the binding constant o f AcD to a representative 
oligonucleotide was 1.5 X107/M (22), it is reasonable to assume that 
all the added drug would be in the bound form up to the saturation 
point. The stoichiometry of binding can be directly determined from 
the binding isotherm at the complete disappearance of the free GC 
peak (Fig. 2), at ~ r = 5. However, the broadness of the peak for the 
complex may indicate different affinities o f binding for the five or 
more molecules of AcD which bind to each GC 12mer, with at least 
one AcD dissociating during electrophoresis. Possible sites are 
indicated by parentheses in tire sequence : 5'-G()GG()CCG()C-
Figure 2. Binding isotherms of actinomycin D (•❖) to GC 12rner and ethidium 
bromide to both AT 12mer (O) and GC 12mer ( • )  obtained by individual 
titration experiments. Peak height of the remaining GC 12mer as a percentage 
of that of a control sample is plotted against r (molar ratio of the drug per GC 
12mer). The peak height of GC 12mer sample with no drug (injected 
immediately before the sample) was taken as 100%. Buffer, 0.22 M TBC, 
pH 7.5. Error bars show relative standard deviations. For EtB, NaCl (0.02 M) 
was added to all samples.
G ( ) C C G 0 C - 3 '.  O f these, four are expected G C  sites and one is an 
unusual GG site, for which there is a precedent (23). Assuming 
five binding sites, probability theory predicts that at 40% 
occupancy there should be 8% free oligomer. Experiment (Fig. 1) 
shows 57% free oligomer at 38% occupancy (r = 1.9), showing 
a high degree o f cooperativity in the binding of AcD to this base 
pair sequence. The G C  12 mer used in the present study was 
designed to test the FSCE method; more detailed information 
about AcD binding could be gained from oligomers with fewer 
binding sites.
Ethidium bromide. The data for EtB were treated in the same way 
as for AcD. Earlier studies on EtB reported the compound to have 
no definite sequence preference (24). However footprinting at 
4 C induced marked changes in the pattern o f cleavage (10) and 
the weakest binding was observed for poly(dA) sequences. In the 
present study, at 20 C, there was no clear preference (Fig. 2).
The binding curve for EtB plateaus above five molecules of 
EtB to both GC and AT 12mers (Fig. 2). At r  > 5 no further 
changes were observed for the oligomer peaks and excess free 
EtB started to appear in the electropherogram (Fig. 3). There are 
two notable differences between the electropherograms for AcD  
and EtB. With AcD, complexes were formed which were 
sufficiently stable to reach the detector, with different migration 
times from the free oligomer, so that the height o f the free 
oligomer peak reached zero (Fig. 2) in die presence o f sufficient 
ligand. With EtB, the complex did not survive to reach the 
detector; dissociation occurred on-column, resulting in peak 
broadening for bodi oligomer and ligand. Thus, a clear peak for 
free EtB only appears above the concentration required to satur ate 
the oligomer (Fig. 3). Beyond this point, there is no further peak 
broadening effect on die oligomer and the oligomer peak height 
plateaus at a non-zero value (Fig. 2).
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Figure 3. Topical electropherograms for equimolar mixtures of AT 12tner and 
GC 12mer incubated with increasing concentrations of ethidium bromide. 
Ratios of EtB per oligonucleotide 12mer duplex (r) are indicated. Peaks: I, AT 
I2mcr; 2, GC 12nter, 3, unknown; 4, excess EtB. Buffer, 0.22 M TBC, pH7.5.
Figure 4. Typical elccuopherograms for equimolar mixtures of AT 12mer and 
GC 12mer incubated with increasing concentrations of netropsin. Ratios of 
netropsin per oligonucleotide 12mer duplex (r) are indicated. Peaks: 1, free AT 
12mer; 2, free GC 12mer; 3, netropsin-AT 12mcr complex. Buffer, 0.22 M 
TBC, pH 7.5.
Minor groove binders
The competition experiment for the oligonucleotide mixture with 
the minor groove binder Nt shows a clear preference for the AT 
12mer over the GC 12mer (Fig. 4), as seen from foe gradual 
decrease in the peak area (and height) o f the AT 12mer and foe 
appearance o f tin AT 12mer-drug complex peak until no further 
AT 12mer remains, while the GC 12mer is not altered. In order 
to make sure that the GC 12mer did not form complexes which 
were not separated from foe free GC 12mer, UV spectra were 
obtained at different points on the GC 12mer peak (i.e. peak 
slicing). These spectra were identical and characteristic o f the GC 
12mer, indicating the presence of only one species. Since Nt and Dst 
complexed to DNA are known to exhibit UV maxima at -320 nm 
(21), the ability to obtain UV spectra o f  the eluting peaks is a 
powerful tool for examining complex formation.
The AT 12mer-Nt complex appears in Figure 4 as a well-defined 
peak, with a longer migration time than the free AT 12mer,
although not separated to baseline. Attempts to achieve complete 
separation o f foe complex by changing foe concentration o f the 
buffer and/or the pH (7.5-9.0) enhanced foe resolution between 
the free AT 12mer and GC 12mer, but only brought about a si ight 
improvement in foe separation o f the free and complexed forms 
of the AT 12mer.
Similar electropherograms to that shown in Figure 4 were 
obtained for titration o f the oligonucleotide mixture with Ht and 
Dst, showing foe clear preference o f  the drugs for the AT 12mer. 
In each case the new peak, which had a migration time longer than 
the free AT 12mer, was confirmed to be the complexed form o f  
foe AT 12mer (with either Nt, Dst or Ht) by obtaining foe UV 
spectra (Fig. 5), which showed the characteristics o f minor 
groove binder-DNA complexes (21).
The experiment was repeated with foe AT 12mer and GC 12mer 
separately. In order to obtain quantitative binding data the peak 
height o f the remaining (free) AT 12mer as a percentage o f foe 






Figure 5. Normalized UV spectra of free Ar 12mer (....) and AT !2mer
complexed to netropsin (- - -). distamycin (-----) and Hoechst 33258 (—).
Buffer, 0.22 M TBC, pH 7.5.
remaining free oligonucleotide. A calibration curve was constructed 
using solutions o f equimolar mixtures o f AT I2mer and GC 
12mer in a similar way to that for EtB and AcD. Binding curves 
were obtained by plotting the peak height o f the AT 12tner in the 
sample (at each r value) divided by the peak height o f  the AT 
12mer control (r = 0), which was injected immediately before the 
sample, against the molar ratio (/ ) o f the added drug per 12mer 
(Fig. 6). Since all three minor groove binders (Ht, Nt and Dst) bind 
strongly to AT-containing oligonucleotides (Ka = I x  10-6 to 
1 ()~y/M) (25,26), the unbound drug at each o f the titration points 
is negligible, so that the stoichiomeUy o f binding can be obtained 
directly from the binding curves. The binding curves in Figure 6 
show a binding stoichiometry o f two drug molecules per AT 
12mer for each of the three compounds at saturation, which is in 
veiy good agreement with the literature data (27,28). However, the 
plot in Figure 6 shows different binding isotherms for Nt, Ht and Dst.
Netmpsin (Nt) and Hoechst 33258 (Ht). For Nt and Ht the binding 
isotherms were essentially linear (Fig. 6), which suggests one 
mode o f binding in a cooperative manner. The cooperativity o f 
binding is evident from the binding curve, since at r = 1 there was 
only 50% of the AT 12mer in the bound form. The binding of Nt and 
Ht to the AT 12mer occurs only in the 2:1 mode, i.e. binding of the 
first drug molecule facilitates binding of die second. Using NMR 
techniques it has been demonstrated diat Ht binds cooperatively to 
a 12mer oligonucleotide with two separate binding sites (28). The 
literature evidence for cooperative binding o f Nt is indirect, since 
dieie have been no binding studies widi similar' oligonucleotides 
containing only two separate binding sites (29).
Distamycin (Dst). For Dst the binding curve was non-linear- (Fig. 6), 
with a saturation binding ratio o f 2:1. Unlike Nt and Ht, at r  =  1 
there was >90% of the AT 12mer in the bound form. In this case 
it is evident that 1:1 binding occurs at lower r  values (<1) and 2:1 
binding occurs at r  > 1.
Since Dst requires a binding site o f 4 -6  bp (27,30,31), the AT 
12mer can accommodate two Dst molecules (possibly separated 
by 1-3 bp). All o f the reported studies on Dst-oiigonucleotide 
complexes were performed with oligonucleotides containing



















Figure 6. Binding curves of netropsin ( o), distamycin ($ )  and Hoechst 33258 
( • )  obtained by titrating AT 12mer with each of the drugs separately. Peak 
height of a control sample (zero drug) was taken as 100%. Buffer, 0.22 M TBC, 
pH 7.5. Error bars show relative standard deviations.
single binding sites or with polynucleotides that contain multiple 
binding sites (29,32).
It is well established that Dst can bind to single binding sites of 
at least five AT bp in 2:1 (Dst:oligonucleotide) mode (29). In 
these 2:1 complexes tire two Dst molecules bind side-by-side 
(head-to-tail) in the minor groove o f the AT sequence. Molecular 
mechanics calculations indicate that the minor groove must 
expand significantly to accommodate two drug molecules 
side-by-side (33). Since there have been no studies on the binding 
of Nt and Dst to 12mer oligonucleotides with AT combinations 
having two potential binding sites, it would be interesting to observe 
the structural detail of the complex at the molecular level using 
X-ray or NMR techniques. The present study does not permit a 
distinction to be made between linear and side-by-side binding.
C O N C L U S I O N S
CE has been successfully used to probe the sequence preference 
of DNA binding agents, including minor groove binders and 
intercalators. In agreement with previous studies, die CE method 
showed the preference of AcD for a GC-containing oligonucleotide 
and the preference o f the minor groove binders Nt, Dst and Ht for 
AT-containing sequences, while EtB showed no significant 
preference.
Since FSCE can separ ate the free and bound ligands and/or the 
free and bound oligonucleotides, it is possible to obtain estimates 
of binding curves and binding ratios. Cooperativity o f  binding can 
be directly probed by observing the change in peak height o f the 
free oligonucleotide as a function of dnig concentration, and the 
method showed such binding o f Ht to an AT 12mer in agreement 
with a previous NMR study (28). CE showed cooperative binding 
o f Nt to an AT 12mer and non-cooperative binding o f Dst to the 
same AT 12mer.
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An important feature o f  FSCE is the dependence o f the 
migration time on the conformation o f the oligonucleotide or 
oligonucleotide-drug complex (13). Since intercalating drugs 
produce changes in DNA secondary structure which are different 
from those induced by minor groove binders, a systematic 
difference in the migration time might be expected for intercalators 
and minor groove binders, provided that the complex survives as 
a single species during electrophoresis. Such differences in 
electrophoretic behaviour between minor groove binders and 
intercalators could provide empirical evidence of the mode of 
binding o f newly designed DNA binding molecules.
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The effect of 12-alkoxy modification on the in 
vitro antileukaemic activity of Af-methyl 
2,3,8,9-tetramethoxybenzo[c]phenanthridinium 
salts
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Summary: Some members of a series o f 12-alkyloxy benzo[c]phenanthridines are potent 
inhibitors o f the growth o f P388 tumour cells in vitro, with a strong dependence on the 
nature o f the 12-substituent. Analogues with a quaternary nitrogen in the side chain bind 
strongly to DNA but are less active against the tumour cells. The multi-drug-resistant cell 
line Pr8/22 shows less sensitivity to the new compounds. K.562 Human leukaemia cells 
undergo differentiation in the presence o f the benzo[c]phenanthridine derivatives with 
a structure-activity relationship which does not correlate well with potency against the 
P388 cell line.
Key words: antileukaemic/benzo(c]phenanthridine/DNA binding/synthesis/ 
structure-activity relationship
Introduction
We have described the antileukaem ic activity in mice o f  several benzo[c]phenanthridines 
obtained by a short and efficient chem ical synthesis (O lugbade et a l. , 1990; O lugbade & 
W aigh, 1996). T he previous results show ed that antileukaem ic poten cy was heavily de­
pendent on  the nature o f  the 12-substituent, where a hydroxy group abolished activity and 
m ethoxy or benzyloxy groups conferred reasonable potency (O lugbade & Waigh, 1996). We 
now  describe the antileukaem ic activity o f  19 further derivatives, designed according to  a 
m odel o f  their probable m ode o f  action.
T he natural benzo[c]phenanthrid ines fagaronine and n itid ine (F igure 1) have both  
been show n (F ang e t al., 1993; Larsen e t al. , 1993; Wang e t al., 1993) to be inhibitors o f  
topoisom erase I and II; these and other benzo[c]phenanthridines have also been shown to
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f a g a r o n i n e  1 nitidine 2
OMe
MeO
■ . f , l .  ■
R = R =
3 H 21 H
4 C H n 22 c h 3
5 C H aC H 3 23 C H 2C H 3
6 (c h 2)2c h 3 24 (c h 2)2 c h 3
7 (CH2)3CH3 25 (CH2)3 CH3
8 (CH2)3Br 26 (CH2)3o s o 2CH3
9 (CH2)4Br 27 CH2Ph
10 CH2Ph 28 (CH2)2N‘(CH3)3
11 (CH2)2N(CH3)2 29 (CH2)2N*(CH3)Pip
12 (CH2)2NPip 30 CH2CH(CH3)CH2N*(CH3).
13 CH2CH(CH3)CH2N(CH3)2a 31 (CH2)3N*(CH3)3
14 (CH2)3N(CH3)2 32 (CH2)4N*(CH3)Pip
15 (CH2)4NPip 33 (CH2)3Phthal
16 (CH2)3Phthal 34 (CH2)4Phthal
18 (CH2)6-bis 35 (CH2)3NH3*
19 (CH2)B-bis 36 (c h 2)4n h 3*
20 c h 2c o o c h 2c h 3 37 (CH2)6-bis
38 (CH2)B-bis
£1 39 c h 2c o o c h 2c h 3a  . .  ..
As racem ates
Figure 1 Structures o f the tested benzophenanthridines and their precursor bases.
bind to DNA and have been presumed to be intercalators from an assessment of the nature 
of the polyaromatic nucleus and from UV data (Baez et al., 1983; Pezzuto et al., 1983; Maiti 
et al., 1984; Smekal et al., 1984; Nandi & Maiti, 1985; Nandi et al., 1985; Kakiuchi et al., 









3 21 R=H, 22 R=Me, 23 R=Et, 24 R=Pr, 25 R=Bu 26 R=(CH2)30 S 0 2CH3, 39 R=CH2COOEt
Figure 2 Products derived from simple O-alkylation and quaternization.
available routes were too long (Mackay, 1997); in the present study we have concentrated on 
the very readily available 2,3,8,9-tetramethoxy series.
Molecular modelling (Mackay, 1990) of the known active 12-benzyloxy derivative showed 
that the 12-substituent might intrude into the minor groove of DNA, with the tetracyclic 
nucleus intercalated between the base pairs. The 12-substituent (R in the general structure, 
Figure 1) was thus an attractive site for molecular modification with a view to optimization 
of binding of the side chain in the minor groove.
M aterials and methods
12-Hydroxy-2,3,8,9-tetramethoxybenzo[c]phenanthridine was synthesized as described 
previously (Olugbade et al., 1990).
Preparation o f  the 1 2 -(O -a lky l)  derivatives o f  2 ,3 ,8 ,9 -te tram ethoxybenzo[c]phenanthrid ine  
(F igure 2 )
A lky la tio n  w ith a halide. A mixture of the phenolic benzo[c]phenanthridine 3 (600 mg,
I.64 mmol) and 60% sodium hydride in oil dispersion (200 mg, 4.9 mmol) in dry di- 
methylformamide (10 ml) was stirred under nitrogen for 20 min. The alkyl or benzyl bromide 
(2.00 mmol) was added and the mixture was stirred under anhydrous conditions for 24 h. The 
reaction mixture was diluted with 5% sodium hydroxide solution, extracted with chloroform, 
dried over anhydrous magnesium sulphate, filtered and the solvent removed under vacuum. 
The residue was redissolved in chloroform (5 ml), added dropwise to acetone and collected 
by filtration. The properties of the products (6 , 7 and 10) are shown in Tables I and
II. Thin-layer chromatography of the products on alumina using chloroforrmethanol 9:1 
indicated the presence of a single compound in each case.
A lky la tio n  w ith a diallcyl su lphate. A mixture of the phenolic benzo[c]phenanthridine 3 
(600 mg, 1.64 mmol) and 60% sodium hydride in oil dispersion (200 mg, 4.9 mmol) was stirred 
in dry dimethylformamide (10 ml) under nitrogen for 20 min. The dialkyl sulphate (2.0 mmol) 
was added and the mixture stirred under anhydrous conditions for 24 h. The reaction mixture 
was diluted with 5% sodium hydroxide solution, cooled and collected by filtration. The
2 1 8
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Table 1 Yields, melting points and MS data for benzo[c]phenanthridines
Cpd Yield Mp (°C ) M S  m/7. (% ) [ FAB/ “
4 78 270-2 379(100),365(9)
5 85 275 393(100),378(12),364(29)
6 80 261-5 407(33),392(7),378( 13),364(33)
7 80 254 421(60),378( 18),364(26)
8 73 162-5 487(43),485(42),405(92),364(100)
9 70 186 501 (74),499(74),419( 18),364(54)
10 62 203-6 455(54),364(100)
11 80 189-193 438(15),437(63),72( 100),58(52)
12 83 175 476(3),365(6), 112(100),98(43)
13 75 162-5 464(27),463(39),379( 14),364( 16), 100( 100)
14 78 180 451 (36),450(42),365(28),86( 100),58(89)
IS 72 178-180 505(6),364(42), 140( 100), 111 (16),98(78)
16 87 195 552(55),364( 13), 188( 100), 160(84)
17 65 201-4 420(4), 160(58)
18 78 167 813(45),365(23)
19 72 171 841(40),365(42)
20 60 176-7 452(93),394(21),364(100)
22 90 235 379( 100),364( 18) [M,l]
23 92 238 408(4),394(72),364(22) [M,7]
24 90 229 407(66),364(83) [M,3]
25 93 230 421 (28),378( 13),364(21) [M,7]
26 88 285-290 406(24),364(5) [M,0.1]
27 82 246 455(38),381(19),364(96) [M,0]
28 80 242-6 451(17),406( 14),379(9), 144( 100) [M+MeS03,5]
29 85 228 476(20),393( 13),379(6),365( 18),225(26), 112(100),98(68) [M,6]
30 88 238 479( 15),420( 18),379( 12),364(25), 100( 100),58(39) [M,5]
31 90 240 465(20),406(24),364(9), 144( 100) [M,9]
32 85 255-7 519(9),364(42),140(100),! 11 (2 1 ),98(53),84(16) [M -l,3]
33 90 245-6 552(25),365(7), 160(47) [M,6]
34 80 251 566(26),365(8), 160(84)
35 94 254 436(6),422( 17),365(24),58(58),44( 100) [M -l ,4]
36 92 255-7 452(30),451 (100),437( 17),408( 12),365( 16) [M -l, 1 ]
37 70 >310 841(22),827(100),365(52)
38 73 >310 869(24),855(70),840( 16),365(55) [M+1,10]
39 80 220 451(90),437(16),365(33),364(30) [M,4]
“Measured ion with absolute value of error in ppm.
properties o f  the products (4  and 5) are listed in Tables I and II. Thin-layer chrom atography  
o f  the products on  alum ina using chloroform :ethanol 9:1 indicated the presence o f  a single  
com pou nd  in each case.
j
Table II NMR data for 12-substituted benzo[c]phenanthridine bases'
Cpd 12-O CH r o c h 3 Ring CH N (C H ^)1 12-alkyl
4 4.05x3,4.09x2 7.35,7.41,7.72x2,8.72,9.10
5 4.36,q,7Hz 4.09x2,4.15,4.19 7.35,7.42,7.71x2,8.70,9.11 1.66,t,7Hz (3H)
6 4.33,t,6Hz 4.09x2,4.17,4.19 7.37,7.46,7.74x2,8.71,9.13 1.23,t,8Hz (3H),2.03,m (2H)
7 4,35,t,6Hz 4.09x2,4.16,4.19 7.35,7.43,7.72x2,8.70,9.11 1.10,t,6Hz (3H),1.63-2.04,m (4H)
8 4.55,t,6Hz 4.19,4.18,4.09x2 7.38,7.55,7.66,7.79,8.73,9.15 2.59,m (2H),3.78,t,7Hz (2H)
9 4.39,t,6Hz 4.03x2,4.08x2 7.29,7.55,7.66,7.77,8.70,9.12 1.54-1.97,m (4H),3.42,t,6Hz (2H)
11 4.51,t,8Hz 4.08x2,4.16,4.19 7.36,7.51,7.70,7.74,8.71,9.12 2.51 3.04,t (2H)
12 4.54,t,7Hz 4.08x2,4.17,4.19 7.36,7.49,7.69,7.74,8.71,9.12 1.59,m (6H),2.71,m (4H),3.07,t (2H)
13 4.22,t,6Hz 4.09x2,4.19x2 7.37,7.52,7.74,7.78,8.72,9.13 2.32 1.25,d (3H),1.87,m,2.35,d (2H)
14 4.43,t,6Hz 4.08x2,4.18x2 7.36,7.48,7.71,7.75,8.71,9.12 2.34 2.2 l,m (2H),2.65,t (2H)
15 4.39,t,6Hz 4.09x2,4.18x2 7.37,7.45,7.71,7.74,8.71,9.12 1.53,m (6H),1.98,m (4H),2.45,m (6H)
16 4.46,t,7Hz 4.09,4.11,4.18,4.19 7.36,7.45,7.59-7.80m (6H),8.78,9.12 2.45,m (2H),4.01,t(2H)
17 4.42,t,6Hz 4.08,4.10,4.19x2 7.36,7.46,7.50-7.78m (6H),8.70,9.15 21 l,m (4H),3.88,t (2H)
18 4.62,m (4H) 3.97,4.09,4.30,4.40 7.27,7.63,7.79,7.87,8.08,9.33 2.07-2.34,m (8H)
19 4.58, m(4H) 4.15,4.19,4.26,4.38 7.26,7.81,8.06,8.14,9.25 1.77-2.26,m (10H)
20 5.01 4.09,4.11,4.17,4.20 7.35 (2H),7.65,7.79,8.69,9.13 1.34,t,7Hz (3H),4.32,q 7Hz (2H)
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Quaternization o f the l2-(O-alkyl) derivatives of 2,3,8,9-tetramethoxybenzo[cj- 
phenanthridines: general procedure
A mixture of the dry benzojcjphenanthridine base (1.5 mmol), methyl methanesulphonate 
(3.0 ml) and diisopropylethylamine (0.9 ml) was treated at 170-180°C for 30 min under 
anhydrous conditions. The reaction mixture was allowed to cool and diluted with dry diethyl 
ether. The clear supernatant was carefully pipetted off. Absolute ethanol was added to the 
resinous material and the mixture stirred for 30 min. The yellow suspension was filtered and 
the remaining yellow powder washed successively with ethanol and dry diethyl ether. 
Recrystallization was from a mixture of methanol and chloroform (22, 27, 23, 33 and 34) or 
ethanol and chloroform (24 and 25). The properties of the products are given in Tables I 
and 111.
Preparation o f the l2-(bromoalkoxy)-2,3,8,9-tetramethoxybenzo[c]phenanthridines 
( Figure 3)
A mixture of the sulphate salt of the phenolic benzo[c]phenanthridine 3 (1.5 g, 3.27 mmol) 
and anhydrous potassium carbonate (1.9 g, 14 mmol) in dry acetone (20 ml) was refluxed for 
30 min. The dibromoalkane (17 mmol) was added and the mixture was refluxed for 24 h 
under anhydrous conditions. The reaction mixture was cooled and the acetone removed 
under vacuum. The residue was diluted with a 3:1 mixture of water and ethanol (50 ml) and 
filtered to leave a pale brown product which was washed with 5% sodium hydroxide solution 
and then with ethanol. The properties of the products (8  and 9) are listed in Tables I and II. 
Thin-layer chromatography of the products on alumina using chloroform:acetonitriIe 7:3 
indicated the presence of a single compound in each case.
1 2-( 4-Piperidylbutoxy) -2,3.8.9-tetramethoxybenzo [c ]phenanthridine 15
A mixture of the 4-bromobutoxy derivative 9 (500 mg, 1 mmol) and piperidine (0.3 ml, 3 
mmol) was refluxed in dry acetone (30 ml) for 40 h. The acetone and remaining piperidine 
were removed under vacuum and the brown powder recrystallized from a mixture of acetone 
and chloroform to produce a pale buff powder (363 mg, 72%). Thin-layer chromatography 
of the product on alumina using chloroform: ethanol 9:1 indicated the presence of a single 
compound, R( 0.72. Other properties are given in Tables I and II.
Direct aminoalkylation of the l2-hydroxy-2,3,8,9-tetramethoxybenzo[ c]phenanthridine 
(Figure 4)
A mixture of the sulphate salt of the phenolic benzo[c]phenanthridine 3 (500 mg, 1.09 
mmol) and anhydrous potassium carbonate (600 mg, 4.5 mmol) in dry acetone (20ml) 
was refluxed for 30 min under anhydrous conditions. The dialkylaminoalkylchloride 
hydrochloride (2.0 mmol) was added and the mixture refluxed for 24 h. The acetone was 
removed under vacuum and the remaining residue diluted with water, stirred for 20  min and 
filtered to leave a pale brown powder. Recrystallization was from methanol and chloroform 
(11, 13 and 14) or acetone and chloroform (12). The properties of the products formed 
are listed in Tables I and II. Thin-layer chromatography of the products on alumina using 
chloroform:ethanol 9:1 indicated the presence of a single compound in each case.
Table in NMR data for 12-substituted benzo[c]phenanthridine quaternary saltsa-b
Cpd 12-OCH-f OCH) Ring CH NM e C H )SO i IVMej 12-alkyl
22 4.24x3,4.38x2 7.75x2,8.14x2,8.19,9.25 5.07 3.17
23 4.53,q,7Hz 4.19x3,4.31 7.69,7.71,8.07,8.08,8.17,9.18 5.01 3.12 1.72,t,7Hz
24 4.58,t,7Hz 4.31x3,4.43 7.80,7.86,8.18,8.20,8.31,9.30 5.13 3.23 1.37,3H,t,7Hz,2.30,2H,m
25 4.58,t,6Hz 4.24x3,4.36 7.72,8.11,8.14x2,8.23,9.24 5.04 3.17 1.17, t,7Hz, 1.73-2.18,4H,m
26 4.68,t,7Hz 4.13x2,4.15,4.28 7.59,7.68,7.82,7.86,7.95,9.15 4.99 3.02° 2.28,2H,m,3.10C,3H,4.15,2H,t
28 5.30,m 4.36,4.40x2,4.54 7.54,8.08,8.15,8.33x2,9.48 5.22 3.38x2 3.69 4.47,2H,m
29 4.85,m 3.87,3.95,4.04,4.15 7.27,7.37,7.48,7.55x2,8.99 4.60 2.72x2 1,69,2H,m, 1.96,4H,m,3.20,3H,s,3 
.50-3.56,4H,m,4.06,2H,m
30 4.63,d,4Hz 4.23,4.26x2,4.38 7.76,7.85,8.03,8.14,8.17,9.30 5.08 3.14x2 3.44 1.70,3H,d,7Hz,2.90,m.
3.74,2H,d,7Hz
31 4.74,t,6Hz 4.26x3,4.38 7.76,8.08,8.14,8.15,8.17,9.29 5.07 3.17x2 3.41 2.94,2H,m,3.98,2H,m
32 4.66,t,6Hz 4.25x3,4.38 7.75,8.08,8.14,8.33x2,9.26 5.07 3.15x2 1.97,6H,m,2.08,4H,m,3.23,3H,s,3 
.52,6H,m
33 4.51,t,7Hz 4.18,4.24,4.25,4.36 7.73x2,7.84,8.10x2,9.24 5.06 2.98 2.45,2H,4.08,t,6Hz
34 4.52,t,6Hz 4.13x2,4.14,4.28 7.70x2,7.98,8.21x2,9.20 4.95 3.03 2.14,4H,m,3.92,t,6Hz
35 4.68,m 4.25x3,4.37 7.72,8.14,9.20x2,8.16x2 5.08 2.68,2H,m,3.79,2H,m
36 4.62,m 4.26x3,4.39 7.73,8.15,9.24x2,8.16x2 5.07 2.32,4H,m, 3.74,2H,m
37 4.67,t,x2 4.02x2,4.25x2,4.28x2,4.39x2 7.81x2,8.18x2,8.19x4,9.30x2 5.13x2 3.21x2 2.08-2.39,8H,m
38 4.50, t,x2 4.10x2,4.18x2,4.20x2,4.31 x2 7.69x2,8.06x2,8.09x4,9.18x2 5.03x2 3.09x2 1.14-2.15,1 OH,m
39 5.50 3.78,4.10,4.13,4.45 6.58,6.76,7.75,7.89,7.99,9.90 4.79 2.57 1.39,3H,t,7Hz,4.38,2H,q,7Hz
aAll in trifluoracetic acid except 26 in CDC1/TFA, 29 in D20  and 39 in CDC13. 























Figure 4 Synthesis o f derivatives with quaternary ammonium side chains via a halo­
alkylamine reaction.
Preparation o f  the  1 2 -(p h tha lim idoa lkoxy )-2 ,3 ,8 ,9  te tra m eth o xyb en zo f c] phenanthrid ines  
( Figure 5 )
A mixture of the phenolic benzo[c]phenanthridine 3 (500 mg, l .26 mmol) and 60% sodium 
hydride in oil dispersion (150 mg, 3.67 mmol) in dry dimethylformamide (10 ml) was stirred 
under nitrogen for 20 min. The A-(bromoalkyl)phthalimide (5 mmol) was dissolved in a 
minimum amount of dry dimethylformamide and added to the mixture, which was then 
stirred at 80°C for 16 h under anhydrous conditions. The reaction temperature was then 
reduced to room temperature and stirred for a further 24 h. The mixture was extracted with 
chloroform, washed with brine, dried over magnesium sulphate, filtered and concentrated 
in vacuo to leave a brown residue. The residue was dissolved in hot acetone followed 
by precipitation with diethyl ether. The product was collected by filtration. Properties of the 
reaction products (16 and 17) are given in Tables I and II. Thin-layer chromatography of 
the products on alumina using ethyl acetate:petroleum ether (bp 60-80°C) 9.5:0.5 indicated 






















35 n=3, 36 n=4
Figure 5 Synthesis o f derivatives with side chain amino groups via phthalimide 
intermediates.
H ydrazino lysis  o f  the ph tha lim ide  group
To a boiling solution of the quaternary 12-(phthalimidoalkoxy) derivative (0.38 mmol) in 
96% ethanol (10 ml) was added hydrazine hydrate (0.5 ml). On addition of the hydrazine, the 
yellow suspension immediately dissolved. A precipitate started to form after 3 h of refluxing. 
After 5 h half of the ethanol was removed under vacuum and the mixture cooled to 0°C. 
Four drops of conc. HC1 and four drops of water were added and the mixture was refluxed 
for a further 45 min. The solvent was removed under vacuum to leave a yellow powder which 
was recrystallized from a mixture o f ethanol and water. The properties of the products (35 
and 36) are listed in Tables I and II.
l2 - (E th o x y c a rb o n y lm e th o x y )-2 ,3 ,8 ,9 -te tram ethoxybenzo[ c]phenanthrid ine (2 0 ) a n d  the  
quaternary  sa lt 39
The phenolic benzo[c]phenanthridine 3 (500 mg, 1.26 mmol) and 60% sodium hydride in oil








37 n=6, 38 n=8
Figure 6 Synthesis of bis-benzophenanthridinium salts.
dispersion (150 mg, 3/67 mmol) in dry dimethylformamide (10 ml) were stirred under 
nitrogen for 20 min. Ethyl bromoacetate (340 mg, 2.05 mmol) was added and the mixture 
stirred under anhydrous conditions for 24 h. A further amount o f ethyl bromoacetate 
(340 mg, 2.05 mmol) was added and the mixture stirred for another 24 h. Dilution with 
water followed by filtration afforded a yellow product (341 mg, 60%), mp 176-177°C. 
Thin-layer chromatography of the product on alumina using ethyl acetatexhloroform 7:3 
indicated the presence of a single compound, R{ 0.60 (the R( value of the starting material 
was 0.26). The derivative 20 thus obtained was quaternized according to the general method 
to yield 39 as a yellow powder (670 mg, 80%), mp 220°C. The properties of 20 and 39 are 
described in Tables I—III.
Preparation o f  b is -(2 ,3 ,8 ,9 -te tra m eth o xyb en zo fc]p h en a n th rid in -l2 -y l)d io xa a lka n es  
(  Figure 6 J
A mixture of dry acetone, anhydrous potassium carbonate (3.0 g, 22 mmol) and the phenolic 
benzo[c]phenanthridine sulphate 3 (2.48 g, 5.4 mmol) was stirred at 75°C for 15 min. The 
dibromoalkane (2.7 mmol) was added and the mixture gently refluxed for 48 h. The mixture 
was allowed to cool and the acetone removed under reduced pressure. The residue was 
diluted with 5% sodium hydroxide and a small amount of acetone, and filtered. After 
drying, the powder was dissolved in hot chloroform, cooled and precipitated with 96% 
ethanol. The precipitate was collected by filtration to leave a pale grey powder. The 
properties of the products (18 and 19) are listed in Tables I and II. Thin-layer chromato­
graphy of the products on alumina using chlorofonn:methanol 8:2 indicated the presence of 










Q uaterniza tion  o f  the his- (2 ,3 ,8 ,9 -te tram ethoxybenzo[ c Jphenant.hridin-12-yl)  d ioxaulkanes: 
general procedure
A mixture of the dry benzo[c]phenanthridine base (1.5 mmol), methyl methanesulphonate 
(6 .0  ml) and diisopropylethylamine (1.8ml) was heated at I70-180°C for 1 h under anhydrous 
conditions. The reaction mixture was allowed to cool and diluted with dry diethyl ether. The 
clear supernatant was carefully pipetted off. Absolute ethanol was added to the resinous 
material and the mixture stirred for 30 min. The yellow suspension was filtered and the 
remaining yellow powder washed successively with ethanol and dry diethyl ether, then 
recrystallized from a mixture of methanol and chloroform. The properties of the products 
(37 and 38) are given in Tables I and III. The bromopropyl derivative 8, on treatment with 
methyl methanesulphonate, underwent substitution of bromine with methanesulphonate to 
give the sulphonate ester 26.
Fast a to m ic  bom bardm ent m ass spectrom etry
Accurate masses for final products (quaternary salts) were obtained using the FAB 
technique on a Jeol JMS-AX505 HA spectrometer with 3-nitrobenzyl alcohol as matrix. All 
bis-quaternary salts gave a major ion at MUCH3SO3 ; in one case this was the ion accurately 
measured but in all other examples M+ or M+ ± 1 was used, depending on the intensity of 
the peak.
T herm al denaturalion  m easurem ents
Highly polymerized calf thymus DNA (type 1) was purchased from Sigma Chemical Co. 
(Poole, UK) and allowed to hydrate in the required buffer over a period of 1 2 days at 4°C. 
The concentrations of the DNA solutions were determined spectrophotometrically in terms 
of nucleotide phosphorus calculated from an extinction coefficient of 6600/M cmat 260 nm. 
All experiments were conducted in 0.03 M Tris and 0.018 M NaCl buffer, pH 7.4, adjusted 
with dilute HC1. Thermal transition profiles were determined using a Philips PU 8800 
UV/IIIS spectrophotometer fitted with an Accuron SPX 876 Series 2 Temperature 
Programme Controller. Measurements were taken at 260 nm with drug:DNA ratios of 1:5 
( 10 p M drug, 50 p M DNA) in a 3 ml quartz cuvette after equilibration for 20 min. The buffer 
solution was used in the reference cell and all measurements were duplicated.
A c tiv ity  against P388 cells in vitro
For cell culture two P388 cell lines were used, one parental and the other (P388R8/22) with 
acquired resistance to daunorubicin, developed from the parental (P388) line by incremental 
challenge with the drug in vitro (McGown & Fox, 1990). The resistant cell line has been 
shown to contain amplified gP170 DNA sequence compared with the parental line. All cell 
tines were grown in RPMI medium supplemented with 10% horse serum (Gibco, Paisley, 
UK). All cell lines were mycoplasma-free and replaced from frozen stock at 3 month 
intervals. Cell viability was determined immediately before all experiments and in all cases 
was >95% as assayed by trypan blue exclusion.
Cell-survival studies were carried out following drug treatment for one cell-cycle period on
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cells in exponential growth by back extrapolation of growth curves for the 10 days following 
drug treatment. All survival experiments were carried out in triplicate.
C ell growth and  differentiation o f  K 562 cells
K562 cells were cultured in DMEM medium (Gibco, Cergy Pontoise, France) with 10% 
fetal bovine serum (Seromed, Berlin, Germany) in flasks at 37°C in a humidified 5% CO2 
atmosphere. Stocks were maintained between 3 x 104 and 8 x 105 cells/ml by dilution into 
fresh medium three times weekly. Cell growth and cell viability were determined by phase- 
contrast microscopy.
A stock solution of test compound was made up in ethanol. Drug solutions for testing 
were obtained by proper dilution with K562 growth medium. The final concentration of 
ethanol in culture medium never exceeded 0 .1%.
K.562 cells in exponential growth were plated at a concentration of 5 x 104 cells/ml in 
multiwell dishes (Nunc, Merelbeke, Belgium). Drug solutions were added at day 0. For 3 
days, cell concentration and lethality were evaluated daily in triplicate.
Dose response curves were used to determine the doses that inhibited growth to 20 (/C2o)> 
50 (/C50) or 80% (/C80) of control growth, or the dose that killed 10% (TC)0) of the cells, 
after 3 days of contact with the drug.
The number of differentiating cells was determined by scoring benzidine-positive cells; 
K562 were stained using a benzidine-H20 2 method in which cells giving an unequivocally 
positive benzidine reaction, seen as an intense blue cytoplasmic staining, are known to 
synthesize haemoglobin. An average of 300 cells was scored for benzidine positivity.
Results
The test data for the benzo[c]phenanthridines against P388 and K562 leukaemia cells are 




The simple 12-O-alkyl derivatives 22, 23, 24 and 25 were synthesized very readily from the 
general precursor 3 by use of an alkyl halide or sulphate in alkaline solution (Figure 2). The 
problem of C-alkylation at the 11-position (Olugbade & Waigh, 1996) was not observed in 
any of the present syntheses, except during benzylation to give 27 where the reaction had 
been previously studied. Following O-alkylation at position 12, quaternization was achieved 
with methyl methanesulphonate as before, using diisopropylethylamine as a proton 
scavenger. Compound 39 was obtained from 20 in an analogous manner.
For those derivatives in which a nitrogen atom was required in the side chain a variety of 
approaches were employed. Alkylation of 3 with a large excess of 1,4-dibromobutane gave 
9, which was treated with piperidine to give 15, which with methyl methanesulphonate 
(Figure 3) gave the bis-quaternary salt 32. In contrast, the best route to the piperidine 
derivative 12 was through 2-chloroethylpiperidine (Figure 4), in a direct reaction with 3,
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Table IV Effect o f benzo[c]phenanthridines on P388 and P388R8/22 tumour 
cell lines




22 0.13 4.4 33.8
23 0.08 10.0 125.0
24 0.10 5.7 57.0
25 0.11 2.07 18.8
26 0.07 1.68 24.0
28 7.5 18.3 2.4
29 4.0 10.4 2.6
30 1.6 2.8 1.75
31 4.1 6.8 1.66
32 0.69 ND
35 4.1 8.6 2.1
36 3.2 11.5 3.6
37 0.2 5.04 25.2
38 0.1 2.1 21.0
39 7.0 9.3 1.33
■’(/C J0 P388R8/22)/(/CS0 P388). 
b A/-Desmet hy 1 fagaroni nc.
giving 29 after quaternization. A  sim ilar approach using chloroalkylam ines gave 11, 13 and  
14, which on  quaternization gave 28, 30 and 31. A lkylation o f  3  w ith a large excess o f  
dib rom opropane gave 8, w hich  was itse lf quaternized for b io log ica l testing; as w ell as 
quaternization, 8 underwent substitu tion o f  brom ine w ith m ethanesulphonate to give 26.
The side chains bearing prim ary am ino groups were obtained  by alkylation o f  3  with 
brom oalk ylphthalim ides to  give 16 and 17, w hich gave respectively 33 and 34 after  
quaternization (Figure 5). T hese two quaternary salts were subjected to  hydrazinolysis to  
give 35 and 36, which were isolated as the chlorides.
T he quaternary bis-benzo[c]phenanthrid ines 37 and 38 w ere obtained  from  1,6- 
dibrom ohexane and 1,8-dibrom ooctane respectively by use o f  a 2:1 ratio o f  base to alkyl 
halide (F igure 6), giving first the bis-bases 18 and 19, which were quaternized using methyl 
m ethanesulphonate as for the sim ple O-alkyl derivatives.
A n tileu ka em ic  effects
In the series H -»  methyl —> ethyl -»  propyl ->  butyl, the greatest potency against the P388 
cell line w as observed with ethyl (com pound 23, Table IV), suggesting som e hydrophobic  
bonding and a lim iting steric constraint. A ll four alkylated derivatives showed sim ilar D N A
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Table V Effects o f benzo[c]phenanthridines on human K562 leukaemia cells
Compound ICS0 (\1m) LCi0 (\x.m) OIC (\IM) %B+ RYB* TD I
Fagaronine 3 30 3.5 70 1 8.6
OMF 6 25 8 10 0.13 3.1
Nitidine 0.4 2 2 60 0.86 1
21 10 10 3 5 0.07 -
22 6 - 15 0.21
23 5 18 4 80 1.33 4.5
25 1.4 - 30 0.43
26 1 7 0.1
27 15 15 0.21 ■
28 >10 10 3 0.043
31 >30 8 0.11 -
32 >10 >10 10 2 0.029
35 39 15 0.21
36 40 20 0.29
38 7 10 to 4 0.057 1
39 >10 10 8 0.11
Abbreviations: OMF, 0-methylfagaronine; 1C, inhibitory concentration; LC, lethal concentration; OIC, optimal 
inductive concentration; %B+, percentage of benzidine-positive cells; RYB+, relative yield of benzidine positive cells 
(%B+ analogue/%B+ fagaronine); TDI, therapeutic differentiation index (LCi0IOIC).
binding properties, as evidenced by changes in ‘m elting’ temperature on com plexation (A7'm, 
Table VI).
M odelling  show ed that a 12-substituent 3 -4  atom s long was capable o f  reaching the 
negatively charged ph osph ate backbone, so  that incorporation o f  a positively  charged  
term inal m oiety such as an am m onium  group in the side chain offered the prospect o f  
im proved D N A  binding. T h e  final step in the synthesis involves quaternization o f  the 
benzo[c]phenanthridine nucleus, so the least com plicated approach to incorporation o f  a 
positive charge into the 12-substituent was the introduction o f  a tertiary am inoalkyl group  
w hich w ould  itse lf  undergo quatern ization  at the final stage (F igures 3 and  4). Five  
quaternary am m onium  salts, 28 -32 , were ob ta in ed  in this way and all show ed  greatly  
increased A T m values, in the range 12-15°C  (Table VI), im plying considerably enhanced  
D N A  binding. However, these quaternary salts show ed activity against the P388 cell line 
(Table IV), which was reduced by 1 - 2  orders o f  m agnitude com pared w ith the sim ple ethoxy  
derivative 23. T he m ost likely explanation  for the reduced poten cy is that these  
dou ble-charged derivatives d o  not penetrate cell m em branes very well. In contrast, the 
single-charged analogues such as 23 can exist in equilibrium  with an uncharged ‘pseu d ob ase’ 
which should penetrate m em branes w ithout difficulty (Sim anek & Preininger, 1977; C aolo  
& Sterm itz, 1979; W alterova e t al., 1981; O lugbade & W aigh, 1996).
A m ino-substitu ted side chains which are not quaternary salts may exist as free bases in a 
non-polar environm ent and according to standard pH -partition theory should pass readily 
through membranes, while possessing a positive charge in aqueous solution at physiological
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Table VI Change of melting temperature o f calf thymus 
DNA at a drug:DNA ratio o f  1:5
























pH. We therefore synthesized the primary am ines 35 and 36 by an indirect synthesis through 
the phthalim ides 33 and 34 (F igure 5). However, although both 35 and 36 show ed reasonably  
high affinity for D N A  (AT m 8 °C ), this was not reflected in their potency against P388 cells, 
which w as reduced by I -2  orders o f  m agnitude com pared with the sim ple alkyl analogues  
(Table IV). N either o f  the phthalim ides show ed any affinity for D N A  (Table V I), perhaps 
because the side chain substituent is too  large; these com pou nds were not tested against the 
P388 cell line.
It is kn ow n  that b is-in tercalators m ay show  increased affinity for D N A , w ith som e  
in teresting b in d in g  properties, notably the ability to  ‘w alk’ a lon g  the D N A  w ith out  
detaching (D enny et a l., 1985). T he 12-OH group offered the prospect o f  sim ple O -alkyl-O  
linkage (F igure 6 ), to  give b is-benzo[c]phenanthrid ine an alogu es o f  the m o st p oten t  
derivative 23. We chose C~Y, and C g linking chains, giving derivatives 37 and 38. B oth  show ed  
satisfactory D N A  binding, giving the sam e A T m as 23 at h a lf the concentration (Table VI): 
there were solubility  problem s with both 37 and 38. A gainst the P388 cell line, 37 and 38  
were slightly less potent than 23 (Table IV).
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W ith a view  to further extension  o f  fu nctionality  in the 12-substituent, the e th oxy- 
carbonylm ethyl derivative 39 w as synthesized  as an interm ediate. W hen tested  for 
antileukaem ic activity 39 showed low  potency and also failed to raise the Tm o f  ca lf  thym us 
D N A . In contrast, the propyl derivative w ith a terminal m ethanesulphonate group (26) 
show ed good  affinity (AT m 8 °C) and w as marginally m ore potent as an antileukaem ic than  
23. It is possible that 26 may benefit from covalent bonding in its interactions with D N A .
A s well as the effect on topoisom erase I and II, a known property o f  fagaronine is the 
prom otion o f  differentiation in hum an K562 cells, which can be m easured by reaction w ith  
benzidine (C om oe e t al., 1987, 1988; Benoist et al., 1989). T he effects o f  som e o f  the present 
com pounds are sum m arized in Table V. The m ost significant m easurem ent is probably the 
percentage o f  benzid ine-positive cells, rather than the inhibitory concen tration . B oth  
nitidine and fagaronine are very effective in inducing differentiation, although nitidine is 
considerably m ore toxic. C om pound 23 is m ore effective than either o f  the natural products 
in this assay. W hile other synthetic  com p ou n d s in the series are m ore poten t grow th  
inhibitors, none approaches 23 in the m ore subtle property o f  differentiation: even the very 
close analogue 22 has much less effect. A lthough it is possible to induce differentiation o f  
K 562 cells by a variety o f  chem ical agents, including such sim ple com p o u n d s as 
dim ethylsulphoxide, com pound 23 does so at very low concentrations. Together w ith the 
very unusual structural specificity, the high potency indicates a very high level o f  target 
selectivity: these observations are not sim ply the consequence o f  D N A  binding, w hich is 
show n by many less potent members o f  the series.
C om paring the potency o f  the benzophenanthridines against P388 cells w ith their effects 
on K562 cells, there are som e m arked discrepancies. C om parin g /C jo  values, com pou nd  26 
is one o f  the m ost potent in both series (0.07 and 1.0 pM respectively). The relative yield o f  
benzidine positive (R Y B+) cells, however, is very low  (0.1) com pared with fagaronine (Table 
V). C om pound 22 is fairly close to 23 in potency against P388 cells (0.13 and 0.08 pM 
respectively) but has an RYB+ value o f  0.21 com pared with 1.33 for 23. C om pound 35 has 
low  potency against both P388 (4.1 pM) and K 562 cells (39 pM) but an RY B+ value o f  0.21, 
w hich is far greater than the RYB+ value for 32, which has an /C 5 0  against P388 o f  0 .60  pM. 
O verall, there is evidence that the inhibitory effects on growth may be m ediated by a different 
m echanism  from the induction o f  haem oglob in  production.
T he reduced potency show n by m any m em bers o f  the series against the m ulti-drug- 
resistant strain Pr8/22 is d isappointing. However, we are encouraged by the high potency  
and the high structural specificity against K562 cells to  continue work in this series.
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The Role of the Iminium Bond in the Inhibition of Reverse 
Transcriptase by Quaternary Benzophenanthridines
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F rance  a n d  t D e p a rtm en t o f  P h a rm a c eu tica l Sc iences , R o y a l C ollege, G eo rg e  S tree t, 
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Abstract
T he quaternary benzo[c]phenanthridines fagaronine, nitidine and 0-m eth ylfagaron in e have 
been review ed as potential antitum our and antiviral agents. T heir m ode o f  action has not 
been established, but their ability to bind w ith D N A  by intercalation is b e lieved  to be 
involved .
O f the three synthetic analogu es o f  O -m ethylfagaronine w hich  w e have synthesized , 
m ethoxidine and ethoxid ine are active against HIV-1 reverse transcriptase (IC 50 values
2 -8 /iM and 2-4 fiM  respectively) w hereas hydroxidine is inactive. O ne o f  the prerequisites  
for the enzym e inhibitory activity o f  this c lass o f  m o lecu le  is the presence o f  an im inium  
group— it is w e ll know n that a p ositive  charge on a polyarom atic nucleus facilitates  
intercalative b inding with D N A . Through U V  spectrophotom etric and m od elling  studies, 
w e have shown that the im inium  bond plays a m ore fundam ental role in en zym e inhibition  
through its susceptib ility  to nu cleoph ilic  attack— the inactive analogue hydroxid ine has a 
non-electrophilic  im inium  bond.
C onsequently, w e  have dem onstrated that im inium  bond electrop hilicity  is a parameter 
w hich  needs to be considered  in ternary com p lex  form ation w ith reverse transcriptase.
The pharm acological activ ity  o f  the b en zo |c]p h en - 
anthridines generally app lies to conditions char­
acterized by rapid cell grow th (S im eon et al 1989). 
Sanguinarine (1) and chelerythrine (2 ) (T able 1) are 
active against fungal organism s (H ejtm ankova et al 
1984) and have significant antibacterial activity  
(L enfield  et al 1981); neither has antitum our 
activity (C aolo  & Sterm itz 1979). Fagaronine (3), 
nitidine (4 ) and O -m ethylfagaronine (5 ) have been  
review ed as potential antitum our and antiviral 
agents, but do not have the b io log ica l activ ity  o f  
sanguinarine or chelerythrine (M essm er et al 1972; 
Z ee-C h en g & Cheng 1975; A risawa et al 1984; 
C om oe et al 1987, 1988). T o date, the locu s o f  
activity o f  these analogu es has not been estab­
lished, but their ability to  bind with D N A  in what 
appears to be an intercalative m ode is b e liev ed  to 
be invo lved  in their m echanism  o f  action (M aiti 
et al 1982, 1984; P ezzuto  et al 1983; Nandi &
Correspondence: S. P. Mackay, School o f Health Sciences, 
Wharaciiffe Street, University of Sunderland, Sunderland, 
Tyne and W ear, SRI 3SD, UK.
M aiti 1985; C asiano Torres & B aez  1986; Sen &  
M aiti 1994).
S in ce the 1970s, the activ ity  o f  these com pounds  
against a number o f  D N A -p rocessin g  enzym es has 
been assessed  (Seth i 1976, 1981, 1984, 1985a, b; 
Kakiuchi et al 1987; Barret & Sauvaire 1992). A 
correlation has been  established betw een  inhibitory 
activity against the R N A  tumour v iruses A M V  and 
M uLV reverse transcriptase (R T) w ith activity  
against the P388 leukaem ia cell line, because  
murine leukaem ia P 388 is an exam p le  o f  the co n ­
version o f  healthy ce lls  to tumour ce lls  by infection  
w ith an on cogen ic  v im s (P o iesz  et al 1980). Sethi 
(1981 , 1985a, b) show ed  that activ ities  w ere  
dependent on the different substituent patterns 
around the benzo[c]phenanthridine nucleus, w ith  
m axim um  inhibition o f  viral D N A  activ ity  requir­
ing 2 ,3 ,8 ,9-substituents and an im inium  group. 
Sterm itz et al (1 9 7 5 ) observed that antitumour 
activity w as confined  to this substituent pattern, 
and that any variation resulted in loss o f  anti­
tumour activity. RT inhibitory activ ity  was in 
c lo se  agreem ent w ith  this generalization  because
2 3 3
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Table 1. The structures of the quaternary benzojc)phenanthridines.
Ra
Compound R. r 2 r 3 R.. r 5 Ro
1 - o c h 2o - - o c h 2o - H H
2 o c h 2o - c h 3o c h 3o H H
3 OH c h 3o H c h 3o c h 3o H
4 -O C H -,0— H c h 3o c h 3o H
5 CH30 c h 3o H c h 3o c h 3o H
6 CH30 c h 3o c h 3o OH H H
7 c h 3o c h 3o H c h 3o c h 3o c h 3o
8 c h 3o c h 3o H c h 3o c h 3o c h 2c h 3o
9 c h 3o c h 3o H c h 3o c h 3o o h
chelerythrine and sanguinarine were only  moderate 
inhibitors (Sethi 1985). O f sign ifican ce w as the 
observation that som e o f  the benzo[c]phenan- 
thridines form ed a ternary com p lex  w ith the RT  
and the nucleic acid to w hich it w as bound (Sethi
1984). Fagaronine and nitidine w hen tested against 
RT from  HIV-1 and H IV -2, show ed  com parable  
activity with A M V  RT, and w ere the m ost potent o f  
156 pure natural products tested; chelerythrine was  
inactive (Tan et al 1992).
M ore recently, topoisom erase en zym es have  
becom e a focus for the expression  o f  antitum our 
activity and it has been  show n (Fang et al 1993; 
Larsen et al 1993) that fagaronine and nitidine  
stabilized  topoisom erase I in a ternary cleavable  
com plex  at low  concentrations, w hereas at higher  
concentrations they inhibited topoisom erase II, but 
did not stabilize the c leavab le  com plex .
W e have used U V  spectrophotom etric and 
m olecular m od elling  studies to propose a m echan­
ism  for the inhibition o f  RT by the benzo[c]p he- 
nanthridines through the form ation o f  these  
ternary benzo[c]phenanthrid ine--nucleic a c id -  
en zym e com plexes.
M aterials and M ethods
C h e m is tiy
The quaternary benzo[c]phenanthridines hydrox­
idine, m ethoxid ine and ethoxid e w ere synthesized  
according to m ethods develop ed  by W aigh and c o ­
workers (O lugbade et al 1990; M ackay et al 1996,
1998). In sum m ary, the 12-hydroxy-2,3,8,9-tetra- 
m ethoxybenzo[c]phenanthridine (prepared by a 
four-step synthesis from  veratraldehyde and vera- 
trylam ine) w as treated with the appropriate di alkyl 
sulphate to produce the corresponding 1 2 -alkoxy  
ethers, w hich  w ere subsequently quaternized w ith  
m ethyl m ethanesulphonate to y ie ld  m ethoxidine  
and ethoxid ine. H ydroxid ine w as prepared by  
in itially  treating the 12-hydroxy-2,3,8,9-tetra- 
m ethoxybenzo[c]phenanthridine w ith benzyl bro­
m ide to y ie ld  the 1 2 -b en zy loxy  analogue; this was 
quaternized with m ethyl m ethanesulphonate and 
the b en zy l ether c leaved  by reaction w ith glacial 
acetic acid  and concentrated hydrochloric acid.
H IV  R T  A ssa y
HIV-1 RT (5 1 /6 6 K  heterodim er) w as expressed  in 
E. co li (T G -1) from  the recom binant plasm id pR T l 
(Larder et al 1987). After a 1 M N aC l extraction  
procedure the RT was purified by chrom atography  
on an RTMAbH im m unoabsorbent colum n (T isdale  
et al 1988). R T w as used to catalyse  the incor­
poration o f  [3 H ]thym idine 5'-m onophosphate with 
rAdT (5 ^ g m L  1 or 50/rgm L  \  3 : 1 )  used as 
tem plate/prim er. R eactions w ere incubated for 
10 m in at 37°C  in the presence and absence o f  the 
three benzo[c|phenanthrid ines in a range o f  tenfold  
dilutions from 100/dVI (d isso lved  in 1% D M SO  
reaction m ixtures consisting o f  50mM Tris-H Cl, 
pH 8 0, lO m M  dithiothreitol, lO m M  M gC l2, 0 05% 
non ylphenoxy polyeth oxy ethanol, 100 fiM  NaCl 
and 5 iiM  TTP, including 0 -1 u M  f3 H ]TTP). A t the
2 3 4
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end o f the incubation, reaction mixtures were 
spotted on to DE81 discs.
The discs were washed to remove unincorporated 
label and the activity determined by scintillation 
counting. IC50 values were calculated from the 
counts.
H9 DNA polymerase a assay 
DNA polymerase a, purified from H9 cells (human 
lymphocytes) as described by Parker et al (1991), 
was used in assays to catalyse the incorporation of  
| 3HJdeoxyAMP; activated calf thymus DNA  
(200/ugm L ') was used as template/primer. 
Reactions were incubated for 30 min at 37°C, in the 
presence and absence o f the three benzo[c]phe- 
nanthridines, in a range o f tenfold dilutions from 
100/iM (dissolved in 5% DM SO reaction mixtures 
consisting o f  I m M  dithiothreitol, 5 m M  M gCl2, 
0-5 mg m L“ 1 bovine serum albumin, 60 m M  Tris- 
HC1 pH 7-4, 100 pM  deoxyCTP, lOO^M deoxyGTP, 
100/xM  thymidine triphosphate, 2 0 0 ^ g m L -1 acti­
vated calf thymus DNA (Pharmacia), and 1 2 /iM  
[ 'HJdeoxyATP). Reaction mixtures were spotted 
on to DE81 discs; these were then washed to 
remove unincorporated label and the activity was 
determined by scintillation counting. IC50 values 
were calculated from the counts.
UV spectrophotometric studies 
Determination of alkanolamine formation. The 
benzo[c]phenanthridines methoxidine (7), ethox- 
idine (8 )  and hydroxidine (9 )  were prepared as 1 0 -  
1 5 m M  solutions in doubly-distilled water. pH was 
measured with a Phillips PW 9418 pH meter cali­
brated beforehand by use o f  pH buffer reference 
standards B-4895 (pH 10 0 ), B-4770 (pH 7 00) and 
B-5020 (pH 4-01) from Sigma. Absorbance mea­
surements were taken over the range 330 to 450 nm 
(Uvikon 930 spectrophotometer) at pH 2 0, 8 0  and 
12 0 (adjusted by addition o f  2 M sodium hydroxide 
or hydrochloric acid solution to the drug solutions).
DNA binding studies. Concentrations o f  highly 
polymerized calf thymus DN A  (type 1) from Sigma 
in  0-03 M Trizma (Sigma) and 0 018 m  NaCl buffer, 
pH 7-4, were determined spectrophotometrically in 
terms o f nucleotide phosphate calculated from an 
extinction coefficient o f 6600 m - 1  cm " 1 at a 
wavelength o f 260 nm. Hydroxidine, methoxidine 
and ethoxidine were prepared as stock solutions in 
buffer and diluted (with buffer) to a final con­
centration within the range 3 0 -4 5  pM . Spectro­
photometric titrations were performed by adding 
different volumes o f the calf thymus DNA  
solution to a solution (2m L ) o f the drug in a 
quartz cuvette (3 mL) to vary the benzo[c]phenan-
1309
thridine/DNA phosphate ratio until no further 
changes in absorbance were measured. Absorbance 
was measured over the range 3 3 0 -4 5 0  nm (Uvikon 
930 spectrophotometer). All measurements were 
made at 20°C and an equilibration time o f 20 min 
was left after each addition of DNA. The mea­
surements were repeated twice for each benzo[cj- 
phenanthridine assayed.
Molecular-modelling studies 
Molecular orbital (MO) calculations for the benzo- 
[cjphenanthridines were performed using the 
MOPAC semi-empirical program with graphics 
visualization using Chem-X (October 1993 version; 
Chemical Design Ltd, Oxon, UK) and Insight II 
software (Version 95.0; MSI Technologies, San 
Diego, CA). Compounds were geometry-optimized 
using the A M I/M O PA C  program, a charge of +1  
was assigned to the quaternary nitrogen and — 1 to 
the anionic oxygen o f hydroxidine; electrostatic 
potentials, atom charges, bond-order matrices, 
er-t-ji bonds and 7t-electron densities were calcu­
lated by the A M I/M O PA C  semi-empirical method. 
Electrostatic potential maps of the benzo[c]phen- 
anthridines using atom-based point charges deter­




The enzyme inhibitory assays (Table 2) indicate 
that two o f our synthetic analogues o f O-methyl 
fagaronine— the 12-alkoxy derivatives methoxidine 
(7 )  and ethoxidine ( 8 )— are potent inhibitors of 
HIV-1 RT (cf. fagaronine; IC50 21-8 pM\ Tan et al 
1992). Hydroxidine (9 )  was inactive against both 
HIV-1 RT and human DNA polymerase a. Both 
methoxidine and ethoxidine showed some selec­
tivity over human DNA polymerase a.
DNA binding studies
The UV spectra o f  the 12-alkoxy analogues titrated 
against DNA show an initial bathochromic and 
hypochromic change at high drug/D N A  ratios, but
Tabic 2. HIV-1 reverse transcriptase inhibitory activity o f the 
quaternary benzo[c]phenanthridines.
Benzo[c|phenanthridine IC50 (/iM ) IC50 (pM )
against HTV-1 against DNA
reverse transcriptase polymerase a
Hydroxidine Inactive Inactive
Methoxidine 2-8 31-0
Ethoxidine 2-4 3 40
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below ratios o f  1 0 0  (methoxidine) and 0-67 
(ethoxidine) a further bathochromic shift occurs 
with a hyperchromic change, until no further 
absorption increases were observed below ratios o f  
0 1 0  and 0 12 ,  for methoxidine and ethoxidine, 
respectively. The biphasic nature o f the interaction 
(Figure 1), with no clear isosbestic points, indicates 
that more than one spectroscopically distinct bound 
form of the drug is present. These interactions are 
reminiscent o f that o f  the related alkaloid, coralyne, 
with DNA (W ilson et al 1976), which is char­
acterized by external association at high cor- 
alyne/D N A  ratios and intercalation as the ratio 
decreases below 10 . The interaction o f hydroxidine 
with DNA also seem s to involve a biphasic binding 
mechanism (Figure 2) with no further changes in 
absorption observed at a hydroxidine/DNA ratio of 
0 1 1 .
Determination o f alkanolamine formation 
The formation o f  the alkanolamine form o f  the 
benzo[c]phenanthridines (Figure 3) at high pH is 
characterized by collapse o f the 2max at 400 nm; 
this is re-established when the pH is reduced, i.e. 
there is no absorbance by the alkanolamine form in 
the long-wave UV band (3 5 0 -4 5 0  nm) (Simanek & 
Preininger 1977; Caolo & Stermitz 1979; Simanek
1985). These spectral changes are seen for meth­
oxidine (data not shown) and ethoxidine (Figure 4), 
but not for hydroxidine (Figure 5). For hydroxidine, 
increasing the pH induces a bathochromic shift of 
the 2 mux from 402 to 446 nm, characteristic o f








W a v e l e n g t h  (n m )
Figure 2. UV absorption spectra of 4 0  r M hydroxidine in 
0-018 M  NaCl and 0 03 M  Tris buffer, pH 7-4, in the absence of 
DNA (curve 1) and after the addition o f calf thymus DNA to 
yield benzo[rlphenanthridine/D NA  (phosphate) ratios o f 2-94 
(curve 2), 1-47 (curve 3), 0-59 (curve 4), 0-43 (curve 5), 0-34 
(curve 6), 0-30 (curve 7), 0-22 (curve 8), 0 1 8  (curve 9) or 0-14 
(curve 10). For clarity not all titration curves are shown.
phenolic ionization; this again is reversed when the 
pH is reduced, a spectral change which is not 
associated with alkanolamine formation. W e con­
clude that the iminium bond in hydroxidine is 
resistant to nucleophilic attack by the hydroxide 
ion, with ionization o f  the phenol group taking 
precedence over alkanolamine formation in the pH 
range covered in our study.
Molecular modelling studies 
The electrostatic potential maps o f  the benzo[c]- 
phenanthridines indicate that the region o f  highest 
interaction energy with a unit positive charge is 
centred around the C-6 position o f the iminium  
bond (>  1 lOkcal mol ') (Figures 6 and 7) with the 
exception o f  hydroxidine. The lowest 7tz-electron 
densities for sanguinarine (1), chelerythrine (2), 
fagaronine (3), O-methylfagaronine (5) and ethox­
idine (8) are observed at C-6 (Table 3). The elec­
trostatic potential plot for the phenolate form of 
hydroxidine (9) (Figure 8) is indicative o f  a m ole­
cular electrostatic potential much lower than those 
o f the other benzo[c]phenanthridines, tending to be 
predominantly negative, and a higher Ttz-electron 
density at C-6. It seems that the negative charge 
resident on the oxygen at the 12-position after 
ionization becom es distributed over the aromatic 
nucleus increasing the 7tz-electron density at the 6- 
position.
W avelength (nm)
Figure 1. UV absorption spectra o f 3-9 gM ethoxidine in 
0  018 m NaCl and 0 03 m Tris buffer, pH 7-4, in the absence 
of DNA (cutve 1) and after the addition o f ealf thymus DNA to 
yield benzo[cJphenanthridine/DNA (phosphate) ratios o f 2-86 
(curve 2), 1 -43 (curve 3), 0-96 (curve 4), 0-58 (curve 5), 0-37 
(curve 6), 0-33 (curve 7), 0-3 (curve 8), 0-22 (curve 9) or 0-19 
(curve 10). For clarity not all titration curves are shown.
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W a v e l e n g t h  (n m )
Figure 5. UV absorption spectra of 15 m M  solutions o f 






W a v e l e n g t h  (n m )
Figure 4. UV absorption spectra of 15-5 inM solutions of 
ethoxidine al pH 1-4 (curve 1), pH 8-0 (curve 2) and pH 11-4 
(curve 3).
Discussion
The quaternary benzo[c]phenanthridines occur as 
two pH-dependent forms (Caolo & Stermitz 
1979)— at low pH the cationic species pre­
dominates whereas at high pH this species under­
goes conversion to the alkanolamine form as a 
consequence o f nucleophilic attack hy a hydroxide 
anion at the electrophilic iminium bond at position 
6 o f the benzo[cJphenanthridine nucleus (Figure 3). 
The pKR+ o f  this equilibrium, which is analogous 
to the pK;i value for a Brpnsted acid (denoting the 
pH at which the heterocyclic cation and alkanol­
amine are present at equal concentrations) is 
dependent on the nature and pattern o f the oxyge­
nated substituents around the nucleus, with the 7,8- 
substituted series having lower pKR+ values than 
the 8,9-substituted series (e.g. sanguinarine, 7-32; 
chelerythrine, 7-53; nitidine, 12-10) (Simanek 
1985). The dichotomy in antitumour activity 
between the active 2,3,8,9-oxygenated and the 
inactive 2,3,7,8-oxygenated benzo[c]phenan- 
thridines has been attributed to these differences in 
the cation-alkanolam ine equilibria. The inter­
calative binding affinity o f sanguinarine for DNA is 
pH-dependent (Sen & Maiti 1994), this being 
ascribed to the predominance o f the cationic spe­
cies at low pH (5-2) whereas at higher pH (10-5) the 
alkanolamine form predominates which, as a con­
sequence o f the loss o f  planarity in the tetracyclic 
system and the absence o f a positive charge on the 
molecule, does not bind with DNA.
We believe there is a more substantial role for the 
iminium group in the inhibition o f  nucleic acid- 
binding enzym es than the provision o f  an electro­
static interaction for binding with DN A . We have 
shown that o f the three analogues o f  0-methyl - 
fagaronine we have synthesized, methoxidine (7), 
ethoxidine (8) and hydroxidine (9), two inhibit 
HIV-1 RT with IC50 values o f 2-8 f.iM (methox­
idine) and 2-4 /.iM (ethoxidine) whereas hydroxidine 
is inactive. Our DNA binding studies indicate that 
all three compounds interact with DNA in a 
biphasic manner reminiscent o f  the interaction of  
the related alkaloid coralyne with D N A  (Wilson et 
al 1976). Coralyne is also a potent inhibitor o f  
MuLV and AMV RT (Sethi 1976, 1985a, b) and 
has a cation-alkanolam ine equilibrium (Simanek
Figure 3. Formation o f the alkanolamine form o f the 
I tlphenanthridines.
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(b)
Figure 6. Molecular electrostatic potential map o f O-methyl- 
fagaronine. (a) Electrostatic potential contours through the 
plane of the molecule with units expressed in kcal mol-1 . (b) 
Electrostatic potential grid showing regions greater than 
I lOkcal mol , predominantly centred over the iminium bond.
& Preininger 1977). However, o f the compounds 
prepared in this study, only the active 12-alkoxy 
benzo[c]phenanthridines are susceptible to nucleo- 
philic attack at position 6 by the hydroxide anion. 
W e believe that the inhibition o f RT and the sus­
ceptibility o f the iminium bond are linked, and to 
investigate the electrophilicity o f the iminium bond 
further we have calculated the electrostatic poten­
tial maps and the 7iz-electron densities o f the aro­
matic systems o f a series o f  quaternary 
benzo|cJphenanthri dines.
The molecular electrostatic potential is a much 
better indicator o f the electrostatic properties o f a 
molecule than atom-centred charges and can be 
calculated on a grid surrounding the molecule with 
contours connecting isopotential points, i.e. points 
at which the energy o f  interaction of the molecule 
with a unit positive charge is identical. Electrostatic 
potentials can therefore be viewed as a key factor in 
the control o f the long-distance interactions during 
the approach o f a nucleophile to the benzo[c]phe- 
nanthridine (Grassy et al 1985). Our electrostatic 
potential maps indicate that an approaching 
nucleophile would be attracted towards the region 
o f  highest interaction energy with a unit positive 
charge centred around the C-6 position o f the 
iminium bond (>  1 lOkcal mol ') (Figures 6 and 7) 
with the exception o f  hydroxidine. When these
(b)
Figure 7. M olecular electrostatic potential map of cheleryth­
rine. (a) Electrostatic potential contours through the plane of 
the molecule with units expressed in kcal m o l 1. (b) Electro­
static potential grid showing regions greater than 
110 kcal mol 1, predominantly cenUcd over the iminium bond.
Figure 8. Molecular electrostatic potential contour map of 
the hydroxidine anion through the plane o f the molecule with 
units expressed in kcal mol .
results are viewed in association with the calculated 
7tz-electron densities o f  the aromatic systems, an 
indication o f  the site o f electrophilicity within the 
benzo[clphenanthridine can be deduced (Meunier 
et al 1988). Because the lowest 7iz-electron den­
sities for sanguinarine (1), chelerythrine (2), 
fagaronine (3), O-methylfagaronine (5) and ethox­
idine (8) are observed at C-6 (Table 3), we can
2 3 8
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Tabic 3. 7tz-EIectron densities o f the quaternary benzo[c]phenanthridines.
1 2  1
V ’V V
4
7 6  J
Atom Benzo[c)phenanthridine n z-electron density o f compound
1 A 90 
|
9
1 10171 1-0195 1-0311 1-0311 1-0185 0-9291
2 0-9748 0-9764 0-9469 0-9469 0-9744 1-0226
3 0-9437 0-9493 0-9551 0 9551 0-9218 0-9713
4 1-0501 1-0504 1-0671 1-0671 1-0495 1-0575
4a 1-0172 1 0208 1-0367 1-0367 1 0082 1-0031
5a 1-0658 1-0582 1-0376 1-0375 1-0842 1 1660
5 1-4108 1-4237 1-4307 1-4307 1-4129 1-3672
6 0-8219 0-8115 0-8596 0-8596 0-8783 1-0349
6a 1-1305 1-1318 10901 1-0901 1-0805 1-0404
7 09696 09409 1-0222 1-0222 1-0251 10265
8 1-0154 1-0239 0-9665 0-9665 0-9632 0-9858
9 0-9306 0-9567 0-9024 0-9024 0-9187 0-9832
10 1-0081 1-0185 1-1077 1 1077 1-0991 0-9882
10a 0-9655 0-9567 0-9235 0-9235 0-9452 0-9773
11a 0-9924 0-9984 I 0081 1-0081 09676 0-9729
II 1-0137 1-0111 1-0208 1-0207 1-1487 11614
12 0-9302 0-9378 0-9359 0-9359 08798 0-7677
12a 0-9921 0-9915 09884 0-9884 1-0359 1-0259
*Calculated as the phenolate anion
conclude that nucleophilic attack will be directed 
towards this site in these compounds. The 2,3,7,8- 
substituted benzo[c]phenanthridines have the lowest 
7tz-electron densities at C-6; this is in accord with 
their greater susceptibility to attack by the hydroxide 
anion (Caolo & Stermitz 1979; Simanek 1985; Dostal 
& Potacek 1990). The electrostatic potential plot for 
the phenolate form o f hydroxidine (9) (Figure 8) 
shows the molecular electrostatic potential to be 
much lower than those o f  the other benzofejphe 
nanthridines; it also shows that the rcz-electron den­
sity at C-6 is higher, indicating that it has a non- 
electrophilic iminium bond resistant to nucleophilic 
attack by the hydroxide ion, as shown by our spec­
troscopic studies. The electron density at C -12 is low, 
but in the absence o f a corresponding high positive 
potential ( —60 kcal m ol-1 ), nucleophilic attack at 
this position is unlikely. Our conclusion therefore, is 
that RT inhibitory activity is linked to the presence of  
an electrophilic iminium bond in the quaternary 
benzo[c]phenanthridines.
Other workers have shown that the iminium bond 
can be attacked by carbon, nitrogen and sulphur
nucleophiles (Dostal & Potacek 1990) and have 
suggested a role for in-vivo hydration, alkylation or 
addition at position 6 by certain biological species 
(Zee-Cheng & Cheng 1975). Studies with AMV 
and MuLV RT indicate that the inhibitory action of 
fagaronine and O-methylfagaronine is associated 
with the formation o f a labile enzym e-nucleic  
acid-alkaloid  ternary com plex (Sethi 1984). The 
model for inhibition which we propose is that on 
complexing with the nucleic acid substrate the 
quaternary benzo[c|phenanthridine is bound in 
such a way that it undergoes nucleophilic attack by 
a residue within the enzym e (such as cysteine, 
serine, threonine or tyrosine) when it binds to the 
substrate-benzo[c]phenanthridine com plex. The 
resulting ternary com plex is stabilized by a labile 
covalent bond between the enzyme and the ben- 
zo[c]phenanthridine which, in turn, is bound to the 
nucleic acid substrate and enzyme inhibition is 
effected. Hydroxidine, with a non-electrophilic 
iminium bond, would be unable to undergo this 
complexation process and therefore enzym e inhi­
bition would not occur.
i
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Electrostatic potential plots and Tiz-electron 
densities for sanguinarine and chelerythrine also 
revealed electrophilicity at the iminium bond. The 
weak RT inhibitory activity associated with these 
alkaloids might be a consequence o f  the assays 
being performed at pH 7 0, where a significant 
percentage o f the compounds would exist as the 
alkanolamine form, thus reducing their affinity for 
the template-primers (Sen & Maiti 1994).
The absence o f inhibitory activity o f fagaronine, 
O-methylfagaronine and nitidine with nucleic acid 
substrates containing only G and C (even though 
binding is evident) (Sethi 1981, 1984, 1985a, b; 
Kakiuchi et al 1987) suggests that iminium bond 
electrophilicity is not the only factor governing 
enzym e inhibition. Enzyme inhibition might be 
influenced by the orientation o f the benzo[c]phen- 
anthridine when bound between the base pairs o f 
the nucleic acid substrate; this, in turn, might be a 
function o f base-pair composition. If inhibition 
requires the formation o f  a covalent bond with a 
residue in the enzyme, then the relative position of 
the iminium bond w ill be important in terms of 
proximity to attack. The macromolecular structure 
o f the enzyme bound with a particular nucleic acid 
substrate might exert considerable influence on the 
geometry of the bound benzo[c|phenanthridine, and 
modelling studies are currently in progress to 
investigate these com plexes. W e must also consider 
the electronic effects o f different neighbouring 
base-pairs on the electronic charge distribution of  
the bound drugs, particularly considering the pro­
posed role for the iminium bond, for which we are 
also developing appropriate models.
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DNA Binding by Fagaronine and Ethoxidine, Inhibitors of Human DNA Topoisomerases I 
and II, Probed by SERS and Flow Linear Dichroism Spectroscopy*
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Raman, surface-enhanced Raman scattering (SERS), and flow linear dichroism (FLD) spectroscopies were 
employed to study the potent anticancer agent fagaronine (FGR, NSC 157995) and its derivative ethoxidine 
(ETX)—inhibitors o f DNA topoisomerases (topos) I and II (Figure 1)—and their complexes with DNA. The 
FLD data obtained suggest that both compounds are strong major groove intercalators with stoichiometries 
1 FGR/2.0 DNA bp and I ETX/4.0 DNA bp The SERS spectra of both compounds were recorded at the 
concentrations down to 10- 8  M for FGR and 10- 6  M for ETX, and the SERS-active modes were assigned by 
comparison o f Raman and SERS spectra o f the drugs following the changes induced by deuteration and pH 
environment. The SERS-active surface was proved not to affect the drug/DNA interactions, since the DNA  
binding constants calculated from the SERS experiments were found to be practically the same as those 
determined previously by viscosimetric measurements. The SERS study o f the FGR/DNA complex showed 
that the OH group o f FGR plays a key role in DNA binding, most probably because o f  formation o f the H 
bond with DNA. Cooperative use o f Raman, SERS, and FLD techniques enabled us to propose a molecular 
model for drug/DNA interactions. The differences in DNA binding by FGR and ETX are discussed in terms 
of different topoisomerases inhibitory activities o f these drugs.
Introduction
Elucidation of the structure—function relationships and search 
of the key structural determinants mediating the mechanisms 
of action of antitumor drugs seem to be one of the most 
important problems in anticancer research. 1 Selective, sensitive, 
and nondestructive physicochemical and particularly optical 
spectroscopic approaches enable us to determine molecular 
groups of drugs and their targets (DNA, proteins, membranes) 
and to propose the ways for design of new molecules with 
desired functions. Among the novel optical spectroscopic 
techniques available up to date, surface-enhanced Raman 
scattering (SERS) spectroscopy and flow linear dichroism (FLD) 
techniques are characterized by high sensitivity and selectivity 
of analysis of individual components within the supramolecular 
complexes. SERS spectroscopy proved to be a powerful 
technique for selective analysis o f the structure o f low-
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molecular-weight ligands (e.g., antitumor drug) in complexes 
with a high-molecular-weight (DNA, protein) target. 2 ’3 Com­
pared to the other techniques, SERS spectroscopy allows us to 
detect signals from the individual molecular groups at extremely 
low (down to 10- 8  M) concentrations. 4 - 6  Molecular models of 
interactions of some antitumor drugs and DNA have been 
proposed and were found to be consistent with NMR and/or 
X-ray data.4 - 7
The linear dichroism technique enables us to determine the 
drug’s orientation relative to the axis of oriented in the flow  
(FLD) or with the electric field (ELD) DNA or protein matrix 
and was found to be extremely sensitive to the changes of degree 
of DNA molecule orientation induced by intercalated drugs. So 
both drug and DNA alterations induced by their interactions 
may be followed by linear dichroism techniques.8’ 9
Most of the antitumor drugs are presumed to induce their 
effects at the DNA level. 10 Some of them are known to be 
effective inhibitors of the topoisomerases, intranuclear enzymes 
participating in all aspects o f cellular replication and transcrip­
tion machinery. 1-11 The enzymes’ poison? kill cells by trapping 
so-called cleavable complexes between the DNA and topoi- 
somerases. The chemical structure of poisons and mode of their 
interactions with DNA determine its ability to interfere with 
topoisomerases in the cleavage complexes. Structural analysis 
and identification o f  functional molecular determinants of 
individual partners of these supramolecular complexes are quite 
complicated and require careful selection o f appropriate and self- 
complementary physicochemical techniques but present an
© 1999 American Chemical Society 
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Figure 1. Chemical structures of fagaronine (FGR) and ethoxidine 
(ETX).
extremely important domain of research, being vital for an 
adequate new drug’s design . 1
Recently, we have applied a combined SERS, Raman, CD, 
and biochemical approach to study molecular mechanisms 
involved in the formation of binary and ternary complexes 
between antitumor drugs and their targets (DNA and topoi­
somerases). Molecular interactions within the complexes of well- 
known (doxorubicine, aclacinomycin, saintopin, netropsins) and 
new (intoplicine, camptothecin derivatives) compounds that are 
just in clinics or have potential antitumor activities have been 
studied. 2 4 - 6 -12
This paper describes the SERS and FLD analysis of DNA 
binding by fagaronine (FGR), a natural antileukemic alkaloid 
and potent differentiation inducer of various hematopoietic cell 
lines, and by its even more biologically active derivative 
ethoxidine (ETX). FGR is known to be a potent double inhibitor 
of DNA topoisomerases I and II, stabilizing in vitro cleavable 
ternary complexes between the enzymes and their DNA 
substrates. 1 3 1 4  It was shown that the drug is a DNA intercala- 
tor, 15 but the mode of its DNA binding is not known and its 
structural determinants playing a key role in interactions remain 
to be defined. Cooperative use of SERS and FLD techniques 
for the study of FGR/DNA and ETX/DNA complexes enabled 
us to address the following questions, (i) What is the orientation 
of the drug’s chromophores within the drug/DNA complexes? 
(ii) What are the molecular groups responsible for the drug/ 
DNA recognition and formation of complexes?
We have found that the OH group of FGR participates directly 
in the drug/DNA binding. According to our model, FGR 
intercalates within the DNA bases so that its OH group is 
directed toward the DNA minor groove and so that quaternary 
N+ (Figure 1) plays the role of anchor for stabilizing this 
interaction. ETX is proposed to intercalate within the DNA in 
a way that its OCH2CH3 moiety (Figure 1) extends into the 
DNA minor groove and probably plays a key role in the 
disturbance of DNA recognition by the topoisomerases that 
attack their DNA substrates from the side of the minor groove.
Materials and Methods
Chemicals. FGR (NSC 157995), provided by Dr. E. Couil- 
lerot, was extracted from the roots o f Fagara xanthoxyloid.es 
Lam. (Rutaceae) as described in ref 16. ETX was synthesized 
by one of us, and the details of the protocol will be published 
elsewhere. Both compounds were prepared in a I mM stock 
solution in methanol.
CT DNA was purchased from Sigma and dissolved in 
potassium-buffered saline (PBS) to 5 mg/mL.
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Drug/DNA complexes were prepared by mixing the drug 
stock solutions with the DNA solution in PBS in order to obtain 
a final drug/DNA bp ratio (r) from 0.005 to 0.8.
Raman and SERS Spectroscopy. Raman and SERS spectra 
were recorded with a PHO (CODERG) spectrometer with a 
double monochromator in the frequency range 300—1800 cm-1. 
An Ar+ ion laser (Coherent Radiation, model Innova 2020) 
operating at 80 mW power at 457.9 nm (for FGR) or at 488 
nm (for ETX) wavelength was used for spectra excitation. For 
Raman spectra the accumulation of 30 independent scans with 
time averaging was used to improve the signal-to-noise ratio. 
SERS spectra were recorded for 1 scan with a 1 s time constant. 
Silver hydrosol was prepared according to the protocols 
published before.4 - 6  The concentrations of the drugs used for 
Raman spectroscopy were 5 mM, and the SERS spectra were 
recorded with the 10—5 —10—8 M concentrations for free drugs 
and 10- 4 —10- 5  M for drug/DNA complexes.
UV/Visible and Flow Linear Spectroscopy. UV/vis spectra 
were recorded with a Philips PU8720 UV/vis scanning spec­
trophotometer.
FLD spectra of DNA and drug/DNA complexes in the region 
220—450 nm were recorded with a Jobin Yvon, Mark III 
dichrograph equipped with a self-made achromatic A/4 device 
to transform circular polarized light to a linear one. The self- 
made flow cell with an optical length of ca. 0.5 mm and a 
volume of 200 fih  was used for orientation of DNA in the flow. 
The details o f the FLD measurements were published else­
where. 17
The linear dichroism AA is defined as the difference at a given 
wavelength between the absorbance for light polarized parallel 
(An) and perpendicular (Aj) to the flow. The reduced linear 
dichroism is
LDr =  AA/A =  (A„ -  Ay)!A
where A is the isotropic absorbance of the sample.
The angle (1 between the transition moment o f the dye 
chromophore and the orientation axis of the DNA molecules 
was calculated from the measured ratios of the reduced linear 
dichroism for the bases and for the drugs:
(AA/A)drug/(AA/A)DNA=  (3 cos2 /3 -  l)/(3 cos2 a  -  1) (1)
where a  =  8 6 ° is the angle between transition moment of the 
bases and the orientation axis o f the DNA molecule. 8
Results
UV/Visible Spectra of FGR and ETX and Their Com­
plexes with DNA. UV/vis spectra of FGR and ETX show two 
groups of bands (Figure 2): one in the region 380—420 nm 
and the second, which is more intense, in the region 270—350 
nm. Both groups of the bands correspond to the n  — n*  
electronic transitions of the conjugated chromophore rings 
system o f types Lb and La, respectively. 18 The La transition 
moment is directed along the Z-axis, whereas Lb lies along the 
K-axis of the chromophore molecule (Figure 1). Complexation 
of the drugs with the DNA induces an increase of intensity of 
the Lb group of bands in the absorption spectra of FGR as well 
as ETX (Figure 2).
FLD of FGR/DNA and ETX/DNA Complexes. Figure 3 
shows reduced linear dichroism as a function of [DNA]/[drug] 
ratios for FGR and ETX molecules. Both curves were found to 
possess a maximum. For FGR the highest value of the reduced 
linear dichroism is observed for a [DNA]/[drug] ratio of about 
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Figure 2. UV/vis spectra of FGR (1). ETX (2), and ETX/DNA 
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Figure 3. Dependence of the reduced linear dichroism (LD,) for FGR
(1) and ETX (2) on the [DNA]/[drug] ratio. LD, was measured at 400 
nm. DNA concentration (bp) is 10 /rM.
ratio at ca. 4.0. These positions of maxima on the reduced linear 
dichroism curves indicate the points of DNA "saturation’* with 
the drugs. So FGR and ETX interact with the DNA in a binding 
stoichiometry o f 1 drug per ca. 2.0 bp of DNA and 1 drug per 
4.0 bp of DNA, respectively.
The FLD technique enables us to determine the relative 
orientation of the plane of the drug chromophore to the plane 
of DNA bases; the linear dichroism of intercalators is known 
to be negative, 'whereas that, of the'minor, groove binders is 
positive.? FLD signals from FGR and ETX bound to DNA at 
“saturation” ratios ([DNA]/[drug] 2.0 and 4.0, respectively) 
were found to be negative in both L„ and Lb regions o f electronic 
transitions. In other words, both compounds were found to be 
typical major groove intercalators with their chromophore’s 
planes rather perpendicular to the flow. ' ' L
, Then eq L was employed to calculate the angle between the 
Lb electronic transition of the drug’s chromophore and the axis 
of orientation of the DNA molecule. These angles were found 
to be ca. 73 dt 5° for FGR and 79 ±  5° for ETX. Owing to the 






Figure 4. Raman spectra of FGR (1) and ETX (2) in FLO. A„c is 
457.9 nm for FGR and 488 nm for ETX. Laser power is 50 tnW. Drugs 
concentrations are 5 mM.
electronic transitions of the drugs, we failed to determine the 
exact angle between this electronic transition moment of the 
drug’s chromophore and the DNA orientation axis. By subtract­
ing the FLD spectrum of DNA from the FLD spectrum of the 
bound drug, we obtained an approximate value of 80—85°. 
Anyway, the plane of the drug’s chromophore was found to be 
nearly perpendicular to the DNA orientation axis, that is, almost 
parallel to the plane of the DNA bases.
Raman Spectra of FGR and ETX. Raman spectra of FGR 
and ETX are characterized as a “preresonance” recorded with 
excitation in the region of the drug absorption (Figure 2). The 
spectra of FGR and ETX recorded at pH 7.5 appeared to be 
quite similar (Figure 4) with the four intense bands at ca. 1620, 
1391, 1360-1370, and 1330 cm ' 1 and a band at 1120-1130  
cm" 1 with moderate intensity. The position and relative intensi­
ties of the bands were found to be unchanged at pH 4.0—11.0, 
and no spectral effects of deuteration was observed (data not 
shown). So these bands represent skeletal vibrations, of the 
conjugated ring system with probable contribution of d(CHa) 
motions.
SERS Spectra of FGR and ETX. General Characteristics. 
When the region of chromophore absorption is excited, the 
SERS spectra of the drugs arise because o f surface enhancement 
itself coupled with the resonance enhancement. 2'3  As a result, 
an extremely high sensitivity for SERS o f FGR and ETX was 
observed, so we managed to record spectra at very low limits 
(down to 10“9 —10- 1 0  M). At the same time, the SERS spectrum 
of FGR was found to be about 100-fold more intense than that 
of ETX. There is no direct evidence that the resonance 
contribution to the overall enhancement must be different for 
each of these compounds because electronic structures of FGR 
and ETX* are very much the same ais'sSeri from their' UV/vis
i j . <’>\ ,*(, it^ -V p ‘1 'f  V ' 1V - r -v -1‘ 'l'- i *■'
spectra (Figure . 2). Therefore, the- peculiarities m surface 
enhancement of the Raman signal: must account for the 
differences observed for the SERS spectra o f FGR and ETX. It 
is known that the “chemical” (or short- range) enhancement 
plays the major role in SERS on silver hydrosols. 19 In other 
words, only compounds with a high ability to be adsorbed by 
the hydrosol may exhibit strong Raman enhancement: Adsorp- 
tivity is affected by the presence of charged and/or hydrophobic 
(hydrophilic) groups.3 Therefore, we propose that the difference 
in the chemical structures of FGR and ETX should explain the 
higher adsorption1 ability'of FGR and,: consequently; higher
2 4 4






Figure 5. SERS spectra of FGR at pH 11.0 (a), 7.5 (b), 4 (c) and in 
a complex with DNA (d) at pH 7.5. Drug concentration is 1 /tM. DNA 
concentration (bp) is 0.1 mM. Acxc =  488 nm. Laser power is 25 mW.
Raman enhancement factor. On the other hand, if the OH group 
of FGR determines its surface enhancement, any changes in 
the environment or interactions of this group (e.g., hydrogen 
bonding) would influence the SERS intensity of FGR.
The SERS spectra contain four strong bands (Figures 5 and 
6 ), which have their counterparts in the Raman spectrum (ca. 
1620, 1400, 1350, and 1320 cm ' 1 for FGR and ca. 1610, 1385, 
1370, and 1330 cm - 1  for ETX). These can be attributed to 
skeletal vibradons of die conjugated ring system. The band at 
1380—1400 cm - 1  may be also contributed from <5(CH3 ) and 
the band at 1320—1330 cm " 1 from C—C—H motions. 20 In 
Wilson’s notation o f vibration modes of benzene, the bands in 
the region 1590—1610 cm ' 1 are assigned to v8a and v«b 
vibrations. 21 The relative intensities of these bands are known 
to be extremely sensitive to the mass of the chromophore 
substituent group20 and its interactions with the ions. 6 Figures 
5 and 6  show that the SERS band of FGR at ca. 1595 cm ' 1 is 
more intense than that at ca. 1615 cm"1, whereas for ETX the 
band at ea. 1611 cm- 1  is more intense than 1597 cm-1. This 
difference correlates with the difference in the structures of FGR 
and ETX; the OH group o f FGR is replaced by the heavier 
OCH3 group in ETX (Figure 1). Moreover, an additional 
massive OCH2CH3 group is presented in the ETX molecule. 
Since these structural differences of FGR and ETX may be 
easily detected by SERS spectroscopy, we may expect that any 
changes in the microenvironment of the OH group of FGR or 
any interactions of this group with the other moieties should 
be elicited in the SERS spectrum as a change in the relative 
intensity of the bands corresponding to vga and Vgb vibrations.
In addition to the bands mentioned above, there are some 
features in the region 400—600 cm - 1  of the SERS spectra of 
FGR and ETX that may be attributed to d(C—C—O) and d- 
(C—O—C) vibrations: the bands in the region 1100-1140 cm"1, 
likely interpreted as due to v fC -O -C H j) and v(C—C—O) 
motion, and the several bands in the region 1200-1600 cm " 1 
typically assigned to the normal vibration of benzene deriva­
tives. 20 -21
Effect o f  pH  on the SERS Spectra. To identify additional 
spectral indicators for the OH group microenvironment of FGR 
and to determine the contribution of N+ (Figure 1) to the 
vibrational structure of FGR and ETX, we have analyzed the 
pH dependence of the SERS spectra. At basic pH, the OH group





400 600 800 1000
Raman shift, 1/cm.
1000
Figure 6 . SERS spectra of ETX at pH 11.0 (a), 7.5 (b), 4 (c) and in 
a complex with DNA (d) at pH 7.5. Drug concentration is 10 ftM. 
DNA concentration (bp) is 0.5 mM. A„c =  488 nm. Laser power is 25 
mW.
of FGR is expected to be deprotonated, whereas at acidic pH 
some perturbations in the microenvironment of N+ are assumed.
First, it should be noted that the overall intensity of the SERS 
spectra at pH different from neutral is significantly lower than 
those at pH ca. 7.5. This may be explained by partial degradation 
of hydrosol at basic and acidic pH that leads to lower SERS 
enhancement factors. 5 For the ETX molecule (which does not 
possess the OH group; see Figure 1) the “pure” effect of the 
N+ environment on the SERS spectrum may be determined. 
The SERS spectrum of ETX, recorded at pH 11.0 (Figure 6 a), 
shows slight changes compared to its spectrum at pH ca. 7.5 
(Figure 6 b). The only detectable difference is a relative decrease 
of the 1370 cm- 1  band at neutral pH. At pH close to 4.0 a further 
loss of this band occurs compared to the band at ca. 1330 cm"1. 
Moreover, some decrease of the 1380 cm " 1 band and an increase 
of the band at ca. 1610 cm" 1 are also observed. The bands 
sensitive to pH were attributed to skeletal vibrations of the 
conjugated ring system with contribution of the d(CH}) motion. 
Therefore, we may conclude that pH and, subsequently, the 
environment of N+ slightly affect the vibrational structure of 
ETX.
FGR comprises two pH-dependent structural elements: OH 
group and N+ (Figure 1). Having established pH-induced 
spectral changes arising from the variation of the environment 
of N+ (in case of ETX), we may interpret all other changes in 
the SERS spectrum of FGR in terms of pH-dependent modifica­
tions of the OH group. Deprotonation of the OH group of FGR 
at basic pH induces significant changes in its SERS spectrum 
(curves a and b of Figure 5). First of all, there are two bands at 
1520 and 1568 cm"1, relative intensities of which are strongly 
increased at pH ca. 11.0. In addition, there is a redistribution 
of the relative intensities of the bands in the region 1250—1450 
cm" 1 compared to the spectrum at neutral pH. At acidic pH we 
find a total disappearance of the bands 1476, 1520, and 1568 
cm"1, a shift of the band at ca. 1279 cm" 1 to 1294 cm " 1 with 
a simultaneous decrease of their relative intensities and increase 
of the band at ca. 1600 cm" 1 (Figure 5c). In addition to these 
changes, all the SERS bands were found to decrease at pH II .0 
versus pH 4.0. We suppose that the bands at 1520 and 1568 
cm " 1 should be assigned to C=C vibrations of the aromatic 
ring with possible contribution of the N+= C  vibration to 1568 
cm"1, whereas the band in the 1270—1295 cm" 1 region most 
probably corresponds to the v (C -0 )  vibration. 20 Although these
2 4 5
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bands cannot be attributed directly to the vibrations of the OH 
group, they undoubtedly depend on the microenvironment of 
this group.
The following spectral indicators of the OH group microen­
vironment in FGR have been characterized. The first is the 
overall intensity of the SERS spectrum revealed from the 
comparison of FGR and ETX spectra. The second is the high 
sensitivity of relative intensities of the v8a and vgb vibrations to 
any interactions of the OH group. Finally, we have revealed 
some other pH-dependent bands sensitive to the protonaUon state 
of the OH group. We can propose therefore the following 
correlation between the SERS spectrum and the environment 
of the OH group. Deprotonated at basic pH, the OH group is 
characterized by strong bands at 1520 and 1568 cm" 1 and a 
relatively strong band at ca. 1279 cm"1. At nearly neutral pH 
7.5, some fraction of the OH groups are still deprotonated. 
Therefore, the bands at 1520 and 1568 cm " 1 as well as at 1279 
cm" 1 are observed but weaker than at basic pH. At acidic pH 
the 1520 and 1569 cm" 1 bands completely disappear, the band 
at ca. 1278 cm " 1 shifts to 1294 cm"1, and, finally, a significant 
increase of the band corresponding to vga is observed. It should 
be noted that the latter change might arise not only from 
interactions of the OH group but also from the O—CH3 group 
environment, since the same effect was observed for ETX.
SERS Spectra of FGR/DNA and ETX/DNA Complexes. 
The SERS spectra of FGR/DNA {Figure 5d) and ETX/DNA 
(Figure 6 d) complexes were recorded at different [drug]/[DNA] 
ratios (from 0.001 to 0.5). It is known2 " 7  that the intensity of 
the SERS signal for intercalating agents (such as adriamycin, 
saintopin, intoplicine) decreases significantly under complex- 
ation with DNA. In drug/DNA complexes the drug is buried 
within the DNA duplex so that it is kept away from the surface, 
and thereby, the SERS sufficiently decreases.
The same effect was observed for FGR and ETX. In the 
complex with DNA, the SERS signal was found to be 10 20 
times weaker than for the free drug. Using this fact, we have 
determined the DNA/dmg association constant for FGR to be 
ca. 3 x  10s M"1. This value is close to that determined 
previously by viscosimetric measurements. 13 Therefore, we 
conclude that interactions between the drug and DNA are poorly, 
if at all, affected by the surface and that the information obtained 
with SERS spectroscopy may be compared and correlated with 
that obtained with other techniques (UV/vis, CD, FLD). The 
same conclusion has been drawn before for a number of other 
anticancer agents. 2 7 . !...
To deduce, spectra),' changes, induced by complexation with 
DNA> the spectja of free drug§,.were compared to those of the 
[DNA]/[drag] complex at a 200; I ratio. Under these, conditions 
all the drug molecules are ensured to participate in the complex 
and no contribution of th  ^free drugs is present. Comparing the 
SERS spec.^rurn of ^ e  ETX/pN A. complex with that of the free
relatively:' lowepfor the! complex than lor- the. free drug, and
:A§ was'jpi^Cated above, the bands in the region 1370-1400
bands hardly provide particular information concerning interac­
tions of individual molecular groups of ETX; Any change in 
the state oftbesegroups mdylead to an alteration of the intensity 
of skefetal vtbrations. Nevertheless; this spectral range was found
to be sensitive to the modification of the N+ environment. Thus, 
we have indications that N+ is involved in the interaction with 
DNA. Moreover, the band at 1113 cm ' 1 (assigned to the v(C— 
O—CHj) vibration) clearly indicates that the exterior group
O—CH3 is involved in the interaction with DNA. Finally, as 
was shown above, bands in the 1580—1620 cm- 1  region may 
also serve as indicators of interaction of the O—CH3 group.
The spectral changes observed for SERS of FGR/DNA 
complexes (Figure 5) are more significant than those for ETX. 
The differences include a decrease or even disappearance of 
the bands at 1476, 1520, and 1570 cm"1, several modifications 
of band intensities in the 1330-1420 and 1590-1610 cm " 1 
regions, a relative increase of the bands at 1100—1130 cm"1, 
and finally, a splitting of the 1278 cm" 1 band into two bands at 
1292 and 1272 cm"1. These changes are very similar to those 
observed for SERS spectra of the free drug at acidic and neutral 
pH and may be attributed to the changes o f the environment of 
N+ and interactions of OH and O—CH3 groups. Therefore, we 
suppose that the effect of DNA on the structure of the drugs 
occurs through interactions between the OH, O—CH3, and N+ 
groups of the drug with the DNA.
The band at 1278 cm" 1 corresponds to the v(C—O) vibration 
and was shown to be sensitive to the formation of the H bond 
with participation of OH groups of various chromophores.7 ,22  
The presence of the two peaks at the expected position of this 
band in the spectrum of the drug/DNA complex may be 
explained as follows. As we have established, a significant 
number of OH groups at neutral pH still exist in deprotonated 
form. Therefore, we may observe the same position of this band 
at neutral as at basic pH. Upon complexation with DNA some 
bond(s) between DNA and the OH group appeared. These bonds 
are most likely H bonds, but we are not able to distinguish if 
the oxygen serves as a donor or as an acceptor of proton. It is 
reasonable to suppose that the oxygen in the deprotonated OH 
group is an acceptor of a proton, while the oxygen of the 
protonated OH group may be either an acceptor or a donor. 
Therefore, we propose that in the SERS spectrum of the drug/ 
DNA complex the bands at 1272 and 1292 cm- 1  correspond to 
vibrations of the OH group participating in H-bonding as an 
acceptor and/or a donor o f proton:
Discussion. * b y -
There are two principal “extreme” modes of anticancer drug 
interactions with DNA: minor groove binding and intercalation. 
The only exception is specific DNA topoisomerase I inhibitor 
camptothecin, exhibiting the extremely low affinity to DNA or 
topoisomerase I alone but exhibiting its anticancer activity, by 
stabilizing the ternary cleavage complex between DNA and 
topoisomerase I enzyme and thus preventing the substrate’s 
religation.23:2^ , : ■ . . > ., ■ . ■ ■■■.....
. , These two .“extreme" modes o f DNA binding by drags were 
found to be; distinguishable using linear dichroism spectroscopy,9 
./!?;! The intercalators exhibit a negative signal in the LD,spectrum, 
;i: whereas the minor groove binders give rise to a positive, signal! 
The most! usual “mixed mode’’.'of DNA interaction, o f agents 
induces normally the superposition of the features characteristic 
for the two “extreme” modes. > i->. ->
In the present study we have demonstrated that FGR and ETX 
induce negative LD signals. Moreover, precise calculations of 
the angle between the transition moment of the drag' and the 
DNA orientation axis show that the planes of the: drug’s 
chromophores are nearly parallel to the plane of the nucleotide 
bases. Therefore, we may conclude that both compounds, FGR 
and ETX?, ate intercalators. The; conclusion concerning, FGR
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supports the result obtained before by measurements of the DNA 
length increase induced by FGR/DNA interactions. 13
In addition to traditional methods providing information on 
DNA/drug interactions, SERS spectroscopy allows the selective 
detection and study of molecular interactions of individual 
molecular groups of drugs. To date, this method was applied 
to the analysis of a number of anticancer drugs and their 
interactions with DNA . 2 - 7  In the case of FGR and ETX, SERS 
appeared to be an extremely sensitive and selective technique, 
owing to tremendous enhancement of Raman scattering from 
these molecules. The SERS spectroscopy reveals pronounced 
differences in molecular interactions of FGR and ETX with 
DNA. These differences were explained in terms of tire chemical 
nature o f the substituent groups of the drugs. The OH group of 
FGR was found to play a key role in the drug’s interactions 
with DNA. In addition, the N+ and OCH3 moieties (Figure 1) 
should be involved in DNA binding. Replacement of the OH 
group by OCH3 and the presence of an additional OCH2CH3 
group in an ETX molecule should lead to redistribution of 
electric charge in the chromophore conjugated system. As a 
result, the orientation of the total dipole moment of the molecule 
should be different for FGR and ETX. Therefore, one may 
suggest that, upon intercalation, orientation of the ETX molecule 
with respect to DNA bases is quite different from that of FGR.
In the previous study of FGR and its complexes with DNA 
by UV/vis spectroscopy it was proposed that the quaternary 
cation (N+) may serve as an anchor that binds the negatively 
charged phosphate group of the backbone of double-stranded 
nucleic acids. 15 Hereupon initial interaction a more hydrophobic 
region of the molecule could intercalate between the stacked 
base pairs.
In the studies of protoberberine analogues whose chemical 
structures are rather similar to those of FGR and ETX, the so- 
called “mixed-mode" DNA binding model was presented.25 This 
model suggests that a portion of the ligand intercalates into the 
double helix, while the nonintercalated portion of the molecule 
protrudes into the minor groove of the host duplex, where it 
becomes available for interactions with the atoms lining the floor 
and/or walls of the minor groove.
This “mixed-mode” DNA-binding model seems very suitable 
for FGR and ETX molecules. Indeed, the quaternary cation may 
serve as an anchor that binds the negatively charged phosphate 
backbone of the double-stranded nucleic acids, and the molecule 
could intercalate between the stacked base pairs. However, a 
significant part o f the molecule enters the DNA minor groove. 
We suppose that FGR is oriented so that its OH group is rather 
directed to minor groove, whereas the OCH2CH3 group of ETX 
protrudes into the minor groove where it becomes accessible 
for interactions with the DNA-binding intracellular enzymes.
FGR is known to be a potent inhibitor of DNA topos I and 
II, stabilizing the cleavable complex between the enzyme and 
its DNA substrate. 1 3 1 4  ETX, a synthetic derivative of FGR, 
seems to be also an effective double inhibitor of topos26 with 
the even higher cytotoxicity on the cellular level. This paper 
presents the first comparative study of the molecular interactions 
of these two antitumor agents with the DNA. The differences 
of the modes of DNA binding by FGR and ETX, especially in 
the terms of their molecular interactions within the DNA minor 
group (minor-groove-directed position of the OH group of FGR 
and minor-groove occupation with the spacious OCH1CH1 group 
of ETX), should obviously modulate the topos inhibitory effect 
of these drugs. The next stage o f our work will concern the 
comparative analysis of molecular interactions of FGR and ETX 
within the ternary cleavable complexes with the DNA and topos.
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This work should provide us with the information enabling us 
to correlate the in vitro results with the cytotoxicity effects 
exhibited by these drugs at the cellular level.
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F ou r n ew  ligan d s th a t b ind to th e m in or groove o f D N A  h a v e  b een  d esign ed , sy n th es ized , and  
ev a lu a te d  by D N A  footprin tin g . T w o o f  th e lig a n d s are p o lyam id es  co n ta in in g  cen tra l reg ions  
w ith  five  or s ix  AZ-m ethylpyrrole u n its , conferring  hyd rop hobicity  and good b in d in g  a ffin ity  
but w ith o u t r e ta in in g  th e correct sp a c in g  for hyd rogen  bon ding in  th e  b a se  o f th e m in or groove. 
T h e tw o rem a in in g  lig a n d s h ave cen tra l reg ion s w h ich  are h ead -to -h ead -lin k ed  p o lyam id es, in 
w hich  th e lin k er  is  d esig n ed  to im p rove th e p h a sin g  o f hyd rogen  b on ding o f th e  ligan d  w ith  
th e  floor o f th e m in or  groove. T he h ig h es t  a ff in ity  w a s  ob ta in ed  w ith  th e tw o p olyp yrroles  
w ith ou t headgroup sp acers, in d ica tin g  th a t H -bond ph asin g  is  secon d ary  in d eterm in in g  a ffin ity  
com pared to the m ajor hydrophobic driv in g force. W ith a d im eth y lam in oa lk y l group, rep resen t 
ing  a m oiety  w ith  m od est b ase  stren g th , a t both en d s, w a ter  so lu b ility  is good and p H -partition  
th eory  pred icts  th a t p en etra tio n  th rou gh  lip id  m em b ran es w ill be en h an ced , com pared to 
s tro n g ly  basic a m id in e  a n a lo g u es  o f  th e  a lk a lo id  precursors. A ll four com pounds b in d to D NA, 
w ith  s tro n g  se le c tiv ity  for AT seq u e n ces  bu t som e to leran ce  o f GC b ase pa irs an d  su b tle  
in d iv id u al p referen ces. T h e d ata  sh o w  th a t v ery  h igh  a ff in itie s  can  be a n tic ip a ted  for fu ture  
com p ou n d s in th is  ser ie s , but d rug  d esig n  m u st tak e  accou n t o f  overa ll ph ysicoch em ica l 
p rop erties  a s w e ll a s  th e  d e ta ils  o f hyd rogen  b on ding b e tw een  lig a n d s and th e floor o f  th e  
m inor groove.
I n t r o d u c t i o n
The attraction s o f drug design  w here the ligand is 
directed a t the primary coding seq uences o f DNA are 
m any. Such a ligand, should it be sufficiently sequence  
selective , would offer the prospect o f gene control in 
d iseases  w here genetic m alfunction is th e primary 
cause, such as cancer. In addition, there are exciting  
p ossib ilities  for the treatm ent o f parasitic  d iseases, 
where the DNA possesses seq uences which do not occur 
in the host.
Sequence selectiv ity  is not a major feature o f the early  
type o f intercalatin g ligands, such a s  ethid ium , but 
m uch atten tion  has been devoted in recent years to the 
developm ent o f ‘lex itropsins’, w hich bind to the minor 
groove of DNA and th us have a greater chance of 
reading th e inform ation w hich is provided by the base 
pair sequence a s  part of th e usual process o f transcrip­
tion. It w as found quite early  in th ese stu d ies  th at the 
natural polypyrroles, such a s  netropsin (1) and dista  
m ycin (2), show ed alm ost total se lectiv ity  for AT rather 
than GC seq u en ces .1 Very recently, it has been shown  
th at th ese  com pounds show  a degree o f se lectiv ity  for 
som e specific AT sequences over o th ers.2,3
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II Strathclyde Institute lor Biomedical Sciences.
An im portant advance was m ade in ligand d esign 4 
when the /V-methylpyrrole units of the natural products 
w ere replaced w ith  other five-m em bered heterocyclic 
rings, in particular im idazole, w hich changed the se ­
quence-binding preference from AT to GC. A combina 
tion o f th ese  u n its  offers the possib ility  of designing  
m olecules to bind preferentially  to any g iven  double­
stranded D NA sequence. A dditionally, it is necessary  
to extend the length o f the molecule to read considerably 
more than th e four base pairs w hich bind the natural 
products, if a  useful level of selectivity is to be achieved,5 
w hich m ay require th e use, for exam ple, of bifunctional 
linkers6 to jo in  chains of am ide-bonded heterocycles. A 
significant variation  on th is approach allow s the chain  
to double back on itse lf.7 Such a ‘hairpin’ structure fills 
the minor groove and reads the seq uence inform ation  
m ore effic ien tly  than a single  chain  but requires the 
construction o f a considerably larger m olecule, up to 
double the length  o f the sequence w hich is being read.
The central part o f the ligand m u st be hydrophobic, 
s ince the m ain driving force for binding is the expulsion  
of w ater from the m inor groove, itse lf  a largely hydro- 
phobic environm ent w ith  a capacity for hydrogen bond 
ing at the bottom of the groove. A recent thermodynamic 
study8 has show n th at binding in th e m inor groove of a 
DNA dodecam er by H oechst 33258  is dom inated by 
hydrophobic forces; clearly, new ligands m ust have large 
nonpolar regions if they are to show  high affinity. A 
major concern in drug design, therefore, is the water
10.I021/jm990620e CCC: $19.00 «  2000 American Chemical Society
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solubility  of a ligand com posed largely o f  nonpolar 
subunits and, if th is is overcome by the use of more than  
one basic end group, the effect that th is w ill have on 
the ability of the molecule to penetrate lipid m em branes 
by passive diffusion.
n h 2 ^
N— \ H
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To test th ese  concepts, w e have synthesized  four new  
ligands 4 —7, w hich com bine building blocks known to 
give good DNA binding, and have correlated their DNA  
binding w ith  th eir calculated partitioning properties. 
L igands 4 and 5 are extended polyam ides, w ith  long  
chains o f nonpolar Af-methylpyrroles rendered more 
soluble by d im ethylam ino groups at both ends. L igands 
6  and 7 are both head-to-head-linked polypyrroles, w ith  
a linker w hich has been designed to improve H-bonding  
in  the base of th e m inor groove: in both cases the linker 
is  m ore hydrophilic than th e polypyrrole chains. The  
dim ethylam ino end groups of structures 4 - 7  w ere  
chosen for three reasons. F irst, they have been used  
before11 and have been show n to be con sisten t w ith  good 
DNA binding. Second, the synthetic  m ethods for their  
incorporation are w ell-established, and third, we w ished  
to use tertiary bases, w hich would have lower pAa 
values than am id ines, guan idines, or secondary bases. 
This is h igh ly sign ifican t w hen pH-partition theory is 
applied to th ese  m olecules.
Fishleigh el al.
The application o f pH -partition theory to drugs w ith  
a lipophilic structure and one basic g r o u p  is well 
estab lished;10 it is a com bination o f the H enderson
if
- O
H asselbach treatm ent o f the ionization of w eak acids 
and bases w ith  the concept of the partition coefficient 
(P) betw een tw o im m iscible so lven ts, giving eq 1, for a 
compound w ith  one basic center:
D =  PI ( 1 +  i o (pAr'_pH>) ( 1)
In th is equation, D  is defined as  the ratio o f the  
concentration o f nonionized m aterial in the organic 
(lipid) phase to th e concentration of the combined 
ionized and nonionized m aterial in the aqueous phase, 
at equilibrium . Since, for a g iven  compound H and p /(a 
are constant, it is possible to plot log D  against pH. 
Where insight is sought into the probable behavior o f a 
m olecule in the body, th e  region o f greatest interest is 
that around pH 7.4, the pH o f m ost body tissues. At pH
7.4 m olecules such as 4 7 are expected to be doubly  
charged, in which case the pH -partition behavior is 
described by a specia l form of eq 1, taking account of 
the existence of two basic centers, here assum ed to have 
the sam e value of pK„, and a doubly charged species  
(eq 2). W here th e two p/Ca va lues are close, but not 
identical, th is form of the equation can be regarded as 
an adequate approxim ation:
D — P /( 1 +  2 (1 0 (p*‘~pHj) +  i o (z(pK“"plD)) (2)
Since the introduction of two charged groups m ight 
influence DNA binding, w e compared the binding char  
acteristics o f com pounds 4 7 u sing the footprinting  
technique.
D is c u s s io n
D N A  B in d in g . We used D N ase 1 and hydroxyl 
radical footprinting to exam ine th e interaction o f th ese  
ligands w ith  natural and syn th etic  DNA fragm ents. 
W ith TyrT DNA (Figure I), a natural DNA fragm ent 
which has been w idely used in footprinting stud ies, w e  
found that each  of the com pounds altered the d igestion
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T y rT  DNA
5--TC ar.G A A C C C |i„C C A C C A C G G G „oC  t A T T a C r n  iMrrA C T C G C C T |2oGCT 
CCCTTA11 ^ CUGGAAGCGGiooGGCGCA I CATmATCAAATGACsoGCGCCGC 1 
G'l J„AAAG 1G n 'A C OTG TIG A G A A A A M1AATGAAGTGG4UTl'G C G T A A rrjoT T C A  
TCCGTAj0ACGGATTAAAii)GGTAACCGGAA-3’
P<A/T)m !
5'-GA IX'-CGGAAl ATl'CCGGAAATATnCGGOAAAATATrr TCCGGAA AAAT 






p (a /T ) 5
.V -G A TCG CG A A A TTTCGCOTATATACGCGTAA'ITACGCGrrTAAACGCGAA
TTCGCGG-IT
Figure 1. Sequences of the various DNA fragments used in 
this work. Only the strand bearing the radioactive label 
(underlined) is shown. TyrT is an £coRl -Aval fragment. The 
numbering system used for this DNA is the same as that used 
in previous publications." 3 Forp(A/T)e 12, pAs «, p(A/T)io. and 
p(A/T)fi only the sequence of the insert (which was cloned into 
the £>’a/nHl site of pUC18) is shown. Every tenth base of the 
TyrT fragment is numbered for easy reference.
pattern a t concentrations o f 0 .1 —3 pM . In each case  
reductions in c leavage w ere seen  around position s 25. 
60. and 80, each of which corresponds to an AT-rich site  
which has previously been show n to be affected by other  
m inor groove-binding ligands. T hese pattern s w ere not 
easy  to interpret since D N ase  I c leavage in the control 
w as very un even and several regions of poor cleavage  
in the control were located in the AT-rich regions around 
positions 2 5 —30 and 4 5 —50, w hich are expected  to be 
good ligand-binding sites. W e therefore repeated the 
experim ents u sing hydroxyl radicals a s  the footprinting  
probe. T hese produced a m uch more even  ladder of 
cleavage products in the control, enabling a more precise 
determ ination  of the ligand-binding s ites. Low concen 
trations o f compound 4 (0.3 and 1 //M) produced attenu  
ated cleavage around positions 2 5 —30, 4 6 - 5 0 ,  6 1 —65, 
and 81 —8 6 . T he first two are located toward the 3'-side  
of long AT tracts (7 and 6  bases, respectively), w hile the 
third contain s only 4 consecutive AT pairs. H owever, it 
m ay be sign ifican t that th is  lies  w ith in  an  AT-rich 
region; the 13 AT pairs betw een positions 5 9 -  71 contain  
only 3 GC pairs. It is possible that th is represents ligand 
binding to a longer s ite  (possibly TGTAAA a t 6 5 —70), 
tolerating a sin g le  guan ine residue. E ach o f th ese  
footprints w a s about 6  bases long, com pared w ith 3 - 4  
bases observed w ith d istam ycin , 1 1 confirm ing the larger 
ligand-binding site . At higher concentrations (3 ^M and 
above) th e footprinting pattern changed and more 
regions w ere protected from cleavage. M ost notable w as 
a new footprint around position 40 (AACTGGTT). The 
regions protected around positions 60 and 80 also  
increased in s ize  and appeared to sp lit into two foot­
prints located on either sid e o f the ones produced at
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lower concentrations. The pattern produced by 1 5
w as sim ilar to that generated by 4 a t low concentrations, 
except that th e footprint around position 65 w as more 
clearly defined , w hile the footprint around position 25 
extended over one or two more bases in the 3'-direction, 
consisten t w ith  its larger size. At h igher concentrations 
(3 //M  and above) hydroxyl radical cleavage w as alm ost 
com pletely abolished. An exam ple of a differential 
cleavage plot, derived from densitom eter scan s o f the 
data for 1 /zM compound 5 only, is presented in Figure  
2A, revealing three d istin ct regions o f protection be­
tw een positions 20—70. Three clear footprints were also  
evident w ith  0 .3  /*M 7 around positions 2 5 —30, 46—50, 
and 8 1 —86, as observed w ith  the other ligands, except 
that there w as little  protection around position 65. With 
1 p M  of ligand 7 new  s ite s  of protection were evident, 
corresponding to th e  pattern produced w ith higher 
concentrations of 4. Compound 7 show ed five binding  
s ite s  betw een positions 20—77. T he first and third 
(around positions 25 and 45) correspond to long AT 
tracts, w hile the latter (around position 6 5 —70) contains 
the sequence TGTAAA. The other two s ite s  are harder 
to define rigorously but appear to contain the sequences 
AACTGGTT (positions 37 44) and TTA G C Tf (5 5 -6 1 ). 
T he changes w ith  1 p M  6  were less  clear, w ith only one 
clear footprint at positions 27—31, w ith attenuated  
cleavage around positions 4 6 - 5 0  and 81 - 8 6 .
T hese resu lts confirm that th e com pounds are indeed  
A T-selective, w ith  larger binding s ite s  than the parent 
antibiotic distam ycin . In addition th ey suggest th at at 
m oderate concentrations these com pounds can bind to 
som e s ite s  w hich contain 1 or 2 GC base pairs and that 
the various derivatives have subtly  d ifferent sequence  
binding properties. We have therefore investigated their 
interaction w ith  several synthetic  DNA fragm ents con 
tain ing d ifferent length  AT tracts and various arrange 
m ents of AT base pairs.
Fragm ent pAAD (not shown) conta in s 5 (A/TL sites, 
each sep arated  by 6  GC base pairs, and has previously  
been used  to d eterm ine AT selectiv ity  o f several minor 
groove-binding ligan ds . 2 None o f com pounds 4 —7 af­
fected e ith er  D N ase  I or hydroxyl radical c leavage of 
th is fragm ent a t concentrations up to 3 pM , though  
higher concentrations abolished cleavage throughout the 
fragm ent. T h is confirm s that, in th is  fragm ent, 4 con­
secutive AT base pairs w ere not su fficien t to constitu te  
a specific ligand-binding site.
Figure 3 show s D N ase  I c leavage o f fragm ent pA;i B 
which contain s 4 A ,/T„ tracts o f various lengths (n =
3 —6). It can be seen  that, w ith th e exception of 3 p M  7. 
cleavage of T 3  w as not affected by the ligands and 
cleavage at T 4 w as only attenuated a t the highest ligand  
concentrations. C leavage o f Tg and Tg w as inhibited at 
lower ligand concentrations w ith  Tg as the better site  
in each case. Both 4 and 7 protected Tg a t the low est 
concentration (0.3 ^M), w hile Tg w as not fully protected  
below 1 /<M. S im ilarly 5 protected Tg at 1 pM , w h ile  Tg 
required 3 p M . For 6 , Tg w as protected a t the h ighest 
concentration, w hile the other site s  w ere hardly affected. 
It therefore appears th at the ligands bind best to s ite s  
contain ing 6  consecutive AT base pairs, although there  
is  a s ign ifican t interaction w ith s ite s  contain ing 5 and 
4 AT pairs. Hydroxyl radical cleavage patterns w ith this 
fragm ent are not easy  to interpret since d igestion  of the
250











, TAT A T ATGOCCA AA AA T TTTTaCOCTAO
Figure 2. Differential cleavage plots showing the interaction of I /<M 5 with the 5 different DNA fragments: A, TyrT DNA; B, 
pA;i u; C, p(A/T)e u; D, p(A/T)ti; E, p(A/T)io- The data were obtained from hydroxyl radical cleavage patterns and were analyzed 
as described in the text
DNA w as atten uated  in each T„ tract in the absence of 
the ligand, consisten t w ith  previous su ggestion s that 
th ese  seq u en ces p ossess narrower than average minor 
grooves. A differential cleavage plot com paring the 
pattern in the presence of 1 /zM 5 w ith  that in the  
control is  show n in Figure 2B. W ith th is compound 
footprints w ere only produced at T 5 and Tg, each  
covering 6  7 bases. 6  a lso  produced clear footprints at 
Tg and Tj, and the protection at T 4 and T 3 coalesced into 
a sing le  footprint. Com pounds 4 and 7 produced foot 
prints a t a ll the T„ sites, each  o f which covers 5 —6 bases. 
H owever, exam ination  of th e pattern a t T3  reveals that 
the apparent protection is far to the 3'-side of the actual 
site, suggesting  that there w as som ething unusual about 
th is interaction .
The resu lts  w ith pA3  0  confirmed that th e compounds 
bind b est to longer AT tracts and show ed th at the  
binding s ite , a s revealed by hydroxyl radicals, covered 
about 6  b ase  pairs. We therefore extended th ese  stu d ies  
to a fragm ent contain ing longer AT tracts. W ith hy 
droxyl radical cleavage o f p(A/T)e 1 2 . for w hich the  
seq u en ce 13 is  given in Figure 1, com pounds 4 and 5 
produced clear footprints covering 6 —7 base pairs a t the
s ite s  contain ing 8 , 1 0 , and 1 2  base pairs but had little  
effect on th e upper s ite  contain ing 6  AT base pairs 
(AATATT) (Figure 3). A differential cleavage plot show ­
ing the resu lts for 5 is show n in F igure 2C. In contrast 
7 produced footprints a t all 4 s ite s , including AATATT. 
However the footprint at th e lon gest s ite  w as much 
broader w ith th is  ligand affecting 8 —9 base pairs. T his  
m ay be because th e  ligand does not adopt a unique 
position w ith in  th is long AT s ite  but can assu m e one o f 
several locations each  of which does not cover th e entire  
s ite . Surprisingly 1 /zM 6  failed to show  appreciable 
protection a t any of th e sites. It shou ld  be em phasized  
that each of these hydroxyl radical footprints is different 
from that produced by the parent antibiotic distam ycin, 
which produces two d istin ct regions o f protection w ithin  
the 8 -, 1 0 -, and 1 2 -base pair s ite s , consisten t w ith  the 
suggestion  th at two ligand m olecules can sim u lta ­
neously bind w ith in  each  s ite . 13
Previous stu d ies have shown that, a lthough d istam y­
cin and other m inor groove-binding ligands can bind to 
all arrangem ents o f 4 consecutive AT base pairs, som e 
s ite s  are better than oth ers . 2 AATT is a particularly  
good binding site , w hile  the ligan d s bind less  w ell to
2 5 1
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p A M  P ( A  Ofr-12
DNase I Hydroxyl radicals
4 5 7 6 4 5
IS^2-«5 S3-3-,
AATATT
A jT A T j
A4TAT4
ASTATS
F ig u r e  3. D N ase I foo tp rin ting  p a t te rn s  for th e  in teraction  
of com pounds 4 7 w ith  th e  frag m en ts  derived  from pAj « and  
p(AT)<; ix. T he concen tration  of th e  ligand (//M) is shown at 
th e  top of each  gel lane. 'Con' ind ica tes th e  control, in th e  
absence o f added  ligand. T ra ck s  labeled 'GA' a re  M axam 
G ilbert sequencing  lanes specific for pu rine s. The position of 
the  various T„ blocks is ind ica ted  a t th e  side  o f th e  au to rad io ­
graph .
sites containing TpA steps, especially TTAA and TATA. 
We therefore performed similar experiments with a 
fragment containing four different arrangements of 6  
AT base pairs (A3T3 , T3A3 , (TA).f, and TAATTA) together 
with AATT for comparison. The results of hydroxyl 
radical footprinting experiments with 5 on this fragment 
are shown in Figure 2D. Compounds 4, 5, and 7 
produced DNase I footprints at each of the (A/T)e sites, 
while cleavage at AATT was not affected. The footprints 
at these various sites appeared at different ligand 
concentrations: cleavage at T3 A3  and TAATTA was 
abolished at 0.2 /tM 7, while (TA)a required higher 
ligand concentrations (1 //M) to produce a footprint. No 
data could be obtained for A3T3  since this region showed 
no cleavage in the drug-free controls. The rank order of 
binding sites for these ligands is T3 A3  > TAATTA > 
(TA)3. It therefore appears that the binding strength 
decreases with increasing numbers of TpA steps. Com­
pound 6  only affected enzyme cleavage at concentrations 
of 3 ,«M and above, though once again protection of (TA) 3  
was weaker. A differential cleavage plot for hydroxyl 
radical cleavage of this fragment in the presence of 
1 pM  5 is shown in Figure 2D. This confirms the 
binding sites and reveals that between 5 —7 residues are 
protected at each position. Figure 2E shows a similar 
differential cleavage plot for hydroxyl radical cleavage 
of the fragment containing blocks of 10 AT base pairs 
in the presence of 1 pM 5. These results are in contrast 
to those with distamycin , 13 which produces two distinct 
footprints at each AT site. This difference is consistent
with the larger binding site size for these ligands, so 
that only one molecule is bound in each AT tract. Once 
again, between 5 —7 bases are protected at each (A/T)m 
site, with much weaker binding at AATT. DNase 1 
cleavage of this fragment shows protection at all the 
(A/T)io sites but reveals that the ligands do not dis 
criminate between the different arrangements of AT 
base pairs.
Analogues 4 and 5 both have central regions which 
are simply extended polypyrroles. Above three pyrrole 
units, the hydrogen-bonding ability of the amide links 
ceases to be in-phase with the spacing on the lloor of 
the minor groove . 6 1 4  resulting in a limit to the reading 
ability. The good affinity of these two analogues is 
therefore a reflection of the extra capacity for hydro 
phobic bonding in the minor groove. Their greater 
length, compared to the natural ligands, accounts for 
their preference for extended A/T base pair sequences. 
The glycine linkers in 6  are spaced appropriately for 
restoration of phasing with the FI bonding opportunities 
in the minor groove and were designed to be tolerant 
of, and perhaps selective toward, GC base pairs. 15 In 
this case, however, the hydrophilic nature of the ainide 
links may affect binding to DNA and also would 
prejudice the chances of such a molecule reaching the 
site of action in vivo. Compound 6  is capable of weakly 
protecting short AT runs (not shown in the figures) 
which may indicate that the molecule is only binding 
at one end, with the central amide groups extending out 
into water, or that the molecule is behaving as a 
hairpin' and folding back to give side by-side filling of 
the minor groove. To do this, at least one of the charges 
on the end amino groups would have to be lost by 
deprotonation.
Analogue 7 is a dimethylamino version of a head to 
head-linked netropsin analogue previously reported to 
display bidentate binding in (AT),,-rich sequences. 16 This 
relatively rigid linker has a length of 4.2 A, close to the
4.4 A required to maintain the ideal phasing of ligand 
amide hydrogens. Although the central fumaramide unit 
has the right length, modeling indicates a distortion in 
the helicity of the molecule in the center, possibly 
accounting for the slightly weaker binding observed 
with this analogue.
C hem istry . For the construction of polypyrroles with 
a dimethylaminoalkyl end group, we used stepwise 
addition of Af-methyl 4 nitro-2-trichIoroacetylpyrrole 
units to amino-substituted mono- or polypyrroles with 
dimethylaminopropylamino tails (Scheme 1). The amino 
groups were generated by catalytic hydrogenation of the 
nitro group of the growing chain, an approach which 
was used to generate oligomers up to four rings in 
length. Addition of further rings resulted in a rapid 
decline in yield.
The syntheses of 4 and 5 were therefore based on the 
coupling of a two-ring and a three- or four-ring unit in 
a convergent fashion, in good yield (Scheme 1). This 
route was designed to allow a flexible approach to the 
synthesis of longer and more complex lexitropsins in the 
future. Analogue 4 was constructed by coupling a three- 
ring amine (Scheme 1) to a two-ring acid (Scheme 2), 
using HBTU/F.t3 N, followed by HPI .C purification. The 
hexapyrrole 5 followed similarly, from a four ring amine 
and a two-ring acid.
2 5 2
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T ab le  1. Input D ata and  Calculated log Distribution 
Coefficients for Extended Lexitropsins
OEl
H = C O O II
R - H
-’ Reagents: (i) Pd/C/H2: (ii) HOOC(CIL),NMe2/HBTU/Et3N/ 
DMF; (iii) NaOH.
T he isophthalic diam ide 6 w as syn th esized  in good 
yield, by First treating isophthaloyl chloride w ith glycine  
m ethyl ester  to give 18, followed by hydrolysis and  
coupling to 10 (R =  N H 2), u sing HBTU/NM M  (Schem e  
1). D erivative 7 cam e directly  from th e coupling of the  
tw o-ring am in e 10 (R =  N H 2 ), used in the previous  
syn th eses , w ith  fum aric acid (Schem e 1).
P a r t i t io n in g .  A pplication o f eq 1 to distam ycin  (2), 
which has expected p/<a ca. 12.4 and ca lcu la ted 17 log P  
value of —0.87, g ives th e curve show n in Figure 4, 
show ing th e effect of the very strongly basic am idine  
m oiety, cf. acetam id in e .18 At pH 7.4, d istam ycin  is 
expected to favor the aqueous phase, w ith potential 
difficulty in p assing through a series of lipid m em brane
rompd log P ' pKu'1 log 7?(pH 7.4)’
1 3.29 12.4 -13.29
2 -0 .87 12.4 -5 .87
3 2.17 9.5 0.07
4 3.89 9.5 -0 .32
5 4.68 9.5 0.47
6 1.47 9.5 -2 .74
7 3.18 9.5 -1.03
■’ Calculated using the program in ref 17. '’ Assumed figures.
1 Calculated from eqs 1 and  2.
barriers. C alculated va lu es of log P, assum ed va lu es of 
pKa, and the resu lting  calculated va lues of log D  at pH
7.4 for com pounds 1 - 7  are given in Table 1.
If the am id ine is replaced with a dim ethylatninoalkyl 
substitu en t, giv ing 3, w hich h as been found to be 
consistent w ith  m aintenance of D NA binding,19 the p/Ca 
is reduced by about 2 log units, by analogy with a range  
of com pounds such as im ipram ine20 and log P  is 
increased by ca. 3 log un its, g iv in g  the curve in Figure  
4. Inspection o f th e curve show s that the behavior in 
the critical region about pH 7.4 is m arkedly affected: 
no longer is there such a  strong preference for the  
aqueous phase. Such an analogue would be expected to 
show m uch im proved bioavailability.
R elatively sm all m olecules such  as 1 3  would be 
expected to be su fficien tly  w ater-soluble to be capable  
of form ulation as drugs. Longer D NA reading fram es, 
however, require long stretch es o f hydrophobic bases, 
which by defin ition  are likely to be less-w ater-soluble. 
Introduction o f a second d im ethylam inoalkyl group at 
th e opposite end o f th e m olecule to th e first one, a s in
4 —7, offers th e possib ility  of im provem ent in w ater  
solubility.
The two basic cen ters are su fficien tly  far apart, to 
behave as individual units, w ith  the sam e or very
2 5 3






 Compound 5 --------- Compound 6
-  -  - - Compound 3 ............ Compound 2
Figure 4. pH-partition behavior of compounds 2, 3. 5, and 6 
calculated from eqs 1 and 2.
sim ilar pK a values, w hich by analogy20 w e expect to be 
in the range 9 —10. Figure 4 show s th e pH -partition  
behavior o f the m ost (5) and least (6) lipophilic of the 
dibasic analogu es described in the present study, cal 
culated from eq 2. Com parison of the data  in Figure 4 
show s th e very marked effect o f the second basic center, 
in 5 and 6, in th e  region about pH 7.4. It is apparent 
that such  analogues can to lerate m uch larger lipophilic 
loads' in the central region; of th ese  analogues, the  
polypyrrole 5, w ith  the h igh est calculated  value of log 
P. prom ises the kind of partitioning behavior consistent  
w ith  good bioavailability. All o f the d ibasic com pounds 
in the present study w ere read ily  w ater-soluble.
O verall, th e significan ce of th ese  resu lts  lies  not only 
w ith  th e  sequence-reading ab ility  of th ese  particular  
m olecules but in the finding that w ater so lub ility  can  
be a designed attribute, w ith ou t com prom ising the  
physicochem ical characteristics theoretically  required 
for tissu e  penetration and m aintain ing affinity for DNA. 
It is becom ing increasingly apparent, especially  w ith the 
larger m olecules required for extended seq uence recog 
nition  in DNA, th at drug design  m u st take account of 
solubility  and tissu e  penetration  as prim ary featu res,10 
alongside receptor affinity and selectiv ity . In th is  con 
text, the insertion  of extra  am ide lin ks to change 
hydrogen-bond phasing, a s  in 6, m ust be approached  
w ith  caution, s in ce  an am ide m akes a strong  negative  
contribution to th e  log P. H owever, if a tten tion  is paid 
to the pH -partitioning characteristics o f designed mol 
ecules, there is no reason lexitropsins cannot be de­
signed to read long len gth s of D NA and also  have  
adequate bioavailability.
E x p er im en ta l S ectio n
C hem istry. *H NMR spectra were recorded at 400 MHz 
on a Bruker AMX spectrometer. Electrospray mass spectra 
were recorded on a Fisons VG Platform Benchtop LC—MS and 
F.IMS on a JF.OL .IMS-AX505HA mass spectrometer. HPLC 
purifications were effected on a Vydac Protein and Peptide CIS 
column using a solvent gradient with two solvents: 0.1% TFA
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in water (A) and acetonitrile 90%. water 10%, TFA 0.1% (B). 
Elution commenced with 95% A, 5% B and finished with 100% 
B. Accurate mass measurements of compounds 4 - 7  were 
carried out at the EPSRC National Mass Spectrometry Service 
Centre, University of Wales, Swansea, U.K.
3 - ( l-M e th y l-4 - n i tr o p y r ro le -2 - c a rb o x a m id o )d im e th y l-  
a m in o p r o p a n e ,  9. A literature procedure21 gave 9 in 90% 
yield: mp 130-131 °C (lit.21 mp 129-130 °C).
3-[ l-i\4ethy l-4 -(l - in e th y l-4 -n itro p y rro le -2 -c a rb o x am id o )- 
p y r ro le -2  c a r b o x a m id o ld im e th y la m in o p r o p a n e ,  10. A 
literature procedure21 gave 10 in 78% yield: mp 191 192 ”C 
(lit.21 mp 190-191 °C).
3 ( l-M e th y l-4 - [ l  m e th y l-4 - ( I -m e th y I-4 -n itro p y rro le -2 -  
c a rb o x a in ld o )p y r r o le - 2 - c a r b o x a m id o |p y r r o le - 2 - c a r b o x -  
a m id o } d in te th y la n i in o p ro p a n e ,  11. A literature proce 
dure21 gave 11 in 63% yield: mp 198 °C (lit.21 mp 136—137 
°C; lit.2223 mp 205-206 °C).
(2£)-A/1,A 1-B is [5 -({ [5 -({ (3 d in ie th y lam in o p io p y l]am in o j 
c a rb o n y l ) - 1 -m e th y l-1 H -p y r ro l- 3 -y l la m in o } c a r b o n y l) - l  - 
m e th y l- i / / - p y r r o l - 3 - y l l - 2 - b u te n e d ia m id e  B is tr i f lu o r -  
a c e ta t e ,  7. 10, R =  NO? (200 mg, 0.53 mmol), and Pd/C-10% 
(200 mg) were suspended in 2-propanol (25 mL) and hydro­
genated for 4 h at room temperature. Filtration of the catalyst 
over Kieselguhr under Nz followed by removal of the solvent 
in vacuo gave the amine 10, R = NHz, as an off-white solid 
that was used without further purification. Fumaric acid (25 
mg, 0.22 mmol), HBTU (190 mg) and AAmethyImorpholine (70 
mL) were dissolved in DMF (1 mL, dry), with stirring at room 
temperature and then left for 30 min. The amine was dissolved 
in DMF (1.5 mL, dry) and added to the reaction mixture at 
room temperature with stirring. The reaction mixture was left 
stirring al room-temperature overnight, then purified by 
HPLC to give 7 as the bis-TFA salt (75 mg, 35% yield): ‘H 
NMR 6 (DMSO-cfc) 1.24-1.84 (4H. p, 2CHZ). 2.79 (311. s, NMe),
2.80 (3H, s, NMe), 3.05-3.10 (4H, in. 2CHZ), 3.24-3.27 (4H. 
m, 2CHz), 3.82 (6H, s. 2NMe, pyrrole), 3.68 (6H. s. 2NMe. 
pyrrole). 6.93 and 6.94 (2H, d), 6.94 and 6.95 (2H, d), 7.09 (2H. 
s), 7.16 and 7.17 (2H. d). 8.13 8.16 (2H, t. 2CONH exchange­
able). 9.32 (2H. broad 2TFA exchangeable), 9.92 (2H. s, 
2CONH exchangeable), 10.47 (2H, s. 2CONH exchangeable); 
ES-MS found (M + 1) 773.4216, calcd for GjbHs-jNizOg 773.4211.
3 -( l-M e th y l-4 - ( l- in e th y l-4 - ( l-m e th y l-4 -{  l-m e th y l-4 -n i-  
t r o p y r r o l e - 2 - c a rb o x a m id o ) p y r r o le -2 - c a rb o x a m id o ) p y r  
r o le  2 - c a rb o x a m id o )p y r ro le -2 - c a rb o x a m id o ld im e th y l-  
a m in o p r o p a n e ,  12. A mixture of I I  (LOO g, 2.01 mmol) and 
Pd/C-10% (1.00 g) in ethanol (100 mL) was hydrogenated at 
room temperature for 20 h. The catalyst was removed by 
filtration through Kieselguhr and the filtrate evaporated under 
reduced pressure to give the crude amine as a pale yellow solid 
residue (772 mg, 82%). This amine (722 mg, 1.6502 mmol) was 
dissolved in dry DMF (3.0 mL) and the solution cooled in an 
ice bath and stirred while a solution of 8 (447 mg, 1.65 mmol) 
in dry DMF (1.0 mL) was added slowly during a period of 5 
min. The resultant mixture was allowed to come to room 
temperature and stirred for 21 h. Water (30 mL) was added 
and the oily precipitate was scratched until it solidified. The 
solid was washed with water and, after drying in  vacuo, 
amounted to 745 mg. Crystallization from aqueous methanol 
gave 12 (425 mg, 34% yield) as a yellow microcrystalline 
solid: mp 192-195 “C (lit.2'’ mp 195 °C); ES-MS |M + 1] found 
622.6, calcd for C?9H ir,N,o06 621.7; •H NMR (DMSO-cfc) A 1.61 
(2H, m, CHz-CT/z-CHz), 2.13 (6H, s, N(CH3)Z). 2.24 (2H, t, 
CHz-CHz- NMez). 3.21 (2H, m, CONH-CHz-CH;.), 3.80 (3F1, 
s. NMe). 3.85 (3H. s, NMe), 3.87 (3H. s, NMe). 3.97 (3H. s. 
NMe), 6.83 (IH, d. ArH), 7.06 (2H, d, 2ArH), 7.19 (1H, d. ArH), 
7.26 (111, d, ArH). 7.29 (1H, d, ArH). 7.60 (IH. d. ArH). 8.09 
(IH. t, CO-NH-CH?. exchangeable), 8.20 (IH. d, ArH), 9.91 
(IH, s, CONN, exchangeable). 10.01 (IH. s, CONN, exchange­
able), 10.31 (IH, s, CONH. exchangeable).
E th y l  1 M e th y l -4 - ( l- m e th y l-4 - n i t r o p y r r o le - 2 - c a r b o x  
a m id o ) p y r r o le -2 - c a rb o x y la te ,  14. The nitro compound 13 
(2.057 g. 10.39 mmol) was hydrogenated over 10% Pd/C (805 
mg) in ethanol (200 mL) at room temperature for 2 h. The 
catalyst was removed by filtration through Kieselguhr and the
254
3264  Journal or Medicinal Chemistry. 2000. Vol. 43. No. 17
Filtrate evaporated under reduced pressure to leave the crude 
amine as a gray oil. This oil was dissolved in an ice—water 
bath, while a solution of 19 (10.39 mmol, prepared*1 from 1.766 
g of the carboxylic acid, using 2.0 mL of thioriyl chloride, and 
8 mL o f DME) in dry DME (10 mL) was added slowly over a 
period of 5 min. The resultant mixture was stirred and allowed 
to come to room temperature overnight then it was evaporated 
under reduced pressure. The residue was stirred for 1 h with 
N HC1 (50 mL) and the solid filtered, washed well with ethanol 
and dried in vacuo to give 14 as a yellow powder (1.377 g, 41% 
yield): mp 232-234 ”C (lit.20 mp 239-240 °C); IR (KBr) vn1ax 
3358, 3131, 1692, 1663, 1572, 1437. 1391, 1317, 1253, 1121 
cm 'H NMR (DMSO-db) d 1.24 -1.30 (3H, t, CHZCH3). 3.84 
(3H. s, NMe), 3.94 (3H, s, NMe), 4.16-4.24 (2H. q. CH £Hs). 
6.90 6.91 (IH, d). 7 .42-7.43 (IH. d), 7.54 7.55 (IH, d), 8.18 
8.19 (IH, d). 10.26 (IH, s. C O N H exchangeable).
E th y l I M e th y l 4 ( 1 -m e th y l-4 -(4 -d iin e th y lam in o b u ty ry  1)- 
a m in o )p y r r o le - 2 - c a r b o x y ia te ,  15. A mixture of 14 (605 mg) 
and Pd/C-10% (627 mg) in ethanol (60 mL) was hydrogenated 
at room temperature for 16 h. The catalyst was removed by 
filtration through Kieselguhr and the filtrate was evaporated 
under reduced pressure to leave the crude amine as a buff 
colored glassy foam (456 mg, 83% yield) which was used 
without further purification. A mixture of 4-dimethylamino 
butyric acid hydrochloride (527 mg, 3.15 mmol, 2 equiv). HBTLI 
(1.1923 g, 3.15 mmol. 2 equiv), EtjN (1.31 mL, 6 equiv) and 
dry DMF (7.0 mL) was placed under Ng and stirred at room 
temperature for 30 min. Then to the stirred mixture was slowly 
added a solution of the above amine (456 mg, 1.57 mmol. 1 
equiv) in dry DMF (2.5 ml.) over a period of 5 min. After 
stirring at room temperature for 3 h the resultant mixture 
was diluted with EtOAc (250 ml.) then extracted with 10% 
NazCOa (100 inL). The organic layer was washed with brine, 
dried (MgSCL), and evaporated under reduced pressure to 
leave a red-brown oil (1.036 g). The crude product was purified 
by flash column chromatography over silica, using MeOH 
containing 3% of concentrated ammonia as eluant, to give 15 
as an amber oil (487 mg, 77% yield): ES-MS (M + 1| found 
404.2. calcd for CzoH?.jN5Oi 404.5; 'H NMR (DMSO-dr.) d l .24 
(3H. t. O-CHz Clh). 1.66 (2H, m. CH;. C.'Hz-CHz), 2.08 (611, 
s, NMcz). 2.20 (4H, m, CHz~CHz-CHz). 3.77 (311, s. pyrrole 
NMe). 3.79 (3H, s, pyrrole NMe), 4.17 (2H. q, O-CHz-CH:,),
6.80 (IH. d. ArH). 7.12 (IH. d. ArH), 7.36 (IH. d, ArH), 9.80 
(IH, s, CONH, exchangeable). 9.90 (IH, s, CONH. exchange­
able).
l - M e th y l-4 - ( l-m e th y l-4 - (4 -d im e th y la m in o b u ty ry l)a m i 
n o )p y rro !e -2  c a rb o x a m id o )p y r ro le -2 -c a rb o x y l ic  A cid , 16.
A solution of 15 (465 mg, 1.15 mmol) in EtOH (5 mL) and 
NaOH (1.73 mmol) was heated under reflux for 1 h and then 
concentrated under reduced pressure. The residue was dis­
solved in MeOH (5 inL) containing 3% of concentrated NIL 
OH, and the resultant solution was applied to a flash column 
of silica. The column was eluted first with a mixture of EtOAc 
(60 parts) and MeOH containing 3% concentrated NFLOII (40 
parts), to elute any unreacted ester 15 and any decarboxylation 
product 17, then MeOH containing 3% of concentrated NFL 
OH was used to elute the carboxylic acid 16. After evaporation 
water was removed from the residue by coevaporation with 
EtOH, and finally the residue was triturated with Et?.0 until 
it solidified. After drying in vacuo the product was obtained 
as a cream-colored powder (258 mg, 60% yield): mp 138 “C 
(gas evolution); ES-MS |M + 1| found 376.2, calcd for 
C,8 Flz5N , 0 4  376.4; IR (KBr) vmm 1639, 1617, 1566 cm '; lH 
NMR (DMSO-cfe) d 1.69 (2H. m, CHz-CHx-CH2). 2.14 (6H. s, 
NMez), 2.26 (4H. m, CHz-CHz- CH* after the addition of DzO 
this became 2H, t, and a new triplet for 2H appeared at 2.85),
3.81 (6H. s. 2 x pyrrole NMe), 6.78 (IH. d, ArH), 6.85 (IH. d, 
ArH), 7.15 (IH, d, ArH), 7.37 (IH. d. ArH). 9.82 (IH. s. 
exchangeable, CONH), 9.83 (IH, s, exchangeable, CONH). The 
COzH signal was not observed.
Note: It was inadvisable to acidify the product of this 
hydrolysis. Whenever this was done, either by using HCI, or 
by attempting to isolate the product by revcrse-phase HPLC 
using an acidic (TFA) solvent system, considerable decarbox
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ylation occurred to give 17. This decarboxylation product had 
a very close HPLC retention time to that of 16, but separation 
could be accomplished using flash column chromatography 
over silica using EtOAc/MoO! I/NFLOH as eluant as described 
above. Compound 17 was thus isolated from one experiment 
as an amber gum: ES-MS 332.1, calcd for CuHzsNsOz 332.4 
|M + t|; 'H NMR (DMSO-oW <5 L79 (2H, m. CFI2-CHz-CHz). 
2.28 (2H, m, C ll2), 2.34 (6H. s, NMez), 3.38 (211, m. CH2). 3.55 
(3H, s, pyrrole NMe) 3.80 (3H, s. pyrrole NMe), 6.05 (IH, m. 
ArH), 6.52 (IH. m. ArH), 6.81 (IH. d. ArH). 7.08 (IH. m, ArH). 
7.13 (IH. d, Art I). 9.71 (1H. s, exchangeable, CONH), 9.86 (IH. 
s, exchangeable, CONH).
3 - ( l-M e th y l-4 - ( l-m e th y l-4 - ( l- in e th y I-4 - ( l-m e th y I-4 - ( l-  
m e th y T 4 - (4 -d in ie th y la n u n o b u ty ry l )a n iin o p y r ro le -2 -c a r-  
b o x a m id o ) p y r r o l e - 2 - c a r b o x a m i d o ) p y r r o l e  2 - c a r b o x -  
a m id o )p y rro !e -2 -c a rb o x a m id o )p y rro le -2 -c a rb o x a tn id o )d i-  
m e th y la m in o p r o p a n e  B is t r i f lu o r a c e ta t e ,  4. A mixture of 
11 (151 mg) and Pd/C-10% (164 mg) in EtOFl (15 mL) was 
hydrogenated at room temperature for 13 h. The catalyst was 
removed by filtration through Kieselguhr, and the filtrate 
evaporated under reduced pressure to leave the crude amine 
(128.5 mg, 90% yield) as a pale yellow solid. This material was 
used at once without further purification. A mixture of the 
carboxylic acid 16 (68.6 mg, 0.18 mmol. 1 equiv), FIBTU (104.1 
tug, 0.275 mmol, 1.5 equiv), EtjN (76 mL, 55.5 mg, 0.55 mmol, 
3 equiv) and dry DMF (1.5 mL) was placed under Nz and 
stirred at room temperature for 30 min. To the resultant clear 
solution was added a solution of the above crude amine (128.5 
mg, 0.275 mmol, 1.5 equiv) in dry DMF (1.0 mL), and the 
mixture stirred at room temperature for 8 h. The resultant 
suspension was purified by reverse-phase HPLC. Fractions 
containing the product were frozen immediately after collection 
and then freeze-dried to give the bis-TFA salt 4 as a fawn 
powder (65.3 mg, 34% yield): ES-MS found |M + 1| 826.4476, 
calcd for CuHmNijOb 826.4476; 'H NMR (DMSO-dfi) d 1.82 
1.93 (4H. 2 x overlapping quintets. 2 x CHz-CHz CHZ). 2.35 
(2H. t, CHz- CHz CO). 2.79 (12H, in, 2 x NMez), 3.07 (4F1, 
m. 2 x CHz CHr NMez), 3.24 (2H, m, N H -C H zC H 2), 3.72 
3.86 (15H, 5 x pyrrole NMe), 6.87 7.22 (I0H, 10 x ArH), 8.14 
(111, t, exchangeable CONH— CHz), 9 .2 -9 .5  (2H, broad, ex­
changeable, 2 x TFA), 9.89 —9.94 (5H, exchangeable. 5 x 
CONH).
3 -( l-M e th y l-4 - ( i-m e th y l-4 - ( l -m e th y l-4 - ( l-m e th y l-4 - ( l-  
m e th y l-4 - ( l-m e th y l-4 - (4 -d im e th y Ia m n in o b u ty ry l)a n iin o -  
p y rro le -2 -c a rb o x a m id o )p y r ro le -2 -c a rb o x a in id o )p y r ro Ie -
2 -c a rb o x a m id o )p y rro le -2 -c a rb o x a m id o )p y rro le -2 -c a rb o x  
a m id o )p y r r o le - 2 - c a r b o x a m id o ) d im e th y la m in o p r o p a n e  
B is t r i f lu o r a c e ta t e ,  5. The nitro compound 12 (1125 mg) was 
hydrogenated in a mixture of MeOH (10.5 mL) and 0.1 N HCI 
(4.5 mL) over Pd/C-10% (125 mg) as described in the previous 
experiment above, to afford, after freeze-drying, the crude 
amine (112.5 mg, 84%). This amine was mixed with the 
carboxylic acid 16 (42.4 mg, 0.11 inmoi), FIBTU (64.2 mg, 0.17 
mmol), NMM (50 mL) and DMF(1.0 mL, dry), and the 
resultant mixture was stirred at room temperature for 24 h. 
The product was isolated by means of reverse-phase HPLC. 
Fractions containing the product were frozen immediately on 
collection then freeze-dried to give the bis-TFA salt of 5 as a 
buff-colored powder (58.3 mg, 37% yield) which had no distinct 
melting point: ES-MS found |M + 1| 948.4964, calcd for 
C47HozN150-, 948.4956; 'H NMR (DMSO-d6) d 1.82-1.93 (4FI, 
2 x overlapping quintets, 2 x CHz CHzCFL), 2.35 (211, t. 
CFiz-CHz-CO), 2.79 (12H, m. 2 x NMez). 3.07 (4H, m. 2 x 
C H z -CH ?-NMez). 3.24 (2H. in, N H - CHz-CHz). 3.82-3.87  
(18H, 6 x pyrrole NMe), 6 .87-7.22 (12FI, 12 x ArH), 8.15 (1FI, 
t, exchangeable, CONH  CHz). 9-30 (1FI, broad, exchangeable, 
TFA). 9.50 (IH, broad, exchangeable, TFA), 9 .90-9.94 (611, 
exchangeable, 6 x CONH).
I s o p h th a l a m id o d ia c e t ic  A cid , 18. A stirred suspension 
of isophthaloyl chloride (200 mg, 1.00 mmol) and glycine 
methyl ester hydrochloride (275 mg, 2.20 mmol) in anhydrous 
methylene chloride (20 mL) was treated dropwise with a 
solution of triethylamine (0.66 g, 6.60 mmol) in dry methylene 
chloride (5 mL.). The resulting solution was then stirred at.
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room temperature for 1.5 h. The solvent was evaporated and 
the residue treated with 2 M HCI (5 mL) then extracted with 
methylene chloride. Evaporation of the extract gave the 
required product as a pale yellow gum (210 mg, 75% yield): 
■H NMR (DMSO-cfe) <5 3.66 (6H, s. 2 x OMc). 4.04 (411. d, J 6 
Hz, 2 x NHC/7?, collapses to a singlet on addition of DzO),
7.62 (II1, t, J  8 Hz, ArH), 8.03 (2H. dd, J„ 8 Hz. J m 2 Hz. 2 x 
ArH), 8.38 (IH, m, ArH), 9.12 (2H. t, J 6  Hz, COHN): ELMS 
found 308.1026, calcd for CuHieNjOo 308.2220. A solution of 
the dimethyl ester (690 mg, 2.30 mmol) in ethanol (30 mL) 
was treated with 2 M NaOH (15 ml.) and the resulting solution 
stirred at room temperature for 1 h. The mixture was 
concentrated by evaporation to a total volume of 10-15 mL 
then acidified with 2 M HCI and extracted with ethyl acetate. 
Evaporation of the extract gave 18 as a colorless solid (260 
mg, 41% yield): mp 152 154 °C; 'II NMR (DMSO-db) d 3.94 
(4H, d, .76 Hz, CHz collapses to a singlet on addition of D2O),
7.62 (IH. d, .78 Hz, ArH), 8.03 (2H. dd, J„ 8 I Iz. Jm 2 Hz. 2 x 
ArH), 8.37 (111, s. ArH), 8.98 (2H. t, .7 6 Hz, 2 x CONHClh  
exchangeable), 13.12 (2H. broad, COzH exchangeable); ES-MS 
found 279.01 |M -  1|, calcd for ClzH,zNzOr, |M 1| 279.17.
/V \/V  Bis(2-{[5-((l5-({ [ 3 -d im e th y la in in o p ro p y lJ  a m in o )  
c a rb o n y l ) - 1 m e th y l- 1 / / - p y r r o l  3-y  11 a m in o  ( c a r b o n y l ) - 1 
m e th y l - 1 / / - p y r r o I - 3 - y l la m in o  }-2 o x o e t h y l ) i s o p h th a l  
a m id e  B is t r i f lu o r a c e ta t e ,  6. A Solution of the dicarboxyl ic 
acid 18 (28 mg, 0.1 mmol), NMM (30 mg, 0.3 mmol) and HBTU 
(165 mg, 0.3 mmol) in DMF (1 mL, dry) was stirred at room 
temperature for 1 h. The mixture was then treated with a 
solution of freshly prepared 10, R — NHZ [prepared beforehand 
by hydrogenating a suspension of 10, R = NOz (165 mg, 0.3 
mmol) with Pd/C 10% (165 mg) in 2-propanol (20 mL) for 6 h| 
in dry DMF (1 mL). The resulting solution was stirred at room 
temperature overnight. The mixture was then purified by 
HPLC to give the required product (60 mg, 52% yield) as a 
pate yellow solid (bis-TFA salt) with no distinct melting 
point: 'H NMR (DMSO-ofe) 6 1.83 (4H. m, J  7 Hz, C \\,C th  
CLL). 2.78 (12H, d, J  4 Hz. 4 x NHAfe*). 3.07 (4H. m, 
CONH C//z, collapses to a triplet on addition of DzO), 3.24 (4H. 
m. 2 x  MezNHC/7z, collapses to a triplet on addition of DzO).
3.81 (6H. s. 2 x NMe). 3.83 (6H, s, 2 x NMe), 4.04 (411, d. .7 6 
Hz, NHC//2CO. collapses to a singlet on addition of DzO), 
6.91-6.93 (4H, m. 2 x ArH), 7.15 (2H, d, J 2  Hz, ArH), 7.17 
(2H, d, J 2 Hz. ArH), 7.61 (IH, t, Ju 8 Hz. ArH), 8.06 (2H. dd. 
J„ 8 Hz. J,„ 2 Hz, ArH), 8.14 (2H, t. J  6 Hz, 2 x  NHCHz, 
exchangeable). 8.43 (11 1. s, ArH), 8.91 (2H, t, J  6 Hz. 2 x 
CONH, exchangeable). 9.27 (2H, broad, 2 x NHMe?., exchange­
able). 9.85 (2H, s, 2 x CONH. exchangeable). 9.96 (2H. s, 2 x 
CONH, exchangeable); ES-MS found [M + 1| 937.4804, calcd 
for CikHbiNuOb 937.4797.
F o o tp r in t in g  S tu d ie s .  L ig a n d s :  The ligands were dis 
solved in 10 mM Tris-HCl pH 7.5 containing 10 mM NaCl at 
a concentration of 10 mM and stored at -2 0  “C. The com­
pounds were diluted to working concentrations in the same 
buffer immediately before use. Oligonucleotides for preparing 
the DNA fragments containing synthetic DNA inserts were 
purchased from Oswel. DNase I was purchased from Sigma 
and stored at -2 0  °C at a concentration of 7200 units/mL.
D NA  f r a g m e n ts :  The sequences of the five most significant 
DNA fragments used in Ibis work are shown in Figure 1. The 
TyrT fragment, derived25 from plasmid pK.MA-98, was ob­
tained by digesting the plasmid with .EcoRl and Aval and 
labeled at the 3'-end of the EcdR 1 site with |a  32PldATP using 
reverse transcriptase. Plasmid pAADl was prepared as previ 
ously described.2 The other plasmids were prepared by cloning 
oligonucleotides into the Smal site of pUC18 as previously 
described. pAADl2 contains an insert which possesses 5 
different (A/PL tracts, separated by 6 GC base pairs (CGCGCG). 
Plasmid pA-j e contains 4 T„ x A„ tracts of varying length (n 
= 3 -6 ) separated by 4 GC base pairs (CGCG). p(A/T) 1} 12 
contains 4 AT tracts of 6. 8, 10. and 12 bases long with the 
sequence A„TAT„ (n =  2 -5 ) separated by 4 GC base pairs 
(CCGG), Plasmid p(AT)(i contains 4 different arrangements of 
(A/T)fi sites together with the sequence AATT, each separated 
by 4 GC base pairs (CGCG). Plasmid p(A/T)io contains 3
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different arrangements of (A/T)io sites together with the 
sequence AATT, each separated by 4 GC base pairs (CGCG). 
Polylinker DNA fragments containing each of these synthetic 
sequences were obtained by digesting with ///ndlll. labeling 
with |a-:!ZP|dATP using reverse transcriptase and digesting 
again with either EcoR 1 (p(A/T)r, v/. and pAj -n) or Sad  (p(A/ 
T): 10 and pAAD 1). The labeled DNAs of interest were separated 
from the remainder of the plasmid on 6-8%  polyacrylamide 
gels and dissolved in 10 mM Tris-HCl pH 7.5 containing 0.1 
mM EDTA.
DNase 1 footprinting: Radiolabeled DNA (1.5 pL) was 
mixed with 1.5 /cL of ligand (dissolved in 10 mM Tris-HCl pH
7.5 containing 10 mM NaCI) and left to equilibrate at room 
temperature for at least 30 min. 2 fiL  of DNase I (ap­
proximately 0.01 units/mL diluted in 20 mM NaCl containing 
2 mM MgClz and 2 mM MnClz) was then added. The reaction 
was stopped after 1 min by adding 4 p h  of formamide 
containing 10 mM EDTA and 0.1% (w/v) bromophenol blue.
Hydroxy! radical footprinting: Radiolabeled DNA (2 /tL) 
was mixed with 2 /d. of ligand (dissolved in 10 mM Tris-HCl 
pH 7.5 containing 10 mM NaCl) and left to equilibrate at room 
temperature for at least 30 min. Digestion was initiated by 
adding 6 ,uL of a freshly prepared solution containing 30 /zM 
ferrous ammonium sulfate. 300/zM EDTA, 3 mM ascorbic acid 
and 0.1% HzOz. The reaction was stopped after 10 min by 
adding 8 /A. of 0.75 M sodium acetate and 60 fiL  of ethanol. 
The DNA was precipitated, washed with 70% ethanol, dried 
and redissolved in 8 mL of formamide containing 10 mM EDTA 
and 0.1 % (w/v) bromophenol blue.
Gel electrophoresis: Samples were denatured by boiling 
for 3 min. cooled on ice arid loaded onto denaturing polyacry­
lamide gels (6-10% w/v) containing 8 M urea. Gels (40 cm 
long) were run at 1500 V for about 2 h before fixing in 10% 
acetic acid (v/v), transferring to Whatman 3MM paper, drying 
under vacuum at 80 °C and exposing to autoradiography at 
-7 0  °C with an intensifying screen. Autoradiographs were 
scanned with a Hoofer 365W scanning microdensitometer. The 
intensity of each band was estimated using the Hoefer 
software. Differential cleavage plots, calculated from these 
scans, represent the intensity of each band in the drug-treated 
lane divided by the intensity of the corresponding band in the 
drug-free control.
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Abstract— A scries of head to head linked dimers of heterocyclic amino acids has been prepared for investigation of affinity and selectivity 
in binding to the minor groove of DNA. The selection of targets for synthesis was led by computer based design. Several novel dicarboxylic 
acid linkers including indoles, phenanthrenes, a fluorenone, and a bisbenzothiophene have been included. Analysis of binding to DNA by 
footprinting showed high affinity for compounds derived from 2,7-dihydrophenanthrene dicarboxylic acid and a predominant selectivity for 
AT rich regions containing at least 4  AT pairs but with tire ability to span up to two CG base pairs. © 2000 Elsevier Science Ltd. All rights 
reserved.
The importance o f nucleic acids as a target for drug action 
has been widely recognised and the potential benefits of  
controlling the biochemistry o f an organism at the level of 
protein synthesis compared with enzyme inhibition empha­
sised.1 A requirement for the effectiveness of drugs that act 
at nucleic acids is the ability to recognise defined sequences 
of DNA so that specific genes or control regions can be 
targeted. Moreover, high affinity for such sites is essential. 
Natural products such as distamycin are oligomers of  
heterocyclic amino acids and have been shown to bind to 
the minor groove of DNA displacing the hydrogen bonded 
water.2 Typically they show a preference for AT rich 
regions and have dissociation constants o f the order o f  
10 5 M.3 Such compounds have intrinsic biological activity 
but they also have many limitations including toxicity, and 
low affinity, specificity, and solubility. Approaches to tackle 
the problems of affinity and specificity have centred on the 
introduction o f additional monomers such as imidazole 
derivatives to promote CG reading,4 on the finking o f  
heterocyclic amino acids head to tail by aliphatic amino 
acids with flexible chains,5 and on the finking of oligomers 
of heterocyclic amino acids head to head. An approach 
from our laboratories to deal with problems of solubility 
and transport is described in another paper.7 In this paper 
we describe the synthesis of a number o f novel head to head 
finked oligomers o f heterocyclic amino acids and demon­
Keywords: DNA; minor groove; lexitropsin dimer; synthesis.
* Corresponding authors.
strate strong affinity when certain polycyclic aromatic 
compounds are used as linkers.
Selection of Compounds for Synthesis
In order to optimise affinity o f minor groove binders such as 
the lexitropsins, it is necessary to maximise the hydrogen 
bonding between the NH of the carboxamides and the 
2-carbonyl group o f thymine and the IN of adenine. The 
spacing o f the NH groups in an extended lexitropsin does 
not closely match the positions o f  the hydrogen bond 
acceptors in DNA. Linking molecules were therefore 
designed to have the correct length and curvature to ensure 
that hydrogen bonding was possible using the pyrrole amino 
acid amides on both sides o f the linker. A series of aromatic 
dicarboxylic acids was assessed for their ability to correct 
ligand misalignment with the DNA bases by computer 
simulation with an in vacuo DNA model using a m b e r  4.0. 
Fig. 1 shows the shape o f the dihydrophenanthrene finked 
compound in comparison with distamycin. The DNA phos­
phate groups were neutralised and the ligand termini were 
truncated to neutral CONH2 groups. The ligands were 
docked into the minor groove o f the hexadecamer 
(d(A)-d(T))l6 in the standard Amott B-DNA conformation 
and minimised prior to molecular dynamics at 300 K for 
200 ps. Geometries from dynamics trajectories were saved 
at 5 ps intervals for minimisation and subsequent energetic 
analysis o f ligand internal energies and interaction energies 
between ligand and DNA. The internal energies of mini­
mised isolated ligands were then subtracted from the ligand
0040-4020/00/$ - see front matter © 2000 Elsevier Science Ltd. All rights reserved. 
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Figure 1. Molecular modelling representation of the cyclic portion of target molecules 19-24, all of which contain a dihydrophenanthrene linker. The 
tripyrrole of distamycin is shown for comparison. The flexible side chains of both compounds are omitted for clarity. (Figures produced by molecular 
mechanics energy minimisation using the c a c h e  molecular modelling software system, Oxford Molecular.)
internal energies from simulation with the DNA model to 
give a quantitative measure o f the ligand distortion upon 
binding. This distortion term was then added to the inter­
action energy for each ligand to give a corrected interaction 
energy, which was then used to rank the linker structures 
(Table 1). The interactions o f cations with anionic sites with 
DNA was considered to be constant in the evaluation of the 
linkers themselves. One o f the compounds included (30) has 
been synthesised before.6
To expand the structural repertoire, a number o f compounds 
containing flexible components were also synthesised 
(indole derivatives and glycine derivatives: Table 1). For 
synthetic convenience, tertiary alkyl amines were 
commonly used as tail groups; this choice is also significant 
in the context of designing compounds with suitable solu­
bility for use as drugs that will reach targets by passive 
diffusion.7,8 Some amidines were also synthesised to 
provide congruence with previous work.6 With the rigid
linkers, all o f these molecules would be expected to bind 
to DNA predominantly in a 1:1 manner unlike those in 
which extended flexible linkers such as GABA are included; 
in such cases, a hairpin or 2:1 structure is formed with an 
expanded minor groove which facilitates recognition of CG 
regions through hydrogen bonding to imidazole amino 
acids.5
Synthesis o f the Heterocyclic Amino Acid Oligomers
The monomeric heterocyclic amino acids (Table 2) were 
synthesised either directly by ring synthesis (for the thiazole 
3)9 or by reduction of the corresponding nitro compound 
(for 1,2,4).10 The terminal carboxyl group was capped 
using either a monomer or a dimer as substrate with an 
aminopropyl amine or a cyanopropyl amine. The amidines 
were prepared by means of the Pinner reaction from the 
corresponding nitriles." For the capping reactions of the
Table 1. Designed linkers and their calculated (and observed) interaction properties with DNA as shown by footprinting. Compounds marked * were 
investigated with amidinium headgroups; the remaining compounds had dimethylamino headgroups. Footprinting was carried out as described in Ref. 7. 
Strong footprint means that protection was observed at a ligand concentration o f 0.3 p,M; Good footprint refers to a concentration between 1 and 10 |xM; 'nt' 
means not tested in these experiments
Linker name and target compound number Net interaction 
energy (units)
Rank Observed interaction 
with DNA
lndole-2,6-dicarboxylate - flexible 33 -108.9 1 Good footprint
Dihydrophenanthrene dicarboxylate 19 -106.6 2 Strong footprint’
Bisbenzothiophene dicarboxylate 26 -105.5 3 Strong footprint'
Phenanthrene dicarboxylic acid 25 -103.5 4 nt
lndole-2,6-dicarboxylate-rigid 32 -100.9 5 Good footprint
Tcrcphthalic acid 28 -100.4 6 Good footprint
Fumaric acid 29 -95.1 7 Good footprint
tndole-2,5-dicarboxylate 35 -92 .6 8 Good footprint*
Indole-2,6-dicarboxylate 31 -92.1 9 Weak footprint'
7Vwi.v-cyclopropane dicarboxylate 30 -88 .6 10 nt
2 5 9
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imidazoles 2a, pivalic anhydride mediated coupling was the 
best method found. For the pyrrole and thiophene deriva­
tives, the amides were readily formed under Schotten 
Baumann conditions from the appropriate acid chloride 
typically in yields in excess of 85%. Alternatively 4-nitro- 
/V-methylpyrrole 2-trichloromethyl ketone was an effective 
acylating agent for the synthesis of capped monomers.12 
Extension of the monomers to capped oligomers (5-9, 
Table 3) was essentially a two-stage process. Firstly the 
nitromonomer was hydrogenated using Pd-C as catalyst 
typically in methanol/ethylene glycol dimethyl ether 
(DME) mixtures or in DME alone. However not all 
compounds proved amenable to hydrogenation, the 
nitrothiophenes requiring extensive research to find appro­
priate reaction conditions. The amines thus produced were 
not isolated and purified but used directly for coupling with
Table 3. Capped oligomers synthesised listed using abbreviations defined 
by structures in Table 2 above
Compound No. Compound No.
0 ;N  pyrr pyrr dmap 5a 0 2N pyrr pyrr dheap 5d
0 ,N  pyrr pyrr pyrp 5b 0 2N pyrr pyrr morphp 5e
0 ;N  pyrr pyrr mpip 5c 0 2N pyrr pyrr amidp 5f
0 ;N  imid imid dmap 6 0 2N pyrr pyrr cyanp 5g
0 2N thio thio dmap 7 Q2N pyrr pyrr imidp 5h
0 ,N  pyrr thia dmap 8 Zgly pyrr pyrr clmap 5i
0 ,N  pyrr thio dmap 9 Gly pyrr pyrr dmap 5j
the second heterocyclic amino acid. The best conditions for 
coupling closely mirrored those found for the capping of the 
corresponding monomer. Coupling yields were in the range 
58-95%, the best yields being obtained using acid 
chlorides. On the other hand, acid chlorides were not used 
in the preparation of the head to head linked compounds 
(see below).
Synthesis of Linkers
The computational design suggested that (a) tricyclic 
aromatic compounds such as phenanthrene and fluorene 
derivatives and (b) 2,5- and 2,6-substituted indole dicar­
boxylic acids would be appropriate components. The synth­
esis of the phenanthrene derivatives is shown in Scheme 1. 
Substantial synthetic effort was required to obtain the indole 
dicarboxylic acids (lOa-e, Table 4) and that work will be 
described in another paper.1' Bisbenzothiophene-2,7-dicar- 
boxylic acid 11 and fluorenone-2,7-dicarboxylic acid 12 
were commercial samples.14
Three examples already described were included to provide 
controls (fiimarate, tra n s-1,2-cyclopropane dicarboxylate, 
and terephthalate).6 For phenanthrene derivatives (13-15, 
Scheme 1), dihydrophenanthrene was bisbromomethylated 
using paraformaldehyde in the presence of hydrobromic 
acid15 to afford 16 which was dehydrogenated using
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14 16
H 02C c O tH BrCH2 CH2Br
H 0 2C— c o 2h -*► r o 2c —
o 2r
viii-xi 18a R = ! l  b R = Et
h o 2c  c o 2h
15a R = H b R = Et
Scheme 1. Reagents: (i) CH3COCI, AlCIf, (ii) I,, pyridine then NaOH/aq. EtOH; (iii) (CH20),„ HBr, H3PO4 in aq HOAc; (iv) DDQ, benzene; (v) DMSO, 
NaHCOj; (vi) bipyHjCrOCl5, CH2C12; (vii) S 270-275°C; (viii) SOC1,; (ix) EtOH; (x) h i', l2, 0 2, toluene; (xi) aq NaOH.
DDQ15 to give 3,6-bisbromomethylphenanthrene 17 (40%). 
The required dicarboxylic acid 13 was obtained by sequen­
tial oxidation firstly with DMSO16 to give the dialdehyde 
and secondly with chromium (VI)17 (25% over 2 steps). The 
corresponding 3,6-dihydrophenanthrene dicarboxylate 14 
was obtained in a separate synthesis by acetylation of dihy­
drophenanthrene itself under Friedel-Crafts conditions18 to 
give the bismethylketone (24%) followed by oxidation to 
give the required diacid 14 and iodoform <J (96%). The 
isomeric phenanthrene-2,7-dicarboxylic acid 15a was 
prepared via pyrolysis of terephthalic acid in the presence 
of sulphur 270-275°C20 to give the /ran.v-stilbene-4,4'- 
dicarboxylate (18a, 20%). Conversion into the correspond­
ing diethyl ester 18b was carried out in two steps via the 
acid chloride (28-44%) and ethanolysis (79-87%). Photo­
lysis in toluene solution in the presence of iodine and air21 
afforded diethyl phenanthrene-2,7-dicarboxylate 15b (32%) 
and hydrolysis with aqueous sodium hydroxide gave the 
required phenanthrene dicarboxylic acid 15a (99%).
Some linkers that seemed promising designs proved to be 
synthetically inaccessible. For example an approach to 
bisbenzofuran 3,7-dicarboxylic acid failed when the cycli- 
sation of the precursor dimethyldihydroxybiphenyl with
polyphosphoric acid afforded a cyclic phosphodiester 
(69%, Scheme 2) as the main isolable product.
Coupling of Dimers with Linker
The slight differences in reactivity and solubility between 
the various linkers meant that no single optimal method was 
found for the coupling reactions. This was true both of the 
hydrogenation of the nitro group of the precursor dimer and 
of the coupling reaction itself. For example, conditions for 
hydrogenating the bisimidazole intermediate 6 were crucial; 
a mixture of methanol and DMF (6:2.5 %) as solvent and a 
temperature of 40°C was found to be necessary. The most 
common methods used HBTU in the presence of iV-methyl- 
morpholine (Scheme 3).23 In the case of the bisimidazole 6 
the yield of isolated coupled product was only 5% after 
purification which contrasts with a yield of over 60% in 
the case of the flexible indole linker 10c and the bispyrrole 
intermediate 5a. Provided that sufficient material had been 
obtained for assay in DNA binding, optimisation experi­
ments were not carried out in these couplings. The most 
difficult linkers to couple were the fully conjugated phen­
anthrene derivatives, perhaps because of the lower reactivity
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'['able 4. Linkers synthesised and their abbreviations
Structure Abbreviation No.
(R = C02H throughout)
dbthia
of the corresponding carboxylic acids. The head to head 
dimers prepared are summarised in (Table 5). All products 
were purified using preparative HPLC under gradient 
elution conditions (see Experimental) and satisfactory 
NMR and electrospray mass spectra were obtained.
Affinity of Products for DNA
A small number of the compounds prepared have been 
evaluated in a preliminary study for their ability to bind to 
DNA;7 we thank Dr Keith Fox (University of Southampton) 
for undertaking this study. Footprinting using TyrT DNA 24 
as the target showed significant differences between the 
compounds studied. The fumaric acid linked compound 
29 was studied in most detail; the results will be reported 
elsewhere.7 The overall conclusion that can be drawn from 
the footprinting data is that these compounds are AT 
selective but cover larger regions than the parent antibiotic, 
distamycin. At moderate concentrations (~  1 p,M) there was 
evidence that they can span one or two CG base pairs. Using 
pAAD, pA^f,, or pA/T3_12 DNA,7 oligomers that offer a 
range of sizes of AT sites, the results suggested that more 
than four consecutive AT pairs are required to provide 
binding sites for these compounds. The tricyclic aromatic 
linkers, bisbenzothiophene 11 and dihydrophenanthrene 14, 
gave compounds 26 and 19-25 with particularly strong 
binding at micromolar concentrations, principally to AT 
rich regions as would be expected. Similarly the indole 
2,5-dicarboxylate derivative (35 from lOe) showed a strong 
footprint. On the other hand, 2,6-dicarboxylate analogues 
(31-34 from lOa-d) were comparatively poor binders. 
Although more detailed examination of these compounds 
is required, it is clear that the basic design strategy can 
lead to compounds of very high affinity for DNA. From 
the point of view of molecular design, compounds highly 
ranked such as 19-25 showed strong footprints but given 
the available binding data the modelling did not appear to 
have high predictive power. Moreover from the data 
available so far we cannot determine whether binding of 
the compounds containing polycyclic aromatic compounds 
involves intercalation. One of the benefits of using a poly­
cyclic aromatic linker is that in principle, additional sub­
stituents can be added to modify solubility or to provide 
additional binding to DNA. Furthermore, it is possible to 
modify the synthetic routes to prepare asymmetric head 
to head linked compounds thereby expanding the ability 
to read defined sequences of DNA.
R“ V J ^ R 
k ^ V _ r






The abbreviation used for each compound in the text and 
tables is given in the title line of each preparation in ita lics.
Instrumentation
Electrospray mass spectra (ES-MS) were obtained on a 
Fisons VG Platform Benchtop LC-MS. Electron impact 
(EI-MS) and fast atom bombardment (FAB-MS) mass 
spectra were obtained on a Jeol JMS-AX505HA mass spec­
trometer. NMR spectra were obtained on a Bruker AMX 
400 speedometer operating at 400 MHz for ‘H. In ’H
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Scheme 2. Reagents: (i) Me?SOj, NaOH; (ii) NiCl2ZnPPli,, tx-dipy, DMF, I20°C; (iii) HBr/HOAc; (iv) polyphosphoric acid.
NMR spectra, the abbreviation ‘exch.’ signifies that the 
relevant resonances disappeared on treatment of the solution 
with D20.
HPLC purification of final products was carried out using a 
Vydac protein and peptide Cl 8 column on a gradient eluting 
system. The solvents were A: water+0.1% trifluoroacetic 
acid, and B: acetonitrile 90% + water 10%+0.1% trifluoro­
acetic acid. The elution programme was as follows: (Table 6)
Preparation of monomers
i-Methyl-4-nitropyrroIe-2-carboxylic acid‘1:' (lb). (0 2N
p y rr  OH ) This was prepared according to the literature'1,5 
and obtained as a pale yellow powder (41% yield); mp 
196-200°C (lit.'’ mp 204-205°C, lit.6 mp 195-197°C).
l-Methyl-4-nitropyrrole-2-carbonyl chloride10 (lc).
(O jN  p y rr  C l) A standard literature procedure was used to 
give the product as grey solid material in quantitative yield, 
mp 90-91°C (lit.10 mp 91-92°C). This acid chloride was 
used in the subsequent coupling without further purification.
l-MethyJ-4-nitro-2-trichloroacetylpyrrole9’10 (Id). (02/V 
p y rr  C C l2) This was prepared in two steps from /V-rnethyl- 
pyrrole by trichloroacetylation followed by nitration (96 and 
41%, respectively) as pale yellow crystals mp 132 137°C 
(lit.9 mp 135-140°C, lit.10 mp 134-136°C).
3-(l-Methyl-4-nitropyrrole-2-carboxamido)dimethyl- 
aminopropane11 (le). ( 0 2N  p y rr  dm ap) This was prepared 
using standard literature procedure. The product was obtained 
in (74% yield); mp 126-128°C (lit.11 mp 126-127°C)
1 -Methyl-4-(3-( 1 -methy l-4-nitropyrrole-2-carboxamido)- 
propyl(piperazine (lg). ( 0 2N  p y r r  m pipp) The pyrrole
0 2N —mono— OH
0 2N —mono---- cap
mono r‘ imid
0 2 N — mono— R — - — O2 N—mono cap
mono - pyrr, thio 
R = Cl, CCI3
0 2N —mono— OH
-*■ (H2 N—mono-— cap)
H2N —thia— cap
0 2N—mono—OH
(H2 N —mono— OH)
0 2N—mono—OH
(H2N —  mono—mono— cap) 0 2N —  mono—mono— cap <*-!!—  q 2N —  mono—mono— OH
cap-mono-mono- //nft-mono-mono-cap ZGly-mono-mono-cap
cap-mono-mono-Gly- link- Gly- mono- mono - cap
Scheme 3. Reagents: (i) SOCl2; (ii) amino or amidino cap, aq NaOH; (iii) H2/P d -C  under solvent and temperature appropriate to each case (see Experimental); 
(iv) M e/X 'OCl, /V-methylninrpholine. aminoacid cap; (v) HBTU. HOBT, /V-methylmorpholine, linker dicarboxylic acid\ (vi) HBTU, HOBT, 7.glyOH.
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Table 5. Head to head dimers synthesised
Compound No. Compound No.
dmap pyrr pyrr 
1 Tphen pyrr pyrr 
dmap
19 dmap pyrr pyrr fuma 
pyrr pyrr dmap
29
dheap pyrr pyrr 
Hyphen pyrr pyrr 
dheap
20 30
pyrp pyrr pyrr 
Hyphen pyrr pyrr 
pyrp
21 ............in d l........ 31
mpip pyrr pyrr 
Hyphen pyrr pyrr 
mpip
22 ........... ind2............ 32
morphp pyrr pyrr 
Htphen pyrr pyrr 
morphp
23 ............ind3............ 33
amidp pyrr pyrr 
Hyphen pyrr pyrr 
amidp
24 ........... ind4............ 34
dmap pyrr pyrr phen 
pyrr pyrr dmap
25 ............indS............ 35
............dbthi............ 26 dmap imid imid 
Hyphen imid imid 
dmap
36
.......... .fluo............. 27 dmap thia pyrr 
Hiphen pyrr thia 
dmap
37
28 dmap (pyrr)2 Gly 
phen Gly (pyrr);, 
dmap
38
carboxylic acid lc  (5.42 g, 31.9 mmol) was suspended in 
thionyl chloride (20 mL) and heated under reflux for 3 h. 
Excess thionyl chloride was removed under reduced 
pressure at room temperature then the remaining traces 
were co-evaporated with dichloromethane (30 mL, dry). 
/V-methylpiperazine (5.00 g, 31.7 mmol) was diluted with 
dichloromethane (25 mL, dry) and added dropwise with 
stirring at 0°C to the solution of the acid chloride in 
dichloromethane (25 mL, dry). The reaction mixture was 
left stirring at room temperature overnight. The required 
p yrro le  carboxam ide  precipitated as a yellow solid and 
filtered off, washed with dichloromethane (dry), and dried 
at 60°C under reduced pressure for 6 h (10.21 g, 93%.). Mp 
185-188°C. iW cm  '(KBr) 1663, 1545, 1515, 1477, 1418, 
1320. 8 h (DMSO-d6): 1.72 (2H, s, CH2); 2.51-3.26 (6H, 
m); 3.90 (3H, s, NMe pyrrole); 7.47 (IH, s, pyrrole); 8.13 
(IH, s, pyrrole); 8.53 (IH, s, CONH exch.); 10.88 (IH, 
broad, HCI exch.). HRFABMS: Found: 310.18768 Calcu­
lated for CMH24N50 3 310.18791.
4-(3-(l -Methyl-4-nitropy rrole-2-carboxamido)propyl)- 
morpholine (lh). ( 0 2N  p y rr  m orphp) (a) A cid  chloride  
m ethod: A solution of lc (3.9 mmol: prepared as described 
ear lier, from 2.36 g of the carboxylic acid lb), using 2.5 mL 
of thionyl chloride, and 10 mL of dimethoxyethane) in dry
Table 6.
Step Time (min) Flow rate (mL min ') %A %B
Equilibration 1 4 95 5
1 40 4 60 40
2 20 4 0 100
3 5 4 95 5
4 10 4 95 5
dimethoxyethane (20 mL) was cooled in an ice/water bath, 
and stirred while a solution of 4-(3-aminopropyl)morpho- 
line (2.00 g, 13.9 mmol) in dry dimethoxyethane (5 mL) 
was added slowly during a period of 15 min. The resultant 
suspension was stirred at room temperature for 4 h, then 
diethyl ether (30 mL) was added. The solid was collected, 
washed with diethyl ether, and after drying under reduced 
pressure amounted to 3.88 g (84% yield of HCI salt of lh). 
This material was dissolved in water (100 mL) at about 
50°C, and the solution was basified with 10% sodium 
carbonate (50 mL), and after cooling to 0°C, the precipitated 
solid was collected, and dried under reduced pressure to 
give the required pyrro le  carboxam ide  (lh) as a fawn- 
coloured powder (0.875 g), mp 116-118°C; Found: C, 
52.7; H, 7.05; N, 19.2% CnH20N5O3 requires: C, 52.69; 
H, 6.80; N, 18.91. (KBr) 3413, 3126, 2962,
2820, 1650, 1619, 1522, 1306, 1117; SH (CDC13) 8 1.79 
(2H, m, CH2-C //2 CH2), 2.54 (6H, m, 3xN-C//2-CH2),
3.50 (2H, q, 7=6.0 Hz becoming t, 7=6.2 Hz after D20, 
CONH-C//2-CH2), 3.77 (4H, t, 7=4.5 Hz, CH2-C //2- 6  
C H 2- C H 2), 4.00 (3H, s, NC//3), 7.10 (IH, d, 7=1.6 Hz, 
Ar/7), 7.55 (IH, d, 7=1.6 Hz Ar/7), 7.97 (IH, bs, exch., 
CON//). An additional 0.46 g of product (mp 112— 116°C; 
IR identical to above) was obtained by extraction of the 
mother liquor with CHCl3/methanol. The combined yield 
was 32%. (b) T rich loroacety l m ethod: A solution of 4-(3- 
aminopropyl)morpholine (2.93 g, 20.4 mmol) in dry THF 
(5 mL) was cooled in an ice/water bath, and stirred while 
a solution of 4-nitro-l-methyl-2-trichloroacetylpyrrole (Id 
5.53 g, 20.4 mmol) in dry THF (15 mL) was added slowly 
during a period of 5 min. The solution was stirred at room 
temperature for 3 h, during which a solid separated out. 
Diethyl ether (40 mL) was added, and the solid was 
collected, washed with ether, and dried under reduced 
pressure to give the required p yrro le  carboxam ide  (lh) 
(4.82 g, 80% yield) as a pale cream-coloured solid, mp 
118-120°C. The mother liquor was evaporated under 
reduced pressure, and the residue was triturated with iso­
propanol to give additional sample (0.56 g, 9% yield) as a 
yellow solid, mp 118-120°C.
A-(3-( 1 -methyl-4-nitropyrroIe-2-carboxaniido)propyI)- 
diethanolamine (li). ( 0 2N  p y rr  d ih eap ) A solution of 
AL(3-aminopropyl)-diethanolamine (500 mg, 3.086 mmol) 
in dry THF (2.0 mL) was cooled in an ice-water bath, and 
stirred while a solution of the trichloroacetyl pyrrole Id 
(837.5 mg, 3.086 mmol) in dry THF (2.0 mL) was added 
slowly over a period of 5 min. The mixture was stirred at 
room temperature for 20 h, then evaporated under reduced 
pressure to leave a golden yellow, syrupy residue. This was 
purified by flash column chomatography over silica, using a 
mixture of ethyl acetate (4 parts) and methanol containing 
3% of conc. aq. ammonia solution (1 part) as eluant, to give 
the required p y rro le  carboxam ide  l i  as a yellow syrup 
(910 mg) which slowly crystallised. Recrystallisation from 
ethyl acetate/hexane gave pure li as a pale yellow powder 
(594.8 mg, 61% yield), mp 80-82°C; i'max/cm~l (KBr) 
3700-2500 (br), 3131, 2936, 2841, 1633, 1558, 1527, 
1306, 1042; SH (CDC13) 1.78 (2H, m, CH2-C //2-CH2),
2.64 (6H, m, 3xN -C //2-CH2), 3.50 (2H, q, 7=4.6 Hz, 
becoming t, 7=4.5 Hz after D20 , NH-C//2-CH2), 3.67 
(4H, t, 7=4.6 Hz, 2xCH2-C //2-0), 3.98 (3H, s, N -C //3),
7.23 (IH, d, 7=1.6 Hz Ar/7), 7.54 (IH, d, 7=1.7 Hz Ar/7);
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(no signals were detected for NH  or for 2x0//); ES-MS: 
315.2; C|3H22N40 5 requires 315.3 (M +l); HREIMS: 
Found: 314.15963 Calculated for C|3H22N4Os 314.15902.
3-(2-Carboxamido-l-methyl-4-nitroiniidazole)dimethyl- 
aminopropane24'25 (2b). { 0 2N  im id  d m a p ) This was 
prepared using standard literature procedure. The product 
was obtained as yellow crystalline material in (60% yield); 
mp 140-142°C (lit.24 mp 134°C; lit.25 mp 210-211°C as 
HC1 salt)
2-(5-Nitrothiophene-2-carboxamido)dimethyIaminopro- 
pane (4b). ( 0 7N  thio d m a p ) 5-Nitrothiophene 2-carboxylic 
acid (2.198 g, 12.69 mmol) was heated under reflux with 
thionyl chloride (10 mL) for 2 h, then the excess was 
removed under reduced pressure at 40°C. Dichloromethane 
(2X10 mL, dry) was added and removed under reduced 
pressure at 40°C. 3-Dimethylaminopropylamine (1.357 g, 
13.28 mmol) was dissolved in dichloromethane (5 mL, 
dry) and added to a solution of the acid chloride in dichloro­
methane (25 mL, dry) dropwise, at 0°C with stirring. The 
yellow suspension that formed immediately was left Stirring 
and allowed to warm to room temperature. The reaction 
mixture was extracted with water and the aqueous layer 
was basified with sodium carbonate. The yellow oil that 
precipitated was extracted with ethyl acetate, dried, and 
filtered, then the solvent was removed under reduced 
pressure at room temperature to give the required th iophene  
carboxam ide  as yellow crystals (2.21 g, 68% yield). Mp 
102- 104°C. (Found: C,46.6; H.5.9; N.16.2; S.12.3 
C|oHisN30 1S requires C.46.7; H,5.9; N.16.3; S,12.5.) 
i'm„/ctn 1 (KBr): 3336, 1628, 1563, 1534, 1514, 1355, 
1340, 1320, 1302. S„ (DMSO-dfl): 1.73-1.82 (2H, qt, 7=  
6.9 Hz, CH,); 2.34 (6H, s, NMe2); 2.57-2.59 (2H, t, 1.6 Hz, 
CH2); 3.53-3.59 (2H, qt, 7=4.5 Hz, CH2); 7.29-7.31 (1H, 
d, 7=1.5 Hz, ArH); 7.85-7.86 (1H, d, 1.5 Hz, ArH); 9.40 
(1H, broad CONH exch.).
Preparation of dimers
3-[ 1 -Methyl-4-( I -methy 1-4-nitropy rrole-2-carboxanrido)- 
py rroIe-2-carboxamidoldimethylaminopropane11 (5a). 
( 0 2N  p y rr  p y rr  dm ap) This was prepared using standard 
literature procedure. The product was obtained as pale 
yellow crystalline material in (79% yield); mp 190-192°C 
(lit.11 mp 193-194°C).
1 -Methyl-4-(3-( 1 -methyl-4-( l-methyl-4-nitropy rroIe-2- 
carboxamido)pyrroie-2-carboxamido)propyl)piperazine 
(5c). ( 0 2N  p y rr  p y rr  m p ip p ) The /V-methylpiperazine amide 
hydrochloride Ig (0.684 g, 1.966 mmol) was dissolved in 
ethanol (20 mL) and HC1 (10 mL, dil). This solution was 
hydrogenated using Pd/C (256 mg, 10%) at room tempera­
ture and atmospheric pressure overnight. Filtration and 
washing the catalyst with water (10 mL) gave a pale yellow 
solution which was evaporated under reduced pressure at 
room temperature to give a pale yellow oil. This oil was 
dissolved in water (10 mL), to which was added gradually 
with stirring sodium hydrogen carbonate (1.305 g). The acid 
chloride was prepared from the carboxylic acid !b (406 mg, 
2.39 mmol) heated under reflux in thionyl chloride (1 mL) 
and dimethoxyethane (5 mL, dry) for 2 h. The solvent was 
removed under reduced pressure at 40°C, then dissolved in
benzene (10 mL), this solution was added dropwise with 
stirring at room temperature to the solution of lg. The 
resulting mixture was heated under reflux for 1/2 h. then 
left to cool to room temperature and stirring was continued 
overnight. The reaction mixture was extracted with 
dichloromethane, dried and solvent removed under reduced 
pressure to give yellow solid product (806 mg, 95%). This 
product was purified by flash column chomatography using 
silica gel and ethyl acetate/methanol/ammonium hydroxide 
(49%/49%/2%). TLC: Rt<= 0.2. Mp 175-177°C (from ben- 
zene/n-hexane). HREIMS: Found: 431.22612 Calculated 
for C2(,H29N70 4 431.22810; v mJ c m  1 (KBr): 1667, 1635, 
1578, 1564, 1543, 1493, 1320. SH(CDC13): 1.70-1.80 (2H, 
qt, 7=6.9 Hz, CH2); 2.29 (3H, s, NMe); 2.41-2.53 (10H, 
in); 3.43-3.50 (2H, q, 7=6.1 Hz, CH2); 3.91 (3H, s, NMe 
pyrrole); 4.04 (3H, s, NMe pyrrole); 6.66 (1H, d, 7=1.7 Hz, 
pyrrole); 7.11 (1H, d, 7=1.6 Hz, pyrrole); 7.26 and 7.27 
(1H, d, 7=1.6 Hz, pyrrole); 7.34-7.38 (IH, t, 7=5.5 Hz, 
CONH exch.); 7.60 and 7.61 (IH, d, 1.8 Hz, pyrrole); 
7.84 (IH, s, CONH exch.).
/V -(3-(l-m ethyl-4-(l-m ethyl-4-nitropyrrole-2-carboxaniido)- 
p yrro le-2 -carb oxam id o)p rop y l)d ieth an o lam in e  (5d).
(O tN  p y rr  p y r r  d heap) A mixture of the nitropyrrole 
amide ( l i )  (549 mg, 1.75 mol), 10% Pd-C (202 mg) and 
isopropanol (25 mL) was hydrogenated at room temperature 
for 5 h. The catalyst was removed by filtration through 
kieselguhr, and the filtrate was evaporated under reduced 
pressure. The green, oily residue was dissolved in dry 
DMF (2.0 mL), and the solution was cooled in an ice- 
water bath while a solution of the trichloroacetyl pyrrole 
Id (474 mg, 1.75 mmol) in dry DMF’ (1.0 inL) was added 
slowly during a period of 5 min. The resultant solution was 
stirred at room temperature for 16 h, then it was chomato- 
graphed over a flash column of silica, using a mixture of 
ethyl acetate (4 parts) and methanol containing 3% of conc. 
ammonium hydroxide (1 part) as eluant, to afford the 
required a m ide  5d  as an amber gum (307 mg, 40% yield). 
HRFABMS: Found: 437.21360 Calculated for C19H29Nf,06 
437.21485; SH (CDC13) 1.74 (2H, m, CH2-C //2-CH2), 2.67 
(6H, m, 3XN-CJ72-CH2), 3.43 (2H, q, 6.1 Hz, becoming t, 
7=3.5 Hz after D20 , NH-CH2-CH2), 3.67 (4H, t, 7=
3.5 Hz, 2xCH2-C //2-OH), 3.86 (3H, s, NMe), 4.01 (3H, 
s, NMe), 6.71 (IH, d, 7=1.6 Hz, Ar//), 7.08 (IH, t, 7=
5.5 Hz, exch., CON//-CH2), 7.17 (IH, d, 7=1.6 Hz, 
Ar//), 7.42 (IH, d, 7=1.6 Hz, ArH), 7.57 (IH, d, 7=
1.6 Hz, Ar//), 8.92 (IH, s, exch., CONH).
4-(3-(l-M ethyl-4-(l-m ethyl-4-n itropyrrole-2-carboxam ido)- 
p yrro le -2 -carb oxam id o)p rop y l)m orp h o lin e  (5e). ( 0 2N  
p y rr  p y rr  m orphp) A mixture of the nitropyrrole morpholine 
amide Ih  (1.30 g, 4.39 mmol.) and 10% Pd-C (510 mg) in 
isopropanol (50 mL) was hydrogenated at room temperature 
for 5 h. The catalyst was removed by filtration though 
kieselguhr, and the filtrate was evaporated under reduced 
pressure. Traces of isopropanol were removed from the 
residue by co-evaporation with dimethoxyethane (5 mL), 
to leave an amber oil. This oil was dissolved in dry 
dimethoxyethane (5 mL), and the solution was cooled in 
an ice/water bath, and stirred while a solution of the 
trichloroacetyl pyrrole Id  (1.19 g, 4.39 mmol.) in a mixture 
of dry dimethoxyethane (2 mL) and dry THF (1.5 mL) was 
slowly added over a period of 5 min. The resultant solution
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was stirred at room temperature for 16 h, then evaporated 
under reduced pressure. The semisolid residue was tritu­
rated with isopropanol until it solidified. The solid was 
collected, washed with isopropanol (5 mL) and dried 
under reduced pressure to give the required am ide  5e as a 
yellow powder (1.09 g, 59%), mp 182-184°C. HREIMS: 
Found: 418.19716 Calculated for CI9H26N(A  418.19647; 
i / J c m ' 1 (KBr) 3408, 3125, 1656, 1634, 1574, 1535, 
1502, 1309, 1116, 1110; SH (DMSO-d6): 1.57-1.69 (2H, 
qt, .7=7.0 Hz); 2.27-2.30 (6H, m); 3.15-3.27 (2H, q, 
.7=6.0 Hz); 3.55-3.59 (4H, t, 7=4.6 Hz); 3.80 (3H, s, 
NMe); 3.95 (3H, s, NMe); 6.83-6.84 (IH, d, .7=1.7 Hz); 
7.19-7.20 (IH, d, 7=1.6 Hz); 7.56-7.57 (IH, d, 7=  
1.8 Hz); 8.05-8.09 (IH, t, 7=5.6 Hz, CONH exch.); 8.17-
8.18 (IH, d, .7=1.8 Hz); 10.23 (IH, s CONH exch.).
3-|l-Methyl-4-(l-methyl-4-nitropyrrole-2-carbnxamido)- 
pyrrole-2-carboxamido)propionitrile4'13 (5g). ( 0 2N  p y rr  
p y rr  cyanp)  This was prepared using standard literature 
procedure. The product was obtained as yellow powder in 
(87% yield); mp 228-230°C (lit.4 mp 230-232°C; lit.13 mp 
254-255°C).
Ethyl 3-[l-methyl-4-( l-methyI-4-nitropyrroIe-2-carboxa- 
mido)pyrrole-2-carboxamido]propioniniidate hydro­
chloride (5h). (<92/V p y rr  p y rr  im idp)  A suspension of the 
foregoing nitrile 5g (6.44 g) in anhydrous ethanol (250 mL) 
was cooled and stirred, and saturated at -20°C with dry 
HCl(g). The resultant mixture was stirred at room tempera­
ture for 3 h, then evaporated under reduced pressure. The 
residue was triturated with dry diethyl ether, decanted and 
dried under reduced pressure to give the required imidate 5h 
(7.93 g, 99% yield) as a yellow solid; mp 134°C (decomp.). 
This was used in the next step without further purification.
3-[l-Methyl-4-(l-methyI-4-nitropyrrole-2-carboxamido)- 
pyrrole-2-carboxamidojpropionamidine hydrochloride4,11,12
(5f). ( 0 2N  p y rr  p y r r  am idp ) A suspension of the above 
imidate 5h (3.345 g) in anhydrous ethanol (100 mL) was 
stirred and cooled to —78°C in an acetone-dry ice bath. 
Liquid ammonia (75 mL) was added, and the resultant 
mixture was allowed to warm up slowly to room tempera­
ture. A clear solution formed, from which a solid separated 
overnight. The precipitate was collected, washed with 
ethanol, then with diethyl ether, and dried under reduced 
pressure to give the required amidine (2.30 g, 74% yield) 
as a yellow powder; mp 308°C (decomp.). [Lit. mp 315°C 
(decomp.), lit.12 mp 324-325°C|. A further sample was 
prepared following the literature11 in 69% yield mp 314- 
315°C [lit.11 mp 246°C]. (Found: C, 54.4; H, 6.15; N, 
19.9%; Cl9H,6N60  requires: C, 54.54; H, 6.26; N, 
20.08%.) SH (DMSO-dfi) 1.64 (2H, m, CH,-C//2-CH2), 
2.33 (6H, m, 3xN-C//2-CH2), 3.20 (2H, q, 7=6.2 Hz 
becoming t, 7=6.1 Hz, after D20 , CONH- C7/2-CH2), 
3.57 (4H, t, 7=4.7 Hz, CH2-CH2-0-C7/2-CH2), 3.80 
(3H, s, pyrrole NMe), 3.95 (3H, s, pyrrole NMe), 6.84 
(IH, d, 7=1.7 Hz, A rH ), 7.20 (IH, d, 7=1.8 Hz, A rH ),
8.07 (IH, t, 7=5.5 Hz, exch., CON/7-CH2), 8.18 (IH, d, 
7=1.7 Hz, A rH ), 10.24 (IH, s, exch., CONH ).
3-{ Carbobenzoxyglycy l-[ I -methyl-4-(4-amino-1 -methyl- 
pyrrole-2-carboxamido)pyrrole-2-carboxamido]} dimethyl- 
aminopropane (55). (Z Gly p y rr  p y r r  dm ap) A  mixture of
5233
the nitropyrrole dimer 5a (0 2N  p y rr  p y rr  dm a p  750 mg) and 
10% Pd-C (690 mg) in isopropanol (75 mL) was hydro­
genated at room temperature for 5 h. The catalyst was 
removed by filtration under an atmosphere of nitrogen, 
and the filtrate was evaporated under reduced pressure to 
leave crude amine as a greenish grey, glassy residue 
(631 mg, 91% yield), which was used immediately without 
further purification.
A mixture of carbobenzoxyglycine (457 mg, 2.19 mmol), 
HBTU (829 mg, 2.i9mmol), NMM (725 p-L, =663 mg,
6.56 mmol.), and dry DMF (2.5 mL) was placed under 
nitrogen and stirred at room temperature for 30 min. To 
the resultant, clear solution was added a solution of the 
crude amine (631 mg, 1.82 mmol) in dry DMF (4 mL) 
slowly over a period of 5 min. The solution was stirred at 
room temperature for 15 h, then it was added to ethyl acetate 
(200 mL), extracted with 5% aqueous sodium carbonate 
solution (50 mL), washed with brine, and dried (Na2SG4) 
then evaporated under reduced pressure. The oily residue 
was dissolved in methanol, and the solution was passed 
though a short column of neutral alumina using methanol 




pane (5j). (G ly  p y rr  p y rr  dm ap) A  mixture of foregoing 
trimer and 10% Pd-C (300 mg) in isopropanol (30 mL) 
was hydrogenated at 60°C for 15 h. The catalyst was 
removed by filtration though kieselguhr, and the filtrate 
was evaporated under reduced pressure to leave the depro­
tected trimer as an amber, gummy residue (196 mg, 82%); 
HPLC showed the material to be 90% pure and no unreacted 
starting material was detected. (Found ES-MS; 403.77, 
201.46: C|9H29N70 3 requires 404.5 (M +l), 202.75 
[(M+2)/2j. The crude product was used immediately with­




(0 2/V im id  im id  d m a p )  This was prepared using standard 
literature procedure. The product was obtained as yellow 
solid in (58% yield); mp 160-161°C as HC1 salt (lit.25 mp 
161-165°C as HC1 salt).
3-[5-(5-Nitrothiophene-2-carboxainido)thiophene-2-car- 
boxamidojdimethylaminopropane (7). ( 0 2N  th io  th io  
dm ap) 3-(5-Nitrothiophene-2-carboxamido)dimethyl- 
aminopropane 4c (226 mg, 0.879 mmol) and Pd/C 
(293 mg, 10%) were suspended in isopropanol (25 mL) 
and hydrogenated for 5 h. The reaction mixture was filtered 
through kieselguhr under nitrogen and the solvent was 
removed under reduced pressure. The acid chloride was 
prepared from 5-nitrothiophene-2-carboxylic acid 4a 
(212 mg, 1.22 mmol) by heating under reflux for 3 h with 
thionyl chloride (3 mL). The excess thionyl chloride was 
removed under reduced pressure and the traces of thionyl 
chloride were removed by co-evaporation with dichloro­
methane. The amine produced by hydrogenation was 
dissolved in dichloromethane (3 mL, dry) and added 
dropwise at 0°C to a solution of the acid chloride in
2 6 6
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dichloromethane (2 mL, dry). The reaction mixture was left 
stirring at room temperature overnight. The solvent was 
removed under reduced pressure and the yellow residual 
solid suspended in brine and extracted with ethyl acetate. 
The aqueous layer was basified with aq. sodium carbonate 
solution then extracted with ethyl acetate, the organic layer 
dried (MgS04) and the solvent removed under reduced 
pressure to give the required am ide d im er  (199 mg, 59% 
yield) as a dark brown solid, mp 185-190°C (softening). 
HRFABMS: Found: 383.08482 Calculated for
C,5H1<)N4 0 4S2 383.08477; rntJX/cm"' (KBr) 1657, 1623, 
1536, 1502, 1462, 1334, 1300. SH (DMSO-d()): 1.64-1.76 
(2H, qt, 7=7.1 Hz, CH2); 2.49-2.51 (2H, t, 7=4.7 Hz, 
CH2); 3.17-3.28 (2H, q, 7=6.1 Hz, CH,); 6.82 and 6.84 
(IH, d, 7=2.1 Hz, thiophene H); 7.22 and 7.24 (IH, d, 
7=2.1 Hz, thiophene H); 7.91 and 7.93 (IH, d, 7=2.1 Hz, 
thiophene H); 8.17 and 8.18 (IH, d, 7=2.1 Hz, thiophene 
FI); 8.33-8.37 (IH, t, 7=5.7 Hz, CONH exch.).
3-[4-Methy!-2-[( 1 -methy l-4-niti opy rrole-2-car boxamido)- 
thiazoIe-5-carboxamido](A^,Af-dimethyl)propanamine 
(8). {()2N p y r r  thia dm ap) 4-Methyl-2-( 1 -methy 1-4-nitropyr- 
role-2-carboxamido)thiazole-5-carboxylic acid (3a) 
(0.400 g, 1.289 mmol) was dissolved in benzene (40 mL, 
dry) and thionyl chloride (3 mL, freshly distilled) and 
heated under reflux for 4 h. The solvent was removed 
under reduced pressure, and the residue was co-evaporated 
with hexane (25x3 mL, dry). The product was used without 
any further purification. A cooled solution of /V,/V-dimethyl- 
aminopropylamine (350 jjiL , 2.781 mmol) and triethyl- 
amine (1 mL) in dichloromethane (20 mL, dry) was added 
dropwise to the above acid chloride in THF (25 mL, dry) 
under nitrogen. After the reaction mixture was stirred at 
room temperature for 12 h, the solvent was removed 
under reduced pressure and the resulting residue was 
extracted in a 1:1 mixture of THF:ethyl acetate 
(2x100 mL) and dil. solution of sodium bicarbonate. The 
organic layer was washed with brine, dried, and evaporated 
under reduced pressure at room temperature. The crude 
product was purified on a column of silica gel (methanol/ 
ethyl acetate 1:1). The second fraction was collected and on 
evaporation afforded the required am ide  8 (255 mg, 50%) as 
yellow crystals, mp 204-206°C. R(= 0 .15 (silica, 1:1 
methanol.ethyl acetate). HRFABMS: Found: 395.15210 
Calculated for C,6H21N60 4S 395.15015; rra„/ctn_l (KBr) 
1625, 1502, 1430, 1430, 1378, 1316. SH (DMSO-df)) 1.55-
1.65 (2H, qt, 7=7.1 Hz, CH2); 2.15- 2.25 (6H, s, NMe2); 
2.26-2.39 (2H, t, 4.6 Hz, CH2); 2.50 (3H, s, thiazole-Me);
3.15-3.28 (2H, q, 7=5.9 Hz, CH2); 3.95-4.50 (3H, s, 
pynrole-Me); 7.75-7.90 (IH, d, 2.2Hz, ArH); 8.02-8.06 
(IH, t, 7=5.7 Hz, NH, exch.); 8.26 (IH, s, ArH).
3-[5-(4-Nitro-A-methylpyrrole-2-carboxamido)thiopheiie- 
2-carboxamido]dimethylamimopropane (9). ( 0 2N  p y rr  
thio d m ap) 4-Nitro-/V-methylpyrrole-2-carboxylic acid lb  
(190 mg, 1.117 mmol) was suspended in thionyl chloride 
(4 mL) and heated under reflux for 1.5 h. Excess thionyl 
chloride was removed under reduced pressure and the last 
traces of it were removed by co-evaporation with dichloro­
methane (2x5 mL, dry). 2-(5-Nitrothiophene-2-carboxa- 
mido) dimethylaminopropane 4c (205 mg, 0.797 mmol) 
and Pd/C (207 mg, 10%) were suspended in isopropanol 
(25 mL) and hydrogenated at room temperature and
atmospheric pressure for 3 h. The catalyst was removed 
by filtration over kieselguhr under nitrogen, then the solvent 
was removed under reduced pressure at 40°C. The amine so 
formed was dissolved in dichloromethane (10 mL, dry) to 
which was added the acid chloride lc  dissolved in dichloro­
methane (10 mL, dry) dropwise at 0°C. Stirring was con­
tinued overnight while the temperature was left to rise to 
room temperature The product precipitated as a yellow 
solid; it was filtered off, and washed with a small amount 
of dichloromethane (dry) to give the required am ide 9 
(163 mg, 50%). Mp>230°C. Some of this material was 
further purified by HPLC for characterisation. HRPABMS: 
Found: 380.13854 Calculated for C,f)H22N ,04S 380.13925; 
"ma\/cm ~1 (KBr): 1670, 1641, 1624, 1533, 1459, 1310, 
1288. S H (DMSO-df,): 1.84-1.88 (2H, qt, 7=7.1 Hz, CH2); 
2.79 (6H, s, NMe2); 3.08 (2H, t, 7=4.7 Hz, CH2); 3.08-3.29 
(2H, q, 7=6.2 Hz, CH2); 3.98 (3H, s, NMe pyrrole); 6.84 
and 6.85 (IH, d, 2.1 Hz); 7.54 and 7.55 (IH, d, 7=2.0 Hz);
7.73 and 7.74 (IH, d, 7=1.9 Hz); 8.28 and 8.28 (IH, d,
1.8 Hz); 8.43-8.46 (IH, t, 7=5.5 Hz, CONH exch); 9.31 
(IH, broad TFA exch); 11.65 (IH, s, CONH exch.).
Preparation of linkers
2.7-Bis(bromomethyl)-9,10-dihydrophenanthrene15’16 (16).
Literature procedures15,16 were adapted as follows. A 
mixture of 9,10-dihydrophenanthene (20.11 g), paraformal­
dehyde (14.72 g), 85% phosphoric acid (22 ml.), 48% aq. 
hydrogen bromide (38.5 mL), and 30% hydrogen bromide 
in acetic acid (44 mL) was placed under nitrogen and stirred 
and heated at 80°C for 21 h, then at 117°C (gentle reflux) for 
5 h., and allowed to cool. The crude product separated as a 
grey solid mass. The supernatant liquid was decanted and 
the solid stirred with acetone (100 mL) at room temperature 
for 18 h, then cooled to 0°C. The insoluble solid was 
collected, washed with cold acetone, and recrystallised 
from benzene/petroleum ether (bp 40-60°C) to give the 
required dibromodihydrophenanthrene 16 as an off-white 
powder (16.23 g, 40% yield); mp 150-154°C (lit.15 mp 
157-158°C, lit.16 mp 150-151°C); v mJ c m  1 (KBr) 3414, 
2925, 2896, 2830, 1640, 1618, 1488, 1243, 1205 cm '. SH 
(CDCl2) 2.87 (4H, s, C//2-C //2), 4.53 (4H, s, 2XAr-C//2-  
Br), 7.28 (2H, s, Ar//), 7.33 (2H, d, 7=8.0 Hz, Ar//), 7.71 
(2H, d, 8.0 Hz, Ar//).
2.7-Diacetyl-9,10-dihydrophenanthene.17’19 Literature 
procedures17'19 for the Friedel-Cralts acetylation of 9,10- 
dihydrophenanthene were adapted as follows. Acetyl 
chloride (9.15 g, 117 mmol) was added with stirring using 
a motor-driven paddle stirrer to a suspension of aluminium 
trichloride (15.56 g, 117 mmol) in dry dichloromethane 
(75 mL), and the resultant solution was heated in a bath at 
a controlled temperature of 40°C, keeping the solvent just 
below the point of reflux. A solution of 9,10-dihydro­
phenanthene (9.54 g, 53.0 mmol) in dry dichloromethane 
(35 mL) was added dropwise over a period of 2 h, keeping 
the solvent just below refluxing temperature. Stirring was 
continued for a further 1 h at 40°C, then for 18 h at room 
temperature. The mixture was cooled in ice, and a solution 
of HC1 (20 mL conc. HC1 diluted with 30 mL water) was 
added slowly with vigorous stirring. An additional 50 mL of 
water was introduced to overcome emulsification and the 
layers were allowed to separate. The organic layer was
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washed with 10% aq. sodium carbonate (250 mL), then with 
brine (100 mL), then dried (Na2S04), and evaporated to 
leave an oil (15.25 g) which solidified slowly. This residue 
was stirred with acetone (20 mL) at room temperature for 
I h, and the solid was filtered off and washed with a little 
cold (—15°C) acetone. This crude product (7.78 g) was 
recrystallised from hot ethanol (100 mL) to afford 3.91 g 
of partially purified product, mp 138-142°C. Further recrys­
tallisation from ethanol (60 mL) afforded the required 
diacetyldihydrophenanthrene, as golden yellow glistening 
plates (3.36 g, 24%) mp 142-144°C (lit.17 mp 144- 
144.5°C); rmaK/cm"' (KBr) 1681, 1677, 1641, 1603, 1262; 
3,i (CDC13) 2.64 (6H, s, 2xC/f,CO), 2.98 (4H, s, CH 2-  
CH 2), 7.82-7.97 (6H, ffi, Ar//).
9,10-Dihydrophenamthrene-2,7-dicarboxylic acid17 (14). 
The foregoing diketone was oxidised with iodine via its 
bispyridinium salt according to a literature procedure,17 to 
give the crude diacid (14) as a dark brown powder (96% 
mp>350°C). Recrystallisation from aqueous DMF 
(decolourising charcoal) gave a lighter brown product, 
mp>360°C (lit.17 mp~350°C); r -J c m '1 (KBr) 1686, 
1640, 1613, 834; 3„ (DMSO-d0) 2.90 (4H, s, C H ,-C H 2), 
7.87-8:01 (6H, m, Ar//)
2.7-Bis(bromomethyl)phenanthrene (17). A mixture of 
the bisbromomethyldihydrophenanthrene (16, 4.62 g, 
12.6inmol), DDQ (3.15 g) mid dry benzene (30 mL) was 
heated under reflux for 18 h. The mixture was filtered while 
still hot though a 2.5 in. column of neutral alumina, rinsing 
with hot benzene. The filtrate was evaporated under reduced 
pressure, and the residue was crystallised from benzene/ 
petroleum ether (bp 40-60°C) to give the required 
b isb rom om ethy lphenan threne  as pale buff-coloured crystals 
(2.94 g, 64% yield); mp 189-191°C. (Found: C, 52.9; H, 
3.3; Br, 43.7%. C1(,H12Bn requires C, 52.78; H, 3.32; Br, 
43.90%). rw /cm  1 (KBr) 1638, 1260, 1212, 1202, 906, 
811 cm '; S„ (CDCL) 4.73 (4H, s, 2xArC//2Br), 7.68-
7.74 (4H, m, 4xAr//), 7.90 (2H, d, 7=1.7 Hz, 2 x A rH ),
8.65 (2H, d, 7=8.6 Hz, 2 x A rH ).
2.7-Diformylphenanthrene.26 This was prepared using 
standard literature procedure. The crude product was puri­
fied by flash column chromatography (Si02/dichloro- 
methane) to give the required diformylphenathrene as 
bright yellow crystals in (52% yield), mp >350°C; v m J  
cm"1 (KBr) 1690, 1639, 1617, 1575 cm"1. SH (CDC13)
7.95 (2H, s, 2xAr//), 8.16-8.21 (2H, dd, 7=1.7 Hz and
8.6 Hz 2xAr/7), 8.42 (2H, d, 7= 1.6 Hz, 2xAr//), 8.84 
(2H, d, 7=8.6 Hz, 2 x A x H \ 10.25 (2H, s, 2xArC//0).
Phenanthrene-2,7-dicarboxyIic acid27 (13). The reagent 
(bipy)H2CrOCl5 reagent was freshly prepared according to 
the literature procedure20 as a brown powder (31 % yield). A 
solution of the foregoing dialdehyde (516 mg, 2.20 mmol) 
in dry dichloromethane (50 mL) was placed under nitrogen, 
and stirred at room temperature. (Bipy)H2CrOCl5 (4.45 g,
11.02 mmol) was added, and the mixture was stirred at room 
temperature for 18 h, then evaporated under reduced 
pressure. The residue was extracted cau tiously  (C02!) 
with a solution of sodium hydrogen carbonate (10 g) in 
water (250 mL). Some insoluble material was removed by 
filtration through kieselguhr, and the filtrate was acidified
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cau tiously  (C02!) with conc. hydrochloric acid. The pre­
cipitated solid was collected, washed with water, and 
dried under reduced pressure (1.66 g of crude product). 
The crude product was dissolved in a solution of sodium 
hydrogen carbonate (2.0 g) in water (100 mL), and repre­
cipitated with conc. hydrochloric acid. After drying under 
reduced piessure, the crude, dark brown solid amounted to 
0.88 g ( ~  150% theoretical yield of the required diacid). For 
further purification, the diacid was converted into its 
dimethyl ester and the ester hydrolysed to the acid as 
follows. The above crude product was suspended in metha­
nol (125 mL) and the mixture was saturated at room 
temperature with dry hydrogen chloride (g), and then heated 
under reflux for 23 h. The resultant clear, green solution was 
evaporated under reduced pressure. The residue was 
extracted with dichloromethane (20 mL), and the dichloro­
methane was decanted from insoluble gummy material. This 
dichloromethane extract was purified by means of flash 
column chromatography (Si02/dichloromethane) to give 
the dimethyl ester as a cream-coloured solid (149 mg, 
25%), mp 182-186°C. (Found: C, 73.5; H, 4.68%. 
C18H140 4 requires C, 73.46; H, 4.79.%) r^ /cm " 1 (KBr) 
1728, 1638, 1617; S„ (CDCL) 4.03 (6H, s, 2xC02C//3), 
7.87 (2H, s, 2xAr//), 8.32 (2H, dd, 7=1.7 Hz and 7=
8.6 Hz, 2xAr//), 8.64 (2H, d, 7=1.6 Hz, 2xAr//), 8.76 
(2H, d, 7=8.6 Hz, 2xAr//).
A suspension of the above dimethyl ester (143.3 mg, 
0.487 mmol) in a mixture of ethanol (5 mL) and 20% 
aqueous sodium hydroxide solution (5 mL, 25.0 mmol) 
was heated under reflux for 1 h. Water (10 mL) was 
added, and refluxing was continued for a further 2 h. The 
resulting solution was evaporated under reduced pressure, 
and the residue was dissolved in water (50 mL). This 
solution was cooled in an ice bath, and acidified with 
conc. HC1. The precipitated solid was collected on a filter 
paper, washed with water, and dried under reduced pressure 
to give the required p h en a n th ren e  d ica rb o xy lic  a c id  (13) as 
a pale yellow powder (118 mg, 91%), mp >350°C (lit. 27 
Mp 165-167°C); (KBr) 1692, 1686, 1654, 1639,
1617 cm"1. 5„ (DMSO-dJ 5 8.09 (2H, s, 2xAr)7), 8.22 
(2H, dd, 7=1.8 Hz and 7=8.6 Hz 2xAr//), 8.67 (2H, d, 
7=1.7 Hz, 2XAxH), 8.99 (2H, d, 7=8.7 Hz, 2xAr/7), 13.26 
(2H, br, exch., 2xCO2H).
Diethyl s tilb en e-4 ,4 '-d ica rb o x y la te21 (18b ). A mixture of
4-toluic acid (50 g, 368 mmol) and sulphur flowers (5.88 g, 
184 mmol) was placed in a 1-litre conical flask, and stirred 
and heated on a sand tray at 260-275°C (just on the bp of the 
toluic acid) for 2 h. The resultant mixture was allowed to 
cool to about 140°C, and hot xylene (200 mL) was added. A 
reflux air-cooled condenser was fitted, and the mixture was 
boiled under reflux for 30 min., then filtered hot. The filter 
cake was boiled with dioxane (75 mL) for 30 min., then 
filtered, washed with hot dioxane (50 mL) and dried under 
reduced pressure to afford the crude dicarboxylic acid 18a  
as a yellow powder (12.71 g). The crude product was taken 
up in a boiling solution of potassium hydroxide (7.0 g) in 
water (300 mL). Some insoluble yellow material was 
removed by filtration, and the filtrate was concentrated to 
100 mL, then allowed to cool. The dipotassium salt crystal­
lised out as yellow plates (11.86 g after drying). The 
dipotassium salt was taken up in boiling water (350 mL),
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and the resultant solution was acidified while hot with conc. 
HC1 (15 mL). The resultant precipitate was digested hot for
1.5 h, and after cooling the product was collected, washed 
with water, and dried under reduced pressure to give the 
required dicarboxylic acid 18a as a pale yellow powder 
(9.09 g, 37% yield based on sulphur), mp >320°C (lit21 
Mp 460°C, [sealed tube]).
Diethyl ester 18b.21’22 The above dicarboxylic acid 
(8.623 g, 32.4 mmol) was refluxed with thionyl chloride 
(50 mL) for 20 h. The resultant mixture was evaporated 
under reduced pressure, and residual thionyl chloride was 
removed from the solid residue by co-evaporation with 
hexane (2X30 mL). Crystallisation from benzene gave the 
acid chloride as a bright yellow powder (2.79 g, 28% yield), 
mp 222-228°C (lit.21 mp 228-232°C, lit.22 mp 223 
224°C). {Note: When this reaction was carried out on a 
smaller scale, but with a reflux period of just 15 h, the 
yield of acid chloride was improved to 44%.) The acid 
chloride (2.78 g) was refluxed with ethanol (100 mL) for 
17 h. The solution was evaporated under reduced pressure, 
and the crystalline residue recrystallised from ethanol to 
give the required diester as pale yellow crystals (2.58 g, 
87% yield), mp 129-133°C (fit.21 mp 129.9-130°C, lit.21 
mp 130-131°C); SH (CDC13) 1.32 (6H, t, 7=7.0 Hz, 
2xCH2-C //3), 4.39 (4H, q, 7=7.0 Hz, 2xO-C//2-CH3),
7.23 (2H, s, Ar-CH = C H  Ar), 7.59 (4H, m, Ar//), 8.06 
(4H, m, Ar//).
Diethyl 3,6-phenanthrene dicarboxylate21 (15b). A solu­
tion of diethyl 4,4'-stilbene dicarboxylate 18b (0.5015 g, 
1.546 mmol) in toluene (1 L) containing iodine (0.1240 g) 
was irradiated for 3 days using a medium-pressure mercury 
lamp (400 W) in a quartz tube while oxygen was slowly 
bubbled though the reaction mixture. After removal of the 
solvent under reduced pressure, the residue was taken up in 
dichloromethane and passed through a short column of 
silica gel. Concentration of the eluate followed by addition 
of methanol precipitated a white solid which, on recrystal 
lization from a dichloromethane/methanol mixture, gave the 
required phenanthrene as white prisms (243 mg, 49% yield) 
mp 162-164°C (lit.21 mp 164-166°C).
3,6-Phenanthrene dicarboxylic acid (15a). Diethyl 3,6- 
phenanthrene dicarboxylate (150 mg, 0.466 mmol) was 
suspended in a mixture of ethanol (5 mL) and aq. sodium 
hydroxide (i.Og in water 15 mL, 25 mmol). The reaction 
mixture was heated under reflux for 3 h, then solvent was 
removed under reduced pressure. The residue was dissolved 
in water (25 mL), cooled in ice, and acidified with conc. 
hydrochloric acid to afford the required phenanthrene dicar­
boxylic acid as a white solid which was filtered, washed 
with water and dried (912 mg, 99%). Mp>250°C; v maJ  
cm-1 (KBr) 2981, 2824, 2641, 1691, 1622, 1449, 1422, 
1295, 1276; SH (DMSO-d6): 8.08-8.23 (6H, m, ArH); 
9.35 (2H, s, ArH); 13.25 (2H, s, 2xC02H); HREIMS. 
Found: 266.05877 Calculated for C16H10O4 266.05791.
Cyclopropane-/ra«.v-l,2-dicarboxylic acid.12,13 Sodium 
hydroxide solution (1.015 g, 2.56 mmol in water 10 mL) 
was added with stirring to a solution of dimethyl trans- 
cyclopropane dicarboxylate (1.085 g, 6.86 mmol) in ethanol 
(5 mL). The clear solution was left standing at room
temperature for 3 h then solvent was removed under 
reduced pressure at room temperature. Water was added 
and removed under reduced pressure at room temperature. 
Ether (25 mL) and water (50 mL) were added and the di­
sodium salt was extracted. The organic layer was extracted 
again with water. The water extracts were combined and 
acidified with conc. hydrochloric acid (pH 2). Water was 
removed under reduced pressure at room temperature, then 
the white solid mass was triturated with ethyl acetate 
(100 mL, dry) and filtered. The filtrate was removed under 
reduced pressure at room temperature to give the required 
diacid as a white solid (0.885 g, 99% yield), mp 177- 178°C. 
[lit.12 mp 172-174°C; lit.13 mp 175°C], (KBr):
1695. ShIDMSO-c^ ): 1.14-1.29 (2H, t, 7=8.1 Hz); 1.85- 
1.91 (2H, t, 7=7.5 Hz); 12.58 (2H, broad 2xC02H exch.).
Separation of head to head linked dimers (target 
compounds)
9,10-Dihydrophenanthrene-2,7-dicarboxamido{3-[l-meth- 
yl-4-(4-amino-1 -methyl-pyr role-2-carboxamido)py r role- 
2-carboxamido]-dimethylaminopropane} (19). (dm ap
p y rr  p y rr  H yphen p y rr  p y rr  d m a p ) The nitro dimer 
compound (5a, 554 mg) in isopropanol (50 mL) was hydro­
genated at room temperature over 10% Pd-C (537 mg) for 
4 h. The catalyst was removed by filtration through kiesel­
guhr under an atmosphere of nitrogen, and the filtrate was 
evaporated under reduced pressure to give the crude amine 
as a pale grey coloured, brittle, glassy solid (424 mg, 83%). 
This material was dissolved in dry DMF (4.0 mL), and the 
resultant solution (containing ~  100 mg per mL) was used 
immediately in the following coupling reactions:
U sing H B T U /N M M : A mixture of dihydrophenathrene-2,7- 
dicarboxylic acid 14 (25.8 mg, 0.0963 mmol), HBTU 
(110 mg, 0.289 mmol), NMM (65 p.L, 0.594 mmol) and 
dty DMF (1.5 mL) was placed under nitrogen and stirred 
at room temperature for 30 min. A 1.0 mL aliquot of the 
solution of the amine derived from 5a (100 mg, 
0.289 mmol) above was added, and the mixture was stirred 
at room temperature for 18 h. The product was isolated from 
the resultant solution using HPLC (see Experimental). The 
fractions containing the product were frozen immediately 
on collection, and then freeze dried to give required linked  
oligom er  19, bis-TFA salt, as a cream-coloured solid (54% 
yield) which had no distinct mp (Found: ES-MS: 925.7, 
462.8; C50H60Ni2O6 (free base) requires 926.10 (M+l),
463.56 [(M+2)/2]); 5„ (DMSO-d6) 8 1.84 (4H, m, 
2xCH2-C //2- CH2), 2.77 (12H, s, 2xNMe2), 2.97 (4H, s, 
C//2-C //2 bridge), 3.04 (4H, m, 2xC//2-CH2), 3.26 (4H, 
m, 2xC//2-CH2), 3.83 (6H, s, 2Xpyrrole NC//3), 3.89 
(6H, s, 2Xpyrrole NCZ/3), 6.95 (2H, d, 7=1.6 Hz, 2Xpyrrole 
Ar//), 7.12 (2H, d, 7=1.6 Hz, 2Xpyrrole Ar//), 7.19 (2H, d, 
7= 1.6 Hz, 2Xpyrrole ArH), 7.34 (2H, d, 7=1.6 Hz, 2X 
pyrrole ArH ), 7.90 (2H, s, A rH ), 7.93 (2H,d, 7=8.0 Hz, 
ArH ), 8.05 (2H, d, 7=8.4 Hz, A rH ), 8.16 (2H, t, exch., 
2xCON//-CH2), 9.95 (2H, s, exch., 2XCONH ), 10.37 
(2H, s, exch., 2XCON//).
U sing d iisopropylcarbod iim ide/H O B T : A  1.0 mL aliquot of 
the solution of the primary amine derived from 5a (100 mg,
0.289 mmol) above was added to a mixture of the dihydro- 
phenathrene dicarboxylic acid 14 (25.8 mg, 0.0963 mmol),
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HOBT (26 mg, 0.1926 mmol) and dry DMF (1.0 mL). The 
resultant mixture was placed under nitrogen, and stirred and 
cooled in an ice bath. A solution of diisopropyicarbodiimide 
(54.5 mg, 0.4325 mmol) in dry DMF (0.5 mL) was added, 
and the resultant solution was allowed to come to room 
temperature. After 18 h, water (2 drops) was added. The 
required linked o ligom er  was isolated as described above 
(49% yield).
The following compounds were prepared similarly.
9,1Q-D ihy dn>phenanthrene-2,7-dicarboxamido{ 3-11 -meth- 
y!-4-(4-amino-l-methyl-pyrrole-2-carboxamido)pyrrole- 
2-carboxamido]-dihydroxyethylaminopropane} (20).
(dheap  p y rr  p y rr  H fp h en  p y rr  p y r r  dheap) In 45% yield 
from 5d and dihydrophenanthrene-2,7-dicarboxylic acid 
using HBTU coupling. (Found: ES-MS: 1046.1, 523.9 
C54H5HN120 |q requires (free base) 1046.2 (M +l) and
523.6 |(M+2)/2]); ^ J c m -1 (KBr) 1682, 1640, 1585, 
1432, 1270, 1202; SH (DMSO-d6) 8 1.91 (4H, m, 2xCH2-  
C//2-CH2), 2.97 (4H, s, A i -C H 2-C H 2 Ar), 3.17-3.24 
( 16H, m, 8XCH 2), 3.75 (8H, m, 4XCH2), 3.82 (6H, s, 2X 
pyrrole NMe), 3.88 (6H, s, 2Xpyrrole NMe), 5.30 (4H, bs, 
exch., 4XOH), 6.94 (2H, d, ./= 1.6 Hz, 2Xpyrrole A rH ), 7.13 
(2H, d, 7=1.6 Hz, 2Xpyrrole ArH ), 7.18 (2H, d, 7=1.6 Hz, 
2Xpyrrole ArH), 7.34 (2H, d, 7=1.6 Hz, 2Xpyrrole ArH ), 
7.90-7.94 (4H, m, 4Xbenzene ArH ), 8.04-8.06 (2H, m, 
2xbenzene ArH ), 8.15 (2H, t, 7=5.6 Hz, exch., 
2xCON//-CH2), 9.07 (2H, bs, exch., 2xTFA), 9.95 (2H, 
s, exch., 2XCON//), 10.34 (2H, s, exch., 2XCONH)-
9,lQ-l)ihydrophenanthrene-2,7-dicarboxamido{3-[l-meth- 
yl-4-(4-amino-1 -methyl-py r role-2-carboxamido)py r role- 
2-carboxamido]-A-pyrrolidiny!propane} (21). (p y rp
p y rr  p y rr  H yphen p y r r  p y rr  p y rp )  In 65% yield from 5b 
and dihydrophenanthrene 2,7-dicarboxylic acid using 
HBTU coupling. (ES-MS: found 978.0, and 488.94; 
C54H6fiN|2Ofl requires (M +l) 979.1 and [(M+2)/2j
489.59.); i^ / c m '1 (KBr) 1679, 1648, 1535, 1439, 1266, 
1201; 5,i (DMSO-d(,): 1.82-1.91 (8H, m, 4xCH2); 2.02-
2.04 (4H, m, 2xCH2); 2.97-3.02 (8H, m and s, 2xCH2 and 
dihydrophenanthrene 2xCH2); 3.13-3.18 (4H, m, 2xCH2); 
3.24-3.27 (4H, m, 2XCH2); 3.56-3.57 (4H, m, 2xCH2);
3.82 (6H, s, 2xNMe pyrrole); 3.88 (6H, s, 2xNMe pyrrole);
6.96 and 6.97 (2H, d, 7=1.6 Hz, pyrrole); 7.12 and 7.13 (2H, 
d, 7=1.6 Hz, pyrrole); 7.17 and 7.18 (2H, d, 7=1.6 Hz, 
pyrrole); 7.33 and 7.34 (2H, d, 7=1.6 Hz, pyrrole); 7.90 
(2H, s, ArH); 7.92 and 7.94 (2H, d, 7=1.6 Hz, ArH); 8.09 
and 8.07 (2H, d, 7=1.6 Hz, ArH); 8.14-8.17 (2H, t, 7=
5.6 Hz, CONH exch.); 9.4 (2H, broad, TFA exch.); 9.95 
(2H, s, 2XCONH exch.); 10.37 (2H, s, 2XCONH exch.).
9,10-Dihydrophenanthrene-2,7-dicarboxamido{3-[l-Meth- 
y I-4-(4-amino-1 -methyl-py rrole-2-carboxamido)pyrroIe- 
2-carboxamido]-(4-mcthy!piperazimyl)propane} (22).
(m p ip  p y rr  p y r r  H jp h en  p y r r  p y rr  m pip)  In 43% yield 
from 5c and dihydrophenanthrene 2,7-dicarboxylate using 
HBTU coupling. (ES-MS: Found: 1036.1, 518.1
C56H70N|4O6 requires (M +l) 1036.2 and [(M+2)/2] 
5 i 8.6; v mJ c r n ~ f  (KBr) 1680, 1641, 1538, 1437, 1267, 
1200; SH (DMSO-d6): 1.77 (4H, m, 2XCH2); 2.72 (6H, s, 
2xNMe); 2.97 (4H, s, dihydro); 3.23-3.24 (4H, q, 7=
5.6 Hz, 2xCH2); 3.53 (20H, broad); 3.82 (6H, s, 2xNMe
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pyrrole); 3.88 (6H, s, 2xNMe pyrrole); 6.95 (2H, s, pyrrole); 
7.12 (2H, s, pyrrole); 7.16 (2H, s, pyrrole); 7.34 (2H, s, 
pyrrole); 7.90 (2H, s, ArH); 7.92 and 7.94 (2H, d, 7=
8.4 Hz, ArH); 8.04 and 8.06 (4H, d, 7=8.4 Hz, ArH and t, 
7=5.4 Hz, CONH exch.); 9.94 (2H, s, CONH exch.); 10.36 
(2H, s, CONH exch.).
9.10-Dihydr«phenanthrene-2,7-dicarboxamido{3-[l-meth- 
yl-4-(4-amino-l-methyI-pyrrole-2-carboxamido) pyrrole- 
2-carboxamido|-morpholine} (23). (m o ip h p  p y rr  p y rr  
H iphen p y rr  p y r r  m orph)  In 67% yield from 5e and dihy- 
drophenanthrene-2,7-dicarboxylic acid 14 using HBTU 
coupling. (Found: ES-MS: 1010.0 and 505.0; C54H64N,20 K 
requires (free base) 1010.18 (M + 1) and 505.60 [(M+2)/2]); 
*w /cnT ‘ (KBr) 1677, 1642, 1534, 1440, 1265, 1201; 5„ 
(DMSO-d6) 5 1.89 (4H, m, 2xCH2-C //,-C H 2), 2.97 (4H, s, 
A r -C H n -C H j-A r ) ,  2.97-3.14 (8H, m, 4xC//2), 3.25 (4H, 
m, 2XCH r), 3.40 (4H, m, 2X C H 2), 3.63 (4H, m, 2xCT/2),
3.83 (6H, s, 2xNMe), 3.88 (6H, s, 2xNMe), 3.98 (4H, m, 
2XCH2), 6.96 (2H, d, 7=1.6 Hz, 2 x A rH ), 7.12 (2H, d, 
7=1.6 Hz, 2xArH), 7.18 (2H, d, 7=2.0 Hz, 2xArH), 7.34 
(2H, d, 7=2.0 Hz, Ix A rH ), 9.6-9.8 (2H, bs, exch., 2xTFA) 
9.95 (2H, s, exch., 2XCONW), 10.37 (2H, s, exch., 
2XCON7/).
9.10-Dihydrophenanthrene-2,7-dicarboxamido{3-[l-meth- 
yl-4-(4-amino-1 -methyl-py rrole-2-carboxamido)pyrrole- 
2-carboxamido]-propanamidine} (24). (am idp  p y r r  p y r r  
l i c h e n  p y rr  p y r r  am idp)  In 35% yield from 5f and dihy- 
drophenanthrene-2,7-dicarboxylic acid 14 using HBTU 
coupling. (Found: ES-MS: 895.86 and 447.84;
C45H5oN1406 (free base) requires: 895.99 (M + l) and 
448.50 [(M+2)/2]); rinas/cm 1 (KBr) 1682, 1640, 1585, 
1540, 1270, 1202, 1134; % (DMSO-dfl) 8  2.61 (4H, t, 
2xCH2-C6f2-C  NH4 ), 2.97 (4H, s, C H 2 -C H 2 bridge),
3.51 (4H, q, 7=6.0 Hz, becoming t, 7=6.2 Hz after DzO, 
2XNH-CH2-CH 2), 3.82 (6H, s, 2XpyrroIe NCH2), 3.88 
(6H, s, 2Xpyrrole NC/ /3), 6.97 (2H, d, 7=1.6 Hz, 2xpyrrole 
ArH), 7.12 (2H, d, 7=1.6 Hz, 2Xpyrrole ArH ), 7.18 (2H, d, 
7=1.6 Hz, 2Xpyrrole ArH ), 7.34 (2H, d, 7=1.6 Hz, 2x 
pyrrole ArH ), 7.90 (2H, s, 2xArH), 7.93 (2H, d, 
7=8.4 Hz, 2 x A sH ), 8.05 (2H, d, 7=8.4 Hz, 2 xA rH ), 8.20 
(2H, t, 7=5.6 Hz, exch., 2xCON//-CH2), 8.53 (4H, s, exch., 
amidine), 8.90 (4H, exch., amidine), 9.95 (2H, s, 2XCON//), 
10.37 (2H, s, 2XCONH).
Phenanthrene-3,6-dicarboxamido{3-[l-methyI-4-(4-amino-
l-methyl-pyrroIe-2-cai’boxainido)pyrrole-2-carboxaniido]- 
dimethylaminopropane} (25). (dm ap  p y r r  p y rr  p h en  p y rr  
p y rr  dm ap)  In 69% yield from 5a and phenanthrene-3,6- 
dicarboxylic acid 15a using HBTU coupling. (Found: ES- 
MS: 924.2 and 462.9 C5oH5gN1206 (free base) requires 924.1 
(M +l) and 462.5 [(M+2)/21); nmax/cnT‘ (KBr) 1682, 
1649, 1535, 1270, 1201; SH (DMSO-d6) 1.85 (4H, qt, 
7=8.0 Hz, 2xCH2-C/72-CH2), 2.80 (12H, d, 7=2.8 Hz, 
becoming s after D20 , 2XNH' (C//3)2), 3.08 (4H, m, 
becoming t, 7=5.6 Hz after D20 , 2xNH-C//2-CH2), 3.26 
(4H, q, 7=6.8 Hz, becoming t, 7=5.6 Hz after D20 , 2xNH- 
C//2-CH2), 3.83 (6H, s, 2Xpyrrole NC//3), 3.91 (6H, s, 
2Xpyrrole NC//3), 6.97 (2H, d, 7= 1.6 Hz, 2XpyrTole 
ArH ), 7.18 (2H,d, 2Xpyrrole Ar77), 7.19 (2H, d, 7=1.6 Hz, 
2Xpyrrole ArH ), 7.40 (2H, d, 7=1.6 Hz, 2x pyrrole 
ArH), 8.06 (2H,s, ArH ), 8.17 (2H, t, 7=5.6 Hz, exch.,
5238 A. I. Khaiaf et al. /  Tetrahedron 56 (2000) 5225-5239
2xCON//-CH2), 8.28 (2H,d, 2=2.1 Hz, 2xAr//), 8.63 (2H, 
d, .7=2.0 Hz, 2XArtf), 9.05 (2H, d, 2=4.5 Hz, 2xArH ) ,  9.28 
(2H, br, exch., 2xNH +), 9.98 (2H, s, exch., 2XCON//), 
10.60 (2H, s, exch., 2XCON//J.
Using HATU/NM M : A mixture of 15a (25.6 mg,
0.0963 mmol), HATU (115 mg, 0.303 mmol), NMM 
(65 |jlL, 0.594 mmol) and dry DMF (1.5 inL) was placed 
under nitrogen and stirred at room temperature for 30 min. 
A 1.0 mL aliquot of the solution of the primary amine 
derived from 5a (100 mg, 0.289 mmol) above was then 
added, and the mixture was stirred at room temperature 
for 18 h. Yield 80.7 mg (73%).
Bisbenzothiophene-3,7~dicarboxamido{3-[l-methyl-4- 
(4-amino-l-methyl-pyrrole-2-carboxamido)pyrrole-2- 
carboxamido]-dimethylamimopropane} (26). (dm ap p y r r  
p y rr  db th i p y rr  p y rr  d m a p ) In 62% yield from 5a and 
bisbenzothiophene-3,7-dicarboxylic acid 11 using HBTU 
coupling. (Found: ES-MS: 929.8, 465.6; C.,8H56N|206S 
requires: (M +l) 929.85, f(M + 2)/2] 464.9). 5„ (DMSO- 
dfi): 1.82-1.86 (4H, qt, 2=6.8 Hz, 2xCH2); 2.78 (12H, s, 
2xNMe2); 3.04-3.08 (4H, t, 2=7.2 Hz, 2xCH2); 3.23- 
3.32 (4H, q, 2=6.8 Hz, 2xCH2); 3.83 (6H, s, 2xNMe 
pyrrole); 3.90 (6H, s, 2xNMe pyrrole); 6.96 and 6.97 (2H, 
d, 2=1.6 Hz); 7.15 (2H, d, 2=1.6 Hz); 7.19 (2H,d, 
2=1.6 Hz); 7.37 (2H, d, 2=1.6 Hz); 8.11 and 8.12 (2H, d, 
2=8.0 Hz); 8.14-8.18 (2H, t, 2=6.0 Hz,CONH exch); 8.59 
and 8.61 (2H, d, 2=8.0 Hz); 8.65 (2H, s); 9.30 (2H, broad, 




dimethylaminopropane} (27). (dm ap p y r r  p y r r  flu o p y r r  
p y rr  dm ap) In 45% yield from 5a and fluorenone-3,6-dicar- 
boxylic acid 12 using HBTU coupling. (Found: ES-MS: 
925.8, 462.7 C49H56NI20 7 requires (M +l) 926.1; [(M+2)/ 
2] 463.5). 8„ (DMSO-d(,): 1.81-11 (4H, qt, 2=8.0 Hz, 
2xCH2); 2.79 (12H, s, 2xMe,); 3.06-3.10 (4H, t, 2=
7.8 Hz, 2XCH2); 3.23-3.26 (4H, q, 2=6.4 Hz, CH2); 3.83 
(6H, s, 2Xpyrrole-Me); 3.89 (6H, s, 2Xpyrrole-Me); 6.96 
and 6.96 (2H, d, 2=1.6 Hz, ArH); 7.14 (2H, d, 2=1.6 Hz, 
ArH); 7.18 and 7.19 (2H, d, 2=1.6 Hz, ArH); 7.35and 7.36 
(2H, d, 2=1.6 Hz, ArH); 8.06 and 8.08 (2H, d, 2=8.4 Hz, 
ArH); 8.14-8.17 (2H, t, 2=8.4 Hz, 2xNH exch.); 8.27-8.28 
(4H, m, ArH); 9.27 (2H, broad, TFA exch.); 9.97 (2H, s, 
2xNH exch.); 10.56 (2H, s, 2XNH exch.).
l,4-Benzenedicarboxamido{ 3-f 1-Methy l-4-(4-amino-1 - 
methyl-pyrrole-2-carboxamido)pyrrole-2 carboxamido |- 
dimethylaminopropane} (28). (dm ap p y r r  p y r r  tere p y r r  
p y rr  dm ap) In 34% yield from 5a and terephthalic acid using 
HBTU coupling. (Found: ES-MS 824.0, 412.8;
C42H54N,20 6 requires: (M + l) 823.68, [(M+2)/2] 412.84); 
iw /cm  ' (KBr) 1680, 1642, 1538, 1267, 1200; SH 
(DMSO-dfc): 1.82-1.86 (4H, qt, 2=8.0 Hz, 2xCH2); 2.79 
(6H, s, 2xNMe); 2.80 (6H, s, 2xNMe); 3.05-3.10 (4H, m, 
2xCH2); 3.22-3.27 (4H, m, 2xCH2); 3.82 (6H, s, 2xNMe 
pyrrole); 3.88 (6H, s, NMe pyrrole); 6.95 and 6.96 (2H, 
d, 2=2.0 Hz); 7.12 and 7.13 (2H, d, 2=1.6 Hz); 7.18 
(2H, d, 2=1.6 Hz); 7.35 (2H, d, 7=1.6 Hz); 8.06 (4H, 
s); 8.14-8.17 (2H, t, 7=5.6 Hz, CONH exch.); 9.35
(2H, broad TFA exch.); 9.95 (2H, s, 2XCONH exch.); 
10.47 (2H, s, 2XCONH exch.).
Trans-cydopropane-1,2-dicarboxamido{3-[ 1 -methyl-4- 
(4-amino-l-methyl-pyrrole-2-carboxamido)pyrrole-2 
carboxamido]-dimethy!aminopropane} (30).f> (dm ap p y rr  
p y rr  cycp  p y r r  p y rr  dm ap) In 46% yield from 5a and trans- 
cyclopropane 1,2-dicarboxylic acid using HBTU coupling. 
(Found: ES-MS 787.0, 393.6. C39H54N,20 6 requires (M +l) 
787.65; [(M+2)/2] 394.5); r^^/cm'1 (KBr) 1682, 1649, 
1582, 1535, 1438, 1201; 3„ (DMSO-df)): 1.21-1.24 (2H, 
t); 1.81-1.85 (4H, qt, 7=7.9 Hz); 2.18-2.21 (2H, t, 7=
7.2 Hz); 2.77 (12H, s, 2xNMe2); 3.03-3.07 (4H, t, 7=
8.0 Hz); 3.21-3.26 (4H, q, 7=6.4 Hz); 3.81 (6H, s, 
2xNMe pyrrole); 3.82 (6H, s, 2xNMe pyrrole); 6.85 and 
6.86 (2H, d, 7=2.0 Hz); 6.92 and 6.93 (2H, d, 7=2.0 Hz);
7.15-7.17 (4H, dd, 7=1.6 Hz and 7=2.0 Hz); 8.12-8.15 
(2H, t, 7=5.6 Hz, CONH exch.); 9.50 (2H, broad TFA 




2-carboxamido]-dimethylaminopropane} (36). (dm ap  
im id im id  Hyphen im id im id dm ap) In 5% yield from 6 and 
dihydrophenanthrene-2,7-dicarboxylic acid 14 using HBTU 
coupling. (Found: ES-MS: 929.7, 464.8 GtfiHs^ NieOf, 
requires (M + l) 930.1 and [(M+2)/2j 465.5); i'rmui/cm 1 
(KBr) 1677, 1641, 1582, 1405, 1265, 1200; SH (DMSO- 
d6): 1.81-1.85 (4H, qt, 7=3.6 Hz); 2.79 (6H, s, 2xNMe2); 
2.77 (6H, s, 2xNMei); 2.92 (4H, s); 3.03-3.07 (4H, t, 
7=18.8 Hz); 3.21-3.26 (4H, q, 7=8.0 Hz); 3.97 (6H, s, 
2xNMe2 imidazole); 4.04 (6H, s, 2xNMe2 imidazole);
7.56 (2H, d, 7=4.8 Hz); 7.68 (2H, d, 7=4.4 Hz); 7.96-
8.07 (6H, in, ArH); 8.45-8.47 (2H, t, 7=6.0 Hz, CONH 
exch.); 9.27 (2H, s, TFA exch.); 9.41 (2H, s, CONH 
exch.); 10.88 (2H, s, CONH exch.).
9.10-Pihydrophenanthrene-2,7-dicarboxamido{ 3-[2-(4- 
amino-i-metliyl-pyrrole-2-carboxamido)thiazol-4-car- 
boxamidoj-dimethylammopropane} (37). (dm ap th ia p yrr  
Hyphen thia p y rr  dm ap) In 40% yield from 8 and dihydro­
phenanthrene 2,7-dicarboxylic acid 14 using HBTU 
coupling. (Found: ES-MS: 962.01, 481.90. C4iiH5f,Of,N12S2 
requires: (M +l) 962.20, [(M+2)/2] 481.60).); umJ c m  1 
(KBr) 1680, 1647, 1538, 1397, 1203, 1130; SH (DMSO- 
d6): 1.84-1.90 (4H, qt, 7=6.7 Hz, 2xCH2); 2.54 (6H, s, 
thiazole Me); 2.67 (6H, s, 2xNMe); 2.79 (6H, s, 2xNMe);
2.97 (4H, s, dihydrophenanthrene); 3.06-3.10 (4H, q, 
7=6.8 Hz, 2xCH2); 3.11-3.27 (4H, m, 2xCH2); 3.93 (6H, 
s, 2xNMe pyrrole); 7.45 (2H, s, pyrrole); 7.60 (2H, s, 
pyrrole); 7.92 (2H, s, ArH); 7.93 and 7.95 (2H, d, 
7=1.9 Hz, ArH); 8.05-8.11 (4H, s and t, 7=4.8 Hz, ArH 
and (CONH exch.}); 9.24 (2H, broad, exch.); 10.47 (2H, 
s, CONH exch.); 12.48 (2H, s, CONH exch.).
Phenanthrene-3,6-dicarboxamido{3-[glycyl-l-methyl-4- 
(4-amino-l-methyl-pyrrole-2-carboxamido)pyrrole-2- 
earboxamidol-diinethylaminopropane} (38). (dm ap p y rr  
p y rr  g ly  phen g ly  p y rr  p y r r  dm ap) In 49% yield from 5j and 
dihydrophenanthrene-3,6-dicarboxylic acid 15a using 
HBTU coupling. (Found: ES-MS: 1037.9 C^H^N^O^ 
requires (free base) (M + l) 1038.2 and [(M+2)/2J
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2519.6); vm;ix/crrT1 (KBr) 1678, 1647, 1582, 1534, 1266, 
1201; 8H(DMSO-d6) l.83(4H,m,2xCH2-CH 3-CH2) ,2.7.8 
( 12H, d, 7=2.8 Hz, becoming, s, after D20 , 2xNH+[CH3]2),
3.06 (4H, in, 2xN-CH 2-CH 2), 3.24 (4H, m, 2XN-CH2-  
CH2), 3.80 (6H, s, 2Xpyrrole NMe), 3.83 (6H, s, 2Xpyrro'le 
NMe), 4.13 (4H, d, 7=5.6 Hz, becoming, s, after DoO. 
2xNH-CH2-CO), 6.92 (2H, d, 7= 1.6 Hz, 2Xpyrrole 
ArH), 6.95 (2H, d, 7=1.6 Hz, 2Xpyrrole ArH), 7.15 (2H, 
d, 7=1.6 Hz, 2Xpyrrole ArH), 7.19 (2H, d, 7=1.6 Hz, 
2XpyiTole Ar//), 8.04 (2H, s, ArH), 8.16 (6H, m, becoming 
4H after D20 , 2xCONHCH2 plus 4xArH), 9.24 (2H, t, 
7=5.6 Hz, exch., 2xCONHCH^), 9.35 (2H, bs, exch., 
2XTFA), 9.48 (2H,s, 2xArH), 9.86 (2H, s, exch., 
2XCON//), 10.01 (2H, s, exch., 2XCONH).
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Synthesis of novel BSMA binding agents: 
indole-containing analogues of bss-netropsin 
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M olecular m od ellin g  s tu d ie s  sh o w e d  that in d ole  dicarboxylic ac id s are potentia l linkers for th e  sy n th esis  o f  b is- 
netropsin a n a lo g u es  w ith a g o o d  fit to  th e m inor g r o o v e  o f DNA. To te s t th is h y p o th esis , 2 -carboxyind ole-6-acetic  
acid, ind ole-2 ,6-d icarb oxyl ic acid, 6-(2-carb oxyelh y l)in dole-2 -carboxylic  acid, 6-{2-carboxy-1-ethenyl)indole-2-car- 
boxylic acid  w ere  prepared  and cou p led  to  3 -[1-m ethyl-4-(T m eth yl-4-am inopyrrole-2-carboxam id o)pyrrole-2-car- 
b o x a m id o jd im e th y ia m in o p r o p a n e . S im ilar ly  in d o le -2 ,5 -d ica rb o x y lic  acid  w a s  p rep ared  and co u p led  to
3-[1-m ethyl-4-(1 -m ethyl-4 -am in opyrrp le-2 -carboxam id o)pyrro le-2-carb oxam ido]prop ionam id ine hydrochloride. The  
derivatives o f 2 6 - 2 8  s h o w e d  e sp ec ia lly  strong  b inding to  AT rich reg ion s  as sh o w n  by footprinting studies.
./. Chem. Research (S), 
2000,264-265 
J. Chem. Research (M), 
2000,0751-0770
Oligomers o f  3-amino-N-methyl-5-carboxylic acid such as the 
natural products distamycin and netropsin have cytotoxic 
properties because o f their ability to bind to AT rich regions o f  
the minor groove o f DNA. In order to extend the available 
reading frame, several groups have prepared head to head 
linked dimers, known as bis-netropsins.1^ 1 Detailed molecular 
modelling studies7 showed that indole dicarboxylic acids 
would be good linking molecules. The selection of com ­
pounds for synthesis was made to include two substitution 
patterns and variation in length and rigidity o f one o f the side 
chains. This paper describes the synthesis o f four new bis- 
nctropsins o f this type'7' 11 the structures o f which are shown in 
F i g .  I-
; v
’w
S ch em e 1 Reagents: i CHCI3, RT.; ii N-methyl-4-2- 
trichloroacetylpyrrole, CHCI3
without further purification. 2-Carboxyindole-6-acetic acid 
(12) was treated with the amine (3b) using DCC as a coupling 
agent and DMAP as a catalyst. After purification by reverse 
phase HPLC the fractions containing the required material 
were freeze-dried immediately. The desired product 24 was 
obtained in a poor yield (13%) therefore an alternative cou­
pling agent was sought. HBTU was generally found to be 
superior to DCC in this series, as shown by the following reac­
tions. Coupling o f the amine 3b with the indole 20 gave rise 
to 25 in 52% yield, while coupling o f the dicarboxylic acid 18
'" ''T o t -'"
Fig. 1 Indole-linked head to head netropsin an a logu es pre­
pared in this work
The pyrrole oligomers (R, and R2, Fig. I) were prepared by 
adaptations o f published methods.12-15 The indole dicar­
boxylic acids were obtained from side-chain modification o f  
products o f Fischer indole synthesis as shown in Schemes 3 
and 4.
3a (Scheme 1) was hydrogenated in the presence o f pal- 
ladised charcoal at room temperature and atmospheric pres­
sure to give the amine 3b which was both air and light 
sensitive. Therefore this amine was used in the next reaction
To receive any correspondence.
U L  „
* x y
S ch em e 2 Reagents: i Pd-C, H2, DME, 40“C, ii 4-nitro-N 
m ethylpyrrole-2carbonyl chloride, Et3N, DME, Hi EtOH (dry), 
HCI (g); /VNH, (dry), EtOH; Pd-C, H„ EtOH, 60oC.
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Schem e 3 Reagents: i NaOAe, H20 , EtOH, 5-7°C;
/ / CH3C0CH2C 0 2Et, TsOH, benzene; /7/ NaOH, EtOH, reflux; 
iv HCI in HO Ac; v 1. KOH, EtOH, 2. HCI; vi pyridine N-oxide. 
Ac20 ; vii KMnO„, actone, H20 , 50°C; viii KOH, EtOH;
ix  pyridine, piperidine, m alonic acid, 50°C; 
x  (carbethoxym ethyl)triphenylphosphonium  brom ide, 
n-BuLi; x i Pd-C, H,.
produced 26 in 61% yietd. Coupling o f  16 gave 27 in 61% 
yield also. Compounds 24—27 were obtained as bis-TFA salts. 
Similar chemistry was used with the nitropyrrole 7a (Scheme 
2) to obtain 28, after purification by HPLC, in 29% yield as a 
bis-TFA salt with no distinct melting point. In this case, the 
DCC route was superior.
As described elsewhere, several o f these indole-containing 
netropsin analogues showed high affinity for AT rich regions 
of DNA. Compound 24 and compounds 26 -28  all bound par­
ticularly strongly as shown by ' ' g studies at I to 3
(.tM concentrations in the presence o f similar concentrations o f  
DNA. Compound 25, however, was a poor ligand.111 This 
result was not predicted by the design calculations7,10 and 
might be explained by a different conformation that does not 
fit the double helix well.
Received 15 February 2000; accepted 4 A pril 2000  
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N H -N = C —C O 2B
HO2C
" O ' *
Scheme 4 R eagents: i CH3C 0 C 0 2Et, HOAc, H20; ii ZnCI2 
heat; Hi 1. KOH, aq. EtOH; 2. HCI.
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Abstract— Mild reaction conditions are described For the preparation of a number o f 2-alkyl- and 2-arylarrtinobenzoxazoles and benzo- 
thiazoles from 2-chlorobenzoxazoie and 2-chIorobenzothiazole and (V-methyl or other simple Af-alkyl tertiary amines. The reaction proceeds 
neat or in THF solution and involves dealkylation o f the amine reactant by nucleophilic substitution by chloride. In the case of V-methyl- 
pyrrolidinc and /V-methylpiperidine demethylation was not observed and the major product was formed by ring opening to give chlorobutyl- 
and chloropentyl-methylainino substituted benzoxazoles and benzothiazoles. Treatment o f the chlorobutyl derivative with iodide in acetone 
afforded the new 1 H,2H,3HAH,5H-[ 1,31diazepitio[2,1-&][ l,3]benzoxazol-6-ium ring system. © 2000 Elsevier Science Ltd. All rights 
reserved.
As part of a programme of synthesis into minor groove 
binders for DNA,1 we required to prepare distamycin 
analogues with heterocyclic head groups. Accordingly 
2-chlorobenzoxazole was reacted with a distamycin 
analogue precursor that bore both a primary and a tertiary 
amine. Surprisingly, substitution to afford the corresponding 
aminobenzoxazole occurred at both amino groups with 
concomitant demethylation or de-ethylation of the tertiary 
amine.2 6 This unexpected reaction of the tertiary amines 
prompted us to investigate the generality of the reaction. 
Although the products of these reactions, /V,/V-dialkylamino 
benzoxazoles and benzothiazoles, have been prepared
before, most recently using high pressure, (see
Table 1 for further references) the reactions described 
here offer simpler and more direct routes to these 
compounds.
Treatment of 2-chlorobenzoxazole (la) with N -methyl- 
morpholine (2a) under reflux in THF (or neat at 130°C) 
afforded 2-/V-morpholinobenzoxazole (3a) in good yield 
(85%) after purification through a short column. In THF 
solution, 2-chlorobenzothiazole (lb) was much less reactive 
giving the corresponding morpholinothiazole (3b) in only 
8% yield. However in the absence of solvent a significantly 
increased yield (50%) was obtained. Concentration and 
temperature therefore seem to be important in this new 
reaction.
Keywords: 2-arylaminobenzoxazoles; 2-chlorobenzoxazole; 2-chloro- 
benzothiazole; dealkylation; [i,31diazepino[2,l-b][l,3]benzazoles.





1a X = 0 
1b X = S
The scope of this substitutive dealkylation reaction was 
studied to examine the influence of ring alkyl substitution 
in the tertiary amines. /V.A-Dimethylbenzylamine under­
went substitution with loss of the benzyl group to give 3d 
(87%) but A./V-dimethylaniline afforded 2-/V-methyl-Ar- 
phenylbenzoxazole (3f) in moderate yield (43%) with loss 
of the methyl group. Triethylamine reacted similarly to the 
other trialkylamines giving the diethylamino derivative 3e 
in 89% yield. On the other hand, dicyclohexylmethylamine 
and /V,A/-diethylaniline failed to react. These results and 
others (Table 1) show that the normal effects of reactivity 
in nucleophilic substitution are followed. Attack of the 
nucleophile on the aryl halide is subject to steric hindrance 
and substitution is preferred at benzylic sites.
The reaction mechanism suggested by these observations 
(Scheme 1) involves initial addition of the tertiary amine 
to the heteroaryl chloride giving an adduct with a positively 
charged nitrogen atom. Instead of chloride acting as a 
leaving group, the adduct decomposes by nucleophilic 
substitution with the quaternary ammonium salt acting as 
a leaving group. Once chloride has been formed in the 
aprotic reaction mixture, it is a potential nucleophile leading 
to alkyl chlorides as the by-products. Benzyl chloride was 
indeed detected from the 'H NMR signal at S 4.6 in the
0040-4020/00/$ - see front matter © 2000 Elsevier Science Ltd, AU rights reserved. 
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Table 1. Synthesis of 3 from 2-chlorobenzoxazole (or 2-chlorobenzothiazole) and tertiary amines
Entry Product X R1 R2 r ' Yield% Mp (°C)
1 3a O Morpholino CH, 80 92-95“
2 3b s Morphotino CH, 50 122-125"
3 3c o CH, CH, CH2Ph 87 89-9 P
4 3d s CH, CH, CHjPh 72 84-86"
5 3c o CH,CH, CH2CH, CHjCH, 89 Oil415
6 3f 0 CH, Ph CH, 43 Oil8
7 3g o Pyrrotidino CH, 7C 134— 135f
8 3h s Pyrrolidino CH, 7C 96-98s
9 3i o Piperidino CHjCH, 86 72-73"
10 3j s Piperidino CHiCH, 41 90-91'
11 3k s CH, Ph CH, 17 Oil'
“ Lit.13 mp 88-89°C.
" Lit.1'1 mp 126-127°C.
1 L it." mp 88-89°C.
*' L it." mp 84-86°C.
L Indicates that the major product was a ring opened derivative (see below). 
'Lit.'; mp 136-137°C.
8 Lit.1* mp 98-100°C.
" Lit.17 mp 7 0 -7 1°C.
' Lit.7 inp 93-95°C.
1 Lit.18 mp 66-67°C.
}  Cl h 3c - n  o  
N0
Scheme 1. Proposed mechanism of dealkylative substitution.
reaction mixture with benzyldimethylamine as substrate and 
the increase of the alkyl chloride was followed during the 
course of the reaction. The action of chloride and bromide as 
nucleophiles in substitution reactions of ammonium salts, 
sulphonium salts, and oxonium salts is well known. It is also 
possible that attack by chloride on the methyl group is 
internal, i.e. the two stages are concerted, a reasonable 
suggestion because of the proximity of the departing 
chloride and the adjacent polarised C-N bond.
Me-zO
A further unusual observation was made. When the products 
of the reactions of 2-chlorobenzoxazole and 2-chloro­
benzothiazole with /V-methylpyrrolidine or /V-ethylpynoli- 
dine were purified, a second product was isolated along with 
the expected adducts 3g and 3h. The new products 
contained covalently bound chlorine and the methyl group 
was still present; they were insoluble in water and clearly 
not salts. In the case of the compound derived from 
/V-methylpyrrolidine, high resolution mass spectroscopy 
established the molecular formula C^HigClNjO. The l3C 
NMR spectrum showed four distinct methylene groups 
deriving from the pyrrolidine ring suggesting that the ring 
opened structure 4 (Scheme 2) represented the new 
compound. This suggestion was also consistent with the 
long range couplings shown by COSY experiments; an 
interaction between the /V-rnethyl protons (5 3.20) and the 
methylene protons (S 3.68) was observed. What is not easily 
understood is that this reaction is strongly favoured in the 
case of pyrrolidine. A small amount of the analogous 
product was characterised from the reaction of /V-ethyl- 
piperidine and 2-chlorobenzoxazole but in other cases no 
ring cleavage product was detected, although it may have 





Scheme 2. Proposed mechanism of formation of ring opened products and further cyclisation.
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release of chlorine from the oxazole ring and attack on the 
pyrrolidine carbon is a concerted process, which may be 
sterically favoured in the five-membered ring. To confirm 
the presence of the chloromethyl group, compound 4 was 
treated with sodium iodide in acetone at room temperature. 
This surprisingly led to the formation of a new fused 
heterocyclic system, 1 -Methyl- IH, 2H, 3H, 4//, 5H- 
[l,3]diazepino[2,l-bj[l,3]benzoxazol-6-ium iodide, 5. 
Evidence for this structure comes from the water solubility 
of 5 and the downfield shift of the methylene protons (SH 
3.68-4.02 and 4.48) and carbons (Sc 44.48 and 49.55 
47.14 and 54.48) and /V-methyl protons (SH 3.20-3.50) 
and carbons (Sc 35.42-41.97). Symmetrical structures 
such as pyrrolidinium salts are ruled out (Scheme 2).
Recently, further reactions under high pressure have been 
described for the preparation of 4-dialky 1-aminopyridines.19 
It would be interesting to discover whether milder condi­
tions such as those described here would be successful in 
that case also.
Experimental
The majority of compounds prepared by the new route have 
been described before. Physical constants for compounds 
obtained and literature comparisons are given in Table 1. 
Spectroscopic data are reported below with the preparative 
details. IR spectra: solids were nan as KBr discs and liquids 
as films, using a Nicolet Impact 400D. Low- and high- 
resolution (EI-MS) mass spectra were obtained on a Jeol 
JMS-AX505HA mass spectrometer. NMR spectra were 
obtained on a Bruker AMX 400 spectrometer operating at 
400 MHz for 'H and 100.6 MHz for l3C. Column chromato­
graphy was performed with silica gel Prolabo (200-400 
mesh).
2-/V-morphoIinobenzoxazole (3a).13 /V-Methylmorpholine 
(329 mg, 3.256 mmol) was dissolved in THF (20 mL, dry) 
I to which 2-chlorobenzoxazole (504 mg, 3.256 mmol) was 
added at room temperature with stirring. The reaction 
mixture was heated under reflux for 3 h then the solvent 
removed under reduced pressure at 50°C. The residue was 
dissolved in a small amount of ethyl acetate and applied to a 
j silica gel column. Ethyl acetate/n-hexane (1:1 v/v) was used 
to elute the product, which was obtained as a pale yellow 
solid (529 mg, 80%); S„ (CDCL): 3.62-3.65 (4H, t, 
7=4.8 Hz, CH2-N -C H 2); 3.83-3.86 (4H, t, 7=4.8 Hz, 
CH2-0 -C H 2); 7.06 (IH, dt, 7=1.2 and 7.8 Hz, ArH);
7.19 (IH, dt, 7=1.2 and 7.8 Hz, ArH); 7.26 (IH, d, 
7=7.8 Hz, ArH); 7.38 (IH, d, 7=7.8 Hz, ArH). nmav: 
1670, 1580, 1461, 1290, 1108, 763, 744 c m 1.
2-/V,/V-dimethylaminobenzoxazole (3c).11 /V,/V-Di methy L 
benzylamine (507 mg, 3.750 mmol) and 2-chlorobenzoxa­
zole (576 mg, 3.750 mmol) were heated at 130°C for 3 h. 
The reaction mixture was left to cool to room temperature 
then the crystalline mass was dissolved in hot ethyl acetate 
and applied to a silica gel column. The required benzoxa- 
zole (3c) was obtained as white crystalline material by 
elution with ethyl acetate/n-hexane (1:1 v/v) (527 mg, 
87%). SH (CDCL): 3.21 (6H, s, NMe2); 7.00 (IH, dt, 
7=1.2 and 7.7 Hz, ArH); 7.16 (IH, dt, 7=1.2 and 7.8 Hz,
ArH); 7.25 (IH, d, 7=7.8 Hz, ArH); 7.36 (IH, d, 7=7.8 Hz, 
ArH). Sc (CDCL): 37.65, 108.55, 115.98, 120.16, 123.82,
143.58, 149.07, 163.05. i w  1665, 1588, 1462, 1426, 901, 
745 cm. ”1
Similarly the following compounds were prepared.
2-/V-Morpholinobenzothiazole (3b).14 As a pale yellow 
crystalline solid (50%); SH (CDCL): 3.64 (4H, t, 
7=4.8 Hz, CH,NCH2); 3.85 (4H, t, 7=4.7 Hz, CH2QCH2); 
7.11 (IH, dt, 7=1.2 and 7.4 Hz, ArH); 7.32 (IH, dt, 7=1.2 
and 7.4 Hz, ArH); 7.58 (IH, d, 7=7.4 Hz, ArH); 7.62 ( IH, d, 
7=7.4 Hz, ArH). v mm: 1596, 1562, 1539, 1443, 1291, 1116, 
759, 727 cm '1. HREIMS: found 220.066. Calculated for 
C,|H12N,OS 220.067,
2-/V,/V-DimethylaminobenzothiazoIe (3d).13 As a white 
crystalline solid (72%). 5H (CDCL): 3.21 (6H, s, NMe2);
7.06 (IH, dt, 7=1.2 and 7.4 Hz, ArH); 7.29 (IH, dt, 7=1.2 
and 7.4 Hz, ArH); 7.57 (IH, d 7=7.4 Hz, ArH); 7.60 (IH, d, 
7=7.4 Hz, ArH). Sc (CDC13): 40.40, 118.99, 120.81, 
121.10, 126.13, 131.34, 153.47, 168.99. v m, x: 1599, 1574, 
1546, 1453, 1416, 1295, 750, cm '1.
2-AyV-DiethyIaminobenzoxazole (3e).415 As a colourless 
oil (89%). S„ (CDCL): 1.27-1.31 (6H, t, 7=7.1 Hz, 
NCH2CH3); 3.57-3.62 (4H, q, 7=7.1 Hz, NCH2CH3); 
6.96-7.01 (IH, dt, 7=1.1 and 7.8 Hz, ArH); 7.12-7.16 
(IH, dt, 7=1.1 and 7.8 Hz, ArH); 7.25 (IH, d, 7=7.8 Hz, 
ArH); 7.36 (IH, d, 7=7.8 Hz, ArH). 8 C (CDCL): 13.44,
42.91, 108.45, 115.77, 119.89, 123.73, 143.65, 148.81, 
162.20. v m.M: 2968, 2937, 1647, 1580. 1466, 1399, 1251, 
784,761,748 cm '.
2-/V-Methyl-/V-phenylaminobenzoxazo!e (31).K As a
colourless oil (43%). 8 n (CDC13): 3.64 (3H, s, NMe); 
7.03-7.08 (IH, dt, 7=1.1 and 7.8 Hz, ArH); 7.18-7.22 
(IH, dt, 7=1.1 and 7.7 Hz, ArH); 7.25-7.31 (2H, m, 
ArH); 7.42-7.48 (5H, m, ArH). 8 C (CDC13): 39.04, 
108.94, 116.66, 121.07, 123.99, 124.43, 126.02, 129.24, 
142.76, 142.95, 148.74, 161.26. vmiix: 3063, 2940, 1632, 
1570, 1503, 1380, 1246, 1138, 755, 747, 701 cm '.
Reaction of /V-methylpyrrolidine and (la): formation of 
/V-(4-chlorobutyl)-/V-methylaminobenzoxazole. 2-Chloro- 
benzoxazole (460 mg, 3.0 mmol) and /V-methylpyrrolidine 
(260 mg, 3.0 mmol) were dissolved in THF (20 mL, dry). 
The reaction mixture was heated under reflux for 6 h. The 
solvent was removed under reduced pressure and the residue 
purified by column chromatography on silica eluted with 
ethyl acetate/n-hexane (1:20 v/v). The first fraction 
(compound of type 4, /V-(4-chlorobutyl)-/V-methyIamino- 
benzoxazole) was obtained as a colourless oil (617 mg, 
86%). SH (CDCL): 1.85 (4H, m, (CH2)2CH2N); 3.20 (3H, 
s, NMe); 3.68 (4H, m, CH2C1 and CH2N); 7.01 (lH,dt, 
7=1.2 and 7.8 Hz, ArH); 7.15 (IH, dt, 7=1.2 and 7.8 Hz, 
ArH); 7.26 (IH, d, 7=7.8 Hz, ArH); 7.36 (IH, d, 7=7.8 Hz, 
ArH). Sc (CDCL): 24.78, 29.48, 35.42, 44.48, 49.55,
108.55, 115.96, 120.18, 123.85, 143.45, 148.85, 162.65. 
*W  2956, 2867, 1598, 1567, 1544, 1447, 1293, 753, 
727 cm HREIMS: found 238.087, calculated for 
C|2H|5N20 33C1 238.087, and found 240.086 calculated for 
C,2H|3N20  37C1 240.086.
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The second fraction was obtained as white solid material 
(40 mg, 7%), identified as 3 g 9 SH (CDCL): 2.05 (4H, t, 
7=8 Hz, (C//2)2CH2N); 3.66 (4H, t, 7=4.0 Hz, C//2N); 
6.99 (IH, t, 7=7.8 Hz, ArH ); 7.15 (IH, t, 7=7.8 Hz, Ar//); 
7.26 (IH, d, 7=7.8 Hz, Ar//); 7.36 (IH, d ,7=7.8 Hz, Ar//). 
Sc (CDC13): 25.58,47.40, 108.55, 115.95, 120.04, 123.81,
143.58, 149.00, 160.98. j w  2922, 1642, 1584, 800, 760, 
740 cm-1.
Reaction of A-ethylpiperidine and (la): /V-(4-chloro- 
pentyl)-/V-ethylaminobenzoxazole. 2-Chlorobenzoxazole 
(460 mg, 3.0 mmol) and 1-ethylpiperidine (679 mg,
6.0 mmol) were dissolved in THF (20 mL, dry). The reac­
tion mixture was heated under reflux for 24 h. The solvent 
was removed under reduced pressure and the residue puri­
fied by column chromatography eluted with ethyl acetate/n- 
hexane (1:9 v/v). The first fraction was obtained as a white 
solid which was identified as 3i,17 (519 mg, 86%). SH 
(CDCL): 1.73 (6H, m, 3xC//2); 3.71 (4H, m, C//2N); 7.04 
(IH, dt, 7=1.2 and 7.8 Hz, Ar//); 7.19 (IH, dt, 7=1.2 and
7.8 Hz, Ar//); 7.28 (IH, d, 7=7.8 Hz, Ar//); 7.39 (IH, d, 
7=7.8 Hz, Ar//). 5C (CDCL): 24.08, 25.24 (2xC); 46.62 
(2xC); 108.54, 116.00, 120.26, 123.82, 143.39, 148.71, 
162.47. t w  2941, 2854, 1643, 1576, 1454, 1275, 792, 
754, 743 cm' '. A second fraction (compound of type 4, 
/V-(4-chloropentyl)-/V-ethylaminobenzoxazole) was obtained 
as a colourless oil (55 mg, 7%). SH (CDCL): 1.27-1.31 (3H, 
t, 7=7.1 Hz, CH2C/73), 1.49-1.58 (2H, m, C//2), 1.69-1.77 
(2H, m, C//2), 1,82-1.89 (2H, qt, 7=6.7 Hz, C//2), 3.51 (2H, 
t, 7=7.4 Hz, C//>N), 3.53 (2H, t, 7=6.7 Hz, C//2C1), 3.57 
(2H, q, 7=7.3 Hz, NC/FCH3), 6.99 (IH, dt, 7=1.2 and
7.8 Hz, Ar//), 7.15 (IH, dt, 7=1.2 and 7.8 Hz, ArH), 7.27 
(IH, d, 7=7.8 Hz, Ar//), 7.34 (IH, d, 7=7.8 Hz, ArH). 8 C 
(CDCL): 13.29, 24.09, 27.54, 32.30, 43.47, 44.80, 48.01, 
108.53, 115.89, 120.04, 123.83, 148.82, 162.47. nmiix: 
2939, 1649, 1585, 1462, 760, 745 cm '. HREIMS: found 
266.119, calculated for C14H19N20 35C1 266.119; and found 
268.116, calculated for C14H,9N20 37C1 268.116.
Reaction of (lb) with /V-methylpyrrolidine: formation of 
/V-(4-chIorobuty!)-/V~methy!aminobenzothiazole. The
same experimental procedure as above was employed to 
give two products eluted with ethyl acetate/petroleum 
ether (1:3 v/v). The first fraction (compound of type 4, 
/V-(4-chlorobutyl)-/V-methylaminobenzothiazole) was obtained 
as a colourless oil (83%). SH (CDCL): 1.82-1.85 (4H, m, 
2xC//>), 3.18 (3H, s, NMe), 3.56-3.59 (4H, m, NCH2 and 
C/LC1), 7.06 (IH, dt, 7=1.2 and 7.8 Hz, Ar//), 7.29 (IH, dt, 
7=1.2 and 7.8 Hz, ArH ), 7.55 (IH, d, 7=7.8 Hz, ArH ), 7.59 
(IH, d, 7=7.8 Hz, ArH ). 8 C (CDCL): 24.84, 29.84, 38.14, 
44.78, 52.47, 118.97, 120.77, 121.14, 126.13, 131.04, 
153.37, 168.50. vma)t: 2956, 2867, 1598, 1544, 1447, 1293, 
754, 727 cm 1. HREIMS: found 254.065 calculated for 
Ci2H,sN2S35C1 254.064; and found 256.063 calculated for 
C,2HI5N2S37C1 256.063. The second fraction (3h) was 
obtained as a white solid (7%).16 SH (CDCL): 2.05 (4H, t, 
7=8.0 Hz, 2XCH 2)\ 3.66 (4H, t, 7=4.0 Hz, 2XNC//?); 7.03-
7.06 (IH, dt, 7 = i.l and 7.8 Hz, Ar//); 7.27-7.31 (IH, dt, 
7=1.1 and 7.8 Hz, Ar//); 7.57-7.61 (2H, m, ArH). 8 C 
(CDCL): 25.88, 49.71, 118.91, 120.88, 126.12, 131.96,
153.55, 165.58. t w  2922, 1642, 1583, 1459, 761 cm"1.
2-Piperidinobenzothiazolc (3j). 2-Chlorobenzothiazole
(504 mg, 2.971 mmol) and /V-ethylpiperidine (1.009 g,
. 8.913 mmol) were heated at 130°C for five days. Excess 
reagent was removed under reduced pressure and the 
crude product was applied to a column chromatography. 
Ethyl acetate/n-hexane 1/10 was used to elute the product 
which was obtained as pale yellow crystalline material (3j) 
(266 mg, 41% yield), /?f=0.33. 8,., (CDC13): 1-68 (6H, br s, 
3xC//->); 3.56 (4H, br s, C//2NC/F); 7.03-7.07 (IH, dt, 
7=1.1 and 7.8 Hz, Ar//); 7.26-7.31 (IH, dt, 7=1.1 and
7.8 Hz, ArH); 7.55-7.59 (2H, m, ArH). 8 C (CDCL): 
24.67, 25.71 (2XC), 50.02 (2xC), 119.21, 120.97, 121.44, 
126.26, 131.12, 153.42, 169.25. um, x: 2945, 2924, 2846, 
1593, 1561, 1535, 1444, 1261, 762, 732 cm"’.
2-/V-methyl-/V-phenylaminobenzothiazole (3k).18 The 
same procedure for the synthesis of (3f) was employed to 
give the product as a colourless oil. 8H (CDClj): 3.66 (3H, s, 
NMe); 7.09 (IH, dt, 7=1.1 and 7.8 Hz, ArH); 7.30-7.52 
(7H, m, ArH); 7.66 (IH, d, 7=7.8 Hz, ArH). Sc  (CDCL):
40.59, 119.36, 120.60, 121.88, 126.00, 126.12 (2xC),
127.55, 130.06 (2XC), 131.33, 145.96, 152.78, 168.37.
3063, 1593, 1521, 755 c m 1.
l-Methyl-l//,2//,3//,4//,5//-[l,3]diazepino[2,l-8][l,3]benz- 
oxazo!-6-ium iodide (compound of type 5). /V-(4-chloro- 
butylHV-methylaminobenzoxazole (20 mg, 0.084 mmol) 
was dissolved in dry acetone (5 mL) to which was added 
anhydrous sodium iodide (25 mg, 0.10 mmol). The solution 
was heated under reflux for 8 h and allowed to cool to room 
temperature. The sodium chloride precipitate was filtered 
and the solvent evaporated to dryness under reduced pres­
sure, to afford the product as a white solid (25 mg, 90%). 
mp>240°C. 8,, (CDCL): 2.27-2.39 (4H, m, 2xC//2), 3.50 
(3H, s, NMe), 4.02 (2H, t, 7=5.6 Hz, NCH2), 4.48 (2H, t, 
7=5.6 Hz, N+CH 2), 7.31-7.36 (IH, m, ArH ), 7.39-7.47 
(3H, m, ArH ). 8C (CDCL): 24.60, 24.42 (CH2-CH2),
41.97 (NM e), 47.14 (NCH2), 54.48 (N+CH2), 111.46,
111.91, 125.54, 126.67 (CH of Ar), 131.92, 144.35 (C of 
Ar), 158.6 (N"=C-0(N)). HRFABMS Found 203.11834 
(95%, base peak), calculated for C12H15N20  203.11844 
(M+ —F ). i/max 1685, 1480, 1400, 1267, 1164, 758 cm-1.
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A Method for the Determination of Substitution Pattern in Coumarins 
using a Lanthanide Shift Reagent
B y  A l e x a n d e r  I. G r a y , R o g e r  D. W a i g h , '1' a n d  P e t e r  G. W a t e r m a n  
{Departm ent o f Pharm aceutical C hem istry, U niversity o f  Strathclyde, Glasgow, G1 1XW )
S u m m a ry  T he n .tn .r. sh if t rea g e n t tris-(7 ,7 -d im ethy l- w here  6  is th e  O -E u - H  bond  ang le a n d  R  th e  H - E u  
1,1, l,2 ,2 ,3 ,3 -hep tafluo ro -oc tane -4 ,6 -d ionato )eu rop ium (n i) d is tance .
[E u (fod)a] com plexes w ith  th e  ca rb o n y l o x y g en  o f cou- T h e  co n s ta n t can  be ignored  since i t  is th e  sam e fo r all
m a rin s  so t h a t  all sh ifts  c a n  be  re la te d  to  a  p o sition  fo r th e  p ro to n s  w ith in  th e  m olecule. C alcu la tion  of va lues  of 
eu rop ium  atom  in th e  p la n e  of th e  rin g  a n d  on  th e  3-H  s ide (3 cos20 — 1)/ R 3 fo r each  p ro to n  th e n  gives ra tio s  of sh ifts
o f th e  C = 0 b o n d ; re la tiv e ly  la rge  sh ifts  a re  p ro d u ced  fo r w hich  in m an y  cases will fit only one likely  s tru c tu re . In
a n  8 -substituen t, an d  in fo rm atio n  a b o u t  o th e r  sub- all cases exam ined  so fa r  <fi =  150 ± 10° an(l  d — 3 dt
s t i tu e n t  positions can  b e  o b ta in ed . 0-5 A.
M a n y  coum arins h av e  been iso la ted  from  p la n ts  an d  a l­
th o u g h  m odern  techn iques  allow  rap id  id e n tifica tion  of 
a t ta c h e d  groups, th e  s u b s titu tio n  p a t te rn  o n  th e  benzene 
r in g  m a y  be d ifficult to  de term ine . O th ers  h av e  a t te m p te d  
to  c o rre la te  th e  su b s t itu t io n  p a t te rn  em pirica lly  w ith  such  
d a t a  as u .v . ab so rp tio n 1 an d  chem ical sh ift,1 •* an d  non- 
em pirica lly , w ith  long-range coup ling  c o n s ta n ts2 an d  
in te rn a l nuc lea r O verhauser effects.3 T he la t te r  is ce rta in ly  
th e  m o s t pow erful te ch n iq u e  b u t  is te chn ica lly  m ore 
d ifficu lt and  less accessible.
(1) R1 =0Me, R2=H
(2) R1 =Hi R2=0Me
F ig u r e
N orm ally  th e  use of a  la n th a n id e  s h if t re a g e n t to  differ­
e n t ia te  isom ers requ ires th e  th ree -d im en sio n a l location  of
W e have ta k en  as an  exam p le  th e  resu lts  fo r tw o  isom eric 
m e thoxy fu ranocoum arin s , x a n th o to x in  (1) and  b erg ap ten  
(2), w hose s tru c tu re s  h av e  been  d e te rm in ed  by  syn th es is .6 
T h e  observed  an d  ca lcu la ted  sh ifts  a re  given in th e  Table, 
w ith  th e  values fo r </> a n d  d  o b ta in ed  by  tria l, f  rom  u.v. 
sp ec tra  b o th  m u s t be linear. T h e  ca lcu la ted  sh ifts  for th e  
m e th o x y s  w ere o b ta in ed  in th e  m a x im a lly  ou t-o f-p lane 
conform ations, w hich  co rrespond  to  m in im um  steric  in te r ­
ac tio n s  in  th e  stereom odels.
T a b l e
S h ifts /p .p .m .: observed (calculated)
Compound f  d (A) |3-H 4-H 5-H 8-H 2 ' H 3 '-lI OMe
(1) 145 2-75 1(1) 0-25(0-28) 0-20(0-18) —  0-10(0-10) 0-11(0-10) 0-29(0-20)
(2) 158 3-45 1(1) 0-34(0-33) — 0-30(0-32) 0-11(0-09) 0-12(0-11) 0 14(0-13)
th e  la n th an id e  a tom  in th e  com plex , a  p rocess needing  a  
c o m p u te r  to  ach ieve a  'b e s t fit' w ith  th e  observed  sh ifts .4 
In  th e  p re sen t w ork  w e h av e  s tr iv e n  fo r a  s im p le r p rac tica l 
ap p ro a c h  by  reducing  th e  p rob lem  to  tw o  dim ensions, 
reg ard in g  th e  coum arin  rings as  p la n a r  a n d  assum ing  co­
p la n a r ity  w ith  th e  eu rop ium  atom . In  th is  w ay  i t  is easy  to  
fix th e  bond  angle (</>, F igure) and  O -E u  d is ta n ce  (d. F igure) 
u s ing  a  field m ap 5 w hich effec tive ly  gives lines of equa l 
induced  sh ift a ro u n d  th e  la n th an id e  a to m . T h e  coum arin  
3 -H  is sh ifted  m ost, a n d  th e  sh ifts  o f th e  o th e r  p ro to n s  a re  
m o s t conven ien tly  expressed  re la tiv e  to  s h if t (3H) =  1. 
W ith  these  ra tio s  m easured , a  stereom odel o f th e  coum arin  
m a y  be placed  on th e  (su itab ly  scaled) field m ap , to  give 
v alues  o f if> an d  d  w hich can  be used  to  m easu re  0 an d  R  for 
s u b s titu tio n  in  th e  M cConnell—R o b ertso n  eq u a tio n 4
. 3 cos2fl — 1
Av (Eu) =  ------— -------  x  c o n s ta n t
T h e  O -M e sh if t in  x a n th o to x in  is so large th a t  th e  
m e th o x y  can  o n ly  be in th e  8-position  of th e  coum arin  and  
in  b e rg ap ten  th e  sh ifts  c learly  d em o n s tra te  th a t  the  8- 
p o sitio n  is unsubstitu tec l.
In  view  of th e  good co rre la tio n s  c o n ta c t sh ifts  can  be 
ignored , as  can  com plexation  w ith  e th e r  oxygens, b u t 
obviously- in com pounds w ith  m ore  pow erfu l com peting  
com plexation  sites th e  sim ple a p p ro ac h  can  on lv  be m a in ­
ta in ed  b y  m ask ing  th e  a lte rn a t iv e  e lec tron  donors. W e 
h a v e  found, for exam p le , th a t fo rm ation  of th e  trim eth y ls ily l 
e th e r  is an  effec tive w ay  of p rev en tin g  in te rac tion  w ith  th e  
side-chain  -O H  g roups com m only  enco u n te red  in n a tu ra lly  
occu rring  coum arins.
O ur confidence in th e  g ene ra lity  of o u r m e thod  is based on 
ex p e rim en ts  using E u (fod )s w ith  6 -m ethy lcoum arin , hern i- 
a r in ,7 4 -m e thy lhe rn ia rin , im p e ra to rin 7 an d  x an th o x y le tin .7 
S everal ad d itio n s  of E u(fod)3 w ere used for each  com pound , 
a n d  th e  re la tiv e  sh ifts  o b ta in ed  g rap h ica lly  w here possible.
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W e have used  th e  m ethod  as  an  aid8 in resolv ing  th e  final W e th a n k  th e  U n iv ers ity  of S tra th c ly d e  fo r a  g ra n t (to
un ce rta in tie s  concern ing  th e  s tru c tu re  of av icenn in .” A .I.G .).
V aria tio n s  in  <f> and  d  m ake s tr ic t com parison  betw een 
com pounds difficult, b u t  th e  sh ifts  fo r sim ila r su b s titu e n ts
a re  alw ays 3 l > i >  4 ~ 8 > 5 ~ 7 > - 6 .  (Received,, 26th A p r i l  1974; Com. 470.)
1 B. E. Nielsen, Dansk Tidsskr. Farm., 1970, 44, 111.
2 W. Steck and M. Mazurek, Lloydia, 1972, 35, 418.
*T. Tom imatsu, M. Hashimoto, T. Shiugu, and K. Tori, Chem. Comm., 1969, 168.
1 The whole field of lanthanide shift reagents has recently been reviewed: A. F. Cockerill, G . C. O. Davies, R. C. H arden, and D. M. 
Rackliam, Chem. Rev., 1973, 73, (6), 653.
6 R. M. Wing, T. A. Early, and J . j .  Uebel, Tetrahedron Letters, 1972, 4153.
8 F. M. Dean, ‘N aturally Occurring Oxygen Ring Compounds,1 Butterw orths, London, 1963, pp. 198—208.
7 For structures and o ther d a ta  see ref. 1.
8 A. I. Gray, R. D. Waigh, and P. G. W aterm an, in preparation.
8 H. R. A rthur and W. D. Otlis, J . Chem. Soc., 1963, 3910.
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Avicermo8: a New Pyranocoumarin from the Root-bark of Zanthoxylum  
avicennae. and its Conversion into Avicennin
By A lexander I. Gray, R oger D. W aigh ,' and P eter G. W aterm an, Department of Pharmaceutical Chemistry, 
University of Strathclyde, Glasgow G1 1XW
A new angular pyranocoumarin. avicennol (4) {6-(3-hydroxy-3-methyl-tra/)s-but-1-enyl)-5-methBxy-2,2- 
dimethyl-2hf-benzo[1.2-b:3,4-6']dipyran-8-one}, has been isolated from the root-bark of Zanthoxylum avicennae 
(R utaceae): the structural assignment is based on chemical and spectral evidence. A lanthanide shift reagent 
and the internal nuclear Overhauser effect have been used to differentiate between possible isomers. Avicennol 
has been converted into avicennin, previously reported from this and other species; thus the total structure of 
avicennin is determined. From this species avicennin may be an artefact.
P r e v io u s  examinations of the root-bark of Zanthoxylum  
avicennae (Lam.) DC (family Rutaceae; sub-family 
Rutoideae) yielded the fiavonoid glycosides hesperidin 
and diosmin,10 the benzophenanthridine alkaloid avi- 
cine,,& and a novel pyranocoumarin, avicennin.1' The 
structure of avicennin was partially defined by Arthur 
and Ollis,2 leaving three possible isomers (I)—(3). 
Avicennin has also been isolated from a second rutaceous 
species, Eriostemon coccmeus C. A. Gard.3 We now 
report the isolation and structural elucidation of a novel 
coumarin, avicennol (4), from the root-bark of Zanth-
■ (a) H . R. Arthur, W. L. H ui, and C. N. Ma, / .  Chem. Soc.. 
1956. 632; (6) H. R. A rthur, W. H . Hui, and Y . L. Ng, ibid.. 1959, 
4007; (c) If. R. A rthur and C. M. Leo, ibid., 1960, 4654.
oxylum avicennae and confirm the structure of avicennin 
as (2) by its synthesis from avicennol.
The light petroleum extract of the ground root-bark 
gave, on cooling, a high yield (2-3%) of yellow crystalline 
material which proved to be a single compound (t.l.c.). 
U.v. and i.r. spectra indicated that the compound pos­
sessed a coumarin nucleus,4 probably having extended 
conjugation and with a non-plienolic hydroxy-group. 
Elemental analysis and accurate mass measurement gave 
the molecular formula C20H22O8. The mass fragment-
“ H . R. A rthur and W. D. Ollis, J .  Chem. Soc., 1963, 3910.
3 P. W. Chow, A. M. Duffield, and P. R. Jeffries, Austral. J .  
Chem., 1966, 10. 483.
* B. E. Nielsen, Dansh Tidsskr. Farm., 1970, 44. 111.
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ation pattern was simple and suggested only loss of water 




viously 8 was used, and the best fit was obtained between 
observed and calculated shifts for values of <j> (the 
C -O -Eu angle) =  152-6° and d  (the O -E u distance) =
2-75 A. This gave exactly the observed shift for the H-4 
(0-31), relative to H-3 * (1-00, b y  defin ition8) and 
reasonable values for all other shifts. W e give in detail 
only the observed shifts for the side-chain olefinic protons
MeO
(4) R = H
(5) R = S iM e , [ 6  )
The n.m .r. spectrum defined all tw enty-tw o protons. 
The occurrence of an AB quartet (J  10 Hz) w ith one half 
downfield a t 8 8-06 confirmed the presence of the a|3- 
unsaturated S-lactone ring of the coumarin nucleus.4,6 
A second A B quartet (J  10 Hz) and a signal for gem- 
methyl groups at 8 T48 indicated the presence of the 2,2 - 
dimethylchromen ring system  encountered in pyrano- 
coumarins.® A three-proton singlet at 8 3-80 indicated  
the presence of a m ethoxy-substituent, leaving only  
hydroxy- and b*a»s-olefinic (J  16 Hz) protons and tw o  
further gew-m ethyl groups unaccounted for. As one of 
the two remaining positions on the benzenoid ring of the  
pyranocoumarin m ust be filled b y  the m ethoxy-group  
these signals can only be attributed to a single unit 
C6H90 . This can be accounted for by the unusual 3- 
hydroxy-3-m ethyl-fratts-but-l-enyl side-chain previously  
encountered only by Chan et a l?  in ehromones from the 
rutaceous plant Spathclia sorbifolia  L. Despite the  
helpful n.m.r. spectrum of avicennol there remained 
twelve possible isomers varying in the positioning of the  
substituents on the benzene ring.
A large contribution to the determination of the abso­
lute structure of avicennol was made by using the lanthan­
ide shift reagent tris-(7,7-dim ethyl-l,1,1,2,2 ,3 ,3-hepta- 
fluoro-octane-4,6-dionato)europium(in) [Eu(fod)s] acord- 
ing to a m ethod described elsewhere.8 We have shown 8 
that Eu(fod)3 complexes w ith the carbonyl oxygen atom  
of coumarins in such a w ay that an 8-substituent shows a  
large downfield shift. W ith avicennol itself results were 
com plicated by preferred com plexation at the side-chain 
hydroxy-group, so this group was masked by  formation of 
the O-trimethylsilyl derivative (5). Complexation then  
proceeded as expected. The same approach as pre-
* In  order to  clarify the tex t, the non-system atic numbering 
system illustrated in formula (4) is used to  refer to  positions on 
the avicennol skeleton.
5 E . V. Lassalc and J . T. P inhey, J . Chem. Soc. (C), 1967, 2000.
0 T. Tomimatsu, M. Hashimoto, T. Shingu, and K. Tori, 
Chem. Comm., 1969, 168.




and those calculated w ith the side-chain in the four 
possible positions on the coumarin benzene ring (Table 1).
T a b l e  1
Observed shifts for HA and H b of O-trimethylsilylavicenno! 
(6) and their calculated values for attachment of the 
side-chain at positions 6, 6. 7, and 8 (relative of H-3 



















The calculations are based on average values for the tw o  
possible conformations of the side-chain double bond in
7 W. R. Chan, D. R . Taylor, and C. R . Willis, / .  Chem. Soc. 
(C), 1967, 2640.




the plane of the benzene ring and therefore are only 
approxim ate, since the side-chain conform ation is not 
known. However, it is clear th at only a side-chain in the 
8-position offers anything approaching a shift of sufficient 
m agnitude. This observation reduces the possible struc­
tures for avicennol from tw elve to four (4) and (6)-—(8). 
Further distinction betw een structures on th e basis of 
Eu(fod)3-induced shifts is less certain, since the shifts for 
protons of substituents in th e  5-, 6-, and 7-positions are 
smaller, and so, therefore, are th e calculated differences 
am ongst th e  four rem aining isomers. H owever, the  
observed m ethoxy-sh ift (0-15) offers clear evidence in 
favour of structures (4) and (6) (calculated shift 0-15) 
rather than (7) and (8) (calculated shift 0-11).
The structure (4) for avicennol was confirmed by  
measurem ent of the intram olecular nuclear Overhauser 
effect (n.O.e.) involving th e  m ethoxy-group and the 
olefinic proton s; this technique was used earlier 8 for a 
similar pyranocoumarin. T he observed n.O.e. is shown 
in Table 2. Structure (4) is the only one in which the
T a b l e  2
O bserved  n u c lea r O v e rh a u se r  effects fo r av icenno l on 
s a tu ra tio n  of th e  m e th o x y  signal a t  8 3-80 
Increase in  in tegrated  intensities of signals of
H - l"  and
H-3 H-4 H -3 ' H-4' -2"
Nil Nil Nil 9% 6%
m ethoxy-group is d ose  to  both  H-4' and the side-chain 
olefinic protons, if structures which do not fit the shift 
reagent data are excluded.
It seem ed possible th at previous isolation lc-2 of avicen­
nin (in sm all quantity) rather than avicennol (in bulk) 
from Z . avicennae m ay have been due to differences in  
extraction and purification techniques, which in the 
earlier work involved treatm ent with acid, base, and 
boiling chloroform. Treatm ent of pure avicennol with 
acid and base as d escribed le gave no useful result, but 
phosgene quickly effected th e dehydration, producing 
avicennin in high yield, w ith the same physical con­
stants as already reported.lc-a Thus avicennin has the  
structure (2).
Catalytic hydrogenation of avicennol afforded two  
products: the expected tetrahydroavicennol (9), m.p. 
165— 165-5°, and hexahydroavicennin (10), m .p. 81— 82°, 
for which the data obtained were in agreement w ith  those 
reported b y  Arthur and O llis.2
N .m .r. shift experim ents w ith avicennin and hexa­
hydroavicennin gave results substantially similar to those 
with the trim ethylsilyl ether of avicennol.
E X P E R IM E N T A L
M .p.s w ere  d e te rm in ed  w ith  a  K ofler h o t-s ta g e  a p p a ra tu s . 
U .v . s p e c tra  (so lv en t e th an o l)  w ere recorded  w ith  a  U nicam  
S P  800A sp ec tro p h o to m e te r , a n d  i.r . sp ec tra  (for KC1 discs) 
w ith  a  P e rk in -E lm e r 237 g ra tin g  sp ec tro p h o to m ete r. 
O p tica l ro ta tio n s  w ere m e asu red  w ith  a  B ellingham  an d  
S tan ley  P o la rim e te r. N .m .r . sp e c tra  w ere reco rded  fo r 
so lu tions in  d eu te ro ch lo ro fo rm  w ith  a  P e rk in -E lm e r R12 60
J.C.S. Perkin I
M H z in s tru m en t, w ith  th e  excep tion  of th e  n.O .e. exp e rim en t 
in  w hich  a  P erk in -E lm e r 90 M Hz in s tru m e n t w as used . 
M ass sp ec tra  a n d  ac cu ra te  m ass d e te rm in a tio n s  w ere ob­
ta in ed  w ith  an  A .E .I . MS 902 spectrom ete r.
E xtraction o f  the Root-bark.— T he d ried , pow dered ro o t- 
b a rk  (150 g) o f Z anthoxy lum  avicennae* w as ex trac te d  
(Soxhlet) w ith  lig h t p e tro leu m  (b p. 40— 60°: 3 1) for 10 h. 
O n cooling, p a le  yellow  cry s ta ls  (3-55 g) w ere deposited  from  
th e  ex tra c t. T .l.c . on  a lu m in a  (W oelm ; ac tiv ity  I), w ith  
ch lo ro fo rm -m eth an o l (98 : 2) as e lu an t, show ed a  single sp o t 
(Rp 0-4) fluorescing o range un d er screened  u .v . lig h t (366 
nm ).
A vicennol (4).— R ecrysta llised  from  n -h ex an e -e th y l 
a c e ta te  (99 : 1) avicennol gave  yellow  p la te s , m .p . 124-5—  
125-5°, [a]D21 0° (c 1-00 in CHC13) (F o u n d : C, 70-35; H , 
G-65% ; M +, 342-1463. C20H 22O 5 requ ires  C, 70-2; H ,
6 -45% ; M , 342-1467), 250 (log e  4-51), 257 (4-61), an d
301 n m  (4-28), vlna:L 3480 (O H), 2960, 1726 (CO), 1585, 1255, 
an d  1140 c m '1, s ‘l-48  (12H , s, 2'-M e2, 3"-M ea), 2-58 (1H , s, 
exchanged  w ith  D aO, O H ), 3-80 (3H, s, OMe), 6-65 an d  5-69 
(2H, A Bq, J  10 H z, H -4 ' an d  -3 '), 6-95 an d  6-81 (2H . 
A Bq, J  16 H z, H - l "  an d  -2"), an d  6-27 <Lnd 8-06 (2H, A Bq, 
J  10 H z, H -3 an d  -4). m /e  342 (M +, 3% ), 327 (CaoH aoO*, 
78), 309 (C11)H t70 4, 100), 277 (14), 263 (6), 253 (5), 251 (8), 
an d  162 (3).
'i"-0 -T rim ethy lsily lav icenno l (5).— A vicenno l (120 mg) 
w as dissolved in  benzene (sodium -dried) an d  an  excess of 
A /'0-b is(trim ethy lsily l)acetam ide w as ad d e d . T he reac tion  
w as followed b y  t.l .c . o n  a lu m in a  w ith  th e  sy stem  a lread y  
described . A fte r 4 h , th e  m ix tu re  w as ev ap o ra ted  to  d ry ­
ness u n d e r reduced  p ressure , an d  th e  re su ltin g  yellow  solid 
recry sta llised  from  m e th an o l; m .p. 100— 101° (F o u n d : 
M * . 414-1840. C2jH 30O 6Si requires M, 414-1862), 251
(log e  4-93), 257 (4-94), an d  301 nm  (4-62), 2950,‘l730,
1585, 1140, 1050, an d  840 cm -1 (SFC), 8 0-18 (9H, s, SiMea), 
1 -48 (12H, s, 2 '-M e2, 3"-M ee), 3-80 (3H , s. OMe), 6-66 an d  
5-69 (2H, A Bq, J  10 H z, H -4 ', H -3 ') , 6-95 and  6-81 (2H , 
A Bq, J  16 H z, H - l" ,  H -2 "), an d  6-27, 8-06 (2H, ABq. J  10 
H z, H -3  an d  -4), m /e 414 (Af+, 24% ), 399 (C2tH 2, 0 6Si, ioO), 
371 (12), 279 (21), an d  180 (60).
Catalytic H ydrogenation o f A vicenno l.— A vicennol (200 
mg) in  ab so lu te  e th an o l (100 ml) w as h y d ro g en a ted  fo r 10 h  
a t  room  te m p e ra tu re  a n d  a tm ospheric  p ressu re  o ver A dam s 
c a ta ly s t  (20 m g). T he m ix tu re  was th e n  filte red ; t.l .c . on 
a lu m in a  (as a lread y  described) ind ica ted  tw o  com pounds, Rp
0-4 (A) an d  0-7 (B), b o th  show ing a  b lu e  fluorescence in  
screened u .v . lig h t (366 nm ). S ep a ra tio n  w as ach ieved  b y  
p rep a ra tiv e  t.l .c . on  n eu tra l a lu m in a  (W oelm  a c tiv i ty  I) 
w ith  ch lo ro fo rm -e th an o l (98 : 2) as e lu a n t. T he p ro d u c ts  
w ere e x tra c te d  from  th e  b a n d s  w ith  chloroform .
C om pound (A) w as recrysta llised  from  m ethano l to  give 
tetrahydroavicennol (9) as  prism s, m .p . 165— 166-5° (F o u n d : M+, 346-1779. C20H 2aO 6 requ ires M, 346-1780), 213
(log s 4-42), 258 (3-84), an d  316 nm  (4-09), vmax 3420 (O H), 
2940, 1710 (CO), 1600, an d  1115 c m '1, 8 1-36 (6H, s, Mea),
1-39 (6 H ,s , M e2), 1-83 (4H , m, 2"- a n d  3 '-H 2), 1-96 (IH , s, 
exchanged  w ith  D aO, O H ), 2-83 (4H , m , 1"- an d  4 '-H 2), 
3-90 (3H , s, OMe), an d  6-27 an d  8-12 (2H , A B q, J  10 H z, 
H -3  an d  -4), m /e  346 (M1, 21% ), 331 (6), 329 (15), 328 (66), 
313 (12), 273 (Cl0H 17O„, 100), an d  217 (51).
C om pound (B) w as recry sta llised  fro m  lig h t p e tro leu m  
(b.p. 40— 60) to  g ive h ex a h y d ro a v ice n n in  (10) as w h ite
* Voucher Specimen No. STRATHCLYDE 30 has been 




prism s, m .p . 81— 82° (lit.,lc 81— 82°) (F o u n d : M+, 380-1824. 
Calc, for CMH M0 4: M , 330-1831), ^  217, 257, an d  315 
nm , 2920, 1725 (CO), 1600, an d  1120 c m '1, m je  330 
(M +, 91% ), 275 (29), 274 (35), 273 (C16H l70 „  100), and  217 
(23), n .m .r. sp ec tru m  id e n tic a l w ith  th a t  p rev iously  re ­
co rded .2
A v icenn in  (2).— A vicennol (100 mg) w as dissolved in 
benzene (sodium -dried) an d  a  12-6% so lu tion  (0-25 ml) of 
phosgene in  to luene  added . A fte r  3 h th e  excess o f phosgene 
w as deg raded  by  ad d itio n  of ab so lu te  e th an o l (1 ml). T he 
m ix tu re  w as ev a p o ra ted  to  d ry n ess  to  y ie ld  a  so lid  w hich w as 
recrysta llised  from  m e th an o l to  give av icen n in  as  yellow  
needles, m .p . 138— 140° (lit.,3 m .p. 136-6— 138-5°) (F ound : 
M +, 324-1359. C^FI^O * requ ires  M , 324-1361), ^  270, 
278, an d  301 nm , vuu][ 2940, 1730 (CO), 1585, an d  1140 c m '1, 
n .m .r. sp ec tru m  iden tica l w ith  th a t  p rev iously  reco rded .2
N .m .r. S h if t  E xperim en ts .— All ex p e rim en ts  w ere ca rried  
o u t w ith  CDCla as so lven t, te tram e th y ls ilan e  as in te rn a l 
s ta n d a rd , an d  E u (fod )3 as sh ift reagen t. T h e  w eighed 
sam p le  (60— 80 mg) was d isso lved  (0-3— 0-5 m l so lvent) an d  
th e  sp ec tru m  recorded . T h e  s h if t reag e n t w as th e n  added  
in  w eighed q u a n titie s  of ca. 10 m g, a t  le a s t four sp ec tra
491
being recorded  for each  com pound, each  w ith  a  la rger q u a n ­
ti ty  of sh if t reag e n t. G raphs w ere th e n  p lo t te d  o f sh ift 
(Hz) versus  w eigh t of E u (fod )3 added  to  find sh ifts  fo r all 
p ro tons , w hich  w ere th e n  expressed  8 re la tiv e  to  th a t  o f H -3 
( =  1-00). T he resu lts  w ere as follow s: av icenno l (4) H -3 
(1-00). H -4  (0-40), H -2 "  (2-56), H - l "  (2-08), MeO (0-40), 
H -4 ' (0-26), H -3 ' (0-14), 2'-Me» (0-14), 3"-M ea (1-59), O H  
(8-57); 3 "-0 -trim eth y ls iIy lav icen n o l (5) H -3 (TOO), H -4 
(0-31), H -2 "  (0-52), H - l "  (0-40), MeO (0-15). H -4 ' (0-13), 
FI-3' (0-08), 2'-M e2 (0-08), 3"-M e, (0-13); av icenn in  (2) H -3 
(1-00), H -4  (0-29), H -2 "  (0-38), H - l "  (0-41), MeO (0-13), 
H -4 ' (0-12), H -3 ' (0-08), 2'-M e2 (0-08), 3"-M e (0-09), 4 " -H 2 
(0-03, 0-09); hexahyd ro av icen n in  (10) FI-3 (1-00), FI-4 (0-30), 
2 " -H a (0-24), 1 "-H 2 (0-30), MeO (013 ), 4 '-H 2 (0-13), 3 '-H 2 
(0-11), 2'-M e2 (0-09), 3"-M e2 (0-11).
W e th a n k  D r. R . A. S pragg, P erk in -E lm e r, Beaconsfteld , 
B ucks., for ca rry in g  o u t  th e  n.O .e. m easu rem en ts, M r. S. P . 
L au , A gricu ltu re  and  F isheries D ep a rtm e n t, G ov t, o f H ong  
K ong, for th e  collection an d  iden tifica tion  of p la n t m a te ria l, 
an d  th e  U n iv ers ity  of S tra th c ly d e  fo r a  g ra n t (to A. I. G .).
[4/1694 Received, 12th August, 1974]
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DIPETALOLACTONE: A NOVEL PYRANOCOUMARIN FROM 
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Abstract A novel dipyranocoumarin, dipetalolactone [2-oxo-6,6,10,10-tetramethylbenzo[l,2-b:3,4-b';5,6-b'']tn- 
pyran}, has been isolated rrom the root bark of Zanthoxylum dipetalum and its structure proven by the synthesis 
of tetrahydrodipetalolactone. A second new pyranocoumarin, dipetaline, has been assigned the tentative structure 
of 6-(3,3-dimethylallyl)-5-melhoxy-2,2-dimethyl-2H-benzo[I,2-b:3,4-b']dipyran-8-one on the basis of PMR analysis 
using the lanthanide shift reagent Eu(fod)3.
INTRODUCTION
In a previous publication [1] we reported the isolation 
of the alkaloids canthin-6-one, chelerythrine, nitidine, 
tembetarine and magnoflorine, the pyranocoumarins avi­
cennol and xanthoxyletin, the triterpcnes lupcol and sito­
sterol. and the flavanone hesperidin from the Hawaiian 
tree Zanthoxylum dipetalum H. Mann (Rutaceae). A third 
pyranocoumarin (designated ZD/1), isolated only in 
small amounts and in an impure state, was tentatively 
assigned a unique dipyranocoumarin nucleus, largely on 
the basis of MS data.
We now report the complete structure elucidation of 
this novel coumarin, to which wc give the trivial name 
dipetalolactone (1), and the synthesis of its tetrahydro 
derivative. In addition it has been shown that the con­
taminant preventing the crystallisation of dipetalolactone 
from ZD/1 is another pyranocoumarin. This compound, 
which we have called dipetaline, is tentatively identified 
as the angular pyrano[2,3-f]coumarin (8) which is closely 
related to avicennol, the major coumarin of this species.
RESULTS AND DISCUSSION
The petrol extract of the root bark of Z. dipetalum, 
after deposition of avicennol, was subjected to repeated 
PLC over alumina to give 65 mg of a yellow oil desig­
nated ZD/1 [1]. Although exhibiting only a single spot 
on TLC this material was shown (by PMR) to be a mix­
ture of two coumarins in the approximate ratio of 4:1. 
Repeated recrystallisation of the oil from absolute EtOH 
gave dipetalolactone (46 mg) mp 119-120". The MS, UV 
and IR, reported previously [1], were all typical of pyr­
anocoumarins [2J. Accurate mass measurement gave a 
molecular ion M 1 310-1206 (C10H 1RO4) and a base peak 
at m/e 295 for loss of Me'. Further loss of Me" from 
the ion at m/e 295 gave a doubly charged fragment at 
m/e 140.
To whom communications should be addressed.
The PMR spectrum readily resolved all eighteen pro­
tons of dipetalolactone. An AB quartet (J 10 Hz) <5 6-19 
(IH) and 8-02 (IH) confirmed the presence of the a,/(-un- 
saturated lactone ring of the coumarin nucleus [2]. The 
presence of two of the 2,2-dimethylchromene ring sys­
tems encountered in pyranocoumarins [3,4] was indi­
cated by the occurrence of a singlet for gem-methyl 
groups at 5 1-48 (12H) and two AB quartets (both .1 
10 Hz) centered at 5 6-88 (IH), 565 (IH) and <5 6-71 
(IH), 5-62 (IH). This easily rationalised PMR spectrum 
confirmed that the major component of the oil ZD/I 
had the previously suggested [1] dipyranocoumarin 
structure but failed to distinguish between the four poss­
ible isomers (1-4).
D ipetalolactone (1) ( 2 )
Of the possible isomeric structures (1) was considered 
the most likely in view of the following. Firstly, almost 
all naturally occurring coumarins are oxygenated in the
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7-.posi.iion* [5|, thereby requiring that the C-4" attach­
ment be in the 8- position, as in structures (1) and (2). 
Secondly, avicennol and xanthoxyletin, the two cou­
marins already reported from this species, both exhibit 
a 5,7-oxygenation pattern [cf. (t)].
A significant contribution to the assignment of struc­
ture (1) to dipetalolactone was made by PMR studies 
using the lanthanide shift reagent Eu(fod)3 (tris-(7,7-di­
methyl- 1,1,1,2,2,3,3-hcptafluoro-oclanc-4,6-dionalo)euro- 
pium) according to a method described elsewhere [6]. 
Complexation proceeded al the carbonyl group as 
expected with the observed shift of the 4-H (relative to 
3H = 100) as before [7], However other shifts, particu­
larly that of the putative C-8 pyran substituent, were 
less than the calculated values. This may be explained 
by a preferred out-of-plane conformation lor the lactone 
ring due to interaction of the 4"-H with the electron 
clouds of the lactone oxygen and thereby resulting in 
the formation of a non-coplanar complex [8], Despite 
the variation of shift values obtained from those 
observed previously [6,7] the results obtained still gave 
a ‘best-fit’ for, and could only be assigned to, structure 
( 1).
In order to confirm the structure of dipetalolactone 
its telrahydro derivative (6) was synthesised. The nuclear 
prcnylation or 5,7-dihydroxy-coumarin, in which one of 
the major products was S,7-dihydroxy-6,8-di-(3,3-dimethy- 
lallyl)-coumarin (5), has been described [9], Acid-cata­
lysed eyclisation of an or(/io-(3,3-dimethylallyl)-hydroxy- 
coumarin (osthenol) to the corresponding dihydropyr- 
anocoumarin (dihydroseselin) has also been reported 
[10], These synthetic steps provide a convenient method 
for the preparation of 2-oxo-6,6,10,l0-tetramethyl- 
7,8,11,12-tetrahydro-benzo[l,2-b:3,4-b' .5,6-b”]tripyran
(6), although the alternative eyclisation to the linear 
dihydropyranocoumarin dihydrotrachyphyllin (7) might 
also occur. Refiuxing (5) with formic acid and subsequent 
PLC gave (6) mp 154-155" as the major product with 
minor amounts of a second compound, possibly (7).
(S )  
( 5 )
( 7 )  Dipetaline (8 )
* In order to clarify the text, the non-systematic numbering 
system illustrated in formula (t) is used to refer to positions 
on the dipetalolactone skeleton.
Hydrogenation of dipetalolactone over Adam’s cata­
lyst yielded colourless plates, mp 154-155", undepressed 
on admixture with (6). Tctrahydrodipetalolactone and (6) 
were found to be identical in all respects (IJV, IR, PMR, 
MS) thereby confirming the structure of dipetalolactone 
as (1). A lanthanide shift experiment with tetrahydrodipe- 
talolactone gave essentially the same results as dipetalo­
lactone.
The minor coumarin, dipetaline, which remained in 
a 1 : 1 mixture with dipetalolactone in the supernatant 
after the deposition of the latter, was not further purified. 
MS of the mixture indicated a molecular formula for 
dipetaline of CjqHjjO* with a major ion at m/e 311 
for the loss of Me'. PMR of the mixture permitted all 
twenty-two protons of dipetaline to be distinguished 
from those of dipetalolactone. An AB quartet (J  10 Hz) 
at <5 6'30 (IH) and 8-10 (IH) demonstrated the presence 
of an a,/j-unsaturated lactone ring. A second AB quartet 
(J 10 Hz) at 8 5-71 (IH) and 6-64 (IH) together with 
a singlet for yem-methyl groups at 8 1 -48 (6H) was again 
indicative of the 2,2-dimethylchromene ring system of 
pyranocoumarins. The presence of a methoxy substituent 
was shown by a singlet at S 3-85 (3H) whilst broad sing­
lets at 8 I -72 (3H) and 1-87 (3H) together with multiplets 
at 8 3-50 (2H) and 5-33 (IH) could be accounted for 
by a 3,3-dimethylallyl unit. Therefore dipetaline is a pyr­
anocoumarin with the two remaining positions on the 
benzenoid nucleus filled by methoxy and 3,3-dimethyl­
allyl substituents, respectively.
In an attempt to determine the substitution pattern 
of dipetaline it was examined using Eu(fod)3. Addition 
of Eu(fod)3 to the mixture allowed, in the light of pre­
viously obtained shift values for the protons of dipetalo­
lactone. the determination of the shift for the protons 
of dipetaline (relative to 3H = 1-00). In this case ‘best- 
fit’ was obtained between observed and calculated shifts 
for values of cfi (C-O-Eu bond angle) of 152'5° and cl 
(O-Eu distance) of 2-75A. in agreement with our previous 
findings [6,7]. The large observed shifts for the allylic 
protons (Table 1) indicated the placement of the 3,3-di­
methylallyl unit in the 8-position. The observed methoxy 
shift (015) suggested its placement in the 7-position (cal­
culated shift 0-15) rather than the 5-position (calculated 
shift O'11). Furthermore observed and calculated shifts 
for the pyran ring methyl protons offer marginally better 
fits with pyran ring attachment through the oxygen at 
C-5 rather than that at C-7 and therefore also support 
the angular structure (8) for dipetaline. Circumstantial 
evidence in favour of this assignment for dipetaline is
Table I. Observed and calculated shift values for dipetaline 
with Eu(fod), (relative to 3H = 100)
(aI for the allylic protons
observed calculated for iattachment at
C-5 C-6 C-7 C-8
CH,* 035 015 0-12 0 15 032
CM* O’54 017 0-12 016 048
(h) ftn the methoxy and pyran lint? methyl groups
calculated for :iiltncbmcnl to
observed oxygtcn at
C-5 C-7
OMe 015 O il 015
Me, 008 008 009
* The calculated values are the average of the two extreme 
conformations of the side-chain in the plane of the coumarin 
benzene ring with the allylic protons frans-orientated.
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provided in its obvious relationship to avicennol, the 
major coumarin of Z. dipetalum.
The presence of several derivatives of 5,7-dihydroxy- 
<Mii(3J-dimethykllyljeouitiarin in Z. dipetalum is of sys­
tematic interest. A similar range of 5,.7-dihy d r ox y-6,8( .3, .3- 
dimelhylallyl)-2-me^hylchl■on'vones, including the dipyra- 
noid compound spatheliabischromene, occur in the small 
aberrant genus Spathelia L. [11]. The co-occurrence of 
this unusual type of substitution might be considered 
to offer further chemical support to that already avail­
able [12] in favour of the retention of Spathelia in the 
Rutaceae and against its transfer to the Simaroubaceae. 
Other dipyranoid substituents have been reported among 
the aeridonc alkaloids of the rutaceous genus Alalatuia 
Correa [13] and among the chromones of Cneorum tri- 
cucvtm L. [14] of the closely allied family Cneoraceae.
EXPERIMENTAL
UV spectra were recorded in EtOH and IR spectra in ICC I. 
PMR (60 MHz) were recorded in CDCIj with TMS as internal 
standard. MS were recorded on an AEI MS9Q2 spectrometer 
at 70 eV. Mp's (uncorr) were determined on a Kofler hot 
stage. PLC were carried out on I mm thick layers eluting with
CHClj.
Plant material. Root hark of Zanthoxylum dipetalum H. 
Mann (Voucher: GS 8 at BISH, HLA and NBV [15]) was 
collected at the Pupukca-Paumalu Forest Reserve, Koolau 
Mountains. Oahu Hawaii.
Extraction and Isolation. Milled bark (55 g) was extracted 
in a Soxhlet with petrol (bp 40-60“) and the extract conc under 
red. pres. On standing a ppt. of avicennol (560 mg) was 
obtained [1]. An aliquot of die supernatant (50%) was sub­
jected to PLC 011 alumina (Woelm, neutral, activity I) with 
u-hcxane-ElOAc as eluting solvent. Xanthoxyletin and lupeol 
were isolated and identified as previously described [I], A 
third yellow band, designated ZD/1 (R{ 0-5, 10 mg), was eluted 
and on careful re-PLC of adjacent alumina bands a further 
15 mg of this material was obtained. The remainder of the 
petrol extract was similarly treated by PLC on Si gel G, elut­
ing with CHClj, to give further ZD/1 (/< r 0-5, 45 mg) together 
with canthin-6-onc. Repeated PLC of the combined ZD/I frac­
tions over alumina gave 65 mg, as a yellow oil, which was 
shown, by PMR (CDCIj), to be a mixture or two coumarins.
Dipetalolactone ( 1). Recrystallisation of the mixture ZD/I 
from absolute EtOH gave, after several days, yellow plates, 
mp 119-120“. Found M ’ 310 1206, CwH lg0 4 requires 
3101205- UV 2m,„ nm (log e): 222(4-17), 244x6(4-37), 250(4-47), 
294x6(4-37), 297(4-38), 307x6(4-28), 344(4-04); absence of batli- 
ochroniic shift on addition of NaOH solution. 1R vm,ix cm 1: 
2990, 1730(0=0), 1610, 1360, 1135, 1025, 825, 740, 705. MS 
m/e: 310(35%), 295(100), 140(MJ' ion). PMR <5: I-48 (12H, 
x, 2'-Me,, 2"-Me2), 5-62, 6-71 (2H, ABq, ./ 10Hz, 3 -H, 4-Hf), 
5-65, 6-88 (2H, ABq, J 10 Hz. 3"-H, 4”-Ht), 6-19, 8-02 (2H, 
ABq, ./ 10 Hz, 3-H, 4-H).
Tetrcihydrodipetalolactone (6). Hydrogenation of dipetalolac­
tone (30 mg) over Adam’s catalyst (20 mg) in EtOH (absolute), 
hydrogen uptake occurring over 4 hr, gave, on filtration and 
rccrystallisation from MeOH, tetrahydrodipetalolactonc 
(25 mg) as colourless plates mp 154 155°. Found M ' 314-1514, 
C „H 220 4 requires 314-1518. UV 2m,„ nm (log e); 211(4-55), 
225x6(4-13), 253(3-80), 262(3-85), 337-5(4-16). IR vm„„ c m '1: 
3000, 2950, 17 3 0 (0 0 ), 1620. 1380, 1165, 825, 820. MS m/e: 
314(80%), 259(100), 258(56), 243(23), 203(76). PMR 6: 1-37 
( I2H, x, 2 -Mcj, 2"-Me2), I -80. 2-64 (4H, 2 X tr, J  7 Hz, 3'-CH2, 
4'-CHjt), 1-83, 2-85 (4H, 2 x tr, J 7 Hz, 3"-CH2, 4"-CH,), 6 16,
8-10 (2H, ABq, J 10 Hz. 3-H, 4-H).
t  Assignments of pyran ring signals in the PMR spectra 
of (I) and (6) were made on the basis of observed shifts with 
F.u(fod)3.
Synthesis of 2-o.vo-6,6,10,l0-te[rainethyl-7,S,l 1.12-tetrahydro- 
6ciizo[l,2-6: 3,4-6':5.6-b"]tripyran (6). Preparation o f 5,7-dihyd­
roxycoumarin. Perkin condensation [16] of phloroglucinalde- 
hyde with ACjO in the presence of anhydrous NaOAc gave 
5,7-diacctoxycoumarin. recrystalliscd from EtOFl as prisms 
mp 140“ (lit. [16] I40‘). The previously reported [16] alkaline 
hydrolysis of 5,7-diaceloxycoumarin resulted in an intense red 
solution from which no 5,7-dihydroxycoumarin could be re­
covered, Acid hydrolysis of 5,7-diacetoxycoumarin was 
achieved by heating a conc ethanolic solution in 50%, HCI 
for 4 hr at 100’C. Evaporation of the EtOH gave 5,7-di- 
hydroxycoumarin, recrystallised from dil AcOH as needles 
(83%, yield) mp 283 285“ (lit. [16] 285- 286”).
Preparation o f 5J-(lihydroxy-6,th-di-(3,5-(liinelhylallyl)cou- 
marin (5). Reaction of 5,7-dihydroxycoumarin with 2-methyl- 
but-3-en-2 ol by the method of Mahcy et al. [9] afforded an 
oil having identical characteristics (UV, IR, PMR) to those 
recorded for 5,7-dihydroxy-6,8-di-(3,3-dimethylallyl)coumarin 
[9].
Preparation o f 2-oxo-6,6,10,1O-tetramethyl-IS, 11,12-tetra- 
hydrohenzo[ 1,2-6:3,4-6' :5.6-b"]lripynm (6). 5,7-Dihydroxy-6,8- 
di-(3,3-dimethylalIyl)coumarin (60 mg) was healed on a water 
bath with formic acid for 4 hr. The reaction mixture was 
diluted with H 20  and extracted with OH,CI ,. Concn of the 
CH 2CI2 extract followed by PLC over alumina, eluting with 
CHClj (blue fluorescent band, Rf  0-63), gave, on recrystalhsa- 
tion from MeOH, colourless plates (25 mg) mp 154-155" iden­
tical in all respects (UV, IR, PMR, MS, TLC, rnmp) with 
tetrahydrodipetalolactonc.
Dipetaline (8). The supernatant EtOH solution after deposi­
tion of dipetalolactone was subjected to MS and PMR analy­
sis. The following data were obtained after comparison with 
spectra of pure dipetalolactone. Found M 1 326-1513, 
C 20H ,,O 4 requires 326 1518. MS m/e: 326, 311. PMR <5: 1-48 
(6H, x. pyran-Me2). I 72 (3H, x. allylic Me). 1-87 (3H, x. allylic 
Me), 3-50 (2H, br. d.. allylic CH 2), 3-85 (3H, s, OMe), 5-33 
(IH, hr. tr.. allylic CH). 5-71. 6-64 (2H, ABq, ./ 10Hz. pyran 
C H ; CH), 6-30. 8 10 (2H, ABq, J  10 Hz, 3-H, 4-H).
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dewevrei (C. dewevrei De Wild, et D urand  var. excelsa 
Chev. and  C. dewevrei D e Wild, et D urand  var. aruwimien- 
sis (De Wild.) Chev.).
The dried and finely g round  leaf m aterial (portions of 
1 g) was boiled in 125 ml 0.01 n H 2S 0 4 (20m in), mixed 
with 13 g M gO, cooled and  filtered th rough  glass filter 
G4. The filtrate was extracted  with CHC13 (100 ml x
3). Follow ing evapora tion  of CHC13, the concen trate  was 
chrom atographed by prepara tive TL C  on Si gel (CHC13 - 
M eO H  9:1). The zone w ith Rf  0.52 w aselu ted  w ith M eO H  
and rechrom atographed. C rystallization from M eO H  
(and few drops of H 20 )  yielded needles (mp 202°) with 
mass, UV and IR spectra  [1] identicl to  those of the 
au thentic sample of 3 with mp 205° prepared  by methyl- 
a tion of 7,9-dim ethyluric acid [3,4]. Therm al rearrange­
ment of both the na tu ra l and synthesized sam ple gave 
1,3,7,9-tetramethyluric acid (1).
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Key Word Index —Uvaria ova la: Annonaceae; chondrofoline; W.v-l-benzyltctrahydroisoquinoline alkaloid.
Chondrofoline, a  m em ber of the rare g roup  o f 7 ,3" '-8 \4"- 
linked bis-benzyl isoquinolines, has been found in Uvaria 
ovata  (A nnonaceae); it has previously been found only 
in Chondrodendron platyphyllum  M iers (M enisperm - 
aceae) [1]. A lkaloids of this type have previously been 
isolated only from M enisperm aceae and  L auraceae [2 ] 
and their discovery in another, closely allied, R analean 
family yet again illustrates the potential value of alkaloids 
in the system atics of the Ranales.
E X P E R IM E N T A L
Plant. Uvaria ovata A. DC; Voucher. Enti 1284, deposited at 
the herbarium of the Royal Botanic Garden, Edinburgh; Source. 
Achimota, Ghana.
Alkaloid isolation. Powdered leaf (650g) was extracted suc­
cessively with petrol (40-60°), CHCI3 and MeOH. Acid extrac­
tion of the CHCIj concn, basification of the acid extract with 
NH3 and re-extraction into CHC13 gave a mixture of alkaloids. 
Col. chr. of the mixture over AI gave, on elution with CHCI , 
MeOH (99:1), a single alkaloid. Rccrystallisation of the alkaloid 
from CHC13-E t20  and finally Et20  gave plates (97 mg) mp 
136-140°. [<x]!26 -  257 (c 0.10 in 0.1 N HC1). Found, M + 
608.2877; C37H.10N 2O6 requires 608.2886. UV 2®'°H nm (log e) 
232 (4.57), 281 (3.97), undergoing a bathochromic shift on the 
addition of alkali. IR vranx (KBr) cm ‘ 1 3450 (OH). PMR (CDC13) 
6 2.30 (3H, s N-Me), 2.58 (3H, s N-Mc), 3.78 (3H, s OMe), 3.92 
(6H, s 2 x OMe), 2.60-3.85 (14H, m CH2 and CH), 6.00 (1H, s 
C-8 -H), 6.65-7.35 (9H, m Har). MS 608 (91), 607 (50), 487 (2). 
312 (92), 311 (19), 299 (24), 298 (100), 266 (10), 204 (23), 192 (12),
* Part 3 in the series ‘Chemical Studies on the Annonaceae’. 
For Part 2 see Panichpol, IC., Waigh, R. D. and Waterman, P. G.
(1976) J. Phann. Pharmacol. 28, 7Ip.
190(15), 176(11.5), 174(19), 161 (6.5), 159(10), 146(11), 145(15). 
From UV, IR and PMR spectra and accurate mass measurement 
of the molecular ion, it appeared likely that the alkaloid was of 
the his- 1 -benzyltetrahydroisoquinoline type, with one OH, 
3 x OMe and 2 x NMc substituents. The significance of MS 
fragmentation patterns in the identification of bis-benzyliso- 
quinoline alkaloids and the probable origin of the fragments 
observed have been thoroughly discussed [3], The major ions, at 
m/e 312(C19H 22N 0 3) and m/e 298(C1BH 2(,N 0 3), indicated that 
the two benzylisoquinoline moieties were linked head to tail. In 
addition, the relatively high abundance of an ion at m/e 204 
(C12H 14N 0 2) suggested the presence of a 6,7-dimethoxyiso- 
quinoline fragment, and the relatively low abundance of an ion 
corresponding to loss of Me from the other benzylisoquinoline 
subunit indicated MeO substitution in this isoquinoline unit 
rather than in the benzyl group attached to it. A detailed com­
parison of the complete MS with those of known head to tail 
linked fiis-benzylisoquinolines [4] suggested that the alkaloid
622 Short Reports
was chondrofoline (1) or a stereoisomer thereof. The stereo­
chemical coidentity of the alkaloid from V. ovata was ascertained 
by comparison of the ORD spectrum [1,5] with that of authentic 
chondrofoline and the structure was finally confirmed by direct 
comparison (UV, IR, mmp, TLC).
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dimcthoxyphenethylaminc; /V-mcthyl-3,4-dimethoxyphencthy!amine; Ai-methyl-3,4-dimcthoxyphcnethylaminc
In a  field screening of M exican cacti for the presence of 
alkaloids, Echinocereus cinerascens (DC.) R um pler and 
Pilosocereus chrysacanthus (Web.) Byl. et Rowl. were 
found to  give positive tests w ith the DragendorfT re ­
agent [1]. P lan ts were collected and the alkaloids 
ex tracted  and studied. The present report describes the 
iso lation  and identification of the m ajo r phenethylam inc 
alkalo ids of these tw o cactus species.
A lthough several alkalo id  screening papers have listed 
various Echinocereus species [2 -4 ], only one species, E. 
merkeri, has been investigated in m ore detail. N ,N -  
d im ethyl-3,4-dim ethoxyphenethylam ine was isolated for 
the first time from E. merkeri, Which con tains several 
add itiona l phenethylam ines and the tetrahydro iso - 
quinoline salsoline [5, 6].
We have now identified the m ajor alkalo id  of E. 
cinerascens as Af,Af-dimethyl-3,4-dimethoxyphenethyla- 
mine. A lkaloid extraction  followed by fractionation  on 
an alum ina colum n led to  the isolation o f this com pound, 
as well as small am ounts of /V-methyl-3,4-dimethoxy- 
phenethylam ine. E. cinerascens has an edible fruit [7 ] 
and  dry plants are used as fuel [ 8], but no  medicinal uses 
seem to have been recorded for E. cinerascens o r Pilo­
socereus chrysacanthus. The m ajor a lkato id  of the latter 
species was identified as W -methyl-3,4-dimcthoxyphene- 
thylam ine.
The alkaloids now  isolated were identified by com ­
parison  with synthetic reference m aterials using TLC, 
G C , IR, and  MS. A part of the (V,7V-dimethyI-3,4- 
dim ethoxyphenethylam inc isolated from E. cinerascens 
was oxidized to  the corresponding 3,4-dim ethoxy- 
benzoic acid, identified by IR and m p com parison  w ith 
an  au then tic  sample.
*Cactaceae Alkaloids. 27.
/V-Methyl- and  Af,/V-dimethyl-3,4-dimethoxyphene- 
thylam ine have been reported  from  E. merkeri [5], and 
are also found in o ther genera of the Cactaceae, e.g. 
Coryphantha  [9] and  Ariocarpus [  10].
EXPERIMENTAL
Plant material. Echinocereus cinerascens (DC.) Riimpler 
(4.1 kg) was collected north of Pachuca, Hidalgo, and Piloso­
cereus chrysacanthus (Web.) Byl. et Rowl. (3.0 kg) near San 
Antonio Texcala, Puebla, by the authors.
Alkaloid extraction. Fresh plant material was homogenized 
in EtOH. The filtered extracts were evaporated to dryness and 
dissolved in 3% HOAc. The aq. phases were extracted with 
CHCIj and the CHC13 discarded. Aq. phases were basified with 
NH , cone (pH 10) and alkaloids extracted with CHC1, and 
CHCIj-EtOH (3:1). Crude alkaloids were purified on an acid 
diatomaccous earth column (Celite 545). Yield of alkaloids: 
E. cinerascens 585 m g;0.014%; P. chrysacanthus 684 mg; 0.02 "/„.
Isolation and identification. Thealkaloid extract of E. cinerascens 
(525 mg) was fractionated on an aluminium oxide column 
(Merck, act. II—III acc. to Brockmann) as earlier described [5], 
The cluates were analyzed by TLC and GC (5 % SE-30 and 5 % 
XE-60 columns, col. temp. 150”) [11]. MS were obtained with 
a combined GC-MS instrument (ion source 2.5 kV, electron 
energy 70 eV, and ionization current 60 pA). /V,N-Dimethyl- 
3,4-dimethoxyphenethylamine was eluted with CHCI3-C 6H 6 
(1:2) and crystallized as the hydrochloride (292 mg) mp 193— 
197”; lit. mp 194-196° [4]. Alkaline permanganate oxidation of 
50 mg of this compound gave 10 mg of 3,4-dimethoxybenzoic 
acid, mp 178-181°; lit. mp 181° [12], /V-methyl-3,4-dimethoxy- 
phenethylamine was isolated from the CHCl3-McOH (4:1) 
fractions as the hydrochloride (yield 8 mg), mp 134-136°; lit. 
mp 136-137" [4], Preparative TLC on Si gel GF plates in 
CHCIj- EtOH -N Hj cone (80:20:0.4) of 80 mg of the P. chrysa­
canthus alkaloids yielded N-methyl-3,4-dimethoxyphenethyla- 
mine, which was crystallized as the hydrochloride (yield 21 mg), 
mp 134-135"; lit. mp 136-137" [4],
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A bstract— A new pyranocoum arin  has been isolated from  the ro o t bark o f Z anthoxylum  elephantiasis and identified 
as ci's-avicennol (6-(3-hydroxy-3-methyl-ci.s,-but-I-enyl)-5-m ethoxy-2,2-dim ethyl-2//-benzo [1 ,2 b :3,4b'] dipyran- 
8-one) on the basis o f  com parison o f  spectral d ata  with tha t o f  ira/w-avicennol and conversion to  le trahydroavicennol. 
T he usefulness o f  the lan than ide shift reagent E u(fod )3 in the assignm ent o f  cis configuration  to  the butenyl sidc- 
chain is briefly discussed.
IN T R O D U C T IO N
The angular pyranocoum arin  avicennol (1) has, to  
date, been found to  occur only in three species of the 
ru taceous genus Z anthoxylum  L : Z. avicennae (Lam.) 
D C. [ I ] ,  Z. dipetalum  M ann  [2 ] and  Z . elephantiasis 
M acfad. [3]. In the determ ination  of the structure of 
avicennol [ 1] considerable use was m ade o f  the shifts 
induced in the PM R  spectrum  of its O -TM Si ether by 
the lanthanide shift reagent Eu(fod)3. Subsequently the 
s tructure o f avicennol, w ith its unusual 3-hydroxy-3- 
m ethyl-irans-but-I-enyl side-chain, was confirm ed by 
synthesis [4].
We now wish to  rep o rt the isolation o f the co rrespond ­
ing cis isomer o f avicennol from the ro o t bark  o f Z. 
elephantiasis and its identification by com parison  of 
spectral da ta  and shift values with Eu(fod), w ith those 
previously obtained  for trans-avicennol.
R E S U L T S  A N D  D IS C U S S IO N
O n concentration  th e  petrol ex tract o f the root bark  
o f Z. elephantiasis deposited, in high yield, avicennol, 
xanthoxyletin and  can th in -6-one. P L C  o f the super­
natan t liquor gave, in addition , dihydrochelerythrine, 
aviccnnin, d ipetalo lactone and triacon tano ic acid [3]. 
C oncentration  o f the superna tan t so lu tion  from which 
triacontanoic acid had  been obta ined  yielded 95 mg
of a yellow oil, fluorescing dull yellow under UV. The 
yellow oil, a lthough giving a  single sp o t on  T L C  using 
several systems, could n o t be ob ta ined  in crystalline 
form.
M S of the oil ind icated  a m olecular ion  M + 342.1453 
(C 20H 22O 5) with a fragm entation p a tte rn  showing only 
relative abundance variations from  th a t observed for 
Nwi.v-avicennoi [1], Likewise, the IR  spectrum , apart 
from  a  distinct broadening  o f the O H  band, was in close 
agreem ent w ith th a t previously recorded for trans- 
avicennol.
Conversely the m axim a observed in the UV spectrum  
of the oil (236, 275 and 294 n m ; cf. 250, 257 and  301 nm 
for frans-avicennol) and  the chemical shifts o f some 
of the p ro tons in the P M R  (Table 1) showed distinct 
differences. W ith respect to the P M R  spectrum , whilst 
the resonance signals were indicative o r a coum arin 
w ith sim ilar substituents to  irans-avicennol, differences 
in chemical shifts in all signals derived from the 3- 
hydroxy-3-m cthylbut-l-eny! side-chain and  in theolcfinic 
coupling constan t (J  =  13 H z; cf. J  = 16 Hz) were 
apparen t. As the coupling  constant o f 13 H z cannot 
definitely be assigned to either a  cis o r  trans o rien tated  
olefine [5 ] this new coum arin  could , theoretically, 
have been any one o f tw enty-three possible isomers of 
ftm s-avieennol.
C om parison  o f the Eu(fod)3-induced shifts [1, 6] in 
the PM R  spectrum  of the O-TM Si derivative o f the new
Table 1. Comparison of chemical shifts (<5) of the protons of trons-avicennol (1) and the ‘yellow oil’*
3-H 4-H 3'-H 4'-H 2'-Me2 OMe 1"-H 2"-H 3"-Mc2 OH
frons-Avicennol 6.27 8.06 5.69 6.65 1.48 3.80 6.95 6.81 1.48 2.58
J (Hz) 10 10 10 10 16 16
‘Yellow oil’ 6.29 8.05 5.69 6.65 1.49 3.85 6.25 6.01 1.31 2.85
J (Hz) 10 10 10 10 13 13
* The non-systematic numbering system adopted (see formula 1) is used to allow comparison with other coumarin shift data 
[ 1. 6].
1 0 1 7
2 9 2
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Table 2. Com parison of induced shift values (relative to 3H = 1.00) for frans-aviccnnol and ‘yellow oil’ O-TMSi ethers with Eu(fod)3*
3-H 4-H 3-H 4 -H 2'-M e, OM e 1"-H 2"-H 3"-M e2 O-TMSi
framx-Aviccnnol 1.00 0.31 0.08 0.13 008 0.15 0.40 0.52 0.13 0.11
‘Yellow oil' 1.00 0.32 0.09 0.15 0.08 0.16 0.32 0.25 0.28 0.19
* See Table 1
com pound with those o f O -TM Si-trans-avicennol (Table 
2) aided the s tructu re  assignm ent. N o significant change 
was noted in shift ratios for p ro tons  o f the lactone ring, 
pyran ring o r O M e group. O n  the o the r hand the olefinic 
p ro tons of the side-chain o f the  new com pound were 
less shifted th a n  in trrw s-avicennol but were once 
again o f such a  m agnitude as to  restrict side-chain 
attachm ent to  C -8  o f the coum arin  nucleus [1 ]. The 
shifts of the gem -dimethyl an d  O -TM Si groups were, 
however, m arkedly  larger th an  those o f the correspond­
ing trims side-chain indicating th a t these groups were 
closer to  the p o in t o f com plexation . These results are in 
agreem ent with those an tic ipated  for the cis isom er o f
O-TM Si-avicennol (2b).
2a R =  H
2b R =  Si(Me),
3
The substitu tion  pattern  o f the new coum arin was con­
firmed by hydrogenation  to  give the  corresponding 
te trahydro- derivative w hich proved identical to  the 
previously synthesised te trahydroav icenno l (3) [1], 
thereby indicating  tha t it was cis-avicennol (2 a).
It has recently com e to  o u r  no tice tha t synthetically 
derived 7 - m ethoxy- 8 -(3 - hydroxy - 3 - methyl - cis -b u t -1 - 
enyl) coum arin  show ed a h igh coupling constan t 
(J  =  12 Hz) for the side-chain olefinic p ro tons and, 
like cis-avicennol, proved im possible to  crystallise [7].
E X P E R IM E N T A L
Plant Material. Root bark of Zanthoxylum elephantiasis 
Macfad. was collected at Falmouth, Trelawny, Jamaica 
(Voucher: A.I. Gray 3) and at Zalaya, Santo Domingo,
Dominican Republic (voucher: J. Jimenez 5972). Vouchers 
have been deposited at the herbarium of the Royal Botanic 
Garden, Edinburgh.
Extraction and isolation. The milled bark (800 g from A.I. 
Gray 3 collection) was extracted with petrol bp 40-60°. The 
cone petrol extract, after deposition of canthin-6-one, xanthoxy- 
letin and avicennol, was subjected to PLC (1 mm) over Si gel. 
Elution with EtOAc-hcxane (3:2) yielded dihydrochelerythrine, 
avicennin, dipetalolactonc and triacontanoic acid [3]. On 
concn of the ethanolic supernatant from the rccrystallisation 
of triacontanoic acid a  yellow oil (2a, 95 mg, Rf  0.55 in PLC 
system) was obtained.
Cis-avicennol (2a). The yellow oil could not be obtained in 
crystalline form. Found M* 342.1453; C 20H22O5 requires 
342.1467. UV A*°Hnm: 236, 275, 294. IR v™"'cm ~1: 3490, 
1725, 1140. PMR (60 MHz, CDClj, 5): 1.31 (6H. s, 3"-Me2), 
1.49 (6H, s, 2'-Me2), 2.85 (1H, br s, lost on D20  exchange. 
3"-OH), 3.85 (3H, s, OMe), 5.69, 6.65 (2H, ABq, J = 10 Hz, 
3’-H and 4'-H), 6.25, 6.01 (2H, ABq, .1 =  13 Hz, l"-H and 2"-H), 
6.29, 8.05 (2H, ABg, J  =  10 Hz, 3-H and 4-H). MS m/e (rel. 
int.): 342 (42%, M ’ ), 327 (100), 324 (19), 309(20).
Gis-avicennol-O-TMSi-ether (2b). 2a (50 mg) was dissolved 
in dry C6H6 and an excess of BSA added. After 7 hr the mixture 
was evap. to dryness and the residue chromatographed on 
Si gel. Elution with EtOAc-hcxane (1:1) gave a yellow oil 
(45 mg, Rf  0.71). UV A*°H nm: 238, 275, 298. PMR (60 MHz, 
CDClj, 6): -0.24 (9H, s, SiMe3), 1.38 (6H, s, 3"-Me2), 1.47 
(6H, s, 2'-Me2), 3.81 (3H, s, OMe), 5.60,6.59 (2H, ABij.J = 10Hz, 
3'-H and 4'-H), 5.78.6.01 (2H, AB<j, 7 = 13 Hz, 2“-H and 1"-H), 
6.20, 8.00 (2H, ABq, J - 10 Hz, 3-H and 4-H).
Tetrahydroavicennol (3). 2a (20 mg) in EtOH was hydro­
genated over Adams catalyst. The reaction mixture was filtered 
and evap. to dryness. TLC [1] indicated a single product, 
Rf  0.4. The residue on recryst. from MeOH as colourless prisms 
(18 mg) mp 165-165.5", identical in all respects (UV, IR, PMR, 
TLC, mmp) with an authentic sample of tetrahydroavicennol
M ,
Cis-avicennol in Z. elephantiasis—Jimenez 5972. A similar 
extraction and isolation procedure indicated the presence 
of small amounts of cis-avicennol in this material also.
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Interactions of Coumarins with a Lanthanide Shift R eagent: Determin­
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The effects of Eu(fod)3 on the 'H n.m.r. spectra of 22 coumarins with alkyl, alkoxy, furano. and pyrano substituents 
and of coumarin itself have been studied, and a method for obtaining information on the substitution pattern of the 
coumarins has been developed.
T h e  frequent occurrence and structural diversity of 
natural coumarins1 has led to the application of a 
variety of n.m.r. techniques to their structure elucidation, 
particularly the use of chemical shifts and coupling,2 the 
internal nuclear Overhauser effect,3,4 and recently 13C 
n.m.r.®"7 Some of these techniques are not readily 
available, and even when they are, the unambiguous 
structure determination of certain types of coumarin 
still presents problems.
We have described briefly8 a simple, rapid, non- 
degradative, non-empirical method for the structure 
elucidation of coumarins using the n.m.r. shift reagent 
Eu(fod)3. We explain here how it can be used as a 
practical method, when the method is most useful, and 
also where difficulties may be encountered.
To evaluate the approach fully we have used a variety 
of natural and synthetic coumarins (1)—(23) with 
different functional groups and substitution patterns.
M E T H O D
A fu ll d iscussion  of th e  use  of lan th an id e  sh if t reagen ts  
(l.s.r.) in  n .m .r. sp ec tro sco p y  has been pub lish ed  0 an d  an  
ea rlie r review  m a y  also be found  help fu l.10
I t  is e ssen tia l th a t  th e  so lv en t should n o t com plex  w ith  
th e  s h if t reag e n t, w h ich  red u ces  th e  choice, b u t  we hav e  
found  CDCf, ideal for co u m arin s  when using E u (fod )a, and  
h av e  had  no reason  to  conside r a lte rn a tiv es . F o r  use in a  
s ta n d a rd  60 M H z sp ec tro m e te r, we have  d isso lved  coum arin  
(ca. 60 mg) in CDCL, (0.3 m l) con ta in ing  te tram e th y ls ilan e  
as in te rn a l s ta n d a rd . T h e  n o rm a l spectrum  w as ob ta in ed , 
an d  th e n  E u (fo d )3 (ca. 10 m g) added , disso lved , an d  th e  
sp ec tru m  re-run . In  each  case th e  sh ifts of a ll th e  p ro to n s  
w ere m easured  re la tiv e  to  te tram e th y ls ilan e , so th a t  th e  
lan th an id e -in d u ce d  sh ift (l.i.s.) could be o b ta in ed . Thus, 
8H [I5u(fod)3] -  SH(untrc,ltnr|) =  l.i.s. In  our ap p ro ac h  th e  
l.i.s. fo r each  p ro to n  w as th e n  d iv ided  by  th e  l.i.s. for th e  
p ro to n  a t ta c h e d  to  C-3 of th e  coum arin . T h is gave  a series 
of s h if t  ra tio s  w hich a re  in d e p en d en t of th e  w eigh t of 
coum arin  o r  s h if t  reag en t, an d  can  be used to  d e te rm in e  th e  
s u b s t itu t io n  p a t te rn  o f th e  coum arin .
W e chose to  use severa l ad d itio n s  (usually  four) o f sh if t 
reag en t, an d  to  p lo t th e  induced  sh ift a g a in s t th e  in teg ra l 
of th e  m a in  resonance  of th e  s h if t reagen t, so as to  o b ta in  a  
series o f s tr a ig h t lines w h ich  can  be used to  d e te rm in e  th e
|  Three coum arins (21)— (23) were excluded from the. averag­
ing (see Discussion section).
> B. E. Nielsen, Dansk. Tidsskr. Farm., 1970, 44. I l l ; R. D. H. 
M urray, Aromatic Hetcroaromatic Chem., 1976, 4, 422.
2 W. Steele and  M. Mazurek, Lloydia, 1972, 35. 418.
3 T Tom imatsu, M. H ashim oto, T. Shingu.and K. Tori, Chem. 
Comm., 1969, 168; Tetrahedron, 1972, 28, 2003.
4 A. I. Gray, R. D. W aigh, and P. G. W aterm an, J.C .S . 
Perkin I ,  1976, 488.
sh ift ratios. T h is  ap p ro ach  has ad v a n ta g e s  where th e re  is 
o verlapp ing  of peaks, e ith e r in th e  orig inal spectrum  or 
a f te r  add itio n  of E u(fod )3, w hen th e  precise position  of a  
peak  m ay  be d ifficu lt to  determ ine. In  sim ple cases th e re  
is no ad v a n tag e  in th e  g raph ical app roach , a lthough  m ore 
th a n  one ad d itio n  of E u (fod )s is adv isab le , so th a t  average  
sh ift values m ay  be ob ta ined  as a  p recau tion  ag a in st 
random  error.
C oum arins no rm a lly  give v ery  sh a rp  resonances w ith  good 
reso lu tion , b u t ad d itio n  of large am o u n ts  of sh ift re ag e n t 
a lm o st alw ays b ro ad en s  th e  lines. T h u s  th e re  m ay be an  
a d v a n tag e  in using  sm aller am o u n ts  of coum arin  in itia lly , 
w here in s tru m e n t perfo rm ance p erm its , so th a t  less l.s.r. 
is needed. C oncen tra ted  solutions o f th e  coum arin  should  
be avoided for th is  reason.
H av ing  o b ta in ed  a  series of sh ift ra tio s  b y  e ith e r  approach , 
th e re  a re  tw o  w ays in w hich th e  d a ta  can  be used. As a  
qu ick  m ethod , we hav e  ca lcu la ted  (Tables 2— 4) th e  sh ift 
ra tio s  expec ted  using average f com p lex a tio n  p a ram e te rs  
for H, CH 3, p y ran , an d  fu ran  su b s t itu e n ts  in all positions 
(except, of course, C-3). T hus a com parison  of th e  ex p e ri­
m en ta l ra tio s  w ith  those in T ab les 2— 4 m ay  o ften  give 
valuab le  s tru c tu ra l info rm ation , som etim es am oun ting  to  
to ta l s tru c tu re  e lucidation .
If i t  is considered  desirable to  refine th e  ca lcu la ted  
figures for th e  specific coum arin  u n d e r  s tu d y , as w e h av e  
done,4,11’-1® it is necessary  to  a d ju s t </> a n d  d  (F igure 1) fo r an  
op tim u m  fit to  th e  expe rim en ta l d a ta .
F i g u r e  1
In  ou r experience th e  easiest w ay  to  do  th is  is to  use a  
field m ap  13 an d  a  D reid ing  stereom odel. W ith  th e  m odel 
fla t on  th e  m ap  th e  ca rbony l oxygen is p laced  on  th e  m id ­
line of th e  field m ap. M ovem ent a long  th is  line varies d, 
and  ro ta tio n  of th e  m odel in th e  p lane  o f th e  m ap w ith  th e  
ca rbony l oxygen  alw ays on th e  m id-line , varies <f>. R ap id
6 Ching-jer Chang, H. G. Floss, and W. Steck, J . Org. Chem., 
1977, 42, 1337, and references cited.
0 K. K. Chan. D. D. Giannini, A. H. Cain, J . D. Roberts, W. 
Porter, and W. F. Trager, Tetrahedron, 1977, 83, 899.
7 D. Bergenthal, K. Szendrei, and J . Reisch, Arch. Pharm. 
1977, 310, 390.
“ A. 1. Gray, R. D. Waigh, and P. G. W aterm an, J.C .S . Chem. 
Comm., 1974, 632.
0 A. F. Cockerill, G. L. O. Davies, R. C. Harden, and D. M. 
Rackham, Chem. Rev., 1973, 73, 653.
10 P. V. DeMarco, Lloydia. 1972, 35. 362.
11 F. Fish, A. I. Gray, R. D. Waigh, and P. G. W aterman, 
Phytochemistry, 1976, 15, 313.
13 A. 1. Gray, R. D. Waigh, and P. G. W aterm an, Phytochemis­
try, 1977, 16, 1017.
13 R. M. Wing, T. A. Early, and J . J .  Uebel, Tetrahedron 
Letters, 1972, 4153.
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OMe
Substituent Substituent (12)
3 4 5 S 7 a 5 8
(1) H H H H H H ( 9 ) H OMe
(2) H H H H OMe H (10) OMe H
(3) H H H Me H H (11) H OCH2CH=C(Me)2
(4) H Me H H OMe H
(5) H Me H OMe H H
(6) H H OMe H OMe H
(7) H H H OMe OMe H
(S) H Me H H OMe Me
Me Me
MeO
(13) R = trans -  CH— CH *C (OSiMe 3 >Me2
(14) R = c/*-CH=CH >C(O SiM e3)Me2 
05) R = f«w*-CH=CH-C(OH)M e2
(16) R = r»*-CH=CH-C(OH)M e2
(17) R =  fra/>*-CH =  C H -C (M e)=C H 2
(20) R = CH2 -CH=:CMe2
Me Me
(18) R = CH2CH2C(H)Me2
(19) R = CH2CH2C(OH)Me2 (2 1 )
(2 2 )
v isu a l in spec tion  of p ro to n  positions  on  th e  m a p  will th e n  
rev ea l if th e  sh if t ra tio s  a re  reasonab le  fo r th e  com pound  in  
q uestion . W hen  a  ' b e s t  f i t  ’ h a s  been  o b ta in ed , th e  p ro to n  
p o s itio n s  can  be  m a rk ed  o n  th e  field m a p  so th a t  0 an d  R 
c a n  b e  m easu red  for ea ch  o n e  (F igure 2).
F i g u r e  2
T h e  va lue  o f (3 cosa0  — 1 ) /R s can  th e n  be  ca lcu la ted  fo r 
each  p ro to n  to  give th e  re la tiv e  sh ifts . F o r  com parison  
w ith  th e  ex p e rim en ta l figures, th e  re la tiv e  sh ifts  m u s t be
(23)
norm alised  to  re la tiv e  sh ift 3-H  =  1.00, an d  th is  is done by  
d iv id ing  each  re la tiv e  sh ift figure b y  th e  va lu e  of 
(3cosa0 — 1 )/f?3 o b ta in ed  fo r 3-H . T o  save  tim e  on  th e  
ca lcu la tions w e p lo t te d  3cosa0 — 1 fo r a ll possible va lues of 
0 , so th a t  va lues  d id  n o t need to  be ca lcu la ted  ind iv idually .
W here s u b s t itu e n ts  a re  n o t in  th e  p la n e  of th e  ring , as 
w ith  m e th y lp y ra n  a n d  m e th o x y  (see D iscussion section) 
m easu rem en ts  of 0 an d  I t  a re  m ore aw kw ard , b u t  once </> and  
d  h av e  been  chosen  w ith  s u b s titu e n ts  w hich  do  fall in  th e  
p lane  of th e  field m a p  th e  p roblem  is sim plified.
T he ex p e rim en ta l a n d  ca lcu la ted  v a lu es  o b ta ined  as above 
fo r all th e  co um arin s  a re  g iven  in  T ab le  I.*
* Non-systematic numbering has been used wherever necessary 
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Normally correlations of structure with l.i.s. are three- 
dimensional problems, for which a computer is required 
to calculate the direction and length of the lanthanide- 
ligand bond which give a ‘ best fit' to the observed data. 
The advantage of the present method is that the problem 
of location of the europium atom has been reduced to 
two dimensions so that a computer is not necessary. 
While this involves assumptions about the bonding of 
coumarins to Eu(fod)s which may not be universally 
valid, a good fit has been obtained for a large number of
ship between induced shift and substituent position 
which is the basis of the method. Where the additional 
site is a side-chain hydroxy, as in cis- and trans- 
avicennol ,4ilz it can be conveniently protected as the 
trimethylsilyl ether. In other cases the method of 
protection would have to be devised specifically, but a 
special problem may be posed by the presence of o- 
methoxys. An isolated methoxy does not complex 
significantly with Eu(fod)s, but o-methoxys do,9 and the 
difference has been used to confirm the structure of 
2,4,5-trimethoxystyrene.16 Similar complexation occurs
T a b l e  1
O bserved an d  c a lcu la ted  sh ift va lues  for coum arins, re la tiv e  to  3-H  =  1.00 (calcu la ted  values in  parentheses)
Substituent position
Compound * o d jk 4 5 6 7 8 2' 3' 4 '
Coumarin (1) 156 3.00 0.31(0.32) 0.19(0.19) *1 0.15(0.14) “ 0.19(0.17)“ 0.31(0.33)
H erniarin (2) 159 3.30 0.34(0.34) 0 .20(0 .20) 0.16(0.16) 0 .10(0 . 12) 0.29(0.32)
6-Methylcoumarin (3) 158 3.25 0.29(0.32) 0.20(0.18) 0 .10(0 .11) 0.15(0.18) 0.27(0.31)
4-M ethylhemiarin (4) 160 2.60 0 .22 (0 .20) 0 .22 (0 .20) 0.18(0.16) 0 . 12(0 .12) 0.34(0.34)
0-Methoxy-4-methytcou-
m arin (5) 160 2.00 0 .20(0 .20) 0 .20 (0 .20) 0 .11(0 .11) 0.18(0.17) 0.33(0.34)
Lim ettin (6 ) 158 3.25 0.31(0.32) 0 .0 0 (0 .10) ' : 0.16(0.14) 0.13(0.14) ‘ 0.28(0.31)
Scoparon (7) b 0.40 0.64 0.38 0.36 0.61
4,8-Diinethytherniarin (8) 100 2.03 0 .22(0 .20) 0 .2 2 (0 .20) 0.18(0.16) 0.13(0.12) 0.30(0.29)
X anthotoxin (9) 145 2.75 0.26(0.26) 0.20(0.18) 0.29(0.29) 0 .10(0 .10) 0 .11(0 .10)
Bergapten (10) 158 3.45 0.34(0.33) 0.14(0.13) 0.30(0.32) 0.11(0.09) 0 .12(0 .11)
Im peratorin (11) 142.5 2.60 0.31(0.30) 0 .2 2 (0 .22) d 0 .12(0 .12) 0.14(0.13)
X anthoxyletin (12) 159.5 3.36 0.30(0.33) 0.17(0.14) 0.30(0.32) 0.07(0.09) 0.06(0.08) 0 .11(0 .12)
hrtMs-Avicennoltrimethyl-
silyl e ther (13) 152.5 2.76 0.31(0.31) 0.16(0.15) d 0.08(0.08) 0.08(0.08) 0.13(0.12)
eis-Avicennoltrimethyl-
silyl ether (14) 152.5 2.75 0.32(0.31) 0.16(0.15) d 0.08(0.08) 0.09(0.08) 0.16(0.12)
trans-Avicennol (15) ft 0.40 0.40 d 0.14 0.14 0.20
c»s-Avicennol (16) ft 0.35 0.29 d 0 09 0.08 0.18
Avicennin (17) 151 2.80 0.29(0.30) 0.13(0.13) d 0.08(0.08) 0.08(0.08) 0 .12(0 .11)
Hexahydroavicennin (18) 151 2.80 0.30(0.30) 0.13(0.13) d 0.09(0.08) 0.11(0.09) 0.13(0.12)
Tetrahydroavicennol (19) ft 0.30 0.60 d 0.12 0.20 0.41
Dipetaline (20) 152.5 2.75 0.31(0.31) 0.15(0.15) d 0.08(0.08) 0.08(0.08) 0 .12(0 .11)







4 4' 2" 4"
Dipetalolactone (22) 184 2.40 0 31(0.37) 0.08(0.10) 0.07(0.08) 0.09(0.10) 0.06(0.06) 0.03(0.06) 0.22(0.23)
T etrahydrodipetalolactone
(23) 184 2.40 0.29(0.37) 0.07(0.11) 0.07(0.11) 0.08(0.11) 0.04(0.07) 0.06(0.07) 0.19(0.24)
Assignments uncertain owing to  complex sp litting  and overlapping. 4 Two complexation sites. e See tex t. s See Table 6 .
coumarins for all substituents (Table 1), and the method 
has been applied successfully .4U*12-14 Theoretical calcu­
lations of the electron densities in coumarins also tend to 
support our findings.15
The only examples in which a poorer than usual fit 
was obtained were those with 7,8-pyran substitution 
[seselin (21), dipetalolactone (22), and tetrahydro- 
dipetalolactone (23)]. For these three compounds the
4-H shift was less than calculated if the if> and d  values 
were altered to give a good fit elsewhere, and the <f> and 
d values thus obtained were atypical (Table 1). Possibly 
a better fit could be obtained by allowing movement of 
the europium atom or the ring substituents out of the 
plane of the coumarin ring or to allow the ring to become 
non-planar, but the present method could not then be 
used.
Some coumarins [e.g. (7), (15), (16), (19)] possess 
additional complexation sites for Eu(fod)a. Obviously 
the presence of such a site destroys the simple relation-
14 K. K. Purushotham an. S. Vasanth, J . D. Connolly, and  C. 
Labbd, J.C .S . Perkin  / ,  1970, 2594.
with the methoxys of scoparon (7) and it is clear from 
the figures in Table 1 that the relative l.i.s. for all
T a b l e  2
C alcu la ted  sh ifts  fo r sim ple s u b s t itu e n ts  in  all po sitions 
(0 150”, d 3.0 A), re la tiv e  to  3-H  =  1.00
Position
Substituent 4 5 6 7 8
H 0.32 0.19 0.14 0.17 0.33
Me 0.19 0.15 0.11 0.13 0 29
OMe(C) 0.13 0.17 0.10 0.11 0.16
OMe(A) 0.16 0.11 0.10 0.15 0.60
OMe(O) 0.16 0.13 0.10 0.12 0.20
C =  Clockwise, A =  anticlockwise, O =  out-of-plane (cou­
marin as drawn in this paper).
protons in scoparon (except by definition 3-H) are much 
larger than usual. Subtraction of average values for 
shifts in each position from Table 2, calculated for 
complexation at the lactone carbonyl only, gives an 
16 C. Decoret and  J . Royer, Bull. Soc. chim. France, 1976, 587; 
M. Abou-Asrali, C. Decoret, J. Royer, and  J. Dreux, Tetrahedron, 
1978, 82, 1655.
16 P. G. W aterm an, Phytochemistry, 1976, 15, 347.
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T a b l e  3
C alcu la ted  sh ifts  for d im e th y lp y ran o co u m a rin s  (<f> 156° 
d 3.0 A), re la tiv e  to  3-H  =  1.00
Substituent
Ring fusion 2',2'-Mc, 3'-H 4'-H
6.5 0.08 0.08 0.16
6.6 0.09 0.08 0.11
7.6 0.09 0.08 0.11
6.7 0.09 0.09 0.14
8.7 0.16 0.11 0.12
7.8 0.10 0.13 0.33
T a b l e 4
C alcu la ted  sh ifts  for fu ranocoum arin s  (<f> 156°, d 3.0 A), 























approximate measure of the effect of o-methoxy com­
plexation with scoparon (Figure 3). In a recent con-
0 26 0-35 o-oa
MeOXXX
J.C.S. Perkin II
that complexation between Eu(fod)3 and the methylene- 
dioxy group would be weak and unlikely to interfere 
with the method.
In most of our work we have assumed that methoxy 
substituents would adopt an out-of-plane conformation 
in order to minimise steric interactions with groups ortho 
to them. Where the orfAo-substituents are small this 
may not be valid, results in other areas 17 suggesting that 
there is a favourable conformation for the methyl in the 
plane of the ring, stabilised by overlap of the lone pairs 
of the ether oxygen with the aromatic 7i-electrons. The 
good fit we have obtained in most cases suggests that 
the out-of-plane conformation is a reasonable approxim­
ation, except where a substituent on one side of the 
methoxy dictates a move towards the less hindered side. 
Thus in the case of limettin (6) the observed shift for 
what we assume to be the 5-methoxy is lower than 
calculated, unless rotation towards C-6 away from 4-H 
is invoked (Table 2). This may cause rotation of the 
7-methoxy away from the 5-methoxy, resulting in a 
conformation which fits the observed shifts (Figure 4).
Me.
0-24 0 28
trasting example only simple complexation with a 
coumarin occurred,14 despite the presence of 6,7-di- 
methoxy substitution. Clearly some further work needs 
to be done before the effect of molecular structure on
Clearly further work would be needed to justify these 
refinements, but there is a probability that low values 
may be observed for 5-methoxys in coumarins lacking
6-substitution, for this reason.
T a b l e  5
S hifts fo r 8-isopreny l s u b s titu e n ts  (from  p o in t of a t ta c h m e n t to  coum arin ) 1
Compound
(H )
Chemical shift (3-H = 1.00)
CH , 0.29 CH 0.21 Me, 0.13, 0.07
(13) CH 0.40(0.33) CH 0.52(0.45) SiMe, 0.11(0.11) Me, 0.13(0.12)
(14) CH 0.32 CH 0.25 SiMe, 0.19 Me, 0.28
(16) CH 2.08 CH 2.56 OH 8.67 Me, 1.59
(16) CH 0 66 CH 0.74 OH 3.78 Me, 0.81
(17) CH 0.41(0.32) CH 0.38(0.45) Me 0.09(0.15) =CH, 0.09, 0.03(0.15, 0.08)
(18) CH , 0.36 CH, 0.24 CH* Me, 0.11
(19) CH, 2.92 CH, 4.03 OH 7.35 Me, 2.17
(20) CH , 0.36(0.32) CH 0.54(0.48) Me, 0.08, 0.19(0.12, 0.15)
lated values, where given in parentheses, arc for simple averages of in-plane conformations. * N ot identifiei
methoxy complexation is fully understood. Complex­
ation with m-methoxys does not appear to be significant, 
as shown by the results for limettin (6) (Table 1). No
c h 2 - c h = c h 2
O -C H ,
(24)
methylenedioxy-substituted coumarins were readily 
available to us, but experiments with safrole (24) indicate
While the calculated figures in Table 2 refer to a 
limited number of substituents, it is clear that the 
figures for CH3 and OCH3 will serve as a reasonable 
approximation for hydrogens attached to the first 
carbon of longer chains. The flexibility of longer chains 
is such as only to allow estimates for the predicted 
shifts, but particularly where an 8-substituent is con­
cerned shift differences are large enough to allow the 
positional assignment to be made with fair confi- 
dence.4'11,12 In Table 5 we have given the observed 
and, in three cases, calculated values for flexible prenyl- 
derived side-chains in all the compounds we have had
17 A. Hofer, Tetrahedron Letters, 1975, 3416.
2 9 7
1978
the opportunity to evaluate. Where given, the calcu­
lated values are based on average values for two extreme 
conformations, so that only an approximate fit would be 
expected. In some cases extra information can be 
obtained from simplification of splitting patterns in the 
side chain, and even configurational information may be 
obtained.12
The relatively poor fit obtained for 7,8-pyrano- 
coumarins may be tentatively explained by means of 
steric interactions between a relatively inflexible 8- 
substituent and the lactone ring oxygen. For such 
compounds the method still offers useful structural 
information on a more empirical basis, since the shift for 
the 8-substituent is larger than would be obtained
395
elsewhere. Further work is in progress in an attempt to 
clarify this anomaly.
EXPERIMENTAL
S p ec tra  w ere recorded  on  a  P erk in -E lm er R 12  n .m .r. 
spectrom ete r. C oum arins w ere o b ta in ed  from  a  v a r ie ty  of 
n a tu ra l an d  com m ercial sources, or b y  ro u tin e  m e th y la tio n  
of com m ercially  ava ilab le  h yd roxycoum arin s . S tru c tu re s  
w ere confirm ed b y  com parison  w ith  l i te ra tu re  d a ta  (u.v., 
i.r., n .m .r., m .s., m .p.) ex c ep t for new  com pounds w hich  
w ere identified  p rev iously .4' u ' 12
W e th a n k  D r. R . D . H . M urray  fo r a  sam p le  o f seselin, 
D r. R . M. W ing for a  field m ap, an d  th e  U n iv e rs ity  of 
S tra th c ly d e  fo r a  scho la rsh ip  (to  A. I. G .).
[7/1278 Received. 18th Ju ly , 1977]
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AbstracS—The stem bark o f  Nauclea diderrichii has yielded d iderroside, a new secoiridoid glucoside, as well as quinovic 
acid, 3-oxoquinovic acid and 3-O-glucosylquinovic acid. T he hydrocarbon fraction was dom inated by n-heptacosane 
and «-nonacosane, which accords with the predom inance o f  n-octacosanoic acid in the alkanoic acid fraction.
INTRODUCTION
Nauclea diderrichii (D e Wild) M err. (Sarcocephuhts dider­
richii D e Wild) is a large evergreen tree abundan t in the 
rain forests o f West Africa. The bark finds some local use 
in the treatm ent o f  gonorrhoea, for stom ach pains, fever 
and sometimes d iarrhoea. Its strength  as a tim ber and 
resistance to  termites m ake it valuable in construction 
w ork, a lthough sawmill w orkers have been reported  to 
suffer from  cardiac poisoning associated with its use [ 1].
Previous work on N. diderrichii has yielded a num ber o f 
alkaloids [2 -7 ], some o f  which may be artefacts [ 8]. O ur 
own results with the alkaloids will be reported  separately. 
The non-alkaloidal constituents reported by o the r w ork­
ers include naueleol, an tiaro l and the secoiridoid nauc- 
ledal [7] and, som ew hat earlier, 'sitostero l palm itale’, 
me.so-inositol and O-methyl-meso-inositol from  the heart- 
w ood [9], O ur analysis o f  the sterol ester m ixture from  
the stem bark has been reported  previously [ 10].
R E S U L T S  A N D  D IS C U S S IO N
Extraction o f the pow dered bark with petrol, followed 
by CC, gave four fractions, identified as hydrocarbons, 
sterol esters [10], sterols and  fatty acids. The sterols 
proved to be an unexceptional m ixture o f  sitosterol, 
stigm asterol and cam pesterol. The hydrocarbons were 
mainly norm al alkanes, the most abundan t being n- 
heptacosane, followed by n-nonacosane. This pattern  was 
reflected in the alkanoic acids, o f  which the most abundan t 
was n-octacosanoic acid. T he relative abundancies o f the 
alkanes and alkanoic acids may be o f  som e chem otaxo- 
nom ic value since they are certainly easier to  isolate and 
identify, using G C /M S , than m ore com plex metabolites.
C hlo ro fo rm  extraction gave further am oun ts  o f the 
four types o f  m ixture obta ined  from  the petrol extract. 
M ore po lar fractions yielded two triterpenic acids ten tat­
ively identified from mass spectral and  N M R  data as 
quinovic acid ( la )  [11] and  the rarely reported  [12] 3- 
oxoquinovicacid (lb). These were separated by prep. TL C  
as the ir methyl esters, one o f  which was show n to  be 
identical to  a sample o f  quinovic acid obtained  elsewhere, 
and similarly m ethylated. The latter sam ple also con­
tained 3-oxoquinovic acid, which may indicate that it is
COOH
COOHR --
la R ' = O H , R‘ = H 
lb R '=  R ^ =  O 
Ic R ' = O g l u , R*= H
m ore com m on than supposed. The 3-oxoquinovic acid 
dim ethyl ester was converted to quinovic acid dimethyl 
ester on reduction with sodium  borohydride by analogy 
with the reduction o f 3-oxocadam bagenic acid dimethyl 
ester described by previous workers [11]. An even more 
polar fraction from  this extract was show n to contain 
quinovic acid 3-O-glucoside (lc), purified and  character­
ized as the dim ethyl ester tetra-acetate. This glucoside was 
first reported from  the Rubiaceae [13],
The w ater-soluble part o f the ch loroform  extract 
contained small quantities o f  a substance la ter designated 
W F2A, larger am ounts o f which were present in the 
m ethanol extract. T he water-soluble portion  o f  the latter 
was subjected to  charcoal-C C  to rem ove sugars, and then 
gave a fraction which H P L C  showed to con ta in  a complex 
mixture. O ne com ponent o f  the m ixture was separated as 
a pure com pound by semi-prep. H PL C , and  called WF2A, 
identical to  the smaller am ount o f  m aterial isolated from 
the chloroform  extract. Experience show ed W F2A to 
possess limited stability in solution, bu t sufficient data 
were obtained  on samples soon after purification to allow 
structu re elucidation.
The UV spectrum  o f W F2A showed absorp tion  at 
234 nm, typical o f  the 0 - C = C  -C O O M e system of 
iridoids [14]. This suggestion was supported  by the 
l H N M R  spectrum  which showed a one-p ro ton  singlet at 
(57.55 (H-3) and  a three-pro ton  singlet at 3.71 (CO OM e-
4). A three-proton  singlet at 2.07 suggested an  acetyl
9 7 5
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group, and  a llircc-proton  doublet ( J  =  7 Hz) at 1.40 
correlated well w ith a methyl g roup  with a hydroxyl or 
acetoxy group on the neighbouring carbon atom . O ther 
signals provisionally assigned were a doublet (-'J =  8 Hz) 
at 5.80 (H -l) and a one-proton  multiple! at 5.25 (H -8 ) 
which suggested that an  acetoxy group was attached a t C- 
8 as well as the C-10 methyl. There was a doublet at 4.80 
( J  =  7 Hz) for the anom eric p ro ton  o f  a sugar, for the 
rem aining protons o f  which there was complex abso rp ­
tion in the region 3.3 -4.08. O ther separated resonances 
assigned subsequently were a tw o-pro ton  doublet ( J  
=  7 Hz) at 2.33 and  a m ultiplet for one p ro ton  at 2 .20 .
Hydrolysis with /J-glucosidase showed that the sugar 
was fi- D-glucose, a lthough we could not isolate the 
aglucone, and the presence o f  a /f-glucoside was confirm ed 
by the 1 ■*€ N M R spectrum , which showed the character­
istic resonances [ 15] at 99.7, 77.2,76.7, 73.7,70.8 and 6 1.9. 
O th er resonances confirm ed the iridoid skeleton [14], 
w ith C-1 at 97.2, C-3 at 154.2 ,C -4al 110.4, C -II  at 169.6, 
m ethoxy at 52.6 and C-10 methyl at 19.1. The acetoxy 
g roup  was confirmed by resonances at 21.8 and 174.0. 
O ther signals, consistent with a secoiridoid structure and 
subsequently assigned, were located at 70.5 (C-8 ), 43.6 
(C-9) and 29.6 (C-5). A broadened signal at 36.4,a triplet in 
the olf-resonance spectrum , was assigned to C-6  which left 
C-7 unaccounted for.
At this stage we were able to m ake a tentative structure 
assignm ent as 2a, excluding C-7, and sought further 
evidence from mass spectrom etry. However, even direct 
p robe  insertion w ith chemical ionization failed to  give a 
m olecular ion. This problem  was overcom e w ith field 
desorption , which indicated a M W o f 464, and  this was 
confirm ed by desorption-chem ical ionization [16], the 
la tter technique giving the simplest spectrum . W ith a 
consideration o f the previous data, the missing carbon 
had to be part o f  a  carboxylic acid group, so tha t in the 
13C  N M R  spectrum  it may have been superim posed on 
one o f the other carbonyl carbons; shortage o f  m aterial 
has prevented confirm ation o f  this by changing solvent. 
T he broadening o f  the C -6 signal may also have been 
reflected in broadening o f  the C-7 signal, if the form er was 
a ttribu tab le  to conform ational changes caused by alter­
n ate  hydrogen bond ing  to ester g roups on  cither side, and 
m ay have obscured the presence o f  the C-7 signal.
It was apparent tha t W F2A was a secoiridoid, p re­
viously unknow n, to which we gave the nam e ‘d ider­
roside’, and  allocated structure 2a. Acetylation gave 
diderroside tetra-acetate (2 b), previously know n as a 
synthetic intermediate [17], for which the lH N M R  spec­
trum  was consistent w ith the proposed structure. 
M ethylation o f  the te tra-aceta te w ith diazom ethane con­
firm ed the presence o f  the free carboxylic acid group, with 
a second methoxy signal in the 'H  N M R  spectrum , and 
gave a  product (2 c) w ith sufficient volatility to allow 
accurate mass m easurem ent o f  the m olecular ion 
(C 26H 350 15) and several fragm ents.
As final confirm ation o f  the struc tu re  a series o f 
decoupling  experim ents was carried out on m ethyl d ider­
roside tetra-acetate (2c) at 300 M H z, which allow ed 
assignm ent o f all the resonances.
T he question o f the relative stereochem istry o f d ider­
roside (2a) was fortunately solved by the very recent 
s truc tu re  elucidation [18] o f alpigenoside (2d), for which 
the stereochem istry has been defined by conversion to  
tetra-acetylkingiside (3), o f  know n absolu te configur­
a tion  [17]. C om parison  o f  d iderroside tetra-acetate
R'CH
2a R1 = COOH, R*= Me CO. R:' “ GUi 
2b R1 -  COOH, l#= MeCO , R1-- Gtu (Ack, 
2c R1 = COOMe, R?= MeCO, R3= Gtu (Ac 1* 
2d R’ = COOMe, R*= H , R3= Gtu
i  H
Me 0 Gtu (Ac),
m ethyl ester w ith penta-acctylalpigenoside by TLC and 
300 M H z N M R  showed that d iderroside is des-7-0- 
inethyl-8-O-acetylalpigenoside, with all four secoiridoid 
asym m etric centres in the same relative configurations. 
Shortage o f m aterial prevented m easurem ent o f the 
optical ro ta tion  o f  m ethyldiderrosidc te tra-aceta te  which, 
by com parison with the m easured ro ta tion  o f penta- 
acetylalpigenoside [18], w ould confirm  the absolute 
stereochem istry. However, it is highly im probable that 
d iderroside has a different absolute stereochem istry from 
alpigenoside.
E X P E R IM E N T A L
Plant material was collected from a forest reserve on the 
Benin-ljcbu-Odc road, Nigeria and identified by Mr. Daramola, 
senior plant collector of the Forestry Research Institute of 
Nigeria. This identification was confirmed by comparison with 
voucher specimens at the institute’s herbarium. Herbarium 
specimens have been deposited with the University of 
Manchester Museum.
Extraction and separatum. The powdered stem bark (4 kg) was 
extracted with cold petrol (bp 40-60”, 101., 2 x 5 1.) for 48 hr each 
time. The combined residue (9.13 g) was extracted withCHCl3 to 
give a sticky residue (33 g). The MeOH extract of the stem bark 
was a brown powder (370 g). The powdered heartwood (4 kg) was 
extracted only with cold MeOH (15 I., 3 x 6 1.) to give 217 g of a 
brown powder.
The petrol extract (6 g) was chromatographed on a Si gel 
column, eluting with petrol (bp 60-80”) with increasing propor­
tions of CHC1, to yield an alkane fraction (1.70 g), steryl esters 
(0.42 g),sterols (2.00 g) and fatty acids (0.33 g). TheCHCI, extract 
(20 g) was extracted with petrol to give 7.25 g of material similar 
to the petrol extract. The petrol insoluble material was further 
divided into H20  soluble (1.54 g) and H 20  insoluble (7.85 g) 
material. The H20-insoIuble residue (2 g) was chromatographed 
on Si gel using petrol, petrol-CHCl3 and GHCly MeOH to give 
(with 5%  MeOH in CHCI3) a mixture of quinovic acid and 3- 
oxoquinovic acid (340 mg). Elution with. 10% MeOH in CHCI3 
gave 3-0-glucosyl-quinovic acid (90 mg).
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The MeOH extract (250 g) was extracted with H 20  to give a 
bro wn gum (t It) g). This material (25 g) was chromatographed on 
a prepared charcoal column, eluting lirst with H ,0  and then with 
aq. MeOH (5 4 0 ) .  Fractions obtained with 20 30'/,, MeOH 
were bulked and evaporated at 30 40" in vacua to give a yellow 
powder (1.52g) which gave negative tests lor reducing sugars. 
This powder was dissolved in 10",, MeCN and chromatographed 
in 100/tl aliquots on a semi-prep. HPLC column, eluting with 
10 *>„ MeCN and detecting at 254 nm. Fractions containing the 
major component were combined and frcczc-dricd to give a light 
ofT-white powder (46 mg) which undoubtedly represented only a 
small part of the material originally present, but was pure by 
analytical HPLC.
The only non-alkaloidal component isolated from the heart- 
wood was O-mcthylinosilol, which has previously been reported 
from this species [9].
Hydrocarbons. GC/MS using a 1 Dexsil 300 column, temp, 
programmed at 100“ for 2 min followed by a rise of 8"/min to 
250“ gave the following percentages (chain lengths): n-alkanes
0.1(14), 1.0(15), 2.9(16), 5.0(17), 4.2(18), 1.7(19), 2.8(20),
2.5 (21), 2.7 (22), 3.1 (23). 2,7 (24), 7.5 (25). 2.9(26), 30.5 (27), 
4.3 (28), 13.7 (29), 7.0(30), 3.5 (31), I 8 (32), n-atkencs ( j-, C 22,
1.w>-alkanes C t ,-C j5, none greater than 0.3",,.
Alkanoic acids. These showed the expected carbonyl absorp­
tion at 1705cm 1 and 'H  NMR absorption at <59.8 (brs, 
COOH), 1.25 [/)/■ x, (CHj),,] and 0.9 (t, Me). Mcthylation with 
BF, MeOH complex gave the methyl esters, with IR absorption 
at 1748cm 1 and an additional 1H NMR spectral peak at <53.65 
(OMe). GC/MS using a 1 % Dexsil 300 column programmed at 
I S0“ for 2 min and a rise of IO“/min to 270“ gave the following 
percentages (chain lengths): 10.1(16), 13.6(18, Al), 9.0(18), 
3.2(24), 16.0 (26), 2.1 (27), 39.8 (28), 6.0(30).
Quinovic acid and 3-oxo-quinovic acid. The mixture o f these 
two components obtained by chrom atography had mp 267" 
(decomp.) and showed IR carbonyl absorption at 1695 cm 
1H NM R (80 MHz, D M SO -d6) 612.1 (hr. CO O H ), 5.5 (brs. M- 
12), 3.3 (hr nr, H-3), 0.8- 0.9 (in. Me). Separation o f  the acids was 
not feasible, so the mixed acids were methylated with C H 2N 2 and 
separated by prep. TLC  on Si gel, developing with C H C lj C (, H 
(9:1). From  100 mg o f crude mixed acids was obtained 27 mg 
dimethyl quinovatc and 40 mg dimethyl 3-oxoquinovate. Each 
was crystallized from petrol (bp 40 60 j  and then from petrol 
containing a small am ount o f  MeOH. Dimethyl quinovale had 
mp 163 165" (lit. [19-21] 169 171”, 179.5-181“, 174 176") [ a ] D 
t 73.3" (CHC1,; c 1.76), IR v,nalcm ':  3650, 1720, 1700; 
'H  NMR (300M H z,C D C lj): <5 5 .6 6 (IH ,/,./  -  2 Hz. H-12), 3.62 
(314, .v, COOM e). 3.61 (3H ,s,C O O M e),3.19 (IH , q.J  = 6 H z ,H -
3), 0.91 (3H, <1. Me), 0.87, 0.85, 0.83, 0,74 (I2H , 4s, 4 x Me),
0.82 (3H ,d. Me); El MS 70 c V.m/e (rcl. int.): 514.3624 (13.7), calc, 
for C j jH 50O 5; 514.3645 [ M ] ' ,  496.3442 (2.6), ealc. for 
C j2H40O 4; 496.3552 [ M - H j O ] ' .  395.3402 (6.0), calc, for 
C jbH4jO ; 395.3314 [M  -  2 x CO OM e — H] *. 306.1810(26.7). 
calc, for C ,„ H 360 4; 306.1831 [M  - C j „ H 240 ] ' .  207.1748 (100), 
calc, for C ,4H 250 ;  207.1749 [M  -  C ,aH 250 4]* , 190.1724
(74.2), calc, for C ,» H i,;  190.1721 [M  -  H 20  -  C 18H 240 4 ] *. 
Prominent ions not accurately mass measured were 482 [M  
-  32] * (24.3). 464 [M  -  50] ' (3.8), 455 [M  -  59] ' (17.2). 
328 [M  -  186]" (6.9). 274 [M  -  240]* (62.8), 247 [M  -  267]*
(50.9). (Found: C, 74.2; H. 9.8. Calc. Tor C j 2H ,„ O s: C, 74.6; 
H, 9.8%.)
Dimethyl 3-oxoquinovate had mp 144-144.5’ (lit. [12] 
156-157"), [a ]D + 98.0" (CHCI3;c 1.00), IR i’m4Xcm ‘ 1: 1720, 1690, 
'H  NMR (300 MHz, CDClj): <55.69 (lH ,f, H-12), 3.64 (6H,x, 2 
x OMe), 2.5 (2H, in. H-2), 0.83 1.04 (18H. 2</, 4.v. 6 x Me). El MS 
70cV, m/z (rcl int.): 512.3492 (27.4), calc, for C j2H480 5; 
512.3502 [ M ] ' , 453.3368 (57.5); calc, for C ,0H4i O.,; 453.3369
| M - CO O M e | ' ,  306.1834 (23.5), calc, for C ,„ H 21, 0 4; 306.1831 
[M  - 206] ’ , 274.1565 (45.0), calc, for C j  ,I1220 3; 274.1569 [M 
238] *. Prom inent ions not accurately mass measured were 
480 [ M -  32] * (67.4), 421 [M  - 9 1 ] ' (11.3), 393 [ M - 129]'
(25.9), 262 [M  -  250] ' (17.7), 247 [M  -  265] ‘ (35.3), 215 [M 
- 2 9 7 ] ' (46.7), 205 [M  -  307]' (38.9), 128 [M  3 8 4 ] ' (20.2). 
105 [ M -407]* (33.1), 91 [M  421] * (50.4). 55 [ M - 4 5 7 ] ’
(62.3), 41 [M  471] ' (100). (Found: C, 75.1; H. 9.7. Calc, for 
Cj2H4aO!,: C, 75.0; H,9.4'>„.)
A sample of quinovic acid (see acknowledgements) was found, 
after mcthylation, to give two spots on TLC, corresponding to 
dimethyl quinovatc and dimethyl 3-oxoquinovate, in three 
solvent systems.
Dimethyl 3-oxoquinovate was converted to dimethyl quin- 
ovate (mp, ramp, TLC) by reduction in MeOH with NaBl-l.,.
3-O-Glucosyl-quinovic acid. This compound was difficult to 
purify and characterize owing to poor solubility in most solvents 
and lack of mobility on TLC. The dimethyl ester tetra-acetate was 
obtained as a while powder after prep. TLC on Si gel using 
CHClj MeOH (4:1), and had mp 117 120", broad IR band al 
1750cm ]H NMR (300 MHz, CDClj): <55.7 (IH, in. H-12),
5.6 (IH, d. .1 = 8 Hz, H-F), 4.1-5.3 (5H, m. H-2', H-3’, H-4\ H-5' 
and H-6 '). 3.65 (3H, .v, COOMe), 3.63 (3H,.s, COOMe), 2.0- 2.14 
(I2H, 4s, 4xCO M e), 0.78-0.98 (18H,;n,6x Me). E1MS 70eV 
m/z (rcl. int.): 496,3663 (1.5), calc. Tor C32H4B0 4; 496.3552 [M 
-glucose tetra-acetate]' ,  331.1083 (8.7), calc, for C ,4H ,,O g; 
331.1029 [M -  dimethyl quinovale]', 271.0890 (19), calc, for 
C ,2H 150 2; 271.0818 [M dimethyl quinovale • MeCOOH]*, 
190.1746 (7.2) calc, for C ,4H 22; 190.1721 [M -glucose tetra­
acetate - C , 8H 240 4] ' ,  169.0508 (24.7), calc, for C„H,0.,; 
169.0501 [acetylated glucose fragment]*. No molecular ion was 
observed; the base peak was at m/z 43. Acid hydrolysis gave 
glucose (identified by PC)and,after rcmethylaiion with CH 2N 2, 
dimethyl quinovatc, identified by comparison with an authentic 
sample,
Diderroside. This compound was obtained as a white amorph­
ous powder with no discrete mp. [a ]D —34.6" (MeOH; c 1.16), 
CD (MeOH; <■ 0.40) Ai;220 - 4.18, At:24,,+ 0 .47 , UV A$JS?Hwh 
(loge): 234 (3.91), IR v J^ cm  ': 3400, 1700. 'H NMR
(300 MHz. D20): 37.55 (IH .s, H-3), 5.8 (IH ,d , J = 8 Hz, H-l), 
5.25(11-1, m.H-8), 4.8 (IH, d. 7 = 8 Hz, H-l ), 3.71 (3H, ,s, 
COOMe), 3.3-4.08 (7H, m, H-2’, H-3*, H-4\ H-5’, H-6a', H-6b \ 
H-5), 2.33 (2H, d, J = 7 Hz, H-6), 2.2 (IH, m, H-9), 2.07 (3H. .v, 
COMc), 1.4 (3H, d. 7 = 7 Hz, FI-10). ° C  NMR (25.1MHz, 
DjO); 3174.0 (.v, CO Me), 169.6 (s,C-tl), 154.2 (W. C-3), 110.4 
(s. C-4), 99.7 (d,C-l*), 97.2 (d, C-l), 77.2 (d, C-5*), 76.7 (d. C-3’), 
73.7 (</, C-2 ), 70.8 (d, C-4'), 70.5 (d,C-8), 61.9 (r. C-6*), 52.6 (q. 
OMe), 43.6 (d. C-9), 36.4 (r, C-6), 29.6 (d. C-5), 21.8 (q, MeCO),
19.1 (q, C-10). FDMS m/z (rcl. int.); 487 [M  + Na] * (100), 469 
[M -1 8 +  Na] * (12.5),. 464 [M] * (10.0), 446 [M ~ 18 ] * (6.0), 
437 [M 27]* (7.2), 406 [ M -  58]* (15.7). DCI (NH3) m/z 
(rel. int.): 464 [M ] ’ (4.0), 447 [M + H -  H 2OJ * (4.0), 422 [M 
I H -  43] * (3.7), 405 [M — 59] ’ (1.6), base peak
180 [glucose] 1. A small sample of diderroside was hydrolysed 
with //-glueosidase in aq. soln, freeze-dried and chromatographed 
on paper to confirm glucose as a hydrolysis product. A further 
small sample was acetylated with Ac20-pyridine and the product 
purified by prep. TLC on Si gel using CHClj-M eOH (4: Ij and 
obtained as a gum; ‘H NMR (300 MHz, CDClj); <57.42 
(IH .s, H-3), 5.59 (lH ,d, 7 =  6 Hz, H-l), 5.27 (IH, i,
7 = 9  Hz, H-3’), 5.15 (IH, m, H-8), 5.13 (1H ./.7  = 9 Hz, 
H-4’), 5.01 ( IH, dd, 7 =  9 Hz, H-2’), 4.99 ( lH ,d ,7  = 6 Hz, H-l ), 
4.31 (IH, dd, 7 =  4.5,12 Hz, H-6a’), 4.16 (lH ,d , 7 =  12 Hz, 
H-6b’), 3.77 (IH, m, H-5’), 3.70 (3H, s, OMe), 3.3 (IH, m, H-9), 
2.64 (1H, m, H-6a), 2.42 (1H, m, H-6b), 2.1 (1H, m, H-5),
1.99-2.08 (l5H,S.v,5 xCOMe), 1.32 (3H,d, 7 =  6 Hz, H-10).
A. O. A d e o y i :  and R D. Waiuh
This sample of diderroside letra-acetatc was treated with 
ethereal CH2N 2 to give the methyl ester as a gum; 1H NMR 
(300 MHz, CDClj): 57.41 (IH, .s, H-3). 5.57 (IH, d, J = 6 Hz, H- 
1), 5.24 (IH, i, J -  9 Hz, H-3'), 5.12 (IH, r,J  = 9 Hz, H-4'),
5.1 (lH , w, H-8), 5.03 (IH, t, .1 -  9 Hz, H-2 ), 4.95 (IH, d, J 
=  7.5 Hz,H-l ).4.28 (IH .dd.J = 4.5,12 Hz, H-6a'),4.l4(1H, dd,
J = 2. 12 Hz, H-6b'), 3.72 (IH, m, H-5'), 3.67 (311.x, OMe), 3.62 
(3H, x, OMe), 3.26 (IH, m, H-5), 2.56 (IH, dd, J = 6, 16.5 Hz, H- 
6a), 2.49 (IH, dd, J = 7.5, 16.5 Hz, H-6b), 2.14, 2.06, 2.01, 1.98.
(15H, 5x, 5 x  CO Me), 2.1 (lH ,m , H-9), 1.31 ( lH ,d ,J  = 6 Hz, H- 
10). These assignments were confirmed by decoupling H-5', H-5, 
H-9 and H -10. El MS 70 cV, m/z (rel. int.): 587.1586 (0.1), calc, for 
C'jJHasO, s; 587.1583 [M ]* , 239.0913 (15.6), calc. for.
C l 2H 15O s; 239.0919 [M — glucose tetra-acetate -  MeCOOH ]+,
165.0556 (73.0), catc. for C ,,! ! ,/) ,; 165.0554 [3-carbomethoxy-5- 
vinylpyrilium] ' ,  139.0396 (26.4), calc, for C 7H 70 3; 139.0395 [3- 
carbomcthoxypyrilium] *.
Comparison of methyl diderroside tetra-acetate with alpige­
noside pcnta-acetate (300 MHz 'H NMR,TLC)showed that the 
two were identical.
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Abstract The heartwood o f the stems o f  Nauclea diderrichii yielded as its major alkaloid the parent diacid o f  
desoxycordifoline, which has been named desoxycordifolinic acid.
IN T R O D U C T IO N
Previous work on the stems o f Nauclea diderrichii, a large 
evergreen timber tree common in the rain forests o f  west 
tropical Africa, has shown the plant to be capable o f  
elaboration o f  simple /?-carbolines [1 6J, in com m on with 
other species o f the Rubiaceae, and a seco-iridoid [7 ]. A 
series o f  pyridines and /i-carboline-pyridines has also been 
reported from the species [ 1 6 ] ,  after extraction pro­
cedures which utilized ammonia; the presence o f  these in 
the original plant material has been questioned [8], We 
have re-examined the heartwood, avoiding the use o f  
ammonia and strong acids. The plant material was 




la  R = Me 
lb  R=H
R E S U L T S  A N D  D IS C U S S IO N
The powdered heartwood was subjected only to extrac­
tion with methanol and the methanol extract treated 
according to Brown and Warambwa [9 ] to achieve separ­
ation into neutral, basic and amphoteric fractions. The 
major alkaloid, and the only one so far obtained from the 
wood in sufficient quantity for identification, came from 
the amphoteric fraction after gel permeation chromato­
graphy, and was obtained crystalline from aqueous aceto- 
nitrile. UV data were consistent with a fully aromatic fl- 
carboline structure and IR showed conjugated carbonyl 
as well as hydroxyl absorption. The 300 M H z 'H  NM R  
spectrum was o f  very high quality and showed only one 
misleading resonance: we at first interpreted a signal at 
ca <511,9 as being caused by a carboxylic acid proton, but 
later work with model compounds showed that it was 
almost certainly attributable to the indolic N -H . The 
remainder o f  the spectrum allowed us to go som e way to a 
structural assignment which will be explained by reference 
to the numbering in structure 1. The /i-carboline C-ring 
was represented by a singlet at <5 8.77, showing that the 5- 
position was substituted. There was a doublet a 8 8.36, a 
two-proton multiplet at ca 7.6 and a triplet at 7.30 
showing that the benzenoid ring o f  the /i-carboline was 
unsuhstitutcd. There was clearly a substituent at C-3, and 
several resonances suggested that this was a seco-iridoid 
moiety similar to secologanin. There was a singlet at <5 7.50 
corresponding to H -l 7 and a doublet at 5.56 for H -21. The 
vinyl group o f secoioganin-like iridoids was indicated by a 
doublet at <5 4.9 (J =  10 Hz), a doublet at 4.79 (J 
=  17 Hz), and the olefinic proton to which these were,
respectively, cis and irons coupled appeared as a double 
triplet at 5.70.
A doublet at <5 4.59 was interpreted as the anomeric 
proton o f  a sugar, and this was supported by complex 
absorption in the range 2.9-3.8. There was a broad multi­
proton exchangeable peak at ca 8 5. The 13C NM  R 
spectrum showed typical resonances for a /i-gluco- 
sid e[10 ], as well as resonances for 21 other carbons, 
including two carbonyls, which could all be rationalized in 
terms o f  a structure similar to desoxycordifoline, la  [9], 
On this basis all the I3C N M R  data could be assigned, 
with the proviso that some o f the /i-carboiine assignments 
are uncertain. Our own data on model compounds do not 
support all the assignments for these carbons made by 
either o f two earlier groups [11,12], which are themselves in 
some respects contradictory. The assignments given in the 
Experimental are only quoted where there is definite 
agreement.
Methylation o f  the alkaloid with diazomethane gave a 
compound with two O-methyl resonances in the 'H  NM R  
spectrum, confirming the presence o f  two carboxylic acid 
groups, and implying that the original carboxyl reson­
ances were included in the broad exchangeable peak at 
ca 8 5. The dimethyl ester o f  the new alkaloid proved to be 
identical in all respects with an authentic sample o f  
desoxycordifoline methyl ester [9], allowing structural 
assignment o f  the new alkaloid, which we have called 
desoxycordifolinic acid lb.
After acetylation and methylation, desoxycordifolinic 
acid was compared with desoxycordifoline methyl ester 
tetra-acetate, again confirming identity. It was also poss-
2097
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ible, partially with the aid o f  decoupling, to assign all the 
peaks in the 300 M H z 1H N M R  spectrum o f  the double 
derivative, including the sugar protons. All the mass 
spectral, IR and UV data arc in accord with the proposed 
structure (see Experimental).
It may be noted that the isolation o f  a 5-carboxy 
alkaloid o f  this type from a species o f  Nauclea does not 
support the taxonomic separation o f  the subtribe 
Adininae from the subtribe Naucleinae [13]. It is clear 
from the present work that such alkaloids are not 
restricted to Adininae. It is also possible that the adoption  
o f  suitable extraction procedures will show that the 
retention o f glucose, a major characteristic o f Adininae 
alkaloids [13], may be a feature o f  Naucleinae alkaloids as 
well. In this respect, the use o f ammonia and/or strong 
acid with highly labile seco-iridoid moieties not only 
ensures the production o f  artefacts but may also obscure 
the true nature o f  the alkaloids present naturally, by 
removing glucose residues.
So far we have not identified any pyridine-containing 
alkaloids from N . diderrichii but we are continuing our 
efforts to identify the tetrahydro-/?-carbolines which have 
been isolated in small quantities from the same extract, 
and which again appear to retain sugar moieties.
EXPERIMENTAL
Powdered heartwood of N. diderrichii (De Wild.) Merr. 
(Sarcocephatus diderrichii De Wild) (4 kg) was exhaustively 
percolated with cold MeOH. The extract was evaporated to give a 
brown powder (217 g). The powder (100 g) dissolved in MeOH 
(300 ml) and passed through a column of Amberlyst A15 resin, 
eluting first with MeOH and then with 10% Et2N in MeOH, the 
latter giving a brown powder (30 g) after evaporation. This 
material was passed through a column of Amberlyst A26 resin, 
eluting first with MeOH to give a basic fraction (8.2 g) and then 
with 10 % HOAc in MeOH to give an ‘amphoteric’ fraction (21 g). 
The ‘amphoteric’ fraction (10 g) was passed through a Sephadex
1.H20 column, eluting with MeOH. Contiguous fractions with 
UV and TLC indications of an alkaloidal nature were bulked to 
give a dark brown powder (5.9 g). This powder (0.4 g) was shaken 
with 80% aq. MeCN (25 ml), the clear soln decanted and left in 
the dark for 48 hr. Desoxycordifolinic acid was obtained as 
brown rosettes (56 mg), mp 206-208” (dec.). [« ]D -45 .7” 
(MeOH; c 0.126) Ae242 + 2.09, A e2(, 7 -  11.9, A«2»0 -  2.28, Ai:3 03 
-  1.22, Ae376 -  1.25 (MeOH; c 0.160) IR v j ^ c m '1: 1650 (> C  
=  0). UV iEiOHnm. 216, 236, 272, 306sh, 354. 'H N M R  
(300 MHz, DMSO-d6): <5 11.93 (IH .s,N H ),8.77 (IH,s, H-6),8.36 
(1H, d, J = 8 Hz, H-9) 7.62 (1H, rn, H -12), 7.58 (1H, m, H-11), 7.50 
(IH, x, H -l7), 7.30 (IH, (,,/ = 7 Hz, H-10), 5. 7 (IH, d r,./ =  10, 
17 Hz, H-I9), 5.56 (IH, d, J  =  5 Hz, H-21), 4.90 (IH, d, J  
= 10 Hz, H -l8a), 4.79 (IH, d, J  = 17 Hz, H-18b), 4.59 (IH, d, J 
= 8 Hz, H-l), 3.69 (2H, m, H-6’ a,b), 3.45 (IH,m, H -l5),3.07 3.25 
(6H, m, H- 14a,b, H-2’, H-3', H-4’, H-5’), 2.64 (IH, m, H-20). 
,3C NMR (20.1 MHz, DMSO-d6): & 167.6 (s. COOH), 151.1 (d, 
C-I7), 143.4 (s, C-3), 140.4 (s), 136.0 (s), 135.7 (s, C-5), 134.1 (d, C- 
19), 128.0 (d), 127.0 (s), 121.7 (d, C-9), 121.0 (s). 119.8 (d), 118.2 (t, 
C-18), 114.8 (d, C-6) 112.0 (d,C.-12), 110.1 (s, C-16), 98.3 (d, C-T),
95.4 (d, C-21), 77.1 (d, C-5’), 76.5 (d, C-3’), 72.9 (d, C-2'), 69.9 (d, C- 
4'), 60.9 (r, C-6'), 43.3 (d, C-20), 32.8 (t,C-14), 30.4 (d,C-15). EIMS,
70eV m/z (rcl. int.); 332 [M -g lu  -C O O H ] 1 (3). 314 (1), 288 (6), 
270 (6), 259 (3), 243 (4), 226 (5), 205 (3), 182 (23), 179 (1), 154 (4), 
126 (15), 97 (15), 44 (100). CIMS (NH,)m/z (rel. int.); 333 (36), 315
(12), 289 (72), 271 (13), 227 (100), 198(11), 183 (33), 180(81), 162
(13), 144 (39), 127 (79). f  ound C, 56.0; H, 5.2; N, 4.8%. 
C21H2BN 2O n H20  requires C, 56.4; H, 5.2; N, 4.9%. 
Treatment of a MeOH soln of desoxycordifolinic acid with 
CH2H , -Et20  followed by prep. TLC on Si gel gave di Me 
desoxycordifolinate mp 144-146”, mnip with Me desoxycordi­
foline, 145-147”, UV, IR, 'H  NMR and MS in accord with 
structure. Acetylation (Ac20 ,  pyridine) followed by methylation 
and prep. TLC on Si gel gave diMe desoxycordifolinate tetra­
acetate, mp 102-104°, mmp with methyl desoxycordifoline tetra­
acetate, 101-104”. UV 2Mjx0 l l nm; 235, 274, 318, 337, 350. IR 
I'SJP’cm 1750, 1680. 'H  NMR (300MHz, CDClj): 510.82 
(IH, .v, NH), 8.83 (IH, s, H-6), 8.22 (IH, d, J =  8 Hz, H-9), 7.72 
(IH ,d ,./ =  8 Hz, H-12),7.63 (IH, f, J = 8 Hz, H-l 1), 7.54 (IH ,s, 
H -l7), 7.38 (IH, t ,J  =  8 Hz, H-10), 5.89 (IH, df, J = 10, 17 Hz, 
H-19), 5.50 (IH, d, J = 5 Hz, H-21), 5.23 (IH, d, 7 = 1 7  Hz, H- 
18a), 5.23 (IH, l ,J  = 8.5 Hz, H-3j, 5.22 (IH, d, J = 10 Hz, H-I8b),
5.06 (IH, t ,J  = 10 Hz, H-4’), 4.90-4.91 (2H, m, H -l’, H-2’), 4.30 
(IH ,dd ,J  =  12,4.5 Hz, H-6’a),4.15 (lH,dd, J = 12,2 Hz, H-6 'b),
4.05 (3H,s, OMe), 3.90 (3H,s, OMe), 3.76 (1H, m, H-5'), 3.69 (1H, 
d, J  = 14 Hz, H-14a), 3.35 (IH, dd, J = 14, 10 Hz, Il-!4b), 3.23 
(IH, dd, J =  10, 5 Hz, H -l5), 2.67 (IH, dr, J =  10, 5 Hz, H-20),
I.97, 1.98,2.02,2.10 (12H, 4s, 4 x COMc). EIMS, 70 eV m/z (rel. 
int.): 752.2449 [M ] \  Calc, for C ,7H40N 2O , s: 752.2428 (5), 
421.1398; calc, for C23H 2I0 6: 421.1399 (19), 405.1449; calc, for 
C2jH 21N20 5: 405.1450 (27), 376 (5), 335 (12), 331 (6), 240 (27), 
169 (57), 165 (6), 139 (5), 127 (14), 115 (12), 109 (44), 85 (58), 83 
(100), 47 (18), 43 (86).
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Abstract: The dried stems of Arbutus unedo 
Itave been investigated for secondary metabo­
lites. In addition to the previously reported 
lupeol, ursolic acid, inonotropein, unedoside, 
and stilbcricosidc, the iridoids geniposide (2 ) 
and inonotropein methyl ester (1) have been 
isolated for the first time from this source. Be- 
tulinic acid (4) has also been isolated for the 
first time from this plant.
Introduction
The commercial importance o f Arbutus 
unedo  in herbal m edicine, based on a 
reputation for astringent, diuretic, and 
antiseptic properties (1) has resulted in a 
considerable amount o f phytochem ical 
work. This has led to the isolation o f the 
iridoids monotropein (2), stilbericoside
(3), unedide (2 ), and unedoside (4), all 
from the aerial parts. The phenolic 
glucoside arbutin and its methyl ether 
have been found in the leaves (5 ), as has 
the ubiquitous lupeol (6). O ther isolated  
constituents include anthocyanins from  
the fruits (7), glycolic acid (8), and 
carotenoids (9), and “urson” (10) from  
the leaves. Sosa has reported arbutolic 
acid, unedosterol, ursolic acid, and a 
variety o f other less specific products 
(11). Several flavonoids have recently 
been reported from the leaves (12).
The rationale behind our re-investiga- 
tion o f a plant which has already been  
thoroughly exam ined mainly concerned  
the iridoid content o f the stem s. When 
found, iridoids are often present as com­
plex mixtures which cannot b e separated  
by normal open-colum n chrom ato­
graphic m ethods. W e have therefore 
used small-scale preparative HPLC for 
the separation o f the iridoids, but having 
made extracts, we also exam ined the 
material for other secondary m etabo­
lites.
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Material and Methods
The mass spectra were measured at 70 eV by 
direct inlet on a Kratos M-25 spectrometer fit­
ted with a DS 55 computer data output. ‘H- 
NMR spectra were determined on a Bntker 
WP 80 Spectrospin (80 MHz). I3C-NMR 
spectra were determined on the same spec­
trometer at a frequency of 20.1 MHz.
Isolation
The aerial parts of the plant were collected 
from Mount Parnis, near Athens, Greece. 
The material was air-dried and voucher speci­
mens deposited with the Manchester Univer­
sity herbarium, where the material was au­
thenticated.
The leaves were separated, the stems di­
vided into bark and wood and each was pow­
dered before being extracted successively 
with petrol (b. p. 40-60° C), CHCi3 and 
MeOH in a Soxhlet apparatus.
The CHC1, extract of the bark was itself ex­
tracted with both petrol and water. The re­
sidue after this treatment was chromato­
graphed on silica gel to give betulinic acid (4; 
50 mg) m. p. 275° C (lit. m. p. 275 -278° C), 
identified by comparison of IR and NMR 
spectra with those published (13) and by com­
parison of i3C-NMR data (14).
As expected, the most interesting results 
were obtained from the MeOH extracts. The 
crude extract from the heartwood (70 g from 
680 g wood) was treated according to the 
method of Davini (2), in which the extract is 
adsorbed on charcoal and extracted succes­
sively with increasing concentrations of aque­
ous EtOH. Extraction with 30% aqueous 
EtOH gave a mixture of glycosides (4 g) which 
was first subjected to preparative TLC on 
silica gel using CH2C12 -  MeOH H20  
(40 :10 :1 ) to give impure monotropein (22 
mg) and an iridoid mixture (20 mg).
Preparative HPLC of both fractions on an 
octadecylsilanc column (Spherisorb 5 ODS2), 
eluting with MeCN -  H20  (10:90), gave pure 
monotropein (15 mg), monotropein methyl 
ester (1; 12 mg) and geniposide (2; 6 mg). The 
structures of monotropein methyl ester and 
geniposide were elucidated by derivatisation 
and spectroscopic analysis.
Similar treatment of the MeOH extract 
from the bark gave a mixture of glycosides 
(1.3 g), which ultimately gave two further 
iridoids, unedoside (25 mg) and stilbericoside 
(27 mg).
The iridoids were identified from spectral 
data, as given.
??3
Methyl ester o f monotropein (1)
Colourless gum; UV: (MeOH) kmaj 233 nm, 
'H-NMR see Table 1. CIMS m/z (rel. int. %), 
422 (M +  N H / ;  22.0), 404 (M +; 9.1), 242
(43.9), 225 (100), 207 (77.9), 193 (69.4), 180
(91.5), 167 (64.4). L1C-NMR see Table II.
Table L 'H-NMR spectral data of com­
pounds 1,2 ,3 , (80 MI Iz, D20  as solvent for 1, 
2; CDClj as solvent for 3)
1 2 3
H-l 5.53(d) 5.25(d) 5.16(d)
H-3 7.30 (br.s)1 7.48(d) 7.38(d)
H-5 3.30 (m) 3.82 (m) 3.23 (m)
H-6 6.10 (dd) - -
H-7 5.61 (dd) 5.75 (m) 5.88 (m)
H-9 2.63 (dd) -
H-10 3.54(br.s) 4 .20(m) 4.72(s-like)
O-Me 3.62(s) 3.67 (s) 371 (s)
OAc - 1.96-2.09 (15H)
Table: 11. ,3(: : - n m r  1chemical shift (lata of
compound 1 (80 MHz, D20 ,  dioxan as inter-
nal standard)
C - l 94.40 C~ 8 84.73 C - l ' 98.36
C -3 151.19 C -  9 44.06 C -2 ' 72.71
C -4 110.30 C -10 69.59 C -3 ' 76.28
C -5 37.07 C - l l 169.32 C -4 ' 72.52
C - 6 137.04 C -1 2 51.81 C -5 ' 75.70
C -7 132.09 C - 6 ' 60.73
Geniposide (2)
Yellow gum; UV: (MeOH) 236.5 nm; 
'H-NMR see Table I. CIMS m/z (rel. int. %) 
404 (M+ + NH,; 6.0), 387 ( M - l ;  7.9), 242
(59.7), 225 (100), 209 (22.4), 207 (83.3), 205 
(89.0), 193(25.5), 180(79.8), 175 (45.1).
Monotropein pentacetate
Colourless gum; ‘H-NMR (CDCI3), 7.46 (IH , 
br. s, H-3), 6.26 (IH , dd, H-6), 5.63 (IH , dd, 
H-7), 5.57 (IH , d, H -l), 5.17 (IH , d, 
anomeric H), 3.76-5.10 (m sugar protons), 
3.74 (2H, br. s, H-10), 3.48-3.61 (IH , m, H-
5), 2.68 (IH , dd, H-9), 1.98-2.11 (12H, m). 
CIMS m/z (rel. int. % ), 600 (M ‘ ; 7.8), 583 
(M + —OH; 4.1), 366 (23.8), 331 (74.9), 213
(30.8), 186(28.9), 169 (17.0).
Geniposide pentacetate (3)
Yellow gum; ‘H-NMR see Table I. CIMS m/z 
(rel. int. %), 615 (M* + NH,; 3.9), 597 
(M - l ;  4.1), 366 (330 + 2NH„+) (13.2), 331 
(54.2), 289 (5.0), 271 (10.2), 249 (19.5), 229 
(7.4; sugar moieties) 205 (21.2), 191 (24.6), 80 
( 100).
Betulinic acid (4)
l3C-NMR see Table III; EIMS m/z (rel. int. 














2  #  :  H




Tuttle III. °C-NMR chemical shift data of 
compound 4 (80 MHz), CDCIy-C5D5N 1:1)
c - - 1 38.97 C - 16 32.56
c - - 2 27.69 C -17 56.28
c - • 3 78.65 C -18 47.19
C-- 4 38.97 C - l  9 50.17
c - 5 55.63 C -20 150.81
c - - 6 18.43 C-21 29.89
c - - 7 34.53 C-22 37.23
C-■ 8 39.74 C-23 28.21
C-- 9 50.69 C-24 15,73
c - -10 37.23 C-25 16.08
C- 11 20.92 C-26 16.08
C--12 25.75 C-27 14.62
c 13 38.28 C-28 179.19
C- 14 43.18 C-29 19.35
c -15 30.88 C -30 109.35
Methylation o f Monotropein
Monotropein (10 mg) was dissolved in MeOH 
(5 ml) treated with excess diazomethane in 
ether at 0° C and the solution taken to dry­
ness. The residue chromatographed on silica 
gel with CHjClj -  MeOH -  H20  (40 :10:1) 
afforded the pure methyl ether of monotro­
pein (1, 4 mg), identical with the isolated 
material.
A cetylation o f Iridoids
The iridoid glucosides (5-10 mg) were 
treated with dry C5H5N and Ac20  for 2 h at 
room temperature. MeOH was added and 
after 15 min the solvent was evaporated. The 
pentacetates were isolated by preparative 
TLC using the system EtjO -  EtOAe (9 :1).
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Table I. Effect of isopimpinellin (1) and 
8-MOP (2 ) on viruses and cells






Phage T4 0.78 < 10' s
Sindbis virus 0.90 4 x 10"’
MCMV 0.64 <  10 '5
3T3 cells 0.82 CIO ' 5
“ Virus infectivity was assessed as plaque- 
forming units; pfu; cell viability as colony- 
forming units, cfu.
Initial values (1.00) represented 1 X  10" pfu/ 
ml of virus and 1 x  IQ6 cfu/ml of cells. AH 
values were approximately 1.00 in the ab­
sence of UVA. Concentrations of compounds 
were 10 pg/ml. Irradiation was for 20 min.
are e ith e r quickly repaired  o r they do not 
in terfere  w ith the  norm al tem p la te  ac­
tivities o f D N A  o r  R N A . If  this is the
Received: January 23,1987
The dried leaves o f A rctostaphylos uva- 
ursi (Ericaceae) have been re-investi­
gated for secondary m etabolites. In ad­
dition to the previously reported arbutin 
and methyl arbutin the phenolic 
glucoside piceoside (1) has been isolated 
for the first time from this plant and from 
the family Ericaceae. I3C-NM R data are 
reported for p iceoside and its acetate.
The commercial importance o f 
A rctostaphylos uva-ursi is based on a 
reputation for astringent properties and 
beneficial effects in nephritis and other 
diseases o f  the urinary system (1). A  con­
siderable amount o f research on the 
plant has led to the isolation o f triter­
penoids (2), iridoids (3, 4 ), and, re­
cently, flavonoids (5), as well as arbutin 
and methylarbutin (6).
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case, then the type of D N A  cross-link 
formed by isopimpinellin must be quite 
different from the characteristic biad- 
duct formed by 8-MOP. Thus, further in­
vestigations will have to focus on the 
type o f interaction that occurs between  
D N A  and isopimpinellin.
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Materials and Methods
The leaves were from a commercial source, 
originating in Spain: a sample has been depo­
sited with the Manchester University her­
barium, where the material was authenti­
cated.
IR spectra were recorded on a Pye-Unicam 
SP3-100 spectrometer in chloroform. Mass 
spectra were measured at 70eV by direct inlet 
on a Kratos MS-25 spectrometer fitted with a 
DS55 computer data output. 'H-NMR 
spectra were determined on a Brulcer WP80 
Spectrospin (80 MHz). l3C-NMR spectra 
were determined on the same spectrometer at 
a frequency of 20.1 MHz.
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The leaves (350 g) were powdered before 
being extracted successively with petroleum 
ether (b.p. 40-60° C), CHCI,, and MeOH in 
a Soxhlet apparatus. The MeOH extract was 
treated according to the method (7) in which 
the extract is absorbed on decolourising char­
coal (which has previously been boiled for 15 
min with distilled water) amd extracted suc­
cessively with increasing concentrations of 
aqueous EtOH. Extraction with 30% aque­
ous EtOH gave a mixture of phenolic 
glucosides (3 g) which was first subjected to 
preparative TLC on silica gel using CH2C12- 
MeOH-H20  (40:10: 1) to give pure arbutin 
(40 mg), methylarbutin (20 mg), and a 
glucosidic mixture.
Preparative HPLC of this glucosidic mix­
ture on an octadecyisilane column 
(Spherisorb 5 ODS 2) eluting with MeCN 
H20  (35:65) gave pure piceoside (1) and 
traces of methylarbutin. Their structures have 
been established by spectral data (UV, IR, 
'H-NMR, l3C-NMR) of the glucosides and 
glucoside acetates. The isolated arbutin was 
compared with a commercial sample and the 
penta-acetates of both were found to be iden­
tical. Synthetic methylarbutin was found to be 
identical to the isolated glucoside. Piceoside 
tetra-acetate (2) was synthesised directly from
4-hydroxyacetophenone and acetobromoglu- 
cose, and found to be identical to the product 
of acetylation of compound 1.
Piceoside (1): White crystals from MeOH; 
m.p. 160-165° C; UV(MeOH)Xm„  205, 262 
nm; 'H-NMR (D20 )  7 .8-7.9 (2H, d, 7 = 8.2 
Hz) 7 .0 -7 .1 (2H, d, 7 = 8.2 Hz) 5.0 (IH , d, 
anomeric H) 3.3-4.8 (m, sugar protons), 2.47 
(3H, s); "C-NMR see Table I ; CIMS m/z (rel. 
int. %): 316(M + N H /;7 .6 ) , 180 (68.1), 154
(48.5), 138 (49.0), 137 (100.0), 124(43.6).
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Table I. 'T -N M R  spectral data of com­























NS = Not seen.
Piceoside teiracetatc (2): White crystals 
from EtOH; m.p. 126° C; 'H-NMR (CDClj) 
7.87 -7.98 (2H, d, 7 =  8.8  Hz), 6.97-7.08 
(2H, d, 7 =  8.8 Hz), 5.2 (IH , d, 7 = 4.4 Hz, 
anomeric H), 3.77 -4.27 (m, sugar protons), 
2.56 (3H, s), 2.06-2.04 (12H, nr); 15C-NMR 
see Table I; CIMS m/z (rel. in t.% ); 484 
(M +  NR,*; 12.4), 33.1 (68.0), 137(100.0).
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It is w ell known that undifferentiated  
cell cultures o f Digitalis lanata Erh. 
(Scrophulariaceae) are not able to prod­
uce cardenolides (1, 2 ), w hereas mor­
phological differentiation leads to car­
diac glycoside formation (3 , 4 , 5). The 
relative cardenolide content is usually 
measured as digitoxin or digoxin equiva­
lents by radioimmunological methods 
(4 ,5 ) .
W c now  wish to report the isolation 
and identification o f five m ajor cardiac 
glycosides from an embryogenic cell 
strain o f D igitalis lanata.
The differentiation process was in­
itiated by transferring cells o f  an em ­
bryogenic long-term suspension cultured 
strain derived from filament to an ap­
propriate differentiation medium . After 
6 w eeks cardenolide formation started 
(as monitored by radioimmunoassay) 
and reached a constant maximum of 110
1 Pharmazeutisches lnstitut der Universitat, 
Auf der Morgenstellc 8 , D-7400 Tubingen,
Federal Republic of Germany.
3 Address for correspondence.
|,ig/g dry weight after approximately 15 
w eeks.
At that time odorosid H , odorobiosid  
G , glucodigifucosid, verodoxin and 
strospesid (for structural formula see 
Table I) could be isolated from a highly 
purified extract. The freeze-dried plant 
material was hom ogenized and sonically 
extracted with M eO H -H 20  (8 :2 )  at 40° 
C. T he filtrate was diluted with water 
and purified by precipitation with lead 
acetate (6). The cardenolides w ere ex­
tracted with CHC13 and CHC13 -  isop­
ropanol (3 :2 ) . T he pooled organic pha­
ses w ere brought to dryness and further 
purified by column chromatography on 
RP- 18 cartridges (Baker™ ). The car­
denolides were eluted with EtO H - H 20  
( 7 :3 ) ,  the solvent evaporated to dryness 
and the residue d issolved in M eO H . This 
extract was fractionated by preparative 
HPLC on N ucleosil RP-18 colum ns, 5 
pm, em ploying a gradient from 20 to 
55 % acetonitrile/water during 60 min­
utes (m odified after (7)). Each fraction 
was m onitored by TLC on silicagel 
plates developed in C H C l3-M e0H -H 20
Tabelle I. Main Cardiac Glycosides in Em­
bryogenic Cultures of Digitalis lanata.
R‘ r 2C,>
-H Dtl- Odorosid H
-H Gluc-Dtl- Odorobiosid G
-H Gluc-Fuc- Glucodigifucosid
-OCHO Dtl- Verodoxin
-OH . Dtl- Strospesid





„  2 - 0 4
( 8 0 :1 8 :2 ) . In five fractions car­
denolides could be positively detected by 
spraying with Jensen’s and K eede’s rea­
gent (8). N o positive colour reaction was 
obtained with xanthydrol, indicating 
that none o f the cardiac glycosides con­
tained 2,6-dideoxy sugars such as di- 
gitoxose (8). Mild acidic hydrolysis o f all 
fractions with M eO H -lN  HC1 (1 :1 )  at 
50° C yielded no aglyca either. A fter di­
rect hydrolysis on the TLC plate with 
HC1 vapors and detection with thymol/ 
sulfuric acid (8) digitalose, fucose and 
glucose were found as sugar com po­
nents. The identification of the five car­
denolides was verified by comparison
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Abstract The roots of Cluiia abyssinica have yielded three new diterpenes with a 6,7-secolabdane skeleton. Detailed 
structural assignments have been made from high-field N M R  data, particularly nuclear Overhauser effects.
IN T R O D U C T IO N
The perennial shrub Clutia abyssinica Jaub and Spach 
var. abyssinica (syn. C. glabrescens Knauf) is widespread 
in the drier regions o f Africa. Extracts o f the aerial parts 
are popularly used in Ethiopia to treat skin ailments [1], 
Apart from our previous work on C. abyssinica [2, 3], 
there appear to be only two reports on the chemistry o f 
the genus, secolabdane diterpenes having been reported 
[4, 5] from Cluytia richardiana. The preferred spelling is 
Clutia [6], based on the latinized form Clutius o f the 
name of the Dutch botanist Cluyt.
R E S U L T S  A N D  D IS C U S S IO N
The three new diterpenes were obtained in a high state 
of purity from the chloroform extract of the powdered 
roots by means o f chromatography on silica gel and 
repeated crystallization from methanol. As well as the 
usual MS and IR measurements, the com pounds were 
subjected to NM R spectroscopy at frequencies up to 
500 M Hz and it is largely on these data that the structural 
proposals are based. The molecular formula o f clutiolide 
(la) from accurate mass measurement is C 2oH 220 5. In 
the high field 'H  NM R spectrum the four-spin system at 
positions 1-2-3 can be readily assigned because it is 
characterized by chemical shifts and spin-spin coupling  
in 1-D and COSY spectra. Similarly, the four-spin 'H 
system at positions 9-11-12 can be assigned from the same 
spectra; chemical shifts and coupling are completely 
compatible and in agreement with data for similar com ­
pounds. The coupling constants for H -l la  and H -l 1/i 
with H -l 2 agree closely with those reported for fibraurin
[7], while the chemical shifts for these protons correlate 
with those for the analogous system in seconidorella 
lactone [8], one of the few examples o f a similar four-spin 
system. The precise figures for chemical shifts and coup­
ling constants are given in Fig. 1, as are COSY and 
HETCOR (' H - ,3C) correlations. The chemical shifts and 
coupling constants for the protons at positions 14, 15 and 
16 are characteristic for 3-substituted furans, as for 
example in saudin [4].
The two protons attached to position 19 resonate at 
(54.02 and 4.07 in accord with their position adjacent to
oxygen. The protons o f the exocyclic methylene group 
attached to position 7 have a large chemical shift differ­
ence, 8 5.51 and 6.12, consistent with their position next to 
the carbonyl and comparable with similar exocyclic 
methylenes [9], The single proton attached to saturated 
carbon at 52.26 assigned to position 5 and the two 
methyls at 8 1.09 and 1.24 complete the assignments for all 
22 protons. The higher field methyl has to be C-20 to 
satisfy the N O E data below.
The 2-D HETCOR plots for clutiolide were very clean 
and unambiguous. The correlations given in Fig. 1 show  
13C resonance frequencies which are completely com ­
patible with positions in the proposed structure. The 
numbers of attached protons for all carbons were 
obtained using D EPT and are as the structure requires. 
The only ambiguities in the I3C assignments concern the
Q c
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Fig. I. NMR data for clutiolide obtained at 500 MHz. Assign­
ments marked * and ** may be reversed.
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quaternary carbons 6,17 and 4,10. Interchange of these 
assignments does not affect the structure proposal.
There are many structures which would accommodate 
the ID, COSY and HETCOR data. However, the mo­
lecular formula indicates that there are 10 ring or double 
bond equivalents. After the double bonds are accounted 
for, four rings remain. One of these is the furati and 
another can be allocated to the y-lactone. IR absorption 
at 1775 cm 1 tended to support this suggestion. M ost of 
the remainder of the molecule therefore consists o f two 
rings. Both NOESY and ID  N O E  difference spectro­
scopy demonstrate that these are two six-membered rings 
as shown and allow the relative stereochemistry to be 
assigned.
For the sake o f simplicity we have assumed that the 
absolute stereochemistry at position 12 is S, because the 
majority o f diterpenes with similar furanolactone moi­
eties have this configuration, as do the specifically related 
compounds [5 ] richardianidin-1 and -2. With this as­
sumption, the configuration at position 9 is R, because 
there was a N O E  between protons at positions 9 and 12 
which are therefore cis and pseudoaxial. The relative 
stereochemistry within the bicyclic residue attached to 
position 9 is readily established. A N O E between the 
proton at position 5 and methyl 18 showed that the ring 
junction is cis. A further N O E  between this methyl and 
the alkene proton at position 3 confirms the position of 
the double bond, as does a N O E between this alkene 
proton and the proton at position 19 resonating at (54.07. 
A crucial N O E  between this proton at position 19 and 
methyl 20 demonstrates that methyl 20 is trans to methyl 
18 and to the proton at position 5. These N O E ’s are 
indicated on the stereostructure (Fig. 2).
It is more difficult to assign the stereochemistry of the 
bicyclic residue relative to that o f the 5 -lactone to which it 
is attached. However, assuming that the bicycle prefers to 
be pseudoequatorial relative to the (5-lactone, and that the 
5-lactone prefers to be pseudo-equatorial relative to the 
cyelohexane ring, there are several interactions between 
protons on both residues which help to establish the 
relative configuration. The ring junction proton at posi 
tion 5 has a pivotal role in view of the numerous N O E ’s in 
which it is involved (Fig. 2). In order to satisfy these and 
those involving protons at position 1 with position 11 and 
methyl 20 with position 9, a conformation is required 
similar to that shown in Fig. 2, in which the dihedral angle
1-10-9-11 is approximately 60°. If the relative configura­
tion between positions 9 and 10 is reversed, NOEs as 
observed result in severe steric interactions between the 
exocyclic methylene group (position 7) and the carbonyl 
at position 6.
The analogue lb  has a molecular formula C 20H 24O 5, a 
gain o f two hydrogens. These are readily assigned to the 2 
and 3 positions from NMR data, the alkene protons at 
55.57 and 5.71 having disappeared and the alkane region 
having gained. The other 'H chemical shifts are similar to 
those for la . The U C data including multiplicities are all 
consistent with the proposed structure and are given 
along with COSY connections and 'H  data in Fig. 3.
The N O E data for l b  confirmed the relative stereo­
chemistry to be similar to that of l a .  Of particular 
significance are NOEs between Me-20 and the [I proton 
attached to position 19, between M e-18 and the oc proton 
attached to position 19 and between M e-18 and the ring 
junction proton at position 5. A N O E between Me-20 
and the single proton at position 9 offers further support 
for the stereochemistry assigned to both l a  and l b .  
Attempts to convert l a  to l b  by hydrogenation have so 
far given complex mixtures.
The isomer 2  of the dihydro compound l b  showed two 
features in the ‘H NMR spectrum which are of immediate 
significance. The pattern for the two protons at ca 54, 
previously an AB quartet in both l a  and l b ,  became a 
pair of triplets showing that both protons of the quartet 
are coupled to a third proton. This third proton res­
onated at 52.48 and corresponds to the proton, pre­
viously a singlet in l a  and l b ,  resonating at 52.26 and 2.08 
respectively. On this basis it is not difficult to propose 
structure 2  for the isomer o f l b  and this assignment is 
supported by all the 'H data, including coupling con­
stants and chemical shifts, by COSY, 13C chemical shifts 
and multiplicities and by HETCOR correlations (Fig. 4). 
The N O E data are particularly helpful, because they 
confirm som e of the spatial relationships proposed for la  
and l b ,  as follows.
A N O E  between protons at positions 9 and 12 in 
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Fig. 2. Significant NOE’s observed for clutiolide at 500 MHz; a 
combination of ID and 2D data.
Fig. 3. NMR data for dihydroclutiolide obtained at 300 MHz. 
Assignments marked * and ** may be reversed.
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Fig. 4. NMR data for isodihydrocluliolide obtained at 
300 MHz. Assignments marked * and ** may be reversed.
bulky substituents on the 5-lactone. From a N O E  be­
tween the protons at positions 5 and 9 it can be deduced 
that the 5-lactone and the proton at position 5 are cis with 
respect to the cyclohexane ring. This proton and methyl 
18 are also cis, from the presence of a N OESY cross-peak. 
M ethyl 18 and the 5-lactone must therefore be cis, and 
this is confirmed by the existence of N OESY cross-peaks 
between methyl 18 and the higher field proton at position  
7, the exocyclic methylene. In isomer 2 a conformation is 
permitted in which the exocyclic methylene approaches 
position 6, there being no carbonyl at this position. When 
this occurs methyl 20 com es under the anisotropic shield­
ing influence of the 7c-electrons of the exocyclic methylene, 
accounting for the marked upheld shift o f this methyl, 
from 51.10 in lb  to 50.76 in 2.
Fig. 5. Derivation of clutiolide and related diterpenes from 
labdane.
The electron impact mass spectra for all three com­
pounds were consistent with the proposed structures. In 
particular, there is a tendency for cleavage o f the 9,10 
bond to give fragments, in the case o f clutiolide, 
C |0H 10O 3 and C 10H 13O 2. For lb  and 2 the fragment 
corresponding to the latter is C 10H ls O 2. The base peak 
for clutiolide, C 7H 50 ,  is probably derived from the furan 
ring and three carbons of the 5-lactone in the relatively 
stable bicyclic ion 3.
Our assumption that there is a biogenetic relationship 
between these diterpenes and labdane (Fig. 5) is con­
sistent with the observed relative stereochemistry. Lab­
dane is found in both mirror image forms, but if we 
assume 5S,9S,10R stereochemistry as a starting point we 
arrive at the stereochemistry of the present diterpenes as 
suggested above. This is particularly gratifying for posi­
tions 9 and 10, where free rotation can occur in the seco- 
labdanes.
E X P E R IM E N T A L
Mps: uncorr. 'H  (300, 400, 500 MHz) and 13C (75.4 MHz) 
NMR: CDCl3 with TMS as int. standard. MS: 70 eV. CC: silica 
gel 0.125-0.25 p (70%) and silica gel for TLC type H KMOp 
(30%). Plant material was collected in Jan. 1983 near Kibremen- 
gist, Sidamo region, Ethiopia and identified at the Herbarium of 
the Biology Department, Addis Ababa University, where a 
voucher specimen was deposited.
Extraction and isolation. Ground root of C. abyssinica (2 kg) 
was successively extracted with petrol, CHCI3 and MeOH at 
room temp. The CHC13 extract was evapd in vacuo to give a 
brownish gummy residue (33 g) which was exhaustively washed 
with petrol. The petrol-insoluble material (26 g) was washed with 
H 20  and dried to give a brownish-yellow gum. Of this, 6 g was 
chromatographed on a silica gel column, eluting with petrol 
containing increasing amounts of EtOAc. EtOAc petrol (1:4) 
gave fractions B-l, B-2 and B-3. B-l furnished a crystalline 
compound (la) from MeOH. B-2 and B-3 on further purification 
by centrifugal chromatography and repeated crystallization 
from MeOH yielded, crystalline lb  and 2 respectively.
Clutiolide (la) (34 mg). Mp 165-166° (MeOH); [ot]D -68.9° 
(CHClj, c 0.189). 2“ ;?" nm (log c): 210 (3.76). c m 1: 1775 (y- 
lactone), 1750 (5-Iactone), 1638, 1618 (C=C), 1501, 1422, 1363, 
1159, 1068, 1032, 877. EIMS m/z (rel. int.): 342.1468 (C20H 22O 5, 
ealed 342.1467) [M ] ' (4.4), 314 (5.4), 298 (5.4), 218 (6.8), 178 (48), 
177(18), 165(35), 134(20), 133(55), 132(31), 119(56), 107(46), 105 
(100), 94 (80), 93 (88), 91 (88), 86 (61); NOEs not given in the text
1 a  XV- CH-CH- 
b  XY“  -CHj CH j -
311
R . D . W a i g h  et al.
( 'H -'H ): 14-15, 2-3, la-1 ft, l/i-2, 19*19/3, 1 la-11/1 and 7a-7b.
Dihydroclutiolide (lb) (74 rag). Mp 119-120° (MeOH); [ a ]D
90° (CHC13; c  0.186). nm (logs): 210 (3.78). c m ' '; 
3147, 2935, 2876, 1763 (y-lactone), 1750 (5-lactone), 1638, 1618, 
1502,1458,1386,1364,1238,1056,1010,877. EIMS m/z (rel. int.): 
344.1623 (C20H24O 5, calcd 344.1623) [M ]+ (8.9), 268 (21), 251 
(8.6), 236 (7), 178 (100), 177 (22), 167 (64), 133 (70), 123 (78), 105 
(46), 81 (13); NOEs not included in the text (*H-‘H): 14-15,9-7a, 
7a-7b, lla-ll/J , 19a-19/i and 9-11/3.
Isodihydroclutiolide (2) (112 mg). Mp 156-157° (MeOH); [a ]D 
-44.4° (CHClj; c0.18). nm (logs): 211 (3.86). v“ tm  ': 
3135, 2947, 2863, 1767 (y-lactone), 1733 (5-lactone), 1638, 1512, 
1490, 1357, 1109, 1026, 876. EIMS: 344.1648 (C20H24O s calcd 
344.1624) [M ]* (0.8), 179 (13), 178 (100), 167 (46), 166 (10), 133 
(41), 123 (17), 109 (65), 105 (25), 93 (36), 81 (33); NOEs not 
included in the text: ( 'H - ‘H) 1 la-11/i, 9-11/i, 11/3-12, 7a-7b and 
14-15.
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Abstract The chloroform extract o f the powdered whole root of Clutia abyssinica has yielded a complex mixture of 
5-methylcourriarins, of which 10 have been isolated in pure form and identified, mostly by NMR.
IN T R O D U C T IO N
The East African shrub Clutia abyssinica has proved to be 
a rich source of secondary metabolites [I ] . As a continua­
tion o f our work on the species we have made a careful 
examination of the chloroform extract of the powdered 
whole roots. This has yielded a total o f 10 5-methyl- 
coumarins and there are traces of yet more. O f the 10 
which we have isolated in a pure form, seven have not 
been previously reported, including three which contain 
sulphur.
R E SU L T S A N D  D IS C U S S IO N
Taking the non-sulphur containing compounds first, in 
order of increasing substitution, the simplest structure 
isolated was 4-methoxy-5-methylcoumarin ( la ), also 
known as ekersenin [2 ] or pereflorin [3]; the compound  
was first reported with the wrong structure and without a 
trivial name [4], It appears that the name ekersenin takes 
historical precedence. The structure was first confirmed 
by a simple synthesis from meta-cresol and malonic acid 
which gives a mixture o f isomers [5]. The unwanted
7-methyl isomer predominates and was reportedly re­
moved by crystallization [5]. In our hands it was easier to 
mcthylate the mixture and separate by semi-preparative 
HPLC.
The structure o f the previously unknown 3,5-dimethyl-
4-methoxycoumarin lb  was confirmed by an analogous 
synthesis using methylmalonic acid. As expected, the 
required isomer was the minor component of the mixture 
o f products and was again separated by semi-prep. 
HPLC.
Isolation of the known [63 8-hydroxy-4-methoxy-5- 
methylcoumarin !c (8-hydroxypereflorin) was confirmed 
by comparison with an authentic sample. The previously 
unknown 3-methyl analogue Id  was distinguished from 
other possible hydroxy isomers by the observation of 
ortho coupling between the aromatic protons and an 
N O E between the 5-methyl group and one o f the aro­
matic protons.
Two di-oxygenated analogues presented greater diffi­
culty in identification, because the measurement o f NO Es 
allowed alternative possibilities. Both 3,5-dimethyl-4,6,7- 
trimethoxycoumarin (le) and 3,5-dimethyl-4,6-dimeth- 
oxy-7-hydroxycoumarin (Iff) showed NOEs (Figs 1 and
Me R2
R' R2 R3 R4 R5
a H OMe H H H
b Me OMe H H H
c H OMe H H OH
d Me OMe H H OH
e Me OMe OMe OMe H
1 Me OMe OMe OH H
9 H SMe H H H
h Me SMe H H OH
i H SMe OMe OH H
i H SMe OMe OMe H
2), which leave open the question o f whether there is 
oxygenation in the 7 or 8 position. This ambiguity was 
resolved by the measurement o f 13C chemical shifts for 
the methoxy groups, which show two methoxys out-of- 
plane (chemical shifts ca 60 ppm) for both analogues, 
consistent with substituents on both sides of each meth- 
oxy [7]. The 7-methoxy group in le  is in-plane, with a 
chemical shift o f 56.0 ppm. Final confirmation o f the 
structures and complete assignments for the 13C spectra 
were obtained by a combination o f 2D  heteronuclear 
correlation experiments and long-range correlations 
achieved using the FLO CK pulse sequence [8 ]. The 13C 
assignments for If were completed by treatment of the 
chloroform-4 solution with a H 20 - D 20  mixture, which 
caused slow exchange o f the hydroxyl proton and a 
resultant broadening and reduction in intensity o f the line 
for C-7. The chemical shifts and FLOCK correlations are 
given in Figs 1 and 2.
Four 4-methyithiocoumarins were isolated, the sim­
plest being the known [9 ] 5-methyl-4-methylthio- 
coumarin Ig. To confirm the structure, 4-hydroxy-
5-methylcoumarin, obtained in a mixture in the first 
stage o f the synthesis o f the 4-methoxy analogues as 
described above, was separated by prep. TLC, tosylated 
and substituted with methanethiolate. This is a slight
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Fig. I. NOE data and long-range (FLOCK) H -C  connections 
for coumarin le.












,1 0 9  8 4 a
-127  9 5
-1 AT ? 6
-1 5 1 .6 7
101 .5 8
-151  2 8 a




Fig. 2. NOE data and long-range (FLOCK) H -C connections 
for coumarin If.
im provem ent on the later stages of the previously re­
ported m ethod [9],
The structu re o f 3 ,5-dim ethyl-8-hydroxy-4-m ethyl- 
thiocoum arin Ih  was largely established from 'H  
N M R data. O bservation  o f a N O E  between the 5- 
methyl group and  an  arom atic p ro ton  established tha t 
the hydroxy g roup  was not a t position 6. U nfortunately  
the arom atic p ro tons  were m agnetically equivalent, pre­
venting the m easurem ent o f coupling constants: the struc­
ture was confirm ed by the observation o f ortho coupling 
between the a rom atic  p ro tons in the methyl ether, pre­
pared by reaction  with diazom ethane.
The final two coum arins were 7-hydroxy-6-m ethoxy-5- 
m ethyl-4-m ethylthiocoum arin (li) and its 7-m ethoxy 
analogue lj. T he la tter showed N O E s as in Fig. 3, and 
confirm ation o f the substitu tion  pattern  was ob ta ined  as 
for le  and I f  by a com bination  of l3C N M R  chemical 
shifts, which show  the 6-m ethoxy g roup to  be out-of­
plane, and by heteronuclear correlation, including 
F L O C K  experim ents (Fig. 3). The stru c tu re  o f the 
7-hydroxy ana logue li  follows from com parison  o f N M R  
d a ta  with those for lj , m ost significantly the chem ical shift 
for the m ethoxy g roup  at 61.4 ppm  which is out-of-plane 
and therefore a t position  6, while the hydroxy g roup  has 
to  be at position  7.
EXPERIMENTAL
Collection anti preparation o f plant material. Roots of 
C. abyssinica Jaub and Spach were collected in January 1983 
near Kibremengist, Sidamo region, Ethiopia and identified at the 
Herbarium of the Biology Department, Addis Ababa University, 
where a voucher specimen is deposited.
Extractionation and fractionation. Ground whole root of 
C. abyssinica (2 kg) was successively extracted with petrol 
(bp 60-80°), CHC1 j and MeOH at room temp, for 2,3 and 4 days 
respectively. The CHClj extract was cvapd in vacuo to give a 
brown gummy residue (33 g) which was exhaustively washed 
with petrol. The petrol-insoluble material (26 g) was washed with 
H 20  and dried to give a brownish-yellow gum, of which 6 g was 
chromatographed on a silica gel column and eluted with petrol, 
and petrol containing increasing quantities of EtOAc. Appropriate 
combinations of centrifugal chromatography, semi-prep. H PLC, 
prep. TLC and crystallization from MeOH gave the 10 cou­
marins. Mps: uncorr.1H NMR spectra were recorded at 270 and 
300 MHz with TMS as int. standard in CDClj. ,3CNM R 
spectra were recorded at 67.5 MHz with TMS as int. standard in 
CDClj. Carbon atom type (‘multiplicity’) was determined from 
broad-band decoupled and DEPT 135 experiments. HPLC 
separations were carried out on a Dynamax-60A normal phase 
column (25 cm x  10 mm i.d.) with a Waters detector at 254 nm.
4-Methoxy-5-methylcaumarin (ekersenin, pereflorin la). Mp 
152-153° (MeOH) (lit. [2] 165° [3] 115°); / Mc0!l nm: 274, 284, 
304; vKB’ cm ': 1704, 1616, 1600, 1562, 1257; EIMS: m/z (rel. 
int.): 190 (100), 175 (6.7), 162 (43), 147 (55), 132 (24); ‘H NMR 
(CDClj): 7.49-7.02 (3H, m, H-6, 7 and 8), 5.65 (IH, s, H-3), 3.94 
(3H, s, OMe-4), 2.64 (3H, s, Me-5). A sample for comparison was 
synthesized from m-cresol (11.25 g) and malonic acid (12.35 g) 
which were heated at 60-65“ with POC1, (33 ml) and ZnCl2 
(49 g) for 36 hr. Work-up according to the lit. method [5] gave a 
yellow-orange solid (9.0 g) which was a mixture of 4-hydroxy-7- 
methylcoumarin and the desired 4-hydroxy-5-methylcoumarin. 
These could be separated with difficulty, but for the 4-meth- 
oxy compound it was easier to methylate a sample with 
K jCOj-M ejSOa and separate on normal phase HPLC with 
EtOAc-hexane (3:7), giving pure material, identical with the 
natural coumarin.
4-Methoxy-3,5-dimethylcoumarin (lb). Mp 102-103°; 
AMcOH nm (log e): 217 (4.4), 283 (4.4), 314 (sh„ 4.15); El MS: m/z (rel. 
int.): 204(89), 189(73), 161 (100), 145(13), 135(13), 115(17), 105 
(18), 91 (14), 77 (16); ‘H NMR (CDClj): 7.35-7.07 (3H, m, H-6, H- 
7 and H-8), 3.88 (3H, s, OMe-4), 2.70 (3H, s, Me-5), 2.18 (3H, s, 
Me-3). Synthetic material was obtained essentially as for la,
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except that methylmalonic acid was used in place of malonic 
acid. From m-cresol (4.5 g)and methylmalonic acid (5 g) the yield 
of mixed Coumarins was 0.67 g. A sample of this mixture was 
methylated and separated on normal phase HPLC with 
EtOAc-hexane (1:4) to give lb, identical with the natural 
coumarin.
8-Hydroxy-4-methoxy-5-methylcoumarin (8-hydroxypereflorin, 
lc). Mp 234-236“ (lit. [6] 230-232“); 2M'° "  nm: 205, 253, 285; 
EIMS: m/2 (rel. int.): 206 (23.5), 191 (11.8), 179 (17.6), 178 (11.8), 
163 (23.5), 149 (182.4), 105 (76.5), 97 (100), 77 (88.2); ‘HNMR 
(CDClj): 7.01 (IH, d, 7 = 8 Hz, H-7), 6.96 (1H, d, 7 = 8 Hz, H-6), 
3.97 (3H, s, OMe-4), 2.57 (3H, s, Me-5).
8-Hydroxy-4-methoxy-3,5-dimethylcoumarin (Id ). Mp 200- 
201"; 2M'°"  nm (log e): 204 (3.57), 257 (3.07), 294 (3.19); EIMS: 
m/z (rel. int.): 220 (100), 205 (38), 192 (14), 177 (47), 161 (32), 149 
(28), 133 (21), 105 (24), 90 (23), 77 (31); ‘HNM R (CDClj): 6.98 
(1H, d, 7 = 8 Hz, H-7), 6.96 (1H, d, 7 = 8 Hz, H-6), 5.7 (I H, br s, 
exch., OH-8), 3.88 (3H, s, OMe-4), 2.61 (3H, s, Me-5), 2.18 (3H, s, 
Me-5).
4,6,7- Trime[hoxy-3,5-dimeihylcoitman>i (le). Mp 123-124"; 
l Mc0,lnm (log e): 275 (3.8), 284 (3.9), 305 (3.7), 318 (3.5); 
\,KBr cm ': 1719, 1609, 1562, 1401, 1362, 1259, 1197, 811, 741; 
EIMS m/z (rel. int.) 264 (100), 249 (79), 236 (32), 221 (69), 206 (8), 
194 (10), 177 (34), 163 (18), 162 (32), 147 (23), 91 (48), 77 (38); ‘H 
and IJCN M R data are given in Fig. I: delays in the FLOCK 
pulse sequence [8] were A1 =46.5 msec. A2 =  25.5 msec with a 
relaxation delay of 3.0 sec.
7-Hydrc>xy~4fi-dhnethoxy-3,5-dimethylcoumarin (If). Mp 
199-200“; 2M“°" nm (log e): 228 (4.1), 255 (3.2), 298 (3.9), 325 
<4,11); vKB’ cm *: 1686, 1617, 1570, 1431, 1360, 1289,1138, 1101, 
897,782,743; EIMS m/z (ret. int.): 250 (72), 235 (45), 222 (100), 207 
(69), 179(14), 163(10), 147(16), 91 (21), 77(18);'H  and 15CNM R 
data are given in Fig. 2: delays in the FLOCK pulse sequence [8] 
were A1 = 86.5 msec, A2 =46.5 msec with a relaxation delay of 
2.0 sec.
5-Methyl-4-melhylthiocoumarin (Ig). Mp 184-185“ (MeOH) 
(lit. [9] 192.5“); 2Me0H nm: 236, 271, 333 (sh); vKB'c m ' 1706, 
1597, 1553,1401, 1332,1278, 1160, 899, 788; EIMS m/z (rel. int.): 
206 (100), 191 (76), 178 (64), 163 (42), 159 (21), 147 (10), 134 (17), 91
(21), 77 (23); ‘H NMR (CDClj): 7.39 7.01 (3H, m, H-6, 7 and 8),
6.06 (1H, x, H-3), 2.86 (3H,s, Me-5), 2.52 (3H, s, Me-4). A sample 
was obtained for comparison by synthesis from the mixture of 4- 
hydroxycoumarins obtained as described under la. The mixture 
(88 mg) in dry pyridine (3 ml) was treated with p-tolucnesulphon- 
ylchloride (95 mg) in dry pyridine (3 ml). After 12 hr the mixture 
was poured onto ice and extracted with Et20 . The tosylate 
(50 mg) was treated with sodium thiomethoxide (15 mg) in dry 
pyridine (3 ml) for 24 hr, the pyridine removed under vacuum 
and the products separated by prep. TLC on silica gel using 
E tjO -petrol (2:3) to give Ig (8 mg), identical with the natural 
product.
8-Hydroxy-3,5-dimethyT4-melhylthiocouniarin (Ih). Mp 174- 
175"; 2Mc°"nm  (log e): 265 (4.02), 309 (4.01); v K n ,c m  ': 1674, 
1611, 1548, 1489, 1401, 1356, 1248,1139,837,764; EIMS m/z (rel.
int.): 236 (100), 221 (17), 208 (24), 193 (55), 162 (49), 147 (55), 132 
(32), 103 (29), 91 (41), 77 (55); 'H N M R (CDClj): 6.98 (2H, ,v, H-6 
and H-7), 2.81 (3H, s, Me-5), 2.47 (3H,s, Me-3), 2.34 (3H, s, SMe-
4). Treatment with diazomethane gave 3,5-dimethyl-8-methoxy-
4-methylthiocoumarin as an oil: EIMS m/z (rel. int.): 250 (100), 
222 (31.0), 175 (27.6), 138 (69.0), 121 (72.4), 103 (69.0), 77 (79.3); 
'H N M R  (CDClj): 6.97 (IH, d, 7 =  8 Hz, H-7), 6.94 (1H, d, J 
=  8 Hz, H-6), 3.92 (3H, s, 8-OMe), 2.81 (3H, s, Me-5), 2.47 (3H, s, 
Me-3), 2.34 (3H, s, SMe-4).
7-H ydroxy-6-methaxy-5-methyl-4-methylthiocoumarin (li). Mp 
224-225"; 2Mc°" nm (log e): 221 (4.02), 284 (3.83), 308 (3.85), 331 
(3.86); vKBt c m '1: 1703, 1613, 1526, 1401, 1365. 1275, (143, 1069, 
833,719; EIMS m/z (rel. int.): 252 (100), 237 (81), 224 (52), 209 (62), 
189 (20), 177 (11), 149 (12), 139 (12), 93 (13), 77 (28); 'H N M R 
(CDClj): 6.84 (1H,s, H-8), 6.23 (IH, hr s, OH-7), 5.94(1H, s, H-3), 
3.77 (3H, s, OMe-6), 2.77 (3H, s, Me-5), 2.50 (3H, s, SMe); 
13C NMR (CDClj): 160.1 (C-4), 159.3 (C-2), !51.9(C-7), 151.5(C- 
8a), 143.1 (C-6), 129.6 (C-5), 111.9 (C-4a), 104.3 (C-3), 102.2 (C-8),
61.4 (OMe-6), 16.4 (SMe-4), 16.0 (Me-5): the latter two assign­
ments may be reversed, as may those for C-4/C-2, C-7/C-8a and 
C-3/C4S.
6J-Dimethoxy-5-melhyT4-methylthiocoumarin (lj). Mp 146— 
147"; 2Mc0H nm (log e): 225 (4.11), 282 (3.92), 310 (3.96), 331 (3.93), 
345 (sh., 3,8); vKB( cm ': 1703, 1596,1529, 1403, 1350, 1289, 1233, 
1197, 1053, 898, 716; EIMS m/z (rel. int.): 266 (100), 251 (54), 238
(24), 223 (31), 77(14); 'H  and " C  NMR data are given in Fig. 3: 
delays in the FLOCK pulse sequence [8] were A' =86.5 msec, 
A2 =  46.5 msec with a relaxation delay of 2.0 sec.
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Abstract— Polyhydroxylated tropane alkaloids, n o t hitherto  recorded from  the po ta to  (Solarium tuberosum), were 
detected in the leaves and  tubers of this plant. They are po ten t inhibitors o f glycosidases and may be responsible for 
neurological disorders in livestock. These alkaloids were also extracted from a  sphingid m oth  and an ithomiine 
butterfly, the larvae o f which feed on Solatium.
INTRODUCTION
The haw k-m oths a re  essentially a cryptic group b o th  as 
adult and larva, but am ong them  are a few sequesterers 
and  storers of toxins [1 -3 ]  and  also a num ber o f enig­
matic species which could be classified as either cryptic or 
aposem atic. The death 's-head  haw k-m oth (Acherontia  
atropus), the iarvae o f which feed on potatoes, pertains to 
the la tte r category and its co loration  and behaviour 
suggest tha t it contains som e plant-derived deterrent. We 
verified that, like M anduca sexta  and  m ost Solatium  
feeders, this m oth  does not store the glycoalkaloids 
present in Solarium o r  the know n alkaloids of Datura, on  
which plants we reared  it a t A shton. We could, however, 
detect o ther unusual bases in several o f the m oths and 
therefore decided to  search the p lan ts as the possible 
source of some deterren t h itherto  overlooked.
R E S U L T S  A N D  D IS C U S S IO N
White, heaithy tubers o f S. tuberosum  cv ‘Estim a’ were 
purchased in a superm arke t and  found to con tain  0.01 %  
(fresh weight) of tropane alkaloids in the skin w hereas the 
rest of the tuber contained  one-tenth o f this concen tra­
tion. The m ajor alkaloids were la.20,3a-trihydroxy-nor- 
tro p a n e (l)  and la,2/?,3a,4/?-tetrahydroxy-/ior-tropane(2), 
recently reported to  occur in Calystegia sepium  (b ind­
weed) and given the trivial nam es calystegine A 3 and  B2, 
respectively [4, 5], T he tw o alkaloids occurred in a 1:2 
ratio.
Calystegine B2 (2) was also identified by G C -m ass 
spectrometry in leaves o f S. tuberosum, cvs ’King Edw ard’, 
‘Dunluce’, ’Desiree’ and  ‘C ara’, Solanum dulcamara (b itter­
sweet), Solatium melotigena (aubergine fruits), and  in
■V
s-OH
herbarium  (R. B. G. Kew) leaf fragm ents of two species of 
Solatium reported  to cause a degenerative neurological 
disorder in ca ttle  [6]. These are S. dimidiatutn from Texas 
(specimen from  M cLennan C ounty 1946, C. L. York, coll. 
no. 46113) an d  S. kwebense from S outhern  Africa (speci­
men from N am ibia 1914, Giess & Miller, coll. no. 11808). 
Datura wrightii leaves also contained calystegine B2.
Polyhydroxylated tropane alkaloids have not been 
previously reported  from Solanum o r Datura species and 
further investigation is necessary before one can claim  a 
defensive function for these substances o r  possibly a 
synergistic role associated with the o ther alkaloids. 
N evertheless, it may be significant tha t S. dimidiatutn and
S. kwebense cause the neurological disorders know n as 
’crazy cow syndrom e' and  ‘M aldronksiekte’, respectively, 
if fed to  ca ttle  [6]. T he diseases a re  characterized by 
depression and  m uscular incoordination; clinical signs 
are  intense cellular vacuolation and  lesions in the 
cerebellar cortex  and degeneration of P urkinje cell axons. 
They are strikingly sim ilar to  locoism, which is caused by 
ingestion o f legumes containing the 1,2,8-trihydroxy- 
indolizidine alkalo id  swainsonine [7]. Swainsonine 
is a po ten t inhib ito r o f x-m annosidase and causes 
vacuolation o f CN S cells with neuroaxonal dystrophy
1281
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by inhibiting glycoprotein synthesis and degradation [8],
It is interesting that neither tropane alkaloid was strongly 
inhibitory to jack bean a-mannosidase at 0.3 mM but 
calystegine B , caused 50% inhibition of almond fi- 
glucosidase at 15 gM  (35 pM for calystegine A3). Defi­
ciency of lysosomal /f-glucosidase activity is known to 
cause a glucocerebroside storage disorder with neuronal 
damage [9]. Yeast x-glucosidase was not inhibited by
0.3 mM of either compound.
It should also be noted that in some cases o f ‘poisoning’ 
in man and livestock for which sprouted green or spoiled 
potatoes were held responsible, the concentration of 
glycoatkaloids was thought to be too low to cause 
intoxication [10], Again an unidentified substance in 
certain tubers has been suggested as a possible cause o f 
anencephaiy and spina bifida [ I I ] .  It has also been 
reported (unpublished observations) that diarrhoea in 
canaries followed the accidental ingestion of 7 mg of a 
mixture of the two calystegines dissolved in approxim­
ately 20 ml o f drinking water.
The strain o f Acherontia  used in these experiments was 
captured in the Canary Isles, feeding on Datura, but was 
subsequently reared on privet (Ligustrum vulgare) for a 
number of generations. They appeared to be no longer 
well adapted to feed on these natural food plants, for 
despite great care only a single specimen survived to 
pupate on Datura  and the caterpillars reared on Solanum  
tuberosum  (cv ‘Dunluce’) were flaccid, inactive, their fae­
ces liquid, like pale greenish water, and mortality was 
high—a great contrast to those fed on privet. They lacked 
glycoatkaloids [2 ] but contained the glycosidase-inhibi- 
ting hydroxylated tropane alkaloids in both pupae and 
adults. The concentrations present varied greatly from 
moth to moth.
We also examined dried specimens o f the butterfly 
Mechanitis polymnia  which feeds in the larval stage on 
Solanum. Keith Brown, in a series of brilliant investiga­
tions [12, 13], has shown that this butterfly and related 
species also do not sequester giycoalkaloids from their 
food plant, but after eclosion search for, and imbibe, 
pyrrolizidine alkaloids from the nectar o f certain plants, 
such as Eupatorium. and the exudate from specific wilting 
foliage, which affords them protection from various pre­
dators.
We surmised that these butterflies must possess some 
defence mechanism which protects them during their 
vulnerable ‘searching period' following eclosion. We 
therefore looked for the tropane alkaloids which might 
fulfil this rote, and found we were able to detect (by GC- 
mass spectrometry) calystegines in dried specimens col­
lected in 1907.
Where the Lepidoptera are concerned, it is highly 
significant that the ultra brilliant day-flying moth Urania 
fulgens  stores alkaloid glycosidase inhibitors, sequestered 
from its food plant (Euphorbiaceae) [14]. It is now  
evident that these com pounds are com m on in various 
plants. Their storage by certain apparently unprotected, 
brightly coloured, conspicuous Lepidoptera may be the 
solution of a perennial puzzle.
SH ei al.
Sw ynnerton [ 15] who, in Africa, fed literally thousands 
of insect prey to both wild and captive predators, con­
cluded ‘indigestability is the real defence’.
E X P E R IM E N T A L
Isolation. P lant and  insect m aterial was extracted in 
75% E tO H  (2 x 2 ml 200 m g ' ‘) and  the extracts com ­
bined. The calystegines were purified by ion exchange 
chrom atography. Calystegine A 3 (1) was eluted after 
calystegine B : (2) from Amberlite CG -50 (in the H + form) 
using 0.1 M HOAc. T he calystegines can be detected by 
high voltage paper electrophoresis using ninhydrin (0.2% 
in M e,C O ) with which they give a yellow product, o r  by 
G C -M S of the pertrimethylsilyl derivatives (M * ions 376 
and  464 for A 3 and  B2, respectively). The calystegines are 
insoluble in CHC13 and  do not react w ith D ragendorff’s 
o r iodop latinate reagents. 'H  and  13C N M R  spectral 
da ta  m atched reported  data for the two calystegines 
[4, 5], but the absolute stereochem istry could not be 
assigned. EIM S M + m/z 160 (A ,) and  176 (B2). Enzyme 
dosage: all enzym e assays were carried ou t using enzymes 
from Sigma ( l O g g m ! 1) and 10 m M  p-nitrophenylgly- 
cosides [16].
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A bstract— A novel xanth ine alkaloid and tw o know n flavonoids have been isolated from the leaves o f Bosistoa floydii 
and  identified as l,3-di(3-m ethylbut-2-enyl)-7-m ethylxanthinc, 5,4’-dihydroxy-3,7,3 '-trim ethoxyflavone and 5- 
hydroxy-3,3',4',5',7-pentam ethoxyflavone.
IN T R O D U C T IO N
The genus Bosistoa F. M uell. ex Benth (Rutaceae) is 
confined to  the forests o f  eastern Australia. Bosistoa 
floyd ii T. H artley is a  sm all tree found in rain  forest in 
northeast New S outh  W ales, in the vicinity of D origo and 
Cofls H arbou r [1 ]. N o previous chemical w ork has been 
carried out on this species an d  all tha t is know n abou t the 
chem istry o f the genus is the occurrence o f triterpenes in 
B. pentacocca [2 ] and  triterpenes and flavonoids in
B. brassii [3]. In this paper, wc report the result of 
exam ination o f the leaf o f B. floydii, w ith the isolation and 
identification o f a novel xanthine alkalo id  and  two 
know n flavonoids.
R E S U L T S  A N D  D IS C U S S IO N
The g round leaves of B. floydii were ex tracted  with 
chloroform  and the ex tract was subjected to V LC over 
silica gel. C om pounds 1 -3  were purified by prepara tive 
circular chrom atography  and  preparative TLC.
C om pound 1 was found to  be a novel alkalo id , identi­
fied as l,3-di(3-m ethylbut-2-enyl)-7-m ethylxanthine on 




(3) OM e OMe
the m olecular form ula to be C I6H 22N40 2. The fragment 
ion at 166 (80% ; [ M — C 10H ,6] +) suggested the loss of 
two isoprene units, and left a skeleton o f C 6H 6N 40 2. U V 
and IR spectra  (see Experim ental) showed characteristics 
typical of a xanthine [4, 5]. The ‘H N M R  spectrum  
showed signals for two 3-m ethylbut-2-enyl groups, a 
methyl singlet a t <53.97 and a p ro ton  singlet a t <57.48. The 
N M R  assignm ents for the com pound were made unam ­
biguously by H M B C  [6 ] and  H -C C O B I experiments 
(Fig. 1). The H -1 ’ of one prenyl group show ed 3 J  coupling 
with the xanth ine carbonyls at C-2 and C-6, while the H- 
1" o f the o th e r prenyl showed 3J  coupling with C-2 and 
C-4, so th a t the prenyl units m ust be placed at N-1 and N-
3. The p ro tons  o f the N -M e group showed 1J  coupling 
w ith C-5 an d  C-8, while the p ro ton  a t C-8 showed 3J  
coupling with N M e-7, C-5 and  C-4. O nly structure 1 
satisfies all these H M B C  correlations.
T he tw o flavonols were identified as 5,4'-dihydroxy- 
3,7,3 '-trim ethoxyflavonc (pachypodol) (2) [7, 8] and 5- 
hydroxy-3,3 ',4 ',5 ',7-pentam ethoxyflavone (com bretol) (3)
[9] by d irect com parison o f their spectral d a ta  with those 
o f au then tic  samples.
E X P E R IM E N T A L
UV: 0.1 M H O  Ac and M eO H ; IR: K B r discs; NM R: 
run in C D C lj, N OESY  and H M B C  experim ents were
Fig. I. Selected HMBC correlations for I.
535
536 Short Reports
obtained on a Bruker AMX-400 instrument using stand­
ard microprograms. EIMS: direct probe insert (90-130°) 
at 70eV. Petrol refers to bp 60-80° fraction.
Plant material. A voucher (T. G. Hartley 15156) has 
been deposited at the Australian National Herbarium, 
Canberra.
Extraction and isolation. The ground leaves (280 g) 
were extracted sequentially in a Soxhlet with CHC13 and 
MeOH. The CHC13 extract (6 g) was fractionated by 
VLC over silica gel eluting with petrol containing increas­
ing amounts of EtOAc. A 40-50% EtOAc eluate was 
collected and the pigments removed by using a short 
column of Sephadex LH-2Q. Further fractionation of the 
sample by circular prep. TLC using petrol-EtOAc follow­
ed by prep. TLC (silica gel; CHC13 EtOAc, 3:2) gave 3 
major compounds 1 (200 mg, Rf  0.31), 2 (12 mg, Rf  0.45) 
and 3 (8.0 mg, R , 0.55).
l,3-Di(3-methylbut-2-enyl)-7-methylxanthine (1). Pow­
der. Found: [M ]+ 302.1726; CI6 H2 2 N 4 0 2 requires 
302.1743. UV 2“° Ac nm (log s): 275 (3.78). IR vm>1 cm "1: 
2900, 1710, 1543, 1510, 1025; 'HNM R (400 MHz, 
CDC13): <57.48 (IH, s, H-8 ), 5.35 (IH, t, m ,J  = 6 .8 , 1.4 Hz, 
H-2"), 5.25 (IH, t, m, J =  6 .8 , 1.4 Hz, H-2'), 4.68 (2H, d, J 
=  6.7 Hz, CHj-l"), 4.60 (2H, d, J  = 6.7 Hz, CH2 -1'), 3.97 
(3H, s, NMe-7), 1.84 (3H, s, Me-5"), 1.80 (3H, s, Me-5'), 
1.71 (2 x 3H, 2 x s, Me-4', Me-4"); ,5CNMR (100 MHz, 
CDC13): 5 155.5 (C-6 ), 151.3 (C-2), 148.6 (C-4), 141.5 (C-8 ), 
137 (C-3"), 136.5 (C-3'), 119.5 (C-2'), 118.8 (C-2"), 108.1 (C-
5), 41.6 (C-l"), 39.7 (C-l'), 33.7 (C-NMe-7), 25.9 (C-4"), 
25.9 (C-4'), 18.4 (C-5"), 18.3 (C-5'). EIMS m/z (rel. int.): 302 
[M ] + (65), 234 (38), 166 (80), 150 (100).
5,A'-Dihydroxy-3,1,3'-trimethoxyflaeone (2). Yellow need­
les from CHC13 -MeOH, mp 172° (lit. [8 ] 168-170°). 
Found: [M ]+ 344.0896; C 1 8H 1 60 7 requires 344.0896. 
UV nm: 262, 345. The spectral data are identical 
with authentic sample.
5-H ydroxy-3,3' ,A\5' ,7-pentamethoxyflavone (3). Yellow 
needles from CHCl3 -MeOH, mp 145-150° (lit. [9] 144°). 
Found: [M ]+ 388.1158; C2 0 H2 0 O 8 requires 388.1158. 
UV nm: 258, 352. The spectral data are identical 
with authentic sample.
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Casuarine: A Very Highly Oxygenated Pyrrolizidine Alkaloid
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Abstract: I'he isolation from Casuarina equisetifolia L. (Casuarinaceae) bark of casuarine 1, 
(lR,2R,3R,6S,7S.7aR)-3-(hydroxymethyl)-l,2,6,7-tetrahydroxypyrrolizidine is reported.
Both natural1 and synthetic mono- and bi-cyclic nitrogen analogues of carbohydrates have potential as 
chemotherapeutic agents,2  both as free bases3  and as alkaloidal glycosides.4 -5 Alexine 26  and australine 
37  were the first pyrrolizidine alkaloids to be isolated with a carbon substituent at C-3, rather than the more 
usual C-1 substituents.*1 Further stereoisomers of alexine and the related amino acid 7a-epialexaflorine 4, 
found in Alexa grandiflora.?  have also been isolated The alexines and castanospermine 5 occur in all 
species of the genus Alexa  and also in the related species Castanospermum australe\ 5 is a potent 
glucosidasc inhibitor111 some of its derivatives may have potential for the treatment of patients with HIV. 11 
Because of the reported antiviral properties of some of the alexines12 -1 3  and other potential applications, 14 
there has been considerable interest in the synthesis of the natural products and of synthetic analogues. 15
CH2OHCH2OH CH2 OH
1 2 3 4 5
As part o f a programme for the extraction of bioactive compounds from plants, this paper reports 
the isolation and characterisation of casuarine 1, a more highly oxygenated analogue of 2 and 3 and at the 
highest oxidation level of any aminosugar analogue yet found as a natural product from any source.
Casuarina equisetifolia L. (Casuarinaceae) wood, bark and leaves have been claimed to be useful 
against diarrhoea, dysentery and colic. 1 6  A sample of bark has recently been prescribed in Western Samoa 
for the treatment of breast cancer; analysis by GC-MS of the pertrimethylsilylated extract o f the bark 
revealed the presence of a pentahydroxylated pyrrolizidine alkaloid and a glycoside thereof as the major 
nitrogen-containing compounds present. The alkaloids were readily isolated from 75% aqueous ethanol 
extracts of the bark by ion-exchange chromatography using Amberlite CGI20 (NH4 + form) by elution 
with 0 . 1 M ammonium hydroxide to give first a glycoside of casuarine and subsequently the free casuarine 
1, m.p. 181-182°C (from 95% aqueous alcohol), [cx]d 24+ 16.9 ( c  0.8 in H2 O ) , 1 7  in 0 .013% yield; the 
casuarine glycoside1 8  was present at approximately the same concentration as the free base.
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The NMR spectrum of casuarine I (Figure 1] identified1 9  ten 
inequivalent, non-exchanging protons and eight carbons. The proton 
chemical shifts, multiplicities and three-bond coupling constants (^JpjH) 
[from the ID and 2D ^H-*H COSY spectra] and carbon chemical shifts, 
multiplicities and one-bond coupling constants (*Jch) [from the ID and 
2D 1H-13c HMQC spectra] are given in the table.
H8H6 H8’
H1
H2 H5p H7a H5cc 
. i H3
4.2 .84.0 3.8 3.0 23.6 3.4 3.2
Chemical Shift (ppm)
Figure 1. 500 MHz *H NMR spectrum of casuarine 1 in D2 O 
The 2D COSY and RELAY spectra show a linear sequence of -*JhH correlations as follows: 
H5cx/p -  H6  -  H7 -  H7a -  HI - H2 -  H3 -  H8 /8 ' which define the carbon backbone structure. This 
sequence is confirmed by the 2 J c h  an(l ^CH correlations observed in the HMBC spectrum. In addition, 
extra ^Jch correlations are observed in the HMBC spectrum as follows: C3 to H5a, H5P and H7a, C5 to 
H7a and possibly H3, and C7a to H5a and H5p. These define the ring structure as shown above and this 
is again confirmed by a ^H-^H NOE between H3 and H5a. Information about the relative configurations 
of the 6  chiral carbons may be obtained from the values of the ^JhH coupling constants (related to torsion 
angles) and 1 H 1 H NOEs (related to distances), if the ring conformations (puckering) can also be 
determined. The coupling constants of 8.0 Hz for H3/H2, H2/H1 and Hl/H7a are only consistent with 
these four protons being approximately anti periplanar, thus defining both the relative configurations at, 
and ring conformation for, the ring containing these four carbons. Further confirmation of this geometry 
was obtained by the observation of a stronger NOE between HI and H3 than between HI and H2, 
indicating that HI and H3 are on the same side of the ring, whilst H2 is on the opposite side. The 
observation of a strong NOE (corresponding to a distance of 2.5 A or less) between H3 and H5ot and no 
NOE between H3 and H5P indicates that H3 and H5a must be on the same side of the molecule.
Casuarine 1 show ing  





! Label ........................ "™rfi....  ..... .... ........ Label ------------- ITC
8  (ppm) mult 3jHH (Hz) 8  (ppm) mult lJCH (Hz.)
HI 4.162 t 8 . 0 C l . 77.77 d 146
H2 3.796 t 8 . 0 C2 76.63 d 139









C5 57.96 t 139
H6 4.21 m 4.0, 4.7, x C6 77.40 d 151
H7 4.19 m x. 3.5 C7 78.79 d 148








11.9, 6 . 6
C8 62.24 t 142
Table and 13c assignments and coupling constants for casuarine in D2 O, pH=8.25 and 3Q°C.
A stronger NOE is observed between H6  and H5p than between H6  and H5a, indicating that H6  
and H5oc are on the same side of the ring. This tentatively assigns the configuration at C6  relative to G3, 
The coupling constant of 3.5 Hz for H7a/H7 is consistent with either a cis or trans relationship, depending 
on the conformation of the second ring. The H7/H6 coupling constant cannot be determined because of 
considerable overlap in the spectra. Thus NMR studies gave firm indications of the relative configurations 
at 5 of the chiral centres of casuarine 1 but could not unambiguously assign the relative configuration of 
the sixth stereogenic centre; an X-ray crystallographic study2® resolved the ambiguity of the remaining 
centre and determined the absolute configuration of the new alkaloid (Figure 2).
H 141
H 102' H 131
H101
Figure 2. X-ray Molecular Structure of casuarine 1, showing crystallographic numbering scheme
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In summary this paper reports the isolation of casuarine, the first example of a per.tahydroxyiated 
pyrrolizidine alkaloid with 6  adjacent stereogenic centres and functional groups on all of the 8  carbon 
atoms, and a structure that provides a considerable challenge for its synthesis.21
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Bioassa.y-guided fractionation of extracts of Toddalia asiatica, a plant used by the Pokot tribe of Kenya to 
treat fevers, has yielded the alkaloid nitidine as the major antimalarial component. Fractions containing 
nitidine have in vitro 50% inhibitory concentrations against Plasmodium falciparum in the range of 9 to 108 
ng/ml for a range of chloroquine-susceptible and -resistant strains. The results show a lack of cross-resistance 
between chloroquine and nitidine.
Although malaria is in principle preventable and curable, in 
practice the majority of the population at risk cannot pay for 
modern treatment and the disease remains a major cause of 
childhood mortality in the developing world. Recent results 
with the vaccine sP/6 b show a mean protective effect of only 
30%, with very wide confidence limits (1). The rapid spread of 
resistance to chloroquine and related quinoline-based antima- 
iarial agents has greatb increased the risk of malaria to many 
rural populations, so that there is an urgent need for affordable 
treatment. One possible source of such treatment lies in the 
traditional herbal remedies used by ethnic groups, but treat­
ment with these remedies has suffered from a number of de­
ficiencies. Diagnosis is often a problem, identification of plant 
material may be insecure, and the chemical content of extracts 
may vary considerably. We have set out to overcome these 
barriers to effective treatment by systematically evaluating the 
effectiveness of some of the remedies used by an ethnic group 
of Kenyan farmers.
The Pokot traditionally inhabit a highland plateau, west of 
the Rift Valley in Kenya. However, the present study con­
cerned a group of Pokot who live on Ol Ari Nviro Ranch, 
Laikipia, Kenya, a plateau to the east of the Rift Valley, and 
who have previously been described in some detail (5).
In interviews, the Pokot herbalist Cheptosai Selale. who is 90 
years old, described the use of 26 plants for the treatment of 
malaria and fever, of which only 14 were available at the time 
of collection (see Table 1). Two of the 14 plants produced 
extracts with significant antimalarial activity against laboratory' 
strains of Plasmodium falciparum. Bioassay-guided fraction­
ation of the extract from Toddalia asiatica gave a pure alkaloid, 
nitidine, which has potentially useful antimalarial activity.
MATERIALS AND METHODS
P la n t m a te r ia l .  P lan t m ateria , w as co llec ted  fro m  O l A rt Nytro R anch  an d  w as 
bo tan ically  au th e n tic a te d  by C r,risiinc K abuyc an d  Jo sh u a  M uasya o f the  H e r ­
barium , N atio n a l M useum s o f K enya, w h e re  v o u c h e r  sp ec im en s w ere dep o sited . 
In fo rm a tio n  p ro v id ed  by the  herbalist in c lu d ed  th e  re q u ire d  p a r t  o f the  p lan t, the  
p rec ise  locality  fo r co llection , and th e  tim e  w hen c u ra tiv e  potency was m axim al. 
P lan t m a te ria l fo r study  was dried  a t  ro o m  te m p e ra tu re , pu lverized , and  s to red  
dry in p la s tic  bags un til extracts w e re  o b ta in ed .
P re p a ra tio n  o f aq ueous crude e x tra c ts  fo r p re lim in a ry  ana lysis. A q u eo u s
* Corresponding author. Phone: 0141552440(1. Fax: 01415526443.
cru d e  ex trac ts  I lOOr) w ere  p re p a re d  in a m a n n e r  ana logous to  tha t u sed  by the  
h erbalist. Pow dered  p lan t m a te ria l (10 g) w as w eighed in to  a  b eak er, 100 m l o f 
d istilled  w a te r  w as a d d ed , an d  the  m ixture Was b rough t to  th e  boil, co o led , a n d  
left o vern igh t to  m acera te . E x trac ts  w ere tille red  th ro u g h  no. I W h a tm an  fillet 
p ap er, a n d  the volum e o f filtra te  w as no ted . S o lu tions w ere  then  seq u en tia lly  
filtered  th ro u g h  m em brane  filte rs (M illtpo re. H a rro w . U n ited  K in g d o m ) w ith  
po re  sizes o f 0 .5 0 4 5 . and  finally. 0.22 pm . a n d  the  final vo lum e o f filtra te  w as 
no ted . A liquo ts  o f 2 ml w e re  freczc-d ried  to  d e te rm in e  the  c o n c e n tra tio n  (in  
g rains p e r  m illiliter) o f  so lu te  in e a c h  extract b e fo re  freeze-dry ing  the  rem a in in g  
c rude  ex tract
P re p a ra tio n  o f extracts in a  form  suitab le  fo r  the  in v itro  lest re q u ire d  con 
sid c ra tio n  o f  bo th  th e  a q u e o u s  solubility and  the s terility  o f each  ex trac t. E ach  
co m p o u n d  w as red issolved in a  m easu red  vo lum e o f e ith e r  w a te r  o r  e th a n o l, 
w hich was then  fu r th e r  d ilu ted  w ith  its c o u n te rp a r t to  yield a 70%  e th a n o l 30 ',i 
w a te r  m ix ture  con ta in ing  a  know n co n cen tra tio n  o f  ex tract. T h is  so lu tio n  w as 
allow ed to  s tan d  a t room  te m p e ra tu re  for 30 m in  to  sterilize the  so lu tion . F u r th e r  
dilutions- w ere m ade w ith P. falciparum  cu ltu re  m ed ium  (R PM 1 1640 m ed iu m  
co n ta in ing  25 m m ol o f  H E P E S  |/V -2-hydroxycthy lp iperazine-A /'-2-cthanesu lfonic  
ae id | buffer p e r  liter. 25 m m ol o f sodium  b ica rb o n a te  p e r  liter, and  10%  n o rm a l, 
po o led  h u m an  serum ). F ina l d ilu tio n s o n  the  in  v itro  test p la te  co n ta in e d  < 0 .1 %  
e th an o l, w hich is no t in h ib ito ry  to  the  p a ra s ite  in  th is  system  (3 ). a lth o u g h  
co n tro ls  w ere included  in each  te st series
E x tra c tio n  a n d  frac tiu n a tio n  o f  T. asiatica. A ir-d ried , pu lverized  ro o t b a rk  w as 
first ex trac ted  twice w ith  d ich lo ro m c th an e  (500 g  to  1 lite r)  by o v e rn igh t m a c ­
e ra tio n  to  rem ove fats. T h e  re s id u e  w as then ex trac ted  twice w ith  co ld  m e th a n o l 
(500 g  to  1 liter), and  the  filtra te s  w ere co m b in ed  and  d ried  in vacuo . T h e  
alkalo ids in the c ru d e  m e th an o lic  fraction  w e re  co n cen tra ted  by th e  ac id -b ase  
p ro ced u re  (6). and  the  resu ltin g  ch lo ro fo rm  frac tio n  w as fu r th e r  f ra c tio n a te d  by 
vacuum -liqu id  co lum n ch ro m a to g rap h y  with silica gel 60 and  a  so lvent sy stem  o f  
increasing  polarity (p e tro l, ch lo ro fo rm , m e th an o l). F ifteen  frac tions w ere  co l­
lec ted . d r ie d  in vacuo , an d  s to re d  a t  4°C until they  w ere tested .
F o r  in v itro  tests, app rox im ate ly  10 mg. w eighed  to  0.01 m g, w as d isso lved  in 
70%  e th a n o l and  was allow ed to  s tan d  for 30 m in  to  sterilize the  so lu tio n . T h e  
e th an o lic  so lu tion  was fu r th e r  d ilu ted  in cu ltu re  m edium  to  an  a p p ro p ria te  test 
co n cen tra tio n . A stock so lu tion  o f au th en tic  n itid in e  was p re p a re d  in  a  s im ila r  
m anner.
in  v itro  a n tim a la r ia l  activ ity  te s ts . T h e  a n tim a la ria l activity test w as b ased  on  
previously rep o rted  m e th o d s  (3 , 10). L abora to ry  cu ltu re s  o f  P falciparum  w e re  
m ain ta in ed  by  s tan d a rd  m eth o d s. F o r the  test, 25-p.l aliquo ts o f  c u ltu re  m ed iu m  
w ere a d d ed  to  all o f th e  wells o f a 96-well f la t-bo ttom  m icroeu ltu rc  p la te  (S te ri-  
lin. T ed d in g to n . U n ited  K ingdom ). A liquots o f  th e  test so lu tions o f  25 p.1 w e re  
a d d ed , in d u p lica te , to  the  first w ells, and a  T ite r te k  m o to rized  h an d  d ilu te r  
(F low  L abora to ries . U xbridge, U n ited  K ingdom ) w as used  to  m ake se ria l 2-fold 
d ilu tions of each  sam ple o v e r a 64-fold c o n cen tra tio n  range. A liq u o ts  o f  200 p.1 
o f a  1.5%  (v p lv o l) su sp en sio n  o f  p arasitized  e ry th rocy tes  in  cu ltu re  m ed iu m  
(0 .4%  parasitem ia : g row th  ra te . > th ree fo ld  p er 48  h) w ere ad d ed  to  all te s t  w ells. 
P arasitized  an d  no n p a ra sitiz ed  ery th rocy tes an d  so lvent co n tro ls  w ere  in c o rp o ­
ra te d  in to  all tests. T h e  p la te s  w ere incubated  a t 37”C in a gas m ix ture  o f  3%  
C Q 3-5 %  0 , -9 2 %  N „  A fte r 48 h each  well w as pu lsed  w ith 25  p.1 o f  c u ltu re  
m ed ium  co n ta in ing  0.5 p C i o f  [■1H ]hypoxanth ine an d  the p la tes  w ere  in c u b a te d  
fo r a  fu r th e r  18 h T he c o n ten ts  o f  each  well w e re  th en  harvested  o n to  g lass fiber 
filters, w ashed  thoroughly  w ith  distilled  w ater, an d  d ried , an d  th e  rad ioac tiv ity  (in  
co un ts  p e r m inu te  I w as m e a su re d  by liquid sc in tilla tion  T h e  reg ression  fu n c tio n  
log eptn a -  ; • t log drug  co n cen tra tio n  i. w here  a is the  v in te rcep t an d  b is
26110
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TABLE I. In vilrp activities ol aqueous extracts from Kenyan plants used by the Pokot herbalists, Laikipia. Kenya, against three Kenyan
strains of P. falciparum
P lan t species Family Plan t p a n
IC ,„  (n-g/ml)"
M24 K67 E N T  7
Canthium phyllantlioideitm Rubiaceac Stem b a rk 208 360 540
Olinia usambarensis Oliniaceae Stem b a r k 204 130 380
Pittosponim vividiflorum Pittosporaceae Stem b a rk 80 30 170
Aspilia mossambicensis Composttae Leaves 406 730 720
Gardenia jovis-tonantis Rubiaceae Root b a r k 820 880 1.750
Toddalia asiatica Rutaceae Root bark 20 5 20
Rhoicissus tridentata Vitaceae Whole tu b e r 100 40 70
Turraea mombassana Meliaceae Whole root 150 90 100
Hcteromorpha trifolia Uinbeltiferae Stem b a r k 475 370 580
Shrebera alata Oleaceae Stem b a rk 627 160 380
Maytenus arbutifolia Celastraceae Whole root 4 4 10
Rhamnus staddo Rhamnaceae Root b a rk 520 490 740
Scutia myrtina Rhamnaceae Root b a r k 40 240 320
Cucumis aculeatus Cucurbitaceae Whole fruit 60 30 30
" E ach  IC SU is th e  m ean  o f  at least two iri v itro  tes ts  e a rn e d  out on  d iffe ren t days.
the slope , w as ca lcu la ted  by using d u p lica te  po in ts above and  below  th e  m idpo in t 
o f  the  c o u n ts  p e r  m inu te  betw een  th e  parasitized  an d  n onparasitized  con tro ls, 
t  he co n c e n tra tio n  causing  30%  in h ib ition  o f rad io iso to p e  inco rp o ra tio n  ( IC SU) 
was d e te rm in e d  by in te rpo la tion  as described  prev iously  (13). T his m e th o d  gives 
a  value eq u a l to  100.4% ~ 10.6% (m ean  i  s ta n d a rd  dev iation) o f  the value 
e s tim a ted  by n o n lin ea r regression analysis (14). S tatistical differences betw een  
m ean s fo r sm all p o pu la tions w ere exam ined  by S tu d en t's  i test.
RESULTS
The results of tests with crude extracts against three strains 
of P. falciparum are presented in Table 1. Only the extracts of 
the root bark of 71 asiatica and the whole root of Maytenus 
arbutifolia showed significant activity in this test. Although this 
preliminary screen does not preclude the possibility that the 
other extracts may be active antimalarial agents by the oral 
route, subsequent work focused on the plants with demonstra­
ble activity. Of these. \l. arbutifolia was known as a source of 
cytotoxic agents such as maytansine (7) and produced extracts 
of great complexity: the present study therefore concentrated 
on 71 asiatica, which has also been intensively studied (2) but 
which proved to be much more amenable to bioassay-guided 
fractionation.
Sequential extracts from T. asiatica showed different levels 
of antimalarial activity (Table 2). The methanolic extract 
showed the highest activity, with a mean 50*7- inhibitory dose 
of 0.98 p-g/ml for the chloroquine-susceptible strains K.67, K39, 
and M24. Acid-base extraction of the methanolic extract (6.08 
g) yielded 0.1893 g (3.1%) of petroleum ether-soluble extract,
0.0246 g (0.4%) of acidic chloroform extract, and 0.99 g





Dichlorome thane 11.93 7.65 18.05
Methanol 0.7 0.7S 1.46





" E ach  IC 5|, is th e  m ean  ol at least tw o in vitro  tes ts  carried  o u t o n  differen t 
days. F o r th e  V 1/s stra in . w ere 0.057 ml fo r ch lo ro q u in e  and  0.941 |xg/ml 
f o r  d ih y d ron itid inc .
(16.3% 1 of basic chloroform extract. The highest potency was 
observed in the basic chloroform extract coded TA106(13), 
which had an IC5 0  of <1 p.g/ml. This extract was further frac­
tionated by chromatography on silica by circular preparative 
thin-layer chromatography by eluting with ethyl acetate-meth- 
anol-water-ammonia (100:17:13:3). which gave a single yellow 
compound at a 10-mg yield from 500 g of powdered root bark. 
The UV spectrum showed absorbances at 235, 275. 293, 303, 
332, and 380 nm, which is similar to the data for nitidine (18). 
Comparison with an authentic sample of nitidine (compound 
1 ) both chromatographically and spectroscopically (mass spec­
trometry. infrared spectroscopy, and high-field nuclear mag­
netic resonance) proved the identity of the unknown com­
pound.
The electron impact mass spectrum gave a molecular ion at 
m/z 348 with the formula C2 |H ,KN 0 4 by accurate mass mea­
surement. The base peak in the spectrum, at m/z 333. is attrib­
utable to the loss of a methyl group. The 1H nuclear magnetic 
resonance spectrum showed seven aromatic protons, live sin­
glets at 6  9.61, 8.27, 8.22, 7.80, and 7.59. as well as two doublets 
(7 = 9.2 Hz) centered at 8  8.72 and 8.21. The methylenedioxy 
group resonated as a two-proton singlet at 8  6.27, and there 
were three signals for methyl groups at 8  4.93, 4.26, and 4.11, 
with that at the lowest field being attributable to the A-methyl. 
Comparison of the active fraction with an authentic sample of 
nitidine by thin-layer chromatography on silica with ethyl ac- 
etate-methanol-water-ammonia (100:17:13:3) as the mobile 
phase gave spots with Rf  values of 0.25. having the same color 
and response to UV light.
Subsequent in vitro studies examined the chemosensitivity of 
additional laboratory strains of P. falciparum, characterized for 
chloroquine susceptibility, to the active fraction and authentic 
nitidine by using three chloroquine-resistant and four chloro­
quine-susceptible strains. Each !C?I, measurement was deter­
mined in duplicate as described above, and each test was per­
formed in duplicate; Table 3 compares the activities of the 
active fraction, authentic nitidine. and chloroquine against 
groups of chloroquine-susceptible and chloroquine-resistant 
laboratory strains of P. falciparum  in vitro.
DISCUSSION
The antimalarial activities of a number of Tanzanian plants, 
many of w hich also occur in Kenva. have been reviewed by
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"  E ach  I C m, is the  m ean o f at least tw o i
days.
vitrei te s ts  ca rried  o u t on  d ifferent
Weenen et al. (17). Only 2 t)f 49 plants from that review 
(Gardenia jovis-ionantis and T. usiatica) were also used by the 
Kenyan Pokot herbalists. It is of interest that T. asiatica. one of 
the two plants producing active extracts in our study, is also 
used bv herbalists in Tanzania and has been reported to pro­
duce extracts with moderate in vitro activity against the para­
site (16).
Nitidine is a well-known cytotoxic agent which has received 
considerable attention as a potential anticancer drug following 
the discovery of potent antileukemic activity in mice (9). Clin­
ical trials were eventually terminated for reasons which are 
unclear but which inav have been due to host toxicity. Nitidine 
is a quaternary salt, charged at all pH values, and therefore, in 
theory it is prone to poor absorption from the gastrointestinal 
tract, but it is capable of existing as the tautomeric pseudobase 
(compound 2). which would be absorbable (Fig. 1). It was also 
possible that dihvdronitidine (compound 3), identified as a 
minor component of 7. asiatica , could account for the in vivo 
antimalarial activity. Dihvdronitidine is not charged and is 
therefore able to pass membranes; inside cells it could be 
oxidized to release nitidine. However, dihydronitidine was only 
weakly antimalarial (Table 2), suggesting that it is not a pro- 
drug for nitidine in our test system.
Although the crude aqueous extract, with an IC5„ of 20 
p.g/ntl. exhibited comparatively weak activity, when we com­
pared both the active fraction of T. asiatica and authentic 
nitidine against P. falciparum  strains with different responses to 
chloroquine. it was apparent that the alkaloid exerted potent 
activity (Table 3). The active fraction, with a mean 1CS 0  of 51.6 
ng/ml for chloroquine-resistant strains, is more active than 
quinine against Kenyan parasites (IC50. ca. 120 ng/ml) (11).
The isolation procedure concentrated on obtaining a sample 
pure enough for identification. No attempt was made to de­
termine the total amount of nitidine in the root bark. Such a 
determination would be complicated by the known instability 
of nitidine in alkaline solution, whereby the pseudobase form 
(compound 2 ) disproportionates to give the dihydro form 
(compound 3) and the 6 -keto form known as oxynitidine, 
which is not charged and which is unlikely to be biologically 
active. Our experience with other species of the family R uta ­
ceae suggests that there are unlikeiy to be major amounts of 
alkaloids similar to nitidine in the root bark of T. asiatica , nor 
was there chromatographic evidence for other major active 
constituents. This does not preclude the existence of chemi­
cally unrelated compounds in the extracts with direct or syn­
ergistic activity: however, from the data in Tables 1 and 2, it 
may be seen that nitidine is two orders of magnitude more 
potent than the crude extract. Given the inevitable losses in the 
extraction process, there is little doubt that nitidine accounts 
for a high proportion of the observed activity.
The mean IC„, of chloroquine for the chloroquine-resistant 
isolates of 47.2 ng/ml (189 nmol/liter) exceeds the threshold 
MIC of 114 nmol/liter used to define chloroquine-resistant 
infections in Kenya and elsewhere (12, 15), confirming the 
chemosensitivity of the isolates used. We found a significant 
difference in the mean 1C5 0  of chloroquine between those for 
chloroquine-resistant isolates and those for chloroquine-sus­
ceptible isolates (P  < 0.05) but not between the IC50s of the 
active fraction or nitidine (P >  0.05 for both comparisons). 
The resistance of P. falciparum  to chloroquine is now a major 
health problem in Kenya, as in many parts of Africa, and these 
data suggest a potential role for J. asiatica extracts in the 
treatment of chloroquine-resistant falciparum malaria. Further 
work is needed to confirm the activity of this alkaloidal extract 
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exactly the compositions of ihe extracts prepared by the Pokot 
herbalists.
It is possible that long-term consumption of T. asiatica may 
be deleterious, given the cytotoxic effects of nitidine, although 
short-term use to treat a life-threatening disease may, in fu­
ture, be supportable on risk-benefit analysis and in view of the 
availability of the plant and its low cost. Nitidine and its sister 
alkaloid fagaronine have recently been shown to be topoi- 
somerase inhibitors (4, 8 ): thus, it is possible that the antima­
larial action is mediated through the inhibition of the parasite 
enzyme. If this is the case, analogs which bind preferentially to 
the parasite enzyme may represent a source of new antimalar­
ial drugs, and we are pursuing this. The absence of cross­
resistance between nitidine-containing extracts and chloro­
quine may be of particular significance in the potential use of 
these compounds as drugs for antimalarial treatment.
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Abstract The n-hexane and ethyl acetate extracts of the aerial parts of Vahlia capensis yielded the coumarins 
umbelliferone, scopoletin and scoparone, and the terpenoids sitosterol, cycloartenol, 24-methylenecycloartanol, 
cycloart-23-en-3/?,25-diol, glutinol and a seco ring-A triterpene acid, 3,4-seeo-olean-4,(23),l8-dien-3-oic acid.
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IN T R O D U C T IO N
The small perennial shrub Vahlia capensis (L. f) Thunb. 
ssp. vulgaris Bridson is found mainly in the grazing areas 
of Botswana, Lesotho, Na- libia, Zimbabwe and South 
Africa [1 j. The genus Vahlia was initially placed in the 
family Saxifragaceae, but later moved into a family of its 
own, the Vahliaceae [1]. Vahlia capensis is a medicinal 
plant that has been used widely in Botswana to cure sore 
eyes, especially in small children [2], To date there has 
been no phytochemieal or pharmacological report on the 
plant.
R E S U L T S  A N D  D IS C U S S IO N
The compound 3,4 seco-oIcan-4, (23), 18-dien-3-oic 
acid (1 ) was obtained from the n-hexane and ethyl acetate 
extracts of powdered aerial parts by a combination of 
column chromatography and PTLC.The 'HNM R spec­
trum (Table 1) revealed that 1 contained seven methyl 
singlets, resonating in the chemical shift range SH
23
1
*Author to whom correspondence should be addressed.
0.77-1.75, while a combination of ,3CNMR with lH 
broad band decoupling, JMOD and DEPT-135 deter­
mined both the number and nature of the carbon atoms. 
The signal at <5H 1.75 (3H) suggested an olefinic methyl 
group [3-5] Me-C = ], while signals al <5H 4.70 (1H hrs) 
and 4.90 (IH brs) indicated an exomethylene group, and 
a further broad singlet, also at 5H 4.90, suggested an 
olefinic proton forming part of a trisubstituted double 
bond. The IR data (vmll, at 1750 and 3560cm"1) in­
dicated a carboxylic acid, while the absorptions at 
vm„x 1360, 890 and 850 cm" '■ pointed to the presence of 
geminal dimethyls, an olefinic CH and an exomcthylene 
(C =C H 2) group, respectively.
The high resolution El mass spectrum of the com­
pound gave a molecular ion at m/z 440.3654, which 
solved for the empirical formula C3 0 H4 8 O 2. The cal­
culated double bond equivalents are seven which can be 
accounted for by two double bonds, one carbonyl and 
four rings. The observed mass spectral fragment at m/z 
367 for loss of C3 H 50 2  [M — 73] + is consistent with the 
presence of a -CH2CH2COOH moiety leading to the 
conclusion that the compound possesses a seco-oleanene 
skeleton. The base peak at m/z 111 [C , , H2 , ] 1 and other 
high intensity ions at m/z 205 [C 1 5 H2S] +, 204 
[C 1 5 H24] + and 189 [C l4 H2)] + strongly supported 
a A18-oleanene derivative [6 ], The latter three ions have 
been reported in Al8 -oleanenes, e.g. methyl moronate, 
methyl morolate and germanicol acetate, and arise by 
a retro-Diels-Alder reaction involving the rupture of ring 
C followed by loss of a methyl [6 ], The ion at m/z 177 
[C 1 3 H2 i ] +, found in those derivatives with a methyl at 
C -l7 (A18-oleanene and germanicol acetate), is thought 
to arise from a fragment at m/z 205 by another retro- 
Diels-Alder reaction involving the elimination of ethene 
[6].
The ‘H and 13C NMR data were very similar to litera­
ture values for other A18-oleanene derivatives [7-10]. 
Application of 2D NMR methods (HMBC, HC-COBI 
and NOESY) allowed the resolution of structure 1 as
461
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Table I. ‘H - ‘H COSY and l3C - ‘H direct for 1





















  4.7 br sL _  4.9 br s
1.75 3H .s 
0.90 3H s 
1.13 3H.v 
0.77 3H s 
1.04 3H .5 
































1 Assignments may be reversed.
"‘Assignments which differ from those of Tanaka et al. [11].
3,4-sec<;-olean-4 (23), 18-dien-3-oic acid which was very 
recently reported by Tanaka et al. [11] from Euphorbia 
chamaesyce (Euphorbiaceae). The NMR data reported 
for 1 [ 1 1 ] agree with our findings with the exception of 
the l3C assignments for C-2, C- 6  and C -l2. The long 
range heteronuclear coupling data we obtained allowed 
C-2, C- 6  and C-12 to be assigned unambiguously and 
also agree with published data on related compounds
[9]. The melting points also differ significantly, which 
may be explained by use of different solvents for recrys­
tallization.
The A12-isomer of 1, nyctanthic acid was first isolated 
from the shrub N yctanthis abor-tristis by Turnbull et al. 
[12,13]. This acid was later isolated mixed with roburic 
acid from oak galls formed by the insect Cynips m ayri on 
common oak (Quercus robur) [14].
3 3 0
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E X P E R IM E N T A L
General. Mp: uncorr. l H (250,400 MHz) and 13C 
(100 MHz) NMR: CDC13 with TMS as int. standard. 
HR EIMS: 70 eV. CC: silica gel 60 (70-230 mesh). TLC: 
Merck silica gel 60 F254 (0.25 mm). PTLC: silica gel 60 
F 254 (0.50 mm). Visualization: UV radiation A-254, 
366 nm and vanillin sulphuric acid. The plant material 
was collected in Serowe, Central District, Botswana, in 
January 1991 and identified at the National Herbarium, 
Gaborone, Botswana, where a voucher specimen was 
deposited.
Extraction and isolation. The whole plant (1 kg) was 
ground and extracted at room temp, successively with 
n-hexane, EtOAc and MeOH. The n-hexane and the 
EtOAc extracts were evapd in vacuo to give 6 and 10 g, 
respectively, of dark green tar. The combined extracts 
were subjected to CC using n-hexane with increasing 
proportions of EtOAc. The fr. showing distinctive streak­
ing on analyt. TLC plates, that gave a dark brown band 
upon spraying with vanillin sulphuric acid, was further 
purified (PTLC:toluene-EtOAc-HOAc 35:14:1) to give 
needles of 1 which were recrystallized from hexane 
(15 mg). Other frs yielded umbelliferone (8 mg), scopo- 
letin (5 mg), scoparone (4 mg), sitosterol (30 mg), cycloar- 
tenol (10 mg), cycloart-23-en-3/J,35-diol (15 mg), 24-methyl- 
enecycloartanol (25 mg) and glutinol (8 mg). The 1H and 
13CNMR data for these compounds agreed with re­
ported data [7,15-19]. The identity of cycloart-23-en- 
3/?,25-diol and 25-methylenecycloartanol was confirmed 
by detailed 2D experiments.
Compound 1. C30H48O 2, needles (from hexane) mp 
196-198°, [a]D + 10 (CHC13; cO.10). IR: v“ cm 
3560, 2950, 2850, 1720, 1650,1640, 1450, 1370, 1360,1260, 
1180, 1140, 1110, 1040, 890, 880 and 850. 'H and 
I3C NMR: Table 1.
EIMS (rel. int.). 440 (71.7) [ M ] '; 425 (30.2) 
[M -  Mc] + , 367 (8.8) [M -  C3H50 2] ' , 359 (12.2), 218 
(16.7), 205 (19.5), 204 (30.2), 203 (19.5), 191 (10.1), 190
(11.4), 189 (38.9), 178 (22.0), 177 (100), 176 (31.0), 175
(15.4), 163 (12.6), 161 (13.2), 149 (12.6), 157 (13.3), 135
(14.0), 133 (16.0), 123 (12.0), 121 (26.7), 119 (21.2), 109
(31.2), 105 (18.4), 95 (45.6), 93 (24.0), 91 (14.9), 83 (11.7), 81
(37.0), 79 (16.0) and 69 (34.4).
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Key Word Index— Bosistoa transversa', Rutaceae; 2- and 4-prenylated 9-( 10)-acridone alkaloids; 
bosistidine; bosistine; 4-(2f-hydroxy-3-methylbut-3-enyl)yukocritrine.
Abstract—Eight acridone alkaloids were isolated from Bosistoa transversa. Three of them are novel and have 
been identified as l,3,5-trihydroxy-2-(2£-hydroxy-3-mcthylbut-3-enyl)-l0-methylacridan-9-one (trivial name, 
bosistidine), 1,3,5-trihydroxy-2-(2f-hydroxy-3-methylbut-3-cnyl)-4-(3-methylbut-2-cnyI)-10-methylacridan-9-one 
(bosistine) and l,3,5-trihydroxy-4-(2f-hydroxy-3-methylbut-3-enyl)-yukocritine. The structures were elucidated on 
the basis of NMR spectral data, notably NOESY and HMBC experiments.
IN T R O D U C T IO N
In continuation of our investigation into the chemistry 
of the genus Bosistoa [1,2] we have undertaken a study 
of the aerial parts of B. transversa J. F. Bailey and C. 
T. White, a small- to medium-sized tree found in the 
rain forests of Queensland and northeast New South 
Wales [3], In the present paper wc report the isolation 
and identification of eight acridone alkaloids, of which 
three appear to be novel. )H Me FI3
R E SU L T S A ND D ISC U SSIO N
By a combination of vacuum liquid chromatography 
(VLC), gel filtration and preparative TLC procedures, 
the hexane and ethyl acetate extracts of the leaf 
material afforded six acridones (1, 2 and 4-7). Similar 
treatment of the stem bark again gave these alkaloids, 
plus the two additional acridones. 3 and 8. The al­
kaloids were all yellow in colour and gave UV, IR and 
NMR spectra typical of the 1,3,5-oxygenated-W- 
methylacridan-9-one nucleus [4-6].
Five were known compounds which were identified, 
by direct comparison of their spectral data with that 
published, as citrusamine (1) [7], junosine (2) [8], 
Af-methylataphylline (5) [9], yukocitrine (7) [10] and 
iV-methylataphyllinine (6) [11], The remaining com­
pounds (3, 4 and 8) were novel acridones, which had 
several NMR spectral features in common. There were 
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aromatic protons, one of which was deshielded and 
therefore placed peri to the carbonyl at H-8, an N- 
methyl group, and signals for a 2-hydroxy-3-methylbut-
3-enyl moiety (Table 1).
In bosistidine (3), the only additional signal in the 
H NMR spectrum was for a single A-ring proton, 
which must be placed at cither C-2 or C-4. As this 
proton exhibited a strong NOE interaction with the 
N-methyl, it must be assigned to C-4 and bosistidine 
must be 3.
Table 1. 'H NMR (400 MH/., acctone-d,,) spectral data for 
compounds 3 and 8
H 3 8
I-OH 15.26 ,v 14.70 j
4 6.45 s
5-OH 9.40 .v 9.36 s
6 7.27 dd (7.8 1.4) 7.28 dd (7.9,1.5)
7 7.121 (7.8) 7.18/(7.9)
8 7.90 dd (7.8,1.6) 7.90 dd (7.9,1.5)
N-Me 4.05 s 3.781
1’ 3.15 dd (14.4, 8.0) 3.22 dd (14.4, 8.0)
2.85 dd( 14.4, 8.0) 3.18 dd( 14.4, 8.0)
2’ 4.40 in 4.64 m
2'-OH 5.35 i 5.35 x
H2-4' 4.96 s 4.66 i
4.76 ,v 4.544
.V-Me 1.85 s 1.76 4
r 6.72 d (  10.0)
2" 5.70 d (10.0)
(Me); 1.524
1.504
The 'H NMR spectrum of bosistine (4), showed in 
place of an A-ring proton, an additional 3-methyl-2- 
enyl group substituent. The problem of placing the two 
different prenyl substituents at C-2 and C-4 was 
resolved in a number of ways, (a) In the C NMR 
spectrum (Table 2), the methylene of the 3-methylbut- 
2-enyl side-chain appeared at S 27.3, which is charac­
teristic of a C-4 substituent of this type [6]. (b) A 
'H-'H NOESY experiment revealed a strong inter­
action between the W-methyl and the olefinic proton of 
the 3-methylbut-2-enyl side-chain at S 5.40, again 
indicating that this side-chain is at C-4. (c) In an 
HMBC experiment (Table 2) long-range coupling ( 'J )  
was observed between the methylene protons H-l'a and 
H-l'b of the 2-hydroxy-3-methy!but-3-enyl side-chain 
and the carbon nuclei resonating at S 161.2 (C-l) and
164.5 (C-3), with a 2 ./-coupling with C-2 (8 108.3).
The third new alkaloid gave a 'H NMR spectrum 
that showed signals for a 2,2-dimethyl chromene sys­
tem and a 2-hydroxy-3-mcthylbut-3-enyl which must be 
located on ring A. The orientation of the pyran ring 
with respect to the acridone nucleus was suggested as 
linear by the UV spectrum [6, 10]. This required place­
ment of the 2-hydroxy-3-methylbut-3-enyl side-chain at 
C-4; this was further confirmed by the observation of 
NOESY cross-peaks between the /V-methyl and the 
exomethylene protons of the side-chain. The chemical 
shifts of the chromene system protons were very similar 
to those of yukocitrine (7) 110]. On the basis of these 
data. 8 has been assigned.
The three novel compounds all possessed the 2- 
hydroxy-3-methy!but-3-enyl side-chain, which has a 
chiral centre. Unfortunately, insufficient quantities were 
isolated to permit establishment of any absolute con­
figurations.
Our study has revealed that B. transversa is a major 
source of 1,3,5-oxygenated-2,4-prenylated acridones. 
Many of the compounds isolated have previously been 
reported from two other rutaceous genera, Atalanlia 
[9,11] and Citrus [7,8,10]. Both of these genera are 
members of the sub-family Aurantioideae, while Bosis­
toa is part of the tribe Zanthoxyleae (sub-family 
Rutoideae). The co-occurrence of this unusual type of 
acridone in these taxonomically distance taxa of the 
Rutaceae is rather surprising. Bosistoa transversa ap­
pears to be chemically distinct from the previously 
studied Bosistoa species, B. brassii [2] and B. floydii
[1], where the major metabolites are flavonoids. No 
flavonoids were detected in our study.
E X P E R IM E N T A L
Mps uncorr. UV: MeOH. IR: CHC1,. EIMS: probe 
(90-130°) at 70 eV. FABMS: nitrobenzyl alcohol ma­
trix. NMR: run in CDClj or Me.,CO-dfl. NOESY and 
HMBC [12] expts were obtained on a Bruker AMX- 
400 instrument using standard Bruker microprograms.
Plant material. The sample investigated was col­
lected on 22nd October 1991 near Mount French, 
Queensland. A voucher (T. G. Hartley 15168) is
3 3 3
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Tabic 2. 'H and "C  NMR chemical shift data (400 MHz, acctone-c/fl) and selected ~J and \ f  H-C 
couplings for compound 4
Position Sc 2J V
1 13.39 s 161.2
2 108.4




5 9.25 s 148.4
6 7.27 d (8.0) 120.5 123.7,148.4 117.3, 139.1
7 7.15 t (8.0) 123.7 117.3,120.5 125.9, 148.4
8 7.77 dd (8.0, 1.2) 117.3 123.7,125.9 120.5, 139.1,183.5
8a - - 125.9
9 183.5
9a — 105.0
N-Me 3.69 r 48.5 139.1, 150.5
l'a 2.85 dd (14.4,8.0) 30.0 77.5, 108.4 161 ;2, 164.5
I ’b 3.1944 (14.4,8.0) —
2' 4.3944(8.0, 2.1) 77.5
2'-OH 6.08 br s —
3' ------ 148.2
4’ 4.82 j 
5.04 .v
110.5
3'-Me 1.86 br s 18.7 148.2 77.5, 110.5
1” 3.56 m 27.3 110.0,125.4 164.5
2" 5.40 m 125.4
3" 131.5
3"-Me 1.78 s 18.2 131.5 25.9,125.4
3”-Me 1.69 s 25.9 131.5 18.2, 125.4
deposited at the Australian National Herbarium, Can­
berra.
Extraction and isolation o f alkaloids. Ground leaves 
(400 g) and stem bark (80 g) were separately extracted 
(Soxhlet) with hexane, then EtOAc and finally MeOH. 
The hexane extract of the leaves (4g) was fractionated 
by VLC over silica gel, eluting with petrol (bp 60-80°) 
containing increasing amounts of EtOAc. The 10-20% 
EtOAc eluate was passed through a column of 
Sephadex LH-2Q, eluting with CHCI,, followed by 
prep. TLC (silica gel, CHCI,-EtOAc, 9:1) to give 5 
(10 mg) and 6 (5 mg). The EtOAc extract was passed 
through a column of Sephadex LH-20 followed by 
prep. TLC (silica gel, CHCI,-EtOAc, 7:3) to give 1 
(6 mg), 2 (4 mg), 4 (5 mg) and 7 (4 mg).
The hexane extract of the stem bark, when treated in 
an identical manner, gave two further alkaloids 3 
(5 mg) and 8 (3 mg), together with 5 (20 mg) and 6 
(7 mg). The EtOAc extract gave 1 (12 mg), 2 (12 mg), 
4 (10 mg) and 7 (8 mg) on separation following the 
same procedures as used for the leaf extract.
Citrusamine (1). Yellow, amorphous. Found: |M ]' 
271.0841; C^H^NO,, requires 271.0845. The spectral 
data (UV, IR, NMR, MS) were in agreement with that 
published [7],
Junosine (2). Orange needles from CHCI,-MeOH, 
mp 220° (lit. [8] 210-213°). Found: [M f 325.1325; 
C 19H19N 04 requires 325.1314. Spectral data (UV, IR, 
NMR, MS) were in agreement with that published [8].
1,3,5 - Trihydroxy - 2 - (2£ - hydroxy - 3 - methylbut -
3 - enyl) - 10 - mcthylacridan - 9 - one (bosistidine) (3 ) . 
Yellow, amorphous. [a ]D -15,1 (c 0.0018, CHCI,). 
Found: [M ]f 341.1263; C l9H 19N 0 5 requires 341.1263. 
u v  nm C°g *)’• 235 (4-2°). 260 (4-27), 280 (4.35), 
335 (3.90), 410 (3.50). IR ymllll c m '1: 3400, 1630, 
1560. 'H NMR: Table I. HREIMS: m /z  (rel. int.): 341 
(44), 323 (15), 308 (31), 270 (100), 236 (12).
1,3,5 - Trihydroxy - 2 - (2 f  - hydroxy - 3 - methylbut - 
3 - enyl) - 4 - (3 - methylbut - 2 - enyl) - 10 - methyl- 
acridan - 9 - one (bosistine) (4). Yellow, amorphous. [« ]D 
-4 .1  (c =  0.0013, CHCI,). Found: [M]+ 409.1879; 
C24H27NO, requires 409.1879. UV Amo, nm (log e): 
222 (4.16),'267 (4.36), 350 (4.15), 410 (3.55). IR ymiix 
c m 1: 3580, 1710, 1625, 1573, 1455, 1285, 1040. 'H 
and 13C NMR: Table 2. HRELMS: m lz  (rel. int.): 409 
(12), 338 (85), 295 (5), 282 (100).
N-Melhylataphylline (5). Orange needles from pet- 
rol-EtOAc, mp 187-190° (lit. [9] 190-193°). Found: 
|M] ‘ 393.1926; C24H27NO, requires 393.1940. Spec­
tral data (UV, IR, NMR, MS) were in agreement with 
that published [9].
N-Methylataphyllinine (6). Orange needles from pet- 
rol-EtOAc, mp 195° (lit. [11] 195-196°). Found: [M ]' 
391.1178; C24H25N 0 4 requires 391.1793. Spectral data 
(UV, IR, NMR, MS) were in agreement with that 
published [11].
Yukocitrinc (7). Yellow oil. Found: [M ]' 323.1155; 
C 19H,7NO„ requires 323.1158. Spectral data (UV, IR, 
NMR, MS) were in agreement with that published [10].
4-(2£-Hydroxy-3-methylbut-3-enyl)-yukocitrine (8).
3 3 4
A . A . A ll/J  el al.238
Yellow oil. [<*]„ +16.4 (c 0.0005, CHCI,). Found: 
FABMS [M + 1)' 408 = C,„H25NO,. UV A,tes nm 
(loge): 225 (4.15), 266 (4.30), 300 (4.65), 305 (34.15), 
335 (3.55), 405 (3.55). IR yMW cm 3320, 3010, 
1650, 1608, 1555. 'H NMR: Table 1. FABMS: m /z (rel. 
int.): 408 [M + I f ,  336 (100), 165 (21).
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PHLOROGLUCINOL DERIVATIVES FROM LEAVES OF BOSISTOA  
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Key Word Index —Bosistoa penlacocca; B. penlacocca var. connaricarpa; B. penlacocca var. 
dryanderensis; Rutaceae; leaves; phloroglucinol derivatives; pentacoccols.
Abstract- Leaves from four collections o f Bosistoa penlacocca, two of the variety connaricarpa and one each 
of the type variety and var. dryanderensis, have been examined. In each, the major metabolite isolated was 
characterized as 2-(3,7-dimethyloct-2,5-dienyl)-6-(3-methylbut-2-cnyl)phloroglucinol-l-acetate (trivial name 
pentacoccol). Four other pentacoccol derivatives were obtained as minor components, pentacoccol-5-methyl 
ether (from var. penlacocca and var. dryanderensis), 2,2-dimethyl-.R,7-dihydroxy-5-acetoxy-6-(3,7-dimelhyloct-
2,5-dicnyl)-3,4-dihydrobenzo-(2//]-pyran (3'-hydroxydihydropyranopeutacoccol from var. connaricarpa), 2-(l- 
hydroxy-1-methylethyl)-4-acetoxy-5-(3,7-dimethyloct-2,5-dienyl)-6-hydroxybenzo-[2//]-furan (2'-(I -hydroxy- 
osopropyljfuranopentacoccol from var. penlacocca) and 4-acetoxy-5-(3,7-dimethyloct-2,5-dienyl)-6-hyd- 
roxybenzo-[2H]-furan (furanopentacoccol from var. dryanderensis). All compounds were identified on the basis 
of their spectroscopic data. (T) 1997 Elsevier Science Ltd. All rights reserved
IN T R O D U C T IO N
The genus Bosistoa F. Muell. ex Benth., as currently 
delineated by Hartley [I], consists of seven species of 
small trees found in the rain forests of New South 
Wales and Queensland. In a series of studies, we have 
reported on flavonoids from B. brassii Hartley [2] and 
B. medicinalis (F. M. Bailey) Hartley [3], a xanthine 
alkaloid from B. floydii Hartley [4] and acridone alka­
loids from B. transversa [3] and B. sehvynii Hartley 
[61-
In the present work, we wish to report the results 
of a study on the leaves o f B. penlacocca (F. Muell.) 
Baillon. Hartley [1] recognized three varieties of this 
species: var. penlacocca occurring in south-east 
Queensland and north-east New South Wales, var. 
connaricarpa (Domin) Hartley occurring in east cen­
tral Queensland from Bowen south to Gin-Gin, and 
var. dryanderensis Hartley also occurring in east cen­
tral Queensland around Mount Dryander and 
MacKay. A previous investigation on B. penlacocca, 
reported under the illegitimate name B. sapindiformis, 
yielded the pentacyclic triterpenes, taraxero! and tar- 
axerol methyl ether [7]. The only other phytochemical
j  Author to whom correspondence should be addressed.
report citing the genus was for B. euodiiformis, which 
yielded acetophenones, furoquinoline alkaloids, a 
limonoid and the triterpene, bosistoin [8], Bosistoa 
euodiiformis is now considered [1] to be a species of 
Acradenia rather than Bosistoa.
R E S U L T S  A N D  D IS C U S S IO N
The major compound isolated from each of the four 
samples gave an ion at m /z 395 [M I- N a]1 in FAB 
mass spectra, which corresponded with an empirical 
formula, CjjHjjO,,. Two major fragments in the HREI 
mass spectra indicated the loss of Q H , and C ,H ,S 
fragments, which suggested the presence o f C-prenyl 
and C-geranyl units, while a major ion at m /z 43 was 
typical o f an acetoxyl substituent.
The 'H NMR spectra (Table 1) confirmed the pres­
ence o f an acetyl methyl and of 3-methylbut-2-enyl 
and geranyl moieties. This accounted for all but three 
protons, which were observed as an aromatic proton 
singlet at 5 6.36 and two aromatic phenols at <5 8.08 
(br). The ”C NMR spectrum (Table 1) revealed signals 
typical o f prenyl and geranyl side-chains and the 
acetoxy, leaving six further carbons, the single aro­
matic methine (5 101.3), two equivalent shielded quat­
ernary carbons (<5 II3.1) and three deshielded oxy­
genated aromatics (5 150.4 and 154.7 double inten-
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Table I. 'H and "C  NMR chemical shift values for compounds 1 and 2
'H "C
C/H 1 2 I 2
1 150.4 148.2
2 113.1 111.7*
3 (OH) 8.08.5 154.7 156 9
4 6.38 .s 6.30 .v 101.3 98.1
5 (011) 8.08 .t 154.7 154.1
6 113.1 114.9*
l-OCOMe 2.25 .v 2.29 * 169.3, 20.8 169.5, 20,7
5-OMc 3.74 s 55.8
1' 3.08 d  (6.6) 3.17 rf(6.7) 23.8* 23.8
2' 5.12/(6.6) 5.20 / (6.7) 124.3 122.0
3' 130.7 134.4
3'-Me 1.71 .v 1.77 .v 25.9 25.8
3'-Me 1.63 4 1.72.V 17.8 17.9
r 3.08 d (6.6) 3.15 d  (6.8) 23.9* 23.2
2“ 5 .12 /(66) 5.08 / (6.8) 124.3 122.8
3“ 134.5 134.8
3"-Me 1.72.1 1.72 4- 16.3 16.2
4" 1.94 m 1.95 m 40.3 39.8
5" 2.08 m 2.06 m 27.4 26.8
6" 5.12/ (6.6) 5.08 / (6.7) 125.3 124.5
V 131.7 131.3
7"-Mc 1.63 s 1.63 4 25.9 25.8
1.57 .v 1.57 x 17.8 17.8
1 in acetone-//,,. 2 in CDC1, 
* Signals interchangeable.
sity). This required the presence of a systematically 
trioxygenated ring system (e.g. phloroglucinol), in 
which two o f the non-oxygcnaled carbons were sub­
stituted by the 3-methylbut-2-enyl and geranyl groups; 
one of the oxygenated positions was acetylated.
The positions of the various substituents were estab­
lished by means of long-range heteronuclear coupling 
(HMBC) experiments [9] on the basis o f the following 
observations. The single aromatic proton revealed two 
interactions, with the two equivalent resonances at S 
154.7 (’/ )  and with the second equivalent pair at S
113.1 (3J). From the two phenolic hydroxyl protons, 
}J  interactions were revealed to the carbons resonating 
at 5 154.7, while there was an intense V  interaction to 
the signals at 5 101.3 and 113.1. These observations 
required the compound to have the symmetrical struc­
ture 1. Unequivocal assignment o f the carbon res­
onances (Table I) was confirmed from the full analysis 
of HMBC and HC-COB1 [10] experiments. Com­
pound 1 appears to be novel and has been assigned 
the trivial name, pentacoccol.
A very similar compound differing only in the 
methyiation o f one of the aromatic hydroxyls 
(CmH340 4 from HREI mass spectrum, 5 3.74 (3H), 
55.7) was obtained from B. penlacocca var. penlacocca 
and B. penlacocca var. dryanderensis. The l3C NMR 
spectrum (Table 1) indicated the phloroglucinol oxy­
genation pattern and, together with the 'H NMR spec­
trum, that the same prenyl and geranyl side-chains 
were present. The relatively shielded resonance for the 
methyoxyl carbon at ca 6 56 (cf. 60-62 ppm where 
both or/Ao-positions are substituted) required place­
ment adjacent to the aromatic proton [11]. Assign­
ment to C-5, adjacent to the prenyl substituent, was 
resolved from a HMBC experiment, where both H -I’ 
of the prenyl side-chain and the OMe protons showed 
a coupling to the carbon at <5 156.9. On this basis, 
the compound could be characterized as pentacoccol-
5-methyl ether (2), which is again novel.
Three further phloroglucinol derivatives were 
obtained as minor components, each based on cycli- 
zation o f the prenyl side-chain with the adjacent 
hydroxyl. Both samples o f B. penlacocca var. con­
naricarpa yielded a compound which analysed (HREI 
mass spectrum) for C2jHj2Oj. The NMR spectra 
(Table 2) revealed the presence o f the phloroglucinol 
system with the acetoxyl and geranyl substituents but 
the signals for the prenyl unit were not present, being 
replaced, in the 'H NMR spectrum, by a CH2-CH(0)- 
spin system and two methyls and, in the l5C NMR 
spectrum, by a methylene, an oxymethine, an oxy­
genated quaternary sp1 carbon and two methyls. These 
resonances could be assigned to a 3-hydroxy-2,2- 
dimethyldihydropyran system which could be formed 
by cyclizalion o f a 2,3-dihydroxy-3-methylbutanyl 
side-chain and the 5-OH with the loss o f the elements
3 3 7
Phloroglucinols from Bosistoa penlacocca
1 R = H
2  R = Me
4
5
of water. This was confirmed by an HMBC 
experiment (Table 2). Thus, this compound is ident­
ified as 5-acetoxy-3,4-dihydro-3£,7-diliydroxy-6-(3,7- 
dimethyloct-2,5-dienyl)-2,2-dimethyl-[2H]-benzopy- 
ran (3), to which we assign the trivial name, 3'^-hyd- 
roxy-dihydropyranopentacoccol.
A minor isolate from B. penlacocca var. penlacocca 
gave a [M] * for Cj3H 10O 5 (HREI mass spectrum). In 
this case, the signals originating from the modified 
prenyl group were an aryl methine at <5 6.87 showing 
a small coupling(0.8 Hz) to the phloroglucinol proton 
(cf. H-4 in 1) and geminal methyls resonating at <31.64. 
The "C NMR spectrum and a HC-COBI experiment 
revealed that the methine carbon resonated at 5 95.7, 
the methyls al <5 28.8. An HMBC experiment showed 
that the methine and methyl protons coupled with 
quaternary carbons at S 69,4 and 162.0, which must 
be oxygen-bonded sp* mid sp2 carbons, respectively. - 
There are two plausible structures that could fit these 
data, a 3-hydroxy-2,2-dime thy Ipyran or a 2-(l-hyd- 
roxyisopropyl)furan. The resonance positions 
observed were very similar to those uoted previously 
for the acetophenonc, furostipitol [12], In particular, 
the resonance for the sp2 quaternary carbon (5 69.4) 
was typical o f the I -hydroxyisopropyl group, whereas, 
in the comparable C-2' position of benzopyrans, this
R = C(OH)Me2 
R = H
occurs at ca S 78 (cf. 3). On this basis, the compound 
is identified as 2-(I-hydroxy-l-methylethyl)-4-ace- 
loxy-6-hydroxybenzofuran, to which we have 
assigned the trivial name 2'-(l-hydroxyisopropyl) 
furanopentacoccol (4).
From B. penlacocca var. dryanderensis another 
minor compound was obtained which analysed 
(HREI mass spectrum) for C20H24O4. The 'H N M R  
spectrum once again identified the phloroglucinol 
ring, and geranyl and acetoxyl substituents. The 
remaining two methines formed a simple spin system 
(,J =  2.2 Hz) typical o f a furan ring. Insufficient 
material was available to obtain a satisfactory l5C 
NMR spectrum but this compound must be a simple 
derivative furanopentacoccol (5).
A search of the Dictionary of Natural Products [13] 
failed to show any compounds directly analogous to 
the pentacoccols. Within the Rutaceae, a number of 
acetophenones with a phloroglucinol oxygenation 
pattern substituted with prenyl, geranyl and farnesyl 
substituents are known, many of which exhibit simi­
larly modified and cyclized sidc-chains [14], In B. pen­
lacocca, it seems that the phloroglucinol system has 
been biosynthesized from the combination of three 
acetate units, whereas, in the acetophenones, four 
acetate units are involved. The differences in pro­
3 3 8
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Tabic 2. M l and " C NMR chemical shift values for compound 3
’H uc 'J V
2 77.1
2-Mc 1.34 .v 25.9 77.1 25.9,69.5, 152.3
1.29 s 25.9 77.1 25.9, 69.5, 152.3
3 3.75 t (5.2) 69.5 105.5






8 6.25 s 102.9 152.3, 154.8 105.5, 112.9
8a 152.3
OCOMe 2.31 x 169.0, 20.7
1" 3.17 4(6.7) 23.6 112.9, 121.7 138.5, 148.5,
154.8
2" 5.17 t (6.7) 121.7 23.6 16.3, 39.9
y 138.5
r-M e 1.81 A 16.3 138.5 39.9, 121.7
4" 2.03 m 39.9 26.6, 138.5 16.3, 121.7
5" 2.08 m 26.6 39.9, 124.0 132.2
6” 5.05 I (6.8) 124.0
V 132.2
7"-Me 1.67 a 25.9 132.2 17.9, 124.0
1.59a 17.9 132.2 25.9, 124.0
Spectra in CDCI,
duction of minor components are not considered to 
have taxonomic significance; rather, the codominance 
of pentacoccol is considered to support the close 
affinity between these taxa proposed by Hartley [1].
EXPERIMENTAL
Extractions were carried out using a Soxhlet appar­
atus using, sequentially, petrol (bp 60-80c’), EtOAc 
and MeOH as solvents. UV: MeOH. IR: solvent-free 
film. HREI MS: 70 eV, FABMS: NOBA-matrix. 
NMR spectra were obtained on a Bruker AMX-400 
instrument using standard Bruker microprograms for 
2D expts [15].
Plant m aterial. Bosistoa penlacocca var. penlacocca: 
voucher: T. G. Hartley 15170 collected 22 October 
1991 on Mount French, Moreton Bay District, 
Queensland, B. penlacocca var. connaricarpa: vou­
cher: T. G. Hartley 13201 collected II April 1993, 
State of Forest 50, Glenbar, Wide Bay District, 
Queensland, voucher: P. Vorstcr 9398 collected 18 
January 1992, Mount Colosseum National Park, Port 
Curtis District, Queensland, and B. penlacocca  var. 
dryanderensis: voucher P. Vorster 9411 collected 19 
January 1992, Mount Dryander, North Kennedy Dis­
trict, Queensland.
Extraction o f  B. pentacocca var. penlacocca. Dried, 
milled leaves (230 g) yielded a concentrate (2.5 g) from 
the petrol extract. CC o f this material over Sephadex 
LH-20, eluting with CHCI, removed the chlorophylls
and yielded a fr, containing 1 as an amorphous solid 
(I g). The EtOAc concentrate (5 g) was treated in a 
similar manner, eluting the Sephadex LH-20 with 10% 
MeOH in CHCI, which yielded, in sequence of elution, 
sitosterol (30 mg), 2 and 5. Prep. TLC of 2 and 5 
(silica gel; petrol-EtOAc, 9 :1) yielded pure 2 (100 mg, 
Rf 0.67) and 4 (4 mg, fyO.14).
Extraction o fB . pentacocca var. connaricarpa (H ar­
tley 13201). Dried, milled leaves (290 g) yielded a 
petrol concentrate (6 g) and an EtOAc concentrate 
(10 g). These were subjected to identical treatment to
B. pentacocca  var. pentacocca  to yield, from the petrol 
extract, 1 (425 mg), and from the EtOAc extract, sito­
sterol (20 mg) and 3 (3.5 mg, Rf  0.45, petrol-EtOAc, 
1 : 1).
Extraction o f  B. pentacocca var. connaricarpa 
(Vorster  9398). Dried, milled leaves (185 g) yielded a 
petrol concentrate (2 g) and an EtOAc concentrate (5 
g). These were subjected to identical treatment noted 
above, to yield, from the petrol extract, 1 (1.2 g), and 
from the EtOAc extract, sitosterol (30 mg) and 3 (5 
mg).
Extraction o f  B. pentacocca var. dryanderensis. 
Dried, milled leaves (400 g) yielded a petrol con­
centrate (15 g) and an EtOAc concentrate (10 g). These 
were subjected to identical treatment to that noted 
above, to yield, from the petrol extract, 1 (1.5 g), and 
from the EtOAc extract, sitosterol (30 mg), 2 (100 mg) 
and 5 (4 mg, R, 0.74 in petrol -EtOAc, 9:1).
Pentacoccol (1). Amorphous solid. FABMS: m /z
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Tabic .V ‘11 anil "CNMR chemical shill data and long-range H-C coupling for compounds 4, and 'H NMR data for 5
H 'H "C -./ 5
2 162.0 7.47 d (2.2)





7 6.32 cl (0.8) 95.7** 153.3, 154.4 115.7, 115.9 6.96 hr s
7a 154.4
OCOMe 2.42 .« 169.1,20.9 169.1 2.40 .*
1" 69.4
l"-Mc 1.64 s 28.8 69.4 28.8, 162.0
1.64 a 28.8 69.4 28.8, 162.0
1" 3.30 z/ (6.8) 23.7 115.7, 121 5 138.7, 141.1, 153.3 3.36 d  (6.6)
2” 5.19 t (6,8) 121.5 5.21 r (6.6)
3" 138.7
3"-Me 1.83 a 16.4 138.7 39.8, 121.5 1,80 a-
4" 2.10 m 39.8 26.6, 138.7 16.4, 123.9 2.06 m
5" 2.16 m 26.6 39.8, 123.9 132.2 2.12 m
6" 5.03 t (6.6) 123.9 5.05 t (7.0)
7" 132.2
7"-Me 1.72 a- 25.8 132.2 17.9, 123.9 1 .6 8  a-
1.59 a- 17.9 132.2 25.8, 123.9 1 .60 a-
Spectra in CDCI,.
*/** signals with sutnc number of * arc interchangeable
395 [M + Na| V UV Amnx nm (log e ) :  208 (4.18). 225 
(3.99). 273 (3.63). IR vmnx cm 3436, 2924. 1744. 
1633, 1598, 1466, 1370, 1199, 1050. NMR: Table 1. 
EIMS m/z  (rel. int.): 249 (35), 207 (70), 151 (52), 123 
( 100).
Pentacoccol-5-methyl ether (2). Oil. FABMS: m/z 
409 [M + Na] + . HREIMS: found [M] m/z 386.2485; 
CmMmO„ requires 386.2458. UV 2,„„x nm (log «): 210 
(4.28), 226 (4.05), 274 (3.70). IR v,naxcm 3436, 2916, 
1735, 1620, 1487, 1433, 1368, 1208, 1164, 1001. NMR: 
Tabic 1. EIMS m /z (rel. int.): 363 (33), 247 (12), 221 
(48), 219 (100), 166(8), 123 (43).
h'-Hydroxydihydropyranopentacoccol (3). Oil. 
fa]„ 7.5" (c 0.002, CHCI,). HREIMS: found [M ]' 
m/z 388.2196; CJ3H „ 0 5 requires 388.2250. UV A„,„x 
nm (log e): 209 (4.47), 225 (4.17), 285 (3.87). IR v„1Jlx 
cm ': 3393, 2921, 1738, 1627, 1599, 1447, 1369, 1201, 
1117. 1063. NMR: Table 7. EIMS m/z (rel. int.): 388 
(56), 265 (63), 223 (100).
2’-( 1 -Hydroxyisopropyt)furanopentacoccol (4). Oil. 
HREIMS: found fM ]1 m/z 386.2057; CnHJ0O5 
requires 386.2094. UV Xmm nm (log e): 210 (4.32), 249 
(3.95), 295 (3.81). IR vnli>5 cm ': 3360, 2924, 1742, 
1633, 1467, 1369, 1208,1163,1105,1074. NMR: Table
3. EIMS m/z (rel. ini.): 386 (40), 344 (39), 327 (27), 
221 (100), 123 (31).
Furanopentacoccol (5). Oil. HREIMS: found [M ]' 
m/z 328.1665; C2nHM0 4 requires 328.1675. UV 2,,,.,,.
nm (log <;): 213 (4.47), 228 (4.10), 273 (3.93). IR v„ux 
cm"1: 3452,2919, 1735, 1623, 1469, 1445, 1370, 1164, 
1049, 1043. NMR: Table 3. EIMS m/z (rel. int.): 328 
(86), 286 (84), 163 (100).
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Abstract—An investigation of the stem bark of Friesodielsia enghiana led to the isolation of benzyl benzoate and 
benzyl 2-hydroxybenzoate, two bisabolene sesquiterpenes and nine flavonoids, two of which were new. The new 
compounds were identified by analysis of their spectroscopic data as 2,5-dihydroxy-7-methoxy-8-methylflavanone 
and 2,5-dihydroxy-7-methoxy-6-methylflavanone. Three of the co-occurring flavones also have 6- and/or 8-C- 
methylation. Copyright © 1996 Elsevier Science Ltd
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IN T R O D U C T IO N
Friesodielsia van Steenis is a genus of Annonaceae 
with about 60 species found in Africa and Asia [1], 
Until 1948, species belonging to this genus were placed 
under Oxymitra [2], The first phytochemical report on 
the genus was made in 1960, in which the presence of 
alkaloids in an unidentified species was noted [3]. Since 
then only two species have been investigated, F. kingii 
(syn. Oxymitra kingii) from which hexahydroxanthenic 
derivatives and a llavanone were isolated [4], and F. 
velutina (syn. O. velutina) which yielded flavonoids, 
phenylpropanoids, sterols and alkaloids [5J. In this 
report we present the results of a phytochemical 
investigation on the stem bark of F. enghiana (Diels) 
Verde., a large woody climber found in the tropical rain 
forest of West Africa, from Sierra Leone to Zaire [ 1 ].
R E S U L T S  AND D ISC U SSIO N
The stem bark of F. enghiana was successively 
extracted with petrol (bp 60-80°) and CHC1,. The
concentrated petrol extract, after repeated column chro­
matography and preparative TLC on silica gel, yielded 
benzyl benzoate ( 1), benzyl 2-hydroxybenzoate (2 ) [6], 
two bisabolene sequiterpenes, /3-bisabodol (3) [7] and 
gossonorol (4) [8], and the flavonoids 5-hydroxy-7- 
methoxy-8-methylflavone (5) [101, 5-hydroxy-7-
methoxy-6-methylflavone (6) [10], 5-hydroxy-7-
methoxyflavone (7) [11 ], 5-hydroxy-7-methoxy-6,8-di- 
methylflavone (8) [10], 5-hydroxy-7-methoxyfiavanone
(9) [12], 2,5-dihydroxy-7-methoxy-8-methylflavanone
' Author to whom correspondence should be addressed.
(10) and 2,5-dihydroxy-7-methoxy-6-methylflavanone
(11). The CHClj extract after similar treatment gave 
compounds 1, 5, 6, 9, 10 and 11, and in addition
2,5-dihydroxy-7-methoxyflavanone (12) [13, 14] and 
5.7-dihydroxy-6-methylflavanone (13) [15]. Com­
pounds 1. 5 and 6 formed the major constituents of the 
petrol extract; 10 and 11 the major constituents of the 
CHC1, extract. All the known compounds were iden­
tified by comparison of their spectroscopic data with 
those published.
Compounds 10 and 11 were isolated as a mixture 
(10:11 = 1; 0.94) as shown by the 'H NMR. The 
HR-EIMS gave a single molecular ion peak at mlz 
300.1006 which analysed for Cl7H,60 5. The UV 
analysis showed a strong absorption at 276 nm and a 
shoulder at 336 nm, which is typical of flavanones [10], 
and the IR spectrum indicated hydroxyl and carbonyl 
functions. The 'H NMR spectrum of 10, the major 
compound of the mixture, showed a singlet at S 12.64, 
and aromatic multiplets at 5 7.43 (3H) and S 7.68 (2H), 
suggesting a 5-hydroxyflavanone with an unsubstituted 
phenyl moiety (B-ring) which was supported by the 
fragment at m /z 77 in the mass spectrum. The 'H NMR 
further showed an aromatic methyl singlet (8-Me), an 
aromatic proton singlet (H-6) and a methoxyl singlet 
(7-MeO). The positions of H-6 and 8-Me were un­
ambiguously assigned from an HMBC experiment 
(Table 1) which showed 3./ couplings of the former 
with C-8 and C-I0, and the latter with C-7 and C-9.
The absence of a double doublet in the region of 
5 5.20 suggested the absence of an H-2 proton which 
normally couples with the H-3 protons in flavanones 
[11]. That this proton was substituted by an OH was 
supported by the presence of a doubly oxygenated sp ' 
carbon signal at S 101.8 (C-2) in the |:*C NMR
315
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9 H Me H H
10 Me Me H OH
11 H Me Me OH
12 H Me H OH
13 H H Me H
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suggesting a pseudo-equatorial configuration of die 
phenyl substituent.
Compound 11 gave signals similar to and sometimes 
overlapping with those of 10 in both the 'H and ,5C 
NMR spectra (Table 2). Analysing the HC-COBI and 
HMBC experiments the structure of this compound was 
established as the corresponding 2,5-dihydroxy-7- 
methoxy-6-methylflavanone.
Although flavonoids are widespread in nature, the 
occurrence of such stable hemiacetals with hydroxyl 
substitution at position C-2, as in compounds 10, 11 and 
12, is rare. Previously, only 7-methoxy-2,5-dihydroxy- 
llavanone from Populus nigra [14] and Uvaria rufas 
113], 7-glucosyloxy-2,5-dihydroxyflavanone from M ai 
lus sp. [16] and 6-formyl-2,5,7-trihydroxy-8- 
methylflavanone and 8-formyl-2,5,7-trihydroxy-6- 
methylflavanone from Unona lawii [17], have been 
encountered. The biogenesis of these compounds re­
mains unknown. However, they have been regarded as 
precursors of 5-hydroxyflavones because of the ease 
with which they are dehydrated to the latter [17]. In this 
regard, the co-occurrence of the 2.5-dihydroxy- 
flavanones and their corresponding 5-hydroxyflavones 
in the stem bark of F. enghiana is noteworthy.
E X P E R IM E N T A L
Mps: uncorr.; UV-MeOH; IR-CHCI,; NMR experi­
ments were ran on a Broker AMX 400 instrument; 
HR-EIMS were obtained on a AEI MS 902 double
Table 2. 'f-1 and ' ’C NMR data for 10 and 11
Position
5 ‘H* 8 " 'C t
10 11 12 10 11
2 101.8 .v 101.3 s
3„q 2.83 d 2.81 d 2.77 d 48.4 r 48.7 r
(7 = 17 Hz) (J -  17 Hz) (7 = 17 Hz)
3„„ 2.55 dd 2.60 dd 2.56 dd
(7 = 2.6, 17 Hz) (7 = 2.4, 17 Hz) (7 = 2.6, 17 Hz)
4 195.0 v 194.6 s
5 162.2 .v 160.3 s
6 6.02 .r 6.134 92.8 4 106.7 s
(7 = 2.0 Hz)
7 166.3 s 165.9 s
8 5.99 ,v 6.19 4 106.0 .v 91.94
(7 = 2.0 Hz)
9 155.7 s 158.0 jt
10 102.5 s 102.5 ,v
r 142.4 .v 142.1 m
276 ' 7.43 in 7.39 m 125.24 125.24
375 ' 7.14 m 7.09 m 128.94 128.94
4' 7.14 m 7.09 in 129.44 129.4 4
6-Mc 2.22 s 7-1 4
7-OMc 3.16.V 3.25 .v 3.13 s 56.1 q 56.0 q
8-Me 2.28 ,r 8.0 q
2-011 2.70 d 3.02 d 2.84 4
(J = 2.7 Hz) (7 = 2.6 Hz) (7 = 2.6 Hz)
5-OH 12.64 .v 12.57 s 12.56 s
^Solution in C,,Df, referenced to C,,D6 at 5 7.16 (400 MHz). 
fSolution in CDCI, referenced to CHCI, at 5 77.23 (100 MHz).
Table 1. Long-range ' I I -n C correlations shown by 10 itt 
HMBC experiment
11 ’j *7
H-3 101.8 (C -2), 195.9 (C -4)
H-6 162.2 (C -5), 166.3 (C -7) 106.0 (C -8), 102.5 (C-10)
8-M e 106.0 (C -8) 166.3 (C -7), 155.7 (C-9)
H -2 7 6 ' 142.4 ( C - i ') .  128.9 (C -3 ‘) 101.8 (C -2), 129.4 (C -4 ')
spectrum. The position of this carbon was established 
from 5J  coupling with the H-276' protons in the 
HMBC experiment. This 2-OH gave a doublet at 8 2.70 
while the H-3 protons formed an AB system with 
resonance signals at 8 2.55 (H-3„) and 8 2.83 (H-3cq). 
These data led to the assignment of the structure of 10 
as 2,5-dihydroxy-7-methoxy-8-methylflavanone. The 
small J  of 2.5 Hz for the 2-OH proton must be due to 
long range W-coupling with the 3-H„„ (Fig. 1) thus
MeO Me
HO
Fig. I. W'-coupling between H., and 2-OH.
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focusing spectrometer using direct probe insertion at 
120° and 70 eV.
Plant material. The stem bark of F. enghiana was 
collected from the Bobre Forest Reserve, Ghana, in 
August 1993, and was identified by comparison with 
herbarium specimens at the Forest Herbarium of the 
forestry Department, Kumasi.
Extraction and isolation o f compounds. Oven-dried 
(40°) powdered stem bark (500 g) was Soxhlet ex­
tracted successively with petrol (bp 60-80°) and 
CHC1,. The extracts were evaporated at 30° under red. 
pres, to give 11.08 and 10.51 g extract, respectively. 
The concd petrol extract gave a ppt, which was filtered 
and recrystallized from CHC1, to give 6 (64 mg). The 
residual extract (4.6 g) was repeatedly subjected to CC 
over silica gel (230-400 mesh) eluting with petrol 
(40-60°), followed by petrol-EtOAc mixtures and 
EtOAc to give a series of compounds which were 
purified by PTLC using toluene, toluene-EtOAc (9:1; 
8:2) and CHCl,-MeOH (98:2) to give: 1 (206 mg), 2 
(14 mg), 3 (38 mg), 4 (4 mg), 5 (137 mg), 6 (60 mg), 7 
(19 mg), 8 (6 mg), 9 (38 mg) and 10/11 (35 mg). The 
concd CHClj extract (6g) was subjected to VLC over 
silica gel eluting with petrol, petrol-EtOAc mixtures, 
EtOAc and EtOAc-MeOH mixtures to give 4 frs 
labelled A-D. Fr. A was CC over silica gel, eluting 
with toluene and toluene-EtOAc mixtures. The early 
fractions after PTLC (toluene-EtOAc, 9.5:0.5) gave 1 
(15 mg). Fr. B was similarly treated and after PTLC 
(toluene-EtOAc, 8:2) gave 5 (72 mg), 6 (34 mg) and 7 
(30 mg). Frs C and D gave ppts which were filtered and 
recrystallized from CHC13 to give 10/11 (553 mg). 
Further PTLC of the supernatant using CHCI3-MeOH 
(95:5) gave more 10/11 (94 mg), 12 (5 mg) and 13 
(14 mg).
2,5-Dihydroxy-l-metho\y-&-inethlyflavanone and
2,5-dihydroxy l -methoxy-6-methylflavanone 10 and 11 
(in 1:0.94 mixture). Pale yellow crystalline powder; 
rnp 134-136°; [a ]D +20.7 (c =0.105, CHC13); UV: 
Am„„: 277, 334 (sh) nm; IR Kmnl cm"': 3346 (OH), 
2916, 1639 (C=0), 1448, 1317, 1205, 1155, 1126, 767; 
HR-E1MS: m lz  (rel. int.): 300.1006 TM ‘ ] (100) (ealed 
300.0998), 283 (41), 282 (99), 281 (30), 154 (23), 181 
(16), 77 (11); 'H NMR and '"C NMR (Tabic 2).
Acknowledgements—-T.C.F. thanks the Association of 
Commonwealth Universities for the award of scholar­
ship. NMR studies were performed at the NMR labora­
tory of the University of Strathclyde.
REFERENCES
1. Le Thomas, A., in Flore du Gabon, Vol. 16, ed. A. 
Aubreville. Paris, 1969, p. 240.
2. Perry, L. M., Medicinal Plants o f East and South­
east Asia: Attributed Properties and Uses, MIT 
Press, U.S.A., 1980, p. 20.
3. Kiang, A. K., Douglas, B. and Morsingh, F„ 
Journal o f Pharmacy and Phannacology, 1960, 13, 
98.
4. Richomme, P., Sinbandhil, S., David, B., Hadi, A. 
H. A. and Bruneton, J., Journal o f Natural Prod­
ucts, 1990, 53, 294.
5. Achcnback, H. and Hermrich, H., Phytochemistiy, 
1991, 30, 1265.
6. Kodpinid, M., Sadavongvivad, C., Thebtaranonth,
C. and Thebtaranonth, Y., Phytochemistry, 1984, 
23, 199.
7. Prater, G. and Muller, U., Helvetica Chiinica Acta, 
1989, 72, 653.
8. Wcyerstahl, P., Schneider, S., Marshall, H. and 
Rustaiyan, A., Liebigs Annals o f Chemistry, 1993,
1 1 1 .
9. Agrawal, P. K., ' ' ( '  NMR o f Flavonoids. Elsevier, 
Tokyo, 1989.
10. Mayer, R„ Phytochemistiy, 1990, 29, 1340.
11. Mabry, T. J., Markham, K. R. and Thomas, M. B., 
The Systeiiiatic Identification o f Flavonoids. 
Springer, New York, 1970.
12. Burke, B. and Nair, M., Phytochemistiy, 1986, 25, 
1427.
13. Chantrapromma, K., Pakawatchai, C., Skelton, B. 
W., White, A. H. and Worapatamasri, S., Australian 
Journal o f Chemistiy, 1989, 42, 2289.
14. Chadenson, M., Hauteville, M. and Chopin, J., 
Journal o f The Chemical Society, Chemical Com­
munications, 1972, 107.
15. Byrne, L. T., Cannon, J. R., Gawad, D. H., Joshi, 
B. S., Skelton, B. W., Toia, R. F. and White, A. H., 
Australian Journal o f Chemistiy, 1982, 35, 1851.
16. Williams, A. H„ Chemistiy in Industry (London), 
1967, 1526.
17. Chopin, J., Hautville, M., Joshi, B. S. and Gawad,
D. H. (1978) Phytochemistiy, 1918, 17, 332.
3 4 5
188 Planta Med. 63 (1997)
Bufadiertolides and Other Constituents 
of Urginea sanguinea
Runner R. T. Majinda'-3, Roger D. W aigh2, 
and Peter G. W aterm an2
1 Department of Chemistry. University of Botswana,
P/Bag 0022 Gaborone, Botswana 
- Phytochemistry Research Laboratories, Department of 
Pharmaceutical Sciences, University of Strathclyde,
Glasgow G1 IXW, U.K.
3 Address for correspondence
Received: June 2 7 ,1996; Revision accepted: October s, 1996
Abstract: Fresh bulbs of Urginea sanguinea yielded stigmasterol, 
phloroglucinol, phloroglucinol 1 -/i-o-glucopyranoside (phlorin), 
scillaren A, a novel compound 5«-4,5-dihydrosciliaren A (1), 
salicylic acid, and 3-hydroxy-4-methylbenzoic acid. The latter 
tw o show ed weak antibacterial activity. The compounds were 
identified using spectroscopic techniques such as ID and 2D 
NMR. EI-MS and FAB-MS.
Urginea sanguinea (Schinz) jessop (Drimia sanguinea Schinz) 
Liliaceae (Fiyacynthaceae) is common in Southern Africa, with 
preference for hilly areas (1). The bulb is red and bleeds when 
cut, hence the name sanguinea. This species had not been in­
vestigated phytochemically until recently (2) but U. sanguinea 
is known to be among the most important poisonous plants 
hazardous to livestock in South Africa (2). After ingestion of the 
leaves, cattle, sheep, and goats show symptoms typical of 
cardiac glycoside poisoning (3). Tswana herbalists and tradi­
tional doctors use U. sanguinea to treat venereal diseases (1).
The ’H- and nC-NMR (Table 1) spectra of 1 indicated a glucose, 
a rhamnose and a steroid nucleus. Several structural features 
were evident from the 400 MHz 'H-NMR spectrum of 1. Clearly 
defined signals at 5 = 6.27 (d,J  = 9.7 Hz, H-23), 7.43 (d, J =
2.1 Hz, H-21 )and 7.98 (d d j = 2.1 and 9.7 Hz. H-22) are charac­
teristic of protons constituting the 5-pyrone ring (4). The 
nature and stereochemistry of glycosyl moieties viz a-i- 
rhamnosyl and /3-n-glucosyl were determined by anomeric 
proton resonances, respectively, at 5 = 4.83 (d,J = 1.4 Hz, H-V 
and 4.57 (d,J = 7.8 Hz, H-1"). The steroid nucleus showed two 
methyls, eight methines, nine methylenes, and five quaternary 
carbons. The structure determination and assignments for 1 
were achieved using COSY, HC-direct, HMBC, HOHAHA tech­
Letters
niques and these data were consistent with the structure of 1 
being a bufadienolide, a class of compounds which is very 
common in the genus Urginea (5-7). Most proton signals from 
rhamnose and glucose units were all superimposed and over­
lapped greatly. To resolve this signals HOHAHA was used to 
locate the individual spin systems of these sugar residues.
Table 1 l3C-NMR (5c. 100 MHz) data for scillaren A and 1.
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Complete assignment of the sugar protons was done using 
HC-direct (Table 2), HMBC (Table 2), and HOHAHA (Table 3). The 
order in which the two sugars were attached to the aglycone 
was determined by HMBC which showed a correlation be­
tween H-3 (5h = 3 .52-3 .59) and the rhamnose anomeric 
carbon, C-T (<5C = 99.6, d). This connectivity was further con­
firmed by an HMBC between the rhamnose anomeric proton
Table 2 HC-direct and HMBC correlations for 1.
Protons Carbon
>H V 5(
7.98 149.5 d 150.6 d, 165.0
7.43 150.6 d 125.2 s 52.4 d, 149.5 d. 165.0 s
6.29 115.5 d 165.0 s 125.2 s
2.541 52.4 d 30.21.49.2 s. 125.2 s 41.9 t, 86.1 s, 149.5 s,
150.6 d
0.71 (Me) 17.5 q 49.2 s 41.9 t, 52.4 d. 86.1 s
1.64-1.70 30.21 52.4 d 49.2 s, 86.1 s
1.67-1.75; 22.7 t 41.91 43.0 d
1.32-1.36
1.59 43.0 d 86.1 s 49.21
0.82 (Me) 12.7 q 37.1 s 38.5 t. 45.7 d. 51.4 d
0.96-1.00 51.4 d
1.06-1.13 45.7 d 12.7 q
3.52-3.59 m 77.2 d 99.6 d*
4.83 d 99.6 d 72.8 d 68.8 d, 72.6 d, 77.5 d
3.75 72.8 d 72.6 d 83.8 d
3.57-3.59 83.8 d 68.8d 18.3 q. 72.8 d, 105.9
A'
1.31 d 18.3 q 68.8 d
( I
83.8 d
4.57 d 105.9 d 83.3 d*
3.21 -3.23 76.2 d 78.2 d. 105.9 d
3.27-3.28 78.2 d 78.3 d
3.34-3.35 71.6 d 76.2 d
3.30-3.31 78.3 d 78.2 d
3.68-3.70 62.91 78.3 d
3.83-3.86 62.91 78.3 d
* Key HMBC correla tions.
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(5|, = 4.83) and the aglycone C-3 {Sc = 77.5, d). The rhamnose 
was therefore attached directly to the C-3 of the aglycone 
moiety. The sequence of sugar residues was also determined 
by HMBC which showed a cross peak between the rhamnose 
H4' proton (<5H = 3 .58-3 .63) and the glucose anomeric carbon 
(5C = 105.9, d). This was further confirmed by another HMBC 
cross peak between the glucose anomeric proton (<5h = 4.57) 
and the rhamnose C-4' (83.3, d) carbon.
The assignment of the aglycone moiety was done using HMBC, 
HC-direct and HOHAHA. The carbons which could not be 
assigned using the above methods were assigned using 
literature assignments for related compounds (5). The FAB-MS 
confirmed the molecular weight and the sugar sequence. The 
spectrum gave a peak at m/z 533 indicating the loss of a glucose 
residue and another peak at m/z 387 showing the loss of a glu­
cose followed by the loss of a rhamnose moiety. The above in­
formation led to the determination of the structure of 1 as 14- 
hydroxybufa-2O,22-dienolide-3-O-a-i-rhamnopyranosyl-4'-j0- 
i>-glucopyranoside (5a-4,5-dihydroscillaren A) which has not 
been previously reported.
The antibacterial activity of the crude water extract, the n- 
BuOH fraction and pure compounds are shown in Table 4. 
Salicylic acid is a well known antibacterial and preservative. 
However, it only showed activity at a loading of 100 pg/disc. 
Phenolic compounds like phloroglucinol which are expected to 
show antibacterial activity are not active at this loading but 
phloroglucinol derivatives show impressive activity against the 
same microorganisms (8,9). Other phenolic compounds which 
show good activity are gallic acid (10) and caffeic acid esters
(11). The activities of the isolated compounds compare very 
well with those of two antibacterial flavonoid glycoside de­
rivatives tiiiroside and platanoside (12). The toxic components 
(bufadienolides) make the plant unsafe to use it as a medicinal 
plant.
Table 3 HOHAHA correlations for 1 at 30 ms spin lock time. Table 4 Antibacterial activity of Urginea sanguinea and its con-
'H proton HOHAHA correlation (30 ms)






H3' H2',H4',H5',Me6' S, aureus chloramphenicol 10 18
H4' H3',H4'.H5',Me6' chloramplienicol 25 20
H5' H3',H4',Me6' chloramphenicol 50 25
Me6' H3',H4',H5' crude water extr* 500 9
HI" H2". H3'\ H4" n-butanol fr* * 100 10
H2" HI", H3", H4" salicylic add 100 7.5
H3" HI", H2", H4", H5", H6"A, H6"B 3h-4-m-b 100 7
H4" H1", H2". H3", H5", H6"A, H6"B B. subtilis chloramphenicol 10 20
H5" H1". H2", H3", H4", H6"A, H6"B chloramphenicol 25 25
H6“A, H6"B H2", H3”, H4", H5" chloramphenicol 50 31
H17 H16a, H16/1, HIS/? . crude water extr* 500 8
Hi 6a H17, H16/3, HI 5/3 n-butanol fr* * 100 9
Hi 6/1 H17, H16a, H15/1 salicylic acid 100 8
Hl5a H15 P 3h-4-m-b*’ * 100 < 7





* Extr = extract.
* ‘ fr = fraction.
H23 H22, H21 ' * *3h-4-m-b = 3-hydroxy-4-methylbenzoic acid.
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Materials and Methods
M.p.'s uncorrected: Kofler Hot Stage. NMR: on Bruker AMX 
400; 'H-NMR (400 MHz) and nC-NMR (100 MHz), iri either 
DMSO-d6 or CD3OD. 'H- and nC-NMR chemical shifts were ref­
erenced to the residual solvent signals. MS: HREI AEI-MS 902 
(70 eV) or a VG ZAB-E FAB MS. IR: Mattson Genesis Series FT-IR 
or a Perkin-Elmer 781, KBr discs. UV specti a: in CH3OH on CE 
505 UV Spectrophotometer. Specific rotations («]D: Polatronic-D.
U. sanguinea bulbs were collected in Kgale, 10 km south of 
Gaborone, in May 1993, identified by Drs. L Turton and B. 
Hargreaves and a voucher specimen (USRM 001) was placed at 
the National Herbarium, Gaborone. Botswana. Extraction: bulbs 
(3 kg) were chopped in pieces, extracted with cold water, con­
centrated, then freeze-dried to give 200 g residue. The crude 
water extract (195 g) was dissolved in distilled water (400 ml) 
and partitioned successively between 4 x 300 ml aliquots each 
of n-hexane, EtOAc, and it-BuOH. The extracts were evaporated 
in vacuo to yield 0.5, 1.5, and 120g crude fractions, re­
spectively. The residual water extract was freeze-dried to give 
74g of solid. The fractions were each tested (in triplicate) for 
antibacterial activity at a loading of 500 and 100 /rg/disc using 
the disc diffusion assay (13,14). Separation: The n-butanol ex­
tract (lOOg) was added to a polyamide (300g) column and 
eluted in a step-wise manner with toluene, toiuene/EtOH 
(I : I). EtOH, EtOH/MeOH (1:1), MeOH. MeOH/(CH3)2CO (1:1)  
and (CH3)2CO. Twenty-two fractions (150 ml each) were col­
lected and the first seven fractions gave fatty acids and 
stigmasterol (50 mg).
TLC analyses of fractions 8 -1 3  showed two major compounds 
and two minor Ones. These fractions were purified on 100 g 
polyamide column and eluted with EtOH, EtOH/MeOH (1:1), 
MeOH, MeOH/HjO (1:1) and H20  in that order. The two major 
compounds were found in the first four (100 ml each). HPLC of 
these using a semi-preparative column (RP-18, MeOH/H20  
68:32, flow rate lOml/min) led to isolation of scillaren A 
(65 mg). [tR = lOmin] and 5a-4,5-dihydroscillaren A (26 mg), [tR 
= 11.2 mini.
Fractions 14-17 were put on Sephadex l.H-20 (lOg, eluted 
with MeOH/CHCI3, 1 :1 ) and fractions containing the three 
minor components were further purified on HPLC (conditions 
same as above) to yield 3-hydroxy-4-methylbenzoic acid 
(6 mg) |tR = 12.1 min] and salicylic acid (5 mg) [tR = 13 .4min]. 
Fractions 18 -22  showed two major spots which gave a bright 
red colour on spraying with 1 % vanillin in sulphuric acid and 
heating. These were put on Sephadex G-10 (MeOH/H20  1:1). 
Ten fractions (50 ml each) were collected. Fractions 3 -6  to 
yielded pure phlorin (78 mg) and fractions 8 -1 0  gave phloro­
glucinol (24 mg).
5a~4,5-Dihydroscillaren A (1): Needles (from methanol), m.p. 
192 -194“C, [«]D: -4 4 .4  (c 0.12, MeOH) and formula C36H540 13. 
UV Amax (MeOH) nm: 298. IR umjx (ICBr) cm"1: 3394, 2931, 
1712, 1636, 1541, 1450, 1064. 'H-NMR (400MHz in CD3OD): 
<5h (J values in brackets) = 0.71 3H s, 0.82 3H s, 1.31 d (6.2).
2 .05-2 .08  m, 2 .16 -2 .18  m. 2.54 t, 3 .21-3 .23  m, 3 .27-3 .28  
m. 3.30-3.31 m, 3 .34-3 .35  m, 3.37 d. 3 .5 7 -3 .5 9  m, 3.61 m, 
3.68 -3 .70  dd (12.0,4.2), 3.75 s. 3.83 -3 .86  dd (12.0,1.6). 4.57 
d (7.8), 4.83 d (1.4), 6.27 (9.7), 7.43 (2.1), 7.98 (2.1, 9.7). ,3C- 
NMR (see Table 1). FAB-MS: 717 (M + Na)*, 695 (M + H)\ 533 
(M + H -  162 (glucosyl))4, 387 (M + H 162 - 1 4 6  (rhamno- 
syl))4, 369 (aglycone + H -  H20 )4, 351.
Letters
Scillaren A: Needles (from methanol), m.p. 270°C dec, |a lD:
-  68.6 (c 0.82, MeOH). UV, IR, NMR and MS data agreed well 
with literature data (5,6).
Stigmasterol: ('H-NMR, MS. Rf, colour reaction with vanillin 
sulphuric acid) matched those of an authentic sample of 
stigmasterol.
Phloroglucinol: Brown amorphous powder, m.p. U7°C. UV, IR, 
NMR and MS consistent with literature data (15).
Phlorin: Brown amorphous powder, m.p. 231 -233°C, [a)D:
-  71.0 (c 0.10. MeOH). UV. IR, NMR and MS data showed good 
agreement with literature data (15).
Salicylic acid: Needles, m.p. 158-160°C. Spectral data were 
consistent with literature data (16).
3-Hydroxy-4-methylbenzoic acid: Needles, m.p. 215 “C (dec). 
UV Anux (MeOH): 250, 272, 278 sh. IR umax (KBr): 3422, 2920, 
1706, 1630, 1529, 1449, 1236, 1064. 'H-NMR (400MHz in 
CD3OD): Sh = 2.19 3H s, 7.09 d (8.2), 7.19 dd (2.2, 8.2), 7.49 d 
(2 Hz). nC-NMR (100MHz in CD3SOCD3): Sc 16.2 q, 115.4 d, 
120.3 d. 129.5 s. 129.6 s, 130.3 d, 155.4 s, 167.8 s.
Microorganisms and antibacterial assay: The test organisms 
consisted of Staphylococcus aureus (NCTC 6751), Bacillus subtilis 
(NCTC 8326), Escherichia coli (NCTC 9001) and Pseudomonas 
aeruginosa (NCTC 6750). The agar disc diffusion assay (13, 14) 
was used to screen the crude water extract, the fractions and 
purified compounds. Paper discs (6 mm diameter) containing 
500 and 100/ig of sample were placed on agar plates in­
oculated with test organisms. Experiments were carried out in 
triplicate and discs of standard antibiotic (chloramphenicol) 
were used as a positive control. The presence of a clear zone of 
inhibition after 18 hours was taken as a positive result.
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A b stract—From the aerial parts of B osistoa se lw yn ii (Rutaceae) four 
novel prenylated acetophenones were isolated and identified as  
pyranoselwynone (5-hydroxy-6-acetyl-{6,6-dim ethyl-5!;-hydroxy-4,5-di- 
hydropyrano}-(3,2-h)-2,2-dim ethylbenzopyran), selwynone (5,7-dihy- 
droxy-6-acetyl-8-(3-m ethylbut-2-enyl)-3,4-dihydro-2,2-dim ethyl-3£-hydr- 
oxypyran), furanoselwynone (5-hydroxy-6-acetyl-{5-[l-hydroxy-1 -m ethyl- 
ethyl]-4,5~dihydro-furano}-[3,2-h]-2,2-dim ethylpyran), and isofurano- 
selwynone (7-hydroxy-8-acetyl-{5-[ 1 -hydroxy-1 -m ethylethyl]-4,5-dihydro- 
furano}-[3,2-f]-2,2-dim ethylpyran). Other com pounds isolated were a 
series of eight acridone alkaloids (reported on previously), the coum arins 
scopoletin and braylin and  the triterpenes lupeol and p-amyrin. The 
structures of the new acetop henones were elucidated on the b a sis  of 
NMR spectral data.
K eyw ords:--Bosistoa se lw yn ii; Rutaceae; Prenylated Acetophenones; 
Selwynone; Pyranoselw ynone; Furanoselwynone; Iso furanoselwynone.
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INTRODUCTION
In a continuation o f our investigation of the chem istry of the gen u s  
B osistoa  (Rutaceae)1 6 we have undertaken a study of the aerial parts of 
B. se lw yn ii Hartley, a tree found in the rain forests of sou th -east 
Q ueensland and north-east New Sou th  W ales.7 In a  preliminary report 
on th is sp ec ies4 we presented evidence for the occurrence o f prenylated  
acridone alkaloids identical to those found in B osistoa  transversa .3 In 
th is paper we report the isolation and identification o f non-alkaloidal 
com pounds; coum arins, pentacyclic triterpenes and four novel 
prenylated acetophenones.
RESULTS AND DISCUSSION
By a com bination of vacuum  liquid chrom atography (VLC), gel filtration 
and PTLC procedures the hexane and ethyl acetate extracts of the lea f  
material of B. se lw yn ii sam ple Hartley 15172  afforded the sim ple  
coum arin scopoletin and the com m on pentacyclic triterpenes lupeol and  
P-amyrin. In addition two novel acetophenones were obtained w hich  
were identified, primarily by NMR and MS as 1 and 2 , and given the  
trivial nam es selw ynone and pyranoselwynone.
Selwynone gave, by HREIMS, a m olecular ion at m /z  32 0  w hich  
solved for the em pirical form ula C18H2 4 O5 , with a major fragment for M+- 
C4H7 , which is  characteristic of a 3-m ethylbut-2-enyl substituent. The 
lH NMR spectrum  (Table 1) confirmed the presence of the 3-m ethylbut-2- 
enyl moiety, an H -bonded phenolic proton, another arom atic phenol, an  
acetyl methyl and sign a ls for two further m ethyls, probably gem inal, and  
an ABX system  -CH2 -CH(0 )-. The 13C NMR spectrum  (Table 1) revealed  
signals for an arom atic ring with a  phloroglucinol oxygenation pattern
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an d  a n  acety l carbonyl. D irect H -C b o n d in g  w a s  e s ta b lish e d  by m e a n s  
of a n  HC-COBI ex p er im en t.8
Table 1. >H and t3C NMR Chemical Shift Data (400 MHz, CDCla) and Selected 
'■■J and 3JH-C Couplings for Selwynone, i .
Position 5H (J, Hz) SC 2J 3 J
2 78.3
2-Me 1.35 s 25.0 78.3 22.2, 69.9
2-Me 1.40 s 2 2 . 2 78.3 25.0, 69.9
3 3.80 t (5.8) 69.9 97.8
4 2.59 dd (16.8, 5.8) 2 2 . 1 97.8 154.4, 160.3
2.87 dd (16.8, 5.8)
4a 97.8
5(OH) 6.30 s 160.3 97.8
5 160.3
6 105.5




1 ’ 3.40 d (7.4) 26.1 105.5, 122.0 136.6, 160.3,
162.7
2’ 5.27 tq (7.4, 1.4) 1 2 2 . 0 26.1
3’ 135.5
3’-Me(E) 1.68 d (1.4) 26.0 136.6 18.1, 1 2 2 . 0
3’-Me(Z) 1.61 s 18.1 136.6 26.0, 1 2 2 . 0
c = o 203.5
COMe 2.60 s 33.6 203.5 106.0
On the b a sis of these data selwynone m u st be a 1 ,3 ,5
trioxygenated  a c e to p h e n o n e  w ith  tw o free h yd roxy ls, o n e  ad ja cen t to  th e  
acety l, a  3 -m e th y lb u t-2 -e n y l grou p  a n d  a  cy c lised  p ren y l group w h ich  
a p p ea rs to b e  a  2 ,2 -d im eth y ld ih y d ro p y ra n  carrying furth er oxygen ation . 
The p o sit io n s  o f  th e  v a r io u s  su b s t itu e n ts  w ere e s ta b lish e d  th rou gh  an  
HMBC exp erim en t8 w h ic h  rev ea led  2J  a n d  3J  H-C c o u p lin g s . N otab ly  3J  
co u p lin g s  from  H2 - I ’ o f  th e  3 -m e th y lb u t-2 -e n y l s id e  ch a in  e s ta b lish e d
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that it w as located between the two hydroxyls on the arom atic ring. 
Similarly :iJ  couplings from the gem inal m ethyl groups and Ha-4 o f the  
dihydropyran ring confirmed its placem ent. From the HMBC experim ent 
the resonance position o f all signals in the 13C NMR spectrum  could be  
unam biguously assigned . Selwynone m u st therefore have structure i ,  
the stereochem istry of the secondary hydroxyl h a s not been established.
A second acetophenone from the extract analysed for m /z  3 1 9  
(M+H) by FAB m ass spectroscopy, solving for C1 8H2 2 O5 - The 'H NMR 
spectrum  (Table 2) revealed the H -bonded hydroxyl, acetyl m ethyl and 3- 
hydroxy-2,2-dim ethyldihydropyran ring seen  in 1. However, neither the  
second phenolic OH nor the 3-m ethylbut-2-enyl m oiety were observed  
and were replaced by a  2,2-dim ethylpyran. The 13C NMR spectrum  
(Table 2) confirmed the sam e phloroglucinol oxygenation pattern and the  
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dihycl ropy ran rings. This com pounds (2), which appears to be novel, h a s  
been given the trivial nam e pyranoselwynone.
Table 2 'H and ‘3c  NMR Chemical Shift Data (400 MHz, CDC13) and Selected 2J  
and 3J  H-C Couplings for Pyranoselwynone, 2.
Position 6 H 8 C 2J 3 J
2 78.4
2-Me2 1.45 s 28.7 78.4 125.2
3 5.45 d (10.0) 125.2 78.4 1 0 2 . 6
4 6.65 d (10.0) 116.4 1 0 2 . 6 78.4, 158.1, 
160.4
4a 1 0 2 . 6







2-Me 1.35 s 25.2 78.8 22.1 ,68 .9
2’-Me 1.40 s 2 2 . 1 78.8 25.2, 68.9
3’ 3.80 t (5.8) 68.9 98.4
4 ’ 2.55 dd (17.0, 5.8) 
2.85 dd (17.0, 5.8)
25.7 68.9, 98.4 78.8, 155.9, 
158.1
c = o 203.4
COMe 2.60 s 33.5 203.4 105.8
A second sam ple of B. se lw yn ii  (Hartley 15176) yielded  
pyranoselwynone, scopoletin , lupeol and p-amyrin but did not contain  
selwynone. In addition it yielded the com m on furoquinoline alkaloid  
skim m ianine, the pyranocoum arin braylin and a  m ixture o f two further 
novel acetophenones. The HREIMS of the m ixture suggested  a single  
m olecular ion, solving for C 18H22O5 w ith a major fragment at M-C3 H7 O 
indicative of a  hydroxyisopropanyl group. The >H NMR of the m ixture,
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run in acetone-ck, revealed several features (H-bonded OH, acetyl, 2 ,2 - 
dimethylpyran) in com m on with 2 . The rem aining signals consisted  of 
an ABX system  with different coupling constan ts to the dihydropyran 
ring of 1  and 2 , and resonances for two m ethyls (in each  com ponent of 
the mixture) between 8  1 .35  and 1 .22. While paucity o f m aterial did not 
allow u s to obtain an adequate 13C NMR spectrum  the H-detected HMBC 
experim ent revealed that these m ethyl resonances show ed 3J  coupling to 
a carbon at ca. 8  9 3 , w hich is  typical for C-2 oxym ethine carbon o f a 
dihydrofuran . 9 Other couplings observed from the HMBC experim ent 
confirmed that these acetop henones shared the sam e oxygenation  
pattern as 1  and 2 .
The rem aining problem w as to identify the positions o f the 
pyran and dihydrofuran rings in the two com ponents. To do th is the 'H 
NMR spectrum  of 2  w as re-run in acetone-cfc. This revealed that the 
resonances for the pyran olefinic protons had identical chem ical sh ift in 
2  and in the major constituent of the m ixture which m ust therefore have  
structure 3 , to w hich we a ss ig n  the trivial nam e furanoselw ynone. The 
minor com ponent of the m ixture m ust be 4 , which we call 
isofuranoselwynone.
The chem istry o f B. se lw yn ii  is  striking in that it produ ces a 
series o f acridone alkaloids very sim ilar to those o f B. tra n sv e rsa l  By 
contrast the previous study on B. tran sversa  failed to reveal the presence  
of either acetophenones or coum arins.
EXPERIMENTAL
Mps uncorr. UV: MeOH; IR: KBr or CHCla; EIMS: direct probe 
insertion (90-130°C) at 70  eV. FABMS: VG ZAB-E with nitrobenzyl alcohol 
matrix. NMR: run in CDCla or acetone-efo. NOESY and HMBC experim ents 
were obtained on a Bruker AMX-400 instrum ent u sin g  standard Bruker 
mic roprograms.
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Plant material. Hartley 15172, collected 24th October 1991, Wide Bay 
District, State Forest 220, Maimaison, Queensland; Hartley 15176, collected 
24th October 1991, Wide Bay District, Didcot, Stony Creek, Queensland. Both 
vouchers are deposited at the Australian National Herbarium, Canberra.
Extraction and isolation of non-alkaloidal compounds. The ground 
leaves of the two samples (TGH-15172, 120 g; TGH-15176, 180 g) were 
separately extracted (Soxhlet) with petroleum ether (b.p. 60-80°C), then EtOAc, 
and finally MeOH. The petrol extract of TGH-15172 was concentrated under 
reduced pressure to give 5.5 g of solid. Part of this (2 g) was fractionated by 
column chromatography with Sephadex LH-20 eluting with CHCH, followed by 
PTLC of the fractions with silica gel (solvent CHCh. EtOAc, 19:1). This 
procedure yielded p-amyrin (40 mg), lupeol (3 mg), i  (3.5 mg), scopoletin (11 
mg) and 2  (3.5 mg). Similar treatment of 2 g of the petrol extract of TGH-15176 
(total yield 7 g) gave braylin ( 6  mg), 1 (4 mg), a mixture of 3 and 4  (3 mg), and 
scopoletin ( 2  mg).
Identification o f known compounds. Skimmianine: - Identical (UV, IR, 
NMR, MS) with sample reported previously . 10 Scopoletin - Identical (UV, IR, 
NMR, MS) with commercial sample.11 p-Amyrin - Identical (UV, IR, NMR, MS) 
with commercial sample . 11 Lupeol - Identical (UV, IR, NMR, MS) with sample . 12 
Braylin -  Amorphous, Found: M+ 258.0883; CisHt40t requires 258.0892; UV 
Umax (MeOH) nm: 261, 270, 350 nm, IR vmax (KBr) c m 1: 1720, 1565, 1285,
1150, >H NMR (400MHz, CDCb) 5 7.57 (d, J 9 .4  Hz, H-4), 6.77 (s, H-5), 6.26 (d, 
J  9.4 Hz, H-3), 6.24 (d, J  10.0 Hz, H-4"), 5.74 (d, J  10.0 Hz, H-31), 3.90 (s, 6 - 
OMe), 1.53 (s, 2’-Me2), EIMS m /z  (rel. int.): 258 (M]+ (38), 263 (100), 228 (16).
Pyranoselwynone (1): Amorphous, [ajo +16.2° (c. = 0.004, CHCL), UV 
Amax (MeOH) nm (log e): 213 (4.15), 295 (3.82), 350 (3.47), IR vmax (CHCb) cm 
3446, 2930, 1598, 1432, 1365, 1283, 1192, 1126, 1101, 996, 887, 734, NMR 
see Table 2, FABMS m /z (rel. int.): 319 [M+H]+ (80), 318 (100), 303 (60), 247
(45).
Selwynone (2): Amorphous, [<xJd +15° (c. = 0.001, CHCb), UV Amax 
(MeOH) nm (log c): 215 (4.02), 295 (4.21), 345 (3.28), IR vmax (CHCb) c m 1: 
3380, 2925, 1611, 1429, 1368, 1269, 1227, 1088, 757, NMR -  see Table 1, 
EIMS m /z (rel. int.): 320 [M]+ (70), 305 (10), 265 (100), 247 (67), 218 (42), 193 
(53).
Furanoselwynone and Isofuranoselwynone (3, 4): M+ = 318.1489, UV 
Amax (MeOH) nm: 212, 269, 300, 348, IR vmax (KBr) cm •: 3420, 2928, 1616, 
1435, 1365, 1288, 1198, 1103, 1012, 756, >H NMR (400MHz, acetone-de) 5: 
13.86, 13.55 (2 x OH -  H-bonded), pyran ring protons, 6.56, 5.55 (ABq, J  10.1 
Hz) and 6.41, 5.53 (ABq, J =  9.9 Hz), pyran ring methyls, 1.51, 1.49, 1.44, 1.43, 
dihydrofuran ABX system, 3.01 (dd, J 15.0, 8.1 Hz), 2.95 (dd, J 15.0, 8.1 Hz), 
4.85 (t, J 8 . 1  Hz), and 3.01 (dd, J 15.0, 8.1 Hz), 2.95 (dd, J 15.0, 8.1 Hz), 4.81 (t, 
J 8.1 Hz), isopropyl methyls, 1.35, 1.35, 1.28, 1.22, acetyl methyls, 2.61, 2.59, 
EIMS m /z (rel. int.): 318 (37), 303 (100), 300 (25), 244 (45).
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A NOVEL RETRODIHYDROCHALCONE FROM THE STEM BARK OF 
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oxoaporphine alkaloids.
Abstract—Investigation o f the ethyl acetate extract o f the stem bark of IJvaria mocoli resulted in the isolation 
of the novel retrodihydrochalcone 2-hydroxy-4,5,6-trimethoxydihydrochalcone together with the known fla­
vonoids 2'-hydroxy-4',6'-dimethoxychalcone, 2'-hydroxy-4',5',6'-trimethoxychalcone, 5,7-dimethoxyflavanone 
and 5,7,8-trimethoxyflavanone, the oxoaporphines lysicamine, liriodenine and isomoschatoline, benzoic acid 
and a mixture of sitosterol and stigmasterol. All the compounds were identified by analysis of their spectral 
data. ©  1998 Elsevier Science Ltd. All rights reserved
/  Pergamon
I N T R O D U C T I O N
The genus Uvaria L. (Annonaceae) comprises some 
150 species (1]. About 20 o f these have so far been 
investigated and have yielded a wide range of sec­
ondary metabolites with interesting biological activi­
ties [2], including sesquiterpenes [3, 4], indole deriva­
tives [5,6], 1-benzyltetrahydroisoquinoline derivatives 
[1,7], benzyl benzoate esters [8], cyclohexene epoxides 
[9, 10], flavonoids [II, 12] and acetogcnins [13, 14]. 
We have examined the stem bark o f Uvaria mocoli De 
Wild. & Th. Dur., a large woody climber which grows 
in the tropical forest zone of west Africa between 
Sierra Leone and Zaire [15], and in this paper report 
the isolation of five flavonoids, three oxoaporphines, 
benzoic acid and a mixture of sitosterol and stig­
masterol. Among the flavonoids is the novel retro­
dihydrochalcone 2-hydroxy-4,5,6-trimethoxydihy- 
drochalcone (3).
R E S U L T S  A N D  D IS C U S S IO N
The ethyl acetate extract of the stem bark of U. 
mocoli, through a series of chromatographic frac­
tionations, yielded the flavonoids 1-5, the oxoapor­
phines alkaloids 6-8, benzoic acid and a mixture of 
sitosterol and stigmasterol. The 'H NMR spectra of 
1 and 2 showed the presence o f an unsubstituted fi­
ring and the characteristic /nww-propenone moiety
* Author to whom correspondence should be addressed.
and a 2'-hydroxylated ring A o f a chalcone [16]. Com­
pound 1 further showed signals for two aromatic 
methoxyl groups and two protons we/a-coupled to 
each other, which identified it as 2'-hydroxy-4',6'- 
dimethoxychalcone [17], Compound 2 differed in 
showing a single aromatic proton and three methoxyl 
singlets. It was identified as 2'-hydroxy-4',5\6'-tri- 
methoxychalcone [18] rather than 2'-hydroxy-3',5',6'- 
trimethoxychalcone, on the basis o f the l3C NMR 
chemical shift values for the methoxyl carbons (5 62.1,
61.5, 56.3) which revealed that two of them were steri- 
cally hindered by being flanked by substituents in both 
ortlio positions [20, 21],
The ‘H NMR spectra of 4 and 5 showed the typical 
AMX system of flavanones [16] and an unsubstituted 
ring B. Based on the spectral characteristics they were 
identified as 5,7-dimethoxyflavanone [19] and 5,7,8- 
trimethoxyflavanone [20], respectively. Evidence for 
the substitution pattern of 5 was again derived from 
the IJC NMR spectrum which revealed that only one 
of the methoxyl groups was sterically hindered (5 61.7,
56.5, 56.3), whereas for the 5,6,7-methoxylation pat­
tern two would be hindered.
The novel compound 3 was isolated as a yellow- 
brown amorphous solid. The UV spectrum showed 
maxima at 228, 275 and 307 nm, suggesting an 
extended benzyl chromophore and the IR spectrum 
showed hydroxyl and carbonyl absorptions. The 
HRE1 mass spectrum gave a molecular ion at m/z 
316.1186 which solved for C|«H20O5. The ’H NMR 
spectrum (Table 1) indicated the presence o f an unsub­
stituted aromatic ring, an aromatic proton singlet, 
a broad proton singlet for a hydroxyl group, three
1387
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S 17.5 (C-a). <5 II 3 .5(C -I) 6 151.2 (C-2), 5 152.3 (C-6), <5 203. (C=<
2'/6' 7.99 m 128.8
3'/5' 7.44 m 128.6
4' 7.59 in 134.0
2-OH 8.45
4-OMe 3.80 55.9 6 152.8 (C-4)
5-OMe 3.78 61.0 8 136.0 (C-5)
6-OMc 3.95 61.0 8 152.3 (C-6)
* Solutions were referenced to CHCI, at <5 7,27 (400 MHz), 
t Solutions were referenced to CHCI, at 8 77.23 ( 100 MHz).
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methoxyls and ivvo methylene multiplets. The "C 
NMR spectrum (Table 1) revealed six aromatic tnelh- 
incs, five o f which contributed to the unsubstituted 
phenyl ring, six quaternary aromatic carbons, a car­
bonyl at <5 203.3, two methylenes and three methoxyl 
signals. These data suggested a dihydrochalcone struc­
ture for 3.
Examination o f the unsubstiluted aromatic moiety 
revealed that the two aromatic proton multiplets ortho 
to the ring junction (H-2'/H-6') are relatively de­
shielded (i> 7.99) compared to those of compounds 1 
(t5 7.61) and 2 (5 7.66), suggesting the inductive effect of 
an adjacent C = 0  function and hence a benzoyl par­
tial structure in 3. This was confirmed by the ion 
at m/z 105 in the El mass spectrum. Thus, 3 was a 
dihydrochalcone with substitution in ring B and not 
in ring A. In the nC NMR spectrum, two equivalent 
methoxyl carbons resonated at 5 61.0, with the other 
at 5 55.9, suggesting that the latter must be placed 
ortho to a proton while the former two, which are 
both stericaily hindered, must he flanked by the ring 
junction and/or ortho oxygenated functions [20, 2 1 ]. 
This suggested that 3 was either 2-hydroxy-4,5,6-tri- 
methoxydihydrochalcone or 4-hydroxy-2,5,6~tri- 
methoxydihydrochalcone. The structure was estab­
lished from 2D NMR experiments including HMBC 
and NOESY.
In the HMBC spectrum (Table 1) the position of 
the carbonyl function was confirmed by the V  cor­
relation to H2-a and the V  correlations to H,-/t and 
H-2'/6' protons. The three methoxyl singlets showed
correlations to the signals at <5C 136.0 (C-5), 5C 152.8 
(C-4) and <5C 152.3 (C-6), leaving the other oxygenated 
carbon at 5 151.2 (C-2) for the hydroxyl substitution. 
The aromatic proton singlet showed \ /  correlations to 
one methoxyl-bearing carbou (C-4) and the hydroxyl- 
bearing carbon (C-2), and ’./ correlations to the ring 
junction carbon (C-1) and the shielded methoxyl-bear- 
ing carbon (C-5). The H2-/J also showed V  correlation 
to the same ring junction carbon and V correlations 
to the hydroxyl-bearing carbon (C-2) as well as a 
methoxyl-bearing carbon (C-6). This established 
unambiguously the position of the OH at C-2 rather 
than C-4. In the NOESY experiment, an nOe cor­
relation was observed between the protons of the 
4-OMc and H-3, and Hr a and H-2'/6'. Thus, 3 
was identified as 2-hydroxy-4,5,6-trimethoxy- 
dihydrochalcone.
2-Hydroxy-4,5,6-trimethoxydihydrochalcone (3) 
belongs to the retro-dihydrochalcone group of fla­
vonoids because of the phloroglucinol-like oxy­
genation pattern of ring A [22]. It has been shown 
by feeding experiments that these retrochalcones are 
formed through carbonyl transposition of the cor­
responding normal chalcones, so that ring A is derived 
from cinnamoyl CoA and ring B, from the acetate- 
malonatc pathway [22, 23]. Consequently, the co-iso­
lation of 3 with 2 is significant, as 2 could serve as the 
normal chalcone intermediate which undergoes 1,3- 
carbonyl transposition to give 3. This is the first report
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of a retrodihydrochalcone in the Annonaceae but the 
retrochalcone, lepanone (2-hydroxy-3,4,6-trimeth- 
oxychalcone) has been isolated from the root and stem 
bark of Ellipeia cuneifolict [24] and the stem bark of 
U. pandensis [25],
Alkaloids 6 8 were also identified by analysis of 
their spectral data and comparison with those pub­
lished as the known oxoaporphines iysicamine [26], 
liriodeninc [26] and isomoschatoline [27] respectively. 
This is, surprisingly, the first report of oxoaporphine 
alkaloids in Uvaria.
Ex p e r i m e n t a l
General
Mps: uncorr; UV: MeOH;. IR: CHCI,; 'H and 
UC NMR : recorded on Bruker AMX-400 instrument; 
MS: AEI-MS 902 double focusing instrument with 
direct probe insert at 70 eV ; Si gel CC and VLC: 
Merck 60, 230-400 mesh; Petrol is petroleum ether 
(bp 60-80").
Plant material
The plant materials used Tor this study were col­
lected from Gyakye (Ashanti Region) in Ghana by 
the Herbarium Unit of the Forestry Department, 
Kumasi, Ghana, and identified by comparison with 
herbarium specimens.
Extraction and isolation o f  compounds
The stem bark powder (0.5 kg) of U. mocoli was 
Soxhlct extracted with EtOAc and concentrated under 
reduced pressure to give 10.2 g o f dry extract. VLC 
fractionation of the EtOAc extract (10 g) over Si gel, 
eluting with toluene, toluene-CHCI, mixtures, CHCI, 
and finally CHCI,-MeOH mixtures, yielded four frs: 
A (up to 5% CHCI, in toluene), B (up to 10% CHCI, 
in toluene), C (up to 20% CHCI, in toluene), D  (up 
to 20% MeOH in CHCI,). Fr A was CC over Si gel, 
eluting with petrol and increasing the polarity with 
EtOAc; frs 28-41 were bulked together and subjected 
to prep-TLC  (toluene: EtOAc 9 : 1) to give 1(118 mg). 
Fraction B was treated as in fr A and frs 21-31 after 
prep-TLC gave 2 (41 mg). Fraction C was CC over Si 
gel and eluted with petrol, petrol-EtOAc mixtures 
and EtOAc; frs 16-20after prep-TLC(petrol: EtOAc, 
8:2) gave sitosterol/stigmasterol (12 mg); frs 23-31 
on prep-TLC (petrol: EtOAc, 8:2) yielded 3 (32 m g); 
frs 58-80 were further CC over Si gel using petrol- 
EtOAc mixtures and frs 13-24 yielded 4 (99 mg). The 
rest of the frs collected were pooled and further frac­
tionated on prep-TLC (petrol: EtOAc, 8:2) to give 
benzoic acid (3 mg), 4(11 mg) and 5 (9 mg). Fr D was 
VLC over Si gel and eluted with 10% CHCI, in petrol 
and increasing the polarity till 20% MeOH in CHCI,. 
Frs 7-8 (from CHCI,: MeOH 95 : 5) was fractionated 
by prep-TLC (petrol: EtOAc, 8 : 2) to give 6 (35 mg)
3 5 9
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and 7(12 mg). Fr 10 (10% MeOH in CHCI,) was CC 
over Si gel and 8 was collected as a blue band (4 mg)
Benzoic acid
Amorphous precipitate, identity confirmed by co- 
TLC with authentic sample.
Sitosterol/Stigmasterol
Needle crystals, identity confirmed by co-TLC with 
authentic samples isolated in our laboratory.
Liriodenine (7)
Yellow amorphous solid; [M]' 275.0582,
(C17H,NO, requires 275.0582), UV, IR, 'H NMR, 
MS, in agreement with published data [26].
Isomoschatoline (8)
Dark red amorphous powder; [M ]' 307.0803, 
(C,kH i}N0 4 requires 307.0845), UV, IR, 'H NMR, 
MS, in agreement with published data [27].
Acknowledgements—T.C.F. thanks the Association of 
Commonwealth Universities for the award of a schol­
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2 -Hydroxy-4',6'-dimethoxychalcone (1)
Yellow amorphous solid, mp 92-94" (lit. 91.5-92", 
[17]), [M ]' 284.1041 (Ci?H|60., requires 284.1049), 
UV, IR, 'FI NMR, nC NMR, MS, in agreement with 
published data [17],
2'-Hydroxy-4',5',6'-trimethoxychalcone (2)
Yellow amorphous solid, mp 99-101" (lit. 102" 
118]); [M] ’ 314.1144 (Cl8H180 5 requires 314.1154), 
UV, IR, ‘H NMR, nC NMR, MS, in agreement with 
published data [18].
2-Hydroxy-4,5,6-trimcthoxydihydrochalcone (3)
Brown-yellow amorphous compound; Found: 
[MJ  ^ 316.1186 (C|SHjnO, requires 316.1311), UV Am„„ 
(MeOH) 228, 275, 307 (sh) nm; IR (CHCI,, cm -') 
3332 (OH) 1668 (C = 0 );  EIMS m/z (rel. int., %) 316 
(44) (M '), 301 (75), 197 (44) 184 (35), 153 (545), 105 
(100), 77 (95).
5,7-Dimethoxyflavanone (4)
White amorphous solid, mp 166-166° (lit. 169-172°, 
[19]), [M ]1 284.1044 (C17H lf,0 4 requires 284.1049), 
UV, IR, 'H NMR, nC NMR, MS, in agreement with 
published data [19],
5,7,8-Trimethoxyflavanone (5)
White amorphous solid, mp 151-152° (lit 154" [20]), 
[M ]' 314.1144 (C,8H|k0 5 requires 314.1154), UV, IR, 
'H NMR, "CNMR, MS, in agreement with published 
data [20].
I .ysicamine (6)
Yellow amorphous solid; [M]' 291.0892,
(C|kH |,0 3N requires 291.0895); UV, IR, 'H NMR, 
MS, in agreement with published data [26],
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!. Subject and source
Aerial parts of the Australian species M elicope melanophloia C.T. White (Rutaceae), 
a tree 3 m high growing in dry rocky rain forest bordering a creek, were collected from 
Stony Creek, near Didcot, Wide Bay District, southeastern Queensland. A voucher 
specimen (TGH 15173) was deposited at the Australian National Herbarium, 
Canberra.
2. Previous work
The isolation of the furanocoumarin isopimpinellin has been reported previously 
(Jones et al., 1968).
3. Present study
The n-hexane extract of the dried, ground aerial parts of M. melanophloia (500 g) 
was subjected to VLC (eluting with n-hexane and EtOAc in mixtures of increasing
♦Corresponding author.
0305-1978/98/$ 19.00 CO 1998 Elsevier Science Ltd. All rights reserved. 
PIE S 0 3 0 5 -1978(97)001 16-6
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polarity). Fractions were collected and combined according to composition and 
subjected to gel filtration chromatography (Sephadex LH-20 eluting with CHC13) and 
PTLC (n-hexane: EtOAc 3:2, C H C I,: EtOAc 19:1). All the compounds isolated were 
identified using ‘H and l3C NM R along with various 2D NMR experiments (e.g. 
COSY, HMBC, NOESY), and HREIMS, comparing data with literature values where 
available. The compounds isolated and identified were the furanocoumarins xan- 
thotoxin (19 mg), bergapten (18 mg) and isopimpinellin (15 mg) along with the angu­
lar pyranocoumarin alloxanthoxyletin (4 mg) and the simple coumarin limettin 
(3 mg). In addition, the isobutylamide fagaramide (30 mg) and the closely related 
3,4-dimethoxy-N-(2'-methylpropyl)-phenyIpropylamide (4 mg), the latter previously 
reported from the family Piperaceae (Achenbach el al., 1986), were also isolated.
4. Chemotaxonomic significance
The presence of coumarins is relatively common throughout the family Rutaceae. 
The occurrence of isobutylamides, however, is much rarer, being confined to the 
proto-rutaceous species Z a n lh o xy lu m  and Tetradium  (Ng et a l ,  1987) whilst the 
structurally similar amides of isovaleric and senecioic acids have been found from 
some G tycosm is  species (Greger et al., 1996). The taxonomic placements of the genera 
Euodia  and M elicope  are currently under review (Hartley, 1997) with M elicope  
m elanophloia  to be placed into a new genus. Some Euodia  species have been transfer­
red to the closely related proto-rutaceous genus Tetradium  (Hartley, 1981). The 
presence o f isobutylamide compounds in M. m elanophloia, therefore, suggests that this 
plant may well have a close affiliation to the proto-rutaceous genera of Tetradium  and 
Z a n lh o xy lu m .
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N ovel and In sec tic id a l Isob u ty lam id es from  D in o sp erm a  ery th rococca
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P hytochem istry Research Laboratories, D epartm ent o f  P harm aceu tica l Sciences, U niversity  o f  S tra thclyde ,
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Through insecticidal bioassay-guided fractionation and isolation, five isobutylamides 1—5 were 
isolated from n-hexane and EtOAc extracts of the aerial parts of D in o sp e rm a  ery th rococca  
(Rutaceae). The structures of compounds 1—5 were established through ID and 2D NMR. 
Compounds 1—3 were identified as erythrococcamides A—C and represent two novel classes of 
isobutylamide. Compounds 4—5 were identified as AT-(2-hydroxy-2-methylpropyl)-6-phenyl 
2(E),4(/?)-hexadienamide (4)1'2 and AL(2-methylpropyl)-6-phenyl-2(E),4CE)-hexadienamide (5),13 
respectively. Compound 1 showed lethal activity against the housefly (M u sca  d o m e stica ) (kill 
EC50 =  20.2 ppm) and the tobacco budworm (H e lio th is  v ire sce n s) (kill EC50 =  74.2 ppm). 
Compound 4 showed lethal activity against//, v irescen s  at 500 ppm, while compound 5 showed 
lethal activity against M . d o m e stica  at 500 p
The Australian rainforest tree, formerly known as 
M elicope erythrococca F. Muell. (Rutaceae), has recently 
been reassigned to a new genus and renamed D ino­
sperm a erythrococca  (F. Muell.) T. G. Hartley.4 Previous 
screening of this species had indicated that an aqueous 
extract of the seeds had weak insecticidal activity 
against the milkweed bug (O ncopeltus fa sc ia tu s ).5 Fur­
ther examination had shown that a CHCI3 extract of 
the aqueous extract of the aerial parts had moderate 
antifeedant activity against the black carpet beetle 
(A ttagen u s p iceus); however, no followup work on these 
observations has since been reported.5 Previous phy­
tochemical studies on D. erythrococca (as M. erythro­
cocca) reported the isolation of the common triterpene 
lupeol and the phenylpropanoid compound elemicin.6
In ongoing work to find novel insecticidal compounds 
from natural sources, screening of an EtOH extract of
D. erythrococca against six economically important 
insect species7 suggested it to have slight insecticidal 
activity. In this paper, we report the bioassay-guided 
fractionation of D. erythrococca  based on insecticidal 
activity, which led to the isolation and identification of 
five isobutylamides (1—5). All five compounds were 
either novel or had not previously reported from natural 
sources.
Results and Discussion
Soxhlet extraction of the dried ground aerial parts 
sequentially with n-hexane, EtOAc, and MeOH, followed 
by screening of the extracts, showed the n-hexane and 
EtOAc extracts to have lethal activity against the 
housefly and the tobacco budworm at 10  0 0 0  ppm.
Bioassay-guided fractionation of both extracts gave an
* To whom correspondence should be addressed. Tel.: +(44)-141- 
548-2028. Fax: +(44)-141-552-6443. E-mail: P.G.Waterman@
strath.ac.uk.
t Current Address: Xenova Discovery Ltd., 545 Ipswich Rd., Slough 
SL1 9DJ, U.K.
! Australian National Herbarium, GPO Box 1600, Canberra, ACT 
2601, Australia.
5 Zeneca Agrochemicals, Jealott’s Hill Research Station, Bracknell,
Berkshire RG12 42EY, U.K.
S0163-3864(97)00556-9 CCC: $15.00 © 1998 American Chemical Society and American Society of Pharmacognosy
Published on Web 04/28/1998
1 Erythrococcam ide A
2  Erythrococcam ide B
3 E rythrococcam ide C
5 R= H
active fraction from which compounds 1—3 were iso­
lated. A polar fraction of the EtOAc extract also showed 
activity against the two-spotted spider mite. From this 
fraction compound 4 was isolated, although this com­
pound was inactive against the mites when tested. 
Further investigation of the activity against the two- 
spotted spider mite was undertaken by extraction and 
bioassay-guided fractionation of the remaining wood of 
M. erythrococca. This led to the detection of a mite- 
active fraction in the n-hexane extract from which 
compound 5 was isolated.
From the lH and 13C NMR and MS, compounds 1-5  
could be identified as being isobutylamides (see Tables
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Table 1. lH NMR Spectral Data for Compounds 1 -5  (in CDClg a t 400 MHz)
position 1 2 3 4 5
2 5.82 (d, J  =  15.8 Hz) 2.58 (dd, J = 14.8,7.9 Hz), 
2.52 (dd, J  =  14.8, 4.0 Hz)
5.81 (d, J  = 15.0 Hz) 5.84 (d, J  =  15.2 Hz) 5.80 (d, J  = 15.3 Hz)
3 7.21 (dd, J  = 15.8, 
10.7 Hz)
7.24 (dd, J  =  15.0, 
10.6 Hz)
7.24 (m) 7.23 (m)
4 6.24 (dd, J  = 15.2, 6.30 (dd, J  =  15.3, 6.17 (dd, J  =  16.2, 6.15 (dd, J  =  15.3,
10.7 Hz) 10.6 Hz) 10 Hz) 9.6 Hz)
5 6.12 (dt, J =  15.2, 
7.0 Hz)
6.19 (dt, c/ =  15.3, 
7.0 Hz)
6.24 (d tjC/ =  15.1,6.2 Hz) 6.22 (dt, J  =  15.3, 
6.3 Hz)
6 2.57 (m), 2.46 (m) 2.56 (m), 2.73 (m) 3.49 (d, J  = 6.2 I-lz) 3.49 (d, J  =  6.3 Hz)
1' 3.97 (m) 4.33 (dddd, J  =  12.1, 7.9, 
4.0, 2.2 1-Iz)
4.10 (m)
2' 1.94 (m), 1.67 (m) 2.00 (m), 1.64 (m) 2.05 (m), 1.78 (m) 7.17 (br d, J  =  7.1 Hz) 7.17 (br d, J  =  6.9 Hz)
2.72 (m), 2.64 (m) 2.65 (ddd, J  =  16.4, 5.6, 
3.2 Hz), 2.80 (ddd, J  
= 16.4, 10.2, 6.3 Hz)
2.93 (m), 2.89 (m) 7.31 (br t, J  =  7 Hz) 7.31 (br t, J  =  7 Hz)
4' 6.47 (s) 6.50 (s) 6.94 (s) 7.24 (m) 7.23 (m)
5' 5.84 (s) 5.86 (d, J  =  1.4 Hz), 5.87 
(d, J  =  1.4 Hz)
6.61 (d, J  =  2.2 Hz)
6' 6.34 (b) 6.30 (a) 7.49 (d, J  =  2.2 Hz)
7'-OCHa 4.10 (s)
1" 5.70 (br s) 6.13 (br s) 5.48 (br t) 5.98 (br s) 5.58 (br s)
2" 3.16 (t, J  =  6.7 Hz) 3.15 (dt, J  =  13.4, 6.5 Hz), 
3.08 (dt, J  = 13.4, 6.5 Hz)
3.18 (t, J  =  6.3 Hz) 3.35 (d, J  =  6.1 Hz) 3.17 (t, J  =  6.4H z)
3" 1.80 (n, J  =  6.7 Hz) 1.80 (m) 1.80 (n, J  =  6.4 Hz) R =  -O H , 1.71 (br s) 1.81 (n ,J  =  6.7 Hz)
4" 0.92 (d, J  =  6.7 Hz) 0.93 (d, J  = 6.7 Hz) 0.92 (d, J  =  6.4 Hz) 1.24 (a) 0.93 (d ,J =  6.7 Hz)
Table 2. 13C NMR Spectral Data for Compounds 1 -5  (in 
CDCI3)
position 1 2 3 4 5
1 166.4 170.4 166.3 167.4 166.4
2 123.1 43.0 123.1 122.5 123.0
3 140.8 140.9 141.6 140.9
4 131.1 131.3 129.5 129.6
5 137.4 137.4 141.4 140.8
6 38.9 38.9 39.4 39.4
V 75.1 73.3 75.7 139.2 139.3
2' 27.2 27.5 27.1 128.9 128.9
3' 24.8 24.7 25.2 128.8 128.8
3a' 113.3 113.4 119.6
4' 108.3 108.5 114.2 126.6 126.6
4a' 141.5“ 141.9“ 122.1
5' 100.9 101.1 106.4
5a' 146.5“ 146.7“
6 ' 98.8 98.6 144.5




2" 47.2 47.0 47.2 50.7 47.2
3" 28.8 24.7 28.8 71.3 28.8
4" 20.3 20.30, 20.29 20.3 27.5 20.3
“ Assignments interchangeable.
1 and 2 for *H and 13C NMR data, respectively). The
IR spectrum of compound 1 suggested a secondary 
amide function (1662, 1567 cm-1), while the mass 
spectrum gave the molecular formula C20H25NO4 with 
a fragment indicative of an isobutylamide at M'+ 72 (loss 
of t-BuNH through a-cleavage at carbonyl) and the 
appearance of fragments at 57 amu (i-Bu) and 100 amu 
(CONH-i-Bu).8
The *H NMR and ^ - ‘H COSY spectra of 1 gave 
signals for an isobutylamide group (<5 5.70 (H-l"), 3.16 
(Hz-2"), 180 (H-3"), 0.92 (2  x H3-4' ') ) .9-11 In addition, 
the signals of a conjugated diene moiety were apparent 
(d 5.82 (H-2), 7.21 (H-3), 6.24 (H-4), 6.12 (H-5)) in a 
trans-trans configuration as indicated by the coupling 
constants of 15.8 and 15.2 Hz for each pair of olefinic 
protons.11 The protons of the conjugated diene moiety 
could be linked together from the 1H—!H COSY spec-





Figure 1. Im portant 2J  and 3J  H —C correlations seen in 
HMBC spectra of 1—5.
trum and placed adjacent to the carbonyl carbon (C-l) 
from a 2J  HMBC correlation (Figure 1) from the olefinic 
proton H-2 to C-l. The last proton of the conjugated 
diene chain (H-5) showed coupling to a methylene group 
Hz-6 (6 2.57, 2.46), which, in turn, coupled to a deshield­
ed, oxygen-bearing methine H-T (d 3.97). H-l' exhibited 
further coupling to methylene protons H2-2 ' (<5 1.94, 
1.67), which, in turn, showed coupling to methylene 
protons of Hz-3' (<5 2.72, 2.64). From Hz-3' no further
3 6 5
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coupling was seen in the *H— COSY spectrum, 
indicating that the carbon adjacent to H2-3' was qua­
ternary. The 13C resonances for the partial structures 
were assigned from the HC-COBI experiment.
Analysis of the aromatic region of the 13C NMR 
spectrum showed the presence of six aromatic carbons. 
Four quaternary aromatic carbons were seen, C-3a' (d
113.3), C-4a' (d 141.5), C-5a' (d 146.5), and C-6a' (d
149.4), the latter three being deshielded due to bonding 
to oxygen atoms. Two aromatic methines were observed 
at d 108.3 (C-4') and 98.8 (C-6')- The lack of visible 
coupling between the two aromatic protons H-4' (d 6.47) 
and H-6' (d 6.34) and the presence of only one aromatic 
ring in the molecule suggested that the aromatic protons 
were para to one another. A methylenedioxy group (H2- 
5 'd 5.84, dc 100.9) could be identified from the ID NMR 
spectra, while the HMBC experiment (Figure 1) re­
vealed these protons to show AJ  correlations to the 
aromatic carbons C-4a' (d 141.5) and C-5a' (d 146.5).
The structure of compound 1 was finally determined 
from the HMBC experiment (Figure 1), which allowed 
the partial structures to be linked together. The at­
tachment of the methylene C-3' to the quaternary C-3a' 
was shown through 3J  correlations of H-3' to C-4' and 
H-4' to C-3', thereby establishing C-3a' as the non- 
oxygen-bearing quaternary carbon (d 113.3). Two of the 
oxygen-bearing quaternary carbons were accounted for 
as part of the methylenedioxy ring. The remaining 
oxygen must be attached to C-6a' (d 149.4), bridging the 
gap between C-6a' and the deshielded oxygen-bearing 
methine H-l'/C-T (dji 3.97, dc 75.1) to form a benzopy- 
ran moiety and give the final structure 1. A NOESY 
experiment was carried out in an attempt to determine 
whether H-l' was axial or equatorial, but no firm 
conclusions could be made from the NOE correlations 
seen.
The ‘H and I3C JMOD spectra of compound 2 were 
very similar to those seen for 1, showing the presence 
of the (methylenedioxy)benzopyran moiety and the 
isobutylamide function but lacking the conjugated diene. 
The ‘H—*H COSY and HMBC experiments allowed the 
various partial structures to be linked together. The 
’H— 'H COSY spectrum showed a correlation from the 
methylene group H2-2 (d 2.58, 2.52) to the sp3 oxyme- 
thine H-l' (d 4.33) of the pyran ring and from H-l' to 
the adjacent methylene protons H2-2 ' (d 1.64, 2.00) and 
then H2-3 ' in the pyran ring (d 2.65, 2.80). From the 
HMBC experiment, the correlations shown by the H2 - 2  
protons confirmed that this methylene joined the pyran 
ring and the isobutylamide function, through 2J  cor­
relations between H-2 and C-l (d 170.4) and C-l' (d 73.3) 
and a 3J  correlation to C-2' (d 27.5). Finally, the H-2" 
protons showed a V  correlation to C-l (d 170.4), 
confirming the attachment of the isobutylamine function 
to the carbonyl group.
The JH and 13C NMR spectra revealed compound 3 
to also be similar to compound 1. Similarities included 
a benzopyran moiety and the 2CE),4(E)-hexadieneisobu 
tylamide group, with novel features being the presence 
of an aromatic methoxyl group and a furan moiety. In 
the 13C NMR spectrum the methoxyl group resonated 
at d 61.1, which indicated that the ortho positions were 
both substituted.12 This suggested that the furan ring 
was in a linear configuration with respect to the
m/z= 177(1,2)
COX
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mlz= 203 (3)
O C H ,
Figure 2. Probable major fragments seen from the mass 
spectra of compounds 1 -3.
benzopyran moiety. The HMBC experiment (Figure 1) 
allowed the piecing together of the molecule and final 
determination of the structure. The significant correla­
tions came from the sole aromatic proton H-4', which 
showed 3J  correlations with the methylene C-3' (d 25.2) 
and with the oxygen-bearing aromatic carbons at C-6a' 
(d 146.1) and C-7a' (d 144.4), the latter being part of 
the pyran ring. In addition, a 3J  correlation was seen 
between the aromatic proton H-4' and the furan methine 
H-5' at d 106.4, which meant that the oxygen substitu­
ent of the furan ring was meta to the aromatic proton, 
which was further substantiated by the fact that the 
furan proton H-5' was relatively shielded at d 6.61. Had 
the methoxyl group been in the C-4' position, then the 
H-5' proton would have been deshielded to ca. d 7 due 
to the peri-deshielding effect of the methoxyl. This is 
analogous to the XH NMR chemical shifts seen with the 
furanocoumarins bergapten (6) and xanthotoxin (7).13
O C H 3
a
The mass spectra of compounds 1 -3  gave typical 
fragmentation patterns for isobutylamides as described 
above but also showed major fragments that could be 
ascribed to cleavage of the benzopyran moiety from the 
amide side chain (Figure 2).
Both the JH and 13C NMR spectra showed compounds 
4 and 5 to have the conjugated 2(E),4(E)-hexadiene
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T a b le  3. Insecticidal Activity of Compounds 1 - 5  and 8 —9
compd insecticidal activity0 other observations
1 housefly kill ECso =  20.2 ppm. rel potency =  3% of 
cyperm ethrin tobacco budworm lull ECsu = 74.2 
ppm. Rel potency =  0.9% of profenofps
also Bhowed housefly knockdown activity a t 500 ppm
2 inactive at 500 ppm
3 inactive a t 500 ppm
4 gave 80-100%  kill aga inst tobacco budworm a t  500 ppm'1
5 housefly kill EC bo =  59.9 ppm.c
Rel potency =  1.8% of cyperm ethrin1
also showed housefly knockdown activity a t 500 ppm
8 inactive a t 1000 ppm also showed housefly knockdown activity a t 2500 ppm
9 inactive a t 2500 ppm
" Tested against the six pest species listed in re f  7. 1‘ Due to shortage in compound, only prelim inary activity-studies done. c Results 
a re for the synthetic compound m ade during  o ther research carried out by Zeneca Agrochemicals Ltd.31
system of 1 together with a monosubstituted aromatic 
ring. In 4, an isobutylamide group was not immediately 
apparent. Two deshielded 2H doublets were observed 
(<5 3.35, 3.49) together with a deshielded 6 H singlet (<5 
1.24), the latter suggestive of two methyl groups at­
tached to a quaternary oxygen-bearing carbon. In the 
‘H- 'H COSY experiment, starting from H-2 (olefinic 
adjacent to carbonyl), it was possible to trace the 
conjugated diene function to H-5, which showed a 
correlation to a 2H doublet at (5 3.49 (H2-6 ). The N -H  
proton meanwhile showed a correlation to the 2H 
doublet at 6 3.35 (H2-2"). The JMOD 13C NMR revealed 
the presence of two nonaromatic quaternary carbons, 
one of which could be identified as the carbonyl C-l (<5
167.4) while the other (<5 71.3) must be the carbon to 
which the two methyl groups were attached and which 
is deshielded due to an OH substituent. The 2 D HC- 
COBI allowed the assignment of direct lJ  C—H correla­
tions, and HMBC (Figure 1) facilitated the complete 
assignment of the structure. The correlations of im­
portance from the HMBC experiment showed attach­
ment of the aromatic ring to the 2(£),4(E)-hexadiene 
chain as demonstrated by a 3J  correlation between H-5 
and the aromatic quaternary C-l' (d 139.3). Similarly, 
the protons H2 - 6  gave a AJ  correlation with the carbon 
C-2'. The protons H2-2" showed correlations to C-l, 
C-3", and C-4". Compound 4 was thus identified as 
N-(2-hydroxy-2-methylpropyl)-6-phenyl-2(I?),4(.E)-hexa- 
dienamide. Comparison of the physical and spectro­
scopic properties of compound 4 with those quoted in 
the literature1’2  for the synthetic compound showed 
them to be identical.
Analysis of the XH and 13C NMR spectra of compound 
5 showed the same unsubstituted isobutylamide group 
as 1 -3 , together with the phenyl-2(£),4(E)-hexadiena- 
mide emit of 4. From ID and 2D NMR experiments 
compound 5 was confirmed as N-(2-methylpropyl)-6- 
phenyl-2(/i),4(jE')-hexadienamide and showed physical 
and spectral properties identical to the synthetic com­
pound reported. 1 - 3
The insecticidal activities of compounds 1—5 are 
shown in Table 3 together with those of the isobutyl­
amides pellitorine (8 ) isolated from Zanthoxylum tess- 
mannii14 and fagaramide (9) isolated from Dinosperma 
melanophloia (formerly Melicope melanophloia).15 Vari­
ous naturally occurring isobutylamides have been shown 
to be active against insect species. 1 6 1 7 ’20 Synthetic work 
on isobutylamides used compound 5 as a lead compound 
and structural variations led to improved activity, the 
most potent compounds being 1 0  and 1 1 . 3>18-19
The results found in this work mirror the synthetic 
studies, with 1  being implicated as the major active 
compound of the crude extract. The active compounds 
all possessed conjugated 2 (f?),4 (I?)-hexadienamide moi­
eties, which are crucial to activity . 3 -1 8 -2 0  The absence 
of the diene function in 2 and 9 resulted in a complete 
loss in activity. Compound 1 was shown to be more 
potent than 5  and to possess a broader range of activity. 
This suggested that substitution of the aromatic ring 
can lead to further increases in potency, a view sub­
stantiated by the synthetic work.3 1 8 -19 Compound 3 was 
inactive at 500 ppm on all screens, which suggested a 
limit to substitution on the aromatic ring above which 
total loss of activity is seen, possibly due to restricted 
access to the receptor site.
The close resemblance of the aromatic moiety of 3 to 
xanthotoxin (7) may possibly allow the plant to exploit 
two modes of insecticidal action. Furanocoumarins such 
as bergapten (6 ) and xanthotoxin (7) have been reported 
to have antifeedant and insecticidal activity, 2 1 -2 4  and 
the presence of hexadienamide and furanocoumarin-like 
moieties in 3 could lead to a dual mode of action against 
pest species that D. erythrococca encounters in the wild. 
The substitution of 1 with a methylenedioxy moiety may 
enhance the activity of this compound through inhibi­
tion of metabolism, an activity characterized by the 
sesamin-type insecticide synergists. 25 26
Compounds 4 and 5 came from mite active fractions 
but when tested did not show any activity against mites. 
These fractions were then recombined and tested, but 
activity against the two-spotted spider mite could not 
be reestablished. The isolation of two structurally very 
similar isobutylamides from fractions that showed 
activity against mites suggests that they may be impli­
cated in the activity seen for the fractions. The pos­
sibility of synergism between the isobutylamides and 
compound(s) unknown (that are possibly unstable) 
cannot be entirely ruled out, although the lack of 
activity in the recombined fractions points to another 
compound being responsible for activity in the mite 
screen.
In an assay measuring relative potency, compound 1 
possessed 3 % of the activity of the pyrethroid insecticide 
cypermethrin against the housefly. It has been reported 
that 11 gave 40% of the activity of the pyrethroid 
permethrin against houseflies. 19 A general comparison 
of activity between permethrin and cypermethrin sug­
gested that cypermethrin was approximately three to 
four times more potent than permethrin, 27 which in turn 
suggests that 1 has approximately 9-12% of the activity 
of permethrin.
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The taxonomic placements of the genera Euodia and 
Melicope in the Rutaceae are currently under review .28 
Some northern Euodia species have been transferred 
to the closely related “proto-rutaceous” genus Tetra- 
dium.7a For the family Rutaceae as a whole, the 
distribution of isobutylamides has been restricted to the 
two proto-rutaceous genera Zanthoxylum  and Tetra 
dium 30 and to the species Dinosperma melanophloia 
(formerly Melicope melanophloia) , 15 which is to be 
placed into the newly reassigned genus Dinosperma 
along with D. erythrococca on morphological grounds.4 -28 
This work represents the second report of the isolation 
of isobutylamides from this newly created genus. The 
compounds isolated in this study mark an advance in 
biosynthetic complexity for this class of compound as a 
whole, employing both cinnamate and acetate pathways 
(probably with mevalonate involvement in the formation 
of the furan ring) to yield more potent insecticidal 
compounds. The isobutylamides may also prove to be 
chemotaxonomic markers to identify other members of 
this genus.
Experim ental Section
G eneral Procedures. Melting points (uncorrected) 
were determined on a Kofler hot-stage apparatus. UV 
spectra were recorded using a Perkin-Elmer 552 spec­
trophotometer with the sample dissolved in MeOH. IR 
spectra were recorded as KBr disks on a Matson Genesis 
series FT-IR spectrophotometer. Optical rotations were 
measured on a Bellingham and Stanley ADP220 instru­
ment and the samples dissolved in CHCI3 . HREIMS 
were run on a JEOL JMS-AX505HA double-focusing 
instrument at 70 Ev. EIMS were run on a JEOL DX303 
in El mode. NMR spectra (both one- and two-dimen­
sional) were obtained on a Bruker AMX 400 (400 MHz 
for 'H) spectrometer, all samples dissolved in CDCI3 . 
Vacuum—liquid chromatography (VLC) was carried out 
using Merck silica gel 60H. Column chromatography 
was carried out using silica gel (Merck 0.063—0.2 /im) 
or Sephadex LH-20 (Pharmacia). Preparative HPLC 
was performed using a Gilson 601 system with a 
Spherisorb ODS2 C-18 column (25 mm i.d. x 250 mm). 
Analytical and preparative TLC (PTLC) were performed 
on Merck silica gel 60 F264 (0.2 mm thick) and Merck 
silica gel 60 PF254 ( 1  mm thick) plates, respectively, and 
the plates visualized under UV (254 and 366 nm) and 
by spraying with 1% vanillin—H2SO4 and then heating.
P lant M aterial. Aerial parts of D. erythrococca (F. 
Muell.) T. G. Hartley were collected from rainforest (at 
500 m altitude), Atherton Tableland, Cook District, 
Queensland. A voucher specimen (voucher no. Water­
man 91/3) was deposited at the Australian National 
Herbarium, Canberra.
T esting for Insecticidal A ctivity. The initial 
screening involved counting out approximately 1 0  of the 
individual test species7 into a container prepacked with 
an adequate food supply. The extract/fraction/com- 
pound was dissolved in a 50:50 mixture of acetone and 
an aqueous suspending agent, and the complete mixture 
was sprayed into the container holding the test species. 
After a period of time (different for each species, 
typically 3—5 days), the assay was assessed for percent­
age lethality and scored. The control experiment in­
volved spraying a similar container holding insects and
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food supply with the same volume of carrier and 
assessing mortality after the same period of time. 
Crude extracts were screened at a concentration of 
10 000 ppm with fractions being tested at 1000-5000 
ppm. Pure active compounds in sufficient quantity were 
tested further at varying concentrations to ascertain 
EC50 values.
Extraction. The dried, ground plant material was 
extracted using a Soxhlet apparatus. The initial EtOH 
extract showed weak activity against the housefly and 
the tobacco budworm. Large-scale extraction was done 
sequentially with /i-hexane followed by EtOAc and then 
MeOH. Two different extracts were prepared, one for 
all aerial parts, the second for the wood.
Bioassay-G uided Fractionation and Isolation. 
Results from the insecticidal bioassays showed the 
n-hexane and EtOAc extracts to possess lethal activity 
against the housefly and the tobacco budworm. The 
EtOAc extract also showed lethal activity against the 
two-spotted spider mite. VLC fractionation of the 
n-hexane extract on silica gel was carried out, eluting 
with n-hexane and then n-hexane with increasing 
amounts of EtOAc. Fractions were analyzed by TLC 
and similar fractions combined. The fractions were 
tested for biological activity, and the fraction F3 (eluted 
with 30%-70% EtOAc) was active against the housefly 
and the tobacco budworm. This fraction was then 
subjected to column chromatography using Sephadex 
LH-20, eluting with CHCI3 and collecting 40 mL frac­
tions. Fraction 2 again showed lethality against the 
housefly and the tobacco budworm. Fraction 2  was 
dissolved in 1 : 1  n-hexane/EtOAc, and a precipitate 
formed that was filtered off to give compound 1  (18 mg). 
The solution was subjected to PTLC (n-hexane/EtOAc 
4:1) to give compounds 2 ( 8  mg) and 3 (4 mg).
The EtOAc extract showed lethal activity against the 
two-spotted spider mite, the housefly, and the tobacco 
budworm. VLC fractionation of the n-hexane extract 
on silica gel was carried out, eluting with n-hexane and 
then n-hexane containing increasing amounts of EtOAc, 
and finally with MeOH. The activity against the 
housefly and tobacco budworm could be attributed to 
the presence of 1. The activity against the two-spotted 
spider mite was found to occur in a more polar fraction, 
eluted from the VLC column using 60% EtOAc in MeOH 
to 100% MeOH. The active fraction was twice subjected 
to column chromatography using Sephadex LH-20, 
eluting with CHCI3 with increasing amounts of MeOH 
and collecting 40 mL fractions. The fractions were 
analyzed by TLC and like fractions combined and 
screened for activity. Compound 4 was isolated from 
the active fraction by preparative HPLC using a Gilson 
601 system with a Spherisorb ODS2 C-18 column (25 
mm i.d x 250 mm) and eluting with 40% MeOH in H20, 
collecting the major peak at 10.3 min. Compound 4 was 
inactive against mites when screened at a concentration 
o f2500 ppm. A reexamination of the mite activity was 
undertaken by extracting the remaining wood of D. 
erythrococca as above. The activity against mites was 
concentrated in the n-hexane extract. VLC of the 
n-hexane extract led to an active fraction eluted by 2 0 -  
70% EtOAc in n-hexane. The active fraction was 
subjected to gel chromatography using Sephadex LH- 
20 eluting with CHCI3 and collecting 40 mL fractions.
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Fraction 2 was found to be active, and this was subjected 
to column chromatography using silica gel (eluting 
n hexane/EtOAc). The mite-active fraction was eluted 
using 22—30% EtOAc in ra-hexane. The major com­
pound from this fraction was compound 5, which 
precipitated out of a CHClg/MeOH mixture.
Erythrococcamide A (1) [6-[3,4-dihydro-8,7-(meth 
ylenedioxy)-2J9-l-benzopyran-2-yl]-iV-(2-m ethyl- 
propyl)-2(jE),4(E)-hexadienamide|: needles from hex- 
ane/EtOAc; mp 160-161 °C; [alo (c 0.01, CHCI3) +133°; 
UV Am„  (MeOH) 257, 310 nm (sh); IR vmnx (KBr disk) 
3391, 3283, 2959, 1662, 1635, 1621, 1567, 1513, 1486 
cm-1; EIMS m/z 343 [M+] (62), 271 (6 ), 193 (23), 177 
(100), 167 (55), 151 (42), 141 (11), 135 (24), 119 (18), 
100 (12), 91 (17), 77 (12), 6 8  (23), 57 (58), 28 (47).
Erythrococcamide B (2) [2-[3,4-dihydro-6,7-(meth- 
ylenedioxy)-2fT-l-benzopyran-2-yl)-AT-(2-methyl- 
propyljacetam ide]: pale yellow solid; mp 95 °C; [alo 
(c 0 .0 0 1 , CHCI3 ) +73°; UVAmax (MeOH) 256 nm; IR vmHX 
(KBr disk) 3432, 2958, 1643, 1508, 1487, 1477 cm '; 
HREIMS 291.1468 (calcd for Ci6H2 iNO.i, 291.1471); 
EIMS m/z 291 [M+l (100), 220 (18), 218 (25), 202 (10), 
190 (14), 177 (32), 176 (23), 175 (24), 162 (36), 151 (56), 
149 (42), 141 (20), 134 (23), 123 (28), 121 (30), 6 8  (59), 
57 (70).
Erythrococcam ide C (3)[6-(5,6-dihydro-9-meth- 
Qxy-7//-furo[3,2-g|-l-benzopyran-7-yl)-A-(2-methyl- 
propyl)-2(E),4(A?))-hexadienamide|: pale yellow wax;
mp 42 °C; [a]n (c 0.001, CHCI3 ) +185°; UV AmttX (MeOH) 
255, 260, 270, 295 nm; IR vmax (KBr disk) 3440, 3324, 
2958, 1631, 1624, 1573, 1504,1496, 1478, 1296, 1153 
cm '; HREIMS 369.1969 (calcd for C22H27N0 4 , 369.1940); 
EIMS m/z 369 [M+] (73), 345 (11), 343 (14), 291 (54), 
267 (18), 256 (14), 218 (18), 203 (100), 177 (53), 176 (20), 
167 (79), 151 (55), 57 (91).
iV-(2-Hydroxy-2-methylpropyl)-6-phenyl-2CE),4(E)- 
hexadienam ide (4): yellow waxy solid; mp 77 °C; UV 
Amax (MeOH) 257 nm; IR vmax (KBr disk) 3440, 2876, 
1658, 1627, 1550, 1460, 1377, 1257 cm"1; EIMS m/z 259 
[M M (13), 201 (28), 171 (12), 143 (23), 128 (23), 115(10), 
110 (100), 91 (18), 59 (14).
AM2-Methylpropyl)-6-phenyl-2(l?),4(jE)-hexadi- 
enam ide) (5): needles; mp 116 °C; UV Amnx (MeOH) 256 
nm; IR vmnx (KBr disk) 3305, 2960, 2875, 1650, 1608, 
1540,1475 c m 1; HREIMS 243.1566 (C16H2]NO requires 
243.1623); EIMS m/z 243 [M M (75), 171 (54), 152 (32), 
143 (28), 128 (91), 84 (100).
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Effect of the Nature of the Hydrophobic Group on the 
Mode of Association of Amphiphilic Molecules 
in Aqueous Solution
B y  D a v id  A t t w o o d ,* S u r a j  P. A g a r w a l * a n d  R o g e r  D .  W a ig h  
Departm ent o f Pharmacy, University o f M anchester, M anchester M13 9PL
The importance of the flexibility of the hydrophobic group in determining the association pattern of an 
amphiphilic molecule has been examined by comparing the solution properties of a flexible diphcnylmcthane 
derivative, adiphenine hydrochloride, with those of a similar molecule, pavatrine hydrochloride, in which the 
two phenyl rings of the hydrophobic group are linked in the form of a rigid fluoretie group. The 
concentration dependence of the light scattering from aqueous solutions of pavatrine hydrochloride showed 
no significant discontinuity attributable to a critical micelle concentration and could not be simulated using 
the mass-action model of micellisation, indicating that the association pattern does not conform to that of a 
monodisperse micellar system. In contrast, adiphenine hydrochloride exhibited a typical micellar 
association pattern.
The association of pavatrine hydrochloride in water may be represented by a two-parameter stepwise 
association model in which the dimerization constant is treated as an independent variable and higher 
association constants, K N, decrease with increasing aggregation number, N, according to the relationship 
Kfi — K(N -  1 )/{N — 2). Addition of sodium chloride causes not only an increase in the magnitude of the 
association constants but also a change in the pattern of association. In the presence of 0.1 mol d m ' 3 NaCl 
the association is best represented by a two-parameter model in which higher stepwise association constants 
are identical. At higher electrolyte concentrations (0.2 and 0.5 mol dm ~ 3) the association follows a one- 
paramctcr scheme in which association constants increase with N according to KN = K(N — 1 )/N.
The m ode o f association of am phiphilic m olecules is thought to  be strongly  
influenced by the nature o f the hydrophobic group.1 In typical surfactants the 
hydrophobic group is a flexible hydrocarbon chain which can intertwine during the 
aggregation process to form approxim ately spheroidal micelles. In contrast, rigid 
planar m olecules such as the cationic dyes 2 associate by face-to-face stacking in a 
stepwise association pattern. Whereas in micellar association there is a predom in­
ance o f aggregates o f an energetically preferred size, in stepwise association the 
products o f association are generally multimers with a broad size distribution.
Previous studies 3 have established a micellar m ode o f association for amphiphilic  
drug m olecules with diphenylm ethane hydrophobic groups. R otation around the 
central C atom  of diphenylm ethane clearly hinders stacking o f these molecules. In 
this investigation a direct com parison is made o f the association behaviour o f the
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diphenylmethane derivative, adiphenine hydrochloride, 1, and that of a rigid analogue 
o f this com pound, pavatrine hydrochloride, II, in which the two phenyl rings of the 
hydrophobic group are linked in the form o f a rigid fluorene group.
E X PE R IM E N T A L .
M A T E R I A L S
Pavatrine hydrochloride (2-diethylaminoet'nyl 9-fluorene carboxylate hydrochloride) was 
prepared by the interaction of 9-fluorenecarboxylic acid and /1-diethylaminoethyl 
chloride.4 The product was recrystallised from isopropanol and dried over phosphorus 
pentoxide under vacuum, m.p. 143°C [lit.4 143-144"C] i.r. and 'H n.m.r. spectra were in accord 
with the structure and indicated a satisfactory deree of purity. (Found : C, 68.9; H, 7.2; N, 
4.1. Calculated for C20H 24C IN 02: C, 69.45; H, 7.0; N, 4.05.) Sodium chloride was of AnalaR 
grade.
L I G H T  S C A T T E R I N G  M E A S U R E M E N T S
A Fica 42000 photogoniodilTusometer (A.R.I.. Ltd) was used at 303 K with incident light of 
wavelength 546 nm. Aqueous solutions were clarified by ultrafiltration through 0.1 /mi 
Millipore filters until the ratio of light scattering at angles of 30 and 150° did not exceed 
1.10. Refractive index increments determined at 546 nm using a differential refractometer were
0.070 kg m ol' 1 in water, 0.1 and 0.2 mol dm ~3 NaCl and 0.067 kg m ol~1 in 0.5 mol dm - 3 NaCl.
RESULTS
The concentration dependence o f the light scattering intensity at 90°, S90, from 
solutions o f pavatrine hydrochloride both in the presence and absence o f added 
electrolyte is com pared in fig. 1 with the previously reported 5 light scattering curve for 
adiphenine hydrochloride in water. The latter curve shows a marked deviation from 
the theoretical scattering line for unassociated m onom ers (calculated assum ing 
thermodynamic ideality) at a well-defined critical micelle concentration (c.m.c.). In 
contrast the S 90 — m  curves o f pavatrine hydrochloride increase continuously with 
concentration, with no apparent inflection points. The absence o f an inflection point 
does not itself constitute proof o f a non-micellar type o f association since the 
abruptness o f the change in the scattering intensity at the c.m.c. is determined by the 
aggregation number, N, the micellar charge, p, and the equilibrium constant, K,„. A  
m ethod o f com puter sim ulation o f the light scattering curves based on the application  
o f the law o f mass action to the micellar process has been described previously.6 The 
scattering intensity as a function o f concentration was com puted for a large series o f  
com binations o f the parameters K m, N  and the degree of dissociation, a. ( =  p /N ) in 
w hich N  was varied in increments of 0.2 from 1.0 to 40.0 and a was varied in increments 
o f 0.02 over the range 0.02-0.98. For each com bination o f N  and a, K m was adjusted 
by an iterative procedure to give the best fit to the experimental data as indicated by a 
goodness-of-fit parameter which was equally weighted over the entire concentration  
range. The light scattering results for adiphenine hydrochloride could be reproduced 
within the limits o f error of the experimental data with N  =  10.0, K m =  1 .0 x l0 45 and 
a =  0.23. It was not, however, possible to satisfactorily represent any o f the S 90—m  
curves o f pavatrine hydrochloride using the mass action equation, indicating that the 
association pattern does not conform to that o f  a m onodisperse micellar system.
The light-scattering data were analysed using curve-fitting procedures developed 
by Rosotti and R osotti,7 details o f which have been previously given.8 The variation
371
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Fig. I. Concentration dependence of the scattering ratio, S9U, for pavatrine hydrochloride in O, H20 ; SI, 
0.1 mol dm " 3 N aC l; A , 0.2 mol dm 3 N aCl; A , 0.5 mol dm 3 NaCl and x  , adiphenine hydrochloride in
H 20  [from ref. (5)]. ( --------- ) Scattering intensity calculated using mass action equations for micellar
association of pavatrine hydrochloride with N = 7.6, K,„ ~ 0.25 x 10*s, a — 0.10 in water; N = 17.4, fC 
= 0.1 x I092, a = 0.20 in 0.1 mol drrT3 NaCl; N =  17.5, K = 0 .t3x  1097,a  = 0.10 in 0.2 mol dm 3NaCI; 
and N = 32.3, K =  0,32 x 10*7B, o = 0.1 in 0.5 mol dm ~3 NaCl. For adiphenine hydrochloride in H 20 ,
IV = 10.0, K,„ -  1.0 x 10*5 and a =  0.23. (---------) Theoretical scattering calculated using stepwise
association models given in table 1.
o f m onomer concentration, b ,, with total solution concentration, m, was determined by 
integration of the light-scattering data according to
In x  =  £ [ ( M / M npp) - l ] d l n c .  (1)
x is the weight fraction o f m onom ers, c is the weight concentration o f the solution, M  is 
the m onomer m olecular weight and M app the apparent weight-average molecular 
weight calculated from the light-scattering intensity assum ing ideality.
Several m odels o f self-association were considered, the number o f variables being 
restricted to one or two. In one-parameter models an explicit relationship between all 
stepwise association constants was assumed, the relationship being expressed using a 
generalized parameter K. In two-param eter models the association constant for 
dimerization, K 2 was considered as an independent variable and higher K N values 
related to K.
The one-param eter m odels considered were 2
M odel X ; In this, the simplest one-param eter model, the equality o f all K  values is 
assumed leading to the relation
(,b j m )* =  1 - K b v (2)
Eqn (2) gave poor representation o f the experimental data in all systems.
M odel Y : Stepwise association constants increase sequentially with N  according to
K n =  K ( N - l ) / N (3)
: i S !
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leading to the relation
m /b , =  1 +  Km. (4)
Fig. 2 shows linear relationship between m /b l and m for pavatrine hydrochloride in 0.2 
and 0.5 m ol dm "1 NaCl. Values o f K from the slope of the plots for these two systems 
are given in table I. In the remaining systems, model Y gave unsatisfactory (its o f the 
experimental data and these systems were analysed using two-parameter models.
40 40
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Fig. 2 .- Dala plotted according to one-parameter association model Y for pavatrine hydrochloride in x , 
H 2O j □ , 0.1 mol dm “ 3 NaCl; A .  0.2 mo! dm ' 3 N aC l; m, 0.5 mol dm - 3 NaCl.
T a b l e  1 . - - E f f e c t  o f  e l e c t r o l y t e  o n  t h e  p a t t e r n  o f  a s s o c i a t i o n  o f  p a v a t r i n e  h y d r o ­
c h l o r i d e  IN  AQUEOUS s o l u t i o n
association constants 
[NaCl] /dm3 m ol-1
/m oldm -3 association model K 2 K
0.00 K n = K (N — l)/(N — 2) 3 95 76
0.10 K n = K N > 3 98 180
0.203 101 202
0.50J k n
= K(N  — 1 )/N N > 2
238 476
In two-param eter association models, plots o f log T  against log b were compared  
with normalized curves o f log T *  against log  b* for each association m odel, where
b*  =  K  by (5)
T *  =  T K / K 2 (6)
T  =  (m (7)
3 7 3
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Fig. 3. Experimental log T  against log b data for pavatrine hydrochloride in ffil, water and A . 0.1 mol din ' 
NaCl superimposed on normalized curves of log T* against log b* for two-parameter association models 
described by cqn (8H15).
The four m odels considered are defined in eqn (8)-(15).
M odel A : Stepwise association constants are identical for N  >  3
K 3 =  K 4 =  K n =  K  (8)
and T* =  b*(2 -*>*)/( 1 - b * ) 2 for b* <  1. (9)
Model B : Stepwise association constants increase in a mild sequence according to
K N =  K (N  — 2)/(N  — 1) for Af >  3 (10)
a n d T *  =  [b * /( l - /> * } ]- I n  (1 - b * )  for b* <  1. (11)
Model C : Stepwise association constants decrease in a mild sequence according to
K n =  K {N  — l)/(Af — 2) forAl 5: 3 
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M odel D : Stepwise association constants decrease relatively rapidly with N  
according to
The experimental log  T  against log curves for pavatrine hydrochloride in water 
and in the presence o f 0.1 mol dm 3 electrolyte are compared with the normalized 
curves in fig. 3. This figure shows clearly the change in the pattern of stepwise 
association from a model in which K N decreases with increasing N  in water to one in 
which K n increases with N  in the presence o f electrolyte. K 2 and K  values were 
calculated from the displacements of the coordinate axes required to achieve the best fit 
of the curves, using eqn (5) and (6).
Values o f the association constants derived from the one- and two-parameter 
schemes were used to recalculate the light scattering curves in the following way.
The weight-average degree o f association, N m  of the system  including the 
m onomers is given by
For an associating system conforming to the one-parameter m odel Y, summation  
of the series for G and C yields
K n = K / ( N -  I) for N  >  3 
and T* =  e6*(l +  b * ) -  I for b* <  1.
(14)
(15)
N„  =  G /C (16)
N
where C =  £  ^ [6*,] and G =  £  N 2[6 W],
C  =  b J ( l - X )  
G =  b J i l - X ) 2
(17)
(18)
where X  =  K b i .
The weight-average degree of association is thus
N„ =  l / l  — X.





=  X ( K  - K 2) ( 1 - Y ) 3 +  /C2Y (1  +  Y)
w  ~  x ( k ~ k 2) ( \ ~ x ) 3 + k 2x  (\  ' - x y
(22)
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Hence
= X K ( l - X r  + 2K2X 2 (2+ 2Q 
w X K ( I - A r)4 +  2K 2X 2 ( 1 - A r)' 1 '
The scattering intensity was calculated as a function o f concentration from the 
values o f N w for the appropriate association model, assum ing ideality. Eqn (19), (22) 
and (25) were used where necessary to im prove the initial estim ates o f K  by an iterative 
method. Fig. 1 shows a satisfactory fit o f the experimental data for all systems using  
the association m odels and constants given in table 1.
D IS C U S S IO N
It has been shown in this investigation that replacement o f a flexible, diphenyl­
methane group o f an amphiphilic m olecule with a rigid, planar fluorenc group can 
result in conversion from a micellar to a non-micellar m ode of association. N ote  
however that, although rigidity of the hydrophobic group is clearly an im portant 
requirement for non-micellar association, it is not the only requirement. A large 
number o f amphiphilic m olecules with rigid tricyclic hydrophobic groups, such as the 
phenothiazines 9 and antidepressant drugs,10 associate in a micellar manner. Other 
factors affecting the m ode of association will be reported in later papers.
In an investigation o f the effect o f ionic strength on the association o f the cationic  
dye methylene blue, G hosh and Mukerjee 2 noted only a small counterion effect on  the 
magnitude o f the association constants. Similar conclusions were reported by  
Padday 11 for the association o f  other dyes. Although pavatrine hydrochloride, like 
methylene blue, possesses a planar, tricyclic ring system it bears a closer resemblance to 
conventional surfactants since its charge is localised at the end o f the side chain rather 
than delocalised as in m ethylene blue. In typical surfactants, electrolyte addition  
leads to an increase in aggregation number and a lowering o f the c.m.c. due to a 
reduction in the repulsive interaction o f the ionic head groups. In this investigation it 
is shown that the reduction o f  this repulsive interaction not only causes an increase in 
the mean aggregate size but also profoundly affects the pattern o f association; 
converting from a model in water show ing anticooperativity to one in the presence o f  
electrolyte which exhibits cooperativity.
We thank the University o f Nigeria for granting leave o f absence to Suraj P. 
Agarwal and Mr A. D ewsnup for technical assistance.
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Parabolic structure-activity relationships: a simple pharm aco­
kinetic model
L .  A A r o n s * , D .  B eu .t , R .  W a i g u , O .  Y e , Pharmacy Department University o f  Manchester, Manchester, U .K .,I Control 
Systems Centre University o f  Manchester, Institute o f  Science and Technology, Manchester, U.K.
Several models have been proposed for the parabolic 
relationship that many drugs show between pharm aco­
logical response and lipophilicity. Hansch and co­
workers (Penniston et al 1969; Hansch & Clayton 1973) 
have proposed that the parabolic relationship arises 
from the passive diffusion of the drug through alternat­
ing aqueous and lipid phases and produced com puter 
simulations to substantiate this argum ent. McFarland 
(1970) also considered a system comprising alternating 
aqueous and lipid phases and using probability argu­
m ents derived a bilinear equation to describe the 
relationship between pharmacological response and 
lipophilicity. Kubinyi (1976, 1977) has extended M cFar­
land’s work and reported that the bilinear model 
explains most o f the data  in the literature better than 
H ansch’s quadratic model.
Since an in vivo biological system is much more 
complicated than a series of alternating aqueous and 
lipid phases, these models must be viewed as empirical 
rather than fundam ental. Consequently we will use the 
term  ‘parabolic’ to  describe the situation in which, 
amongst a group of com pounds with varying lipophil­
icity one com pound elicits the largest pharmacological 
response (per unit d o se). The term  is not m eant to imply 
quadratic in the sense o f Hansch.
All of the approaches that have been proposed so far 
* Correspondence.
have as their basis tire postulate that pharmacological 
response is determ ined by the ability of the drug to 
reach its receptor site. While this postulate is undoubt­
edly correct, the contribution of the drug's pharm aco­
kinetics to its concentration at the receptor site has been 
neglected. T hus all o f the proposed models are closed in 
that the drug accumulates at the receptor site. It was the 
purpose of the present study to investigate, in the most 
elem entary fashion, the impact of pharm acokinetics on 
structure-activity relationships.
Closed model
The simplest example of alternating aqueous and lipid 
phases consists of an aqueous-lipid-aqueous sequence as 
shown in Fig. 1. T he aqueous to lipid rate constant is k, 
and the lipid to aqueous rate constant is k2. Assuming 
that the volumes o f the three com partm ents are equal, 
the rate equations governing the drug concentralion in 
the three com partm ents are
dCi 
= -k ,G | + k7C2 




— k2C2 -  k|C3
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Introducing a reduced time, t = k3t, and dimensionless 
concentrations, Cj' = C|/C|(0), C2' = Cj/C,(G) and 
Gj' =  CVC((0) where C|(0) is the concentration of drug 
in compartment 1 at time zero, equations (I) become
dC!
= - p c ;  + a  (2)
dCj
= PC| -  2Q + PQ
747
dCJ
dx = CJ -  PCi
where P = k,/k2 represents the drug’s lipophilicity. If 
the drug is introduced as a bolus into compartment 1 the 
solution for C /,  the proposed receptor site, is
C '(t) _ | 2  + Pe (p+2|I- ( P  + 2)e *'} 
2(P + 2) (3)
(4)
If the drug equilibrates with the receptor site in a time 
much shorter than that required for distribution equilib­
rium with other tissues and for drug elimination, then 
the closed model, under the pseudo steady-state 
hypothesis, is a good representation of the in vivo 
situation: otherwise it is not.
A q u e o u s Lipid A q u e o u s
F ig ,  I .  T h r e e  c o m p a r t m e n t  c lo s e d  m o d e l  o f  a l t e r n a t i n g  
a q u e o u s - l i p id  phases.
T — T 
o 32 2
I
This equation has been extensively studied by Cooper et 
al (1981) and they found that for any fixed value of t 
there is a value of P for which C3'(t) is maximal. The 
results of these studies are summarized in Fig. 2 which 
shows the relationship between optimal lipophilicity, 
Popl, and sampling time, t. It can be seen that as the 
sampling time becomes longer the optimal lipophilicity 
decreases. When the variables are transformed back 
into their original units it becomes apparent that for 
each combination of t  and Pa|), there is an infinite set of 
values for k,, k2 and t which satisfy the relationships 
Pup. = k,/k2 and t = k2t.
There are two problems associated with this model. 
Firstly the sampling time is arbitrary and consequently 
so is the optimal lipophilicity. Secondly, the model is 
closed in that the ultimate concentration in compart­
ment 3 decreases monotonically as a function of P, viz
Fig. 2. Optimal lipophilicity, P01„, as a function of sampling 
lime, x, for a three compartment closed model.
Open model
The previous model can be made open by the inclusion 
of an exit rate constant, k, from compartment 1 as 
shown in Fig. 3. Although the model is not mammalian 
in the sense of usual pharmacokinetic models, it is the 
simplest open model which shows parabolic behaviour. 
The equations for this model are
^ - P C i  + C ' , - k 'C i
^  =  PCi -  2Q  + PC( 
dx
* 2  = C2-  PCi
d t
where k' = k/k2. The solution for Ct is
(5)
rcV
CJ = P I —
( A , - \ 2)(X ,-L ») (A2-A ,)(X 2-A ,)
(6 )
Where X, are the roots of the cubic equation
V  +  (2P + k' + 2)X2 + (P2 + 2P +
k'P + 2k')X + k'P = O (7)
Simulations using equation (6) for k' =  1 and various 
values of P demonstrate that there is an optimal value 
for P for which the peak concentration is maximal (sec 
Fig. 4). If the peak concentration is equated to peak 
response this means that there is a parabolic relation­
ship between response and lipophilicity.
Further simulations confirmed this finding. The effect 
of lipophilicity on peak concentration in compartment
748 C O M M U N ICA TIO N S





F ig .  3. Three compartment open model.
3, for several values of k', is shown in Fig. 5. The 
bilinear nature of the curves is evident. It can be seen 
that as k increases the optimal lipophilicity also 
increases at the expense of the peak concentration, 
which decreases. This behaviour is summarized in Fig. 
6. As with the closed model there is an infinite set of 
values of the variables k,, k2 and k, satisfying the 
relationships Pot„ = k,/k2 and k' =  k/k2, corresponding 
to any given combination of k1 and Popl.
Discussion
Two variations of the open model were studied. Firstly 
elimination from compartment 3 was considered and 
secondly a restraint was placed on the rate constants, k.
P=2
015-
0 1 - P = 0  25
005—
0 2 6 e 10A
T
F ig .  4. Effect of lipophilicity, P, on the concentration (C3)- 
time (x) profile in compartment 3 of a three-compartment 
open model. The elimination rate constant, k', is equal to 1.
and k2. There is some evidence (Lippold & Schneider 
1975; Van de Waterbeemd et al 1980) that, far from 
increasing to infinity, these rate constants reach limiting 
values. One possible explanation is that, when the rate 
of transfer between the two phases becomes so rapid, 
the rate limiting step becomes not the transfer, but 
diffusion to the interface. Consequently we tried 
imposing the following restrictions on the rate constants 
(similar constraints were used by Van de Waterbeemd 
et al 1980)
where a and b are constants. These two variations on the 
basic model produced quantitative changes but the 
parabolic behaviour was still retained. Unlike previ­
ously, when the constraints of equation (8) are applied, 
to each combination of k' and PopI there corresponds 
only one set of values for the variables k^ k2 and k.
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F ig .  5. Effect of lipophilicity, P, on peak concentration in 
compartment 3 (C3' max) of a three-compartment open 
model as a function of elimination rate constant, k'.
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F i g .  6 . Optimal lipophilicity, P„pl, as a function of 
elimination rate constant, k \  for a three-compartment 
open model.
a definitive model which would relate molecular struc­
ture to pharmacological activity. Instead we raise 
several issues which, we feel, have been treated 
inadequately. The validity of the model herein des­
cribed and that of previous models is not established by 
the fact that they predict parabolic structure-activity 
relationships. In order to define a structurally valid in 
vivo model detailed pharmacokinetic experiments are 
needed: preferably on a homologous group of com­
pounds. From the results of these experiments it would 
be possible to define the effect of structure, perhaps in 
the guise of a parameter such as lipophilicity, on 
fundamental pharmacokinetic parameters such as clear­
ance and volume of distribution. However it would then
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be necessary to separate the effect of structure on a 
drug’s pharmacokinetics and its pharmacological 
response. Pharmacological activity is related to the drug 
concentration at the receptor site whereas most phar­
macokinetic studies are restricted to measurements of 
drug concentration in blood or plasma. Consequently it 
is often difficult to relate the pharmacokinetics of a drug 
to its pharmacodynamics. In the simplest situation 
pharmacological response is directly related to blood or 
plasma concentration. However, if the receptor site is in 
a tissue which does not rapidly equilibrate with blood it 
may not be possible to separate structural effects 
associated with pharmacokinetics from those associated 
with pharmacological response.
At the present time detailed experiments such as 
those described above do not exist. Consequently we 
have not elaborated on the simple model discussed in 
this paper but we believe it to be a more realistic 
representation of the in vivo situation than previously 
described closed models.
Since the paper was submitted a comprehensive review 
of the existing literature on structure-pharmacokinetic 
relationships has appeared (Seydel & Schaper 1982).
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Some O bservations on the W ATR M ethod 
W ater Suppression at 80 M H z
Noel A. Dickinson, Ronald E. Lythgee and Roger D. Waigh*
D e p a r t m e n t  o f  P h a r m a c y ,  U n i v e r s i t y  o f  M a n c h e s t e r ,  M a n c h e s t e r  M 1 3  9 P L ,  U K .
The WATR method for water suppression in 'H NM R spectroscopy has been evaluated at 80 M H z, using both 
ammonium and guanidinium chloride, with and without the addition of buffer salts. The pH of maximum effect has 
been found to depend on field strength and to be markedly affected by buffer salts, particularly phosphates. Provided 
that the pH is carefully controlled the method is simple and effective.
k e y w o r d s  'H  N M R  W A T R  W a t e r  s u p p r e s s i o n  A m m o n i u m  c h l o r i d e  G u a n i d i n i u m  c h l o r i d e  B u f f e r  s a l t s
It has been shown that effective water suppression in 
proton NMR spectra can be achieved using ammonium 
chloride as a relaxation enhancer.1 Chemical exchange 
between water and the added reagent results in consider­
able shortening of the spin-spin relaxation time of the 
exchanging protons: a Carr-Purcell-Meiboom-Gill 
spin-echo sequence then selectively removes the water 
signal, provided that the cumulative delay is sufficient.
Our results with ammonium chloride confirm that the 
effect is highly pH dependent. However, our experiments 
at 80 MHz suggest that the greatest effect occurs at ca 
pH 5 in unbuffered solutions, unlike the results of the 
original authors at 360 MHz, where the greatest effect 
was observed at ca pH 6.5. 1
We have also tested the hypothesis that other selected 
nitrogenous compounds will show effects similar to those 
of ammonium chloride. Of the relatively simple 
analogues, guanidine salts appeared to offer two possible 
advantages, since on a molar basis the guanidinium ion 
has two more exchangeable protons than the ammonium 
ion and a much higher pKa value2 of 14.46 in water at 
25 °C compared with 9.3 for ammonium. Guanidinium 
might therefore be expected to be more potent on a 
molar basis and possibly to have a different pH of 
maximum effect. We have also examined the effects of 
urea, which is present naturally in urine samples. When 
this work was nearing completion, a detailed account 
of the use of guanidinium chloride and hydroxylamine 
hydrochloride appeared.3 In this report we have there­
fore concentrated on those aspects of our work which 
complement the results of the other authors.
As is shown in Fig. 1, guanidinium chloride was 
slightly more effective at 80 MHz than ammonium 
chloride on a molar basis. There was a marked difference 
in the pH of maximum effect, however, that for 
guanidinium occurring at ca pH 7 when an 80 MHz 
spectrometer was used. Again, there is evidence for field 
dependence of the pH for maximum effect from some 
results obtained for comparison at 500 MHz, where the 
maximum effect was obtained at ca pH 8 (Fig. 2).
One further difference between the two reagents emer­
ged when buffer solutions were used to stabilize the pH
*  A u t h o r  t o  w h o m  c o r r e s p o n d e n c e  s h o u l d  b e  a d d r e s s e d .
for ammonium chloride solutions. Unlike guanidinium 
chloride solutions, different buffers with ammonium 
chloride produced discontinuities in the plot of log T2 
against pH when the buffers were used in their normal 
ranges (phthalate buffer in the pH range 4.2~6.2, phos­
phate at pH 5.0-8.0 and borate at pH 7.8-9.2). Use of
cno
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buffer solutions beyond their normal ranges showed that 
the apparent discontinuities were caused by differences 
in the pH of maximum effect (Fig. 3).
Various observations may be made concerning the use 
of guanidine hydrochloride to suppress the water signal. 
Guanidine is such a strong base that the natural pH of 
solutions of its salts is close to pH 7, and little adjustment 
of most solutions is required to reach the pH of 
maximum effect at 80 MHz. Since guanidine is for prac­
tical purposes completely protonated at pH 7, the 
observed relaxation effect must occur with the 
guanidinium cation. This is the dominant species over 
the whole of the aqueous pH region, so the pH depen­
dence of the effect must arise from interactions between 
the water and the solute rather than from the solute 
alone.
The use of mixtures of reagents has been recommen­
ded3 in order to widen the pH range. We can confirm 
that this is effective (Fig. 4) but note that good water 
suppression was achieved without buffer over the range 
pH 5-7; at higher field the reported effective range3 for 
a mixture of these two salts was pH 6-9.
An example of the use of guanidine hydrochloride to 
suppress the water signal at 80 MHz is given in the 
spectrum of procaine hydrochloride (Fig. 5). The 
methylene protons adjacent to the ester oxygen can be 
clearly seen, even though they lie very close to the water 
resonance frequency. The method is particularly useful 
at low field owing to the problems encountered with 
other methods of water suppression, despite the rela­
tively small reduction in T, compared with high field 
(Fig. 2).
Urea proved to be less effective as a relaxation enhan­
cer than either ammonium or guanidinium chloride and 
had little effect on relaxation produced by the other 
reagents. It may be preferable to hydroxylamine for
3 4 S 6 7 B 9
p H
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a m m o n i u m  a n d  g u a n i d i n i u m  c h l o r i d e  ( e a c h  0 .2 5  m) i n  u n b u f f e r e d
s o l u t i o n .
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water suppression at low pH values since urea is not 
toxic.
EXPERIMENTAL________________________________
The experiments were carried out on a Brulcer WP80 
NMR spectrometer at 35 °C, except for those at 
500 MHz, which were obtained on a Brulcer AM 500 
instrument at 25 °C. Solutions made with distilled water 
were adjusted to the required pH before adding sufficient 
deuterium oxide for an internal lock and adjusted to 
volume. The CPMG pulse sequence employed echoes 
of 1 ms duration. A spectral width of 1500 Hz was used 
throughout. Digital data printouts were used to find T2 
by least-squares regression analysis. The magnitude of 
T2 is affected by other factors such as the oxygen con­
centration; solutions made with boiled distilled water 
gave longer relaxation times but did not differ in the pH 
of maximum effect.
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Antibacterial Action of 2-BiT>mo-2-Nitropropane-l,3-Diol (Bronopol)
JULIA A. SHEPHERD, ROGER D. WAIGH, a n d  PETER GILBERT*
Department of Pharmacy, University of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom 
R e c e i v e d  1 9  F e b r u a r y  1 9 8 8 / A c c e p t e d  2  A u g u s t  1 9 8 8
Patterns of growth inhibition of Escherichia coli in the presence of 2-bromo-2-nitropropane-l,3-diol 
(bronopol) indicate a period of biocide-induced bacteriostasis followed by growth at an inhibited rate. The 
length of the bacteriostatic period, but not the subsequent growth inhibition, was reduced by the addition of 
excess cysteine. Patterns of growth inhibition were unaffected by catalasc or superoxide dismutase. The 
bactericidal concentrations (100 to 500 p.g/nil) were considerably in excess of the MIC (13 p.g/ml) and generally 
produced first-order reductions in viability. Bactericidal activity was considerably reduced by anoxic 
conditions and by the presence of catalase or superoxidc dismutase. Results indicate that there are two distinct 
reactions between bronopol and thiols. Under aerobic conditions, bronopol catalytically oxidizes thiol- 
containing materials such as cysteine, with atmospheric oxygen as the final oxidant. By-products of this 
reaction are active oxygen species such as superoxide and peroxide, which are directly responsible for the 
bactericidal activity of the compound and for the reduced growth rate after the bacteriostatic period. The latter 
effect probably results from the oxidation of intracellular thiols such as glutathione and cysteine. Catalytic 
oxidation of thiols in the presence of excess thiol leads to the creation of an anoxic state. Under these conditions, 
the slower reaction with thiols, which consumes bronopol, predominates. Consumption of bronopol by its 
reaction with thiols, without the involvement of oxygen, leads to the eventual removal of bronopol from treated 
suspensions and the resumption,of growth.
2-Bromo-2-nitropropane-l,3-diol (bronopol) has a broad 
spectrum of antibacterial activity (12) and is widely used, at 
concentrations of up to 0.1% (wt/vol), as a preservative for 
pharmaceutical and cosmetic products (4, 15). Previous 
studies o f the mechanism of action of bronopol all conclude 
that the antibacterial activity of bronopol relates to its 
interaction with essential thiols within the cell (3, 16, 18). 
Such interaction is thought to lead to the oxidation of thiols 
through a radical anion intermediate (11). Unlike other 
thiol-interactive antimicrobial agents, bronopol possesses 
significant bactericidal activity that cannot be explained 
solely in terms of thiol oxidation.
This paper examines the hypothesis that separate actions 
are responsible for the growth inhibitory and bactericidal 
activities of the compound.
MATERIALS AND METHODS
Organisms, chemicals, and culture maintenance. Esche­
richia coli ATCC 8739 was used throughout the study. 
Cultures were maintained on nutrient agar (Oxoid CM 3) 
slopes at room temperature in the dark after incubation at 
35°C. 2-Bromo-2-nitropropane-l,3-diol (bronopol) was ob­
tained from the Boots Chemical Co., Nottingham, England. 
Catalase, superoxide dismutase, cytochrome c, cysteine, 
cystine, cysteine hydrochloride, and cystine dimethyl ester 
were obtained from the Sigma Chemical Co., St. Louis, Mo. 
All other reagents were of the purest available grade obtain­
able from BDH, Poole, England.
Growth inhibitory activity. To a series of Erlenmeyer 
flasks (250 ml) containing 98 ml of chemically defined simple 
salt medium (1) were added 1-mi portions of a similarly 
grown overnight culture. The flasks were shaken in an 
orbital incubator (35°C, 200 oscillations per min), and optical 
density measurements at 470 nm (E470 nm) were made at 
15-min intervals. When the cultures were in the logarithmic
* Corresponding author.
phase of growth and E470 nm was 0.15, various concentra­
tions of a bronopol solution were added (1 ml). Growth was 
monitored in the flasks by optical density measurements for 
a further 2 h. In selected experiments, cysteine was added at 
various times following the addition of biocide to give molar 
ratios of cysteine to biocide of 10:1 and 1:1. In other 
experiments, catalase (50 U/ml) or superoxide dismutase (60 
U/ml) was added simultaneously with bronopol. Experi­
ments were performed in duplicate.
Preparation of washed cell suspensions. Erlenmeyer flasks 
(250 ml) containing 100 ml of a chemically defined simple salt 
medium (1) were inoculated from nutrient agar slopes and 
incubated at 35°C in an orbital incubator (200 oscillations per 
min) for 16 h. The cells were harvested by centrifugation 
(10,000 x g, 15 min, 35°C), washed twice in sterile saline 
(0.9%, wt/vol), and suspended to an appropriate optical 
density in phosphate-buffered saline (pH 7.0, 0.1 M). Sus­
pensions were used within 1 h of preparation.
Bactericidal activity. Washed suspensions of E. coli (19 ml, 
5 x 108 cells per ml) in Erlenmeyer flasks (100 ml) were 
equilibrated at 35°C in an orbital incubator (200 oscillations 
per min) for 30 min prior to the addition of biocide (1 ml). At 
appropriate times, 1-ml portions were removed and serially 
diluted in thioglycolate medium (Oxoid CM173). Suitable 
dilutions (0.1 ml) were spread on the surfaces of. triplicate 
predried (50°C, 30 min) nutrient agar plates. Viable counts 
were determined following incubation of the plates at 35°C 
for 16 h. Preliminary experiments confirmed that dilution (1: 
10) of bronopol, at the concentrations used, in thioglycolate 
medium completely neutralized the bactericidal effect. Ex­
periments were repeated at various temperatures at pH 7.0 
and at various pH values at 35°C. Selected experiments were 
performed in the presence of catalase (100 U/ml) or super­
oxide dismutase (200 U/ml) or under anoxic conditions 
obtained by flushing the culture media with nitrogen before 
inoculation and performing the experiment in static tubes 
sealed from the atmosphere by a layer of light liquid paraffin.
Chemical analyses. Chemical analyses of the reaction
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products of bronopol-thiol mixtures were conducted by 
performing the reactions in 5-mm-diameter nuclear magnetic 
resonance (NMR) tubes and obtaining lH and 13C spectra by 
using a Fourier transform NMR spectrometer at 80 MHz 
(Bruker WP80 SY). Proton and two-dimensional XH-13C 
(HETCOR) spectra of isolated reaction products were ob­
tained by using a 300-MHz, Fourier transform spectrometer 
(Varian XL-300). Infrared and mass spectroscopy were 
conducted with a Pye Unicam SP 3-300 spectrometer and 
Kratos MS 25 spectrometer, respectively.
Thin-layer chromatographic (TLC) analysis of reaction 
products was conducted on Kiesel gel 60 TLC plates (Ma- 
cherey-Nagel, Duren) with butan-l-ol-glacial acetic acid- 
water (60:15:25). Plates were developed either with ninhy- 
drin in acetone (0.2%, wt/vol) (13) or with sodium carbonate 
solution (10%, wt/voi), followed by 0.7 N Folin-Ciocalteau 
reagent (14). The latter stain was superior for visualization of 
the bronopol spots.
Gas chromatographic (GC) analysis of reaction products 
was performed with a Hewlett-Packard 5840A gas chromato­
graph, 7671A automatic sampler, and 5840 GC terminal and 
an E301 silicone elastomer (10%)-celite column. Tempera­
tures were increased at 10°C/min up to 250°C. Peaks were 
detected by flame ionization.
RESULTS
Growth inhibition studies. After the addition of biocide (4 
to 20 pg/ml) to actively growing cultures of E. coli, growth 
immediately ceased. Bronopol-induced bacteriostasis per­
sisted for up to 90 min, and when growth was resumed, it 
was at a lower rate than that of the controls (Fig. 1). The 
length of the bronopol-induced bacteriostasis was propor­
tional to the applied biocide concentration, as was the degree 
of growth inhibition measured immediately after recovery 
from this bacteriostasis. Plots of growth rate inhibition after 
the induced bacteriostasis against bronopol concentration 
allowed estimates of the MIC to be made (13 pg/ml; Fig. 1).
The ability of thiols to neutralize and reverse the growth 
inhibitory action of bronopol was examined by the addition 
of cysteine to growth-inhibited cultures at various times after 
the addition of biocide (7 pg/rnl). Bronopol concentrations of 
one-half the MIC were used so that both activation and 
neutralization of the growth inhibitory effects might be 
observed. When the molar ratio of cysteine to bronopol was 
1:1, cysteine failed to alter the pattern of inhibition. How­
ever, at a 10:1 molar ratio the length of the induced bacte­
riostatic Reriod was substantially reduced provided that the 
addition of cysteine was made less than 40 min after that of 
the biocide. In no case was the inhibited growth rate 
following the shortened bacteriostatic period increased by 
the presence of a neutralizer (Fig. 2). The addition of the 
enzyme catalase or superoxide dismutase to the growth- 
inhibited cultures caused no change in the pattern of inhibi­
tion.
Bactericidal activity. Bactericidal activity was approxi­
mated to first-order kinetics for concentrations of bronopol 
greater than 100 p-g/ml (Fig. 3a). The compound had a 
concentration exponent of 0.9 (Fig. 3b) and a temperature 
coefficient (01O) of 2.9 (Fig. 3c), and activity increased with 
increasing pH (Fig. 3d).
Time-surviva! data were redetermined for bronopol at 500 
ixg/ml under anoxic conditions and under aerobic conditions 
in the presence of catalase and superoxide dismutase. All 
three sets of conditions significantly reduced the degree of 









FIG. I. Growth inhibitory activity o f bronopol towards E. coli 
ATCC 8739. (a) Cultures were grown in a simple salt, chemically 
defined medium until logarithmic phase and E470 nm of 0.15. Brono­
pol ( • ,  0 pg/ml; ■ , 5 p-g/tnl; A, 10 p-g/ml; V, 12.5 p.g/ml) was added, 
and growth was monitored as E470 nm for up to 2 h. (b) Plot of the 
inhibition o f growth rate relative to untreated controls after the 
biooide-induced bacteriostatic period versus bronopol concentration 
for the determination o f the minimum growth inhibitory concentra­
tion (13 p.g/ml).
under anoxia and in the presence of superoxide dismutase 
(Fig. 4).
Reactions of bronopol with thiols. The reactions of brono­
pol with cysteine, cysteine methyl ester, and glutathione 
were assessed in DzO in 5-mm-diatneter NMR tubes. The 
results of these studies were checked by TLC, and when 
necessary, larger scale reactions were conducted with a view 
to separate and identify the reaction products.
The results of previous TLC studies suggest that in the 
presence of air the major reaction product of cysteine and 
bronopol is cystine (16). This result was readily confirmed 
with equimolar amounts of the two reactants by using a 
combination of XH NMR and TLC, with the additional 
observation that consumption of cysteine was not accompa­
nied by any measurable loss of bronopol. Even with molar 
ratios of cysteine to bronopol of 10:1, the NMR signals for 
bronopol were clearly seen when the cysteine had been 
completely consumed. In the absence of bronopol, cysteine 
hydrochloride w$s essentially unchanged after several hours 
in solution in an NMR tube. With cysteine methyl ester, 
essentially similar results were obtained. In this case, the 
differences in the NMR spectra of the free bases of the thiol 
and disulfide were more marked, and the conversion was 
confirmed without the need for TLC. With the methyl ester,
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FIG. 2. Effect o f cysteine on the growth inhibitory activity of 
bronopol toward E. coli ATCC 8739. Cultures were grown in a 
simple salt, chemically defined medium until logarithmic phase and 
-^470 nm of 0.3. Bronopol (7 p-g/ml) was added to all cultures except 
the control (A), followed by cysteine (62 p.g/ml) at various times (O, 
0 min; B , 20 min; and □ , 40 min). ©, No cysteine. Growth was 










FIG. 4. Bactericidal activity of bronopol (500 p-g/ml toward 
washed suspensions of E. coli ATCC 8739 (□ ) in phosphate-buffered 
saline (0.1 M, pH 7.0) in the presence of catalase (# , 100 U/ml) or 
superoxide dismutase (H, 200 U/ml) and under anoxic conditions
(O).
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FIG. 3. Bactericidal activity of bronopol toward washed suspen­
sions of E. coli ATCC 8739 in phosphate-buffered saline (0.1 M). (a) 
Time-survival data determined at 35°C and pH 7.0. Bronopol 
concentrations: ®, 100 p-g/ml; O, 200 p.g/mi; ®, 300 pg/ml; □ , 400 
(cg/ml; and A, 500 pg/ml. (b) Plot of decimal reduction times 
following bronopol treatment (pH 7, 35°C) versus bronopol concen­
tration for the determination of the concentration exponent (0.9). (c) 
Effect o f temperature on the bactericidal activity o f bronopol (500 
pg/ml) at pH 7.0 (0IO = 2.9). (d) Effect o f pH on the bactericidal 
activity o f bronopol (500 pg/ml) at 35"C.
it was possible to make the solution alkaline and to extract 
the disulfide with chloroform. Comparison of the extract 
with an authentic sample confirmed that the disulfide was the 
sole significant reaction product.
At the relatively low field of 80 MHz, the reaction of 
bronopol with glutathione gave spectra with considerable 
areas of overlapping peaks that did not permit assignments 
to be made with confidence. However, comparison with 
spectra of authentic material suggested that glutathione was 
oxidized to the disulfide, as were cysteine and cysteine 
methyl ester. This result was readily confirmed by TLC. 
Again, the disulfide was the only significant reaction prod­
uct, with the bronopol remaining unchanged.
In the presence of air, the reactions of bronopol with all 
the above-mentioned thiols were extremely rapid even at the 
lower bronopol/thiol ratios and despite the relatively poor 
aeration that is expected in a 5-mm-diameter NMR tube. The 
most likely oxidant for consumption in these reactions is 
oxygen because the bronopol itself clearly plays a catalytic 
role. Oxygen consumption after mixing bronopol (50 p.g/ml 
in phosphate buffer, 0.1 M, pH 7.0) and cysteine (0.15 mg/ml 
in phosphate buffer, 0.1 M, pH 7.0) was assessed by con­
ducting the reaction in a metabolic chamber with an oxygen 
electrode (Rank Bros., Cambridge, United Kingdom) and a 
strip chart recorder. Immediately after bronopol addition, 
oxygen was rapidly consumed and a state of anoxia was 
achieved within 2 inin (Fig. 5).
In the absence of air, the reactions took a different course. 
Two observations were made in the NMR experiments. 
First, the bronopol was consumed; second, the reactions 
were considerably more complex than those observed in the 
presence of air. The reaction was considerably slower than 
that observed previously, with significant levels of cysteine 
remaining after 2 h when a bronopol/cysteine ratio of 1:10 
was used. In the case of cysteine methyl ester, there was 
also evidence from both NMR and TLC data for the forma­
tion of the disulfide, but this was no longer the exclusive 
product. In view of the complexity of the reaction, no 
attempt was made to follow the reaction with glutathione 
under anoxic conditions. Instead, cysteine methyl ester was 
used in a relatively large-scale reaction to allow the isolation 
of at least some of the reaction products.
m
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FIG. 5. Oxygen consumption following the interaction of solu­
tions o f bronopol (50 pg/ml in phosphate buffer, 0.1 M, pH 7.0) and 
cysteine (0.15 mg/ml in phosphate buffer, 0.1 M, pH 7.0) in a 
metabolic chamber with oxygen electrode. Arrow denotes time of 
bronopol addition, arb., Arbitrary.
When cysteine methyl ester hydrochloride (8.6 g) was 
treated with bronopol (10 g) in phosphate buffer at pH 7.0 
after removal of oxygen by bubbling nitrogen in, the solution 
became cloudy. After 2 days, a yellow solid and a yellow oil 
separated. The solid was collected by filtration, and the oil 
was removed by solvent extraction. The solid was insoluble 
in all common solvents. Mass spectrometry showed the 
sequential loss of 32 mass units, and simple chemical tests 
confirmed the solid to be sulfur.
The oil was a complex mixture, but flash chromatography 
followed by GC-mass spectometry and two-dimensional 
NMR allowed the identification of the most volatile compo­
nents. 'These components were two closely related isomers, 
which at first were difficult to separate on GC, and were not 
physically separable for NMR analysis. They were therefore 
examined as a mixture, and the NMR spectrum in CDC13 at 
300 MHz showed resonances that were assigned as follows: 
8 1.64, CH3; 8 1.81, CH3; 8 2.02, impurity; 8 2.82 to 3.31, a 
complex region of multiplets due to nonequivalent protons of 
CH2 coupled to CH; 8 3.67, 3.73, 3.74, and 3.75, four OCH3 
groups; 8 4.0, CH; and 8 4.32, CH. The ,3C NMR spectrum 
was easier to interpret and showed very clearly that the 
sample was a mixture of two very similar compounds. The 
spectrum showed the following resonances in CDCI3: 8 24.96 
(CH3), 27.78 (CH3), 38.53 (CH2), 39.62 (CH2), 51.99 (OCH3), 
52.64 (OCHj), 65.12 (CH), and 65.31 (CH). The multiplicities 
of hydrogen resonances (CH, CH2 and CH3) were deter­
mined by the DEPT pulse sequence.
A two-dimensional (HETCOR) NMR experiment con­
firmed the assignments and correlated the proton multiplets 
at 8 4.0 and 4.32 with the carbon resonances at 8 65.12 and 
65.31, respectively. The proton and carbon resonances for 
the methoxy groups correlated as expected. The carbon with 
signal at 8 39.62 correlated with multiplets and 8 3.3 and 2.8 
in the proton spectrum, and the carbon with signal at 8 38.53
H H
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FIG. 6 . Proposed structures for the anoxic reaction products of 
cysteine and bronopol.
H3 COOC N COOCH3  
C H - , /
COOCH3
h 3c
I W . H
\ - 4- H -HCOO CH3 J
-COOCH3
CH 3 -OOC 5-






N X O O C H 3
‘-Cfc m/z 204
FIG. 7. Proposed fragmentation pattern for the anoxic reaction 
products o f cysteine and bronopol subjected to GC-mass spectrom­
etry.
correlated with multiplets at 8 3.3 and 3.0 in the proton 
spectrum. The carbon resonances at 8 27.78 and 24.96 o f the 
remaining methyl groups correlated with proton resonances 
at 8 1.64 and 1.81, respectively.
These observations are entirely consistent with the cis and 
trans structures given in Fig. 6. The fragmentation pattern 
after GC-mass spectrometry was also consistent with the 
proposed structure^. Although there was no molecular ion, 
there was a small peak at m/z 204, representing the loss of a 
CH3 group, and the remainder of the anticipated fragmenta­
tion pattern was easily reconciled (Fig. 7). Structures for 
smaller peaks at m/z 119 and 87 have not yet been assigned.
The formation of thiazolidines has been observed when 
aqueous solutions of cystine are exposed to air for prolonged 
periods (5). Presumably, the reaction proceeds by the oxi­
dation of cystine to pyruvic acid and the condensation of 
pyruvic acid with a molecule of cysteine (Fig. 8), which is 
also formed by the breakdown of cystine.
In the present study, a reaction involving the methyl ester 
gave reaction products analogous to those depicted in Fig. 6. 
Presumably, bronopol acts as an oxidizing agent in the 
absence of oxygen, although no breakdown products of 
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FIG. 9. Absorption spectra o f cytochrome c (2 p.g/ml in phos­
phate buffer, 0.1 M, pH 7.0) alone (a) and following addition of 
bronopol (200 p-g/ml) (b) or cysteine (100 p.g/ml) (c) or the simulta­
neous addition of bronopol and cysteine (d).
Cytochrome c. '£he absorption spectra of cytochrome c (2 
|xg/ml in phosphate buffer, 0.1 M, pH 7.0 [Fig. 9a]) were 
determined with a Pye Unicam SP8-500 spectrophotometer 
following addition of bronopol (200 p.g/ml [Fig. 9b]) or 
cysteine (100 p-g/ml [Fig. 9c]) or both (Fig. 9d). The addition 
of bronopol alone caused no change in the cytochrome c 
spectrum, but the addition of cysteine caused a gradual shift 
in the spectrum, indicating the formation of the reduced form 
of cytochrome c (Fig. 9c). Simultaneous addition of brono­
pol and cysteine caused an immediate change in the cyto­
chrome c spectrum to that of the reduced form (Fig. 9d).
DISCUSSION
Chemical studies of the interactions of bronopol with 
cysteine, cysteine methyl ester, and glutathione demon­
strated that in the presence of air bronopol acts as a catalyst 
for the oxidation of thiol groups to disulfides, with the rapid 
consumption of oxygen. The observation that bronopol was 
not consumed in this reaction allows an extension of the 
reaction mechanism proposed by Stretton and Manson (16), 
according to which a radical anion intermediate is formed 
from bronopol during the conversion of cysteine to cystine
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and of glutathione to its disulfide (Fig. 10). NMR spectros­
copy is a more convenient and more informative technique 
for observing such reactions than TLC because it unambig­
uously shows that bronopol is not destroyed while thiol is 
consumed. In Cell suspensions, such catalysis leads to an 
alteration in the redox state, oxidation of glutathione to its 
disulfide, and inhibition of enzyme function and growth. 
These consequences of catalysis are evidenced by the im­
mediate cessation of growth on bronopol addition to actively 
growing cultures and the generation of anoxic conditions. 
The length of the induced bacteriostatic period depended on 
bronopol concentration and was shortened by the addition of 
exogenous thiols such as cysteine. This observation sug­
gested that there is a second slower reaction that did not 
require oxygen and that consumed or neutralized the brono­
pol within the cell. This neutralization occurred at a rate that 
depended on the concentration of accessible thiols. Presum­
ably, restoration of cellular function follows bronopol con­
sumption and occurs through the resumption of respiration 
and the reduction of glutathione disulfide to glutathione via 
glutathione reductase. Reductions in the rate of growth, 
relative to those of control cultures, following the induced 
bacteriostasis probably reflect irreversible damage to the cell 
caused by bronopol treatment, possibly through the genera­
tion of oxygen radicals (6) during the catalytic period (Fig. 
10) and from the continued diffusion of oxygen into the 
suspensions during bacteriostasis. When the slower reac­
tions of bronopol with thiols were examined by maintaining 
anoxia, a number of reaction products other than the disul­
fide were, indeed, produced and bronopol was consumed. 
The production of elemental sulfur in the reaction of brono­
pol with cysteine methyl ester indicates an oxidative degra­
dation of the cysteine derivative that is comparable with the 
slow autoxidation of cysteine observed in air (5). In this 
study, the oxidation of the thiol occurred in the absence of 
oxygen and presumably resulted in the chemical reduction of 
bronopol. The reaction was complex, and the observed 
products in this work should not be taken as reflective of the 
products formed in vivo under anoxic conditions.
The bactericidal activity of bronopol was expressed at 
concentrations greatly in excess of the MIC and was sup­
pressed by the absence of oxygen or the presence of catalase 
or superoxide dismutase. The estimated concentration ex­
ponent (0.92) agreed with that reported by Hurwitz and 
McCarthy (9). The activity of bronopol increased with 
increasing pH from 5.5 to 8.0. This result is consistent with 
the published data (17) and suggests that the presence of the 
thiolate anion contributes to the reactivity of the thiol (10). 
The enzymes superoxide dismutase and catalase scavenge
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FIG. 10. Formation o f radical anion intermediate from bronopol.
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peroxide and superoxide from suspension supernatants (8). 
The protection against the bactericidal activity of bronopol 
afforded by these enzymes suggests that the activity stems 
from the aerobic interaction and the generation of active 
oxygen species from oxygen diffusing into the suspensions 
during bronopol treatment. Such reactions would act as a 
continuous source of superoxide for as long as bronopol 
remained. The generation of superoxide by the aerobic 
reaction of bronopol with thiols was demonstrated by the 
reduction of cytochrome c by superoxide (Fig. 9) (2, 7).
The results therefore suggest a dual action of bronopol, 
with catalytic oxidation of accessible thiols being responsi­
ble for the growth inhibition and generation of free radicals 
causing cell death. The extent of killing reflects the number 
of free radicals generated from oxygen diffusing into the 
suspension during the biocide-induced bacteriostasis and 
therefore relates to bronopol concentration and the length of 
the bacteriostatic period.
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Peak Selection through Orthogonal Focusing 
R o g e r  D . W a ig h
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Received November 30, 1987; revised February 17, 1988
The majority of NMR spectroscopists have abandoned the off-resonance decou­
pling technique for determining the number of protons attached to each carbon in a 
l3C spectrum, in favor of techniques such as APT and DEPT which provide better 
signal-to-noise and greater clarity of presentation ( 1 ). A feature of both these tech­
niques is that CH2 signals can be obtained with opposite phase from CH and CH3 
peaks, thereby increasing the information content o f the spectrum. At relatively low 
field, however, there is a reasonable probability of peak overlap in a crowded spec­
trum which may cause confusion. At 20.1 MHz, for example, the ,3C spectrum of 
cholesteryl acetate contains two examples of complete and one partial overlap. If the 
overlapping peaks happen to have opposite phases, the nulling which results is very 
misleading.
It is possible, using DEP T, to achieve subspectra of individual CH, CH2, and CH3 
carbons by manipulation of data in memory. In theory this should overcome the 
overlap problem, but in practice the data manipulation is only convenient where 
the machine is supplied with suitable software, and the manipulated subspectra are 
sometimes ambiguous, depending on the quality of the original data; there are draw­
backs inherent in only presenting manipulated data. Eschewing manipulation, qua­
ternary carbons may be selected (2) or CH carbons alone may be obtained with 
DEPT. The technique described here gives “even” and “odd” subspectra as required 
but, unlike earlier ways of achieving this, results in good nulling of unwanted signals, 
uses only one memory block, and does not require data manipulation. By taking 
advantage of nuclear Overhauser enhancements and slow relaxation rates for quater­
nary carbons the “even” spectrum can usually be reduced to CH2 only. The “odd” 
spectrum provides useful support for DEPT, in cases where there is doubt.
The basis of the technique is the production of orthogonally focused signals for 
carbons with even and odd numbers of attached protons. With reference to the rotat­
ing frame (Fig. 1) following a 90° carbon pulse and comparing only CH and CH2 for 
simplicity, it is apparent that after a delay of 1 /4 ./the lines will have progressed as in 
(A). At this point 180° pulses for both 13C and 'H will result in double interchange 
of “fast” and “slow” components, so that after a further delay of 1 /4 7  the lines will 
have reached the position in (B) and will be focused. This point has been recognized 
as a means of producing a subspectrum of quaternary carbons only (3). It is possible 
to impose a further 90° carbon pulse (with either x or y  phasing) to rotate either the 
even or odd signals into the z  direction, giving (C). A delay of 1/2.7 reunites the
0022-2364/88 $3.00 306
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Fig. I. Diagrammatic representation of orthogonal focusing followed by selection o f “odd” or “even" 
multiplicities.
signal components as in (D ). A 180° 13C pulse followed by a further delay of I /2 ./  
with broadband 'H decoupling focuses the signals for recording, giving either a C 
+ CH2 or CH + CH) subspectrum depending on the phase of the second 90° car­
bon pulse.
Spectra obtained using both x  and y  pulses at stage B in Fig. 1 are shown in Fig. 2 
for limonene,
ocquire
( ® j  CH2 no s ig n a l
G -
acquire
along with the normal broadband-decoupled spectrum (a). Limonene is a good test 
of this kind of technique, since it contains sp3 CH, CH2, and CH3, sp2 CH and CH2, 
and quaternary carbons. The compound is also cheap, is readily available, and can 
be used almost neat. The quaternary carbon peaks in Fig. 2c can be virtually elimi­
nated by reducing the relaxation delay, or enhanced by increasing it.
In the rare instances of compounds where quaternary carbons undergo rapid longi­
tudinal relaxation, this observation does not apply and quaternaries may be observed 
as relatively intense signals owing to their minimal proton coupling and insensitivity 
to the J  values assumed in the sequence: such carbons are readily identified us­
ing DEPT.
Coupling constants which are different from the assumed value result in incom­
plete nulling owing to imperfect alignment of the unwanted signals in the z direction: 
the result is an out-of-phase signal of reduced intensity which is readily distinguished, 
and in practice the method is not unduly sensitive to differences between coupling 
constants. An analysis of unwanted residuals from misset delays shows that the inten­
sity of the unwanted lines has essentially a sin2 relationship to the difference in angle
3 9 0
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Fig. 2. Broadband-decoupled llC spectrum oflimonene using 90° pulses; (b) CH + CH:i subspectrum 
obtained using an a pulse at stage B in Fig. I; ( c ) C +• CH2 subspectrum obtained using y  pulse at stage B 
in Fig. 1. All three spectra were obtained at 20.1 MHz in absolute intensity mode with 24 scans, 2 s relax­
ation delay. In (b) and (c) 1 /4 J was set to 0.0017 s. The sample contained sufficient deuterochlorofonn 
for a lock signal and about 5% tetramethylsilanc; quadrature phase cycling was used throughout.
at the orthogonal focusing point from the desired 90”. As an example, for a carbon 
atom attached to one proton a ± 10% difference from the assumed 90° is calculated 
to result in a residual line intensity of only about 2%. The residual intensities are 
calculated to be greatest for methyl carbons, owing to the greater angular error on the 
outer lines when the coupling constant is poorly matched. It may therefore be best to 
set the delays to suit the coupling constants for sp 3 carbons, although in practice it 
does not matter very much. The efficient nulling for methine carbons contrasts with 
the situation in the normal ./-modulated spin-echo experiment (4) .
For routine application this technique has provided reliable support for DEPT, 
particularly for the occasional spectrum where the nulling produced by DEPT is 
worse than usual or where CH2 and CH3 chemical shifts are very close. The spectra 
retain nuclear Overhauser enhancements if the decoupler is kept on during the relax­
ation delay. As a general observation, for spectra obtained with the same pulse widths 
and relaxation delays, signal-to-noise is usually about 60% of that obtained in a 
broadband-decoupled spectrum.
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Mechanisms of Chemical Reactions with Biomolecules
R . D .  W a i g i i  a n d  P .  G i l b e r t  
Department of Pharmacy, University of Manchester, Oxford Road, Manchester 
M l3 9PL, UK
Chemical antimicrobial agents exert their effect upon bacterial cells either 
through irreversible covalent associations with biomolecular targets resulting 
in adjunct formation or through reversible interactions of a physico-chemical 
nature winch alter the physical chemistry of the target molecule. In the former 
instance, an understanding of the mechanisms and range of chemical interac­
tions between biocide and potential targets is crucial to the elucidation of the 
mechanism of action in the intact cell (Gilbert 1985). Traditional methods for 
the evaluation of the chemical mechanism of action of reactive antimicrobial 
compounds have tended to involve two separate stages following exposure of 
cells to tire agent. The first stage is one of separation and purification of the 
reaction products, often involving chromatography, and the second is the 
application of spectroscopy of various kinds to determine the molecular structure 
of the adjuncts. While these methods are still useful, it is becoming possible to 
carry out direct spectroscopic studies on systems in vivo and in vitro which are 
quicker, easier and more elegant and informative. The principal technique for 
such studies is nuclear magnetic resonance (NMR) spectroscopy, which in 
recent years has made substantial advances in sensitivity, with accompanying 
detailed improvements in experimental technique to enhance the information 
content of the spectra. Potential users of the technique, who have a basic 
grounding in N1VIR spectroscopy, will find the recent books by Sanders & 
Hunter (1987) and Derome (1987) particularly informative with respect to the 
latest developments. We propose to illustrate die usefulness of NMR spec­
troscopy as a tool for understanding the mode of action of biocides by 
reference to in vitro studies backed up by more traditional approaches (in the 
case of bronopol and uothiazolones) and also by reference to direct in vivo 
methodologies (for noxythiolin and taurolin).
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Bronopol (2-bromo-2-nitro-propan-l,3-diol)
Bronopol has a broad spectrum of antibacterial activity (Saito & Onoda 1974) 
and is widely used, at concentrations up to 0 .1%, as a preservative of pharma­
ceutical and cosmetic products (Croshaw el al 1964; Storrs & Bell 1983). 
There have been a number of studies of die mechanism of action of bronopol, 
all of which conclude that activity relates to interaction with essential thiols 
within die cell (Strctton & Manson 1973; Bryce cl al. 1978; Wong & Preecc 
1985). Such interaction is thought to lead to oxidation of thiols dirough a 
radical anion intermediate (Russell & Dancn 1967). Unlike odier thiol- 
interactive antimicrobial agents (e.g. thiomersal), bronopol possesses significant 
bactericidal activity which cannot be explained solely in terms of thiol oxidation.
Earlier studies on die mode of action have shown that in aqueous solution 
cysteine is rapidly oxidized to cysteine in the presence of bronopol (Stretton & 
Manson 1973). This experiment is easy to repeat, by using thin-layer chroma­
tography as the analytical method. In such systems, however, bronopol is not 
easy to detect and is even harder to quantify by this means. When die 
bronopol—cysteine reaction is carried out inside the spectrometer (Fig. 1) it is 
possible, not only to follow the disappearance of the cysteine and die forma­
tion of cystine but also to observe the bronopol quantitatively (Shepherd cl al. 
1988). The spectra in b ig. 1 show very clearly that die bronopol is scarcely 
consumed in diis reaction, while the cysteine is rapidly oxidized. When the 
reactions were monitored by oxygen electrode it was apparent that die reaction 
mixture, and indeed bacterial suspensions, were rapidly depleted of oxygen 
upon bronopol addition, irrespective of die bronopol; thiol ratio. The bronopol is 
therefore acting as an oxidative catalyst in die presence of oxygen.
In the absence of air (Fig. 2) the reaction is much slower and the bronopol 
disappears at a comparable rate to die cysteine (Shepherd cl al. 1988). While 
the reaction is far too complex to allow the direct determination of the 
structures of the reaction products, the experiment does indicate that different 
modes of action must apply under oxic and anoxic conditions. Subsequent 
work with cysteine methyl ester, involving solvent extraction and chromato­
graphic separation of die reaction products, showed that the thiol had been 
extensively degraded, under anaerobic conditions, by an oxidative mechanism 
to elemental sulphur. In this case the bronopol itself must be chemically 
reduced since there is no oxygen available.
Such chemical information is compatible with the observed biological 
effects of bronopol. Following the addition of bronopol to actively growing 
cultures of bacteria, growth ceases immediately for a period dependent upon 
die concentration applied. After this induced bacteriostasis, growth proceeds 
at an inhibited rate. Bactericidal concentrations (100- 500 pg/ml) are con­
siderably in excess of the minimum growdi inhibitory concentration (MIC; 
10-15 pg/ml). Bactericidal activity, but not growth inhibitory actions, may be
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Fit;. 1 80-MI 1/ *11 NMR spectra in deuterium oxide of; (a) bronopol, (b) cysteine, (c) cquimolar 
mixtures of bronopol (20 mg) and cysteine (17 mg) reacted, in air at room temperature, within the 
NMR tube, and (d) cystine. Note that (c) shows die continued presence of die bronopol doublet 
whilst cystine is a major product. (For a detailed assignment of the peaks readers are directed to 
Shepherd cl al. 1988.)
significantly reduced by the exclusion of air or inclusion of die enzymes 
catalase or superoxide dismutase in cell suspensions. It is apparent that 
bronopol undergoes two distinct types of reaction with accessible thiols within 
cells. Under aerobic conditions, bronopol catalyses the oxidation of thiols such 
as glutathione and cysteine to their disulphides, utilizing atmospheric oxygen 
as the oxidant and generating an anoxic state. Further oxygen diffusing into 
die system will be used catalytically in this manner so long as bronopol 
remains. Such reactions will bring about the immediate cessation of bacterial 
growth. By-products or intermediates in this aerobic reaction are active oxygen 
species such as superoxide and peroxide. These are direcdy responsible for
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Fig. 2. 80-MHz lH NMR spectrum of equiniolar mixtures of bronopol (20 mgr) and cysteine 
(17 mg) in deuterium oxide reacted in the absence of air at room temperature in the NMR tube. 
Note the loss of die bronopol doublet and the formation of a new product which does not 
resemble cysteine or cystine (sec Fig. l i ­
the bactericidal activity of the compound and for die reduced rate of growdi 
following the bacteriostatic period. Once an anoxic state has been created in 
the reaction mixture it will be maintained by the presence of unreacted 
bronopol and reduced thiols but it will allow the slower, consumptive reactions of 
bronopol to predominate until all die bronopol is consumed. Only then may 
enzymes such as glutathione reductase restore the redox state of die cell and 
allow growth to resume. Whether this occurs depends upon the extent of free 
radical damage incurred during the interim period.
i s o t h ia z o lo n e  B io c id e s
/rothiazolone biocides such as benshothiazolone (BIT), N-methyl f.wthiazolonc 
(MIT) and 5-chloro-N-methylm»diiazolonc (Cl—MIT) are widely used as 
environmental biocides. BIT has been shown to interact oxidatively widi 
accessible thiols and specifically to inhibit glucose transport in vivo (Fuller ct 
al. 1985). Addition of thioglycollate, mercaptoethanol, glutathione or cysteine 
at cquimolar concentrations to all dirce biocides totally neutralizes dieir in­
hibitory effects. For Cl—MIT activity is also reversed in vivo by die addition 
of valine or histidine.
Conventional spectral and analytical studies have suggested that the reac­
tions of BIT with thiols are as outlined below. Initial reaction leads to the 
formation of a disulphide conjugate. Reaction of the conjugate widi further 
thiols leads to the formation of a thiol dimer and a ring-opened form of 
the biocide which itself could serve as a further source of interactive thiol to
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give a dimerized biocide as an additional product (Fuller cl al. 1985). Cl—MIT 
and MIT are thought to act similarly to BIT but whilst BIT is a hypersensitizing 
agent, Cl—MIT is both a primary skin irritant (>25 |tg/ml; Weaver cl al. 1985) 
and Ames positive (Monte cl al. 1983). Cl—MIT has reported bactericidal 
activity, unlike BIT which is primarily bacteriostatic in action. Cl—MIT is 
antibacterial at considerably lower concentrations than BIT. The reasons 
behind these fundamental differences in activity were unclear until NMR 
spectroscopy studies were undertaken.
Reactions of BIT widi cysteine were examined by ’ IT NMR spectroscopy 
with a Bniker WP80 spectrometer and the reaction pathway suggested by 
Fuller cl al. (1985) confirmed. When similar studies were undertaken widi 
Cl—MIT, however, (Fig. 3) loss of the downfield proton peak indicated ex­
change with D20  and suggested that die ring-opened form of the biocide 
could tautomerize, to give a highly reactive thio-acid chloride.
Tautomerization
Formation of the thio-acid chloride in vivo would explain die apparendy 
anomalous toxicological and antimicrobial activity of die chlorinated nothin-- 
zolone in diat it would possess a far higher reactivity than the parent molecule.
Noxythiolin and Taurolin
Investigations into these and odier ‘masked formaldehyde’ antibacterial agents 
can be conceptually separated into those studies which deal with the nature ol 
the active antibacterial form and those dealing with the detoxification processes 
possessed by die organism. In both cases the critical experiments have been 
conducted using NMR spectroscopy, cither for direct observation of chemical 
equilibria, for which it was superior to alternative methods, or for in vivo 
observation of metabolites, a task for which NMR is uniquely suited.





1'lG. 80-Mllz ' I I  NMR spectra of; (a) 5 -chloro-N-methyl uodiiazolone, and (b) equimolar 
mixtures of 5-choloro-N-mcdiyl twthiazolone (Sing) and cysteine (10mg) in deuterium oxide 
reacted al room temperature in the NMR tube. Note the loss of the downfield proton of 
5-chloro-N-mediyl uothinzolone indicating exchange with die I)20  solvent and therefore 
isomerization.
f o r m a l d e h y d e - p r o d u c i n g  a n t ib a c t e r ia l  a g e n t s ,  t h e  o v e r a l l  s im p l i f i e d  e q u a t io n s  
f o r  t h e ir  a q u e o u s  d e c o m p o s i t i o n  b e in g  a s  d e s c r ib e d  in  d i e  f o l l o w i n g  s c h e m e s .
CHsNHCNHCHjOH
Noxythiolin
CH3NHCN H2 I HCHO
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2 H?NCH2CH2S 0 2NH? i 3 HCHO
Taurolin
A simple chemical experiment (Gidley cl al. 1981; Gidley & Sanders 1983) 
demonstrates an important difference in the chemical behaviour of the two 
compounds. Sodium cyanoborohydride is a reducing agent which is reasonably 
stable in aqueous solution, and which reacts slowly with formaldehyde to give 
methanol. (It should be noted that formaldehyde exists largely as the hydrated 
form in aqueous solution.)
NaBH3CN
When a solution of noxythiolin is treated with reducing agent the only reaction 
is the slow reduction of formaldehyde to methanol. The reaction tends to 
show that noxythiolin is truly a source of formaldehyde as the toxic species 
and it is no surprise that Escherichia cnli survival curves, after exposure to 
noxythiolin solutions, are very close to those obtained with formaldehyde itself 
(Gidley & Sanders 1983). In contrast, treatment of taurolin solutions with the 
reducing agent gives almost quantitative conversion to an N-methyl inter­
mediate.
NaBH3CN
The methylene iminium ion R2N ' —CH2 is a more reactive species than 
formaldehyde towards hydride ions provided by the reducing agent, so that 
the reaction is chemically quite orthodox, proving die presence of the iminium 
ion. NMR spectroscopy provides a convenient means of following die reaction
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as it proceeds vvidiont the necessity for repetitious chemical analyses (Gidley 
el al. 1981).
We now have an explanation for the enhanced antibacterial activity of 
taurolin and for the increased antibacterial activity of formaldehyde in the 
presence of certain amines. 1'he iminium ion is likely to be more readily 
attacked than formaldehyde by the biological nucleophile, in an analogous 
manner to die attack by hydride ions, resulting in more rapid inactivation of 
die susceptible bacterial system. For systems in which the amine is added 
separately, the distinction can be made between weak and strong bases, in an 
exactly comparable way.
R,NH + HCHO ^  R2NCH2OH
Weak base
R?NH + HCHO ~ ~ T g T  R2NCH2OH R2N =  CH2 + H20
Strong base More toxic
In diese studies the major role of NMR spectroscopy is as an elegant, non- 
disruptive, simultaneous assay for formaldehyde and other reaction products 
or intermediates. An illustration of die extraordinary power of the method, 




This system does not produce iminium ions in great quantity but was none 
die less more effective than formaldehyde alone. Another NMR spectroscopy 
experiment showed that the above equilibrium was capable of producing 
naked (non hydrated) formaldehyde about 40 times more frequently dian a 
simple aqueous solution of formaldehyde alone, thus providing a feasible 
explanation for the enhanced antibacterial activity.
Metabolic studies
In order to study metabolic reactions involving potentially toxic species it is 
necessary to use concentrations below those which kill the cell. The pathways 
which are revealed are thus essentially detoxification processes and probably 
compete with those through which die antibacterial agent exerts its desired 
effects. Whedier comparable studies of the toxic reactions will ever be feasible 
remains to be seen.
;• ; i':
■' ;; :-;>a •
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In vivo "C A/M/? spectroscopy
While there is no room here for a general discourse on NMR spectroscopy, 
some explanation of die special attributes o f ' NMR spectroscopy will help 
to explain how the experiments with formaldehyde were conceived.
One of the most significant features of 1 3C NMR spectroscopy, compared 
to *H NMR as used in the work described previously, is dial I3C is a minor 
isotope, constituting only 1.1% of natural carbon. If die material whose 
metabolism is to be studied is labelled with a high concentration of I3C, the 
peaks for die added material ar e of greater intensity and can be studied widi 
minimal interference from background natural abundance carbon. In addition, 
the range of resonance frequencies for l3C is very wide, so that interference 
between peaks is less likely, even for chemically similar molecules, and the 
exact resonance frequency (chemical shift) is highly characteristic for any 
given position in a molecule, provided that pH is held constant. Given that 
carbon—carbon coupling is not a problem (owing to the low natural abun ­
dance), that each carbon resonance can be reduced to a single line, and diat 
efficient techniques are available for die determination of the number of 
protons attached to the labelled carbon, it can thus be seen that ,3C NMR 
spectroscopy is tailor-made for the problem in hand.
Formaldehyde metabolism by Escherichia coli
The work described by Sanders and co-workers (Hunter el al. 1984, 1985; 
Mason ct al. 1986) examines diis subject in great depth, and includes a con­
sideration of deuterium incorporation which can also be measured and pro­
vides further insight. The major findings, however, can be simply stated as 
follows.
A 13C spectrum of an F. coli suspension, Heated with ,3C-labellcd formal­
dehyde at a sublethal concentration, initially shows only one major peak, 
corresponding to 13CH2(OH)2, die hydrated form of formaldehyde, at 683.2 
(Fig. 4a). Three hours later there are five other peaks corresponding to 
medianol, formate and three rather similar products, namely propane-1,2 diol, 
propane-1,3-diol and glycerol (Fig. 4b), the latter identified with the aid 
of bacteria grown on l3C-labelled glucose. Subsequent experiments showed 
that the first-formed adduct is 5-(hydroxymethyl)-glutathione, formed non- 
enzymically widiin a very short time after formaldehyde addition.
SH SCH2OH
X  —  X / G,y ,H2°







Fig. 4. 100.6-MI Iz UC. NMR spectrum in deuterium oxide of a uon-aerated coli suspension 
(101 z cells/ml) initially containing 10 mmol/1 u C-lnbclIed formaldehyde, (a) Spectrum obtained 
during the first 20 tnin after formaldehyde addition, and (b) 3 h later. A total of 500 transients 
was collected, with a 2-s relaxation delay and 45° pulse width. (Reproduced with permission from 
Hunter el al. 1984.)
This glutathione adduct, widi a labelled 13C resonance at 8 6 6 .6 , remains until feT  
die one-carbon residue is disposed of by metabolism. There is no evidence 
for incorporation of the label into serine, methionine or other methyl groups, 
which effectively rules out die incorporation of diis exogenous formaldehyde 1% 1 
into the telrahydrofolate pool. Deoxygenation virtually abolishes metabolism, 
while aeration results in loss of label, presumably through oxidation to bicar- ^ 
bonatc and loss of carbon dioxide.
While the identification of metabolites such as methanol and formate plnfi
follows very simply from measurement of the chemical shift and determination 
of the number of protons attached to the labelled carbon, die identity of the t
similar three-carbon products is less easy to establish. The chemical shifts of 
die labelled carbons arc similar at 868.0, 63.9 and 59.8; all three of these have T  |
two attached protons with CH-coupling constants of about 140 Hz. All three 
are therefore consistent with the unit Rl3CH2OH. This problem was solved piT
quite elegantly by feeding die bacteria with glucose, uniformly labelled with 
L C at a level of 14.3%, compared to the 90% labelling of the formaldehyde.
In the spectra obtained it is therefore possible to distinguish carbons arising I S
from glucose (14.3% label) from diose arising from formaldehyde (90% | |y
label), and to infer the diverse origins of carbons with intermediate levels of 
labelling. The more immediate intention, however, was to allow the unident­
ified carbons, labelled from n C formaldehyde, to interact with their neighbours, I
which will now be seen in the spectrum. This reveals their chemical shift and 
gives a clue as to dteir chemical environment. This concept may be expressed 
as follows for propane- 1,2 -diol, one of the previously identified metabolites |¥%
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(* 0 9 0 %  label, °C=14% label). Using 12C glucose die UC NMR spectrum 
shows
HO*ClI2 -  CHOH -  CH3.
(CHOH-CI% is of low relative intensity) 
Using pardally C glucose shows
HO*CH, -  °CHOH "CM,.
*C and °C are coupled, i.e. they each cause splitting of the others’ signal. 
We therefore know die chemical shift of die carbon adjacent to *C and die 
number of protons attached to it; a great aid to identification. Similar arguments 
apply to glycerol and propane-1,3 diol, with some subdeties which cannot be 
expounded here.
While t3C NMR is ahnost ideal for studies of formaldehyde metabolism, 
there are limitations to the technique imposed mainly by the inherent lack of 
sensitivity associated with this nucleus. Even at the relatively high field strength 
used by Sanders and co-workers, spectrum accumulation normally took 20 min 
to give acceptable signal-to-noise. In a rapidly changing system this would be 
too slow. Nevertheless, it is likely that the use of NMR specnoscopy to in­
vestigate the mode of action of antibacterial agents will become more common 
and even more effective.
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C h e m i c a l  r e a c t i o n s  b e t w e e n  t h e  i s o t h i a z o l o n e  b i o c i d e s ,  N - m e t h y l i s o t h i a z o l - 3 - o n e  
( M I T ) ,  b e n z i s o t h i a z o l - 3 - o n e  ( B I T )  a n d  5 - c h l o r o - N - m e t h y l i s o t h i a z o l - 3 - o n e  ( C M I T )  
w i t h  c y s t e i n e  h a v e  b e e n  i n v e s t i g a t e d  b y  u .v .  a n d  N M R  s p e c t r o s c o p y .  A t  p h y s i o l o g i ­
c a l  p H  a l l  t h r e e  a g e n t s  i n t e r a c t e d  o x i d a t i v e l y  w i t h  t h i o l s  t o  f o r m  d i s u l p h i d e s .  
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r e d u c e d ,  r i n g - o p e n e d  f o r m  o f  t h e  b i o c i d e  ( m e r c a p t o a c r y l a m i d e ) .  I n  a n  a n a l o g o u s  
f a s h i o n  t o  t h e  i n i t i a l  r e a c t i o n  t h e  m e r c a p t o a c r y l a m i d e  r e a c t e d  w i t h  a n o t h e r  m o l ­
e c u l e  o f  b i o c i d e  t o  g i v e  b i o c i d e  d i m e r s .  N M R  s p e c t r a l  s t u d i e s  i n d i c a t e d  t h a t  f o r  
C M I T  t h e  m e r c a p t o a c r y l a m i d e  f o r m  is  c a p a b l e  o f  t a u t o m e r i z a t i o n  t o  a  h i g h l y  r e a c ­
t i v e  t h i o - a c y l  c h l o r i d e .  F o r m a t i o n  o f  m e r c a p t o a c r y l a m i d e  w a s  i n  a l l  c a s e s  h i g h l y  
p H - d e p e n d e n l .  A l c o h o l  d e h y d r o g e n a s e  w a s  i n s e n s i t i v e  t o  a l l  t h r e e  a g e n t s  b u t  w a s  
h i g h l y  s e n s i t i v e  t o  C M I T  w h e n  c o - a d m i n i s t e r e d  w i t h  d i t h i o t h r e i t o l .  C a p a c i t y  t o  
f o r m  a  t h i o a c y l  c h l o r i d e  f r o m  t h e  m e r c a p t o a c r y l a m i d e  i s  s u g g e s t e d  t o  a c c o u n t  f o r  
m u c h  o f  t h i s  e n h a n c e d  a c t i v i t y .  S t o p p e d - l l o w  s p e c t r o s c o p i c  s t u d i e s  s h o w e d  r a t e s  o f  
r e a c t i o n  w i t h  g l u t a t h i o n e  ( G S H )  t o  d i r e c t l y  p a r a l l e l  a n t i m i c r o b i a l  a c t i v i t y .  A d d i ­
t i o n a l l y ,  C M I T  w a s  a b l e  t o  r e a c t  d i r e c t l y  w i t h  b o t h  i o n i z a t i o n  s t a t e s  o f  G S H  ( p H  
7 - 1 0 )  w h i l s t  B I T  a n d  M I T  a p p e a r e d  o n l y  t o  i n t e r a c t  w h e n  t h e  g l u t a m y l - n i t r o g c n  o f  
G S H  w a s  c h a r g e d  ( p H  8 -5 ) .
Isothiazolone biocides such as benzisothiazol- 
one (BIT, I), N-methylisothiazolonc (MIT, II) 
and 5-chloro-N-methylisothiazolone (CMIT, III) 
are widely used as industrial biocides (Singer 
1976; Andrykovitch & N eihof 1987). Mixtures 
of CM IT and M IT (Kathon, Rohin & Haas 
Inc.) are also used in the preservation of cos­
metic products (Zeelie & McCarthy 1983; Law 
et al. 1984, 1987).
n-ch3 N -C H 5
Cl
r u m  
All three agents are strongly antagonized by 
exogenous thiol-containing agents and are
■f C o r r e s p o n d i n g  a u t h o r .
thought to interact oxidatively with accessible 
thiols, such as glutathione, within the cell 
(Fuller et al. 1985; Collier et al. 1990). W hilst 
BIT is a skin sensitizing agent, CM IT is both a 
primary skin irritant ( >  25 /ig/m l; Weaver et al. 
1985) and Ames positive (M onte et al. 1983). 
Earlier studies (Collier et al. 1990) also show  
that CMIT, but not BIT and MIT, is neutral­
ized by the addition o f  histidine and valine and 
produces patterns o f growth inhibition and 
associated m orphological changes which are 
reminiscent o f inhibition o f initiation o f D N A  
replication.
The chemical reactions o f M IT and C M IT  
with thiols have not been previously reported. 
Fuller et al. (1985), however, identified S-(2- 
carbamoylpheny lthio)-y-i,-glutamyl-L. - cysteinyl - 
glycine (VI, Fig. 1) as an initial by-product of 
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Fig. I. Reaction pathway proposed by Fuller (1986) 
for the interaction of glutathione (RSH) with benziso- 
thiazolone (I).
BIT and suggested that BIT reacted with most 
thiol-containing com pounds to form disulphide 
adjuncts. Further interaction with thiols caused 
the release o f oxidized thiol dimers and a 
reduced, ring-opened form of BIT (tner- 
captobenzamide, V, Fig. I). In an analogous 
fashion to the initial reaction with thiol the mer- 
eaptobenzam ide was able to  provide further 
sources o f thiol for the unreacted biocide to give 
BIT dimers (IV, Fig. I). Results described in the 
previous paper (Collier et at. 1990) suggest 
CM IT reacted differently from non-chlorinated  
isothiazolones such as BIT and that such differ­
ences might be associated with the special toxi- 
cological problems associated with this 
compound. The present paper reports on such 
chemistry.
Materials and Methods
C H E M I C A L S
Benzisothiazolone (Proxel, ICI pic Organics 
Division) was kindly donated by ICI pic 
Organics D ivision (M anchester, UK). 5- 
chloro-N-methylisothiazolone and N-methyl- 
isothiazolone were prepared according to the 
methods described by Lewis et al. (1971). G luta­
thione, N A D  and cysteine were obtained from 
Sigma and purified yeast alcohol dehydrogenase 
(ADH) from Boehringer Mannheim (FDR). All 
other reagents were o f the purest available 
grade and obtained from S D H  (UK).
N M R  S P E C T R O S C O P I C  S T U D I E S  O F  
t S O T H I A Z O L O N E / T H I O L  I N T E R A C T I O N S
N-M ethylisothiazolone (5 mg) and C M IT (5 mg) 
were allowed to react at room temperature with 
cysteine (10 mg) in deuterated water (DjO). 
Reactions were carried out in 5 mm NM R  
tubes. Cysteine was used instead o f G SH as a 
source o f thiol, as the interpretation of its NM R  
spectrum is less complicated. After 5 min, 
proton-NM R  ('H -N M R ) spectra were deter­
mined using a Bruker 80 M H z spectrometer.
A S S A Y  F. O R Y E A S T . A L C O H O L  
D E H Y D R O G E N A S E  A C T I V I T Y
Phosphate buffer (25“C, 50 mm ol/i, pH 7 0), 
ethylenediaminetetracedc acid (EDTA, 30 
mmol/l), N A D  (0-4 mmol/1) and purified yeast 
alcohol dehydrogenase (0-01 units) were mixed 
in a quartz cuvette. Reactions were started by 
the addition o f ethanol (0-2 ml, 96%), after pre­
incubation for 1 min with biocide (0 -2 0  //mol/l) 
and dithiothreitol (0-35 //mol/1). Preliminary 
experiments had determined that in the absence 
of biocide these conditions gave zero-order 
kinetics over an incubation period o f > 5  min. 
Reactions were monitored by the increase in 
optical density (A340 nm).
R E A C T I O N S  O F  G L U T A T H I O N E  W I T H  
I S O T H I A Z O L O N E  B I O C I D E S
u.v. absorption spectra (250-400 nm) were 
determined for solutions o f BIT (175 //mol/1), 
MIT (110 //mol/1) and CM IT (90 //mol/1) and 
also for mixtures (3 : 1 molar ratio, 
GSH : isothiazolone) of these solutions with 
GSH (phosphate buffer, 50 m m ol/l, pH 6 0 -8  0). 
Absorption maxima were observed at 300, 275 
and 272 nm for BIT, MIT and CM IT, respec­
tively. These did not alter with pH. On reaction 
with G SH , solutions o f BIT decreased in their 
absorption at 300 nm and gave new absorption  
maxima at 270 and 340 nm. Both o f the new 
peaks became more marked as pH increased to 




580 P. J. Collier et al.
and appropriate standards and showed that 
these spectra! peaks arose from the formation of 
a mercaptobenzamide (V, Fig. 1). In the present 
study arid that o f  Mattisek & Lchnguth (1987), 
MIT was seen to behave similarly with a new 
absorption maximum appearing al 300 nm, also 
corresponding to a mercaptoacrylamide. This 
pattern was not repeated by CM IT which gave 
distinctive peaks at pH 6 0  (245 and 300 nm) 
and pH 8 0 (265 and 305 nm). At physiological 
pH the peak produced at 305 nm was most 
prominent. Whilst it was unlikely that any 
observable product o f the C M IT reaction corre­
sponded to a m ercaptoacrylamide the product 
formed at 305 nm was selected as a suitable 
indicator of reaction rate for stopped-flow spec­
trometry.
Rates of reaction between GSH and the iso­
thiazolone biocides in phosphate buffer (50 
mmol/l; pH 7 10) were determined by stopped- 
flow spectroscopy (M odel SF-3A, Nortech  
Laboratories, Canterbury, UK.) and the tech­
niques described by Dawber & M oore (1980). 
The ionic strength o f the reaction mixtures was 
kept constant by the addition o f potassium  
chloride. Reactions were studied at 25“C under 
pseudo first-order conditions with isothiazolone 
concentrations kept constant (5 k 10 A mol/l) 
and very low in relation to those o f GSH  
(2-0 x  10 “ 2—I -6 x  10” 1 m ol/l) which were 
varied. Preliminary experiments indicated that 
at these values, isothiazolone concentrations did 
not influence reaction rates determined at 275 
nm (BIT), 300 nm (MIT) and 305 nm (CMIT). 
Buffers, containing EDTA (10 4 mol/l), used for 
stopped-flow experiments were bubbled with N 2 
for 5 min before use to minimize oxidative 
destruction o f G SH  during the studies. For 
stopped-flow studies, rate constants were 
average values taken from a minimum set o f  
four individual runs.
Results and Discussion
C H E M I S T R Y  O F  I S O T H I A Z O L O N E  B I O C I D E S  
W I T H  C Y S T E I N E
Proton N M R  spectra indicate that M IT (Fig. 
2a) reacts with cysteine to give a single reaction 
product together with som e residual unreacted 
cysteine. Chemical shift o f the C H 2 peak in the 
product (5 3-2-3-3) from that o f cysteine (<5 2-9
3-0) suggests that the products are simple
adjuncts with MIT (Fig. 2b) and analogous to 
structure VI (Fig. 1). This suggestion is sup­
ported by AM I (Dewar et al. 1985) and 
C N D O /2  (Pople & Beveridge 1970) calculations 
of charge distribution within M IT which show  
the sulphur as the most likely site for nucleo- 
philic attack (S, + 0  0209; C s , - 0  0004; N, 
- 0 1 7 0 8 ) .  N M R  spectra determined under 
similar conditions for C M IT (Fig. 4) were 
complex and indicated a number o f different 
reaction products which were not characterized 
further. Significantly, the resonance correspond­
ing to the 4' hydrogen o f CM IT (<5 6-24) was no 
longer apparent in the spectrum after reaction 
with cysteine. The results o f AM 1 (Dewar et al. 
1985) and C N D O /2  (Pople & Beveridge 1970) 
calculations o f charge distribution for CM IT  
suggest that both C 5 (+ 0 0 7 5 4 )  and the S— N 
(S, + 0  0453; N , - 0  175) bond are likely to be 
susceptible to nucleophilic attack. Attack at C 5 
would lead to loss o f chlorine and formation of
5 H 4  H
JL jA l





5'H  4 'H
x X X X X
o6 28 4
Chem ical shift (ppm )
Fig. 2. 'H-NMR s p e c t r a  f o r  ( a )  N -m e th y l-  
i s o t h i a z o lo n c  (II) a n d  (b) m ix tu r e s  o f  N -m e th y l-  
i s o th i a z o lo n e  (5 m g )  w i th  c y s te in e  (10 mg).
4 0 6
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Fig. 3. Proposed p a t h w a y  f o r  t h e  i n t e r a c t i o n  of 5- 
c h l o r o - N - m e t h y l i s o t h i a z o l o n e  (III) w i t h  c y s t e i n e  
(RSH)
P roducta stable G-S product, w ithout the possibility of 
exchange o f the 4'H with solvent (Fig. 4b).
The alternative reaction route is similar to 
that for M IT and BIT and involves nucleophilic 
attack at the S -N  bond to form a mixed di­
sulphide (VII, Fig. 3). Further reaction with 
cysteine would then, as before, lead to the 
release o f a mercaptoacrylamide (VIII, Fig. 3). 
In the case o f  CMIT, the mercaptoacrylamide 
would be unstable and tautomerize to give a 
thioacyl chloride (IX, Fig. 3) and loss o f the 
alkene proton (4'H) in N M R  spectra. Indeed, ab 
initio calculations, using the methods of Dewar 
et al. (1985) for the thioacyl chloride, show it to 
be the preferred tautomer with an energy state 
2-42-6-69 K cal/m ol less than that o f the mer­
captoacrylamide (VIII). Thioacyl chlorides are 
highly reactive chemicals and will provide 
strong electrophilic centres which would inter­
act not only with thiols but also with amines, 
water, etc. (Fig. 5). The existence o f thioacyl 
chlorides in vivo would be short-lived so their 
effects upon cellular proteins, nucleic acids, etc., 
whilst marked, would be severe only in the 
immediate vicinity o f their bioformation. Indeed 
formation o f  such acylating agents is likely to 
account for the increased antimicrobial activity 
and unexpected toxicity associated with Kathon  
and CMIT.
Absence o f a readily accessible thiol in the 
enzyme yeast alcohol dehydrogenase (A DH ) 
renders it relatively insensitive to classical thiol- 
interactive agents. If the especial activity o f  
CM IT is caused by activation to mercaptoacryl 
amide and subsequently to a thioacyl chloride,
C hem ical sh ift (ppm)
F i g .  4. ‘ H - N M R  spectra for (a) S-chloro-N-methyl- 
isothiazolone ( I I I )  and (b) mixtures o f  5-chloro-N- 
m ethylisothiazolonc ( S  mg) with cysteine ( 1 0  mg).
then activity of CM IT towards A D H  ought to 
be significantly increased by sim ultaneous incu­
bation with a source o f thiol.
D ithiothreitol provides a source o f thiol, as 
does cysteine, but without an associated amine 
which might otherwise quench the reactivity of 
thioacyl chloride. The effects of various concen­
trations o f CM IT (0-20  /tmol/1), M IT (0-2  
mmol/l) and BIT (0-0-5 mmol/l) on A D H  activ­
ity were assessed in the presence o f various con­
centrations of dithiothreitol (0-35  /rmol/1). In 
the absence o f dithiothreitol all three com ­
pounds were relatively inactive towards this 
enzyme (ID S0% 0-5-2  mmol/l). After pre­
incubation o f enzyme with isothiazolone and 
dithiothreitol, activity was enhanced signifi­
cantly (Fig. 6) for CM IT but not for MIT or 
BIT. The degree o f activation o f CMIT 
increased with increasing concentration of 
dithiothreitol.
4 0 7
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and since drug concentration was kept so low  as 
to be negligible
k ,[G S H ]
+  RSSR
Observed reaction rates (kob8) were derived from  
simple first-order reaction kinetics for BIT and  
MIT and, after correction for a steady upward 
drift in the absorbance at 305 nm with time for 
CMIT, over the time-course o f the stopped-flow  
experiment.
Pseudo-first-order rate constants for these 
reactions closely paralleled antimicrobial activ­
ity, being 20 times greater for C M IT  
(1 053 x 103/m ol/s) than for BIT (4-883 x  101/  
mol/s) and 100 times greater than for M IT  
(1-077 x lO '/mol/s). This relates to estimates of 
minimum growth inhibitory concentration o f 14 
and 18 pg/m l for BIT, 41 and 240 //g/m l for 
MIT and 0-5 and 0-1 ^tg/ml for CM IT towards 
Escherichia coli and Schizosaccharomyces pombe 
respectively (Collier et al. 1990).
Dependence of reaction rate upon pH in the 
range pH 7 -10  was determined at a single 
glutathione : isothiazolone molar ratio (2 0 0 : 1) 
as k„hs. Glutathione possesses seven different 
ionization states. Only two o f these involve thiol 
group ionization (D ouglas 1988). These ions 
have pKa values o f 8-93 (G SH [A ]) and 9-08 
and 9-28 (G SH fB]). Each o f these species is 
nucleophilic and this will lead to a com posite 
sigmoidal pH reaction rate profile (D ouglas 
1988) in the range pH 7-10. Reaction rate pH  
profiles for the isothiazolones (Fig. 7) clearly 
show bell-shaped curves for MIT and BIT and a 
com posite sigmoidal curve for CMIT.
The sigmoidal dependance o f kob5 for C M IT  
(Fig. 7c) gives a value o f pK„pp =  8-4. This is 
close to the value o f the pKa for the — SH  
group of G SH  (D ouglas 1988) and in line with 
attack by the G S~ form of glutathione on  
CMIT. Attack by G S ", as opposed to G S H , is 
comm on in reactions between GSH and other 
thiols (Douglas 1988). The bell-shaped curve for 
BIT (Fig. 7a) indicates that at least tw o ion­
izations are affecting the observed kinetics. By 
analogy with the other systems, the GS -  form is 
likely to be the kinetically reactive form o f  glu­
tathione. The rate decreases at higher pH indi­
cates that an additional feature is decreasing the 
rate at higher pH. The simplest explanation o f 
this is that BIT ionizes, according to equation  
(3), and that the attack by G S ' upon the conju-
Fig. 5. Proposed pathway for the interactions of 
thioacyl chloride (IX) with water, amines and thiols.
R E A C T I O N  O F  G L U T A T H I O N E  W I T H  
I S O T H I A Z O L O N E  B I O C I D E S
Rates o f reaction o f  the isothiazolone biocides 
with glutathione were monitored by stopped- 
flow spectroscopy at 305 nm. Numerical 
analysis o f the data collected by stopped-flow  
spectroscopy enabled determination o f first- 
order reaction rate constants (k ,), where:
kobs =  k.CGSHKdrug] (1)
CMIT concn. (/imol/t)
Fig. 6. Inhibition of yeast alcohol dehydrogenase by 
5-chloro-N-methylisothiazolonc when pre-incubated 
with various concentrations of dithiothreitol. O, zero; 
A, 8-5 //mol/l; □ ,  17 //mol/l and 35 //mol/l.
4 0 8
f k -  ^ H y
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decrease in concentration o f V by disulphide 
formation which is expected to become rapid at 
higher pH values as com monly found for thiol 
oxidations. T he disulphide does not absorb light 
at 305 nm and w ould not therefore directly con­
tribute to kobs.
5-chloro-N-methylisothiazolone does not give 
the rate decrease at higher pH values. This is 
probably because the mercaptoacrylamide in 
this instance (VIII) is rapidly destroyed by 
thiolysis and hydrolysis after rapid tauto- 
merization to the thioacyl chloride (Figs 3 and
gate base (below) is less than that upon BIT (I).
The rate o f reaction w ould then decrease at 
higher pH. However, MIT (II) with an n-C H 3 
site blocking such an ionization still has a bell­
shaped pH profile. We have also found that n- 
methylated BIT reacts similarly to BIT with a 
bell-shaped pH profile.
If the full rate equation were derived for Fig. 
1 it would contain k2 and k} . The amount of  
RSH reacting (i.e. GSH) would depend on its 
pKa (i.e. G SH  — GS ) but the reaction rate 
would also depend on the mercaptoacrylamide 
(V) and reflect its fate also. This species is the 
tautomer o f an unstable thioaldehyde where the 
tautomerism is highly likely to be acid : base 
catalysed. This was considered as a possible 
explanation o f the rate decreases at higher pH. 
NM R spectra (Fig. 2), however, show that the 
product o f the reaction, unlike that for CM IT, is 
not deuterium-exchanged at position 4 (a to the 
sulphur) indicating that keto : thioenol equili­
bration had not occurred for MIT nor BIT  
reactions. The decrease in rate at higher pH pre­
sumably reflects partitioning o f the mercap­
toacrylamide (k2 and k , processes) or the
This and the previous paper (Collier et al. 
1990) demonstrate the especial reactivity of the 
chlorinated isothiazolones (CMIT) and suggest 
possible interactions o f these at the level of  
D N A  synthesis. At physiological pH, interaction  
of thiols with the — S— N —  bond o f the iso­
thiazolone ring is likely to predominate in all 
cases. In the case o f C M IT this interaction leads 
to increases in biological activity, through the 
formation first o f a mercaptoacrylamide and 
subsequently a highly reactive thio-acyl chloride 
tautomer. Such a reaction mechanism might 
explain the reported Ames positivity and potent 
skin-sensitizing properties o f CM IT-containing  
compounds.
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C O M M U N IC A T IO N S
'H N M R  as an analytical tool for the investigation o f  hydrolysis rates: 
a m ethod for the rapid evaluation o f the shelf-life o f  aqueous solutions o f  
drugs with ester groups
a  a t :  J.  f e r d o u s ,  n o e l  A .  D I C K I N S O N .  RO GE R D .  w a i g h , *  Department o f  Pharmacy. University o f  Manchester. Manchester M 13 9PL, UK
Abstract -The rate o f  hydrolysis of esters o f  prim ary and secondary 
alcohols can be determ ined quickly and easily by 'H  N M R in 
aqueous solution, provided that the water signal is suppressed by the 
W A TR (W ater A ttenuation by T j Relaxation) method. T o evaluate 
this approach, Arrhenius plots have been constructed for hydrolysis 
o f acetylcholine, carbachol and atropine, and the effect o f  pH on the 
hydrolysis o f procaine has been determined over a limited range. The 
results agree well with literature values for rate constants.
T he ad v an tag es  and  d isadvan tages  o f  N M R  as an  analy tical tool 
are  well know n. A m o n g  the  m ain ad van tages  a re  the  high 
in fo rm a tio n  co n ten t o f  N M R  spectra  an d  the sim plicity  o f  
m ethod  developm ent co m p ared  w ith c h ro m a to g ra p h ic  p ro ­
cedures. A m ajo r co n sid e ratio n  in the ro u tin e  use o f  *H N M R . 
how ever, is the  necessity for the  so lvent to  have  a  low 'H  
co n cen tra tio n . F o r exam ple, if  the sam ple  has a high w ater 
c o n ten t, the  'H  signal from  the solvent will sw am p all the solute 
resonances. M any m eth o d s a re  availab le to  suppress the w ater 
signal, but alm ost w ith o u t exception p a rt o f  the  spectrum  
a ro u n d  the w ater frequency is lost.
A recent m ethod  (kn o w n  as W A T R , w ater a tte n u a tio n  by T 2 
relaxation) fo r w ater suppression  involves the use o f  a  chem ical 
agen t, usually an  am m onium  o r  guanid in ium  salt, to  accelerate 
transverse  (sp in-sp in) relaxation  o f  exchangeab le  p ro to n s  
(R abenstein  et al 1985; R abenstein  & F an  1986; D ickinson et al 
1987). W ith  a sp in-echo pulse sequence the w ater signal can  then  
be rem oved from  the spectrum  while so lu te  signals a re  in m ost 
cases relatively little affected. T his is o f  p a rticu la r  value where 
the so lu te  signals o f  in te res t lie under o r  close to  the  w ater peak. 
Such is the  case w ith e s te r groups, where th e  hyd ro g en  a ttach ed  
to  ca rb o n  adjacent to  oxygen resonates in th e  <54-5-5 region. F or 
stud ies o f  ester hydrolysis th is  resonance is m ost im p o rtan t, as it 
is closest to  th e  reactive cen tre  and show s the g reatest chem ical 
shift difference w hen b o n d  cleavage occurs. It is thus  the  ideal 
rep o rte r  g ro u p  for hydro lysis  studies, p rov ided  th a t th e  overly­
ing w ater signal can be selectively suppressed .
W e chose tw o types o f  experim ent to ev a lu a te  the  m ethod, 
b o th  having  lite ra tu re  resu lts  fo r co m parison . W e exam ined first 
the  effect o f  pH  on the hydrolysis o f  p ro ca in e  an d  then we 
o b tain ed  A rrhenius p lo ts  fo r the hydrolysis o f  acetylcholine, 
carb ach o l and  a tro p in e  a t  single pH  values.
Materials and methods
A so lu tion  o f  the este r (0-5%  w/v fo r acety lcholine ch loride, 1 % 
w/v fo r carbacho l ch lo ride, a tro p in e  su lp h a te  a n d  p rocaine 
hydroch lo ride) was p laced  in a  jacketed  vessel th ro u g h  which 
hot w ater was circu lated  to  m ain tain  th e  desired  tem pera tu re
* Present address and correspondence to R. D. W aigh, D epart­
ment o f  Pharmaceutical Sciences. University o f  Strathclyde, 204 
George Street. Glasgow G I IXW . UK
(see Tables 1-5). D istilled w ater was used as the solvent except 
fo r procaine w here p h o sp h a te  buffer (0 25 m ) w as em ployed. pH 
was ad justed  and  m ain tained  as requ ired  using  a pH  sta t, 
p um ping N aO H  (0-5 o r  TO m). Sam ples (3-5 m L ) were w ith­
d raw n  a t the beginning  and  a t m easured  in tervals, each sam ple 
being im m ediately frozen in liquid n itrogen  an d  kept frozen until 
required for m easurem ent.
Im m ediately before m easurem ent the sam ple was thaw ed a l  
room  tem pera tu re . T o  this so lu tion  w as ad d ed  a  so lu tion  (0-5 
mL) con ta in in g  th e  in ternal s tan d a rd , p h o sp h a te  buffer (OT m) 
where this w as n o t a lready  present, d eu te riu m  oxide (5% v/v) for 
an  N M R  lock signal an d  guanid ine hy d ro ch lo rid e  (1-0 m ) .  The 
so lu tion  was ad ju sted  to  pH  7-3 using 0-5 o r  TO m N aO H . For 
p rocaine and  ca rb ach o l the  in ternal s ta n d a rd  was acetam ide 
(0-05% w/v), b u t fo r acetylcholine a n d  a tro p in e  the s tandard  
used was sod ium  3 -trim ethy lsily lp ropanesu lphonate  (0-025 and 
0-05% w/v, respectively) to  avoid ov e rlap p in g  peaks in the N M R  
spectrum . T he  spectra  were o b tained  o n  a  Bruker W P80 
spectrom eter o p e ra tin g  at 80 M H z using  a s tan d ard  C arr- 
Purccll-M eiboom -G ill (C P M G ) sp in-echo sequence w ith a 
cum ulative delay  sufficient to  cause a d eq u ate  w a te r  suppression, 
in the range 0-5—1-5 s. F o r each sp ectru m  32 scans were 
accum ulated  for acetylcholine, c arb ach o l an d  a trop ine. 64 scans 
fo r procaine.
The integral fo r the  a p p ro p ria te  hydrogen(s) was obtained 
electronically, no rm alized  w ith reference to  the  in ternal s tan d ­
a rd , and  the log arith m  o f  th is  value p lo tted  against tim e to 
ob tain  the ap p a re n t first o rd er ra te  co n s ta n t, th e  slope being 
o b tained  by com puterized  curve-fitting. F o r  carb ach o l. a trop ine 
and  procaine the  p ro to n  ad jacen t to  the  este r oxygen was used to 
m o n ito r d eg rad a tio n  as described above. T h is  procedure  could 
also have been used fo r acetylcholine, b u t in this case there was 
sufficient sep ara tio n  betw een the acetyl g ro u p  chemical shifts 
before and  a fte r  hydrolysis for these to  be in teg rated  separately, 
giving a slightly  b e tte r  signal to  noise  ratio .
Results
T he first-order ra te  c o n stan ts  for este r hydrolysis a re  show n in 
T ables I -4 . A ctiva tion  energies and  frequency fac to rs a re  given 
in Table  5.
A typical p lo t o f  In p ro to n  integral ( fo r  the  p ro to n  adjacent to 
the ester oxygen) ag a in st tim e is show n fo r a tro p in e  in Fig. I. 
with exam ples o f  typical spectra  from  w hich the d a ta  were 
o b tained  in Fig. 2 an d  the resulting A rrh en iu s  p lo t in Fig. 3.
Discussion
Ester g roups a re  co m m o n  and  p red ictab le  sites o f  d ru g  d egrada­
tion  in aqueous so lu tio n . T he present m eth o d  offers a m eans of
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Table 1. First order rate const;ants for hydrolysis of procaine;at 80°C
and varying pH.
pH k(obs) (min ') log k s.d. log k*
8-0 1-893 x 10 2 — 1-723 0-080 —1-785
7-8 I -643 x 10 2 -1-784 0-064
7-7 1-672 x 10~2 -1-777 0-076
7-5 1-148 x10 2 -1-940 0-077 -2-047
7-0 4-638 x I O '1 -2-334 0-034 - 2  433
6-75 3-934 x 10 3 -2-405 0-062 -2-656
6-5 1 568x 10 ' -2-805 0-039 •2-890
6-0 5-589 x I 0 1 -3-253 0-048 -  3-376
5-5 3-167 x 10 4 -3-499 0-067 -3-871
50 4-514 x 10 5 -4-345 0-044 -4-369
* Catculated from the data of Higuchi et al (1950).
Table 2. First order rale constants for hydrolysis o f acetylcholine at 
pH 7 0.
Temperature (°C) k(obs) (min ') log k s.d.
45 3-766x 10 5 -2-424 0-064
so 6-803 x 10 3 - 2  167 0-047
60 2-298x I0"2 -1-639 0-068
65 3-760 x 10 2 -1-425 0099
Table 3. First order rate constants for hydrolysis of carbachol al pH
8-5.
Temperature (”C) k(obs) (min ') log k s.d.
70 4 219x10 3 -2-375 0046
80 1-538 x 10 2 -1-813 0-048
90 6-865 x 1 0 -2 - 1 163 0-071
Table 4. First order rate constants for hydrolysis of atropine al pH 
80.
Temperature ("C) k(obs) (m in '1) log k s.d.
60 2-952 x 10 1 -2-530 0038
70 9-655 x 10 3 -2-015 0-050
80 2-019 x 10 2 -1-695 0-051
88 4-945x10 2 1 306 0-038
analysis th a t will be readily ap p licab le  to  m ost este r so lu tions, 
with o r  w ithou t excipients and  irrespective o f  the  presence o f  
m ost o th er solutes.
F'rom  a co m p ariso n  o f  the d a ta  in T ables 1 an d  5 w ith  the 
lite ra tu re  values a lso  presented  there , it is a p p a re n t th a t the 
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Fig. t . Plot of In integral of triplet at 5 06 ppm against time for 
atropine degradation at four different temperatures.
with those previously reported . T h e  slightly h igher values for 
first o rd er ra te  c o n stan ts  fo r hydrolysis o f  p ro ca in e  (T able 1) 
com pared  w ith H iguchi et al (1950) are  p ro b ab ly  a  reflection o f 
the higher co n cen tra tio n  o f  buffer salts in the p resen t s tudy (0-25 
m) com pared  w ith th o se  used by H iguchi et al (1950) (0-05-0-2 
M). T he ac tiva tion  energies and  frequency fac to rs  for the 
hydrolysis o f  acetylcholine, carbacho l and  a tro p in e  a re  in b road  
agreem ent w ith lite ra tu re  values (T able  5). T he differences which 
are  ap p a ren t a re  presum ably  a  reflection o f  experim ental 
pro toco l, such as tem p era tu re  range, pH , buffer salts an d  d rug  
c oncen tration .
T he  inheren t a d v an tag e  o f  a  spectroscopic  o v e r a  c h ro m ato ­
g raph ic  m ethod  o f  analysis, p articu larly  w here N M R  is used, is 
th a t little m ethod  developm ent is required  once the general 
ap p ro ach  is estab lished . In  the present case  a  m ethod was 
developed using p roca ine  which was then app lied , w ith little 
m odification , to  the  o th e r  three esters. T h e  p ro ced u re  could 
equally  well be app lied  to  any  o th er w ater-so lub le  ester, 
provided th a t a  rep o rte r  g roup  is present. T h is  proviso  m ay 
exclude esters o f  som e tertia ry  alcohols w hich d o  n o t have a 
hydrogen a to m  in the sensitive position  ad ja c e n t to  the ester 
oxygen, a lthough  in these cases o th er spectral chan g es  are  likely 
which m ay allow the d ecom position  to  be follow ed.
In principle any  chem ical d eg rad a tio n  cou ld  b e  m onito red  by 
this m eth o d  to  o b ta in  ra te  d a ta , b u t w here th e  peak to be 
m onito red  is fu rth er aw ay from  the w ater p eak  an  alternative 
m ethod  fo r solvent su ppression  cou ld  be used, w ith som e 
ad v an tag e  in sim plicity  o f  sam ple p rep a ra tio n .




(J mol “ J)
Frequency factor 
(m in '1) Source
Acetylcholine 0-20 12-5-13 50995 l-00x 10'2 Butterworth et al (1953)
20-40 8-0 10-0 50032 1-47 x 109 Kunz (1973)
45-65 7-0 53 549 5-20 x 109 Present expt
Carbachol 70 90 0 7-7 93784 2-50 x 1013 Lundgren (1969)
70 90 8-5 97 163 4-33 x I013 Present expt
Atropine 40 59-8 70-8-0 53172 2-IOx 101(1 Zvirblis etal(l956)
60 88 8-0 47 596 6-5 x I012 Present expt
412
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F ig . 2. W ater-suppressed 1H N M R spectrum o f atropine before hydrolysis and (inserts) the peak at 5 0 6  ppm after (a) 0, 
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F i g . 3 . A r r h e n iu s  p lo t  o f  lo g  k  (m in  ')  a g a in s t  r e c ip r o c a l  o f  a b s o lu t e  
t e m p e r a tu r e  o f  a t r o p in e  h y d ro ly s is .
W e have show n previously th at the op tim u m  pH  fo r w ater 
suppression  varies w ith field s treng th  (D ickinson e t al 1987), as 
o f  course  does T j, reflecting the transverse re lax a tio n  ra te  which 
is significant in the  W A T R  m ethod. T he  m ach ine used in this 
s tudy  is one o f  the least pow erful allow ing the use o f  the  pulsed
technique which is essential to the m eth o d . T he use o f  m achines 
op e ra tin g  a t higher field w ould m ean higher sensitivity, better 
signal to  noise ra tio  an d  g rea te r spectra l reso lu tion , all o f  which 
w ould im prove th e  scope o f  the technique.
We th an k  the C om m onw ealth  S cho larsh ip  Com m ission  for 
financial su p p o rt o f  A, J. Ferdous.
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S u m m a r y
The potential applicability of l9F-N M R  imaging in observing a fluorinated pharm aceutical in vivo using the ra t as a model has 
been assessed. ,9F-N M R  imaging was used in parallel w ith ( ’H )-N M R  imaging to observe and  locate a solid dosage form in vivo. In 
vitro images o f a  tube phan tom  containing the fluorinated derivative were acquired initially in order to determ ine optim al acquisition 
param eters. Subsequently, in vivo ,9F images o f the solid dosage form in the gastrointestinal tract of anaesthetised (fasted and 
nonfasted) rats were obtained  and com pared. Corresponding 1H images were acquired al the m id-abdom en level of the rat. All 
images were acquired a t a field strength of 4.7 T using a 16-scgmenl copper birdcage resonator as the imaging probe. The 19F images 
were obtained al the resonant frequency of 188.5 M H z and the proton images al the resonant frequency of 200.3 M Hz using a 
spin-echo pulse sequence. A natom ical p ro ton  images showing gross structure of the gastrointestinal tract were acquired in as little as 
2 min. Fluorine images w ere observed in approx. 3 min with a  signal-lo-noise (SN R ) ratio o f 7,5 per pixel.
Introduction
There has been an increasing awareness of the 
value in understanding the behaviour of phar­
maceutical formulations in vivo (Anie et al., 1988). 
Transit times of orally administered pharmaceuti­
cal dosage forms through the gastrointestinal tract 
are of significance as drug absorption is consid­
ered to take place primarily from the small in­
testine. For this reason, the residence time of the 
dosage form in the stomach and the contact time 
with the absorption sites of the small intestine will 
influence the profile of drug absorption.
Correspondence: J.T. Fell, D ept of Pharmacy, University of 
M anchester, M anchester M13 9PL, U.K.
The assessment of the localisation and move­
ment of oral formulations has been examined pre­
viously using X-ray (Evans and Roberts, 1981) 
and radioisotope imaging including gamma scin­
tigraphy (Davis et al., 1984; Fell and Digenis,
1984). To date, NM R imaging has not been used 
for this application. NMR imaging can, in theory, 
overcome problems inherent in the previous meth­
ods by permitting imaging of a much wider range 
of materials. Furthermore, 19F-NM R imaging pro­
vides an as yet unexplored area for the localisation 
of formulations in the gastrointestinal tract. 19F is 
a sensitive nucleus and is chosen for these investi­
gations because of several specific advantages. 
These are the low intrinsic concentration of fluo­
rine in soft tissue, the high NM R sensitivity of the 
fluorine nucleus, the 100% natural abundance of
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(C H 2O H )4C
Pentaerythritol 
MWT =  136 g
CH2OCOCFj
I
c h 2o h — c — c h 2o h  
I 
c h 2o h
Monosubstituted MWT =  232 g
c h 2o c o c f ;, 
CH jOCOCF, —  C —  CH 2OH  
C H 2OCOCF3 
Trisubstituted MWT = 424 g
(C F3C 0 ) 20
Trifluoroacetic acid 
M WT =  194 g
C H 2OCOCF3
I
CH 2OCOCF3 —  C — CH  2O H  
c h 2o h
Disubstituted MWT =  328 g 
C H jO C O C F,
I
C H  jOCOCF, —  C —  C H 2O CO CF3 
c h 2o c o c f 3
Tetrasubstituted MWT =  520 g
the F isotope and the large gyromagnetic ratio 
of the fluorine nucleus, 25.17 X  107 rad T -1 s _1, 
which is close to that of the proton nucleus, 26.75 
X  107 rad T ~ 1 s ~ '  thereby enabling the observa­
tion of 19F with existing 'H RF components.
Previous work on 19F magnetic resonance spec­
troscopy and imaging has been largely concerned 
with various blood substitutes and fluorinated 
anaesthetics. The blood substitutes which have 
been studied include perfluorodecalin (Joseph et 
al., 1985), perfluorotributylamine (FTBA) (Long- 
maid et al., 1985), perfluorooctylbromide (PFOB) 
(Ratner et al., 1988) and perfluorophenanthrene 
(Thomas et al., 1986). There have also been inves­
tigations focused primarily on the potential appli­
cations of perfluorocarbons (PFCs) as contrast 
agents for a variety of organs (McFarland et al., 
1985). Fluorinated anaesthetics such as halothane 
have been monitored using 19F-NM R spec­
troscopy to detect the uptake and elimination 
from rabbit brain (Wyrwicz et al., 1983). A signifi­
cant problem, however, in using fluorinated agents, 
especially at the high fields required for imaging, 
is the multiplicity of resonances arising from 
chemically non-equivalent fluorine atoms. These 
widely spaced resonances (50-150 ppm) introduce 
chemical shift artifacts in the frequency encoded 
spatial dimension.
For our investigations, this problem was over­
come by synthesising pentaerythritol trifluoro- 
acetates which are symmetrical structures with a 




Pentaerythritol (2 g) was refluxed with trifluo­
roacetic anhydride (8 ml) over an oil bath at 35 ° C 
for 4 h (Scheme 1). The colourless liquid obtained 
was evaporated on a Buchi rotary evaporator to 
remove any trifluoroacetic acid and purified by a 
bulb-to-bulb distillation. Spectroscopic analyses 
was performed, infrared (IR) and NMR (both *H 
and 19F). The product exhibited a predominant 
resonance line at 0.97 ppm with respect to pure 
trifluoroacetic acid used as a reference.
Animal studies
The animal studies utilised Sprague-Dawley 
male rats (200 g). Half the rats were in an 18 h 
fasted state and the other half had been fed nor­
mally. Each rat was anaesthetised (urethane, in- 
traperitoneal; 5% in saline; 0.6 m l/100  g) prior to 




Fig. 1. (a, b) ,VF transverse images of a pellet in the gastrointestinal tract of a nonfastcd rat. (a) 15 min after dosing; (b) 115 min after
dosing, (c, d) Proton images corresponding to above after (c) 15 min and (d) 115 min after dosing.
enable immobilisation of the animal in the mag­
net. Hollow capsule-shaped pellets made of 
Nylon-6,6 (bore 2.2 mm, diameter 2.6 mm, length 
7.0 mm) were filled with the fluorinated formula­
tion (0.006 g) and sealed to prevent leakage. An
administration tube comprising a Luer stainless- 
steel needle and cone hollowed out to form a cup 
for the pellet was used during oral dosing of the 
rat. The pellet was deposited into the distal end of 




all the studies. The rat was then placed supine in a 
perspex restraint cage and positioned in the bird­
cage coil. Each rat was killed (halothane inhala­
tion) and dissected after the experiment to ascer­
tain the position of the pellet.
Instrumentation /  imaging protocol
fn vivo images were acquired on an O R S / 
Bruker biospectrometer (Oxford Research Sys­
tems, Abingdon, U.K) operating at a field strength 
of 4.7 T. A 16-segment copper birdcage resonator 
was employed as the imaging probe with corre­
sponding 90 and 180° pulse lengths of 190 and 
380 /j.s respectively. The 19F images were obtained 
at the resonant frequency of 188.5 MHz and the 
proton images at the resonant frequency of 200.3 
MHz. A two-dimensional FT sequence was used 
to obtain all images. All images consisted of 128 
X  128 independent picture points. Image acquisi­
tion was commenced 15 min after the administra­
tion of the pellet to the rat. The animals under­
went both i9F and 1H scanning in the birdcage 
coil tuned successively from the 19 F frequency to 
the 1H frequency. There was a time lag of approx. 
2 min during which the birdcage was retuned and 
rematched. 19F imaging was used to locate the 
pellet in vivo and 'H imaging to assign the pellet 
to a specific region of the rat. Transverse images 
were acquired at the level of the abdomen at time 
intervals to note gross movement of the pellet.
The pulse repetition time for both l9F and !H 
imaging, TR, was 1045.2 ms and the echo time, 
TE, was 35.6 ms. The slice thickness of each image 
was 4 mm. The proton scans took 2 min to acquire. 
Due to the low signal-to-noise ratio of the 19F 
resonance, image acquisition of the fluorine images 
took approx. 3 min.
Results and Discussion
Fig. la  and b shows 19F transverse images of a 
pellet in the gastrointestinal tract of a nonfasted 
rat, acquired 15 and 115 min, respectively, after 
dosing. The cursor position shown by the coordi­
nates indicates the position of the pellet, and is 
different in Fig. la  as compared with Fig. lb . The 
pellet appears to be changing in position and is
moving in the anticlockwise direction. Proton 
images corresponding to the 19F images acquired 
15 and 115 min after dosing are shown in Fig. lc  
and d, respectively. These depict structures such 
as the spinal canal, muscle, stomach, kidneys, 
small and large intestines, bowel gas and body 
wall. The cursor positions on the proton images 
mark the location of the pellet with time. For the 
proton images, the cursor indicates the pellet is in 
the stomach of the rat and remains iri the stomach 
even after 265 min. On account of the varying 
cursor coordinates on the 19F images, one may 
conclude that the pellet is moving in vivo. The 
minor changes in pellet position could be attri­
buted to the fact that the experiment was per­
formed with a nonfasted rat, therefore the stomach 
contained ingested food before the experiment 
was commenced. The pellet mixes with food in the 
stomach and its movement is restricted. Further­
more, the rat was anaesthetised prior to imaging 
and it is likely that urethane interferes with the 
normal peristaltic waves of the stomach thus in­
hibiting gastric emptying of the pellet. On dissec­
tion, the pellet was located in the forestomach 
close to the limiting ridge and imbedded in food 
remnants within the stomach of the rat.
Fig. 2a and b are 19F transverse images of a 
pellet in vivo acquired with a fasted rat. The 
movement of the pellet as indicated by the cursor 
coordinates appears to be more pronounced in 
this case as compared with the nonfasted state. In 
Fig. 2a, acquired 15 min after dosing, the fluorine 
image of the pellet appears vertical. However, 265 
min after dosing (see Fig. 2b) there appears to be 
an anticlockwise tilt of the pellet from its previous 
position. Selected proton images corresponding to 
fluorine images obtained 15 and 265 min after 
dosing are provided in Fig. 2c and d, respectively. 
The proton scans differ and reveal that the pellet 
has moved significantly during the experiment as 
compared with the results obtained with the non­
fasted state. On dissection, the pellet was located 
in the pylorus at the junction of the duodenum. In 
the absence of urethane, used as an anaesthetic to 
immobilise the animals during these experiments, 
motility of the pellet could be enhanced resulting 
in the observation of the pellet in the intestinal 
processes of the rat. However, it is essential that
f f i .
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Fig. 2. (a, b) ,VF transverse images of a pellet in the gastrointestinal tract of a fasted rat. (a) 15 min after dosing; (b) 265 min after 
dosing, (c, d) Proton images corresponding to above after (c) 15 min and (d) 265 min after dosing.
movements of the animal are prevented as far as 
possible to improve image quality and to reduce 
motional artifacts on the image, which are already 
prevalent due to normal heart function and re­
spiratory motion of the animal. Perhaps the use of
a sedative such as diazepam would alleviate this 
problem. Overall greater movement o f the pellet 
occurs in the fasted state as deduced from these 
experiments using 19F- and 'H -N M R imaging.
These images represent initial results on the use
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of 19 F- and ‘H-NMR imaging to observe and 
localise a solid dosage form in the gastrointestinal 
tract. In these studies advantage is taken of the 
fact that there are no background signals, originat­
ing from the animal, so that signals observed are 
exclusively from the pellet containing the fluorin­
ated derivative. The initial aim was to select a 
product containing a high proportional mass of 
fluorine and a single line in its NM R spectrum, 
with convenient handling characteristics. Another 
important feature of these studies was the accurate 
spatial correlation that was achieved between the 
fluorine and proton images. This was possible due 
to the selection of the birdcage resonator as the 
imaging probe. The birdcage resonator may be 
tuned and matched to the appropriate frequency 
between successive 19F and ’H imaging without 
moving the animal or resonator because the re­
spective resonant frequencies of 19F and ' H are 
close, i.e 188.5 and 200.3 MHz, respectively. The 
reliability of the administration procedure means 
that provided the administration tube reaches the 
distal end of the oesophagus, pellets deposited 
reach the stomach within 10 min.
The relative sensitivity of fluorine is 94% to 
that of hydrogen at constant frequency and there­
fore, fluorine and hydrogen produce similar signal 
strengths as observed in our images. The acquisi­
tion time associated with the 19F images, 3 min, 
shows an improvement on previously published 
data. The geometry of the birdcage imaging probe 
is such that the restraint cage containing the rat 
fills the volume of the probe, so that detection 
sensitivity is maximised and a better SNR is re­
alised.
Further studies would involve the use of non­
anaesthetised rats or sedated rats to enable greater 
movement of the pellet in vivo. Other 19 F imaging
agents could be formulated having the characteris­
tics previously mentioned. These could be poten­
tially administered in dosage forms and the entire 
movement through the GI tract observed. We 
conclude that the method is sufficiently fast and 
sensitive to obtain data regarding transit times.
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Summary
1<,F-NMR has been used to assess the movement of a non-disintegrating pellet containing a fluorinated derivative of 
pentaerythritol in the gastrointestinal tract of a rat. The data were treated using computer graphics to provide a three-dimensional 
representation of the movement of the pellet.
The behaviour and transit of solid oral dosage 
forms in the gastrointestinal tract are related to 
drug absorption. NM R imaging is a potentially 
valuable method of obtaining such data and may 
have advantages over gamma scintigraphy, the 
current method of choice.
Previous studies have shown that 19F-NM R  
imaging may be used in conjunction with 1H-NM R
Correspondence: J.T. Fell, Dept of Pharmacy, University of 
Manchester, Manchester M13 9PI.., U.K.
imaging to observe and locate a pellet in vivo 
(Anie et al., 1989; Anie, 1990). A significant prob­
lem encountered is the time associated with the 
acquisition of the images. Due to the rapid move­
ment o f the pellet in the gastrointestinal tract of 
the rat, a faster method of assessment would be 
useful. In view of this, I9F-NM R has been investi­
gated for this application without the require­
ment for the generation of images.
Studies utilised 200 g sedated (diazepam; in- 
traperitoneal; 2.5 m g /k g ) or anaesthetised  
(urethane; intraperitoneal; 5%  in saline; 0.6 
m l/100  g) Sprague-Dawley male rats, in an 18 h 
starved state. Hollow capsule-shaped pellets were 
filled with a fluorinated derivative o f pentaery­
thritol (0.006 g) (Anie et al., 1991) and sealed to 
prevent leakage. A single pellet was orally admin­
420
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istered into the stomach. A reference pellet con­
taining the derivative was fixed to the dorsal 
region of the rat. The sedated or anaesthetised 
rat was placed in a perspex restraint cage, posi­
tioned in a birdcage coil and finally into the 
magnet. Each rat was killed and dissected on 
completion of the study to ascertain the position 
of the pellet in the gastrointestinal tract and to 
correlate this position with the NM R data.
Data acquisition was commenced 15 min after 
the administration of the pellet to the rat. The 
instrument used was an O R S/B ruker biospec­
trometer. The experiment was performed at 4.7 T  
with the birdcage coil tuned and matched to 188 
MHz. Pulses of 90 and 180° were applied for 275 
and 550 /zs, respectively. The sequence repetition 
time (TR) was 2031 ms and the excitation pulse 
to echo duration (TE) was 24.8 ms. A  one-dim en­
sional experiment in each of the three gradients 
x, y and z allows rapid location of the centre of 
the pellets with a precision of roughly 0.5 mm. 
Field gradients used in the x, y  and z directions 
were 2558, 2408 and 2257 H z/cm , respectively. 
To increase the signal-to-noise ratio, each signal 
was acquired repeatedly, i.e. averaged. Signal av­
erages were obtained approximately every 2 min 
for 5 h.
In each experiment, l9F-NM R signals originat­
ing from the two pellets were obtained. Measure­
ments made relative to the reference pellet (R) 
provided information as to the pellet mobility. 
Fig. 1 shows a selected portion of the Z  profile 
acquired from a sedated rat. Each field map 
consists of 22 19F spectra and shows two peaks, 
one corresponding to the reference and the other 
to the pellet in the gastrointestinal tract. A  
three-dimensional pattern of movement relative 
to the reference pellet can thus be obtained. A  
greater movement o f the pellet was obtained when 
the rats were sedated as opposed to being anaes­
thetised by urethane. This was confirmed on dis­
section.
The data can be treated using computer graph­
ics to give a visual representation of the pellet 
movement. Typical displays are shown in Fig. 2a 
and b for anaesthetised and sedated rats depict­
ing greater movement after sedation. The x, y 
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Fig. 1. The Z profile of a pellet in a sedated rat (scale: 1000 
units = 0.44 cm).
viewing plane. The plots can be rotated to obtain 
the three-dimensional image.
These studies coupled with previous work 
(Anie et al., 1991) demonstrate the non-invasive 
feature and potential of NM R methods for gas­
trointestinal transit studies. Linking NM R spec-
421
185
Fig. 2. (a) A three-dimensional plot of the pathway of a pellet acquired with an anaesthetised rat. (b) A three-dimensional plot of
the pathway of a pellet acquired with a sedated rat.
troscopy with computer graphics allows rapid data Anie, S.J., Fell, J.T. and Waigh, R.D., Visualisation of a
acquisition and a visual representation of transit. fluorinated pharmaceutical formulation in the anaes­
thetised rat using 1 ’F and 1H-NMR imaging. Int. J. Pharm.,
69 (1991) 181-186.
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Application of the WATR Technique for Water Suppression in 
lH NM R Spectroscopy in Determination of The Kinetics of 
Hydrolysis of Neostigmine Bromide in Aqueous Solution
ABU 5. FERD O U S* AND ROGER D . W A IG H 'I'
Department o f Pharmacy, University o f  Manchester, Manchester M U  9PL, UK
Abstract Both ammonium chloride and guanidinium chloride were used to secure water suppression in 'H 
NMR spectra using the ‘Water Attenuation by Tj Relaxation’ (WATR) technique. The effect o f phosphate 
buffer in the suppression was investigated over a range o f pH values at 80 MHz. The spin-spin relaxation 
time of water protons at 80 MHz was found to reach a minimum at pH 7-3 in the presence of 0-1 m phosphate 
buffer and 1 m  guanidinium chloride; these conditions were therefore chosen for subsequent use of the 
WATR technique in a study of the kinetics o f hydrolysis o f neostigmine bromide. The method was found to 
be very convenient for studies of the hydrolysis o f this representative amide.
Nuclear magnetic resonance (NM R) spectroscopy has been 
widely used in the study o f drug degradation rates (Mitsu- 
mori et al 1977; Baltzer et al 1979; Dcgelacn et al 1979; 
Nishikawa et al 1987). As an analytical tool it offers various 
advantages compared with other methods o f analysis (Fcr- 
dous 1989). Drugs undergoing hydrolytic degradation in 
aqueous solution are not amenable to direct 'H  NM R 
spectroscopic analysis; the high concentration o f water 
protons (ca. 1 1 0  m ) causes dynamic range problems in 
recording the NMR spectra and the huge water peak 
obscures or distorts all nearby weak solute peaks. The 
problem of removing the water peak from the spectra o f 
aqueous solutions has been successfully overcome by using 
the ‘Water Attenuation by T2 Relaxation’ (WATR) method 
(Rabenstein et al 1985). Using this method, peaks in the 
region of <5 4 -5 ppm can be easily observed (Rabenstein & 
Fan 1986; Dickinson et al 1987). Various relaxation agents 
have been used to suppress the water peak. In the present 
study the relaxation effect o f ammonium chloride and 
guanidine hydrochloride and the effect of pH on water 
suppression are reported. As an extension of the use o f the 
technique in studies of ester hydrolysis (Ferdous et al 1991), 
the method has been used to study the hydrolysis rate o f a 
representative amide, neostigmine bromide.
Materials and Methods
Ammonium chloride (BDH, Poole, Dorset), guanidine 
hydrochloride (Aldrich, Gillingham), acetamide (BDH), 
potassium dihydrogen phosphate and sodium hydroxide 
were of analytical grade. Deuterium oxide (99-88%D) was 
obtained from Fluorochem (Glossop). Neostigmine bromide 
(Aldrich) was used without further purification. Distilled 
water was used in all experiments.
The spin-spin relaxation time (T2) was measured using the 
CPM G pulse sequence (Carr & Purcell 1954; Meiboom &
* Present address: Department of Pharmacy, University of 
Dhaka, Dhaka 1000, Bangladesh.
f  Present address and correspondence: R. D. Waigh, Department 
of Pharmaceutical Sciences, University of Strathclyde, Glasgow G1 
IXW. UK.
Gill 1958). The sample solution contained 5% (v/v) DjO and 
a measured amount o f relaxation agent (ammonium chloride 
or guanidine hydrochloride). The solution contained buffer 
salts to stabilize pH. About 0-5 mL solution was used in a 
5-mm diameter NM R tube. The CPMG data were obtained 
as a stack plot. Digital data printouts were used to calculate 
Tj by least square regression analysis.
The water suppressed 'H  NMR spectra o f neostigmine 
bromide samples in aqueous solution were recorded using 
the WATR method (Ferdous et al 1991). The experiments 
were carried out on a Bruker WP80 N M R spectrometer 
operating at 80 MHz a t 20"C.
The degradation of neostigmine bromide was studied at 
four different temperatures at pH 9-3. W ater (50 mL) was 
adjusted to the desired pH. A flask containing 45 mL of this 
solution was placed in the water bath and kept there until it 
reached the required temperature. Neostigmine bromide 
(1 % w/v) was measured and dissolved in the remaining 5 mL 
solution and the pH was adjusted. The two solutions were 
mixed and transferred to a jacketed vessel through which hot 
water was circulated to maintain the desired temperature. 
The jacketed vessel was placed in a pH-stat and the pH was 
constantly monitored. As the degradation continued the pH 
of the solution was kept constant by adding sodium hydrox­
ide solution (0-7-1-4 m ) automatically. Samples were col­
lected at the beginning and at timed intervals. Each sample 
was placed in a screw-cap tube, instantly frozen in liquid 
nitrogen and kept at — 6°C until the spectrum was recorded. 
Before obtaining the spectrum, the sample was thawed and a 
solution was added containing acetamide (0-075% w/v) as 
internal standard, 0-1 m  phosphate buffer, 5% (v/v) D20  for 
an NM R lock signal and 1 m  guanidine hydrochloride as 
relaxation agent. The final pH of the solution was adjusted to 
7-3. A total of 32 scans was accumulated for each spectrum 
with a total delay of 0-8 s.
After acquisition o f NM R spectra, digital printouts were 
obtained containing peak area (integral) for each chemical 
shift. The integral o f the two singlets at <5 31 ppm was 
normalized with reference to the integral o f the internal 
standard acetamide peak at S 1 -9 ppm. Three spectra were 
recorded for each sample. The integrals for the peak from
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each spectrum after normalization were added together and 
the average value was taken. The In integral values were 
plotted against time for each degradation experiment. The 
slope of the line of best fit was computed which gave the first 
order rate constant for that degradation experiment. All 
experiments were performed in triplicate and the average 
value was recorded.
Results and Discussion
The spin-spin relaxation time (T2) of water protons was 
determined in varying concentrations of phosphate buffer 
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Fig. 3. Ln of spin-spin relaxation time (T2) of water protons (in 
presence of 1 m guanidine hydrochloride at pH 7 2) plotted as a 
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Fig. 4. pH dependence of Log T2 of water protons in the presence of 
1 m guanidine hydrochloride and O' 1 m  phosphate buffer.
protons in the presence of 0-25 M ammonium chloride as 
relaxation agent and increasing concentration of phosphate 
buffer at pH 5 5 and 6 0 is shown in Fig. 1. The change in T2 
of water protons with increasing concentration of phosphate 
buffer in the presence of 1 m  ammonium chloride at pH 5-5 is 
shown in Fig. 2. For Fig. 1, two pH values were chosen 
because the relaxation effect of ammonium chloride was 
maximum around the pH range 5-5-6 0 (Dickinson et al 
1987). The T2 o f water protons increased with increasing 
phosphate buffer up to a maximum (0-35-0-45 m ; Figs 1, 2); 
T2 then slightly decreased with further increase of phosphate 
buffer. The spin-spin relaxation times are slightly longer at 
pH 6-0 than at pH 5-5 in the presence of the same
424
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CH:
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F i g . 5. Water suppressed *H NMR spectrum of neostigmine bromide before hydrolysis and (inserts) the double singlets at 
<5 3-1 ppm after (a) 0, (b) 30, (c)60, (d) 120 and (c) 180 min. Samples were degraded at 70"C. W marks the suppressed water 
peak, and A acetamide peak. The structure of neostigmine bromide is given in the insert.
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T i m e  ( m i n )
F ig . 6. Plot of 1 n integral of double singlet at <5 3-1 ppm against time 
for neostigmine bromide degradation at four different temperatures 
and at pH 9-3. a  60, O 70, ■ 80 and D 88°C.
concentration of phosphate buffer and ammonium chloride. 
Increasing the ammonium chloride concentration from 0-25 
to 1 m significantly decreased the relaxation time (Fig. 2) 
which is in accordance with previous findings (Dickinson et 
al 1987). Phosphate buffer at pH 5-5 is slightly below its 
recommended buffering range. Phosphate buffers at or 
above pH 5-5 can be used in obtaining the W ATR spectra, 
but a higher concentration of ammonium chloride would be
Table I. First order rate constants for hydrolysis of neostigmine 
bromide at pH 9-3.
Temperature K.
C O (min '') Log K s.d.
60 1-38947x 10 4 -3-857144 0-01134
70 1 I3l33x 10 3 -2-946410 0-01215
80 8-39509 x 10“3 2-075974 0-01956
88 3-83084 x 10-J -1-416706 0-01057
Table 2. Activation energy for hydrolysis of neostigmine bromide.
Temperature Activation energy
(°C) pH (kJ mol-1) Source
70-90 7-6 1011 Porst & K.ny (1985)
10-45 13-0 14-0* Christenson (1964)
60-88 9-3 43-9 Present study
* Calculated from Christenson (1964).
necessary at higher pH values for complete suppression of 
the water signal.
The effect o f phosphate buffers on T2 of water protons in 
the presence of 1 M guanidine hydrochloride is shown in Fig.
3. T 2 decreased with increase o f phosphate buffer up to 0-05 m. 
In the range of 0 0 5 -0 -2  m phosphate buffer, T2 was almost 
constant. Above that concentration, there was a slight 
increase in the T2 of the water protons. Therefore, subse­
quently the WATR spectra of all compounds were measured 
in 0-1 M phosphate buffer. The relaxation effect of guanidine 
hydrochloride was greater than that of ammonium chloride 
(Dickinson et al 1987). Guanidine hydrochloride was also 
found to be less susceptible to interference from phosphate
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F ig .  7 . Arrhenius plot of ln K  (min ') against reciprocal o f  absolute 
temperature of neostigmine hydrolysis degradation.
was calculated. The results thus obtained can be compared 
(Table 2) with those reported by Christensen (1964) and 
Porst & Kny (1985). The differences in Table 2 are due to 
temperature, pH, buffer salts and drug concentration. At low  
pH, more energy is required for hydrolysis, so the activation 
energy is high; at higher pH values the activation energy is 
lower.
The W ATR technique has the advantage over chrom ato­
graphic procedures in that there is little method develop­
ment, and separation o f  degraded products from the parent 
com pound is not necessary The method is rapid and 
straightforward and both undegraded and degraded pro­
ducts can be analysed and quantified easily. In this experi­
ment an N M R  spectrometer o f relatively low sensitivity and 
resolving power was used. If an instrument o f higher field 
strength were used then greater spectral resolution and better 
signal-to-noise ratio would be obtained which would further 
improve the scope o f  this technique.
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buffers (Fig. 3), so guanidine hydrochloride was used as the 
relaxation agent to suppress the water peak in all subsequent 
experiments.
The T2 o f  water protons in 0-1 m phosphate buffer and 1 M 
guanidine hydrochloride in the pH range 7•0-7-7 was 
determined: the results are presented in Fig. 4. In this pH 
range in unbuffered solution Dickinson et al (1987) found T2 
to be at a minimum. In phosphate buffer, the T2 was found to 
be at a minimum in the pH range 7-2-7 4. A bove and below  
the pH range, T2 increased significantly. Therefore, pH 7-3 
was chosen as the optimum pH for obtaining W ATR spectra 
in the presence o f  0-1  M phosphate buffer and 1 m  guanidine 
hydrochloride as the relaxation agent.
The hydrolysis rate o f  neostigmine brom ide was deter­
mined at 6 0 ,7 0 ,80 and 88°C at pH 9-3. The W ATR spectrum 
was recorded for each sample obtained during each degrada­
tion experiment. Since spectra were obtained at pH 7-3, at 
which pH hydrolysis is likely to be slow (compare data in 
Table 2) and at ambient temperature, ca. 20“C  (compare data 
in Fig. 6), it can be assumed that hydrolysis during acqui­
sition o f the W ATR spectra would be negligible. A typical 
spectrum o f  neostigmine bromide at the beginning o f  
degradation is shown in Fig. 5. The integral o f  the two methyl 
singlets at <5 3-1 ppm thus obtained was normalized with the 
integral o f  the peak o f  the internal standard acetamide. The 
amide methyl peaks at 8 3-1 ppm were chosen because they 
were well separated from the peak for dimethylamine at ca. <5 
2-7, present after hydrolysis. The 1 n integral (after normaliz­
ation) was then plotted against time (Fig. 6). The slope o f  
each line gave the rate constant (K) for hydrolysis (Table I). 
The Arrhenius plot (Fig. 7) was obtained by plotting the rate 
constant for hydrolysis against the reciprocal o f absolute 
temperature. From the slope o f  the line, the activation energy
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The *H NMR spectrum of chlorpromazine hydrochloride was fully assigned at 400 MHz. Similarly, the ,3C NMR 
spectrum was assigned unambiguously using two-dimensional NMR. Measurements of chemical shift as a function 
of concentration in D 2Q showed appreciable changes of shift of both protons and carbons which were apparent even 
at solution concentrations two orders of magnitude lower than the critical micelle concentration (CMC). The 
relative magnitude of the shifts of the aromatic protons and carbons on dilution below the CM C were compatible 
with vertical stacking of the molecules in an olf-set manner such that maximum overlap of the chlorinated rings 
occurred. Proton chemical shift data were interpreted using a stepwise association model to quantify the extent of 
association in the pre-CMC region.
keywords Chlorpromazine ‘HNMR l3CNMR Association models
INTRODUCTION
The pharmacological groups of tranquillizing drugs 
based on the phenothiazine ring system are surface 
active and exhibit self-association in aqueous solution. 
The occurrence of an abrupt change in physico­
chemical properties at a critical concentration led early 
workers1 to assume a micellar mode of association, the 
inflection being identified with the critical micelle con­
centration (CMC) of typical surfactants. More recent 
work has cast doubt on this inference. The demonstra­
tion of additional discontinuities in the light-scattering 
data of several phenothiazine drugs at higher solution 
concentration2,3 suggests a more complex association 
pattern for these drugs. There is also recent evidence 
from calorimetric,4 6 osmotic,7 e.m.f. and ultrasonic 
relaxation8 studies that limited association occurs 
below the first critical concentration in water and dilute 
electrolyte. It is this aspect of the association process 
that was addressed in this study.
An earlier study9 of the changes in the proton chemi­
cal shifts of the f NH(CH3)2 group, the CHCH3 and the 
aromatic region of the phenothiazine molecule on dilu­
tion led to the suggestion of vertical stacking of these 
drugs in the manner of the tricyclic dyes. In this paper
* Author to whom correspondence should be addressed.
we report a more detailed examination of the changes in 
chemical shift, both 1H and l3C, over a wide concentra­
tion range. The use of a much higher field strength than 
previous workers who have studied the phenothiazine 
drugs9"16 allowed the observation of changes in chemi­
cal shift of individual aromatic protons and carbon 
atoms of chlorpromazine (1) extending to regions of 
high dilution, from which deductions of the orientation 
of the molecules in the stacks have been made.
CHaCHxCHaN(CH3), 
9  V H
1
EXPERIMENTAL
Chlorpromazine hydrochloride (Sigma Chemical) con­
formed to the purity requirements of the British Phar­
macopoeia and, as such, contained not less than 98.5%
CCC 0749-1581/94/080468-05 
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NMR SPECTRA OF CHLORPROMAZINE HYDROCHLORIDE
Table 1. H,H coupling constants for chlorpromazine 
hydrochloride, 11.12 mmol kg- * in D 2Q"




3J{fiy) = 3J(P'y) 10.6
3J t f y ) = 3J(J?y) 5.6
*J( 13) 2.0
3J (  34) 8.2




“Values for the protons for the side-chain were ealeu-
lated using the simulation program LAOCOON; those 
for the ring protons are experimental values.
were SF, =  100.622 MHz, SW, =  150573 ppm and 
those for the F 2 domain were SF2 =  400.137 MHz, 
SW2 =  2336 Hz. Normal and long-range HC COSY 
spectral data were processed with square-sinusoidal 
multiplication prior to both Fourier transformations. 
NOESY spectra were recorded at 400.137 MHz using 
the TPPI mode in the F , domain, with a sweep width 
of 2325 Hz. Data were collected as 420 x ?,K complex 
points, zero filled to IK in F , to give a IK x IK 
contour plot and processed with sinusoidal multiplica­
tion prior to both Fourier transformations. Studies of 
the proton shift on dilution were carried out on a Jeol 
EX-270 instrument at 270 MHz (‘H); l3C shifts were 
measured using a Varian Unity-500 instrument at 125 
MHz. The spectra were referenced to dioxane as an 
external standard. Al! measurements were made at 303 
K.
of the specified compound. All solutions were prepared 
by mass in 99.93% deuterium oxide immediately prior 
to use to minimise photodegradation. Errors arising 
from adsorption of the surface-active drug on to glass­
ware in very dilute solution were minimized by soaking 
the glassware with solutions of identical concentration 
for approximately 2 h, thus saturating the walls of the 
containers, before replacing with fresh solution imme­
diately before measurement. Any storage of solutions 
was in the dark to reduce photodegradation.
’H and 13C NMR spectra were assigned using a 
Bruker AM400X spectrometer with 5 mm dual and 
reverse probe heads at 400 MHz (*H) and 100 MHz 
(13C). The 'H I D  spectra were recorded with inversion- 
partial recovery of water, using 64K points, sweep width 
(SW) = 3623 Hz, frequency (SF) =  400.137 MHz. The 
13C ID spectra were acquired using 32K points, 
SW = 22 727 Hz, SF =  100.623 MHz. Data processing 
was by exponential multiplication with 2 Hz line 
broadening. HC COSY spectra were acquired as 
512 x  IK complex points zero filled to give a data 
matrix consisting of IK x  IK points, using the TPPI 
mode in the F , domain. Parameters for the F, domain
RESULTS
Spectra! assignments
Assignments of the 'H spectra for chlorpromazine 
hydrochloride were carried out in 99.93% D 20  at a 
concentration of 11.12 mmol kg-1 (below the literature1 
CMC of 19 mmol kg-1). Chemical shift and coupling 
splitting pattern combined with nuclear Overhauser 
enhancement measurements allowed the unambiguous 
assignment of the protons. Irradiation of the a-protons 
of the side-chain allowed a distinction to be made 
between H-9 and H-6 by observation of the nuclear 
Overhauser effect. Values of the coupling constants 
(Table 1) were measured directly for the ring protons 
and calculated using the simulation program 
LAOCOON for the protons of the chain. The values 
obtained for the latter confirmed the preferred gauche- 
trans conformation of the alkyl chain,12,13 which allows 
the hydrophobic region of the molecule to be protected 
more adequately from the aqueous environment. The 
chemical shifts at concentrations of 73.60 and 4.856
Table 2. 13C and ‘H chemical shifts o f chlorpromazine hydrochloride at concentrations above and 
below the CM C in ppm.
Position 4.858 mmol k g - ’ 73.60 mmol kg- ’ 4.858 mmol k g - ’ 73.60 mmol kg*
1 117.16 116.74 6.93 6.59
2 134.02 133.82
3 123.75 123.33 6.94 6.51
4 129.03 128.74 7.06 6.56
4a 124.64 124.23
5a 125.81 125.34
6 128.46 128.36. 7.19 6.84
7 124.47 124.36 7.00 6.77
8 128.88 128.87 7.24 7.08
9 117.42 117.40 6.97 6.73
9a 145.02 144.19
10a 146.75 146.80
a 44.35 44.33 3.91 3.54
P 22.09 22.19 2.06 1.81
y 56.28 55.83 3.10 2.82
Me 43.40 43.36 2.66 2.48
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Figure 1. Chemical shift, <5, as a function of log (concentration) 
for aromatic protons of chlorpromazine hydrochloride in D20  
Dashed line, literature value of CMC.
mmol k g -1 (above and below the CMC) are given in 
Table 2 and show a significant dependence of chemical 
shift on solution concentration.
Assignments of the l3C spectra were made on a 
sample of concentration 73.60 mmol kg 1 using two- 
dimensional NMR with inverse detection. A two- 
dimensional CH COSY plot allowed the assignment of 
the proton-bearing carbons whilst a long-range CH 
COSY plot allowed the assignment of the quaternary 
carbon atoms. The chemical shifts given here for the 
C-4, C-6 and C-8 carbons differ markedly from those 
previously reported by Patra et al.15 and Jovanovic and 
Biehl16 from coupled 13C spectra in D zO and DMSO, 
respectively, at concentrations exceeding 1 mol dm 3. 
However, these differences can be explained by the con­
centration dependence of the relative position of the 
carbon signals as seen from a comparison of the values 
given in Table 2 for solutions of concentrations 73.60 
and 4.856 mmol kg ‘ .
Concentration dependence of chemical shifts
The variation of the chemical shift, <5, of the aromatic 
protons with concentration as measured from spectra 
recorded over a very wide concentration range 
(5 x 10 5-0.5 mol kg *) are presented in Fig. 1. Partic­
ular attention was given in investigations of the chemi­
cal shift in the region below the literature value of the 
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Figure 2. Change of chemical shift, Ad, as a function of log 
(concentration) for the aromatic and aliphatic protons of chlor- 
promazine hydrochloride in D20  over the pre-CMC concentration 
range.
of all of the protons, including those of the side-chain, 
over the concentration range 10-4 —10 2 mol kg 
relative to the chemical shift in the most dilute solution 
(assumed to represent that of the free monomer). It is 
clear from these figures that the changes of shift of the 
protons of the ring bearing the Cl substituent (protons 
in positions 1, 3 and 4) are significantly larger than 
those of the unsubstituted ring and are appreciable at 
concentrations extending down to at least one tenth of 
the CMC. As all the external factors are maintained
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Figure 3. Schematic structures of chlorpromazine hydrochloride 
showing change in chemical shift over the pre-CMC concentration 
range, (a) Carbon shift over the range 0.9-18 mmol kg- ';  (b) 
proton shift over the range 0 .05-18 mmol kg '.
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DISCUSSION
Figure 4. Schematic representation of the stacking of two mol­
ecules of chlorpromazine.
constant, it may be concluded that the chemical shifts 
must signify changes in the environment of the protons 
arising from the association of the chlorpromazine mol­
ecules. Shifts of similar magnitude were noted for the 
carbon atoms of this ring over a similar wide range of 
concentration. Figure 3 summarizes the shifts for each 
proton and carbon atom as measured from the differ­
ence between the constant value obtained in very dilute 
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Downfield shifts of *H resonances on dilution have 
been reported previously in studies of the association of 
nucleotides17 and azo dyes1819 and attributed to paral­
lel rather than coplanar assocation of the molecules. 
The phenothiazine ring system is V-shaped about an 
axis from the N to S atoms with an internal angle of 
approximately 155°. A concave to convex vertical stack­
ing of the aggregate with the alkyl side-chains on alter­
nate sides of the stack has been suggested previously by 
Florence and Parfitt,9 and such an arrangement of mol­
ecules would appear to be both thermodynamically and 
sterically stable. Inspection of the relative magnitude of 
the changes in chemical shifts of aromatic protons and 
carbon atoms now provides more information on the 
possible spatial orientations of the stacked molecules. 
The greater involvement of the chlorinated rings in the 
association process suggests an offset orientation of the 
molecules of the stack with maximum overlap of these 
rings rather than the perfect alignment of the tricyclic 
ring system as originally envisaged (see Fig. 4).
Figure 2 shows that significant changes of the chemi­
cal shifts of the aromatic protons of chlorpromazine 
occur over a wide concentration range commencing at a 
concentration well below the literature value of the 
CMC. These results show clear evidence of premicellar 
association, supporting the findings from other experi­
mental techniques.4 8
The proton chemical shifts over the concentration 
range up to the CMC were analysed using the method 
proposed by Dimicoli and Helene20 to quantify the 
extent of the association over this concentration region. 
For a stepwise association process in which multimers 
b„ are formed according to the equilibrium
b i +  b t ^ b 2
b2 + b t ^ b 3
b„-i +
it was shown that
A S (ppm)
Figure 5. Chemical shift data for the protons of chlorpromazine 
hydrochloride below the CMC plotted according to Eqn (2).
A S/bl =  2KA5bl (1)
(A<5/60)1/2 =  (K/2A<5b2)1/2(2A<5b2 -  AS) (2)
In Eqns (1) and (2), AS =  5 — <5bl where S is the 
observed chemical shift and <5bl is that of the free 
monomer; A<5b2 =  <5b2 — <5bl where <5b2 is the chemical 
shift of the dimer; b0 and h, represent the total concen­
tration and the free monomer concentration respec­
tively ; and K  is the association constant, assumed to be 
identical for each association step. The assumptions 
underlying the application of the method of data treat­
ment are that the magnetic anisotropic effects of neigh­
bouring molecules are additive and that only the 
anisotropy of nearest neighbours need be considered. In 
the application of Eqns (1) and (2) it was assumed that 
the constant value of S at low concentration was an 
adequate representation of the chemical shift of the 
monomer, <5bl.
Plots of (ASlb0)l/1 against AS for the aromatic 
protons were linear (Fig. 5) in accordance with Eqn (2),
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and a mean value of K =  20.0 ±  8.8 kg m ol" 1 was 
derived from the gradient (K/2A5b2)112 and intercept on 
the abscissa (2A(5bj). The percentage of drug existing as 
free monomer at the CMC was calculated to be 55% 
from Eqn (1) using the mean K  value. Previous detailed 
examinations5,6,8 of the premicellar association of 
phenothiazine drugs have concentrated on prometha­
zine hydrochloride. A reasonable fit of calorimetric data 
for this drug was obtained using an association model 
similar to that used here in which the stepwise equi­
librium constants were assumed to be of equal magni­
tude. The reported values5 of K  increased from 12 to 38 
kg mol ” 1 with increase in electrolyte concentration
from 0.1 to 0.6 mol dm -3 NaCl. The Cl substituent on 
the tricyclic ring system of chlorpromazine imparts a 
greater hydrophobicity compared with promethazine 
and consequently should result in higher values of K. 
The value obtained in this study for chlorpromazine in 
the absence of electrolyte is thus of the magnitude 
expected for this drug.
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Geometry-based simulation of the hydration of small molecules 
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The behaviour of water structure-makers and breakers is of practical importance in protein folding in aqueous solution (G. 
Nemethy, A n g e w .  C h e m . ,  I n t l .  E d .  E n g l . ,  1967, 6, 195), but the mechanism for this process is not fully understood (K. A. T. 
Silverstein, A. D. J. Haymet and K. A. Dill, J .  A m .  C h e m . Soc., 1998, 120, 3166). A computer simulation has been developed, of 
water structure around solutes, using only hydrogen bond geometry data rather than traditional forcefieid methods. The 
simulation builds networks of hydrogen bonded water around structure-makers such as sulfate and phosphate, but not around 
structure-breakers such as urea and guanidinium. We have tested the software with a preliminary set of 17 varying solutes and 
our results are generally consistent with existing practical data.
introduction
On the basis of volume and entropy measurements, Frank 
and Evans found that non-polar solutes affect the structure 
of the water around them, essentially making it more ice­
like.' They also suggested that some molecules might act in 
the opposite way, making the water more mobile than bulk 
water. This ‘iceberg’ theory has often been misinterpreted, 
but has since become the standard model of hydrophobic 
hydration.2 The concept was taken a stage further1 when 
Frank and Wen classified various small ions as either 
structure-makers or structure-breakers. They also estimated 
that the individual water structures were very short-lived, 
with a half-life assumed to be 10“*°—10“"  s, and referred to 
these as ‘flickering clusters’ to distinguish them from solid 
‘icebergs’.
The term hydrophobicity was introduced by Kauzmann,4 as 
an interpretation of protein denaturation using Frank’s 
theories. He suggested that the attractive interactions 
between non-polar molecules in aqueous solution are 
promoted by the solvent as a result of destructive overlap of 
hydration shells releasing structured water into the bulk. 
Hydrophobic effects play a pivotal role in protein folding,'1 
helical stabilisation,6 micelle formation,7 and the action of 
surfactants.8 Strong structure-breaking molecules such as 
urea and guanidinium will cause protein denaturation,9 in 
which the protein unfolds and may precipitate out of 
solution. This process is governed by the effect these 
structure-breakers have on the water molecules mound 
them.10 In contrast, structure makers such as sulfate ions 
can be used to assist the folding or renaturation of 
proteins.11
Water molecules are potentially tetrahedral, with two 
hydrogen bond donor and two acceptor positions. 
Information about the geometric preferences of aggregates 
of these tetrahedra may be found from clathrate hydrates, 
solid crystalline complexes in which a small non-polar 
molecule is encaged in a regular network of five- and six- 
membered rings of hydrogen-bonded water molecules.'2 
Rings of water molecules have also been proved to exist 
near the surface of proteins,13 at DNA interfaces,14 and in
the hydration shells of DNA-drug complexes,13 suggesting 
that water in these environments has much in common with 
the arrangement in clathrate hydrates. The three most 
common cavity types found in clathrates have also been 
found in the gaseous phase16 around small ions such as Cs*. 
The existence of such structures in the liquid state has been 
the subject of speculation for many years but recent work*7 
involving the hydrophobic hydration o f krypton using 
extended X-ray absorption fine-structure (EXAFS) 
spectroscopy has shown that the liquid to solid phase 
transition produces a clathrate hydrate, indicating that 
Frank’s ‘structuring’ of liquid water by non-polar solutes 
may be very similar to clathrate hydrate structures.
Quantum mechanical calculations on randomly generated 
arrangements of water molecules have shown that rings are 
more stable than chains,18 and it has been experimentally 
verified that the predicted minimum energy structures are 
found in bulk water.19 We have developed software to 
model possible hydrogen bonded water structure around 
different solute molecules, using a purely structural model 
of water, with ring formation as a primary feature. As we 
are only using hydrogen bond geometries to constrain the 
program, it is important that the values used are realistic.
Method
We have surveyed the hydrogen-bond geometries of 14 ice 
and 11 clathrate crystal structures and 60 hydration 
structures of small biological molecules, the latter from the 
Cambridge Crystallographic Data Centre,20 using neutron 
scattering data where available as these include the 
deuterium positions. Information was taken from 
diffraction studies of 18 carbohydrates and hydration 
structures of nucleosides, nucleotides, purines, pyrimidines 
and other molecules where hydrogen bonds with water 
have been observed. More restricted searches have been 
published for carbohydrates21 and small-tnolecule 
components of the nucleic acids.22
Our survey has shown a narrow distribution of 0-H---0 
bond lengths in these different environments [Fig. Kail, in 
the range 2.8 ± 0.1 A, the value used in the simulation. The
DOl: 10.1039/b003723k
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hydrogen bond angle distribution is wider fFig. l(b)l and 
the angle constraint our program uses for the ring-forming 
hydrogen bonding step is normally set in the range 180 ± 
25° to reflect the experimental data. Measurements of pair 
correlation functions in liquid water indicate that our 
chosen values are realistic,2 with the 0 - 0  distance very 
close to 2.8 A and the O-H distance at 1.8 A. This implies 
that the O-H -O  bond angle is near to 180°, since the O-H 
covalent bond length is close to 0.96 A.
□ tea and clathfaiw:
□ CCOC data
2 1 J', 2 5 -2  7 2.7 -29
O 0  irtntalomic dislanm/A
29 - J I 3.1-33
□ Ico and dalhralos 
OCCDC data
145 -150 150 -155 155 1 BO 160-165 165 170 170 -175 175 -180 
0-0  0  angle/”
Kig. 1 Survey of hydrogen bond geometries in ices and clathrate 
hydrates, and small biological molecules from the CCDC. (a) 
Distribution of 0 —0  interatomic distances for ices and clathrate 
hydrates (grey bars) and hydrates of small biological molecules 
tfom the CCDC (clear bars), (b) Distribution of O-D—O bond 
angle for ices and clathrate hydrates (grey bars) and hydrates of 
small biological molecules from the CCDC (clear bars).
Solutes without internal rotation
In our model, a random hydrogen-bonding site (X) on a 
solute molecule is chosen. A water molecule is added at this 
site, such that the X-H-O angle is 180° and the X-O 
distance is 2.8 A. A test is carried out, to determine whether 
the water oxygen is the correct distance for H-bonding to any 
other site (Y) in the molecule; if this test is passed, the water 
is rotated in 10° steps, to determine whether a hydrogen bond 
can be formed, satisfying the O-H -Y  angle criterion of 180 ± 
25°. If this test is also passed, a ring is formed and another 
site is chosen at random, for the whole sequence to be 
repeated. If either the proximity or angle test fails, no ring is 
formed and another water is bonded to the first water. The 
proximity test is again carried out, between the terminal 
water oxygen and any other potential H-bonding site. If this 
test is passed, the terminal water is rotated as before, testing 
for possible H-bonding and ring formation. If either test fails, 
the penultimate X-H-O bond is rotated in steps, testing after 
each rotation for proximity of the terminal oxygen to a 
potential H-bond site and if appropriate for angle, as before. 
If no ring is formed, a further water is added and the whole 
process is repeated, if necessary making a complete stepwise 
rotation around the penultimate O-H-O bond, then a one- 
step rotation around the X-H-O bond, followed by a 
complete rotation around the penultimate O-H-O bond and 
so on until the X-H-O bond has rotated through 360°. In this 
way the whole of the space is tested for potential ring- 
formation. In a long chain of waters every X-H-O or O -H - 
O bond is rotated, except that the most recently added water
is rotated only when the proximity test is passed. Once a 
ring is formed, the ring is retained without further 
adjustment and the process is restarted.
The speed at which the simulation occurs is directly 
affected by the chosen rotational increment. If each 
increment is 10°, there are 36 steps to achieve complete 
rotation and the time taken is proportional to 36" where n  is 
the number of bonds around which rotation occurs. Despite 
the very large number of calculations required, on a 400 
MHz PC the simulation takes only a matter of seconds 
when rotation occurs around four bonds or less, but rotation 
around five bonds takes over a minute and rotation around 
six bonds takes about one hour (see below). In practice, 
there is no need to add more than four waters, since further 
water molecules will tend to form rings with the First added 
water in the chain, excluding the solute, as shown in Fig. 2 
below.
Fig. 2 Methylamine with a ring of water molecules attached by 
just one hydrogen bond.
The structures of all the solute molecules used in the 
simulations were taken from diffraction studies and the 
lone-pair electrons were placed and oriented by examining 
the structures of the solute molecules and the positions of 
water molecules from published hydration studies of the 
solute, where available.
The solutes are described in terms of three-dimensional 
coordinates and the locations, either hydrogens or lone 
pairs, which allow hydrogen bonding. For each hydrogen 
bonding opportunity, a vector is stored specifying the 
direction of the hydrogen bond. The coordinates, together 
with the van der Waals radii of the atoms, specify the size
AVI)




and shape of the m olecule and the regions into 
which the water cannot encroach.
R esults
With a water molecule as the initial ‘solute’, the 
simulation rapidly produces a cluster of mainly five- 
membered rings (Video 1). Using a 400 MHz PC, this 
simulation runs in 90 s for a total of 50 water 
molecules. Each simulation is different, although it is 
not possible to show this in the video. In Video 2 the 
simulation of the formation of the first water ring is 
slowed down to show how the rotations occur. Table 
I  describes the colour notation used.
a  >11 s'hclvoi-
r
Water
AVI motion picture (2 Mb)
GIF motion picture (0.2 Mb)
Video 2
If the water chain reaches a length o f four m olecules 
and the rotations do not detect any hydrogen 
bonding opportunities, as for the structure-breakers 
urea and guanidinium , then that particu lar water 
chain is ‘dissolved’ and the process restarted, 
reflecting a ‘flickering c lu ster’ with a very short 
life. (Video 3) In this way a network o f hydrogen- 
bonded water m olecules is only constructed around 
the solute molecule if  rings can be formed. W ith the 
structure-breaking solutes, many thousands o f  water 
molecules can be added and then ‘disso lved’ w ithout 
a longer-lasting structure being formed.
In contrast, rings o f w ater readily form around the 
s tru c tu re -m a k in g  s o lu te s  su lfa te  ( V ideo  4 ) and
Table 1 Colour scheme for all videos and still 







Lone pair ‘pseudoatoms' Dark blue 
Covalent bond Purple
Hydrogen bond Green
AVI motion picture (8 Mb)
GIF motion picture (0.4 Mb)
Video 3
phosphate, leading to large netw orks around these 
species. The recruitm ent o f the first water molecule 
is random among all the available H-bonding sites 
on the solute. Subsequent w ater m olecules may be 
added at any o f  the three H -bonding sites on the 
end-term inal w ater as the chain is formed, so there 
is a substantial random elem ent in the formation of 
the structured hydration layer. Repetition o f the 
simulation gives d ifferent results every time, but the 
structure-m akers always produce rings o f water 
m olecules, which are allowed to persist. For both 
sulfate and phosphate we assume three H-bonding 
opportunities for each oxygen, disposed at three 
corners o f a tetrahedron. There is a question 
concerning the o rientation  o f these H-bonds, 
relative to the rem aining three oxygens. We have 
assumed that the m olecule w ill adopt a non­
eclipsed conform ation  (Fie. 3 ) and this is 
supported by X-ray data on hydrated su lfa tes.21
Sulfate
AVI motion picture (6 Mb) 
GIF motion picture (0.2 Mb)
Video 4
H aving estab lished  that the sim ulation  gives 
sensible results, in accord w ith the measured 
behaviour o f  the so lu tes, we extended the 
sim ulation to a range o f  m olecules which we 
anticipated would have in te resting  interactions 
with w ater. The sim ple alkylamines have been
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Fig. 3 Structure of the sulfate ion. Lone pairs are shown in blue.
shown to produce clathrates in which the primary amino 
group is H-bonded into the clathrate cage.25 To model this 
efficiently using our software required one small change, to 
avoid the added water molecules orientating H-bond 
vectors towards the alkyl group, since this does not happen 
in reality. In practice only the first water molecule has to be 
controlled in this way, subsequent additions being directed 
by the first one. The result is a strong tendency to form 
cages around the alkyl group, similar to the clathrate 
structure (Video 5).
Methylamine
AVI motion picture (2 Mb)
GIF motion picture (0.03 Mb)
V id eo  S
Phenol and catechol arc both structure-breakers.26 In both 
cases, the hardest part of the simulation lies in deciding 
how the structure should be represented, in terms of the Pi- 
bond vectors. We assumed, in the case of phenol, that one 
lone pair is conjugated with the benzene ring and that the 
other lone pair and the hydroxy proton are in the plane of 
the ring. Water molecules added to this system cannot form 
a ring with four water molecules [Fig. 4(a)! and further 
addition of water molecules results in water->only rings 
forming. In the case of catechol, we assumed that one OH 
hydrogen is H-bonded to the adjacent oxygen and that both 
oxygens have one lone pair conjugated with the ring. This 
results, again, in one H-bond donor and one acceptor and 
again added waters cannot form a ring fFig. 4(b)!.
Fig. 4 Four water molecules attached to phenol (a) and catechol 
(b) showing that a ring cannot be formed.
Solutes with internal rotation
Given that there are practical limits on the number of bonds 
about which rotation can be allowed to occur, very large or 
complex solutes are beyond the presently available 
computing power (a 400 MHz PC). However, solutes can 
be modelled in which up to four internal bonds are allowed 
to rotate, with up to two added waters, in a tolerable time 
span. Bthanedio! (1,2-dihydroxyethane, ethylene glycol) is 
a known structure-brcaker,-- with rotation possible about 
three internal bonds. We are therefore able to add up to 
three water molecules in reasonable computer time. When 
we do this, using rotational increments of 10°, a ring is 
sometimes formed with two water molecules but most often 
with three: we assume that the model misses with two 
waters when chance puts the potential bond between two 
10° steps. Presumably, if we were able to use sufficiently 
small rotational increments, a ring would be formed with 
two waters every time. However, a reduction to even 5° 
increments would increase the computation time for 
rotation around five bonds by a factor o f 725/365 i .e . it 
would take 32 times as long (25). With the existing 
processor this is not feasible. Reducing the angle increment 
from 10 to 1° would take 105 times as long for rotation 
around five bonds.
Video 6 shows the start of the search with ethanediol and 
one water molecule: the process takes too long to show the 
addition of the second and third waters. Video 7 shows ring
•  »
Ethylene Glycol
AVI motion picture (8 Mb) 




AVI motion picture (2 Mb)
GIF motion picture (0.1 Mb)
Video 7
formation with three waters and the subsequent build up of 
more rings to give a complex 3D structure.
With either two or three waters, the ring formed with 
ethanediol has the solute in a g a u c h e  conformation (Fig. 5). 
Since the simulation takes no account of conformational 
energy, the preferred conformation is fortuitous, but may 
indicate a driving force for the adoption of the g a u c h e  
conformation, rather than the t r a n s ,  in aqueous solution. 
Since ethanediol is a structure-breaker (and is used as 
'antifreeze'), the formation of rings implies that the 
geometry of the water structure so formed is not compatible 
with the geometry of structures formed in the absence of 
solute.
Fig. 6 Ethanolaminc forming a ring with three added water 
molecules.
Fig. 7 1,3-Propanediol showing a cyclic structure involving just 
one water molecule.
Fig. 5 Ethanediol with three added water molecules.
Bthanolamine behaves in a similar manner. The hydroxy 
group again adopts a g a u c h e  position relative to the amine. 
In both these cases, the internal torsion angle in the solute 
(O -C -C -O  or O -C-C-N) when a ring is formed is always 
close to 60°, i .e .  a non-eclipsed conformation (Fig. 6).
We also ran the simulation using 1,3-propanediol as solute. 
In this case rings formed with either one or two added 
water molecules. The diol again tends to be oriented close 
to the gauche conformation. The two internal torsion angles 
( O -C -C -C  and C -C -C -O ) are close to 60° in the 
structures with one and two conjugated waters (Fig. 7 ).
Discussion
The simulations we have run have given results which 
largely conform with the known behaviour of the solutes, 
as measured by, for example, the depression in the (feezing 
point of water. The widely used structure-breakers urea and 
guanidinium produce non-cyclic, short-lived structures 
which conform to the notion of ‘flickering clusters’, while 
the important structure makers sulfate and phosphate 
produce complex three-dimensional water structures, 
similar to ice. Phenol and catechol behave similarly to the 
other known structure-breakers, while methylainine readily 
produces cages around the alkyl group, in accord with the 
clathrate structure.
The flexible diols are more difficult to assess in the initial 
stage of hydration, as shown here. Further addition of water 
molecules is required, to build up more complex structures. 
These structures will require the development of new 
methods of assessment, to compare their geometry with that 
of the ices and clathrates, in a quantitative manner. We are
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working on methods to accomplish this, since it could be 
argued that the very simple structures depicted here could 
be modelled by physical means. The strength o f the 
computer method lies in the ability to add large numbers of  
waters and to assess the nature o f the structures so formed.
It is central to our approach dial rings are more stabie than 
chains, as predicted by theory, and that the higher levels o f  
3D structure are more stable than simple rings: the analogy 
with the chemistry o f sp3 carbon is that the most stable 
structure is diamond, which is geometrically analogous to 
many o f the ices and clathrates, except that diamond does 
not have the cavities. We would assume that the random 
transfer o f thermal energy would relatively easily break a 
chain, with little probability o f  re-formation, whereas a ring 
requires two breakages and higher order structures are even 
less likely to be broken up. The overall effect, we assume, 
is not that the ice-like structures persist indefinitely, but 
that they have a longer lifetime than lower-order structures. 
The increased statistical probability o f higher order is 
sufficient to change the properties o f the solution. The 
results shown here are the first stage in the simulation o f  
larger structures, involving large numbers o f water 
molecules, which may show differences in hydration 
between different solutes which are not amenable to easy 
inspection.
The applicability of our approach is potentially wide- 
ranging. It may be possible, for example, to predict the 
formation o f clathrates in situations o f practical utility, such 
as in the development o f new aerosol formulations where a 
hydrophobic gas may come into contact with water and 
block the delivery device. Of broader significance, 
however, is the potential to model the interactions of  
biochemically and pharmacologically important molecules 
with water. Adrenaline and noradrenaline, for example, 
both have structure-breaking geometry in the catechol 
moiety and an ethanolamine unit at the other end o f the 
molecule. Whether this is significant in the context o f  their 
interactions with adrenoceptors remains to be seen; it is 
possible that a local, specific ‘denaturing’ effect on the 
receptor protein is central to their biological action. With 
increased computing power and refinement o f  the present 
software, it will be possible to simulate the hydration layer 
of these more complex molecules.
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R e v i e w  A r t i c l e
Water structure theory and som e implications 
for drug design
T. H. P lum ridge a n d  R. D. W aigh
Abstract
The development of theories of w ater structure has been hindered in the  past by the difficulty of 
experimental measurement. Both measurem ent and computer modelling studies have now  reached 
th e  stage where theoretical treatm ents of w ater structure are converging to  a broadly acceptable 
model. In current understanding, w ater is a mixture of randomly hydrogen-bonded molecules and 
larger structures comprised of tetrahedral oxygen centres which, w hen hydrogen-bonded to  each 
other, lead to  five-membered and o ther rings which can aggregate to  form three-dimensional 
structures. Evidence is taken from studies of the  ices, from clathrates and o ther solid solutions, as well 
as from liquid solutions, th a t certain motifs occur very frequently and have relatively high stability, 
such as th e  (H2O)20 cavity-forming structure known from studies on clathrates. The implications of 
recent models of w ater structure for an understanding of biological events, including the  interactions 
of drugs with receptors, are profound. It is becoming clear th a t modelling of aqueous solutions of any 
molecule must consider the  explicit interactions with w ater molecules, which should not be regarded 
as a continuum: w ater itself is not a continuum. Solute molecules which possess hydrogen-bonding 
groups will provoke the formation of further hydrogen-bonding chains o f w ater molecules: if these 
can form rings, such rings will tend to  persist longer than chains, giving th e  solute a secondary identity 
of associated w ater which may play a role in molecular recognition. Solutes tha t do not have 
hydrogen-bonding capability, or regions of solutes which are non-polar, may also produce partial 
cage-like w ater structures th a t are characteristic of the solute.
The classification of many solutes as structure makers or^tructure breakers has relevance to  the  
interactions between ligands and large biomolecules such as proteins. While it is generally accepted 
th a t sulfate and urea, respectively structure maker and breaker, may alter protein conform ation 
through effects on water, it has not been recognised th a t bioactive ligands, which also change the  
conform ation of proteins, may do so by a related, but m ore selective, mechanism. Very early studies 
of cell contents suggested th a t the  associated w ater m ight be different from bulk water, a concept 
th a t lost support in the mid-20th century. Current theories of water structure may invite a reappraisal 
of this position, given the  observation th a t structuring may extend for many molecular diam eters 
from an ordered surface.
Introduction
Water is the dispersion medium for all the biochemical reactions that constitute the 
living process and takes part in many of these reactions. Despite the chemical simplicity 
of the water molecule, its bulk properties are very peculiar and have attracted a large 
amount of scientific attention. Recent physico-chemical studies, allied to increasingly 
sophisticated computer simulations, have reached the stage where many o f the old 
controversies have been resolved. Structuring in liquid water is being described with 
increasing confidence, in the pure liquid, at interfaces and in solutions. This review 
attempts to draw together much current understanding of water and to place the 
interactions of small molecules (e.g. drugs) and large molecules (e.g. receptors) into that 
context.
Early theories of water structure
The immiscibility of water with extruded cytoplasm from plant and animal cells led 
some mid-19th-century biologists to believe that water in the cytoplasm is bound
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to the macromolecular constituents (Nageli 1855; Kuhne 
1864). The suggestion was made that water may contain 
solid particles, and in 1891 Vernon postulated that maxi­
mum density effects could be explained by the aggregation 
of water molecules (Davidson 1973). Some water in protein 
solutions and in living cells refused to freeze at temperatures 
as low as -20°C  (Rubner 1922).
In the 1930s Gortner and co-workers carried out experi­
ments dissolving sucrose into water in various environ­
ments and determining how much had dissolved by 
measuring lowering o f the freezing point (Gortner & 
Gortner 1934). They found that bound water, for example 
cell water, dissolved less sucrose than free water did and 
hence inferred that water in these situations was more 
structured than the bulk.
At the same time, the first X-ray (Morgan & Warren 
1938) and infrared studies (Magat 1936) on liquid water 
were carried out, and this new perspective allowed Bernal 
& Fowler (1933) to advance the first plausible model for 
liquid water -  the uniform continuum model. In this model, 
all oxygen atoms retain their four-coordination, but the 
hydrogen bonds are bent to such an extent that an in­
stantaneous view from the central oxygen would see no 
order beyond the nearest neighbours. A random network 
model with soft hydrogen bonds implies a water network 
with apex-linked polygons in rings o f 4-, 5-, 6- or more- 
membered rings, similar to ices and clathrates, but 
randomly arranged.
Even at this early stage the bound water theories met 
with considerable opposition. In a 1940 review, Blanchard 
compiled evidence against the bound water viewpoint on 
the basis of vapour-pressure measurements and the fact 
that ethylene glycol will distribute itself evenly between 
erythrocytes and external solution (Blanchard 1940). He 
also stated that water can be supercooled to — 20°C and 
suggested that the complexity o f the protein system made 
accurate determination of freezing point almost impossible. 
This review marked the end o f the first phase o f  research 
into structured water as the membrane theory, where the 
cell was assumed to maintain a different composition from 
that o f its surroundings by the use of sodium pumps located 
in the cell membrane, became generally accepted and the 
hydration theory of cell water was virtually abandoned.
Following on from work on the origin o f negative partial 
entropies exhibited by various simple solutes in aqueous 
solution (Eley 1939), Frank & Evans (1945) introduced the 
concept of icebergs induced in water by solute molecules. 
On the basis of volume and entropy measurements, while 
studying the effects o f non-polar molecules dissolving in 
water (noble gases, CO, methane, etc.), they found that 
these molecules affect the water around them making it less 
dense, at lower entropy and less mobile than bulk water, 
essentially making it more crystalline and more structured. 
They postulated that some species would act in the opposite 
way, making the water less structured and more dense than 
bulk. This was the first mixture model o f liquid water. 
Subsequent models have generally been based either on 
this work or on Bernal & Fowler’s continuum model 
(Bernal & Fowler 1933).
At the same time, Samoilov (1946) was investigating the
nature of the interactions between water and ions in 
solution. Hall (1948), on the basis o f acoustic relaxation in 
water, advanced the first detailed mixture model, based on 
the concept of water as a mixture o f two distinguishable 
species. Pople (1951), working with the model proposed by 
Bernal & Fowler (1933) and his own studies into the 
properties o f the hydrogen bond, suggested that hydrogen- 
bond bending could explain properties such as the tem­
perature dependence o f  the dielectric constant o f water.
The next major step forward for the structured water 
viewpoint occurred when Frank & Wen (1957) postulated 
that the existence o f long-lived structures in liquid water 
was unlikely and that a more useful description might 
involve flickering clusters of hydrogen-bonded water 
molecules. They classified ions as either being structure 
makers or structure breakers, and suggested a mechanism 
by which this may occur. Basically, the ion is surrounded 
by three concentric regions: the innermost, in which all 
water is immobilised; the second in which water is less ice­
like (i.e., more random than normal); and the third, normal 
water polarised in the normal way by the ionic field, which 
has become relatively weak this distance from the ion.
The ions originally classified by Frank & Wen were as 
follows:
structure makers: L i\  F", Mg2*, OH", (n-C4H,)4N + 
structure breakers: K+, Rb+, Cs+, Cl", Br“, I", NOj,
CIOJ, so;
They postulated that the structure-breaking region was 
caused by the balance between the two competing orienting 
influences acting on any given water molecule in this region 
(i.e. the normal water influence from the outer zone and the 
spherically symmetrical ionic field dominating in the inner 
zone). They also attributed stronger structure-making ions 
with a high enough degree of incipient hydrolysis o f the 
first water layer around the ion to produce hydrogen charge 
centres which would act as edge nuclei for cluster formation 
and stabilisation for clusters once formed. This increases 
the ice-likeness o f the water in these environments.
Shortly afterwards, Kauzmann (1959) discussed the 
possible role of water in protein conformation and 
denaturation incorporating Frank and Evans’ model. He 
reviewed the role o f  apolar group interactions or hydro- 
phobic bonding in maintaining the tertiary structures o f  
proteins, and suggested that comparative studies o f aque­
ous and non aqueous solutions o f simple analogues o f  
apolar amino-acid side chains (alkanes, for example) may 
provide an insight into the peculiarities o f  water as a 
solvent. This sparked off a whole range o f publications 
describing various aspects of hydrophobic bonding in 
biological systems.
Pauling (1959) proposed a model for the structure o f 
water in which clathrate cages are present and may be 
occupied by interstitial non-bonded water molecules. This 
model was considered to be too crystalline (Stillinger 1980), 
and is not consistent with X-ray diffraction data, but less 
rigidly defined cavities, more disordered than the clathrates, 
would fit the experimental evidence available both in 1959 
and today.
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Most of the material arising from this vast amount o f  
research in the 1960s and ’70s is summarised in Felix 
Franks’ 7-volume collection, Water : a comprehensive treat­
ise (Franks 1972-1982).
At present, all models developed for the structure of 
liquid water still fall into two main classes: continuum 
models, originally proposed by Bernal & Fowler, and 
mixture models based on Franks’ work. Speculation re­
garding the nature of molecular motions in water led to 
comparisons of various bulk and microscopic transport 
processes (e.g. viscosity, self-diffusion and dielectric and 
NMR spin-lattice relaxation). High-precision Raman 
studies o f the hydrogen bonding modes in liquid water 
followed (Walrafen 1964), and infrared and Raman tech­
niques have been applied to the study o f intramolecular 
OH and OD stretching modeS in H20  and D ,0  (Walrafen 
1968; Senior & Verall 1969). This information was carefully 
analysed to deduce whether evidence suggested that water 
should be treated as a mixture and, although this was not 
fully resolved, mixture models were favoured. Frank & 
Evans’ iceberg theory has now become accepted as the 
standard model o f hydrophobic hydration (Blokzijl & 
Engberts 1993).
Structure-making and structure-breaking  
m olecules
It has long been known that the native conformations of  
proteins, as assessed by enzyme activity, denaturation 
temperature and solubility, are stabilised by some solutes 
and destabilised by others (e.g. Collins & Washabaugh
1985). These effects are additive; a strongly denaturing 
(structure breaking) solute such as urea can be balanced by 
the action o f a strongly stabilising (structure making) solute 
such as trimethylamine oxide. Two structure-breaking 
solutes will destabilise protein structure more than if either 
was used separately.
The structure-making (kosmotropic) or structure- 
breaking (chaotropic) action o f solutes is determined in 
aqueous solution by:
A change in viscosity (structure breakers lower it)
The rate of exchange of water molecules (structure breakers 
lower energy of activation)
The longitudinal relaxation rate of water molecules as 
measured by NMR (structure breakers increase the rate).
The entropy of hydration is related to the structure- 
making and -breaking properties of solutes. Marcus (1986) 
estimated the entropy contribution of structured water 
effects by subtracting contributions due to compression, 
immobilisation and electrostatic effects from the standard 
molar entropies o f hydration for a set o f 50 ions. This 
structural entropy contribution is positive for structure 
breakers and negative for structure makers, and was found 
to be in accord with experimental findings despite the 
assumptions involved in the calculations.
The Hofmeister series, discovered over a hundred years 
ago (Hofmeister 1888) originates from the ranking of
various ions based on their ability to precipitate hen egg- 
white proteins. This series has also been shown to affect the 
structuring (at one end of the series) or denaturing (at the 
other end of the series) of biological macromolecules in the 
same order (Collins 1997). The series shows opposite 
correlations for anions and cations with their degree o f  
hydration.
citrate3' > sulfate2- >  phosphate2- >  F- >  Cl- >  Br- >  I- >
NOj > CIO-
Strongly hydrated Weakly hydrated
Protein stabilising Protein denaturing
N(CHj)J > NH4+ > Cs+ > Rb* > K+ > Na+ > H* > Ca2+ >
Mg24 > Al3+
Weakly hydrated Strongly hydrated
Protein stabilising Protein denaturing
Structure-breaking ions destroy the hydrogen-bonded 
water network in a manner which is similar to the effect o f  
increased temperature or pressure (Leberman & Soper
1995). Anions hydrate more strongly than cations of the 
same ionic radius, as water hydrogens can approach about 
0.8 A more closely than the water oxygen. Small ions are 
strongly hydrated with small or negative hydration 
entropies creating local order. Large singly charged ions 
have larger positive entropies o f hydration, and so act like 
hydrophobic molecules, their binding being dependent on 
van der Waals forces as well as their charge.
Very similar molecules often have totally opposite effects. 
Both meta- and /rara-hydroxybenzoic acids are structure 
makers, whereas the ortho-form is a structure breaker 
(Chatteijee & Seal 1992). Sulfate is almost exactly the same 
size and shape as perchlorate, but sulfate is a strong 
structure maker and perchlorate a strong structure breaker 
(Collins & Washabaugh 1*985; Yokoyama et al 1992). The 
reasons for this still remain unclear.
The Walden product, which is the product o f viscosity 
and conductivity at infinite dilution o f  a solution, has been 
shown to be a measure of the water-structuring activity o f  
the solute. This has been used to quantify structure-making 
and -breaking effects o f amino acids, in conjunction with 
viscosity and spectroscopic studies. Most amino acids 
exhibited some structure-breaking activity. L-Lysine, l- 
glutamic acid, L-aspartic acid and their salts showed 
stronger structure-breaking activity. Dextrose, however, 
behaved as a classic structure maker and reversed the 
structure-breaking action of L-lysine (Lutz et al 1994).
Pure w ater
Structure o f  the isolated water molecule 
The structure o f the isolated water molecule is known 
accurately from spectroscopic studies. The H—O—H angle 
and O— H bond lengths were first determined accurately 
by Darling* Dennison^ 1940). They found the O— H bond 
length to be 0.95718 A and the H—O— H angle to be 
104.523°. These values have since been validated by ex­
perimental (neutron scattering: Soper & Phillips 1986) and 
theoretical calculations (e.g. ab-initio: Goddard & Hunt
1974).
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Figure 1 Three possible arrangements of cyclic hydrogen bonds: homodromic (A); antidromic (B); and heterodromic (C).
Each water molecule can form up to four hydrogen 
bonds in a tetrahedral arrangement: two acceptor bonds 
through the lone pairs and two donors through the 
hydrogens. This is a unique feature of the water molecule 
and leads to three-dimensional networks as, for example, 
in ice structures.
Cooperative effects
An important feature o f hydrogen bonds is that one will 
tend to reinforce another. This is known as cooperativity, 
and allows large tetrahedral networks of hydrogen-bonded 
water to form. Cooperativity, or non-additivity o f  hy­
drogen bonds, was conceptually inferred from the early 
theories o f liquid water and aqueous solutions (Frank 
1958; Kavanaugh 1964), and first demonstrated by early 
ab-initio quantum mechanical calculations on water com­
plexes (Del Bene & Pople 1970; Hankins et al 1970). 
Cooperative patterns were found in the first systematic 
studies o f hydrogen bonding in carbohydrates (Jeffrey et al 
1977). The water molecule acting as acceptor in a particular 
hydrogen bond will strengthen the other hydrogen bonds 
of the water molecule acting as a donor (Tombari et al
1999), and so in liquid water cooperativity strengthens the 
hydrogen bonds by up to 2.5 times the strength o f the 
hydrogen bond in the water dimer (Luck 1998).
This effect is also apparent in rings of hydrogen-bonded 
water. For example in the five-membered rings shown in 
Figure 1 the homodromic system (a) where the hydrogens 
all point in the same direction (clockwise or anticlockwise) 
around the ring is more stable than the antidromic system 
(b) where some hydrogens point in the same direction, 
which is itself more stable than the heterodromic arrange­
ment (c) with only two hydrogens aligned (Peeters 1995).
Pure water in the solid state
Much more information can be obtained by diffraction 
methods on the structure o f solids than o f liquids. In a 
liquid there are continuous rearrangements o f structure 
occurring within a very short time. This means that only a 
mean environment can be determined, which is the number 
and spatial arrangements o f nearest neighbours of a mol­
ecule averaged over both time and space. The only in­
formation obtainable by X-ray diffraction of a liquid at a 
given temperature is the radial distribution function. This 
is the probability of finding an atom at a radius, r, from the 
central atom, averaged over both space and time. For 
example, an X-ray diffraction study on water will yield 
only the probability o f finding an oxygen atom at a certain 
distance from another oxygen.
With the advent of neutron diffraction, using deuterated 
samples, distribution factors can be determined which give 
the O ...O, O ...D  and D ...D  spacings from which the 
hydrogen-bonding patterns in the first hydration shell can 
be inferred, but interpretation of these patterns in terms of  
nearest neighbours is very difficult.
On the other hand, X-ray diffraction on a solid sample 
will usually establish the crystal structure (i.e., will yield the 
coordinates of all non-hydrogen atoms). Using neutron 
diffraction techniques with deuterated samples, the 
positions o f the hydrogens (deuterous) can also be found, 
allowing hydrogen-bonding patterns to be clearly and 
unequivocally elucidated in the solid state.
Ices
The ice structures reveal the structural patterns for the 
regular cohesion of water molecules in the absence o f other 
species. Arrangements of four-connected tetrahedrally or 
nearly tetrahedrally coordinated hydrogen-bonded water 
molecules are found in all known ice structures. These ice 
structures are characterised by maximisation of the number 
of hydrogen bonds and minimisation of the short-range 
repulsive restraints.
At least 14 distinct ice structures exist, along with at least 
two distinct amorphous phases (Jeffrey & Saenger 1991). 
In all known ice structures each water molecule is hydrogen 
bonded to four neighbouring water molecules. Only ices 
Ih, III, V, VI and VII can be in equilibrium with liquid 
water. All other ices are not stable with liquid water under 
any conditions.
The high-pressure phase lines o f ice-X and ice-XI are still 
subject to experimental verification. Two different forms of
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ice-XI have been found, the high-pressure form having the 
hydrogen atoms equally spaced between the oxygen atoms 
(Benoit et al 1996) whereas the low-temperature form has 
ordered hydrogen bonding (Lobban et al 1998). Ices II, 
XIII, IX, X and XI (both forms) have ordered hydrogen 
bonding whereas in all other ices the hydrogen bonding is 
disordered even down to 0 K, if this is reachable (Suga 
1997). As well as five- and six-membered water rings, the 
high-pressure ices contain four-, seven- and eight- 
membered rings (Saenger 1987).
It has been discovered that the structure of normal ice 
(Ih) is not as simple as originally thought. To explain two 
well-separated optic bands in a high-resolution inelastic 
neutron-scattering study of ice, two different interaction 
strengths o f hydrogen bonds were proposed (Li & Ross 
1993). It was estimated that the numerical ratio o f strong- 
to-weak hydrogen bonds was o f the order o f 2:1. The two 
interaction strengths were attributed to dipole or other 
types o f electronic interactions, caused by proton disorder 
and the relative strengths were estimated to be approxi­
mately 2 :1 (Li et al 1994).
It has recently been found that water under extreme 
pressure at low temperature (493 atmospheres at -40°C ), 
between two hydrophobic plates held a nanometre apart, 
will contract into a two-dimensional glass rather than 
expanding into a known ice form. This glass, known as 
Nebraska ice, is made up of approximately planar 5-, 6- 
and 7-membered rings (Koga et al 2000).
Hydrogen-bond geometry in water in the solid slate 
A wide-ranging survey o f  all the known ice structures, 
together with data for clathrates and simple hydrates, found 
that the length of the hydrogen bond is remarkably constant 
in all the ices and differs only slightly with a wide variety of 
hydrogen-bond donors and acceptors (Plumridge et al
2000). The hydrogen-bond angle normally assumes values 
in the range 180 +  25°, consistent with maintenance of the 
0 . . . 0  distance (Figure 2).
Pure water in the liquid state
While there is general agreement that the structure of liquid 
water is determined by hydrogen bonding, the structure 
has been notoriously difficult to describe. In liquids, atom 
topologies exist for very short lifetimes, so they can only be 
observed by techniques recording the structure on an even 
shorter timescale. The techniques available, in decreasing 
timescale resolution, are infrared and Raman spectroscopy, 
dielectrical absorption and NMR spectroscopy, and in­
elastic neutron scattering. Despite the increasing scope of 
these techniques, for example by using isotopic substitution 
to enhance neutron diffraction data, the very short lifetimes 
of particular liquid-phase topologies, estimated on the basis 
of relaxation times to be of the order o f 10_n s (Frank & 
Evans 1945), mean that the only structural information 
which can be obtained by any of these techniques has to be 
averaged over time. Thermodynamic properties can be 
derived from the averaged long-lifetime atom distributions 
obtained from X-ray and neutron scattering.
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Figure 2 Survey of hydrogen-bond geometries in ices and clathrate 
hydrates, and small biological molecules from the CCDC. A. Dis­
tribution o f O .. .O interatomic distances for ices and clathrate hydrates 
(grey bars) and hydrates o f small biological molecules from the CCDC 
(clear bars). B. Distribution o f O—D ...O  bond angle for ices and 
clathrate hydrates (grey bars) and hydrates o f small biological 
molecules from the CCDC (clear bars).
In liquidsf the molecules are in constant translational 
motion. Although this requires that long-range order is 
lost, there is still some short-range order. This short-range 
order has been found to extend to at least 8 A even with 
totally inert, non-polar and spherically symmetrical 
molecules such as in liquid argon (Eisenstein & Gingrich 
1942). The distance over which this short-range order exists 
should be greater when there is extensive hydrogen 
bonding, as in water.
There is a large number of anomalies in the physico­
chemical properties o f  water, including its unusually high 
melting point and boiling point, and the density anomaly. 
Whereas most liquids are less dense than their respective 
solids, water at 4°C is 8% more dense than ice. Upon 
melting, ice undergoes an increase in density that continues 
during heating until the temperature reaches 4°C. This 
contradicts the idea of thermal expansion, where most 
substances increase in volume with an increase in tem­
perature. Above this maximum density, water behaves 
normally, decreasing in density with increasing tempera­
ture.
There are o f the order of 38 such anomalies in the 
macroscopic properties of water and, while the physical 
bases o f most are well understood, it has not been possible 
so far to devise a computer simulation method that can 
explain all o f  them.
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Computer simulation o f pure water
Since about 1980, increasing computing power has meant 
that complex simulations involving many hundreds of 
simulated water molecules have become possible. A large 
number of different models have been, and still are, 
proposed to represent water, and although each is capable 
of reproducing some of the macroscopic properties of 
water, no one model has explained all o f them. Simulations 
involving just water molecules are now usually only run to 
test the ability of new water models to predict measurable 
thermodynamic properties of water and hence to refine the 
parameters involved in the simulation.
The models are usually used in conjunction with either 
molecular dynamics or Monte Carlo techniques, usually 
modelling dilute aqueous solutions involving o f  the order 
of a few hundred water molecules and usually only one or 
two solute molecules. These techniques are very powerful 
and are now routinely applied to increasingly complex 
systems such as docking ligands to hydrated protein 
structures.
Monte Carlo methods can be loosely described as stat­
istical simulation methods where the simulation is driven 
by random numbers. Many simulations are performed 
(multiple trials or histories) using these random numbers 
and the desired result is taken as an average over the 
number of observations. In many practical applications, 
the statistical error can be predicted in this average result, 
and hence the number o f Monte Carlo trials that are 
needed to achieve a given error can also be estimated.
The first Monte Carlo calculations on water that were 
able to simulate experimentally derived distribution 
functions with any degree of accuracy used 343 water 
molecules at 26°C (Ben-Naim 1971) using an improved 
Hartree-Fock potential with empirical corrections for the 
electron correlation energy. This success prompted 
Clemen ti and coworkers to lead a long and computationally 
expensive series of simulations beginning with the wave 
functions o f water monomer, dimer, trimer and tetramer 
systems using potential functions from quantum mech­
anics, and Monte Carlo techniques to move the molecules 
classically (Clementi et al 1976). This study proved that 
accurate thermodynamic data could be obtained from ab- 
initio calculations in quantum chemistry (see Ab-initio 
section). At this time, no evidence from Monte Carlo 
studies had been found to support two-state or iceberg 
theories of liquid water.
Molecular dynamics simulation is a technique whereby 
successive configurations of the system are generated by 
integrating Newton’s laws of motion, based on the positions 
and the velocities o f the individual particles. In pictorial 
terms, atoms will move in the computer, bumping into each 
other, wandering around (if the system is fluid), oscillating 
in waves in concert with their neighbours, perhaps evap­
orating away from the system if there is a free surface, and 
so on, similarly to the way atoms in a real substance 
behave. This method allows the prediction of the static and 
dynamic properties o f substances directly from the under­
lying interactions between the molecules.
Computer simulations have increased the demand for 
accuracy o f the models. For instance, a molecular dynamics 
simulation allows the melting temperature o f a material to 
be evaluated, and modelled with an interaction law. This is 
a difficult test for the theoretical model to pass so the 
simulation discloses critical areas and provides suggestions 
to improve the models.
When computer simulation results can be compared 
directly with experimental results, simulation becomes an 
extremely powerful tool, not only to understand and in­
terpret the experiments at the microscopic level, but also to 
study regions which are not accessible experimentally, or 
which would need very expensive experiments.
Molecular mechanics studies o f conformational preferences 
Molecular mechanics treats molecules as atoms linked 
together with springs, allowing for harmonic bond 
stretching and bond angle bending. Each atom has finite 
spherical volume and relatively sharp boundaries with 
sinusoidal torsional energies. The force field for a typical 
molecule (e.g. a protein) can be given as a sum o f the 
various components inducting bond stretching and bend­
ing, torsional potentials and non-bonded interactions. The 
resulting equations for the total energy can be combined 
with a variety o f algorithms to locate energy minima on a 
conformational surface.
Models used to describe water
The TIP (transferable intermolecular potential) family of  
potentials has been used for modelling liquid water. TIP4P 
(Table 1) is a rigid four-site water molecule (Jorgensen et al 
1983). This model attempts to capture the characteristics of  
a dipolar molecule by creating an imaginary fourth charged 
site on the bisector between the two hydrogen sites (Figure
Table 1 A comparison o f common water models.
Model Type £ (kJ mor1) 1, (A) h(A) 1i 92 0° <D°
SPC A 0.6500 1.0000 _ + 0.410 -0.8200 109.47 -
SPC/E A 0.6500 1.0000 - + 0.4238 -0.8476 109.47 -
TIP3P A 0.6364 0.9572 - +0.4170 -0.8340 104.52 -
TIP4P B 0.6480 0.9572 0.15 +0.5200 -1.0400 104.52 52.26
T1P5P C 0.6694 0.9572 0.70 +0.2410 -0.2410 104.52 109.47
The type refers to the structures shown in Figure 7 (Jorgensen et al 1983; Mahoney & Jorgensen 2000).
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Figure 3 Models used to describe water.
3). The imaginary fourth site and the two hydrogens have 
an electrostatic charge, while the oxygen has only a 
Lennard-Jones potential. The parameters were obtained 
by fitting experimental, thermodynamic and X-ray struc­
tural data for liquid water at 298 K and 1 atm.
This model yields reasonable geometric and energetic 
results for the water dimer and is routinely used in simu­
lations o f aqueous solution (Barnes & Finney 1979).
SPC, the simple point charge model (Table 1), is an 
intermolecular potential function that gives good agree­
ment with liquid water. This is a three-point charge model 
with a (6-12) Lennard-Jones potential on the oxygen, and 
charges of0.41 on the hydrogens and —0.82 on the oxygen. 
The water geometry is shown in Figure 3, with O—H 
distances o f 0.9572 A, and an H—O—H angle of 104.52°. 
SPC/E is an extended version o f this model.
Recently, the TIP5P model has been developed 
(Mahoney & Jorgensen 2000). This is a variation on the 
TIP3 and TIP4 families o f models with five atom centres 
(i.e., the lone pairs are explicitly defined). Although this is 
a new model that has not yet been used widely, in-house 
development has shown that this model is more accurate 
than any previous simple models. The TIP5P model ac­
curately predicts the diffusion constant o f  water at 
temperatures between —25 and 75°C and pressures be­
tween 1 and 300 atm. The predicted value is 2.62 +  0.04 as 
compared with the experimental value of 2.30 (Mahoney & 
Jorgensen 2001). This is much better than any other 
method, with TIP4P predicting 3.29 +  0.05, and signifi­
cantly improves the model’s ability to describe the maxi­
mum density anomaly.
The water models are Jpsted by how accurately they am  
reproduce quantitative information that can be determined 
experimentally. Table 2 shows that recent models can 
predict the physical properties o f water with a reasonable 
degree o f accuracy. However, the approximations involved 
mean that no present model can explain all the macroscopic 
properties o f water (Finney 2001).
These and other similar models are routinely used in 
conjunction with either molecular dynamics or Monte 
Carlo simulation techniques to predict low energy con­
figurations o f aqueous solutions, or using ab-initio tech­
niques if the system is simple enough to be solved by this 
method.
Ab-initio calculations
Ab-initio molecular orbital computation has reached the 
stage that in some areas the calculations are more accurate 
than experimental results. However, there are so many 
possible variables in terms o f the position of the nuclei that 
even in a system such as (H20 ) 3 a vast amount o f computer 
time is required to satisfy the statistical mechanics 
constraints.
It is possible to calculate extremely accurate wave 
functions for monomeric HzO incorporating the effects o f  
many thousands o f excited configurations. Properties such 
as dipole moment, charge distribution and spectroscopic
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Table 2 Comparison of physical properties o f water calculated for each o f the common water models with experimentally determined results.
Model Dipole moment Dielectric constant Self diffusion Average configurational Density maximum Expansion coefficient
(10 s cm2 s ') energy (kJ mol ') CC) (10^°C-')
SPC 2.27 65 3.85 -41 .0
SPC/E 2.35 71 2.49 -41.5 -3 8
TIP3P 2.35 82 5.19 -41.1 - 1 3 9.2
TIP4P 2.18 53* 3.29 -41.8 -2 5 4.4
TTP5P 2.29 81.5 2.62 -41.3 + 4 6.3
Expt 2.65, 3.0 78.4 2.30 -41 .5 + 3.984 2.53
Expt = experimentally determined. All the data are al 25°C and 1 atm, except *at 20°C (Jorgensen et al 1983; Kusalik & Svischev 1994;
Mahoney & Jorgensen 2000).
H
H
Figure 4 The structure o f the water dimer. R00 =  2.98 A ; 0a =  58°;
=  50° (Dyke et al 1977). Dotted lines arc the bisectors of the 
H—O—H angles.
constants have been calculated many times in good agree­
ment with experimentally determined values (see for 
example Goddard & Hunt 1974), but the techniques be­
come much more computationally demanding when larger 
water complexes are considered.
The water dimer (H ,0 )2 has been studied spectro­
scopically (Dyke et al 1977) by expanding water vapour 
through a pinhole nozzle to produce a molecular beam of 
hydrogen-bonded dimers. Radio frequency and microwave 
transitions were observed, resulting from changes in the 
rotational energy of the dimer. These spectra were inter­
preted along with the dipole moment o f the dimer to give 
the structure in Figure 4. This is the trans-linear complex 
and is in reasonable agreement with previous ab-initio 
calculations (Morokuma & Pedersen 1968; Lie & Clementi 
1975), with the intermolecular distance in excellent agree­
ment, good agreement with 0d but only poor accord with 
the dK angle. Such comparisons between theoretically calcu­
lated structures without prior structural knowledge and 
experimentally determined structures allow models to be 
evaluated, and indeed many of the currently used models 
for liquid water are derived from potential functions tested 
on the water dimer. The best fit with the water dimer was 
given by a simple point charge model, similar to those 
proposed by Bernal & Fowler (1933).
The calculations become much more complex when 
considering three or more waters. The water trimer was 
investigated regularly in the 1970s and ’80s (e.g. Del Bene 
1971), but the structure remained unresolved; the investi­
gators could not be certain whether it was an open structure
Figure 5 The global minimum conformation for five TIP4P 
molecules (Wales & Hodges 1998).
with two hydrogen bonds or a cyclic structure with three. 
McDonald &J£lein (1978^concluded that there was little 
chance o f reconciling the properties of the liquid and 
gaseous states on the basis of a single water dimer potential. 
The first accurate calculations on the structures of clusters 
involving three and four water molecules were carried out 
by Clementi and coworkers (Niesaret al 1990). They found 
that the extra waters make the clusters more stable than the 
dimer. Model potentials were derived which included 
many-body terms and when used in simulation o f  bulk 
water gave radial distribution functions that agreed well 
with those deduced from X-ray and neutron diffraction 
studies. Calculations using the best currently available 
potentials have indicated that a square ring of four water 
molecules and a cubic array of eight waters are particularly 
stable (Vegiri & Farantos 1993). Cooperative effects have 
also been demonstrated by ab-initio computation. It has 
been shown that a cyclic homodromic water tetramer has 
30 % more energy than four isolated dimers (Koehler et al 
1987).
Various quantum mechanical calculations on randomly 
generated arrangements o f water molecules have shown 
that rings are more stable than chains (Gregory & Clary
1996), and it has been experimentally verified that the 
predicted minimum energy structures are found in bulk 
water (Liu et al 1996). Figure 5 shows the global minimum 
energy conformation for five TIP4P water molecules.
Weinhold (1998a) has used a combination of ab-initio
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Figure 6 Geometry configurations, corresponding to the stationary points on the potential energy surface of the (H20 )n clusters as predicted 
by the diatomics-in-molecules (DIM) method (reprinted from Grigorenko et al (2000) with permission from the American Institute of Physics 
and Dr Grigorenko).
computational techniques and Natural Bond Order analy­
sis to shed light onto the electronic principles governing 
hydrogen-bonded clusters. The energetics o f these clusters 
were found to be largely dependent on cooperative charge 
transfer which led to aggregation patterns markedly 
different from those predicted by the pairwise-additive 
potentials in common usage. Weinhold devised the quan­
tum cluster equilibrium theory of hydrogen-bonded liquids 
in which the clusters are treated as the fundamental con­
stituent units rather than individual water molecules. This 
method has been applied to water and has demonstrated 
numerical accuracy for a wide range o f thermodynamic 
properties (Weinhold 1998b).
A related method by which potential energy surfaces of 
hydrogen-bonded aggregates are generated, the diatomics- 
in-molecules (DIM) theory has been developed to over­
come some of the shortcomings o f traditional molecular 
mechanics techniques using quantum mechanical calcu­
lations. The technique was applied to hydrogen fluoride 
clusters (Nemukhin et al 2000) and was found to give 
results in good agreement with both experimental infor­
mation and previous simulations. The theory has been 
applied to water clusters o f up to six molecules (Grigorenko 
et al 2000) and the minimum energy structures are shown in 
Figure 6.
This method is very computationally demanding, but the 
structures and binding energies of the complexes show a
better correlation with experimentally derived terms than 
has previously feteen shown with any simulation method.
Various novel computational methods have been devised 
that bypass the conventional water models and methods. 
Chaplin (2000) attempted to explain water structure in 
terms o f a network constructed from icosahedral water 
clusters. The 14-water structures (see Figure 7) can be 
joined together to form large networks. This model can 
explain some, though not all, o f the properties o f liquid 
water.
A further approach used the geometric information 
described in Figure 2 to constrain a simulation o f water 
molecules with various solutes in which hydrogen bonds 
would be accepted if their length and angle fell within 
stated boundaries (Plumridge et al 2000). The simulation 
has built large ice-like structures and successfully distin­
guished between structure-making and structure-breaking 
solutes. This approach assumes that the hydrogen-bonding 
observed in solid water is similar to that in the liquid state, 
an assumption that appears more likely as modern tech­
niques reveal the details o f liquid water structure. This 
simulation would not succeed with a continuum model of 
water structure.
Water in contact with interfaces
Thermal expansion o f water in glass capillaries shows 
normal behaviour in tubes of inner diameter greater than
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Figure 7 Icosahedrai water cluster (reprinted from Chaplin (2000) 
with permission from Elsevier Science and Prof. Chaplin).
I /tin, but in narrower tubes the curves began to deviate. In 
fine capillaries the minimum specific volume at 4°C dis­
appears and the coefficient o f expansion becomes constant 
(Fedyakin 1962). Metsik studied the thermal conductivity 
of water between mica sheets, and found normal con­
ductivity in films wider than 1 /tm (Derjaguin 1970). How­
ever, as the film becomes thinner the conductivity rises 
sharply. At a thickness o f 0.1 /tm, the thermal conductivity 
is ten times that o f normal water (Derjaguin 1970). It is 
worth noting that a l-/tm film is more than 3000 water 
molecules thick.
Hori (1956) measured the freezing point o f water between 
mica sheets and polished glass surfaces. He found that if 
the film is between 1 mm and 10 /tm, the freezing point is 
between —10 and — 30°C. At a thickness less than 10 /tm, 
he found no evidence of freezing down to — 90°C. Hori 
also studied the equilibrium vapour pressure o f  thin water 
films held between a flat and a curved glass or quartz 
surface. When the film was thicker than 1 /tm, the vapour 
pressure decreased with increasing temperature. Below this 
the vapour pressure was lower than that o f the thicker film 
at the same temperature, and when the films were as thin as 
0.1 /tm there was no detectable vapour pressure at 
temperatures up to 300°C.
DeBoer & Zwikker (1929), in an early study o f the 
condensation of water on glass surfaces, presented a theory 
whereby multi-layer condensation was attributed to a 
propagation of the electric polarisation at the polar solid 
surface. They also found that thicker layers built up if the 
solid surface contained alternating positive and negative 
charges. Ling (1971) found that if a surface contains 
positive and negative charges in a regular array, and in
particular if two of these surfaces are brought together, 
then deep layers o f water will exist in an ordered array of 
dipolar lattices. A stabilised three-dimensional matrix of 
polarised water molecules may then be established.
Soviet soil scientists have studied water in soils, and 
categorised it as either being suspended (i.e., similar to 
bulk), loosely bound or bound. Bound water is the liquid in 
air-dried soils, and is no more than one or two molecules 
thick. The loosely bound water has been described as being 
formed by a process o f multilayer sorption by successive 
polarisation of water dipoles. The thickness o f such 
envelopes may be hundreds or even thousands o f molecular 
diameters. Loosely bound water has a diminished capacity 
for dissolving electrolytes. (Forslind & Jacobsson 1975). 
NMR studies by Ducros (1960) and Woessner & Snowden 
(1969) have shown signal splitting in the deuteron signal of  
DjO-clay systems, indicating that the dipole-dipole inter­
actions do not average out as in liquid water, indicating 
deep layers o f structured water.
Ever since the discovery (Derjaguin 1966) and subse­
quent demise of polywater (Rousseau & Porto 1970), most 
novel work on water has been viewed very sceptically by 
the scientific community. In fact, the analyses which dis­
proved the poly water findings were also found to be flawed. 
The samples were only available in miniscule volumes and 
there were delays in the analysis. Some samples had no 
impurities, and some samples contained silica that was 
thought to be insoluble in water. An unrelated high-density 
form of liquid water has since been proved to exist at low 
temperatures (Mishima & Stanley 1998).
It is only recently that neutron diffraction and spec­
troscopic techniques have reached high enough resolutions 
to investigate pure water in confined conditions. A neutron 
diffraction study of watef confined in Vycor glass, with 
pores o f 40 A eo average, showed that the orientational 
preferences o f  the confined water molecules are very 
different from those o f bulk water (Bruni et al 1998). 
Molecular dynamics using data from this experiment pre­
dict that the waters have very slow relaxation times, and 
this was thought to indicate the presence of longer-lived 
cavity structures encaging other waters (Starr et al 1999).
Recently, several groups have investigated water in con­
fined conditions by means o f ultrafast laser spectroscopy to 
shed light on dielectric relaxation times (Bhattacharyya & 
Bagchi 2000). The most striking of the results is that water, 
in a variety o f conditions, exhibits a bimodal response, with 
not only a normal fast sub-picosecond response as would 
be expected from bulk water, but also a slow component in 
the timescale between hundreds and thousands of pico­
seconds. This slow component constitutes 10-30% of the 
total response and is totally absent in pure water. The 
confined environments in these studies were a range o f  
molecular assemblies, such as reverse micelles and micro­
emulsions (Riter et al 1998), cyclodextrin (Vajda et al 
1995), micelles (Telgmann & Kaatze 2000), lipids (Datta et 
al 1998), proteins (Jordanides et al 1999) and DNA (Halle 
& Denisov 1998), as well as several macroscopic solids 
which trap water (e.g. hydrogels (Datta et al 1997)). In all 
cases, the slow component was detected and, after dis­
cussion between the groups, its origin was attributed to a
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dynamic exchange between free and bound water. A com­
prehensive understanding of the mechanism and impli­
cations of this phenomenon is not yet available.
Overall, it is apparent that water in contact with regular 
hydrogen-bonding surfaces can adopt the pattern expressed 
at the surface and extend that pattern out into the bulk 
water, at least to several hundred molecular diameters. 
Such well-characterised effects are reminiscent o f the early 
ideas on cellular water (see above). It would be ironic if the 
very earliest ideas on cellular water were found to have 
merit, nearly 150 years after they were first expressed.
A queous solutions
Solid solutions
The advantage of studies on solids is that all the intra- and 
inter-molecular parameters can be measured with con­
fidence. While extrapolation to liquids must be approached 
with caution, some valuable conclusions can be drawn 
concerning the intrinsic properties o f aggregates o f water 
molecules. These aggregates may be present as simple or 
complex hydrates, or clathrates. There is increasing evi­
dence for the formation of comparable structures in liquid 
water.
Hydrate inclusion compounds
Hydrate inclusion compounds are solid crystalline com­
plexes in which water molecules are hydrogen bonded to 
form regular three-dimensional four-connected networks. 
Guest molecules are included either in void spaces in the 
network, or hydrogen bonded to the water network. At 
present, four classes o f hydrate inclusion compounds are 
known: clathrate hydrates, alkylamine hydrates, alkyl- 
ammonium salt hydrates and the polyhydrates o f some 
strong acids.
Clathrate hydrates are a type of hydrate inclusion com­
pound in which a small, usually non-polar, guest molecule 
is encaged in a host network of hydrogen-bonded water. 
The guest in true clathrate hydrates will only interact with 
the host through van der Waals interactions with no other 
guest-host bonding involved. In the alkylamine hydrates, 
hydrogen bonds are formed between the amine group and
the water network. Alkylammonium salt hydrates are 
formed with an anionic guest inside a cationic host lattice.
The first reported preparations of a crystalline clathrate 
hydrate were made by Davy in 1811 and then by Faraday 
in 1823, who were both investigating the hydrate o f chlor­
ine. The term clathrate was introduced by Powell (1948), 
who deduced that these were, in fact, inclusion compounds 
and named them from the Greek for lattice. Concurrent 
work by three teams, von Stackleburg & Muller (1951), 
Pauling & Marsh (1952), and Claussen (1951a, b) estab­
lished the common 12-A and 17-A clathrate structures. 
These structures, now referred to as structures I and II, 
accounted for the stoichiometry and powder diffraction 
patterns for the majority of known hydrates. The most 
common clathrate cavity types are shown in Figure 8. 
Structure-I clathrates are comprised of pentagonal 
dodecahedra and tetrakaidecahedra (A, B) while structure- 
II clathrates are built from pentagonal dodecahedra and 
hexakaidecahedra (A, C). The pentagonal dodecahedron 
corresponding to (H,O)20 occurs in all true clathrate 
structures and many related inclusion compounds.
Clathrates are known to occur in natural environments, 
from deep-sea sediments (Appenzeller 1991) to nucleation 
processes in the atmosphere (Yang & Castleman 1991). 
Upon decomposition they can cause explosions in high- 
pressure gas pipelines (Kelkar et al 1998).
A clathrate o f CH,CCl,F (CFC R-141b) has been 
observed to form at the interface between liquid water and 
liquid CHjCCljF (Ohmura et al 1999). The system was 
observed with a video camera with a micrographic zoom 
lens, and plate-like crystals were formed over a number of 
hours, that dissolved if the temperature was raised. The 
water shell was apparently left unchanged, as the crystals 
reformed if the tamperaftire was lowered again.
A series of alkylammonium salt hydrates were first 
prepared by Fowler and co-workers in 1940 (Fowler et al 
1940). Unlike the clathrates, each guest molecule produced 
a different host water lattice. At the request o f Henry 
Frank, McMullan & Jeffrey (1959) carried out an initial X- 
ray diffraction study of these compounds. This work 
revealed structures very similar to the clathrates and 
a subsequent detailed study showed close structural
A B C
Figure 8 The cavity types in structure-I and -II clathrate hydrates. A. Pentagonal dodecahedron (H2O),0. B. Tetrakaidecahedron (H ,0 )w. 
C. Hexakaidecahedron (H20 ) 26.
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analogies, with some alkylammonium salt hydrates being 
isostructural with clathrate hydrates.
Jeffrey and co-workers carried out similar diffraction 
studies of alkylamine hydrates, which again had different 
lattice structures for each guest molecule (McMullan et al 
1966). These structures included hydrogen bonding be­
tween the guest and the water lattice, but again there were 
many similarities with the clathrates. Using results from 
these three types of compound, a common structural theme 
was discovered, based on the (HjO)^ pentagonal dodeca­
hedron.
Some strong acids (HPF6, HBF6 and HC104) were found 
to form crystalline hydrates at lowered temperatures, and 
X-ray diffraction confirmed that they were iso-structural 
with the 12-A cubic structure^ clathrate hydrates. These 
were the first clathrate structures where cationic hosts were 
found (Mootz et al 1987).
In inorganic hydrates, the water molecules generally 
complete the coordination shell of the cations, and hy­
drogen bond to the anions. This means that the structures 
formed are governed largely by the stereochemical require­
ments o f the ions rather than those of water.
Organic hydrates can be subdivided into hydrates with 
isolated water molecules, in which the structure is de­
termined principally by the ionic coordination or hydrogen- 
bonding function of the solute, and water framework 
structures. Water framework structures include the hydrate 
inclusion compounds, and also systems in which water 
molecules form nets, sheets, columns, ribbons or chains, 
with the functional groups of the organic molecules 
strongly influencing the structure, and no recognisable 
clathrate voids (Luck 1998).
The three-dimensional structures o f all biological macro­
molecules are intimately associated with water. The solid- 
state hydration structures of small biological molecules 
(carbohydrates, purines, pyrimidines, nucleosides and 
nucleotides) are determined mainly by packing forces, and 
hydrogen bonding between the functional groups of the 
organic molecules. Water plays a secondary role in these 
structures, occupying the space between the organics, and 
adding to the hydrogen bond energy of the lattice while in 
competition with the molecular packing in the absence of 
water. If biological molecules aggregate, or if a substrate 
enters the active site o f an enzyme, the water molecules 
have to move from the contact surface of the biological 
molecule in a coordinated manner with the least expen­
diture of energy. Hydrogen bonding must play an im­
portant role in this substitution process (Jeffrey & Saenger
1991).
Aqueous solutions in the liquid state 
As has been stated above, the structural information that 
can be obtained from diffraction studies on liquid species is 
limited because of the continual translational and 
rotational movement o f the molecules. However, the in­
creasing sophistication of computer simulation techniques 
along with accurate models of the water molecule has 
allowed the structural aspects of aqueous solutions to be 
investigated.
Computer simulations
Molecular dynamics studies on aqueous solutiotts Molecular 
dynamics has been used to study the hydrophobic hy­
dration of noble gases (Tanaka & Nakanishi 1991). It was 
found that the introduction o f a xenon solute gives rise to 
a restructuring o f the water to form a clathrate-type struc­
ture. This is shown by an increase in population o f  the 
cyclic water pentamer, which gives rise to an exothermic 
hydration process.
A molecular dynamics simulation (Skipper 1993) of a 
system containing four methane molecules and 256 waters 
at around room temperature found solvent-separated 
methane interactions which were compatible with a first 
hydration shell in which the water dipole vectors were 
predominantly tangential, and a second hydration shell 
where they were predominantly radial. This orientational 
information and the sizes of the cavities are compatible 
with a simple clathrate-type structure. A similar, though 
more exhaustive and computationally more complex, study 
(Marcera et al 1997) confirmed these findings.
Molecular dynamics has also been used to study the 
hydrogen-bonded network in liquid water. In a study of 
liquid water, topological defects were found which directly 
affected the mobility of the water. The network defects act 
as catalysts, providing lower energy pathways between 
different tetrahedral local arrangements (Sciortino et al
1992).
Molecular dynamics has been used to investigate water 
clusters. (H ,0)n clusters, where n =  3-6, were investigated 
by Dang & Chang (1997). They found cyclic planar 
structures to be the most stable for n =  3-5. For the water 
hexamer, several structures were suggested, very close 
together in energy. A prism-like structure was found to be 
the lowest energy structure, with cyclic boat and cage 
structures at Slightly higher energy. Using the same 
methods, Dang (1999) characterised the water octamer, 
nonamer and decamer, and investigated the water-iodide 
cluster. The lowest energy octamer was found to be a rough 
cubic structure with four-membered rings, the nonamer 
was a similar system with a five-membered ring, and the 
decamer was found to be a system with two five-membered 
rings one above the other with hydrogen bonding between 
the rings. The iodide-water clusters are in excellent agree­
ment with optimised structures developed from accurate 
electronic structure theory calculations (Combariza et al
1993).
Molecular dynamics has been used together with a 
number of novel water potentials (van Maaren & van der 
Spoel 2001) designed to investigate biomolecular 
hydration. Flexible, as well as fixed, water models were 
tested and it was found that varying the water potentials 
based on their distance from the biomolecule improves the 
accuracy o f the method to reproduce measurable liquid- 
phase properties. This work, though still in its early stages, 
could help to elucidate the role o f water in biological 
processes.
Another water potential has been devised to reproduce 
long-range effects by putting diffuse charges on the 
hydrogens and oxygens as well as the normal point charges 
(Guillot & Guissani 2001). This method can accurately
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model polarisation effects when calculating the dipole 
moment, and so the technique can accurately predict the 
dielectric constant at any state point. This supports the 
idea that induction effects in water are more important 
than previously expected.
Monte Carlo simulations o f aqueous solutions. The first 
Monte Carlo simulations o f aqueous solutions were 
reported for the systems Li+F” and Li+CI“ (Fromm et al
1975) and Na+F~ and K+F (Clementi et al 1976). The 
coordination and shell radii were found to be in good 
agreement with neutron diffraction experiments.
The first Monte Carlo simulation claiming to reproduce 
the iceberg model was carried out on pure water and an 
infinitely dilute solution ofmethanol(Nakanishietal 1981). 
Water molecules in the vicinity of the hydrophobic methyl 
group are energetically more stable than those in the 
hydrophilic region. This is clear evidence of conventional 
hydrophobic hydration where a water cage structure forms 
around the hydrophobic group.
A study of the aqueous hydration of benzene has shown 
a complex with two water molecules attached, one either 
side o f the 7r-cloud, and a hydration shell with 21 water 
molecules around this (Ravishanker et al 1984). The struc­
ture involves puckered 5-membered rings o f waters, and 
also larger ring structures. Water-a interactions have been 
observed in aqueous benzene using X-ray diffraction 
(Atwood et al 1991). This system has been re-investigated 
(Urahata & Canuto 1999) with more advanced techniques. 
The results confirmed these findings, the authors conclud­
ing that the first hydration shell must be similar to a 
clathrate cavity.
In a similar study o f the hydration o f small alkanes, the 
hydration numbers in the first hydration shell were de­
termined using a TIP4P model of water together with an 
OPLS set of Lennard-Jones parameters optimised for liquid 
hydrocarbons (Jorgensen et al 1985). The hydration shells 
were consistent with clathrate structures with more ir­
regular forms. Methane formed a structure-I clathrate with 
an (H2O)20 cavity in close agreement with the Monte Carlo 
value of (HjO)^ , (Jeffrey & Saenger 1991).
A study o f the hydration of ethanol with TIP3P waters 
using Monte Carlo techniques predicted the hydration 
energy o f —57.1 +6.5  kJ m ol'1, agreeing well with the 
experimental value o f —54 kJ mol-1 (Levchuk et al 1991). 
This meant that more complex problems could be tackled. 
In an attempt to understand the interactions between 
protein denaturants and aromatic rings, the approach of 
urea and guanidinium to benzene, and the approach of 
urea to naphthalene in aqueous solution were studied by 
Monte Carlo techniques (Duffy et al 1993). Single minima 
were observed at around 4 A in all cases, which indicated 
the existence o f direct interactions between the structure 
breaker and the aromatic ring with unstructured water in 
the vicinity.
Recent Monte Carlo studies have shown that water 
structuring around hydrophobic solutes is very sensitive to 
solute size and shape (Fang et al 1997). The hydration 
structure around hypothetical spherical ions was shown to
generate clathrate-type structures if the radius o f the ion 
was within specific limits, whereas different sized and 
shaped ions produced much more irregular structures. A 
similar investigation (Martinez et al 1999) showed that, 
when considering small highly charged ions such as Cr3+, it 
is more useful to consider the hydrated ion’s interactions 
with bulk water rather than the naked ion (e.g. [Cr(H20 ) 6],+ 
is used rather than CrJ+). This has been shown to reproduce 
experimental radial distribution functions more accurately.
A Monte Carlo study of the hydration of methane 
(Hernandez-Cobos et al 2001) gave essentially the same 
results as the molecular dynamics simulation (Skipper
1993), and the direct experimental methods (Bowron et al 
1998c -  see EXAFS spectroscopy section, below) with dis­
ordered hydration shells around the methane. The radial 
distribution functions from the simulation compared very 
favourably with those for aqueous methane (Soper & 
Finney 1993).
Advanced Monte Carlo techniques involving specialised 
potentials have been applied to the hydration of Li+ 
(Lyubartsev et al 2001). The results show almost identical 
radial distribution functions to those derived from neutron 
diffraction (Howell & Neilson 1996) with four waters 
arranged tetrahedrally around the ion.
Reverse Monte Carlo (McGreevy 1990) is a computer 
simulation technique which works with scattering patterns 
derived from, for example, neutron diffraction or EXAFS 
patterns (see below). The process then generates con­
figurations that will fit the radial distribution curve. No 
potentials are used, and the system works by optimising the 
difference between the experimental pattern and the pattern 
generated by the trial system. This has been applied to 
liquid water (da Silva et al 2001) and has successfully 
reproduced energy ternis and hydrogen-bond con­
figurations, bflt flaws in the existing water models have 
been highlighted in this study.
Experimental evidence for the structure o f liquid aqueous 
solutions
X-ray and neutron diffraction. In an X-ray diffraction study 
of aqueous /-butanol at 20°C, Nishikawa & Iijima (1990) 
found that, at mole fractions around 0.17, some /-butanol 
molecules were encaged by water molecules in clusters, 
which tended to clump together in larger aggregates of 
structured water by sharing their polyhedra. They found 
that for compositions (TBA)m(H20), the ratio 1/m is be­
tween 17 and 25, consistent with the structure-II clathrate 
structure. At a higher temperature (55°C) they found 
evidence of clusters, but at this temperature the structures 
were looser and more distorted.
In an attempt to understand the structure-breaking 
properties o f nitrate and perchlorate ions, neutron 
diffraction experiments have been carried out on concen­
trated aqueous solutions using isotopic substitution on the 
chlorine. The results showed that both species have a 
reduced number o f waters in the first hydration shell: 3-4 
for NOj (Neilson & Enderby 1982) and 4-5 for CIO* 
(Neilson et al 1985) compared with, for example, the value
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obtained for Cl~ of 7-8 (Neilson & Enderby 1983). The 
distances between the central atom and the deuteriums and 
oxygens of water are very simila r in all three cases (carbon- 
deuterium distance =  2.9-3.1 A; carbon-oxygen =  3.6- 
3.8 A). This is a consequence of the strength o f the 
structure-breaking properties, nitrate >  perchlorate >
chloride.
A more recent higher resolution neutron diffraction 
study on the hydration o f chloride (Yamaguchi & Soper 
1999), using a more advanced procedure to refine the data, 
found 9-10 waters in the first hydration shell, but found 
that only 5-6 pointed a deuterium at the chloride atom 
(i.e., were involved in conventional hydration).
The use of hydrogen/deuterium (H /D ) isotopic sub­
stitution in structural studies o f water and organic liquids 
provides more information, particularly when hydrogen 
bonding is involved (Soper & Egelstaff 1981). Separated 
partial distribution functions can be obtained from the 
radial distribution function when partially deuterated 
species (e.g. HDO) are used which can give direct in­
formation on local hydrogen-bond configuration. This 
technique can also be used to acquire more structural 
information when dealing with aqueous solutions (Turner 
et al 1990; Bowron et al 1998c).
A neutron diffraction experiment on a 1:9 molar ratio 
methanol-water mixture, in which isotopic substitution 
was used to isolate the methyl-hydrogen to water-hydrogen 
pair correlation function from the other interactions, con­
firmed the existence o f a definite hydration shell of water 
molecules at a distance o f 3.7 A from the methyl carbon 
atom (Soper & Finney 1993). The water molecules in this 
shell formed a disordered cage but retained the roughly 
tetrahedral local coordination found in pure water. Some 
degree o f polarisation of the water molecules was aiso 
apparent, and the shape o f the shell implied a weak 
alignment of the water molecule dipoles with that o f the 
methanol. This was the first experimental evidence of a 
hydration shell around methanol, and served to reinforce 
Frank’s theories, as well as closely agreeing with the results 
of various simulation studies (Okazaki et al 1984; Ferrario 
et al 1990; Guillot et al 1991; Skipper 1993).
Neutron diffraction with isotopic substitution was used 
to study the hydration structure of methane in aqueous 
solution (De Jong et al 1997). H /D  substitution was used 
on both the solute and the solvent to determine the partial 
pair correlation functions. Analysis o f these functions 
showed that the methane molecule is surrounded by 19 +  2 
water molecules, and showed that these waters were tan- 
gentially oriented with respect to the methane. This figure 
is in excellent agreement with the pentagonal dodeca­
hedron, with twenty waters found in clathrates and many 
simulations.
A recent study, on concentrated sodium hydroxide in the 
liquid state using neutron diffraction with isotopic sub­
stitution (Bruni et al 2001), showed that a large change in 
the water structure relative to that of pure water occurred 
at around 300 K. The peaks corresponding to orientational 
correlation between neighbouring water molecules were 
considerably shifted relative to those o f pure water and this 
was thought to indicate that ions in aqueous solutions
induce a change in water structure equivalent to the ap­
plication of high pressure.
Dielectric measurements. It is known that the dielectric 
relaxation times of liquids are influenced by temperature 
and concentration. The relaxation times can be derived 
from time domain reflectometry in the microwave region 
(commonly 500 MHz to 25 GHz) at different temperatures 
and concentrations. In considering interactions in water 
mixtures, accurately measured dielectric relaxation times 
allow the activation enthalpy (AH) and entropy (AS) to be 
separated from the activation free energy (AG), and hence 
allow excess partial molar activation free energy, enthalpy 
and entropy to be calculated for the water and for the other 
component as a function o f temperature and concentration. 
Maxima in the excess enthalpy and entropy are due to 
structural enhancement o f the water network by the other 
component.
In a study ofethanol-water mixtures using these methods 
(Sato et al 1999), two maxima were found in both the 
excess enthalpy and entropy of ethanol in the dilute region. 
These maxima occurred at mole fractions of ethanol in 
water o f 0.04 and 0.08 which were clearly attributed to 
structural enhancement o f the water network by the etha­
nol. The mixing schemes for the two points appear to be 
qualitatively different. The 0.04 mole fraction corresponds 
to a ratio o f one ethanol to 24 water molecules, possibly 
indicating a clathrate-type cage. The 0.08 mole fraction 
refers to a ratio o f one ethanol molecule to 12 waters; the 
type of structural enhancement associated with this maxi­
mum is unknown. At mole fractions of ethanol as low as 
0.005 (one ethanol to around 200 waters), positive values 
in the rates of change o f the excess enthalpy and entropy 
indicate that ethsyjol-etharlbl interaction through the water 
network is operative with each ethanol surrounded in a 
spherical fashion by waters. At a mole fraction of approxi­
mately 0.15, a minimum is observed in the excess enthalpy 
and entropy of ethanol and a maximum in those o f water. 
This can be attributed to the formation of a structure-I 
clathrate hydrate o f the formula 6C2HsOH.46H20 . This is 
also suggested by adiabatic compressibility results on the 
ethanol-water system (Onori 1988).
In a further study of methanol-water mixtures using the 
same techniques (Sato at al 2000), again two maxima were 
found in the methanol excess enthalpy and entropy in the 
dilute region, both attributed to structural enhancement of 
the water network.
Microwave dielectric relaxation measurements have 
been used to study water structure around larger molecules. 
In a study of polysaccharides, all molecules showed two 
dielectric relaxation peaks, except for glucose which only 
showed one (Mashimo et al 1992). One peak is due to the 
orientation of the water molecules whereas the other is due 
to the orientation o f the saccharide molecules. Glucose can 
occupy a site in an ice lattice corresponding to the position 
of a six-membered water ring. From this it was inferred 
that glucose behaves in a similar manner in liquid water, 
with several hydrogen bonds between glucose and waters, 
and that the glucose can only reorient itself when the water 
structure is broken.
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Similar studies have been carried out using a sample of 
DNA (Mashimo 1994). The sample was dissolved in a 
buffer and subjected to microwave dielectric measurements 
at different temperatures. The DNA solution exhibited two 
peaks at all temperatures, attributed to bound and bulk 
water. However, measurements between — 15 and — 65°C, 
where all bulk water was frozen, showed definite evidence 
of the participation of two types of bound water. Part o f  
the water would freeze gradually in the temperature range 
— 15 to — 35°C, but some water would not freeze at — 65°C. 
These phases were shown to be different from bulk water, 
and each other, so were designated as tightly bound and 
loosely bound.
NMR.  Deuterium spin-lattfce relaxation times were 
reported for undercooled (180-300 K) solutions of tetra- 
alkylammonium ions (Bradl & Lang 1993). A comparison 
with undercooled alkali-metal halide solutions allowed the 
competing influence o f coulombic, hydrophobic and 
hydrogen-bond interactions on the dynamic structure of 
the transient hydrogen-bonded network to be studied. 
Solvent dynamics were found to be closely related to the 
glass-forming tendency of undercooled Me4N + and Pr4N + 
solutions, and the clathrate-forming tendency of the Bu4N f 
solutions.
The NMR rotational correlation times for heavy water 
molecules have been measured in aqueous solutions of 
benzene and phenol. The measurements were made by the 
integrated capillary method and showed that the corre­
lation time for shell water molecules was 4 times as long in 
benzene as in phenol. Benzene is a known structure maker, 
while phenol is a structure breaker. The increased cor­
relation time indicates that the hydrophobic hydration of 
benzene is associated with a remarkable rotational 
slowdown, or increase in local viscosity (Nakahara & 
Yoshimoto 1995).
In a similar study, the l70  NMR spin-lattice relaxation 
times o f  the solvent water have been determined in aqueous 
solutions of nine alcohols and five diols at 25°C (Ishihara et 
al 1997). From these data, the coordination numbers and 
rotation correlation times compared with pure water have 
been estimated. The correlation times are inversely related 
to the alcohol’s structure-breaking capability, so /-butanol 
provides the longest-lived water structure.
Fourier transform infrared spectroscopy. Fourier transform 
infrared (FTIR) spectroscopy can be used to give insight 
into the structural perturbations which occur when hydro- 
phobic solutes are introduced into water by examining the 
vibrational transitions occurring in the solute-induced hy­
dration shells. Infrared spectroscopy has been used to 
detect the vibrations o f DOH molecules in the solvation 
shells o f inorganic salts (Kristiansson et al 1988). By a 
calculated difference spectrum, where the spectrum of pure 
water is subtracted from that of a solute in water, the 
water-structuring capacity o f solutes can be quantitatively 
compared. Shifts in absorbance intensity and frequency 
reflect changes in populations o f water molecules with
different hydrogen-bonding patterns (Lindgren & 
Tegenfeldt 1974). In a study of methane, ethane, propane, 
butane, pentane and hexane sulfonates, Hecht et al (1992) 
compared the difference plots obtained from the FTIR 
analysis, and found shifts in the vibrational intensity and 
frequency which were consistent with increased ordering of  
the water shell as the hydrocarbon length was increased. 
These results are consistent with theories o f hydrophobic 
interactions as well as other experimental techniques such 
as excess molar heat capacity measurements (Muller 1990) 
and relative solubility in aqueous and non-aqueous 
solutions (Nozaki & Tanford 1971).
Heat capacity measurements. The analysis o f heat capacity 
changes is o f central importance in understanding the 
thermodynamics of protein folding, protein-protein bind­
ing, protein-nucleic acid binding and hydrophobic effects 
(e.g. Murphy & Freire 1992). The improved sensitivity and 
accuracy of calorimeters has provided much heat capacity 
data. Heat capacity is useful as it relates enthalpy, entropy 
and free energy to each other. Processes such as protein 
folding or unfolding produce large changes in heat capacity 
due to the desolvation of polar and nonpolar groups 
(Sturtevant 1977). The change in heat capacity involved on 
hydration is large and positive for nonpolar groups, and 
negative for polar groups (Marcus 1994). This is more 
useful than entropy and enthalpy measurements as these 
hydration processes can be either entropy- or enthalpy- 
driven. Computer simulation has suggested that heat ca­
pacity changes can be explained by non-polar solutes 
causing a concerted decrease in the hydrogen-bond length 
in the first hydration shell and polar solutes increasing the 
oxygen-oxygen distance, ajpd causing the hydrogen bonds 
to bend (Sharp &*Madan 1997).
HPLC. The molar free energy, enthalpy and entropy of 
transfer o f a non-polar solute from a highly polar liquid 
(e.g. poly(dimethylsiloxane)) into water can be deduced 
from HPLC measurements (Shinoda et al 1987). In a study 
of toluene and ethylbenzene in water, Silveston & Kronberg 
(1989) found a large positive free energy when the two 
probes were transferred from the polymer liquid into water, 
along with a large negative entropy change. This was 
interpreted as a consequence of water structuring around 
the toluene and ethylbenzene molecules.
EXAFS spectroscopy. Recent work on the hydrophobic 
hydration of krypton, using extended X-ray absorption 
fine structure (EXAFS) spectroscopy (Filipponi et al 1997; 
Bowron et al 1998a), has shown that the liquid-to-solid 
transition produces a clathrate hydrate, indicating that 
Frank’s structuring of liquid water by non-polar solutes 
may be very similar to clathrate hydrate structures.
The EXAFS probe is intrinsically short-ranged and 
element specific, so is ideal for comparing local structure in 
the solid and liquid phases due to its insensitivity to long- 
range order in the crystalline phase. In this case the 
structural signal was dominated by K r-O ^ ,^  correlations.
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The size of the liquid hydration shell was found to correlate 
very well with the small structure-II clathrate cage, but this 
cage was more loosely defined than in the solid state. The 
experimentally determined coordination numbers indi­
cated that one water molecule was drawn into the 4.5-5.1 A 
range to form the large clathrate cavity, although the 
number of water molecules in the 2.6-5.7 A region 
remained constant at 22.5 in both states. This figure agrees 
very well with the values for structure-II clathrates, where 
the small cavity is composed of 20 waters and the large 
cavity 26.
In a further EXAFS study, the temperature dependence 
of the hydrophobic hydration shell was investigated for 
krypton and xenon in the range 277-368 K. (Bowron et al 
1998b). The experiment provided clear evidence that as the 
temperature is raised, systematic thermal perturbation 
leads to increased entropy, and the cage becomes less 
clearly defined.
The hydration o f Ca2t was investigated in a combined 
EXAFS, large angle X-ray scattering and molecular dy­
namics study (Jalilehvand et al 2001). The results accurately 
confirmed the radii o f the first and second hydration shells 
at 2.46 and 4.58 A, as well as the number o f waters in the 
first shell (8). These findings agreed well with existing 
experimental data on the system and the molecular dy­
namics results.
Structured w ater in th e  gaseou s sta te
Clusters are weakly bound aggregates o f atoms or 
molecules. Water clusters occur in the gaseous phase and 
have been studied extensively to further an understanding 
of hydrogen bonding, and solvation and nucleation 
phenomena in general. In the mass spectra of polymeric 
compounds or complexes the appearance of prominent 
peaks in an otherwise continuous distribution of signals is 
called a magic number cluster, and may indicate the exist­
ence of species with enhanced stability.
In water systems, it is well known that the cluster 
corresponding to (H20 ) 2lH* always exhibits a pronounced 
magic number under different experimental conditions (e.g. 
expansion of ionised vapour (Beuhler & Friedman 1982), 
ion bombardment o f ice surfaces (Haberland 1984); elec­
tron impact ionisation (Echt et al 1989) and vacuum 
photoionisation o f neutral clusters (Shinohara et al 1985)).
Shinohara et al (1985) employed a neutral supersonic 
nozzle linked to a molecular-beam mass spectrometer 
supplied with premixed water-ammonia gas, to investigate 
the formation of mixed binary water-ammonium clusters. 
Evidence was found for exceptional structural stability of 
protonated clusters corresponding to (HjO J^NH j^ H*  
(m =  1-6) and (H20 ) 27NH4. A parallel Monte Carlo sim­
ulation yielded larger binding energies for these structures 
compared with their close neighbours, in agreement with 
the mass spectrometry results, and a deformed pentagonal 
dodecahedron enclosing an NH4 ion was proposed, with 
the stability due to strong coulombic interactions (ionic 
hydrogen bonding) between the NH 4 and the 20 waters, as 
well as the inherent stability of pentagonal rings and the 
pentagonal dodecahedron. The authors suggested that this
may also explain the exceptional stability o f the (H ,0 )2lIT 
cluster. To account for the exceptional stability o f this 
cluster, a pentagonal dodecahedral structure has been 
proposed (Miller et al 1983) in which H ,0 + is encaged. If 
this structure were present, then it is known from clathrate 
studies that ten non-bonded hydrogens would extend out­
ward from the cage.
In a mass spectrometry study of water-trimethylamine 
clusters, Wei et al (1991) found that the maximum number 
of trimethylamines that can bond to an (H ,0)2|H+ cluster 
is ten, indicating that the pentagonal dodecahedron is 
present.
The same group carried out a similar experiment in 
which methanol was introduced into the system. Methanol 
can replace the water molecules in the (H ,0)2,H+ cluster 
only where the CH3 group can extend outward from the 
cage, so it was expected that a maximum of ten methanol 
molecules would replace water molecules in a single cluster. 
It was found that this was the case, as (H20 ) n(C H ,0H )niH+ 
showed maximum intensity at n +  m = 21 for m = 1-9 (Shi 
et al 1992).
Other cavity types found in clathrate hydrates have also 
been found as clusters in the gaseous phase. Selinger & 
Castleman ( 1991) found that magic numbers were exhibited 
in clusters surrounding small ions such as C s \  correspond­
ing to Cs+(H2O)20, but also found magic numbers at 22, 24, 
27 and 29 water molecules. All these systems can be 
rationalised using clathrate-type cages involving 5- and 6- 
membered rings of water molecules. Cs+(H20 ) 24 corre­
sponds to the large cavity in structure-I clathrates, and 
Cs+(H20 ) 27 corresponds to the large cavity in structure-II 
clathrates with Cs+-H20  enclosed.
Similar structures have been observed around other small 
ions such as K+, Li+, Na**and Rb+ (Steel et al 1995).
Ionic clathfates have been observed by mass spectro­
metry from aqueous solution using laser-induced liquid- 
beam ionisation/desorption (LILBID) techniques (Sobott 
et al 1999) around K+, Cs* and ammonium ions. The 
largest peak was observed at (HjOJjo as has been demon­
strated above. Other peaks were observed correspond­
ing to other clathrate cages encaging ions or ion-water 
pairs, but the ammonium ion showed a single peak 
at NH4(H2O)20, corresponding to the pentagonal do­
decahedron.
Biological system s
Crystallographic studies have revealed a wide range of 
hydration processes in biological macromolecules, ranging 
from neo-clathrates down to single hydrogen-bonded 
waters. The formation o f the more complex hydrates may 
give some insight into the processes occurring in solution.
The most direct method o f examining the hydration o f a 
macromolecule is by using X-ray or neutron diffraction at 
a resolution better than 1.8 A. In the crystal structures o f  
proteins the macromolecules are heavily hydrated; 20-90 % 
of the total volume is water. The amino-acid atoms at the 
periphery o f the molecules display larger thermal motion 
than those in the interior and, as the hydrating water 
molecules are attached to these, they sometimes have even
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larger thermal motions and this can lead to ambiguities in 
the analysis concerning the water positions (Soper & 
Phillips 1986).
In biological systems, water is in a wide range of environ­
ments. Far away from a protein, for example, water should 
have a structure similar to the bulk, unless the protein 
produces an effect comparable with that of a silica surface, 
in which case the effect could be felt many molecular 
diameters away from the macromolecule.
Ordered water molecules at protein surfaces -  clusters and 
pentagons
Most water molecules identified from X-ray electron den­
sity maps are individually bound to the protein with one or 
more hydrogen bonds formed with main-chain and side- 
chain functional groups. Two-water chains are also found 
in significant numbers bound to the surface o f the protein. 
Larger clusters occur rarely but are o f special interest as 
hydration phenomena. Clathrate hydrates form with small 
guest molecules that have little or no hydrogen-bonding 
character. In this sense the water structure around proteins 
must be different as the strong hydrogen-bonding groups 
on the side chains will determine the initial hydration shell, 
and whether this shell is compatible with partial clathrate 
cage structures will differ markedly with subtle changes in 
conformation. As may be expected, in the majority of 
protein hydration structures, the strong hydrogen-bonding 
groups are not compatible with clathrate geometry, and 
the hydration structures are characterised by single water 
molecules hydrogen-bonded to the functional groups. 
Although a minority, arrangements o f hydrogen-bonded 
waters resembling partial clathrate structures have been 
found in some biological hydration structures.
In human lysozyme, the methyl group of Ala92 is sur­
rounded by four hydrogen-bonded water molecules in a 
semicircle (Blake et al 1983). These waters are buried deep 
within the protein. If such hydration schemes were to occur 
at the periphery of a protein, the waters would probably 
not be seen in the analyses due to thermal motion.
Two fused water quadrilaterals are found between vari­
able domains in the Bence-Jones protein Rhe (Furey et al
1983). The rings have an edge in common and are bonded 
to two tightly bound water molecules, and to two peptide 
N-H sites. Comparable quadrilateral water structures are 
found in structure-H clathrates, and also in cyclodextrin 
hydrates.
A chain of two triangles, five quadrilaterals and one 
pentagon o f water molecules is found in a cavity between 
two subunits in glutathione reductase (Karplus & Schulz 
1987). The water molecules are all connected to the protein 
main-chain or side-chain functional groups, or to other 
water molecules acting as anchor points. This structure 
does not share any structural motifs with the clathrates, 
and three-membered rings are not a feature of clathrates or 
ices. The five-membered ring in this system has two ex­
tended sides.
Three fused water pentagons are found capping an apolar 
valine3 side chain of the A-chain in insulin (Baker et al 
1985). They are anchored by two-ring water molecules and
are further stabilised by the nearby His28 side chain. The 
three pentagons have near-ideal pentagonal dodecahedron 
geometry.
Five fused pentagons forming a clathrate-like structure 
are the predominant feature of the hydration of the small 
(MW 4720) hydrophobic plant protein, crambin (Teeter
1984). Again, these rings have very close to ideal clathrate- 
like geometry. The network of pentagons covers a hydro- 
phobic patch on the surface of crambin.
The crystals of crambin diffract to at least 0.88 A, which 
is a far better resolution than has been obtained with any 
other known protein. The analysis of insulin is based on 
1.5-A data, which is also rather better resolution than most 
similar studies. In both these cases, the anchor points for 
the water structure are very tightly defined. This suggests 
that there may well be structures in which clathrate-like 
structured water may occur, but sufficient resolution to see 
the structure may not be achievable.
In X-ray diffraction studies on [Phe4Val6] anta- 
manide. 12H20  (Karle 1986), all 12 water oxygens have 
been located, and pentagonal water rings have been found.
Substrates can sometimes mimic the hydration water 
structure o f enzymes. An example o f this is S. griseus 
protease A, which in the native state has a cluster of water 
molecules associated with the active site (James et al 1980). 
These waters are replaced by the product tetrapeptide, Ac- 
Pro-Ala-Pro-Tyr, and the water cluster closely resembles 
the shape of the product in the hydrophilic and hydro- 
phobic areas.
Hydration o f nucleic acids
The conformation o f DNA is determined by water activity 
that can be attend by the addition o f salts. If the DNA is 
fully hydrated, there are about twenty water molecules per 
nucleotide. If the hydration is reduced, the minimum 
number of waters per nucleotide is 3.6. The hydration of 
DNA can be most simply described by two hydration shells 
(Cohen & Eisenberg 1968), as suggested by sedimentation 
equilibrium studies. The first hydration shell is imper­
meable to ions and does not freeze into an ice-like state. Of 
the twenty waters per nucleotide, 11 or 12 are directly 
bound to the DNA. The waters have binding affinity for 
phosphate, phosphodiester plus sugar oxygen atoms and 
functional groups o f bases, in order of decreasing affinity. 
These waters are observed in crystal structure analyses, and 
are hydrogen-bonded to DNA oxygen and nitrogen atoms. 
The second hydration shell is permeable to cations and 
freezes to ice I. In this respect, this shell resembles bulk 
water, but as Donnan-type equilibria could have an 
influence on the structure o f this water layer around the 
DNA polyelectrolyte, it is believed that this layer is subtly 
different from bulk water far away from the DNA. In 
considering the hydration of A-, B-, and Z-DNA, charac­
teristic hydration patterns are observed which can be 
broadly grouped into sequence-dependent and sequence- 
independent motifs.
Most sequence-independent motifs can be found in the 
minor grooves, at the sugars and at the phosphates (Jeffrey 
& Saenger 1991). The water molecules can bridge sites in
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the same nucleotide (e.g. purine N(7) with 0(6)/N (6) 
groups) or they can occur between different nucleotides 
(e.g. between a free phosphate atom and a base atom in A- 
DNA). Such intranucleotide bridges usually involve only 
one or two waters, and can bridge between strands. The 
separation between adjacent base pairs ( ~  3.4 A) is com­
parable with the separation of water-water hydrogen 
bonds; the waters associated with one base pair can hy­
drogen bond to the water associated with the adjacent base 
pair. In this way, extended filaments and nets o f water can 
be built up which will cover major and minor grooves. 
Hydration of the phosphate backbone is sequence inde­
pendent, but is structure dependent. The different 
puckering modes in the three DNA structures significantly 
affect the phosphate-phospfiate distances, and hence affect 
the hydration structure.
At present, there are only a few cases known of sequence- 
specific hydration of double helical nucleic acids. In the 
crystal structure analyses o f the two isomorphous octa- 
nucleotides, d(GGTATACC) and d(GGBrUABrUACC), 
the same characteristic hydration pattern is observed, 
comprising four fused five-membered rings of water 
molecules (Kennard et al 1986). It seems that the sequence 
TATA induces the formation o f these pentagons in the 
major groove of A-DNA. In other sequences, such as 
TTAA or G /C  sequences, pentagons are unlikely to form 
because o f steric reasons, and have not been observed. An 
isolated 5-membered ring of water molecules has been 
observed hydrogen bonded to G(3) 0 6 , G(3) N3, C(4) N4 
and G(13) 0 6  in an A-conformation octamer of 
d(GTGCGCAC) (Bingman et al 1992).
A spine of hydration has been observed in the minor 
groove o f B-DNA in the central AATT sequence of the 
dodecamer d(CGCGAATTCGCG) (Kopla et al 1983). 
The waters span 0(2) and N(3) atoms o f bases in adjacent 
base pairs. These water molecules form the first hydration 
layer, but are connected to waters in the second hydration 
layer so that each water in the first layer is tetrahedrally 
coordinated. The N(2) amino groups in G /C  interfere 
sterically with this regular structure; it is disrupted at both 
ends of the AATT sequence. In sequences other than A /T , 
the minor groove is wider and adjacent nucleotides are 
bridged by intra-chain waters between 0(4') and either 
purine-N(3) or pyrimidine-0(2). A further X-ray dif­
fraction study o f the same system (Tereshko et al 1999) 
resolved the water positions, showing four fused water 
hexagons dissecting the central portion o f the minor 
groove, with the inner corners o f the hexagons coinciding 
with the original spine water positions, and so it may be 
more appropriate to refer to this as a ribbon of hydration.
A spine of hydration is also observed in the minor 
groove o f Z-DNA (Chevrieret al 1986), in which the water 
molecules are primarily hydrogen bonded to the 0(2) atoms 
of the cytosine bases. These are cross-linked and there are 
additional water molecules bridging these waters with the 
phosphate oxygen atoms and with the guanine N(2) amino 
group.
In a room temperature X-ray diffraction study of 
a deoxynucleotide phosphate d(CpG)-proflavine 
complex.27H,0 (Niedle et al 1980), most water oxygens
were located, showing a hydrogen-bonding scheme in­
volving a system of four pentagonal rings. In a low- 
temperature study on the same complex (Schneider et a!
1992) at — 2°C and -130°C , similar structures were 
observed, but additional water molecules were located. 
Nine of the waters bonded only with other waters, and 
these allowed the formation of water pentagons in the 
structure, which formed new polyhedra, giving an infinite 
tetrahedrally coordinated three-dimensional water net­
work. This network was mainly constructed of pentagons, 
but also included 6- and 7-membered rings.
Other biological molecules
A vitamin B12 coenzyme (C72H l00CoN,8Ol7P) was analysed 
at 279 K in a combined X-ray and neutron diffraction 
experiment in which more than 140 water oxygens and 4 
acetones were located (Savage et al 1987). The hydrogen- 
bonding scheme was disordered and an unambiguous 
representation o f the water structure was impossible. A 
further study at 15 K, using a high-resolution (0.9 A) neu­
tron data set (Bouquiere et al 1994), showed two discrete 
water networks, each made up of 17 waters. One is a 
channel comprising statically disordered water molecules, 
and leading into this channel is a pocket region of highly 
ordered water molecules. This pocket region is mainly 
made up of five-membered rings in geometries concordant 
with clathrate structures. Although the channel region is 
disordered, the water molecules are arranged tetrahedrally 
in geometries similar to ices and clathrates.
Cyclodextrin hydrate
In the crystal structure of a-cyclodextrin hexahydrate, the 
hydrogen-bonding scheme has infinite chains extending 
throughout tfie crystal, and cyclic motifs are present, 
consisting of 4-, 5- and 6-membered hydrogen-bonded 
rings. Both the water molecules and the O—H groups of 
the cyclodextrin participate in these rings (Saenger 1979). 
This crystal structure has homodromic rings throughout, 
except where a water has to donate two hydrogen bonds to 
the same ring. This shows clearly that cooperative effects 
may be important in stabilising hydrogen-bonded rings. 
Rings in which the hydrogen bonds are randomly oriented 
(heterodromic) do not occur in any cyclodextrin hydrate 
structures.
Cryoprotective agents
Sugars, polyhydric alcohols and oligosaccharides are 
widely used as excipients in solid pharmaceutical 
preparations involving proteins and liposomes (Crowe et al 
1996a). They are used not only because of their com­
patibility with, for example, proteins, but also because they 
are reluctant to crystallise during the drying process 
(Aldous et al 1995) and so increase the stability o f the 
biomolecule.
Trehalose is found widely in plants and animals and 
performs a protective role, allowing survival during periods 
of total dehydration (Crowe et al 1996b). The exact mech­
anism by which trehalose exerts its protective effect is not 
fully known, but it is thought that the extensive hydrogen-
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bonding functionality allows it to replace water molecules 
in the biological membranes (Miller et al 1997). This 
increases resistance to air-drying, and also to freeze-drying, 
as the number of water molecules present will be reduced 
and their arrangements around the trehalose molecules will 
prevent the formation of an extensive ice lattice. Many 
cryoprotective solutions have been shown to produce a 
glass on cooling, and a stable, wholly amorphous, state on 
warming (Baudot et al 2000), and this is thought to relate 
to their cryoprotective function. A study of trehalose 
solutions by Raman spectroscopy and viscosity measure­
ments (Branca et al 1999) suggested that trehalose promotes 
a destructuring effect on the tetrahedral hydrogen-bond 
network of pure water, imposing on adjacent water 
molecules positions and orientations incompatible with the 
crystallization process.
The structural and functional features o f antifreeze pro­
teins enable them to protect living organisms by depressing 
freezing temperatures, modifying or suppressing ice-crystal 
growth, inhibiting ice recrystallization and protecting cell 
membranes from cold-induced damage (Fletcher et al 
1999). The proteins, which are found in northern cod and 
antarctic fish, are up to 500 times more effective at lowering 
the freezing temperature than any other known solute 
molecule because of unique aspects o f their tertiary 
structures, and act by specifically adsorbing to the surface 
o f ice crystals as they form, thereby preventing their growth 
(Fletcher et al 2001).
Implications for drug-receptor interactions
As has been demonstrated from both experiment and 
computer modelling, water is composed o f tetrahedral 
molecules which, when bonded to each other, tend to 
promote further bonding. The most stable resulting 
structures are rings and there is considerable evidence for 
the formation of higher-order assemblies which have pro­
nounced geometric shapes in repeating motifs.
In considering the role of water in drug-receptor inter­
actions, it is clear that a model that regards this solvent as 
a continuum is inadequate since water does more than 
simply separate the solute molecules. Formation of a 
hydrogen bond between a drag molecule and water will 
polarise the water, resulting in further hydrogen bonding 
to other water molecules. In many cases, geometry per­
mitting, this will lead to the formation of at least one ring, 
which is likely to persist longer than other structures. It is 
apparent that the drug will tend to be hydrogen bonded 
with a pattern of water molecules that may play a role in 
receptor identification. Even in the absence of hydrogen 
bonding, non-polar drug molecules will tend to cause water 
structuring -  formation of partial or total cages -  which 
again means that the molecule will have an identifiable 
water ‘signature’.
In the vast majority of cases, the drug will have a 
combination o f hydrogen-bonding and non-polar groups, 
which will tend to give it a unique secondary identity when 
surrounded by water: it is possible that the primary rec­
ognition process is through the water surrounding the drag
and the water surrounding the receptor. One consequence 
of this idea is that a drug substituent does not need to come 
into direct contact with the receptor to affect recognition; 
even when pointing outwards, towards the bulk solvent, a 
non-polar group which is too large may disrupt a water 
cage and change the recognition face. Similarly, a 
destructuring substituent wili have a dramatic effect on the 
surrounding water, as will a polar group which is hydrogen- 
bonding but not destracturing.
The simplest kind of ligand-'receptor’ interaction, 
which is almost entirely non-specific, is the denaturation 
of proteins and peptides by structure breakers such as urea 
and guanidinium. Denaturation is primarily a change of 3- 
dimensional geometry and does not require breaking of 
covalent bonds. The effect can sometimes be reversed by 
addition o f a structure maker, such as sulfate. Both these 
effects are most easily explained by an effect on the water 
surrounding the macromolecule, primarily in regions where 
there is water structuring, which may hold the shape by 
virtue of ‘hydrophobic bonding’ between non-polar parts 
of the molecule. The driving force for ‘ hydrophobic bond­
ing’ is normally assumed to be the gain in entropy when 
structured water is liberated between two hydrophobic 
regions. Addition of urea or guanidinium disrupts the 
water structure and removes the driving force for close 
association o f  hydrophobic residues.
It is normally accepted that the binding of a drug to its 
receptor is mediated by ion-ion interactions, hydrogen 
bonding, dipole-dipole interactions, lipophilicity and 
shape complementarity (the latter being an optimisation of 
the first four effects), although the relative contribution of 
each is poorly understood. It has been shown that the 
optimisation of hydrophobic interactions can produce tight 
binding, even at the exjSfense o f possible hydrogen bonds, 
and this plays a large part in the ‘induced fit’ of receptors 
to ligands, allowing molecules o f apparently different 
shapes to bind to the same part o f the same receptor 
(Williams et al 1993). By the same token, the drag molecule 
may also be coerced into a certain conformation by the re­
ceptor protein (Davis & Teague 1999). These concepts are 
probably sufficient to account for the biological effects of 
many antagonists of natural ligands, since tight binding is 
a prerequisite to passive receptor occupancy. However, 
where the ligand induces a conformational change in the 
receptor, sufficient to trigger a biological response, passive 
receptor occupancy is insufficient. In this case, it may be 
useful to analyse the interaction as a specialised example of 
denaturation.
An agonist is recognised by the receptor and provokes a 
conformational change in the macromolecule. The change 
in conformation and possibly the recognition are likely to 
be mediated through the water which surrounds both 
partners. Receptor agonists such as adrenaline (epineph­
rine; Figure 9A) and 5-hydroxytryptamine (Figure 9B) 
have identifiable recognition sites around the amino group 
and structure-breaking moieties on the benzene ring. It is 
not difficult to perceive an interaction that depends on the 
structure-breaking effects o f the catechol or phenol moiety 
to induce a change in receptor geometry. In comparison, 
analogues o f the neurotransmitters that have no phenolic
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Figure 9 The structure of adrenaline (epinephrine; R =  CH3) and 
noradrenaline (norepinephrine; R = H) (A) and 5-
hydroxytryptamine (B).
or similar structure-breaking groups will potentially be 
unable to induce the required conformational change and 
will, at best, be antagonists. It should be noted that this 
concept does not require the structure-breaking moiety to 
fit the receptor, merely to be brought into fairly close 
proximity, and that the effect is essentially directed out­
wards, towards the solvent sheath. If this idea is correct, it 
will be necessary, in designing a bioactive molecule, to take
note of the parts o f the molecule which are not in direct 
contact with the receptor and to explore the effect of 
structural changes in those regions; these changes may not 
only affect biodistribution and metabolism.
There are likely to be at least four ways in which water 
may influence the structure o f a biological macromolecule 
(Figure 10). The first is simple bridging between two 
hydrogen-bonding substituents; there are several examples 
where this is known to occur and such effects are normal. 
The second is known as hydrophobic bonding, where two 
or more non-polar regions come together, releasing the 
water that is structured around both. The third involves a 
polar residue that is geometrically incompatible with struc­
tured water, in which case the effect may be transmitted by 
water molecules to neighbouring groups, disrupting hydro- 
phobic bonding. The fourth, which does not appear to 
have been discussed elsewhere, would involve the con­
nection of two domains o f structured water, where these 
are geometrically compatible. This could occur over a 
relatively long range, by analogy, with the water at inter­
faces. Such interactions could occur in the water between 
non-polar groups, or could be promoted by, for example, 
phosphate residues; introduction of these by ‘kinases’ 
has a profound effect on the structure and function o f 
proteins.
A vast amount o f effort has been devoted to elucidation 
o f the interactions of water with various solutes. The weight 
of evidence points strongly to the preference for water 
molecules to bond together in structures, allowing the 
O—0  bond distance and the O— H—O bond angle to be 
maintained close to their optimum values. Water ‘bucky




Figure 10 Types of water interaction possibly important in biological processes. A. Water bridging two hydrogen-bonding sites; note that 
the water is more likely to bridge between a hydrogen-bond donor and an acceptor. B. Hydrophobic effects hold the two substituents together. 
C. Structure-breaking substituent disrupts the hydrophobic interaction. D. Structured water between two groups holds them together.
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balls’, for example, are found very frequently in gas pipe­
lines and inside mass spectrometers. However, water is not 
a continuum: there are regions o f structuring and 
destructuring, dictated largely by the geometry of the 
system, particularly the relative disposition of functional 
groups on solutes. If these ideas are to be pursued, mod­
elling of ligand-receptor interactions will have to include 
specific geometric considerations related to the associated 
water structure. This does not mean that the water around 
drug molecules has to be ‘frozen’, merely that certain 
structures may be favoured in a rapidly changing dynamic 
system, in the same way that certain conformations o f the 
drug molecule may be favoured.
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